<SEC-DOCUMENT>0001829126-23-004526.txt : 20230630
<SEC-HEADER>0001829126-23-004526.hdr.sgml : 20230630
<ACCEPTANCE-DATETIME>20230630170118
ACCESSION NUMBER:		0001829126-23-004526
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		111
FILED AS OF DATE:		20230630
DATE AS OF CHANGE:		20230630

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CXApp Inc.
		CENTRAL INDEX KEY:			0001820875
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				852104918
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-271340
		FILM NUMBER:		231062555

	BUSINESS ADDRESS:	
		STREET 1:		FOUR PALO ALTO SQUARE, SUITE 200
		STREET 2:		3000 EL CAMINO REAL
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94306
		BUSINESS PHONE:		(650) 575-4456

	MAIL ADDRESS:	
		STREET 1:		FOUR PALO ALTO SQUARE, SUITE 200
		STREET 2:		3000 EL CAMINO REAL
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94306

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KINS Technology Group, Inc.
		DATE OF NAME CHANGE:	20200812
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>cxapp_s1a3.htm
<DESCRIPTION>S-1/A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:cxai="http://kins-tech.com/20230331">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_cxai_kins%2Dtech.com_20230331 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20230101_20230331 -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0001820875 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DDocumentFiscalYearFocus_2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_064_Integer_5_Integer -->
<body>
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityCentralIndexKey">0001820875</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:AmendmentFlag">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" id="xdx2ixbrl0014" name="dei:DocumentType">S-1/A</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl0074" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:PromissoryNoteRelatedParty" contextRef="AsOf2021-12-31" id="xdx2ixbrl0077" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:DeferredOfferingCostsNoncurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl0085" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-12-31" id="xdx2ixbrl0108" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2021-12-31" id="xdx2ixbrl0109" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31" id="xdx2ixbrl0146" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2021-12-31" id="xdx2ixbrl0147" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:GainLossOnEliminationOfDeferredUnderwritingFee" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0177" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0186" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_custom_ClassACommonStockMember" id="xdx2ixbrl0203" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0205" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_custom_ClassACommonStockMember" id="xdx2ixbrl0209" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_custom_ClassACommonStockMember" id="xdx2ixbrl0213" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_custom_ClassBCommonStockMember" id="xdx2ixbrl0214" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0215" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_ClassACommonStockMember" id="xdx2ixbrl0219" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0221" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_ClassACommonStockMember" id="xdx2ixbrl0225" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="From2022-01-012022-12-31_custom_ClassACommonStockMember" id="xdx2ixbrl0229" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="From2022-01-012022-12-31_custom_ClassBCommonStockMember" id="xdx2ixbrl0230" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0231" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_ClassACommonStockMember" id="xdx2ixbrl0235" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_ClassBCommonStockMember" id="xdx2ixbrl0236" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0237" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ClassACommonStockMember" id="xdx2ixbrl0241" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0243" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_ClassACommonStockMember" id="xdx2ixbrl0247" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:IncreaseDecreaseInDeferredUnderwritingFee" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0267" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0276" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0288" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:ProceedsFromTrustAccountInConnectionWithRedemption" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0291" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0294" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0300" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0303" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0305" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:ChangeInValueOfClassCommonStockSubjectToPossibleRedemption" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0324" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0327" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:DeferredUnderwritingFeePayable" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0329" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0420" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember" id="xdx2ixbrl0432" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0460" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember" id="xdx2ixbrl0472" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0503" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember" id="xdx2ixbrl0515" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember" id="xdx2ixbrl0543" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember" id="xdx2ixbrl0555" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember" id="xdx2ixbrl0567" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember" id="xdx2ixbrl0585" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember" id="xdx2ixbrl0594" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember" id="xdx2ixbrl0612" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl0628" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl0644" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl0660" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0696" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2022-12-31" id="xdx2ixbrl1069" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2022-12-31" id="xdx2ixbrl1078" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2021-12-31" id="xdx2ixbrl1079" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl1087" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1095" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl1096" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1098" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl1099" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" id="xdx2ixbrl1105" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl1158" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" contextRef="From2021-01-012021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl1187" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" contextRef="From2021-01-012021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl1195" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl1199" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl1201" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl1203" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareNet" contextRef="AsOf2023-03-31_custom_SuccessorMember" id="xdx2ixbrl1241" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:AcquisitionLiability" contextRef="AsOf2023-03-31_custom_SuccessorMember" id="xdx2ixbrl1268" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ExtendedProductWarrantyAccrualCurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" id="xdx2ixbrl1272" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" id="xdx2ixbrl1283" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2022-12-31_custom_PredecessorMember" id="xdx2ixbrl1287" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassAMember" id="xdx2ixbrl1303" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassCMember" id="xdx2ixbrl1310" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31_custom_PredecessorMember" id="xdx2ixbrl1313" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31_custom_PredecessorMember" id="xdx2ixbrl1316" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2023-03-31_custom_SuccessorMember" id="xdx2ixbrl1318" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:NetParentInvestment" contextRef="AsOf2023-03-31_custom_SuccessorMember" id="xdx2ixbrl1321" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:ChangeInFairValueOfEarnout" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" id="xdx2ixbrl1362" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:ChangeInFairValueOfEarnout" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1363" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1383" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" id="xdx2ixbrl1384" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" id="xdx2ixbrl1402" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember" id="xdx2ixbrl1431" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember" id="xdx2ixbrl1435" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:ParentsCommonSharesIssuedForCxappEarnout" contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember" id="xdx2ixbrl1439" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits" contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember" id="xdx2ixbrl1443" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:NetInvestmentsFromParent" contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember" id="xdx2ixbrl1447" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:CumulativeTranslationAdjustment" contextRef="From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember" id="xdx2ixbrl1450" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember" id="xdx2ixbrl1463" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember" id="xdx2ixbrl1467" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:NetInvestmentsFromParent" contextRef="From2023-01-012023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember" id="xdx2ixbrl1471" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:CumulativeTranslationAdjustment" contextRef="From2023-01-012023-03-14_custom_NetParentInvestmentMember_custom_PredecessorMember" id="xdx2ixbrl1474" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-14_custom_ClassCCommonStockMember_custom_SuccessorMember" id="xdx2ixbrl1483" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember" id="xdx2ixbrl1486" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-14_custom_ClassCCommonStockMember_custom_SuccessorMember" id="xdx2ixbrl1489" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:SharesIssuedInConnectionWithBusinessCombination" contextRef="From2023-03-152023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember" id="xdx2ixbrl1491" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:SharesIssuedInConnectionWithBusinessCombination" contextRef="From2023-03-152023-03-31_us-gaap_RetainedEarningsMember_custom_SuccessorMember" id="xdx2ixbrl1494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:SharesIssuedInConnectionWithBusinessCombination" contextRef="From2023-03-152023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember" id="xdx2ixbrl1495" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember" id="xdx2ixbrl1501" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember" id="xdx2ixbrl1502" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember" id="xdx2ixbrl1503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember" id="xdx2ixbrl1505" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-152023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember" id="xdx2ixbrl1508" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-152023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember" id="xdx2ixbrl1509" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-152023-03-31_us-gaap_RetainedEarningsMember_custom_SuccessorMember" id="xdx2ixbrl1511" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-152023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember" id="xdx2ixbrl1512" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember" id="xdx2ixbrl1519" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1550" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:GainOnEarnoutPaymentLiability" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" id="xdx2ixbrl1557" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:GainOnEarnoutPaymentLiability" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1558" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:GainOnChangeInFairValueOfDerivativeLiability" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1566" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:GainOnChangeInFairValueOfDerivativeLiability" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" id="xdx2ixbrl1567" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1582" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInIncomeTaxes" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" id="xdx2ixbrl1593" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInIncomeTaxes" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1594" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:InvestmentInCapitalizedSoftware" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" id="xdx2ixbrl1617" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1622" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" id="xdx2ixbrl1623" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:NetEquityInvestmentFromParent" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" id="xdx2ixbrl1633" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:TaxesPaidRelatedForStockBasedCompensation" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" id="xdx2ixbrl1637" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:TaxesPaidRelatedForStockBasedCompensation" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1638" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:RepaymentOfCxappAcquisitionLiability" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" id="xdx2ixbrl1641" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1646" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" id="xdx2ixbrl1647" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" id="xdx2ixbrl1653" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" id="xdx2ixbrl1673" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1674" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" id="xdx2ixbrl1675" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" id="xdx2ixbrl1677" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1678" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" id="xdx2ixbrl1679" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:ParentsNetEquityIssuedForCxAppEarnout" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" id="xdx2ixbrl1685" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:ParentsNetEquityIssuedForCxAppEarnout" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1686" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:NoncashDistribution" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" id="xdx2ixbrl1689" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:NoncashDistribution" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" id="xdx2ixbrl1691" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1694" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" id="xdx2ixbrl1695" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:FinancingOfDirectorAndOfficerInsurance" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" id="xdx2ixbrl1698" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:FinancingOfDirectorAndOfficerInsurance" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" id="xdx2ixbrl1699" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2023-03-31_custom_SuccessorMember" id="xdx2ixbrl1980" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" contextRef="AsOf2023-03-31_custom_SuccessorMember" id="xdx2ixbrl1983" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareNet" contextRef="AsOf2023-03-31_custom_SuccessorMember" id="xdx2ixbrl1986" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-03-14_custom_SuccessorMember" id="xdx2ixbrl2005" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_NoncompeteAgreementsMember" id="xdx2ixbrl2045" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_NoncompeteAgreementsMember" id="xdx2ixbrl2046" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_NoncompeteAgreementsMember" id="xdx2ixbrl2048" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_PatentsAndIntellectualPropertyMember" id="xdx2ixbrl2060" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_PatentsAndIntellectualPropertyMember" id="xdx2ixbrl2061" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_PatentsAndIntellectualPropertyMember" id="xdx2ixbrl2063" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:InsurancePremiumsAndAccruedInterest" contextRef="AsOf2022-12-31_custom_PredecessorMember" id="xdx2ixbrl2117" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:RelatedPartyPromissoryNote" contextRef="AsOf2022-12-31_custom_PredecessorMember" id="xdx2ixbrl2120" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccruedIncomeTaxes" contextRef="AsOf2022-12-31_custom_PredecessorMember" id="xdx2ixbrl2123" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:RelatedPartyPayable" contextRef="AsOf2022-12-31_custom_PredecessorMember" id="xdx2ixbrl2126" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_IN" id="xdx2ixbrl2267" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_IN" id="xdx2ixbrl2279" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EliminationsMember" id="xdx2ixbrl2283" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_IN" id="xdx2ixbrl2291" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_IN" id="xdx2ixbrl2303" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_IN" id="xdx2ixbrl2315" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_EliminationsMember" id="xdx2ixbrl2319" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_IN" id="xdx2ixbrl2327" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_EliminationsMember" id="xdx2ixbrl2331" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_PH" id="xdx2ixbrl2341" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_PH" id="xdx2ixbrl2353" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_PH" id="xdx2ixbrl2365" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="cxai:NetAssets" contextRef="AsOf2023-03-31_custom_SuccessorMember_country_IN" id="xdx2ixbrl2375" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2023-03-31_custom_SuccessorMember_country_IN" id="xdx2ixbrl2387" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_EliminationsMember" id="xdx2ixbrl2391" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember_country_CA" id="xdx2ixbrl2397" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember_country_IN" id="xdx2ixbrl2399" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember_country_PH" id="xdx2ixbrl2401" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_EliminationsMember" id="xdx2ixbrl2403" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_EliminationsMember" id="xdx2ixbrl2427" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember_country_US" id="xdx2ixbrl2431" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember_country_CA" id="xdx2ixbrl2433" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember_country_IN" id="xdx2ixbrl2435" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember_country_PH" id="xdx2ixbrl2437" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_EliminationsMember" id="xdx2ixbrl2439" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cxai-20230331.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-01-01to2023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CommonClassaSubjectToRedemptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cxai:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CommonClassaSubjectToRedemptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cxai:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ClassACommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ClassBCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassBCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-17_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-17_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-17_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-17_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-09_custom_CommonClassaSubjectToRedemptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cxai:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cxai:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-09-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_CommonStockSubjectToRedemptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cxai:CommonStockSubjectToRedemptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CommonStockSubjectToRedemptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cxai:CommonStockSubjectToRedemptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_SuccessorMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_SuccessorMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-17_us-gaap_CommonClassAMember_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_CommonClassAMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-07-27_custom_FounderSharesMember_custom_SponsorMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-07-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-10-012020-10-31_custom_FounderSharesMember_custom_DirectAnchorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:DirectAnchorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-10-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_FounderSharesMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-10-012020-10-31_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-10-01</xbrli:startDate>
        <xbrli:endDate>2020-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_FounderSharesMember_custom_SponsorMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_FounderSharesMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_FounderSharesMember_custom_DirectAnchorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:DirectAnchorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-31_custom_FounderSharesMember_custom_SponsorMember_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_FounderSharesMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_FounderSharesMember_custom_SponsorMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-14_custom_AdministrativeServicesAgreementMember_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:AdministrativeServicesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-08-10_custom_PromissoryNoteWithRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:PromissoryNoteWithRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-08-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PromissoryNoteWithRelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:PromissoryNoteWithRelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_WorkingCapitalLoansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:WorkingCapitalLoansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_WorkingCapitalLoansWarrantMember_custom_WorkingCapitalLoansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:WorkingCapitalLoansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_WorkingCapitalLoansWarrantMember_custom_WorkingCapitalLoansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:WorkingCapitalLoansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-06-012022-06-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-06-01</xbrli:startDate>
        <xbrli:endDate>2022-06-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_custom_CXAppCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:CXAppCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_custom_InpixonMember_custom_SeparationAgreementMember_custom_CxappHoldingCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cxai:InpixonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:SeparationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cxai:CxappHoldingCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-012022-09-25_custom_MergerAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-01</xbrli:startDate>
        <xbrli:endDate>2022-09-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_custom_MergerAgreementMember_custom_CxappHoldingCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cxai:CxappHoldingCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-012022-09-25_us-gaap_CommonClassAMember_custom_MergerAgreementMember_custom_CxappHoldingCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cxai:CxappHoldingCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-01</xbrli:startDate>
        <xbrli:endDate>2022-09-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-012022-09-25_us-gaap_CommonClassCMember_custom_MergerAgreementMember_custom_CxappHoldingCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cxai:CxappHoldingCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-01</xbrli:startDate>
        <xbrli:endDate>2022-09-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-25_custom_MergerAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-012022-09-25_custom_MergerAgreementMember_custom_CxappHoldingCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cxai:CxappHoldingCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-01</xbrli:startDate>
        <xbrli:endDate>2022-09-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-14_custom_MergerAgreementMember_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-14_custom_MergerAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-14_custom_MergerAgreementMember_custom_CxappHoldingCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cxai:CxappHoldingCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-14_us-gaap_CommonClassBMember_custom_SponsorSupportAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:SponsorSupportAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-14_us-gaap_CommonClassAMember_custom_SponsorSupportAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:SponsorSupportAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CashMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CashMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_MoneyMarketFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MoneyMarketFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_NetParentInvestmentMember_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:NetParentInvestmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PredecessorMember_custom_TotalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_NetParentInvestmentMember_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:NetParentInvestmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_custom_TotalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_custom_ClassACommonStockMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_custom_ClassCCommonStockMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassCCommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_us-gaap_RetainedEarningsMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_custom_TotalMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:NetParentInvestmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PredecessorMember_custom_TotalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_NetParentInvestmentMember_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:NetParentInvestmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_TotalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassCCommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_us-gaap_RetainedEarningsMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_TotalMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:NetParentInvestmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_PredecessorMember_custom_TotalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_custom_NetParentInvestmentMember_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:NetParentInvestmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_custom_PredecessorMember_custom_TotalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassCCommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_TotalMember_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_custom_SuccessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_custom_PredecessorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_StockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:StockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_custom_PredecessorMember_custom_MergerAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_MergerAgreementMember_us-gaap_CommonClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_MergerAgreementMember_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_custom_PredecessorMember_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-14_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_SubscriptionRevenueMember_custom_SoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:SubscriptionRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cxai:SoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_SubscriptionRevenueMember_custom_SoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:SubscriptionRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cxai:SoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PredecessorMember_custom_SubscriptionRevenueMember_custom_SoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:SubscriptionRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cxai:SoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PredecessorMember_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_NonSubscriptionRevenueMember_custom_ProfessionalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:NonSubscriptionRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cxai:ProfessionalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_NonSubscriptionRevenueMember_custom_ProfessionalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:NonSubscriptionRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cxai:ProfessionalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PredecessorMember_custom_NonSubscriptionRevenueMember_custom_ProfessionalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:NonSubscriptionRevenueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cxai:ProfessionalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_NonSubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:NonSubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_NonSubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:NonSubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PredecessorMember_custom_NonSubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:NonSubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_us-gaap_TransferredOverTimeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_TransferredOverTimeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PredecessorMember_us-gaap_TransferredOverTimeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_OfficeEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_custom_SoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cxai:SoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_custom_SoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cxai:SoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_TrademarksAndTradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_TrademarksAndTradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_DevelopedTechnologyRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_DevelopedTechnologyRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_PatentsAndIntellectualPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cxai:PatentsAndIntellectualPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_custom_PatentsAndIntellectualPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cxai:PatentsAndIntellectualPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_custom_PatentsAndIntellectualPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cxai:PatentsAndIntellectualPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_LicensingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_LicensingAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_custom_ProfessionalServiceAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cxai:ProfessionalServiceAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_custom_ProfessionalServiceAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cxai:ProfessionalServiceAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_DirectorAndOfficersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cxai:DirectorAndOfficersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-10_custom_N2023EquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cxai:N2023EquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cxai:EmployeeStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cxai:EmployeesAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cxai:EmployeeStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cxai:EmployeesAndDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cxai:EmployeeStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cxai:EmployeesAndDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cxai:EmployeeStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_PublicPlacementWarrantsMember_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicPlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_country_IN">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_country_PH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cxai:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-15</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_country_IN">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_country_PH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cxai:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PredecessorMember_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PredecessorMember_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PredecessorMember_country_IN">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PredecessorMember_country_PH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PredecessorMember_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cxai:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_country_IN">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_country_PH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SuccessorMember_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cxai:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_country_IN">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_country_PH">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PH</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PredecessorMember_custom_EliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001820875</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cxai:EliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>cxai:Integer</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact001924" toRefs="Footnote001935 Footnote001936"></ix:relationship>
  <ix:relationship fromRefs="Fact001926" toRefs="Footnote001935 Footnote001936"></ix:relationship>
  <ix:relationship fromRefs="Fact001928" toRefs="Footnote001935 Footnote001936"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"><b>As
filed with the Securities and Exchange Commission on June 30, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
No. 333-271340</b></span></p>





<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_909_edei--AmendmentDescription_c20230101__20230331_zqrTqUMrtDNk"><b><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:AmendmentDescription">AMENDMENT
NO. 3</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span><b>TO</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>FORM
<span id="xdx_901_edei--DocumentType_dxL_c20230101__20230331_zjEdr3N29Ay" title="::XDX::S-1%2FA"><span style="-sec-ix-hidden: xdx2ixbrl0014">S-1</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGISTRATION
STATEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNDER
THE SECURITIES ACT OF 1933</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>



<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b><span id="xdx_905_edei--EntityRegistrantName_c20230101__20230331_zADqlVi2lCL9"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityRegistrantName">CXApp Inc.</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
    name of registrant as specified in its charter)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20230101__20230331_zd7oBmqP59ki"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7370</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20230101__20230331_zJo6mRpfFGIh" title="Entity Tax Identification Number"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityTaxIdentificationNumber">85-2104918</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
or jurisdiction of</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
or organization)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary
    Standard Industrial<br/>
    Classification Code Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
No.)</span></p></td></tr>
  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_909_edei--EntityAddressAddressLine1_c20230101__20230331_zVRlbhiSjBWi"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityAddressAddressLine1">Four Palo Alto Square</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressAddressLine2_c20230101__20230331_zqCaE37DvYs3"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityAddressAddressLine2">Suite 200</ix:nonNumeric></span>,</span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressAddressLine3_c20230101__20230331_zKX6Dq01m7jc"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityAddressAddressLine3">3000 El Camino Real</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityAddressCityOrTown_c20230101__20230331_zPOhjal1PZua"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityAddressCityOrTown">Palo Alto</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20230101__20230331_zoFgJScS4Ljg"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20230101__20230331_z4glDtNTzFWi"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityAddressPostalZipCode">94306</ix:nonNumeric></span><br/>
<span id="xdx_90A_edei--CityAreaCode_c20230101__20230331_zMXURG5VTzfj" title="City Area Code"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:CityAreaCode">(650)</ix:nonNumeric></span> <span id="xdx_909_edei--LocalPhoneNumber_c20230101__20230331_zlXAQa9Ojl3i" title="City Area Code"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:LocalPhoneNumber">575-4456</ix:nonNumeric></span></b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address and telephone number
    of registrant&#8217;s principal executive offices and principal place of business)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--ContactPersonnelName_c20230101__20230331__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zURZ3YaxEpL8"><ix:nonNumeric contextRef="From2023-01-012023-03-31_dei_BusinessContactMember" name="dei:ContactPersonnelName">Khurram
P. Sheikh</ix:nonNumeric></span><br/>
Chairman, Chief Executive Officer<br/>
CXApp Inc.<br/>
<span id="xdx_901_edei--EntityAddressAddressLine1_c20230101__20230331__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zwwLj7LH4ry7"><ix:nonNumeric contextRef="From2023-01-012023-03-31_dei_BusinessContactMember" name="dei:EntityAddressAddressLine1">Four Palo Alto Square</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine2_c20230101__20230331__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zrXk28V7wpog"><ix:nonNumeric contextRef="From2023-01-012023-03-31_dei_BusinessContactMember" name="dei:EntityAddressAddressLine2">Suite 200</ix:nonNumeric></span>,</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityAddressAddressLine3_c20230101__20230331__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zHV7H6nacXPl"><ix:nonNumeric contextRef="From2023-01-012023-03-31_dei_BusinessContactMember" name="dei:EntityAddressAddressLine3">3000
El Camino Real</ix:nonNumeric></span><br/>
<span id="xdx_900_edei--EntityAddressCityOrTown_c20230101__20230331__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zTfJA2FOr9x7"><ix:nonNumeric contextRef="From2023-01-012023-03-31_dei_BusinessContactMember" name="dei:EntityAddressCityOrTown">Palo Alto</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20230101__20230331__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zta3AedZjNl4"><ix:nonNumeric contextRef="From2023-01-012023-03-31_dei_BusinessContactMember" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_907_edei--EntityAddressPostalZipCode_c20230101__20230331__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z6lTy6r1gPjl"><ix:nonNumeric contextRef="From2023-01-012023-03-31_dei_BusinessContactMember" name="dei:EntityAddressPostalZipCode">94306</ix:nonNumeric></span><br/>
(<span id="xdx_903_edei--CityAreaCode_c20230101__20230331__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zrlxc2GdLT8f"><ix:nonNumeric contextRef="From2023-01-012023-03-31_dei_BusinessContactMember" name="dei:CityAreaCode">650</ix:nonNumeric></span>) <span id="xdx_90D_edei--LocalPhoneNumber_c20230101__20230331__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zWDoLx4ANQNc"><ix:nonNumeric contextRef="From2023-01-012023-03-31_dei_BusinessContactMember" name="dei:LocalPhoneNumber">575-4456</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Copy to:
    </i></b><br/>
    <b>Michael J. Mies, Esq. <br/>
    Skadden, Arps, Slate, Meagher &amp; Flom LLP<br/>
    525 University Ave, Suite 1400<br/>
    Palo Alto, CA 94301<br/>
    (650) 470-4500</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
address and telephone number of agent for service)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate
date of commencement of proposed sale to the public:</b> As soon as practicable following the effective date of this Registration Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under
the Securities Act of 1933, check the following box: &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, please check
the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule&#160;462(d) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. (Check one)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 21%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 25%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 18%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--EntityFilerCategory_c20230101__20230331_zKYcVL5XrPD2"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntitySmallBusiness_c20230101__20230331_zQFOxPL2mkx"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20230101__20230331_zzOxYiABNm0c"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of Securities Act. <span id="xdx_90D_edei--EntityExTransitionPeriod_c20230101__20230331_zDx8wIdcV0gj"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective
in accordance with Section&#160;8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such
date as the Commission, acting pursuant to said Section&#160;8(a), may determine</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>



<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>



<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROSPECTUS
FOR</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6,977,776
SHARES OF COMMON STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10,280,000
WARRANTS TO PURCHASE SHARES OF COMMON STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>24,080,000
SHARES OF COMMON STOCK UNDERLYING WARRANTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OF</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CXAPP
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This
prospectus relates to (i) the resale of up to 6,977,776 shares of common stock, par value $0.0001 per share (the &#8220;common stock&#8221;)
previously issued to certain of the selling securityholders named in this prospectus (each a &#8220;Selling Securityholder&#8221; and,
collectively, the &#8220;Selling Securityholders&#8221;) at a price of approximately $0.004 per share, (ii) the resale of up to 10,280,000
private placement warrants to purchase common stock at an exercise price of $11.50 per share, which were originally issued to our Sponsor
(as defined below) and the Direct Anchor Investors (as defined below) in a private placement at a price of $1.00 per private placement
warrant, (iii) 24,080,000 shares of common stock reserved for issuance upon the exercise of warrants to purchase common stock, which
are comprised of 13,800,000 shares of common stock issuable upon exercise of the public warrants and 10,280,000 shares of common stock
issuable upon exercise of the private placement warrants, and (iv) the resale of up to 10,280,000 shares of common stock issuable upon
exercise of the private warrants held by KINS Capital LLC (&#8220;Sponsor&#8221;), its affiliates and certain funds and accounts managed
by BlackRock, Inc. (the &#8220;Direct Anchor Investors&#8221;). The public warrants were initially included in the units issued in connection
with the initial public offering of KINS (as defined below), which comprised one share of Class A common stock and one-half of a redeemable
warrant.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March&#160;14, 2023, we consummated the transactions contemplated by that certain Agreement and Plan of Merger, dated as of September&#160;25,
2022 (the &#8220;Merger Agreement&#8221;), by and among KINS Technology Group Inc., a Delaware corporation (&#8220;KINS&#8221;), KINS
Merger Sub Inc., a Delaware corporation and a direct wholly-owned subsidiary of KINS (&#8220;Merger Sub&#8221;), CXApp Holding Corp.,
a Delaware corporation (&#8220;Legacy CXApp&#8221;) and Inpixon, a Nevada corporation and parent company of Legacy CXApp (&#8220;Inpixon&#8221;).
As contemplated by the Merger Agreement, Merger Sub merged with and into Legacy CXApp, the separate corporate existence of Merger Sub
ceased and Legacy CXApp survived as a wholly-owned subsidiary of KINS (the &#8220;Merger&#8221; and, together with the other transactions
contemplated by the Merger Agreement, the &#8220;Business Combination&#8221;). Following the closing of the Merger, KINS changed its
name to CXApp Inc. (&#8220;CXApp&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span>We
are registering the resale of shares of common stock and warrants as required by (i) the registration rights agreement, dated as of December&#160;14,
2020 (the &#8220;Registration Rights Agreement&#8221;), entered into by and among KINS, Sponsor and certain funds and accounts managed
by BlackRock, Inc. (the &#8220;Direct Anchor Investors&#8221;) and (ii) the subscription agreements entered into by and among KINS, Sponsor
and Direct Anchor Investors relating to the purchase of shares of common stock in private placements consummated in connection with the
Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>We
are also registering the resale of 100,000 shares of common stock held in private placements by BTIG, LLC (&#8220;BTIG&#8221;). BTIG
entered into a letter agreement with KINS on March 14, 2023, to provide strategic and capital markets advisory services to KINS (and
following the Business Combination, CXApp) (the &#8220;Advisory Agreement&#8221;). The services to be provided by BTIG pursuant to the
Advisory Agreement include providing market and trading color and feedback, capital markets analysis and strategic advice, institutional
shareholder targeting, introduction and feedback and such other advisory services as the parties may from time to time agree upon. The
services are to be provided by BTIG over the one-year term of the Advisory Agreement. BTIG agreed to accept 100,000 shares of KINS&#8217;
stock as the fee for its services pursuant to the Advisory Agreement. The approximate cash equivalent of BTIG&#8217;s fee, and thus the
approximate value of BTIG&#8217;s services pursuant to the Advisory Agreement, may be implied by reference to the market price of KINS&#8217;
stock at the time the Advisory Agreement was entered into. The closing price of KINS&#8217; stock on Nasdaq on the day the Advisory Agreement
was entered into was $9.94. Therefore, the implied value of BTIG&#8217;s services pursuant to the Advisory Agreement is approximately
$994,000. The Advisory Agreement was entered into on the date of the consummation of the Business Combination and on the following day,
the first day of trading after the Business Combination, the closing price of the Company&#8217;s Common Stock was $4.10.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span>Due
to the significant number of redemptions of our Class A common stock in connection with our Business Combination, the shares of common
stock being registered for issuance or resale are anticipated to constitute a considerable percentage of our public float. Additionally, all
the shares of common stock being registered for resale were purchased by the Selling Securityholders for prices considerably below the
current market price of our Class A common stock. This discrepancy in purchase prices may have an impact on the market perception of
the stock&#8217;s value and could contribute to potential downward pressure on the public trading price of our Class A common stock.
The registration of these shares for issuance or resale creates the possibility of a significant increase in the supply of our Class
A common stock in the market. The increased supply, coupled with the potential disparity in purchase prices, may lead to heightened selling
pressure, which could negatively affect the public trading price of our Class A common stock. We will not receive the proceeds from the
resale of the shares of common stock by the Selling Securityholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span>The
exercise price of the warrants, in certain circumstances, may be higher than the prevailing market price of the underlying securities.
The exercise price of the warrants is subject to market conditions and may not be advantageous if the prevailing market price of the
underlying securities is lower than the exercise price. The cash proceeds associated with the exercise of warrants to purchase our common
stock are contingent upon our stock price. The value of our common stock may fluctuate and may not align with the exercise price of the
warrants at any given time. If the warrants are &#8220;out of the money,&#8221; meaning the exercise price is higher than the market
price of our common stock, there is a high likelihood that warrant holders may choose not to exercise their warrants. As a result, we
may not receive any proceeds from the exercise of such warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span>Furthermore,
with regard to the Private Placement Warrants, it is possible that we may not receive cash upon their exercise since these warrants may
be exercised on a cashless basis. A cashless exercise allows warrant holders to convert the warrants into shares of our common stock
without the need for a cash payment. Instead of receiving cash upon exercise, the warrant holder would receive a reduced number of shares
based on a predetermined formula or method as further described in &#8220;<i>Description of Capital Stock</i>&#8221; further below. As
a result, the number of shares received through a cashless exercise may be lower than if the warrants were exercised on a cash basis,
which could impact the value and dilution of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will bear all costs, expenses and fees in connection with the registration of the shares of common stock and warrants. The Selling Securityholders
will bear all commissions and discounts, if any, attributable to their respective sales of the shares of common stock and warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Trading
of our common stock and warrants began on The Nasdaq Capital Market (the &#8220;Nasdaq&#8221;) on March&#160;15, 2023, under the new
ticker symbol &#8220;CXAI&#8221; for the common stock and &#8220;CXAIW&#8221; for the warrants. Prior to the Merger, KINS&#8217; units,
Class A common stock and public warrants are publicly traded on the Nasdaq under the symbols &#8220;KINZU&#8221;, &#8220;KINZ&#8221;
and &#8220;KINZW&#8221;, respectively. On June 29, 2023, the closing sale price of our common stock as reported by Nasdaq was $10.45
per share and the closing price of our warrants was $0.49 per warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing
in shares of our common stock or warrants involves risks that are described in the &#8220;Risk Factors&#8221; section beginning on page
13 of this prospectus.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the securities to be issued
under this prospectus or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>



<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 90%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_001">ABOUT THIS PROSPECTUS</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_002">TRADEMARKS, TRADE NAMES AND SERVICE MARKS</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003">MARKET AND INDUSTRY DATA</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004">SELECTED DEFINITIONS</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_006">PROSPECTUS SUMMARY</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_007">THE OFFERING</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_008">RISK FACTORS</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_009">USE OF PROCEEDS</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_010">DETERMINATION OF OFFERING PRICE</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_011">DIVIDEND POLICY</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_012">MARKET INFORMATION</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_013">UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_014">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_015">BUSINESS</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_016">MANAGEMENT</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_017">EXECUTIVE AND DIRECTOR COMPENSATION</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_018">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_019">PRINCIPAL STOCKHOLDERS</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_020">SELLING SECURITYHOLDERS</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_021">DESCRIPTION OF CAPITAL STOCK</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_022">SECURITIES ACT RESTRICTIONS ON RESALE OF COMMON STOCK</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_023">PLAN OF DISTRIBUTION (CONFLICT OF INTEREST)</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_024">LEGAL MATTERS</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_025">EXPERTS</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_026">WHERE YOU CAN FIND MORE INFORMATION</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_027">INDEX TO FINANCIAL STATEMENTS</a></span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 3; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_001"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ABOUT
THIS PROSPECTUS</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">You
should rely only on the information contained in this prospectus or in any applicable prospectus supplement prepared by us or on our
behalf. Neither we nor the Selling Securityholders have authorized anyone to provide any information or to make any representations other
than those contained in this prospectus, any accompanying prospectus supplement or any free writing prospectus we have prepared. We and
the Selling Securityholders take no responsibility for, and can provide no assurance as to the reliability of, any other information
that others may give you. This prospectus is an offer to sell only the securities offered hereby and only under circumstances and in
jurisdictions where it is lawful to do so. No dealer, salesperson or other person is authorized to give any information or to represent
anything not contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus. This prospectus
is not an offer to sell securities, and it is not soliciting an offer to buy securities, in any jurisdiction where the offer or sale
is not permitted. You should assume that the information appearing in this prospectus or any prospectus supplement is accurate only as
of the date on the front of those documents only, regardless of the time of delivery of this prospectus or any applicable prospectus
supplement, or any sale of a security. Our business, financial condition, results of operations and prospects may have changed since
those dates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">This
prospectus is part of a registration statement on Form S-1 that we filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
using the &#8220;shelf&#8221; registration process. Under this shelf registration process, the Selling Securityholders hereunder may,
from time to time, sell the securities offered by them described in this prospectus. We will not receive any proceeds from the sale by
such Selling Securityholders of the Common Stock or Warrants offered by them described in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">A
prospectus supplement may also add, update or change information included in this prospectus. Any statement contained in this prospectus
will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in such prospectus
supplement modifies or supersedes such statement. Any statement so modified will be deemed to constitute a part of this prospectus only
as so modified, and any statement so superseded will be deemed not to constitute a part of this prospectus. You should rely only on the
information contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus. See &#8220;<i>Where
You Can Find More Information</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">This
prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the
actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some
of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration
statement of which this prospectus is a part, and you may obtain copies of those documents as described in the section entitled under
&#8220;<i>Where You Can Find More Information</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">As
used in this prospectus, unless otherwise indicated or the context otherwise requires, references to &#8220;we,&#8221; &#8220;us,&#8221;
&#8220;our,&#8221; the &#8220;Company,&#8221; &#8220;Registrant,&#8221; and &#8220;CXApp&#8221; refer to the consolidated operations
of CXApp Inc. and its subsidiaries. References to &#8220;KINS&#8221; refer to the Company prior to the consummation of the Business Combination
and references to &#8220;Legacy CXApp&#8221; refer to CXApp Holding Corp. prior to the consummation of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_002"></span>TRADEMARKS,
TRADE NAMES AND SERVICE MARKS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade
names referred to in this prospectus may appear without the<sup>&#174;</sup> or&#8482; symbols, but such references are not intended
to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these
trademarks and trade names. We do not intend our use or display of other companies&#8217; trade names, trademarks or service marks to
imply a relationship with, or endorsement or sponsorship of them by, any other companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_003"></span>MARKET
AND INDUSTRY DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus includes industry position and industry data, forecasts, market size and growth and other data that we obtained or derived
from internal company reports, independent third-party publications, surveys and studies by third parties and other industry data, such
as reports by research companies. Some data are also based on good faith estimates, which are derived from internal company research
or analyses or review of internal company reports as well as the independent sources referred to above. Although we believe that the
information on which the companies have based these estimates of industry position and industry data are generally reliable, the accuracy
and completeness of this information is not guaranteed and they have not independently verified any of the data from third-party sources
nor have they ascertained the underlying economic assumptions relied upon therein. Information cannot always be verified with complete
certainty due to the limits on the availability and reliability of raw data, the voluntary nature of the data gathering process and other
limitations and uncertainties. Each publication, study and report speaks as of its original publication date (and not as of the date
of this prospectus). Certain of these publications, studies and reports were published before the COVID-19 pandemic and therefore do
not reflect any impact of COVID-19 on any specific market or globally. In addition, we do not know all of the assumptions regarding general
economic conditions or growth that were used in preparing the forecasts from the sources relied upon or cited herein. Among other items,
certain of the market research included in this prospectus was published prior to the COVID-19 pandemic and did not anticipate the virus
or the impact it has caused on our industry. We have utilized this pre-pandemic market research in the absence of updated sources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, certain information contained in this document represents our management&#8217;s estimates. While we believe our internal estimates
to be reasonable, and we are not aware of any misstatements regarding the industry data presented herein, they have not been verified
by any independent sources. Such data involve risks and uncertainties and are subject to change based on various factors, including those
discussed under the captions &#8220;<i>Risk Factors,</i>&#8221; &#8220;<i>Cautionary Statement Regarding Forward-Looking Statements</i>&#8221;
and &#8220;<i>Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_004"></span>SELECTED
DEFINITIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
used in this prospectus, unless the context otherwise requires:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Board&#8221;
                                            refers to the board of directors of CXApp;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Bylaws&#8221;
                                            refers to the existing bylaws of CXApp currently in effect;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Charter&#8221;
                                            refers to the existing amended and restated certificate of incorporation of CXApp currently
                                            in effect;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Class
                                            A Common Stock&#8221; refers to shares of Class A common stock of CXApp, par value $0.0001
                                            per share;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Class
                                            C Common Stock&#8221; refers to shares of Class C common stock of CXApp, par value $0.0001
                                            per share;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Closing&#8221;
                                            refers to the closing of the Merger;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Common
                                            Stock&#8221; refers to the Class A Common Stock and the Class C Common Stock;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;CXApp&#8221;
                                            refers to CXApp Inc., a Delaware corporation;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Design
                                            Reactor&#8221; refers to Design Reactor Inc., a California corporation, which was formerly
                                            doing business under the name &#8220;The CXApp&#8221;;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;DGCL&#8221;
                                            refers to the General Corporation Law of the State of Delaware;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Distribution&#8221;
                                            refers to distribution of the Enterprise Apps Business to the holders of Inpixon stock and
                                            other Inpixon securities on a certain record date through the distribution of all of the
                                            outstanding shares of Legacy CXApp capital stock to holders of Inpixon stock and other Inpixon
                                            securities on a certain record date on a pro rata, one for one basis, as described in the
                                            Separation and Distribution Agreement;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Distribution
                                            Time&#8221; refers to the time at which Distribution occurs, which is deemed to be 12:01
                                            a.m., New York time on March&#160;14, 2023;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Enterprise
                                            Apps Business&#8221; refers to the business conducted by CXApp and its direct and indirect
                                            subsidiaries, including the business related to the (i) software-as-a-service app and mapping
                                            platforms which enable corporate enterprise organizations to provide a custom-branded, location-aware
                                            employee app focused on enhancing the workplace experience and hosting virtual and hybrid
                                            events, (ii) augmented reality (or AR), computer vision, localization, navigation, mapping,
                                            and 3D reconstruction technologies, and (iii) on-device &#8220;blue dot&#8221; indoor location
                                            and motion technologies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Exchange
                                            Act&#8221; refers to the Securities Exchange Act of 1934, as amended;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;GAAP&#8221;
                                            refers to accounting principles generally accepted in the United States of America;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Inpixon&#8221;
                                            refers to Inpixon, a Nevada corporation;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;JOBS
                                            Act&#8221; refers to the Jumpstart Our Business Startups Act of 2012;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;KINS&#8221;
                                            refers to KINS Technology Group Inc., a Delaware corporation;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;KINS
                                            Initial Public Offering&#8221; refers to KINS&#8217; initial public offering that was consummated
                                            on December&#160;17, 2020;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Legacy CXApp&#8221; refers to CXApp Holding Corp., a Delaware corporation, prior to the Merger;</span></p></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Merger&#8221;
                                            refers to the merger of Merger Sub with and into Legacy CXApp, with Legacy CXApp surviving
                                            the merger as a wholly-owned subsidiary of CXApp and the other transactions contemplated
                                            by the Merger Agreement;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Merger
                                            Agreement&#8221; refers to the Agreement and Plan of Merger, dated as of September&#160;25,
                                            2022, by and among KINS, Merger Sub, Inpixon and Legacy CXApp, as amended and modified from
                                            time to time;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Merger
                                            Sub&#8221; refers to KINS Merger Sub Inc.;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Nasdaq&#8221;
                                            refers to the Nasdaq Capital Market;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Preferred
                                            Stock&#8221; refers to shares of &#8220;blank check&#8221; preferred stock, each having a
                                            par value of $0.0001;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Stockholders&#8221;
                                            refers to the stockholders of CXApp;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;pro
                                            forma&#8221; refers to giving pro forma effect to the Merger;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Registration
                                            Rights Agreement&#8221; refers to that certain registration rights agreement, dated as of
                                            December&#160;14, 2020, by and among KINS, the Sponsor and certain other securityholders
                                            party thereto;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Sarbanes-Oxley
                                            Act&#8221; refers to the Sarbanes-Oxley Act of 2002;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;SEC&#8221;
                                            refers to the United States Securities and Exchange Commission;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Securities
                                            Act&#8221; refers to the Securities Act of 1933, as amended;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Separation&#8221;
                                            refers to a series of transactions by Inpixon and certain of Inpixon&#8217;s subsidiaries
                                            as result of which Inpixon&#8217;s Enterprise Apps Business is held by Legacy CXApp and its
                                            subsidiaries and is separated from the remainder of Inpixon&#8217;s businesses, on the terms
                                            and subject to the conditions of the Separation and Distribution Agreement;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Separation
                                            and Distribution Agreement&#8221; refers to the Separation and Distribution Agreement, dated
                                            as of September&#160;25, 2022, by and among Inpixon, Design Reactor, CXApp and KINS, as amended
                                            and modified from time to time;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Sponsor&#8221;
                                            refers to KINS Capital, LLC, a Delaware limited liability company; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Subsidiary&#8221;
                                            refers to, with respect to a Person, a corporation or other entity of which more than 50%
                                            of the voting power of the equity securities or equity interests is owned, directly or indirectly,
                                            by such Person;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Warrants&#8221;
                                            refers to warrants to purchase one share of Common Stock at an exercise price of $11.50;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_005"></span>CAUTIONARY
STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains forward-looking statements. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221;
&#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;future,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221;
&#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221;
&#8220;propose,&#8221; &#8220;schedule,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would&#8221;
and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not
forward-looking. All statements other than statements of historical facts contained in this prospectus, including statements regarding
CXApp&#8217;s future results of operations and financial position, business strategy and its expectations regarding the application of,
and the rate and degree of market acceptance of the CXApp technology platform and other technologies, CXApp&#8217;s expectations regarding
the addressable markets for our technologies, including the growth rate of the markets in which it operates, and the potential for and
timing of receipt of payments under CXApp&#8217;s agreements, are forward- looking statements. These forward-looking statements are not
guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions
and other important factors, many of which are outside the control of CXApp, that could cause actual results or outcomes to differ materially
from those discussed in the forward-looking statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forward-looking statements contained in this prospectus and in any document incorporated by reference in this prospectus are based on
current expectations and beliefs concerning future developments and their potential effects on CXApp. There can be no assurance that
future developments affecting CXApp will be those that CXApp has anticipated. These forward-looking statements involve a number of risks,
uncertainties (some of which are beyond the control of CXApp) or other assumptions that may cause actual results or performance to be
materially different from those expressed or implied by these forward- looking statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements contained in this prospectus include, but are not limited to, statements such as the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">realize
                                            the benefits expected from the Merger;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">successfully
                                            defend litigation;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">successfully
                                            deploy the proceeds from the Merger;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            sufficiency of sources of funding;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">factors
                                            relating to the business, operations and financial performance of the Enterprise Apps Business,
                                            and CXApp and its subsidiaries, including:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in general economic conditions, geopolitical risk, including as a result of the COVID-19
                                            pandemic or the conflict between Russia and Ukraine;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            ability to continue to meet Nasdaq&#8217;s listing standards following the consummation of
                                            the Business Combination;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            volatility of CXApp&#8217;s securities due to a variety of factors, including the inability
                                            to implement business plans or meet or exceed financial projections and changes in the capital
                                            structure; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            anticipated benefits of the Separation may not be achieved;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CXApp&#8217;s
                                            historical combined financial data and pro forma financial statements are not necessarily
                                            representative of the results CXApp would have achieved as a standalone company and may not
                                            be a reliable indicator of its future results;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CXApp&#8217;s
                                            operating results and financial performance;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">acceptance
                                            by new and existing partners in CXApp&#8217;s market;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CXApp&#8217;s
                                            ability to manage and grow its business and execution of its business and growth strategies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks
                                            arising from changes in technology;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            competitive environment in the enterprise apps market;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
                                            to maintain, protect and defend our intellectual property rights;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in government laws and regulations, including laws governing intellectual property, and the
                                            enforcement thereof affecting our business;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
                                            with performance of third parties we will rely on for our business growth;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
                                            developing and sustaining relationships with commercial counterparties;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CXApp
                                            may not be able to engage in certain transactions and equity issuances following the Distribution;
                                            </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CXApp
                                            may have certain indemnification obligations to Inpixon under a tax matters agreement; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
                                            factors detailed under the section titled &#8220;<i>Risk Factors</i>.&#8221;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CXApp
has based the forward-looking statements contained in this prospectus primarily on our current expectations and projections about future
events and trends that we believe may affect CXApp&#8217;s business, financial condition, results of operations, prospects, business
strategy and financial needs. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties,
assumptions and other factors described in the section captioned &#8220;<i>Risk Factors</i>&#8221; and elsewhere in this prospectus.
These risks are not exhaustive. Other sections of this prospectus include additional factors that could adversely impact our business
and financial performance. Moreover, CXApp operates in very competitive and rapidly changing environments. New risks and uncertainties
emerge from time to time and it is not possible for CXApp to predict all risks and uncertainties that could have an impact on the forward-looking
statements contained in this prospectus. CXApp cannot assure you that the results, events and circumstances reflected in the forward-looking
statements will be achieved or occur, and actual results, events or circumstances could differ materially from those described in the
forward-looking statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
one or more of these risks or uncertainties materialize, or should any of CXApp&#8217;s assumptions prove incorrect, actual results may
vary in material respects from those projected in these forward-looking statements. CXApp does not undertake any obligation to update
or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required
under applicable securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These
statements are based upon information available to CXApp as of the date of this prospectus, and while CXApp believes such information
forms a reasonable basis for such statements, such information may be limited or incomplete, and its statements should not be read to
indicate that CXApp has conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements
are inherently uncertain and investors are cautioned not to unduly rely upon these statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this prospectus completely and with the understanding that our actual future results may be materially different from what
we expect. We qualify all of our forward-looking statements by these cautionary statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1pt solid; padding: 5pt; width: 98%">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>PROSPECTUS
SUMMARY</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif"><i>This
summary highlights, and is qualified in its entirety by, the more detailed information and financial statements included elsewhere in
this prospectus. This summary does not contain all of the information that may be important to you in making your investment decision.
You should read this entire prospectus carefully, especially the &#8220;Risk Factors&#8221; section beginning on page 13 and our
consolidated financial statements and the related notes appearing at the end of this prospectus, before deciding to invest in our Common
Stock.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">CXApp&#8217;s
platform is a workplace experience platform for enterprise customers. Our technologies and solutions help enterprise customers deliver
a comprehensive business journey in a work &#8216;from-anywhere&#8217; world for employees, partners, customers and visitors. CXApp offers
native mapping, analytics, on-device positioning (or ODP) and applications technologies that aim to bring people together.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
customers use our enterprise solutions in a variety of ways, including, but not limited to, workplace experience, employee engagement,
desk and meeting room reservations, workplace analytics, occupancy management, content delivery, corporate communications and notifications,
event management, live indoor mapping, wayfinding and navigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
enterprise app platform is the intersection of technology, intelligence, automation and experience for today&#8217;s hybrid workplace
and the workplace of the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
workplace experience solution is a software-as-a-service (or SaaS) platform for the enterprise. Our technology platform delivers the
following core components that work in combination to deliver an incredible experience for companies around the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Workplace
Experience</i> <span style="font-weight: normal">&#8212; Our workplace experience solution enhances employee experience by providing organizations
with a holistic, location-aware, customer-branded employee app for a more connected workplace. This solution helps organizations provide
a frictionless work environment to employees with features such as: hot desk and room booking, indoor navigation with turn-by-turn directions
on a digital map, company-wide news feeds, an in-app company directory of colleagues and workplace amenities, as well as bookable opportunities
and experiences. Our clients include facilities teams solving space utilization challenges, workplace operations teams building incredible
experiences for employees and IT teams focused on streamlining their tech stacks to boost productivity and efficiency.</span></span></td>
</tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hybrid
Meeting</i> <span style="font-weight: normal">&#8212; Our executive briefing solution helps enterprise organization create high-touch,
high-value, and personalize customer journeys for in-office, remote and hybrid meetings. Our hybrid solution offering streamlines multi-point
customer experiences through one environment with support for multiple meetings and diversified locations, agendas for single or multi-day
uses, and customizable components for every customer briefing program.</span></span></td>
</tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Hybrid
Events</i> <span style="font-weight: normal">&#8212; Our hybrid event solution provides both mobile app and virtual event capabilities
to connect tens of thousands of remote and in-person audiences through a fully branded, end-to- end event journey. Our hybrid event platform
can host multiple events for enterprise organizations and support ongoing event engagement touchpoints to attendees before, during, and
after the event through features such as customizable agendas, real-time activity feeds, instant notifications and more.</span></span></td>
</tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mapping
Solutions</i> <span style="font-weight: normal">&#8212; Our indoor mapping solution helps enterprise organizations add intelligence to
complex indoor spaces by integrating business data with geospatially accurate indoor maps to create relevant views of indoor environments.
Indoor mapping is integral to supporting location-aware, &#8220;internet of things&#8221; (or IoT) enabled smart office touchpoints or
devices within the customer&#8217;s premises. Developers use our mapping solution to bring indoor maps to apps, enabling multiple uses
with a single set of maps. This product is intended to serve as a digital twin of a physical space facilitates and can be used for facility
management, security, customer or worker experiences, asset tracking and more.</span></span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Analytics
Dashboard</i> <span style="font-weight: normal">&#8212; Our robust cloud-based analytics dashboards give enterprise organizations insights
into how real estate, technology and people interact across the workplace, so they can make business decisions to unlock savings, improve
employee experience or optimize services. With our analytics platform, we allow data from multiple sensors and data sources (third-party
sensors, native mapping solutions and data) to be visualized for action by workplace operations teams.</span></span></td>
</tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>On-Device
Positioning (or ODP)</i> <span style="font-weight: normal">&#8212; Our on-device positioning technology, commonly known as &#8220;blue
dot,&#8221; enables powerful location-based uses and builds upon our mapping offering to give enterprises clients a seamless way to provide
navigation assistance within a venue (workplace, event show floor etc.). Our solution displays a user&#8217;s precise location and runs
on a smartphone, smartwatch or other IoT wearable device and can operate without the internet.</span></span></td>
</tr></table>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1pt solid; padding: 5pt; width: 98%">
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Business Combination and Related Transactions</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">On
September&#160;25, 2002, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), by and among
the Company, Inpixon, (&#8220;Inpixon&#8221;), Legacy CXApp and KINS Merger Sub Inc. (&#8220;Merger Sub&#8221;). The Merger Agreement
provided for, among other things, the merger of Merger Sub with and into Legacy CXApp (the &#8220;Merger&#8221; and, together with the
other transactions contemplated by the Merger Agreement, the &#8220;Business Combination&#8221;), with Legacy CXApp surviving the Merger
as a wholly-owned subsidiary of CXApp, in accordance with the terms and subject to the conditions of the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">On
March&#160;14, 2023 (the &#8220;Closing Date&#8221;), pursuant to the Merger Agreement, Merger Sub merged with and into Legacy CXApp,
with Legacy CXApp surviving the merger as a wholly-owned subsidiary of the Company (the &#8220;Closing&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">In
connection with Closing, we changed our name from KINS to CXApp Inc. The Business Combination will be accounted for using the acquisition
method (as a forward merger), with goodwill and other identifiable intangible assets recorded in accordance with GAAP, as applicable.
Under this method of accounting, CXApp is treated as the &#8220;acquired&#8221; company for financial reporting purposes. KINS has been
determined to be the accounting acquirer because KINS maintains control of the Board of Directors and management of the combined company.
For accounting purposes, the acquirer is the entity that has obtained control of another entity and, thus, consummated a business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
rights of holders of our Common Stock and Warrants are governed by our amended and restated certificate of incorporation (our &#8220;certificate
of incorporation&#8221; or &#8220;Charter&#8221;), our amended and restated bylaws (the &#8220;Bylaws&#8221;), and the Delaware General
Corporation Law (the &#8220;DGCL&#8221;), and, in the case of the Warrants, the Warrant Agreement, dated as of December&#160;14, 2020,
by and between KINS and Continental Stock Transfer &amp; Trust Company, as warrant agent (the &#8220;Warrant Agreement&#8221;). See the
section titled &#8220;<i>Description of Capital Stock</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Resale
of Shares in this Registration Statement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Due
to the significant number of redemptions of our Class A common stock in connection with our Business Combination, the shares of common
stock being registered for issuance or resale are anticipated to constitute a considerable percentage of our public float. Additionally,
all the shares of common stock being registered for resale were purchased by the Selling Securityholders for prices considerably below
the current market price of our Class A common stock. This discrepancy in purchase prices may have an impact on the market perception
of the stock&#8217;s value and could contribute to potential downward pressure on the public trading price of our Class A common stock.
The registration of these shares for issuance or resale creates the possibility of a significant increase in the supply of our Class
A common stock in the market. The increased supply, coupled with the potential disparity in purchase prices, may lead to heightened selling
pressure, which could negatively affect the public trading price of our Class A common stock. We will not receive the proceeds from the
resale of the shares of common stock by the Selling Securityholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The
exercise price of the warrants, in certain circumstances, may be higher than the prevailing market price of the underlying securities.
The exercise price of the warrants is subject to market conditions and may not be advantageous if the prevailing market price of the
underlying securities is lower than the exercise price. The cash proceeds associated with the exercise of warrants to purchase our common
stock are contingent upon our stock price. The value of our common stock may fluctuate and may not align with the exercise price of the
warrants at any given time. If the warrants are &#8220;out of the money,&#8221; meaning the exercise price is higher than the market
price of our common stock, there is a high likelihood that warrant holders may choose not to exercise their warrants. As a result, we
may not receive any proceeds from the exercise of such warrants. On June 29, 2023, the closing sale price of our common stock as reported
by Nasdaq was $10.45 per share and the closing price of our warrants was $0.49 per warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Furthermore,
with regard to the Private Placement Warrants, it is possible that we may not receive cash upon their exercise since these warrants may
be exercised on a cashless basis. A cashless exercise allows warrant holders to convert the warrants into shares of our common stock
without the need for a cash payment. Instead of receiving cash upon exercise, the warrant holder would receive a reduced number of shares
based on a predetermined formula or method as further described in &#8220;<i>Description of Capital Stock</i>&#8221; further below. As
a result, the number of shares received through a cashless exercise may be lower than if the warrants were exercised on a cash basis,
which could impact the value and dilution of our common stock.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1pt solid; padding: 5pt; width: 98%">

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
of Risk Factors</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">In
addition to the other information contained in this prospectus, the following risks have the potential to impact the business and operations
of CXApp. An investment in our securities involves a high degree of risk. You should consider carefully all of the risks described in
this prospectus, together with the other information contained in this prospectus. These risk factors are not exhaustive and all investors
are encouraged to perform their own investigation with respect to the business, financial condition and prospects of CXApp. The occurrence
of any of the following risks or additional risks and uncertainties not presently known to us or that we currently believe are immaterial
could have a material adverse effect on our business, financial condition, results of operations and future growth prospects. In that
event, the trading price of our securities could decline, and you could lose all or part of your investment. Such risks include, but
are not limited to, the following (See &#8220;<i>Risk Factors</i>&#8221;). Unless the context otherwise requires, all references in this
subsection to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refer to the business of CXApp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                            have a history of operating losses and there is no assurance that we will ever be able to
                                            earn sufficient revenue to achieve profitability or raise additional financing to successfully
                                            operate our business plan.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                            rely on a limited number of key customers, the importance of which may vary dramatically
                                            from year to year, and a loss of one or more of these key customers may adversely affect
                                            our operating results.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">We
                                            may need additional cash financing and any failure to obtain cash financing, could limit
                                            our ability to grow our business and develop or enhance our service offerings to respond
                                            to market demand or competitive challenges.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
                                            competitiveness depends significantly on our ability to keep pace with the rapid changes
                                            in our industry. Failure by us to anticipate and meet our customers&#8217; technological
                                            needs could adversely affect our competitiveness and growth prospects.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
                                            historical financial results and unaudited pro forma combined financial information included
                                            in this prospectus is preliminary and the actual financial condition and results of operations
                                            after the Merger may differ materially.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Because
                                            we have not conducted an underwritten offering of our securities, no underwriter has conducted
                                            a due diligence review of our business, operations or financial condition or reviewed the
                                            disclosure in this prospectus.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The
                                            market price of our Common Stock may be volatile and fluctuate substantially, which could
                                            cause the value of your investment to decline.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The
                                            requirements of being a public company, including compliance with the reporting requirements
                                            of the Exchange Act and Nasdaq, require significant resources, increase our costs and distract
                                            our management, and we may be unable to comply with these requirements in a timely or cost-
                                            effective manner. We will incur increased costs as a result of operating as a public company,
                                            and our management will devote substantial time to new compliance initiatives.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
                                            historical combined financial data and pro forma financial statements are not necessarily
                                            representative of the results we would have achieved as a standalone company and may not
                                            be a reliable indicator of our future results.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Emerging
Growth Company</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">CXApp
is an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a) of the Securities Act, as modified by the JOBS Act. As such,
CXApp is eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies
that are not &#8220;emerging growth companies&#8221; including, but not limited to, not being required to comply with the auditor attestation
requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic
reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and
stockholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive
as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">In
addition, Section&#160;107 of the JOBS Act also provides that an &#8220;emerging growth company&#8221; can take advantage of the extended
transition period provided in Section&#160;7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In
other words, an &#8220;emerging growth company&#8221; can delay the adoption of certain accounting standards until those standards would
otherwise apply to private companies. CXApp intends to take advantage of the benefits of this extended transition period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">CXApp
will remain an emerging growth company until the earlier of: (1) the last day of the fiscal year (a) following the fifth anniversary
of the completion of the initial public offering of our securities, (b) in which we have total annual gross revenue of at least $1.07
billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common equity that is held
by non-affiliates exceeds $700 million as of the end of the prior fiscal year&#8217;s second fiscal quarter; and (2) the date on which
we have issued more than $1.00 billion in non-convertible debt securities during the prior three-year period. References herein to &#8220;emerging
growth company&#8221; have the meaning associated with it in the JOBS Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1pt solid; padding: 5pt; width: 98%">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Smaller
Reporting Company</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">CXApp
is a &#8220;smaller reporting company&#8221; as defined in Item&#160;10(f)(1) of Regulation S-K. Smaller reporting companies may take
advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements.
CXApp will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of its common equity
held by non-affiliates exceeds $700 million as of the prior September&#160;30<sup>th</sup> or (2) the market value of its common equity
exceeds $250 million and its annual revenues exceeds $100 million during such fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1pt solid; padding: 5pt; width: 98%">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_007"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THE
OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Shares
    of Common Stock Offered by the Selling Securityholders</span></td>
    <td style="width: 3%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">6,977,776
    shares of Common Stock and 10,280,000 shares of Common Stock issuable upon exercise of Warrants</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of Common Stock offered by the Company</span></td>
    <td><span>&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,080,000
    shares of Common Stock issuable upon exercise of Warrants</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    offered by the Selling Securityholders</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,280,000
    Warrants</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Shares
    of Common Stock outstanding prior to this offering</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">14,069,999
    shares of Common Stock (as of June 29, 2023)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Warrants
    outstanding prior to this offering</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">24,080,000
    Warrants (as of June 29, 2023)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
    price per warrant</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$11.50</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of proceeds</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will not receive any proceeds from the sale of shares of Common Stock or Warrants by the Selling Securityholders pursuant to this
    prospectus.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    factors</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    should carefully read the section titled &#8220;<i>Risk Factors</i>&#8221; beginning on page 13 and the other information included
    in this prospectus for a discussion of factors you should consider carefully before deciding to invest in our Common Stock or Warrants</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
    symbol for our Common Stock</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;CXAI&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
    symbol for our Warrants</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;CXAIW&#8221;</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
</div>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_008"></span>RISK
FACTORS</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>You
should carefully consider the risks and uncertainties described below and the other information in this prospectus before making an investment
in our Common Stock or Warrants. Our business, financial condition, results of operations, or prospects could be materially and adversely
affected if any of these risks occurs, and as a result, the market price of our Common Stock and Warrants could decline and you could
lose all or part of your investment. This prospectus also contains forward-looking statements that involve risks and uncertainties. See
&#8220;Cautionary Statement Regarding Forward-Looking Statements.&#8221; Our actual results could differ materially and adversely from
those anticipated in these forward-looking statements as a result of certain factors, including those set forth below.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to this Offering by the Selling Securityholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sales
of a substantial number of our securities in the public market by the Selling Securityholders and/or by our existing securityholders
could cause the price of our shares of Common Stock and Warrants to fall.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The
Selling Securityholders can sell, under this prospectus, up to (i) 31,057,776 shares of Common Stock constituting approximately 220%
of our issued and outstanding shares of Common Stock as of June 29, 2023, consisting of (a) up to 6,877,776 shares of Common Stock that
were originally issued to the Sponsor in the form of sponsor shares prior to the KINS Initial Public Offering at a price of approximately
$0.004 per share, (b) up to 10,280,000 shares of Common Stock that are issuable upon the exercise of the Private Placement Warrants at
an exercise price of $11.50 per share, which were originally issued to Sponsor and the Direct Anchor Investors in a private placement
at a price of $1.00 per Private Placement Warrant in connection with the KINS Initial Public Offering by certain of the Selling Securityholders
named in this prospectus, (c) up to 13,800,000 shares of Common Stock that are issuable upon the exercise of the Public Warrants, (d)
the resale of up to 10,280,000 shares of common stock issuable upon exercise of the private warrants held by the Sponsor, its affiliates
and the Direct Anchor Investors and (e) up to 100,000 shares of Common Stock issued in a private placement to BTIG, LLC, which were initially
issued without cash consideration (holding an implied value of $9.94 per share based on the closing price of KINS&#8217; stock at the
time the Advisory Agreement was entered into) in exchange for their engagement to provide strategic and capital markets advisory services
and (ii) 10,280,000 Warrants constituting approximately 42.7% of our issued and outstanding Warrants as of June 29, 2023, which were
originally issued at a price of $1.00 per Warrant. The sale of all or a portion of the securities being offered in this prospectus could
result in a significant decline in the public trading price of our securities. Despite such a decline in the public trading price, some
of the Selling Securityholders may still experience a positive rate of return on the securities they purchased due to the price at which
such Selling Securityholder initially purchased the securities. See &#8220;<i>Certain existing stockholders purchased, or may purchase,
securities in the Company at a price below the current trading price of such securities, and may experience a positive rate of return
based on the current trading price. Future investors in the Company may not experience a similar rate of return.</i>&#8221; below.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of a substantial number of our shares of Common Stock and/or Warrants in the public market by the Selling Securityholders and/or by our
other existing securityholders, or the perception that those sales might occur, could depress the market price of our shares of Common
Stock and Warrants and could impair our ability to raise capital through the sale of additional equity securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Certain
existing stockholders purchased, or may purchase, securities in the Company at a price below the current trading price of such securities,
and may experience a positive rate of return based on the current trading price. Future investors in the Company may not experience a
similar rate of return.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
stockholders in the Company, including certain of the Selling Securityholders, as well as Inpixon, Inpixon&#8217;s management (through
their interests in the Sponsor), and the Direct Anchor Investors, acquired, or may acquire, shares of our Common Stock or Warrants at
prices below the current trading price of our Common Stock, and may experience a positive rate of return based on the current trading
price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This
prospectus relates to the offer and resale from time to time by the Selling Securityholders of (i) up to 31,057,776 shares of Common
Stock constituting approximately 220% of our issued and outstanding shares of Common Stock as of June 29, 2023, consisting of (a) up
to 6,877,776 shares of Common Stock that were originally issued to the Sponsor in the form of sponsor shares prior to the KINS Initial
Public Offering at a price of approximately $0.004 per share, (b) up to 10,280,000 shares of Common Stock that are issuable upon the
exercise of the Private Placement Warrants at an exercise price of $11.50 per share, which were originally issued to the Sponsor and
the Direct Anchor Investors in a private placement at a price of $1.00 per Private Placement Warrant in connection with the KINS Initial
Public Offering certain of the Selling Securityholders named in this prospectus, (c) up to 13,800,000 shares of Common Stock that are
issuable upon the exercise of the Public Warrants, (d) the resale of up to 10,280,000 shares of common stock issuable upon exercise of
the private warrants held by the Sponsor, its affiliates and the Direct Anchor Investors and (e) up to 100,000 shares of Common Stock
issued in a private placement to BTIG, LLC and (ii) 10,280,000 Warrants constituting approximately 42.7% of our issued and outstanding
Warrants as of June 29, 2023, which were originally issued at a price of $1.00 per Warrant.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Based
on the closing price of our Common Stock of $10.45 on June 29, 2023, (i) the Sponsor may experience potential profit of up to $10.45
per share of Common Stock based on the Sponsor&#8217;s initial purchase price of shares of Common Stock in the form of sponsor shares
prior to the KINS Initial Public Offering at a price of approximately $0.004 per share, (ii) Inpixon and Inpixon&#8217;s management may
experience potential profit of up to $10.45 per share of Common Stock based on approximately 598,000 shares of Common Stock attributable
to them through their interests in the Sponsor, (iii) the Direct Anchor Investors may experience potential profit of up to $10.45 per
share of Common Stock based on the Direct Anchor Investors&#8217; initial purchase of Private Placement Warrant in connection with the
KINS Initial Public Offering at a price of approximately $1.00 per Private Placement Warrant, and (iv) BTIG may experience potential
profit of up to $0.51 per share of Common Stock based on the Company issuing 100,000 shares of Common Stock to BTIG in a private placement
(as a fee for its services pursuant to the Advisory Agreement) and assuming that the &#8220;purchase price&#8221; of the Common Stock
was the market price of KINS&#8217; stock on the date the Advisory Agreement was entered into (which was $9.94 on March 14, 2023).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Public
securityholders may not be able to experience the same positive rates of return on securities they purchase due to the low price at which
the Selling Securityholders purchased shares of our Common Stock or our warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Warrants are exercisable for shares of our Common Stock, which exercises will increase the number of shares of Common Stock eligible
for future resale in the public market and result in dilution to our existing stockholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
outstanding Warrants to purchase an aggregate of 24,080,000 shares of our Common Stock will become exercisable on April&#160;13, 2023,
subject to other conditions set forth in &#8220;<i>Description of Capital Stock</i>&#8221; further below. Each Warrant entitles the holder
thereof to purchase one share of our Common Stock at a price of $11.50 per whole share. Warrants may be exercised only for a whole number
of shares of Common Stock. To the extent such warrants are exercised, additional shares of our Common Stock will be issued, which will
result in dilution to the then existing holders of our Common Stock and increase the number of shares eligible for resale in the public
market. Sales of substantial numbers of such shares in the public market could adversely affect the market price of our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span><b><i>Our
warrants may not be exercised at all or may be exercised on a cashless basis and we may not receive any cash proceeds from the exercise
of the warrants.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Due
to the significant number of redemptions of our Class A common stock in connection with our Business Combination, the shares of common
stock being registered for issuance or resale are anticipated to constitute a considerable percentage of our public float. Additionally,
all the shares of common stock being registered for resale were purchased by the Selling Securityholders for prices considerably below
the current market price of our Class A common stock. This discrepancy in purchase prices may have an impact on the market perception
of the stock&#8217;s value and could contribute to potential downward pressure on the public trading price of our Class A common stock.
The registration of these shares for issuance or resale creates the possibility of a significant increase in the supply of our Class
A common stock in the market. The increased supply, coupled with the potential disparity in purchase prices, may lead to heightened selling
pressure, which could negatively affect the public trading price of our Class A common stock. We will not receive the proceeds from the
resale of the shares of common stock by the Selling Securityholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>The
exercise price of the warrants, in certain circumstances, may be higher than the prevailing market price of the underlying securities.
The exercise price of the warrants is subject to market conditions and may not be advantageous if the prevailing market price of the
underlying securities is lower than the exercise price. The cash proceeds associated with the exercise of warrants to purchase our common
stock are contingent upon our stock price. The value of our common stock may fluctuate and may not align with the exercise price of the
warrants at any given time. If the warrants are &#8220;out of the money,&#8221; meaning the exercise price is higher than the market
price of our common stock, there is a high likelihood that warrant holders may choose not to exercise their warrants. As a result, we
may not receive any proceeds from the exercise of such warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Furthermore,
with regard to the Private Placement Warrants, it is possible that we may not receive cash upon their exercise since these warrants may
be exercised on a cashless basis. A cashless exercise allows warrant holders to convert the warrants into shares of our common stock
without the need for a cash payment. Instead of receiving cash upon exercise, the warrant holder would receive a reduced number of shares
based on a predetermined formula or method as further described in &#8220;<i>Description of Capital Stock</i>&#8221; further below. As
a result, the number of shares received through a cashless exercise may be lower than if the warrants were exercised on a cash basis,
which could impact the value and dilution of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Relating to our Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>You
should carefully consider the risks and uncertainties described below, together with the information included elsewhere in this prospectus.
The risks and uncertainties described below are those that we have identified as material but are not the only risks and uncertainties
facing us. Our business is also subject to general risks and uncertainties that affect many other companies, such as market conditions,
economic conditions, geopolitical events, changes in laws, regulations or accounting rules, fluctuations in interest rates, terrorism,
wars or conflicts, major health concerns, natural disasters or other disruptions of expected business conditions. Additional risks and
uncertainties not currently known to us or that we currently believe are immaterial also may impair our business, including our results
of operations, liquidity and financial condition.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unless
the context otherwise requires, all references in this subsection to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or
&#8220;our&#8221; refer to CXApp Inc.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span><b><i>We
have a history of operating losses and there is no assurance that we will ever be able to achieve sufficient bookings growth, maintain
license renewals and earn revenue to achieve profitability or raise additional financing to successfully operate our business plan.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>We
have a history of operating losses and may not have sufficient bookings, license renewals and earn revenue to support our operations.
We have incurred recurring net losses of approximately $29.2 million and $42.0 million for the fiscal years ended 2022 and 2021, respectively.
Our continuation is dependent upon attaining and maintaining profitable operations and raising additional capital as needed, but there
can be no assurance that we will be able to raise any further financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Our
ability to generate positive cash flow from operations is dependent upon sustaining certain cost reductions and generating sufficient
growth in bookings from new and existing customers, maintaining the level of renewals from existing customers and to achieve growth in
revenues. Our operations have primarily been funded by our previous parent company with proceeds from public and private offerings of
capital stock and secured and unsecured debt instruments. Based on our current business plan, we may need additional capital to support
our operations, which may be satisfied with additional debt or equity financings. Future financings through equity offerings will be
dilutive to existing stockholders. In addition, the terms of securities we may issue in future capital transactions may be more favorable
to new investors than our current investors. Newly issued securities may include preferences, superior voting rights, and the issuance
of warrants or other derivative securities. We may also issue incentive awards under our equity incentive plans, which may have additional
dilutive effects. We may also be required to recognize non-cash expenses in connection with certain securities we may issue in the future
such as convertible notes and warrants, which would adversely impact our financial condition and results of operations. Our ability to
obtain needed financing may be impaired by factors, including the condition of the economy and capital markets, both generally and specifically
in our industry, and the fact that we are not profitable, which could affect the availability or cost of future financing. If the amount
of capital we are able to raise from financing activities, together with our revenues from operations, is not sufficient to satisfy our
capital needs, we may need to reduce our operations by, for example, selling certain assets or business segments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b><i>Our
ability to maintain sufficient cash flow to support operations over the next year is dependent upon achieving substantial growth in bookings
and maintaining the level of customer renewals.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Our
ability to maintain sufficient cash flow to support operations over the next year depends on achieving significant growth in new bookings
from both new and existing customers, and ensuring a consistent level of customer renewals. Our business operates under a SaaS subscription
model, where the majority of our bookings come from new customer licenses, expansions, or feature upgrades from existing customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Under
this model, our licensing agreements are typically invoiced upfront for the initial term of the license, usually 12 months, shortly after
the contract begins. The cash collected for each invoice is specific to the terms of the agreement. However, according to GAAP, revenue
recognition for the subscription licenses occurs gradually over a 12-month period following the commencement of the contract. In the
event of early customer termination, certain agreements may allow for a refund based on the elapsed time, approximating the unearned
deferred revenue on our balance sheet at that time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Consequently,
our cash flow relies on achieving growth in new bookings while maintaining the level of renewals from existing customers. Any difficulties
in sustaining growth in bookings, delays in securing new bookings, or reductions/delays in customer renewals could have a negative impact
on our ability to maintain sufficient cash flow and sustain our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b><i>We
have identified a material weakness in our internal control over financial reporting. This material weakness could continue to adversely
affect our ability to report our results of operations and financial condition accurately and in a timely manner.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Our
management and our audit committee concluded that it was appropriate to restate previously issued and audited financial statements as
of and for the period ended December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Our
management is responsible for establishing and maintaining adequate internal control over financial reporting designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with GAAP. Our management is likewise required, on a quarterly basis, to evaluate the effectiveness of our internal controls and to disclose
any changes and material weaknesses identified through such evaluation in those internal controls. A material weakness is a deficiency,
or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material
misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>As
described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as amended, we identified a material weakness
in our internal control around the interpretation and accounting for extinguishment of a significant contingent obligation in June 2022.
As a result of this material weakness, our management concluded that our internal control over financial reporting was not effective
as of December 31, 2022. This material weakness resulted in a material misstatement of our reported accretion of Class A common stock
subject to possible redemption, reported net income and earnings per share and related financial disclosures for the three and six months
ended June 30, 2022, the three and nine months ended September 30, 2022 and for the fiscal year ended December 31, 2022 (the &#8220;Affected
Periods&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>To
respond to this material weakness, we have devoted significant effort and resources to the remediation and improvement of our internal
control over financial reporting. We intend to take steps to remediate this material weakness, including plans to enhance processes to
better evaluate our research and understanding of the nuances of the complex accounting standards that apply to our consolidated financial
statements, enhance access to accounting literature, research materials and documents and increase communication among our personnel
and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can
only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects. For a
discussion of management&#8217;s consideration of the material weakness identified related to its accounting for the extinguishment of
contingent obligations see &#8220;Note 2&#8221; to the accompanying financial statements, as well as Part II, Item 9A: Controls and Procedures
included in our Form 10-K, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Efforts
to remediate this material weakness may not be effective or prevent any future material weakness or significant deficiency in our internal
control over financial reporting. If our efforts are not successful or other material weaknesses or control deficiencies occur in the
future, we may be unable to report our financial results accurately on a timely basis, which could cause our reported financial results
to be materially misstated and result in the loss of investor confidence and cause the market price of our common stock to decline. Ineffective
internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect
on the trading price of our stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>We
can give no assurance that the measures we have taken or that we plan to take in the future will remediate the material weakness identified
or that any additional material weaknesses or restatements of financial results will not arise in the future due to a failure to implement
and maintain adequate internal control over financial reporting or circumvention of these controls. We will be required, pursuant to
Section 404 of the Sarbanes-Oxley Act, to annually furnish a report by management on, among other things, the effectiveness of our internal
control over financial reporting. This assessment will need to include disclosure of any material weaknesses identified by our management
in our internal control over financial reporting. Our independent registered public accounting firm may be required to attest to the
effectiveness of its internal control over financial reporting depending on our reporting status. We will be required to disclose changes
made in its internal control and procedures on a quarterly basis. To comply with the requirements of being a public company, we may need
to undertake various actions, such as implementing new internal controls and procedures and hiring accounting or internal audit staff.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Failure
to manage or protect growth may be detrimental to our business because our infrastructure may not be adequate for expansion.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
corporate strategy contemplates potential future acquisitions and to the extent we acquire other businesses, we will also need to integrate
and assimilate new operations, technologies and personnel. The integration of new personnel will continue to result in some disruption
to ongoing operations. The ability to effectively manage growth in a rapidly evolving market requires effective planning and management
processes. We will need to continue to improve operational, financial and managerial controls, reporting systems and procedures, and
will need to continue to expand, train and manage our work force. There can be no assurance that we would be able to accomplish such
an expansion on a timely basis. If we are unable to effect any required expansion and are unable to perform our contracts on a timely
and satisfactory basis, our reputation and eligibility to secure additional contracts in the future could be damaged. The failure to
perform could also result in contract terminations and significant liability. Any such result would adversely affect our business and
financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will need to increase the size of our organization, and we may experience difficulties in managing growth, which could hurt our financial
performance.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to manage our future growth, we will need to continue to improve our management, operational and financial controls and our reporting
systems and procedures. All of these measures will require significant expenditures and will demand the attention of management. If we
do not continue to enhance our management personnel and our operational and financial systems and controls in response to growth in our
business, we could experience operating inefficiencies that could impair our competitive position and could increase our costs more than
we had planned. If we are unable to manage growth effectively, our business, financial condition and operating results could be adversely
affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business depends on experienced and skilled personnel, and if we are unable to attract and integrate skilled personnel, it will be more
difficult for us to manage our business and complete contracts.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
success of our business depends on the skill of our personnel. Accordingly, it is critical that we maintain, and continue to build, a
highly experienced management team and specialized workforce, including those who create software programs and sales professionals. Competition
for personnel with skill sets specific to our industry is high, and identifying candidates with the appropriate qualifications can be
costly and difficult. We may not be able to hire the necessary personnel to implement our business strategy given our anticipated hiring
needs, or we may need to provide higher compensation or more training to our personnel than we currently anticipate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is labor intensive and our success depends on our ability to attract, retain, train and motivate highly skilled employees, including
employees who may become part of our organization in connection with our acquisitions. The increase in demand for consulting, technology
integration and managed services has further increased the need for employees with specialized skills or significant experience in these
areas. Our ability to expand our operations will be highly dependent on our ability to attract a sufficient number of highly skilled
employees and to retain our employees and the employees of companies that we have acquired. We may not be successful in attracting and
retaining enough employees to achieve our desired expansion or staffing plans. Furthermore, the industry turnover rates for these types
of employees are high and we may not be successful in retaining, training or motivating our employees. Any inability to attract, retain,
train and motivate employees could impair our ability to adequately manage and complete existing projects and to accept new customer
engagements. Such inability may also force us to increase our hiring of independent contractors, which may increase our costs and reduce
our profitability on customer engagements. We must also devote substantial managerial and financial resources to monitoring and managing
our workforce. Our future success will depend on our ability to manage the levels and related costs of our workforce.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event we are unable to attract, hire and retain the requisite personnel and subcontractors, we may experience delays in completing
contracts in accordance with project schedules and budgets, which may have an adverse effect on our financial results, harm our reputation
and cause us to curtail our pursuit of new contracts. Further, any increase in demand for personnel may result in higher costs, causing
us to exceed the budget on a contract, which in turn may have an adverse effect on our business, financial condition and operating results
and harm our relationships with our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Any
</i></b>future acquisitions that we may make could disrupt our business, cause dilution to our stockholders and harm our business, financial
condition or operating results.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are successful in consummating acquisitions, those acquisitions could subject us to a number of risks, including, but not limited
to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            purchase price we pay and/or unanticipated costs could significantly deplete our cash reserves
                                            or result in dilution to our existing stockholders;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may find that the acquired company or technologies do not improve our market position as
                                            planned;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may have difficulty integrating the operations and personnel of the acquired company, as
                                            the combined operations will place significant demands on our management, technical, financial
                                            and other resources;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">key
                                            personnel and customers of the acquired company may terminate their relationships with the
                                            acquired company as a result of the acquisition;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may experience additional financial and accounting challenges and complexities in areas such
                                            as tax planning and financial reporting;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may assume or be held liable for risks and liabilities (including environmental-related costs)
                                            as a result of our acquisitions, some of which we may not be able to discover during our
                                            due diligence investigation or adequately adjust for in our acquisition arrangements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ongoing business and management&#8217;s attention may be disrupted or diverted by transition
                                            or integration issues and the complexity of managing geographically or culturally diverse
                                            enterprises;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may incur one-time write-offs or restructuring charges in connection with the acquisition;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may acquire goodwill and other intangible assets that are subject to amortization or impairment
                                            tests, which could result in future charges to earnings; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may not be able to realize the cost savings or other financial benefits we anticipated.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot assure you that, following any acquisition, our continued business will achieve sales levels, profitability, efficiencies or synergies
that justify the acquisition or that the acquisition will result in increased earnings for us in any future period. These factors could
have a material adverse effect on our business, financial condition and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Insurance
and contractual protections may not always cover lost revenue, increased expenses or liquidated damages payments, which could adversely
affect our financial results.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we maintain insurance and intend to obtain warranties from suppliers, obligate subcontractors to meet certain performance levels and
attempt, where feasible, to pass risks we cannot control to our customers, the proceeds of such insurance or the warranties, performance
guarantees or risk sharing arrangements may not be adequate to cover lost revenue, increased expenses or liquidated damages payments
that may be required in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to damages resulting from claims that we or our employees have wrongfully used or disclosed alleged trade secrets of their
former employers.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be subject to claims that we and our employees may have inadvertently or otherwise used or disclosed trade secrets or other proprietary
information of former employers or competitors. Litigation may be necessary to defend against these claims. We may be subject to unexpected
claims of infringement of third party intellectual property rights, either for intellectual property rights of which we are not aware,
or for which we believe are invalid or narrower in scope than the accusing party. Even if we are successful in defending against these
claims, litigation could result in substantial costs and be a distraction to management. If we fail in defending such claims, in addition
to paying money claims, we may lose valuable intellectual property rights or personnel or be enjoined from selling certain products or
providing certain services. A loss of key research personnel or their work product could hamper or prevent our ability to commercialize
certain products, which could severely harm our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Adverse
judgments or settlements in legal proceedings could materially harm our business, financial condition, operating results and cash flows.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be a party to claims that arise from time to time in the ordinary course of our business, which may include those related to, for
example, contracts, sub-contracts, protection of confidential information or trade secrets, adversary proceedings arising from customer
bankruptcies, employment of our workforce and immigration requirements or compliance with any of a wide array of state and federal statutes,
rules and regulations that pertain to different aspects of our business. We may also be required to initiate expensive litigation or
other proceedings to protect our business interests. There is a risk that we will not be successful or otherwise be able to satisfactorily
resolve any such claims or litigation. In addition, litigation and other legal claims are subject to inherent uncertainties. Those uncertainties
include, but are not limited to, litigation costs and attorneys&#8217; fees, unpredictable judicial or jury decisions and the differing
laws and judicial proclivities regarding damage awards among the states in which we operate. Unexpected outcomes in such legal proceedings,
or changes in management&#8217;s evaluation or predictions of the likely outcomes of such proceedings (possibly resulting in changes
in established reserves), could have a material adverse effect on our business, financial condition, results of operations and cash flows.
Due to recurring losses and net capital deficiency, our current financial status may increase our default and litigation risks and may
make us more financially vulnerable in the face of threatened litigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
loss of key personnel may adversely affect our operations.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends to a significant extent upon the operation, experience, and continued services of certain of our officers, and other
key personnel. While our key personnel are employed under employment contracts, there is no assurance we will be able to retain their
services. The loss of our key personnel could have an adverse effect on us. If certain of our executive officers were to leave we would
face substantial difficulty in hiring a qualified successor and could experience a loss in productivity while any successor obtains the
necessary training and experience. Furthermore, we do not maintain &#8220;key person&#8221; life insurance on the lives of any executive
officer and their death or incapacity would have a material adverse effect on us. The competition for qualified personnel is intense,
and the loss of services of certain key personnel could adversely affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Internal
system or service failures could disrupt our business and impair our ability to effectively provide our services and products to our
customers, which could damage our reputation and adversely affect our revenues and profitability.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
system or service disruptions, on our hosted cloud infrastructure or those caused by ongoing projects to improve our information technology
systems and the delivery of services, if not anticipated and appropriately mitigated, could have a material adverse effect on our business
including, among other things, an adverse effect on our ability to bill our customers for work performed on our contracts, collect the
amounts that have been billed and produce accurate financial statements in a timely manner. We are also subject to systems failures,
including network, software or hardware failures, whether caused by us, third-party service providers, cyber security threats, natural
disasters, power shortages, terrorist attacks or other events, which could cause loss of data and interruptions or delays in our business,
cause us to incur remediation costs, subject us to claims and damage our reputation. In addition, the failure or disruption of our communications
or utilities could cause us to interrupt or suspend our operations or otherwise adversely affect our business. Our property and business
interruption insurance may be inadequate to compensate us for all losses that may occur as a result of any system or operational failure
or disruption and, as a result, our future results could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Systems
failures could damage our reputation and adversely affect our revenues and profitability.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of the systems and networks that we develop, install and maintain for our customers on premise or host on our infrastructure involve
managing and protecting confidential information and other sensitive corporate and government information. While we have programs designed
to comply with relevant privacy and security laws and restrictions, if a system or network that we develop, install or maintain were
to fail or experience a security breach or service interruption, whether caused by us, third-party service providers, cyber security
threats or other events, we may experience loss of revenue, remediation costs or face claims for damages or contract termination. Any
such event could cause serious harm to our reputation and prevent us from having access to or being eligible for further work on such
systems and networks. Our errors and omissions liability insurance may be inadequate to compensate us for all of the damages that we
may incur and, as a result, our future results could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may enter into joint venture, teaming and other arrangements, and these activities involve risks and uncertainties. A failure of any
such relationship could have material adverse results on our business and results of operations.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may enter into joint venture, teaming and other arrangements. These activities involve risks and uncertainties, including the risk of
the joint venture or applicable entity failing to satisfy its obligations, which may result in certain liabilities to us for guarantees
and other commitments, the challenges in achieving strategic objectives and expected benefits of the business arrangement, the risk of
conflicts arising between us and our partners and the difficulty of managing and resolving such conflicts, and the difficulty of managing
or otherwise monitoring such business arrangements. A failure of our business relationships could have a material adverse effect on our
business and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business and operations expose us to numerous legal and regulatory requirements and any violation of these requirements could harm our
business.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to numerous federal, state and foreign legal requirements on matters as diverse as data privacy and protection, employment
and labor relations, immigration, taxation, anticorruption, import/export controls, trade restrictions, internal control and disclosure
control obligations, securities regulation and anti-competition. Compliance with diverse and changing legal requirements is costly, time-consuming
and requires significant resources. We are also focused on expanding our business in certain identified growth areas, such as health
information technology, energy and environment, which are highly regulated and may expose us to increased compliance risk. Violations
of one or more of these diverse legal requirements in the conduct of our business could result in significant fines and other damages,
criminal sanctions against us or our officers, prohibitions on doing business and damage to our reputation. Violations of these regulations
or contractual obligations related to regulatory compliance in connection with the performance of customer contracts could also result
in liability for significant monetary damages, fines and/or criminal prosecution, unfavorable publicity and other reputational damage,
restrictions on our ability to compete for certain work and allegations by our customers that we have not performed our contractual obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we do not adequately protect our intellectual property rights, we may experience a loss of revenue and our operations and growth prospects
may be materially harmed.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not registered copyrights on any of the software we have developed, and while we may register copyrights in the software if needed
before bringing suit for copyright infringement, such registration can introduce delays before suit of over three years and can constrain
damages for infringement. We rely upon confidentiality agreements signed by our employees, consultants and third parties to protect our
intellectual property. We cannot assure you that we can adequately protect our intellectual property or successfully prosecute actual
or potential infringement of our intellectual property rights. In addition, we cannot assure you that others will not assert rights in,
or ownership of, trademarks and other proprietary rights of ours or that we will be able to successfully resolve these types of conflicts
to our satisfaction. Our failure to protect our intellectual property rights may result in a loss of revenue and could materially adversely
affect our operations and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, any patents issued in the future may not provide us with any competitive advantages, and our patent applications may never
be granted. The process of obtaining patent protection is expensive and time-consuming, and we may not be able to prosecute all necessary
or desirable patent applications at a reasonable cost or in a timely manner. Even if issued, there can be no assurance that these patents
will adequately protect our intellectual property, as the legal standards relating to the validity, enforceability and scope of protection
of patent and other intellectual property rights are complex and often uncertain and are subject to change that can affect validity of
patents issued under previous legal standards, particularly with respect to the law of subject matter eligibility. Our inability to protect
our property rights could adversely affect our financial condition, operating results and growth prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
proprietary software is protected by common law copyright laws, as opposed to registration under copyright statutes. We have not registered
copyrights on any of the proprietary software we have developed. Our performance and ability to compete are dependent to a significant
degree on our proprietary technology. Common law protection may be narrower than that which we could obtain under registered copyrights.
As a result, we may experience difficulty in enforcing our copyrights against certain third party infringements. As part of our confidentiality-protection
procedures, we generally enter into agreements with our employees and consultants and limit access to, and distribution of, our software,
documentation and other proprietary information. There can be no assurance that the steps we have taken will prevent misappropriation
of our technology or that agreements entered into for that purpose will be enforceable. The laws of other countries may afford us little
or no protection of our intellectual property. We also rely on a variety of technology that we license from third parties. There can
be no assurance that these third party technology licenses will continue to be available to us on commercially reasonable terms, if at
all. The loss of or inability to maintain or obtain upgrades to any of these technology licenses could result in delays in completing
software enhancements and new development until equivalent technology could be identified, licensed or developed and integrated. Any
such delays would materially and adversely affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
growth of our business is dependent on increasing sales to our existing customers and obtaining new customers, which, if unsuccessful,
could limit our financial performance.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to increase revenues from existing customers by identifying additional opportunities to sell more of our products and services
and our ability to obtain new customers depends on a number of factors, including our ability to offer high quality products and services
at competitive prices, the strength of our competitors and the capabilities of our sales and marketing departments. If we are not able
to continue to increase sales of our products and services to existing customers or to obtain new customers in the future, we may not
be able to increase our revenues and could suffer a decrease in revenues as well.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
competitiveness depends significantly on our ability to keep pace with the rapid changes in our industry. Failure to anticipate and meet
our customers&#8217; technological needs could adversely affect our competitiveness and growth prospects.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate and compete in an industry characterized by rapid technological innovation, changing customer needs, evolving industry standards
and frequent introductions of new products, product enhancements, services and distribution methods. Our success depends on our ability
to develop expertise with these new products, product enhancements, services and distribution methods and to implement solutions that
anticipate and respond to rapid changes in technology, the industry, and customer needs. The introduction of new products, product enhancements
and distribution methods could decrease demand for current products or render them obsolete. Sales of products and services can be dependent
on demand for specific product categories, and any change in demand for or supply of such products could have a material adverse effect
on our net sales if we fail to adapt to such changes in a timely manner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurances that consumer or commercial demand for our future products will meet, or even approach, our expectations. In addition,
our pricing and marketing strategies may not be successful. Lack of customer demand, a change in marketing strategy and changes to our
pricing models could dramatically alter our financial results. Unless we are able to release location based products that meet a significant
market demand, we will not be able to improve our financial condition or the results of our future operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to sell additional products and services to our customers and increase our overall customer base, our future revenue and
operating results may suffer.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future success depends, in part, on our ability to expand the deployment of technologies with existing customers and finding new customers
to sell our products and services to. This may require increasingly sophisticated and costly sales efforts and may not result in additional
sales. In addition, the rate at which our customers purchase additional products and services, and our ability to attract new customers,
depends on a number of factors, including the perceived need for indoor mapping products and services, as well as general economic conditions.
If our efforts to sell additional products and services are not successful, our business may suffer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>



<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
operate in a highly competitive market and we may be required to reduce the prices for some of our products and services to remain competitive,
which could adversely affect our results of operations.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
industry is developing rapidly and related technology trends are constantly evolving. In this environment, we face, among other things,
significant price competition from our competitors. As a result, we may be forced to reduce the prices of the products and services we
sell in response to offerings made by our competitors and may not be able to maintain the level of bargaining power that we have enjoyed
in the past when negotiating the prices of our products and services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
profitability is dependent on the prices we are able to charge for our products and services. The prices we are able to charge for our
products and services are affected by a number of factors, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            customers&#8217; perceptions of our ability to add value through our products and services;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">introduction
                                            of new products or services by us or our competitors;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            competitors&#8217; pricing policies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to charge higher prices where market demand or the value of our products or services
                                            justifies it;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">procurement
                                            practices of our customers; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                                            economic and political conditions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are not able to maintain favorable pricing for our products and services, our results of operations could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A
delay in the completion of our customers&#8217; budget processes could delay purchases of our products and services and have an adverse
effect on our business, operating results and financial condition.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on our customers to purchase products and services from us to maintain and increase our earnings, and customer purchases are frequently
subject to budget constraints, multiple approvals and unplanned administrative, processing and other delays. If sales expected from a
specific customer are not realized when anticipated or at all, our results could fall short of public expectations and our business,
operating results and financial condition could be materially adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Digital
threats such as cyber-attacks, data protection breaches, computer viruses or malware may disrupt our operations, harm our operating results
and damage our reputation, and cyber-attacks or data protection breaches on our customers&#8217; networks, or in cloud-based services
provided by or enabled by us, could result in liability for us, damage our reputation or otherwise harm our business.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
our implementation of network security measures, the products and services we sell to customers, and our servers, data centers and the
cloud based solutions on which our data, and data of our customers, suppliers and business partners are stored, are vulnerable to cyber-attacks,
data protection breaches, computer viruses, and similar disruptions from unauthorized tampering or human error. Any such event could
compromise our networks or those of our customers, and the information stored on our networks or those of our customers could be accessed,
publicly disclosed, lost or stolen, which could subject us to liability to our customers, business partners and others, and could have
a material adverse effect on our business, operating results, and financial condition and may cause damage to our reputation. Efforts
to limit the ability of malicious third parties to disrupt the operations of the Internet or undermine our own security efforts may be
costly to implement and meet with resistance, and may not be successful. Breaches of network security in our customers&#8217; networks,
or in cloud based services provided by or enabled by us, regardless of whether the breach is attributable to a vulnerability in our products
or services, could result in liability for us, damage our reputation or otherwise harm our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Any
failures or interruptions in our services or systems could damage our reputation and substantially harm our business and results of operations.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends in part on our ability to provide reliable remote services, technology integration and managed services to our customers.
The operations of our cloud based applications and analytics are susceptible to damage or interruption from human error, fire, flood,
power loss, telecommunications failure, terrorist attacks and similar events. We could also experience failures or interruptions of our
systems and services, or other problems in connection with our operations, as a result of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">damage
to or failure of our computer software or hardware or our connections;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">errors
                                            in the processing of data by our systems;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">computer
                                            viruses or software defects;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">physical
                                            or electronic break-ins, sabotage, intentional acts of vandalism and similar events;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased
                                            capacity demands or changes in systems requirements of our customers; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">errors
                                            by our employees or third-party service providers.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
production interruptions for any reason, such as a natural disaster, epidemic, capacity shortages, or quality problems, at one of our
manufacturing partners would negatively affect sales of product lines manufactured by that manufacturing partner and adversely affect
our business and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
interruptions in our systems or services could damage our reputation and substantially harm our business and results of operations. While
we maintain disaster recovery plans and insurance with coverage we believe to be adequate, claims may exceed insurance coverage limits,
may not be covered by insurance or insurance may not continue to be available on commercially reasonable terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
rely on a limited number of key customers, the importance of which may vary dramatically from year to year, and a loss of one or more
of these key customers may adversely affect our operating results.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
top three customers accounted for approximately 27% of our gross revenue during the years ended December&#160;31, 2022 and 2021. One
customer accounted for 11% of our gross revenue in 2022, and a separate customer accounted for 12% of our gross revenue in 2021; however,
each of these customers may or may not continue to be a significant contributor to revenue in 2023. The loss of a significant amount
of business from one of our major customers would materially and adversely affect our results of operations until such time, if ever,
as we are able to replace the lost business. Significant customers or projects in any one period may not continue to be significant customers
or projects in other periods. To the extent that we are dependent on any single customer, we are subject to the risks faced by that customer
to the extent that such risks impede the customer&#8217;s ability to stay in business and make timely payments to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may need additional cash financing and any failure to obtain cash financing, could limit our ability to grow our business and develop
or enhance our service offerings to respond to market demand or competitive challenges.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we believe that we have sufficient cash funds to satisfy our working capital needs for the next 12 months, we expect that we may need
to raise funds in order to continue our operations and implement our plans to grow our business. However, if we decide to seek additional
capital, we may be unable to obtain financing on terms that are acceptable to us or at all. If we are unable to raise the required cash,
our ability to grow our business and develop or enhance our service offerings to respond to market demand or competitive challenges could
be limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we cannot collect our receivables or if payment is delayed, our business may be adversely affected by our inability to generate cash
flow, provide working capital or continue our business operations.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business depends on our ability to successfully obtain payment from our customers of the amounts they owe us for products received from
us and any work performed by us. The timely collection of our receivables allows us to generate cash flow, provide working capital and
continue our business operations. Our customers may fail to pay or delay the payment of invoices for a number of reasons, including financial
difficulties resulting from macroeconomic conditions or lack of an approved budget. An extended delay or default in payment relating
to a significant account will have a material and adverse effect on the aging schedule and turnover days of our accounts receivable.
If we are unable to timely collect our receivables from our customers for any reason, our business and financial condition could be adversely
affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
our products fail to satisfy customer demands or to achieve increased market acceptance our results of operations, financial condition
and growth prospects could be materially adversely affected.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market acceptance of our products are critical to our continued success. Demand for our products is affected by a number of factors beyond
our control, including continued market acceptance, the timing of development and release of new products by competitors, technological
change, and growth or decline in the mobile device management market. We expect the proliferation of mobile devices to lead to an increase
in the data security demands of our customers, and our products may not be able to scale and perform to meet those demands. If we are
unable to continue to meet customer demands or to achieve more widespread market acceptance of these products, our business operations,
financial results and growth prospects will be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Defects,
errors, or vulnerabilities in our products or services or the failure of such products or services to prevent a security breach, could
harm our reputation and adversely affect our results of operations.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
our location based security products and services are complex, they have contained and may contain design or manufacturing defects or
errors that are not detected until after their commercial release and deployment by customers. Defects may cause such products to be
vulnerable to advanced persistent threats (&#8220;APTs&#8221;) or security attacks, cause them to fail to help secure information or
temporarily interrupt customers&#8217; networking traffic. Because the techniques used by hackers to access sensitive information change
frequently and generally are not recognized until launched against a target, we may be unable to anticipate these techniques and provide
a solution in time to protect customers&#8217; data. In addition, defects or errors in our subscription updates or products could result
in a failure to effectively update customers&#8217; hardware products and thereby leave customers vulnerable to APTs or security attacks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
defects, errors or vulnerabilities in our products could result in:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenditure
                                            of significant financial and product development resources in efforts to analyze, correct,
                                            eliminate, or work-around errors or defects or to address and eliminate vulnerabilities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delayed
                                            or lost revenue;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">loss
                                            of existing or potential customers or partners;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased
                                            warranty claims compared with historical experience, or increased cost of servicing warranty
                                            claims, either of which would adversely affect gross margins; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation,
                                            regulatory inquiries, or investigations that may be costly and harm our reputation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
current research and development efforts may not produce successful products or features that result in significant revenue, cost savings
or other benefits in the near future. If we do not realize significant revenue from our research and development efforts, our business
and operating results could be adversely affected.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developing
products and related enhancements in our field is expensive. Investments in research and development may not result in significant design
improvements, marketable products or features or may result in products that are more expensive than anticipated. We may not achieve
the cost savings or the anticipated performance improvements expected, and we may take longer to generate revenue from products in development,
or generate less revenue than expected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future plans include significant investments in research and development and related product opportunities. Our management believes that
we must continue to dedicate a significant amount of resources to research and development efforts to maintain a competitive position.
However, we may not receive significant revenue from these investments in the near future, or these investments may not yield the expected
benefits, either of which could adversely affect our business and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Global
events such as the lasting impact of the COVID-19 pandemic and other general economic factors may impact our results of operations.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the impact of the COVID-19 pandemic is generally subsiding, the lasting impact on our business and results of operations continues to
remain uncertain. While we were able to continue operations remotely throughout the pandemic, we have and may continue to see a continued
impact of the pandemic in the deployment and implementation of our products and services as return to office initiatives remain ongoing.
In addition, other global events, such as the recent military conflict between Russian and Ukraine and other general economic factors
that are beyond our control beyond our control may impact our results of operations. These factors can include interest rates; recession;
inflation; unemployment trends; the threat or possibility of war, terrorism or other global or national unrest; political or financial
instability; and other matters that influence our customers spending. Increasing volatility in financial markets and changes in the economic
climate could adversely affect our results of operation. While we have been able to realize growth in the year ended December&#160;31,
2022 as compared to the year ended December&#160;31, 2021, the impact that these global events will have on general economic conditions
is continuously evolving and the ultimate impact that they will have on our results of operations continues to remain uncertain. There
are no assurances that we will be able to continue to experience the same growth or not be materially adversely effected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
international business exposes us to geo-political and economic factors, legal and regulatory requirements, public health and other risks
associated with doing business in foreign countries.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide our products and services to customers worldwide. These risks differ from and potentially may be greater than those associated
with our domestic business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
international business is sensitive to changes in the priorities and budgets of international customers and geo-political uncertainties,
which may be driven by changes in threat environments and potentially volatile worldwide economic conditions, various regional and local
economic and political factors, risks and uncertainties, as well as U.S. foreign policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
international sales are also subject to local government laws, regulations and procurement policies and practices, which may differ from
U.S. Government regulations, including regulations relating to import-export control, investments, exchange controls and repatriation
of earnings, as well as to varying currency, geo-political and economic risks. Our international contracts may include industrial cooperation
agreements requiring specific in-country purchases, manufacturing agreements or financial support obligations, known as offset obligations,
and provide for penalties if we fail to meet such requirements. Our international contracts may also be subject to termination at the
customer&#8217;s convenience or for default based on performance, and may be subject to funding risks. We also are exposed to risks associated
with using foreign representatives and consultants for international sales and operations and teaming with international subcontractors,
partners and suppliers in connection with international programs. As a result of these factors, we could experience award and funding
delays on international programs and could incur losses on such programs, which could negatively affect our results of operations and
financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also subject to a number of other risks including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            absence in some jurisdictions of effective laws to protect our intellectual property rights;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">multiple
                                            and possibly overlapping and conflicting tax laws;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
                                            on movement of cash;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            burdens of complying with a variety of national and local laws;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">political
                                            instability;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">currency
                                            fluctuations;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">longer
                                            payment cycles;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
                                            on the import and export of certain technologies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">price
                                            controls or restrictions on exchange of foreign currencies; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">trade
                                            barriers.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our international operations (or those of our business partners) could be subject to natural disasters such as earthquakes,
tsunamis, flooding, typhoons and volcanic eruptions that disrupt manufacturing or other operations. There may be conflict or uncertainty
in the countries in which we operate, including public health issues (for example, an outbreak of a contagious disease such as 2019-Novel
Coronavirus (2019-nCoV), avian influenza, measles or Ebola), safety issues, natural disasters, fire, disruptions of service from utilities,
nuclear power plant accidents or general economic or political factors. With respect to political factors, the United Kingdom&#8217;s
2016 referendum, commonly referred to as &#8220;Brexit,&#8221; has created economic and political uncertainty in the European Union.
Also, the European Union&#8217;s General Data Protection Regulation imposes significant new requirements on how we collect, process and
transfer personal data, as well as significant fines for non-compliance. Any of the above risks, should they occur, could result in an
increase in the cost of components, production delays, general business interruptions, delays from difficulties in obtaining export licenses
for certain technology, tariffs and other barriers and restrictions, longer payment cycles, increased taxes, restrictions on the repatriation
of funds and the burdens of complying with a variety of foreign laws, any of which could ultimately have a material adverse effect on
our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Difficult
conditions in the global capital markets and the economy generally may materially adversely affect our business and results of operations,
and we do not expect these conditions to improve in the near future.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
results of operations are materially affected by conditions in the global capital markets and the economy generally, both in the U.S.
and elsewhere around the world. Weak economic conditions generally, sustained uncertainty about global economic conditions, or a prolonged
or further tightening of credit markets could cause our customers and potential customers to postpone or reduce spending on technology
products or services or put downward pressure on prices, which could have an adverse effect on our business, results of operations or
cash flows. Concerns over inflation, energy costs, geopolitical issues and the availability of credit, in the U.S. have contributed to
increased volatility and diminished expectations for the economy and the markets going forward. These factors, combined with volatile
oil prices and wavering business and consumer confidence, have precipitated an economic slowdown and uncertain global outlook. Domestic
and international equity markets have been experiencing heightened volatility and turmoil. These events and the continuing market upheavals
may have an adverse effect on our business. In the event of extreme prolonged market events, such as the global economic recovery, we
could incur significant losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in U.S. administrative policy, including changes to existing trade agreements and any resulting changes in international relations, could
adversely affect our financial performance and supply chain economics.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of changes to U.S. administrative policy, among other possible changes, there may (i) changes to existing trade agreements;
(ii) greater restrictions on free trade generally; and (iii) significant increases in tariffs on goods imported into the United States,
particularly those manufactured in China. China is currently a leading global source of hardware products, including the hardware products
that we use. In January&#160;2020, the U.S. and China entered into Phase One of the Economic and Trade Agreement Between the United States
of America and the People&#8217;s Republic of China (the &#8220;Phase One Trade Agreement&#8221;). The Phase One Trade Agreement takes
steps to ease certain trade tensions between the U.S. and China, including tensions involving intellectual property theft and forced
intellectual property transfers by China. Although the Phase One Trade Agreement is an encouraging sign of progress in the trade negotiations
between the U.S. and China, questions still remain as to the enforcement of its terms, the resolution of a number of other points of
dispute between the parties, and the prevention of further tensions. If the U.S.-China trade dispute re-escalates or relations between
the United States and China deteriorate, these conditions could adversely affect our ability to source our hardware products and therefore
our ability to manufacture our products. Our ability to manufacture our products could also be affected by economic uncertainty, in China
or by our failure to establish a positive reputation and relationships in China. The occurrence of any of these events could have an
adverse effect on our ability to source the components necessary to manufacture our products, which, in turn, could cause our long-term
business, financial condition and operating results to be materially adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is also a possibility of future tariffs, trade protection measures, import or export regulations or other restrictions imposed on our
products or on our customers by the United States, China or other countries that could have a material adverse effect on our business.
A significant trade disruption or the establishment or increase of any tariffs, trade protection measures or restrictions could result
in lost sales adversely impacting our reputation and business. A trade war, other governmental action related to tariffs or international
trade agreements, changes in U.S. social, political, regulatory and economic conditions or in laws and policies governing foreign trade,
manufacturing, development and investment in the territories and countries where we currently do business or any resulting negative sentiments
towards the United States could adversely affect our supply chain economics, consolidated revenue, earnings and cash flow.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
intend to use and leverage open source technology in which may create risks of security weaknesses.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
parts of our technology may be based on open-source technology. There is a risk that the development team or other third parties may
intentionally or unintentionally introduce weaknesses or bugs into the core infrastructure elements of our technology solutions interfering
with the use of such technology or causing loss to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not be able to develop new products or enhance our product to keep pace with our industry&#8217;s rapidly changing technology and
customer requirements.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
industry in which we operate is characterized by rapid technological changes, new product introductions, enhancements, and evolving industry
standards. Our business prospects depend on our ability to develop new products and applications for our technology in new markets that
develop as a result of technological and scientific advances, while improving performance and cost-effectiveness. New technologies, techniques
or products could emerge that might offer better combinations of price and performance than the blockchain technology solutions that
are being developed by us. It is important that we anticipate changes in technology and market demand. If we do not successfully innovate
and introduce new technology into our anticipated technology solutions or effectively manage the transitions of our technology to new
product offerings, our business, financial condition and results of operations could be harmed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Domestic
and foreign government regulation and enforcement of data practices and data tracking technologies is expansive, broadly defined and
rapidly evolving. Such regulation could directly restrict portions of our business or indirectly affect our business by constraining
our customers&#8217; use of our technology and services or limiting the growth of our markets.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal,
state, municipal and/or foreign governments and agencies have adopted and could in the future adopt, modify, apply or enforce laws, policies,
and regulations covering user privacy, data security, technologies that are used to collect, store and/or process data, and/or the collection,
use, processing, transfer, storage and/or disclosure of data associated with individuals. The categories of data regulated under these
laws vary widely, are often broadly defined, and subject to new applications or interpretation by regulators. The uncertainty and inconsistency
among these laws, coupled with a lack of guidance as to how these laws will be applied to current and emerging indoor positioning analytics
technologies, creates a risk that regulators, lawmakers or other third parties, such as potential plaintiffs, may assert claims, pursue
investigations or audits, or engage in civil or criminal enforcement. These actions could limit the market for our services and technologies
or impose burdensome requirements on our services and/or customers&#8217; use of our services, thereby rendering our business unprofitable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
features of our services may trigger the data protection requirements of certain foreign jurisdictions, such as the EU General Data Protection
Regulation (the &#8220;GDPR&#8221;), and the EU ePrivacy Directive. In addition, our services may be subject to regulation under current
or future laws or regulations. For instance, the EU ePrivacy Directive is soon to be replaced in its entirety by the ePrivacy Regulation,
which will bring with it an updated set of rules relevant to many aspects of our business. If our treatment of data, privacy practices
or data security measures fail to comply with these current or future laws and regulations in any of the jurisdictions in which we collect
and/or process information, we may be subject to litigation, regulatory investigations, civil or criminal enforcement, financial penalties,
audits or other liabilities in such jurisdictions, or our customers may terminate their relationships with us. In addition, data protection
laws, such as the GDPR, foreign court judgments or regulatory actions could affect our ability to transfer, process and/or receive transnational
data that is critical to our operations, including data relating to users, customers, or partners outside the United States. For instance,
the GDPR restricts transfers of personal data outside of the European Economic Area, including to the United States, subject to certain
requirements. Such data protection laws, judgments or actions could affect the manner in which we provide our services or adversely affect
our financial results if foreign customers and partners are not able to lawfully transfer data to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
area of the law is currently under intense government scrutiny and many governments, including the U.S. government, are considering a
variety of proposed regulations that would restrict or impact the conditions under which data obtained from individuals could be collected,
processed, stored, transferred, sold or shared with third parties. In addition, regulators such as the Federal Trade Commission and the
California Attorney General are continually proposing new regulations and interpreting and applying existing regulations in new ways.
For example, in June&#160;2018, California passed the California Consumer Privacy Act (the &#8220;CCPA&#8221;), which provides new data
privacy rights for consumers and new informational, disclosure and operational requirements for companies, effective January&#160;2020.
Fines for non-compliance may be up to $7,500 per violation. The burdens imposed by the GDPR and CCPA, and changes to existing laws or
new laws regulating the solicitation, collection, processing, or sharing of personal and consumer information, and consumer protection
could affect our customers&#8217; utilization of our services and technology and could potentially reduce demand, or impose restrictions
that make it more difficult or expensive for us to provide our services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, ongoing legal challenges in Europe to the mechanisms allowing companies to transfer personal data from the European Economic
Area to the United States could result in further limitations on the ability to transfer data across borders, particularly if governments
are unable or unwilling to reach new or maintain existing agreements that support cross-border data transfers, such as the EU-U.S. and
Swiss-U.S. Privacy Shield frameworks and the European Commission&#8217;s Model Contractual Clauses, each of which are currently under
particular scrutiny. Additionally, certain countries have passed or are considering passing laws requiring local data residency. The
costs of compliance with, and other burdens imposed by, privacy laws, regulations and standards may limit the use and adoption of our
services, reduce overall demand for our services, make it more difficult to meet expectations from or commitments to customers, lead
to significant fines, penalties or liabilities for noncompliance, impact our reputation, or slow the pace at which we close sales transactions,
any of which could harm our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the uncertain and shifting regulatory environment and trust climate may cause concerns regarding data privacy and may cause our customers
or our customers&#8217; customers to resist providing the data necessary to allow our customers to use our services effectively. Even
the perception that the privacy of personal information is not satisfactorily protected or does not meet regulatory requirements could
inhibit sales of our products or services and could limit adoption of our cloud-based solutions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
our customers fail to abide by applicable privacy laws or to provide adequate notice and/or obtain any required consent from end users,
we could be subject to litigation or enforcement action or reduced demand for our services.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
customers utilize our services and technologies to track connected devices anonymously and we must rely on our customers to implement
and administer notice and choice mechanisms required under applicable laws. If we or our customers fail to abide by these laws, it could
result in litigation or regulatory or enforcement action against our customers or against us directly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Any
actual or perceived failure to comply with our privacy policy or legal or regulatory requirements in one or multiple jurisdictions could
result in proceedings, actions or penalties against us.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
failure or perceived failure to comply with federal, state or foreign laws or regulations, industry standards, contractual obligations
or other legal obligations, or any actual or suspected security incident, whether or not resulting in unauthorized access to, or acquisition,
release or transfer of personal data or other data, may result in governmental enforcement actions and prosecutions, private litigation,
fines and penalties or adverse publicity and could cause our customers to lose trust in us, which could have an adverse effect on our
reputation and business. Any inability to adequately address privacy and security concerns, even if unfounded, or comply with applicable
laws, regulations, policies, industry standards, contractual obligations or other legal obligations could result in additional cost and
liability to us, damage our reputation, inhibit sales and adversely affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Evolving
and changing definitions of what constitutes &#8220;Personal Information&#8221; and &#8220;Personal Data&#8221; within the EU, the United
States and elsewhere, may limit or inhibit our ability to operate or expand our business, including limiting technology alliance partners
that may involve the sharing of data.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are perceived to cause, or are otherwise unfavorably associated with, violations of privacy or data security requirements, it may
subject us or our customers to public criticism, financial penalties and potential legal liability. Existing and potential privacy laws
and regulations concerning privacy and data security and increasing sensitivity of consumers to unauthorized processing of personal data
may create negative public reactions to technologies, products and services such as ours. Public concerns regarding personal data processing,
privacy and security may cause some of our customers&#8217; end users to be less likely to visit their venues or otherwise interact with
them. If enough end users choose not to visit our customers&#8217; venues or otherwise interact with them, our customers could stop using
our platform. This, in turn, may reduce the value of our service, and slow or eliminate the growth of our business, or cause our business
to contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Around
the world, there are numerous lawsuits in process against various technology companies that process personal information and personal
data. If those lawsuits are successful, it could increase the likelihood that our company may be exposed to liability for our own policies
and practices concerning the processing of personal data and could hurt our business. Furthermore, the costs of compliance with, and
other burdens imposed by laws, regulations and policies concerning privacy and data security that are applicable to the businesses of
our customers may limit the use and adoption of our technologies and reduce overall demand for it. Privacy concerns, whether or not valid,
may inhibit market adoption of our technologies. Additionally, concerns about security or privacy may result in the adoption of new legislation
that restricts the implementation of technologies like ours or require us to make modifications to our existing services and technology,
which could significantly limit the adoption and deployment of our technologies or result in significant expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to the excise tax included in the Inflation Reduction Act of 2022 in connection with redemptions of our common stock on
or after January&#160;1, 2023.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August&#160;16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (H.R. 5376), which, among other things, imposes
a 1% excise tax on certain domestic corporations that repurchase their stock on or after January&#160;1, 2023 (the &#8220;Excise Tax&#8221;).
The Excise Tax is imposed on the fair market value of the repurchased stock, with certain exceptions. The Excise Tax is expected to apply
to any redemptions of our Class A common stock occurring on or after January&#160;1, 2023, including redemptions in connection with the
Business Combination, unless an exemption is available. Issuances of securities in connection with the Business Combination are expected
to reduce the amount of the Excise Tax in connection with redemptions occurring in the same calendar year, but the fair market value
of securities redeemed may exceed the fair market value of securities issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
cash and cash equivalents may be exposed to failure of our banking institutions.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we seek to minimize our exposure to third-party losses of our cash and cash equivalents, we hold our balances in a number of large financial
institutions. Notwithstanding, those institutions are subject to risk of failure. For example, on March&#160;10, 2023, Silicon Valley
Bank (&#8220;SVB&#8221;) was unable to continue their operations and the Federal Deposit Insurance Corporation was appointed as receiver
for SVB and created the National Bank of Santa Clara to hold the deposits of SVB after SVB was unable to continue their operations. As
of March&#160;20, 2023, substantially all of our cash and cash equivalents are held with other large financial institutions, and we do
not expect further developments with SVB to have a material impact on our cash and cash equivalents balance, expected results of operations,
or financial performance for the foreseeable future. However, if further failures in financial institutions occur where we hold deposits,
we could experience additional risk. Any such loss or limitation on our cash and cash equivalents would adversely affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Relating to Ownership of our Securities</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b><i>The
market price of our securities have been, and are likely going to continue to be, volatile and fluctuate substantially, which could cause
the value of your investment to decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The
trading price of our Common Stock, as well as our warrants, has been, and is likely going to continue to be volatile. Since the closing
of our initial business combination through June 29, 2023, our stock price has ranged from $1.21 to $21.00. The stock market and our
securities have experienced extreme volatility in the past and may experience similar volatility moving forward. This volatility often
has been unrelated or disproportionate to the operating performance of particular companies. You may not be able to resell your shares
at an attractive price due to a number of factors including the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">results
                                            of operations that vary from the expectations of securities analysts and investors;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">results
                                            of operations that vary from those of our competitors;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in expectations as to our future financial performance, including financial estimates and
                                            investment recommendations by securities analysts and investors;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">price
                                            and volume fluctuations in the market prices of stocks generally;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">strategic
                                            actions by us or our competitors;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in how enterprises perceive the benefits of our platform and products;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            by us or our competitors of new products, solutions or technologies or significant contracts,
                                            acquisitions, joint ventures, other strategic relationships or capital commitments;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            significant change in our management or departures of key personnel;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in general economic or market conditions or trends in our industry or markets;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in business or regulatory conditions, including new laws or regulations or new interpretations
                                            of existing laws or regulations applicable to our business;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">future
                                            sales of our Common Stock or other securities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investor
                                            perceptions or the investment opportunity associated with our Common Stock relative to other
                                            investment alternatives;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            public&#8217;s response to press releases or other public announcements by us or third parties,
                                            including our filings with the SEC;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation
                                            involving us, our industry, or both, or investigations by regulators into our operations
                                            or those of our competitors;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">guidance,
                                            if any, that we provide to the public, any changes in this guidance or our failure to meet
                                            this guidance;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            development and sustainability of an active trading market for our Common Stock;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actions
                                            by institutional or activist stockholders;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in accounting standards, policies, guidelines, interpretations or principles;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                                            economic and political conditions such as recessions, interest rates, fuel prices, trade
                                            wars, pandemics (such as COVID-19), currency fluctuations and acts of war or terrorism; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            effects of natural disasters, terrorist attacks and the spread and/or abatement of infectious
                                            diseases, such as COVID-19, including with respect to potential operational disruptions,
                                            labor disruptions, increased costs, and impacts to demand related thereto.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
broad market and industry fluctuations may adversely affect the market price of our Common Stock, regardless of our actual operating
performance. In addition, price volatility may be greater if the public float and trading volume of our Common Stock is low.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the past, following periods of market volatility, stockholders have instituted securities class action litigation. If we were involved
in securities litigation, it could have a substantial cost and divert resources and the attention of executive management from our business
regardless of the outcome of such litigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
qualify as an &#8220;emerging growth company&#8221; within the meaning of the Securities Act, and if we take advantage of certain exemptions
from disclosure requirements available to emerging growth companies, it could make our securities less attractive to investors and may
make it more difficult to compare our performance to the performance of other public companies.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &#8220;emerging growth company&#8221; within the meaning of the Securities Act, as modified by the JOBS Act, and for as long as
we continue to be an emerging growth company, we may take advantage of certain exemptions from various reporting requirements that are
applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply
with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive
compensation in this prospectus and our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding
advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As a result,
our stockholders may not have access to certain information they may deem important. We cannot predict whether investors will find our
securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result
of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less
active trading market for our securities and the trading prices of our securities may be more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such
extended transition period, which means that when a standard is issued or revised and it has different application dates for public or
private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth
company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of
the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we cease to be an emerging growth company, we will no longer be able to take advantage of certain exemptions from reporting, and, absent
other exemptions or relief available from the SEC, we will also be required to comply with the auditor attestation requirements of Section&#160;404
of the Sarbanes-Oxley Act. We will incur additional expenses in connection with such compliance and our management will need to devote
additional time and effort to implement and comply with such requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
do not intend to pay dividends on our Common Stock, so any returns will be substantially limited to the value of our Common Stock.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no current plans to pay any cash dividends on our Common Stock. The declaration, amount and payment of any future dividends on shares
of our Common Stock will be at the sole discretion of our Board. We currently anticipate that we will retain future earnings for the
development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends from future earnings
for the foreseeable future. Our Board may take into account general and economic conditions, our financial condition and results of operations,
our available cash and current and anticipated cash needs, capital requirements, contractual, legal, tax, and regulatory restrictions,
implications on our or our subsidiaries&#8217; payment of dividends to our stockholders and such other factors as our Board may deem
relevant. In addition, our ability to pay dividends is limited by our indebtedness and may be limited by covenants of any future indebtedness
we incur. As a result, you may not receive any return on an investment in our Common Stock unless you sell our Common Stock for a price
greater than that which you paid for it.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
securities analysts do not publish research or reports about our business or if they publish inaccurate or unfavorable research about
our Common Stock, the stock price and trading volume of our Common Stock could decline.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for our Common Stock will rely, in part, on the research and reports that industry or financial analysts publish about
us or our business. In addition, some financial analysts may have limited expertise with our model and operations. Furthermore, if one
or more of the analysts who do cover us downgrade their evaluations of our Common Stock, the price of our Common Stock could decline.
If one or more of these analysts ceases to cover us, we could lose visibility in the market for our Common Stock, which in turn could
cause our stock price or trading volume to decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Any
future sales or offerings of our common stock may cause substantial dilution to stockholders and could cause the price of our Common
Stock to decline.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sale of shares of our Common Stock in the public market, or the perception that such sales could occur, could harm the prevailing market
price of shares of our Common Stock. These sales, or the possibility that these sales may occur, also might make it more difficult for
us to sell equity securities in the future at a time and at a price that it deems appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Insider Letter (as defined in the Sponsor Support Agreement), during the Founder Shares Lock-Up Period (as defined in the Insider
Letter), KINS&#8217; directors and executive officers will not, subject to the exceptions noted therein, sell, transfer, assign, pledge,
encumber, hypothecate or similarly dispose of any shares of our Common Stock, or any stock options, restricted stock units, or other
equity awards outstanding as of immediately following the Closing in respect of our awards outstanding immediately following the Closing.
Following the expiration or waiver of the Lockup Period, such shares will be eligible for resale, subject to volume, manner of sale and
other limitations under Rule&#160;144. Sales of substantial amounts of our Common Stock in the public market, or the perception that
such sales will occur, could adversely affect the market price of our Common Stock and make it difficult for us to raise funds through
securities offerings in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the stockholders to the Registration Rights Agreement, dated as of December&#160;14, 2020, that was entered into by KINS, the Sponsor
and the other parties thereto in connection with the KINS initial public offering exercise their registration rights, the market price
of shares of our Common Stock could drop significantly if the holders of these shares sell them or are perceived by the market as intending
to sell them. These factors could also make it more difficult for us to raise additional funds through future offerings of our Common
Stock or other securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the shares of our Common Stock reserved for future issuance under our equity incentive plans will become eligible for sale
in the public market once those shares are issued, subject to provisions relating to various vesting agreements and, in some cases, limitations
on volume and manner of sale applicable to affiliates under Rule&#160;144, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future, we may also issue our securities in connection with investments or acquisitions. The amount of shares of our Common Stock
issued in connection with an investment or acquisition could constitute a material portion of our Common Stock. Any issuance of additional
securities in connection with investments or acquisitions may result in additional dilution to our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Anti-takeover
provisions in our organizational documents could delay or prevent a change of control.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
provisions of our Charter and Bylaws have an anti-takeover effect and may delay, defer or prevent a merger, acquisition, tender offer,
takeover attempt or other change of control transaction that a stockholder might consider in its best interest, including those attempts
that might result in a premium over the market price for the shares held by our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions provide for, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            classified board of directors whose members serve staggered three-year terms;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            ability of our Board to issue shares of preferred stock, including &#8220;blank check&#8221;
                                            preferred stock and to determine the price and other terms of those shares, including preferences
                                            and voting rights, without stockholder approval, which could be used to significantly dilute
                                            the ownership of a hostile acquirer;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">advance
                                            notice for nominations of directors by stockholders and for stockholders to include matters
                                            to be considered at our annual meetings;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                            cumulative voting in the election of directors, which limits the ability of minority stockholders
                                            to elect director candidates;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">certain
                                            limitations on convening special stockholder meetings;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limiting
                                            the ability of stockholders to act by written consent;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            limitation of the liability of, and the indemnification of, our directors and officers;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">providing
                                            that our Board is expressly authorized to make, alter or repeal our bylaws; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            removal of directors only for cause and only upon the affirmative vote of holders of the
                                            majority of the voting power of all of the then outstanding shares of our voting stock entitled
                                            to vote at an election of directors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
anti-takeover provisions could make it more difficult for a third party to acquire us, even if the third-party&#8217;s offer may be considered
beneficial by many of our stockholders. As a result, our stockholders may be limited in their ability to obtain a premium for their shares.
These provisions could also discourage proxy contests and make it more difficult for you and other stockholders to elect directors of
your choosing and to cause us to take other corporate actions you desire. See &#8220;<i>Description of Capital Stock</i>&#8221; for more
information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Charter designates the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings
that may be initiated by our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for
disputes with us or our directors, officers, employees or stockholders.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Charter provides that, subject to limited exceptions, any (1) derivative action, suit or proceeding brought on behalf of us, (2) action,
suit or proceeding asserting a claim of breach of a fiduciary duty owed by any of our director, officer or stockholder to us or our stockholders,
(3) action, suit or proceeding arising pursuant to any provision of the DGCL or the Charter or the Bylaws (as either may be amended from
time to time), (4) any action, suit or proceeding as to which the DGCL confers jurisdiction on the Court of Chancery of the State of
Delaware or (5) action, suit or proceeding asserting a claim against us or any current or former director, officer or stockholder governed
by the internal affairs doctrine of the State of Delaware shall, to the fullest extent permitted by applicable law, be exclusively brought
in the Court of Chancery of the State of Delaware or, if such court lacks subject matter jurisdiction thereof, another state or federal
court located within the State of Delaware; provided that, (i) unless we consent in writing to the selection of an alternative forum,
the federal district courts of the United States of America will, to the fullest extent permitted by law, be the sole and exclusive forum
for the resolution of any complaint asserting a cause of action arising under the Securities Act and (ii) such exclusive forum provision
shall not apply to claims or causes of action brought to enforce any liability or duty created by the Exchange Act or any other claim
for which the federal courts of the United States have exclusive jurisdiction. Any person or entity purchasing or otherwise acquiring
any interest in shares of our capital stock shall be deemed to have notice of and to consent to the provisions of the Charter. This choice
of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes
with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and
employees. Alternatively, if a court were to find these provisions of the Charter inapplicable to, or unenforceable in respect of, one
or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other
jurisdictions, which could adversely affect our business and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
requirements of being a public company, including compliance with the reporting requirements of the Exchange Act and the Nasdaq, require
significant resources, increase our costs and distract our management, and we may be unable to comply with these requirements in a timely
or cost-effective manner. We will incur increased costs as a result of operating as a public company, and our management will devote
substantial time to new compliance initiatives.</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
CXApp has previously operated as a privately owned company and expects to incur additional legal, regulatory, finance, accounting, investor
relations and other administrative expenses as a result of having publicly traded common stock. In addition, we will be required under
the Sarbanes-Oxley Act, as well as rules adopted by the SEC and Nasdaq to implement specified corporate governance practices that previously
did not apply to Legacy CXApp as a private company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company with equity securities listed on Nasdaq, we will need to comply with rules and regulations of the SEC and the requirements
of Nasdaq. Complying with these rules, regulations and requirements will occupy a significant amount of the time of our board of directors
and management and will significantly increase our costs and expenses. Furthermore, if any issues in complying with those requirements
are identified (for example, if the auditors identify a material weakness or significant deficiency in the internal control over financial
reporting), we could incur additional costs rectifying those issues, and the existence of those issues could adversely affect our reputation
or investor perceptions of it. In addition, as a public company we will incur substantial costs to obtain director and officer liability
insurance policies. These factors could make it more difficult for us to attract and retain qualified members of our board of directors,
particularly to serve on our audit committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will be required to ensure that we have the ability to prepare financial statements on a timely basis that fully comply with all SEC
reporting requirements and maintain effective internal controls over financial reporting. The additional demands associated with being
a public company may disrupt regular operations of our business by diverting the attention of some of our senior management team away
from revenue producing activities to management and administrative oversight, adversely affecting our ability to attract and complete
business opportunities and increasing the difficulty in both retaining professionals and managing and growing our businesses. In addition,
failure to comply with any laws or regulations applicable to us as a public company may result in legal proceedings and/or regulatory
investigations, and may cause reputational damage. Any of these effects could harm our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_009"></span>USE
OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the shares of common stock and warrants offered by the Selling Securityholders will be sold by them for their respective accounts.
We will not receive any of the proceeds from these sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Due
to the significant number of redemptions of our Class A common stock in connection with our Business Combination, the shares of common
stock being registered for issuance or resale are anticipated to constitute a considerable percentage of our public float. Additionally,
all the shares of common stock being registered for resale were purchased by the Selling Securityholders for prices considerably below
the current market price of our Class A common stock. This discrepancy in purchase prices may have an impact on the market perception
of the stock&#8217;s value and could contribute to potential downward pressure on the public trading price of our Class A common stock.
The registration of these shares for resale creates the possibility of a significant increase in the supply of our Class A common stock
in the market. The increased supply, coupled with the potential disparity in purchase prices, may lead to heightened selling pressure,
which could negatively affect the public trading price of our Class A common stock. We will not receive the proceeds from the resale
of the shares of common stock or warrants by the Selling Securityholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>The
exercise price of the warrants, in certain circumstances, may be higher than the prevailing market price of the underlying securities.
The exercise price of the warrants is subject to market conditions and may not be advantageous if the prevailing market price of the
underlying securities is lower than the exercise price. The cash proceeds associated with the exercise of warrants to purchase our common
stock are contingent upon our stock price. The value of our common stock may fluctuate and may not align with the exercise price of the
warrants at any given time. If the warrants are &#8220;out of the money,&#8221; meaning the exercise price is higher than the market
price of our common stock, there is a high likelihood that warrant holders may choose not to exercise their warrants. As a result, we
may not receive any proceeds from the exercise of such warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Furthermore,
with regard to the Private Placement Warrants, it is possible that we may not receive cash upon their exercise since these warrants may
be exercised on a cashless basis. A cashless exercise allows warrant holders to convert the warrants into shares of our common stock
without the need for a cash payment. Instead of receiving cash upon exercise, the warrant holder would receive a reduced number of shares
based on a predetermined formula or method as further described in &#8220;<i>Description of Capital Stock</i>&#8221; further below. As
a result, the number of shares received through a cashless exercise may be lower than if the warrants were exercised on a cash basis,
which could impact the value and dilution of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholders will pay any underwriting fees, discounts, selling commissions, stock transfer taxes and certain legal expenses
incurred by such Selling Securityholders in disposing of their shares of common stock and warrants, and we will bear all other costs,
fees and expenses incurred in effecting the registration of such securities covered by this prospectus, including, without limitation,
all registration and filing fees, Nasdaq listing fees and fees and expenses of our counsel and our independent registered public accountants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_010"></span>DETERMINATION
OF OFFERING PRICE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot currently determine the price or prices at which shares of Common Stock or Warrants may be sold by the Selling Securityholders
under this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_011"></span>DIVIDEND
POLICY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our capital stock. We currently intend to retain all available funds and future earnings,
if any, to fund the development and growth of the business, and therefore, do not anticipate declaring or paying any cash dividends on
our Common Stock in the foreseeable future. Any future determination related to our dividend policy will be made at the discretion of
our board of directors after considering our business prospects, results of operations, financial condition, cash requirements and availability,
debt repayment obligations, capital expenditure needs, contractual restrictions, covenants in the agreements governing current and future
indebtedness, industry trends, the provisions of Delaware law affecting the payment of dividends and distributions to stockholders and
any other factors or considerations the board of directors deems relevant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_012"></span>MARKET
INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Our
Common Stock and Warrants are listed on Nasdaq under the symbols &#8220;CXAI&#8221; and &#8220;CXAIW,&#8221; respectively. Prior to the
consummation of the Business Combination, the Class A common stock, units and warrants were listed on Nasdaq under the symbols &#8220;KINZ,&#8221;
&#8220;KINZU&#8221; and &#8220;KINZW,&#8221; respectively. As of June 29, 2023, there were approximately 45 holders of record of our
shares of Class A Common Stock, approximately 45 holders of record of shares of Class C Common Stock and approximately six holders of
record of our redeemable Warrants. The actual number of stockholders of our Common Stock and the actual number of holders of our Warrants
is greater than the number of record holders and includes holders of our Common Stock or Warrants whose shares of Common Stock or Warrants
are held in street name by brokers and other nominees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_013"></span>UNAUDITED
PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following unaudited pro forma condensed combined financial information presents the combination of the financial information of KINS
and CXApp adjusted to give effect to the Business Combination and related transactions. The following unaudited pro forma condensed combined
financial information has been prepared in accordance with Article 11 of Regulation S-X. Defined terms included below have the same meaning
as terms defined and included in the prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
historical financial information of KINS was derived from the audited financial statements of KINS as of and for the year ended December&#160;31,
2022. The historical financial information of CXApp was derived from the audited combined carve-out financial statements of Design Reactor
and subsidiaries as of and for the year ended December&#160;31, 2022, included elsewhere in this Report. Such unaudited pro forma financial
information has been prepared on a basis consistent with the financial statements of KINS and Design Reactor and subsidiaries, respectively.
This information should be read together with the financial statements of KINS and Design Reactor and subsidiaries and related notes,
the sections titled &#8220;<i>KINS</i>&#8217; <i>Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</i>&#8221;
and &#8220;<i>Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations of Design Reactor, Inc and
Subsidiaries</i>&#8221; and other information included in the prospectus and this registration statement, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination will be accounted for using the acquisition method (as a forward merger), with goodwill and other identifiable intangible
assets recorded in accordance with GAAP, as applicable. Under this method of accounting, CXApp is treated as the &#8220;acquired&#8221;
company for financial reporting purposes. KINS has been determined to be the accounting acquirer because KINS maintains control of the
Board of Directors and management of the combined company. For accounting purposes, the acquirer is the entity that has obtained control
of another entity and, thus, consummated a business combination. Under the acquisition method of accounting (as a forward merger), KINS&#8217;
assets and liabilities will be recorded at carrying value and the assets and liabilities associated with CXApp will be recorded at estimated
fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired, if
applicable, will be recognized as goodwill. The process of valuing the net assets of CXApp immediately prior to the merger for purposes
of presentation within this unaudited pro forma condensed combined financial information is preliminary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined balance sheet as of December&#160;31, 2022 combines the historical balance sheets of KINS and
CXApp on a pro forma basis as if the Business Combination and related transactions had been consummated on December&#160;31, 2022. The
unaudited pro forma condensed combined statement of operations for the year ended December&#160;31, 2022 gives pro forma effect to the
Business Combination and related transactions as if they had occurred on January&#160;1, 2022, the beginning of the earliest period presented.
KINS and CXApp have not had any historical operating relationship prior to the Business Combination. Accordingly, no pro forma adjustments
were required to eliminate activities between the companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
unaudited pro forma condensed combined financial statements are for informational purposes only. They do not purport to indicate the
results that would have been obtained had the Business Combination and related transactions actually been completed on the assumed date
or for the periods presented, or which may be realized in the future. The pro forma adjustments are based on the information currently
available and the assumptions and estimates underlying the pro forma adjustments are described in the accompanying notes. Actual results
may differ materially from the assumptions within the accompanying unaudited pro forma condensed combined financial information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
of the Merger Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;25, 2022, KINS entered into the Merger Agreement, by and among KINS, Inpixon, CXApp, and Merger Sub, pursuant to which
KINS will combine with CXApp, Inpixon&#8217;s Enterprise Apps Business. Also on September&#160;25, 2022, and in connection with the execution
of the Merger Agreement, KINS, Inpixon, CXApp and the Sponsor entered into the Sponsor Support Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
prior to the Merger and pursuant to the Separation and Distribution Agreement, dated as of September&#160;25, 2022, among KINS, Inpixon,
CXApp and Design Reactor, and other ancillary conveyance documents, Inpixon, among other things and on the terms and subject to the conditions
of the Separation and Distribution Agreement, transferred the Enterprise Apps Business, including certain related subsidiaries of Inpixon,
including Design Reactor, to CXApp and, in connection therewith, effected the Distribution by distributing to Inpixon securityholders
100% of the CXApp Common Stock, as further described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
following the Distribution, in accordance with and subject to the terms and conditions of the Merger Agreement, Merger Sub merged with
and into CXApp, with CXApp continuing as the surviving company in the Merger and as a wholly-owned subsidiary of KINS (the Merger).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>



<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement, along with the Separation and Distribution Agreement and the other transaction documents entered into in connection
therewith, provides for, among other things, the consummation of the following transactions (collectively, the &#8220;Business Combination&#8221;):
(i) Inpixon agreed to transfer the Enterprise Apps Business to its wholly-owned subsidiary, CXApp, and contribute $10 million in capital
thereto (net of cash held by CXApp as of the Effective Time), (ii) following the Separation, Inpixon agreed to distribute 100% of the
shares of CXApp Common Stock to Inpixon securityholders by way of the Distribution and (iii) following the completion of the foregoing
transactions and subject to the satisfaction or waiver of certain other conditions set forth in the Merger Agreement, the parties agreed
to consummate the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Business Combination, New CXApp has two classes of common stock: New CXApp Class A Common Stock and New CXApp Class C Common Stock.
The New CXApp Class A Common Stock and the New CXApp Class C Common Stock are identical in all respects, except that the New CXApp Class
C Common Stock is subject to transfer restrictions and automatically converts into New CXApp Class A Common Stock on the earlier to occur
of (i) the 180th day following the closing of the Merger and (ii) the day that the last reported sale price of the New CXApp Class A
Common Stock equals or exceeds $12.00 per share for any 20 trading days within any 30-trading day period following the closing of the
Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the closing of the Business Combination, each share of KINS Class A Common Stock and Class B Common Stock was exchanged for one share
of New CXApp Class A Common Stock, subject to adjustment pursuant to the Sponsor Support Agreement noted below. Additionally, the outstanding
shares of CXApp Common Stock after the Distribution and immediately prior to the effective time of the Merger were converted into an
aggregate of 6.9 million shares of New CXApp Common Stock which were issued to Inpixon shareholders, subject to adjustment. Each holder&#8217;s
aggregate merger consideration consisted of 10% New CXApp Class A Common Stock and 90% New CXApp Class C Common Stock (such percentages,
in each case, subject to adjustment to comply with the listing requirements set forth under Nasdaq Listing Rule&#160;5505(b)(2). Pursuant
to the Sponsor Support Agreement, the Sponsor and related parties have agreed that, subject to the limitation set forth therein, the
total amount of shares of New CXApp Common Stock issued to CXApp Stockholders (as of immediately after consummation of the Distribution)
at the Closing will exceed the total amount of shares of New CXApp Common Stock issued to all other parties at the Closing by one share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summarizes the pro forma ownership of Common Stock of New CXApp following the Business Combination:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Class A</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Class C</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total<br/>
Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left">CXApp existing Stockholders<sup>(1)</sup></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,547,700</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">11.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,487,300</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">39.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,035,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">50.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">KINS Public Stockholders<sup>(2)(7)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">157,223</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">157,223</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.1</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Sponsor<sup>(3)(6)(7)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,054,776</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,054,776</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Direct Anchor Investors<sup>(4)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">225,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">225,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.6</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Inpixon<sup>(5)(6)(7)</sup></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">598,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4.3</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">598,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4.3</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Pro forma Common Stock</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">8,582,699</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">61.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,487,300</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">39.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">14,069,999</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">100.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(1)</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
New CXApp Class A Common Stock and the New CXApp Class C Common Stock will be identical in all respects, except that the New CXApp Class
C Common Stock will be subject to transfer restrictions and will automatically convert into New CXApp Class A Common Stock on the earlier
to occur of (i) the 180th day following the closing of the Merger and (ii) the day that the last reported sale price of the New CXApp
Class A Common Stock equals or exceeds $12.00 per share for any 20 trading days within any 30-trading day period following the closing
of the Merger. Includes 135,000 shares of New CXApp Common Stock issuable pursuant to a working capital adjustment.</i></span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="text-align: justify; width: 0in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(2)</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Excludes
13,800,000 shares of New CXApp Class A Common Stock underlying the public warrants.</i></span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="text-align: justify; width: 0in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(3)</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Excludes
10,280,000 shares of New CXApp Class A Common Stock underlying the private warrants.</i></span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="text-align: justify; width: 0in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(4)</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Includes
225,000 shares of New CXApp Class A Common Stock held by BlackRock Inc. and reflecting forfeiture to Sponsor of 525,000 shares of KINS
Class B Common Stock prior to Closing.</i></span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="text-align: justify; width: 0in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(5)</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reflects
shares of New CXApp Class A Common Stock attributable to Inpixon for its existing interests in KINS.</i></span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="text-align: justify; width: 0in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(6)</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pursuant
to the Sponsor Support Agreement, the Sponsor and related parties have agreed, subject to the limitation set forth therein, to forfeit
22,224 shares of New CXApp Common Stock (as of immediately prior to the consummation of the Merger).</i></span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="text-align: justify; width: 0in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(7)</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reflects
the redemptions of 230,328 KINS public shares prior to Closing.</i></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
PRO FORMA CONDENSED COMBINED BALANCE SHEET</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AS
OF DECEMBER&#160;31, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(in
thousands, except share and per share amounts)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Autonomous</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Transaction</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Pro</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">KINS</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">CXApp</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Entity</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accounting</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Forma</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Historical)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Historical)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Combined</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 36%; text-align: left">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">224</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,308</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,692</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 2%; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A</b></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,579</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 2%; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C</b></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,223</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(580</td><td style="text-align: left">)</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Accounts receivable, net of allowances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,338</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,338</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Notes and other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">273</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">273</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">650</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">654</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt">Total current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">228</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,569</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,692</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">999</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">13,488</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Cash and investments held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,924</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,345</td><td style="text-align: left">)</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,579</td><td style="text-align: left">)</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">202</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">202</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Operating lease right-of-use asset, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">681</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">681</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Software development costs, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">487</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(487</td><td style="text-align: left">)</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,102</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,102</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,289</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,681</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,970</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Other assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">52</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">52</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 2.5pt">Total Assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,152</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">29,280</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,692</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">40,371</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,495</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,054</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,054</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,834</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,736</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,699</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,037</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(232</td><td style="text-align: left">)</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Operating lease obligation, current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,162</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">226</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,388</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Acquisition liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(197</td><td style="text-align: left">)</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Promissory note - related party working capital loan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">348</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(348</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E</b></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,231</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,415</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,148</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,794</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Operating lease obligation, noncurrent</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">444</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">444</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Other liabilities, noncurrent</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Derivative liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">722</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">722</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt">Total Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,953</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,889</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,148</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,990</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Temporary Equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Common stock subject to possible redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,914</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,345</td><td style="text-align: left">)</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,569</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G</b></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt">Total temporary equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,914</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,914</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stockholders&#8217; Equity (Deficit)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Class A Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Class B Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1</td><td style="text-align: left">)</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Class C Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Parent&#8217;s net equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,391</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,692</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(27,280</td><td style="text-align: left">)</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,569</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">71,918</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70,349</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,716</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,699</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D</b></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(7,415</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt">Total stockholders&#8217; equity (deficit)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,715</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">23,391</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,692</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">41,137</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">64,505</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.5in; text-align: left; padding-bottom: 2.5pt">Total liabilities, temporary equity and stockholders&#8217; equity (deficit)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,152</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">29,280</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,692</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">40,371</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,495</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEAR ENDED DECEMBER&#160;31, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(in
thousands, except share and per share amounts)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Autonomous</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Transaction</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Pro</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">KINS</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">CXApp</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Entity</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Accounting</td><td style="font-weight: bold">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Forma</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Historical)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Historical)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Combined</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 36%; text-align: left">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,470</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 2%; text-align: center">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,470</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Cost of revenues</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,064</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,064</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Gross profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,406</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,406</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Formation and operating costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,951</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,951</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,323</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,323</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,096</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,096</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,571</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">811</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AA</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,699</td><td style="text-align: left">&#160;</td>
    <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CC</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,081</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Acquisition-related costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Impairment of goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,540</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,540</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Amortization of intangibles</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,885</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(162</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DD</b></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,723</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,951</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">35,431</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">811</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,537</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">42,730</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Loss from operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,951</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(29,025</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(811</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,537</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(36,324</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Other income (expense):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Interest income, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Other expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Gain on elimination waiver of deferred underwriting fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">372</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">372</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Change in fair value of derivative liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,553</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,553</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Interest earned on cash and investments held in Trust Account</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">422</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(422</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BB</b></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left">Total other income (expense)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,347</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(422</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10,928</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Income (loss) before income taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,396</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(29,022</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(811</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,959</td><td style="padding-bottom: 1pt; text-align: left">)</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(25,396</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Income tax expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(49</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(153</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(202</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">8,347</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(29,175</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(811</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(3,959</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(25,598</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Net income (loss) per share (Note 4):</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Class A common stock (basic &amp; diluted)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1.82</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Class B common stock (basic &amp; diluted)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Class C common stock (basic &amp; diluted)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1.82</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Weighted average shares outstanding:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Class A common stock (basic &amp; diluted)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,546,423</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,582,699</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Class B common stock (basic &amp; diluted)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,900,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Class C common stock (basic &amp; diluted)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,487,300</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO<br/>
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
1. Basis of Presentation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination will be accounted for using the acquisition method (as a forward merger), with goodwill and other identifiable intangible
assets recorded in accordance with GAAP, as applicable. Under this method of accounting, CXApp is treated as the &#8220;acquired&#8221;
company for financial reporting purposes. KINS has been determined to be the accounting acquirer because KINS maintains control of the
Board of Directors and management of the combined company. For accounting purposes, the acquirer is the entity that has obtained control
of another entity and, thus, consummated a business combination. Under the acquisition method of accounting (as a forward merger), KINS&#8217;
assets and liabilities will be recorded at carrying value and the assets and liabilities associated with CXApp will be recorded at estimated
fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired, if
applicable, will be recognized as goodwill. Significant estimates and assumptions were used in determining the preliminary purchase price
allocation reflected in these unaudited pro forma condensed combined financial statements. As the unaudited pro forma condensed combined
financial statements have been prepared based on these preliminary estimates, the final amounts recorded may differ materially from the
information presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined balance sheet as of December&#160;31, 2022 gives effect to the Business Combination and related
transactions as if they occurred on December&#160;31, 2022. The unaudited pro forma condensed combined statement of operations for the
year ended December&#160;31, 2022 gives effect to the Business Combination and related transactions as if they occurred on January&#160;1,
2022. These periods are presented on the basis that KINS is the acquirer for accounting purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma adjustments reflecting the consummation of the Business Combination and the related transaction are based on currently available
information and certain assumptions and methodologies that New CXApp management believes are reasonable under the circumstances. The
unaudited condensed combined pro forma adjustments, which are described in the accompanying notes, may be revised as additional information
becomes available and is evaluated. Therefore, it is likely that the actual adjustments will differ from the pro forma adjustments, and
it is possible that the difference may be material. New CXApp management believes that its assumptions and methodologies provide a reasonable
basis for presenting all of the significant effects of the Business Combination and the related transactions based on information available
to management at this time and that the pro forma adjustments give appropriate effect to those assumptions and are properly applied in
the unaudited pro forma condensed combined financial information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial information does not give effect to any anticipated synergies, operating efficiencies,
tax savings, or cost savings that may be associated with the Business Combination. The unaudited pro forma condensed combined financial
information is not necessarily indicative of what the actual results of operations and financial position would have been had the Business
Combination and related transactions taken place on the dates indicated, nor are they indicative of the future consolidated results of
operations or financial position of the post-combination company. They should be read in conjunction with the historical financial statements
and notes thereto of KINS and Design Reactor and subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
2. Accounting Policies and Reclassifications</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of the Business Combination, management will perform a comprehensive review of the two entities&#8217; accounting policies.
As a result of the review, management may identify differences between the accounting policies of the two entities which, when conformed,
could have a material impact on the financial statements of New CXApp. Based on its initial analysis, management did not identify any
differences that would have a material impact on the unaudited pro forma condensed combined financial information. As a result, the unaudited
pro forma condensed combined financial information does not assume any differences in accounting policies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
3. Adjustments to Unaudited Pro Forma Condensed Combined Financial Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited pro forma condensed combined financial information has been prepared to illustrate the effect of the Business Combination and
related transactions and has been prepared for informational purposes only. The Company has elected not to present management adjustments
and will only be presenting transaction accounting adjustments and autonomous entity adjustments in the unaudited pro forma condensed
combined financial information. The autonomous entity adjustments are management estimates to reflect incremental costs of CXApp being
a standalone entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pro forma basic and diluted earnings per share amounts presented in the unaudited pro forma condensed combined statement of operations
are based upon the number of shares of New CXApp Common Stock outstanding, assuming the Business Combination and related transactions
occurred on January&#160;1, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Autonomous
Entity Adjustments to Unaudited Pro Forma Condensed Combined Balance Sheet</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
autonomous entity adjustments included in the unaudited pro forma condensed combined balance sheet as of December&#160;31, 2022 are as
follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            Inpixon&#8217;s remaining contribution to CXApp of approximately $3.7 million in accordance
                                            with the Separation and Distribution Agreement, in which Inpixon has agreed to contribute
                                            cash of $10 million to CXApp, net of cash held by CXApp as of the Effective Time (approximately
                                            $6.3 million as of December&#160;31, 2022).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transaction
Accounting Adjustments to Unaudited Pro Forma Condensed Combined Balance Sheet</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction accounting adjustments included in the unaudited pro forma condensed combined balance sheet as of December&#160;31, 2022
are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
                                            redemptions of 230,328 KINS public shares prior to closing, for aggregate payments to redeeming
                                            shareholders of $2.3 million at a redemption price of $10.18 per share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
                                            the reclassification of $1.6 million held in the Trust Account after redemptions, inclusive
                                            of interest earned on the Trust Account, to cash and cash equivalents that becomes available
                                            at closing of the Business Combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            non-recurring estimated transaction costs inclusive of advisory, banking, printing, legal
                                            and accounting fees incurred in connection to the Business Combination. Estimated total transaction
                                            costs of approximately $6.1 million are anticipated to be paid after closing, of which $2.4
                                            million is accrued on the historical financial statements of KINS. Transaction costs expected
                                            to be incurred by CXApp and KINS in connection with the Business Combination totaling $2.8
                                            million and $3.3 million, respectively, are expensed as incurred in accordance with ASC 805.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            the settlement of franchise taxes payable by KINS totaling $0.2 million and repayment of
                                            a KINS related party promissory note totaling $0.3 million at closing of the Business Combination.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
                                            the settlement of the acquisition liability by New CXApp and Inpixon. The acquisition liability
                                            relates to the acquisition of Design Reactor (CXApp) by Inpixon in 2021 which Inpixon has
                                            assumed and therefore will not be an obligation of New CXApp. Inpixon has settled the remaining
                                            acquisition related obligations with the sellers.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
                                            the reclassification of approximately $1.6 million of KINS Class A Common Stock to permanent
                                            equity and conversion of KINS Class B Common Stock to New CXApp Class A Common Stock.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            adjustments for the estimated preliminary purchase price allocation for the Business Combination.
                                            The preliminary calculation of total consideration is presented below as if the Business
                                            Combination was consummated on December&#160;31, 2022:</span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Fair Value</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(in thousands)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Equity consideration
    to CXApp existing Stockholders<sup>(1)</sup></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">69,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Working capital
    adjustment<sup>(2)</sup></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,350</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Total consideration</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">70,350</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Assets acquired:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,338</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Notes and other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">273</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">650</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">202</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Operating lease right-of-use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">681</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Trade names and trademarks</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,960</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,654</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Developed technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,040</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Non-compete agreements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Intellectual property</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,777</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Internal software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">487</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">42,102</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left">Total assets acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">76,268</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Liabilities assumed:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,054</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,736</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,388</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Operating lease obligations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">710</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Other liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt">Total liabilities assumed</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,918</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.5in; text-align: left; padding-bottom: 2.5pt">Estimated fair value of net assets acquired</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">70,350</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(1)</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Represents
the pre-transaction equity value of CXApp of $69.0 million issuable to existing CXApp Stockholders in 6,900,000 shares of New CXApp Common
Stock consisting of 10% New CXApp Class A Common Stock and 90% New CXApp Class C Common Stock (such percentages, in each case, subject
to adjustment to comply with NASDAQ listing requirements), each at a deemed value of $10.00 per share.</i></span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="text-align: justify; width: 0in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(2)</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Represents
additional equity consideration issuable to existing CXApp Stockholders in 135,000 shares of New CXApp Common Stock pursuant to a working
capital adjustment.</i></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below
is a summary of intangible assets identified and acquired in the Business Combination based on the preliminary purchase price allocation
and the resulting adjustments to recognize the step-up in basis:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Fair Value</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Useful Life</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Identified Intangible Assets (in thousands)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(Years)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Trade names and trademarks</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,960</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,502</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7.00</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,654</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,018</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Developed technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,741</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Non-compete agreements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,362</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.58</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Intellectual property</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,777</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,777</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Internal software</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">487</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">487</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">2.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">20,970</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,681</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
represents the excess of total consideration over the estimated fair value of the net assets acquired and is largely attributable to
synergies and acquired workforce. Approximately $42.1 million has been allocated to goodwill pursuant to the preliminary purchase price
allocation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC Topic 350, <i>Goodwill and Other Intangible Assets</i>, Goodwill will not be amortized, but instead will be tested
for impairment at least annually or more frequently if certain indicators are present. In the event that the value of goodwill or other
intangible assets have become impaired, an accounting charge for impairment during the period in which the determination is made may
be recognized. The Company is evaluating whether the goodwill is deductible for income tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
adjustment also eliminates the pro forma historical equity of CXApp of approximately $27.3 million in accordance with the acquisition
accounting at closing, and reflects the issuance of 7,035,000 shares of New CXApp Common Stock at a deemed value of $10.00 per share
as merger consideration at closing within the par value accounts of New CXApp Class A and Class C Common Stock, respectively, and additional
paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Autonomous
Entity Adjustments to Unaudited Pro Forma Condensed Combined Statements of Operations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
autonomous entity adjustments included in the unaudited pro forma condensed combined statements of operations for the year ended December&#160;31,
2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AA.
Reflects estimated incremental general and administrative expenses to reflect CXApp as a standalone entity, primarily including additional
compensation costs, insurance, and other general and administrative costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transaction
Accounting Adjustments to Unaudited Pro Forma Condensed Combined Statements of Operations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction accounting adjustments included in the unaudited pro forma condensed combined statements of operations for the year ended
December&#160;31, 2022 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BB.
Reflects elimination of investment income on the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CC.
Reflects estimated transaction costs not yet recognized within the historical financial information presented of approximately $3.7 million
to be expensed as if incurred on January&#160;1, 2022, the date the Business Combination occurred for the purposes of the unaudited pro
forma condensed combined statement of operations. This is a non-recurring item.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DD.
Represents incremental adjustments to intangible asset amortization for the step-up in basis of intangible assets subject to amortization
acquired in the Business Combination assuming the Business Combination occurred on January&#160;1, 2022. The following table is a summary
of information related to certain intangible assets acquired, including information used to calculate the amortization expense for each
period presented:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Amortization for</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">the Year Ended</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Identified Intangible Assets (in thousands)</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Fair<br/>
Value</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Years of<br/>
Amortization</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December&#160;31,<br/>
2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Trade names and trademarks</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,960</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">423</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Customer relationships</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,654</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,131</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Developed technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,004</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Non-compete agreements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.58</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Intellectual property</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,777</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">889</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Internal software</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">487</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">2.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">244</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Total amortization expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,723</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note
4. Net Loss per Share</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss per share was calculated using the historical weighted average shares outstanding, and the issuance of additional shares in connection
with the Business Combination and the related transactions, assuming the shares were outstanding since January&#160;1, 2022. As the Business
Combination and the related transactions are being reflected as if they had occurred at the beginning of the earliest period presented,
the calculation of weighted average shares outstanding for basic and diluted net loss per share assumes that the shares issuable relating
to the Business Combination and related transactions have been outstanding for the entirety of all periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; font-weight: bold; text-align: center">Year Ended<br/>
December&#160;31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022<sup>(1)</sup></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Class A</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Class C</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Pro forma net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(15,615</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(9,983</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Weighted average shares outstanding - basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,582,699</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,487,300</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Pro forma net loss per share - basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1.82</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1.82</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: left">Excluded securities:<sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,800,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,800,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Private Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,280,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,280,000</td><td style="text-align: left">&#160;</td></tr>
  </table>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(1)</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pro
forma net loss per share includes the related pro forma adjustments as referred to within the section &#8220;Unaudited Pro Forma Condensed
Combined Financial Information.&#8221;</i></span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="text-align: justify; width: 0in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(2)</i></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
potentially dilutive outstanding securities were excluded from the computation of pro forma net loss per share, basic and diluted, because
their effect would have been anti-dilutive.</i></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_014"></span>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF<br/>
OPERATIONS OF DESIGN REACTOR, INC. AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with the accompanying
condensed consolidated financial statements, combined carve-out financial statements and related notes included elsewhere in this prospectus.
Some of the information contained in this discussion and analysis or set forth elsewhere, including information with respect to its plans
and strategy for our business and related financing, includes forward-looking statements that involve risks, uncertainties and assumptions.
You should read the &#8220;Forward-Looking Statements&#8221; and &#8220;Risk Factors&#8221; for a discussion of important factors that
could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained
in the following discussion and analysis.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussion refers to the financial results of Design Reactor, Inc. and Subsidiaries, for the years ended December&#160;31,
2022, and December&#160;31, 2021. For purposes of this following discussion the terms &#8220;we&#8221;, &#8216;our&#8221; or &#8220;us&#8221;
or &#8220;the Company&#8221; and similar references refers to Design Reactor, Inc. and Subsidiaries and its affiliates. The terms defined
in this section shall have the meaning ascribed to it in this section only. Except for per share data and as otherwise indicated, all
dollar amounts set out herein are in millions.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview
of Our Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Design
Reactor, Inc. and subsidiaries is in the business of delivering a workplace experience platform for enterprise customers. Our technologies
and solutions help enterprise customers deliver a comprehensive business journey in a work &#8216;from-anywhere&#8217; world for employees,
partners, customers and visitors. We offer native mapping, analytics, on-device positioning (or ODP) and applications technologies that
aim to bring people together.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
customers use our enterprise solutions in a variety of ways, including, but not limited to, workplace experience, employee engagement,
desk and meeting room reservations, workplace analytics, occupancy management, content delivery, corporate communications and notifications,
event management, live indoor mapping, wayfinding and navigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
enterprise app platform is the intersection of technology, intelligence, automation and experience for today&#8217;s hybrid workplace
and the workplace of the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the closing of the Business Combination, Design Reactor, Inc. and subsidiaries were wholly owned subsidiary of Inpixon (&#8220;Inpixon&#8221;)
and the Company&#8217;s financial statements consist of Design Reactor, Inpixon Canada, Inpixon Philippines and select assets, liabilities,
revenues and expenses of Inpixon and Inpixon India (collectively the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;),
show the historical combined carve-out financial position, results of operations, changes in net investment and cash flows of the Company
and should be read in conjunction with the accompanying notes thereto. The Company&#8217;s combined carve-out financial statements do
not necessarily reflect what the results of operations, financial position, or cash flows would have been had the Company been a separate
entity nor are they indicative of future results of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
combined carve-out operating results of the Company have been specifically identified based on the Company&#8217;s existing divisional
organization. The majority of the assets and liabilities of the Company have been identified based on the existing divisional structure.
The historical costs and expenses reflected in the Company&#8217;s financial statements include an allocation for certain corporate and
shared service functions. Management believes the assumptions underlying our combined carve-out financial statements are reasonable.
Nevertheless, our combined carve-out financial statements may not include all of the actual expenses that would have been incurred had
we operated as a standalone company during the periods presented and may not reflect our results of operations, financial position and
cash flows had we operated as a standalone company during the periods presented. Actual costs that would have been incurred if we had
operated as a standalone company would depend on multiple factors, including organizational structure and strategic decisions made in
various areas, including information technology and infrastructure. We also may incur additional costs associated with being a standalone,
publicly listed company that were not included in the expense allocations and, therefore, would result in additional costs that are not
reflected in our historical results of operations, financial position and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>The
unaudited condensed consolidated financial statements of Successor and Predecessor are not comparable due to a new basis of accounting
that was created from the business combination that occurred on the Closing Date. Therefore, the reporting period has been separated
by a black line in the condensed consolidated financial statements with the Predecessor representing the pre-Closing Date period (January
1, 2023 through March 14, 2023) and the Successor representing the post-Closing Date period (March 15, 2023 through March 31, 2023).
The Company noted that the &#8220;Predecessor&#8221; includes financial information related to the Enterprise Apps Business, while the
&#8220;Successor&#8221; includes financial information related to the newly formed company after the business combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>



<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Events</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;25, 2022, an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), was entered into by and among Inpixon,
KINS Technology Group Inc., a Delaware corporation (&#8220;KINS&#8221;), CXApp Holding Corp., a Delaware corporation and newly formed
wholly-owned subsidiary of Inpixon (&#8220;CXApp&#8221;), and KINS Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary
of KINS (&#8220;Merger Sub&#8221;), pursuant to which KINS acquired Inpixon&#8217;s enterprise apps business (including its workplace
experience technologies, indoor mapping, events platform, augmented reality and related business solutions) (the &#8220;Enterprise Apps
Business&#8221;) in exchange for the issuance of shares of KINS capital stock valued at $69 million (the &#8220;Business Combination&#8221;).
The transaction closed on March&#160;14, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
prior to the Merger and pursuant to a Separation and Distribution Agreement, dated as of September&#160;25, 2022, among KINS, Inpixon,
CXApp and Design Reactor, (the &#8220;Separation Agreement&#8221;), and other ancillary conveyance documents, Inpixon, among other things
and on the terms and subject to the conditions of the Separation Agreement, transferred the Enterprise Apps Business, including certain
related subsidiaries of Inpixon, including Design Reactor, to CXApp (the &#8220;Reorganization&#8221;). Following the Reorganization,
Inpixon distributed 100% of the common stock of CXApp, par value $0.00001, to certain holders of Inpixon securities as of the record
date (the &#8220;Spin-Off&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
following the Spin-Off, in accordance with and subject to the terms and conditions of the Merger Agreement, Merger Sub merged with and
into CXApp (the &#8220;Merger&#8221;), with CXApp continuing as the surviving company and as a wholly-owned subsidiary of KINS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement, along with the Separation and Distribution Agreement and the other transaction documents entered into in connection
therewith, provided for, among other things, the consummation of the following transactions: (i) Inpixon transferred the Enterprise Apps
Business (the &#8220;Separation&#8221;) to its wholly-owned subsidiary, CXApp, and contributed approximately $4 million in additional
cash so that CXApp would have a minimum of $10 million in cash and cash equivalents as of the closing of the Business Combination before
deduction of expenses (the &#8220;Cash Contribution&#8221;), (ii) following the Separation, Inpixon distributed 100% of the shares of
CXApp Common Stock to Inpixon securityholders by way of the Distribution and (iii) following the completion of the foregoing transactions
and subject to the satisfaction or waiver of certain other conditions set forth in the Merger Agreement, the parties consummated the
Merger. The Separation, Distribution and Merger were intended to qualify as &#8220;tax-free&#8221; transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time the Business Combination was effected (the &#8220;Closing&#8221;), the outstanding shares of CXApp Common Stock after the Distribution
and immediately prior to the effective time of the Merger were converted into an aggregate of 7,035,000 shares of KINS Common Stock which
was issued to Inpixon securityholders, subject to adjustment. Each holder&#8217;s aggregate merger consideration consisted of approximately
22% KINS Class A Common Stock and approximately 78% KINS Class C Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>Resale
of Shares in this Registration Statement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>The
Company has filed this registration statement for the resale of a substantial number of shares, which has the potential to significantly
impact the market for our company&#8217;s common stock. When a large number of shares become available for sale, it can create an imbalance
between supply and demand, potentially resulting in downward pressure on the market price of the common stock. The increased supply of
shares from this resale could outweigh the existing demand, leading to a potential decline in market price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Investors
should carefully consider the impact of the Sponsor&#8217;s ability to sell all of its shares, given their significant ownership stake
of approximately 43% of outstanding shares of common stock. The sale of these shares by the Sponsor could have a notable effect on the
overall market for our common stock. It is crucial for investors to evaluate the potential consequences of this significant ownership
concentration and its potential impact on the market price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Furthermore,
the availability of the registration statement allows the Sponsor to sell its shares at any time while the registration statement remains
effective. This unrestricted ability to sell shares may increase the supply of shares in the market, potentially exerting further downward
pressure on the market price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Due
to the significant number of redemptions of our Class A common stock in connection with our Business Combination, the shares of common
stock being registered for issuance or resale are anticipated to constitute a considerable percentage of our public float. Additionally,
all the shares of common stock being registered for resale were purchased by the Selling Securityholders for prices considerably below
the current market price of our Class A common stock. This discrepancy in purchase prices may have an impact on the market perception
of the stock&#8217;s value and could contribute to potential downward pressure on the public trading price of our Class A common stock.
The registration of these shares for resale creates the possibility of a significant increase in the supply of our Class A common stock
in the market. The increased supply, coupled with the potential disparity in purchase prices, may lead to heightened selling pressure,
which could negatively affect the public trading price of our Class A common stock. We will not receive the proceeds from the resale
of the shares of common stock by the Selling Securityholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>The
exercise price of the warrants, in certain circumstances, may be higher than the prevailing market price of the underlying securities.
The exercise price of the warrants is subject to market conditions and may not be advantageous if the prevailing market price of the
underlying securities is lower than the exercise price. The cash proceeds associated with the exercise of warrants to purchase our common
stock are contingent upon our stock price. The value of our common stock may fluctuate and may not align with the exercise price of the
warrants at any given time. If the warrants are &#8220;out of the money,&#8221; meaning the exercise price is higher than the market
price of our common stock, there is a high likelihood that warrant holders may choose not to exercise their warrants. As a result, we
may not receive any proceeds from the exercise of such warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Furthermore,
with regard to the Private Placement Warrants, it is possible that we may not receive cash upon their exercise since these warrants may
be exercised on a cashless basis. A cashless exercise allows warrant holders to convert the warrants into shares of our common stock
without the need for a cash payment. Instead of receiving cash upon exercise, the warrant holder would receive a reduced number of shares
based on a predetermined formula or method as further described in &#8220;<i>Description of Capital Stock</i>&#8221; further below. As
a result, the number of shares received through a cashless exercise may be lower than if the warrants were exercised on a cash basis,
which could impact the value and dilution of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting
Treatment for the Business Combination</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination will be accounted for using the acquisition method (as a forward merger), with goodwill and other identifiable intangible
assets recorded in accordance with GAAP, as applicable. Under this method of accounting, CXApp is treated as the &#8220;acquired&#8221;
company for financial reporting purposes. KINS has been determined to be the accounting acquirer because KINS maintains control of the
Board of Directors and management of the combined company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Key
Factors Affecting Design Reactor&#8217;s Results of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
financial position and results of operations depend to a significant extent on the following factors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Customer
Base</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
customer base is currently operating within approximately 17 different industries, including approximately 24% in software and technology,
24% in healthcare and 20% in retail. Approximately 85% of our customers are headquartered in the United States; however, our products
are deployed across more than 400 customer campuses located in approximately 240 cities and over 55 countries throughout the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management uses key metrics such as total revenue growth, recurring and non-recurring revenue, existing customer expansion rates, number
of customer campuses (which management believes is a more meaningful metric to measure performance than total number of customers), and
churn rates to measure customer growth and market penetration. The CXApp carve-out financials show that our revenue has increased from
approximately $6.4M for the twelve-month period ending December&#160;2021 to approximately $8.5M for the twelve-month period ending December&#160;31,
2022 (which was as a result of a full year of the acquisition of Design Reactor in April&#160;2021). Approximately 65% of the Company&#8217;s
revenue was recurring in 2022 and approximately 53% was recurring in 2021. Approximately 40% of our customers have expanded to add additional
revenue opportunities with new campuses, features, or integrations within twelve months of initial deployment and we have an average
quarterly customer churn rate of less than 5% for the twelve months ended December&#160;31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to increase revenues from existing customers by identifying additional opportunities to sell more of our products and services
and our ability to obtain new customers depends on a number of factors, including our ability to offer high quality products and services
at competitive prices, the strength of our competitors and the capabilities of our sales and marketing departments. If we are not able
to continue to increase sales of our products and services to existing customers or to obtain new customers in the future, we may not
be able to increase our revenues and could suffer a decrease in revenues as well.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
top three customers accounted for approximately 27% of our gross revenue during each of the years ended December&#160;31, 2022 and 2021.
One customer accounted for 11% of our gross revenue in 2022 and a separate customer accounted for 12% in 2021; however, each of these
customers may or may not continue to be a significant contributor to revenue in 2023. The loss of a significant amount of business from
one of our major customers would materially and adversely affect our results of operations until such time, if ever, as we are able to
replace the lost business. Significant customers or projects in any one period may not continue to be significant customers or projects
in other periods. To the extent that we are dependent on any single customer, we are subject to the risks faced by that customer to the
extent that such risks impede the customer&#8217;s ability to stay in business and make timely payments to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Competition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
industry is developing rapidly and related technology trends are constantly evolving. In this environment, we face, among other things,
significant price competition from our competitors. As a result, we may be forced to reduce the prices of the products and services we
sell in response to offerings made by our competitors and may not be able to maintain the level of bargaining power that we have enjoyed
in the past when negotiating the prices of our products and services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
profitability is dependent on the prices we are able to charge for our products and services. The prices we are able to charge for our
products and services are affected by a number of factors, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
customers&#8217; perceptions of our ability to add value through our products and services;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="text-align: justify; width: 0.25in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">introduction
of new products or services by us or our competitors;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="text-align: justify; width: 0.25in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
competitors&#8217; pricing policies;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="text-align: justify; width: 0.25in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
ability to charge higher prices where market demand or the value of our products or services justifies it;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="text-align: justify; width: 0.25in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">procurement
practices of our customers; and</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="text-align: justify; width: 0.25in"/><td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
economic and political conditions.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are not able to maintain favorable pricing for our products and services, our results of operations could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and Development</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future plans include investments in research and development and related product opportunities. Our management believes that we must
continue to dedicate resources to research and development efforts to maintain a competitive position. However, if we do not receive
significant revenue from these investments, if the investments don&#8217;t yield expected benefits or if we don&#8217;t have the needed
funding to invest in the technology, our results of operations could be adversely impacted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pandemic
and World Environment</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business has been impacted by the COVID-19 pandemic and general macroeconomic conditions and may continue to be impacted. While we have
been able to continue operations remotely, we have and continue to experience impact in the demand of certain products and delays in
certain projects and customer orders either because of customer facilities being partially or fully closed during the pandemic or because
of the uncertainty of the customer&#8217;s financial position and ability to invest in our technology. If we are unable to successfully
respond and manage the impact of the pandemic, and the resulting responses to it, our business, operations, financial condition and results
of operations could be adversely impacted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Components
of Results of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenues</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company derives revenue from software as a service, design, deployment and implementation services for its enterprise apps business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of Revenues</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenues includes the direct costs to deliver the services including labor, overhead, hardware and shipping and freight costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Gross
Profit</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
profit, calculated as revenues less costs of revenues, may vary between periods and is primarily affected by various factors including
average selling prices, product costs, product mix, customer mix, and production volumes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Expenses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
expenses consist primarily of research and development costs, sales and marketing costs, and general and administrative costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Income (expense)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
income (expense) consists primarily of interest expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RESULTS
OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Comparison
of the results of operations for the periods ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor), and the three
months ended March 31, 2022 (Predecessor)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our results of operations. This data should be read together with our unaudited financial statements and related
notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: left"><span>(in thousands)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to<br/>
    March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    January&#160;1,<br/>
    2023 to<br/>
    March&#160;14,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Three
    months<br/>
    ended<br/>
    March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Condensed
    Consolidated Statements of Operations Data</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; font-weight: bold; text-align: left"><span>Revenues</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>342</span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>1,620</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>2,582</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Cost
    of revenues</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>87</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>483</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>589</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Gross
    profit</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>255</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>1,137</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>1,993</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    expenses</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>742</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>5,518</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>3,565</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Loss
    from operations</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(487</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(4,381</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(1,572</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Other
    income (expense), net</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>1,685</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>1</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>1</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Income
    tax benefit/(provision)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>1,560</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>-</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(100</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Net
    income (loss)</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>2,758</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>(4,380</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>)</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>(1,671</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenues</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company derives revenue from subscription software as a service, design, deployment and implementation services for its enterprise apps
business. Revenue was $342&#160;thousand and $1,620&#160;thousand for the period ended March 31, 2023 (Successor) and the period ended
March 14, 2023 (Predecessor), respectively, compared to $2,582 thousand for the three months ended March 31, 2022 (Predecessor). This
decrease of $620&#160;thousand is primarily attributable to timing of sales and level of bookings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gross
Margin</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenues includes the direct costs to deliver the services including labor and overhead. Cost of revenues were $87&#160;thousand and
$483&#160;thousand for the period ended March 31, 2023 (Successor) and the period ended March 14, 2023 (Predecessor), respectively, compared
to $589&#160;thousand for the three months ended March 31, 2022 (Predecessor). The gross profit margin was 75% and 70% for the period
ended March 31, 2023 (Successor) and the period ended March 14, 2023 (Predecessor), respectively, compared to 77% for the three months
ended March 31, 2022 (Predecessor). This fluctuation in gross margin is primarily due to the sales mix during the year and the timing
of related support expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Operating
Expenses </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Operating
expenses consist primarily of research and development costs, sales and marketing costs, and general and administrative costs. Operating
expenses were $742&#160;thousand and $5,518&#160;thousand for the period ended March 31, 2023 (Successor) and the period ended March
14, 2023 (Predecessor), respectively, compared to $3,565&#160;thousand for the three months ended March 31, 2022 (Predecessor). This
increase of $2,695&#160;thousand is primarily attributable to a $2,827 thousand benefit recorded during the three months ended March
31, 2022 (Predecessor) related to an earnout.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Income/(Expense)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
income/(expense) was an $1,685&#160;thousand in income and $1&#160;thousand in income for the period ended March 31, 2023 (Successor)
and the period ended March 14, 2023 (Predecessor), respectively, compared to $1&#160;thousand in income for the three months ended March
31, 2022 (Predecessor). This increase in other income was primarily attributable to changes in fair value of derivative warrant liabilities
of $1,686&#160;thousand during the period ended March 31, 2023 (Successor).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Provision
for Income Taxes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>There was
an income tax benefit of approximately $1,560&#160;thousand and $0&#160;thousand for the period ended March 31, 2023 (Successor) and
the period ended March 14, 2023 (Predecessor), respectively, compared income tax expense of $100&#160;thousand for the three months ended
March 31, 2022 (Predecessor). <span style="background-color: white">The income tax benefit relates for the </span>period ended March
31, 2023 (Successor) <span style="background-color: white">primarily a result of the release of valuation allowance attributable to acquired
intangible assets from the Business Combination.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>



<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-GAAP
Financial information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>EBITDA</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company includes a non-GAAP measure that we use to supplement our results presented in accordance with U.S. GAAP. EBITDA is defined as
earnings before interest and other income, tax and depreciation and amortization. Adjusted EBITDA is used by our management as the matrix
in which it manages the business. It is defined as EBITDA plus adjustments for other income or expense items, non- recurring items and
non-cash stock-based compensation. Adjusted EBITDA is a performance measure that we believe is useful to investors and analysts because
it illustrates the underlying financial and business trends relating to our core, recurring results of operations and enhances comparability
between periods.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
EBITDA is not a recognized measure under U.S. GAAP and is not intended to be a substitute for any U.S. GAAP financial measure and, as
calculated, may not be comparable to other similarly titled measures of performance of other companies in other industries or within
the same industry. Investors should exercise caution in comparing our non-GAAP measure to any similarly titled measure used by other
companies. This non-GAAP measure excludes certain items required by U.S. GAAP and should not be considered as an alternative to information
reported in accordance with U.S. GAAP. The table below presents our adjusted EBITDA, reconciled to net income for the periods indicated
(in thousands).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; background-color: white"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold; background-color: white"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; background-color: white"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold; background-color: white"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; background-color: white"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to<br/>
    March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold; background-color: white"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; background-color: white"><span>Period
    from<br/> January&#160;1,<br/> 2023 to<br/>
    March&#160;14,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold; background-color: white"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; background-color: white"><span>Three
    months<br/>
    ended<br/>
    March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold; background-color: white"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; font-weight: bold; text-align: left; padding-bottom: 1pt"><span>Net
    income (loss)</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>$</span></td><td style="width: 9%; padding-bottom: 1pt; text-align: right"><span>2,758</span></td><td style="border-right: Black 1.5pt solid; width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>$</span></td><td style="width: 9%; padding-bottom: 1pt; text-align: right"><span>(4,380</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>$</span></td><td style="width: 9%; padding-bottom: 1pt; text-align: right"><span>(1,671</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Interest
    and other (income)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: right"><span>1</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"/><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: right"><span>(1</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: right"><span>(1</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Income
    tax (benefit)/provision</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: right"><span>(1,560</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: right"><span>-</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: right"><span>100</span></td><td style="padding-bottom: 1pt; text-align: left"/></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Depreciation
    and amortization</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>120</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>1,034</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>1,120</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; vertical-align: top"><span>EBITDA</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: right"><span>1,319</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: right"><span>(3,347</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt; text-align: right"><span>(452</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Adjusted
    for:</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Earnout
    compensation expense (benefit)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>-</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(2,827</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Changes
    in fair value of warrant liabilities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(1,686</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Unrealized
    (gains) losses</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>3</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(32</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(266</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Stock-based
    compensation - compensation and related benefits</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>2</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>158</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>647</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Adjusted
    EBITDA</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(362</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(3,221</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(2,898</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on Adjusted EBITDA, which is a non-GAAP financial measure for the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            compare our current operating results with corresponding periods and with the operating results
                                            of other companies in our industry&#894;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            a basis for allocating resources to various projects&#894;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            a measure to evaluate potential economic outcomes of acquisitions, operational alternatives
                                            and strategic decisions&#894; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            evaluate internally the performance of our personnel.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have presented Adjusted EBITDA above because we believe it conveys useful information to investors regarding our operating results. We
believe it provides an additional way for investors to view our operations, when considered with both our GAAP results and the reconciliation
to net income (loss). By including this information, we can provide investors with a more complete understanding of our business. Specifically,
we present Adjusted EBITDA as supplemental disclosure because of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            believe Adjusted EBITDA is a useful tool for investors to assess the operating performance
                                            of our business without the effect of interest, income taxes, depreciation and amortization
                                            and other non- cash items including acquisition transaction and financing costs, impairment,
                                            unrealized gains, stock based compensation, interest income and expense, and income tax benefit.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            believe that it is useful to provide to investors with a standard operating metric used by
                                            management to evaluate our operating performance&#894; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            believe that the use of Adjusted EBITDA is helpful to compare our results to other companies.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
though we believe Adjusted EBITDA is useful for investors, it does have limitations as an analytical tool. Thus, we strongly urge investors
not to consider this metric in isolation or as a substitute for net income (loss) and the other condensed consolidated statement of operations
data prepared in accordance with GAAP. Some of these limitations include the fact that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
                                            EBITDA does not reflect our cash expenditures or future requirements for capital expenditures
                                            or contractual commitments&#894;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
                                            EBITDA does not reflect changes in, or cash requirements for, our working capital needs&#894;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
                                            EBITDA does not reflect the significant interest expense or the cash requirements necessary
                                            to service interest or principal payments on our debt&#894;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
                                            depreciation and amortization are non-cash charges, the assets being depreciated and amortized
                                            will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash
                                            requirements for such replacements&#894;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
                                            EBITDA does not reflect income or other taxes or the cash requirements to make any tax payments&#894;
                                            and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                            companies in our industry may calculate Adjusted EBITDA differently than we do, thereby potentially
                                            limiting its usefulness as a comparative measure.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of these limitations, Adjusted EBITDA should not be considered a measure of discretionary cash available to us to invest in the growth
of our business or as a measure of performance in compliance with GAAP. We compensate for these limitations by relying primarily on our
GAAP results and providing Adjusted EBITDA only as supplemental information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
describes the ability of a company to generate sufficient cash flows to meet the cash requirements of its business operations, including
working capital needs, debt service, acquisitions, contractual obligations and other commitments. We assess liquidity in terms of our
cash flows from operations and their sufficiency to fund our operating and investing activities. As of March 31, 2023 (Successor), our
principal source of liquidity was cash and cash equivalents of $6,724&#160;thousand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financing
Obligations and Requirements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>As of March
31, 2023 (Successor), the Company has a working capital surplus of approximately $3,052&#160;thousand, and cash and cash equivalents
of approximately $6,724&#160;thousand. For the period ended March 31, 2023 (Successor), the Company had a net income of approximately
$2,758&#160;thousand. During the period ended March 31, 2023 (Successor), the Company used approximately $4,431&#160;thousand of cash
for operating activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company cannot assure you that we will ever earn revenues sufficient to support our operations, or that we will ever be profitable. To
the extent that our resources from the business combination are insufficient to satisfy our cash requirements, we may enter into equity
or debt financing transactions. These transactions are expected to provide us additional cash to fund our capital and liquidity requirements
in the short and long-term. If the financing is not available, or if the terms of financing are less desirable than we expect, we may
be forced to take actions to reduce our capital or operating expenditures, including by not seeking potential acquisition opportunities,
or eliminating redundancies, which may adversely affect our business, operating results, financial condition and prospects. Our business
has been impacted by the COVID-19 pandemic and general macroeconomic conditions and may continue to be impacted. While we have been able
to continue operations remotely, we have and continue to experience impact in the demand of certain products and delays in certain projects
and customer orders either because customer facilities being partially or fully closed during the pandemic or because of the uncertainty
of the customer&#8217;s financial position and ability to invest in our technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            total impact that COVID-19 and general macroeconomic conditions may continue to impact our
                                            results of operations continues to remain uncertain and there are no assurances that we will
                                            be able to continue to experience the same growth or not be materially adversely affected.
                                            The Company&#8217;s recurring losses and utilization of cash in its operations are indicators
                                            of going concern however with the Company&#8217;s current liquidity position and access to
                                            capital markets, the Company believes it has the ability to mitigate such concerns for a
                                            period of at least one year from the date this financial statements were made issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s net cash flows used in operating, investing and financing activities and certain balances are as follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to<br/>
    March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    January&#160;1,<br/>
    2023 to<br/>
    March&#160;14,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Three
    months<br/>
    ended<br/>
    March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td colspan="10" style="text-align: center"/><td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span><b>Cash
    flows (used in) provided by</b></span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"><span>Net
    cash used in operating activities</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>(4,431</span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>)</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>(5,144</span></td><td style="width: 1%; text-align: left"><span>)</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>(4,140</span></td><td style="width: 1%; text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    cash provided by (used in) investing activities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>9,980</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(54</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(51</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    cash (used in) provided by financing activities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(328</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>8,892</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>4,553</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Effect
    of exchange rates on cash</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>-</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>1</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>4</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Net
    increase in cash and cash equivalents</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>5,221</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>3,695</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>366</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0"><span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="border-left: Black 1.5pt solid; font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>March&#160;31,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="border-left: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>December&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Cash
    and cash equivalents</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>6,724</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="border-left: Black 1.5pt solid; width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>6,308</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Working
    capital surplus</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>3,052</span></td><td style="text-align: left"><span>&#160;</span></td><td style="border-left: Black 1.5pt solid"><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>3,154</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating
Activities for the periods ended March 31, 2023 (Successor), March 14, 2023 (Predecessor), and the three months ended March 31, 2022
(Predecessor)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to<br/>
    March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    January&#160;1,<br/>
    2023 to<br/>
    March&#160;14,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Three
    months<br/>
    ended<br/>
    March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"><span>Net
    income (loss)</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>2,758</span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>(4,380</span></td><td style="width: 1%; text-align: left"><span>)</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>(1,671</span></td><td style="width: 1%; text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Non-cash
    income and expenses</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(3,113</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>1,200</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(1,272</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Net
    change in operating assets and liabilities</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(4,076</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(1,964</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(1,197</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span>Net
    cash used in operating activities</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>(4,431</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>)</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>(5,144</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>)</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>(4,140</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>&#160;</span></p>



<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash
Flows from Investing Activities for the periods ended March 31, 2023 (Successor), March 14, 2023 (Predecessor), and the three months
ended March 31, 2022 (Predecessor)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>Net
cash flows provided by investing activities during the period ended March 31, 2023 (Successor) was approximately $9,980 thousand compared
to net cash flows used in investing activities for the period ended March 14, 2023 (Predecessor) and during the three months ended March
31, 2022 (Predecessor) of approximately $54 thousand and $51 thousand, respectively. Cash flows related to investing activities during
the period ended March 31, 2023 (Successor) include $23.0&#160;thousand for the purchase of property and equipment, and $10,003&#160;thousand
for cash acquired in connection with the Business Combination. Cash flows related to investing activities during the period ended March
14, 2023 (Predecessor) include $9 thousand for the purchase of property and equipment, and $45 thousand for the investment in capitalized
software. Cash flows related to investing activities during the three months ended March 31, 2022 (Predecessor) include $12&#160;thousand
for the purchase of property and equipment, and $39&#160;thousand for investment in capitalized software.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash
Flows from Financing Activities for the periods ended March 31, 2023 (Successor), March 14, 2023 (Predecessor), and the three months
ended March 31, 2022 (Predecessor)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Net cash
flows used in financing activities during period ended March 31, 2023 (Successor) was $328 thousand compared to net cash flows provided
by financing activities for the period ended March 14, 2023 (Predecessor) and during the three months ended March 31, 2022 (Predecessor)
of approximately $8,892 thousand and $4,553 thousand, respectively. During the period ended March 31, 2023 (Successor), the Company paid
$328&#160;thousand in cash outflows from a repayment of a related party promissory note. During the period ended March 14, 2023 (Predecessor),
the Company received $9,089 thousand in incoming cash flows from parent, and paid $197&#160;thousand in cash outflows from a payment
of an acquisition liability. During the three months ended March 31, 2022 (Predecessor), the Company received $6,444&#160;thousand in
incoming cash flows from parent, and paid $104&#160;thousand and $1,787&#160;thousand in cash outflows from taxes paid related to share
based compensation and from a payment of an acquisition liability, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Off-Balance
Sheet Arrangements </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any off-balance sheet guarantees, interest rate swap transactions or foreign currency contracts. We do not engage in trading
activities involving non-exchange traded contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual
Obligations and Commitments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual
obligations are cash that we are obligated to pay as part of certain contracts that we have entered during our course of business. Our
contractual obligations consists of operating lease liabilities and acquisition liabilities that are included in our balance sheet. As
of March 31, 2023 (Successor), the total obligation for operating leases is approximately $571&#160;thousand, of which approximately
$195&#160;thousand is expected to be paid in the next twelve months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantitative
and Qualitative Disclosures about Market Risk</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles (&#8220;GAAP&#8221;). In connection
with the preparation of our financial statements, we are required to make assumptions and estimates about future events, and apply judgments
that affect the reported amounts of assets, liabilities, revenue, expenses and the related disclosures. We base our assumptions, estimates
and judgments on historical experience, current trends and other factors that management believes to be relevant at the time our condensed
consolidated financial statements are prepared. On a regular basis, we review the accounting policies, assumptions, estimates and judgments
to ensure that our financial statements are presented fairly and in accordance with GAAP. However, because future events and their effects
cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
significant accounting policies are discussed in Note 2 of the condensed consolidated financial statements which are included elsewhere
in this filing. We believe that the following accounting estimates are the most critical to aid in fully understanding and evaluating
our reported financial results, and they require our most difficult, subjective or complex judgments, resulting from the need to make
estimates about the effect of matters that are inherently uncertain. There have been no changes to estimates during the periods presented
in the filing. Historically changes in management estimates have not been material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue
Recognition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when control is transferred of the promised products or services to its customers, in an amount that reflects
the consideration the Company expects to be entitled to in exchange for those products or services. The Company derives revenue from
software as a service and professional services for its enterprise apps software.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
contracts with customers often include promises to transfer multiple distinct products and services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
licenses are sold as perpetual or term licenses and the arrangements typically contain various combinations of maintenance and professional
services, which are accounted for as separate performance obligations. In determining how revenue should be recognized, a five-step process
is used, which requires judgment and estimates within the revenue recognition process. The most critical judgements required in applying
ASC 606 <i>Revenue Recognition from Customers</i>, and our revenue recognition policy relate to the determination of distinct performance
obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
                                            related to subscription software as a service contract is recognized over time using the
                                            output method (days of software provided) because we are providing continuous access to its
                                            service.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
                                            services revenue is accounted for using the percentage of completion method. As soon as the
                                            outcome of a contract can be estimated reliably, contract revenue is recognized in the statement
                                            of operations in proportion to the stage of completion of the contract. Accounting for these
                                            contracts involves the use of estimates to determine total contract costs to be incurred.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
                                            services revenue under fixed fee contracts is recognized over time using the input method
                                            (direct labor hours) to recognize revenue over the term of the contract. We have elected
                                            the practical expedient to recognize revenue for the right to invoice because our right to
                                            consideration corresponds directly with the value to the customer of the performance completed
                                            to date.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also consider whether an arrangement has any discounts, material rights, or specified future upgrades that may represent additional performance
obligations. We offer discounts in the form of prompt payment discounts and rebates for a decrease in service level percentages. We have
determined that the most likely amount method is most useful for contracts that provides these discounts and rebates as the contracts
have two potential outcomes and a significant reversal in the amount of cumulative revenue recognized is not expected to occur. Discounts
have not historically been significant, but we continue to monitor and evaluate these estimates based on historical experience, anticipated
performance, and our best judgment. Renewals or extensions of licenses are evaluated as distinct licenses (i.e., a distinct good or service),
and revenue attributed to the distinct good or service cannot be recognized until (1) the entity provides the distinct license (or makes
the license available) to the customer and (2) the customer is able to use and benefit from the distinct license. If any of these judgments
were to change it could cause a material increase or decrease in the amount of revenue we report in a particular period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Goodwill,
Acquired Intangible Assets and Other Long-Lived Assets - Impairment Assessments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets are grouped for recognition and measurement of impairment at the lowest level for which identifiable cash flows are largely independent
of the cash flows of other assets. The impairment test for long-lived assets requires us to assess the recoverability of our long-lived
assets by comparing their net carrying value to the sum of undiscounted estimated future cash flows directly associated with and arising
from our use and eventual disposition of the assets. If the net carrying value of a group of long-lived assets exceeds the sum of related
undiscounted estimated future cash flows, we would be required to record an impairment charge equal to the excess, if any, of net carrying
value over fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
assessing the recoverability of our long-lived assets, which include property and equipment and finite-lived intangible assets, we make
assumptions regarding estimated future cash flows and other factors. Some of these assumptions involve a high degree of judgment and
bear a significant impact on the assessment conclusions. Included among these assumptions are estimating undiscounted future cash flows,
including the projection of comparable sales, operating expenses, capital requirements for maintaining property and equipment and residual
value of asset groups. We formulate estimates from historical experience and assumptions of future performance, based on business plans
and forecasts, recent economic and business trends, and competitive conditions. In the event that our estimates or related assumptions
change in the future, we may be required to record an impairment charge. Based on our evaluation we did not record a charge for impairment
related to long-lived assets for the period ended March 31, 2023 (Successor) or the year ended December 31, 2022 (Predecessor).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
evaluate the remaining useful lives of long-lived assets and identifiable intangible assets whenever events or circumstances indicate
that a revision to the remaining period of amortization is warranted. Such events or circumstances may include (but are not limited to):
the effects of obsolescence, demand, competition, and/or other economic factors including the stability of the industry in which we operate,
known technological advances, legislative actions, or changes in the regulatory environment. If the estimated remaining useful lives
change, the remaining carrying amount of the long-lived assets and identifiable intangible assets would be amortized prospectively over
that revised remaining useful life. We have determined that there were no events or circumstances during the period ended March 14, 2023
(Predecessor), period ended March 31, 2023 (Successor), and the three months ended March 31, 2022 (Predecessor), which would indicate
a revision to the remaining amortization period related to any of our long-lived assets. Accordingly, we believe that the current estimated
useful lives of long-lived assets reflect the period over which they are expected to contribute to future cash flows and are therefore
deemed appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have recorded goodwill and other indefinite-lived assets in connection with the Business Combination. Goodwill, which represents the
excess of acquisition cost over the fair value of the net tangible and intangible assets of the acquired company, is not amortized. Indefinite-lived
intangible assets are stated at fair value as of the date acquired in a business combination. The recoverability of goodwill is evaluated
at least annually and when events or changes in circumstances indicate that the carrying amount may not be recoverable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
analyzed goodwill first to assess qualitative factors, such as macroeconomic conditions, changes in the business environment and reporting
unit specific events, to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying
amount as a basis for determining whether it is necessary to perform a detailed goodwill impairment test as required. The more-likely-than-not
threshold is defined as having a likelihood of more than 50%. If we bypass the qualitative assessment or conclude that it is more likely
than not that the fair value of a reporting unit is less than its carrying value, then we perform a quantitative impairment test by comparing
the fair value of a reporting unit with its carrying amount. We calculate the estimated fair value of a reporting unit using a weighting
of the income and market approaches. For the income approach, we use internally developed discounted cash flow models that include the
following assumptions, among others made by management: projections of revenues, expenses, and related cash flows based on assumed long-term
growth rates and demand trends&#894; expected future investments to grow new units&#894; and estimated discount rates. For the market
approach, we use internal analyses based primarily on market comparables. We base these assumptions on its historical data and experience,
third party appraisals, industry projections, micro and macro general economic condition projections, and its expectations. Due to the
variables inherent in our estimates of fair value, differences in assumptions may have a material effect on the result of our impairment
analysis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred
Income Taxes</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 740 &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;), management routinely evaluates the likelihood of the realization
of its income tax benefits and the recognition of its deferred tax assets. In evaluating the need for any valuation allowance, management
will assess whether it is more likely than not that some portion, or all, of the deferred tax asset may not be realized on a jurisdictional
basis. Ultimately, the realization of deferred tax assets is dependent upon the generation of future taxable income during those periods
in which temporary differences become deductible and/or tax credits and tax loss carry-forwards can be utilized. In performing its analyses,
management considers both positive and negative evidence including historical financial performance, previous earnings patterns, future
earnings forecasts, tax planning strategies, economic and business trends and the potential realization of net operating loss carry-forwards
within a reasonable timeframe. To this end, management considered (i) that we have had historical losses in the prior years and cannot
anticipate generating a sufficient level of future profits in order to realize the benefits of our deferred tax asset&#894; (ii) tax
planning strategies and (iii) the adequacy of future income as of and for the period ended March 31, 2023 (Successor), based upon certain
economic conditions and historical losses through March&#160;31, 2023. After consideration of these factors, management deemed it appropriate
to establish a full valuation allowance with respect to the deferred tax assets for the Company as of March 31, 2023 (Successor) and
December 31, 2022 (Predecessor), and no liability for unrecognized tax benefits was required to be reported.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
guidance also discusses the classification of related interest and penalties on income taxes. The Company&#8217;s policy is to record
interest and penalties on uncertain tax positions as a component of income tax expense. No interest or penalties were recorded during
the period ended March 31, 2023 (Successor), the period ended March 14, 2023 (Predecessor), or the three months ended March 31, 2022
(Predecessor).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Combinations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for business combinations using the acquisition method of accounting, and accordingly, the assets and liabilities of the acquired
business are recorded at their fair values at the date of acquisition. The excess of the purchase price over the estimated fair value
is recorded as goodwill. Any changes in the estimated fair values of the net assets recorded for acquisitions prior to the finalization
of more detailed analysis, but not to exceed one year from the date of acquisition, will change the amount of the purchase price allocable
to goodwill. Any subsequent changes to any purchase price allocations that are material to our financial results will be adjusted. All
acquisition costs are expensed as incurred. Separately recognized transactions associated with business combinations are generally expensed
subsequent to the acquisition date. The application of business combination and impairment accounting requires the use of significant
estimates and assumptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
acquisition, the accounts and results of operations are combined as of and subsequent to the acquisition date and are included in our
financial statements from the acquisition date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivative
Warrant Liabilities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>We account
for the Warrants in accordance with the guidance contained in ASC 815-40 under which the Warrants do not meet the criteria for equity
treatment and must be recorded as liabilities. Accordingly, we classify the Warrants as liabilities at their fair value and adjust the
Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheets date until exercised,
and any change in fair value is recognized in our Condensed Consolidated Statements of Operations. We utilized the Public Warrant quoted
market price as the fair value of the Warrants as of each relevant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Year
Ended December&#160;31, 2022 compared to the Year Ended December&#160;31, 2021</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our results of operations for the years ended December&#160;31, 2022 and 2021. This data should be read together
with our financial statements and related notes included elsewhere in this registration statement, and is qualified in its entirety by
reference to such financial statements and related notes in this Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the Years Ended December&#160;31</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="vertical-align: bottom; text-align: center"><b>&#160;</b></td><td style="text-align: center; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; color: #231f20; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="vertical-align: bottom; color: #231f20; font-weight: bold; text-align: center"><b>% of</b></td><td style="text-align: center; color: #231f20; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="vertical-align: bottom; text-align: center"><b>&#160;</b></td><td style="text-align: center; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; color: #231f20; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="vertical-align: bottom; color: #231f20; font-weight: bold; text-align: center"><b>% of</b></td><td style="text-align: center; color: #231f20; font-weight: bold; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="vertical-align: bottom; text-align: center"><b>$</b></td><td style="text-align: center; vertical-align: bottom"><b>&#160;</b></td><td style="text-align: center; vertical-align: bottom"><b>&#160;</b></td>
    <td colspan="2" style="vertical-align: bottom; text-align: center"><b>%</b></td><td style="text-align: center; vertical-align: bottom"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; color: #231f20; font-weight: bold; text-align: left">(in thousands, except percentages)</td><td style="color: #231f20; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; color: #231f20; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt; color: #231f20; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; color: #231f20; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; color: #231f20; font-weight: bold; text-align: center">Revenues</td><td style="text-align: center; padding-bottom: 1pt; color: #231f20; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; color: #231f20; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; color: #231f20; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt; color: #231f20; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; color: #231f20; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; color: #231f20; font-weight: bold; text-align: center">Revenues</td><td style="text-align: center; padding-bottom: 1pt; color: #231f20; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; color: #231f20; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; color: #231f20; font-weight: bold; text-align: center"> Change</td><td style="text-align: center; padding-bottom: 1pt; color: #231f20; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; color: #231f20; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; color: #231f20; font-weight: bold; text-align: center">Change*</td><td style="text-align: center; padding-bottom: 1pt; color: #231f20; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 28%; color: #231f20; text-align: left">Revenues</td><td style="width: 1%; color: #231f20">&#160;</td>
    <td style="width: 1%; color: #231f20; text-align: left">$</td><td style="width: 9%; color: #231f20; text-align: right">8,470</td><td style="width: 1%; color: #231f20; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%; color: #231f20">&#160;</td>
    <td style="width: 1%; color: #231f20; text-align: left">$</td><td style="width: 9%; color: #231f20; text-align: right">6,368</td><td style="width: 1%; color: #231f20; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,102</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; color: #231f20; text-align: left">Cost of revenues</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">2,064</td><td style="color: #231f20; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24</td><td style="text-align: left">%</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">1,646</td><td style="color: #231f20; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">418</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; color: #231f20; text-align: left">Gross profit</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">6,406</td><td style="color: #231f20; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">76</td><td style="text-align: left">%</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">4,722</td><td style="color: #231f20; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,684</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; color: #231f20; text-align: left">Operating expenses</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">35,431</td><td style="color: #231f20; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">418</td><td style="text-align: left">%</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">49,225</td><td style="color: #231f20; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">773</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,794</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; color: #231f20; text-align: left">Loss from operations</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">(29,025</td><td style="color: #231f20; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(343</td><td style="text-align: left">)%</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">(44,503</td><td style="color: #231f20; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(699</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,478</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(35</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; color: #231f20; text-align: left">Other income (expense)</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">3</td><td style="color: #231f20; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">1</td><td style="color: #231f20; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; color: #231f20; text-align: left">Income tax provision</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">(153</td><td style="color: #231f20; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2</td><td style="text-align: left">)%</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">2,527</td><td style="color: #231f20; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,680</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; color: #231f20; text-align: left">Net loss</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">$</td><td style="color: #231f20; text-align: right">(29,175</td><td style="color: #231f20; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(344</td><td style="text-align: left">)%</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">$</td><td style="color: #231f20; text-align: right">(41,975</td><td style="color: #231f20; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(659</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(30</td><td style="text-align: left">)%</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
                                            used to calculate dollar and percentage changes are based on numbers in the thousands. Accordingly,
                                            calculations in this item, which may be rounded to the nearest hundred thousand, may not
                                            produce the same results.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenues</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
for the year ended December&#160;31, 2022 were $8.5 million, compared to $6.4 million for the comparable period in the prior year for
an increase of approximately $2.1 million, or approximately 33%. This increase is primarily the result of the inclusion of a full twelve
months of revenue received from smart office app sales in 2022 as compared to only 8 months of mobile apps sales in 2021 following the
acquisition of Design Reactor in 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross
Margin</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenues for the year ended December&#160;31, 2022 were $2.1 million compared to $1.6 million for the comparable period in the prior
year. This increase in cost of revenues of approximately $0.4 million, or approximately 25%, was primarily attributable to higher hosting
fees and costs associated with the sale of professional services as a result of increased CXApp product line sales during the year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
gross profit margin for the year ended December&#160;31, 2022 was 76% compared to 74% for the year ended December&#160;31, 2021. This
increased margin is primarily due to more smart office app sales in 2022 versus 2021, which has higher overall gross margins.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating
Expenses</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
expenses for the year ended December&#160;31, 2022 were $35.4 million and $49.2 million for the comparable period ended December&#160;31,
2021. Of this $13.8 million decrease, there was a decrease of $6.4 million in impairment of goodwill, decrease of $9.4 million for the
change in earnout expense, decrease of $2.5 million of stock based compensation offset by an increase of approximately $2.9 million that
is attributable to increased operating expenses primarily due to actions taken to consummate the CXApp- acquisition, increased unrealized
foreign exchange loss of $1.4 million and an approximate $0.2 million increase in sales and marketing expenses. With the Company&#8217;s
current liquidity position, the Company has taken steps to reduce operating expenses. Going forward CXApp expects lower acquisition/financing
transaction costs, unrealized losses, lower compensation as a result of headcount reductions in Q4 2022 and Q1 2023, as well as lower
professional fees and insurance expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss
From Operations</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
from operations for the year ended December&#160;31, 2022 was $29.0 million as compared to $44.5 million for the comparable period in
the prior year. This decrease in loss of $15.5 million is primarily attributable to decreased operating expenses of $13.8 million as
detailed above plus the increased gross profit margin of approximately $1.7 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>



<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Income/(Expense)</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
income/expense for the years ended December&#160;31, 2022 and 2021 were income of approximately $0.03 million and $0.01 million, respectively,
and the difference was immaterial.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Provision
for Income Taxes</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
was an income tax loss of $0.2 million for the year ended December&#160;31, 2022 and an income tax benefit of approximately $2.5 million
for the year ended December&#160;31, 2021. The net income tax benefit for the year ended December&#160;31, 2021 is related to a deferred
tax benefit from the release of a valuation allowance following the acquisition of intangibles of Design Reactor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
Loss</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss for the year ended December&#160;31, 2022 was $29.2 million, compared to $42.0 million for the comparable period in the prior year.
This decrease in loss of approximately $12.8 million was primarily attributable to the decrease in operating expenses of $13.8 million
and the higher gross margin of $1.7 million, offset by a lower income tax benefit of approximately $2.7 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-GAAP
Financial information</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>EBITDA</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Report includes a non-GAAP measure that we use to supplement our results presented in accordance with U.S. GAAP. EBITDA is defined as
earnings before interest and other income, tax and depreciation and amortization. Adjusted EBITDA is used by our management as the matrix
in which it manages the business. It is defined as EBITDA plus adjustments for other income or expense items, non-recurring items and
non-cash stock-based compensation. Adjusted EBITDA is a performance measure that we believe is useful to investors and analysts because
it illustrates the underlying financial and business trends relating to our core, recurring results of operations and enhances comparability
between periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
EBITDA is not a recognized measure under U.S. GAAP and is not intended to be a substitute for any U.S. GAAP financial measure and, as
calculated, may not be comparable to other similarly titled measures of performance of other companies in other industries or within
the same industry. Investors should exercise caution in comparing our non-GAAP measure to any similarly titled measure used by other
companies. This non-GAAP measure excludes certain items required by U.S. GAAP and should not be considered as an alternative to information
reported in accordance with U.S. GAAP. The table below presents our adjusted EBITDA, reconciled to net income for the periods indicated
(in thousands).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the<br/>
Years Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December&#160;31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="color: #231f20; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: #231f20; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; color: #231f20; font-weight: bold">&#160;</td><td style="color: #231f20; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: #231f20; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; color: #231f20; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; width: 76%; color: #231f20; text-align: left">Net loss</td><td style="width: 1%; color: #231f20">&#160;</td>
    <td style="width: 1%; color: #231f20; text-align: left">$</td><td style="width: 9%; color: #231f20; text-align: right">(29,175</td><td style="width: 1%; color: #231f20; text-align: left">)</td><td style="width: 1%; color: #231f20">&#160;</td>
    <td style="width: 1%; color: #231f20; text-align: left">$</td><td style="width: 9%; color: #231f20; text-align: right">(41,975</td><td style="width: 1%; color: #231f20; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; color: #231f20; text-align: left">Interest and other income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4</td><td style="text-align: left">&#160;</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">1</td><td style="color: #231f20; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; color: #231f20; text-align: left">Tax expense (benefit)</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">153</td><td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">(2,527</td><td style="color: #231f20; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; color: #231f20; text-align: left; padding-bottom: 1pt">Depreciation and amortization</td><td style="color: #231f20; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: #231f20; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: #231f20; text-align: right">4,531</td><td style="padding-bottom: 1pt; color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: #231f20; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: #231f20; text-align: right">3,571</td><td style="padding-bottom: 1pt; color: #231f20; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; color: #231f20; text-align: left">EBITDA</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">(24,487</td><td style="color: #231f20; text-align: left">)</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">(40,930</td><td style="color: #231f20; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; color: #231f20; text-align: left">Adjusted for:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; color: #231f20; text-align: left">Acquisition transaction/financing costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">628</td><td style="color: #231f20; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; color: #231f20; text-align: left">Earnout compensation expense/(benefit)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,827</td><td style="text-align: left">)</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">6,524</td><td style="color: #231f20; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.5in; color: #231f20; text-align: left">Professional service fees</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">-</td><td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">683</td><td style="color: #231f20; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.5in; color: #231f20; text-align: left">Impairment of goodwill</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">5,540</td><td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">11,896</td><td style="color: #231f20; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; color: #231f20; text-align: left">Unrealized gains on notes, loans, investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,478</td><td style="text-align: left">&#160;</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">(185</td><td style="color: #231f20; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; color: #231f20; text-align: left">Stock-based compensation &#8211; compensation and related benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,640</td><td style="text-align: left">&#160;</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">4,120</td><td style="color: #231f20; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.625in; color: #231f20; text-align: left; padding-bottom: 1pt">Severance costs</td><td style="color: #231f20; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: #231f20; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: #231f20; text-align: right">754</td><td style="padding-bottom: 1pt; color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: #231f20; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: #231f20; text-align: right">135</td><td style="padding-bottom: 1pt; color: #231f20; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.5in; color: #231f20; text-align: left; padding-bottom: 2.5pt">Adjusted EBITDA</td><td style="color: #231f20; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: right">(17,886</td><td style="padding-bottom: 2.5pt; color: #231f20; text-align: left">)</td><td style="color: #231f20; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: right">(17,129</td><td style="padding-bottom: 2.5pt; color: #231f20; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on Adjusted EBITDA, which is a non-GAAP financial measure for the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            compare our current operating results with corresponding periods and with the operating results
                                            of other companies in our industry;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            a basis for allocating resources to various projects;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            a measure to evaluate potential economic outcomes of acquisitions, operational alternatives
                                            and strategic decisions; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            evaluate internally the performance of our personnel.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have presented Adjusted EBITDA above because we believe it conveys useful information to investors regarding our operating results. We
believe it provides an additional way for investors to view our operations, when considered with both our GAAP results and the reconciliation
to net income (loss). By including this information, we can provide investors with a more complete understanding of our business. Specifically,
we present Adjusted EBITDA as supplemental disclosure because of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            believe Adjusted EBITDA is a useful tool for investors to assess the operating performance
                                            of our business without the effect of interest, income taxes, depreciation and amortization
                                            and other non- cash items including acquisition transaction and financing costs, earnout
                                            compensation expense, professional service fees, goodwill impairment, unrealized gains, stock
                                            based compensation, severance costs, interest income and expense, and income tax benefit.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            believe that it is useful to provide investors with a standard operating metric used by management
                                            to evaluate our operating performance; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            believe that the use of Adjusted EBITDA is helpful to compare our results to other companies.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
though we believe Adjusted EBITDA is useful for investors, it does have limitations as an analytical tool. Thus, we strongly urge investors
not to consider this metric in isolation or as a substitute for net income (loss) and the other consolidated statement of operations
data prepared in accordance with GAAP. Some of these limitations include the fact that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
                                            EBITDA does not reflect our cash expenditures or future requirements for capital expenditures
                                            or contractual commitments;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
                                            EBITDA does not reflect changes in, or cash requirements for, our working capital needs;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
                                            EBITDA does not reflect the significant interest expense or the cash requirements necessary
                                            to service interest or principal payments on our debt;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
                                            depreciation and amortization are non-cash charges, the assets being depreciated and amortized
                                            will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash
                                            requirements for such replacements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
                                            EBITDA does not reflect income or other taxes or the cash requirements to make any tax payments;
                                            and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                            companies in our industry may calculate Adjusted EBITDA differently than we do, thereby potentially
                                            limiting its usefulness as a comparative measure.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of these limitations, Adjusted EBITDA should not be considered a measure of discretionary cash available to us to invest in the growth
of our business or as a measure of performance in compliance with GAAP. We compensate for these limitations by relying primarily on our
GAAP results and providing Adjusted EBITDA only as supplemental information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Liquidity
describes the ability of a company to generate sufficient cash flows to meet the cash requirements of its business operations, including
working capital needs, debt service, acquisitions, contractual obligations and other commitments. We assess liquidity in terms of our
cash flows from operations and their sufficiency to fund our operating and investing activities. In light of the significant number of
redemptions and the unlikelihood that the company will receive significant proceeds from exercises of the warrants due to the disparity
between the exercise price of the warrants and the current trading price of the Class A common stock, the company&#8217;s capital resources
and its liquidity position since the business combination are not expected to improve.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>As
of December&#160;31, 2022, our principal source of liquidity was cash of $6.3 million. As part of the business combination with KINS,
our net cash position increased to $10 million at the closing of the transaction. In addition, the net cash position further increased
with the $1.6 million we received from the KINS trust account. The total net cash position will be reduced by the transaction expenses
of the business combination, which are estimated to be approximately $1.2 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>The
resale of shares under this registration statement may impact the company&#8217;s ability to raise additional capital by influencing investor
sentiment, potentially resulting in a decrease in demand for the company&#8217;s securities. Additionally, the resale of shares may lead to
dilution of existing shareholders&#8217; ownership and put downward pressure on the market price of the company&#8217;s securities, which could affect
the company&#8217;s ability to attract new investors and raise capital at favorable terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financing
Obligations and Requirements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2022, the Company had a working capital surplus of approximately $3.2 million, and cash of approximately $6.3 million.
For the year ended December&#160;31, 2022, the Company had a net loss of approximately $29.2 million. During the year ended December&#160;31,
2022, the Company used approximately $18.9 million of cash for operating activities. As part of the Inpixon (&#8220;Inpixon&#8221;) group
of companies, the Company has historically been dependent upon Inpixon for its working capital and financing requirements until the closing,
as Inpixon uses a centralized approach to cash management and financing of its operations. Financial transactions relating to the Company
were accounted for through the net parent investment account. Accordingly, none of Inpixon&#8217;s cash, cash equivalents or debt at
the corporate level has been assigned to the Company in the combined carve-out financial statements other than any such amounts that
may already be represented as cash balances of the Design Reactor, Inpixon Canada and Inpixon Philippines bank accounts as of December&#160;31,
2022. Net parent investment represents Inpixon&#8217;s interest in the recorded net assets of the Company. All significant transactions
between the Company and Inpixon have been included in the accompanying combined carve-out financial statements. Transactions with Inpixon
are reflected in the accompanying Combined Statements of Changes in Equity as &#8220;Parent&#8217;s net investment&#8221; and in the
accompanying Combined Balance Sheets within &#8220;Parent&#8217;s net investment.&#8221; The income statement of the Company includes
revenues and expenses that are specifically identifiable to the Company plus certain allocated corporate overhead or other shared costs
based on methodologies that management deems appropriate for the nature of the cost. All significant intercompany accounts and transactions
between the businesses comprising the Company have been eliminated in the accompanying combined financial statements. As part of the
spin-off transaction, Inpixon contributed the cash needed so that the Company has a $10 million cash balance at the time of the closing
of the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company cannot assure you that we will ever earn revenues sufficient to support our operations, or that we will ever be profitable. To
the extent that our resources from the business combination are insufficient to satisfy our cash requirements, we may enter into equity
or debt financing transactions. These transactions are expected to provide us additional cash to fund our capital and liquidity requirements
in the short and long-term. If the financing is not available, or if the terms of financing are less desirable than we expect, we may
be forced to take actions to reduce our capital or operating expenditures, including by not seeking potential acquisition opportunities,
or eliminating redundancies, which may adversely affect our business, operating results, financial condition and prospects. Our business
has been impacted by the COVID-19 pandemic and general macroeconomic conditions and may continue to be impacted. While we have been able
to continue operations remotely, we have and continue to experience impact in the demand of certain products and delays in certain projects
and customer orders either because of customer facilities being partially or fully closed during the pandemic or because of the uncertainty
of the customer&#8217;s financial position and ability to invest in our technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Despite
these challenges, we were able to realize growth in total revenue for the year ended December&#160;31, 2022 when compared to the year
ended 2021, as a result of the addition of the new CXApp product line during the second quarter of 2021. The total impact that COVID-19
and general macroeconomic conditions may continue to impact our results of operations continues to remain uncertain and there are no
assurances that we will be able to continue to experience the same growth or not be materially adversely affected. The Company&#8217;s
recurring losses and utilization of cash in its operations are indicators of going concern; however, with the company&#8217;s current
liquidity position the company has taken action to reduce operating expenses and extend its runway. This, along with the capital it will
receive in the KINS transaction, leads the company to believe it has the ability to mitigate such concerns for a period of at least one
year from the date these combined carve-out financials statements were issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
and Capital Resources as of December&#160;31, 2022 Compared With December&#160;31, 2021</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s net cash flows used in operating, investing and financing activities for the years ended December&#160;31, 2022 and 2021
and certain balances as of the end of those periods are as follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the<br/>
Years Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December&#160;31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="color: #231f20; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: #231f20; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; color: #231f20; font-weight: bold">&#160;</td><td style="color: #231f20; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: #231f20; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; color: #231f20; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; color: #231f20; text-align: left">Net cash used in operating activities</td><td style="width: 1%; color: #231f20">&#160;</td>
    <td style="width: 1%; color: #231f20; text-align: left">$</td><td style="width: 9%; color: #231f20; text-align: right">(18,895</td><td style="width: 1%; color: #231f20; text-align: left">)</td><td style="width: 1%; color: #231f20">&#160;</td>
    <td style="width: 1%; color: #231f20; text-align: left">$</td><td style="width: 9%; color: #231f20; text-align: right">(16,919</td><td style="width: 1%; color: #231f20; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; color: #231f20; text-align: left">Net cash used in investing activities</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">(482</td><td style="color: #231f20; text-align: left">)</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">(15,469</td><td style="color: #231f20; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; color: #231f20; text-align: left">Net cash provided by financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,728</td><td style="text-align: left">&#160;</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">37,330</td><td style="color: #231f20; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; color: #231f20; text-align: left; padding-bottom: 1pt">Effect of foreign exchange rate changes on cash</td><td style="color: #231f20; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: #231f20; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: #231f20; text-align: right">(71</td><td style="padding-bottom: 1pt; color: #231f20; text-align: left">)</td><td style="color: #231f20; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: #231f20; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: #231f20; text-align: right">(61</td><td style="padding-bottom: 1pt; color: #231f20; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; color: #231f20; text-align: left; padding-bottom: 2.5pt">Net increase in cash and cash equivalents</td><td style="color: #231f20; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: right">1,280</td><td style="padding-bottom: 2.5pt; color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: right">4,881</td><td style="padding-bottom: 2.5pt; color: #231f20; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of<br/>
December&#160;31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; color: #231f20; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents</td><td style="width: 1%; color: #231f20; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; color: #231f20; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 9%; color: #231f20; text-align: right">6,308</td><td style="width: 1%; padding-bottom: 2.5pt; color: #231f20; text-align: left">&#160;</td><td style="width: 1%; color: #231f20; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; color: #231f20; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 9%; color: #231f20; text-align: right">5,028</td><td style="width: 1%; padding-bottom: 2.5pt; color: #231f20; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; color: #231f20; text-align: left; padding-bottom: 2.5pt">Working capital surplus (deficit)</td><td style="color: #231f20; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: right">3,154</td><td style="padding-bottom: 2.5pt; color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: right">(9,702</td><td style="padding-bottom: 2.5pt; color: #231f20; text-align: left">)</td></tr>
  </table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating
Activities for the years ended December&#160;31, 2022 and 2021</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities during the period consisted of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">For the<br/>
Years Ended</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December&#160;31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="color: #231f20; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: #231f20; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; color: #231f20; font-weight: bold">&#160;</td><td style="color: #231f20; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; color: #231f20; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; color: #231f20; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; color: #231f20; text-align: left">Net loss</td><td style="width: 1%; color: #231f20">&#160;</td>
    <td style="width: 1%; color: #231f20; text-align: left">$</td><td style="width: 9%; color: #231f20; text-align: right">(29,175</td><td style="width: 1%; color: #231f20; text-align: left">)</td><td style="width: 1%; color: #231f20">&#160;</td>
    <td style="width: 1%; color: #231f20; text-align: left">$</td><td style="width: 9%; color: #231f20; text-align: right">(41,975</td><td style="width: 1%; color: #231f20; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; color: #231f20; text-align: left">Non-cash income and expenses</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">10,133</td><td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20">&#160;</td>
    <td style="color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; text-align: right">23,585</td><td style="color: #231f20; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; color: #231f20; text-align: left; padding-bottom: 1pt">Net change in operating assets and liabilities</td><td style="color: #231f20; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: #231f20; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: #231f20; text-align: right">147</td><td style="padding-bottom: 1pt; color: #231f20; text-align: left">&#160;</td><td style="color: #231f20; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; color: #231f20; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; color: #231f20; text-align: right">1,471</td><td style="padding-bottom: 1pt; color: #231f20; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; color: #231f20; text-align: left; padding-bottom: 2.5pt">Net cash used in operating activities</td><td style="color: #231f20; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: right">(18,895</td><td style="padding-bottom: 2.5pt; color: #231f20; text-align: left">)</td><td style="color: #231f20; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; color: #231f20; text-align: right">(16,919</td><td style="padding-bottom: 2.5pt; color: #231f20; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
non-cash income and expense for the year ended December&#160;31, 2022 of approximately $10.1 million consisted primarily of the following
(in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,531</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Depreciation and amortization</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right">266</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Amortization of right of use asset</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,640</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock-based compensation expense attributable to warrants and options issued as part of Company operations</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,478</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Unrealized loss on note</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,540</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Impairment of goodwill</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,827</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Earnout payment expense</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(495</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Other</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,133</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Total non-cash expenses</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>



<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net cash used in the change in operating assets and liabilities for the year ended December&#160;31, 2022 aggregated approximately $0.1
million and consisted primarily of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">109</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Decrease in accounts receivable and other receivables</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right">244</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Decrease in inventory, other current assets and other assets</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Increase in accounts payable</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right">583</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Increase in accrued liabilities and other liabilities</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">(257</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Decrease in operating lease liabilities</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(932</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Decrease in deferred revenue</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">147</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Net cash used in the changes in operating assets and liabilities</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
non-cash income and expense for the year ended December&#160;31, 2021 of approximately $23.6 million consisted primarily of the following
(in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,571</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Depreciation and amortization</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right">257</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Amortization of right of use asset</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,120</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock-based compensation expense attributable to warrants and options issued as part of Company operations</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right">(185</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Unrealized gain/loss on note</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,591</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Deferred income tax</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,897</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Impairment of goodwill</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,524</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Earnout payment expense</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(8</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Other</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">23,585</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Total non-cash expenses</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net cash used in the change in operating assets and liabilities for the year ended December&#160;31, 2021 aggregated approximately $1.5
million and consisted primarily of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">255</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Decrease in accounts receivable and other receivables</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right">(427</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Increase in inventory, other current assets and other assets</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">69</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Increase in accounts payable</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right">892</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Increase in accrued liabilities and other liabilities</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: right">(275</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Decrease in operating lease liabilities</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">957</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Increase in deferred revenue</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,471</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Net cash used in the changes in operating assets and liabilities</td></tr>
  </table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash
Flows from Investing Activities as of December&#160;31, 2022 and 2021</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash flows used in investing activities during 2022 was approximately $0.5 million compared to net cash flows used in investing activities
during 2021 of approximately $15.5 million. Cash flows related to investing activities during the year ended December&#160;31, 2022 include
$0.1 million for the purchase of property and equipment and $0.4 million for investment in capitalized software. Cash flows related to
investing activities during the year ended December&#160;31, 2021 include $0.2 million for the purchase of property and equipment, $0.2
million for investment in capitalized software, $15.0 million paid for the acquisition of CXApp, $0.01 million for the acquisition of
intangible assets and $0.1 million paid for acquisition of Visualix.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash
Flows from Financing Activities as of December&#160;31, 2022 and 2021</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash flows provided by financing activities during the year ended December&#160;31, 2022 was $20.7 million. Net cash flows provided by
financing activities during the year ended December&#160;31, 2021 was $37.3 million. During the year ended December&#160;31, 2022, the
Company received incoming cash flows from Inpixon of $26.0 million, paid $0.1 million of taxes related to the net share settlement of
restricted stock units, and paid a $5.1 million liability related to the CXApp acquisition. During the year ended December&#160;31, 2021,
the Company received incoming cash flows from Inpixon of $39.0 million, paid $0.7 million of taxes related to the net share settlement
of restricted stock units, paid a $0.5 million liability related to the CXApp acquisition, and paid a $0.5 million acquisition liability
to the pre-acquisition stockholders of Locality Systems Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Off-Balance
Sheet Arrangements</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any off-balance sheet guarantees, interest rate swap transactions or foreign currency contracts. We do not engage in trading
activities involving non-exchange traded contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual
Obligations and Commitments</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual
obligations are cash that we are obligated to pay as part of certain contracts that we have entered during our course of business. Our
contractual obligations consists of operating lease liabilities and acquisition liabilities that are included in our combined balance
sheet. As of December&#160;31, 2022, the total obligation for operating leases is approximately $0.7 million, of which approximately
$0.3 million is expected to be paid in the next twelve months. As of December&#160;31, 2022, our obligation for acquisition liabilities
related to CXApp is approximately $0.2 million of which all is expected to be paid in the next twelve months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantitative
and Qualitative Disclosures about Market Risk</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not experienced any significant losses in such accounts, nor does management believe it is exposed to any significant credit risk.
The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. We
use an assumed dividend yield of zero as we have never paid dividends and have no current plans to pay any dividends on our common stock.
We account for forfeitures as they occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Policies and Estimates</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
combined financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles (&#8220;GAAP&#8221;). In
connection with the preparation of our combined carve-out financial statements, we are required to make assumptions and estimates about
future events, and apply judgments that affect the reported amounts of assets, liabilities, revenue, expenses and the related disclosures.
We base our assumptions, estimates and judgments on historical experience, current trends and other factors that management believes
to be relevant at the time our consolidated financial statements are prepared. On a regular basis, we review the accounting policies,
assumptions, estimates and judgments to ensure that our combined carve-out financial statements are presented fairly and in accordance
with GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from our
assumptions and estimates, and such differences could be material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
significant accounting policies are discussed in Note 2 of the combined carve-out financial statements that are included elsewhere in
this filing. We believe that the following accounting estimates are the most critical to aid in fully understanding and evaluating our
reported financial results, and they require our most difficult, subjective or complex judgments, resulting from the need to make estimates
about the effect of matters that are inherently uncertain. There have been no changes to estimates during the periods presented in the
filing. Historically changes in management estimates have not been material.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue
Recognition</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when control of the promised products or services is transferred to its customers, in an amount that reflects
the consideration the Company expects to be entitled to in exchange for those products or services. The Company derives revenue from
software as a service, design and implementation services for its enterprise apps systems, and professional services for work performed
in conjunction with its systems.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
contracts with customers often include promises to transfer multiple distinct products and services. Our licenses are sold as perpetual
or term licenses and the arrangements typically contain various combinations of maintenance and professional services, which are accounted
for as separate performance obligations. In determining how revenue should be recognized, a five-step process is used, which requires
judgment and estimates within the revenue recognition process. The most critical judgements required in applying ASC 606 <i>Revenue Recognition
from Customers</i>, and our revenue recognition policy relate to the determination of distinct performance obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            receive fixed consideration for sales of hardware and software products. Revenue is recognized
                                            at the point in time when the customer has title to the product and risks and rewards of
                                            ownership have transferred.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
                                            related to software as a service contract is recognized over time using the output method
                                            (days of software provided) because we are providing continuous access to its service.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Design
                                            and implementation revenue is accounted for using the percentage of completion method. As
                                            soon as the outcome of a contract can be estimated reliably, contract revenue is recognized
                                            in the combined statement of operations in proportion to the stage of completion of the contract.
                                            Accounting for these contracts involves the use of estimates to determine total contract
                                            costs to be incurred.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
                                            services revenue under fixed fee contracts is recognized over time using the input method
                                            (direct labor hours) to recognize revenue over the term of the contract. We have elected
                                            the practical expedient to recognize revenue for the right to invoice because our right to
                                            consideration corresponds directly with the value to the customer of the performance completed
                                            to date.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            recognize revenue related to Maintenance Services evenly over time using the output method
                                            (days of software provided) because we provide continuous service, and the customer simultaneously
                                            receives and consumes the benefits provided by our performance as the services are performed.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also consider whether an arrangement has any discounts, material rights, or specified future upgrades that may represent additional performance
obligations. We offer discounts in the form of prompt payment discounts and rebates for a decrease in service level percentages. We have
determined that the most-likely-amount method is most useful for contracts that provide these discounts and rebates as the contracts
have two potential outcomes and a significant reversal in the amount of cumulative revenue recognized is not expected to occur. Discounts
have not historically been significant, but we continue to monitor and evaluate these estimates based on historical experience, anticipated
performance, and our best judgment. Renewals or extensions of licenses are evaluated as distinct licenses (i.e., a distinct good or service),
and revenue attributed to the distinct good or service cannot be recognized until (1) the entity provides the distinct license (or makes
the license available) to the customer and (2) the customer is able to use and benefit from the distinct license. If any of these judgments
were to change it could cause a material increase or decrease in the amount of revenue we report in a particular period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Goodwill,
Acquired Intangible Assets and Other Long-Lived Assets &#8212; Impairment Assessments</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets are grouped for recognition and measurement of impairment at the lowest level for which identifiable cash flows are largely independent
of the cash flows of other assets. The impairment test for long-lived assets requires us to assess the recoverability of our long-lived
assets by comparing their net carrying value to the sum of undiscounted estimated future cash flows directly associated with and arising
from our use and eventual disposition of the assets. If the net carrying value of a group of long-lived assets exceeds the sum of related
undiscounted estimated future cash flows, we would be required to record an impairment charge equal to the excess, if any, of net carrying
value over fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
assessing the recoverability of our long-lived assets, which include property and equipment and finite-lived intangible assets, we make
assumptions regarding estimated future cash flows and other factors. Some of these assumptions involve a high degree of judgment and
bear a significant impact on the assessment conclusions. Included among these assumptions are estimating undiscounted future cash flows,
including the projection of comparable sales, operating expenses, capital requirements for maintaining property and equipment and residual
value of asset groups. We formulate estimates from historical experience and assumptions of future performance, based on business plans
and forecasts, recent economic and business trends, and competitive conditions. In the event that our estimates or related assumptions
change in the future, we may be required to record an impairment charge. Based on our evaluation we did not record a charge for impairment
related to long-lived assets for the years ended December&#160;31, 2022 or 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
evaluate the remaining useful lives of long-lived assets and identifiable intangible assets whenever events or circumstances indicate
that a revision to the remaining period of amortization is warranted. Such events or circumstances may include (but are not limited to):
the effects of obsolescence, demand, competition, and/or other economic factors including the stability of the industry in which we operate,
known technological advances, legislative actions, or changes in the regulatory environment. If the estimated remaining useful lives
change, the remaining carrying amount of the long-lived assets and identifiable intangible assets would be amortized prospectively over
that revised remaining useful life. We have determined that there were no events or circumstances during the years ended December&#160;31,
2022 and 2021, which would indicate a revision to the remaining amortization period related to any of our long-lived assets. Accordingly,
we believe that the current estimated useful lives of long-lived assets reflect the period over which they are expected to contribute
to future cash flows and are therefore deemed appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have recorded goodwill and other indefinite-lived assets in connection with our acquisitions of Locality, Jibestream, and CXApp. Goodwill,
which represents the excess of acquisition cost over the fair value of the net tangible and intangible assets of the acquired company,
is not amortized. Indefinite-lived intangible assets are stated at fair value as of the date acquired in a business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverability of goodwill is evaluated at least annually and when events or changes in circumstances indicate that the carrying amount
may not be recoverable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
analyzed goodwill first to assess qualitative factors, such as macroeconomic conditions, changes in the business environment and reporting
unit specific events, to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying
amount as a basis for determining whether it is necessary to perform a detailed goodwill impairment test as required. The more-likely-than-not
threshold is defined as having a likelihood of more than 50%. If we bypass the qualitative assessment or conclude that it is more likely
than not that the fair value of a reporting unit is less than its carrying value, then we perform a quantitative impairment test by comparing
the fair value of a reporting unit with its carrying amount. We calculate the estimated fair value of a reporting unit using a weighting
of the income and market approaches. For the income approach, we use internally developed discounted cash flow models that include the
following assumptions, among others made by management: projections of revenues, expenses, and related cash flows based on assumed long-term
growth rates and demand trends; expected future investments to grow new units; and estimated discount rates. For the market approach,
we use internal analyses based primarily on market comparables. We base these assumptions on historical data and experience, third-party
appraisals, industry projections, micro and macro general economic condition projections, and expectations. Due to the variables inherent
in our estimates of fair value, differences in assumptions may have a material effect on the result of our impairment analysis. For example,
a 100 basis points increase or decrease in only the discount rate utilized as part of the discounted cash flow method (income approach)
related to the Indoor Intelligence reporting unit could impact the overall fair value of the reporting unit, on a weighted average, by
approximately $2.0 million (decrease) and $2.5 million (increase), respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
performed impairment testing during the period and have recorded impairment of goodwill of $5.5 million and $11.9 million during the
years ended December&#160;31, 2022 and 2021, respectively. As of December&#160;31, 2022, cumulative impairment changes are approximately
$17.4 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred
Income Taxes</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 740 &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;), management routinely evaluates the likelihood of the realization
of its income tax benefits and the recognition of its deferred tax assets. In evaluating the need for any valuation allowance, management
will assess whether it is more likely than not that some portion, or all, of the deferred tax asset may not be realized on a jurisdictional
basis. Ultimately, the realization of deferred tax assets is dependent upon the generation of future taxable income during those periods
in which temporary differences become deductible and/or tax credits and tax loss carry-forwards can be utilized. In performing its analyses,
management considers both positive and negative evidence including historical financial performance, previous earnings patterns, future
earnings forecasts, tax planning strategies, economic and business trends and the potential realization of net operating loss carry-forwards
within a reasonable timeframe. To this end, management considered (i) that we have had historical losses in the prior years and cannot
anticipate generating a sufficient level of future profits in order to realize the benefits of our deferred tax asset; (ii) tax planning
strategies; and (iii) the adequacy of future income as of and for the year ended December&#160;31, 2022, based upon certain economic
conditions and historical losses through December&#160;31, 2022. After consideration of these factors, management deemed it appropriate
to establish a full valuation allowance with respect to the deferred tax assets for Design Reactor and Inpixon Philippines as of December&#160;31,
2022 and 2021, and no liability for unrecognized tax benefits was required to be reported.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
guidance also discusses the classification of related interest and penalties on income taxes. The Company&#8217;s policy is to record
interest and penalties on uncertain tax positions as a component of income tax expense. No interest or penalties were recorded during
the years ended December&#160;31, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Combinations</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for business combinations using the acquisition method of accounting, and accordingly, the assets and liabilities of the acquired
business are recorded at their fair values at the date of acquisition. The excess of the purchase price over the estimated fair value
is recorded as goodwill. Any changes in the estimated fair values of the net assets recorded for acquisitions prior to the finalization
of more detailed analysis, but not to exceed one year from the date of acquisition, will change the amount of the purchase price allocable
to goodwill. Any subsequent changes to any purchase price allocations that are material to our combined financial results will be adjusted.
All acquisition costs are expensed as incurred and in-process research and development costs are recorded at fair value as an indefinite-lived
intangible asset and assessed for impairment thereafter until completion, at which point the asset is amortized over its expected useful
life. Separately recognized transactions associated with business combinations are generally expensed subsequent to the acquisition date.
The application of business combination and impairment accounting requires the use of significant estimates and assumptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
acquisition, the accounts and results of operations are combined as of and subsequent to the acquisition date and are included in our
Combined Financial Statements from the acquisition date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>JOBS
Act Accounting Election</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the transaction, Design Reactor will be an &#8220;emerging growth company&#8221; as defined in the JOBS Act. As such, Design Reactor
will be eligible to take advantage of certain exemptions from various reporting requirements that apply to other public companies that
are not emerging growth companies, including compliance with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley
Act and the requirements to hold a non-binding advisory vote on executive compensation and any golden parachute payments not previously
approved. Design Reactor has not made a decision whether to take advantage of any or all of these exemptions. If Design Reactor does
take advantage of some or all of these exemptions, some investors may find Design Reactor&#8217;s common stock less attractive. The result
may be a less active trading market for Design Reactor&#8217;s common stock and its stock price may be more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Section&#160;107 of the JOBS Act provides that an emerging growth company may take advantage of the extended transition period
provided in Section&#160;13(a) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), for complying with
new or revised accounting standards, meaning that Design Reactor, as an emerging growth company, can delay the adoption of certain accounting
standards until those standards would otherwise apply to private companies. Design Reactor has elected to take advantage of this extended
transition period, and therefore our financial statements may not be comparable to those of companies that comply with such new or revised
accounting standards. Section&#160;107 of the JOBS Act provides that our decision not to opt out of the extended transition period for
complying with new or revised accounting standards is irrevocable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_015"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BUSINESS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unless
the context otherwise requires, all references in this section to &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refer to CXApp
Inc.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CXApp&#8217;s
platform is a workplace experience platform for enterprise customers. Our technologies and solutions help enterprise customers deliver
a comprehensive business journey in a work &#8216;from-anywhere&#8217; world for employees, partners, customers and visitors. CXApp offers
native mapping, analytics, on-device positioning (or ODP) and applications technologies that aim to bring people together.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
customers use our enterprise solutions in a variety of ways, including, but not limited to, workplace experience, employee engagement,
desk and meeting room reservations, workplace analytics, occupancy management, content delivery, corporate communications and notifications,
event management, live indoor mapping, wayfinding and navigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
enterprise app platform is the intersection of technology, intelligence, automation and experience for today&#8217;s hybrid workplace
and the workplace of the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
office, now, is everywhere. We believe that giving employees and teams the ability to manage different types of &#8216;office scenarios&#8217;
from their personal device will be the dominating path forward for a lot of companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe mobile apps are the only technology that can clearly communicate with employees, other technologies, and physical spaces. Enterprise
organizations are considering mobile apps imperative for the successful management of distributed workforces, and the changing office
landscape. Over the next five years, we believe all enterprise organizations will be using a mobile app to manage their workplace experience
initiatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe CXApp is uniquely positioned as the connection point of hybrid workplace models &#8212; bringing people together through a workplace
experience app that helps companies build a more meaningful and productive work experience. We put key technologies, employee engagement
initiatives, workplace automation and best practices into action with a comprehensive approach to the workplace &#8212; so employees
and operations can make faster, reliable, data-driven decisions that influence performance and improve productivity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
our strategic growth model, we aim to connect every experience in the workplace with the CXApp platform no matter who you are, where
you are, or what you&#8217;re doing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Model</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CXApp workplace solution is a SaaS product for enterprise organizations, distributing a mobile app to all employees within the organization.
It includes a content management system (or CMS) so customers can adjust configurations for their workplace settings autonomously and
spontaneously.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
pricing structure consists of recurring software fees as well as a professional service fee to setup and deploy a new location or campus,
including digitized maps and configurations at the global and regional level.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Technology
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CXApp&#8217;s
platform is a comprehensive workplace experience solution, helping customers drive engagement across their global workforce by introducing
a mobile-first mindset to everyday interactions and business needs. We bring workplace experience initiatives together in one hassle-free
system so customers don&#8217;t have to host, manage, support or maintain. We believe this results in low cost, low overhead and easy
maintenance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
benefits of our technology platform include but are not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            platform is built on a SaaS model with off-the-shelf product and services requiring minimal
                                            customization.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Multiple
                                            uses, features, technology and partners are all pulled into one platform, creating a central
                                            hub.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regular
                                            updates, ongoing enhancements and maintenance are performed to ensure all customer apps are
                                            built with industry best practices.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                            customer apps are hosted in an exclusive cloud instance for increased security and reliability.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            customer has access to their own content management system compliance and authentication,
                                            built into the platform.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            iOS mobile app is natively built with the latest version Swift framework.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            AndroidX mobile app is natively built with the latest version AndroidX framework.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security
                                            and data privacy protocols are compliant with the EU General Data Protection Regulation and
                                            have an ISO 27001 certification.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
                                            security clearances include SSL/TLS 1.2 for Google App Engine, AES256 bit Advanced Encryption
                                            and Google Cloud Key Store.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Products
and Services</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
workplace experience solution is a software-as-a-service (or SaaS) platform for the enterprise. Our technology platform delivers the
following core components that work in combination to deliver an incredible experience for companies around the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Workplace
                                            Experience</i></b> &#8212; Our workplace experience solution enhances employee experience
                                            by providing organizations with a holistic, location-aware, customer-branded employee app
                                            for a more connected workplace. This solution helps organizations provide a frictionless
                                            work environment to employees with features such as: hot desk and room booking, indoor navigation
                                            with turn-by-turn directions on a digital map, company-wide news feeds, an in-app company
                                            directory of colleagues and workplace amenities, as well as bookable opportunities and experiences.
                                            Our clients include facilities teams solving space utilization challenges, workplace operations
                                            teams building incredible experiences for employees and IT teams focused on streamlining
                                            their tech stacks to boost productivity and efficiency.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Hybrid
                                            Meeting</i></b> &#8212; Our executive briefing solution helps enterprise organization create
                                            high-touch, high-value, and personalize customer journeys for in-office, remote and hybrid
                                            meetings. Our hybrid solution offering streamlines multi-point customer experiences through
                                            one environment with support for multiple meetings and diversified locations, agendas for
                                            single or multi-day uses, and customizable components for every customer briefing program.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Hybrid
                                            Events</i></b> &#8212; Our hybrid event solution provides both mobile app and virtual event
                                            capabilities to connect tens of thousands of remote and in-person audiences through a fully
                                            branded, end-to- end event journey. Our hybrid event platform can host multiple events for
                                            enterprise organizations and support ongoing event engagement touchpoints to attendees before,
                                            during, and after the event through features such as customizable agendas, real-time activity
                                            feeds, instant notifications and more.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mapping
                                            Solutions</i></b> &#8212; Our indoor mapping solution helps enterprise organizations add
                                            intelligence to complex indoor spaces by integrating business data with geospatially accurate
                                            indoor maps to create relevant views of indoor environments. Indoor mapping is integral to
                                            supporting location-aware, &#8220;internet of things&#8221; (or IoT) enabled smart office
                                            touchpoints or devices within the customer&#8217;s premises. Developers use our mapping solution
                                            to bring indoor maps to apps, enabling multiple uses with a single set of maps. This product
                                            is intended to serve as a digital twin of a physical space facilitates and can be used for
                                            facility management, security, customer or worker experiences, asset tracking and more.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Analytics
                                            Dashboard</i></b> &#8212; Our robust cloud-based analytics dashboards give enterprise organizations
                                            insights into how real estate, technology and people interact across the workplace, so they
                                            can make business decisions to unlock savings, improve employee experience or optimize services.
                                            With our analytics platform, we allow data from multiple sensors and data sources (third-party
                                            sensors, native mapping solutions and data) to be visualized for action by workplace operations
                                            teams.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>On-Device
                                            Positioning (or ODP)</i></b> &#8212; Our on-device positioning technology, commonly known
                                            as &#8220;blue dot,&#8221; enables powerful location-based uses and builds upon our mapping
                                            offering to give enterprises clients a seamless way to provide navigation assistance within
                                            a venue (workplace, event show floor etc.). Our solution displays a user&#8217;s precise
                                            location and runs on a smartphone, smartwatch or other IoT wearable device and can operate
                                            without the internet.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Product
Roadmap and Enhancements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to adapt to technological advancements within our industry is critical to our long-term success and growth. As a result, our
executive management must continuously work to ensure that it remains informed and prepared to quickly adapt and leverage new technologies
within our product and service offering as such technologies become available. In connection with that goal, we have multi-year product
roadmap development plans which include activities related to expanding the use of augmented reality (or AR) and 3D mapping, new integrations
with our partners to connect enterprise services to our app, changes to our desk booking solution to allow faster and more informed decision
making by the user and improving our on-device positioning solutions and other initiatives described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Positioning
                                            Innovation Powered by Machine Learning</i></b> &#8212; We are expanding our use of machine
                                            learning and neural networks to improve positioning accuracy, reliability and range for our
                                            positioning and mapping. These improvements will impact our on-device positioning technology
                                            used to provide an indoor blue dot for enterprise customers. Following these enhancements,
                                            we believe our products should be able to assist in providing predictive, more accurate,
                                            bidirectional location information to secure and optimize our deployments using hardware
                                            that includes iOS and Android smartphones, IoT sensors, access points or BLE beacons. In
                                            addition, we are implementing predictive AI models across our workplace experience platform
                                            to provide more actionable insights to our customers on their indoor spaces and how these
                                            spaces are being utilized. We expect certain product enhancements related to these initiatives
                                            to be released in the first half of 2023, however, this is continuously evolving technology
                                            and we would expect to continue to allocate resources to additional development initiatives
                                            over the coming years.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mapping
                                            and Digital Twin</i></b> &#8212; Our advanced mapping platform is built with a set of developer
                                            tools to power an infinite number of experiences across multiple platforms. We are researching
                                            and evaluating ways in which laser imaging, detection, and ranging (or LIDAR) research and
                                            technology can aid map development and points of interest (or POI) location in a deployment.
                                            We believe leveraging these technologies in our mapping platform will allow us to explore
                                            new navigation uses, applications for deployment of assets and possibilities for optimization
                                            in manufacturing and office environments. These enhancements to our mapping platform are
                                            part of a longer-term roadmap initiative which may require allocation of resources over the
                                            next 12-36 months. Initiatives over the next twelve months for these activities are anticipated
                                            to be focused on research and the development of a prototype.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>App
                                            </i></b><i>&#8212; </i>With the addition of our on-device positioning technology and the
                                            expanding usage of apps in the workplace, particularly campus-style and large building environments,
                                            we are continuously evaluating ways to improve our app capabilities, including by enhancing
                                            our software development kits (or SDKs) and adding new functionality or features to support
                                            integration with workplace systems and tools. Our application programming interface (or API)
                                            and SDK integrations with customers that provide conferencing, collaboration, delivery, secure
                                            lockers, access control, parking and IoT management are key differentiators that we believe
                                            make our app the gateway for our customers. We have several planned releases over the next
                                            12 months in furtherance of these initiatives.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Analytics
                                            and Insights</i></b> &#8212; We provide data science analytics in the cloud, along with specially
                                            optimized algorithms that are intended to increase usability of the data we collect for our
                                            customers. We have released a beta version of our software with additional analytics capabilities
                                            and expect to release a general availability version before the end of the first quarter
                                            of 2023. In the future, we would look to expand this offering, with the goal of allowing
                                            customers to export data to internal business intelligence systems and to upload additional
                                            datasets that might include security systems, or occupancy information. Our plan is for our
                                            system to deliver data reporting and visualizations to the user combining these data sources.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Augmented
                                            Reality (or AR) and 3D</i></b> &#8212; Our augmented reality SDKs will allow businesses to
                                            easily scan a space and subsequently attach AR content persistently to any position in the
                                            world. AR technologies may be used to both display and capture spatial data that can be overlaid
                                            with the rich, profile-based maps in our CMS. The use of AR technologies will help in connection
                                            with the application of visual asset tracking use cases without beacons, digital twin creation
                                            and applications for the metaverse or other applications. Our AR roadmap initiatives are
                                            anticipated to be implemented over the course of a multiyear plan.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that we will have sufficient funding for planned initiatives on our product roadmap over the next twelve months, however, we expect
that additional funding may be required in connection with certain of the longer term, multi-year development initiatives on the roadmap.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Industry
Background</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Around
2009, we saw digital transformation initiatives begin to impact the corporate workplace, manifesting across components such as conference
room signage, room booking, next-gen intranets, and transparent communications. Technology offered an easy way to begin to integrate
these elements into the workplace.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
were slowly moving towards flexible work models, desk booking and sensor integrations. But timelines for digital workplace transformation
were expedited during the pandemic. Since more people were &#8216;stuck at home&#8217; during this timeframe, especially in the corporate
sector, workplace tools emerged to satisfy niche uses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
more third-party platforms were introduced to the workplace ecosystem, data, information, and experiences became increasingly siloed.
Now, mobile apps are proving to be the main connection point to plug into multiple platforms and bring every experience into one mobile
command center. As the workplace and common workday interactions become more accessible and tied together through a single mobile app,
we&#8217;re seeing efficiencies across workplace experience, boosts in productivity, reduced overhead, and increased insights into key
workplace initiatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
more tools and systems connect together, comprehensive workplace analytics will become crucial for job roles such as corporate real estate,
facilities, and even human resources as they&#8217;ll be able to glean cross- platform, actionable insights that impact spaces, technology,
and the people that use them.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we move towards new versions of the workplace, post-pandemic, analysts and industry experts believe hybrid work will remain, but each
company will be responsible for defining and managing their own protocols, expectations, and operating ratios. We see a fruitful opportunity
where workplace technology apps are significantly growing as more companies adopt this technology to manage hybrid workplaces and bring
distributed teams together.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trends</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have observed that companies want employees back in the office 3-5 days a week, but employees need more engagement to bring them back
in the post-pandemic environment. Pressing issues and considerations include disinterest in &#8216;the purpose&#8217; of the office,
uncertainty of colleague&#8217;s in-office status, a growing inequity of the hybrid work model, apprehension of densely occupied places,
and overall disengagement from employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are things real estate, operations, workplace experience, IT teams and cross-functional groups can do to set-up the workplace for success
such as increasing communication, automating interactions, and having better insights into how space is being utilized. This means investment
in IoT, mobility, and cloud solutions to keep the people and technology in the new workplace connected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
teams continue to re-enter the post-pandemic workplace in phases and at reduced capacities, we believe a mobile app is more relevant
than ever, as a connection point for an increasingly distributed workforce.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe trends that work in our favor include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Heavy
                                            and Complex Tech Stacks</i>. As more technologies come online to fulfill
                                            niche uses, the market becomes saturated, and employees and operations personnel are inundated
                                            with app overload, heavy and somewhat complex tech stacks, and increased expenses. Our one-app
                                            approach and open ecosystem uniquely position CXApp as a one-stop shop for workplace experience,
                                            tying multiple uses together.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Incomplete
                                            and Inaccurate Occupancies</i>. With a hybrid model, desks are no
                                            longer a 1:1 ratio leading to confusion around who is sitting where and when. With point-solutions,
                                            companies can wind up with ghost bookings, double-bookings, or gaps across core collaboration
                                            capabilities for teams. Our native desk booking and room reservation technology support advanced
                                            reservation, hot- desking or on-demand reservations, team insights, and integration with
                                            sensors to always provide the most accurate inventory.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Changing
                                            Spaces and Places</i>. The average corporate campus encompasses dozens,
                                            if not hundreds, of points of interest &#8212; including workstations, conference rooms,
                                            dining areas, lobbies, offices, fitness studios and collaboration zones. With a hybrid work
                                            setting, space has become more flexible and some areas are no longer fixed points of interests.
                                            Spaces can easily be reconfigured to serve a better purpose if they&#8217;re being underutilized.
                                            There is no longer a &#8216;normal workday&#8217; where employees show up to the same cube
                                            on the same floor and eat at the same caf&#233;. It&#8217;s become a scramble. We believe
                                            our mapping solution and blue dot capabilities make it easier for employees to navigate changing
                                            workplace environments and easily locate new desks, new spaces, and find people while on-
                                            the-go.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
new world of work is a combination of technologies shaped by physical, virtual, and augmented experiences that make up the how, when,
where, and sometimes why we show up. Offices, now, are considered innovation hubs and collaboration centers that attract and connect
talent and inspire innovation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe successful organizations will turn to mobile apps to welcome employees back to the office, manage expectations, better support
a hybrid work model, enable data-informed decisions, and deliver excellent experiences to employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Size</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
its <i>Digital Workplace Market Size &amp; Trends Report, 2030</i>, the global digital workplace market size was valued by the research
company Grand View Research (based in San Francisco, CA) at $27.33 billion in 2021 and is expected by Grand View Research to expand at
a compound annual growth rate (or CAGR) of 22.3% from 2022 to 2030. Grand View Research believes that the current growth in this market
can be attributed to the increased digitalization, increasing demand for desktop-as-a-service, and growing demand for employees for greater
flexibility in terms of work-life balance. With the outbreak of the COVID-19 pandemic, businesses have shifted to remote working and
transformed their technologies to create a digital workplace to ensure business continuity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
its <i>Global Virtual Events Market Size &amp; Share Report, 2030</i>, the global virtual events market size was valued by Grand View
Research at $114.12 billion in 2021 and is anticipated by Grand View Research to expand at a CAGR of 21.4% from 2022 to 2030. Grand View
Research anticipates that the widespread use of collaboration and communication tools in various industries and industry verticals, including
retail &amp; e-commerce, healthcare, manufacturing, construction, and education, among others, will boost the market growth during the
forecast period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
its <i>Global Market for Workplace Experience Apps Report, 2020 to 2025</i>, the global workplace experience apps market in the commercial
office space was estimated by the research company Memoori (based in Saltsj&#246;-boo, Sweden) at $406 million in 2020, and is expected
by Memoori to rise to $988 million by 2025, growing at a rate of 19% CAGR.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
occupancy analytics market in the commercial office space (for systems sales) was estimated by Memoori at $2.17 billion in 2019, and
is expected by Memoori to rise to $5.73 billion by 2024, growing at a rate of 21.5% CAGR. We estimate that the workplace experience apps
market is around 15% of this overall occupancy analytics market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Growth
Strategy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our core workplace product&#8217;s inception in 2017, our go to market strategy was direct to customer focusing on the Fortune 3000 enterprise
space. This has benefited us by acquiring customers from the Fortune 500 across financial services, media and software industries, allowing
us to emerge in what we believe is a leadership role for enterprise companies looking for workplace technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also established a technology partner program that we believe is strong and has served us well. As of today, we have more than 75 partners,
including, but not limited to digital lockers, sensors and single sign-on (or SSO) platforms, which allows us to offer seamless integration
and workflow for delivering a holistic employee experience application.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Part
of our future growth strategy includes, but is not limited to, the following strategic initiatives:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continue
                                            to grow our native development roadmap to align with market trends and new features to support
                                            companies and industries going through digital transformation and hybrid workforce models.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Take
                                            our existing direct sales team and expand into new verticals.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continue
                                            to grow our foundational channel partner program to forge mutual relationship between other
                                            workplace technologies that want to become integrators and/or resellers.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Build
                                            a robust sales and marketing roadmap to increase awareness and open channel opportunities,
                                            program opportunities and cross-marketing opportunities with existing industry associations
                                            and organizations to become thought leaders and trusted advisors in the work tech sector.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Research
and Development Expenses</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and development (R&amp;D) activities have primarily been focused on enhancing our workplace app and mapping platform with additional
features and capabilities to strengthen the total offering of our workplace solutions. In addition, we have allocated development resources
to integrating our recently acquired technologies with our existing solutions, such as integrating our mapping and app platform, and
incorporating &#8220;on device&#8221; positioning and analytics capabilities within our platform. Our management believes that we must
continue to dedicate a significant number of resources to research and development efforts to maintain a competitive position in the
market. Our products intersect many emerging fields including AI, the metaverse, augmented reality and space management, and we plan
to continue to innovate and patent new methods to solve problems for our customers. While our R&amp;D expenses have historically exceeded
our revenues, we anticipate R&amp;D expenses will grow at a slower rate than our revenue, however, we may need additional funding to
support our planned R&amp;D activities after the next 12 months or if we decide to accelerate the time to availability for planned development
activities to grow faster or meet customer demand. For more information see &#8220;<i>Business </i>&#8212; <i>Product Roadmap and Enhancements</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sales
and Marketing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
utilize direct sales and marketing through sales representatives, who are compensated with a base salary and, in certain instances, may
participate in incentive plans such as commissions or bonuses. To generate demand for our products and services, we utilize account-based
marketing initiatives, lead gen and demand gen programs, tradeshows, webinars and other direct and indirect marketing activities to reach
our target audience. Additionally, we have dedicated resources to support and grow our business through strategic channel and technology
partner opportunities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products are primarily sold on a recurring SaaS license model along with one-time implementation costs (for professional services). The
SaaS model is typically for a multi-year contract and includes maintenance upgrades. It is common for our customers to expand our products
to additional locations as well as implement new features resulting in additional revenue potential.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Customers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe in a unified workplace where employees have on-demand access to real-time communications, collaboration and contextual experiences
in one app &#8212; from employee to employee, building to building, campus to campus. Customers use the CXApp platform to streamline
operations in a single mobile app platform to deliver the best possible experience to employees whether they are on-site, in-person and
everywhere in between.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe our unique approach to workplace apps offers customers a feature-rich, white label experience allowing the in-app experience
to reflect each customer&#8217;s distinct business goals and brand identity. We go beyond point-solutions, offering a robust product
that serves multiple uses backed by native applications, technology partner integrations and workplace analytics that help employees
and operations make data-informed decisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
customers include Fortune 1000 enterprises primarily in the United States with deployments globally across industries, including, but
not limited to software/technology, financial services, next-gen auto manufacturing, entertainment and life science companies. A list
of customers is available on our website at <i>www.cxapp.com</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competition,
Strengths, and Differentiation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
our workplace experience app, events and executive briefing center products we compete with companies such as Eptura, Modo Labs, HqO,
Robin Powered and Comfy. For our mapping product, we compete with companies such as MappedIn, Mapwize and Esri. For our events product,
we compete with companies such as Cvent, Double Dutch and Event Base.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe we offer a unique and differentiated approach to the market with our workplace experience app that our competition is currently
not positioned/not capable of servicing, as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>One
                                            App</i>. We understand today&#8217;s workplace is a collection of
                                            spaces, people, activity-based work, virtual and physical interactions, culture, experiences
                                            and the technology that binds them. CXApp has built a mobile command center through a single
                                            workplace app that helps enterprise companies build culture, foster innovation, empower employees,
                                            and create equitable experiences for a distributed workforce.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Delivering
                                            On Experience</i>. The CXApp platform is the connection point for
                                            every employee across your workforce. We have built a culture around workplace experience
                                            and help companies deliver that experience direct to employees to help attract and retain
                                            top talent, keep employees engaged and invested in company culture, and support them through
                                            a hybrid workforce model that is easy to navigate and easy to use.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Comprehensive
                                            Uses</i>. The CXApp technology supports a multitude of uses for enterprise
                                            organization including, but not limited to, workplace experience, mapping, meeting room reservations,
                                            desk booking, campus directories, navigation, facility management, analytics and security,
                                            across numerous industries in both the private and public sector.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Growing
                                            Ecosystem</i>. With a strong partner ecosystem and broad product integrations
                                            (Slack, Zoom, Office365, G-suite, Okta, ServiceNow, etc.) our smart office app serves as
                                            the gateway to corporate communications and productivity portfolio. We have over 75 partner
                                            integrations and collaborative approach to creating a workplace ecosystem that helps customers
                                            streamline their technology stack and reduce app overload.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Scalable
                                            Solution</i>. We are built to support customers&#8217; expanding needs
                                            and uses. Our solution allows for employee growth and can aid on-boarding and employee orientation.
                                            We make it easy to add campus locations around the globe as our clients expand their workforce.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Technology-agnostic</i>.
                                                                                                                                                                                                                                                                                    We embrace an ecosystem of hardware, software, integration and distribution partners welcoming integration and synchronization with
                                                                                                                                                                                                                                                                                    third-party data and systems in combination with our platform. Our open architecture is designed to enable the integration of
                                                                                                                                                                                                                                                                                    disparate technologies, preserve investment and avoid obsolescence. APIs make it possible to move data in and out of our platform.
                                                                                                                                                                                                                                                                                    Our SDKs enable developers to build new apps or to integrate location data into their existing mobile apps, websites or
                                                                                                                                                                                                                                                                                    kiosks.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intellectual
Property</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
establish and protect our proprietary rights, we rely on a combination of patents, trademarks, copyrights and trade secrets, including
know-how, license agreements, confidentiality procedures, non-disclosure agreements with third parties, employee disclosure and invention
assignment agreements and other contractual rights. We do not believe that our proprietary technology is dependent on any single patent
or copyright or groups of related patents or copyrights. We believe the duration of our patents is adequate relative to the expected
lives of our products. Our patent portfolio offers protections including detecting objects and positioning in a 3D environment, indoor
navigation with sensor fusion, wireless signal fingerprinting, source-based anonymity and time synchronization methods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the terms of the Separation and Distribution Agreement, each of Inpixon and CXApp have granted the other party a limited
worldwide, non-exclusive, irrevocable, royalty free, fully paid up, perpetual, non-exclusive license (the &#8220;Licensee&#8221;) to
use, practice and otherwise exploit such intellectual property (with certain exceptions) that is owned, controlled or purported to be
owned or controlled by the other party (the &#8220;Licensor&#8221;) to the extent used, practiced or otherwise exploited in the business
of the Licensee during the twelve (12) months prior to the Distribution Time or is reasonably anticipated to be used after the Distribution
Time based on the written business or product plans existing as of the Distribution Time, solely for the conduct of any business of the
Licensee as conducted on or prior to the Distribution Time and reasonably anticipated extension or evolutions thereof that are not substitutes
for any product or service of the Licensor as of the Distribution Time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of this time, and notwithstanding the license granted under the Separation and Distribution Agreement, we do not anticipate that any
of our products and technologies will require reliance on any intellectual property retained by Inpixon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Government
Regulation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, we are subject to numerous federal, state and foreign legal requirements on matters as diverse as data privacy and protection,
employment and labor relations, immigration, taxation, anticorruption, import/export controls, trade restrictions, internal and disclosure
control obligations, securities regulation and anti-competition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Violations
of one or more of these diverse legal requirements in the conduct of our business could result in significant fines and other damages,
criminal sanctions against us or our officers, prohibitions on doing business and damage to our reputation. Violations of these regulations
or contractual obligations related to regulatory compliance in connection with the performance of customer contracts could also result
in liability for significant monetary damages, fines and/or criminal prosecution, unfavorable publicity and other reputational damage,
restrictions on our ability to compete for certain work and allegations by our customers that we have not performed our contractual obligations.
To date, compliance with these regulations has not been financially burdensome.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employees
and Management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March&#160;20, 2023, there are 87 employees, including 3 management personnel, 8 sales personnel, 2 marketing personnel, 32 technical
and engineering personnel, 32 customer service personnel and 10 finance, legal, human resource and other administration personnel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span>Khurram
P. Sheikh currently serves as Chief Executive Officer and as Interim Chief Financial Officer, and Leon Papkoff currently serves as the
Chief Product Officer of CXApp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
History</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March&#160;16, 1998, Design Reactor, Inc. (&#8220;Design Reactor&#8221;), our operating subsidiary, was incorporated in California as
a statutory close corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June&#160;22, 2001, Smart Medium, Inc., a California corporation was merged into Design Reactor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April&#160;30, 2021, Inpixon acquired over 99.9% of the outstanding capital stock of Design Reactor pursuant to the terms of a stock
purchase agreement from various sellers party thereto. On May&#160;10, 2021, Inpixon acquired the remaining interest of Design Reactor
and now own 100% of the outstanding capital stock of Design Reactor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
its acquisition of Design Reactor, Inpixon combined Design Reactor&#8217;s business with the following businesses:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
                                            technology and intellectual property, including patents, related to the analytics business
                                            acquired by Inpixon, through Inpixon Canada as purchaser, in connection with its acquisition
                                            of all of the issued and outstanding capital stock of Locality Systems Inc. on May&#160;21,
                                            2019.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inpixon&#8217;s
                                            mapping product, which Inpixon acquired in connection with the acquisition of Jibestream,
                                            Inc. on August&#160;15, 2019, and which was amalgamated into Inpixon Canada (as defined below)
                                            on January&#160;1, 2020.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inpixon&#8217;s
                                            suite of on-device &#8220;blue-dot&#8221; indoor location and motion technologies, including
                                            patents, trademarks, software and related intellectual property, which Inpixon acquired from
                                            Ten Degrees Inc., Ten Degrees International Limited (&#8220;TDIL&#8221;), mCube International
                                            Limited (&#8220;MCI&#8221;), the holder of a majority of the outstanding capital of TDIL,
                                            and mCube, Inc., the sole stockholder of 100% of the outstanding capital stock of MCI, on
                                            August&#160;19, 2020.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
                                            computer vision, robust localization, large-scale navigation, mapping and 3D reconstruction
                                            technologies (collectively, the &#8220;AR Technology&#8221;), the intellectual property and
                                            patent applications underlying the AR Technology, Inpixon acquired in connection with its
                                            acquisition of substantially all of the assets of Visualix GmbH i.L. (the &#8220;Visualix&#8221;)
                                            via an asset purchase agreement with Visualix, its founders and Future Energy Ventures Management
                                            GmbH on April&#160;23, 2021.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
CXApp was incorporated under the laws of the State of Delaware on September&#160;19, 2022, specifically for the purpose of effecting
the Separation and was a wholly-owned subsidiary of Inpixon. Legacy CXApp has not carried on any activities to date, except for activities
incidental to its formation and activities undertaken in connection with the transactions. Pursuant to the Separation and Distribution
Agreement, (i) Inpixon undertook a series of internal reorganization and restructuring transactions to effect the transfer of its (direct
or indirect) ownership of the Enterprise Apps Business to Legacy CXApp in the Separation and (ii) immediately prior to the Merger and
after the Separation, Inpixon distributed 100% of the outstanding shares of Legacy CXApp Common Stock to Inpixon securityholders in the
Distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March&#160;14, 2023, pursuant to the Merger Agreement, a business combination between KINS and Legacy CXApp was effectuated through the
merger of Merger Sub with and into Legacy CXApp, with Legacy CXApp surviving as the surviving company and as a wholly-owned subsidiary
of KINS. KINS subsequently changed its name to CXApp, and shares of CXApp Class A Common Stock began trading on the Nasdaq on March&#160;15,
2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have four operating subsidiaries: (i) Legacy CXApp, a Delaware corporation, 100% of the capital stock of which is owned by CXApp, (ii)
Design Reactor, Inc., a California corporation (&#8220;Design Reactor&#8221;), 100% of the capital stock of which is owned by Legacy
CXApp; (iii) Inpixon Canada, Inc., a British Columbia corporation, based in Coquitlam, British Columbia (&#8220;Inpixon Canada&#8221;),
100% of the capital stock of which is owned by Design Reactor; and (iv) Inpixon Philippines, Inc., a Philippines corporation (&#8220;Inpixon
Philippines&#8221;), 99.97% of the capital stock of which is owned by Design Reactor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive offices are located at Four Palo Alto Square, Suite 200, 3000 El Camino Rd., Palo Alto, CA 94306. Our Canadian subsidiary
maintains offices in Toronto, Ontario and our Philippines subsidiary maintains offices in Manila, Philippines. Our Internet website is
<i>www.cxapp.com</i>. The information on, or that can be accessed through, our website is not part of this report, and you should not
rely on any such information in making any investment decision relating to our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_016"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MANAGEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">The
following sets forth certain information, as of June 29, 2023, concerning the persons who serve as our directors and executive officers.
Unless the context otherwise requires, all references in this section to &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, and &#8220;the
Company&#8221; are intended to mean CXApp Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"><span>Name</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Age</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Position</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 30%; text-align: left"><span>Khurram P. Sheikh</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 9%; text-align: center"><span>51</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 59%; text-align: justify"><span>Chairman, Chief Executive Officer, and Interim Chief
    Financial Officer</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left"><span>Leon Papkoff</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>50</span></td><td><span>&#160;</span></td>
    <td style="text-align: justify"><span>Chief Product Officer</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mr.
Khurram P. Sheikh</i></b> has served as the Founder, Chairman and Chief Executive Officer of KINS since its inception and Chief Financial
Officer since August&#160;2020. Mr. Sheikh has been at the forefront of innovation in the technology, mobile, semiconductor, telecom
and media industries for the past 25 years with CEO and CTO roles at leading technology companies. Since March&#160;2020, Mr. Sheikh
has been the Founder, Executive Chairman &amp; CEO of Aijaad, a boutique strategic advisory firm where he advises both large private
equity firms as well as boards of public companies on the future of 5G, IoT, Edge Computing and AI technologies and is actively involved
in M&amp;A, technology strategy and market development. From 2016 to early 2020, Mr. Sheikh was the CEO of kwikbit, a private company
building a &#8220;network as a service&#8221; solution using gigabit radios, edge compute, virtualization, and artificial intelligence.
Prior to kwikbit, in 2014, Mr. Sheikh was appointed as the Chief Strategy and Technology Officer for Silicon Image (SIMG) and the President/CEO
of its millimeter wave/5G subsidiary SiBEAM. SIMG was acquired by Lattice Semiconductor (Nasdaq:LSCC) in 2015 for $600 million after
which Mr. Sheikh was appointed the Chief Strategy and Technology Officer of the combined company responsible for corporate strategy,
roadmap, M&amp;A and technology development and was there until 2016. From 2007 onwards, he was the CTO for Powerwave Technologies, a
large wireless infrastructure vendor. Powerwave filed for Chapter 11 bankruptcy protection in January&#160;2013, and in April&#160;2013
Mr. Sheikh was appointed as the CEO of Powerwave to help with the sale of the company. Later that year, Mr. Sheikh successfully facilitated
the sale of approximately 1,400 patents owned by Powerwave to private equity firm Gores Group. From 2005 to 2007, Mr. Sheikh was Vice
President, Wireless Strategy and Development at Time Warner Cable leading the cable company&#8217;s entry into the wireless space. From
1996 to 2005, Mr. Sheikh held senior technology roles at Sprint including CTO Mobile Broadband responsible for deploying the world&#8217;s
first 4G system and acquisition of multi-billion dollar spectrum assets at 2.5GHz. Mr. Sheikh holds a Bachelor of Science degree in Electrical
Engineering with highest honors from the University of Engineering &amp; Technology in Pakistan, as well as a Master of Science degree
in Electrical Engineering from Stanford University. Mr. Sheikh is well qualified to serve as Chairman of the Company board because of
his extensive experience advising boards of directors of public and private companies and his extensive professional experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mr.
Leon Papkoff</i></b> has served as Inpixon&#8217;s Executive Vice President of Experience Apps since April&#160;2021. Currently, Mr.
Papkoff is responsible for establishing the product vision, strategy and overall execution of Inpixon&#8217;s product team for the Enterprise
Apps Business. Mr. Papkoff is the Founder of Design Reactor and from March&#160;1998 until Inpixon&#8217;s acquisition of Design Reactor
in April&#160;2021, Mr. Papkoff was the Chief Financial Officer of Design Reactor. From June&#160;2015 until April&#160;2021, Mr. Papkoff
was also the Chief Strategist of Design Reactor responsible for setting corporate strategy for the company. Mr. Papkoff has over 20 years
of executive leadership, entrepreneurship, fiscal management and innovation experience, setting product vision and corporate strategy,
driving innovation and scaling operations. Mr. Papkoff received a Bachelor of Science degree from Charles H. Lundquist College of Business
at the University of Oregon in 1996. He has also taught Web Programing and Design at the San Jose State University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information with respect to the individuals who serve on our board of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Name</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Age</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Position</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 30%; text-align: left">Khurram P. Sheikh</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: center">51</td><td style="width: 1%">&#160;</td>
    <td style="width: 59%; text-align: left">Class III Director Nominee, Chairman and Chief Executive Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Camillo Martino<sup>(1)(2)(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: center">60</td><td>&#160;</td>
    <td style="text-align: left">Class II Director Nominee</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Di-Ann Eisnor<sup>(1)(2)(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: center">50</td><td>&#160;</td>
    <td style="text-align: left">Class I Director Nominee</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">George Mathai<sup>(1)(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: center">56</td><td>&#160;</td>
    <td style="text-align: left">Class III Director Nominee</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shanti Priya<sup>(2)(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: center">52</td><td>&#160;</td>
    <td style="text-align: left">Class II Director Nominee</td></tr>
  </table>













<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0%"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
                                            of the compensation committee.</span></td></tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0%"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
                                            of the audit committee.</span></td></tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0%"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member
                                            of the nominating and corporate governance committee.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
biography of Khurram P. Sheikh is set forth under the section entitled &#8220;&#8212; <i>Executive Officers</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ms.
Di-Ann Eisnor</i></b> has served as a member of our Board of Directors since August&#160;2020. Since November&#160;2019, Ms. Eisnor has
served as Co-Founder and CEO of Core, a venture-backed construction labor marketplace. Before that, from February&#160;2019 until October&#160;2019,
she was an executive of The We Company, a part of the We Work Companies, where she was responsible for development of their cities platform.
Prior to that, Ms. Eisnor served as Director of Urban Systems at Google, from June&#160;2018 until February&#160;2019. Previously, Ms.
Eisnor was with Waze, Inc., a crowd-sourced navigation and real-time traffic application owned by Alphabet, Inc., for 10 years, most
recently serving as the VP Platform and Director of Growth. Prior to joining Waze, Ms. Eisnor was co-founder and Chief Executive Officer
of Platial Inc., a collaborative, user-generated cartographic website. Ms. Eisnor currently serves on the board of Saia Inc. (Nasdaq:
SAIA) and Gray Area Foundation for the Arts. She is a venture partner at Obvious Ventures and is co-founder with Lupe Fiasco of Neighborhood
Start Fund, a neighborhood-based micro-fund in underserved urban neighborhoods. She holds a Bachelor&#8217;s Degree in Studio Art and
Business Administration from New York University. She is a 2014 Henry Crown Fellow of the Aspen Institute and a member of the Aspen Global
Leadership Network. Ms. Eisnor is well qualified to serve on our board because of her extensive experience advising boards of directors
of public and private companies and her extensive professional experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mr.
Camillo Martino</i></b> has served as a member of our Board of Directors since August&#160;2020. Mr. Martino was a senior global semiconductor
company executive and now serves as a board member and executive advisor to many global technology companies. Prior to his current board
roles, Mr. Martino was a chief executive officer and C-suite executive of a number of high technology companies worldwide. He is currently
Chair of the Board of Directors of Magnachip Semiconductor (NYSE: MX) and has served on this Board since August&#160;2016. Since 2018,
he has also served on the Board of Directors at Sensera (ASX: SE1). Mr. Martino also serves on the Board of Directors at multiple privately
held companies, including VVDN Technologies (fastest growing ODM based in India with a focus on Wireless, Networking &amp; IoT) and Sakuu
Corporation (multi-material, multi-process Additive Manufacturing platform). Mr. Martino&#8217;s prior board service includes serving
on the boards of Cypress Semiconductor from June&#160;2017 through the sale of the company to Infineon in April&#160;2020 and Moschip
Technologies (BOM: 532407) from April&#160;2017 to May&#160;2019. As an operating executive, Mr. Martino served as Chief Executive Officer
of Silicon Image, Inc. (where he also served as a director) from 2010 until the completion of its sale to Lattice Semiconductor Corporation
(Nasdaq: LSCC) in March&#160;2015, Chief Operating Officer of SAI Technology Inc. from January&#160;2008 to December&#160;2009 (where
he also served as director from 2006 to 2010), and Chief Executive Officer of Cornice Inc. from 2005 to 2007 (where he also served as
a director). From August&#160;2001 to July&#160;2005, Mr. Martino served as the executive vice president and chief operating officer
at Zoran Corporation, a global SoC semiconductor company. Prior to that, Mr. Martino held multiple positions with National Semiconductor
Corporation for a total of nearly 14 years. Mr. Martino holds a Bachelor of Applied Science from the University of Melbourne and a Graduate
Diploma (in Digital Communications) from Monash University in Australia. Mr. Martino is well qualified to serve on our board because
of his extensive experience advising boards of directors of public and private companies and his extensive professional experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>



<!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mr.
George Mathai</i></b> has enjoyed decades working, consulting, and investing in early stage and small businesses at the crossroads of
distinct technologies, multiple industries and novel markets. A technically trained business professional, his early experience in bridge
design and infrastructure repair was at Edwards &amp; Kelcey in New York, now Jacobs Engineering. In January&#160;1993, Mr. Mathai transitioned
to managing renovations projects and gaining strong communications and project execution skills, while driving revenue and profitability,
at a small New York construction company. As a founder, he later parlayed his prior management and technical expertise in leading the
biosensor development program at GenoRx in June&#160;2000, an early stage, venture-backed concern in Hayward, California. His team accomplished
a manufacturable process for detecting DNA electronically on a silicon biochip with the eventual sale of the technology to Bridger Technologies
in April&#160;2011. Thereafter, Mr. Mathai helped raise financing for an innovative antibiotic skin care start-up and worked to fundraise
for an early-stage immune-mediated cancer therapeutic while at a boutique brokerage firm Objective Equity LLC. Overlapping these endeavors,
were local business interests in retail, as well as due diligence consulting for mergers and acquisitions. The above broad and varied
interests are also reflected in his educational history which includes bachelors and masters in civil engineering from University of
California, Berkeley (May&#160;1989) and City College of New York (June&#160;1992), respectively, as well as, most recently upskilling
at CalTech&#8217;s cybersecurity program (December&#160;2020). Mr. Mathai&#8217;s extensive experience in several diverse industries,
markets and customer types will bring a unique and inestimable resource to the board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ms.
Shanti Priya</i></b> has been the CFO of Maxfield Enterprises, Inc., a luxury retail company based in Los Angeles and has been leading
the organization&#8217;s finance and operations since February&#160;2018. Prior to that, Ms. Priya worked for over 12 years in corporate
finance at Gap Inc. with her last role at the company as the Global Director of FP&amp;A and Control overseeing the North American, European,
and Asian markets. Before transitioning into a career in finance, Ms. Priya worked as a Producer managing content creation at a tech
start-up, Knowledge Kids Network, an online educational media site. She holds a Bachelor of Arts in Honors English Literature with a
minor in Biology from Scripps College. In addition, she holds a Master of Arts in Print Journalism and a Master of Business Administration
both from the University of Southern California. Ms. Priya also serves on the board and as treasurer of Secular Student Alliance, a non-profit
organization that educates high school and college students regarding secularism and scientific reasoning. She has previously served
on the board of Sequoyah School, a non-profit private school serving the ages from K-8. Ms. Priya is well qualified to serve on our board
of directors because of her substantial financial and operations experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Family
Relationships</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no family relationships between any of our directors and executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Board Composition and Election of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Director
Independence</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s board of directors (&#8220;Company Board&#8221;) consists of five (5) members. We determined that each director, other
than Mr. Sheikh, are independent directors in accordance with the listing requirements of Nasdaq. The Nasdaq independence definition
includes a series of objective tests, including that the director is not, and has not been for at least three years, one of the Company&#8217;s
employees and that neither the director nor any of his, her or their family members has engaged in various types of business dealings
with the Company. There are no family relationships among any of the Company&#8217;s directors or executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Classified
Board of Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company Board is divided into three classes with staggered, three-year terms, in accordance with the terms of the Charter. At each annual
meeting of stockholders, the directors whose terms then expire will be eligible for reelection until the third annual meeting following
reelection. The directors will be divided among the three classes as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Class I directors will be Di-Ann Eisnor, and her term will expire at our first annual meeting
                                            of stockholders following the Merger;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Class II directors will be Camillo Martino and Shanti Priya, and their terms will expire
                                            at our second annual meeting of stockholders following the Merger; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Class III directors will be Khurram P. Sheikh and George Mathai, and their terms will expire
                                            at our third annual meeting of stockholders following the Merger.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Charter provides that the authorized number of directors may be changed only by resolution of the Company Board. Any additional directorships
resulting from an increase in the number of directors will be distributed among the three classes so that, as nearly as possible, each
class will consist of one-third of the directors. The division of the Company Board into three classes with staggered three-year terms
may delay or prevent a change of the Company Board or a change in control of the Company. The Company&#8217;s directors may be removed
only for cause by the affirmative vote of the holders of at least two-thirds of the Company&#8217;s outstanding voting stock then entitled
to vote in an election of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Leadership Structure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company Board does not anticipate implementing a policy requiring the positions of the Chairman of the Board and Chief Executive Officer
to be separate or held by the same individual. Any further determination to create such a policy is expected to be based on circumstances
existing from time to time, based on criteria that are in the Company&#8217;s best interests and the best interests of its stockholders,
including the composition, skills and experience of the Company Board and its members, specific challenges faced by the Company or the
industry in which it operates, and governance efficiency. We elected Mr. Sheikh as Chairman of the Board because Mr. Sheikh&#8217;s strategic
vision for the business, his in-depth knowledge of the Company&#8217;s operations, and his experience in capital markets make him well
qualified to serve as both Chairman of the Board and Chief Executive Officer of the Company. Combining the roles of Chairman and Chief
Executive Officer will help provide strong and consistent leadership for the management team and the Company Board. However, the Company
Board may decide in the future to separate the roles of Chairman and Chief Executive Officers if it determines that such structure provides
better and more effective oversight and management of the Company. If the Company Board convenes for a meeting, it is expected that the
non-management directors will meet in one or more executive sessions, if the circumstances warrant it. The Company Board may also consider
appointing a lead independent director, if the circumstances warrant it.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Committees and Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company Board consists of an audit committee, a compensation committee and a nominating and corporate governance. The composition of
each committee is set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Role
of Board in Risk Oversight Process</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company Board is responsible for the oversight of the Company&#8217;s risk management processes and, either as a whole or through its
committees, regularly discusses with management the Company&#8217;s major risk exposures, their potential impact on the Company&#8217;s
business and the steps the Company takes to manage them. The risk oversight process includes receiving regular reports from board committees
and members of senior management to enable the Company Board to understand the Company&#8217;s risk identification, risk management and
risk mitigation strategies with respect to areas of potential material risk, including operations, finance, legal, regulatory, strategic
and reputational risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee reviews information regarding liquidity and operations, and oversees the Company&#8217;s management of financial risks.
Periodically, the audit committee reviews the Company&#8217;s policies with respect to risk assessment, risk management, loss prevention
and regulatory compliance. Oversight by the audit committee includes direct communication with the Company&#8217;s external auditors,
and discussions with management regarding significant risk exposures and the actions management has taken to limit, monitor or control
such exposures. The compensation committee is responsible for assessing whether any of the Company&#8217;s compensation policies or programs
has the potential to encourage excessive risk-taking. The nominating and corporate governance committee manages risks associated with
the independence of the Company Board, corporate disclosure practices and potential conflicts of interest. While each committee is responsible
for evaluating certain risks and overseeing the management of such risks, the entire Company Board is regularly informed through committee
reports about such risks. Matters of significant strategic risk is considered by the Company Board as a whole.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committees
of the Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit
Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audit committee&#8217;s main function is to oversee the Company&#8217;s accounting and financial reporting processes and the audits of
the Company&#8217;s financial statements. This committee&#8217;s responsibilities include, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assisting
                                            board oversight of (1) the integrity of our financial statements, (2) our compliance with
                                            legal and regulatory requirements, (3) our independent auditor&#8217;s qualifications and
                                            independence, and (4) the performance of our internal audit function and independent auditors;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            appointment, compensation, retention, replacement, and oversight of the work of the independent
                                            auditors and any other independent registered public accounting firm engaged by us;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pre-approving
                                            all audit and permitted non-audit services to be provided by the independent auditors or
                                            any other registered public accounting firm engaged by us, and establishing pre-approval
                                            policies and procedures;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and discussing with the independent auditors all relationships the auditors have with us
                                            in order to evaluate their continued independence;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">setting
                                            clear hiring policies for employees or former employees of the independent auditors;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">setting
                                            clear policies for audit partner rotation in compliance with applicable laws and regulations;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtaining
                                            and reviewing a report, at least annually, from the independent auditors describing (i) the
                                            independent auditor&#8217;s internal quality-control procedures and (ii) any material issues
                                            raised by the most recent internal quality-control review, or peer review, of the audit firm,
                                            or by any inquiry or investigation by governmental or professional authorities within the
                                            preceding five years respecting one or more independent audits carried out by the firm and
                                            any steps taken to deal with such issues;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">meeting
                                            to review and discuss our annual audited financial statements and quarterly financial statements
                                            with management and the independent auditor</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving any related party transaction required to be disclosed pursuant to Item&#160;404
                                            of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            with management, the independent auditors, and our legal advisors, as appropriate, any legal,
                                            regulatory or compliance matters, including any correspondence with regulators or government
                                            agencies and any employee complaints or published reports that raise material issues regarding
                                            our financial statements or accounting policies and any significant changes in accounting
                                            standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other
                                            regulatory authorities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of the Company&#8217;s audit committee are Shanti Priya, Camillo Martino and Di-Ann Eisnor. Shanti Priya serves as the chair
of the committee. All members of the Company&#8217;s audit committee are independent directors and meet the requirements for financial
literacy under the applicable rules and regulations of the SEC and Nasdaq. Shanti Priya is an &#8220;audit committee financial expert&#8221;
as defined by applicable SEC rules and has the requisite financial sophistication as defined under the applicable Nasdaq listing standards.
The Company&#8217;s board of directors adopted a written charter for the audit committee, which is available on the corporate website
at <i>www.cxapp.com</i>. The information on any of the Company&#8217;s websites is deemed not to be incorporated in this prospectus or
to be part of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation committee&#8217;s main function is to oversee the Company&#8217;s policies relating to compensation and benefits of the
Company&#8217;s officers and employees. This committee&#8217;s responsibilities include, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving on an annual basis the corporate goals and objectives relevant to our Chief
                                            Executive Officer&#8217;s compensation, evaluating our Chief Executive Officer&#8217;s performance
                                            in light of such goals and objectives and determining and approving the remuneration (if
                                            any) of our Chief Executive Officer based on such evaluation;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and approving on an annual basis the compensation of all of our other officers;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            on an annual basis our executive compensation policies and plans;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">implementing
                                            and administering our incentive compensation equity-based remuneration plans;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assisting
                                            management in complying with our proxy statement and annual report disclosure requirements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving
                                            all special perquisites, special cash payments and other special compensation and benefit
                                            arrangements for our officers and employees;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            required, producing a report on executive compensation to be included in our annual proxy
                                            statement; and;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing,
                                            evaluating and recommending changes, if appropriate, to the remuneration for directors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant,
legal counsel or other adviser and is directly responsible for the appointment, compensation and oversight of the work of any such adviser.
However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation
committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of the Company&#8217;s compensation committee are Camillo Martino, Di-Ann Eisnor, and George Mathai. Di-Ann Eisnor serves as
the chair of the committee. The Board has determined that each of Camillo Martino, Di-Ann Eisnor, and George Mathai is independent under
the applicable Nasdaq listing standards and is a &#8220;non-employee director&#8221; as defined in Rule&#160;16b-3 promulgated under
the Exchange Act. The Company&#8217;s board of directors adopted a written charter for the compensation committee, which is available
on the corporate website at <i>www.cxapp.com</i>. The information on any of the Company&#8217;s websites is deemed not to be incorporated
in this prospectus or to be part of this prospectus. The compensation committee operates under its written charter and will review and
evaluate at least annually.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nominating
and Corporate Governance Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
nominating and corporate governance committee is responsible for assisting the Company Board in discharging the board of directors&#8217;
responsibilities regarding the identification of qualified candidates to become board members, the selection of nominees for election
as directors at the Company&#8217;s annual meetings of stockholders (or special meetings of stockholders at which directors are to be
elected), and the selection of candidates to fill any vacancies on the Company Board and any committees thereof. In addition, the nominating
and corporate governance committee is responsible for overseeing the Company&#8217;s corporate governance policies, reporting and making
recommendations to the Company Board concerning governance matters and oversight of the evaluation of the Company Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>



<!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
charter also provides that the nominating and corporate governance committee may, in its sole discretion, retain or obtain the advice
of, and terminate, any search firm to be used to identify director candidates, and will be directly responsible for approving the search
firm&#8217;s fees and other retention terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of the Company&#8217;s nominating and corporate governance committee are Camillo Martino, Di-Ann Eisnor, and Shanti Priya. Camillo
Martino serves as the chair of the committee. All members of the Company&#8217;s nominating and corporate governance committee are independent
directors under the applicable Nasdaq listing standards. The Company&#8217;s board of directors adopted a written charter for the nominating
and corporate governance committee, which is available on the corporate website at <i>www.cxapp.com</i>.The information on any of the
Company&#8217;s websites is deemed not to be incorporated in this prospectus or to be part of this prospectus. The nominating and corporate
governance committee operates under its written charter and will review and evaluate at least annually.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Committee Interlocks and Insider Participation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
member of the compensation committee serves or served during the fiscal year ended December&#160;31, 2021, as a member of the Company
Board or compensation committee of a company that has one or more executive officers serving as a member of the board of directors or
compensation committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Diversity</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s nominating and corporate governance committee is responsible for reviewing with the Company Board, on an annual basis,
the appropriate characteristics, skills and experience required for the Company Board as a whole and its individual members. In evaluating
the suitability of individual candidates (both new candidates and current members) for election or appointment, the nominating and corporate
governance committee and the Company Board will take into account many factors, including the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">personal
                                            and professional integrity, ethics and values;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">experience
                                            in corporate management, such as serving as an officer or former officer of a publicly held
                                            company;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">experience
                                            as a board member or executive officer of another publicly held company;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">strong
                                            finance experience;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">diversity
                                            of expertise and experience in substantive matters pertaining to our business relative to
                                            other board members;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">diversity
                                            of background and perspective, including, but not limited to, with respect to age, gender,
                                            race, place of residence and specialized experience;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">experience
                                            relevant to our business industry and with relevant social policy concerns; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">relevant
                                            academic expertise or other proficiency in an area of our business operations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company Board evaluates, each individual in the context of the board of directors as a whole, with the objective of assembling a group
that can best maximize the success of the business and represent stockholder interests through the exercise of sound judgment using its
diversity of experience in these various areas.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>



<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nasdaq
Board Diversity Matrix</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following Board Diversity Matrix presents the Company Board diversity statistics in accordance with Nasdaq Rule&#160;5606, as self-disclosed
by the director nominees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Board
    Diversity Matrix (As of June 29, 2023)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 90%; font-weight: bold; text-align: justify">Total
    Number of Directors</td><td style="text-align: center; width: 1%; font-weight: bold">5</td>
    <td style="width: 9%; font-weight: bold; text-align: center"/></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Female</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Male</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Part I: Gender Identity</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 80%; text-align: left">Directors</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 9%; text-align: center">2</td><td style="text-align: center; width: 1%">&#160;</td>
    <td style="width: 9%; text-align: center">3</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Part II: Demographic Background</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Asian</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">1</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">2</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">White</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Two or More Races or Ethnicities</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">1</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">LGBTQ+</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Business Conduct and Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted a written code of business conduct and ethics that applies to its directors, officers and employees, including its principal
executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions.
A copy of the code is posted on the corporate website at <i>www.cxapp.com</i>. In addition, the Company intends to post on its website
all disclosures that are required by law or the listing standards of Nasdaq concerning any amendments to, or waivers from, any provision
of the code. The reference to the Company&#8217;s website address does not constitute incorporation by reference of the information contained
at or available through its website, and you should not consider it to be a part of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_017"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXECUTIVE
AND DIRECTOR COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section discusses the material components of the executive compensation program for CXApp&#8217;s executive officers who are named in
the &#8220;Summary Compensation Table&#8221; below. As an emerging growth company, CXApp complies with the executive compensation disclosure
rules applicable to &#8220;smaller reporting companies,&#8221; as such term is defined in the rules promulgated under the Securities
Act, which for 2023 require compensation disclosure for CXApp&#8217;s principal executive officer and two most highly compensated executive
officers other than its principal executive officers. These three officers are referred to as CXApp&#8217;s &#8220;named executive officers.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides certain information regarding the compensation earned by the named executive officers from their services to
KINS or Inpixon, as applicable, during the fiscal years ended December&#160;31, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    and Principal Position<sup>(1)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Year</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Salary
    <br/> ($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Bonus<br/>
    ($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Stock
    Awards<br/> ($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Option
    Awards<br/> ($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>All
    Other<br/> Compensation<br/>
    ($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Total<br/>
    ($)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span>Khurram P. Sheikh</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>2022</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span>Chief Executive Officer</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>2021</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 0.125in"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span>Leon Papkoff</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 8%; text-align: center"><span>2022</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 7%; text-align: right"><span>250,000.00</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 7%; text-align: right"><span>100,000.00</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 7%; text-align: right"><span>-</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 7%; text-align: right"><span>-</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 7%; text-align: right"><span>-</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 7%; text-align: right"><span>350,000.00</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span>Chief Product Officer</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>2021</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>283,333.39</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>75,000.00</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>6,113,029.93</span></td><td style="text-align: left"><span><sup>(2)</sup>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>6,471,363.32</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  </table>







<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            listed principal position of each named executive officer is the principal position each
                                            named executive officer holds with CXApp. Mr. Sheikh served as Chairman and Chief Executive
                                            Officer of KINS. Mr. Papkoff served as Executive Vice President of Experience Apps of Inpixon.</span></td></tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            the fair market value of shares of common stock of Inpixon as of April&#160;30, 2021, issued
                                            on March&#160;3, 2022, as an earnout payment pursuant to the terms and conditions of that
                                            certain Securities Purchase Agreement pursuant to which Inpixon acquired all of the outstanding
                                            capital stock of Design Reactor (the &#8220;Legacy CXApp Purchase Agreement&#8221;) and excludes
                                            the value attributed to 1,250,000 shares of restricted stock granted by Legacy CXApp in 2021
                                            and acquired by Inpixon in connection with the terms of the Legacy CXApp Purchase Agreement.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Narrative
Disclosure to the Summary Compensation Table</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khurram
P. Sheikh, our chief executive officer, did not receive any compensation for his services to KINS during the fiscal years ended December&#160;31,
2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leon
Papkoff, our chief product officer, received (i) a salary of $250,000.00 and a bonus of $100,000.00 as compensation for his services
to Inpixon during the fiscal year ended December&#160;31, 2022; and (ii) a salary of $283,333.39, a bonus of $75,000.00 and stock awards
valued at $6,113,029.93 (representing the fair market value of shares of common stock of Inpixon as of April&#160;30, 2021, issued on
March&#160;3, 2022, as an earnout payment pursuant to the terms and conditions of the Legacy CXApp Purchase Agreement and excludes the
value attributed to 1,250,000 shares of restricted stock granted by Legacy CXApp in 2021 and acquired by Inpixon in connection with the
terms of the Legacy CXApp Purchase Agreement) as compensation for his services to Inpixon during the fiscal year ended December&#160;31,
2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Equity Awards at Fiscal Year-End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no outstanding unexercised options, unvested stock, and/or equity incentive plan awards issued to our named executive officers as
of December&#160;31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Compensation Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Offer
of Employment Letters and Employee Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2023, we were party to offer of employment letters with each of our named executive officers, the material terms of which are summarized
below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Khurram
P. Sheikh Offer Letter</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March&#160;29, 2023, the Company entered into an employment agreement (the &#8220;CEO Agreement&#8221;) with Khurram P. Sheikh to serve
as the Company&#8217;s Chief Executive Officer. Pursuant to the CEO Agreement, Mr. Sheikh will continue in his role as Chief Executive
Officer, and the terms of the agreement include an annual salary in the amount of $325,000, benefits, and other terms and conditions
of employment, as well as an annual bonus with a target amount of $325,000 for each complete calendar year. This disclosure is qualified
in its entirety by reference to the full text of the CEO Agreement. A copy of the CEO Agreement is attached hereto as Exhibit 10.6 and
is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Leon
Papkoff Offer Letter</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March&#160;29, 2023, the Company entered into an employment agreement (the &#8220;CPO Agreement&#8221;) with Leon Papkoff to serve as
the Company&#8217;s Chief Product Officer. Pursuant to the CPO Agreement, Mr. Papkoff will serve as Chief Product Officer, and the terms
of the agreement include an annual salary in the amount of $300,000, benefits, and other terms and conditions of employment, as well
as an annual bonus with a target amount of $195,000 for each complete calendar year. This disclosure is qualified in its entirety by
reference to the full text of the CPO Agreement. A copy of the CPO Agreement is attached hereto as Exhibit 10.7 and is incorporated herein
by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Michael
Angel Offer Letter</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into an employment agreement with Michael Angel effective upon the consummation of the Business Combination. Mr. Angel serves
as Chief Financial Officer of CXApp for a term commencing on the consummation of the Business Combination and will continue until terminated
by CXApp or the employee or in accordance with the terms of the employment agreement. Mr. Angel will be paid an annualized base salary
of $240,000, as revised periodically by CXApp, as well as an annual bonus with a target amount of $144,000 for each complete calendar
year. The employment agreement contains provisions regarding non-solicitation, confidentiality of information and arbitration of disputes.
Mr. Angel may terminate his employment by giving advance written notice to CXApp. CXApp may also terminate the employment agreement for
cause as defined in the employment agreement, a copy of which is attached hereto as Exhibit 10.5 and is also incorporated herein by reference.
On May 31, 2023, Michael Angel provided formal notice of his resignation as Chief Financial Officer of CXApp Inc. (the&#8220;Company&#8221;).
Effective June 5, 2023, Mr. Angel's tenure as Chief Financial Officer concluded, and his employment with the Company will cease to be
in an executive capacity. Mr. Angel will continue to remain employed as a non-executive employee of the Company until June 30, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2023
Equity Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the special meeting held on March&#160;10, 2023, the KINS stockholders considered and approved, among other things, the CXApp Inc. 2023
Equity Incentive Plan (the &#8220;Incentive Plan&#8221;). The Incentive Plan was previously approved, subject to stockholder approval,
by KINS&#8217; board of directors. The Incentive Plan became effective immediately upon the Closing. Pursuant to the terms of the Incentive
Plan, there are 2,110,500 shares of CXApp Class A Common Stock available for issuance under the Incentive Plan, which is equal to 15%
of the aggregate number of shares of CXApp common stock issued and outstanding immediately after the Closing (giving effect to the redemptions).
This description is qualified in its entirety by reference to the text of the Incentive Plan, a copy of which is attached hereto as Exhibit
10.7 and also is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Consulting
Agreement with 3AM, LLC</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of the Closing, Design Reactor entered into a consulting agreement (the &#8220;Consulting Agreement&#8221;) with 3AM, LLC, a Delaware
limited liability (3AM) controlled by Nadir Ali, the current Chief Executive Officer and director of Inpixon, pursuant to which 3AM will
provide advisory services in exchange for a one-time payment of $180,000 in consulting fees. The foregoing description is qualified in
its entirety by reference to the text of the Consulting Agreement, a copy of which is attached hereto as Exhibit 10.8 and also is incorporated
herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Compensation Program</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed an executive compensation program, which was approved by our compensation committee, that is designed to align compensation
with business objectives and the creation of stockholder value, while enabling us to attract, motivate and retain individuals who contribute
to our long-term success.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Legacy
CXApp and Design Reactor Practices</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
CXApp is a newly formed wholly owned subsidiary of Inpixon as the holding company for the Enterprise Apps Business following the internal
reorganization. As such, until the closing of the Business Combination, its director compensation practices are governed by Inpixon&#8217;s
practices, which are described below in &#8220;&#8212;<i>Inpixon Practice</i>.&#8221; Similarly, as a wholly owned subsidiary of Inpixon
until the closing of the Business Combination, Design Reactor&#8217;s director compensation practices are also governed by Inpixon&#8217;s
practices. See &#8220;&#8212;<i>Inpixon Practice</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Inpixon
Practice</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash
Compensation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Inpixon&#8217;s non-employee director compensation policy in effect during 2022, each director is eligible to receive $30,000 per year
for their services rendered on the Inpixon board of directors (&#8220;Inpixon Board&#8221;), $15,000 per year for service as the audit
committee chair, $10,000 per year for service as the compensation committee chair, $6,000 per year for service on the audit committee,
$4,000 per year for service on the compensation committee, and $2,500 per year for service on the nominating committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-employee
members of the Inpixon Board are also reimbursed for expenses incurred in connection with such service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Equity
Compensation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Inpixon&#8217;s non-employee director compensation policy, each non-employee director is eligible to receive an annual non-qualified
stock option to purchase up to 20,000 shares of Inpixon common stock, subject to the approval of the Inpixon Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going
Forward</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board will implement an annual compensation program for its non-employee directors. The material terms of this program are not yet known
and will depend on the judgment of the members of our board based on advice and counsel of its advisors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Limitation
on Liability and Indemnification of Directors and Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Charter contains provisions that limit the liability of the Company&#8217;s directors for damages to the fullest extent
permitted by Delaware law. Consequently, the Company&#8217;s directors will not be personally liable to the Company or its stockholders
for damages as a result of an act or failure to act in his or her capacity as a director, unless:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            presumption that directors are acting in good faith, on an informed basis, and with a view
                                            to the interests of the corporation has been rebutted; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                            is proven that the director&#8217;s act or failure to act constituted a breach of his or
                                            her fiduciary duties as a director and such breach involved intentional misconduct, fraud
                                            or a knowing violation of law.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Charter requires the Company to indemnify and advance expenses to, to the fullest extent permitted by applicable law,
its directors, officers and agents. The Company maintains a directors&#8217; and officers&#8217; insurance policy pursuant to which the
Company&#8217;s directors and officers are insured against liability for actions taken in their capacities as directors and officers.
Finally, the Company&#8217;s Charter prohibits any retroactive changes to the rights or protections or increasing the liability of any
director in effect at the time of the alleged occurrence of any act or omission to act giving rise to liability or indemnification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company will enter into separate indemnification agreements with the Company&#8217;s directors and officers. These agreements,
among other things, require the Company to indemnify its directors and officers for certain expenses, including attorneys&#8217; fees,
judgments, fines and settlement amounts incurred by a director or officer in any action or proceeding arising out of their services as
one of the Company&#8217;s directors or officers or any other company or enterprise to which the person provides services at the Company&#8217;s
request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe these provisions in the Company&#8217;s Charter are necessary to attract and retain qualified persons as directors and officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_018"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the compensation arrangements with directors and executive officers described under &#8220;Executive and Director Compensation&#8221;
and &#8220;Management&#8221; and the registration rights described elsewhere in this prospectus, the following is a description of each
transaction since January&#160;1, 2020, and each currently proposed transaction in which:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            have been or are to be a participant;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            amount involved exceeds or will exceed $120,000; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            of our directors, executive officers or beneficial holders of more than 5% of our capital
                                            stock, or any immediate family member of, or person sharing the household with, any of these
                                            individuals (other than tenants or employees), had or will have a direct or indirect material
                                            interest.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CXApp
has policies and procedures designed to minimize potential conflicts of interest arising from any dealings it may have with its affiliates
and to provide appropriate procedures for the disclosure of any real or potential conflicts of interest that may exist from time to time.
Specifically, pursuant to its audit committee charter, the audit committee has the responsibility to review related party transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employment
Offer Letter Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Khurram
P. Sheikh Offer Letter</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March&#160;29, 2023, the Company entered into an employment agreement (the &#8220;CEO Agreement&#8221;) with Khurram P. Sheikh to serve
as the Company&#8217;s Chief Executive Officer. Pursuant to the CEO Agreement, Mr. Sheikh will continue in his role as Chief Executive
Officer, and the terms of the agreement include an annual salary in the amount of $325,000, benefits, and other terms and conditions
of employment, as well as an annual bonus with a target amount of $325,000 for each complete calendar year. This disclosure is qualified
in its entirety by reference to the full text of the CEO Agreement. A copy of the CEO Agreement is attached hereto as Exhibit 10.6 and
is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Leon
Papkoff Offer Letter</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March&#160;29, 2023, the Company entered into an employment agreement (the &#8220;CPO Agreement&#8221;) with Leon Papkoff to serve as
the Company&#8217;s Chief Product Officer. Pursuant to the CPO Agreement, Mr. Papkoff will serve as Chief Product Officer, and the terms
of the agreement include an annual salary in the amount of $300,000, benefits, and other terms and conditions of employment, as well
as an annual bonus with a target amount of $195,000 for each complete calendar year. This disclosure is qualified in its entirety by
reference to the full text of the CPO Agreement. A copy of the CPO Agreement is attached hereto as Exhibit 10.7 and is incorporated herein
by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Michael
Angel Offer Letter</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into an employment agreement with Michael Angel effective upon the consummation of the Business Combination. Mr. Angel serves
as Chief Financial Officer of CXApp for a term commencing on the consummation of the Business Combination and will continue until terminated
by CXApp or the employee or in accordance with the terms of the employment agreement. Mr. Angel will be paid an annualized base salary
of $240,000, as revised periodically by CXApp, as well as an annual bonus with a target amount of $144,000 for each complete calendar
year. The employment agreement contains provisions regarding non-solicitation, confidentiality of information and arbitration of disputes.
Mr. Angel may terminate his employment by giving advance written notice to CXApp. CXApp may also terminate the employment agreement for
cause as defined in the employment agreement, a copy of which is attached hereto as Exhibit 10.5 and is also incorporated herein by reference.
<span style="background-color: white">On May 31, 2023, Michael Angel provided formal notice of his resignation as Chief Financial Officer
of CXApp Inc. (the &#8220;Company&#8221;). Effective June 5, 2023, Mr. Angel's tenure as Chief Financial Officer concluded, and his employment
with the Company will cease to be in an executive capacity. Mr. Angel will continue to remain employed as a non-executive employee of
the Company until June 30, 2023.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Consulting
Agreement with 3AM, LLC</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of the Closing, Design Reactor entered into a consulting agreement (the &#8220;Consulting Agreement&#8221;) with 3AM, LLC, a Delaware
limited liability (3AM) controlled by Nadir Ali, the current Chief Executive Officer and director of Inpixon, pursuant to which 3AM will
provide advisory services in exchange for a one-time payment of $180,000 in consulting fees. The foregoing description is qualified in
its entirety by reference to the text of the Consulting Agreement, a copy of which is attached hereto as Exhibit 10.8 and also is incorporated
herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Relationships and Related Party Transactions &#8212; CXApp</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Agreements
with Inpixon</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CXApp
and Inpixon operate separately, each as a public company. In connection with the Separation, Legacy CXApp has entered into various agreements
to effect the Separation and provide a framework for CXApp&#8217;s relationship with Inpixon after the Separation, including the Separation
and Distribution Agreement, an Employee Matters Agreement, a Tax Matters Agreement and a Transition Services Agreement. These agreements
provide for the allocation between Legacy CXApp and Inpixon of Inpixon&#8217;s assets, employees, liabilities and obligations (including
its property and employee benefits and tax-related assets and liabilities) attributable to periods prior to, at and after Legacy CXApp&#8217;s
separation from Inpixon and will govern certain relationships between CXApp and Inpixon after the Separation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summaries of each of the agreements listed above are qualified in their entireties by reference to the full text of the applicable
agreements which are filed as exhibits to this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Separation
and Distribution Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;25, 2022, in connection with the execution of the Merger Agreement, Inpixon, Legacy CXApp, Design Reactor and KINS entered
into the Separation and Distribution Agreement which sets forth the principal actions to be taken in connection with the Separation.
The Separation and Distribution Agreement identifies assets to be transferred, liabilities to be assumed and contracts to be assigned
to each of Inpixon and Legacy CXApp as part of the internal reorganization described therein and requires an Inpixon contribution to
be made to Legacy CXApp. The Separation and Distribution Agreement also sets forth other agreements that govern certain aspects of Legacy
CXApp&#8217;s relationship with Inpixon following the Business Combination. In connection with the Separation and Distribution Agreement
and related ancillary agreements, Legacy CXApp issued additional shares of Legacy CXApp common stock to Inpixon. Inpixon distributed
on a pro rata basis all of the outstanding shares of Legacy CXApp common stock to the Inpixon securityholders as of March&#160;6, 2023
by delivering to the distribution agent a book-entry authorization representing the shares of Legacy CXApp common stock being distributed
for the account of Inpixon securityholders. The distribution agent held such book-entry shares for the account of Legacy CXApp&#8217;s
stockholders (as of immediately after consummation of the Distribution) pending the Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the date of the Distribution, Inpixon distributed on a pro rata basis all of the outstanding shares of Legacy CXApp common stock to the
holders of Inpixon common stock and certain other holders of its securities as of March&#160;6, 2023. The Distribution was effected by
Inpixon delivering to the distribution agent a book-entry authorization representing the shares of Legacy CXApp common stock being distributed
in the Distribution for the account of Inpixon securityholders. The distribution agent held such book-entry shares for the account of
Legacy CXApp&#8217;s stockholders (as of immediately after consummation of the Distribution) pending the Merger. The shares of Legacy
CXApp common stock were not be transferrable prior to the exchange of such shares for the shares of KINS common stock pursuant to the
Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employee
Matters Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Distribution, KINS, Inpixon, Legacy CXApp and Merger Sub entered into the Employee Matters Agreement, which set forth the terms
and conditions of certain employee-related matters in connection with the transaction, including allocation of benefit plan assets and
liabilities between Inpixon and Legacy CXApp, treatment of incentive equity awards in the Distribution and the Business Combination and
related covenants and commitments of the parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
Matters Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Distribution, KINS, Legacy CXApp and Inpixon entered into the Tax Matters Agreement that governs each party&#8217;s respective
rights, responsibilities and obligations with respect to tax liabilities and benefits, tax attributes, the preparation and filing of
tax returns, the control of audits and other tax proceedings and certain other matters regarding taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, KINS and Legacy CXApp are liable for all U.S. federal, state, local and foreign taxes (and any related interest, penalties or
audit adjustments) that are (i) imposed with respect to tax returns that include both Legacy CXApp and Inpixon, to the extent such taxes
are attributable to Legacy CXApp or the Enterprise Apps Business, or (ii) imposed with respect to tax returns that include Legacy CXApp
but not Inpixon, in each case, for tax periods (or portions thereof) beginning after the Distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, KINS and Legacy CXApp may be liable for certain taxes resulting from the restructuring transactions undertaken to effectuate
the Distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Distribution, together with certain related transactions, is intended to qualify as a reorganization under Sections&#160;355 and 368(a)(1)(D)
of the Code. If the Distribution does not so qualify, the difference between the fair market value and the tax basis of the Legacy CXApp
shares distributed by Inpixon to the Inpixon stockholders will be taxable income to Inpixon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if the contribution and distribution, taken together, otherwise qualify as a transaction described in Sections&#160;355 and 368(a)(1)(D)
of the Code, the Distribution is still taxable to Inpixon (but not to Inpixon stockholders) pursuant to Section&#160;355(e) of the Code
if one or more persons acquire a 50% or greater interest (measured by vote or value) in the stock of Inpixon or Legacy CXApp, directly
or indirectly (including through acquisitions of our stock), as part of a plan or series of related transactions that includes the Distribution.
For purposes of this test, the Merger is treated as part of a plan that includes the Distribution, but the Merger standing alone did
not cause the Distribution to be taxable to Inpixon under Section&#160;355(e) of the Code because holders of Legacy CXApp common stock
own more than 50% of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per
the terms of the Sponsor Support Agreement, the Sponsor has agreed to exchange up to 1 million shares of KINS Class B common stock for
such number of shares of KINS Class A common stock as shall be necessary to ensure that the number of shares of KINS common stock issued
as aggregate merger consideration to the holders of Legacy CXApp common stock exceeds 50% by at least one share than the number of shares
of KINS common stock owned by all other holders of KINS common stock. Pursuant to the Sponsor Support Agreement, the Sponsor and related
parties have agreed, subject to the limitation set forth therein, to forfeit 22,224 shares of KINS common stock (as of immediately prior
to the consummation of the Merger).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tax Matters Agreement requires KINS and Legacy CXApp to comply with the representations made in the materials submitted to RSM US LLP
in connection with a distribution tax opinion that Inpixon received regarding the intended tax treatment of the Distribution and certain
related transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tax Matters Agreement also includes covenants restricting Legacy CXApp&#8217;s and KINS&#8217; ability to take or fail to take any action
if such action or failure to act could reasonably be expected to adversely affect the intended tax treatment. In particular, in the two
years following the Distribution, such restrictive covenants will generally prevent KINS and Legacy CXApp from (i) entering into any
transaction which could, when combined with other transactions (including the Merger), result in a 45% or greater change in ownership
of KINS&#8217; or Legacy CXApp&#8217;s equity as part of a plan or series of related transactions that includes the Distribution, (ii)
ceasing the active conduct of certain of Legacy CXApp&#8217;s businesses, (iii) voluntarily dissolving or liquidating KINS or Legacy
CXApp and (iv) causing, permitting, or agreeing to the sale, transfer, or disposal of assets of Legacy CXApp that, in the aggregate,
constitute more than 30% of the consolidated gross assets of Legacy CXApp, in each case, unless Legacy CXApp obtains a private letter
ruling from the IRS, an unqualified opinion of a nationally recognized tax advisor that such action will not cause a failure of the intended
tax treatment, or Inpixon consents to the undertaking of such action. Notwithstanding receipt of such ruling, opinion or consent, in
the event that such action causes a failure of the intended tax treatment, KINS and Legacy CXApp could be responsible for all taxes arising
therefrom.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transition
Services Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Separation, Legacy CXApp and Inpixon entered into the Transition Services Agreement pursuant to which Inpixon and
its affiliates and Legacy CXApp and its affiliates will provide services to each other primarily related to payroll and benefits administration,
IT support, finance and accounting services, contract administration and management services, and other administrative support services
that may be required on an as needed basis, which services are of the type that Legacy CXApp and Inpixon provided to, and received from,
each other prior to the Separation. The fees for each of the transition services are set forth in the Transition Services Agreement.
The Transition Services Agreement will terminate on the expiration of the term of the last service provided under it, and if no expiration
date is provided for any transition service, then such transition service will terminate twelve months after the date of the Transition
Services Agreement, provided that the receiving party shall have the right to an extension of each or any transition service for up to
six months by providing written notice to providing party in advance of the original termination date for such transition service if,
prior to such request for extension, the receiving party has used commercially reasonable efforts to establish analogous capabilities
of its own. The parties will also discuss in good faith any subsequent requests to further extend the transition services. In addition,
(i) the receiving party may terminate a transition service with prior written notice, with certain exceptions, (ii) either party may
terminate the Transition Services Agreement in the event of an uncured material breach by the other party, upon bankruptcy or insolvency
of the other party, or (iii) the parties may terminate a transition service or the Transition Service Agreement upon mutual agreement.
Legacy CXApp does not anticipate that its net costs associated with the Transition Services Agreement will be materially different than
the historical costs that have been allocated by Inpixon to Legacy CXApp related to these same services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Relationships and Related Party Transactions &#8212; KINS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>KINS
Founder Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November&#160;2020, the Sponsor purchased 150,000 KINS Founder Shares of KINS Class B Common Stock for an aggregate price of $25,000.
On December&#160;11, 2020, KINS effected a 47.91667-for-1 stock split and on December&#160;14, 2020, KINS effected a stock dividend of
1.2 shares of KINS Class B Common Stock for each share of KINS Class B Common Stock outstanding prior to the dividend, resulting in 6,900,000
shares of KINS Class B Common Stock being issued and outstanding. All share and per share amounts have been retroactively restated to
reflect the stock split and stock dividend.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Sponsor Support Agreement entered into among Legacy CXApp, KINS and the Sponsor, certain of the KINS Founder Shares are subject
to restrictions. Prior to our Initial Public Offering, the BlackRock Investors acquired 750,000 shares of KINS Class B Common Stock and
up to 525,000 shares are issuable to the Sponsor under certain conditions (as defined in the Sponsor Support Agreement, the &#8220;Potential
Forfeiture Shares&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative
Support Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing
on December&#160;14, 2020, KINS agreed to pay the Sponsor or an affiliate of the Sponsor a total of $20,000 per month for office space,
utilities, secretarial support and administrative services. Upon completion a business combination or KINS&#8217; liquidation, KINS will
cease paying these monthly fees. KINS incurred and paid $60,000 and $180,000 for the three and nine months ended September&#160;30, 2022,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Due
from Sponsor</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the closing of the KINS Initial Public Offering on December&#160;17, 2020, a portion of the proceeds from the sale of the KINS Private
Placement Warrants in the amount of $2,124,125 was due to KINS to be held outside of the Trust Account for working capital purposes.
KINS received the cash on February&#160;18, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sponsor
Support Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KINS,
the Sponsor and Legacy CXApp entered into the Sponsor Support Agreement, dated as of September&#160;25, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Sponsor Support Agreement, the Sponsor agreed to, among other things, at any meeting of the KINS Stockholders, or in any other
circumstance in which the vote, consent or other approval of the KINS Stockholders is sought, (i) appear at each such meeting or otherwise
cause all of its KINS Common Stock to be counted as present thereat for purposes of calculating a quorum and (ii) vote (or cause to be
voted), or execute and deliver a written consent covering, all of its KINS Common Stock: (1) in favor of each Transaction Proposal; (2)
against any proposal relating to a business combination (other than the Transaction Proposals); (3) against any merger agreement or merger
(other than the Merger Agreement and the Merger), consolidation, combination, sale of substantial assets, reorganization, recapitalization,
dissolution, liquidation or winding up of or by KINS; (4) against any change in the business, management or the KINS Board (other than
in connection with the Transaction Proposals); and (5) against any proposal, action or agreement that would (A) impede, frustrate, prevent
or nullify any provision of the Sponsor Support Agreement, the Merger Agreement or the Merger, (B) result in a breach in any respect
of any covenant, representation, warranty or any other obligation or agreement of KINS or the Merger Sub under the Merger Agreement,
(C) result in any of the conditions set forth in Article IX of the Merger Agreement not being fulfilled or (D) change in any manner the
dividend policy or capitalization of, including the voting rights of any class of KINS capital stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placement Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the KINS Initial Public Offering, KINS completed the private sale of 10,280,000 KINS Private Placement Warrants at
a price of $1.00 per KINS Private Placement Warrant to the Sponsor and the BlackRock Investors, generating gross proceeds of $10,280,000.
The KINS Private Placement Warrants are identical to the KINS Public Warrants underlying the KINS Units sold in the KINS Initial Public
Offering, except that the KINS Private Placement Warrants and the KINS Class A Common Stock issuable upon the exercise of the KINS Private
Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a business combination, subject
to certain limited exceptions. Additionally, except as provided herein, the KINS Private Placement Warrants will be exercisable on a
cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_019"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRINCIPAL
STOCKHOLDERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The
following table sets forth the beneficial ownership of our Common Stock as of June 29, 2023 by:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">each
                                            person who is known to be the beneficial owner of more than 5% of the outstanding shares
                                            of each of our shares of Class A and Class C Common Stock;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            of our current named executive officers and directors; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            our current executive officers and directors as a group.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Beneficial
ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a
security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants
that are currently exercisable or exercisable within 60 days after that date through (a) the exercise of any option, warrant or
right, (b) the conversion of a security, (c) the power to revoke a trust, discretionary account or similar arrangement, or (d) the
automatic termination of a trust, discretionary account or similar arrangement. In computing the number of shares beneficially owned
by a person and the percentage ownership of that person, shares of our Common Stock subject to options or other rights (as set forth
above) held by that person that are currently exercisable, or will become exercisable within 60 days thereafter, are deemed
outstanding for such person, while such shares are not deemed outstanding for purposes of computing percentage ownership of any other person. The
table below also reflects the beneficial ownership of shares of our Common Stock issuable upon the exercise of public warrants or
private placement warrants. Each person named in the table has sole voting and investment power with respect to all of the shares
shown as beneficially owned by such person, except as otherwise indicated in the table or footnotes below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Unless
otherwise indicated, we believe that all persons named in the table below have sole voting and investment power with respect to the voting
securities beneficially owned by them. To our knowledge, no shares of our Common Stock beneficially owned by any executive officer or
director have been pledged as security. Unless otherwise noted, the address of each beneficial owner is c/o CXApp Inc., Four Palo Alto
Square, Suite 200, 3000 El Camino Real, Palo Alto, CA 94306.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As
of June 29, 2023, there were 14,069,999 shares of Common Stock issued and outstanding, which are comprised of 8,582,699 shares of Class
A Common Stock and 5,487,300 shares of Class C Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-indent: 0pt; padding-left: 0pt; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Name
                                            of Beneficial O?wners</b></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Class
    A</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Class
    C</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt;"><b>Total
    Shares<sup>(1)</sup></b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%<sup>(2)</sup></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-indent: 0pt; padding-left: 0pt; text-align: left"><p style="margin: 0; font: 10pt Times New Roman, Times, Serif"><i>5%
                                            Stockholders</i></p></td><td style="font-weight: bold"><i>&#160;</i></td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: 0pt; padding-left: 0pt; text-align: left; width: 28%"><p style="margin: 0; font: 10pt Times New Roman, Times, Serif">KINS
                                            Capital LLC<sup>(3)</sup></p></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">15,756,304</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><p style="margin: 0; font: 10pt Times New Roman, Times, Serif">89.09</p></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">15,756,304</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">67.99</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: 0pt; padding-left: 0pt; text-align: left"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">BlackRock,
                                            Inc.<sup>(4)</sup></p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">2,022,119</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">20.72</p></td><td style="text-align: left">%&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">%&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">2,022,119</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">13.26</p></td><td style="text-align: left">%&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: left">Directors
    and Executive Officers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt;">Khurram
    P. Sheikh<sup>(3)</sup></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">15,756,304</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0; font: 10pt Times New Roman, Times, Serif">89.09</p></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">%&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">15,756,304</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">67.99</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Camillo
    Martino</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Di-Ann
    Eisnor</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Shanti
    Priya</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">George
    Mathai</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Leon
    Papkoff</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: left">All
    directors and executive officers as a group (6 individuals)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,756,304</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0; font: 10pt Times New Roman, Times, Serif">89.09</p></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">%&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,756,304</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">67.99</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt;"><i>(1)</i></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt;"><i>The CXApp Class A Common Stock and the CXApp
    Class C Common Stock are identical in all respects, except that the CXApp Class C Common Stock are subject to transfer restrictions
    and will automatically convert into CXApp Class A Common Stock on the earlier to occur of (i) the 180<sup>th</sup> day following
    the closing of the Merger and (ii) the day that the last reported sale price of the CXApp Class A Common Stock equals or exceeds
    $12.00 per share for any 20 trading days within any 30-trading day period following the closing of the Merger.</i></span></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt;"><i>(2)</i></span></td><td style="text-align: justify"><span style="font-size: 10pt;"><i> The percentage is calculated by dividing
                                                                                                                                                   the number of securities beneficially owned by the total number of outstanding shares of CXApp Class A and CXApp Class C Common
                                                                                                                                                   Stock, inclusive of any securities for which the listed beneficial owner holds the right to acquire beneficial ownership
                                                                                                                                                   within 60 days.</i></span></td>
</tr></table>







<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-size: 10pt;"><i>(3)</i></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt;"><i>Reflects: (a) 6,652,776 shares of CXApp Class A Common Stock held of record by KINS Capital LLC ("Sponsor"), and (b) 9,103,528 shares of Class A Common Stock underlying the private warrants held of record by the Sponsor. Mr. Khurram P. Sheikh is the managing member of the Sponsor, and as such Mr. Khurram P. Sheikh has voting and investment discretion with respect to the securities held of record by the Sponsor and may be deemed to have shared beneficial ownership of the securities held of record by the Sponsor.  Mr. Khurram P. Sheikh disclaims beneficial ownership of the securities held of record by the Sponsor other than to the extent of any pecuniary interest he may have therein, directly or indirectly.  Pursuant to the Sponsor Support Agreement, the Sponsor and related parties have, subject to the limitation set forth therein, forfeited 22,224 shares of CXApp Common Stock (as of immediately prior to the consummation of the Merger). This amount also reflects redemptions of 230,328 KINS public shares prior to Closing. The business address of Sponsor is Four Palo Alto Square, Suite 200, 3000 El Camino Real, Palo Alto, CA 94306.</i></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 0.25in"><span style="font-size: 10pt;"><i>(4)</i></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt;"><i>The registered holders of
    the referenced shares, which are comprised of 845,647 shares of CXApp Class A Common Stock and 1,176,472 shares of CXApp Class A
    Common Stock underlying the private warrants, are funds and accounts under management by BlackRock, Inc. BlackRock, Inc. is the ultimate
    parent holding company of such funds and accounts. On behalf of such funds and accounts, the applicable portfolio managers, as managing
    directors of such entities, have voting and investment power over the shares held by the funds and accounts which are the registered
    holders of the referenced shares. Such portfolio managers expressly disclaim beneficial ownership of all shares held by such funds
    and accounts. The address of such funds and accounts and such portfolio managers is 55 East 52nd Street, New York, NY 10055.</i></span></td></tr>
  </table>
<p style="margin: 0">&#160;&#160;</p>



<!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_020"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SELLING
SECURITYHOLDERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus relates to (i) the resale of up to 6,977,776 shares of common stock previously issued by certain of the Selling Securityholders,
(ii) the resale of up to 10,280,000 warrants to purchase common stock and (iii) the resale of up to 24,080,000 shares of common stock
reserved for issuance upon the exercise of warrants to purchase common stock. The Selling Securityholders may from time to time offer
and sell any or all of the shares of common stock and warrants set forth below pursuant to this prospectus and any accompanying prospectus
supplement. When we refer to the &#8220;Selling Securityholders&#8221; in this prospectus, we mean the persons listed in the table below,
and the pledgees, donees, transferees, assignees, successors, designees and others who later come to hold any of the Selling Securityholders&#8217;
interest in the common stock or warrants other than through a public sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The
following table sets forth, as of the date of this prospectus, the names of the Selling Securityholders, and the aggregate number of
shares of common stock and warrants that the Selling Securityholders may offer pursuant to this prospectus. The following table does
not reflect the beneficial ownership of any shares of common stock issuable upon exercise of warrants unless such securities are exercisable
or convertible within 60 days of June 29, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot advise you as to whether the Selling Securityholders will in fact sell any or all of such common stock or warrants. In addition,
the Selling Securityholders may sell, transfer or otherwise dispose of, at any time and from time to time, the common stock and warrants
in transactions exempt from the registration requirements of the Securities Act after the date of this prospectus. For purposes of this
table, we have assumed that the Selling Securityholders will have sold all of the securities covered by this prospectus upon the completion
of the offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Beneficial<br/>
    Ownership Before<br/>
    the Offering</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares
    to<br/>
    be Sold in<br/>
    the Offering</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Beneficial<br/>
    Ownership After<br/>
    the Offering</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Name
    of Selling Holder</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number
    of<br/>
    Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number
    of<br/>
    Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Number
                                            of</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Shares</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left"><span style="font-size: 10pt;">KINS
    Capital LLC<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">15,756,304</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">67.99</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">15,756,304</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><p style="margin: 0; font: 10pt Times New Roman, Times, Serif">67.99</p></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt;">BlackRock,
    Inc.<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0; font: 10pt Times New Roman, Times, Serif">2,022,119</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.26</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,022,119</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.26</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt;">BTIG,
    LLC<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.006</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.006</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->



<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-size: 10pt;">(1)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt;">KINS Capital LLC (&#8220;Sponsor&#8221;)
    is the record holder of such shares, which are comprised of 6,652,776 shares of CXApp Class A Common Stock and 9,103,528 shares of
    CXApp Class A Common Stock underlying the private warrants. Mr. Khurram P. Sheikh is the managing member of the Sponsor, and as such
    Mr. Khurram P. Sheikh has voting and investment discretion with respect to the shares held of record by the Sponsor and may be deemed
    to have shared beneficial ownership of shares held directly by the Sponsor. Mr. Khurram P. Sheikh disclaims beneficial ownership
    of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly. The business
    address of Sponsor is Four Palo Alto Square, Suite 200, 3000 El Camino Real, Palo Alto, CA 94306.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-size: 10pt;">(2)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt;">The registered holders of the
    referenced shares, which are comprised of 845,647 shares of CXApp Class A Common Stock and 1,176,472 shares of CXApp Class A Common
    Stock underlying the private warrants, are funds and accounts under management by BlackRock, Inc. BlackRock, Inc. is the ultimate
    parent holding company of such funds and accounts. On behalf of such funds and accounts, the applicable portfolio managers, as
    managing directors of such entities, have voting and investment power over the shares held by the funds and accounts which are the
    registered holders of the referenced shares. Such portfolio managers expressly disclaim beneficial ownership of all shares held by
    such funds and accounts. The address of such funds and accounts and such portfolio managers is 55 East 52nd Street, New York, NY
    10055.</span></td></tr>
  </table>






<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">BTIG,
                                            LLC is the record holder of such shares. The business address of BTIG, LLC is 65 E 65th Street,
                                            New York, NY 10065.</span></td>
</tr></table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; font-weight: bold; text-align: left">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Beneficial<br/>
Ownership Before<br/>
the Offering</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Securities to<br/>
be Sold in<br/>
the Offering</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Beneficial <br/> Ownership After <br/> the Offering</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: left"><b>Name of Selling Holder</b></td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Number of <br/> Warrants</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">%</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Number of <br/> Warrants</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">%</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Number of <br/> Warrants</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">%</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KINS Capital LLC<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,103,528</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">37.8</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,103,528</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">37.8</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BlackRock, Inc.<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,176,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,176,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KINS
Capital LLC (&#8220;Sponsor&#8221;) is the record holder of such shares. Mr. Khurram P. Sheikh is the managing member of the Sponsor,
and as such Mr. Khurram P. Sheikh has voting and investment discretion with respect to the shares held of record by the Sponsor and may
be deemed to have shared beneficial ownership of shares held directly by the Sponsor. Mr. Khurram P. Sheikh disclaims beneficial ownership
of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly. The business address
of Sponsor is Four Palo Alto Square, Suite 200, 3000 El Camino Real, Palo Alto, CA 94306.</span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registered holders of the referenced shares are funds and accounts under management by BlackRock, Inc. BlackRock, Inc. is the ultimate
parent holding company of such funds and accounts. On behalf of such funds and accounts, the applicable portfolio managers, as managing
directors of such entities, have voting and investment power over the shares held by the funds and accounts which are the registered
holders of the referenced shares. Such portfolio managers expressly disclaim beneficial ownership of all shares held by such funds and
accounts. The address of such funds and accounts and such portfolio managers is 55 East 52nd Street, New York, NY 10055.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_021"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DESCRIPTION
OF CAPITAL STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description summarizes some of the terms of our certificate of incorporation and bylaws and the DGCL. This description is summarized
from, and qualified in its entirety by reference to, our certificate of incorporation and bylaws, each of which has been publicly filed
with the SEC, as well as the relevant provisions of the DGCL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Our
purpose is to engage in any lawful act or activity for which corporations may now or hereafter be organized under the DGCL. Our authorized
capital stock will consist of 212,000,000 shares, $0.0001 par value per share, of which: 210,000,000 shares will be designated as Common
Stock; and 2,000,000 shares will be designated as Preferred Stock. CXApp has an aggregate of 14,069,999 shares of Common Stock issued
and outstanding as of June 16, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class
A Common Stock and Class C Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>The
amended and restated certificate of incorporation authorizes two classes of common stock, the Class A Common Stock and the Class C Common
Stock. The Class A Common Stock and the Class C Common Stock has the same rights, except the Class C Common Stock are not listed on an
exchange and is subject to a 180-day lock-up period beginning on the Closing Date of the Merger. Upon the expiration of the lock-up period,
such shares of Class C Common Stock will convert into shares of Class A Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividend
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
DGCL permits a corporation to declare and pay dividends out of &#8220;surplus&#8221; or, if there is no &#8220;surplus,&#8221; out of
its net profits for the fiscal year in which the dividend is declared and/or the preceding fiscal year. &#8220;Surplus&#8221; is defined
as the excess of the net assets of the corporation over the amount determined to be the capital of the corporation by the board of directors.
The capital of the corporation is typically calculated to be (and cannot be less than) the aggregate par value of all issued shares of
capital stock. Net assets equals the fair value of the total assets minus total liabilities. The DGCL also provides that dividends may
not be paid out of net profits if, after the payment of the dividend, capital is less than the capital represented by the outstanding
stock of all classes having a preference upon the distribution of assets. Delaware common law also imposes a solvency requirement in
connection with the payment of dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable law and the rights and preferences of any holders of any outstanding series of Preferred Stock, the holders of Common Stock
will be entitled to the payment of dividends on the Common Stock when, as and if declared by the Board in accordance with applicable
law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting
Rights</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Common Stock will be entitled to one vote for each share held as of the record date for determining stockholders entitled to vote
on such matters, except as otherwise required by law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Right
to Receive Liquidation Distributions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the rights and preferences of any holders of any shares of any outstanding series of Preferred Stock, in the event of any liquidation,
dissolution or winding up of CXApp, the funds and assets of CXApp that may be legally distributed to the stockholders will be distributed
among the holders of the then outstanding Common Stock pro rata in accordance with the number of shares of Common Stock held by each
such holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Matters</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
outstanding shares of the Common Stock will be fully paid and nonassessable. The Common Stock will not be entitled to preemptive rights
and will not be subject to redemption or sinking fund provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the certificate of incorporation, the Board is authorized, subject to limitations prescribed by the DGCL, to issue from
time to time Preferred Stock in one or more series, and to determine and fix the number of shares of such series and such designations,
powers, preferences and rights of the shares of each series and any of its qualifications, limitations or restrictions, in each case
without approval by the stockholders. The Board is authorized to increase or decrease the number of shares of any series of Preferred
Stock, but not below the number of shares of that series then outstanding, without approval by the stockholders. The Board may also authorize
the issuance of Preferred Stock with voting or other rights that could adversely affect the voting power or other rights of the holders
of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Public
Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Following
the Business Combination between KINS and Legacy CXApp, there were 13,800,000 public warrants (&#8220;Public Warrants&#8221;) and 10,280,000
private placement warrants (the &#8220;Private Placement Warrants&#8221; and collectively with the Public Warrants, the &#8220;warrants&#8221;)
outstanding. Each whole warrant entitles the registered holder to purchase one share of our Class A Common Stock at a price of $11.50
per share, subject to adjustment as discussed below, at any time commencing on December&#160;15, 2021 (12 months from the closing of
the KINS Technology Group Inc. initial public offering (the &#8220;KINS Initial Public Offering&#8221;)), except as described below.
Pursuant to the warrant agreement, dated as of December&#160;14, 2020, between Continental Stock Transfer &amp; Trust Company (&#8220;Continental&#8221;)
and us (the &#8220;Warrant Agreement&#8221;), a warrant holder may exercise its warrants only for a whole number of shares of our Class
A Common Stock. This means only a whole warrant may be exercised at a given time by a warrant holder. The warrants will expire on the
fifth anniversary of the completion of the Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a Public Warrant and will have no obligation
to settle such warrant exercise unless a registration statement under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;)
covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus
relating to those shares of Class A common stock is available, subject to our satisfying our obligations described below with respect
to registration. No warrant will be exercisable for cash or on a cashless basis, and we will not be obligated to issue any shares to
holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the
securities laws of the state of the exercising holder, or an exemption from registration is available. In the event that the conditions
in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled
to exercise such warrant and such warrant may have no value and expire worthless. In no event will we be required to net cash settle
any warrant. We have agreed that as soon as practicable, but in no event later than 20 business days after the closing of the Business
Combination, we will use our commercially reasonable efforts to file with the SEC, and within 60 business days following the closing
of the Business Combination, to have declared effective, a registration statement covering the issuance of the shares of Class A common
stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until
the warrants expire or are redeemed. If any such registration statement has not been declared effective by the 60th Business Day following
the closing of the Business Combination, holders of the Warrants shall have the right, during the period beginning on the 61st Business
Day after the closing of the Business Combination and ending upon such registration statement being declared effective by the Commission,
and during any other period when the Company shall fail to have maintained an effective registration statement covering the issuance
of the shares of Common Stock issuable upon exercise of the Warrants, to exercise such Warrants on a &#8220;cashless basis,&#8221; by
exchanging the Warrants (in accordance with Section&#160;3(a)(9) of the Securities Act (or any successor statute) or another exemption)
for that number of shares of Common Stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number
of shares of Common Stock underlying the Warrants, multiplied by the excess of the &#8220;fair market value&#8221; (as defined below)
over the Warrant Price by (y) the fair market value and (B) 0.361 shares of Common Stock per Warrant. Notwithstanding the above, if our
Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies
the definition of a &#8220;covered security&#8221; under Section&#160;18(b)(1) of the Securities Act, we may, at our option, require
holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section&#160;3(a)(9)
of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement,
but will use our commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption
is not available. In such event, each holder would pay the exercise price by exchanging the warrants for that number of shares of Class
A common stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying
the warrants, multiplied by the difference between the warrant price and the &#8220;fair market value&#8221; (as defined below) by (y)
the fair market value. &#8220;Fair Market Value&#8221; shall mean the volume weighted average price of the Common Stock as reported during
the ten (10) trading day period ending on the third trading day prior to the date that notice of exercise is received by the Warrant
Agent from the holder of such Warrants or its securities broker or intermediary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Redemption
of warrants when the price per share of Class A common stock equals or exceeds $18.00.</i></b> Once the warrants become exercisable,
we may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            whole and not in part;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                            a price of $0.01 per warrant;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                                            a minimum of 30 days&#8217; prior written notice of redemption, or the 30-day redemption
                                            period, to each warrant holder; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
                                            and only if, the last reported sale price of our Class A common stock equals or exceeds $18.00
                                            per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations
                                            and the like) for any 20 trading days within a 30-trading day period ending on the third
                                            trading day prior to the date on which we send the notice of redemption to the warrant holders.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have established the $18.00 per share (as adjusted) redemption criteria discussed above to prevent a redemption call unless there is
at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and we issue a
notice of redemption of the warrants, each warrant holder will be entitled to exercise its warrant prior to the scheduled redemption
date. However, the price of the Class A common stock may fall below the $18.00 redemption trigger price (as adjusted for stock splits,
stock dividends, reorganizations, recapitalizations and the like) as well as the $11.50 warrant exercise price after the redemption notice
is issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Redemption
of warrants when the price per share of Class A common stock equals or exceeds $10.00.</i></b> Commencing ninety days after the warrants
become exercisable, we may redeem the outstanding warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            whole and not in part;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                            $0.10 per warrant upon a minimum of 30 days&#8217; prior written notice of redemption provided
                                            that holders will be able to exercise their warrants prior to redemption and receive that
                                            number of shares of Class A common stock to be determined by reference to the table below,
                                            based on the redemption date and the &#8220;fair market value&#8221; of our Class A common
                                            stock (as defined below) except as otherwise described below;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
                                            and only if, the last reported sale price of our Class A common stock equals or exceeds $10.00
                                            per share on the trading day prior to the date on which we send the notice of redemption
                                            to the warrant holders;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
                                            and only if, the private placement warrants are also concurrently exchanged at the same price
                                            (equal to a number of shares of Class A common stock) as the outstanding public warrants,
                                            as described above; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
                                            and only if, there is an effective registration statement covering the issuance of the shares
                                            of Class A common stock (or a security other than the Class A common stock into which the
                                            Class A common stock has been converted or exchanged for in the event we are not the surviving
                                            company in our initial business combination) issuable upon exercise of the warrants and a
                                            current prospectus relating thereto available throughout the 30-day period after written
                                            notice of redemption is given.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
numbers in the table below represent the number of shares of Class A common stock that a warrant holder will receive upon exercise in
connection with a redemption by us pursuant to this redemption feature, based on the &#8220;fair market value&#8221; of our Class A common
stock on the corresponding redemption date (assuming holders elect to exercise their warrants and such warrants are not redeemed for
$0.10 per warrant), determined based on the volume-weighted average price of the Class A common stock as reported during the 10 trading
days immediately following the date on which the notice of redemption is sent to the holders of warrants, and the number of months that
the corresponding redemption date precedes the expiration date of the warrants, each as set forth in the table below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the warrant agreement, references above to Class A common stock shall include a security other than Class A common stock into which
the Class A common stock has been converted or exchanged for in the event we are not the surviving company in our initial business combination.
The numbers in the tables below will not be adjusted solely as a result of us not being the surviving entity following our initial business
combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>The
stock prices set forth in the column headings of the table below will be adjusted as of any date on which the number of shares issuable
upon exercise of a warrant is adjusted as set forth in the first three paragraphs under the heading &#8220;<i>&#8212;Anti-dilution Adjustments</i>&#8221;
below. The adjusted stock prices in the column headings will equal the stock prices immediately prior to such adjustment, multiplied
by a fraction, the numerator of which is the number of shares deliverable upon exercise of a warrant immediately prior to such adjustment
and the denominator of which is the number of shares deliverable upon exercise of a warrant as so adjusted. The number of shares in the
table below shall be adjusted in the same manner and at the same time as the number of shares issuable upon exercise of a warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; vertical-align: top; text-align: left">&#160;</td>
    <td colspan="34" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Fair Market Value of Class A Common Stock</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Redemption Date (period to expiration of warrants)</td>
    <td style="vertical-align: bottom; font-weight: bold; text-align: left">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; vertical-align: bottom; font-weight: bold; text-align: center">&#8804;$10.00</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$11.00</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$12.00</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$13.00</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$14.00</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$15.00</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$16.00</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">$17.00</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; vertical-align: bottom; font-weight: bold; text-align: center">&#8805;$18.00</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 10%; text-align: left">59</td><td style="width: 1%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 7%; font-style: italic; text-align: right">0.236</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 1%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 7%; font-style: italic; text-align: right">0.257</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 1%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 7%; font-style: italic; text-align: right">0.277</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 1%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 7%; font-style: italic; text-align: right">0.295</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 1%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 7%; font-style: italic; text-align: right">0.311</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 1%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 7%; font-style: italic; text-align: right">0.325</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 1%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 7%; font-style: italic; text-align: right">0.338</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 1%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 7%; font-style: italic; text-align: right">0.350</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 1%; font-style: italic">&#160;</td>
    <td style="width: 1%; font-style: italic; text-align: left">&#160;</td><td style="width: 7%; font-style: italic; text-align: right">0.361</td><td style="width: 1%; font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">57</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.233</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.255</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.275</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.293</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.309</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.324</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.338</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.350</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">54</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.229</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.251</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.272</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.291</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.307</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.323</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.337</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.350</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">51</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.225</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.248</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.269</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.288</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.305</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.321</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.336</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.349</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">48</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.220</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.243</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.265</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.285</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.303</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.320</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.335</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.349</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">45</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.214</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.239</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.261</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.282</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.301</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.318</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.334</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.348</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">42</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.208</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.234</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.257</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.278</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.298</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.316</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.333</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.348</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">39</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.202</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.228</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.252</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.275</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.295</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.314</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.331</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.347</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">36</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.195</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.222</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.247</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.271</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.292</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.312</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.330</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.346</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">33</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.187</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.215</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.241</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.266</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.288</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.309</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.328</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.345</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">30</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.179</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.208</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.235</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.261</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.284</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.306</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.326</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.345</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">27</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.170</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.199</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.228</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.255</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.280</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.303</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.324</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.343</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">24</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.159</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.190</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.220</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.248</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.274</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.299</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.322</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.342</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">21</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.148</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.179</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.210</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.240</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.268</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.295</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.319</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.341</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">18</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.135</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.167</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.200</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.231</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.261</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.289</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.315</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.339</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">15</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.120</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.153</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.187</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.220</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.253</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.283</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.311</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.337</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">12</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.103</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.137</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.172</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.207</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.242</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.275</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.306</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.335</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">9</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.083</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.117</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.153</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.191</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.229</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.266</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.300</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.332</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">6</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.059</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.092</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.130</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.171</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.213</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.254</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.292</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.328</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">3</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.030</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.060</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.100</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.145</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.193</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.240</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.284</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.324</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">0</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.000</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.000</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.042</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.115</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.179</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.233</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.281</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.324</td><td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">0.361</td><td style="font-style: italic; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>For
example, if the volume-weighted average price of our Class A common stock as reported during the 10 trading days immediately following
the date on which the notice of redemption is sent to the holders of the warrants is $11 per share, and at such time there are 57 months
until the expiration of the warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for
0.233 shares of Class A common stock for each whole warrant. However, the exact fair market value and redemption date may not be set
forth in the table above, in which case, if the fair market value is between two values in the table or the redemption date is between
two redemption dates in the table, the number of shares of Class A common stock to be issued for each warrant exercised will be determined
by a straight-line interpolation between the number of shares set forth for the higher and lower fair market values and the earlier and
later redemption dates, as applicable, based on a 365 or 366-day year, as applicable. For an example where the exact fair market value
and redemption date are not as set forth in the table above, if the volume-weighted average price of our Class A common stock for the
10 trading days immediately following the date on which the notice of redemption is sent to the holders of the warrants is $13.50 per
share, and at such time there are 38 months until the expiration of the warrants, holders may choose to, in connection with this redemption
feature, exercise their warrants for 0.284 shares of Class A common stock for each whole warrant. In no event will the warrants be exercisable
in connection with this redemption feature for more than 0.361 shares of Class A common stock per warrant. Once the average last reported
sale price of our Class A common stock exceeds $18.00, we will have the option to redeem the warrants using this method or as described
above under the heading &#8220;&#8212;<i>Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>This
redemption feature differs from the typical warrant redemption features used in other blank check offerings, which typically only provide
for a redemption of warrants for cash (other than the private placement warrants) when the trading price for the Class A common stock
exceeds $18.00 per share for a specified period of time. This redemption feature is structured to allow for all of the outstanding warrants
to be redeemed when the Class A common stock is trading at or above $10.00 per share, which may be at a time when the trading price of
our Class A common stock is below the exercise price of the warrants. We have established this redemption feature to provide us with
the flexibility to redeem the warrants without the warrants having to reach the $18.00 per share threshold set forth above under &#8220;<i>&#8212;Redemption
of warrants when the price per share of Class A common stock equals or exceeds $18.00.</i>&#8221; Holders choosing to exercise their
warrants in connection with a redemption pursuant to this feature will, in effect, receive a number of shares representing the applicable
redemption price for their warrants based on an option pricing model with a fixed volatility input as of the date of this prospectus.
This redemption right provides us with an additional mechanism by which to redeem all of the outstanding warrants, and therefore have
certainty as to our capital structure. As such, we would redeem the warrants in this manner when we believe it is in our best interest
to update our capital structure to remove the warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
stated above, we can redeem the warrants when the Class A common stock is trading at a price starting at $10.00, which is below the exercise
price of $11.50, because it will provide certainty with respect to our capital structure and cash position while providing warrant holders
with the opportunity to exercise their warrants on a cashless basis for the applicable number of shares. If we choose to redeem the warrants
when the Class A common stock is trading at a price below the exercise price of the warrants, this could result in the warrant holders
receiving fewer shares of Class A common stock than they would have received if they had exercised their warrants for shares of Class
A common stock if and when the Class A common stock trades at a price higher than the exercise price of $11.50.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares of Class A common stock will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional
interest in a share, we will round down to the nearest whole number of the number of shares of Class A common stock to be issued to the
holder. If, at the time of redemption, the warrants are exercisable for a security other than the shares of Class A common stock pursuant
to the warrant agreement (for instance, if we are not the surviving company in our initial business combination), the warrants may be
exercised for such security.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exercise
Limitations.</i></b>&#8199;A holder of a warrant may notify us in writing in the event it elects to be subject to a requirement that
such holder will not have the right to exercise such warrant, to the extent that</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span><b><i>Redemption
Procedures and Cashless Exercise.</i></b> If we call the warrants for redemption as described above under &#8220;<i>&#8212;Redemption
of warrants when the price per share of Class A common stock equals or exceeds $18.00</i>,&#8221; our management will have the option
to require all holders that wish to exercise warrants to do so on a &#8220;cashless basis&#8221; (such option, the &#8220;Cashless Exercise
Option&#8221;). In determining whether to require all holders to exercise their warrants on a &#8220;cashless basis,&#8221; our management
will consider, among other factors, our cash position, the number of warrants that are outstanding and the dilutive effect on our stockholders
of issuing the maximum number of shares of Class A common stock issuable upon the exercise of our warrants. In such event, each holder
would pay the exercise price by surrendering the warrants for that number of shares of Class A common stock equal to the quotient obtained
by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied by the difference between
the warrant price and the &#8220;fair market value&#8221; (defined below) by (y) the fair market value. The &#8220;fair market value&#8221;
for this purpose shall mean the average last reported sale price of the Class A common stock for the 10 trading days ending on the third
trading day prior to the date on which the notice of redemption is sent to the holders of the warrants. If our management takes advantage
of this Cashless Exercise Option, the notice of redemption will contain the information necessary to calculate the number of shares of
Class A common stock to be received upon exercise of the warrants, including the &#8220;fair market value&#8221; in such case. Requiring
a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant
redemption. We believe this Cashless Exercise Option feature is an attractive option to us if we do not need the cash from the exercise
of the warrants after our initial business combination. If we call our warrants for redemption and our management does not take advantage
of this Cashless Exercise Option, KINS Capital LLC, a Delaware limited liability company (&#8220;Sponsor&#8221;) and its permitted transferees
would still be entitled to exercise their Private Placement Warrants for cash or on a cashless basis using the same formula described
above that other warrant holders would have been required to use had management taken advantage of this Cashless Exercise Option, as
described in more detail below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
holder of a warrant may notify us in writing in the event it elects to be subject to a requirement that such holder will not have the
right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person&#8217;s
affiliates), would beneficially own in excess of 4.9% or 9.8% (or such other amount as a holder may specify) of the shares of Class A
common stock outstanding immediately after giving effect to such exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Anti-Dilution
Adjustments.</i></b> If the number of outstanding shares of Class A common stock is increased by a stock dividend payable in shares of
Class A common stock, or by a split-up of shares of Class A common stock or other similar event, then, on the effective date of such
stock dividend, split-up or similar event, the number of shares of Class A common stock issuable on exercise of each warrant will be
increased in proportion to such increase in the outstanding shares of Class A common stock. A rights offering to holders of Class A common
stock entitling holders to purchase shares of Class A common stock at a price less than the &#8220;fair market value&#8221; (defined
below) will be deemed a stock dividend of a number of shares of Class A common stock equal to the product of (1) the number of shares
of Class A common stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering
that are convertible into or exercisable for Class A common stock) multiplied by (2) one minus the quotient of (x) the price per share
of Class A common stock paid in such rights offering divided by (y) the fair market value. For these purposes, (1) if the rights offering
is for securities convertible into or exercisable for Class A common stock, in determining the price payable for Class A common stock,
there shall be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise
or conversion and (2) &#8220;fair market value&#8221; means the volume weighted last reported average price of the Class A common stock
as reported during the ten trading day period ending on the trading day prior to the first date on which the shares of Class A common
stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities
or other assets to the holders of Class A common stock on account of such shares of Class A common stock (or other shares of our capital
stock into which the warrants are convertible), other than as described above or certain ordinary cash dividends, then the warrant exercise
price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value
of any securities or other assets paid on each share of Class A common stock in respect of such event.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the number of outstanding shares of our Class A common stock is decreased by a consolidation, combination, reverse stock split or reclassification
of shares of Class A common stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock
split, reclassification or similar event, the number of shares of Class A common stock issuable on exercise of each warrant will be decreased
in proportion to such decrease in outstanding shares of Class A common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whenever
the number of shares of Class A common stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant
exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the
numerator of which will be the number of shares of Class A common stock purchasable upon the exercise of the warrants immediately prior
to such adjustment, and (y) the denominator of which will be the number of shares of Class A common stock so purchasable immediately
thereafter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
case of any reclassification or reorganization of the outstanding shares of Class A common stock (other than those described above or
that solely affects the par value of such shares of Class A common stock), or in the case of any merger or consolidation of us with or
into another corporation (other than a merger or consolidation in which we are the continuing corporation and that does not result in
any reclassification or reorganization of our outstanding shares of Class A common stock), or in the case of any sale or conveyance to
another corporation or entity of the assets or other property of us as an entirety or substantially as an entirety in connection with
which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the
terms and conditions specified in the warrants and in lieu of the shares of our Class A common stock immediately theretofore purchasable
and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property
(including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any
such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior
to such event. However, if such holders were entitled to exercise a right of election as to the kind or amount of securities, cash or
other assets receivable upon such merger or consolidation, then the kind and amount of securities, cash or other assets for which each
warrant will become exercisable will be deemed to be the weighted average of the kind and amount received per share by such holders in
such merger or consolidation that affirmatively make such election, and if a tender, exchange or redemption offer has been made to and
accepted by such holders under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together
with members of any group (within the meaning of Rule&#160;13d-5(b)(1) under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange
Act&#8221;)) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule&#160;12b-2
under the Exchange Act) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within
the meaning of Rule&#160;13d-3 under the Exchange Act) more than 50% of the outstanding shares of Class A common stock, the holder of
a warrant will be entitled to receive the highest amount of cash, securities or other property to which such holder would actually have
been entitled as a stockholder if such warrant holder had exercised the warrant prior to the expiration of such tender or exchange offer,
accepted such offer and all of the Class A common stock held by such holder had been purchased pursuant to such tender or exchange offer,
subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments
provided for in the Warrant Agreement. Additionally, if less than 70% of the consideration receivable by the holders of Class A common
stock in such a transaction is payable in the form of Class A common stock in the successor entity that is listed for trading on a national
securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following
such event, and if the registered holder of the warrant properly exercises the warrant within thirty days following public disclosure
of such transaction, the warrant exercise price will be reduced as specified in the Warrant Agreement based on the per share consideration
minus Black-Scholes Warrant Value (as defined in the Warrant Agreement) of the warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>The
warrants have been issued in registered form under a Warrant Agreement between Continental, as warrant agent and us. Warrant holders
should review a copy of the Warrant Agreement, which is filed as an exhibit to the registration statement with respect to the KINS Initial
Public Offering, for a description of the terms and conditions applicable to the warrants. The Warrant Agreement provides that the terms
of the Warrant Agreement may be amended without the consent of any holder for the purpose of (i) curing any ambiguity, or curing, correcting
or supplementing any defective provision contained therein or adding or changing any other provisions with respect to matters or questions
arising under the warrant agreement as the parties thereto may deem necessary or desirable and that the parties deem shall not adversely
affect the interest of any holder and (ii) providing for the delivery of an alternative issuance in the case of a reclassification, reorganization,
merger or consolidation, or upon a dissolution. All other modifications or amendments require the vote or written consent of a majority
of the then outstanding Public Warrants and, solely with respect to any amendment to the terms of the Private Placement Warrants or any
provision of the Warrant Agreement with respect to the Private Placement Warrants, at least a majority of the holders of the then outstanding
Private Placement Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrant holders do not have the rights or privileges of holders of Class A common stock and any voting rights until they exercise their
warrants and receive shares of Class A common stock. After the issuance of shares of Class A common stock upon exercise of the warrants,
each holder will be entitled to one vote for each share of Class A common stock held of record on all matters to be voted on by stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placement Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>Sponsor
and the Direct Anchor Investors purchased 9,103,528 and 1,176,472 private placement warrants, respectively, at a price of $10.00 per
unit for an aggregate purchase price of $9,103,528 and $1,176,472, respectively, in a private placement that occurred concurrently
with the KINS Initial Public Offering. With certain limited exceptions, the Private Placement Warrants were not transferable,
assignable or salable (except to our officers and directors and other persons or entities pursuant to the Warrant Agreement, each of
whom was subject to the same transfer restrictions) until the period ended April&#160;13, 2023. The Private Placement Warrants will
not be redeemable by us so long as they are held by Sponsor or its permitted transferees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sponsor,
or its permitted transfers, has the option to exercise the Private Placement Warrants on a cash or cashless basis and is entitled to
certain registration rights. Otherwise, the Private Placement Warrants have terms and provisions that are identical to those of the Public
Warrants. If the Private Placement Warrants are held by holders other than Sponsor or its permitted transferees, the Private Placement
Warrants will be redeemable by us and exercisable by the holders on the same basis as the warrants being sold in this offering. If holders
of the Private Placement Warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering the warrants
for that number of shares of Class A common stock equal to the quotient obtained by dividing (x) the product of the number of shares
of Class A common stock underlying the warrants, multiplied by the difference between the warrant price and the &#8220;fair market value&#8221;
(as defined below), by (y) the fair market value. The &#8220;fair market value&#8221; shall mean the average last reported sale price
of the Class A common stock for the 10 trading days ending on the third trading day prior to the date on which notice of exercise of
the warrant is sent to the warrant agent. If a holder of private placement warrants is affiliated with us, their ability to sell our
securities in the open market will be significantly limited. We have policies in place that prohibit insiders from selling our securities
except during specific periods of time. Even during such periods of time when insiders will be permitted to sell our securities, an insider
cannot trade in our securities if he or she is in possession of material non-public information. Accordingly, unlike public stockholders
who could exercise their warrants and sell the shares of Class A common stock received upon such exercise freely in the open market in
order to recoup the cost of such exercise, the insiders could be significantly restricted from selling such securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declaration
and payment of any dividend is subject to the discretion of our board of directors. The time and amount of dividends will be dependent
upon, among other things, our business prospects, results of operations, financial condition, cash requirements and availability, debt
repayment obligations, capital expenditure needs, contractual restrictions, covenants in the agreements governing current and future
indebtedness, industry trends, the provisions of Delaware law affecting the payment of dividends and distributions to stockholders and
any other factors or considerations our board of directors may regard as relevant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently intend to retain all available funds and any future earnings to fund the development and growth of the business, and therefore
we do not anticipate declaring or paying any cash dividends on Common Stock in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-Takeover
Provisions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
provisions of Delaware law, the amended and restated certificate of incorporation, and the amended and restated bylaws, which are summarized
below, may have the effect of delaying, deferring, or discouraging another person from acquiring control of CXApp. They are also designed,
in part, to encourage persons seeking to acquire control of CXApp to negotiate first with the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Classified
Board of Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amended and restated certificate of incorporation provides that the Board is divided into three classes, designated Class I, Class
II and Class III. Each class will be an equal number of directors, as nearly as possible, consisting of one third of the total
number of directors constituting the entire board of directors. The term of the initial Class I directors shall terminate on the
date of the first annual meeting of stockholders following the effectiveness of the amended and restated certificate of
incorporation, the term of the initial Class II directors shall terminate on the date of the second annual meeting of stockholders
following the effectiveness of the amended and restated certificate of incorporation, and the term of the initial Class III
directors shall terminate on the date of the third annual meeting of stockholders following the effectiveness of the amended and
restated certificate of incorporation. At each annual meeting of stockholders, successors to the class of directors whose term
expires at that annual meeting will be elected for a three-year term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Removal
of Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the special rights of the holders of one or more outstanding series of Preferred Stock to elect directors, the amended and restated
certificate of incorporation provides that directors may be removed from office at any time, with or without cause, only by the affirmative
vote of the holders of at least a majority of the voting power of all of the then outstanding shares of voting stock of CXApp entitled
to vote at an election of directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Board
of Directors Vacancies</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the special rights of the holders of one or more outstanding series of Preferred Stock to elect directors, and except as otherwise
provided by law, the amended and restated certificate of incorporation authorizes only a majority of the remaining members of the Board
(other than any directors elected by the separate vote of one or more outstanding series of Preferred Stock), even though less than a
quorum, to fill vacant directorships, including newly created seats. In addition, the number of directors constituting the Board will
be permitted to be set only by a resolution of the Board. These provisions would prevent a stockholder from increasing the size of the
Board and then gaining control of the Board by filling the resulting vacancies with its own nominees. This will make it more difficult
to change the composition of the Board and will promote continuity of management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stockholder
Action; Special Meeting of Stockholders</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amended and restated bylaws provide that the CXApp stockholders may take any action required or permitted to be taken at an annual or
special meeting of stockholders by written consent in lieu of a meeting. The amended and restated certificate of incorporation and amended
and restated bylaws further provide that special meetings of CXApp stockholders may be called only by the chairman of the Board, the
Chief Executive Officer of CXApp or the Board pursuant to a resolution adopted by a majority of Board, and may not be called by any other
person, including CXApp stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advance
Notice Requirements for Stockholder Proposals and Director Nominations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amended and restated bylaws provide that CXApp stockholders seeking to bring business before CXApp&#8217;s annual meeting of stockholders,
or to nominate candidates for election as directors at CXApp&#8217;s annual or a special meeting of stockholders must provide timely
notice of their intent in writing. To be timely, a stockholder&#8217;s notice must be received by the Secretary at CXApp&#8217;s principal
executive offices (i) in the case of an annual meeting, not later than the close of business on the 90<sup>th</sup> day nor earlier than
the close of business on the 120<sup>th</sup> day before the anniversary date of the immediately preceding annual meeting of stockholders
(subject to certain exceptions), and (ii) in the case of a special meeting of stockholders called for the purpose of electing directors,
not later than the close of business on the 10<sup>th</sup> day following the day on which public announcement of the date of the special
meeting is first made by CXApp. The amended and restated bylaws also specify certain requirements as to the form and content of a stockholders&#8217;
meeting. These provisions may preclude CXApp stockholders from bringing matters before an annual meeting of stockholders or from making
nominations for directors at an annual meeting of stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>No
Cumulative Voting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
DGCL provides that stockholders are not entitled to cumulate votes in the election of directors unless a corporation&#8217;s certificate
of incorporation provides otherwise. The amended and restated certificate of incorporation does not provide for cumulative voting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Amendment
of Amended and Restated Certificate of Incorporation Provisions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments
to the provisions of the amended and restated certificate of incorporation related to preferred stock; the management of the business
and for the conduct of the affairs of CXApp; special meetings; liabilities of directors of CXApp; restrictions on any business combination
with any interested stockholder; indemnification of directors and officers of CXApp; and forum require the affirmative vote of the holders
of at least sixty six and two-thirds percent (66 and 2/3%) of the total voting power of all the then outstanding shares of stock of CXApp
entitled to vote thereon, voting together as a single class.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Authorized
but Unissued Capital Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CXApp&#8217;s
authorized but unissued Common Stock and Preferred Stock are available for future issuances without stockholder approval and could be
utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit
plans. The existence of authorized but unissued and unreserved Common Stock and Preferred Stock could render more difficult or discourage
an attempt to obtain control of CXApp by means of a proxy contest, tender offer, merger or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exclusive
Forum</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amended and restated certificate of incorporation provides that, unless CXApp consents in writing to the selection of an alternative
forum, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, the federal district
court for the District of Delaware or other state courts of the State of Delaware) and any appellate court thereof shall, to the fullest
extent permitted by law, be the sole and exclusive forum for: (i) any derivative action, suit or proceeding (&#8220;Proceeding&#8221;)
brought on behalf of CXApp; (ii) any Proceeding asserting a claim of breach of a fiduciary duty owed by any of CXApp&#8217;s directors,
officers, or stockholders to CXApp or its stockholders; (iii) any Proceeding arising pursuant to any provision of the DGCL, amended and
restated certificate of incorporation or the amended and restated bylaws; (iv) any Proceeding as to which the DGCL confers jurisdiction
on the Court of Chancery of the State of Delaware; or (v) any Proceeding asserting a claim against CXApp or any current or former director,
officer or stockholder governed by the internal affairs doctrine. This provision would not apply to suits brought to enforce any liability
or duty created by apply to suits brought to enforce any liability or duty created by the Securities Act, the Exchange Act or any other
claim for which the federal courts of the United States have exclusive jurisdiction. The amended and restated certificate of incorporation
further provides that, unless CXApp consents in writing to the selection of an alternative forum, the federal district courts of the
United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities
Act. These provisions may have the effect of discouraging lawsuits against CXApp or its directors and officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Limitations
on Liability and Indemnification of Directors and Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amended and restated certificate of incorporation provides that no director of CXApp shall have any personal liability to CXApp or its
stockholders for monetary damages for any breach of fiduciary duty as a director, except to the extent such exemption from liability
or limitation thereof is not permitted under the DGCL. Amendments to these provisions shall not adversely affect any right or protection
of a director of CXApp in respect of any act or omission occurring prior to the time of such amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amended and restated certificate of incorporation further provides that CXApp indemnify directors and officers to the fullest extent
permitted by law. CXApp is also expressly authorized to advance certain expenses (including, without limitation, attorneys&#8217; fees)
to its directors and officers and to maintain insurance, at its expense, to protect itself and/or any director, officer, employee or
agent of CXApp against any expense, liability or loss, whether or not CXApp would have the power to indemnify such person against such
expense, liability or loss under the DGCL.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, CXApp entered into separate indemnification agreements with its directors and officers. These agreements, among other things,
requires CXApp to indemnify its directors and officers for certain expenses, including attorneys&#8217; fees, judgments, fines and settlement
amounts incurred by a director or officer in any action or proceeding arising out of their services as one of CXApp&#8217;s directors
or officers or any other company or enterprise to which the person provides services at CXApp&#8217;s request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dissenters&#8217;
Rights of Appraisal and Payment</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the DGCL, with certain exceptions, our stockholders have appraisal rights in connection with a merger or consolidation of the Company.
Pursuant to Section&#160;262 of the DGCL, stockholders who properly demand and perfect appraisal rights in connection with such merger
or consolidation will have the right to receive payment of the fair value of their shares as determined by the Delaware Court of Chancery.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholders&#8217;
Derivative Actions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the DGCL, any of our stockholders may bring an action in the Company&#8217;s name to procure a judgment in its favor, also known as a
derivative action; provided that the stockholder bringing the action is a holder of our shares at the time of the transaction to which
the action relates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
Agent and Registrar</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our Common Stock is Continental Stock Transfer &amp; Trust Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
Symbols and Market</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is listed on Nasdaq under the symbol &#8220;CXAI,&#8221; and our Warrants are listed on Nasdaq under the symbol &#8220;CXAIW.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_022"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
ACT RESTRICTIONS ON RESALE OF COMMON STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rule&#160;144</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Rule&#160;144, a person who has beneficially owned restricted common stock or warrants of CXApp for at least six months would be entitled
to sell their securities provided that (i) such person is not deemed to have been one of our affiliates at the time of, or at any time
during the three months preceding, a sale and (ii) we are subject to the Exchange Act periodic reporting requirements for at least three
months before the sale and have filed all required reports under Section&#160;13 or 15(d) of the Exchange Act during the 12 months (or
such shorter period as we were required to file reports) preceding the sale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons
who have beneficially owned restricted common stock or warrants of CXApp for at least six months but who are our affiliates at the time
of, or at any time during the three months preceding, a sale, would be subject to additional restrictions, by which such person would
be entitled to sell within any three-month period only a number of securities that does not exceed the greater of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1%
                                            of the total number of shares of CXApp Common Stock then outstanding; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            average weekly reported trading volume of CXApp Common Stock during the four calendar weeks
                                            preceding the filing of a notice on Form&#160;144 with respect to the sale.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
by affiliates of CXApp under Rule&#160;144 are also limited by manner of sale provisions and notice requirements and to the availability
of current public information about CXApp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restrictions
on the Use of Rule&#160;144 by Shell Companies or Former Shell Companies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule&#160;144
is not available for the resale of securities initially issued by shell companies (other than business combination related shell companies)
or issuers that have been at any time previously a shell company. However, Rule&#160;144 also includes an important exception to this
prohibition if the following conditions are met:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            issuer of the securities that was formerly a shell company has ceased to be a shell company;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            issuer of the securities is subject to the reporting requirements of Section&#160;13 or 15(d)
                                            of the Exchange Act;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            issuer of the securities has filed all Exchange Act reports and material required to be filed,
                                            as applicable, during the preceding 12 months (or such shorter period that the issuer was
                                            required to file such reports and materials), other than Form&#160;8-K reports; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                            least one year has elapsed from the time that the issuer filed current Form&#160;10 type
                                            information with the SEC reflecting its status as an entity that is not a shell company (&#8220;Form&#160;10
                                            information&#8221;).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the consummation of the Business Combination, we are no longer a shell company, and so, once the conditions set forth in
the exceptions listed above are satisfied, Rule&#160;144 will become available for the resale of the above noted restricted securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_023"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PLAN
OF DISTRIBUTION (CONFLICT OF INTEREST)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholders, which as used herein includes donees, pledgees, transferees, distributees or other successors-in-interest selling
shares of our common stock or warrants or interests in our common stock or warrants received after the date of this prospectus from the
Selling Securityholders as a gift, pledge, partnership distribution or other transfer, may, from time to time, sell, transfer, distribute
or otherwise dispose of certain of their shares of common stock or warrants or interests in our common stock or warrants on any stock
exchange, market or trading facility on which shares of our common stock or warrants, as applicable, are traded or in private transactions.
These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market
price, at varying prices determined at the time of sale, or at negotiated prices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholders may use any one or more of the following methods when disposing of their shares of common stock or warrants or
interests therein:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
                                            brokerage transactions and transactions in which the broker-dealer solicits purchasers;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one
                                            or more underwritten offerings;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
                                            trades in which the broker-dealer will attempt to sell the shares of common stock or warrants
                                            as agent, but may position and resell a portion of the block as principal to facilitate the
                                            transaction;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
                                            by a broker-dealer as principal and resale by the broker-dealer for its accounts;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            exchange distribution in accordance with the rules of the applicable exchange;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
                                            negotiated transactions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">distributions
                                            to their members, partners or shareholders;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">short
                                            sales effected after the date of the registration statement of which this prospectus is a
                                            part is declared effective by the SEC;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
                                            the writing or settlement of options or other hedging transactions, whether through an options
                                            exchange or otherwise;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            market transactions, including transactions on a national securities exchange or quotations
                                            service or over-the-counter market;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">directly
                                            to one or more purchasers;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
                                            agents;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">broker-dealers
                                            may agree with the Selling Securityholders to sell a specified number of such shares of common
                                            stock or warrants at a stipulated price per share or warrant; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            combination of any such methods of sale.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholders may, from time to time, pledge or grant a security interest in some shares of our common stock or warrants owned
by them and, if a Selling Securityholders defaults in the performance of its secured obligations, the pledgees or secured parties may
offer and sell such shares of common stock or warrants, as applicable, from time to time, under this prospectus, or under an amendment
or supplement to this prospectus amending the list of the Selling Securityholders to include the pledgee, transferee or other successors
in interest as the Selling Securityholders under this prospectus. The Selling Securityholders also may transfer shares of our common
stock or warrants in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling
beneficial owners for purposes of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of shares of our common stock or warrants or interests therein, the Selling Securityholders may enter into hedging
transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of our common stock or warrants
in the course of hedging the positions they assume. The Selling Securityholders may also sell shares of our common stock or warrants
short and deliver these securities to close out their short positions, or loan or pledge shares of our common stock or warrants to broker-dealers
that in turn may sell these securities. The Selling Securityholders may also enter into option or other transactions with broker-dealers
or other financial institutions or the creation of one or more derivative securities that require the delivery to such broker-dealer
or other financial institution of shares of our common stock or warrants offered by this prospectus, which shares or warrants such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate proceeds to the Selling Securityholders from the sale of shares of our common stock or warrants offered by them will be the
purchase price of such shares of our common stock or warrants less discounts or commissions, if any. The Selling Securityholders reserve
the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of share
of our common stock or warrants to be made directly or through agents. We will not receive any of the proceeds from any offering by the
Selling Securityholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholders also may in the future resell a portion of our common stock or warrants in open market transactions in reliance
upon Rule&#160;144 under the Securities Act; provided that they meet the criteria and conform to the requirements of that rule, or pursuant
to other available exemptions from the registration requirements of the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholders and any underwriters, broker-dealers or agents that participate in the sale of shares of our common stock or
warrants or interests therein may be &#8220;underwriters&#8221; within the meaning of Section&#160;2(11) of the Securities Act. Any discounts,
commissions, concessions or profit they earn on any resale of shares of our common stock or warrants may be underwriting discounts and
commissions under the Securities Act. If any Selling Securityholder is an &#8220;underwriter&#8221; within the meaning of Section&#160;2(11)
of the Securities Act, then the Selling Securityholder will be subject to the prospectus delivery requirements of the Securities Act.
Underwriters and their controlling persons, dealers and agents may be entitled, under agreements entered into with us and the Selling
Securityholders, to indemnification against and contribution toward specific civil liabilities, including liabilities under the Securities
Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent required, our common stock or warrants to be sold, the respective purchase prices and public offering prices, the names of
any agent, dealer or underwriter, and any applicable discounts, commissions, concessions or other compensation with respect to a particular
offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement
that includes this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
facilitate the offering of shares of our common stock and warrants offered by the Selling Securityholders, certain persons participating
in the offering may engage in transactions that stabilize, maintain or otherwise affect the price of our common stock or warrants. This
may include over-allotments or short sales, which involve the sale by persons participating in the offering of more shares of common
stock or warrants than were sold to them. In these circumstances, these persons would cover such over-allotments or short positions by
making purchases in the open market or by exercising their over-allotment option, if any. In addition, these persons may stabilize or
maintain the price of our common stock or warrants by bidding for or purchasing shares of common stock or warrants in the open market
or by imposing penalty bids, whereby selling concessions allowed to dealers participating in the offering may be reclaimed if shares
of common stock or warrants sold by them are repurchased in connection with stabilization transactions. The effect of these transactions
may be to stabilize or maintain the market price of our common stock or warrants at a level above that which might otherwise prevail
in the open market. These transactions may be discontinued at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Registration Rights Agreement, we have agreed to indemnify the Selling Securityholders party thereto against certain liabilities
that they may incur in connection with the sale of the securities registered hereunder, including liabilities under the Securities Act,
and to contribute to payments that the Selling Securityholders may be required to make with respect thereto. In addition, we and the
Selling Securityholders may agree to indemnify any underwriter, broker-dealer or agent against certain liabilities related to the selling
of the securities, including liabilities arising under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to maintain the effectiveness of this registration statement until all such securities have been sold under this registration
statement or Rule&#160;144 under the Securities Act or are no longer outstanding. We have agreed to pay all expenses in connection with
this offering, other than underwriting fees, discounts, selling commissions, stock transfer taxes and certain legal expenses. The Selling
Securityholders will pay, on a pro rata basis, any underwriting fees, discounts, selling commissions, stock transfer taxes and certain
legal expenses relating to the offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
Securityholders may use this prospectus in connection with resales of shares of our common stock and warrants. This prospectus and any
accompanying prospectus supplement will identify the Selling Securityholders, the terms of our common stock or warrants and any material
relationships between us and the Selling Securityholders. Selling Securityholders may be deemed to be underwriters under the Securities
Act in connection with shares of our common stock or warrants they resell and any profits on the sales may be deemed to be underwriting
discounts and commissions under the Securities Act. Unless otherwise set forth in a prospectus supplement, the Selling Securityholders
will receive all the net proceeds from the resale of shares of our common stock or warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Selling Securityholder that is an entity may elect to make an in-kind distribution of common stock or warrants to its members, partners
or shareholders pursuant to the registration statement of which this prospectus is a part by delivering a prospectus. To the extent that
such members, partners or shareholders are not affiliates of ours, such members, partners or shareholders would thereby receive freely
tradable shares of common stock or warrants pursuant to the distribution through a registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required to pay all fees and expenses incident to the registration of shares of our common stock and warrants to be offered and sold
pursuant to this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_024"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEGAL
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the shares of Common Stock and Warrants offered hereby will be passed upon for us by Skadden, Arps, Slate, Meagher &amp;
Flom LLP, Palo Alto, California.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_025"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXPERTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">The
financial statements of KINS as of December&#160;31, 2022 and 2021, and for the years ended December&#160;31, 2022 and 2021 appearing
in this prospectus have been audited by WithumSmith+Brown, PC, an independent registered public accounting firm, as set forth in their
report thereon (which contains explanatory paragraphs relating to the correction of certain misstatements related to the consolidated financial
statements and substantial doubt about the ability of KINS to continue as a going concern
as described in Note 1 to the financial statements), appearing elsewhere in this prospectus, and are included in reliance upon such report
given on the authority of such firm as experts in accounting and auditing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
combined carve-out financial statements as of December&#160;31, 2022 and 2021, and for each of the two years in the period ended December&#160;31,
2022 of Design Reactor, Inc. and subsidiaries included in this prospectus have been audited by Marcum LLP, an independent registered
public accounting firm, as stated in their report appearing herein. Such financial statements have been so included in reliance upon
the report of such firm given upon their authority as experts in accounting and auditing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_026"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHERE
YOU CAN FIND MORE INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file annual, quarterly and current reports, proxy statements and other information with the SEC. We have also filed a registration statement
on Form S-1, including exhibits, under the Securities Act with respect to the shares of Common Stock and Warrants offered by this prospectus.
This prospectus is part of the registration statement, but does not contain all of the information included in the registration statement
or the exhibits. Our SEC filings are available to the public on the internet at a website maintained by the SEC located at http://www.sec.gov.
Those filings are also available to the public on, or accessible through, our website under the heading &#8220;Investors Relations&#8221;
at <i>www.cxapp.com</i>. The information on our website, however, is not, and should not be deemed to be, a part of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_027"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 89%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_001">Report of Independent Registered Public Accounting Firm</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Financial
    Statements:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_002">Consolidated Balance Sheets (As Restated)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_003">Consolidated Statements of Operations (As Restated)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_004">Consolidated Statements of Changes in Stockholders&#8217; Deficit (As Restated)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_005">Consolidated Statements of Cash Flows (As Restated)</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_006">Notes to Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7 to F-28</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: justify; width: 89%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    Financial Statements</span></td>
    <td style="width: 1%"><span>&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span>&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span><a href="#c_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
    Consolidated Balance Sheets as of March 31, 2023 (unaudited) (Successor) and December 31, 2022 (audited) (Predecessor)</span></a></span></td>
    <td><span>&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span>F-29</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#c_004">Unaudited
    Condensed Consolidated Statements of Operations and Comprehensive Loss for the Period from March 15, 2023 to March 31, 2023 (Successor),
    the Period from January 1, 2023 to March 14, 2023 (Predecessor), and the Three Months Ended March 31, 2022 (Predecessor)</a></span></td>
    <td><span>&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#c_005">Unaudited
    Condensed Consolidated Statements of Stockholders&#8217; Equity for the Period from March 15, 2023 to March 31, 2023 (Successor),
    the Period from January 1, 2023 to March 14, 2023 (Predecessor), and the Three Months Ended March 31, 2022 (Predecessor)</a></span></td>
    <td><span>&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#c_006">Unaudited
    Condensed Consolidated Statements of Cash Flows for the Period from March 15, 2023 to March 31, 2023 (Successor), the Period from
    January 1, 2023 to March 14, 2023 (Predecessor), and the Three Months Ended March 31, 2022 (Predecessor)</a></span></td>
    <td><span>&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><span><a href="#c_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    to Unaudited Condensed Consolidated Financial Statements</span></a></span></td>
    <td><span>&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-33
    to F-49</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<!-- Field: Page; Sequence: 119; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="b_001"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Stockholders and the Board of Directors of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CXApp,
Inc. (f/k/a KINS Technology Group Inc.):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of CXApp, Inc. (f/k/a KINS Technology Group Inc.) (the &#8220;Company&#8221;)
as of December&#160;31, 2022 and 2021, the related consolidated statements of operations, changes in stockholders&#8217; deficit and
cash flows for the years then ended, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;).
In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company
as of December&#160;31, 2022 and 2021, and the results of its operations and its cash flows for the years then ended, in conformity with
accounting principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restatement
of Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in Note 2 to the financial statements, the Company previously accounted for its deferred underwriting fee waiver as a forgiveness
of debt and recorded a gain on its statement of income for the year ended 2022. Management has since evaluated its accounting treatment
for the forgiveness and has determined that the forgiveness should have been treated as a credit to stockholders&#8217; deficit. Accordingly,
the 2022 financial statements have been restated to correct the accounting and related disclosure for the forgiveness of the deferred
underwriting fee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed
in Note 1 to the consolidated financial statements, if the Company is unable to raise additional funds to alleviate liquidity needs as
well as complete a business combination by June&#160;15, 2023, then the Company will cease all operations except for the purpose of liquidating.
The liquidity condition and date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company&#8217;s
ability to continue as a going concern. Management&#8217;s plans are also described in Note 1. The consolidated financial statements
do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing
an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April&#160;17,
2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCAOB
ID Number 100</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="b_002"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CXAPP
INC</b>. (F/K/A KINS TECHNOLOGY GROUP INC.)</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_111_zFAnF8QnawCe" summary="xdx: Statement - CONSOLIDATED BALANCE SHEETS" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20221231" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20211231" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">December&#160;31,</td><td style="padding-bottom: 1pt; text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">As Restated</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsAbstract_iB_zFKWXYCWNszg" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">ASSETS</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AssetsCurrentAbstract_i01B_zM6LfOWtlFi5" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--Cash_i02I_maCz0h9_zrTdJlqLgT94" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">224,489</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">406,126</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PrepaidExpenseCurrent_i02I_maCz0h9_zTgStXhQa4P3" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Prepaid expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,536</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">126,667</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AssetsCurrent_i02TI_mtCz0h9_maCzAy9_zFlJpjFFxa3l" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left">Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">228,025</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">532,793</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AssetsHeldInTrustNoncurrent_i01I_maCzAy9_ztPqhqpBHY14" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Cash and investments held in trust account</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,923,804</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">278,836,080</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--Assets_i01TI_mtCzAy9_zqZRhfVssBK3" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,151,829</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">279,368,873</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zhfvlg9sdgB1" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS&#8217; DEFICIT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesCurrentAbstract_i01B_zbG69ZvmUfd2" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--AccruedLiabilitiesExcludingOfferingCostsCurrent_i02I_maCzsbe_zXg23BtX4cI" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cxai:AccruedLiabilitiesExcludingOfferingCostsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,833,412</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="cxai:AccruedLiabilitiesExcludingOfferingCostsCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">767,253</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccruedIncomeTaxesCurrent_i02I_maCzsbe_zHRiQ2VUFlVk" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income taxes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0074">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--PromissoryNoteRelatedParty_i02I_maCzsbe_zRGH3hKGnr14" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Promissory note &#8211; related party</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="cxai:PromissoryNoteRelatedParty" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">347,961</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0077">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesCurrent_i02TI_mtCzsbe_maCzIud_zL5xkHKiQPqh" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,230,548</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">767,253</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DerivativeLiabilitiesNoncurrent_i01I_maCzIud_zQIluKunMKHf" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Derivative liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">722,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,275,369</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredOfferingCostsNoncurrent_i01I_maCzIud_zGaCNURE29bc" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Deferred underwriting fee payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0085">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="cxai:DeferredOfferingCostsNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,660,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--Liabilities_i01TI_mtCzIud_maCzhGD_zUmmsM7Rucje" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1pt">TOTAL LIABILITIES</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,952,948</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,702,622</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CommitmentsAndContingencies_i01I_maCzhGD_z9Mv30KoxLM7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Commitments and Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i01I_maCzhGD_zvQgmqQFTBX" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Class A common stock subject to possible redemption, <span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_c20221231__us-gaap--StatementClassOfStockAxis__custom--CommonClassaSubjectToRedemptionMember_pdd" title="Class A common stock subject to possible redemption"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_custom_CommonClassaSubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">387,551</ix:nonFraction></span> and <span id="xdx_906_eus-gaap--TemporaryEquitySharesOutstanding_c20211231__us-gaap--StatementClassOfStockAxis__custom--CommonClassaSubjectToRedemptionMember_pdd" title="Class A common stock subject to possible redemption"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-12-31_custom_CommonClassaSubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,600,000</ix:nonFraction></span> shares at $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_c20221231__us-gaap--StatementClassOfStockAxis__custom--CommonClassaSubjectToRedemptionMember_pdd" title="Purchase price, per unit (in dollars per share)"><span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_c20211231__us-gaap--StatementClassOfStockAxis__custom--CommonClassaSubjectToRedemptionMember_pdd" title="Purchase price, per unit (in dollars per share)"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2022-12-31_custom_CommonClassaSubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2021-12-31_custom_CommonClassaSubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.10</ix:nonFraction></ix:nonFraction></span></span> per share redemption value as of December&#160;31, 2022 and 2021, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,914,265</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">278,760,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--StockholdersEquityAbstract_i01B_znzVBbN78qxc" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Stockholders&#8217; Deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PreferredStockValue_i02I_maCzRKv_zPOh2VfMeuV1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Preferred stock, $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_c20221231_pdd" title="Preferred stock, par value (in dollars per share)"><span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_c20211231_pdd" title="Preferred stock, par value (in dollars per share)"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_c20221231_pdd" title="Preferred stock, shares authorized"><span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_c20211231_pdd" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_dn_c20221231_zUOhLHbUKC5i" title="Preferred stock, shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20221231_zAWSLDzgKbid" title="Preferred stock, shares outstanding"><span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_dn_c20211231_z7GWKKH3ANHb" title="Preferred stock, shares issued"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_dn_c20211231_zrSKgtlFARHf" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued or outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0108">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0109">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CommonStockValue_i02I_maCzRKv_zhag4CRHwAY8" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Class B common stock, $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, par value (in dollars per share)"><span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common stock, par value (in dollars per share)"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common shares, shares authorized"><span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common shares, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_904_eus-gaap--CommonStockSharesIssued_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common shares, shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common shares, shares outstanding"><span id="xdx_907_eus-gaap--CommonStockSharesIssued_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common shares, shares issued"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Common shares, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding at December&#160;31, 2022 and 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">690</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">690</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AdditionalPaidInCapital_i02I_maCzRKv_z6P2KpdOymT3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0146">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0147">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCzRKv_zuO7NixNiEmj" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,716,074</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,094,439</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--StockholdersEquity_i02TI_mtCzRKv_maCzhGD_zICWtBLn7pLf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1pt">Total Stockholders&#8217; Deficit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,715,384</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,093,749</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtCzhGD_zPRJnTSiUbfl" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS&#8217; DEFICIT</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,151,829</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">279,368,873</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="b_003"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CXAPP
INC</b>. (F/K/A KINS TECHNOLOGY GROUP INC.)</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_113_zvl4LNsECZHc" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20220101__20221231_z9F6zp45Bgrg" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20210101__20211231_zkMPQ5dPOLq6" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year Ended</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Year Ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Restated</b></span></td><td style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OperatingCostsAndExpenses_msCz4wd_zPDFzDhfdski" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left; padding-bottom: 1pt">Operating and formation costs</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,950,464</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,497,914</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingIncomeLoss_iT_mtCz4wd_maCzhJV_zJDhhKVZsGVf" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Loss from operations</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,950,464</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,497,914</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zB9ytMtfZ6dl" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Other income:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InterestIncomeExpenseNet_i01_maCz4sm_zAv1tmaKh7B2" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Interest earned on cash and investments held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestIncomeExpenseNet" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">421,504</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestIncomeExpenseNet" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,295</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InvestmentIncomeInterest_i01_maCz4sm_zoeFRtcLvBG2" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Interest income - bank</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--FairValueAdjustmentOfWarrants_i01N_di_msCz4sm_zAJBrq8ttm2k" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Change in fair value of derivative liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,552,969</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,637,431</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--GainLossOnEliminationOfDeferredUnderwritingFee_i01_maCz4sm_zhDJEUm3eYxj" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Gain on forgiveness of deferred underwriting fee</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="cxai:GainLossOnEliminationOfDeferredUnderwritingFee" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">371,910</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0177">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NonoperatingIncomeExpense_iT_maCzhJV_mtCz4sm_zWhSKBGSQouj" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Other income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,346,459</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,705,798</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_mtCzhJV_maCzWBG_zI4GCT8hDkch" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income before provision for income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,395,995</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,207,884</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msCzWBG_zJ91GHeavT2h" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Provision for income taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,175</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0186">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_iT_mtCzWBG_zF39aw6XNYu1" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net income</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,346,820</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,207,884</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock_z8OeSq5Eu1B5" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average shares outstanding, Class A common stock</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,546,423</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,600,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--BasicAndDilutedNetIncomePerShareClassCommonStock_zXWFfKwRXMo" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Basic and diluted net income per share, Class A common stock</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedNetIncomePerShareClassCommonStock" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.43</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedNetIncomePerShareClassCommonStock" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.27</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock_zsUo5yn3tBCf" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average shares outstanding, Class B common stock</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--BasicAndDilutedNetIncomePerShareClassBCommonStock_z6LFZXkB9HH2" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Basic and diluted net income per share, Class B common stock</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedNetIncomePerShareClassBCommonStock" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.43</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedNetIncomePerShareClassBCommonStock" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.27</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="b_004"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CXAPP
INC</b>. (F/K/A KINS TECHNOLOGY GROUP INC.)</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; DEFICIT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED DECEMBER&#160;31, 2022 (AS RESTATED) AND 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_114_z2Vh95uqKwu8" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_custom--ClassACommonStockMember_zZskvWXxQJlg" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_custom--ClassBCommonStockMember_zHVj91S0RHS6" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zlv7m3OpwJUd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B0_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zOkgrDQ9jU9h" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B1_zef2KvCSOaK7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; font-weight: bold; text-align: center">Class A</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="vertical-align: bottom; font-weight: bold; text-align: center">Class B</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Additional</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Total</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Common Stock</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Common Stock</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Paid-in</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Accumulated</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Stockholders&#8217;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Shares</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Shares</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Capital</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Deficit</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Deficit</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr id="xdx_43E_c20210101__20211231_eus-gaap--StockholdersEquity_iS_zX3Ie3lDRLGb" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 30%; font-weight: bold; text-align: left">Balance &#8212; December&#160;31, 2020</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassACommonStockMember_zVNGjtxgHmle" title="Beginning balance, shares" style="width: 7%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0209">-</span></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 7%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0203">-</span></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--ClassBCommonStockMember_zgcMjX1bWHbe" title="Beginning balance, shares" style="width: 7%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-12-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 7%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">690</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 7%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0205">-</span></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 7%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">30,302,323</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 7%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">30,301,633</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_pp0p0_zfAzI8QBzQJ6" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Net income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0213">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0214">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0215">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,207,884</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,207,884</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20220101__20221231_eus-gaap--StockholdersEquity_iS_z0VSZ0nApkD" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Balance &#8212; December&#160;31, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--ClassACommonStockMember_zzxMNE3XCCeg" title="Beginning balance, shares" style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0225">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0219">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--ClassBCommonStockMember_zdQepD4wL927" title="Beginning balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">690</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0221">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,094,439</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,093,749</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_zcnaLwCpxoni" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in value of common stock subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0229">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0230">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0231">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,031,545</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,031,545</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_pp0p0_z0b9tSfY3cc9" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Net income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0235">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0236">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0237">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,346,820</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,346,820</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_433_c20220101__20221231_eus-gaap--StockholdersEquity_iE_zTikSQXKRW2k" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance &#8212; December&#160;31, 2022 (As&#160;Restated)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--ClassACommonStockMember_z4A7dGogXVbf" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0247">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0241">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--ClassBCommonStockMember_z8ibFpcSZzGd" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ClassBCommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">690</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0243">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,716,074</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,715,384</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="b_005"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CXAPP
INC</b>. (F/K/A KINS TECHNOLOGY GROUP INC.)</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_112_z5I1nWbP2Goe" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20220101_20221231" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20210101_20211231" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom; text-align: left">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Year Ended</td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Year Ended</td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom; text-align: left">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December&#160;31,</td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December&#160;31,</td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom; text-align: left">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2021</td><td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: bottom; text-align: left">&#160;</td><td style="vertical-align: bottom; text-align: center; font-weight: bold">&#160;</td>
    <td style="vertical-align: bottom; font-weight: bold; text-align: center">&#160;</td><td style="vertical-align: bottom; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Restated</b></span></td><td style="vertical-align: bottom; font-weight: bold; text-align: center">&#160;</td><td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="vertical-align: bottom; text-align: center">&#160;</td><td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zf7OG3YRKDFa" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Cash Flows from Operating Activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProfitLoss_i01_maCz4UA_zpRGSLtVmT33" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Net income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,346,820</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,207,884</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zsBkqX908CN1" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Adjustments to reconcile net income to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--InterestAndOtherIncome_i02N_di_msCz4UA_zf0TsIiqC6kf" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Interest earned on cash and investments held in Trust Account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">421,504</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,295</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--FairValueAdjustmentOfWarrants_i02_maCz4UA_zMAOo9gcOuk5" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Change in fair value of derivative liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,552,969</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,637,431</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_ecustom--IncreaseDecreaseInDeferredUnderwritingFee_i02_maCz4UA_zJPPXLMOkdv2" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Gain on forgiveness of deferred underwriting fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cxai:IncreaseDecreaseInDeferredUnderwritingFee" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">371,910</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0267">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zawzDyJspRw2" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInPrepaidExpense_i03N_di_msCz4UA_zbSAsARpYuAk" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.375in; text-align: left">Prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">123,131</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">329,967</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maCz4UA_zeWxVHtHJzz4" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.375in; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0276">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i03_maCz4UA_zfInrXcam657" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.375in; text-align: left; padding-bottom: 1pt">Accounts payable and accrued expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,066,159</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">572,554</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCz4UA_maCzZVS_zofiT5HynwA3" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.5in; font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">761,098</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">595,321</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zwKmSfNjOBQb" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Cash Flows from Investing Activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax_i01_maCzjl4_zg5TiZkmNQQk" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Cash withdrawn from trust account to pay franchise tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="cxai:ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">231,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0288">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ProceedsFromTrustAccountInConnectionWithRedemption_i01_maCzjl4_z3v1BfEJlMof" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Cash withdrawn from trust account in connection with redemptions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="cxai:ProceedsFromTrustAccountInConnectionWithRedemption" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,102,280</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0291">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCzjl4_maCzZVS_zWT91Zegb6og" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.5in; font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash provided by investing activities</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,333,780</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0294">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zPk7uIgoQgR6" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Cash Flows from Financing Activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PaymentsForRepurchaseOfCommonStock_i01N_di_msCzXVm_zwn8QSITUInk" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Redemptions of common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">275,102,280</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0300">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ProceedsFromRelatedPartyDebt_i01_maCzXVm_zf7Up12Yxfxi" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Borrowings under promissory note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">347,961</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0303">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--PaymentsOfStockIssuanceCosts_i01N_di_msCzXVm_zYMb3GVADzne" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Payment of offering costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0305">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,579</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzXVm_maCzZVS_zjC6p2rJEB69" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.5in; font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in financing activities</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">274,754,319</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">17,579</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCzZVS_z89QydxzN875" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Net Change in Cash</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">181,637</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">612,900</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zP9JEysHZ9Dh" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Cash &#8211; Beginning of period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">406,126</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,019,026</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_zPAICCIy0VJg" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash &#8211; End of period</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">224,489</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">406,126</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_z5l7sxdS6hn2" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Non-cash investing and financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--ChangeInValueOfClassCommonStockSubjectToPossibleRedemption_i01_zI1oz9PkvWda" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Change in value of Class A common stock subject to possible redemption</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="cxai:ChangeInValueOfClassCommonStockSubjectToPossibleRedemption" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">256,545</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0324">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock_i01_zvczdi5pphW" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Forgiveness of deferred underwriting fee payable allocated to Class A common stock</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="cxai:ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0327">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--DeferredUnderwritingFeePayable_i01_pp0p0" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Deferred underwriting fee payable</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0329">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="cxai:DeferredUnderwritingFeePayable" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,660,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
accompanying notes are an integral part of these consolidated financial statements.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="b_006"></span><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p>

<p id="xdx_048_c20220101__20221231_z5KexVqq7JMi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:NatureOfOperations"><p id="xdx_807_eus-gaap--NatureOfOperations_zfzgoDaJmYSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8212; <span id="xdx_829_z5g7nCVFCdmf">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CXApp
Inc. (the &#8220;Company&#8221;) was incorporated in Delaware on July&#160;20, 2020 as KINS Technology Group Inc. (&#8220;KINS&#8221;).
The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses (the &#8220;Business Combination&#8221;). The Company is not limited to a
particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth
company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has one wholly-owned subsidiary, KINS Merger Sub Inc., which was incorporated in the State of Delaware on September&#160;16,
2022 (&#8220;Merger Sub&#8221;). Merger Sub has no activity from date of incorporation, September&#160;16, 2022 through December&#160;31,
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2022, the Company had not commenced any operations. All activity for the period from July&#160;20, 2020 (inception)
through December&#160;31, 2022 relates to the Company&#8217;s formation, the initial public offering (&#8220;Initial Public Offering&#8221;),
which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The
Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The
Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s Initial Public Offering became effective on December&#160;14, 2020. On December&#160;17,
2020, the Company consummated the Initial Public Offering of <span id="xdx_90D_ecustom--UnitsIssuedDuringPeriodSharesNewIssues_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Number of units issued"><ix:nonFraction name="cxai:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-012020-12-17_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,600,000</ix:nonFraction></span> units (the &#8220;Units&#8221; and, with respect to the Class
A common stock included in the Units sold, the &#8220;Public Shares&#8221;), which includes the full exercise by the underwriter of its
over-allotment option in the amount of <span id="xdx_90C_ecustom--UnitsIssuedDuringPeriodSharesNewIssues_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zjoxgeRjih8l" title="Number of units issued"><ix:nonFraction name="cxai:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-012020-12-17_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,600,000</ix:nonFraction></span> Units, at $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_c20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Purchase price, per unit (in dollars per share)"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-17_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit, generating gross proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvPC2rPMwMn5" title="Proceeds from issuance initial public offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2020-12-012020-12-17_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">276,000,000</ix:nonFraction></span> which is described
in Note 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of <span id="xdx_905_ecustom--NumberOfWarrantsIssued_c20201201__20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Number of warrants issued"><ix:nonFraction name="cxai:NumberOfWarrantsIssued" contextRef="From2020-12-012020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,280,000</ix:nonFraction></span> warrants (the &#8220;Private
Placement Warrants&#8221;) at a price of $<span id="xdx_90F_ecustom--ClassOfWarrantOrRightPriceOfWarrantsOrRights_c20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Price of warrant"><ix:nonFraction name="cxai:ClassOfWarrantOrRightPriceOfWarrantsOrRights" contextRef="AsOf2020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span> per Private Placement Warrant in a private placement to KINS Capital LLC (the
&#8220;Sponsor&#8221;) and certain funds and accounts managed by BlackRock, Inc. (the &#8220;Direct Anchor Investors&#8221; and
which the Direct Anchor Investors, together with the Sponsor, are the &#8220;initial stockholders&#8221;), generating gross proceeds
of $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfWarrants_c20201201__20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pp0p0" title="Proceeds from issuance of warrants"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2020-12-012020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,280,000</ix:nonFraction></span>, which is described in Note 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
costs incurred amounted to $<span id="xdx_901_ecustom--TransactionCosts_c20201217_pp0p0" title="Transaction costs"><ix:nonFraction name="cxai:TransactionCosts" contextRef="AsOf2020-12-17" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,688,848</ix:nonFraction></span>, consisting of $<span id="xdx_905_ecustom--SaleOfStockUnderwritingFees_c20201217_pp0p0" title="Underwriting fees"><ix:nonFraction name="cxai:SaleOfStockUnderwritingFees" contextRef="AsOf2020-12-17" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,520,000</ix:nonFraction></span> in cash underwriting fees, $<span id="xdx_90B_ecustom--DeferredOfferingCostsNoncurrent_c20201217_pp0p0" title="Deferred underwriting fee payable"><ix:nonFraction name="cxai:DeferredOfferingCostsNoncurrent" contextRef="AsOf2020-12-17" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,660,000</ix:nonFraction></span> of deferred underwriting fees
and $<span id="xdx_90A_ecustom--SaleOfStockOtherOfferingCosts_c20201217_pp0p0" title="Other offering costs"><ix:nonFraction name="cxai:SaleOfStockOtherOfferingCosts" contextRef="AsOf2020-12-17" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">508,848</ix:nonFraction></span> of other offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on December&#160;17, 2020, an amount of $<span id="xdx_904_ecustom--PaymentsForInvestmentOfCashInTrustAccount_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Investment of cash into trust account"><ix:nonFraction name="cxai:PaymentsForInvestmentOfCashInTrustAccount" contextRef="From2020-12-012020-12-17_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">278,760,000</ix:nonFraction></span> ($<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_c20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Purchase price, per unit (in dollars per share)"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-17_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.10</ix:nonFraction></span> per Unit) from the net proceeds
of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account
(the &#8220;Trust Account&#8221;), located in the United States and invested only in U.S. government securities, within the meaning set
forth in Section&#160;2(a)(16) of the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity
of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting
certain conditions of Rule&#160;2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion
of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.
The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market
value equal to at least <span id="xdx_90B_ecustom--ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount_dp_c20220101__20221231_zQqs3Kvee19k" title="Threshold minimum aggregate fair market value as a percentage of the assets held in the trust account"><ix:nonFraction name="cxai:ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction>%</span> of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable
on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-transaction company owns
or acquires <span id="xdx_905_ecustom--ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination_dp_c20220101__20221231_zmvaTbYbGSrk" title="Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination"><ix:nonFraction name="cxai:ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction>%</span> or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target
business sufficient for it not to be required to register as an investment company under the Investment Company Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zVHjFXjAQSn1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_231_zY6q2l08Is8b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zzQ499o9unAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide the holders of the outstanding Public Shares (the &#8220;Public Stockholders&#8221;) with the opportunity to redeem
all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting
called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder
approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to
redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.10 per Public Share, plus any
pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights upon the completion of a Business
Combination with respect to the Company&#8217;s warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will only proceed with a Business Combination if the Company has net tangible assets of at least $<span id="xdx_90C_ecustom--MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_c20221209__us-gaap--StatementClassOfStockAxis__custom--CommonClassaSubjectToRedemptionMember_pp0p0" title="Minimum net tangible assets upon consummation of the business combination"><ix:nonFraction name="cxai:MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination" contextRef="AsOf2022-12-09_custom_CommonClassaSubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,001</ix:nonFraction></span> following any related
redemptions and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination.).
On December&#160;9, 2022 the Special Meeting the Stockholders voted to allow the Company to redeem shares of Class A Common Stock in
connection with the amendment to the Charter to the extent that such redemption would result in the Company having net tangible assets
of less than $<span id="xdx_90F_ecustom--MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_c20221231_pp0p0" title="Minimum net tangible assets upon consummation of the business combination"><ix:nonFraction name="cxai:MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,001</ix:nonFraction></span>. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company
does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate
of Incorporation (the &#8220;Certificate of Incorporation&#8221;), conduct the redemptions pursuant to the tender offer rules of the
U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and file tender offer documents with the SEC prior to completing a Business
Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements,
or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction
with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval
in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares
purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder
may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed
transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the
tender offer rules, the Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder
or any other person with whom such stockholder is acting in concert or as a &#8220;group&#8221; (as defined under Section&#160;13 of
the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares with
respect to more than an aggregate of <span id="xdx_90E_ecustom--ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent_c20220101__20221231_pdd" title="Threshold percentage of public shares subject to redemption without the company's prior written consent"><ix:nonFraction name="cxai:ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction>%</span> of the Public Shares, without the prior consent of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares and Public Shares held by it in connection with
the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance
or timing of the Company&#8217;s obligation to allow redemptions in connection with a Business Combination or to redeem <span id="xdx_906_ecustom--PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_c20220101__20221231_pdd" title="Obligation to redeem public shares if entity does not complete a business combination (as a percent)"><ix:nonFraction name="cxai:PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span> of its Public
Shares if the Company does not complete a Business Combination within the Extended Combination Period (as defined below) or (ii) with
respect to any other provision relating to stockholders&#8217; rights or pre-Business Combination activity, unless the Company provides
the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company previously had until June&#160;17, 2022 to consummate a business combination. On June&#160;10, 2022, the Company held a special
meeting of stockholders pursuant to which its stockholders approved amending the Company&#8217;s amended and restated certificate of
incorporation (the &#8220;Initial Charter Amendment&#8221;) to extend the date by which the Company has to consummate a business combination
from June&#160;17, 2022 to December&#160;16, 2022. The Company&#8217;s stockholders approved the Initial Charter Amendment and as such
the Company had until December&#160;16, 2022 to consummate a business combination. On December&#160;9, 2022, the Company held a special
meeting of the stockholders in which the stockholders approved the proposal to amend the Company&#8217;s amended and restated certificate
of incorporation (the &#8220;Charter Amendment&#8221;) to (A) extend the date by which the Company must (1) consummate a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, (2) cease its operations except for
the purpose of winding up if it fails to complete such initial business combination, and (3) redeem all of the shares of Class A common
stock, par value $<span id="xdx_902_eus-gaap--TemporaryEquityParOrStatedValuePerShare_c20221209__us-gaap--StatementClassOfStockAxis__custom--CommonClassaSubjectToRedemptionMember_pdd" title="Common stock, par value"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2022-12-09_custom_CommonClassaSubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share, of the Company (&#8220;Class A Common Stock&#8221;), included as part of the units sold in the IPO,
from December&#160;16, 2022 to June&#160;15, 2023 (the &#8220;Extended Combination Period&#8221;), and (B) allow the Company to redeem
shares of Class A Common Stock in connection with the amendment to the Charter to the extent that such redemption would result in the
Company having net tangible assets of less than $<span id="xdx_90F_ecustom--MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_iI_pp0p0_c20221209__us-gaap--StatementClassOfStockAxis__custom--CommonClassaSubjectToRedemptionMember_zgc4w14lmzu6" title="Minimum net tangible assets upon consummation of the business combination"><ix:nonFraction name="cxai:MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination" contextRef="AsOf2022-12-09_custom_CommonClassaSubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,001</ix:nonFraction></span>. On December&#160;14, 2022, the Company filed the Charter Amendment with the
Secretary of State of the State of Delaware.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zzdYx4JzAcgh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_232_zUuoFGvrb2th" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_z1L5UEtLguNj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we have not completed a Business Combination by June&#160;15, 2023 or during any extended time that we have to consummate a Business
Combination beyond June&#160;15, 2023 as a result of a stockholder vote to amend its certificate of incorporation, the Company will (i)
cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days
thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust
Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes (less up to $<span id="xdx_904_ecustom--MaximumNetInterestsToPayDissolutionExpenses_c20220101__20221231_pp0p0" title="Maximum net interest to pay dissolution expenses"><ix:nonFraction name="cxai:MaximumNetInterestsToPayDissolutionExpenses" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,000</ix:nonFraction></span>
of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish
Public Stockholders&#8217; rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and
the Company&#8217;s board of directors, dissolve and liquidate, subject in each case to the Company&#8217;s obligations under Delaware
law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating
distributions with respect to the Company&#8217;s warrants, which will expire worthless if the Company fails to complete a Business Combination
within the Extended Combination Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination
within the Extended Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such
Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination
within the Extended Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission
(see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Extended Combination
Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund
the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining
available for distribution will be less than $10.10 per Unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims
by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed
entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.10 per Public Share
and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less
than $10.10 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will
not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in
the Trust Account nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the Initial Public Offering
against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Moreover,
in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the
extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify
the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company&#8217;s independent
registered accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements
with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
and Going Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2022, the Company had $<span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20221231_pp0p0" title="Cash operating bank account"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">224,489</ix:nonFraction></span> in its operating bank accounts and a working capital deficit of $<span id="xdx_90E_ecustom--WorkingCapital_iI_pp0p0_c20221231_zqsNaqYkHFT" title="Working capital"><ix:nonFraction name="cxai:WorkingCapital" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,002,523</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the completion of the Initial Public Offering, the Company&#8217;s liquidity needs had been satisfied through a contribution of $<span id="xdx_903_ecustom--ProceedsFromRelatedParty_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--SponsorMember_pp0p0" title="Proceeds from related party"><ix:nonFraction name="cxai:ProceedsFromRelatedParty" contextRef="From2022-01-012022-12-31_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000</ix:nonFraction></span>
from Sponsor to cover for certain offering costs in exchange for the issuance of the Founder Shares, unsecured, non-interest bearing
promissory note of up to $<span id="xdx_90B_eus-gaap--ProceedsFromRelatedPartyDebt_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--SponsorMember_pp0p0" title="Proceeds from related Party debt"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2022-01-012022-12-31_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">300,000</ix:nonFraction></span> from the Sponsor, and the proceeds from the consummation of the Private Placement not held in the Trust
Account. The Note was repaid subsequent to the Initial Public Offering. In addition, in order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may,
but are not obligated to, provide the Company Working Capital Loans. As of December&#160;31, 2022 and 2021, there were no amounts outstanding
under any Working Capital Loan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_ztOAMh9QAxb8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_231_zyCVdMiW5eS8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zLkZaERrBo95" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Company&#8217;s assessment of going concern considerations in accordance with Financial Accounting Standard Board&#8217;s
Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue
as a Going Concern,&#8221; the Company has until June&#160;15, 2023 to consummate a Business Combination. It is uncertain that the Company
will be able to consummate a Business Combination by this time. Additionally, the Company may not have sufficient liquidity to fund the
working capital needs of the Company through one year from the issuance of these consolidated financial statements. If a business combination
is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined
that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution,
raises substantial doubt about the Company&#8217;s ability to continue as a going concern. No adjustments have been made to the carrying
amounts of assets or liabilities should the Company be required to liquidate after June&#160;15, 2023. The Company intends to complete
a Business Combination before the mandatory liquidation date. However, there can be no assurance that the Company will be able to consummate
any Business Combination by June&#160;15, 2023. In addition, the Company may need to raise additional capital through loans or additional
investments from our Sponsor, stockholders, officers, directors or third parties. The Company&#8217;s officers, directors and Sponsor
may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their
sole discretion, to meet the Company&#8217;s working capital needs. Accordingly, the Company may not be able to obtain additional financing.
If the Company is unable to raise additional capital, the Company may be required to take additional measures to conserve liquidity,
which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and
reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable
terms, if at all. These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern through the
liquidation date of June&#160;15, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ErrorCorrectionTextBlock"><p id="xdx_80D_eus-gaap--ErrorCorrectionTextBlock_zdLn6BglcwX9" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8212; <span id="xdx_827_z3UI9tzDYQl8">RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had recognized a liability upon closing of their initial public offering in December&#160;2020 for a portion of the underwriter&#8217;s
commissions which was contingently payable upon closing of a future business combination, with the offsetting entry resulting in an initial
discount to the securities sold in the initial public offering. The underwriter waived all claims to this deferred commission in June&#160;2022.
The Company previously recognized the waiver as an extinguishment, with a resulting non-operating gain recognized in its statement of
operations for the three and six months ended June&#160;30, 2022, nine months ended September&#160;30, 2022 and the year ended December&#160;31,
2022. Upon subsequent review and analysis, management concluded that the Company should have recognized the extinguishment of the contingent
liability as a reversal in the same relative allocation applied at the initial public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Therefore,
the Company&#8217;s management and the Audit Committee of the Company&#8217;s Board of Directors (the &#8220;Audit Committee&#8221;)
concluded that the Company&#8217;s previously issued audited financial statements as of December&#160;31, 2022 (the &#8220;Annual Report&#8221;)
should no longer be relied upon and that it is appropriate to restate the Annual Report. As such, the Company will restate its financial
statements in this Form&#160;10-K/A for the Company&#8217;s unaudited financial statements for three and six months ended June&#160;30,
2022, nine months ended September&#160;30, 2022, and the audited financial statements for the year ended December&#160;31, 2022 included
in the Annual Report on the Company&#8217;s Form&#160;10-K, as filed with the Securities and Exchange Commission (&#8220;SEC&#8221;)
on March&#160;21, 2023 (the &#8220;Original Filing&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zywuGI8BSZZf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_239_zZWBXIk7gO26" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_zZuMbx5FyPk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Impact
of the Restatement</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
impact of the restatement on the consolidated statements of operations, statements of changes in stockholders&#8217; deficit and statements
of cash flows for the affected period is presented below. The restatement had no impact on net cash flows from operating, investing or
financing activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zPUk2TzfC243" summary="xdx: Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8BB_z8jMc3GW9b7j" style="display: none">Summary of impact of the restatement on the financial statements</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9V0T03SUPec" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zkVfltV9ogW" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20220401__20220630_zTYXNm1aHcS8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Operations for the Three Months Ended June&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_i_pp0p0" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,660,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">371,910</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NonoperatingIncomeExpense_i_pp0p0" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,396,046</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,107,956</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_i_pp0p0" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income (loss) before benefit from (provision for) income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,094,313</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">806,223</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProfitLoss_zqq6hziseck" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,071,447</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">783,357</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,481,736</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0420">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-04-012022-06-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">14,481,736</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.47</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right">(<ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.43</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-04-012022-06-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.04</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0432">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-04-012022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.47</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right">(<ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.43</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-04-012022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.04</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_za5gosvHb0Gi" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_ztJwaPCyUFB2" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20220630_z7pKEvHi2Dsf" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Operations for the Six Months Ended June&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zjg7tH5s8vYc" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,660,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">371,910</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NonoperatingIncomeExpense_z5MqFlxcGnXi" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,587,467</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,299,377</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zEwvkVARqcBg" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income (loss) before benefit from (provision for) income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,962,482</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,674,392</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProfitLoss_zYrrHGiVdv5e" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,939,616</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,651,526</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">21,004,630</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0460">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-06-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">21,004,630</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.64</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right">(<ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.33</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-06-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.31</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0472">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zepXfL3fMr8" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.64</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right">(<ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.33</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z0536FcpJPEc" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.31</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zTNJMjYDwJ0d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_232_z4jcTv78Fxg7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_z2fTMHg7jOEc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zpzBqoK6zM0b" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101_20220930_srt--RestatementAxis_srt--RestatementAdjustmentMember" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_497_20220101_20220930" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Operations for the Nine Months Ended September&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zr0FJn9KywL2" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,660,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">371,910</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NonoperatingIncomeExpense_zc7SaILXmNg6" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,560,364</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,272,274</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z4r4QphEEjTf" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income (loss) before benefit from (provision for) income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,838,653</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,550,563</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProfitLoss_zWwll0rilMue" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,811,924</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,523,834</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding &#8211; Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,466,455</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">16,466,455</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share &#8211; Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.81</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right">(<ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.40</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-09-30_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.41</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.81</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right">(<ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.40</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.41</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zK0dZpB3AYih" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zeGWGNAZFCaj" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20221231_zRK7NAYt6hub" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Statement of Operations for the Year Ended December&#160;31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zlDAoOFQjrS6" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,660,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">371,910</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NonoperatingIncomeExpense_zi1ttbcoOQh6" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,634,549</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,346,459</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zc16GdV7HWy6" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income (loss) before benefit from (provision for) income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,684,085</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,395,995</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProfitLoss_zpqpkaFLWYR9" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,634,910</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,346,820</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,546,423</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0543">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,546,423</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.91</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right">(<ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.48</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.43</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0555">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted weighted average shares outstanding (in shares)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.91</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right">(<ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.48</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Basic and diluted earnings per share (in dollars per share)" style="text-align: right"><ix:nonFraction name="cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.43</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unaudited
Statement of Changes in Stockholders&#8217; Deficit for the Three Months Ended June&#160;30, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Deficit</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; font-weight: bold; text-align: left">Balance &#8211; March&#160;31, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zSgv6CfkQ0Wa" title="Balance at the beginning" style="width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">13,226,270</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zaioDZrrH436" title="Balance at the beginning" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0567">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_z22D2btkaD8g" title="Balance at the beginning" style="width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">13,225,580</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKjc4uZxfnui" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,071,447</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_z1yjYMFZiw8l" title="Net income" style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zGeDOwnnS8xc" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">783,357</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Accretion of Class A common stock to redemption value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNN5XGtz0CU1" title="Accretion of Class A common stock to redemption" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">242,995</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpCB8A74vcwa" title="Accretion of Class A common stock to redemption" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,288,090</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zZBO4xgWd1zh" title="Accretion of Class A common stock to redemption" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,045,095</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance &#8211; June&#160;30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4iQ3jHwe2Z4" title="Balance at the end" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,397,818</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zskIucPVM4D4" title="Balance at the end" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0585">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_znc0i1kAl5Ge" title="Balance at the end" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,397,128</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>



<ix:exclude><!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zZ7dW6t90Kg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_238_zEglHjTCLsk3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zXPDW6EM8C07" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statement
of Changes in Stockholders&#8217; Deficit for the Year Ended December&#160;31, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Deficit</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; font-weight: bold; text-align: left">Balance &#8211; December&#160;31, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdx1bW9rYUoj" title="Balance at the beginning" style="width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">21,094,439</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zEQjAVpq2mJ3" title="Balance at the beginning" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zDASNPb4Wihc" title="Balance at the beginning" style="width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">21,094,439</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zFoD6jeyyzPf" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,634,910</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpsRTnIk1QQ1" title="Net income" style="text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zpfn9ROF4a66" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,346,820</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Accretion of Class A common stock to redemption value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAwMLggIUvEa" title="Accretion of Class A common stock to redemption" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">256,545</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zbOhKUqY1YGb" title="Accretion of Class A common stock to redemption" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,288,090</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zHneQqjOnYud" title="Accretion of Class A common stock to redemption" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,031,545</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance &#8211; December&#160;31, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5zJh9p93jl9" title="Balance at the end" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,716,074</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_z2FZje8sfps5" title="Balance at the end" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0612">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zCc6Ym4kI9k5" title="Balance at the end" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,716,074</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZcy8ntEFtWf" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49A_20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z95ehG0xqS5f" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220630_zxITM733eJce" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Cash Flows for the Six Months Ended June&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ProfitLoss_z6RX6DXwrlek" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Net Income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,939,616</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-06-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,651,526</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zNRTLVifJE34" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,660,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">371,910</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zxrggmtn20P6" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Non-Cash Investing and Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_zNkWaAF5G9Wd" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Extinguishment of deferred underwriting fee payable allocated to public shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" contextRef="From2022-01-012022-06-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z88Zh7Mm8ym5" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zXiE7uqfPLE3" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20220930_zSPqzF9nLYGh" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Cash Flows for the Nine Months Ended September&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProfitLoss_z2gj1pbyAOa" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Net Income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,811,924</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,523,834</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zrVYm9o87Axb" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,660,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">371,910</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_z35gCeneCNJb" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Non-Cash Investing and Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_z20ybcrtXbE" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Extinguishment of deferred underwriting fee payable allocated to public shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" contextRef="From2022-01-012022-09-30" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zMYNTNN8CaOf" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zCcGeEVBlfo1" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_497_20220101__20221231_zT2ZdbJcxSIk" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Statement of Cash Flows for the Year Ended December&#160;31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProfitLoss_zttqKxTZhZHk" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Net Income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,634,910</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,346,820</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zpZ2gyZcPeJj" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,660,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">371,910</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zlR89okIc0Oe" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Non-Cash Investing and Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_zwg1cb66dG4k" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Extinguishment of deferred underwriting fee payable allocated to public shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0660">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zeDfbudSk0il" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<ix:exclude><!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zPtKkVhSixPl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_235_zh0s108cgLne" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zwCpe6dk7MIb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_z8xGBXA0mHXk" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8212; <span id="xdx_827_zNyovCW7LCJi">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zuktqF2w8fJ1" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Basis
of Presentation</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles
generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and pursuant to the accounting and disclosure rules and
regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 2&#8212;Restatement of Previously Issued Financial Statements, the Company&#8217;s financial statements for the year
ended December&#160;31, 2022 (collectively, the &#8220;Affected Period&#8221;), are restated in this Annual Report on Form&#160;10-K/A
(Amendment No. 1) (this &#8220;Annual Report&#8221;) to correct the misapplication of accounting guidance related to the liability extinguishment
in the Company&#8217;s previously issued audited financial statements for such period. The restated financial statements are indicated
as &#8220;Restated&#8221; in the audited financial statements and accompanying notes, as applicable. See Note 2&#8212;Restatement of
Previously Issued Financial Statements for further discussion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_84B_eus-gaap--ConsolidationPolicyTextBlock_z5OXF1lZ1sd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Principles
of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="cxai:EmergingGrowthCompanyPolicyTextBlock"><p id="xdx_847_ecustom--EmergingGrowthCompanyPolicyTextBlock_zTskIQfKuDvh" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Emerging
Growth Company</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not
being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley
Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s consolidated financial statements with another public
company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition
period difficult or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_84C_eus-gaap--UseOfEstimates_zLhWUjXH4x1k" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Use of Estimates</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting
estimates included in these consolidated financial statements is the determination of the fair value of the warrant liabilities. Accordingly,
the actual results could differ significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 132; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_z8zpxJZKaGAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_236_zD2HEEpnJsF4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_zCceDKNoJWy" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zKK0E1m2SDX" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Cash
and Cash Equivalents</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of six months or less when purchased to be cash equivalents. The
Company did not have any cash equivalents as of December&#160;31, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zpNq8gvDt5d5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Concentration
of Credit Risk</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit
of $<span id="xdx_907_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zbxBYEbSbSJe" title="Insured amount"><ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span>. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#8217;s financial
condition, results of operations, and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="cxai:TemporaryEquityPolicyPolicyTextBlock"><p id="xdx_842_ecustom--TemporaryEquityPolicyPolicyTextBlock_zPUqISlM1ggd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Class
A Common Stock Subject to Possible Redemption</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards
Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Shares of Class A common stock subject
to mandatory redemption are classified as liability instruments and are measured at fair value. Conditionally redeemable common stock
(including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon
the occurrence of uncertain events not within the Company&#8217;s control) is classified as temporary equity. At all other times, common
stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock features certain redemption rights that are
considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, as of December&#160;31,
2022 and 2021, <span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_c20221231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_pdd" title="Class A common stock subject to possible redemption, outstanding (in shares)"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_custom_CommonStockSubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">387,551</ix:nonFraction></span> and <span id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_c20211231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_pdd" title="Class A common stock subject to possible redemption, outstanding (in shares)"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2021-12-31_custom_CommonStockSubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,600,000</ix:nonFraction></span> shares of Class A common stock subject to possible redemption are presented as temporary equity,
outside of the stockholders&#8217; deficit section of the Company&#8217;s consolidated balance sheets, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to
equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock
are affected by charges against additional paid in capital (to the extent available) and accumulated deficit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December&#160;31, 2022 and 2021, the Class A common stock reflected in the consolidated balance sheets are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:TemporaryEquityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--TemporaryEquityTableTextBlock_zECvghHTCwL6" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8B3_z5tspC3QNLU4" style="display: none">Schedule of reconciliation of Class A common stock reflected in the condensed balance sheet</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 88%; text-align: left">Class A common stock subject to possible redemption, January&#160;1, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_pp0p0_c20210101__20211231_zATWP7fZf60h" title="Class A common stock subject to possible redemption, at beginning of year" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">278,760,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20211231_pp0p0" title="Accretion of carrying value to redemption value" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0696">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Class A common stock subject to possible redemption, December&#160;31, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_pp0p0_c20220101__20221231_zjkwtljQn1Hj" title="Class A common stock subject to possible redemption, at beginning of year" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">278,760,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: left">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: left">Waiver of Class A common stock issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--TemporaryEquityWaiverOfShareIssuanceCosts_c20220101__20221231_pp0p0" title="Waiver of Class A common stock issuance costs" style="text-align: right"><ix:nonFraction name="cxai:TemporaryEquityWaiverOfShareIssuanceCosts" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,288,090</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: left">Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: left">Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--TemporaryEquityAccretionToRedemptionValue_iN_pp0p0_di_c20220101__20221231_zJ3VEP2gCel2" title="Accretion of carrying value to redemption value" style="text-align: right">(<ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,031,545</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Redemption of Class A Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--TemporaryEquityRedemption_iN_pp0p0_di_c20220101__20221231_zdNc46iem556" title="Redemption of Class A Common Stock" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="cxai:TemporaryEquityRedemption" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">275,102,280</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Class A common stock subject to redemption, December&#160;31, 2022</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_pp0p0_c20220101__20221231_zBkDV3Rqvs4h" title="Class A common stock subject to possible redemption, at end of year" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,914,265</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_z11GjiUIYBD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:DeferredChargesPolicyTextBlock"><p id="xdx_843_eus-gaap--DeferredChargesPolicyTextBlock_zdDaWmFTZVp2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Offering
Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the
Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based
on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities were expensed as
incurred in the consolidated statements of operations. Offering costs associated with the Class A common stock issued were initially
charged to temporary equity. Offering costs incurred amounted to $<span id="xdx_908_ecustom--TransactionCosts_iI_pp0p0_c20201217_zpUUBSq82EV3" title="Transaction costs"><ix:nonFraction name="cxai:TransactionCosts" contextRef="AsOf2020-12-17" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,688,848</ix:nonFraction></span>, consisting of $<span id="xdx_907_ecustom--SaleOfStockUnderwritingFees_iI_pp0p0_c20201217_z7DhoIX1DKZd" title="Underwriting fees"><ix:nonFraction name="cxai:SaleOfStockUnderwritingFees" contextRef="AsOf2020-12-17" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,520,000</ix:nonFraction></span> in cash underwriting fees, $<span id="xdx_905_ecustom--DeferredOfferingCostsNoncurrent_iI_pp0p0_c20201217_zACM8B1o1Kjd" title="Deferred underwriting fee payable"><ix:nonFraction name="cxai:DeferredOfferingCostsNoncurrent" contextRef="AsOf2020-12-17" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,660,000</ix:nonFraction></span>
of deferred underwriting fees and $<span id="xdx_90E_ecustom--SaleOfStockOtherOfferingCosts_iI_pp0p0_c20201217_zbglZAMf0A8i" title="Other offering costs"><ix:nonFraction name="cxai:SaleOfStockOtherOfferingCosts" contextRef="AsOf2020-12-17" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">508,848</ix:nonFraction></span> of other offering costs, of which $<span id="xdx_90A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_pp0p0_c20201201__20201217_zWImPD8D2FUj" title="Charged to temporary equity"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2020-12-012020-12-17" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,239,420</ix:nonFraction></span> was charged to temporary equity and $<span id="xdx_904_ecustom--OfferingCost_pp0p0_c20201201__20201217_zdVtpvILLUm9" title="Offering cost expense"><ix:nonFraction name="cxai:OfferingCost" contextRef="From2020-12-012020-12-17" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">449,428</ix:nonFraction></span>
was allocated to the warrant liability and expensed through the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 133; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zAWZF3XlnZW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_23E_z01hixZhuzRb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zdSXy3CQdx6i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="cxai:WarrantLiabilityPolicyTextBlock"><p id="xdx_845_ecustom--WarrantLiabilityPolicyTextBlock_zy7gcJxh8IRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Derivative
Warrant Liabilities</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s
specific terms and applicable authoritative guidance in Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards
Codification (&#8220;ASC&#8221;) 480, Distinguishing Liabilities from Equity (&#8220;ASC 480&#8221;) and ASC 815, Derivatives and Hedging
(&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet
the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under
ASC 815, including whether the warrants are indexed to the Company&#8217;s own common stock, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification,
the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the consolidated statements of operations.
The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a
binomial lattice model. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market
price was used as the fair value of the Warrants (as defined below) as of each relevant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zAkXDmrMgUre" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Income
Taxes</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes under ASC 740, &#8220;Income Taxes.&#8221; ASC 740, Income Taxes, requires the recognition of deferred
tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation
allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740-270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in
interim periods under ASC 740-270-30-5. As of December&#160;31, 2022 and December&#160;31, 2021, the Company&#8217;s deferred tax asset
had a full valuation allowance recorded against it. The Company&#8217;s effective tax rate was <span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20220101__20221231_zeSoHveIZU2j" title="Effective tax rate (in percent)"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction>%</span> and <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20210101__20211231_zbw1V8igdRf8" title="Effective tax rate (in percent)"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction>%</span>, respectively. The effective
tax rate differs from the statutory tax rate of <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c20220101__20221231_zwkDRRygxUJ8" title="Statutory tax rate"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c20210101__20211231_zX7MjNWI9J04" title="Statutory tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></ix:nonFraction>%</span></span> for the years ended December&#160;31, 2022 and 2021, due to changes in fair value
in warrant liability and the valuation allowance on the deferred tax assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
period, disclosure and transition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were <span id="xdx_903_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20221231_zI6apnoPaO7i" title="Unrecognized tax benefits"><span id="xdx_901_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20211231_zXaHWhMffC9f" title="Unrecognized tax benefits"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> unrecognized
tax benefits and <span id="xdx_906_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pp0p0_do_c20221231_zUiuIorm9u89" title="Unrecognized tax benefits accrued for interest and penalties"><span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pp0p0_do_c20211231_zFEkKd3bn3eh" title="Unrecognized tax benefits accrued for interest and penalties"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> amounts accrued for interest and penalties as of December&#160;31, 2022 and December&#160;31, 2021. The Company is
currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has identified the United States as its only &#8220;major&#8221; tax jurisdiction. The Company is subject to income taxation
by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus
of income among various tax jurisdictions and compliance with federal and state tax laws. The Company&#8217;s management does not expect
that the total amount of unrecognized tax benefits will materially change over the next twelve months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 134; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zrQ218CsN5c4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_235_zGolBvzMPHMb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zVsHb4oE4cTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zvnZTRGy3S6a" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Net
Income per Common Share</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share&#8221;. Net income per
common share is computed by dividing net income by the weighted average number of shares of common stock outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class
A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of diluted income per share does not consider the effect of the Warrants issued in connection with the (i) Initial Public
Offering, and (ii) the private placement since the exercise of the Warrants is contingent upon the occurrence of future events. The Warrants
are exercisable to purchase <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Number of warrants to purchase shares issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,080,000</ix:nonFraction></span> shares of Class A common stock in the aggregate. As of December&#160;31, 2022 and 2021, the Company
did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and
then share in the earnings of the Company. As a result, diluted net income per common share is the same as basic net income per common
share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zYz80eOXU9p1" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B0_zsXmGyV3aD93" style="display: none">Schedule of Reconciliation of net income per common share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20220101_20221231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassAMember" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20220101_20221231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z6j1d9NrCpC5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20210101_20211231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="14" style="font-weight: bold; text-align: center">Year Ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December&#160;31,</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class A</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class B</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class A</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class B</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: left">Basic and diluted net income per common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_i01B" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i02_pp0p0" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,385,193</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,961,627</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-012021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,366,307</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-01-012021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,841,577</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i02_pdd" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Basic and diluted weighted average shares outstanding</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,546,423</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-012021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,600,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-01-012021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Basic and diluted net income per common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.43</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.43</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-012021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.27</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-01-012021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.27</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8AD_zOrPjkSBYWej" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zezPmwmkfduc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value
Measurement,&#8221; approximate the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their
short-term nature, except the derivative warrant liabilities (see Note 10).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmqYJbCeT0sg" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Recent
Accounting Standards</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August&#160;2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2020-06, Debt &#8212; Debt with Conversion
and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU
2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation
of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance
pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures
for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends
the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU
2020-06 is effective January&#160;1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted
beginning on January&#160;1, 2021. The Company adopted ASU 2020-06 as of January&#160;1, 2021 and the adoption did not have an impact
on its financial position, results of operations or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 135; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zigG0DdvcBWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_23D_zzWpxMDfpU19" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_z4L0NTIDuDXf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="cxai:InitialPublicOfferingDisclosureTextBlock"><p id="xdx_802_ecustom--InitialPublicOfferingDisclosureTextBlock_zUBYCtXAY5l8" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 &#8212; <span id="xdx_829_zjJpzYbqkTT5">PUBLIC OFFERING</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Initial Public Offering, the Company sold <span id="xdx_90A_ecustom--UnitsIssuedDuringPeriodSharesNewIssues_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zruFXjZeX0A2" title="Number of units sold"><ix:nonFraction name="cxai:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-012020-12-17_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,600,000</ix:nonFraction></span> Units which includes a full exercise by the underwriters of their over-allotment
option in the amount of <span id="xdx_906_ecustom--UnitsIssuedDuringPeriodSharesNewIssues_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zpOJDyEvWTp5" title="Number of units sold"><ix:nonFraction name="cxai:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="From2020-12-012020-12-17_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,600,000</ix:nonFraction></span> Units, at a price of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z4ubdRWRzD97" title="Purchase price, per unit (in dollars per share)"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-12-17_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Unit. Each Unit consists of one share of Class A common stock and one-half
of one redeemable warrant (&#8220;Public Warrant&#8221; and, together with the Private Placement Warrants, the &#8220;Warrants&#8221;).
Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201217__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zLDqxvTR2fU6" title="Exercise price of warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-12-17_us-gaap_CommonClassAMember_us-gaap_IPOMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per share, subject to
adjustment (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="cxai:PrivatePlacementDisclosureTextBlock"><p id="xdx_805_ecustom--PrivatePlacementDisclosureTextBlock_zpmKsKsUDvxh" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 &#8212; <span id="xdx_825_z8Qgj4hAL57l">PRIVATE PLACEMENT</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Sponsor and the Direct Anchor Investors purchased an aggregate of <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zgUzerlDWx14" title="Number of warrants to purchase shares issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,280,000</ix:nonFraction></span> Private
Placement Warrants at a price of $<span id="xdx_900_ecustom--ClassOfWarrantOrRightPriceOfWarrantsOrRights_iI_c20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zuzrIOCCWYzc" title="Price of warrants"><ix:nonFraction name="cxai:ClassOfWarrantOrRightPriceOfWarrantsOrRights" contextRef="AsOf2020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span> per Private Placement Warrant, or $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfWarrants_pp0p0_c20201201__20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zVmmfwojmtbc" title="Aggregate purchase price"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2020-12-012020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,280,000</ix:nonFraction></span>. Each Private Placement Warrant is exercisable to
purchase one share of Class A common stock at a price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zV3vu3JualOg" title="Exercise price of warrant"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_CommonClassAMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per share, subject to adjustment (see Note 8). The proceeds from the
sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If
the Company does not complete a Business Combination within the Extended Combination Period, the proceeds from the sale of the Private
Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of
applicable law) and the Private Placement Warrants will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_ziWg9MRDSGL6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8212; <span id="xdx_823_zc5rFk0SwlC">RELATED PARTIES</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Founder
Shares</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July&#160;27, 2020, the Sponsor paid $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20200701__20200727__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zDl99LScjEI8" title="Aggregate purchase price"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-07-012020-07-27_custom_FounderSharesMember_custom_SponsorMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000</ix:nonFraction></span> to cover certain offering costs of the Company in consideration for <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20200727__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-07-012020-07-27_custom_FounderSharesMember_custom_SponsorMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,750,000</ix:nonFraction></span> shares of
Class B common stock (the &#8220;Founder Shares&#8221;). In October&#160;2020, the Sponsor forfeited <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201001__20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DirectAnchorMember_pdd" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-10-012020-10-31_custom_FounderSharesMember_custom_DirectAnchorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">625,000</ix:nonFraction></span> Founder Shares and the Direct
Anchor Investors purchased <span id="xdx_906_ecustom--NumberOfSharesSubjectToForfeiture_c20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pdd" title="Shares subject to forfeiture"><ix:nonFraction name="cxai:NumberOfSharesSubjectToForfeiture" contextRef="AsOf2020-10-31_custom_FounderSharesMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">625,000</ix:nonFraction></span> Founder Shares for an aggregate purchase price of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20201001__20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember_pp0p0" title="Aggregate purchase price"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2020-10-012020-10-31_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,717</ix:nonFraction></span>, or approximately $<span id="xdx_90C_eus-gaap--SharePrice_c20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember_pdd" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-10-31_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.004</ix:nonFraction></span> per share. In December&#160;2020,
the Company effected a 1:<span id="xdx_90E_eus-gaap--StockholdersEquityNoteStockSplitConversionRatio1_c20200101__20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zo7m9mlDAXm5" title="Stock split"><ix:nonFraction name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" contextRef="From2020-01-012020-12-31_custom_FounderSharesMember_custom_SponsorMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">1.2</ix:nonFraction> </span>stock split of its Class B common stock, resulting in the Sponsor holding an aggregate of <span id="xdx_903_ecustom--AggregateNumberOfSharesOwned_c20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pdd" title="Aggregate number of shares owned"><ix:nonFraction name="cxai:AggregateNumberOfSharesOwned" contextRef="AsOf2020-12-31_custom_FounderSharesMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,150,000</ix:nonFraction></span> Founder
Shares, the Direct Anchor Investors holding an aggregate of <span id="xdx_907_ecustom--AggregateNumberOfSharesOwned_c20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DirectAnchorMember_pdd" title="Aggregate number of shares owned"><ix:nonFraction name="cxai:AggregateNumberOfSharesOwned" contextRef="AsOf2020-12-31_custom_FounderSharesMember_custom_DirectAnchorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">750,000</ix:nonFraction></span> Founder Shares and there being an aggregate of <span id="xdx_90B_ecustom--AggregateNumberOfSharesOwned_c20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember_pdd" title="Aggregate number of shares owned"><ix:nonFraction name="cxai:AggregateNumberOfSharesOwned" contextRef="AsOf2020-12-31_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></span> Founder
Shares outstanding. The Founder Shares included an aggregate of up to <span id="xdx_90E_ecustom--NumberOfSharesSubjectToForfeiture_c20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Shares subject to forfeiture"><ix:nonFraction name="cxai:NumberOfSharesSubjectToForfeiture" contextRef="AsOf2020-10-31_custom_FounderSharesMember_custom_SponsorMember_us-gaap_OverAllotmentOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> shares subject to forfeiture by the Sponsor to the extent
that the underwriters&#8217; over-allotment was not exercised in full or in part, so that the number of Founder Shares would equal, on
an as-converted basis, approximately <span id="xdx_90D_ecustom--PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_c20200101__20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember_pdd" title="Percentage of issued and outstanding shares after the initial public offering collectively held by initial stockholders"><ix:nonFraction name="cxai:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" contextRef="From2020-01-012020-12-31_custom_FounderSharesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction>%</span> of the Company&#8217;s issued and outstanding common stock after the Initial Public Offering.
As a result of the underwriters&#8217; election to fully exercise their over-allotment option, no Founder Shares are currently subject
to forfeiture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
initial stockholders have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the
earlier to occur of: (A) one <span id="xdx_90B_ecustom--RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_dtY_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zLaqyPEqxE75" title="Restrictions on transfer period of time after business combination completion" style="display: none"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_FounderSharesMember_custom_SponsorMember" format="ixt-sec:duryear" name="cxai:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion">1</ix:nonNumeric></span> year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x)
if the last reported sale price of the Class A common stock equals or exceeds $<span id="xdx_90A_ecustom--TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)"><ix:nonFraction name="cxai:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" contextRef="From2022-01-012022-12-31_custom_FounderSharesMember_custom_SponsorMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.00</ix:nonFraction></span>
per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any <span id="xdx_90C_ecustom--TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_dtD_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zvqpKZtovvj6" title="Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_FounderSharesMember_custom_SponsorMember" format="ixt-sec:durday" name="cxai:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays">20</ix:nonNumeric></span>
trading days within any <span id="xdx_90B_ecustom--TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_dtD_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z5KrA2jtlz43" title="Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_FounderSharesMember_custom_SponsorMember" format="ixt-sec:durday" name="cxai:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays">30</ix:nonNumeric></span>-trading
day period commencing at least <span id="xdx_90B_ecustom--ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_dtD_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zMWcahWRI6zi" title="Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_FounderSharesMember_custom_SponsorMember" format="ixt-sec:durday" name="cxai:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences">150</ix:nonNumeric></span>
days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or
other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock
for cash, securities or other property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative
Services Agreement</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement, commencing on December&#160;14, 2020 through the earlier of the Company&#8217;s consummation of a
Business Combination and its liquidation, to pay the Sponsor a total of up to $<span id="xdx_90E_ecustom--RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_c20201201__20201214__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pp0p0" title="Expenses per month"><ix:nonFraction name="cxai:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" contextRef="From2020-12-012020-12-14_custom_AdministrativeServicesAgreementMember_custom_SponsorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,000</ix:nonFraction></span> per month for office space, utilities and secretarial
and administrative support. For each of the years ended December&#160;31, 2022 and 2021, the Company incurred and paid $<span id="xdx_905_ecustom--ExpensesIncurredAndPaid_pp0p0_c20220101__20221231_zccqLjpQRm4h" title="Expenses incurred and paid"><span id="xdx_900_ecustom--ExpensesIncurredAndPaid_pp0p0_c20210101__20211231_zqbS1Y8w8oM4" title="Expenses incurred and paid"><ix:nonFraction name="cxai:ExpensesIncurredAndPaid" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="cxai:ExpensesIncurredAndPaid" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">240,000</ix:nonFraction></ix:nonFraction></span></span> in fees
for these services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 136; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zvDUxGS6Fzl4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_23C_zPglLPPt94bh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z8tEam69ypj8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Promissory
Note &#8212; Related Party</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August&#160;10, 2022, KINS Capital LLC issued an unsecured promissory note to the Company, pursuant to which the Company may borrow up
to an aggregate principal amount of $<span id="xdx_907_eus-gaap--DebtInstrumentCollateralAmount_c20220810__us-gaap--RelatedPartyTransactionAxis__custom--PromissoryNoteWithRelatedPartyMember_pp0p0" title="Aggregate principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentCollateralAmount" contextRef="AsOf2022-08-10_custom_PromissoryNoteWithRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">400,000</ix:nonFraction></span>. The Promissory Note was non-interest bearing and payable on the earlier of (i) closing
of the Merger as described in the BCA or (ii) June&#160;15, 2023. As December&#160;31, 2022, $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--PromissoryNoteWithRelatedPartyMember_pp0p0" title="Amount outstanding under promissory note"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-12-31_custom_PromissoryNoteWithRelatedPartyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">347,961</ix:nonFraction></span> was outstanding under the Promissory
Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Working
Capital Loans</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain
of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#8220;Working
Capital Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of
a Business Combination, without interest, or, at the lender&#8217;s discretion, up to $<span id="xdx_90C_ecustom--MaximumLoansConvertibleIntoWarrants_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_pp0p0" title="Loan conversion agreement warrant"><ix:nonFraction name="cxai:MaximumLoansConvertibleIntoWarrants" contextRef="AsOf2022-12-31_custom_WorkingCapitalLoansMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,500,000</ix:nonFraction></span> of the notes may be converted upon completion
of a Business Combination into warrants at a price of $<span id="xdx_90C_ecustom--ClassOfWarrantOrRightPriceOfWarrantsOrRights_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_pdd" title="Price of warrant"><ix:nonFraction name="cxai:ClassOfWarrantOrRightPriceOfWarrantsOrRights" contextRef="AsOf2022-12-31_custom_WorkingCapitalLoansMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span> per warrant. Such warrants would be identical to the Private Placement Warrants.
In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to
repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December&#160;31,
2022 and 2021, there were <span id="xdx_901_ecustom--MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_iI_pp0p0_do_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--WorkingCapitalLoansWarrantMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_z5Mq9VxhXbyd" title="Maximum borrowing capacity of related party promissory note"><span id="xdx_903_ecustom--MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_iI_pp0p0_do_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--WorkingCapitalLoansWarrantMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_zGBj4iPb25Ha" title="Maximum borrowing capacity of related party promissory note"><ix:nonFraction name="cxai:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" contextRef="AsOf2022-12-31_custom_WorkingCapitalLoansWarrantMember_custom_WorkingCapitalLoansMember" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD"><ix:nonFraction name="cxai:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" contextRef="AsOf2021-12-31_custom_WorkingCapitalLoansWarrantMember_custom_WorkingCapitalLoansMember" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> amounts outstanding under the Working Capital Loans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z7vAgnHWSr26" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8212; <span id="xdx_82D_z3QBY4QkvWs1">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Various
social and political circumstances in the United States and around the world (including wars and other forms of conflict, including rising
trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the United States
and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such
as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility
and economic uncertainties or deterioration in the United States and worldwide. Specifically, the rising conflict between Russia and
Ukraine, and resulting market volatility could adversely affect the Company&#8217;s ability to complete a Business Combination. In response
to the conflict between Russia and Ukraine, the United States and other countries have imposed sanctions or other restrictive actions
against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could
have a material adverse effect on the Company&#8217;s ability to complete a Business Combination and the value of the Company&#8217;s
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
continues to evaluate the impact of these types of risks and has concluded that while it is reasonably possible that these risks and
uncertainties could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target
company, the specific impact is not readily determinable as of the date of these consolidated financial statements. The consolidated
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Inflation
Reduction Act of 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August&#160;16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;) was signed into federal law. The IR Act provides
for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations
and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January&#160;1, 2023. The excise
tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise
tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating
the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair
market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department
of the Treasury (the &#8220;Treasury&#8221;) has been given authority to provide regulations and other guidance to carry out and prevent
the abuse or avoidance of the excise tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 137; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zJjQtnJDarK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_23B_ziVr5xDc9y0i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zrNzzWz5vlol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
redemption or other repurchase that occurs after December&#160;31, 2022, in connection with a Business Combination, extension vote or
otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection
with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of
the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business
Combination, (iii) the nature and amount of any &#8220;PIPE&#8221; or other equity issuances in connection with a Business Combination
(or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination)
and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the
Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing
could cause a reduction in the cash available on hand to complete a Business Combination and in the Company&#8217;s ability to complete
a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a registration rights agreement entered into on December&#160;14, 2020, the holders of the Founder Shares, Private Placement
Warrants and securities that may be issued upon conversion of Working Capital Loans will be entitled to registration rights pursuant
to a registration rights agreement. The holders of at least <span id="xdx_906_ecustom--MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands_c20201201__20201214_pdd" title="Minimum percentage of founder share holders entitled to make demands"><ix:nonFraction name="cxai:MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands" contextRef="From2020-12-012020-12-14" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction>%</span>
in interest of these securities will be entitled to make up to three <span id="xdx_907_ecustom--MaximumNumberOfDemandsForRegistrationOfSecurities_iI_c20201214_z54hT6zpgLWa" title="Maximum number of demands for registration of securities" style="display: none"><ix:nonFraction name="cxai:MaximumNumberOfDemandsForRegistrationOfSecurities" contextRef="AsOf2020-12-14" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">3</ix:nonFraction></span> demands, excluding short form registration demands, that we
register such securities for sale under the Securities Act. In addition, these holders will have certain &#8220;piggy-back&#8221;
registration rights to include their securities in other registration statements filed subsequent to the completion of a Business
Combination and rights to require us to register for resale such securities pursuant to Rule&#160;415 under the Securities Act. The
Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriting
Agreement</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters were entitled to a deferred fee of $<span id="xdx_902_ecustom--DeferredFeePerUnit_c20221231_pdd" title="Deferred fee per unit"><ix:nonFraction name="cxai:DeferredFeePerUnit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.35</ix:nonFraction></span> per Unit, or up to $<span id="xdx_90F_ecustom--DeferredOfferingCostsNoncurrent_iI_pp0p0_c20211231_z3rqmbkjDVGa" title="Deferred underwriting fee payable"><ix:nonFraction name="cxai:DeferredOfferingCostsNoncurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,660,000</ix:nonFraction></span> in the aggregate. The deferred fee was to become
payable to the underwriters from the amounts held in the Trust Account in the event that the Company completed a Business Combination,
subject to the terms of the underwriting agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June&#160;9, 2022, one of the underwriters waived its entitlement to the payment of any deferred fee to be paid under the terms of the
underwriting agreement and is no longer serving in an advisor capacity. As a result, the Company recognized $<span id="xdx_909_ecustom--IncomeRecognizedFromReductionOfDeferredUnderwriterFee_c20220601__20220609_pp0p0" title="Income recognized from reduction of deferred underwriter fee"><ix:nonFraction name="cxai:IncomeRecognizedFromReductionOfDeferredUnderwriterFee" contextRef="From2022-06-012022-06-09" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,660,000</ix:nonFraction></span> of income in relation
to the reduction of the deferred underwriter fee in the accompanying consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Merger
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;25, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), by and among
the Company, Inpixon, a Nevada corporation (&#8220;Inpixon&#8221;), CXApp Holding Corp., a Delaware corporation and wholly-owned subsidiary
of Inpixon (&#8220;CXApp&#8221; and, together with Inpixon, collectively, the &#8220;Companies&#8221;), and Merger Sub, pursuant to which
the Company will combine with CXApp, Inpixon&#8217;s enterprise apps business (including its workplace experience technologies, indoor
mapping, events platform, augmented reality and related business solutions) (the &#8220;Enterprise Apps Business&#8221;). Also on September&#160;25,
2022, and in connection with the execution of the Merger Agreement, the Company, Inpixon, CXApp and the Sponsor entered into that certain
sponsor support agreement (the &#8220;Sponsor Support Agreement&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
prior to the Merger (as defined below) and pursuant to a Separation and Distribution Agreement, dated as of September&#160;25, 2022,
among the Company, Inpixon, CXApp and Design Reactor, Inc., a California corporation (&#8220;Design Reactor&#8221;) (the &#8220;Separation
Agreement&#8221;), and other ancillary conveyance documents, Inpixon will, among other things and on the terms and subject to the conditions
of the Separation Agreement, transfer the Enterprise Apps Business, including certain related subsidiaries of Inpixon, including Design
Reactor, to CXApp (the &#8220;Reorganization&#8221;) and, in connection therewith, will distribute (the &#8220;Distribution&#8221;) to
Inpixon stockholders and other security holders 100% of the common stock of CXApp, par value $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220925__us-gaap--StatementEquityComponentsAxis__custom--CXAppCommonStockMember_zGG8DefANBxg" title="Common stock, par value (in dollars per share)"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-25_custom_CXAppCommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.00001</ix:nonFraction></span> (the &#8220;CXApp Common Stock&#8221;),
as further described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 138; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_z10OrKXsmAVd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_23D_zfGo5Gafnfqj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_zOA9JstQwwxh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
following the Distribution, in accordance with and subject to the terms and conditions of the Merger Agreement, Merger Sub will merge
with and into CXApp (the &#8220;Merger&#8221;), with CXApp continuing as the surviving company in the Merger and as a wholly-owned subsidiary
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement, along with the Separation Agreement and the other transaction documents to be entered into in connection therewith,
provides for, among other things, the consummation of the following transactions (collectively, the &#8220;Business Combination&#8221;):
(i) Inpixon will transfer the Enterprise Apps Business (the &#8220;Separation&#8221;) to its wholly-owned subsidiary, CXApp, and contribute
$<span id="xdx_90F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_pp0n3_dm_c20220925__srt--CounterpartyNameAxis__custom--InpixonMember__us-gaap--TypeOfArrangementAxis__custom--SeparationAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zgwpD32BjIt2" title="Cash Contribution upon seperation"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" contextRef="AsOf2022-09-25_custom_InpixonMember_custom_SeparationAgreementMember_custom_CxappHoldingCorpMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">10</ix:nonFraction></span> million in capital thereto (the &#8220;Cash Contribution&#8221;), (ii) following the Separation, Inpixon will distribute <span id="xdx_90A_ecustom--PercentageOfCommonStockDistributed_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_pdd" title="Percentage of common stock distributed"><ix:nonFraction name="cxai:PercentageOfCommonStockDistributed" contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction>%</span> of
the shares of CXApp Common Stock to Inpixon stockholders and other security holders by way of the distribution and (iii) following the
completion of the foregoing transactions and subject to the satisfaction or waiver of certain other conditions set forth in the Merger
Agreement, the parties shall consummate the Merger. The Separation, Distribution and Merger are intended to qualify as &#8220;tax-free&#8221;
transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of the Business Combination, the Company will have two classes of common stock: Class A common stock, par value $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_c20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common stock, par value (in dollars per share)"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-25_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>
per share (the &#8220;Company&#8217;s Class A Common Stock&#8221;), and Class C common stock, par value $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_c20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Common stock, par value (in dollars per share)"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-25_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share (the &#8220;Company&#8217;s
Class C Common Stock&#8221; and together with the Company&#8217;s Class A Common Stock, the &#8220;Company&#8217;s Common Stock&#8221;).
The Company&#8217;s Class A Common Stock and the Company&#8217;s Class C Common Stock will be identical in all respects, except that
the Company&#8217;s Class C Common Stock will be subject to transfer restrictions and will automatically convert into Company&#8217;s
Class A Common Stock on the earlier to occur of (i) the <span id="xdx_90F_ecustom--MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_z9CooSiozhrc" title="Maximum term for automatic conversion of stock following the closing of the Merger"><ix:nonNumeric contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember" format="ixt-sec:durday" name="cxai:MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger">180</ix:nonNumeric></span>th day following the closing of the Merger and (ii) the day that the last
reported sale price of the Company&#8217;s Class A Common Stock equals or exceeds $<span id="xdx_906_ecustom--CommonStockStockPriceTrigger_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zmfc5C4n4Cxf" title="Stock price trigger"><ix:nonFraction name="cxai:CommonStockStockPriceTrigger" contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.00</ix:nonFraction></span> per share for any <span id="xdx_90B_ecustom--ThresholdTradingDays_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_z18vCC1eSJx5" title="Threshold trading days"><ix:nonNumeric contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember" format="ixt-sec:durday" name="cxai:ThresholdTradingDays">20</ix:nonNumeric></span> trading days within any
<span id="xdx_906_ecustom--ThresholdConsecutiveTradingDays_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_ztl2WmhDMSqi" title="Threshold consecutive trading days"><ix:nonNumeric contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember" format="ixt-sec:durday" name="cxai:ThresholdConsecutiveTradingDays">30</ix:nonNumeric></span>-trading day period following the closing of the Merger. The Company&#8217;s Class A Common Stock will be listed on the Nasdaq Capital
Market (&#8220;Nasdaq&#8221;) and are expected to be trading under a new ticker symbol. The outstanding warrants of the Company will
be listed on Nasdaq and are expected to be trading under a new ticker symbol.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Consideration
Paid</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time the Business Combination is effected (the &#8220;Closing&#8221;), the outstanding shares of CXApp Common Stock after the Distribution
and immediately prior to the effective time of the Merger will be converted into an aggregate of <span id="xdx_903_ecustom--NumberOfSharesIssuableUponMerger_iI_pdn3_dm_c20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zOpnlBGcXtt3" title="Number of shares issuable upon merger"><ix:nonFraction name="cxai:NumberOfSharesIssuableUponMerger" contextRef="AsOf2022-09-25_custom_MergerAgreementMember_custom_CxappHoldingCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="6" unitRef="Shares">6.9</ix:nonFraction></span> million shares of The Company&#8217;s
Common Stock which shall be issued to Inpixon shareholders, subject to adjustment. Each holder&#8217;s aggregate merger consideration
will consist of <span id="xdx_901_ecustom--PercentageOfStockAsMergerConsideration_c20220901__20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zJP9vPMVMYH9" title="Percentage of stock as merger consideration"><ix:nonFraction name="cxai:PercentageOfStockAsMergerConsideration" contextRef="From2022-09-012022-09-25_us-gaap_CommonClassAMember_custom_MergerAgreementMember_custom_CxappHoldingCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction>%</span> Company&#8217;s Class A Common Stock and <span id="xdx_903_ecustom--PercentageOfStockAsMergerConsideration_c20220901__20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_pdd" title="Percentage of stock as merger consideration"><ix:nonFraction name="cxai:PercentageOfStockAsMergerConsideration" contextRef="From2022-09-012022-09-25_us-gaap_CommonClassCMember_custom_MergerAgreementMember_custom_CxappHoldingCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">90</ix:nonFraction>%</span> Company&#8217;s Class C Common Stock (such percentages, in each case,
subject to adjustment to comply with the listing requirements set forth under Nasdaq Listing Rule&#160;5505(b)(2) with respect to KINS).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Representations
and Warranties &amp; Covenants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement, the Company, CXApp and Inpixon each made representations and warranties customary for transactions of this type
regarding themselves and their respective businesses. The representations and warranties made pursuant to the Merger Agreement will not
survive the Closing. In addition, the parties to the Merger Agreement agreed to be bound by certain covenants that are customary for
transactions of this type. The covenants made under the Merger Agreement generally will not survive the Closing, with the exception of
certain covenants and agreements that by their terms are to be performed in whole or in part after the Closing, which will survive in
accordance with the terms of the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 139; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zaxfWx8vv4Vb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_234_zBoBZ3K024ja" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zTsy9AFFA64c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conditions
to Closing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consummation of the Business Combination is subject to conditions customary for transactions involving special purpose acquisition companies,
including, among others: (i) there is not in force any order, judgment, injunction, decree, writ, stipulation, determination or award,
in each case, entered by or with any governmental authority of competent jurisdiction, statute, rule or regulation enjoining or prohibiting
the consummation of the Merger, (ii) the Company shall have at least $<span id="xdx_908_ecustom--ThresholdNetTangibleAssets_c20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_pp0p0" title="Threshold net tangible assets"><ix:nonFraction name="cxai:ThresholdNetTangibleAssets" contextRef="AsOf2022-09-25_custom_MergerAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000,001</ix:nonFraction></span> of net tangible assets as of the Closing, (iii) the Company&#8217;s
Class A Common Stock issuable pursuant to the Business Combination shall have been approved for listing on Nasdaq, (iv) CXApp and the
Company shall each have performed and complied in all material respects with the covenants required by the Merger Agreement to be performed
by it as of or prior to Closing, (v) customary bring down conditions related to the accuracy of the CXApp&#8217;s and the Company&#8217;s
respective representations and warranties in the Merger Agreement, (vi) the consummation of the Distribution, the Reorganization and
other transactions contemplated by the Separation and Distribution Agreement, (vii) the Company&#8217;s registration statement to be
filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) shall have become effective (and no stop order suspending effectiveness
have been issued and no proceedings for that purpose has been initiated or threatened by the SEC), (viii) each of the Company&#8217;s
and CXApp&#8217;s stockholder approvals shall have been obtained and (ix) the sum of (A) the aggregate amount of cash available in KINS&#8217;s
trust account following the Company&#8217;s stockholders&#8217; meeting, after deducting the amount required to satisfy the Acquiror
Share Redemption Amount (as defined in the Merger Agreement) (but prior to payment of any transaction expenses), (B) the aggregate gross
purchase price of any other purchase of shares of the Company&#8217;s Common Stock (or securities convertible or exchangeable for the
Company&#8217;s Common Stock) actually received by the Company prior to or substantially concurrently with the closing of the Merger,
and (C) the aggregate gross purchase price of any other purchase of shares of CXApp Common Stock (or securities convertible or exchangeable
for CXApp Common Stock) actually received by CXApp prior to or substantially concurrently with the closing of the Merger, shall be equal
to or greater than $<span id="xdx_901_ecustom--ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares_pp0n3_dm_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zozBBC4g4UI6" title="Threshold aggregate gross purchase price of any other purchase of shares"><ix:nonFraction name="cxai:ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares" contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">9.5</ix:nonFraction></span> million. The Company&#8217;s obligation to consummate the Business Combination is also conditioned on there having
been no event that has had, or would reasonably be expected to have, individually or in the aggregate, a &#8220;Material Adverse Effect&#8221;
on CXApp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Termination</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing, including (i)
by the mutual written consent of the Company and CXApp, (ii) by the Company or CXApp, if the Closing shall not have occurred on or before
March&#160;16, 2023, (iii) by the Company or CXApp, if there has been any order, judgment, injunction, decree, writ, stipulation, determination
or award, in each case, entered by or with any governmental authority that would make the Merger illegal or otherwise prevent or prohibit
the Merger, (iv) by the Company or CXApp, if KINS has not obtained the requisite approval from its stockholders, (v) by KINS or CXApp
if the other party breaches certain representations, warranties, or covenants, as specified in the Merger Agreement, and that breach
is unable to be cured, or is not cured, within <span id="xdx_904_ecustom--TermOfBreachUnableToBeCuredOrIsNotCured_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zgtlwRhE9w7i" title="Term of breach unable to be cured, or is not cured"><ix:nonNumeric contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember_custom_CxappHoldingCorpMember" format="ixt-sec:durday" name="cxai:TermOfBreachUnableToBeCuredOrIsNotCured">30</ix:nonNumeric></span> days, or by CXApp if there has been an uncured breach by Sponsor of certain of its
obligations under the Sponsor Support Agreement or (vi) by the Company if CXApp has not obtained the requisite approval from its stockholders
within one hour of the effective date of the Company&#8217;s registration statement, provided that CXApp or the Company pay a termination
fee of $<span id="xdx_901_ecustom--TerminationFee_pp0n3_dm_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zcm6CsTaMVPh" title="Termination fee"><ix:nonFraction name="cxai:TerminationFee" contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember_custom_CxappHoldingCorpMember" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">2.0</ix:nonFraction></span> million to the other party if the Merger Agreement is terminated pursuant to (v) or (vi) above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Separation
and Distribution Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;25, 2022, in connection with the execution of the Merger Agreement, the Company entered into the Separation Agreement
with CXApp, Inpixon and Design Reactor, pursuant to which, among other things, (i) Inpixon will undertake a series of internal reorganization
and restructuring transactions to effect the transfer of its (direct or indirect) ownership of the Enterprise Apps Business to CXApp
in the Separation and (ii) immediately prior to the Merger and after the Separation, Inpixon will distribute 100% of the outstanding
shares of CXApp Common Stock to Inpixon&#8217;s stockholders and certain other security holders in the Distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Separation Agreement also sets forth other agreements among Inpixon and CXApp related to the Separation, including provisions concerning
the termination and settlement of intercompany accounts and the obtaining of third-party consents. The Separation Agreement also sets
forth agreements that will govern certain aspects of the relationship between Inpixon and CXApp after the Distribution, including provisions
with respect to release of claims, indemnification, access to financial and other information and access to and provision of records.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 140; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_z4UEP4MIUtKd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_231_zhLTiBxsENVj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_234_z1RXpgCn6BO5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consummation
of the Distribution is subject to a number of conditions, including, among others, (i) the completion of the Reorganization and other
related transactions, (ii) the execution of the ancillary agreements by the parties and (iii) the satisfaction or waiver of all conditions
under the Merger Agreement (other than those conditions that are to be satisfied contemporaneously with the Distribution and/or the Merger,
provided that such conditions are capable of being satisfied at such time).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sponsor
Support Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;25, 2022, in connection with the execution of the Merger Agreement, the Company, Inpixon, CXApp and the Sponsor entered
into the Sponsor Support Agreement, pursuant to which, among other things, the Sponsor agreed to vote any of the Company&#8217;s securities
held by it to approve the Business Combination and the other of the Company&#8217;s stockholder matters required pursuant to the Merger
Agreement, and not to seek redemption of any of the Company&#8217;s securities in connection with the consummation of the Business Combination.
Pursuant to the Sponsor Support Agreement, the Sponsor and the Company also agreed to amend the letter agreement, dated as of December&#160;14,
2020 between the Sponsor and the Company (the &#8220;Insider Letter&#8221;) to amend the Founder Shares Lock-Up Period (as defined in
the Insider Letter) to provide for lock-up of its shares of the Company&#8217;s Class B common stock, par value $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20201214__us-gaap--TransactionTypeAxis__custom--MergerAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zjM90cv4eljd" title="Common stock, par value (in dollars per share)"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-12-14_custom_MergerAgreementMember_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share (&#8220;Company&#8217;s
Class B Common Stock&#8221;) (or Company&#8217;s Class A Common Shares issuable upon conversion thereof) until the earlier of (A) the
<span id="xdx_90A_ecustom--CommonStockLockUpPeriod_dtD_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zjPs1ggtZaWk" title="Lock-up period"><ix:nonNumeric contextRef="From2020-12-012020-12-14_custom_MergerAgreementMember" format="ixt-sec:durday" name="cxai:CommonStockLockUpPeriod">180</ix:nonNumeric></span>th day after the closing of the Merger and (B) (x) the date on which the Company completes a liquidation, merger, stock exchange,
reorganization or other similar transaction following the closing of the Merger or (y) the day that the last reported sale price of the
Company&#8217;s Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any <span id="xdx_90C_ecustom--ThresholdTradingDays_dtD_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zIzaBI3ZCH02" title="Threshold trading days"><ix:nonNumeric contextRef="From2020-12-012020-12-14_custom_MergerAgreementMember" format="ixt-sec:durday" name="cxai:ThresholdTradingDays">20</ix:nonNumeric></span> trading days within any <span id="xdx_906_ecustom--ThresholdConsecutiveTradingDays_dtD_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zVfWYSgOx60b" title="Threshold consecutive trading days"><ix:nonNumeric contextRef="From2020-12-012020-12-14_custom_MergerAgreementMember" format="ixt-sec:durday" name="cxai:ThresholdConsecutiveTradingDays">30</ix:nonNumeric></span>-trading day period following the Closing of the Merger; provided,
that <span id="xdx_908_ecustom--PercentageOfSharesNotBeSubjectToForegoingLockUp_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_pdd" title="Percentage of shares not be subject to foregoing lock-up"><ix:nonFraction name="cxai:PercentageOfSharesNotBeSubjectToForegoingLockUp" contextRef="From2020-12-012020-12-14_custom_MergerAgreementMember_custom_CxappHoldingCorpMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22</ix:nonFraction>%</span> of such shares (subject to adjustment) shall not be subject to foregoing lock-up. Additionally, Sponsor has agreed to exchange
<span id="xdx_900_ecustom--NumberOfSharesExchanged_c20201201__20201214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--TypeOfArrangementAxis__custom--SponsorSupportAgreementMember_pdd" title="Number of shares exchanged"><ix:nonFraction name="cxai:NumberOfSharesExchanged" contextRef="From2020-12-012020-12-14_us-gaap_CommonClassBMember_custom_SponsorSupportAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,150,000</ix:nonFraction></span> shares of the Company&#8217;s Class B Common Stock, equal to such that the number of shares of the Company&#8217;s Common Stock
issued as aggregate merger consideration exceeds (by one share): (i) the aggregate number of shares of the Company&#8217;s Class A Common
Stock held by Sponsor at Closing (after taking into the exchange), plus (ii) the aggregate number of shares of the Company&#8217;s Class
B Common Stock held by certain funds and accounts managed by BlackRock, Inc. (including all Potential Forfeiture Shares (as defined in
the Sponsor Support Agreement)), plus (iii) the aggregate number of shares of the Company&#8217;s Class A Common Stock that have not
properly elected to redeem their shares of the Company&#8217;s Class A Common Stock pursuant to the Company&#8217;s governing documents,
plus (iii) any shares of the Company&#8217;s Common Stock issued as incentives for non-redemption transactions and financing transactions,
in each case, free and clear of all liens; provided, that, in no instance shall the number of shares issued to Sponsor in the exchange
be less than <span id="xdx_901_ecustom--MinimumNumberOfSharesIssuableToSponsor_c20201201__20201214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SponsorSupportAgreementMember_pdd" title="Minimum number of shares issuable to sponsor"><ix:nonFraction name="cxai:MinimumNumberOfSharesIssuableToSponsor" contextRef="From2020-12-012020-12-14_us-gaap_CommonClassAMember_custom_SponsorSupportAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,150,000</ix:nonFraction></span> shares of the Company&#8217;s Class A Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zI2iVJ20rS6h" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8212; <span id="xdx_824_zDKdRnHUFGxg">STOCKHOLDERS&#8217; DEFICIT</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock &#8212;</i></b> The Company is authorized to issue <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_zcQUOsD0Hrp2" title="Preferred shares, shares authorized"><span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231_ze8W0FVGF7mg" title="Preferred shares, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000,000</ix:nonFraction></ix:nonFraction></span></span> shares of preferred stock with a par value of $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_zFZX3IpXUdq3" title="Preferred stock, par value, (per share)"><span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211231_zr7lhwkFBXL6" title="Preferred stock, par value, (per share)"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> per share with
such designations, voting and other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.
At December&#160;31, 2022 and 2021, there were <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zKMsp8u8YjIg" title="Preferred shares, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_do_c20211231_zDNWwjvaOjpj" title="Preferred shares, shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_z760sd5L7v8j" title="Preferred shares, shares outstanding"><span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20211231_zUsZktTTQVDe" title="Preferred shares, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2021-12-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares of preferred stock issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Class
A Common Stock &#8212;</i></b> The Company is authorized to issue <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zbO4RlY8I2l4" title="Common shares, shares authorized (in shares)"><span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zzXogzOYJVll" title="Common shares, shares authorized (in shares)"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span>
shares of Class A common stock with a par value of $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zDtBAcLoSRY2" title="Common shares, par value (in dollars per share)"><span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zwvkxdQ4OJS9" title="Common shares, par value (in dollars per share)"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>
per share. Holders of Class A common stock are entitled to one <span id="xdx_90E_ecustom--CommonStockNumberOfVotesPerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zI45fHn3Mbl3" title="Common shares, votes per share" style="display: none"><ix:nonFraction name="cxai:CommonStockNumberOfVotesPerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">1</ix:nonFraction></span> vote for each share. At December&#160;31, 2022 and 2021, there were
<span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_zBukIontxXpl" title="Common shares, shares issued (in shares)"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_zaFOQeWfH6Wk" title="Common shares, shares outstanding (in shares)"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31_custom_CommonStockSubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_custom_CommonStockSubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">387,551</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_z4a5pWJIC34i" title="Common shares, shares issued (in shares)"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_zsrU0JPNRUu" title="Common shares, shares outstanding (in shares)"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_custom_CommonStockSubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_custom_CommonStockSubjectToRedemptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,600,000</ix:nonFraction></ix:nonFraction></span></span> shares of Class A common stock issued and outstanding which are subject to possible redemption and presented
as temporary equity, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Class
B Common Stock &#8212;</i></b> The Company is authorized to issue <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhsvbxMYlgPd" title="Common shares, shares authorized (in shares)"><span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zySZYhJYIMzj" title="Common shares, shares authorized (in shares)"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,000,000</ix:nonFraction></ix:nonFraction></span></span>
shares of Class B common stock with a par value of $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zBUJQ00hgFSd" title="Common shares, par value (in dollars per share)"><span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z66M5u3oDxZh" title="Common shares, par value (in dollars per share)"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>
per share. Holders of Class B common stock are entitled to one <span id="xdx_90D_ecustom--CommonStockNumberOfVotesPerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zlQmTpI51E0l" title="Common shares, votes per share" style="display: none"><ix:nonFraction name="cxai:CommonStockNumberOfVotesPerShare" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">1</ix:nonFraction></span> vote for each share. At December&#160;31, 2022 and 2021, there were <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zsfPDiDxRCJ2" title="Common shares, shares issued (in shares)"><span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zTeHSgb5LETd" title="Common shares, shares issued (in shares)"><span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zRnlapfUCC5j" title="Common shares, shares outstanding (in shares)"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zBmYF8QAHi9b" title="Common shares, shares outstanding (in shares)"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span>
shares of Class B common stock issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
holders of the Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders
of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of
our stockholders except as otherwise required by law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 141; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_z9wNfvVZFV4i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_23A_z1ZUS31Ym2d3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_237_zlfkPuYG9m83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier
at the option of the holder (except for any Founder Shares held by the Direct Anchor Investors who have agreed not to effect a conversion
with respect to such Founder Shares until the consummation of the initial Business Combination), on a one-for-one basis, subject to adjustment.
In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the
amounts issued in the Initial Public Offering and related to the closing of a Business Combination (including pursuant to a specified
future issuance), the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted
(unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment with respect
to any such issuance or deemed issuance, including pursuant to a specified future issuance) so that the number of shares of Class A common
stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, <span id="xdx_90F_ecustom--ConvertibleStockConversionRatio_c20220101__20221231_pdd" title="Ratio to be applied to the stock in the conversion"><ix:nonFraction name="cxai:ConvertibleStockConversionRatio" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction>%</span> of the
sum of the total number of all shares of common stock outstanding upon the completion of Initial Public Offering plus all shares of Class
A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or
equity-linked securities issued or issuable to any seller in a Business Combination).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"><p id="xdx_80E_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zEDEffAVJVlh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8212; <span id="xdx_827_z11alReubFy2">DERIVATIVE WARRANT LIABILITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2022 and 2021 there were <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_c20221231_pdd" title="Warrants outstanding"><span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_c20211231_pdd" title="Warrants outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,800,000</ix:nonFraction></ix:nonFraction></span></span> Public Warrants outstanding and <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_pdd" title="Warrants outstanding"><span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_pdd" title="Warrants outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,280,000</ix:nonFraction></ix:nonFraction></span></span> Private Placement Warrants Outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and
only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) <span id="xdx_90D_ecustom--WarrantExercisePeriodConditionOne_dtD_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zKY7y4YgAJ4" title="Warrant exercise period condition one"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_PublicWarrantsMember" format="ixt-sec:durday" name="cxai:WarrantExercisePeriodConditionOne">30</ix:nonNumeric></span>
days after the completion of a Business Combination and (b) <span id="xdx_90B_ecustom--WarrantExercisePeriodConditionTwo_dtM_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zwIuyZeE7t51" title="Warrant exercise period condition two"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_PublicWarrantsMember" format="ixt-sec:durmonth" name="cxai:WarrantExercisePeriodConditionTwo">12</ix:nonNumeric></span>
months from the closing of the Initial Public Offering. The Public Warrants will expire five <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zIosOuh7nGEi" title="Public Warrants expiration term" style="display: none"><ix:nonNumeric contextRef="AsOf2022-12-31_custom_PublicWarrantsMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">5</ix:nonNumeric></span> years after the completion of a
Business Combination or earlier upon redemption or liquidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation
to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class
A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying
its obligations with respect to registration. No warrant will be exercisable, and the Company will not be obligated to issue shares of
Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has agreed that as soon as practicable, but in no event later than <span id="xdx_905_ecustom--MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement_dtD_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zpulS8OQokC1" title="Maximum period after business combination in which to file registration statement"><ix:nonNumeric contextRef="From2022-01-012022-12-31_us-gaap_WarrantMember" format="ixt-sec:durday" name="cxai:MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement">20</ix:nonNumeric></span> business days after the closing of a Business Combination,
the Company will use its commercially reasonable efforts to file, and within <span id="xdx_903_ecustom--PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective_dtD_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zV5yGGrWOYg7" title="Period of time within which registration statement is expected to become effective"><ix:nonNumeric contextRef="From2022-01-012022-12-31_us-gaap_WarrantMember" format="ixt-sec:durday" name="cxai:PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective">60</ix:nonNumeric></span> business days following a Business Combination to have
declared effective, a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable
upon exercise of the warrants. The Company will use its commercially reasonable efforts to maintain the effectiveness of such registration
statement and a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. Notwithstanding
the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such
that it satisfies the definition of a &#8220;covered security&#8221; under Section&#160;18(b)(1) of the Securities Act, the Company may,
at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance
with Section&#160;3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or
maintain in effect a registration statement, but we will be required to use our commercially reasonable efforts to register or qualify
the shares under applicable blue sky laws to the extent an exemption is not available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemptions
of warrants when the price of Class A common stock equals or exceeds $<span id="xdx_907_ecustom--WarrantRedemptionConditionMinimumSharePrice_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_pdd" title="Warrant redemption condition minimum share price"><ix:nonFraction name="cxai:WarrantRedemptionConditionMinimumSharePrice" contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.00</ix:nonFraction></span></i> &#8212; Once the warrants become exercisable, the Company
may redeem the Public Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
whole and not in part;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
a price of $<span id="xdx_900_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd" title="Redemption price per public warrant (in dollars per share)"><ix:nonFraction name="cxai:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per warrant;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 142; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zk4Next9Wnjl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_23A_zdAgib1O5tEh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_234_zxpJUgDDx5f8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
not less than 30 days&#8217; prior written notice of redemption, or the <span id="xdx_90F_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zoMnAYyBDLe7" title="Threshold consecutive trading days for redemption of public warrants"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember" format="ixt-sec:durday" name="cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays">30</ix:nonNumeric></span>-day redemption period, to each warrant holder; and</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
and only if, the reported last sale price of the Company&#8217;s Class A common stock equals or exceeds $<span id="xdx_90C_ecustom--WarrantRedemptionConditionMinimumSharePrice_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd" title="Warrant redemption condition minimum share price"><ix:nonFraction name="cxai:WarrantRedemptionConditionMinimumSharePrice" contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.00</ix:nonFraction></span> per share (as adjusted
for stock splits, stock dividends, reorganizations, recapitalizations, and the like) for any <span id="xdx_903_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zVsyX4XcoOqj" title="Threshold trading days for redemption of public warrants"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember" format="ixt-sec:durday" name="cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays">20</ix:nonNumeric></span> trading days within a <span id="xdx_900_ecustom--RedemptionPeriod_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zNBr8S9w5ysk" title="Redemption period"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember" format="ixt-sec:durday" name="cxai:RedemptionPeriod">30</ix:nonNumeric></span>-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
of warrants when the price per share of Class A common stock equals or exceeds $<span id="xdx_903_ecustom--WarrantRedemptionConditionMinimumSharePriceScenarioTwo_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_pdd" title="Warrant redemption condition minimum share price scenario two"><ix:nonFraction name="cxai:WarrantRedemptionConditionMinimumSharePriceScenarioTwo" contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> &#8211;</i> Once the warrants become exercisable,
the Company may redeem the outstanding warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
whole and not in part;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
a price of $<span id="xdx_906_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_pdd" title="Redemption price per public warrant (in dollars per share)"><ix:nonFraction name="cxai:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></span> per warrant provided that holders will be able to exercise their warrants prior to redemption and receive that number
of shares of Class A common stock determined based on the redemption date and the &#8220;fair market value&#8221; of the Company&#8217;s
Class A common stock;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
not less than 30 days&#8217; prior written notice of redemption, or the <span id="xdx_903_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zTOqUocrJej" title="Threshold consecutive trading days for redemption of public warrants"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember" format="ixt-sec:durday" name="cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays">30</ix:nonNumeric></span>-day redemption period;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
and only if, the last reported sale price of the Company&#8217;s Class A common stock equals or exceeds $<span id="xdx_901_ecustom--WarrantRedemptionConditionMinimumSharePriceScenarioTwo_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" title="Warrant redemption condition minimum share price scenario two"><ix:nonFraction name="cxai:WarrantRedemptionConditionMinimumSharePriceScenarioTwo" contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per share (as adjusted
for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the
Company sends the notice of redemption to the warrant holders;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise
of the warrants and a current prospectus relating thereto is available throughout the <span id="xdx_90A_ecustom--RedemptionPeriod_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zXBtww4vpE11" title="Redemption period"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember" format="ixt-sec:durday" name="cxai:RedemptionPeriod">30</ix:nonNumeric></span>-day period after the written notice of redemption
is given.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes
in connection with the closing of a Business Combination at an issue price or effective issue price of less than $<span id="xdx_908_ecustom--SharePricetriggerUsedToMeasureDilutionOfWarrant_c20221231_pdd" title="Share PriceTrigger Used To Measure Dilution Of Warrant"><ix:nonFraction name="cxai:SharePricetriggerUsedToMeasureDilutionOfWarrant" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.20</ix:nonFraction></span> per share of Class
A common stock (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors,
and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor
or its affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from
such issuances represent more than <span id="xdx_901_ecustom--PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant_c20220101__20221231_pdd" title="Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant"><ix:nonFraction name="cxai:PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction>%</span> of the total equity proceeds, and interest thereon, available for the funding of a Business Combination
on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the
Company&#8217;s Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company
completes a Business Combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, the exercise price of the warrants
will be adjusted (to the nearest cent) to be equal to <span id="xdx_901_ecustom--WarrantExercisePriceAdjustmentMultiple_c20220101__20221231_pdd" title="Warrant exercise price adjustment multiple"><ix:nonFraction name="cxai:WarrantExercisePriceAdjustmentMultiple" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">115</ix:nonFraction>%</span> of the higher of the Market Value and the Newly Issued Price, and the $18.00
per share redemption trigger price will be adjusted (to the nearest cent) to be equal to <span id="xdx_903_ecustom--WarrantRedemptionPriceAdjustmentMultiple_c20220101__20221231_pdd" title="Warrant redemption price adjustment multiple"><ix:nonFraction name="cxai:WarrantRedemptionPriceAdjustmentMultiple" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">180</ix:nonFraction>%</span> of the higher of the Market Value and the
Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted will be adjusted (to the nearest cent) to be equal
to the higher of the Market Value and the Newly Issued Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2022 and 2021 there were <span id="xdx_90F_ecustom--NumberOfWarrantsIssued_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zrPvNSsJQb04" title="Number of warrants issued"><span id="xdx_900_ecustom--NumberOfWarrantsIssued_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z0otJ00KClji" title="Number of warrants issued"><ix:nonFraction name="cxai:NumberOfWarrantsIssued" contextRef="From2022-01-012022-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="cxai:NumberOfWarrantsIssued" contextRef="From2021-01-012021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,280,000</ix:nonFraction></ix:nonFraction></span></span> Private Placement Warrants outstanding. The Private Placement Warrants are identical
to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the shares
of Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable
until <span id="xdx_90F_ecustom--RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_dtD_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zrXuMuSdI9ha" title="Restrictions on transfer period of time after business combination completion"><ix:nonNumeric contextRef="From2022-01-012022-12-31_custom_PublicWarrantsMember" format="ixt-sec:durday" name="cxai:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion">30</ix:nonNumeric></span> days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement
Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial
purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or
their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the
same basis as the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 143; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zBQ7xx24DiDe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_23C_zE5dyjRBy7f1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_238_z5lGPhE0DAH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_z1s0BM0UfUQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8212; <span id="xdx_829_zR8i78vii3M4">INCOME TAX</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s net deferred tax assets are as follows as of December&#160;31, 2022 and 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z9RDlEVPdePk" summary="xdx: Disclosure - INCOME TAX (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B0_zft8pkkbm5w8" style="display: none">Schedule of Company's net deferred tax assets</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20221231_zszdqVXesDWf" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20211231_zloN0f9oOWt8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNetOfValuationAllowanceAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_i01I_pp0p0_maDTAGzH2n_zJZsPEnXuOj9" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left">Organizational costs/startup expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="cxai:DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">924,537</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="cxai:DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">322,963</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzH2n_z83CmBuNPOZ2" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Net operating loss carryforward</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1069">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">28,689</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_mtDTAGzH2n_maDTANzcuz_zfIn9amPvV82" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">924,537</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">351,652</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di_msDTANzcuz_zXJTTxY4oi33" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">924,537</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">351,652</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_mtDTANzcuz_zU4RTzO2VSyh" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Deferred tax asset, net of allowance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1078">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1079">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zJAMNsc6dsP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax provision consists of the following for the years ended December&#160;31, 2022 and 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYSYFdTFxEch" summary="xdx: Disclosure - INCOME TAX (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B4_zXy6iR0jPuOb" style="display: none">Schedule of income tax provision</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20220101__20221231_zX2KOWuZTfga" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20210101__20211231_z2x1GBkFAzl" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zNtjJVGYBcp2" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">49,175</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1087">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zjsFhKNWOmr9" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">572,885</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">300,205</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--StateAndLocalAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">State and Local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zPC3k8mPn9t4" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1095">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1096">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zLND9QSxl1V2" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1098">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1099">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_i01N_pp0p0_di_msITEBzXu4_z54jCOYWgLf1" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">572,885</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">300,205</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXu4_zFkYyLe9CNyc" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Income tax provision</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">49,175</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zQsJ1tkCFRn7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2022 and 2021, the Company had U.S. federal net operating loss carryover of approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2022-12-31_us-gaap_DomesticCountryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_c20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2021-12-31_us-gaap_DomesticCountryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">137,000</ix:nonFraction></span> available
to offset future taxable income indefinitely, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all
of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of
future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible.
Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies
in making this assessment. After consideration of all of the information available, management believes that significant uncertainty
exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the
year ended December&#160;31, 2022 and 2021, the change in the valuation allowance was $<span id="xdx_90A_eus-gaap--DeferredTaxAssetsValuationAllowance_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Change in valuation allowance"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-12-31_us-gaap_DomesticCountryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">572,885</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_c20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Change in valuation allowance"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2021-12-31_us-gaap_DomesticCountryMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">300,205</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the federal income tax rate to the Company&#8217;s effective tax rate for the years ended December&#160;31, 2022 and
2021 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zlhQov4oX2Ne" summary="xdx: Disclosure - INCOME TAX (Details 2)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BB_zwCBpaYt83ld" style="display: none">Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Statutory federal income tax rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20221231_zFtLmiIvZ26f" title="Statutory federal income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span>.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231_zCwUfSn3qwO3" title="Statutory federal income tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span>.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">State taxes, net of federal tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20220101__20221231_z79RxeKSIjx" title="State taxes, net of federal tax benefit"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20210101__20211231_zh6TFuXVlok" title="State taxes, net of federal tax benefit"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Transaction costs allocated to derivative warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_dp_c20220101__20221231_zmbK1VPPXoVk" title="Transaction costs allocated to derivative warrant liabilities"><ix:nonFraction name="cxai:EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_dp_c20210101__20211231_zX1y4EtnpWIj" title="Transaction costs allocated to derivative warrant liabilities"><ix:nonFraction name="cxai:EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in fair value of derivative warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_dp_c20220101__20221231_zfZxnyCwqHsa" title="Change in fair value of derivative warrant liabilities">(<ix:nonFraction name="cxai:EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">23.9</ix:nonFraction></span></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_dp_c20210101__20211231_zxi5rbQvqu3c" title="Change in fair value of derivative warrant liabilities">(<ix:nonFraction name="cxai:EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">24.3</ix:nonFraction></span></td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20221231_zNuNGX5EssVe" title="Valuation allowance"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.2</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210101__20211231_z84014VhQuT" title="Valuation allowance"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.3</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Income tax provision</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20221231_znxEB3DdQHq1" title="Income tax provision"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20211231_zskHnT7LV0C" title="Income tax provision"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2021-01-012021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zvM7s5Ue5cNg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files income tax returns in the U.S. federal jurisdiction in various state and local jurisdictions and is subject to examination
by the various taxing authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 144; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zeDWerClYBCf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_230_zmXMpCE4anc7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zLrvWHYXeHia" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_800_eus-gaap--FairValueDisclosuresTextBlock_zax6DXdQOwm" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 &#8212; <span id="xdx_821_znIKLQ02bgH6">FAIR VALUE MEASUREMENTS</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.6in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                              1:</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted
prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.6in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                              2:</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable
inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
and quoted prices for identical assets or liabilities in markets that are not active.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.6in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                              3:</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable
inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 &#8220;Investments
- Debt and Equity Securities.&#8221; Held-to-maturity securities are those securities which the Company has the ability and intent to
hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying consolidated balance sheets
and adjusted for the amortization or accretion of premiums or discounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December&#160;31 2022, assets held in the Trust Account consisted of $<span id="xdx_90E_eus-gaap--AssetsHeldInTrustNoncurrent_c20221231__us-gaap--FinancialInstrumentAxis__us-gaap--CashMember_pp0p0" title="Assets held in the Trust Account"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2022-12-31_us-gaap_CashMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,923,804</ix:nonFraction></span> held in an interest-bearing commercial checking account.
Cash held in commercial checking accounts is reported on the balance sheet at its approximate fair value. During the year ended December&#160;31,
2022, the Company withdrew $<span id="xdx_90C_ecustom--ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax_c20220101__20221231_pp0p0" title="Cash withdrawn from trust account to pay franchise tax"><ix:nonFraction name="cxai:ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">231,500</ix:nonFraction></span> of interest income from the Trust Account for taxes and $<span id="xdx_908_ecustom--ProceedsFromTrustAccountInConnectionWithRedemption_c20220101__20221231_pp0p0" title="Cash withdrawn from trust account in connection with redemption"><ix:nonFraction name="cxai:ProceedsFromTrustAccountInConnectionWithRedemption" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">275,102,280</ix:nonFraction></span> was withdrawn from the Trust
Account in connection with the redemption of Class A common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December&#160;31, 2021, assets held in the Trust Account were comprised of $<span id="xdx_90F_eus-gaap--AssetsHeldInTrustNoncurrent_c20211231__us-gaap--FinancialInstrumentAxis__us-gaap--CashMember_pp0p0" title="Assets held in the Trust Account"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2021-12-31_us-gaap_CashMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">898</ix:nonFraction></span> in cash and $<span id="xdx_905_eus-gaap--AssetsHeldInTrustNoncurrent_c20211231__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember_pp0p0" title="Assets held in the Trust Account"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2021-12-31_us-gaap_MoneyMarketFundsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">278,835,182</ix:nonFraction></span> in money market funds, respectively.
Through December&#160;31, 2021, the Company did not withdraw any interest income from the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets and liabilities that are measured at fair value on a recurring
basis at December&#160;31, 2022 and 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine
such fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z4PIr496IIQ1" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BB_zpXDUooqaxq9" style="display: none">Schedule of company's assets and liabilities that are measured at fair value on a recurring basis</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="5" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="5" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Description</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Assets:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Money Market Funds</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AssetsHeldInTrustNoncurrent_c20221231__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" title="Assets held in the Trust Account" style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsHeldInTrustNoncurrent_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember_pp0p0" title="Assets held in the Trust Account" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MoneyMarketFundsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">278,835,182</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Liabilities:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Warrant liabilities &#8211; public warrants</td><td>&#160;</td>
    <td style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" title="Warrant liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" contextRef="AsOf2022-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">414,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" title="Warrant liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" contextRef="AsOf2021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,461,798</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Warrant liabilities &#8211; private placement warrants</td><td>&#160;</td>
    <td style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" title="Warrant liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">308,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" title="Warrant liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" contextRef="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,813,571</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zN5RHb7MXnc1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the accompanying
December&#160;31, 2022 and 2021 consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a
recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statements
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 145; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zxYrX50VBgYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>
<ix:exclude><p id="xdx_234_zCKaGqgMrr0i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CXAPP INC. (F/K/A KINS
TECHNOLOGY GROUP INC.)<br/>
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS<br/>
DECEMBER 31, 2022<br/>
AS RESTATED</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zinSl0ntjVHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants are measured at fair value on a recurring basis. The Public Warrants were initially valued using a lattice model, specifically
a binomial lattice model incorporating the binomial lattice methodology. As of December&#160;31, 2022, the Public Warrants were valued
using the instrument&#8217;s publicly listed trading price as of the balance sheet date, which is considered to be a Level 1 measurement
due to the use of an observable market quote in an active market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placement Warrants were initially valued using a lattice model, specifically a binomial lattice model incorporating the binomial
lattice methodology, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized in determining
the fair value of the Private Placement Warrants is the expected volatility of our common stock. The expected volatility as of the Initial
Public Offering date was derived from observable public warrant pricing on comparable &#8216;blank-check&#8217; companies without an
identified target. The subsequent measurements of the Private Placement Warrants after the detachment of the Public Warrants from the
Units is classified as Level 2 due to the use of an observable market quote for a similar asset in an active market, as the transfer
of Private Placement Warrants to anyone outside of a small group of individuals who are permitted transferees would result in the Private
Placement Warrants having substantially the same terms as the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the changes in the fair value of Level 3 warrant liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zwu4cfXkCZrf" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BA_zraT7XkGrG62" style="display: none">Schedule of change in the fair value of the Level 3 warrant liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Private Placement</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Public</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrant Liabilities</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Fair value as of December&#160;31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zQBCMnSg4Ycb" title="Fair value at beginning" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,354,800</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z4cUM70bNR1l" title="Fair value at beginning" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,558,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zj7rzQFsIys" title="Fair value at beginning" style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,912,800</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" title="Change in fair value" style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2021-01-012021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,672,800</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" title="Change in fair value" style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2021-01-012021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,588,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" title="Change in fair value" style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,260,800</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Transfer to Level 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" title="Transfer to Level 1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" title="Transfer to Level 1" style="text-align: right">(<ix:nonFraction name="cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" contextRef="From2021-01-012021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">8,970,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" title="Transfer to Level 1" style="text-align: right">(<ix:nonFraction name="cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">8,970,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Transfer to Level 2</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" title="Transfer to Level 2" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" contextRef="From2021-01-012021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,682,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" title="Transfer to Level 2" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" title="Transfer to Level 2" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,682,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Fair value as of December&#160;31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zsqdPXH9bslk" title="Fair value at ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1199">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zCwVI7FgBuw8" title="Fair value at ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zj0KR7eFqBq7" title="Fair value at ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1203">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_zVCpjJuSrMIc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfers
to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs.
The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement during the
period ended December&#160;31, 2021 was approximately $<span id="xdx_903_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_pp0n3_dm_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zMkJ0VYPeTu2" title="Transfer to Level 1"><ix:nonFraction name="cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" contextRef="From2022-01-012022-12-31_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">9.0</ix:nonFraction></span> million, when the Public Warrants were separately listed and traded and the
estimated fair value of the Private Warrants of approximately $<span id="xdx_902_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_pp0n3_dm_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zy42tSojGoCl" title="Transfer to Level 2"><ix:nonFraction name="cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" contextRef="From2022-01-012022-12-31_us-gaap_FairValueInputsLevel3Member" format="ixt:numdotdecimal" decimals="0" scale="6" unitRef="USD">6.7</ix:nonFraction></span> million was transferred from a Level 3 to a Level 2 fair value measurement.
There were no transfers during the year ended December&#160;31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-01-012022-12-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zSNjuNmfq1l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12 &#8212; <span id="xdx_826_zFPmDdvQPfp9">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated
financial statements were issued. Based upon this review, other than as noted below, the Company did not identify any subsequent events
that would have required adjustment or disclosure in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January&#160;9, 2023, the Company received a notice from the Listing Qualifications Department of The Nasdaq Stock Market (&#8220;Nasdaq&#8221;)
stating that the Company failed to hold an annual meeting of stockholders within 12 months after its fiscal year ended December&#160;31,
2021, as required by Nasdaq Listing Rule&#160;5620(a). In accordance with Nasdaq Listing Rule&#160;5810(c)(2)(G), the Company had 45
calendar days (or until February&#160;23, 2023) to submit a plan to regain compliance and, if Nasdaq accepts the plan, Nasdaq may grant
the Company up to 180 calendar days from its fiscal year end, or until June&#160;29, 2023, to regain compliance. The Company submitted
a compliance plan within the specified period. While the plan is pending, the Company&#8217;s securities will continue to trade on Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January&#160;21, 2023, the Company received a written notice (the &#8220;Notice&#8221;) from the Listing Qualifications Department of
The Nasdaq Stock Market (&#8220;Nasdaq&#8221;) indicating that the Company is not in compliance with Listing Rule&#160;5550(a)(4), due
to the Company&#8217;s failure to meet the minimum 500,000 publicly held shares requirement for continued listing on the Nasdaq Capital
Market. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading
of the Company&#8217;s securities on the Nasdaq Capital Market. The Notice stated that the Company had until March&#160;9, 2023 to submit
a plan to regain compliance with Listing Rule&#160;5550(a)(4). The Company believes that the issue identified in the Notice will be resolved
upon completion of the previously announced proposed business combination with CXApp Holding Corp. The Company submitted a compliance
plan within the specified period. If Nasdaq accepts the Company&#8217;s plan, Nasdaq may grant the Company an extension of up to 180
calendar days from the date of the Notice to evidence compliance with Listing Rule&#160;5550(a)(4). If Nasdaq does not accept the Company&#8217;s
plan, the Company will have the opportunity to appeal the decision in front of a Nasdaq Hearings Panel.</span></p>

</ix:nonNumeric><p id="xdx_81C_zgA59BXV7n0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 146; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="c_003"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CXAPP
INC. AND SUBSIDIARIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
thousands, except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_111_pn3n3_zF1KwNla11ih" summary="xdx: Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; padding-left: 0.125in; font-weight: bold; text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zDJSOe10JJp1" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_490_20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zM5F1Dkhy8j5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>December&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td colspan="2" style="text-align: center"><span>(unaudited)</span></td><td style="border-right: Black 1.5pt solid"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td colspan="2" style="text-align: center"><span>&#160;</span></td><td><span>&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsAbstract_iB_zRGxxwPVZN6b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 0.125in; font-weight: bold; text-align: center"><span>Assets</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; padding-left: 0.125in; font-weight: bold; text-align: center"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--AssetsCurrentAbstract_i01B_z2BfStK4ndyk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Current
    Assets</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maCzcSC_zLh4rhAYSYlf" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"><span>Cash
    and cash equivalents</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,724</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,308</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--AccountsReceivableNetCurrent_i02I_maCzcSC_zQ7jOhytnYTg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Accounts
    receivable</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,671</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,338</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OtherReceivablesNetCurrent_i02I_maCzcSC_zsx5bHEwgrz8" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Notes
    and other receivables</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">273</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--PrepaidExpenseAndOtherAssets_i02I_maCzcSC_zg2kJsQfqnxi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Prepaid
    expenses and other current assets</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssets" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,232</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssets" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--AssetsCurrent_i01TI_mtCzcSC_maCztZO_z9hNuxNe4kW8" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left"><span>Total
    current assets</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,729</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,569</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCztZO_zveauFcdtsMh" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Property
    and equipment, net</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">153</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">202</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maCztZO_zZPtiInV2Pq3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Intangible
    assets, net</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,753</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,289</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maCztZO_zXJemwR0kC35" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Operating
    lease right-of-use asset, net</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">549</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">681</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--CapitalizedComputerSoftwareNet_i01I_maCztZO_zF6PukIRjt64" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Software
    development costs, net</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1241">-</span></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareNet" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">487</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--Goodwill_i01I_d0_maCztZO_zFqnpdZnnEG3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Goodwill</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,122</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherAssetsNoncurrent_i01I_maCztZO_zRs12BUmoZ41" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Other
    assets</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">78</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--Assets_iTI_mtCztZO_znW2XQiVNvAb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    Assets</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,384</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,280</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zhQIpkGGKK9k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; padding-left: 0.125in; font-weight: bold; text-align: center"><span>Liabilities
    and Stockholders&#8217; Equity</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesCurrentAbstract_i01B_zjyUCcNpCja2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Current
    Liabilities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--AccountsPayableCurrent_i02I_maCz8gP_zDzjvyPGnec1" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Accounts
    payable</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">596</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,054</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--AccruedLiabilitiesCurrent_i02I_maCz8gP_zdDYpQ6mj17d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Accrued
    liabilities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,233</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,736</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--DeferredRevenueCurrent_i02I_maCz8gP_zveVodq4mDs7" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Deferred
    revenue</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,690</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,162</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--AcquisitionLiability_i02I_maCz8gP_zbOaRjRD97Q8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Acquisition
    liability</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1268">-</span></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:AcquisitionLiability" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">197</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--ExtendedProductWarrantyAccrualCurrent_i02I_maCz8gP_zQlfI2l0Diuk" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Warrant
    liability</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:ExtendedProductWarrantyAccrualCurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">963</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1272">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maCz8gP_zfB4npCg5kI8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Operating
    lease obligation, current</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">195</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">266</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesCurrent_i02TI_mtCz8gP_maCzSr9_zwXVBe1BrDZb" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.375in; text-align: left"><span>Total
    current liabilities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,677</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,415</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityNoncurrent_i02I_maCzSr9_zmDR3FtbdcZe" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Operating
    lease obligation, noncurrent</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">376</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">444</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OtherLiabilitiesNoncurrent_i02I_maCzSr9_zsUb0odqOSre" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Other
    liabilities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1283">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredIncomeTaxLiabilitiesNet_i02I_maCzSr9_zSnCxHUjqr27" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Deferred
    tax liability</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,778</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1287">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--Liabilities_i02TI_mtCzSr9_maCzgf3_zigEmuFnS7d1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Total
    Liabilities</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,831</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,889</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--CommitmentsAndContingencies_i01I_zg913WOVSp9j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Commitments
    and Contingencies</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--StockholdersEquityAbstract_iB_z56kc81NPla" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Stockholders&#8217;
    Equity</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Class
    A Common Stock, $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction>
    </span></span><span>par value; <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000,000</ix:nonFraction>
    </span>shares authorized, <span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,582,699</ix:nonFraction>
    </span>shares issued and outstanding as of March 31, 2023</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_98F_eus-gaap--CommonStockValue_i01I_pn3n3_maCzk5o_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z3dVEJoBD8lk" title="Common Stock value" style="text-align: right"><span><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_980_eus-gaap--CommonStockValue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pn3n3" title="Common Stock value" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1303">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Class
    C Common Stock, $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction>
    </span></span><span>par value; <span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction>
    </span>shares authorized, <span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,487,300</ix:nonFraction>
    </span>shares issued and outstanding as of March 31, 2023</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_98E_eus-gaap--CommonStockValue_i01I_pn3n3_maCzk5o_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3vAjwNoXaT5" title="Common Stock value" style="text-align: right"><span><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_98F_eus-gaap--CommonStockValue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" title="Common Stock value" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1310">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AdditionalPaidInCapital_i01I_maCzk5o_zHRer2mpOLR5" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Additional
    paid-in capital</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">71,536</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1313">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_maCzk5o_zJUcR5mgadGi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Accumulated
    deficit</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,985</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1316">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i01I_maCzk5o_z1A9bQanB6if" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Accumulated
    other comprehensive income</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1318">-</span></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,155</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--NetParentInvestment_i01I_maCzk5o_zECZSKOGf0L5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Net
    parent investment</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1321">-</span></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="cxai:NetParentInvestment" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,236</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--StockholdersEquity_i01TI_mtCzk5o_maCzgf3_z0pipqvZtJWi" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1pt"><span>Total
    Stockholders&#8217; Equity</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">65,553</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>$</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,391</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtCzgf3_zJThxN9lQr32" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    Liabilities and Stockholders&#8217; Equity</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,384</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,280</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements.</span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



<!-- Field: Page; Sequence: 147; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"> <span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="c_004"></span>CXAPP INC. AND
SUBSIDIARIES</b></span></span></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</b></span></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
thousands, except share and per share data)</b></span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" id="xdx_304_113_pn3n3_zoL4WlaoJLMf" summary="xdx: Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_ze4EWS0cuCIg" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zI5c4LyXNDF7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zqUfrYBKXmWa" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    January&#160;1,<br/>
    2023 to March&#160;14,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Three
    months ended<br/>
    March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--Revenues_maCzVb8_zzw3hLnuYxdb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; font-weight: bold; text-align: left"><span>Revenues</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">342</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,620</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,582</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--CostOfRevenue_msCzVb8_z5993ZSrOvF4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Cost
    of Revenues</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">483</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">589</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--GrossProfit_iT_mtCzVb8_maCzqVX_zhu4haXkuel1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Gross
    Profit</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">255</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,137</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,993</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingExpensesAbstract_iB_ziyJ6RZs5pId" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Operating
    Expenses</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--ResearchAndDevelopmentExpense_i01_maCz86m_zbYiwE2EscKi" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Research
    and development</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">211</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,455</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,991</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--SellingAndMarketingExpense_i01_maCz86m_zSCUgKW6oCn1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Sales
    and marketing</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">174</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">964</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,122</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--GeneralAndAdministrativeExpense_i01_maCz86m_zkFeNiYsoqnf" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>General
    and administrative</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">241</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"/><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,293</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,304</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AmortizationOfIntangibleAssets_i01_maCz86m_zjNqjfwHCYHd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Amortization
    of intangible assets</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">116</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">806</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">975</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--ChangeInFairValueOfEarnout_i01N_di_msCz86m_zPlCT1vbEwD" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Change
    in fair value of earnout</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1362">-</span></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1363">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="cxai:ChangeInFairValueOfEarnout" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,827</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr id="xdx_406_eus-gaap--OperatingExpenses_i01T_mtCz86m_msCzqVX_zQuZHt9yvef7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Total
    Operating Expenses</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">742</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"/><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,518</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,565</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OperatingIncomeLoss_i01T_mtCzqVX_maCzo0E_z7P7UnPDTP9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Loss
    from Operations</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">487</ix:nonFraction>)</span></td><td style="border-right: Black 1.5pt solid; text-align: left"/><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,381</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,572</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zGiV7JLWGnA9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Other
    Income (Expense)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--InterestIncomeExpenseNet_i01_maCzsCi_zqjezRX8P8l8" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Interest
    income (expense), net</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:InterestIncomeExpenseNet" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:InterestIncomeExpenseNet" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:InterestIncomeExpenseNet" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--GainLossOnSaleOfDerivatives_i01_maCzsCi_zoynLdSzvjJ4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Change
    in fair value of derivative liability</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,686</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1383">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1384">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--NonoperatingIncomeExpense_i01T_mtCzsCi_maCzo0E_zoZpkM5xT6Lb" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Total
    Other Income (Expense)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,685</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_i01T_mtCzo0E_maCznrM_zC7FVlNOBote" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Net
    Income (Loss), before tax</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,198</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,380</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,571</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxExpenseBenefit_i01N_di0_msCznrM_zYfJSB8v5hz9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Income
    tax benefit/(provision)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,560</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">-</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_i01T_mtCznrM_maCzNRA_zlTM4x0NhULk" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Net
    Income (Loss)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,758</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,380</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,671</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_404_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_i01N_di_msCzNRA_zLWxQVCSraQg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Unrealized
    foreign exchange loss from cumulative translation adjustments</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1402">-</span></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">189</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--ComprehensiveIncomeNetOfTax_i01T_mtCzNRA_zriGgUdWb4I1" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Comprehensive
    Income (Loss)</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,758</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"/><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,408</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>)</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,860</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock_i01_pid_znMIc0Cwdng7" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span>Basic
    and dilutive weighted average shares outstanding, Class A common stock</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="cxai:BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,582,699</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--BasicAndDilutiveNetIncomePerShareClassCommonStock_i01_pid_zMUeSnAXJnol" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Basic
    and dilutive net income per share, Class A common stock</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="cxai:BasicAndDilutiveNetIncomePerShareClassCommonStock" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.20</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span>&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span>&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock_i01_pid_zGREgKGzcwr6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span>Basic
    and dilutive weighted average shares outstanding, Class C common stock</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="cxai:BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,487,300</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--BasicAndDilutiveNetIncomePerShareClassCCommonStock_i01_pid_zkYeId8V5ZJ9" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Basic
    and dilutive net income per share, Class C common stock</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="cxai:BasicAndDilutiveNetIncomePerShareClassCCommonStock" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.20</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span>&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: right"><span>&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 148; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="c_005"></span>CXAPP
INC. AND SUBSIDIARIES</b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
thousands, except share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_114_pn3n3_zHCeikTpGJYd" summary="xdx: Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_custom--NetParentInvestmentMember_srt--StatementScenarioAxis_custom--PredecessorMember_zhB1u23oIRil" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_srt--StatementScenarioAxis_custom--PredecessorMember_zPkwxVTWOjU" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BA_srt--StatementScenarioAxis_custom--PredecessorMember_us-gaap--StatementEquityComponentsAxis_custom--TotalMember_zYCJyzHlVfX7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Net
    parent<br/>
    investment</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Accumulated<br/>
    other<br/>
    comprehensive<br/> income (loss)</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Total<br/>
    Stockholders&#8217;<br/>
    Equity</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr id="xdx_437_c20220101__20220331_eus-gaap--StockholdersEquity_iS_zxVvjxDfMz5h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; font-weight: bold; text-align: left"><span>Balance
    at January 1, 2022</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_NetParentInvestmentMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,155</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">56</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_PredecessorMember_custom_TotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,211</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zmnMzcuuujn2" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Net
    loss</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,671</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1431">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_TotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,671</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ShareBasedCompensation_zqyTffXNm4D4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Stock-based
    compensation allocated from parent</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">647</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1435">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_TotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">647</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--ParentsCommonSharesIssuedForCxappEarnout_zCY0ULc08IKi" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Parent&#8217;s
    common shares issued for CXApp earnout</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:ParentsCommonSharesIssuedForCxappEarnout" contextRef="From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,697</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1439">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:ParentsCommonSharesIssuedForCxappEarnout" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_TotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,697</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits_zbtv2Q9JyRqd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Taxes
    paid related to net share settlement of restricted stock units</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="cxai:TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits" contextRef="From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">104</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1443">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="cxai:TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_TotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">104</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_407_ecustom--NetInvestmentsFromParent_zL5MXsVimjyi" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Net
    investments from parent</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:NetInvestmentsFromParent" contextRef="From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,444</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1447">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:NetInvestmentsFromParent" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_TotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,444</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--CumulativeTranslationAdjustment_zbEyJMPNfZVk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Cumulative
    translation adjustment</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1450">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"/><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="cxai:CumulativeTranslationAdjustment" contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">189</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="cxai:CumulativeTranslationAdjustment" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_TotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">189</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr id="xdx_437_c20220101__20220331_eus-gaap--StockholdersEquity_iE_zw1HvUQM50Sg" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Balance
    at March 31, 2022</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,168</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">133</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>)</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_custom_PredecessorMember_custom_TotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,035</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_439_c20230101__20230314_eus-gaap--StockholdersEquity_iS_zQ2uQe3STmM9" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Balance
    at January 1, 2023</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_NetParentInvestmentMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,236</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,155</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_TotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,391</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zqZ4J6jmZu3d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Net
    loss</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-14_custom_NetParentInvestmentMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,380</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1463">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_TotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,380</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ShareBasedCompensation_zQHEdL3pjB62" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Stock-based
    compensation allocated from parent</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-03-14_custom_NetParentInvestmentMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">158</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1467">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_TotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">158</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--NetInvestmentsFromParent_zETKIByu7To8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Net
    investments from parent</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:NetInvestmentsFromParent" contextRef="From2023-01-012023-03-14_custom_NetParentInvestmentMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,680</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1471">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:NetInvestmentsFromParent" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_TotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,680</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--CumulativeTranslationAdjustment_zg2m0LnyHWUl" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Cumulative
    translation adjustment</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1474">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"/><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="cxai:CumulativeTranslationAdjustment" contextRef="From2023-01-012023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">28</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="cxai:CumulativeTranslationAdjustment" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_TotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">28</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr id="xdx_43C_c20230101__20230314_eus-gaap--StockholdersEquity_iE_zSS2i3fROxC8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Balance
    at March 14, 2023</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-14_custom_NetParentInvestmentMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,694</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,127</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-14_custom_PredecessorMember_custom_TotalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">27,821</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_custom--ClassACommonStockMember_srt--StatementScenarioAxis_custom--SuccessorMember_ztZIIL79S5b4" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_custom--ClassCCommonStockMember_srt--StatementScenarioAxis_custom--SuccessorMember_zeRHbdkLfU7d" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_srt--StatementScenarioAxis_custom--SuccessorMember_zThYBnfKcnf3" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_srt--StatementScenarioAxis_custom--SuccessorMember_zH0SDG8pCTo5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_srt--StatementScenarioAxis_custom--SuccessorMember_zN9yDhS6Q4C5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_custom--TotalMember_srt--StatementScenarioAxis_custom--SuccessorMember_zrna8ImxNpeh" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="33" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Successor</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Class
    A<br/>
    Common Stock</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Class
    C<br/>
    Common Stock</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Additional<br/>
    paid-in</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Accumulated</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Accumulated<br/>
    other<br/>
    comprehensive</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total
    Stockholders&#8217;<br/>
    Equity</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Shares</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Amount</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Shares</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Amount</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>capital</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Deficit</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>income</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(Deficit)</b></span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></td></tr>
  <tr id="xdx_438_c20230315__20230331_eus-gaap--StockholdersEquity_iS_zOG4P1yobytf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 36%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance
    at March 15, 2023</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20230315__20230331__us-gaap--StatementEquityComponentsAxis__custom--ClassACommonStockMember__srt--StatementScenarioAxis__custom--SuccessorMember_zhRA71CLfkrd" style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-14_custom_ClassACommonStockMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,034,999</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-14_custom_ClassACommonStockMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_c20230315__20230331__us-gaap--StatementEquityComponentsAxis__custom--ClassCCommonStockMember__srt--StatementScenarioAxis__custom--SuccessorMember_zOt6X5TYLqTe" style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1489">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1483">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-14_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,607</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-14_us-gaap_RetainedEarningsMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,743</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1486">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-14_custom_TotalMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,135</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td></tr>
  <tr id="xdx_402_ecustom--SharesIssuedInConnectionWithBusinessCombination_zLGJWiRNQqP9" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Shares
    issued in connection with Business Combination</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td id="xdx_98D_ecustom--SharesIssuedInConnectionWithBusinessCombinationShares_pid_c20230315__20230331__us-gaap--StatementEquityComponentsAxis__custom--ClassACommonStockMember__srt--StatementScenarioAxis__custom--SuccessorMember_zbB04afmx489" title="Shares issued in connection with Business Combination, shares" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="cxai:SharesIssuedInConnectionWithBusinessCombinationShares" contextRef="From2023-03-152023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,547,700</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1491">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td id="xdx_98B_ecustom--SharesIssuedInConnectionWithBusinessCombinationShares_pid_c20230315__20230331__us-gaap--StatementEquityComponentsAxis__custom--ClassCCommonStockMember__srt--StatementScenarioAxis__custom--SuccessorMember_zBHvM8DUFYTf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="cxai:SharesIssuedInConnectionWithBusinessCombinationShares" contextRef="From2023-03-152023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,487,300</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="cxai:SharesIssuedInConnectionWithBusinessCombination" contextRef="From2023-03-152023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="cxai:SharesIssuedInConnectionWithBusinessCombination" contextRef="From2023-03-152023-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69,927</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1494">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1495">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="cxai:SharesIssuedInConnectionWithBusinessCombination" contextRef="From2023-03-152023-03-31_custom_TotalMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69,928</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zMV1RTK6re59" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Net
    income</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1501">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1502">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1503">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_us-gaap_RetainedEarningsMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,758</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1505">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_custom_TotalMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,758</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--ShareBasedCompensation_zwZUpkr3rhxa" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Stock-based
    compensation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1508">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1509">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-152023-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1511">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1512">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-152023-03-31_custom_TotalMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr>
  <tr id="xdx_437_c20230315__20230331_eus-gaap--StockholdersEquity_iE_z2LBv9cfpua" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance
    at March 31, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20230315__20230331__us-gaap--StatementEquityComponentsAxis__custom--ClassACommonStockMember__srt--StatementScenarioAxis__custom--SuccessorMember_zY3Y19CMOA67" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,582,699</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20230315__20230331__us-gaap--StatementEquityComponentsAxis__custom--ClassCCommonStockMember__srt--StatementScenarioAxis__custom--SuccessorMember_zhXGZf0IOxRe" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,487,300</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></p></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">71,536</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,985</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1519">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_custom_TotalMember_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">65,553</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td></tr>
  </table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements.</span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



<!-- Field: Page; Sequence: 149; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="c_006"></span>CXAPP INC. AND
SUBSIDIARIES</b></span></span></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</b></span></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in
thousands)</b></span></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" id="xdx_30B_112_pn3n3_zB91oZ3PjBPi" summary="xdx: Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_ze2Qli1jgc39" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_494_20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zNSOh2TOoM21" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zsXwYdd9pCOb" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    January&#160;1,<br/>
    2023 to March&#160;14,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Three
    months ended<br/>
    March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zvMESSw0js06" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Operating
    activities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLoss_i01_maCzkDj_zTFai8u6ZL48" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"><span>Net
    income (loss)</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,758</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,380</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>)</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,671</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>)</span></td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Adjustments
    to reconcile net income (loss)&#160;to net cash used in operating activities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--DepreciationDepletionAndAmortization_i02_maCzkDj_zzlmDL5zoBof" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Depreciation
    and amortization</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">145</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AmortizationOfIntangibleAssets_i02_maCzkDj_zc9hYBHUBE5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Amortization
    of intangible assets</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">116</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">806</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">975</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--FinanceLeaseRightOfUseAssetAmortization_i02_maCzkDj_zaYEmieGE35d" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Amortization
    of right of use asset</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">56</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DeferredIncomeTaxExpenseBenefit_i02_maCzkDj_zrStilIKUYM2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Deferred
    income taxes</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,560</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1550">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_404_eus-gaap--ShareBasedCompensation_i02_maCzkDj_zIoGxY11iXK4" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Stock-based
    compensation expense</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">158</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">647</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--GainOnEarnoutPaymentLiability_i02N_di_msCzkDj_zvuoL0ShjuKb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Gain
    on earnout payment liability</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1557">-</span></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1558">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="cxai:GainOnEarnoutPaymentLiability" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,827</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_409_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_i02N_di_msCzkDj_znDPhDKDVD3h" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>(Gain)
    loss on foreign currency transactions</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">266</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_407_ecustom--GainOnChangeInFairValueOfDerivativeLiability_i02N_di_msCzkDj_z3Ye04JplB6l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Gain
    on change in fair value of derivative liability</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="cxai:GainOnChangeInFairValueOfDerivativeLiability" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,686</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1566">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1567">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_zFEFYakFFUdl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Change
    in assets and liabilities:</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsAndOtherReceivables_i02N_di_msCzkDj_zwcBOTQYviak" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Accounts
    receivable and other receivables</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">335</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">857</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">304</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i02N_di_msCzkDj_zQVSYAvxYVh3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Prepaid
    expenses and other current assets</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">521</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInOtherOperatingAssets_i02N_di_msCzkDj_zptwif1s2Mu9" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Other
    assets</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1582">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">42</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayable_i02_maCzkDj_z8OensWSh9Vk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Accounts
    payable</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">135</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">796</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">94</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i02_maCzkDj_ztXPL785OrBf" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Accrued
    liabilities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,888</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">787</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInIncomeTaxes_i02_maCzkDj_zHZ1a2yTAGp5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Income
    tax liabilities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1593">-</span></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1594">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:IncreaseDecreaseInIncomeTaxes" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i02_maCzkDj_zlsEKHWdBdmb" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Operating
    lease liabilities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">56</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInDeferredRevenue_i02_maCzkDj_z1sNuDACylbc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Deferred
    revenue</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">156</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">534</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">370</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzkDj_maCzvbh_z5tXdlSZfng3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Net
    cash used in operating activities</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,431</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,144</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,140</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zBe1NDQxrsZ2" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Investing
    activities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCzFRp_zHtfq3U5GSZe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Purchases
    of property and equipment</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_40A_ecustom--InvestmentInCapitalizedSoftware_i01N_di_msCzFRp_zMYetRkro1qh" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Investment
    in capitalized software</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1617">-</span></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="cxai:InvestmentInCapitalizedSoftware" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="cxai:InvestmentInCapitalizedSoftware" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_401_eus-gaap--CashAcquiredFromAcquisition_i01_maCzFRp_zgKE1Da8RpD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Cash
    acquired in connection with Business Combination</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,003</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1622">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1623">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCzFRp_maCzvbh_zsqF6Z61Pihc" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Net
    cash provided by (used in) investing activities</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,980</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">54</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">51</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_i01B_zrHh6M02Xhg3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Financing
    activities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--NetEquityInvestmentFromParent_i02_maCzyhB_zR4AATToeqfe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Net
    equity investment from parent</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1633">-</span></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:NetEquityInvestmentFromParent" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,089</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:NetEquityInvestmentFromParent" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,444</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--TaxesPaidRelatedForStockBasedCompensation_i01N_di_msCzyhB_zasPCY1Y6Rmf" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Taxes
    paid related to stock based compensation</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1637">-</span></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1638">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="cxai:TaxesPaidRelatedForStockBasedCompensation" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">104</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_408_ecustom--RepaymentOfCxappAcquisitionLiability_i01N_di_msCzyhB_zVIL4DXdlrza" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span>Repayment
    of CXApp acquisition liability</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1641">-</span></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="cxai:RepaymentOfCxappAcquisitionLiability" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">197</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>(<ix:nonFraction name="cxai:RepaymentOfCxappAcquisitionLiability" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,787</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr id="xdx_407_eus-gaap--RepaymentsOfNotesPayable_i01N_di_msCzyhB_zudSehRzTdPd" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span>Repayment
    of related party promissory note</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">328</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1646">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1647">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzyhB_maCzvbh_zxkPXL3mzX36" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Net
    cash (used in) provided by financing activities</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">328</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,892</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,553</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01_maCzvbh_z0mlRdzOzMid" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Effect
    of exchange rate changes on cash and cash equivalents</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1653">-</span></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_i01T_mtCzvbh_zrjK93VWQCX2" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    increase in cash and cash equivalents</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,221</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,695</ix:nonFraction></span></td><td style="text-align: left"/><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">366</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01S_zoyOOchglw4a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Cash
    and cash equivalents, beginning of period</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-03-14_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,503</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,308</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,028</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01E_zYFFLJP9Ozna" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span>Cash
    and cash equivalents, end of period</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,724</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,003</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,394</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>

<tr id="xdx_401_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zCsCKmPa73l5" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Supplemental
    disclosures of cash flow information</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncomeTaxesPaid_i01_zwQN7LX52xYj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"><span>Cash
    paid for taxes</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1673">-</span></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1674">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1675">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--InterestPaid_i01_zCRuoMoFpE2a" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"><span>Cash
    paid for interest</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1677">-</span></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1678">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1679">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract_iB_zWCnONglFlKh" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Supplemental
    schedule of noncash investing and financing activities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--ParentsNetEquityIssuedForCxAppEarnout_i01_pn3n3_zsPVoBDBmARf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"><span>Parent&#8217;s
    net equity issued for CX App earnout</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1685">-</span></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1686">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="cxai:ParentsNetEquityIssuedForCxAppEarnout" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,697</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--NoncashDistribution_i01_zTtiUQSUMVj" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"><span>Noncash
    distribution</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1689">-</span></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="cxai:NoncashDistribution" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">409</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1691">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination_i01_z0bJWY45csrj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"><span>Class
    A Common Stock and Class C Common Stock issued in connection with Business Combination</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="cxai:ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69,928</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1694">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1695">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--FinancingOfDirectorAndOfficerInsurance_i01_z2IDLLTIGhxc" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"><span>Financing
    of Director and Officer Insurance (see Note 9)</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="cxai:FinancingOfDirectorAndOfficerInsurance" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">537</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1698">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1699">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>



<!-- Field: Page; Sequence: 150; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span><b><span id="c_007"></span>CXAPP INC. AND SUBSIDIARIES<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p id="xdx_046_c20230101__20230331_zP6dLDA9ReG8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p id="xdx_80C_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zkCn7rVV06pa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            1 &#8211; <span id="xdx_823_zpQ1i1tyFSV9">Organization, Nature of Business and Basis of Presentation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>CXApp
Inc. and its subsidiaries (&#8220;CXApp&#8221; or the &#8220;Company&#8221;) is in the business of delivering intelligent enterprise
workplace experiences. <span style="background-color: white">The CXApp SaaS platform offers a suite of leading-edge technology workplace
experience solutions including an enterprise employee application, indoor mapping, on-device positioning, augmented reality technologies
and an AI-based analytics platform, targeting the emerging hybrid workplace market to provide enhanced experiences across people, places,
and things. CXApp creates a connected workplace by reducing app overload, data fragmentation, and complex workflows and streamlines all
capabilities through The Workplace SuperApp. All features, services and integrations are housed in one easy-to-access platform allowing
businesses to deliver a more holistic employee experiences in a hybrid workplace.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The accompanying
unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting
principles in the United States of America (&#8220;GAAP&#8221;), for interim financial information and the rules and regulations of the
Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly, CXApp does not include all of the information and footnotes required
by GAAP for complete financial statements. In the opinion of CXApp, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Interim results for the three months ended March 31, 2023 are not necessarily indicative
of the results for the full year ending December 31, 2023. These interim unaudited condensed consolidated financial statement should
be read in conjunction with KINS Technology Group Inc.&#8217;s (&#8220;KINS&#8221;) audited consolidated financial statements and notes
for the year ended December 31, 2022 and 2021 included in the annual report on Form 10-K/A for the year ended December 31, 2022, filed
with the SEC on April 19, 2023, and the annual report of Legacy CXApp for the year ended December 31, 2022 and 2021 included as an exhibit
to Form 8-K filed with the SEC on March 20, 2023. All material inter-company balances and transactions have been eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>On September
25, 2022, an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), was entered into by and among Inpixon, KINS Technology
Group Inc., a Delaware corporation, CXApp, and KINS Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of KINS (&#8220;Merger
Sub&#8221;), pursuant to which KINS acquired Inpixon&#8217;s enterprise apps business (including its workplace experience technologies,
indoor mapping, events platform, augmented reality and related business solutions) (&#8220;Legacy CXApp&#8221;) in exchange for the issuance
of shares of KINS capital stock (the &#8220;Business Combination&#8221;). As a result of the Business Combination, KINS changed their
name to CXApp Inc. (&#8220;New CXApp&#8221;). The shares are now trading on the Nasdaq using the ticker CXAI. The transaction closed
on March 14, 2023. See Note 3 for more details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>Unless
the context otherwise requires, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;CXApp&#8221; and the &#8220;Company&#8221;
refer to CXApp Inc., a Delaware corporation, and its consolidated subsidiaries following the Business Combination (as defined below).
Unless the context otherwise requires, references to &#8220;KINS&#8221; refer to KINS Technology Group Inc., a Delaware corporation (&#8220;KINS&#8221;),
the Company prior to the Business Combination. All references herein to the &#8220;Board&#8221; refer to the board of directors of the
Company. &#8220;Legacy CXApp&#8221; refers to CXApp Holding Corp., a Delaware corporation and a wholly owned subsidiary of the Company,
which the Company acquired through the Business Combination. Prior to the Separation (as defined below), Legacy CXApp was a wholly owned
subsidiary of Inpixon, a Nevada corporation (&#8220;Inpixon&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Business
Combination was accounted for using the acquisition method (as a forward merger), with goodwill and other identifiable intangible assets
recorded in accordance with GAAP, as applicable. Under this method of accounting, the &#8220;Enterprise Apps Business&#8221; (formerly
known as CXApp) is treated as the &#8220;acquired&#8221; company for financial reporting purposes. KINS (now known as CXApp Inc.) has
been determined to be the accounting acquirer because KINS maintains control of the Board of Directors and management of the combined
company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited condensed consolidated financial statements of Successor and Predecessor are not comparable due to a new basis of accounting
that was created from the business combination that occurred on the Closing Date (Note 3). Therefore, the reporting period has been separated
by a black line in the condensed consolidated financial statements with the Predecessor representing the pre-Closing Date period (January
1, 2023 through March 14, 2023) and the Successor representing the post-Closing Date period (March 15, 2023 through March 31, 2023).
The Company noted that the &#8220;Predecessor&#8221; includes financial information related to the Enterprise Apps Business (as defined
in Note 3), while the &#8220;Successor&#8221; includes financial information related to the newly formed company after the business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zPmLo5HYi1l6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            2 &#8211; Summary of Significant Accounting Policies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>&#160;</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_829_zAfnR3Sa9x59" style="display: none">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="cxai:LiquidityAndGoingConcernPolicyTextBlock"><p id="xdx_846_ecustom--LiquidityAndGoingConcernPolicyTextBlock_zw3E5NpOJlNg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
                                            </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2023 (Successor), the Company has a working capital surplus of approximately $<span id="xdx_900_ecustom--WorkingCapital_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Working capital"><ix:nonFraction name="cxai:WorkingCapital" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,052</ix:nonFraction></span>&#160;thousand and cash and cash equivalents of approximately
$<span id="xdx_907_eus-gaap--Cash_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,724</ix:nonFraction></span>&#160;thousand. For the period ended March 31, 2023 (Successor), the Company incurred net income
of approximately $<span id="xdx_906_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Net income"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,758</ix:nonFraction></span> thousand. During the period ended March 31, 2023 (Successor), the Company used approximately $<span id="xdx_90D_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_di_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFXCqwS29eM8" title="Cash for operating activities"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,431</ix:nonFraction></span> thousand of
cash for operating activities, of which $<span id="xdx_903_eus-gaap--OtherAccruedLiabilitiesCurrent_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Reduction in accrued liabilities"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,888</ix:nonFraction></span> thousand was from a reduction in accrued liabilities, primarily paying merger related
transaction liabilities. In assessing the Company&#8217;s ability to continue as a going concern, the Company monitors and analyzes its
cash and its ability to generate sufficient cash flow in the future to support its operating and capital expenditure commitments.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 151; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zddIKjz7O9wg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zjSU2dtqBIFg" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span>CXAPP INC. AND SUBSIDIARIES<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></b></p></ix:exclude>

<ix:exclude><p id="xdx_235_zZzI2kURTZzl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>The
Company cannot assure that it will ever earn revenues sufficient to support their operations, or that it will ever achieve profitable
operations. The Company&#8217;s recurring losses and utilization of cash in its operations are indicators of substantial doubt that the
entity can continue as a going concern however with the Company&#8217;s current liquidity position the Company has taken steps to reduce
operating expenses and extend it&#8217;s runway. The Company intends to finance its future working capital requirements and capital expenditures
from cash generated from operating activities and may consider raising funds from equity financings. Management believes that the actions
presently being taken to further implement its business plan and generate its revenues provide the opportunity for the Company to continue
as a going concern for at least 12 months from the issuance of these condensed consolidated financial statements. While the Company believes
in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that
effect for at least twelve months from the issuance of these condensed consolidated financial statements. The ability of the Company
to continue as a going concern is dependent upon the Company&#8217;s ability to further implement its business plan. The accompanying
unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization
of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments
relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might
result from the outcome of the uncertainties described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_849_eus-gaap--UseOfEstimates_z2Ou3EfIXRz8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
                                            of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;)
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during each of the reporting
periods. Actual results could differ from those estimates. The Company&#8217;s significant estimates consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            valuation of stock-based compensation;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            valuation of warrant liabilities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            allowance for credit losses;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            valuation allowance for deferred tax assets; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">impairment
                                            of long-lived assets and goodwill.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zWE2s2Vjh8xk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
                                            and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents consist of cash, checking accounts, money market accounts, temporary investments and certificates of deposit with
maturities of three months or less when purchased. <span id="xdx_90B_ecustom--CashAndCashEquivalentsDescription_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFNmvvmyQX9l" title="Cash and cash equivalents, description"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember" name="cxai:CashAndCashEquivalentsDescription">As of March 31, 2023 (Successor), the Company had cash equivalents  of approximately $2,000 thousand of certificates of
deposit held by a number of banks limited to $250 thousand per bank with a duration of 90 days or less</ix:nonNumeric></span> and at December 31, 2022 (Predecessor)
the Company had no cash equivalents.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="cxai:AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock"><p id="xdx_84A_ecustom--AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock_zefF4QCGnSNj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Accounts
                                            Receivable, net and Allowance for Credit Losses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Accounts
receivables are stated at the amount the Company expects to collect. The Company recognizes an allowance for credit losses to ensure
accounts receivables are not overstated due to un-collectability. Bad debt reserves are maintained for various customers based on a variety
of factors, including the length of time the receivables are past due, significant one-time events and historical experience. An additional
reserve for individual accounts is recorded when the Company becomes aware of a customer&#8217;s inability to meet its financial obligation,
such as in the case of bankruptcy filings, or deterioration in such customer&#8217;s operating results or financial position. If circumstances
related to a customer change, estimates of the recoverability of receivables would be further adjusted. The Company&#8217;s allowance
for credit losses is not significant as of March 31, 2023 (Successor) and at December 31, 2022 (Predecessor).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 152; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_z3LyYChuuqul" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zXerDI2GPt17" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span>CXAPP INC. AND SUBSIDIARIES<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zMq603EBIyfb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>


</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zNREgUj0V3nh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Property
                                            and Equipment, net</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are recorded at cost, less accumulated depreciation and amortization. The Company depreciates its property and equipment
for financial reporting purposes using the straight-line method over the estimated useful lives of the assets, which range from 3 to
10 years. Leasehold improvements are amortized over the lesser of the useful life of the asset or the initial lease term. Expenditures
for maintenance and repairs, which do not extend the economic useful life of the related assets, are charged to operations as incurred,
and expenditures, which extend the economic life, are capitalized. When assets are retired, or otherwise disposed of, the costs and related
accumulated depreciation or amortization are removed from the accounts and any gain or loss on disposal is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:IntangibleAssetsFiniteLivedPolicy"><p id="xdx_84F_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z4fAlHyLJg8e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intangible
                                            Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets primarily consist of developed technology, customer lists/relationships, non-compete agreements, intellectual property
agreements, export licenses and trade names/trademarks. They are amortized ratably over a range of <span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zZPQov9BPJu7" title="Intangible assets useful life"><ix:nonNumeric contextRef="From2023-01-012023-03-31_custom_SuccessorMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">1</ix:nonNumeric> </span>
to <span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_ziSd4Biku1B2" title="Intangible assets useful life"><ix:nonNumeric contextRef="From2023-01-012023-03-31_custom_SuccessorMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">10</ix:nonNumeric></span>
years, which approximates customer attrition rate and technology obsolescence. The Company assesses the carrying value of its
intangible assets for impairment each year. Based on its assessments, the Company did not incur any impairment charges for the
period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022
(Predecessor).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:GoodwillDisclosureTextBlock"><p id="xdx_843_eus-gaap--GoodwillDisclosureTextBlock_zotamlkSrV76" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Goodwill</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company tests goodwill for potential impairment at least annually, or more frequently if an event or other circumstance indicates that
the Company may not be able to recover the carrying amount of the net assets of the reporting unit. The Company has determined that the
reporting unit is the entire company, due to the integration of all of the Company&#8217;s activities. In evaluating goodwill for impairment,
the Company may assess qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50%) that
the fair value of a reporting unit is less than its carrying amount. If the Company bypasses the qualitative assessment, or if the Company
concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs
a quantitative impairment test by comparing the fair value of a reporting unit with its carrying amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company calculates the estimated fair value of a reporting unit using a weighting of the income and market approaches. For the income
approach, the Company uses internally developed discounted cash flow models that include the following assumptions, among others: projections
of revenues, expenses, and related cash flows based on assumed long-term growth rates and demand trends; expected future investments
to grow new units; and estimated discount rates. For the market approach, the Company uses internal analyses based primarily on market
comparables. The Company bases these assumptions on its historical data and experience, third party appraisals, industry projections,
micro and macro general economic condition projections, and its expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="cxai:LeasesAndRightofUseAssetsPolicyTextBlock"><p id="xdx_844_ecustom--LeasesAndRightofUseAssetsPolicyTextBlock_zH39sJYL1091" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Leases
                                            and Right-of-Use Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if an arrangement is a lease at its inception. Operating lease liabilities are recognized at the lease commencement
date based on the present value of lease payments over the lease term. The Company generally uses their incremental borrowing rate based
on the information available at the lease commencement date in determining the present value of future payments, because the implicit
rate of the lease is generally not known. Right-of-use assets related to the Company&#8217;s operating lease liabilities are measured
at lease inception based on the initial measurement of the lease liability, plus any prepaid lease payments and less any lease incentives.
The Company&#8217;s lease terms that are used in determining their operating lease liabilities at lease inception may include options
to extend or terminate the leases when it is reasonably certain that the Company will exercise such options. The Company amortizes their
right-of-use assets as operating lease expense generally on a straight-line basis over the lease term and classify both the lease amortization
and imputed interest as operating expenses. The Company does not recognize lease assets and lease liabilities for any lease with an original
lease term of less than one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 153; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_z8jb7JFvAxfh" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zdKwrI7NYPQk" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span>CXAPP INC. AND SUBSIDIARIES<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zTJHzsglqTwf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>


</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zHn9JBCIYIBb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
                                            Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes using the asset and liability method. Accordingly, deferred tax assets and liabilities are recognized
for the future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities
and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in the tax rate is recognized in income or expense in the period that the change is effective. Income tax benefits
are recognized when it is probable that the deduction will be sustained. A valuation allowance is established when it is more likely
than not that all or a portion of a deferred tax asset will either expire before the Company is able to realize the benefit, or that
future deductibility is uncertain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_844_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zlwVv8rtPbOj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Comprehensive
                                            Income (Loss) and Foreign Currency Translation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reports comprehensive income (loss) and its components in its unaudited condensed consolidated financial statements. Comprehensive
loss consists of net loss and foreign currency translation adjustments, affecting stockholders&#8217; equity that, under GAAP, are excluded
from net loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities related to the Company&#8217;s foreign operations are calculated using the Philippine peso and Canadian Dollar, and are
translated at end-of-period exchange rates, while the related revenues and expenses are translated at average exchange rates prevailing
during the period. Gains or losses resulting from transactions denominated in foreign currencies are included in general and administrative
expenses in the unaudited condensed consolidated statements of operations. The Company engages in foreign currency denominated transactions
with customers that operate in functional currencies other than the U.S. dollar. Aggregate foreign currency net transaction losses were
not material for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and three months ended March
31, 2022 (Predecessor).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zp5bNAYYFyRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
                                            Recognition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>The
Company recognizes revenue when control is transferred of the promised products or services to its customers, in an amount that reflects
the consideration the Company expects to be entitled to in exchange for those products or services. The Company derives revenue from
its software as a service for cloud based software, as well as design, implementation and other professional services for work performed
in conjunction with its cloud based software. The Company enters into contracts with its customers whereby it grants a non-exclusive
cloud-based license for the use of its proprietary software and for professional services. The contracts may also provide for on-going
services for a specified price, which may include maintenance services, designated support, and enhancements, upgrades and improvements
to the software, depending on the contract. Licenses for cloud software provide the customer with a right to use the software as it exists
when made available to the customer. All software provides customers with the same functionality and differ mainly in the duration over
which the customer benefits from the software.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>License
Subscription Revenue Recognition (Software As A Service)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>With respect
to sales of the Company&#8217;s license agreements, customers generally pay fixed annual fees in advance in exchange for the Company&#8217;s
software service provided by via electronic, which are generally recognized ratably over the license term. Some agreements allow the
customer to terminate their subscription contracts before the end of the applicable term, and in such cases the customer is generally
entitled to a refund pro-rata but only for the elapsed time remaining at the point of termination, which would approximate the deferred
revenue at such time. The Company&#8217;s performance obligation is satisfied over time as the electronic services are provided continuously
throughout the service period. The Company recognizes revenue evenly over the service period using a time-based measure because the Company
is providing continuous access to its service. The Company&#8217;s customers generally pay within 30 to 60 days from the receipt of a
customer approved invoice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 154; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zB01ZnAOCIta" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_ziZPYfzFH0xk" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span>CXAPP INC. AND SUBSIDIARIES<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></b></p></ix:exclude>

<ix:exclude><p id="xdx_235_zx4Qq3MlJA04" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The timing
of the Company&#8217;s revenue recognition related to the licensing revenue stream is dependent on whether the software licensing agreement
entered into represents a service. Software that relies on an entity&#8217;s IP and is delivered only through a hosting arrangement,
where the customer cannot take possession of the software, is a service. Customers may purchase perpetual licenses or subscribe to licenses,
which provide customers with the same functionality and differ mainly in the duration over which the customer benefits from the software.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Renewals
or extensions of licenses are evaluated as distinct licenses and revenue attributed to the distinct service is not recognized until (1)
the entity provides the distinct license (or makes the license available) to the customer and (2) the customer is able to use and benefit
from the distinct license. Renewal contracts are not combined with original contracts, and, as a result, the renewal right is evaluated
in the same manner as all other additional rights granted after the initial contract. The revenue is not recognized until the customer
can begin to use and benefit from the license, which is typically at the beginning of the license renewal period. The Company recognizes
revenue resulting from renewal of licensed software over time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
Services Revenue Recognition</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s professional services include milestone, fixed fee and time and materials contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
services under milestone contracts are accounted for using the percentage of completion method. As soon as the outcome of a contract
can be estimated reliably, contract revenue is recognized in the statement of operations in proportion to the stage of completion of
the contract. Contract costs are expensed as incurred. Contract costs include all amounts that relate directly to the specific contract,
are attributable to contract activity, and are specifically chargeable to the customer under the terms of the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Professional
services are also contracted on the fixed fee and in some cases on a time and materials basis. Fixed fees are paid monthly, in phases,
or upon acceptance of deliverables. The Company&#8217;s time and materials contracts are paid weekly or monthly based on hours worked.
Revenue on time and material contracts is recognized based on a fixed hourly rate as direct labor hours are expended. Materials, or other
specified direct costs, are reimbursed as actual costs and may include markup. The Company has elected the practical expedient to recognize
revenue for the right to invoice because the Company&#8217;s right to consideration corresponds directly with the value to the customer
of the performance completed to date. For fixed fee contracts provided by in house personnel, the Company recognizes revenue evenly over
the service period using a time-based measure because the Company is providing continuous service. Because the Company&#8217;s contracts
have an expected duration of one year or less, the Company has elected the practical expedient in ASC 606-10-50-14(a) to not disclose
information about its remaining performance obligations. Anticipated losses are recognized as soon as they become known. For the period
ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor), the
Company did not incur any such losses. These amounts are based on known and estimated factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contract
Balances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
timing of the Company&#8217;s revenue recognition may differ from the timing of invoicing to and payment by its customers. The Company
records an unbilled receivable when revenue is recognized prior to invoicing and the Company has an unconditional right to payment. Alternatively,
when invoicing a customer precedes the company providing of the related services, the Company records deferred revenue until the performance
obligations are satisfied. The Company had deferred revenue of approximately $<span id="xdx_906_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3"><ix:nonFraction name="us-gaap:DeferredRevenue" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,690</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand and $<span id="xdx_90D_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3"><ix:nonFraction name="us-gaap:DeferredRevenue" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,162</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand as of March 31, 2023 (Successor) and
December 31, 2022 (Predecessor), respectively, related to customer invoices rendered in advance for software licenses and professional
services provided by the Company&#8217;s technical staff. The Company expects to satisfy its remaining performance obligations for the
deferred revenue associated with professional services, and recognize the deferred revenue related to licenses generally over the remaining
contract term generally twelve months following the commencement of the license. The Company recognized revenue in the reporting period
of $<span id="xdx_901_ecustom--RevenueRecognized_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zCVavrmQRK1" title="Revenue Recognized"><ix:nonFraction name="cxai:RevenueRecognized" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">170</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;thousand,
$<span id="xdx_90E_ecustom--RevenueRecognized_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zApkMSdjWAUj"><ix:nonFraction name="cxai:RevenueRecognized" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">865</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand, and $<span id="xdx_902_ecustom--RevenueRecognized_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zdkdnojahzE7"><ix:nonFraction name="cxai:RevenueRecognized" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,328</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand that was included in the contract liability
balance at the beginning of the period, for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and
three months ended March 31, 2022 (Predecessor), respectively.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 155; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zgvP52r7mky8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zVfaPVpu5uy6" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span>CXAPP INC. AND SUBSIDIARIES<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></b></p></ix:exclude>

<ix:exclude><p id="xdx_230_zCkHizaIeoHb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Costs
to Obtain a Contract</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
recognizes eligible sales commissions as an asset as the commissions are an incremental cost of obtaining a contract with the customer
and the Company expects to recover these costs. The capitalized costs are amortized over the expected contract term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cost
to Fulfill a Contract</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
incurs costs to fulfill their obligations under a contract once it has obtained. These costs are generally not significant and are recorded
to expense as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Multiple
Performance Obligations</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company enters into contracts with customers for its technology that include multiple performance obligations. Each distinct performance
obligation was determined by whether the customer could benefit from the good or service on its own or together with readily available
resources. The Company allocates revenue to each performance obligation based on its relative standalone selling price. The Company&#8217;s
process for determining standalone selling price considers multiple factors including the Company&#8217;s internal pricing model and
market trends that may vary depending upon the facts and circumstances related to each performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
and Use Taxes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company presents transactional taxes such as sales and use tax collected from customers and remitted to government authorities on a net
basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shipping
and Handling Costs</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling costs are expensed as incurred as part of cost of revenues. These costs were deemed to be nominal during each of the reporting
periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:BusinessCombinationsPolicy"><p id="xdx_841_eus-gaap--BusinessCombinationsPolicy_zcQe09j48jy1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
                                            Combinations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for business combinations under Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification
(&#8220;ASC&#8221;) 805 &#8220;Business Combinations&#8221; using the acquisition method of accounting, and accordingly, the assets and
liabilities of the acquired business are recorded at their fair values at the date of acquisition. The excess of the purchase price over
the estimated fair value is recorded as goodwill. All acquisition costs are expensed as incurred. Upon acquisition, the accounts and
results of operations are included as of and subsequent to the acquisition date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:SegmentReportingPolicyPolicyTextBlock"><p id="xdx_849_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zyLHpZiIf0o" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Segments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and its Chief Executive Officer (&#8220;CEO&#8221;), acting as the Chief Operating Decision Maker (&#8220;CODM&#8221;) determines
its reporting units in accordance with FASB ASC 280, &#8220;Segment Reporting&#8221; (&#8220;ASC 280&#8221;). The Company evaluates a
reporting unit by first identifying its operating segments under ASC 280. The Company then evaluates each operating segment to determine
if it includes one or more components that constitute a business. If there are components within an operating segment that meet the definition
of a business, the Company evaluates those components to determine if they must be aggregated into one or more reporting units. If applicable,
when determining if it is appropriate to aggregate different operating segments, the Company determines if the segments are economically
similar and, if so, the operating segments are aggregated. The Company has one operating segment and reporting unit. The Company is organized
and operated as one business. Management reviews its business as a single operating segment, using financial and other information rendered
meaningful only by the fact that such information is presented and reviewed in the aggregate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 156; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zxIFaTbTqVU7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zS4NDUXNKici" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span>CXAPP INC. AND SUBSIDIARIES<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z4p19MAgDZMi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>


</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:CompensationRelatedCostsPolicyTextBlock"><p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zqhxlV67YbOj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-Based
                                            Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for options granted to employees by measuring the cost of services received in exchange for the award of equity instruments
based upon the fair value of the award on the date of grant. The fair value of that award is then ratably recognized as an expense over
the period during which the recipient is required to provide services in exchange for that award. Forfeitures of unvested stock options
are recorded when they occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred stock-based compensation charges of approximately $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Stock-based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></span>&#160;thousand, $<span id="xdx_907_eus-gaap--ShareBasedCompensation_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Stock-based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">158</ix:nonFraction></span>&#160;thousand and $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Stock-based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">647</ix:nonFraction></span>&#160;thousand for the period ended March 31, 2023 (Successor), the period ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor),
respectively, which are included in general and administrative expenses.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:StandardProductWarrantyPolicy"><p id="xdx_842_eus-gaap--StandardProductWarrantyPolicy_z8jbBFSUKXZb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Derivative
                                            Warrant Liabilities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s specific
terms and applicable authoritative guidance in FASB ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC 480&#8221;)
and ASC 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#8217;s own common
stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted
at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. The Company currently
has two sets of warrants outstanding, known as the Private Placement Warrants and the Public Warrants, which are both classified as a
liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>For issued or modified warrants that meet all
of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the
time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required
to be recorded at their initial fair value on the date of issuance as a warrant liability, and adjusted to the then fair value in each
balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the condensed
consolidated statements of operations and amounted to approximately $<span id="xdx_90E_ecustom--ChangesInEstimatedFairValueOfWarrants_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zlU3FR3IFPcj" title="Changes in estimated fair value of warrants"><ix:nonFraction name="cxai:ChangesInEstimatedFairValueOfWarrants" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,686</ix:nonFraction>&#160;</span>thousand for the period ended March 31, 2023 (Successor).
The Company utilized the Public Warrant quoted market price as the fair value of the Warrants as of each relevant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zExbuawx3YWi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Earnings
                                            Per Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
computes basic and diluted earnings per share by dividing net income by the weighted average number of common shares outstanding during
the period. Diluted earnings per share are similarly calculated with the inclusion of dilutive common stock equivalents. The following
table summarizes the number of common shares and common share equivalents excluded from the calculation of diluted net income per common
share for period ended March 31, 2023 (Successor), which are excluded from the calculation because (i) the warrants were below their
exercise price and (ii) the stock options were not vested :</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_pn3n3_zXBF2PB15Bxd" summary="xdx: Disclosure - Summary of Significant Accounting Policie (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; text-align: left"><span id="xdx_8B3_zmSyfTTgVZU" style="display: none">Schedule of antidilutive shares</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to<br/>
    March&#160;31,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"><span>Stock
    options</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zn1dqT8iNFke" style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_StockOptionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">1,377</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" title="Total" style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,080</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pdd" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,457</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><p id="xdx_841_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zw0p08iuU5m" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
                                            Value Measurements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FASB
ASC 820, &#8220;Fair Value Measurements&#8221; (&#8220;ASC 820&#8221;), provides guidance on the development and disclosure of fair value
measurements. The Company follows this authoritative guidance for fair value measurements, which defines fair value, establishes a framework
for measuring fair value under generally accepted accounting principles in the United States, and expands disclosures about fair value
measurements. The guidance requires fair value measurements be classified and disclosed in one of the following three categories:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.25in"/><td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date
                                            for identical assets or liabilities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.25in"/><td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            2: Observable prices that are based on inputs not quoted on active markets but corroborated
                                            by market data.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.25in"/><td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            3: Unobservable inputs which are supported by little or no market activity and values determined
                                            using pricing models, discounted cash flow methodologies, or similar techniques, as well
                                            as instruments for which the determination of fair value requires significant judgment or
                                            estimation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value measurements discussed herein are based upon certain market assumptions and pertinent information available to management. Fair
value measurements are applied, when applicable, to determine the fair value of the Company&#8217;s warrant liability at each reporting
period. See Note 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>



<ix:exclude><!-- Field: Page; Sequence: 157; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zRYmtfYt7rEf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zC6gxHDTtCKc" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span>CXAPP INC. AND SUBSIDIARIES<br/>
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></b></p></ix:exclude>

<ix:exclude><p id="xdx_237_zZIfZjdR9ul8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>


</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z1Yer2XJkN4k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
                                            Value of Financial Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments consist of cash and cash equivalents, accounts receivable, notes and other receivable and accounts payable. The Company determines
the estimated fair value of such financial instruments presented in these financial statements using available market information and
appropriate methodologies. These financial instruments are stated at their respective historical carrying amounts, which approximate
fair value due to their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zchAKvjusoEg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Carrying
                                            Value, Recoverability and Impairment of Long-Lived Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
has adopted FASB ASC 360 &#8220;Property, Plant, and Equipment&#8221; (&#8220;ASC 360&#8221;) for its long-lived assets. Pursuant to
ASC 360-10-35-17, an impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable
and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted
cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the
carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount
by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. Pursuant to ASC 360-10-35-20 if an impairment
loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset,
the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized
impairment loss is prohibited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 360-10-35-21, the Company&#8217;s long-lived asset (asset group) is tested for recoverability whenever events or changes in circumstances
indicate that its carrying amount may not be recoverable. The Company considers the following to be some examples of such events or changes
in circumstances that may trigger an impairment review: (a) significant decrease in the market price of a long-lived asset (asset group);
(b) a significant adverse change in the extent or manner in which a long-lived asset (asset group) is being used or in its physical condition;
(c) a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset (asset
group), including an adverse action or assessment by a regulator; (d) an accumulation of costs significantly in excess of the amount
originally expected for the acquisition or construction of a long-lived asset (asset group); (e) a current-period operating or cash flow
loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated
with the use of a long-lived asset (asset group); and (f) a current expectation that, more likely than not, a long-lived asset (asset
group) will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. The Company tests
its long-lived assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on its assessments, the Company recorded <span id="xdx_908_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zAfiZuSmiNrc" title="Impairment charges of long-lived assets"><span id="xdx_903_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zITBxcg1cf54" title="Impairment charges of long-lived assets"><span id="xdx_90F_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zzYDZSs08Vac" title="Impairment charges of long-lived assets"><ix:nonFraction name="us-gaap:OtherAssetImpairmentCharges" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="us-gaap:OtherAssetImpairmentCharges" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="us-gaap:OtherAssetImpairmentCharges" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="USD">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span> impairment charges on long-lived assets for period ended March 31, 2023 (Successor), period
ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor), respectively.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zKtKg42HkPn6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recently
                                            Issued and Adopted Accounting Standards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>In October
2021, the FASB issued ASU 2021-08, &#8220;Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&#8221;
(&#8220;ASU 2021-08&#8221;), which addresses diversity in practice related to the accounting for revenue contracts with customers acquired
in a business combination. Under the new guidance, the acquirer is required to apply Topic 606 to recognize and measure contract assets
and contract liabilities in a business combination. The effective date of the standard is for fiscal years beginning after December 15,
2022, including interim periods within those fiscal years, with early adoption permitted. CXApp adopted ASU 2021-08 on January 1, 2022.
As a result of management&#8217;s evaluation, the adoption of ASU 2021-08 did not have a material impact on the consolidated financial
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
evaluated recently issued FASB accounting pronouncements and noted that no recent announcements were applicable to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_808_eus-gaap--BusinessCombinationDisclosureTextBlock_z6l5vQG58VVj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            3 &#8211; <span id="xdx_822_zylb3tY9vZZ2">Business Combination</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 14, 2023, the Company completed the Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), by and among KINS,
Inpixon, CXApp, and KINS Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of KINS (&#8220;Merger Sub&#8221;),
pursuant to which KINS combined with CXApp, Inpixon&#8217;s enterprise apps business (including its workplace experience
technologies, indoor mapping, events platform, augmented reality and related business solutions) (the &#8220;Enterprise Apps
Business&#8221;). In exchange for the agreed upon aggregate purchase price of approximately $<span id="xdx_903_ecustom--AggregatePurchasePriceAssetsAndLiabilities_iI_pn3n3_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zgDijKiUOD48" title="Aggregate purchase price assets and liabilities"><ix:nonFraction name="cxai:AggregatePurchasePriceAssetsAndLiabilities" contextRef="AsOf2023-03-14_custom_PredecessorMember_custom_MergerAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69,928</ix:nonFraction></span>
thousand, the Company acquired all of the related assets and liabilities of Legacy CXApp. The consideration transferred in
connection with the Business Combination consisted of <span id="xdx_90D_ecustom--ConsiderationTransferredInConnection_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zpGRYGUgslNh" title="Consideration transferred in connection"><ix:nonFraction name="cxai:ConsiderationTransferredInConnection" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_MergerAgreementMember_us-gaap_CommonClassAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,547,700</ix:nonFraction></span>
shares of the Company&#8217;s Class A Common Stock and <span id="xdx_90A_ecustom--ConsiderationTransferredInConnection_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Consideration transferred in connection"><ix:nonFraction name="cxai:ConsiderationTransferredInConnection" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_MergerAgreementMember_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,487,300</ix:nonFraction></span>
shares of the Company&#8217;s Class C Common Stock valued at a price of $<span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20230314_ztb8ypzqLNdg" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-03-14" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.94</ix:nonFraction></span>
per share. The preliminary estimated goodwill of approximately $<span id="xdx_904_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_pn3n3" title="Business combination goodwill"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" contextRef="AsOf2023-03-14_custom_PredecessorMember_custom_MergerAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,122</ix:nonFraction></span>
thousand arising from the Business Combination consists of an acquired workforce, as well as synergies expected from combined
operations of KINS and the CXApp.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
has authorized Class A and Class C common stock. Class A common stock and New CXApp Class C common stock are identical in all respects,
except that New CXApp Class C common stock is not listed and will automatically convert into New CXApp Class A common stock on the earlier
to occur of (i) the 180th day following the closing of the Merger and (ii) the day that the last reported sale price of New CXApp Class
A common stock equals or exceeds $12.00 per share for any 20 trading days within any 30-trading day period following the closing of the
Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Business
Combination is being accounted for as a business combination in accordance with ASC 805 Combinations. The Company has determined preliminary
fair values of the assets acquired and liabilities assumed in the Business Combinations. These values are subject to change as we perform
additional reviews of our assumptions utilized.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 158; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zMaG69zkTrej" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zIq57DrCdN04" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span><b>CXAPP
            INC. AND SUBSIDIARIES<br/>
            NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zmJId3xKA9jf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has made a provisional allocation of the purchase price of the Business Combination to the assets acquired and the liabilities
assumed as of the closing date. The following table summarizes the preliminary purchase price allocations relating to the Business Combination
(in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_pn3n3_zv4J4BGrrAyi" summary="xdx: Disclosure - Business Combination (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B8_zaXlKB5klXAa" style="display: none">Schedule of assets acquired</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zhQ5zTcRifU6" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"><span>Description</span></td><td style="text-align: center; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Fair
    Value</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Weighted<br/>
    Average Useful<br/>
    Life<br/>
    (in years)</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--PurchasePrice_iI_z2LNiZ782CYl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Purchase
    Price</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:PurchasePrice" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69,928</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Assets
    acquired:</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Cash
    and cash equivalents</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,003</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 10%; text-align: center"><span>&#160;</span></td>
    <td style="width: 1%"><span>&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accounts
    receivable</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,226</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables_iI_pn3n3_z8CKXpYtCFU8" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Notes
    and other receivables</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">209</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Prepaid
    assets and other current assets</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">588</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset_iI_pn3n3_za8u4DXnd5Yg" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    lease right of use asset</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">557</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Property
    and equipment, net</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">133</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Other
    assets</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Developed
    technology</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" title="Intangible assets" style="text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="AsOf2023-03-14_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,268</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zvIHvLVrFPaj"><ix:nonNumeric contextRef="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">10</ix:nonNumeric>
    </span><span>years</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Patents</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pn3n3" title="Intangible assets" style="text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="AsOf2023-03-14_custom_PredecessorMember_us-gaap_PatentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,703</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zrChEHYpjyw9"><ix:nonNumeric contextRef="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_PatentsMember" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">10</ix:nonNumeric>
    </span><span>years</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Customer
    relationships</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Intangible assets" style="text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="AsOf2023-03-14_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,604</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zxUVCZ4SNAm8"><ix:nonNumeric contextRef="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">5</ix:nonNumeric>
    </span><span>years</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Tradenames
    and trademarks</span></td><td><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" title="Intangible assets" style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="AsOf2023-03-14_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,294</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zMy29Hf6sfih"><ix:nonNumeric contextRef="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">7</ix:nonNumeric>
    </span><span>years</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span>Total
    assets acquired</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,627</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Liabilities
    assumed:</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_i01I_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accounts
    payable</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">461</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_i01I_pn3n3_z1WqlsOPdQ1g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    liabilities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">911</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_i01I_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Deferred
    revenues</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,534</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent_i01I_pn3n3_zFEBnlRS0kK6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    lease obligation, current</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">194</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent_i01I_pn3n3_z1lNtq0USiYg" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    lease obligation, noncurrent</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">384</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_i01I_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Deferred
    tax liability</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,337</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_i01I_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Total
    liabilities assumed</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,821</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span>Goodwill</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,122</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td></tr>
  </table>






</ix:nonNumeric><p id="xdx_8AF_zlPUGCuVIHii" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The value
of the intangible assets and goodwill were calculated by a third party valuation firm based on projections and financial data provided
by management of the Company. Goodwill represents the excess fair value after allocation to the intangible assets. The calculated goodwill
is not tax deductible for tax purposes.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
acquisition-related costs for the Business Combination were approximately $<span id="xdx_904_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3"><ix:nonFraction name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,000</ix:nonFraction>
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand, which were incurred by KINS prior to
the close of the Business Combination. These costs are included in the opening retained earnings of the Company on March 15, 2023.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span><b>Measurement
Period</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>The preliminary
purchase price allocations for the acquisitions described above are based on initial estimates and provisional amounts. In accordance
with ASC 805-10-25-13, if the initial accounting for a business combination is incomplete by the end of the reporting period in which
the combination occurs, the acquirer shall report in its financial statements provisional amounts for the items for which the accounting
is incomplete. During the measurement period, acquirer shall adjust the provisional amounts recognized at the acquisition date to reflect
new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the
measurement of the amounts recognized as of that date. The Company continues to refine its inputs and estimates inherent in (i) the valuation
of intangible assets, (ii) deferred income taxes, (iii) realization of tangible assets and (iv) the accuracy and completeness of liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span><b>&#160;</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CXApp
Proforma Financial Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following unaudited proforma financial information presents the condensed consolidated results of operations of the Company for the three
month periods ended March 31, 2023 and March 31, 2022, as if the acquisition had occurred as of the beginning of the first period presented
(January 1, 2022) instead of on March 14, 2023. The proforma information does not necessarily reflect the results of operations that
would have occurred had the entities been a single company during those periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proforma financial information for the Company and the acquired CXApp is as follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_pn3n3_zHZrWn2FodT3" summary="xdx: Disclosure - Business Combination (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B4_zNFFs4LTose" style="display: none">Schedule of proforma financial information</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>For
    the<br/>
    Three Months Ended March&#160;31,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>For
    the<br/>
    Three Months Ended March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Revenues</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20230101__20230331_pn3n3" title="Revenues" style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,962</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20220101__20220331_pn3n3" title="Revenues" style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,582</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    income (loss)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20230101__20230331_pn3n3" title="Net income (loss)" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,365</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20220101__20220331_pn3n3" title="Net income (loss)" style="text-align: right"><span><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,197</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zVPkCzQkjR56" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>



<ix:exclude><!-- Field: Page; Sequence: 159; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zGPT92beEe49" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_ztUBZgUFVRJd" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span><b>CXAPP
            INC. AND SUBSIDIARIES<br/>
            NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zCi2OTeoFSQf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>


</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="cxai:DisaggregationOfRevenueTextBlock"><p id="xdx_80A_ecustom--DisaggregationOfRevenueTextBlock_zWEQkTvVP2u4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            4 &#8211; <span id="xdx_821_zuDvnBSQj8Ue">Disaggregation of Revenue</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when control is transferred of the promised products or services to its customers, in an amount that reflects
the consideration the Company expects to be entitled to in exchange for those products or services. The Company derives revenue from
software as a service, design and implementation services for its enterprise apps solutions systems, and professional services for work
performed in conjunction with its systems.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
consisted of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zzydvqXZ8SN7" summary="xdx: Disclosure - Disaggregation of Revenue (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;<span id="xdx_8B9_zYzbr6c27m1a" style="display: none">Schedule of disaggregation of Revenue</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to <br/>
    March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    January&#160;1,<br/>
    2023 to<br/>
    March&#160;14,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Three
    months ended March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Subscription
    revenue</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left; padding-bottom: 1pt"><span>Software</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_98B_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" title="Total Revenue" style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_SubscriptionRevenueMember_custom_SoftwareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">240</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_98D_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" title="Total Revenue" style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_SubscriptionRevenueMember_custom_SoftwareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,204</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_98D_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" title="Total Revenue" style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_SubscriptionRevenueMember_custom_SoftwareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,259</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    subscription revenue</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" title="Total Revenue" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_SubscriptionRevenueMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">240</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" title="Total Revenue" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_SubscriptionRevenueMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,204</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" title="Total Revenue" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_SubscriptionRevenueMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,259</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Non-subscription
    revenue</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Professional
    services</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" title="Total Revenue" style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_NonSubscriptionRevenueMember_custom_ProfessionalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_981_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" title="Total Revenue" style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_NonSubscriptionRevenueMember_custom_ProfessionalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">416</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_98C_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" title="Total Revenue" style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_NonSubscriptionRevenueMember_custom_ProfessionalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,323</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    non-subscription revenue</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" title="Total Revenue" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_NonSubscriptionRevenueMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98D_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" title="Total Revenue" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_NonSubscriptionRevenueMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">416</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" title="Total Revenue" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_NonSubscriptionRevenueMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,323</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    Revenue</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Total Revenue" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">342</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Total Revenue" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,620</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Total Revenue" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,582</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to <br/>
    March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    January&#160;1,<br/>
    2023 to<br/>
    March&#160;14,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Three
    months ended March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left; padding-bottom: 1pt"><span>Revenue
    recognized over time<sup>(1)(2)</sup></span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_986_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zKxJyCgzCnc9" title="Total Revenue" style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_us-gaap_TransferredOverTimeMember" id="Fact001924" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">342</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zNqBoDOyYQlh" title="Total Revenue" style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_TransferredOverTimeMember" id="Fact001926" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,620</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zd6PyQcWxDfd" title="Total Revenue" style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_us-gaap_TransferredOverTimeMember" id="Fact001928" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,582</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFN8f9NMFGB8" title="Total Revenue" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">342</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zUzL3VcqZNy" title="Total Revenue" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,620</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zREhXGB3TMm3" title="Total Revenue" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,582</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span id="xdx_F00_zuAxaoM7qA89" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F13_z22eIkMiIlRk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001935" xml:lang="en-US">
                                            Professional services are also contracted on the fixed fee and time and materials basis.
                                            Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company has
                                            generally elected the practical expedient to recognize revenue for the right to invoice because
                                            the Company&#8217;s right to consideration corresponds directly with the value to the customer
                                            of the performance completed to date, in which revenue is recognized over time.</ix:footnote></span></td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td/><td style="text-align: left"><span id="xdx_F0F_z8YOj0PS32me" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span id="xdx_F14_zZN9vikJNp6l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001936" xml:lang="en-US">Software
                                            As A Service Subscription Revenue&#8217;s performance obligation is satisfied evenly over
                                            the service period using a time-based measure because the Company is providing continuous
                                            access to its service and service is recognized overtime.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A7_zAwhJnBd8XMf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 160; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zSm1AM1iQGfi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zvvVEi2Y6Ft2" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span><b>CXAPP
            INC. AND SUBSIDIARIES<br/>
            NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zrpK4VDtIjre" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>


</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z4aE0IySPPne" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            5 &#8211; <span id="xdx_82E_zvwoDPQWpmUe">Property and Equipment, net</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment consisted of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--PropertyPlantAndEquipmentTextBlock_pn3n3_zIZ1SnmXGa01" summary="xdx: Disclosure - Property and Equipment, net (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BA_zyFVPiBxajK6" style="display: none">Schedule of property and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"/><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>December&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Computer
    and office equipment</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pn3n3" title="Total" style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_OfficeEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">139</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zJRkraja9hdj" title="Total" style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_OfficeEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">992</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Furniture
    and fixtures</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pn3n3" title="Total" style="text-align: right"><span><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z0UDzglPTCQi" title="Total" style="text-align: right"><span><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">185</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Leasehold
    improvements</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pn3n3" title="Total" style="text-align: right"><span><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmvgAo2RnXZ4" title="Total" style="text-align: right"><span><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Software</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SoftwareMember_pn3n3" title="Total" style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_SoftwareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SoftwareMember_zJfaGhxk2Z" title="Total" style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_SoftwareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Total</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Total" style="text-align: right"><span><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">157</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zI5WFlAWHCy1" title="Total" style="text-align: right"><span><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,213</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Less:
    accumulated depreciation and amortization</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z21EFw5MvTFe" title="Less: accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zwDw0DkaJ0Y7" title="Less: accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,011</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    Property and Equipment, Net</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentNet_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Total Property and Equipment, Net" style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">153</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Total Property and Equipment, Net" style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">202</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
and amortization expense were approximately $<span id="xdx_901_eus-gaap--DepreciationAndAmortization_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;thousand,
$<span id="xdx_90B_eus-gaap--DepreciationAndAmortization_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;thousand
and $<span id="xdx_908_eus-gaap--DepreciationAndAmortization_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand for the period ended March 31, 2023
(Successor), the period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022 (Predecessor), respectively.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="cxai:SoftwareDevelopmentCostsNetTextBlock"><p id="xdx_802_ecustom--SoftwareDevelopmentCostsNetTextBlock_zC7lWFLpM2Xg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            6 &#8211; <span id="xdx_82D_zbNpWqcN1bb7">Software Development Costs, net</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
software development costs consisted of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="cxai:ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock_pn3n3_zUikV4J7Y759" summary="xdx: Disclosure - Software Development Costs, net (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span id="xdx_8B3_zr6VD5hpp3K9" style="display: none">Schedule of capitalized software development</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zG7dxHOXEaB1" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zoUyBm8ovIEl" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>December&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_maCCSNzf4y_zVllVuO8Mafh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Capitalized
    software development costs</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1980">-</span></span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,680</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--CapitalizedComputerSoftwareAccumulatedAmortization_iNI_pn3n3_di_msCCSNzf4y_zUOdvQtZJVGh" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Accumulated
    amortization</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1983">-</span></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,193</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr id="xdx_409_eus-gaap--CapitalizedComputerSoftwareNet_iTI_pn3n3_mtCCSNzf4y_zwVYEIK8Njjf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Software
    development costs, net</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1986">-</span></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareNet" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">487</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for capitalized software development costs was approximately $<span id="xdx_90D_eus-gaap--AdjustmentForAmortization_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Amortization expense"><ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">209</ix:nonFraction></span>&#160;thousand and $<span id="xdx_90E_eus-gaap--AdjustmentForAmortization_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Amortization expense"><ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">113</ix:nonFraction></span>&#160;thousand for the period ended March
14, 2023 (Predecessor) and the three months ended March 31, 2022 (Predecessor). There was <span id="xdx_908_eus-gaap--AdjustmentForAmortization_pn3n3_do_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zeVLxg7jsuba" title="Amortization expense"><ix:nonFraction name="us-gaap:AdjustmentForAmortization" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="USD">no</ix:nonFraction></span> amortization expense for capitalized software
development costs for the period ended March 31, 2023 (Successor).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock"><p id="xdx_803_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zQbGWVp1VLHj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            7 &#8211; <span id="xdx_828_zm6IetZ2kADi">Goodwill and Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews goodwill for impairment on a reporting unit basis on December 31 of each year and whenever events or changes in circumstances
indicate the carrying value of goodwill may not be recoverable. The Company noted that the carrying amount of Goodwill for the period
ended March 31, 2023 (Successor) was $<span id="xdx_907_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Goodwill"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,122</ix:nonFraction></span>&#160;thousand, which was entirely due to the business combination noted in Note 3. The Company
did <span id="xdx_907_eus-gaap--Goodwill_iI_pn3n3_do_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zWZeCA8lcHRc" title="Goodwill"><span id="xdx_90B_eus-gaap--Goodwill_iI_pn3n3_do_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zBHy2OK2asI4" title="Goodwill"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span>t have any goodwill for the period ended March 14, 2023 (Predecessor) and the year ended December 31, 2022 (Predecessor).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
consisted of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfGoodwillTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfGoodwillTextBlock_pn3n3_zCdhsSSFZI4" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"><span id="xdx_8BC_z1G4BW8PF20f" style="display: none">Schedule of goodwill</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: bold; text-align: left"><span>Acquisition</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    as of March 14, 2023</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--Goodwill_iS_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zENOXH1riS2c" title="Beginning balance" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2005">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition
    of Legacy CXApp</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_989_ecustom--AcquisitionOfLegacyCxapp_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z45yDj18TUrc" title="Acquisition of Legacy CXApp" style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><span><ix:nonFraction name="cxai:AcquisitionOfLegacyCxapp" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,122</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance
    as of March 31, 2023</b></span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Goodwill_iE_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z4fv8NKdKfr" title="Ending balance" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,122</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zYX3VCiO7N0b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>



<ix:exclude><!-- Field: Page; Sequence: 161; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zv68XoUlWBSe" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_z8snAnQe7EOe" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span><b>CXAPP
            INC. AND SUBSIDIARIES<br/>
            NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_ztEAeZ0yUGhi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets consisted of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zWZlcw7OwmSc" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details 1)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BE_zZ6JNFlydzsh" style="display: none">Schedule of intangible assets</span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="12" style="border-bottom: Black 1pt solid; text-align: center"><span><b>March&#160;31,
    2023 (Successor)</b></span></td>
    <td style="border-right: Black 1.5pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="9" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span><b>December&#160;31,
    2022 (Predecessor)</b></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-align: center"><span><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span><b>Weighted Average Remaining<br/>
    Useful Life<br/>
    (Years)</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span><b>Gross
    Amount</b></span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span><b>&#160;</b></span></td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span><b>Accumulated
    Amortization</b></span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span><b>Net
    Carrying Amount</b></span></td>
    <td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span><b>Gross<br/>
    Amount</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span><b>Accumulated
    Amortization</b></span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span><b>&#160;</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span><b>Net Carrying<br/>
    Amount</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 30%; text-align: left"><span>Trade
    Name/Trademarks</span></td>
    <td style="width: 1%"><span>&#160;</span></td>
    <td style="text-align: center; width: 9%"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zNdfQJYF8MMh"><ix:nonNumeric contextRef="From2023-01-012023-03-31_us-gaap_TrademarksAndTradeNamesMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">7</ix:nonNumeric>
    </span><span>years</span></td>
    <td style="width: 1%"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"><span><ix:nonFraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_TrademarksAndTradeNamesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,294</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td>
    <td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"><span>(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_TrademarksAndTradeNamesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">20</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>)</span></td>
    <td style="width: 1%"><span>$</span></td>
    <td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" title="Net carrying amount" style="text-align: right; width: 7%; vertical-align: bottom"><span><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_TrademarksAndTradeNamesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,274</ix:nonFraction></span></td>
    <td style="border-right: Black 1.5pt solid; width: 1%"><span>&#160;</span></td>
    <td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%"><span>$</span></td>
    <td id="xdx_983_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" title="Gross carrying amount" style="text-align: right; width: 7%; vertical-align: bottom"><span><ix:nonFraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,183</ix:nonFraction></span></td>
    <td style="width: 1%"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"><span>(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">725</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>)</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%"><span>$</span></td>
    <td id="xdx_980_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" title="Net carrying amount" style="vertical-align: bottom; width: 7%; text-align: right"><span><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,458</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Customer
    Relationships</span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zB8897e0y01e"><ix:nonNumeric contextRef="From2023-01-012023-03-31_us-gaap_CustomerRelationshipsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">5</ix:nonNumeric>
    </span><span>years</span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"/><td id="xdx_988_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"><span><ix:nonFraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,604</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: left"/><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">47</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td>
    <td/>
    <td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Net carrying amount" style="text-align: right; vertical-align: bottom"><span><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,557</ix:nonFraction></span></td>
    <td style="border-right: Black 1.5pt solid"><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td/>
    <td id="xdx_98B_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Gross carrying amount" style="text-align: right; vertical-align: bottom"><span><ix:nonFraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,401</ix:nonFraction></span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,765</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td id="xdx_98D_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Net carrying amount" style="vertical-align: bottom; text-align: right"><span><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,636</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Developed
    Technology</span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zx0RCeDD1eC5"><ix:nonNumeric contextRef="From2023-01-012023-03-31_us-gaap_DevelopedTechnologyRightsMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">10</ix:nonNumeric>
    </span><span>years</span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"/><td id="xdx_981_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"><span><ix:nonFraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_DevelopedTechnologyRightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,268</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: left"/><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_DevelopedTechnologyRightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td>
    <td/>
    <td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" title="Net carrying amount" style="text-align: right; vertical-align: bottom"><span><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_DevelopedTechnologyRightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,230</ix:nonFraction></span></td>
    <td style="border-right: Black 1.5pt solid"><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td/>
    <td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" title="Gross carrying amount" style="text-align: right; vertical-align: bottom"><span><ix:nonFraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,179</ix:nonFraction></span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,398</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" title="Net carrying amount" style="vertical-align: bottom; text-align: right"><span><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,781</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Non-compete
    Agreements</span></td>
    <td><span>&#160;</span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"/><td style="text-align: right"/><td id="xdx_98E_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"><span>&#160;<span style="-sec-ix-hidden: xdx2ixbrl2045">-</span></span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: left"/><td style="text-align: right"/><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"><span>&#160;<span style="-sec-ix-hidden: xdx2ixbrl2046">-</span></span></td>
    <td/>
    <td style="text-align: right; vertical-align: bottom"/>
    <td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Net carrying amount" style="text-align: right"><span>&#160;<span style="-sec-ix-hidden: xdx2ixbrl2048">-</span></span></td>
    <td style="border-right: Black 1.5pt solid"><span>&#160;</span></td>
    <td/>
    <td style="text-align: right; vertical-align: bottom"/>
    <td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Gross carrying amount" style="text-align: right"><span>&#160;<ix:nonFraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,150</ix:nonFraction></span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"/><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,736</ix:nonFraction></span></td><td><span>)&#160;</span></td>
    <td><span>&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"/><td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Net carrying amount" style="text-align: right"><span>&#160;<ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,414</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Patents
    and Intellectual Property</span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_zdp9tDsk1yF7"><ix:nonNumeric contextRef="From2023-01-012023-03-31_custom_PatentsAndIntellectualPropertyMember" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">10</ix:nonNumeric>
    </span><span>years</span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"/><td id="xdx_980_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_PatentsAndIntellectualPropertyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,703</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"/><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right"><span>(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_PatentsAndIntellectualPropertyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td>
    <td style="border-bottom: Black 1pt solid"/>
    <td id="xdx_98E_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" title="Net carrying amount" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"><span><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_PatentsAndIntellectualPropertyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,692</ix:nonFraction></span></td>
    <td style="border-right: Black 1.5pt solid; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"/>
    <td id="xdx_98B_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" title="Gross carrying amount" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"><span><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2061">-</span></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span>&#160;</span></td>
    <td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" title="Net carrying amount" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2063">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Totals</span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: center"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span><ix:nonFraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,869</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span>(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">116</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>)</span></td>
    <td style="border-bottom: Black 2.5pt double"><span><b>$</b></span></td>
    <td id="xdx_98E_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Net carrying amount" style="border-bottom: Black 2.5pt double; text-align: right; vertical-align: bottom"><span><b><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,753</ix:nonFraction></b></span></td>
    <td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double"><span><b>$</b></span></td>
    <td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Gross carrying amount" style="border-bottom: Black 2.5pt double; text-align: right; vertical-align: bottom"><span><b><ix:nonFraction name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,913</ix:nonFraction></b></span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span>(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,624</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>)</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double"><span><b>$</b></span></td>
    <td id="xdx_982_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Net carrying amount" style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right"><span><b><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,289</ix:nonFraction></b></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>



</ix:nonNumeric><p id="xdx_8A1_zHbyDIQA6UV4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Aggregate
Amortization Expense</span>:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
amortization expense for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and three months ended
March 31, 2022 (Predecessor) was $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Aggregate amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">116</ix:nonFraction></span>&#160;thousand, $<span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Aggregate amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">806</ix:nonFraction></span>&#160;thousand and $<span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Aggregate amortization expense"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">975</ix:nonFraction></span>&#160;thousand, respectively.&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Future amortization
expense on intangible assets is anticipated to be as follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zJqYwSInNWFc" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details 2)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_z5HTfbrUy6d3" style="display: none">Schedule of future amortization expense</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20230331_zwQ9856fRWWf" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>For the Years Ending December 31,</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span><b>Amount</b></span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_zxjyh7QA55Y9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left"><span>2023</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,091</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_zbdwcY16FOg2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span>2024</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,788</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_zKVmOOAolct4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span>2025</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,788</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_zLAji46mngA7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span>2026</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,788</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_zS9JgRbwsq17" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span>2027</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,788</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_zZj7dbgJRHy4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span>2028 and thereafter</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,510</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zwOlRtjNtPj2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span>Total</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,753</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



</ix:nonNumeric><p id="xdx_8A1_zMmLpUyh3tc8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="cxai:DeferredRevenueTextBlock"><p id="xdx_80F_ecustom--DeferredRevenueTextBlock_zgU2ny2ItPb3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            8 &#8211; <span id="xdx_825_z1IP8sJhoCDk">Deferred Revenue</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
revenue consisted of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="cxai:ScheduleOfDeferredRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfDeferredRevenueTableTextBlock_pn3n3_zj2KgLFIIkKg" summary="xdx: Disclosure - Deferred Revenue (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span id="xdx_8B2_zchqaZqkPx6i" style="display: none">Schedule of deferred revenue</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>December&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>License
    agreements</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_pn3n3" title="Total Deferred Revenue" style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:DeferredRevenue" contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_LicensingAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,388</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_pn3n3" title="Total Deferred Revenue" style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:DeferredRevenue" contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_LicensingAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,937</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Professional
    Service agreements</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_987_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProfessionalServiceAgreementsMember_pn3n3" title="Total Deferred Revenue" style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:DeferredRevenue" contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_ProfessionalServiceAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">302</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_984_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProfessionalServiceAgreementsMember_pn3n3" title="Total Deferred Revenue" style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:DeferredRevenue" contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_ProfessionalServiceAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">225</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    Deferred Revenue</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Total Deferred Revenue" style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:DeferredRevenue" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,690</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Total Deferred Revenue" style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:DeferredRevenue" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,162</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the deferred revenue approximates the services to be rendered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_80B_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zG91zv8YL3pd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            9 &#8211; <span id="xdx_823_zOglLK1mChUl">Accrued Liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
liabilities consisted of the following (in thousands):</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_pn3n3_zOeSOxMe5APg" summary="xdx: Disclosure - Accrued Liabilities (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BC_zKl5L4jOGS6k" style="display: none">Schedule of accrued Liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zmL8jaAuCRW9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zhCV2sZdbhz4" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>March
    31, <br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>December
    31, <br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--InsurancePremiumsAndAccruedInterest_iI_pn3n3_maALCzxmM_zz1sEcoAmQ0j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Insurance
    premiums and accrued interest</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><ix:nonFraction name="cxai:InsurancePremiumsAndAccruedInterest" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">538</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2117">-</span></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--RelatedPartyPromissoryNote_iI_pn3n3_maALCzxmM_zvwDIWs3f5Wk" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Related
    party promissory note</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:RelatedPartyPromissoryNote" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2120">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedIncomeTaxes_iI_pn3n3_maALCzxmM_zenaZb0oeUsj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Income
    tax payables</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AccruedIncomeTaxes" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">57</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2123">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--RelatedPartyPayable_iI_pn3n3_maALCzxmM_zjU5qnO5OgEh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Related
    party payable</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:RelatedPartyPayable" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,155</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2126">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--AccruedCompensationAndBenefits_iI_pn3n3_maALCzxmM_zq3R15YIGTvc" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    compensation and benefits</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:AccruedCompensationAndBenefits" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:AccruedCompensationAndBenefits" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">586</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_pn3n3_maALCzxmM_zBOB8vq7dQv6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    bonus and commissions</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AccruedBonusesCurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">192</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AccruedBonusesCurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">422</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedRentCurrent_iI_pn3n3_maALCzxmM_zXTwKPJlqCo9" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    rent</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AccruedRentCurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="us-gaap:AccruedRentCurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">559</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--AccruedOther_iI_pn3n3_maALCzxmM_zu4KRip245Wf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    other</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:AccruedOther" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">561</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><ix:nonFraction name="cxai:AccruedOther" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_iI_pn3n3_maALCzxmM_zgDiEBkmJ6H9" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Accrued
    sales and other indirect taxes payable</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><ix:nonFraction name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">86</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iTI_pn3n3_mtALCzxmM_z07ywXVdp7mk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255); vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span>Accrued
    liabilities</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,182</ix:nonFraction></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,736</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>



<ix:exclude><!-- Field: Page; Sequence: 162; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zMibSf6ZOxu1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zsgIztx8CY7d" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span><b>CXAPP
            INC. AND SUBSIDIARIES<br/>
            NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z7DcDA7rCfi9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financed
Director &amp; Officers Insurance</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into a Directors &amp; Officers (&#8220;D&amp;O&#8221;) insurance agreement with Oakwood D&amp;O Insurance,
effective on March 14, 2023. The agreement states that the Company will pay a total of $<span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--TitleOfIndividualAxis__custom--DirectorAndOfficersMember_zo7hS853Zt03" title="Debt payment"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_DirectorAndOfficersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">671</ix:nonFraction></span>
thousand in premiums at an annual percentage rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_z7GuFfgoV4Tj" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction>%</span>.
The first of nine monthly separate installment payments begin on April 14, 2023. The Company paid a down payment on the policy of
$<span id="xdx_907_eus-gaap--PaymentsOfDebtIssuanceCosts_pn3n3_c20230101__20230314__srt--TitleOfIndividualAxis__custom--DirectorAndOfficersMember__srt--StatementScenarioAxis__custom--PredecessorMember_zKF2pVhORR22" title="Debt issuance cost"><ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_DirectorAndOfficersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">134</ix:nonFraction></span>
thousand.  As of March 31, 2023 (Successor) the  Company currently owes $<span id="xdx_901_eus-gaap--OtherBorrowings_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zVv0BhrcV6pd" title="Debt owed balance"><ix:nonFraction name="us-gaap:OtherBorrowings" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">538</ix:nonFraction></span>
thousand on the D&amp;O insurance policy.</span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Related
Party Liabilities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><span id="xdx_901_ecustom--RelatedPartyDescription_c20230101__20230331_zM0ziQc2RUf7" title="Related party description"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="cxai:RelatedPartyDescription">As
of March 31, 2023, the Company&#8217;s related party liabilities consisted of a promissory note payable to the KINS sponsor in the amount of $20 thousand for working capital. As of March 31, 2023, accrued
liabilities include an estimate of approximately $1,045 thousand due to Inpixon by CXApp resulting from an agreement to reimburse
Inpixon (subject to review and acceptance by the Company) for certain transaction related costs incurred by Inpixon on behalf of KINS prior to March
14, 2023. This amount is subject to an ongoing review and evaluation by the Company. Additionally, as of March 31, 2023, accrued
liabilities include (i) $30 thousand for estimated costs related to transition services provided by Inpixon to CXApp and (ii) $80
thousand of reimbursable expenses incurred by Inpixon on behalf of CXApp during the period from March 15, 2023 to March 31,
2023.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>In connection
with a distribution of CXApp securities by KINS Capital LLC, Inpixon is entitled to acquire 2,500,000 CXApp Private Placement Warrants,
which reflects Inpixon&#8217;s existing indirect interests in CXApp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="cxai:WarrantLiabilitiesTextBlock"><p id="xdx_806_ecustom--WarrantLiabilitiesTextBlock_zBzaT0tsQVla" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            10 - <span id="xdx_82B_zQ857yPpDFV4">Warrant Liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2023 (Successor) there were <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zw3oxaz5fTM1" title="Warrants outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">13,800</ix:nonFraction></span> thousand Public Warrants outstanding. Each whole warrant entitles the holder thereof to purchase one share of the Company&#8217;s Class A common stock at a price of $<span id="xdx_906_eus-gaap--WarrantExercisePriceIncrease_pid_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zXYamto7cQk8" title="Warrant Price"><ix:nonFraction name="us-gaap:WarrantExercisePriceIncrease" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per share, subject to adjustments described in the Company&#8217;s registration statement on Form S-1 (Registration No. 333-249177) filed in connection with its initial public offering. </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and
only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) <span id="xdx_902_ecustom--WarrantExercisePeriodConditionOne_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zKCNTaUvQ0z5" title="Warrant exercise period condition one"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_PublicWarrantsMember" format="ixt-sec:durday" name="cxai:WarrantExercisePeriodConditionOne">30</ix:nonNumeric></span>
days after the completion of a Business Combination and (b) <span id="xdx_90C_ecustom--WarrantExercisePeriodConditionTwo_dtM_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zioXhGENb6ad" title="Warrant exercise period condition two"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_PublicWarrantsMember" format="ixt-sec:durmonth" name="cxai:WarrantExercisePeriodConditionTwo">12</ix:nonNumeric></span>
months from the closing of the Initial Public Offering. The Public Warrants will expire five <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zpCYGmvO5gnc" title="Public Warrants expiration term" style="display: none"><ix:nonNumeric contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_PublicWarrantsMember" format="ixt-sec:duryear" name="us-gaap:WarrantsAndRightsOutstandingTerm">5</ix:nonNumeric></span> years after the completion of a
Business Combination or earlier upon redemption or liquidation.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation
to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class
A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying
its obligations with respect to registration. No warrant will be exercisable, and the Company will not be obligated to issue shares of
Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
has filed a registration statement on Form S-1 (Registration No. 333-271340) under the Securities Act on April 19, 2023 covering the
issuance of the shares of Class A common stock issuable upon exercise of the warrants, and will use its commercially reasonable efforts
to have it declared effective by the SEC within 60 business days following a Business Combination. The Company will use its commercially
reasonable efforts to maintain the effectiveness of such registration statement and a current prospectus relating to those shares of
Class A common stock until the warrants expire or are redeemed. Notwithstanding the above, if the Class A common stock is at the time
of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a &#8220;covered security&#8221;
under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants
to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so
elects, the Company will not be required to file or maintain in effect a registration statement, but we will be required to use our commercially
reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemptions
of warrants when the price of Class A common stock equals or exceeds $<span id="xdx_904_ecustom--WarrantRedemptionConditionMinimumSharePrice_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_pdd" title="Warrant redemption condition minimum share price"><ix:nonFraction name="cxai:WarrantRedemptionConditionMinimumSharePrice" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.00</ix:nonFraction></span> &#8211; </i>Once the warrants become exercisable, the Company
may redeem the Public Warrants:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            whole and not in part;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                            a price of $<span id="xdx_903_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd" title="Redemption price per public warrant (in dollars per share)"><ix:nonFraction name="cxai:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per warrant;</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 163; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_z9zWKHOfqr83" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zx55sxDvZ7vj" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span><b>CXAPP
            INC. AND SUBSIDIARIES<br/>
            NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_236_z5bcN7dXokjf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            not less than <span id="xdx_903_ecustom--RedemptionPeriod_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zy6C2BXNoJC5" title="Redemption period"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember" format="ixt-sec:durday" name="cxai:RedemptionPeriod">30</ix:nonNumeric></span> days&#8217; prior written notice of redemption, or the <span id="xdx_90A_ecustom--RedemptionPeriod_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zezs0zxXwX61" title="Redemption period"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember" format="ixt-sec:durday" name="cxai:RedemptionPeriod">30</ix:nonNumeric></span>-day redemption
                                            period, to each warrant holder; and</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
                                            and only if, the reported last sale price of the Company&#8217;s Class A common stock equals
                                            or exceeds $<span id="xdx_908_ecustom--WarrantRedemptionConditionMinimumSharePrice_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd" title="Warrant redemption condition minimum share price"><ix:nonFraction name="cxai:WarrantRedemptionConditionMinimumSharePrice" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.00</ix:nonFraction></span> per share (as adjusted for stock splits, stock dividends, reorganizations,
                                            recapitalizations, and the like) for any <span id="xdx_90D_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zRMp2O3txJkc" title="Threshold trading days for redemption of public warrants"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember" format="ixt-sec:durday" name="cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays">20</ix:nonNumeric></span> trading days within a <span id="xdx_900_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zT4ioKX3vogh" title="Threshold consecutive trading days for redemption of public warrants"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember" format="ixt-sec:durday" name="cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays">30</ix:nonNumeric></span>-day trading period ending
                                            on the <span id="xdx_909_ecustom--ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zgEtUvNM2ECl" title="Threshold number of business days before sending notice of redemption to warrant holders"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember" name="cxai:ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders">third trading day</ix:nonNumeric></span> prior to the date on which the Company sends the notice of redemption
                                            to the warrant holders.</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
of warrants when the price per share of Class A common stock equals or exceeds $<span id="xdx_904_ecustom--WarrantRedemptionConditionMinimumSharePriceScenarioTwo_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_pdd" title="Warrant redemption condition minimum share price scenario two"><ix:nonFraction name="cxai:WarrantRedemptionConditionMinimumSharePriceScenarioTwo" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> &#8211; </i>Once the warrants become exercisable,
the Company may redeem the outstanding warrants:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            whole and not in part;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                            a price of $<span id="xdx_907_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_pdd" title="Redemption price per public warrant (in dollars per share)"><ix:nonFraction name="cxai:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></span> per warrant provided that holders will be able to exercise their warrants
                                            prior to redemption and receive that number of shares of Class A common stock determined
                                            based on the redemption date and the &#8220;fair market value&#8221; of the Company&#8217;s
                                            Class A common stock;</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                                            not less than <span id="xdx_90E_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zVpQtCbeOiAh" title="Threshold consecutive trading days for redemption of public warrants"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember" format="ixt-sec:durday" name="cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays">30</ix:nonNumeric></span> days&#8217; prior written notice of redemption, or the <span id="xdx_90D_ecustom--RedemptionPeriod_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zjhoZJNdH5vg" title="Redemption period"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember" format="ixt-sec:durday" name="cxai:RedemptionPeriod">30</ix:nonNumeric></span>-day redemption
                                            period;</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
                                            and only if, the last reported sale price of the Company&#8217;s Class A common stock equals
                                            or exceeds $<span id="xdx_904_ecustom--WarrantRedemptionConditionMinimumSharePriceScenarioTwo_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" title="Warrant redemption condition minimum share price scenario two"><ix:nonFraction name="cxai:WarrantRedemptionConditionMinimumSharePriceScenarioTwo" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per share (as adjusted for stock splits, stock dividends, reorganizations,
                                            recapitalizations and the like) on the trading day prior to the date on which the Company
                                            sends the notice of redemption to the warrant holders;</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
                                            and only if, there is an effective registration statement covering the issuance of the shares
                                            of Class A common stock issuable upon exercise of the warrants and a current prospectus relating
                                            thereto is available throughout the 30-day period after the written notice of redemption
                                            is given.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2023 (Successor), there were <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zfuk3j9tQgi9" title="Warrants outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_PrivatePlacementWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,280</ix:nonFraction></span> thousand Private Placement Warrants outstanding. The Private Placement Warrants are identical
to the Public Warrants, except that the Private Placement Warrants and the shares
of Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable
until <span id="xdx_904_ecustom--RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTjl8sAUjwXk" title="Restrictions on transfer period of time after business combination completion"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_PublicWarrantsMember" format="ixt-sec:durday" name="cxai:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion">30</ix:nonNumeric></span> days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement
Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial
purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or
their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the
same basis as the Public Warrants.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<ix:exclude><!-- Field: Page; Sequence: 164; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zoDW6GRzr3p7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zUiO2VulnKr1" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span><b>CXAPP
            INC. AND SUBSIDIARIES<br/>
            NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zMc8xqfptG5h" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>


</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="cxai:StockAwardPlansAndStockbasedCompensationTextBlock"><p id="xdx_809_ecustom--StockAwardPlansAndStockbasedCompensationTextBlock_zOpakbRmBmck" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            11 &#8211; <span id="xdx_82F_zU3OF0LA6Z87">Stock Option Plan and Stock-Based Compensation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
calculate the stock-based compensation resulting from the issuance of options uses the Black-Scholes option pricing model, which is affected
by the Company&#8217;s fair value of its stock price as well as assumptions regarding a number of subjective variables. These variables
include, but are not limited to, the Company&#8217;s expected stock price volatility over the term of the awards, and actual and projected
employee stock option exercise behaviors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><b><i>2023
Equity Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>At the special meeting held on March 10, 2023, the KINS stockholders
considered and approved, among other things, the CXApp Inc. 2023 Equity Incentive Plan (the &#8220;Incentive Plan&#8221;). The Incentive
Plan was previously approved, subject to stockholder approval, by KINS&#8217; board of directors. The Incentive Plan became effective
immediately upon the closing of the Business Combination. Pursuant to the terms of the Incentive Plan, there are <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20230310__us-gaap--PlanNameAxis__custom--N2023EquityIncentivePlanMember_ztqMr22lpbE4" title="Shares available for issuance"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="AsOf2023-03-10_custom_N2023EquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,110,500</ix:nonFraction></span> shares of CXApp
Class A Common Stock available for issuance under the Incentive Plan, which is equal to 15% of the aggregate number of shares of CXApp
common stock issued and outstanding immediately after the closing (giving effect to the redemptions).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employee
Stock Options</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period ended March 31, 2023 (Successor), a total of <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pin3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember_z2mNWCKJr3ib" title="Stock option granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember" format="ixt:numdotdecimal" decimals="INF" scale="3" unitRef="Shares">1,377</ix:nonFraction></span>&#160;thousand of stock options for the purchase of the Company&#8217;s
common stock were granted to employees and directors of the Company. These options vest over a <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember_zWLF8Q8WGDx7" title="Vesting period"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">2</ix:nonNumeric></span> year period, with 50% vested at the
end of year one and 50% vested at the end of year two. The options have a life of <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember__srt--RangeAxis__srt--MinimumMember_zSQqtXnw9qaa" title="Option life"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">5</ix:nonNumeric></span> to <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember__srt--RangeAxis__srt--MaximumMember_z5QCiCysYhRb" title="Option life"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">7</ix:nonNumeric></span> years and an exercise price of $1.53 per share.
The stock options were valued using the Black-Scholes option valuation model and the fair value of the awards was determined to be approximately
$<span id="xdx_904_ecustom--FairValueOfOptions_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember_zrA3xvph6opa" title="Fair value of options"><ix:nonFraction name="cxai:FairValueOfOptions" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">688</ix:nonFraction></span>&#160;thousand. The fair value of the common stock as of the grant date was determined to be $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember_pdd" title="Fair value of common stock as of grant date"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.53</ix:nonFraction></span> per share.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period ended March 31, 2023 (Successor), the Company recorded a charge of approximately $<span id="xdx_904_ecustom--AmortizationOfEmployeeStockOptions_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember_z6hglpJJRA3" title="Amortization of employee stock options"><ix:nonFraction name="cxai:AmortizationOfEmployeeStockOptions" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></span>&#160;thousand for the amortization of
employee stock options, which is included in the general and administrative section of the condensed
consolidated statement of operations.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2023 (Successor), the fair value of non-vested options totalled approximately $<span id="xdx_90A_ecustom--FairValueOfNonvestedOptions_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zKtxUbYztgm" title="Fair value of non-vested options"><ix:nonFraction name="cxai:FairValueOfNonvestedOptions" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">686</ix:nonFraction></span>&#160;thousand, which will be amortized
to expense over the weighted average remaining term of <span id="xdx_90B_ecustom--WeightedAverageRemainingTermOfNonvestedOptions_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zbQD81Cr97Ic" title="Weighted average remaining term of non-vested options"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt-sec:duryear" name="cxai:WeightedAverageRemainingTermOfNonvestedOptions">2</ix:nonNumeric></span>.0 years.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each employee option grant is estimated on the date of the grant using the Black-Scholes option-pricing model. Key weighted-average
assumptions used to apply this pricing model during the period ended March 31, 2023 (Successor) were as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_pn3n3_z2NUvsA0cEHe" summary="xdx: Disclosure - Stock Award Plans and Stock-Based Compensation (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BF_znZ31CjRifj1" style="display: none">Schedule of assumptions used</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Risk-free
    interest rate</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zVRZ3IzFBiO5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_srt_MinimumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.62</ix:nonFraction></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>%
    &#8211; <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_zLB2ZDOvl8d2"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_srt_MaximumMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.67</ix:nonFraction></span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>%</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Expected
    life of option grants</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zsjbfmPoo0R2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_srt_MinimumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5</ix:nonNumeric>
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#8211; <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_zcGebklMyTh5"><ix:nonNumeric contextRef="From2023-03-152023-03-31_custom_SuccessorMember_srt_MaximumMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">7</ix:nonNumeric>
    </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>years</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 80%; text-align: left"><span>Expected
    volatility of underlying stock</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 18%; text-align: center"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zUPdCMrAqrC9"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">37.35</ix:nonFraction></span><span>%</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Dividends
    assumption</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z6AuyXgzoIa2"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="1" unitRef="Pure">0</ix:nonFraction>%</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_80D_eus-gaap--FairValueDisclosuresTextBlock_z35Sy0q81rx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>NOTE
                                            12 &#8211; <span id="xdx_82A_zhmle8mvvbWl">Fair Value of Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company&#8217;s estimates of fair value for financial assets and financial
liabilities are based on the framework established in ASC 820. The Company noted that the only financial asset or financial liability
that is subject to the fair value framework established in ASC 820 are the Warrant Liabilities (Note 10). The framework is based on the
inputs used in valuation and gives the highest priority to quoted prices in active markets and requires that observable inputs be used
in the valuations when available. The disclosure of fair value estimates in the ASC 820 hierarchy is based on whether the significant
inputs into the valuation are observable. In determining the level of the hierarchy in which the estimate is disclosed, the highest priority
is given to unadjusted quoted prices in active markets and the lowest priority to unobservable inputs that reflect the Company&#8217;s
significant market assumptions. The Company classified the public placement warrants recorded at fair value of on a recurring basis of
$<span id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicPlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMq2GTSKfxM1" title="Fair value of warrants"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_PublicPlacementWarrantsMember_us-gaap_FairValueInputsLevel1Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">552</ix:nonFraction></span> thousand as a level 1 investment, as the fair value was determined using quoted prices of the security in active markets. The Company
classified the private placement warrants liabilities recorded at fair value of $<span id="xdx_902_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNC91dQta9lf"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel2Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">411</ix:nonFraction></span> thousand as a level 2 investment, as the fair
value was determined utilizing the observable market price for the public placement warrants as the private placement warrants are not
actively traded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zi27H6MNvap6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            13 &#8211; <span id="xdx_828_z5DrixpnJT98">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company recorded an income tax benefit of
approximately $<span id="xdx_90D_ecustom--IncomeTaxBenefitprovision_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zqiJeTBvEli8" title="Income tax benefit/(provision)"><ix:nonFraction name="cxai:IncomeTaxBenefitprovision" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,560</ix:nonFraction></span> thousand for the period ended March 31, 2023 (Successor). The Company recorded an income tax expense of approximately
$<span id="xdx_90D_ecustom--IncomeTaxBenefitprovision_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zMIdmVgyll" title="Income tax benefit/(provision)"><ix:nonFraction name="cxai:IncomeTaxBenefitprovision" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span> thousand and $<span id="xdx_90F_ecustom--IncomeTaxBenefitprovision_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zFSCLOziUpod" title="Income tax benefit/(provision)"><ix:nonFraction name="cxai:IncomeTaxBenefitprovision" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></span> thousand for the period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022 (Predecessor),
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The effective tax rate for period ended March 31, 2023 (Successor)
was approximately (<span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zKPxfDx39M04" title="Effective tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">164.0</ix:nonFraction>%</span>). The income tax benefit, and negative effective tax rate, for the period ended March 31, 2023 (Successor) is
a result of the release of valuation allowance attributable to acquired intangible assets from the Business Combination. The Company acquired
approximately $<span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Deferred tax liability"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" contextRef="AsOf2023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,337</ix:nonFraction></span> thousand of deferred tax liability associated with the Business Combination. As a result of the Company released
its valuation allowance as deferred tax assets will become realizable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<ix:exclude><!-- Field: Page; Sequence: 165; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zwfc5rLJFoR7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zguPfObiK6qh" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span><b>CXAPP
            INC. AND SUBSIDIARIES<br/>
            NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zsi9iMsOmoQ2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_808_eus-gaap--ConcentrationRiskDisclosureTextBlock_zYqz7SmNeksk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            14 &#8211; <span id="xdx_822_z6MSvn9T5Lfc">Credit Risk and Concentrations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that subject the Company to credit risk consist principally of trade accounts receivable and cash and cash equivalents. The
Company performs certain credit evaluation procedures and does not require collateral for financial instruments subject to credit risk.
The Company believes that credit risk is limited because the Company routinely assesses the financial strength of its customers and,
based upon factors surrounding the credit risk of its customers, establishes an allowance for credit losses and, consequently, believes
that its accounts receivable credit risk exposure beyond such allowances is limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains cash deposits with financial institutions, which, from time to time, may exceed federally insured limits. Cash is also
maintained at foreign financial institutions for its Canadian and Philippines subsidiaries and its majority-owned India subsidiary. Cash
in foreign financial institutions as of March 31, 2023 (Successor) and December 31, 2022 (Predecessor) was immaterial. The Company has
not experienced any losses and believes it is not exposed to any significant credit risk from cash.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="cxai:ForeignOperationsTextBlock"><p id="xdx_802_ecustom--ForeignOperationsTextBlock_zY2GsZ0N4Jq4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            15 &#8211; <span id="xdx_823_z9bKqAln93S3">Foreign Operations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s operations are located primarily in the United States, Canada, and the Philippines. Revenues by geographic area are attributed
by country of domicile of the Company&#8217;s subsidiaries. The financial data by geographic area are as follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_zZGvyLMcGts1" summary="xdx: Disclosure - Foreign Operations (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;<span id="xdx_8BC_zLbtzx9EEIa3" style="display: none">Schedule of financial data by geographic area</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span>&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>United</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>States</b></span></p></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Canada</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>India</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Philippines</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Eliminations</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Total</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">For
    the Period Ended March 31, 2023 (Successor)</span>:</td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left"><span>Revenues
    by geographic area</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" title="Revenues by geographic area" style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">272</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" title="Revenues by geographic area" style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_CA" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" title="Revenues by geographic area" style="width: 9%; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2267">-</span></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" title="Revenues by geographic area" style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_PH" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">196</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" title="Revenues by geographic area" style="width: 9%; text-align: right"><span>(<ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">196</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>)</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zHHHk5YCIdDb" title="Revenues by geographic area" style="width: 9%; text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">342</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_zWzzmjbBiyM3" title="Operating income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">486</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_zQnReV5rrAW2" title="Operating income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_CA" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">158</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_zXKExpq4bLPk" title="Operating income (loss) by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2279">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_PH" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">157</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2283">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">487</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,780</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_CA" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">158</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2291">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_PH" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">157</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">21</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,758</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">For
    the Period Ended March 14, 2023 (Predecessor)</span>:</td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Revenues
    by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" title="Revenues by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,395</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" title="Revenues by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_CA" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">285</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" title="Revenues by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2303">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" title="Revenues by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_PH" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">160</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" title="Revenues by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">220</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zKQARgGUsx78" title="Revenues by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,620</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,479</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_CA" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">905</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2315">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_PH" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2319">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,381</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,342</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_CA" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,041</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2327">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_PH" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2331">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,380</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">For
    the Three Months Ended March 31, 2022 (Predecessor)</span>:</td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Revenues
    by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" title="Revenues by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,167</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" title="Revenues by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_CA" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">601</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" title="Revenues by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_IN" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">270</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" title="Revenues by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2341">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" title="Revenues by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">456</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zuwXX0ESDeF8" title="Revenues by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,582</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">650</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98D_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_CA" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,008</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_IN" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2353">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Operating income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,572</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">519</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_CA" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,139</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_IN" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">27</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2365">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Net income (loss) by geographic area" style="text-align: right"><span>(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,671</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">As
    of March 31, 2023 (Successor)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Identifiable
    assets by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_znpZI1Rc6fhf" title="Identifiable assets by geographic area" style="text-align: right"><span><ix:nonFraction name="cxai:NetAssets" contextRef="AsOf2023-03-31_custom_SuccessorMember_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">75,059</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_zZYPA1LCaawe" title="Identifiable assets by geographic area" style="text-align: right"><span><ix:nonFraction name="cxai:NetAssets" contextRef="AsOf2023-03-31_custom_SuccessorMember_country_CA" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">991</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_znpRbfRKD09l" title="Identifiable assets by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2375">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_zJ7a49f51zpi" title="Identifiable assets by geographic area" style="text-align: right"><span><ix:nonFraction name="cxai:NetAssets" contextRef="AsOf2023-03-31_custom_SuccessorMember_country_PH" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">405</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98C_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_zOFdFNj8rmg8" title="Identifiable assets by geographic area" style="text-align: right"><span>(<ix:nonFraction name="cxai:NetAssets" contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">71</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zXRC4kDjFI48" title="Identifiable assets by geographic area" style="text-align: right"><span><ix:nonFraction name="cxai:NetAssets" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76,384</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Long
    lived assets by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" title="Long lived assets by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2023-03-31_custom_SuccessorMember_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,817</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" title="Long lived assets by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2023-03-31_custom_SuccessorMember_country_CA" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">417</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" title="Long lived assets by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2387">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" title="Long lived assets by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2023-03-31_custom_SuccessorMember_country_PH" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">222</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" title="Long lived assets by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2391">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Long lived assets by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,455</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Goodwill
    by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" title="Goodwill by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,122</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" title="Goodwill by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2397">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" title="Goodwill by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2399">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" title="Goodwill by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2401">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" title="Goodwill by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2403">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Goodwill by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,122</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">As
    of December 31, 2022 (Predecessor)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Identifiable
    assets by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_zPVGKa173qfg" title="Identifiable assets by geographic area" style="text-align: right"><span><ix:nonFraction name="cxai:NetAssets" contextRef="AsOf2022-12-31_custom_PredecessorMember_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,591</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_zf9p6NSjtU52" title="Identifiable assets by geographic area" style="text-align: right"><span><ix:nonFraction name="cxai:NetAssets" contextRef="AsOf2022-12-31_custom_PredecessorMember_country_CA" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,484</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_z6K5KYsdGEVe" title="Identifiable assets by geographic area" style="text-align: right"><span><ix:nonFraction name="cxai:NetAssets" contextRef="AsOf2022-12-31_custom_PredecessorMember_country_IN" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98D_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_zeJEIqXxOymd" title="Identifiable assets by geographic area" style="text-align: right"><span><ix:nonFraction name="cxai:NetAssets" contextRef="AsOf2022-12-31_custom_PredecessorMember_country_PH" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">415</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_zlP5RMOQkOxk" title="Identifiable assets by geographic area" style="text-align: right"><span>(<ix:nonFraction name="cxai:NetAssets" contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_EliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,438</ix:nonFraction></span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zFo4trmxzHp3" title="Identifiable assets by geographic area" style="text-align: right"><span><ix:nonFraction name="cxai:NetAssets" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,280</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Long
    lived assets by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" title="Long lived assets by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2022-12-31_custom_PredecessorMember_country_US" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,558</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" title="Long lived assets by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2022-12-31_custom_PredecessorMember_country_CA" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,788</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" title="Long lived assets by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2022-12-31_custom_PredecessorMember_country_IN" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">98</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" title="Long lived assets by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2022-12-31_custom_PredecessorMember_country_PH" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">215</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" title="Long lived assets by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2427">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Long lived assets by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:NoncurrentAssets" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,659</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Goodwill
    by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" title="Goodwill by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2431">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" title="Goodwill by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2433">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" title="Goodwill by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2435">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" title="Goodwill by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2437">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" title="Goodwill by geographic area" style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2439">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--Goodwill_iI_pn3n3_d0_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zMfxFSYSCSji" title="Goodwill by geographic area" style="text-align: right"><span><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">-</ix:nonFraction></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<ix:exclude><!-- Field: Page; Sequence: 166; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zia9gNTdg8o8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zZQHgE7PFQ4l" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span><b>CXAPP
            INC. AND SUBSIDIARIES<br/>
            NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zwBeQL9VArf5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>



</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:LeasesOfLesseeDisclosureTextBlock"><p id="xdx_807_eus-gaap--LeasesOfLesseeDisclosureTextBlock_zt5UZGhTPTgh" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            16 &#8211; <span id="xdx_824_zOLZNaQx4c16">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has operating leases for administrative offices in Canada and the Philippines. The Manila, Philippines office lease expires
in May 2025 and the Canada lease expires in June 2026. The Company entered into a 13-month lease for administrative offices in
California on April 1, 2023 with lease payments of approximately <span id="xdx_907_ecustom--LeasePeriodicPayments_pn3n3_c20230101__20230331_zDFG3rrpw2Aa" title="Lease periodic payments">$<ix:nonFraction name="cxai:LeasePeriodicPayments" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></span>
thousand per month. The Company has no other operating or financing leases with terms greater than 12 months.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
expense for operating leases recorded in the balance sheet is included in operating costs and expenses and is based on the future minimum
lease payments recognized on a straight-line basis over the term of the lease plus any variable lease costs. Operating lease expenses,
inclusive of short-term and variable lease expenses, recognized in the Company&#8217;s condensed consolidated statement of operations
for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022 (Predecessor)
was approximately $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zP7S67bygUP3" title="Operating lease expenses"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2023-03-152023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></span>&#160;thousand, $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Operating lease expenses"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2023-01-012023-03-14_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">57</ix:nonFraction></span>&#160;thousand and $<span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Operating lease expenses"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2022-01-012022-03-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">97</ix:nonFraction></span>&#160;thousand, respectively.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining
the present value of lease payments, the Company used its incremental borrowing rate based on the information available at the date
of adoption of ASC 842 &#8220;Leases&#8221; (&#8220;ASC 842&#8221;). As of March 31, 2023 (Successor), the weighted average
remaining lease term is <span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z8dWSnnnDn2f" title="Weighted average remaining lease term"><ix:nonNumeric contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">2.7</ix:nonNumeric></span> years and the weighted average discount rate used to determine the operating lease liabilities was <span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zxZ9JyQ3IzT9" title="Weighted average discount rate used to determine operating lease"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2023-03-31_custom_SuccessorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.0</ix:nonFraction></span>%.
As of year ended December 31, 2022 (Predecessor), the weighted average remaining lease term is <span id="xdx_900_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zmGyzXZpStpb" title="Weighted average remaining lease term"><ix:nonNumeric contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">2.8</ix:nonNumeric></span>
years and the weighted average discount rate used to determine the operating lease liabilities was <span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_z5OFOmEqz349" title="Weighted average discount rate used to determine operating lease"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2022-12-31_custom_PredecessorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.0</ix:nonFraction></span>%.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zJJyEZ35MR49" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            17 &#8211; <span><span id="xdx_828_zxnRMO3h1XN7">Commitments and Contingencie</span>s</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Litigation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
conditions may exist as of the date the financial statements are issued which may result in a loss to the Company, but which will only
be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment
inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the
Company, or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings
or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability
can be estimated, then the estimated liability would be accrued in the Company&#8217;s financial statements. If the assessment indicates
that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then
the nature of the contingent liability and an estimate of the range of possible losses, if determinable and material, would be disclosed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
contingencies considered remote are generally not disclosed, unless they involve guarantees, in which case the guarantees would be disclosed.
There can be no assurance that such matters will not materially and adversely affect the Company&#8217;s business, financial position,
and results of operations or cash flows.</span></p>

</ix:nonNumeric><p id="xdx_818_zKx9fzOkesQ7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<!-- Field: Page; Sequence: 167; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INFORMATION
NOT REQUIRED IN PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.75in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 13.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Expenses of Issuance and Distribution</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the costs and expenses, payable by the registrant in connection with the registration of its common stock.
All amounts are estimates except the Securities and Exchange Commission registration fee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Amount to</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">Item</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Be Paid*</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Securities and Exchange Commission registration fee</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">31,704.61</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Blue Sky fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Legal fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accounting fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Printing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Miscellaneous</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">31,704.61</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>




























<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates
not presently known.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will bear all costs, expenses and fees in connection with the registration of the securities, including with regard to compliance with
state Securities or &#8220;blue sky&#8221; laws. The Selling Securityholders, however, will bear all underwriting commissions and discounts,
if any, attributable to their sale of the securities. All amounts are estimates except the SEC registration fee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.75in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
14.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification
of Directors and Officers</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&#160;145
of the DGCL provides, generally, that a corporation shall have the power to indemnify any person who was or is a party or is threatened
to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative
(other than an action by or in the right of the corporation) by reason of the fact that such person is or was a director, officer, employee
or agent of the corporation against all expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred by
such person in connection with such action, suit or proceeding if such person acted in good faith and in a manner such person reasonably
believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had
no reasonable cause to believe his or her conduct was unlawful. A corporation may similarly indemnify such person for expenses actually
and reasonably incurred by such person in connection with the defense or settlement of any action or suit by or in the right of the corporation,
provided that such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests
of the corporation, and, in the case of claims, issues and matters as to which such person shall have been adjudged liable to the corporation,
provided that a court shall have determined, upon application, that, despite the adjudication of liability but in view of all of the
circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which such court shall deem proper.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Section&#160;102(b)(7) of the DGCL, our Charter provides that a director will not be personally liable to CXApp or the
CXApp stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (i) for any breach of the director&#8217;s
duty of loyalty to CXApp or the CXApp stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct
or a knowing violation of law, (iii) under Section&#160;174 of the DGCL, or (iv) for any transaction from which the director derived
an improper personal benefit. No such provision shall eliminate or limit the liability of a director for any act or omission occurring
prior to the date when such provision became effective. Accordingly, these provisions will have no effect on the availability of equitable
remedies such as an injunction or rescission based on a director&#8217;s breach of his or her duty of care.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Bylaws provide that CXApp will indemnify its present and former directors and officers to the maximum extent permitted by the DGCL and
that such indemnification will not be exclusive of any other rights to which those seeking indemnification may be entitled under any
certificate of incorporation provision, bylaw provision, agreement, vote of the CXApp stockholders or disinterested directors or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 168; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
our Charter contains provisions that limit the liability of CXApp&#8217;s directors for damages to the fullest extent permitted by Delaware
law. Consequently, CXApp&#8217;s directors will not be personally liable to CXApp or its stockholders for damages as a result of an act
or failure to act in his or her capacity as a director, unless the presumption that directors are acting in good faith, on an informed
basis, and with a view to the interests of the corporation has been rebutted and it is proven that the director&#8217;s act or failure
to act constituted a breach of his or her fiduciary duties as a director and such breach involved intentional misconduct, fraud or a
knowing violation of law. Our certificate of incorporation requires CXApp to indemnify and advance expenses to, to the fullest extent
permitted by applicable law, its directors, officers and agents. CXApp maintains a directors&#8217; and officers&#8217; insurance policy
pursuant to which CXApp&#8217;s directors and officers are insured against liability for actions taken in their capacities as directors
and officers. Finally, our Charter prohibits any retroactive changes to the rights or protections or increasing the liability of any
director in effect at the time of the alleged occurrence of any act or omission to act giving rise to liability or indemnification. In
addition, CXApp will enter into separate indemnification agreements with CXApp&#8217;s directors and officers. These agreements, among
other things, require CXApp to indemnify its directors and officers for certain expenses, including attorneys&#8217; fees, judgments,
fines and settlement amounts incurred by a director or officer in any action or proceeding arising out of their services as one of CXApp&#8217;s
directors or officers or any other company or enterprise to which the person provides services at CXApp&#8217;s request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.75in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
15.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Sales of Unregistered Securities</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>On
July 27, 2020, we issued 6,877,776 shares of Common Stock to the Sponsor in the form of sponsor shares prior to the KINS Initial Public
Offering at a price of approximately $0.004 per share in a private placement pursuant to Section 4(a)(2) of the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>On
December 14, 2020, we issued 10,280,000 Private Placement Warrants to the Sponsor and the Direct Anchor Investors in connection with
the KINS Initial Public Offering at a price of $1.00 per Private Placement Warrant pursuant to Section 4(a)(2) of the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span>On
April 23, 2023, we issued 100,000 shares of common stock to BTIG in a private placement pursuant to Section 4(a)(2) of the Securities
Act. These shares were granted to BTIG without cash consideration in exchange for their engagement to provide strategic and capital markets
advisory services. The approximate cash equivalent of BTIG&#8217;s fee, and thus the approximate value of BTIG&#8217;s services pursuant
to the Advisory Agreement, may be implied by reference to the market price of KINS&#8217; stock at the time the Advisory Agreement was
entered into. The closing price of KINS&#8217; stock on Nasdaq on the day the Advisory Agreement was entered into was $9.94. Therefore,
the implied value of BTIG&#8217;s services pursuant to the Advisory Agreement is approximately $994,000. The Advisory Agreement was entered
into on the date of the consummation of the Business Combination and on the following day, the first day of trading after the Business
Combination, the closing price of the Company&#8217;s Common Stock was $4.10.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>




<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                            16.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibits</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; padding-left: 0pt; padding-right: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt">
    <th style="border-bottom: Black 1pt solid; font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
                                            </b><br/><b>Number</b></span></p></th>
    <th style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; vertical-align: bottom; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></th>
    <th style="border-bottom: Black 1pt solid; font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></p></th></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1+</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap; width: 1%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top; width: 90%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465922102856/tm2226567d1_ex2-1.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Agreement
                                            and Plan of Merger, dated as of September 25, 2022, by and among KINS, KINS Merger Sub Inc.,
                                            Inpixon and Legacy CXApp (incorporated herein by reference from Exhibit 2.1 on KINS&#8217;
                                            Form 8-K, filed September 26, 2022).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2+</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465922102856/tm2226567d1_ex2-2.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Separation
                                            and Distribution Agreement, dated as of September 25, 2022, by and among Legacy CXApp, Design
                                            Reactor, Inc., Inpixon and KINS (incorporated herein by reference from Exhibit 2.2 on KINS&#8217;
                                            Form 8-K, filed September 26, 2022).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex3-1.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Certificate
                                            of Incorporation of CXApp (incorporated herein by reference from Exhibit 3.1 on KINS&#8217;
                                            Form 8-K filed March 20, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex3-2.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Bylaws
                                            of CXApp (incorporated herein by reference from Exhibit 3.2 on KINS&#8217; Form 8-K filed
                                            March 20, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex4-1.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Specimen
                                            Warrant Certificate of CXApp Inc. (incorporated herein by reference from Exhibit 4.1 on KINS&#8217;
                                            Form 8-K filed March 20, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex4-2.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Specimen
                                            CXApp Inc. Class A Common Stock Certificate (incorporated herein by reference from Exhibit
                                            4.2 on KINS&#8217; Form 8-K filed March 20, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex4-3.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Specimen
                                            CXApp Inc. Class C Common Stock Certificate (incorporated herein by reference from Exhibit
                                            4.3 on KINS&#8217; Form 8-K filed March 20, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465920138071/tm2038766d1ex4-1.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Warrant
                                            Purchase Agreement, dated as of December 14, 2020, by and between KINS and Continental Stock
                                            Transfer &amp; Trust Company, as warrant agent (incorporated herein by reference from Exhibit
                                            4.1 on KINS&#8217; Form 8-K, filed December 21, 2020).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1***</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
                                            of Skadden, Arps, Slate, Meagher &amp; Flom LLP.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923014719/tm2228049d13_ex8-1.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Distribution
                                            Tax Opinion of RSM US LLP (incorporated herein by reference from Exhibit 8.1 of KINS&#8217;
                                            Registration Statement on Form S-4 (File No. 333-267938, filed February 9, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465922102856/tm2226567d1_ex2-3.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Sponsor
                                            Support Agreement, dated as of September 25, 2022, by and among KINS, the Sponsor and Legacy
                                            CXApp (incorporated herein by reference from Exhibit 2.3 on KINS&#8217; Form 8-K, filed September
                                            26, 2022).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex10-9.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Employee
                                            Matters Agreement, dated March 14, 2023, by and among KINS, KINS Merger Sub Inc., Inpixon
                                            and Legacy CXApp (incorporated herein by reference from Exhibit 10.9 on KINS&#8217; Form
                                            8-K filed March 20, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3+</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex10-11.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Transition
                                            Services Agreement, dated March 14, 2023, by and between Inpixon and Legacy CXApp (incorporated
                                            herein by reference from Exhibit 10.11 on KINS&#8217; Form 8-K filed March 20, 2023).</span></a></span></p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 169; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; padding-left: 0pt; padding-right: 0pt; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt">
    <th style="border-bottom: Black 1pt solid; font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
                                            </b><br/><b>Number</b></span></p></th>
    <th style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; vertical-align: bottom; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></th>
    <th style="border-bottom: Black 1pt solid; font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></p></th></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex10-10.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Tax
                                            Matters Agreement, dated March 14, 2023, by and among KINS, Inpixon and Legacy CXApp (incorporated
                                            herein by reference from Exhibit 10.10 on KINS&#8217; Form 8-K filed March 20, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5#</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923014719/tm2228049d13_ex10-13.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Employment
                                            Agreement, dated as of January 9, 2023, by and between Design Reactor, Inc. and Michael Angel
                                            (incorporated herein by reference from Exhibit 10.13 of KINS&#8217; Registration Statement
                                            on Form S-4 (File No. 333-267938, filed February 9, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6#</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923040315/tm2311221d1_ex10-1.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Employment
                                            Agreement, dated as of March 29, 2023, by and between Design Reactor, Inc. and Khurram Sheikh
                                            (incorporated herein by reference from Exhibit 10.1 on KINS&#8217; Form 8-K filed March 29,
                                            2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7#</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923040315/tm2311221d1_ex10-2.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Employment
                                            Agreement, dated as of March 29, 2023, by and between Design Reactor, Inc. and Leon Papkoff
                                            (incorporated herein by reference from Exhibit 10.2 on KINS&#8217; Form 8-K filed March 29,
                                            2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8#</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex10-12.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Consulting
                                            Agreement, dated March 14, 2023, by and between Design Reactor, Inc. and 3AM, LLC (incorporated
                                            herein by reference from Exhibit 10.12 on KINS&#8217; Form 8-K filed March 20, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9#</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex10-14.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">CXApp
                                            Inc. 2023 Equity Incentive Plan (incorporated herein by reference from Exhibit 10.14 on KINS&#8217;
                                            Form 8-K filed March 20, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10#</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex10-15.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Form
                                            of CXApp Inc. Indemnification Agreement for Directors and Officers (incorporated herein by
                                            reference from Exhibit 10.15 on KINS&#8217; Form 8-K filed March 20, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11#</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex10-16.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Form
                                            of CXApp Inc. 2023 Equity Incentive Plan Stock Option Agreement (incorporated herein by reference
                                            from Exhibit 10.16 on KINS&#8217; Form 8-K filed March 20, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12#</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex10-17.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Form
                                            of CXApp Inc. 2023 Equity Incentive Plan Restricted Stock Unit Agreement (incorporated herein
                                            by reference from Exhibit 10.17 on KINS&#8217; Form 8-K filed March 20, 2023).</span></a></span></p></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap; width: 1%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top; width: 90%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex14-1.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Code
                                            of Ethics and Business Conduct (incorporated herein by reference from Exhibit 14.1 on KINS&#8217;
                                            Form 8-K filed March 20, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1820875/000110465923034553/tm239336d1_ex21-1.htm" style="-sec-extract: exhibit; font-family: Times New Roman,Times,serif"><span style="font-style: normal; font-weight: normal">Subsidiaries
                                            of the Registrant (incorporated herein by reference from Exhibit 21.1 on KINS&#8217; Form
                                            8-K filed March 20, 2023).</span></a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="cxapp_ex23-1.htm">Consent of Marcum LLP.</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2*</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="cxapp_ex23-2.htm">Consent of WithumSmith+Brown, PC.</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3***</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
                                            of Skadden, Arps, Slate, Meagher &amp; Flom LLP (included in Exhibit 5.1).</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1820875/000182912623003783/cxapp_ex99-1.htm">Audited combined carve-out balance sheets of Design Reactor as of December 31, 2022 and 2021, and the related combined carved-out statements of operations, changes in parent company net investment and cash flows for the years ended December 31, 2022 and 2021.</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1820875/000182912623003783/cxapp_ex99-2.htm">Unaudited pro forma condensed combined financial information of KINS and Legacy CXApp as of and for the year ended December 31, 2022.</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3**</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1820875/000141057823000744/cxai-20221231xex99d3.htm">Nominating and Governance Committee Charter</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4**</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1820875/000141057823000744/cxai-20221231xex99d4.htm">Audit Committee Charter</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.5**</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1820875/000141057823000744/cxai-20221231xex99d5.htm">Compensation Committee Charter</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.6**</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1820875/000141057823000744/cxai-20221231xex99d6.htm">Corporate Governance Guidelines</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.7**</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1820875/000141057823000744/cxai-20221231xex99d7.htm">Code of Business Conduct and Ethics</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.8**</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1820875/000141057823000744/cxai-20221231xex99d8.htm">Related Party Transactions Policy</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.9**</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1820875/000141057823000744/cxai-20221231xex99d9.htm">Insider Trading Policy</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.10**</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1820875/000141057823000744/cxai-20221231xex99d10.htm">Regulation FD Communications Guidelines</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.11**</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8203;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="http://www.sec.gov/Archives/edgar/data/1820875/000141057823000744/cxai-20221231xex99d11.htm">Whistleblower Policy</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; height: 12pt; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107*</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; vertical-align: top; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"><a href="cxapp_107.htm">Filing Fee Table.</a></span></p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->






<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
                                            herewith.</span></td>
</tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span>**</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span>Previously
                                            filed.</span></td></tr>
     </table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            be filed by amendment.</span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedules
                                            and exhibits have been omitted pursuant to Item&#160;601(b)(2)&#160;of Regulation&#160;S-K.&#160;The
                                            Registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to
                                            the SEC upon request.</span></td>
</tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates
                                            a management contract or compensatory plan.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 170; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>







<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.75in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
17.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Undertakings</b></span></td>
</tr></table>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
include any prospectus required by section&#160;10(a)(3) of the Securities Act;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, any increase or decrease in the volume of securities offered (if the total dollar value of securities offered would not
exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected
in the form of prospectus filed with the SEC pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent
no more than 20% change in the maximum aggregate offering price set forth in the &#8220;<i>Calculation of Registration Fee</i>&#8221;
table in the effective registration statement; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any
material change to such information in the registration statement.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to
be the initial bona fide offering thereof.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            remove from registration by means of a post-effective amendment any of the securities being
                                            registered which remain unsold at the termination of the offering.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
                                            for the purpose of determining liability under the Securities Act to any purchaser, each
                                            prospectus filed pursuant to Rule&#160;424(b) as part of a registration statement relating
                                            to an offering, other than registration statements relying on Rule&#160;430B or other than
                                            prospectuses filed in reliance on Rule&#160;430A, shall be deemed to be part of and included
                                            in the registration statement as of the date it is first used after effectiveness. Provided,
                                            however, that no statement made in a registration statement or prospectus that is part of
                                            the registration statement or made in a document incorporated or deemed incorporated by reference
                                            into the registration statement or prospectus that is part of the registration statement
                                            will, as to a purchaser with a time of contract of sale prior to such first use, supersede
                                            or modify any statement that was made in the registration statement or prospectus that was
                                            part of the registration statement or made in any such document immediately prior to such
                                            date of first use.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
                                            for the purpose of determining liability of the registrant under the Securities Act to any
                                            purchaser in the initial distribution of the securities, that in a primary offering of securities
                                            of the undersigned registrant pursuant to this registration statement, regardless of the
                                            underwriting method used to sell the securities to the purchaser, if the securities are offered
                                            or sold to such purchaser by means of any of the following communications, the undersigned
                                            registrant will be a seller to the purchaser and will be considered to offer or sell such
                                            securities to such purchaser:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            preliminary prospectus or prospectus of the undersigned registrant relating to the offering
                                            required to be filed pursuant to Rule&#160;424;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            free writing prospectus relating to the offering prepared by or on behalf of the undersigned
                                            registrant or used or referred to by the undersigned registrant;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 171; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            portion of any other free writing prospectus relating to the offering containing material
                                            information about the undersigned registrant or its securities provided by or on behalf of
                                            the undersigned registrant; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
                                            other communication that is an offer in the offering made by the undersigned registrant to
                                            the purchaser.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
                                            as indemnification for liabilities arising under the Securities Act may be permitted to directors,
                                            officers and controlling persons of the registrant pursuant to the foregoing provisions,
                                            or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification
                                            is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
                                            In the event that a claim for indemnification against such liabilities (other than the payment
                                            by the registrant of expenses incurred or paid by a director, officer or controlling person
                                            of the registrant in the successful defense of any action, suit or proceeding) is asserted
                                            by such director, officer or controlling person in connection with the securities being registered,
                                            the registrant will, unless in the opinion of its counsel the matter has been settled by
                                            controlling precedent, submit to a court of appropriate jurisdiction the question of whether
                                            such indemnification by it is against public policy as expressed in the Securities Act and
                                            will be governed by the final adjudication of such issue.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Page; Sequence: 172; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant
to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereunto duly authorized, in the City of Palo Alto, State of California, on June&#160;30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CXAPP INC.</b></span></td>
    <td style="width: 60%">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Khurram
    P. Sheikh</span></td>
    <td>&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Khurram P. Sheikh</span></td>
    <td>&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Chairman</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following person on
behalf of the registrant and in the capacities and on the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"><b>Position</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">/s/
    Khurram P. Sheikh</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Chief
    Executive Officer, Chairman and Interim Chief Financial Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">June
    30, 2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Khurram
    P. Sheikh</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;"><i>(Principal
    Executive Officer and Principal Financial and Accounting Officer)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">/s/
    Leon Papkoff</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Chief
    Product Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">June
    30, 2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Leon
    Papkoff</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">/s/
    Camillo Martino</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">June
    30, 2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Camillo
    Martino</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">/s/
    Di-Ann Eisnor</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">June
    30, 2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Di-Ann
    Eisnor</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">/s/
    George Mathai</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">June
    30, 2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">George
    Mathai</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">/s/
    Shanti Priya</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">June
    30, 2023</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">Shanti
    Priya</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt;">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<!-- Field: Page; Sequence: 173; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>

    <!-- Field: /Page -->





</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>cxapp_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM&#8217;S CONSENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the inclusion in this
Registration Statement of CXApp Inc. on Form S-1 Amendment No. 3 [File No. 333-271340] of our report dated March&nbsp;20, 2023, with
respect to our audits of the combined carve-out financial statements of Design Reactor, Inc. and Subsidiaries as of
December&nbsp;31, 2022 and 2021 and for the years ended December&nbsp;31, 2022 and 2021, which report appears in the Prospectus,
which is part of this Registration Statement. We also consent to the reference to our Firm under the heading &ldquo;Experts&rdquo;
in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Marcum LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marcum
LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">June 30, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>cxapp_ex23-2.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consent
of Independent Registered Public Accounting Firm</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the use in this
Registration Statement on Amendment No. 3 to Form S-1 of our report dated April&nbsp;17, 2023 (which includes explanatory paragraphs relating to the correction of certain misstatements related to the consolidated
financial statements and the Company&rsquo;s ability to continue as a going concern), relating to the consolidated balance
sheets of CXApp Inc. (f/k/a KINS Technology Group Inc.) as of December&nbsp;31, 2022 (as restated) and 2021, and the related
consolidated statements of operations, changes in stockholders&rsquo; deficit and cash flows for the years then ended, appearing in
the proxy statement/prospectus, which is a part of this Registration Statement, and to the reference to our Firm under the caption
&ldquo;Experts&rdquo; in the proxy statement/prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
WithumSmith+Brown, PC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
30, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>cxapp_107.htm
<DESCRIPTION>EXHIBIT 107
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
107</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation
of Filing Fee Tables</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
Resale S-1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Form
Type)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>CXApp
Inc.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Table
1: Newly Registered Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border: black 1pt solid; padding: 2pt; text-indent: 0pt; width: 15%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Security<BR>
    Type</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-indent: 0pt; width: 25%; padding: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Security<BR>
    Class<BR>
    Title</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-indent: 0pt; width: 10%; padding: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Fee
    Calculation or <BR>
    Carry Forward <BR>
    Rule</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-indent: 0pt; width: 10%; padding: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Amount<BR>
    Registered<SUP>(1) </SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-indent: 0pt; width: 10%; padding: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Proposed<BR>
    Maximum<BR>
    Offering<BR>
    Price Per<BR>
    Unit</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-indent: 0pt; width: 10%; padding: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Maximum
    <BR>
    Aggregate <BR>
    Offering Price</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-indent: 0pt; width: 10%; padding: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Fee
    Rate</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-indent: 0pt; width: 10%; padding: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Amount
    of <BR>
    Registration Fee</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-indent: 0pt; padding: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Equity</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Common
    Stock, par value $0.0001 per share (&ldquo;Common Stock&rdquo;)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">457(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,977,776</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$1.44<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$10,047,997.40</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">.00011020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$1,107.29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-indent: 0pt; padding: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Equity</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Common
    Stock<SUP>(5)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">457(g)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">24,080,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$11.50<SUP>(3)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$276,920,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">.00011020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$30,516.58</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-indent: 0pt; padding: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Equity</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap"><P STYLE="margin: 0; font: 8pt Times New Roman, Times, Serif">Common Stock (held by sponsor and other affiliates)</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">457(g)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">10,280,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><SUP>(4)</SUP></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-indent: 0pt; padding: 2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Warrants</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Warrants
    to purchase Common Stock (&ldquo;Warrants&rdquo;)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">457(g)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">10,280,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><SUP>(4)</SUP></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="4" STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-indent: 0pt; padding: 2pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Total
    Offering Amounts </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$286,967,997.40</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$31,623.87</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="4" STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-indent: 0pt; padding: 2pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Total
    Fees Previously Paid </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$0.00</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="4" STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-indent: 0pt; padding: 2pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Total
    Fee Offsets </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$0.00</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="4" STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-indent: 0pt; vertical-align: top; padding: 2pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt"><B>Net
    Fee Due </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-right: black 1pt solid; border-bottom: black 1pt solid; padding: 2pt; text-indent: 0pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$31,623.87</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 24px; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Rule&nbsp;416(a) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), there are also being registered
    an indeterminable number of additional securities as may be issued as a result of stock splits, stock dividends or similar transactions.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 24px; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    in accordance with Rule&nbsp;457(c) solely for purposes of calculating the registration fee. The maximum price per security and the
    maximum aggregate offering price are based on the average of the $1.64 (high) and $1.29 (low) sale price of the Common Stock as reported
    on The Nasdaq Stock Market LLC on April&nbsp;12, 2023, which date is within five business days prior to filing this registration
    statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 24px; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated
    pursuant to Rule&nbsp;457(g) under the Securities Act, based on the exercise price of the Warrants.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 24px; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    separate registration fee is required pursuant to Rule&nbsp;457(g) under the Securities Act.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 24px; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
    the shares of Common Stock that may be issued upon exercise of outstanding Warrants, for an exercise price of $11.50 per share of
    Common Stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>cxai-20230331.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +KIpo7xRiXgen8uAZHZcOa2ISbPtxZ97iekhsmR2bcnqny0vLce0AyOLDk4GYcoH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:cxai="http://kins-tech.com/20230331" elementFormDefault="qualified" targetNamespace="http://kins-tech.com/20230331">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://kins-tech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
          <link:definition>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
          <link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" id="ConsolidatedStatementsOfChangesInStockholdersDeficit">
          <link:definition>00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
          <link:definition>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
          <link:definition>00000007 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
          <link:definition>00000008 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss">
          <link:definition>00000009 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit" id="UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit">
          <link:definition>00000010 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" id="UnauditedCondensedConsolidatedStatementsOfCashFlows">
          <link:definition>00000011 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperations" id="DescriptionOfOrganizationAndBusinessOperations">
          <link:definition>00000012 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatements" id="RestatementOfPreviouslyIssuedFinancialStatements">
          <link:definition>00000013 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/PublicOffering" id="PublicOffering">
          <link:definition>00000015 - Disclosure - PUBLIC OFFERING</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/PrivatePlacement" id="PrivatePlacement">
          <link:definition>00000016 - Disclosure - PRIVATE PLACEMENT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/RelatedParties" id="RelatedParties">
          <link:definition>00000017 - Disclosure - RELATED PARTIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/StockholdersDeficit" id="StockholdersDeficit">
          <link:definition>00000019 - Disclosure - STOCKHOLDERS&#8217; DEFICIT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/DerivativeWarrantLiabilities" id="DerivativeWarrantLiabilities">
          <link:definition>00000020 - Disclosure - DERIVATIVE WARRANT LIABILITIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/IncomeTax" id="IncomeTax">
          <link:definition>00000021 - Disclosure - INCOME TAX</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/FairValueMeasurements" id="FairValueMeasurements">
          <link:definition>00000022 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>00000023 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/OrganizationNatureOfBusinessAndBasisOfPresentation" id="OrganizationNatureOfBusinessAndBasisOfPresentation">
          <link:definition>00000024 - Disclosure - Organization, Nature of Business and Basis of Presentation</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/BusinessCombination" id="BusinessCombination">
          <link:definition>00000025 - Disclosure - Business Combination</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/DisaggregationOfRevenue" id="DisaggregationOfRevenue">
          <link:definition>00000026 - Disclosure - Disaggregation of Revenue</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
          <link:definition>00000027 - Disclosure - Property and Equipment, net</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNet" id="SoftwareDevelopmentCostsNet">
          <link:definition>00000028 - Disclosure - Software Development Costs, net</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssets" id="GoodwillAndIntangibleAssets">
          <link:definition>00000029 - Disclosure - Goodwill and Intangible Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/DeferredRevenue" id="DeferredRevenue">
          <link:definition>00000030 - Disclosure - Deferred Revenue</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/AccruedLiabilities" id="AccruedLiabilities">
          <link:definition>00000031 - Disclosure - Accrued Liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/WarrantLiabilities" id="WarrantLiabilities">
          <link:definition>00000032 - Disclosure - Warrant Liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensation" id="StockOptionPlanAndStock-basedCompensation">
          <link:definition>00000033 - Disclosure - Stock Option Plan and Stock-Based Compensation</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/FairValueOfFinancialInstruments" id="FairValueOfFinancialInstruments">
          <link:definition>00000034 - Disclosure - Fair Value of Financial Instruments</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>00000035 - Disclosure - Income Taxes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/CreditRiskAndConcentrations" id="CreditRiskAndConcentrations">
          <link:definition>00000036 - Disclosure - Credit Risk and Concentrations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/ForeignOperations" id="ForeignOperations">
          <link:definition>00000037 - Disclosure - Foreign Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/Leases" id="Leases">
          <link:definition>00000038 - Disclosure - Leases</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/CommitmentsAndContingencie" id="CommitmentsAndContingencie">
          <link:definition>00000039 - Disclosure - Commitments and Contingencie</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" id="RestatementOfPreviouslyIssuedFinancialStatementsTables">
          <link:definition>00000041 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/IncomeTaxTables" id="IncomeTaxTables">
          <link:definition>00000043 - Disclosure - INCOME TAX (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
          <link:definition>00000044 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/BusinessCombinationTables" id="BusinessCombinationTables">
          <link:definition>00000045 - Disclosure - Business Combination (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/DisaggregationOfRevenueTables" id="DisaggregationOfRevenueTables">
          <link:definition>00000046 - Disclosure - Disaggregation of Revenue (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
          <link:definition>00000047 - Disclosure - Property and Equipment, net (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNetTables" id="SoftwareDevelopmentCostsNetTables">
          <link:definition>00000048 - Disclosure - Software Development Costs, net (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables" id="GoodwillAndIntangibleAssetsTables">
          <link:definition>00000049 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/DeferredRevenueTables" id="DeferredRevenueTables">
          <link:definition>00000050 - Disclosure - Deferred Revenue (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/AccruedLiabilitiesTables" id="AccruedLiabilitiesTables">
          <link:definition>00000051 - Disclosure - Accrued Liabilities (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationTables" id="StockOptionPlanAndStock-basedCompensationTables">
          <link:definition>00000052 - Disclosure - Stock Option Plan and Stock-Based Compensation (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/ForeignOperationsTables" id="ForeignOperationsTables">
          <link:definition>00000053 - Disclosure - Foreign Operations (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" id="DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative">
          <link:definition>00000054 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails" id="RestatementOfPreviouslyIssuedFinancialStatementsDetails">
          <link:definition>00000055 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails" id="SummaryOfSignificantAccountingPoliciesDetails">
          <link:definition>00000056 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1" id="SummaryOfSignificantAccountingPoliciesDetails1">
          <link:definition>00000057 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000058 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/PublicOfferingDetailsNarrative" id="PublicOfferingDetailsNarrative">
          <link:definition>00000059 - Disclosure - PUBLIC OFFERING (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/PrivatePlacementDetailsNarrative" id="PrivatePlacementDetailsNarrative">
          <link:definition>00000060 - Disclosure - PRIVATE PLACEMENT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/RelatedPartiesDetailsNarrative" id="RelatedPartiesDetailsNarrative">
          <link:definition>00000061 - Disclosure - RELATED PARTIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>00000062 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/StockholdersDeficitDetailsNarrative" id="StockholdersDeficitDetailsNarrative">
          <link:definition>00000063 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative" id="DerivativeWarrantLiabilitiesDetailsNarrative">
          <link:definition>00000064 - Disclosure - DERIVATIVE WARRANT LIABILITIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/IncomeTaxDetails" id="IncomeTaxDetails">
          <link:definition>00000065 - Disclosure - INCOME TAX (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/IncomeTaxDetails1" id="IncomeTaxDetails1">
          <link:definition>00000066 - Disclosure - INCOME TAX (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/IncomeTaxDetails2" id="IncomeTaxDetails2">
          <link:definition>00000067 - Disclosure - INCOME TAX (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/IncomeTaxDetailsNarrative" id="IncomeTaxDetailsNarrative">
          <link:definition>00000068 - Disclosure - INCOME TAX (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/FairValueMeasurementsDetails" id="FairValueMeasurementsDetails">
          <link:definition>00000069 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/FairValueMeasurementsDetails1" id="FairValueMeasurementsDetails1">
          <link:definition>00000070 - Disclosure - FAIR VALUE MEASUREMENTS (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative" id="FairValueMeasurementsDetailsNarrative">
          <link:definition>00000071 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails" id="SummaryOfSignificantAccountingPolicieDetails">
          <link:definition>00000072 - Disclosure - Summary of Significant Accounting Policie (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/BusinessCombinationDetails" id="BusinessCombinationDetails">
          <link:definition>00000073 - Disclosure - Business Combination (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/BusinessCombinationDetails1" id="BusinessCombinationDetails1">
          <link:definition>00000074 - Disclosure - Business Combination (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/BusinessCombinationDetailsNarrative" id="BusinessCombinationDetailsNarrative">
          <link:definition>00000075 - Disclosure - Business Combination (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/DisaggregationOfRevenueDetails" id="DisaggregationOfRevenueDetails">
          <link:definition>00000076 - Disclosure - Disaggregation of Revenue (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/PropertyAndEquipmentNetDetails" id="PropertyAndEquipmentNetDetails">
          <link:definition>00000077 - Disclosure - Property and Equipment, net (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative" id="PropertyAndEquipmentNetDetailsNarrative">
          <link:definition>00000078 - Disclosure - Property and Equipment, net (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails" id="SoftwareDevelopmentCostsNetDetails">
          <link:definition>00000079 - Disclosure - Software Development Costs, net (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative" id="SoftwareDevelopmentCostsNetDetailsNarrative">
          <link:definition>00000080 - Disclosure - Software Development Costs, net (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails" id="GoodwillAndIntangibleAssetsDetails">
          <link:definition>00000081 - Disclosure - Goodwill and Intangible Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1" id="GoodwillAndIntangibleAssetsDetails1">
          <link:definition>00000082 - Disclosure - Goodwill and Intangible Assets (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2" id="GoodwillAndIntangibleAssetsDetails2">
          <link:definition>00000083 - Disclosure - Goodwill and Intangible Assets (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" id="GoodwillAndIntangibleAssetsDetailsNarrative">
          <link:definition>00000084 - Disclosure - Goodwill and Intangible Assets (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/DeferredRevenueDetails" id="DeferredRevenueDetails">
          <link:definition>00000085 - Disclosure - Deferred Revenue (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/AccruedLiabilitiesDetails" id="AccruedLiabilitiesDetails">
          <link:definition>00000086 - Disclosure - Accrued Liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative" id="AccruedLiabilitiesDetailsNarrative">
          <link:definition>00000087 - Disclosure - Accrued Liabilities (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative" id="WarrantLiabilitiesDetailsNarrative">
          <link:definition>00000088 - Disclosure - Warrant Liabilities (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails" id="StockAwardPlansAndStock-basedCompensationDetails">
          <link:definition>00000089 - Disclosure - Stock Award Plans and Stock-Based Compensation (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative" id="StockOptionPlanAndStock-basedCompensationDetailsNarrative">
          <link:definition>00000090 - Disclosure - Stock Option Plan and Stock-Based Compensation (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative" id="FairValueOfFinancialInstrumentsDetailsNarrative">
          <link:definition>00000091 - Disclosure - Fair Value of Financial Instruments (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>00000092 - Disclosure - Income Taxes (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/ForeignOperationsDetails" id="ForeignOperationsDetails">
          <link:definition>00000093 - Disclosure - Foreign Operations (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://kins-tech.com/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
          <link:definition>00000094 - Disclosure - Leases (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="cxai-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cxai-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cxai-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cxai-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="cxai_CommonClassaSubjectToRedemptionMember" name="CommonClassaSubjectToRedemptionMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ClassACommonStockMember" name="ClassACommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ClassBCommonStockMember" name="ClassBCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PrivatePlacementWarrantsMember" name="PrivatePlacementWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_SponsorMember" name="SponsorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_CommonStockSubjectToRedemptionMember" name="CommonStockSubjectToRedemptionMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_SuccessorMember" name="SuccessorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PredecessorMember" name="PredecessorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_FounderSharesMember" name="FounderSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DirectAnchorMember" name="DirectAnchorMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_AdministrativeServicesAgreementMember" name="AdministrativeServicesAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PromissoryNoteWithRelatedPartyMember" name="PromissoryNoteWithRelatedPartyMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_WorkingCapitalLoansMember" name="WorkingCapitalLoansMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_WorkingCapitalLoansWarrantMember" name="WorkingCapitalLoansWarrantMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_CXAppCommonStockMember" name="CXAppCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_InpixonMember" name="InpixonMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_SeparationAgreementMember" name="SeparationAgreementMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_CxappHoldingCorpMember" name="CxappHoldingCorpMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_MergerAgreementMember" name="MergerAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_SponsorSupportAgreementMember" name="SponsorSupportAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PublicWarrantsMember" name="PublicWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" name="RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" name="RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_NetParentInvestmentMember" name="NetParentInvestmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_TotalMember" name="TotalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ClassCCommonStockMember" name="ClassCCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_StockOptionsMember" name="StockOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_SubscriptionRevenueMember" name="SubscriptionRevenueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_SoftwareMember" name="SoftwareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_NonSubscriptionRevenueMember" name="NonSubscriptionRevenueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ProfessionalServicesMember" name="ProfessionalServicesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PatentsAndIntellectualPropertyMember" name="PatentsAndIntellectualPropertyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ProfessionalServiceAgreementsMember" name="ProfessionalServiceAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DirectorAndOfficersMember" name="DirectorAndOfficersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_N2023EquityIncentivePlanMember" name="N2023EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_EmployeeStockOptionsMember" name="EmployeeStockOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_EmployeesAndDirectorsMember" name="EmployeesAndDirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PublicPlacementWarrantsMember" name="PublicPlacementWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_EliminationsMember" name="EliminationsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_AccruedLiabilitiesExcludingOfferingCostsCurrent" name="AccruedLiabilitiesExcludingOfferingCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PromissoryNoteRelatedParty" name="PromissoryNoteRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DeferredOfferingCostsNoncurrent" name="DeferredOfferingCostsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_GainLossOnEliminationOfDeferredUnderwritingFee" name="GainLossOnEliminationOfDeferredUnderwritingFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock" name="BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BasicAndDilutedNetIncomePerShareClassCommonStock" name="BasicAndDilutedNetIncomePerShareClassCommonStock" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock" name="BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BasicAndDilutedNetIncomePerShareClassBCommonStock" name="BasicAndDilutedNetIncomePerShareClassBCommonStock" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_IncreaseDecreaseInDeferredUnderwritingFee" name="IncreaseDecreaseInDeferredUnderwritingFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" name="ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ProceedsFromTrustAccountInConnectionWithRedemption" name="ProceedsFromTrustAccountInConnectionWithRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ChangeInValueOfClassCommonStockSubjectToPossibleRedemption" name="ChangeInValueOfClassCommonStockSubjectToPossibleRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock" name="ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DeferredUnderwritingFeePayable" name="DeferredUnderwritingFeePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_AcquisitionLiability" name="AcquisitionLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_NetParentInvestment" name="NetParentInvestment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ChangeInFairValueOfEarnout" name="ChangeInFairValueOfEarnout" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock" name="BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BasicAndDilutiveNetIncomePerShareClassCommonStock" name="BasicAndDilutiveNetIncomePerShareClassCommonStock" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock" name="BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BasicAndDilutiveNetIncomePerShareClassCCommonStock" name="BasicAndDilutiveNetIncomePerShareClassCCommonStock" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ParentsCommonSharesIssuedForCxappEarnout" name="ParentsCommonSharesIssuedForCxappEarnout" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits" name="TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_NetInvestmentsFromParent" name="NetInvestmentsFromParent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_CumulativeTranslationAdjustment" name="CumulativeTranslationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_SharesIssuedInConnectionWithBusinessCombination" name="SharesIssuedInConnectionWithBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_SharesIssuedInConnectionWithBusinessCombinationShares" name="SharesIssuedInConnectionWithBusinessCombinationShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_GainOnEarnoutPaymentLiability" name="GainOnEarnoutPaymentLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_GainOnChangeInFairValueOfDerivativeLiability" name="GainOnChangeInFairValueOfDerivativeLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_InvestmentInCapitalizedSoftware" name="InvestmentInCapitalizedSoftware" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_NetEquityInvestmentFromParent" name="NetEquityInvestmentFromParent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_TaxesPaidRelatedForStockBasedCompensation" name="TaxesPaidRelatedForStockBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_RepaymentOfCxappAcquisitionLiability" name="RepaymentOfCxappAcquisitionLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract" name="SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ParentsNetEquityIssuedForCxAppEarnout" name="ParentsNetEquityIssuedForCxAppEarnout" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_NoncashDistribution" name="NoncashDistribution" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination" name="ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_FinancingOfDirectorAndOfficerInsurance" name="FinancingOfDirectorAndOfficerInsurance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DisclosurePublicOfferingAbstract" name="DisclosurePublicOfferingAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_InitialPublicOfferingDisclosureTextBlock" name="InitialPublicOfferingDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DisclosurePrivatePlacementAbstract" name="DisclosurePrivatePlacementAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PrivatePlacementDisclosureTextBlock" name="PrivatePlacementDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DisclosureDisaggregationOfRevenueAbstract" name="DisclosureDisaggregationOfRevenueAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DisaggregationOfRevenueTextBlock" name="DisaggregationOfRevenueTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DisclosureSoftwareDevelopmentCostsNetAbstract" name="DisclosureSoftwareDevelopmentCostsNetAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_SoftwareDevelopmentCostsNetTextBlock" name="SoftwareDevelopmentCostsNetTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DisclosureDeferredRevenueAbstract" name="DisclosureDeferredRevenueAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DeferredRevenueTextBlock" name="DeferredRevenueTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DisclosureWarrantLiabilitiesAbstract" name="DisclosureWarrantLiabilitiesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_WarrantLiabilitiesTextBlock" name="WarrantLiabilitiesTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract" name="DisclosureStockOptionPlanAndStockbasedCompensationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_StockAwardPlansAndStockbasedCompensationTextBlock" name="StockAwardPlansAndStockbasedCompensationTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DisclosureForeignOperationsAbstract" name="DisclosureForeignOperationsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ForeignOperationsTextBlock" name="ForeignOperationsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_EmergingGrowthCompanyPolicyTextBlock" name="EmergingGrowthCompanyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_TemporaryEquityPolicyPolicyTextBlock" name="TemporaryEquityPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_WarrantLiabilityPolicyTextBlock" name="WarrantLiabilityPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_LiquidityAndGoingConcernPolicyTextBlock" name="LiquidityAndGoingConcernPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock" name="AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_LeasesAndRightofUseAssetsPolicyTextBlock" name="LeasesAndRightofUseAssetsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock" name="ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ScheduleOfDeferredRevenueTableTextBlock" name="ScheduleOfDeferredRevenueTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_UnitsIssuedDuringPeriodSharesNewIssues" name="UnitsIssuedDuringPeriodSharesNewIssues" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_NumberOfWarrantsIssued" name="NumberOfWarrantsIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights" name="ClassOfWarrantOrRightPriceOfWarrantsOrRights" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_TransactionCosts" name="TransactionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_SaleOfStockUnderwritingFees" name="SaleOfStockUnderwritingFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_SaleOfStockOtherOfferingCosts" name="SaleOfStockOtherOfferingCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PaymentsForInvestmentOfCashInTrustAccount" name="PaymentsForInvestmentOfCashInTrustAccount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount" name="ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination" name="ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination" name="MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent" name="ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" name="PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_MaximumNetInterestsToPayDissolutionExpenses" name="MaximumNetInterestsToPayDissolutionExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_WorkingCapital" name="WorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ProceedsFromRelatedParty" name="ProceedsFromRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable" name="GainOnForgivenessOfDeferredUnderwritingFeePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares" name="BasicAndDilutedWeightedAverageSharesOutstandingInShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare" name="BasicAndDilutedEarningsPerShareInDollarsPerShare" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" name="ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_TemporaryEquityWaiverOfShareIssuanceCosts" name="TemporaryEquityWaiverOfShareIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_TemporaryEquityRedemption" name="TemporaryEquityRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_OfferingCost" name="OfferingCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_CashAndCashEquivalentsDescription" name="CashAndCashEquivalentsDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_RevenueRecognized" name="RevenueRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ChangesInEstimatedFairValueOfWarrants" name="ChangesInEstimatedFairValueOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_NumberOfSharesSubjectToForfeiture" name="NumberOfSharesSubjectToForfeiture" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_AggregateNumberOfSharesOwned" name="AggregateNumberOfSharesOwned" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" name="PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" name="RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" name="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" name="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" name="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" name="ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" name="RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ExpensesIncurredAndPaid" name="ExpensesIncurredAndPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_MaximumLoansConvertibleIntoWarrants" name="MaximumLoansConvertibleIntoWarrants" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" name="MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands" name="MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_MaximumNumberOfDemandsForRegistrationOfSecurities" name="MaximumNumberOfDemandsForRegistrationOfSecurities" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DeferredFeePerUnit" name="DeferredFeePerUnit" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee" name="IncomeRecognizedFromReductionOfDeferredUnderwriterFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PercentageOfCommonStockDistributed" name="PercentageOfCommonStockDistributed" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger" name="MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_CommonStockStockPriceTrigger" name="CommonStockStockPriceTrigger" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ThresholdTradingDays" name="ThresholdTradingDays" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ThresholdConsecutiveTradingDays" name="ThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_NumberOfSharesIssuableUponMerger" name="NumberOfSharesIssuableUponMerger" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PercentageOfStockAsMergerConsideration" name="PercentageOfStockAsMergerConsideration" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ThresholdNetTangibleAssets" name="ThresholdNetTangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares" name="ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_TermOfBreachUnableToBeCuredOrIsNotCured" name="TermOfBreachUnableToBeCuredOrIsNotCured" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_TerminationFee" name="TerminationFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_CommonStockLockUpPeriod" name="CommonStockLockUpPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp" name="PercentageOfSharesNotBeSubjectToForegoingLockUp" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_NumberOfSharesExchanged" name="NumberOfSharesExchanged" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_MinimumNumberOfSharesIssuableToSponsor" name="MinimumNumberOfSharesIssuableToSponsor" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_CommonStockNumberOfVotesPerShare" name="CommonStockNumberOfVotesPerShare" nillable="true" xbrli:periodType="instant" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ConvertibleStockConversionRatio" name="ConvertibleStockConversionRatio" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_WarrantExercisePeriodConditionOne" name="WarrantExercisePeriodConditionOne" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_WarrantExercisePeriodConditionTwo" name="WarrantExercisePeriodConditionTwo" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" name="MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" name="PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_WarrantRedemptionConditionMinimumSharePrice" name="WarrantRedemptionConditionMinimumSharePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" name="ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" name="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" name="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_RedemptionPeriod" name="RedemptionPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo" name="WarrantRedemptionConditionMinimumSharePriceScenarioTwo" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant" name="SharePricetriggerUsedToMeasureDilutionOfWarrant" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant" name="PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant" nillable="true" xbrli:periodType="duration" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_WarrantExercisePriceAdjustmentMultiple" name="WarrantExercisePriceAdjustmentMultiple" nillable="true" xbrli:periodType="duration" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_WarrantRedemptionPriceAdjustmentMultiple" name="WarrantRedemptionPriceAdjustmentMultiple" nillable="true" xbrli:periodType="duration" type="xbrli:pureItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" name="DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_StateAndLocalAbstract" name="StateAndLocalAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent" name="EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent" name="EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" name="FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" name="FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_PurchasePrice" name="PurchasePrice" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_AggregatePurchasePriceAssetsAndLiabilities" name="AggregatePurchasePriceAssetsAndLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ConsiderationTransferredInConnection" name="ConsiderationTransferredInConnection" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_AcquisitionOfLegacyCxapp" name="AcquisitionOfLegacyCxapp" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_InsurancePremiumsAndAccruedInterest" name="InsurancePremiumsAndAccruedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_RelatedPartyPromissoryNote" name="RelatedPartyPromissoryNote" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_RelatedPartyPayable" name="RelatedPartyPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_AccruedCompensationAndBenefits" name="AccruedCompensationAndBenefits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_AccruedOther" name="AccruedOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_RelatedPartyDescription" name="RelatedPartyDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders" name="ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_FairValueOfOptions" name="FairValueOfOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_AmortizationOfEmployeeStockOptions" name="AmortizationOfEmployeeStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_FairValueOfNonvestedOptions" name="FairValueOfNonvestedOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_WeightedAverageRemainingTermOfNonvestedOptions" name="WeightedAverageRemainingTermOfNonvestedOptions" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_IncomeTaxBenefitprovision" name="IncomeTaxBenefitprovision" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_NetAssets" name="NetAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="cxai_LeasePeriodicPayments" name="LeasePeriodicPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>cxai-20230331_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://kins-tech.com/role/Cover" xlink:href="cxai-20230331.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedBalanceSheets" xlink:href="cxai-20230331.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cxai-20230331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedStatementsOfOperations" xlink:href="cxai-20230331.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:href="cxai-20230331.xsd#ConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cxai-20230331.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CondensedConsolidatedBalanceSheets" xlink:href="cxai-20230331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="cxai-20230331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="cxai-20230331.xsd#UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit" xlink:href="cxai-20230331.xsd#UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="cxai-20230331.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperations" xlink:href="cxai-20230331.xsd#DescriptionOfOrganizationAndBusinessOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatements" xlink:href="cxai-20230331.xsd#RestatementOfPreviouslyIssuedFinancialStatements" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PublicOffering" xlink:href="cxai-20230331.xsd#PublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PrivatePlacement" xlink:href="cxai-20230331.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RelatedParties" xlink:href="cxai-20230331.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CommitmentsAndContingencies" xlink:href="cxai-20230331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockholdersDeficit" xlink:href="cxai-20230331.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DerivativeWarrantLiabilities" xlink:href="cxai-20230331.xsd#DerivativeWarrantLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTax" xlink:href="cxai-20230331.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurements" xlink:href="cxai-20230331.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SubsequentEvents" xlink:href="cxai-20230331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/OrganizationNatureOfBusinessAndBasisOfPresentation" xlink:href="cxai-20230331.xsd#OrganizationNatureOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombination" xlink:href="cxai-20230331.xsd#BusinessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DisaggregationOfRevenue" xlink:href="cxai-20230331.xsd#DisaggregationOfRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PropertyAndEquipmentNet" xlink:href="cxai-20230331.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNet" xlink:href="cxai-20230331.xsd#SoftwareDevelopmentCostsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssets" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DeferredRevenue" xlink:href="cxai-20230331.xsd#DeferredRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/AccruedLiabilities" xlink:href="cxai-20230331.xsd#AccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/WarrantLiabilities" xlink:href="cxai-20230331.xsd#WarrantLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensation" xlink:href="cxai-20230331.xsd#StockOptionPlanAndStock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueOfFinancialInstruments" xlink:href="cxai-20230331.xsd#FairValueOfFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxes" xlink:href="cxai-20230331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CreditRiskAndConcentrations" xlink:href="cxai-20230331.xsd#CreditRiskAndConcentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ForeignOperations" xlink:href="cxai-20230331.xsd#ForeignOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/Leases" xlink:href="cxai-20230331.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CommitmentsAndContingencie" xlink:href="cxai-20230331.xsd#CommitmentsAndContingencie" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:href="cxai-20230331.xsd#RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxTables" xlink:href="cxai-20230331.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurementsTables" xlink:href="cxai-20230331.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombinationTables" xlink:href="cxai-20230331.xsd#BusinessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DisaggregationOfRevenueTables" xlink:href="cxai-20230331.xsd#DisaggregationOfRevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PropertyAndEquipmentNetTables" xlink:href="cxai-20230331.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNetTables" xlink:href="cxai-20230331.xsd#SoftwareDevelopmentCostsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DeferredRevenueTables" xlink:href="cxai-20230331.xsd#DeferredRevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/AccruedLiabilitiesTables" xlink:href="cxai-20230331.xsd#AccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationTables" xlink:href="cxai-20230331.xsd#StockOptionPlanAndStock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ForeignOperationsTables" xlink:href="cxai-20230331.xsd#ForeignOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:href="cxai-20230331.xsd#DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails" xlink:href="cxai-20230331.xsd#RestatementOfPreviouslyIssuedFinancialStatementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PublicOfferingDetailsNarrative" xlink:href="cxai-20230331.xsd#PublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PrivatePlacementDetailsNarrative" xlink:href="cxai-20230331.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RelatedPartiesDetailsNarrative" xlink:href="cxai-20230331.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="cxai-20230331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockholdersDeficitDetailsNarrative" xlink:href="cxai-20230331.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative" xlink:href="cxai-20230331.xsd#DerivativeWarrantLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxDetails" xlink:href="cxai-20230331.xsd#IncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxDetails1" xlink:href="cxai-20230331.xsd#IncomeTaxDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxDetails2" xlink:href="cxai-20230331.xsd#IncomeTaxDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxDetailsNarrative" xlink:href="cxai-20230331.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurementsDetails" xlink:href="cxai-20230331.xsd#FairValueMeasurementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurementsDetails1" xlink:href="cxai-20230331.xsd#FairValueMeasurementsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative" xlink:href="cxai-20230331.xsd#FairValueMeasurementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPolicieDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombinationDetails" xlink:href="cxai-20230331.xsd#BusinessCombinationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombinationDetails1" xlink:href="cxai-20230331.xsd#BusinessCombinationDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombinationDetailsNarrative" xlink:href="cxai-20230331.xsd#BusinessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DisaggregationOfRevenueDetails" xlink:href="cxai-20230331.xsd#DisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PropertyAndEquipmentNetDetails" xlink:href="cxai-20230331.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="cxai-20230331.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails" xlink:href="cxai-20230331.xsd#SoftwareDevelopmentCostsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative" xlink:href="cxai-20230331.xsd#SoftwareDevelopmentCostsNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DeferredRevenueDetails" xlink:href="cxai-20230331.xsd#DeferredRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/AccruedLiabilitiesDetails" xlink:href="cxai-20230331.xsd#AccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative" xlink:href="cxai-20230331.xsd#AccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative" xlink:href="cxai-20230331.xsd#WarrantLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails" xlink:href="cxai-20230331.xsd#StockAwardPlansAndStock-basedCompensationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative" xlink:href="cxai-20230331.xsd#StockOptionPlanAndStock-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative" xlink:href="cxai-20230331.xsd#FairValueOfFinancialInstrumentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxesDetailsNarrative" xlink:href="cxai-20230331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ForeignOperationsDetails" xlink:href="cxai-20230331.xsd#ForeignOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/LeasesDetailsNarrative" xlink:href="cxai-20230331.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AccruedLiabilitiesExcludingOfferingCostsCurrent" xlink:label="loc_cxaiAccruedLiabilitiesExcludingOfferingCostsCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_cxaiAccruedLiabilitiesExcludingOfferingCostsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PromissoryNoteRelatedParty" xlink:label="loc_cxaiPromissoryNoteRelatedParty" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_cxaiPromissoryNoteRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredOfferingCostsNoncurrent" xlink:label="loc_cxaiDeferredOfferingCostsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_cxaiDeferredOfferingCostsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaapInterestIncomeExpenseNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeExpenseNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainLossOnEliminationOfDeferredUnderwritingFee" xlink:label="loc_cxaiGainLossOnEliminationOfDeferredUnderwritingFee" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_cxaiGainLossOnEliminationOfDeferredUnderwritingFee" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; DEFICIT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaapInterestAndOtherIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInterestAndOtherIncome" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_IncreaseDecreaseInDeferredUnderwritingFee" xlink:label="loc_cxaiIncreaseDecreaseInDeferredUnderwritingFee" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_cxaiIncreaseDecreaseInDeferredUnderwritingFee" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" xlink:label="loc_cxaiProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_cxaiProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProceedsFromTrustAccountInConnectionWithRedemption" xlink:label="loc_cxaiProceedsFromTrustAccountInConnectionWithRedemption" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_cxaiProceedsFromTrustAccountInConnectionWithRedemption" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaapCapitalizedComputerSoftwareNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapCapitalizedComputerSoftwareNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AcquisitionLiability" xlink:label="loc_cxaiAcquisitionLiability" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_cxaiAcquisitionLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyAccrualCurrent" xlink:label="loc_us-gaapExtendedProductWarrantyAccrualCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapExtendedProductWarrantyAccrualCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetParentInvestment" xlink:label="loc_cxaiNetParentInvestment" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_cxaiNetParentInvestment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000008 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="00000009 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ChangeInFairValueOfEarnout" xlink:label="loc_cxaiChangeInFairValueOfEarnout" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_cxaiChangeInFairValueOfEarnout" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaapInterestIncomeExpenseNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeExpenseNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit" xlink:title="00000010 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY (DEFICIT)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000011 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAssetAmortization" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainOnEarnoutPaymentLiability" xlink:label="loc_cxaiGainOnEarnoutPaymentLiability" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_cxaiGainOnEarnoutPaymentLiability" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainOnChangeInFairValueOfDerivativeLiability" xlink:label="loc_cxaiGainOnChangeInFairValueOfDerivativeLiability" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_cxaiGainOnChangeInFairValueOfDerivativeLiability" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsAndOtherReceivables" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsAndOtherReceivables" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxes" xlink:label="loc_us-gaapIncreaseDecreaseInIncomeTaxes" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInIncomeTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_InvestmentInCapitalizedSoftware" xlink:label="loc_cxaiInvestmentInCapitalizedSoftware" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_cxaiInvestmentInCapitalizedSoftware" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetEquityInvestmentFromParent" xlink:label="loc_cxaiNetEquityInvestmentFromParent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_cxaiNetEquityInvestmentFromParent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TaxesPaidRelatedForStockBasedCompensation" xlink:label="loc_cxaiTaxesPaidRelatedForStockBasedCompensation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_cxaiTaxesPaidRelatedForStockBasedCompensation" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RepaymentOfCxappAcquisitionLiability" xlink:label="loc_cxaiRepaymentOfCxappAcquisitionLiability" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_cxaiRepaymentOfCxappAcquisitionLiability" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperations" xlink:title="00000012 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatements" xlink:title="00000013 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PublicOffering" xlink:title="00000015 - Disclosure - PUBLIC OFFERING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PrivatePlacement" xlink:title="00000016 - Disclosure - PRIVATE PLACEMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RelatedParties" xlink:title="00000017 - Disclosure - RELATED PARTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CommitmentsAndContingencies" xlink:title="00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockholdersDeficit" xlink:title="00000019 - Disclosure - STOCKHOLDERS&#8217; DEFICIT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DerivativeWarrantLiabilities" xlink:title="00000020 - Disclosure - DERIVATIVE WARRANT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTax" xlink:title="00000021 - Disclosure - INCOME TAX" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurements" xlink:title="00000022 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SubsequentEvents" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/OrganizationNatureOfBusinessAndBasisOfPresentation" xlink:title="00000024 - Disclosure - Organization, Nature of Business and Basis of Presentation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombination" xlink:title="00000025 - Disclosure - Business Combination" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DisaggregationOfRevenue" xlink:title="00000026 - Disclosure - Disaggregation of Revenue" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PropertyAndEquipmentNet" xlink:title="00000027 - Disclosure - Property and Equipment, net" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SoftwareDevelopmentCostsNet" xlink:title="00000028 - Disclosure - Software Development Costs, net" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssets" xlink:title="00000029 - Disclosure - Goodwill and Intangible Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DeferredRevenue" xlink:title="00000030 - Disclosure - Deferred Revenue" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/AccruedLiabilities" xlink:title="00000031 - Disclosure - Accrued Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/WarrantLiabilities" xlink:title="00000032 - Disclosure - Warrant Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensation" xlink:title="00000033 - Disclosure - Stock Option Plan and Stock-Based Compensation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueOfFinancialInstruments" xlink:title="00000034 - Disclosure - Fair Value of Financial Instruments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxes" xlink:title="00000035 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CreditRiskAndConcentrations" xlink:title="00000036 - Disclosure - Credit Risk and Concentrations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ForeignOperations" xlink:title="00000037 - Disclosure - Foreign Operations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/Leases" xlink:title="00000038 - Disclosure - Leases" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CommitmentsAndContingencie" xlink:title="00000039 - Disclosure - Commitments and Contingencie" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:title="00000041 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxTables" xlink:title="00000043 - Disclosure - INCOME TAX (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurementsTables" xlink:title="00000044 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombinationTables" xlink:title="00000045 - Disclosure - Business Combination (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DisaggregationOfRevenueTables" xlink:title="00000046 - Disclosure - Disaggregation of Revenue (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PropertyAndEquipmentNetTables" xlink:title="00000047 - Disclosure - Property and Equipment, net (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SoftwareDevelopmentCostsNetTables" xlink:title="00000048 - Disclosure - Software Development Costs, net (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables" xlink:title="00000049 - Disclosure - Goodwill and Intangible Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DeferredRevenueTables" xlink:title="00000050 - Disclosure - Deferred Revenue (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/AccruedLiabilitiesTables" xlink:title="00000051 - Disclosure - Accrued Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationTables" xlink:title="00000052 - Disclosure - Stock Option Plan and Stock-Based Compensation (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ForeignOperationsTables" xlink:title="00000053 - Disclosure - Foreign Operations (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:title="00000054 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails" xlink:title="00000055 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000056 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:title="00000057 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000058 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PublicOfferingDetailsNarrative" xlink:title="00000059 - Disclosure - PUBLIC OFFERING (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000060 - Disclosure - PRIVATE PLACEMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RelatedPartiesDetailsNarrative" xlink:title="00000061 - Disclosure - RELATED PARTIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000062 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000063 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative" xlink:title="00000064 - Disclosure - DERIVATIVE WARRANT LIABILITIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxDetails" xlink:title="00000065 - Disclosure - INCOME TAX (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" xlink:label="loc_cxaiDeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_cxaiDeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxDetails1" xlink:title="00000066 - Disclosure - INCOME TAX (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxDetails2" xlink:title="00000067 - Disclosure - INCOME TAX (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxDetailsNarrative" xlink:title="00000068 - Disclosure - INCOME TAX (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurementsDetails" xlink:title="00000069 - Disclosure - FAIR VALUE MEASUREMENTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurementsDetails1" xlink:title="00000070 - Disclosure - FAIR VALUE MEASUREMENTS (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative" xlink:title="00000071 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails" xlink:title="00000072 - Disclosure - Summary of Significant Accounting Policie (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombinationDetails" xlink:title="00000073 - Disclosure - Business Combination (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombinationDetails1" xlink:title="00000074 - Disclosure - Business Combination (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombinationDetailsNarrative" xlink:title="00000075 - Disclosure - Business Combination (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DisaggregationOfRevenueDetails" xlink:title="00000076 - Disclosure - Disaggregation of Revenue (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PropertyAndEquipmentNetDetails" xlink:title="00000077 - Disclosure - Property and Equipment, net (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000078 - Disclosure - Property and Equipment, net (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails" xlink:title="00000079 - Disclosure - Software Development Costs, net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaapCapitalizedComputerSoftwareNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaapCapitalizedComputerSoftwareGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalizedComputerSoftwareNet" xlink:to="loc_us-gaapCapitalizedComputerSoftwareGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:label="loc_us-gaapCapitalizedComputerSoftwareAccumulatedAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCapitalizedComputerSoftwareNet" xlink:to="loc_us-gaapCapitalizedComputerSoftwareAccumulatedAmortization" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative" xlink:title="00000080 - Disclosure - Software Development Costs, net (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails" xlink:title="00000081 - Disclosure - Goodwill and Intangible Assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1" xlink:title="00000082 - Disclosure - Goodwill and Intangible Assets (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2" xlink:title="00000083 - Disclosure - Goodwill and Intangible Assets (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" xlink:title="00000084 - Disclosure - Goodwill and Intangible Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DeferredRevenueDetails" xlink:title="00000085 - Disclosure - Deferred Revenue (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/AccruedLiabilitiesDetails" xlink:title="00000086 - Disclosure - Accrued Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_InsurancePremiumsAndAccruedInterest" xlink:label="loc_cxaiInsurancePremiumsAndAccruedInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_cxaiInsurancePremiumsAndAccruedInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RelatedPartyPromissoryNote" xlink:label="loc_cxaiRelatedPartyPromissoryNote" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_cxaiRelatedPartyPromissoryNote" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxes" xlink:label="loc_us-gaapAccruedIncomeTaxes" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapAccruedIncomeTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RelatedPartyPayable" xlink:label="loc_cxaiRelatedPartyPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_cxaiRelatedPartyPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AccruedCompensationAndBenefits" xlink:label="loc_cxaiAccruedCompensationAndBenefits" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_cxaiAccruedCompensationAndBenefits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaapAccruedBonusesCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapAccruedBonusesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRentCurrent" xlink:label="loc_us-gaapAccruedRentCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapAccruedRentCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AccruedOther" xlink:label="loc_cxaiAccruedOther" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_cxaiAccruedOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="loc_us-gaapAccrualForTaxesOtherThanIncomeTaxesCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapAccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative" xlink:title="00000087 - Disclosure - Accrued Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative" xlink:title="00000088 - Disclosure - Warrant Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails" xlink:title="00000089 - Disclosure - Stock Award Plans and Stock-Based Compensation (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative" xlink:title="00000090 - Disclosure - Stock Option Plan and Stock-Based Compensation (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative" xlink:title="00000091 - Disclosure - Fair Value of Financial Instruments (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000092 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ForeignOperationsDetails" xlink:title="00000093 - Disclosure - Foreign Operations (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/LeasesDetailsNarrative" xlink:title="00000094 - Disclosure - Leases (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>cxai-20230331_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://kins-tech.com/role/Cover" xlink:href="cxai-20230331.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedBalanceSheets" xlink:href="cxai-20230331.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cxai-20230331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedStatementsOfOperations" xlink:href="cxai-20230331.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:href="cxai-20230331.xsd#ConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cxai-20230331.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CondensedConsolidatedBalanceSheets" xlink:href="cxai-20230331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="cxai-20230331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="cxai-20230331.xsd#UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit" xlink:href="cxai-20230331.xsd#UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="cxai-20230331.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperations" xlink:href="cxai-20230331.xsd#DescriptionOfOrganizationAndBusinessOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatements" xlink:href="cxai-20230331.xsd#RestatementOfPreviouslyIssuedFinancialStatements" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PublicOffering" xlink:href="cxai-20230331.xsd#PublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PrivatePlacement" xlink:href="cxai-20230331.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RelatedParties" xlink:href="cxai-20230331.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CommitmentsAndContingencies" xlink:href="cxai-20230331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockholdersDeficit" xlink:href="cxai-20230331.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DerivativeWarrantLiabilities" xlink:href="cxai-20230331.xsd#DerivativeWarrantLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTax" xlink:href="cxai-20230331.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurements" xlink:href="cxai-20230331.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SubsequentEvents" xlink:href="cxai-20230331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/OrganizationNatureOfBusinessAndBasisOfPresentation" xlink:href="cxai-20230331.xsd#OrganizationNatureOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombination" xlink:href="cxai-20230331.xsd#BusinessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DisaggregationOfRevenue" xlink:href="cxai-20230331.xsd#DisaggregationOfRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PropertyAndEquipmentNet" xlink:href="cxai-20230331.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNet" xlink:href="cxai-20230331.xsd#SoftwareDevelopmentCostsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssets" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DeferredRevenue" xlink:href="cxai-20230331.xsd#DeferredRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/AccruedLiabilities" xlink:href="cxai-20230331.xsd#AccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/WarrantLiabilities" xlink:href="cxai-20230331.xsd#WarrantLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensation" xlink:href="cxai-20230331.xsd#StockOptionPlanAndStock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueOfFinancialInstruments" xlink:href="cxai-20230331.xsd#FairValueOfFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxes" xlink:href="cxai-20230331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CreditRiskAndConcentrations" xlink:href="cxai-20230331.xsd#CreditRiskAndConcentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ForeignOperations" xlink:href="cxai-20230331.xsd#ForeignOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/Leases" xlink:href="cxai-20230331.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CommitmentsAndContingencie" xlink:href="cxai-20230331.xsd#CommitmentsAndContingencie" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:href="cxai-20230331.xsd#RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxTables" xlink:href="cxai-20230331.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurementsTables" xlink:href="cxai-20230331.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombinationTables" xlink:href="cxai-20230331.xsd#BusinessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DisaggregationOfRevenueTables" xlink:href="cxai-20230331.xsd#DisaggregationOfRevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PropertyAndEquipmentNetTables" xlink:href="cxai-20230331.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNetTables" xlink:href="cxai-20230331.xsd#SoftwareDevelopmentCostsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DeferredRevenueTables" xlink:href="cxai-20230331.xsd#DeferredRevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/AccruedLiabilitiesTables" xlink:href="cxai-20230331.xsd#AccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationTables" xlink:href="cxai-20230331.xsd#StockOptionPlanAndStock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ForeignOperationsTables" xlink:href="cxai-20230331.xsd#ForeignOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:href="cxai-20230331.xsd#DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails" xlink:href="cxai-20230331.xsd#RestatementOfPreviouslyIssuedFinancialStatementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PublicOfferingDetailsNarrative" xlink:href="cxai-20230331.xsd#PublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PrivatePlacementDetailsNarrative" xlink:href="cxai-20230331.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RelatedPartiesDetailsNarrative" xlink:href="cxai-20230331.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="cxai-20230331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockholdersDeficitDetailsNarrative" xlink:href="cxai-20230331.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative" xlink:href="cxai-20230331.xsd#DerivativeWarrantLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxDetails" xlink:href="cxai-20230331.xsd#IncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxDetails1" xlink:href="cxai-20230331.xsd#IncomeTaxDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxDetails2" xlink:href="cxai-20230331.xsd#IncomeTaxDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxDetailsNarrative" xlink:href="cxai-20230331.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurementsDetails" xlink:href="cxai-20230331.xsd#FairValueMeasurementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurementsDetails1" xlink:href="cxai-20230331.xsd#FairValueMeasurementsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative" xlink:href="cxai-20230331.xsd#FairValueMeasurementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPolicieDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombinationDetails" xlink:href="cxai-20230331.xsd#BusinessCombinationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombinationDetails1" xlink:href="cxai-20230331.xsd#BusinessCombinationDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombinationDetailsNarrative" xlink:href="cxai-20230331.xsd#BusinessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DisaggregationOfRevenueDetails" xlink:href="cxai-20230331.xsd#DisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PropertyAndEquipmentNetDetails" xlink:href="cxai-20230331.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="cxai-20230331.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails" xlink:href="cxai-20230331.xsd#SoftwareDevelopmentCostsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative" xlink:href="cxai-20230331.xsd#SoftwareDevelopmentCostsNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DeferredRevenueDetails" xlink:href="cxai-20230331.xsd#DeferredRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/AccruedLiabilitiesDetails" xlink:href="cxai-20230331.xsd#AccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative" xlink:href="cxai-20230331.xsd#AccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative" xlink:href="cxai-20230331.xsd#WarrantLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails" xlink:href="cxai-20230331.xsd#StockAwardPlansAndStock-basedCompensationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative" xlink:href="cxai-20230331.xsd#StockOptionPlanAndStock-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative" xlink:href="cxai-20230331.xsd#FairValueOfFinancialInstrumentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxesDetailsNarrative" xlink:href="cxai-20230331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ForeignOperationsDetails" xlink:href="cxai-20230331.xsd#ForeignOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/LeasesDetailsNarrative" xlink:href="cxai-20230331.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_30" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_30" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_30" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_30" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_30" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_30" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_30" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_30" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_30" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_30" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_30" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_30" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_30" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_30" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_30" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_30" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_30" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_30" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_30" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_30" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_30" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_30" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_30" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_30" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_30" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_30" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_30" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_30" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_30" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_30" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_30" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_30" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_30" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName_30" xlink:type="arc" order="58" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonClassaSubjectToRedemptionMember" xlink:label="loc_cxaiCommonClassaSubjectToRedemptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_cxaiCommonClassaSubjectToRedemptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_70" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; DEFICIT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassACommonStockMember" xlink:label="loc_cxaiClassACommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cxaiClassACommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassBCommonStockMember" xlink:label="loc_cxaiClassBCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cxaiClassBCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValueAdjustment_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValueAdjustment_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsCurrentAbstract_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapOtherReceivablesNetCurrent_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_70" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssets_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsCurrent_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaapCapitalizedComputerSoftwareNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapCapitalizedComputerSoftwareNet_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapGoodwill_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapOtherAssetsNoncurrent_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssets_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAccountsPayableCurrent_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapDeferredRevenueCurrent_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AcquisitionLiability" xlink:label="loc_cxaiAcquisitionLiability_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_cxaiAcquisitionLiability_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyAccrualCurrent" xlink:label="loc_us-gaapExtendedProductWarrantyAccrualCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapExtendedProductWarrantyAccrualCurrent_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrent_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent_70" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet_70" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapLiabilities_70" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommitmentsAndContingencies_70" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract_70" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommonStockValue_70" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapAdditionalPaidInCapital_70" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_70" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetParentInvestment" xlink:label="loc_cxaiNetParentInvestment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_cxaiNetParentInvestment_70" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_70" xlink:type="arc" order="35" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000008 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="00000009 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfRevenue_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_40" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_40" xlink:to="loc_us-gaapSellingAndMarketingExpense_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_40" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_40" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ChangeInFairValueOfEarnout" xlink:label="loc_cxaiChangeInFairValueOfEarnout_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_40" xlink:to="loc_cxaiChangeInFairValueOfEarnout_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_40" xlink:to="loc_us-gaapOperatingExpenses_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_40" xlink:to="loc_us-gaapOperatingIncomeLoss_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaapInterestIncomeExpenseNet_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_40" xlink:to="loc_us-gaapInterestIncomeExpenseNet_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_40" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_40" xlink:to="loc_us-gaapNonoperatingIncomeExpense_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_40" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_40" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_40" xlink:to="loc_us-gaapNetIncomeLoss_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_40" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_40" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock" xlink:label="loc_cxaiBasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_40" xlink:to="loc_cxaiBasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutiveNetIncomePerShareClassCommonStock" xlink:label="loc_cxaiBasicAndDilutiveNetIncomePerShareClassCommonStock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_40" xlink:to="loc_cxaiBasicAndDilutiveNetIncomePerShareClassCommonStock_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock" xlink:label="loc_cxaiBasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_40" xlink:to="loc_cxaiBasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutiveNetIncomePerShareClassCCommonStock" xlink:label="loc_cxaiBasicAndDilutiveNetIncomePerShareClassCCommonStock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_40" xlink:to="loc_cxaiBasicAndDilutiveNetIncomePerShareClassCCommonStock_40" xlink:type="arc" order="23" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit" xlink:title="00000010 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY (DEFICIT)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetParentInvestmentMember" xlink:label="loc_cxaiNetParentInvestmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cxaiNetParentInvestmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TotalMember" xlink:label="loc_cxaiTotalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cxaiTotalMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassACommonStockMember" xlink:label="loc_cxaiClassACommonStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cxaiClassACommonStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassCCommonStockMember" xlink:label="loc_cxaiClassCCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cxaiClassCCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ParentsCommonSharesIssuedForCxappEarnout" xlink:label="loc_cxaiParentsCommonSharesIssuedForCxappEarnout_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiParentsCommonSharesIssuedForCxappEarnout_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits" xlink:label="loc_cxaiTaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiTaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetInvestmentsFromParent" xlink:label="loc_cxaiNetInvestmentsFromParent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiNetInvestmentsFromParent_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CumulativeTranslationAdjustment" xlink:label="loc_cxaiCumulativeTranslationAdjustment_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiCumulativeTranslationAdjustment_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SharesIssuedInConnectionWithBusinessCombination" xlink:label="loc_cxaiSharesIssuedInConnectionWithBusinessCombination_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiSharesIssuedInConnectionWithBusinessCombination_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SharesIssuedInConnectionWithBusinessCombinationShares" xlink:label="loc_cxaiSharesIssuedInConnectionWithBusinessCombinationShares_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiSharesIssuedInConnectionWithBusinessCombinationShares_100" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000011 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapNetIncomeLoss_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAssetAmortization_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAssetAmortization_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapShareBasedCompensation_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainOnEarnoutPaymentLiability" xlink:label="loc_cxaiGainOnEarnoutPaymentLiability_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_cxaiGainOnEarnoutPaymentLiability_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainOnChangeInFairValueOfDerivativeLiability" xlink:label="loc_cxaiGainOnChangeInFairValueOfDerivativeLiability_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_cxaiGainOnChangeInFairValueOfDerivativeLiability_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsAndOtherReceivables_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsAndOtherReceivables_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxes" xlink:label="loc_us-gaapIncreaseDecreaseInIncomeTaxes_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" xlink:to="loc_us-gaapIncreaseDecreaseInIncomeTaxes_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_40" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_40" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_InvestmentInCapitalizedSoftware" xlink:label="loc_cxaiInvestmentInCapitalizedSoftware_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:to="loc_cxaiInvestmentInCapitalizedSoftware_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:to="loc_us-gaapCashAcquiredFromAcquisition_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetEquityInvestmentFromParent" xlink:label="loc_cxaiNetEquityInvestmentFromParent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_40" xlink:to="loc_cxaiNetEquityInvestmentFromParent_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TaxesPaidRelatedForStockBasedCompensation" xlink:label="loc_cxaiTaxesPaidRelatedForStockBasedCompensation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:to="loc_cxaiTaxesPaidRelatedForStockBasedCompensation_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RepaymentOfCxappAcquisitionLiability" xlink:label="loc_cxaiRepaymentOfCxappAcquisitionLiability_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:to="loc_cxaiRepaymentOfCxappAcquisitionLiability_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:to="loc_us-gaapRepaymentsOfNotesPayable_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_40" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract_40" xlink:to="loc_us-gaapIncomeTaxesPaid_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract_40" xlink:to="loc_us-gaapInterestPaid_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract" xlink:label="loc_cxaiSupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiSupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ParentsNetEquityIssuedForCxAppEarnout" xlink:label="loc_cxaiParentsNetEquityIssuedForCxAppEarnout_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cxaiSupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract_40" xlink:to="loc_cxaiParentsNetEquityIssuedForCxAppEarnout_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NoncashDistribution" xlink:label="loc_cxaiNoncashDistribution_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cxaiSupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract_40" xlink:to="loc_cxaiNoncashDistribution_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination" xlink:label="loc_cxaiClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cxaiSupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract_40" xlink:to="loc_cxaiClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FinancingOfDirectorAndOfficerInsurance" xlink:label="loc_cxaiFinancingOfDirectorAndOfficerInsurance_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cxaiSupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract_40" xlink:to="loc_cxaiFinancingOfDirectorAndOfficerInsurance_40" xlink:type="arc" order="43" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperations" xlink:title="00000012 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatements" xlink:title="00000013 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PublicOffering" xlink:title="00000015 - Disclosure - PUBLIC OFFERING" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PrivatePlacement" xlink:title="00000016 - Disclosure - PRIVATE PLACEMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RelatedParties" xlink:title="00000017 - Disclosure - RELATED PARTIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CommitmentsAndContingencies" xlink:title="00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockholdersDeficit" xlink:title="00000019 - Disclosure - STOCKHOLDERS&#8217; DEFICIT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DerivativeWarrantLiabilities" xlink:title="00000020 - Disclosure - DERIVATIVE WARRANT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTax" xlink:title="00000021 - Disclosure - INCOME TAX" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurements" xlink:title="00000022 - Disclosure - FAIR VALUE MEASUREMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SubsequentEvents" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/OrganizationNatureOfBusinessAndBasisOfPresentation" xlink:title="00000024 - Disclosure - Organization, Nature of Business and Basis of Presentation" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombination" xlink:title="00000025 - Disclosure - Business Combination" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DisaggregationOfRevenue" xlink:title="00000026 - Disclosure - Disaggregation of Revenue" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PropertyAndEquipmentNet" xlink:title="00000027 - Disclosure - Property and Equipment, net" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SoftwareDevelopmentCostsNet" xlink:title="00000028 - Disclosure - Software Development Costs, net" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssets" xlink:title="00000029 - Disclosure - Goodwill and Intangible Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DeferredRevenue" xlink:title="00000030 - Disclosure - Deferred Revenue" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/AccruedLiabilities" xlink:title="00000031 - Disclosure - Accrued Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/WarrantLiabilities" xlink:title="00000032 - Disclosure - Warrant Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensation" xlink:title="00000033 - Disclosure - Stock Option Plan and Stock-Based Compensation" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueOfFinancialInstruments" xlink:title="00000034 - Disclosure - Fair Value of Financial Instruments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxes" xlink:title="00000035 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CreditRiskAndConcentrations" xlink:title="00000036 - Disclosure - Credit Risk and Concentrations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ForeignOperations" xlink:title="00000037 - Disclosure - Foreign Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/Leases" xlink:title="00000038 - Disclosure - Leases" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CommitmentsAndContingencie" xlink:title="00000039 - Disclosure - Commitments and Contingencie" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:title="00000041 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxTables" xlink:title="00000043 - Disclosure - INCOME TAX (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurementsTables" xlink:title="00000044 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombinationTables" xlink:title="00000045 - Disclosure - Business Combination (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DisaggregationOfRevenueTables" xlink:title="00000046 - Disclosure - Disaggregation of Revenue (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PropertyAndEquipmentNetTables" xlink:title="00000047 - Disclosure - Property and Equipment, net (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SoftwareDevelopmentCostsNetTables" xlink:title="00000048 - Disclosure - Software Development Costs, net (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables" xlink:title="00000049 - Disclosure - Goodwill and Intangible Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DeferredRevenueTables" xlink:title="00000050 - Disclosure - Deferred Revenue (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/AccruedLiabilitiesTables" xlink:title="00000051 - Disclosure - Accrued Liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationTables" xlink:title="00000052 - Disclosure - Stock Option Plan and Stock-Based Compensation (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ForeignOperationsTables" xlink:title="00000053 - Disclosure - Foreign Operations (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:title="00000054 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SponsorMember" xlink:label="loc_cxaiSponsorMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_cxaiSponsorMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="loc_cxaiPrivatePlacementWarrantsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPrivatePlacementWarrantsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonClassaSubjectToRedemptionMember" xlink:label="loc_cxaiCommonClassaSubjectToRedemptionMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_cxaiCommonClassaSubjectToRedemptionMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="loc_cxaiUnitsIssuedDuringPeriodSharesNewIssues_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiUnitsIssuedDuringPeriodSharesNewIssues_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NumberOfWarrantsIssued" xlink:label="loc_cxaiNumberOfWarrantsIssued_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiNumberOfWarrantsIssued_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="loc_cxaiClassOfWarrantOrRightPriceOfWarrantsOrRights_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightPriceOfWarrantsOrRights_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TransactionCosts" xlink:label="loc_cxaiTransactionCosts_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiTransactionCosts_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SaleOfStockUnderwritingFees" xlink:label="loc_cxaiSaleOfStockUnderwritingFees_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiSaleOfStockUnderwritingFees_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredOfferingCostsNoncurrent" xlink:label="loc_cxaiDeferredOfferingCostsNoncurrent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiDeferredOfferingCostsNoncurrent_120" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SaleOfStockOtherOfferingCosts" xlink:label="loc_cxaiSaleOfStockOtherOfferingCosts_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiSaleOfStockOtherOfferingCosts_120" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="loc_cxaiPaymentsForInvestmentOfCashInTrustAccount_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiPaymentsForInvestmentOfCashInTrustAccount_120" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount" xlink:label="loc_cxaiThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount_120" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination" xlink:label="loc_cxaiThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination_120" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination" xlink:label="loc_cxaiMinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiMinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_120" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent" xlink:label="loc_cxaiThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent_120" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:label="loc_cxaiPercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiPercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_120" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_120" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumNetInterestsToPayDissolutionExpenses" xlink:label="loc_cxaiMaximumNetInterestsToPayDissolutionExpenses_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiMaximumNetInterestsToPayDissolutionExpenses_120" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_120" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WorkingCapital" xlink:label="loc_cxaiWorkingCapital_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiWorkingCapital_120" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProceedsFromRelatedParty" xlink:label="loc_cxaiProceedsFromRelatedParty_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiProceedsFromRelatedParty_120" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt_120" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails" xlink:title="00000055 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRestatementAdjustmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable" xlink:label="loc_cxaiGainOnForgivenessOfDeferredUnderwritingFeePayable_550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_cxaiGainOnForgivenessOfDeferredUnderwritingFeePayable_550" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpense_550" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_550" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapProfitLoss_550" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares" xlink:label="loc_cxaiBasicAndDilutedWeightedAverageSharesOutstandingInShares_550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_cxaiBasicAndDilutedWeightedAverageSharesOutstandingInShares_550" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare" xlink:label="loc_cxaiBasicAndDilutedEarningsPerShareInDollarsPerShare_550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_cxaiBasicAndDilutedEarningsPerShareInDollarsPerShare_550" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_550" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValueAdjustment_550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValueAdjustment_550" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_550" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" xlink:label="loc_cxaiExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_550" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_550" xlink:to="loc_cxaiExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_550" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000056 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:title="00000057 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareAbstract_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasicAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareAbstract_50" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasicAbstract_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasicAbstract_50" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareAbstract_50" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract_50" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareAbstract_50" xlink:to="loc_us-gaapEarningsPerShareBasic_50" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000058 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonStockSubjectToRedemptionMember" xlink:label="loc_cxaiCommonStockSubjectToRedemptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_cxaiCommonStockSubjectToRedemptionMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TransactionCosts" xlink:label="loc_cxaiTransactionCosts_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiTransactionCosts_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SaleOfStockUnderwritingFees" xlink:label="loc_cxaiSaleOfStockUnderwritingFees_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiSaleOfStockUnderwritingFees_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredOfferingCostsNoncurrent" xlink:label="loc_cxaiDeferredOfferingCostsNoncurrent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiDeferredOfferingCostsNoncurrent_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SaleOfStockOtherOfferingCosts" xlink:label="loc_cxaiSaleOfStockOtherOfferingCosts_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiSaleOfStockOtherOfferingCosts_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_OfferingCost" xlink:label="loc_cxaiOfferingCost_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiOfferingCost_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_170" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_170" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WorkingCapital" xlink:label="loc_cxaiWorkingCapital_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiWorkingCapital_170" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCash_170" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapNetIncomeLoss_170" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_170" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent_170" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CashAndCashEquivalentsDescription" xlink:label="loc_cxaiCashAndCashEquivalentsDescription_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiCashAndCashEquivalentsDescription_170" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_170" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDeferredRevenue_170" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RevenueRecognized" xlink:label="loc_cxaiRevenueRecognized_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiRevenueRecognized_170" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapShareBasedCompensation_170" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ChangesInEstimatedFairValueOfWarrants" xlink:label="loc_cxaiChangesInEstimatedFairValueOfWarrants_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiChangesInEstimatedFairValueOfWarrants_170" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges" xlink:label="loc_us-gaapOtherAssetImpairmentCharges_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOtherAssetImpairmentCharges_170" xlink:type="arc" order="24" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PublicOfferingDetailsNarrative" xlink:title="00000059 - Disclosure - PUBLIC OFFERING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="loc_cxaiUnitsIssuedDuringPeriodSharesNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiUnitsIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000060 - Disclosure - PRIVATE PLACEMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="loc_cxaiPrivatePlacementWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPrivatePlacementWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="loc_cxaiClassOfWarrantOrRightPriceOfWarrantsOrRights_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightPriceOfWarrantsOrRights_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RelatedPartiesDetailsNarrative" xlink:title="00000061 - Disclosure - RELATED PARTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FounderSharesMember" xlink:label="loc_cxaiFounderSharesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_cxaiFounderSharesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AdministrativeServicesAgreementMember" xlink:label="loc_cxaiAdministrativeServicesAgreementMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_cxaiAdministrativeServicesAgreementMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PromissoryNoteWithRelatedPartyMember" xlink:label="loc_cxaiPromissoryNoteWithRelatedPartyMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_cxaiPromissoryNoteWithRelatedPartyMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WorkingCapitalLoansMember" xlink:label="loc_cxaiWorkingCapitalLoansMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_cxaiWorkingCapitalLoansMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SponsorMember" xlink:label="loc_cxaiSponsorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_cxaiSponsorMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DirectAnchorMember" xlink:label="loc_cxaiDirectAnchorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_cxaiDirectAnchorMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WorkingCapitalLoansWarrantMember" xlink:label="loc_cxaiWorkingCapitalLoansWarrantMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiWorkingCapitalLoansWarrantMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_220" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_220" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NumberOfSharesSubjectToForfeiture" xlink:label="loc_cxaiNumberOfSharesSubjectToForfeiture_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiNumberOfSharesSubjectToForfeiture_220" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSharePrice_220" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaapStockholdersEquityNoteStockSplitConversionRatio1_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteStockSplitConversionRatio1_220" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AggregateNumberOfSharesOwned" xlink:label="loc_cxaiAggregateNumberOfSharesOwned_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiAggregateNumberOfSharesOwned_220" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:label="loc_cxaiPercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiPercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_220" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:label="loc_cxaiRestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiRestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_220" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:label="loc_cxaiTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_220" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:label="loc_cxaiTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_220" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:label="loc_cxaiTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_220" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:label="loc_cxaiThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_220" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:label="loc_cxaiRelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiRelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_220" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ExpensesIncurredAndPaid" xlink:label="loc_cxaiExpensesIncurredAndPaid_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiExpensesIncurredAndPaid_220" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="loc_us-gaapDebtInstrumentCollateralAmount_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentCollateralAmount_220" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_220" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumLoansConvertibleIntoWarrants" xlink:label="loc_cxaiMaximumLoansConvertibleIntoWarrants_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiMaximumLoansConvertibleIntoWarrants_220" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="loc_cxaiClassOfWarrantOrRightPriceOfWarrantsOrRights_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightPriceOfWarrantsOrRights_220" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:label="loc_cxaiMaximumBorrowingCapacityOfRelatedPartyPromissoryNote_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiMaximumBorrowingCapacityOfRelatedPartyPromissoryNote_220" xlink:type="arc" order="18" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000062 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CXAppCommonStockMember" xlink:label="loc_cxaiCXAppCommonStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cxaiCXAppCommonStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_InpixonMember" xlink:label="loc_cxaiInpixonMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cxaiInpixonMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SeparationAgreementMember" xlink:label="loc_cxaiSeparationAgreementMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_cxaiSeparationAgreementMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MergerAgreementMember" xlink:label="loc_cxaiMergerAgreementMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_cxaiMergerAgreementMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SponsorSupportAgreementMember" xlink:label="loc_cxaiSponsorSupportAgreementMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_cxaiSponsorSupportAgreementMember_180" xlink:type="arc" order="182" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CxappHoldingCorpMember" xlink:label="loc_cxaiCxappHoldingCorpMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_cxaiCxappHoldingCorpMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MergerAgreementMember" xlink:label="loc_cxaiMergerAgreementMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_cxaiMergerAgreementMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands" xlink:label="loc_cxaiMinimumPercentageOfFounderShareHoldersEntitledToMakeDemands_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiMinimumPercentageOfFounderShareHoldersEntitledToMakeDemands_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:label="loc_cxaiMaximumNumberOfDemandsForRegistrationOfSecurities_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiMaximumNumberOfDemandsForRegistrationOfSecurities_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredFeePerUnit" xlink:label="loc_cxaiDeferredFeePerUnit_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiDeferredFeePerUnit_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredOfferingCostsNoncurrent" xlink:label="loc_cxaiDeferredOfferingCostsNoncurrent_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiDeferredOfferingCostsNoncurrent_210" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee" xlink:label="loc_cxaiIncomeRecognizedFromReductionOfDeferredUnderwriterFee_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiIncomeRecognizedFromReductionOfDeferredUnderwriterFee_210" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_210" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationConsideration_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationConsideration_210" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfCommonStockDistributed" xlink:label="loc_cxaiPercentageOfCommonStockDistributed_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiPercentageOfCommonStockDistributed_210" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger" xlink:label="loc_cxaiMaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiMaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger_210" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonStockStockPriceTrigger" xlink:label="loc_cxaiCommonStockStockPriceTrigger_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiCommonStockStockPriceTrigger_210" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdTradingDays" xlink:label="loc_cxaiThresholdTradingDays_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiThresholdTradingDays_210" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdConsecutiveTradingDays" xlink:label="loc_cxaiThresholdConsecutiveTradingDays_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiThresholdConsecutiveTradingDays_210" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NumberOfSharesIssuableUponMerger" xlink:label="loc_cxaiNumberOfSharesIssuableUponMerger_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiNumberOfSharesIssuableUponMerger_210" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfStockAsMergerConsideration" xlink:label="loc_cxaiPercentageOfStockAsMergerConsideration_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiPercentageOfStockAsMergerConsideration_210" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdNetTangibleAssets" xlink:label="loc_cxaiThresholdNetTangibleAssets_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiThresholdNetTangibleAssets_210" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares" xlink:label="loc_cxaiThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares_210" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TermOfBreachUnableToBeCuredOrIsNotCured" xlink:label="loc_cxaiTermOfBreachUnableToBeCuredOrIsNotCured_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiTermOfBreachUnableToBeCuredOrIsNotCured_210" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TerminationFee" xlink:label="loc_cxaiTerminationFee_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiTerminationFee_210" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonStockLockUpPeriod" xlink:label="loc_cxaiCommonStockLockUpPeriod_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiCommonStockLockUpPeriod_210" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp" xlink:label="loc_cxaiPercentageOfSharesNotBeSubjectToForegoingLockUp_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiPercentageOfSharesNotBeSubjectToForegoingLockUp_210" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NumberOfSharesExchanged" xlink:label="loc_cxaiNumberOfSharesExchanged_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiNumberOfSharesExchanged_210" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MinimumNumberOfSharesIssuableToSponsor" xlink:label="loc_cxaiMinimumNumberOfSharesIssuableToSponsor_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiMinimumNumberOfSharesIssuableToSponsor_210" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000063 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonStockSubjectToRedemptionMember" xlink:label="loc_cxaiCommonStockSubjectToRedemptionMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_cxaiCommonStockSubjectToRedemptionMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonStockNumberOfVotesPerShare" xlink:label="loc_cxaiCommonStockNumberOfVotesPerShare_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_cxaiCommonStockNumberOfVotesPerShare_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ConvertibleStockConversionRatio" xlink:label="loc_cxaiConvertibleStockConversionRatio_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_cxaiConvertibleStockConversionRatio_100" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative" xlink:title="00000064 - Disclosure - DERIVATIVE WARRANT LIABILITIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="loc_cxaiPrivatePlacementWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPrivatePlacementWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PublicWarrantsMember" xlink:label="loc_cxaiPublicWarrantsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPublicWarrantsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_us-gaapWarrantMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:label="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:label="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantExercisePeriodConditionOne" xlink:label="loc_cxaiWarrantExercisePeriodConditionOne_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiWarrantExercisePeriodConditionOne_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantExercisePeriodConditionTwo" xlink:label="loc_cxaiWarrantExercisePeriodConditionTwo_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiWarrantExercisePeriodConditionTwo_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" xlink:label="loc_cxaiMaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiMaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" xlink:label="loc_cxaiPeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiPeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantRedemptionConditionMinimumSharePrice" xlink:label="loc_cxaiWarrantRedemptionConditionMinimumSharePrice_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiWarrantRedemptionConditionMinimumSharePrice_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="loc_cxaiClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:label="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:label="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionPeriod" xlink:label="loc_cxaiRedemptionPeriod_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiRedemptionPeriod_150" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo" xlink:label="loc_cxaiWarrantRedemptionConditionMinimumSharePriceScenarioTwo_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiWarrantRedemptionConditionMinimumSharePriceScenarioTwo_150" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant" xlink:label="loc_cxaiSharePricetriggerUsedToMeasureDilutionOfWarrant_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiSharePricetriggerUsedToMeasureDilutionOfWarrant_150" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant" xlink:label="loc_cxaiPercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiPercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant_150" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantExercisePriceAdjustmentMultiple" xlink:label="loc_cxaiWarrantExercisePriceAdjustmentMultiple_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiWarrantExercisePriceAdjustmentMultiple_150" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantRedemptionPriceAdjustmentMultiple" xlink:label="loc_cxaiWarrantRedemptionPriceAdjustmentMultiple_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiWarrantRedemptionPriceAdjustmentMultiple_150" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NumberOfWarrantsIssued" xlink:label="loc_cxaiNumberOfWarrantsIssued_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiNumberOfWarrantsIssued_150" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:label="loc_cxaiRestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiRestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_150" xlink:type="arc" order="17" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxDetails" xlink:title="00000065 - Disclosure - INCOME TAX (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxDetails1" xlink:title="00000066 - Disclosure - INCOME TAX (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxDetails2" xlink:title="00000067 - Disclosure - INCOME TAX (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxDetailsNarrative" xlink:title="00000068 - Disclosure - INCOME TAX (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurementsDetails" xlink:title="00000069 - Disclosure - FAIR VALUE MEASUREMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaapMoneyMarketFundsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapMoneyMarketFundsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PublicWarrantsMember" xlink:label="loc_cxaiPublicWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPublicWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="loc_cxaiPrivatePlacementWarrantsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPrivatePlacementWarrantsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:label="loc_us-gaapSharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapSharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_70" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurementsDetails1" xlink:title="00000070 - Disclosure - FAIR VALUE MEASUREMENTS (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="loc_cxaiPrivatePlacementWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPrivatePlacementWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PublicWarrantsMember" xlink:label="loc_cxaiPublicWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPublicWarrantsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" xlink:label="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" xlink:label="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_100" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative" xlink:title="00000071 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashMember" xlink:label="loc_us-gaapCashMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapCashMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaapMoneyMarketFundsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapMoneyMarketFundsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" xlink:label="loc_cxaiProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_cxaiProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProceedsFromTrustAccountInConnectionWithRedemption" xlink:label="loc_cxaiProceedsFromTrustAccountInConnectionWithRedemption_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_cxaiProceedsFromTrustAccountInConnectionWithRedemption_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" xlink:label="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" xlink:label="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails" xlink:title="00000072 - Disclosure - Summary of Significant Accounting Policie (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_StockOptionsMember" xlink:label="loc_cxaiStockOptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cxaiStockOptionsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombinationDetails" xlink:title="00000073 - Disclosure - Business Combination (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaapDevelopedTechnologyRightsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapDevelopedTechnologyRightsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaapTrademarksAndTradeNamesMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksAndTradeNamesMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PurchasePrice" xlink:label="loc_cxaiPurchasePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_cxaiPurchasePrice_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables" xlink:label="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset" xlink:label="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_100" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_100" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_100" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_100" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_100" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities" xlink:label="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_100" xlink:to="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_100" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_100" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_100" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent" xlink:label="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_100" xlink:to="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent_100" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent" xlink:label="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_100" xlink:to="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent_100" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_100" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_100" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_100" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_100" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_100" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombinationDetails1" xlink:title="00000074 - Disclosure - Business Combination (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombinationDetailsNarrative" xlink:title="00000075 - Disclosure - Business Combination (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MergerAgreementMember" xlink:label="loc_cxaiMergerAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_cxaiMergerAgreementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AggregatePurchasePriceAssetsAndLiabilities" xlink:label="loc_cxaiAggregatePurchasePriceAssetsAndLiabilities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_cxaiAggregatePurchasePriceAssetsAndLiabilities_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ConsiderationTransferredInConnection" xlink:label="loc_cxaiConsiderationTransferredInConnection_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_cxaiConsiderationTransferredInConnection_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharePrice_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaapBusinessCombinationAcquisitionRelatedCosts_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationAcquisitionRelatedCosts_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DisaggregationOfRevenueDetails" xlink:title="00000076 - Disclosure - Disaggregation of Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaapSubsegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsegmentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaapSubsegmentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsegmentsAxis" xlink:to="loc_us-gaapSubsegmentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaapSubsegmentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsegmentsAxis" xlink:to="loc_us-gaapSubsegmentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SubscriptionRevenueMember" xlink:label="loc_cxaiSubscriptionRevenueMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsegmentsDomain" xlink:to="loc_cxaiSubscriptionRevenueMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NonSubscriptionRevenueMember" xlink:label="loc_cxaiNonSubscriptionRevenueMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsegmentsDomain" xlink:to="loc_cxaiNonSubscriptionRevenueMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SoftwareMember" xlink:label="loc_cxaiSoftwareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_cxaiSoftwareMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProfessionalServicesMember" xlink:label="loc_cxaiProfessionalServicesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_cxaiProfessionalServicesMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember" xlink:label="loc_us-gaapTransferredOverTimeMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:to="loc_us-gaapTransferredOverTimeMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_190" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PropertyAndEquipmentNetDetails" xlink:title="00000077 - Disclosure - Property and Equipment, net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SoftwareMember" xlink:label="loc_cxaiSoftwareMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_cxaiSoftwareMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000078 - Disclosure - Property and Equipment, net (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails" xlink:title="00000079 - Disclosure - Software Development Costs, net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaapCapitalizedComputerSoftwareGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalizedComputerSoftwareGross_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:label="loc_us-gaapCapitalizedComputerSoftwareAccumulatedAmortization_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalizedComputerSoftwareAccumulatedAmortization_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaapCapitalizedComputerSoftwareNet_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalizedComputerSoftwareNet_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative" xlink:title="00000080 - Disclosure - Software Development Costs, net (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentForAmortization_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails" xlink:title="00000081 - Disclosure - Goodwill and Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AcquisitionOfLegacyCxapp" xlink:label="loc_cxaiAcquisitionOfLegacyCxapp_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiAcquisitionOfLegacyCxapp_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1" xlink:title="00000082 - Disclosure - Goodwill and Intangible Assets (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaapTrademarksAndTradeNamesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksAndTradeNamesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaapDevelopedTechnologyRightsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapDevelopedTechnologyRightsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PatentsAndIntellectualPropertyMember" xlink:label="loc_cxaiPatentsAndIntellectualPropertyMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_cxaiPatentsAndIntellectualPropertyMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapOtherFiniteLivedIntangibleAssetsGross_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOtherFiniteLivedIntangibleAssetsGross_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_170" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2" xlink:title="00000083 - Disclosure - Goodwill and Intangible Assets (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" xlink:title="00000084 - Disclosure - Goodwill and Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_70" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DeferredRevenueDetails" xlink:title="00000085 - Disclosure - Deferred Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaapLicensingAgreementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLicensingAgreementsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProfessionalServiceAgreementsMember" xlink:label="loc_cxaiProfessionalServiceAgreementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_cxaiProfessionalServiceAgreementsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredRevenue_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/AccruedLiabilitiesDetails" xlink:title="00000086 - Disclosure - Accrued Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_InsurancePremiumsAndAccruedInterest" xlink:label="loc_cxaiInsurancePremiumsAndAccruedInterest_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiInsurancePremiumsAndAccruedInterest_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RelatedPartyPromissoryNote" xlink:label="loc_cxaiRelatedPartyPromissoryNote_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiRelatedPartyPromissoryNote_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxes" xlink:label="loc_us-gaapAccruedIncomeTaxes_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedIncomeTaxes_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RelatedPartyPayable" xlink:label="loc_cxaiRelatedPartyPayable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiRelatedPartyPayable_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AccruedCompensationAndBenefits" xlink:label="loc_cxaiAccruedCompensationAndBenefits_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiAccruedCompensationAndBenefits_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaapAccruedBonusesCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedBonusesCurrent_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRentCurrent" xlink:label="loc_us-gaapAccruedRentCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedRentCurrent_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AccruedOther" xlink:label="loc_cxaiAccruedOther_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiAccruedOther_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="loc_us-gaapAccrualForTaxesOtherThanIncomeTaxesCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccrualForTaxesOtherThanIncomeTaxesCurrent_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent_30" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative" xlink:title="00000087 - Disclosure - Accrued Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DirectorAndOfficersMember" xlink:label="loc_cxaiDirectorAndOfficersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_cxaiDirectorAndOfficersMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaapOtherBorrowings_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherBorrowings_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RelatedPartyDescription" xlink:label="loc_cxaiRelatedPartyDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiRelatedPartyDescription_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative" xlink:title="00000088 - Disclosure - Warrant Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PublicWarrantsMember" xlink:label="loc_cxaiPublicWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPublicWarrantsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_us-gaapWarrantMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="loc_cxaiPrivatePlacementWarrantsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPrivatePlacementWarrantsMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:label="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:label="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease" xlink:label="loc_us-gaapWarrantExercisePriceIncrease_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantExercisePriceIncrease_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantExercisePeriodConditionOne" xlink:label="loc_cxaiWarrantExercisePeriodConditionOne_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiWarrantExercisePeriodConditionOne_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantExercisePeriodConditionTwo" xlink:label="loc_cxaiWarrantExercisePeriodConditionTwo_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiWarrantExercisePeriodConditionTwo_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantRedemptionConditionMinimumSharePrice" xlink:label="loc_cxaiWarrantRedemptionConditionMinimumSharePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiWarrantRedemptionConditionMinimumSharePrice_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="loc_cxaiClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionPeriod" xlink:label="loc_cxaiRedemptionPeriod_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiRedemptionPeriod_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:label="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:label="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_100" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders" xlink:label="loc_cxaiThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders_100" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo" xlink:label="loc_cxaiWarrantRedemptionConditionMinimumSharePriceScenarioTwo_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiWarrantRedemptionConditionMinimumSharePriceScenarioTwo_100" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:label="loc_cxaiRestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiRestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_100" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails" xlink:title="00000089 - Disclosure - Stock Award Plans and Stock-Based Compensation (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative" xlink:title="00000090 - Disclosure - Stock Option Plan and Stock-Based Compensation (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_N2023EquityIncentivePlanMember" xlink:label="loc_cxaiN2023EquityIncentivePlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_cxaiN2023EquityIncentivePlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EmployeeStockOptionsMember" xlink:label="loc_cxaiEmployeeStockOptionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_cxaiEmployeeStockOptionsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EmployeesAndDirectorsMember" xlink:label="loc_cxaiEmployeesAndDirectorsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cxaiEmployeesAndDirectorsMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_20" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueOfOptions" xlink:label="loc_cxaiFairValueOfOptions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_cxaiFairValueOfOptions_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AmortizationOfEmployeeStockOptions" xlink:label="loc_cxaiAmortizationOfEmployeeStockOptions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_cxaiAmortizationOfEmployeeStockOptions_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueOfNonvestedOptions" xlink:label="loc_cxaiFairValueOfNonvestedOptions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_cxaiFairValueOfNonvestedOptions_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WeightedAverageRemainingTermOfNonvestedOptions" xlink:label="loc_cxaiWeightedAverageRemainingTermOfNonvestedOptions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_cxaiWeightedAverageRemainingTermOfNonvestedOptions_70" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative" xlink:title="00000091 - Disclosure - Fair Value of Financial Instruments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PublicPlacementWarrantsMember" xlink:label="loc_cxaiPublicPlacementWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPublicPlacementWarrantsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="loc_cxaiPrivatePlacementWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPrivatePlacementWarrantsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000092 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_IncomeTaxBenefitprovision" xlink:label="loc_cxaiIncomeTaxBenefitprovision_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiIncomeTaxBenefitprovision_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_50" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ForeignOperationsDetails" xlink:title="00000093 - Disclosure - Foreign Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_countryUS_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA" xlink:label="loc_countryCA_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IN" xlink:label="loc_countryIN_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIN_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_PH" xlink:label="loc_countryPH_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPH_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EliminationsMember" xlink:label="loc_cxaiEliminationsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_cxaiEliminationsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_310" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_310" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_310" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetAssets" xlink:label="loc_cxaiNetAssets_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiNetAssets_310" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaapNoncurrentAssets_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNoncurrentAssets_310" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill_310" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://kins-tech.com/role/LeasesDetailsNarrative" xlink:title="00000094 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_LeasePeriodicPayments" xlink:label="loc_cxaiLeasePeriodicPayments_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiLeasePeriodicPayments_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent_70" xlink:type="arc" order="3" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>cxai-20230331_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonClassaSubjectToRedemptionMember" xlink:label="cxai_CommonClassaSubjectToRedemptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CommonClassaSubjectToRedemptionMember" xlink:to="cxai_CommonClassaSubjectToRedemptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_CommonClassaSubjectToRedemptionMember_lbl" xml:lang="en-US">Class A Common Stock Subject to Redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassACommonStockMember" xlink:label="cxai_ClassACommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ClassACommonStockMember" xlink:to="cxai_ClassACommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ClassACommonStockMember_lbl" xml:lang="en-US">Class A Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassBCommonStockMember" xlink:label="cxai_ClassBCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ClassBCommonStockMember" xlink:to="cxai_ClassBCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ClassBCommonStockMember_lbl" xml:lang="en-US">Class B Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="cxai_PrivatePlacementWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PrivatePlacementWarrantsMember" xlink:to="cxai_PrivatePlacementWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PrivatePlacementWarrantsMember_lbl" xml:lang="en-US">Private Placement Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SponsorMember" xlink:label="cxai_SponsorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SponsorMember" xlink:to="cxai_SponsorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_SponsorMember_lbl" xml:lang="en-US">Sponsor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAxis_lbl" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">Previously Reported [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="srt_RestatementAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAdjustmentMember" xlink:to="srt_RestatementAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAdjustmentMember_lbl" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassAMember_lbl" xml:lang="en-US">Common Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonStockSubjectToRedemptionMember" xlink:label="cxai_CommonStockSubjectToRedemptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CommonStockSubjectToRedemptionMember" xlink:to="cxai_CommonStockSubjectToRedemptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_CommonStockSubjectToRedemptionMember_lbl" xml:lang="en-US">Common stock subject to redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="cxai_SuccessorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SuccessorMember" xlink:to="cxai_SuccessorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_SuccessorMember_lbl" xml:lang="en-US">Successor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="cxai_PredecessorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PredecessorMember" xlink:to="cxai_PredecessorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PredecessorMember_lbl" xml:lang="en-US">Predecessor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FounderSharesMember" xlink:label="cxai_FounderSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_FounderSharesMember" xlink:to="cxai_FounderSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_FounderSharesMember_lbl" xml:lang="en-US">Founder Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DirectAnchorMember" xlink:label="cxai_DirectAnchorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DirectAnchorMember" xlink:to="cxai_DirectAnchorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DirectAnchorMember_lbl" xml:lang="en-US">Direct Anchor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AdministrativeServicesAgreementMember" xlink:label="cxai_AdministrativeServicesAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_AdministrativeServicesAgreementMember" xlink:to="cxai_AdministrativeServicesAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_AdministrativeServicesAgreementMember_lbl" xml:lang="en-US">Administrative Services Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PromissoryNoteWithRelatedPartyMember" xlink:label="cxai_PromissoryNoteWithRelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PromissoryNoteWithRelatedPartyMember" xlink:to="cxai_PromissoryNoteWithRelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PromissoryNoteWithRelatedPartyMember_lbl" xml:lang="en-US">Promissory Note With Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WorkingCapitalLoansMember" xlink:label="cxai_WorkingCapitalLoansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WorkingCapitalLoansMember" xlink:to="cxai_WorkingCapitalLoansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_WorkingCapitalLoansMember_lbl" xml:lang="en-US">Working Capital Loans</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WorkingCapitalLoansWarrantMember" xlink:label="cxai_WorkingCapitalLoansWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WorkingCapitalLoansWarrantMember" xlink:to="cxai_WorkingCapitalLoansWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_WorkingCapitalLoansWarrantMember_lbl" xml:lang="en-US">Working capital loans warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CXAppCommonStockMember" xlink:label="cxai_CXAppCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CXAppCommonStockMember" xlink:to="cxai_CXAppCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_CXAppCommonStockMember_lbl" xml:lang="en-US">C X App Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US">Counterparty Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_InpixonMember" xlink:label="cxai_InpixonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_InpixonMember" xlink:to="cxai_InpixonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_InpixonMember_lbl" xml:lang="en-US">Inpixon</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SeparationAgreementMember" xlink:label="cxai_SeparationAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SeparationAgreementMember" xlink:to="cxai_SeparationAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_SeparationAgreementMember_lbl" xml:lang="en-US">Separation Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CxappHoldingCorpMember" xlink:label="cxai_CxappHoldingCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CxappHoldingCorpMember" xlink:to="cxai_CxappHoldingCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_CxappHoldingCorpMember_lbl" xml:lang="en-US">CXApp</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MergerAgreementMember" xlink:label="cxai_MergerAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MergerAgreementMember" xlink:to="cxai_MergerAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_MergerAgreementMember_lbl" xml:lang="en-US">Merger Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="us-gaap_CommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassCMember_lbl" xml:lang="en-US">Common Class C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransactionTypeAxis_lbl" xml:lang="en-US">Transaction Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SponsorSupportAgreementMember" xlink:label="cxai_SponsorSupportAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SponsorSupportAgreementMember" xlink:to="cxai_SponsorSupportAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_SponsorSupportAgreementMember_lbl" xml:lang="en-US">Sponsor Support Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PublicWarrantsMember" xlink:label="cxai_PublicWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PublicWarrantsMember" xlink:to="cxai_PublicWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PublicWarrantsMember_lbl" xml:lang="en-US">Public Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:label="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:to="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_lbl" xml:lang="en-US">Redemption Of Warrants When The Price per Class A Ordinary Share Equals Or Exceeds $18.00 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:label="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:to="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_lbl" xml:lang="en-US">Redemption Of Warrants When The Price Per Class A Ordinary Share Equals Or Exceeds $10.00 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashMember" xlink:label="us-gaap_CashMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashMember" xlink:to="us-gaap_CashMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashMember_lbl" xml:lang="en-US">Cash [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US">Money Market Funds [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetParentInvestmentMember" xlink:label="cxai_NetParentInvestmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NetParentInvestmentMember" xlink:to="cxai_NetParentInvestmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_NetParentInvestmentMember_lbl" xml:lang="en-US">Net Parent Investment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TotalMember" xlink:label="cxai_TotalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TotalMember" xlink:to="cxai_TotalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_TotalMember_lbl" xml:lang="en-US">Total [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassCCommonStockMember" xlink:label="cxai_ClassCCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ClassCCommonStockMember" xlink:to="cxai_ClassCCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ClassCCommonStockMember_lbl" xml:lang="en-US">Class C Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_StockOptionsMember" xlink:label="cxai_StockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_StockOptionsMember" xlink:to="cxai_StockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_StockOptionsMember_lbl" xml:lang="en-US">Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopedTechnologyRightsMember" xlink:to="us-gaap_DevelopedTechnologyRightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DevelopedTechnologyRightsMember_lbl" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="us-gaap_TrademarksAndTradeNamesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksAndTradeNamesMember" xlink:to="us-gaap_TrademarksAndTradeNamesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TrademarksAndTradeNamesMember_lbl" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis" xlink:label="us-gaap_SubsegmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsegmentsAxis" xlink:to="us-gaap_SubsegmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsegmentsAxis_lbl" xml:lang="en-US">Subsegments [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SubscriptionRevenueMember" xlink:label="cxai_SubscriptionRevenueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SubscriptionRevenueMember" xlink:to="cxai_SubscriptionRevenueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_SubscriptionRevenueMember_lbl" xml:lang="en-US">Subscription Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SoftwareMember" xlink:label="cxai_SoftwareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SoftwareMember" xlink:to="cxai_SoftwareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_SoftwareMember_lbl" xml:lang="en-US">Software [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NonSubscriptionRevenueMember" xlink:label="cxai_NonSubscriptionRevenueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NonSubscriptionRevenueMember" xlink:to="cxai_NonSubscriptionRevenueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_NonSubscriptionRevenueMember_lbl" xml:lang="en-US">Non Subscription Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProfessionalServicesMember" xlink:label="cxai_ProfessionalServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ProfessionalServicesMember" xlink:to="cxai_ProfessionalServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ProfessionalServicesMember_lbl" xml:lang="en-US">Professional Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember" xlink:label="us-gaap_TransferredOverTimeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransferredOverTimeMember" xlink:to="us-gaap_TransferredOverTimeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransferredOverTimeMember_lbl" xml:lang="en-US">Transferred over Time [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficeEquipmentMember_lbl" xml:lang="en-US">Office Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="us-gaap_NoncompeteAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PatentsAndIntellectualPropertyMember" xlink:label="cxai_PatentsAndIntellectualPropertyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PatentsAndIntellectualPropertyMember" xlink:to="cxai_PatentsAndIntellectualPropertyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PatentsAndIntellectualPropertyMember_lbl" xml:lang="en-US">Patents And Intellectual Property [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember" xlink:label="us-gaap_LicensingAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicensingAgreementsMember" xlink:to="us-gaap_LicensingAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LicensingAgreementsMember_lbl" xml:lang="en-US">Licensing Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProfessionalServiceAgreementsMember" xlink:label="cxai_ProfessionalServiceAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ProfessionalServiceAgreementsMember" xlink:to="cxai_ProfessionalServiceAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ProfessionalServiceAgreementsMember_lbl" xml:lang="en-US">Professional Service Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DirectorAndOfficersMember" xlink:label="cxai_DirectorAndOfficersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DirectorAndOfficersMember" xlink:to="cxai_DirectorAndOfficersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DirectorAndOfficersMember_lbl" xml:lang="en-US">Director And Officers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_N2023EquityIncentivePlanMember" xlink:label="cxai_N2023EquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_N2023EquityIncentivePlanMember" xlink:to="cxai_N2023EquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_N2023EquityIncentivePlanMember_lbl" xml:lang="en-US">N 2023 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EmployeeStockOptionsMember" xlink:label="cxai_EmployeeStockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_EmployeeStockOptionsMember" xlink:to="cxai_EmployeeStockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_EmployeeStockOptionsMember_lbl" xml:lang="en-US">Employee Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EmployeesAndDirectorsMember" xlink:label="cxai_EmployeesAndDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_EmployeesAndDirectorsMember" xlink:to="cxai_EmployeesAndDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_EmployeesAndDirectorsMember_lbl" xml:lang="en-US">Employees And Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PublicPlacementWarrantsMember" xlink:label="cxai_PublicPlacementWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PublicPlacementWarrantsMember" xlink:to="cxai_PublicPlacementWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PublicPlacementWarrantsMember_lbl" xml:lang="en-US">Public Placement Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">UNITED STATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA" xlink:label="country_CA" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CA" xlink:to="country_CA_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CA_lbl" xml:lang="en-US">CANADA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IN" xlink:label="country_IN" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IN" xlink:to="country_IN_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IN_lbl" xml:lang="en-US">INDIA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_PH" xlink:label="country_PH" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_PH" xlink:to="country_PH_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_PH_lbl" xml:lang="en-US">PHILIPPINES</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EliminationsMember" xlink:label="cxai_EliminationsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_EliminationsMember" xlink:to="cxai_EliminationsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_EliminationsMember_lbl" xml:lang="en-US">Eliminations [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xml:lang="en-US">Cash and investments held in trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AccruedLiabilitiesExcludingOfferingCostsCurrent" xlink:label="cxai_AccruedLiabilitiesExcludingOfferingCostsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_AccruedLiabilitiesExcludingOfferingCostsCurrent" xlink:to="cxai_AccruedLiabilitiesExcludingOfferingCostsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_AccruedLiabilitiesExcludingOfferingCostsCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PromissoryNoteRelatedParty" xlink:label="cxai_PromissoryNoteRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PromissoryNoteRelatedParty" xlink:to="cxai_PromissoryNoteRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PromissoryNoteRelatedParty_lbl" xml:lang="en-US">Promissory note &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xml:lang="en-US">Derivative liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredOfferingCostsNoncurrent" xlink:label="cxai_DeferredOfferingCostsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DeferredOfferingCostsNoncurrent" xlink:to="cxai_DeferredOfferingCostsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DeferredOfferingCostsNoncurrent_lbl" xml:lang="en-US">Deferred underwriting fee payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US">Class A common stock subject to possible redemption, 387,551 and 27,600,000 shares at $10.10 per share redemption value as of December&#160;31, 2022 and 2021, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.0001 par value; 2,000,000 shares authorized; none issued or outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,900,000 shares issued and outstanding at December&#160;31, 2022 and 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Stockholders&#8217; Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US">Class A common stock subject to possible redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Purchase price, per unit (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common shares, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common shares, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common shares, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Operating and formation costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="us-gaap_InterestIncomeExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNet" xlink:to="us-gaap_InterestIncomeExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeExpenseNet_lbl" xml:lang="en-US">Interest earned on cash and investments held in Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest income - bank</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Change in fair value of derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainLossOnEliminationOfDeferredUnderwritingFee" xlink:label="cxai_GainLossOnEliminationOfDeferredUnderwritingFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_GainLossOnEliminationOfDeferredUnderwritingFee" xlink:to="cxai_GainLossOnEliminationOfDeferredUnderwritingFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_GainLossOnEliminationOfDeferredUnderwritingFee_lbl" xml:lang="en-US">Gain on forgiveness of deferred underwriting fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income before provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock" xlink:label="cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock" xlink:to="cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding, Class A common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutedNetIncomePerShareClassCommonStock" xlink:label="cxai_BasicAndDilutedNetIncomePerShareClassCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BasicAndDilutedNetIncomePerShareClassCommonStock" xlink:to="cxai_BasicAndDilutedNetIncomePerShareClassCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BasicAndDilutedNetIncomePerShareClassCommonStock_lbl" xml:lang="en-US">Basic and diluted net income per share, Class A common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock" xlink:label="cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock" xlink:to="cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding, Class B common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutedNetIncomePerShareClassBCommonStock" xlink:label="cxai_BasicAndDilutedNetIncomePerShareClassBCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BasicAndDilutedNetIncomePerShareClassBCommonStock" xlink:to="cxai_BasicAndDilutedNetIncomePerShareClassBCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BasicAndDilutedNetIncomePerShareClassBCommonStock_lbl" xml:lang="en-US">Basic and diluted net income per share, Class B common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance &#8212; December&#160;31, 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xml:lang="en-US">Change in value of common stock subject to redemption</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance &#8212; December&#160;31, 2022 (As&#160;Restated)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US">Interest earned on cash and investments held in Trust Account</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xml:lang="en-US">Change in fair value of derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_IncreaseDecreaseInDeferredUnderwritingFee" xlink:label="cxai_IncreaseDecreaseInDeferredUnderwritingFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_IncreaseDecreaseInDeferredUnderwritingFee" xlink:to="cxai_IncreaseDecreaseInDeferredUnderwritingFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cxai_IncreaseDecreaseInDeferredUnderwritingFee_lbl" xml:lang="en-US">Gain on forgiveness of deferred underwriting fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US">Income tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" xlink:label="cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" xlink:to="cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax_lbl" xml:lang="en-US">Cash withdrawn from trust account to pay franchise tax</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProceedsFromTrustAccountInConnectionWithRedemption" xlink:label="cxai_ProceedsFromTrustAccountInConnectionWithRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ProceedsFromTrustAccountInConnectionWithRedemption" xlink:to="cxai_ProceedsFromTrustAccountInConnectionWithRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ProceedsFromTrustAccountInConnectionWithRedemption_lbl" xml:lang="en-US">Cash withdrawn from trust account in connection with redemptions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xml:lang="en-US">Redemptions of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Borrowings under promissory note</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payment of offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash used in financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net Change in Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash &#8211; Beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash &#8211; End of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Non-cash investing and financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ChangeInValueOfClassCommonStockSubjectToPossibleRedemption" xlink:label="cxai_ChangeInValueOfClassCommonStockSubjectToPossibleRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ChangeInValueOfClassCommonStockSubjectToPossibleRedemption" xlink:to="cxai_ChangeInValueOfClassCommonStockSubjectToPossibleRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ChangeInValueOfClassCommonStockSubjectToPossibleRedemption_lbl" xml:lang="en-US">Change in value of Class A common stock subject to possible redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock" xlink:label="cxai_ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock" xlink:to="cxai_ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock_lbl" xml:lang="en-US">Forgiveness of deferred underwriting fee payable allocated to Class A common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredUnderwritingFeePayable" xlink:label="cxai_DeferredUnderwritingFeePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DeferredUnderwritingFeePayable" xlink:to="cxai_DeferredUnderwritingFeePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cxai_DeferredUnderwritingFeePayable_lbl" xml:lang="en-US">Deferred underwriting fee payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsAbstract_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_2_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US">Notes and other receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssets" xlink:to="us-gaap_PrepaidExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use asset, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="us-gaap_CapitalizedComputerSoftwareNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareNet" xlink:to="us-gaap_CapitalizedComputerSoftwareNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedComputerSoftwareNet_lbl" xml:lang="en-US">Software development costs, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_2_lbl" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_2_lbl" xml:lang="en-US">Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AcquisitionLiability" xlink:label="cxai_AcquisitionLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_AcquisitionLiability" xlink:to="cxai_AcquisitionLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_AcquisitionLiability_lbl" xml:lang="en-US">Acquisition liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyAccrualCurrent" xlink:label="us-gaap_ExtendedProductWarrantyAccrualCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtendedProductWarrantyAccrualCurrent" xlink:to="us-gaap_ExtendedProductWarrantyAccrualCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtendedProductWarrantyAccrualCurrent_lbl" xml:lang="en-US">Warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease obligation, current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease obligation, noncurrent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US">Deferred tax liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_2_lbl" xml:lang="en-US">Stockholders&#8217; Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockValue_2_lbl" xml:lang="en-US">Common Stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetParentInvestment" xlink:label="cxai_NetParentInvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NetParentInvestment" xlink:to="cxai_NetParentInvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_NetParentInvestment_lbl" xml:lang="en-US">Net parent investment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_2_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ChangeInFairValueOfEarnout" xlink:label="cxai_ChangeInFairValueOfEarnout" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ChangeInFairValueOfEarnout" xlink:to="cxai_ChangeInFairValueOfEarnout_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cxai_ChangeInFairValueOfEarnout_lbl" xml:lang="en-US">Change in fair value of earnout</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_2_lbl" xml:lang="en-US">Other Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNet" xlink:to="us-gaap_InterestIncomeExpenseNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestIncomeExpenseNet_2_lbl" xml:lang="en-US">Interest income (expense), net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="us-gaap_GainLossOnSaleOfDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfDerivatives" xlink:to="us-gaap_GainLossOnSaleOfDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainLossOnSaleOfDerivatives_lbl" xml:lang="en-US">Change in fair value of derivative liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Net Income (Loss), before tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income tax benefit/(provision)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_lbl" xml:lang="en-US">Unrealized foreign exchange loss from cumulative translation adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock" xlink:label="cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock" xlink:to="cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock_lbl" xml:lang="en-US">Basic and dilutive weighted average shares outstanding, Class A common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutiveNetIncomePerShareClassCommonStock" xlink:label="cxai_BasicAndDilutiveNetIncomePerShareClassCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BasicAndDilutiveNetIncomePerShareClassCommonStock" xlink:to="cxai_BasicAndDilutiveNetIncomePerShareClassCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BasicAndDilutiveNetIncomePerShareClassCommonStock_lbl" xml:lang="en-US">Basic and dilutive net income per share, Class A common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock" xlink:label="cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock" xlink:to="cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock_lbl" xml:lang="en-US">Basic and dilutive weighted average shares outstanding, Class C common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutiveNetIncomePerShareClassCCommonStock" xlink:label="cxai_BasicAndDilutiveNetIncomePerShareClassCCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BasicAndDilutiveNetIncomePerShareClassCCommonStock" xlink:to="cxai_BasicAndDilutiveNetIncomePerShareClassCCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BasicAndDilutiveNetIncomePerShareClassCCommonStock_lbl" xml:lang="en-US">Basic and dilutive net income per share, Class C common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ParentsCommonSharesIssuedForCxappEarnout" xlink:label="cxai_ParentsCommonSharesIssuedForCxappEarnout" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ParentsCommonSharesIssuedForCxappEarnout" xlink:to="cxai_ParentsCommonSharesIssuedForCxappEarnout_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ParentsCommonSharesIssuedForCxappEarnout_lbl" xml:lang="en-US">Parent&#8217;s common shares issued for CXApp earnout</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits" xlink:label="cxai_TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits" xlink:to="cxai_TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits_lbl" xml:lang="en-US">Taxes paid related to net share settlement of restricted stock units</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetInvestmentsFromParent" xlink:label="cxai_NetInvestmentsFromParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NetInvestmentsFromParent" xlink:to="cxai_NetInvestmentsFromParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_NetInvestmentsFromParent_lbl" xml:lang="en-US">Net investments from parent</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CumulativeTranslationAdjustment" xlink:label="cxai_CumulativeTranslationAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CumulativeTranslationAdjustment" xlink:to="cxai_CumulativeTranslationAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_CumulativeTranslationAdjustment_lbl" xml:lang="en-US">Cumulative translation adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SharesIssuedInConnectionWithBusinessCombination" xlink:label="cxai_SharesIssuedInConnectionWithBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SharesIssuedInConnectionWithBusinessCombination" xlink:to="cxai_SharesIssuedInConnectionWithBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_SharesIssuedInConnectionWithBusinessCombination_lbl" xml:lang="en-US">Shares issued in connection with Business Combination</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SharesIssuedInConnectionWithBusinessCombinationShares" xlink:label="cxai_SharesIssuedInConnectionWithBusinessCombinationShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SharesIssuedInConnectionWithBusinessCombinationShares" xlink:to="cxai_SharesIssuedInConnectionWithBusinessCombinationShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_SharesIssuedInConnectionWithBusinessCombinationShares_lbl" xml:lang="en-US">Shares issued in connection with Business Combination, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2_lbl" xml:lang="en-US">Operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net income (loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2_lbl" xml:lang="en-US">Adjustments to reconcile net income (loss)&#160;to net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl" xml:lang="en-US">Amortization of right of use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred income taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Stock-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainOnEarnoutPaymentLiability" xlink:label="cxai_GainOnEarnoutPaymentLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_GainOnEarnoutPaymentLiability" xlink:to="cxai_GainOnEarnoutPaymentLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cxai_GainOnEarnoutPaymentLiability_lbl" xml:lang="en-US">Gain on earnout payment liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">(Gain) loss on foreign currency transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainOnChangeInFairValueOfDerivativeLiability" xlink:label="cxai_GainOnChangeInFairValueOfDerivativeLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_GainOnChangeInFairValueOfDerivativeLiability" xlink:to="cxai_GainOnChangeInFairValueOfDerivativeLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cxai_GainOnChangeInFairValueOfDerivativeLiability_lbl" xml:lang="en-US">Gain on change in fair value of derivative liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2_lbl" xml:lang="en-US">Change in assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xml:lang="en-US">Accounts receivable and other receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxes" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInIncomeTaxes" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxes_lbl" xml:lang="en-US">Income tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2_lbl" xml:lang="en-US">Investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_InvestmentInCapitalizedSoftware" xlink:label="cxai_InvestmentInCapitalizedSoftware" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_InvestmentInCapitalizedSoftware" xlink:to="cxai_InvestmentInCapitalizedSoftware_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cxai_InvestmentInCapitalizedSoftware_lbl" xml:lang="en-US">Investment in capitalized software</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xml:lang="en-US">Cash acquired in connection with Business Combination</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2_lbl" xml:lang="en-US">Financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetEquityInvestmentFromParent" xlink:label="cxai_NetEquityInvestmentFromParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NetEquityInvestmentFromParent" xlink:to="cxai_NetEquityInvestmentFromParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_NetEquityInvestmentFromParent_lbl" xml:lang="en-US">Net equity investment from parent</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TaxesPaidRelatedForStockBasedCompensation" xlink:label="cxai_TaxesPaidRelatedForStockBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TaxesPaidRelatedForStockBasedCompensation" xlink:to="cxai_TaxesPaidRelatedForStockBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cxai_TaxesPaidRelatedForStockBasedCompensation_lbl" xml:lang="en-US">Taxes paid related to stock based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RepaymentOfCxappAcquisitionLiability" xlink:label="cxai_RepaymentOfCxappAcquisitionLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RepaymentOfCxappAcquisitionLiability" xlink:to="cxai_RepaymentOfCxappAcquisitionLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cxai_RepaymentOfCxappAcquisitionLiability_lbl" xml:lang="en-US">Repayment of CXApp acquisition liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of related party promissory note</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosures of cash flow information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Cash paid for taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Cash paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract" xlink:label="cxai_SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract" xlink:to="cxai_SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract_lbl" xml:lang="en-US">Supplemental schedule of noncash investing and financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ParentsNetEquityIssuedForCxAppEarnout" xlink:label="cxai_ParentsNetEquityIssuedForCxAppEarnout" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ParentsNetEquityIssuedForCxAppEarnout" xlink:to="cxai_ParentsNetEquityIssuedForCxAppEarnout_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ParentsNetEquityIssuedForCxAppEarnout_lbl" xml:lang="en-US">Parent&#8217;s net equity issued for CX App earnout</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NoncashDistribution" xlink:label="cxai_NoncashDistribution" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NoncashDistribution" xlink:to="cxai_NoncashDistribution_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_NoncashDistribution_lbl" xml:lang="en-US">Noncash distribution</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination" xlink:label="cxai_ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination" xlink:to="cxai_ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination_lbl" xml:lang="en-US">Class A Common Stock and Class C Common Stock issued in connection with Business Combination</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FinancingOfDirectorAndOfficerInsurance" xlink:label="cxai_FinancingOfDirectorAndOfficerInsurance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_FinancingOfDirectorAndOfficerInsurance" xlink:to="cxai_FinancingOfDirectorAndOfficerInsurance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_FinancingOfDirectorAndOfficerInsurance_lbl" xml:lang="en-US">Financing of Director and Officer Insurance (see Note 9)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_AccountingChangesAndErrorCorrectionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract_lbl" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ErrorCorrectionTextBlock" xlink:label="us-gaap_ErrorCorrectionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionTextBlock" xlink:to="us-gaap_ErrorCorrectionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ErrorCorrectionTextBlock_lbl" xml:lang="en-US">RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosurePublicOfferingAbstract" xlink:label="cxai_DisclosurePublicOfferingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DisclosurePublicOfferingAbstract" xlink:to="cxai_DisclosurePublicOfferingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DisclosurePublicOfferingAbstract_lbl" xml:lang="en-US">Public Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_InitialPublicOfferingDisclosureTextBlock" xlink:label="cxai_InitialPublicOfferingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_InitialPublicOfferingDisclosureTextBlock" xlink:to="cxai_InitialPublicOfferingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_InitialPublicOfferingDisclosureTextBlock_lbl" xml:lang="en-US">PUBLIC OFFERING</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosurePrivatePlacementAbstract" xlink:label="cxai_DisclosurePrivatePlacementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DisclosurePrivatePlacementAbstract" xlink:to="cxai_DisclosurePrivatePlacementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DisclosurePrivatePlacementAbstract_lbl" xml:lang="en-US">Private Placement</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementDisclosureTextBlock" xlink:label="cxai_PrivatePlacementDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PrivatePlacementDisclosureTextBlock" xlink:to="cxai_PrivatePlacementDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PrivatePlacementDisclosureTextBlock_lbl" xml:lang="en-US">PRIVATE PLACEMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">STOCKHOLDERS&#8217; DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xml:lang="en-US">DERIVATIVE WARRANT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAX</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">Organization, Nature of Business and Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">Business Combination</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureDisaggregationOfRevenueAbstract" xlink:label="cxai_DisclosureDisaggregationOfRevenueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DisclosureDisaggregationOfRevenueAbstract" xlink:to="cxai_DisclosureDisaggregationOfRevenueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DisclosureDisaggregationOfRevenueAbstract_lbl" xml:lang="en-US">Disaggregation Of Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisaggregationOfRevenueTextBlock" xlink:label="cxai_DisaggregationOfRevenueTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DisaggregationOfRevenueTextBlock" xlink:to="cxai_DisaggregationOfRevenueTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DisaggregationOfRevenueTextBlock_lbl" xml:lang="en-US">Disaggregation of Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureSoftwareDevelopmentCostsNetAbstract" xlink:label="cxai_DisclosureSoftwareDevelopmentCostsNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DisclosureSoftwareDevelopmentCostsNetAbstract" xlink:to="cxai_DisclosureSoftwareDevelopmentCostsNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DisclosureSoftwareDevelopmentCostsNetAbstract_lbl" xml:lang="en-US">Software Development Costs Net</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SoftwareDevelopmentCostsNetTextBlock" xlink:label="cxai_SoftwareDevelopmentCostsNetTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SoftwareDevelopmentCostsNetTextBlock" xlink:to="cxai_SoftwareDevelopmentCostsNetTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_SoftwareDevelopmentCostsNetTextBlock_lbl" xml:lang="en-US">Software Development Costs, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureDeferredRevenueAbstract" xlink:label="cxai_DisclosureDeferredRevenueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DisclosureDeferredRevenueAbstract" xlink:to="cxai_DisclosureDeferredRevenueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DisclosureDeferredRevenueAbstract_lbl" xml:lang="en-US">Deferred Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredRevenueTextBlock" xlink:label="cxai_DeferredRevenueTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DeferredRevenueTextBlock" xlink:to="cxai_DeferredRevenueTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cxai_DeferredRevenueTextBlock_lbl" xml:lang="en-US">Deferred Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureWarrantLiabilitiesAbstract" xlink:label="cxai_DisclosureWarrantLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DisclosureWarrantLiabilitiesAbstract" xlink:to="cxai_DisclosureWarrantLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DisclosureWarrantLiabilitiesAbstract_lbl" xml:lang="en-US">Warrant Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantLiabilitiesTextBlock" xlink:label="cxai_WarrantLiabilitiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantLiabilitiesTextBlock" xlink:to="cxai_WarrantLiabilitiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cxai_WarrantLiabilitiesTextBlock_lbl" xml:lang="en-US">Warrant Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract" xlink:label="cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract" xlink:to="cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract_lbl" xml:lang="en-US">Stock Option Plan And Stock-based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_StockAwardPlansAndStockbasedCompensationTextBlock" xlink:label="cxai_StockAwardPlansAndStockbasedCompensationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_StockAwardPlansAndStockbasedCompensationTextBlock" xlink:to="cxai_StockAwardPlansAndStockbasedCompensationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_StockAwardPlansAndStockbasedCompensationTextBlock_lbl" xml:lang="en-US">Stock Option Plan and Stock-Based Compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_2_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_2_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">Credit Risk and Concentrations</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureForeignOperationsAbstract" xlink:label="cxai_DisclosureForeignOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DisclosureForeignOperationsAbstract" xlink:to="cxai_DisclosureForeignOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DisclosureForeignOperationsAbstract_lbl" xml:lang="en-US">Foreign Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ForeignOperationsTextBlock" xlink:label="cxai_ForeignOperationsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ForeignOperationsTextBlock" xlink:to="cxai_ForeignOperationsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cxai_ForeignOperationsTextBlock_lbl" xml:lang="en-US">Foreign Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:label="us-gaap_LeasesOfLesseeDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_LeasesOfLesseeDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesOfLesseeDisclosureTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2_lbl" xml:lang="en-US">Commitments and Contingencie</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EmergingGrowthCompanyPolicyTextBlock" xlink:label="cxai_EmergingGrowthCompanyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_EmergingGrowthCompanyPolicyTextBlock" xlink:to="cxai_EmergingGrowthCompanyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_EmergingGrowthCompanyPolicyTextBlock_lbl" xml:lang="en-US">Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TemporaryEquityPolicyPolicyTextBlock" xlink:label="cxai_TemporaryEquityPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TemporaryEquityPolicyPolicyTextBlock" xlink:to="cxai_TemporaryEquityPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_TemporaryEquityPolicyPolicyTextBlock_lbl" xml:lang="en-US">Class A Common Stock Subject to Possible Redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xml:lang="en-US">Offering Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantLiabilityPolicyTextBlock" xlink:label="cxai_WarrantLiabilityPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantLiabilityPolicyTextBlock" xlink:to="cxai_WarrantLiabilityPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_WarrantLiabilityPolicyTextBlock_lbl" xml:lang="en-US">Derivative Warrant Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Issued and Adopted Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_LiquidityAndGoingConcernPolicyTextBlock" xlink:label="cxai_LiquidityAndGoingConcernPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_LiquidityAndGoingConcernPolicyTextBlock" xlink:to="cxai_LiquidityAndGoingConcernPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_LiquidityAndGoingConcernPolicyTextBlock_lbl" xml:lang="en-US">Liquidity</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock" xlink:label="cxai_AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock" xlink:to="cxai_AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock_lbl" xml:lang="en-US">Accounts Receivable, net and Allowance for Credit Losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="us-gaap_GoodwillDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_LeasesAndRightofUseAssetsPolicyTextBlock" xlink:label="cxai_LeasesAndRightofUseAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_LeasesAndRightofUseAssetsPolicyTextBlock" xlink:to="cxai_LeasesAndRightofUseAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_LeasesAndRightofUseAssetsPolicyTextBlock_lbl" xml:lang="en-US">Leases and Right-of-Use Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Comprehensive Income (Loss) and Foreign Currency Translation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="us-gaap_BusinessCombinationsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xml:lang="en-US">Business Combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="us-gaap_StandardProductWarrantyPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyPolicy" xlink:to="us-gaap_StandardProductWarrantyPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StandardProductWarrantyPolicy_lbl" xml:lang="en-US">Derivative Warrant Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Carrying Value, Recoverability and Impairment of Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xml:lang="en-US">Summary of impact of the restatement on the financial statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityTableTextBlock" xlink:to="us-gaap_TemporaryEquityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xml:lang="en-US">Schedule of reconciliation of Class A common stock reflected in the condensed balance sheet</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Reconciliation of net income per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of antidilutive shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Company's net deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of income tax provision</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Schedule of company's assets and liabilities that are measured at fair value on a recurring basis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Schedule of change in the fair value of the Level 3 warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">Schedule of assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xml:lang="en-US">Schedule of proforma financial information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of disaggregation of Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock" xlink:label="cxai_ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock" xlink:to="cxai_ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock_lbl" xml:lang="en-US">Schedule of capitalized software development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US">Schedule of goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of future amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ScheduleOfDeferredRevenueTableTextBlock" xlink:label="cxai_ScheduleOfDeferredRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ScheduleOfDeferredRevenueTableTextBlock" xlink:to="cxai_ScheduleOfDeferredRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ScheduleOfDeferredRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of assumptions used</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xml:lang="en-US">Schedule of financial data by geographic area</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="cxai_UnitsIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="cxai_UnitsIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_UnitsIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Number of units issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Proceeds from issuance initial public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NumberOfWarrantsIssued" xlink:label="cxai_NumberOfWarrantsIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NumberOfWarrantsIssued" xlink:to="cxai_NumberOfWarrantsIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_NumberOfWarrantsIssued_lbl" xml:lang="en-US">Number of warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:to="cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights_lbl" xml:lang="en-US">Price of warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Proceeds from issuance of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TransactionCosts" xlink:label="cxai_TransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TransactionCosts" xlink:to="cxai_TransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_TransactionCosts_lbl" xml:lang="en-US">Transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SaleOfStockUnderwritingFees" xlink:label="cxai_SaleOfStockUnderwritingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SaleOfStockUnderwritingFees" xlink:to="cxai_SaleOfStockUnderwritingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_SaleOfStockUnderwritingFees_lbl" xml:lang="en-US">Underwriting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SaleOfStockOtherOfferingCosts" xlink:label="cxai_SaleOfStockOtherOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SaleOfStockOtherOfferingCosts" xlink:to="cxai_SaleOfStockOtherOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_SaleOfStockOtherOfferingCosts_lbl" xml:lang="en-US">Other offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="cxai_PaymentsForInvestmentOfCashInTrustAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PaymentsForInvestmentOfCashInTrustAccount" xlink:to="cxai_PaymentsForInvestmentOfCashInTrustAccount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PaymentsForInvestmentOfCashInTrustAccount_lbl" xml:lang="en-US">Investment of cash into trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount" xlink:label="cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount" xlink:to="cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount_lbl" xml:lang="en-US">Threshold minimum aggregate fair market value as a percentage of the assets held in the trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination" xlink:label="cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination" xlink:to="cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination_lbl" xml:lang="en-US">Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination" xlink:label="cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination" xlink:to="cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_lbl" xml:lang="en-US">Minimum net tangible assets upon consummation of the business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent" xlink:label="cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent" xlink:to="cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent_lbl" xml:lang="en-US">Threshold percentage of public shares subject to redemption without the company's prior written consent</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:label="cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:to="cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_lbl" xml:lang="en-US">Obligation to redeem public shares if entity does not complete a business combination (as a percent)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumNetInterestsToPayDissolutionExpenses" xlink:label="cxai_MaximumNetInterestsToPayDissolutionExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MaximumNetInterestsToPayDissolutionExpenses" xlink:to="cxai_MaximumNetInterestsToPayDissolutionExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_MaximumNetInterestsToPayDissolutionExpenses_lbl" xml:lang="en-US">Maximum net interest to pay dissolution expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash operating bank account</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WorkingCapital" xlink:label="cxai_WorkingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WorkingCapital" xlink:to="cxai_WorkingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_WorkingCapital_lbl" xml:lang="en-US">Working capital</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProceedsFromRelatedParty" xlink:label="cxai_ProceedsFromRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ProceedsFromRelatedParty" xlink:to="cxai_ProceedsFromRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ProceedsFromRelatedParty_lbl" xml:lang="en-US">Proceeds from related party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_2_lbl" xml:lang="en-US">Proceeds from related Party debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable" xlink:label="cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable" xlink:to="cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable_lbl" xml:lang="en-US">Gain on forgiveness of deferred underwriting fee payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Total other income (expenses)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_lbl" xml:lang="en-US">Income (loss) before benefit from (provision for) income taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares" xlink:label="cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares" xlink:to="cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare" xlink:label="cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare" xlink:to="cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare_lbl" xml:lang="en-US">Basic and diluted earnings per share (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Balance at the beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_2_lbl" xml:lang="en-US">Accretion of Class A common stock to redemption</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Balance at the end</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable" xlink:to="cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable_2_lbl" xml:lang="en-US">Gain on forgiveness of deferred underwriting fee payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_2_lbl" xml:lang="en-US">Non-Cash Investing and Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" xlink:label="cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" xlink:to="cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_lbl" xml:lang="en-US">Extinguishment of deferred underwriting fee payable allocated to public shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_2_lbl" xml:lang="en-US">Class A common stock subject to possible redemption, at beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl" xml:lang="en-US">Accretion of carrying value to redemption value</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TemporaryEquityWaiverOfShareIssuanceCosts" xlink:label="cxai_TemporaryEquityWaiverOfShareIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TemporaryEquityWaiverOfShareIssuanceCosts" xlink:to="cxai_TemporaryEquityWaiverOfShareIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_TemporaryEquityWaiverOfShareIssuanceCosts_lbl" xml:lang="en-US">Waiver of Class A common stock issuance costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_2_lbl" xml:lang="en-US">Accretion of carrying value to redemption value</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TemporaryEquityRedemption" xlink:label="cxai_TemporaryEquityRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TemporaryEquityRedemption" xlink:to="cxai_TemporaryEquityRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cxai_TemporaryEquityRedemption_lbl" xml:lang="en-US">Redemption of Class A Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3_lbl" xml:lang="en-US">Class A common stock subject to possible redemption, at end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Basic and diluted net income per common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xml:lang="en-US">Numerator:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Allocation of net income, as adjusted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Denominator:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic and diluted weighted average shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic and diluted net income per common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">Insured amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_2_lbl" xml:lang="en-US">Class A common stock subject to possible redemption, outstanding (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xml:lang="en-US">Charged to temporary equity</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_OfferingCost" xlink:label="cxai_OfferingCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_OfferingCost" xlink:to="cxai_OfferingCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_OfferingCost_lbl" xml:lang="en-US">Offering cost expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective tax rate (in percent)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Unrecognized tax benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US">Unrecognized tax benefits accrued for interest and penalties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Number of warrants to purchase shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Cash for operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Reduction in accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CashAndCashEquivalentsDescription" xlink:label="cxai_CashAndCashEquivalentsDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CashAndCashEquivalentsDescription" xlink:to="cxai_CashAndCashEquivalentsDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_CashAndCashEquivalentsDescription_lbl" xml:lang="en-US">Cash and cash equivalents, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Intangible assets useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US">Deferred Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RevenueRecognized" xlink:label="cxai_RevenueRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RevenueRecognized" xlink:to="cxai_RevenueRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_RevenueRecognized_lbl" xml:lang="en-US">Revenue Recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ChangesInEstimatedFairValueOfWarrants" xlink:label="cxai_ChangesInEstimatedFairValueOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ChangesInEstimatedFairValueOfWarrants" xlink:to="cxai_ChangesInEstimatedFairValueOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ChangesInEstimatedFairValueOfWarrants_lbl" xml:lang="en-US">Changes in estimated fair value of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges" xlink:label="us-gaap_OtherAssetImpairmentCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetImpairmentCharges" xlink:to="us-gaap_OtherAssetImpairmentCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetImpairmentCharges_lbl" xml:lang="en-US">Impairment charges of long-lived assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="cxai_UnitsIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cxai_UnitsIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Number of units sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Exercise price of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:to="cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights_2_lbl" xml:lang="en-US">Price of warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_2_lbl" xml:lang="en-US">Aggregate purchase price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Exercise price of warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Aggregate purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Number of shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NumberOfSharesSubjectToForfeiture" xlink:label="cxai_NumberOfSharesSubjectToForfeiture" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NumberOfSharesSubjectToForfeiture" xlink:to="cxai_NumberOfSharesSubjectToForfeiture_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_NumberOfSharesSubjectToForfeiture_lbl" xml:lang="en-US">Shares subject to forfeiture</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xml:lang="en-US">Stock split</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AggregateNumberOfSharesOwned" xlink:label="cxai_AggregateNumberOfSharesOwned" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_AggregateNumberOfSharesOwned" xlink:to="cxai_AggregateNumberOfSharesOwned_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_AggregateNumberOfSharesOwned_lbl" xml:lang="en-US">Aggregate number of shares owned</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:label="cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:to="cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_lbl" xml:lang="en-US">Percentage of issued and outstanding shares after the initial public offering collectively held by initial stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:label="cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:to="cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_lbl" xml:lang="en-US">Restrictions on transfer period of time after business combination completion</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:label="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:to="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_lbl" xml:lang="en-US">Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:label="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:to="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_lbl" xml:lang="en-US">Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:label="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:to="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_lbl" xml:lang="en-US">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:label="cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:to="cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_lbl" xml:lang="en-US">Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:label="cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:to="cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_lbl" xml:lang="en-US">Expenses per month</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ExpensesIncurredAndPaid" xlink:label="cxai_ExpensesIncurredAndPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ExpensesIncurredAndPaid" xlink:to="cxai_ExpensesIncurredAndPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ExpensesIncurredAndPaid_lbl" xml:lang="en-US">Expenses incurred and paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="us-gaap_DebtInstrumentCollateralAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCollateralAmount" xlink:to="us-gaap_DebtInstrumentCollateralAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCollateralAmount_lbl" xml:lang="en-US">Aggregate principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Amount outstanding under promissory note</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumLoansConvertibleIntoWarrants" xlink:label="cxai_MaximumLoansConvertibleIntoWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MaximumLoansConvertibleIntoWarrants" xlink:to="cxai_MaximumLoansConvertibleIntoWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_MaximumLoansConvertibleIntoWarrants_lbl" xml:lang="en-US">Loan conversion agreement warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:label="cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:to="cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_lbl" xml:lang="en-US">Maximum borrowing capacity of related party promissory note</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands" xlink:label="cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands" xlink:to="cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands_lbl" xml:lang="en-US">Minimum percentage of founder share holders entitled to make demands</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:label="cxai_MaximumNumberOfDemandsForRegistrationOfSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:to="cxai_MaximumNumberOfDemandsForRegistrationOfSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_MaximumNumberOfDemandsForRegistrationOfSecurities_lbl" xml:lang="en-US">Maximum number of demands for registration of securities</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredFeePerUnit" xlink:label="cxai_DeferredFeePerUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DeferredFeePerUnit" xlink:to="cxai_DeferredFeePerUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DeferredFeePerUnit_lbl" xml:lang="en-US">Deferred fee per unit</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee" xlink:label="cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee" xlink:to="cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee_lbl" xml:lang="en-US">Income recognized from reduction of deferred underwriter fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_lbl" xml:lang="en-US">Cash Contribution upon seperation</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfCommonStockDistributed" xlink:label="cxai_PercentageOfCommonStockDistributed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PercentageOfCommonStockDistributed" xlink:to="cxai_PercentageOfCommonStockDistributed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PercentageOfCommonStockDistributed_lbl" xml:lang="en-US">Percentage of common stock distributed</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger" xlink:label="cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger" xlink:to="cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger_lbl" xml:lang="en-US">Maximum term for automatic conversion of stock following the closing of the Merger</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonStockStockPriceTrigger" xlink:label="cxai_CommonStockStockPriceTrigger" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CommonStockStockPriceTrigger" xlink:to="cxai_CommonStockStockPriceTrigger_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_CommonStockStockPriceTrigger_lbl" xml:lang="en-US">Stock price trigger</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdTradingDays" xlink:label="cxai_ThresholdTradingDays" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdTradingDays" xlink:to="cxai_ThresholdTradingDays_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ThresholdTradingDays_lbl" xml:lang="en-US">Threshold trading days</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdConsecutiveTradingDays" xlink:label="cxai_ThresholdConsecutiveTradingDays" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdConsecutiveTradingDays" xlink:to="cxai_ThresholdConsecutiveTradingDays_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ThresholdConsecutiveTradingDays_lbl" xml:lang="en-US">Threshold consecutive trading days</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NumberOfSharesIssuableUponMerger" xlink:label="cxai_NumberOfSharesIssuableUponMerger" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NumberOfSharesIssuableUponMerger" xlink:to="cxai_NumberOfSharesIssuableUponMerger_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_NumberOfSharesIssuableUponMerger_lbl" xml:lang="en-US">Number of shares issuable upon merger</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfStockAsMergerConsideration" xlink:label="cxai_PercentageOfStockAsMergerConsideration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PercentageOfStockAsMergerConsideration" xlink:to="cxai_PercentageOfStockAsMergerConsideration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PercentageOfStockAsMergerConsideration_lbl" xml:lang="en-US">Percentage of stock as merger consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdNetTangibleAssets" xlink:label="cxai_ThresholdNetTangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdNetTangibleAssets" xlink:to="cxai_ThresholdNetTangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ThresholdNetTangibleAssets_lbl" xml:lang="en-US">Threshold net tangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares" xlink:label="cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares" xlink:to="cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares_lbl" xml:lang="en-US">Threshold aggregate gross purchase price of any other purchase of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TermOfBreachUnableToBeCuredOrIsNotCured" xlink:label="cxai_TermOfBreachUnableToBeCuredOrIsNotCured" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TermOfBreachUnableToBeCuredOrIsNotCured" xlink:to="cxai_TermOfBreachUnableToBeCuredOrIsNotCured_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_TermOfBreachUnableToBeCuredOrIsNotCured_lbl" xml:lang="en-US">Term of breach unable to be cured, or is not cured</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TerminationFee" xlink:label="cxai_TerminationFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TerminationFee" xlink:to="cxai_TerminationFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_TerminationFee_lbl" xml:lang="en-US">Termination fee</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonStockLockUpPeriod" xlink:label="cxai_CommonStockLockUpPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CommonStockLockUpPeriod" xlink:to="cxai_CommonStockLockUpPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_CommonStockLockUpPeriod_lbl" xml:lang="en-US">Lock-up period</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp" xlink:label="cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp" xlink:to="cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp_lbl" xml:lang="en-US">Percentage of shares not be subject to foregoing lock-up</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NumberOfSharesExchanged" xlink:label="cxai_NumberOfSharesExchanged" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NumberOfSharesExchanged" xlink:to="cxai_NumberOfSharesExchanged_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_NumberOfSharesExchanged_lbl" xml:lang="en-US">Number of shares exchanged</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MinimumNumberOfSharesIssuableToSponsor" xlink:label="cxai_MinimumNumberOfSharesIssuableToSponsor" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MinimumNumberOfSharesIssuableToSponsor" xlink:to="cxai_MinimumNumberOfSharesIssuableToSponsor_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_MinimumNumberOfSharesIssuableToSponsor_lbl" xml:lang="en-US">Minimum number of shares issuable to sponsor</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_2_lbl" xml:lang="en-US">Preferred shares, shares authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Preferred stock, par value, (per share)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_2_lbl" xml:lang="en-US">Preferred shares, shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_2_lbl" xml:lang="en-US">Preferred shares, shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_3_lbl" xml:lang="en-US">Common shares, shares authorized (in shares)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_3_lbl" xml:lang="en-US">Common shares, par value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonStockNumberOfVotesPerShare" xlink:label="cxai_CommonStockNumberOfVotesPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CommonStockNumberOfVotesPerShare" xlink:to="cxai_CommonStockNumberOfVotesPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_CommonStockNumberOfVotesPerShare_lbl" xml:lang="en-US">Common shares, votes per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_2_lbl" xml:lang="en-US">Common shares, shares issued (in shares)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_3_lbl" xml:lang="en-US">Common shares, shares outstanding (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ConvertibleStockConversionRatio" xlink:label="cxai_ConvertibleStockConversionRatio" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ConvertibleStockConversionRatio" xlink:to="cxai_ConvertibleStockConversionRatio_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ConvertibleStockConversionRatio_lbl" xml:lang="en-US">Ratio to be applied to the stock in the conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantExercisePeriodConditionOne" xlink:label="cxai_WarrantExercisePeriodConditionOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantExercisePeriodConditionOne" xlink:to="cxai_WarrantExercisePeriodConditionOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_WarrantExercisePeriodConditionOne_lbl" xml:lang="en-US">Warrant exercise period condition one</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantExercisePeriodConditionTwo" xlink:label="cxai_WarrantExercisePeriodConditionTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantExercisePeriodConditionTwo" xlink:to="cxai_WarrantExercisePeriodConditionTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_WarrantExercisePeriodConditionTwo_lbl" xml:lang="en-US">Warrant exercise period condition two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Public Warrants expiration term</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" xlink:label="cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" xlink:to="cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement_lbl" xml:lang="en-US">Maximum period after business combination in which to file registration statement</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" xlink:label="cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" xlink:to="cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective_lbl" xml:lang="en-US">Period of time within which registration statement is expected to become effective</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantRedemptionConditionMinimumSharePrice" xlink:label="cxai_WarrantRedemptionConditionMinimumSharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantRedemptionConditionMinimumSharePrice" xlink:to="cxai_WarrantRedemptionConditionMinimumSharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_WarrantRedemptionConditionMinimumSharePrice_lbl" xml:lang="en-US">Warrant redemption condition minimum share price</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:to="cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_lbl" xml:lang="en-US">Redemption price per public warrant (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:label="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:to="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_lbl" xml:lang="en-US">Threshold consecutive trading days for redemption of public warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:label="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:to="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_lbl" xml:lang="en-US">Threshold trading days for redemption of public warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionPeriod" xlink:label="cxai_RedemptionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RedemptionPeriod" xlink:to="cxai_RedemptionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_RedemptionPeriod_lbl" xml:lang="en-US">Redemption period</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo" xlink:label="cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo" xlink:to="cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo_lbl" xml:lang="en-US">Warrant redemption condition minimum share price scenario two</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant" xlink:label="cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant" xlink:to="cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant_lbl" xml:lang="en-US">Share PriceTrigger Used To Measure Dilution Of Warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant" xlink:label="cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant" xlink:to="cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant_lbl" xml:lang="en-US">Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantExercisePriceAdjustmentMultiple" xlink:label="cxai_WarrantExercisePriceAdjustmentMultiple" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantExercisePriceAdjustmentMultiple" xlink:to="cxai_WarrantExercisePriceAdjustmentMultiple_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_WarrantExercisePriceAdjustmentMultiple_lbl" xml:lang="en-US">Warrant exercise price adjustment multiple</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantRedemptionPriceAdjustmentMultiple" xlink:label="cxai_WarrantRedemptionPriceAdjustmentMultiple" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantRedemptionPriceAdjustmentMultiple" xlink:to="cxai_WarrantRedemptionPriceAdjustmentMultiple_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_WarrantRedemptionPriceAdjustmentMultiple_lbl" xml:lang="en-US">Warrant redemption price adjustment multiple</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_lbl" xml:lang="en-US">Deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" xlink:label="cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" xlink:to="cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_lbl" xml:lang="en-US">Organizational costs/startup expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax asset, net of allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_StateAndLocalAbstract" xlink:label="cxai_StateAndLocalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_StateAndLocalAbstract" xlink:to="cxai_StateAndLocalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_StateAndLocalAbstract_lbl" xml:lang="en-US">State and Local</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Income tax provision</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_lbl" xml:lang="en-US">Statutory federal income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State taxes, net of federal tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent" xlink:label="cxai_EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent" xlink:to="cxai_EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_lbl" xml:lang="en-US">Transaction costs allocated to derivative warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent" xlink:label="cxai_EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent" xlink:to="cxai_EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_lbl" xml:lang="en-US">Change in fair value of derivative warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_2_lbl" xml:lang="en-US">Income tax provision</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating loss carryforwards</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_2_lbl" xml:lang="en-US">Assets held in the Trust Account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_lbl" xml:lang="en-US">Warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Fair value at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xml:lang="en-US">Change in fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" xlink:label="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" xlink:to="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_lbl" xml:lang="en-US">Transfer to Level 1</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" xlink:label="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" xlink:to="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_lbl" xml:lang="en-US">Transfer to Level 2</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xml:lang="en-US">Fair value at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_lbl" xml:lang="en-US">Schedule of Fair Value, off-Balance-Sheet Risks [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_lbl" xml:lang="en-US">Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ProceedsFromTrustAccountInConnectionWithRedemption" xlink:to="cxai_ProceedsFromTrustAccountInConnectionWithRedemption_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cxai_ProceedsFromTrustAccountInConnectionWithRedemption_2_lbl" xml:lang="en-US">Cash withdrawn from trust account in connection with redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_lbl" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PurchasePrice" xlink:label="cxai_PurchasePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PurchasePrice" xlink:to="cxai_PurchasePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_PurchasePrice_lbl" xml:lang="en-US">Purchase Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_lbl" xml:lang="en-US">Assets acquired:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables" xlink:label="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables" xlink:to="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables_lbl" xml:lang="en-US">Notes and other receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid assets and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset" xlink:label="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset" xlink:to="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right of use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xml:lang="en-US">Total assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities assumed:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities" xlink:label="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities" xlink:to="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_lbl" xml:lang="en-US">Accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl" xml:lang="en-US">Deferred revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent" xlink:label="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent" xlink:to="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent_lbl" xml:lang="en-US">Operating lease obligation, current</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent" xlink:label="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent" xlink:to="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent_lbl" xml:lang="en-US">Operating lease obligation, noncurrent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_lbl" xml:lang="en-US">Deferred tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xml:lang="en-US">Total liabilities assumed</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xml:lang="en-US">Net income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AggregatePurchasePriceAssetsAndLiabilities" xlink:label="cxai_AggregatePurchasePriceAssetsAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_AggregatePurchasePriceAssetsAndLiabilities" xlink:to="cxai_AggregatePurchasePriceAssetsAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_AggregatePurchasePriceAssetsAndLiabilities_lbl" xml:lang="en-US">Aggregate purchase price assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ConsiderationTransferredInConnection" xlink:label="cxai_ConsiderationTransferredInConnection" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ConsiderationTransferredInConnection" xlink:to="cxai_ConsiderationTransferredInConnection_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ConsiderationTransferredInConnection_lbl" xml:lang="en-US">Consideration transferred in connection</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2_lbl" xml:lang="en-US">Business combination goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Total Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Total Property and Equipment, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="us-gaap_CapitalizedComputerSoftwareGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareGross" xlink:to="us-gaap_CapitalizedComputerSoftwareGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedComputerSoftwareGross_lbl" xml:lang="en-US">Capitalized software development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:label="us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:to="us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareNet" xlink:to="us-gaap_CapitalizedComputerSoftwareNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CapitalizedComputerSoftwareNet_2_lbl" xml:lang="en-US">Software development costs, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization" xlink:label="us-gaap_AdjustmentForAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentForAmortization_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_Goodwill_2_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AcquisitionOfLegacyCxapp" xlink:label="cxai_AcquisitionOfLegacyCxapp" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_AcquisitionOfLegacyCxapp" xlink:to="cxai_AcquisitionOfLegacyCxapp_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_AcquisitionOfLegacyCxapp_lbl" xml:lang="en-US">Acquisition of Legacy CXApp</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_Goodwill_3_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_OtherFiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_OtherFiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherFiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross carrying amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Net carrying amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US">2028 and thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_2_lbl" xml:lang="en-US">Aggregate amortization expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenue_2_lbl" xml:lang="en-US">Total Deferred Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_InsurancePremiumsAndAccruedInterest" xlink:label="cxai_InsurancePremiumsAndAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_InsurancePremiumsAndAccruedInterest" xlink:to="cxai_InsurancePremiumsAndAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_InsurancePremiumsAndAccruedInterest_lbl" xml:lang="en-US">Insurance premiums and accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RelatedPartyPromissoryNote" xlink:label="cxai_RelatedPartyPromissoryNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RelatedPartyPromissoryNote" xlink:to="cxai_RelatedPartyPromissoryNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_RelatedPartyPromissoryNote_lbl" xml:lang="en-US">Related party promissory note</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxes" xlink:label="us-gaap_AccruedIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxes" xlink:to="us-gaap_AccruedIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxes_lbl" xml:lang="en-US">Income tax payables</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RelatedPartyPayable" xlink:label="cxai_RelatedPartyPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RelatedPartyPayable" xlink:to="cxai_RelatedPartyPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_RelatedPartyPayable_lbl" xml:lang="en-US">Related party payable</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AccruedCompensationAndBenefits" xlink:label="cxai_AccruedCompensationAndBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_AccruedCompensationAndBenefits" xlink:to="cxai_AccruedCompensationAndBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_AccruedCompensationAndBenefits_lbl" xml:lang="en-US">Accrued compensation and benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="us-gaap_AccruedBonusesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedBonusesCurrent" xlink:to="us-gaap_AccruedBonusesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedBonusesCurrent_lbl" xml:lang="en-US">Accrued bonus and commissions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRentCurrent" xlink:label="us-gaap_AccruedRentCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedRentCurrent" xlink:to="us-gaap_AccruedRentCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedRentCurrent_lbl" xml:lang="en-US">Accrued rent</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AccruedOther" xlink:label="cxai_AccruedOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_AccruedOther" xlink:to="cxai_AccruedOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_AccruedOther_lbl" xml:lang="en-US">Accrued other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:to="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_lbl" xml:lang="en-US">Accrued sales and other indirect taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xml:lang="en-US">Debt payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US">Debt issuance cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherBorrowings" xlink:label="us-gaap_OtherBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherBorrowings" xlink:to="us-gaap_OtherBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherBorrowings_lbl" xml:lang="en-US">Debt owed balance</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RelatedPartyDescription" xlink:label="cxai_RelatedPartyDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RelatedPartyDescription" xlink:to="cxai_RelatedPartyDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_RelatedPartyDescription_lbl" xml:lang="en-US">Related party description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease" xlink:label="us-gaap_WarrantExercisePriceIncrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl" xml:lang="en-US">Warrant Price</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders" xlink:label="cxai_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders" xlink:to="cxai_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders_lbl" xml:lang="en-US">Threshold number of business days before sending notice of redemption to warrant holders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Shares available for issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Stock option granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vesting period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Option life</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueOfOptions" xlink:label="cxai_FairValueOfOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_FairValueOfOptions" xlink:to="cxai_FairValueOfOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_FairValueOfOptions_lbl" xml:lang="en-US">Fair value of options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Fair value of common stock as of grant date</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AmortizationOfEmployeeStockOptions" xlink:label="cxai_AmortizationOfEmployeeStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_AmortizationOfEmployeeStockOptions" xlink:to="cxai_AmortizationOfEmployeeStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_AmortizationOfEmployeeStockOptions_lbl" xml:lang="en-US">Amortization of employee stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueOfNonvestedOptions" xlink:label="cxai_FairValueOfNonvestedOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_FairValueOfNonvestedOptions" xlink:to="cxai_FairValueOfNonvestedOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_FairValueOfNonvestedOptions_lbl" xml:lang="en-US">Fair value of non-vested options</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WeightedAverageRemainingTermOfNonvestedOptions" xlink:label="cxai_WeightedAverageRemainingTermOfNonvestedOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WeightedAverageRemainingTermOfNonvestedOptions" xlink:to="cxai_WeightedAverageRemainingTermOfNonvestedOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_WeightedAverageRemainingTermOfNonvestedOptions_lbl" xml:lang="en-US">Weighted average remaining term of non-vested options</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_3_lbl" xml:lang="en-US">Fair value of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_IncomeTaxBenefitprovision" xlink:label="cxai_IncomeTaxBenefitprovision" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_IncomeTaxBenefitprovision" xlink:to="cxai_IncomeTaxBenefitprovision_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_IncomeTaxBenefitprovision_lbl" xml:lang="en-US">Income tax benefit/(provision)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_3_lbl" xml:lang="en-US">Effective tax rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_3_lbl" xml:lang="en-US">Revenues by geographic area</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating income (loss) by geographic area</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_4_lbl" xml:lang="en-US">Net income (loss) by geographic area</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetAssets" xlink:label="cxai_NetAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NetAssets" xlink:to="cxai_NetAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_NetAssets_lbl" xml:lang="en-US">Identifiable assets by geographic area</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets" xlink:label="us-gaap_NoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncurrentAssets" xlink:to="us-gaap_NoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncurrentAssets_lbl" xml:lang="en-US">Long lived assets by geographic area</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Goodwill_4_lbl" xml:lang="en-US">Goodwill by geographic area</link:label>
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_LeasePeriodicPayments" xlink:label="cxai_LeasePeriodicPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_LeasePeriodicPayments" xlink:to="cxai_LeasePeriodicPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_LeasePeriodicPayments_lbl" xml:lang="en-US">Lease periodic payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Operating lease expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted average remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate used to determine operating lease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CommonClassaSubjectToRedemptionMember" xlink:to="cxai_CommonClassaSubjectToRedemptionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_CommonClassaSubjectToRedemptionMember_doc" xml:lang="en-US">Classification of common stock representing ownership interest in a corporation that is subject to redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DeferredUnderwritingFeePayable" xlink:to="cxai_DeferredUnderwritingFeePayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_DeferredUnderwritingFeePayable_doc" xml:lang="en-US">Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="cxai_UnitsIssuedDuringPeriodSharesNewIssues_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_UnitsIssuedDuringPeriodSharesNewIssues_doc" xml:lang="en-US">Number of new units issued during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:to="cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights_doc" xml:lang="en-US">Price per share or per unit of warrants or rights outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PrivatePlacementWarrantsMember" xlink:to="cxai_PrivatePlacementWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_PrivatePlacementWarrantsMember_doc" xml:lang="en-US">Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NumberOfWarrantsIssued" xlink:to="cxai_NumberOfWarrantsIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_NumberOfWarrantsIssued_doc" xml:lang="en-US">Represents the number of warrants issued during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TransactionCosts" xlink:to="cxai_TransactionCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_TransactionCosts_doc" xml:lang="en-US">Represents the amount of transaction costs incurred.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SaleOfStockUnderwritingFees" xlink:to="cxai_SaleOfStockUnderwritingFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_SaleOfStockUnderwritingFees_doc" xml:lang="en-US">Represents the amount of offering fees incurred and paid for underwriters.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SaleOfStockOtherOfferingCosts" xlink:to="cxai_SaleOfStockOtherOfferingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_SaleOfStockOtherOfferingCosts_doc" xml:lang="en-US">Represents the amount of other offering costs incurred.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PaymentsForInvestmentOfCashInTrustAccount" xlink:to="cxai_PaymentsForInvestmentOfCashInTrustAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_PaymentsForInvestmentOfCashInTrustAccount_doc" xml:lang="en-US">The amount of cash outflow for investment of cash in trust account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount" xlink:to="cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount_doc" xml:lang="en-US">Represents the threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination" xlink:to="cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination_doc" xml:lang="en-US">Represents the threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination" xlink:to="cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_doc" xml:lang="en-US">Represents the minimum net tangible assets upon consummation of the Business Combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent" xlink:to="cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent_doc" xml:lang="en-US">This represents threshold percentage of Public Shares subject to redemption without the Company's prior written consent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:to="cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_doc" xml:lang="en-US">Represents the threshold percentage of Obligation to redeem Public Shares if entity does not complete a Business Combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MaximumNetInterestsToPayDissolutionExpenses" xlink:to="cxai_MaximumNetInterestsToPayDissolutionExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_MaximumNetInterestsToPayDissolutionExpenses_doc" xml:lang="en-US">Represents the maximum net interest to pay dissolution expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WorkingCapital" xlink:to="cxai_WorkingCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_WorkingCapital_doc" xml:lang="en-US">Amount represents the information about the working capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ProceedsFromRelatedParty" xlink:to="cxai_ProceedsFromRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_ProceedsFromRelatedParty_doc" xml:lang="en-US">Definition: The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SponsorMember" xlink:to="cxai_SponsorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_SponsorMember_doc" xml:lang="en-US">This member stands for sponsor.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable" xlink:to="cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable_doc" xml:lang="en-US">The amount of gain on forgiveness of deferred underwriting fee payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" xlink:to="cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_doc" xml:lang="en-US">The amount of extinguishment of deferred underwriting fee payable allocated to public shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CommonStockSubjectToRedemptionMember" xlink:to="cxai_CommonStockSubjectToRedemptionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_CommonStockSubjectToRedemptionMember_doc" xml:lang="en-US">Classification of common stock representing shares subject to possible redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TemporaryEquityWaiverOfShareIssuanceCosts" xlink:to="cxai_TemporaryEquityWaiverOfShareIssuanceCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_TemporaryEquityWaiverOfShareIssuanceCosts_doc" xml:lang="en-US">Amount of waiver of share issuance costs pertaining to temporary equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TemporaryEquityRedemption" xlink:to="cxai_TemporaryEquityRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_TemporaryEquityRedemption_doc" xml:lang="en-US">Value of temporary equity redeemed during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_OfferingCost" xlink:to="cxai_OfferingCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_OfferingCost_doc" xml:lang="en-US">The amount of offering cost expense through statement of operations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_FounderSharesMember" xlink:to="cxai_FounderSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_FounderSharesMember_doc" xml:lang="en-US">n/a</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DirectAnchorMember" xlink:to="cxai_DirectAnchorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_DirectAnchorMember_doc" xml:lang="en-US">This member stands for Direct Anchor.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NumberOfSharesSubjectToForfeiture" xlink:to="cxai_NumberOfSharesSubjectToForfeiture_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_NumberOfSharesSubjectToForfeiture_doc" xml:lang="en-US">The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_AggregateNumberOfSharesOwned" xlink:to="cxai_AggregateNumberOfSharesOwned_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_AggregateNumberOfSharesOwned_doc" xml:lang="en-US">The number of shares owned by the founders after the impact of the stock dividend.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:to="cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_doc" xml:lang="en-US">The expected ownership percentage by the founders after completion of the proposed public offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:to="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_doc" xml:lang="en-US">The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:to="cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_doc" xml:lang="en-US">The period of time after a business combination which must elapse before consideration of the share price condition for transfer of shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:to="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_doc" xml:lang="en-US">When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:to="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_doc" xml:lang="en-US">When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:to="cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_doc" xml:lang="en-US">The period of time after completion of a business combination during which the shares or warrant may not be transferred.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PromissoryNoteWithRelatedPartyMember" xlink:to="cxai_PromissoryNoteWithRelatedPartyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_PromissoryNoteWithRelatedPartyMember_doc" xml:lang="en-US">This member stands for promissory note with related party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:to="cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_doc" xml:lang="en-US">The contractual monthly amount to be paid for support services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_AdministrativeServicesAgreementMember" xlink:to="cxai_AdministrativeServicesAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_AdministrativeServicesAgreementMember_doc" xml:lang="en-US">This member stands for Administrative Services Agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MaximumLoansConvertibleIntoWarrants" xlink:to="cxai_MaximumLoansConvertibleIntoWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_MaximumLoansConvertibleIntoWarrants_doc" xml:lang="en-US">The maximum amount which a potential loan could have repaid through issuance of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WorkingCapitalLoansMember" xlink:to="cxai_WorkingCapitalLoansMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_WorkingCapitalLoansMember_doc" xml:lang="en-US">This member stands for working capital loans.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:to="cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_doc" xml:lang="en-US">Amount of maximum borrowing capacity of related party promissory note.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WorkingCapitalLoansWarrantMember" xlink:to="cxai_WorkingCapitalLoansWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_WorkingCapitalLoansWarrantMember_doc" xml:lang="en-US">Working capital loans warrant.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands" xlink:to="cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands_doc" xml:lang="en-US">Minimum Percentage of Founder Share Holders Entitled To Make Demands.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:to="cxai_MaximumNumberOfDemandsForRegistrationOfSecurities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_MaximumNumberOfDemandsForRegistrationOfSecurities_doc" xml:lang="en-US">Represents the maximum number of demands for registration of securities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DeferredFeePerUnit" xlink:to="cxai_DeferredFeePerUnit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_DeferredFeePerUnit_doc" xml:lang="en-US">Represents the deferred fee per unit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee" xlink:to="cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee_doc" xml:lang="en-US">The amount of income recognized from reduction of deferred underwriter fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PercentageOfCommonStockDistributed" xlink:to="cxai_PercentageOfCommonStockDistributed_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_PercentageOfCommonStockDistributed_doc" xml:lang="en-US">Represents the percentage of common stock distributed.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MergerAgreementMember" xlink:to="cxai_MergerAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_MergerAgreementMember_doc" xml:lang="en-US">Represents information pertaining to merger agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_InpixonMember" xlink:to="cxai_InpixonMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_InpixonMember_doc" xml:lang="en-US">Represents information pertaining to Inpixon.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SeparationAgreementMember" xlink:to="cxai_SeparationAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_SeparationAgreementMember_doc" xml:lang="en-US">Represents information pertaining to separation agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CxappHoldingCorpMember" xlink:to="cxai_CxappHoldingCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_CxappHoldingCorpMember_doc" xml:lang="en-US">Represents information pertaining to CXApp Holding Corp.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CommonStockStockPriceTrigger" xlink:to="cxai_CommonStockStockPriceTrigger_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_CommonStockStockPriceTrigger_doc" xml:lang="en-US">Represents the stock price trigger.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger" xlink:to="cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger_doc" xml:lang="en-US">Represents the maximum term for automatic conversion of stock following the closing of the Merger.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PercentageOfStockAsMergerConsideration" xlink:to="cxai_PercentageOfStockAsMergerConsideration_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_PercentageOfStockAsMergerConsideration_doc" xml:lang="en-US">Represents the percentage of stock as merger consideration.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdNetTangibleAssets" xlink:to="cxai_ThresholdNetTangibleAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_ThresholdNetTangibleAssets_doc" xml:lang="en-US">Represents the threshold net tangible assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares" xlink:to="cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares_doc" xml:lang="en-US">Represents the threshold aggregate gross purchase price of any other purchase of shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TerminationFee" xlink:to="cxai_TerminationFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_TerminationFee_doc" xml:lang="en-US">Represents the amount of termination fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TermOfBreachUnableToBeCuredOrIsNotCured" xlink:to="cxai_TermOfBreachUnableToBeCuredOrIsNotCured_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_TermOfBreachUnableToBeCuredOrIsNotCured_doc" xml:lang="en-US">Represents the term of breach unable to be cured, or is not cured.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CommonStockLockUpPeriod" xlink:to="cxai_CommonStockLockUpPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_CommonStockLockUpPeriod_doc" xml:lang="en-US">Represents the lock-up period of shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp" xlink:to="cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp_doc" xml:lang="en-US">Represents the percentage of shares not be subject to foregoing lock-up.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NumberOfSharesExchanged" xlink:to="cxai_NumberOfSharesExchanged_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_NumberOfSharesExchanged_doc" xml:lang="en-US">Represents the number of shares exchanged.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SponsorSupportAgreementMember" xlink:to="cxai_SponsorSupportAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_SponsorSupportAgreementMember_doc" xml:lang="en-US">Represents information pertaining to Sponsor Support Agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MinimumNumberOfSharesIssuableToSponsor" xlink:to="cxai_MinimumNumberOfSharesIssuableToSponsor_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_MinimumNumberOfSharesIssuableToSponsor_doc" xml:lang="en-US">Represents the minimum number of shares issuable to sponsor.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_CommonStockNumberOfVotesPerShare" xlink:to="cxai_CommonStockNumberOfVotesPerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_CommonStockNumberOfVotesPerShare_doc" xml:lang="en-US">The number of votes that each common share is entitled.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ConvertibleStockConversionRatio" xlink:to="cxai_ConvertibleStockConversionRatio_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_ConvertibleStockConversionRatio_doc" xml:lang="en-US">The ratio to be applied to the stock in a conversion of convertible stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantExercisePeriodConditionOne" xlink:to="cxai_WarrantExercisePeriodConditionOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_WarrantExercisePeriodConditionOne_doc" xml:lang="en-US">The period of time after completion of a business combination before a warrant may be exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PublicWarrantsMember" xlink:to="cxai_PublicWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_PublicWarrantsMember_doc" xml:lang="en-US">Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantExercisePeriodConditionTwo" xlink:to="cxai_WarrantExercisePeriodConditionTwo_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_WarrantExercisePeriodConditionTwo_doc" xml:lang="en-US">The alternate period of time after completion of an initial public offering before a warrant may be exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" xlink:to="cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement_doc" xml:lang="en-US">The period of time after completion of a business combination in which the reporting entity is required to file a registration statement with the SEC.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" xlink:to="cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective_doc" xml:lang="en-US">The period of time after filing within which the registration statement filed with the SEC is expected to become effective.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantRedemptionConditionMinimumSharePrice" xlink:to="cxai_WarrantRedemptionConditionMinimumSharePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_WarrantRedemptionConditionMinimumSharePrice_doc" xml:lang="en-US">The minimum trading price for the reporting entity's stock which must be achieved as a condition for redemption of the warrant.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:to="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_doc" xml:lang="en-US">This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $18.00.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:to="cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_doc" xml:lang="en-US">Redemption price per share or per unit of warrants or rights outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:to="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_doc" xml:lang="en-US">Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RedemptionPeriod" xlink:to="cxai_RedemptionPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_RedemptionPeriod_doc" xml:lang="en-US">Redemption period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:to="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_doc" xml:lang="en-US">Threshold number of specified trading days for stock price trigger considered for redemption of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo" xlink:to="cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo_doc" xml:lang="en-US">The minimum trading price for the reporting entity's stock which must be achieved as a condition for redemption of the warrant under another scenario.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:to="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_doc" xml:lang="en-US">This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $10.00.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant" xlink:to="cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant_doc" xml:lang="en-US">The ratio of gross proceeds from a future offering to total equity proceeds which is used to measure whether dilution of the warrant has occurred. If aggregate gross proceeds from a new offering exceeds a specified percentage of total equity proceeds, the warrant exercise price will be adjusted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant" xlink:to="cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant_doc" xml:lang="en-US">The cut off price used to measure whether dilution of the warrant has occurred. Shares issued below this price will cause the exercise price of the warrant to be adjusted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantRedemptionPriceAdjustmentMultiple" xlink:to="cxai_WarrantRedemptionPriceAdjustmentMultiple_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_WarrantRedemptionPriceAdjustmentMultiple_doc" xml:lang="en-US">In the event of dilution of the warrant, the multiple to be applied to the higher of the market price or the price of newly issued shares in order to obtain the adjusted redemption price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantExercisePriceAdjustmentMultiple" xlink:to="cxai_WarrantExercisePriceAdjustmentMultiple_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_WarrantExercisePriceAdjustmentMultiple_doc" xml:lang="en-US">In the event of dilution of the warrant, the multiple to be applied to the higher of the market price or the price of newly issued shares in order to obtain the adjusted exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" xlink:to="cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_doc" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from capitalized start up and organization costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent" xlink:to="cxai_EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_doc" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Transaction costs allocated to derivative warrant liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent" xlink:to="cxai_EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_doc" xml:lang="en-US">Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Change in fair value of derivative warrant liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" xlink:to="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_doc" xml:lang="en-US">Amount of transfers of financial instrument classified as a liability into level 1 of the fair value hierarchy.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" xlink:to="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_doc" xml:lang="en-US">Amount of transfers of financial instrument classified as a liability into level 2 of the fair value hierarchy.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_NumberOfSharesIssuableUponMerger" xlink:to="cxai_NumberOfSharesIssuableUponMerger_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cxai_NumberOfSharesIssuableUponMerger_doc" xml:lang="en-US">Represents the number of shares issuable upon merger.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_2_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_4_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndOtherIncome_2_lbl" xml:lang="en-US">Interest and Other Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_IncreaseDecreaseInDeferredUnderwritingFee" xlink:to="cxai_IncreaseDecreaseInDeferredUnderwritingFee_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_IncreaseDecreaseInDeferredUnderwritingFee_2_lbl" xml:lang="en-US">IncreaseDecreaseInDeferredUnderwritingFee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_3_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DeferredUnderwritingFeePayable" xlink:to="cxai_DeferredUnderwritingFeePayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DeferredUnderwritingFeePayable_3_lbl" xml:lang="en-US">Deferred Underwriting Fees Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ChangeInFairValueOfEarnout" xlink:to="cxai_ChangeInFairValueOfEarnout_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ChangeInFairValueOfEarnout_2_lbl" xml:lang="en-US">ChangeInFairValueOfEarnout</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfDerivatives" xlink:to="us-gaap_GainLossOnSaleOfDerivatives_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfDerivatives_2_lbl" xml:lang="en-US">Gain (Loss) on Sale of Derivatives</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_GainOnEarnoutPaymentLiability" xlink:to="cxai_GainOnEarnoutPaymentLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_GainOnEarnoutPaymentLiability_2_lbl" xml:lang="en-US">GainOnEarnoutPaymentLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_GainOnChangeInFairValueOfDerivativeLiability" xlink:to="cxai_GainOnChangeInFairValueOfDerivativeLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_GainOnChangeInFairValueOfDerivativeLiability_2_lbl" xml:lang="en-US">GainOnChangeInFairValueOfDerivativeLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts and Other Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_InvestmentInCapitalizedSoftware" xlink:to="cxai_InvestmentInCapitalizedSoftware_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_InvestmentInCapitalizedSoftware_2_lbl" xml:lang="en-US">InvestmentInCapitalizedSoftware</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TaxesPaidRelatedForStockBasedCompensation" xlink:to="cxai_TaxesPaidRelatedForStockBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_TaxesPaidRelatedForStockBasedCompensation_2_lbl" xml:lang="en-US">TaxesPaidRelatedForStockBasedCompensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_RepaymentOfCxappAcquisitionLiability" xlink:to="cxai_RepaymentOfCxappAcquisitionLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_RepaymentOfCxappAcquisitionLiability_2_lbl" xml:lang="en-US">RepaymentOfCxappAcquisitionLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_DeferredRevenueTextBlock" xlink:to="cxai_DeferredRevenueTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_DeferredRevenueTextBlock_2_lbl" xml:lang="en-US">DeferredRevenueTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_WarrantLiabilitiesTextBlock" xlink:to="cxai_WarrantLiabilitiesTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_WarrantLiabilitiesTextBlock_2_lbl" xml:lang="en-US">WarrantLiabilitiesTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_ForeignOperationsTextBlock" xlink:to="cxai_ForeignOperationsTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_ForeignOperationsTextBlock_2_lbl" xml:lang="en-US">ForeignOperationsTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillDisclosureTextBlock_2_lbl" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyPolicy" xlink:to="us-gaap_StandardProductWarrantyPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StandardProductWarrantyPolicy_2_lbl" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_TemporaryEquityRedemption" xlink:to="cxai_TemporaryEquityRedemption_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_TemporaryEquityRedemption_3_lbl" xml:lang="en-US">Temporary Equity, Redemption</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Earnings Per Share, Basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Federal, State and Local, Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_2_lbl" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables" xlink:to="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables_2_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities" xlink:to="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_2_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent" xlink:to="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent_2_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent" xlink:to="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent_2_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_2_lbl" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:to="us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_2_lbl" xml:lang="en-US">Capitalized Computer Software, Accumulated Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Accrued Liabilities [Default Label]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>cxai-20230331_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.19a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://kins-tech.com/role/Cover" xlink:href="cxai-20230331.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedBalanceSheets" xlink:href="cxai-20230331.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cxai-20230331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedStatementsOfOperations" xlink:href="cxai-20230331.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:href="cxai-20230331.xsd#ConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cxai-20230331.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CondensedConsolidatedBalanceSheets" xlink:href="cxai-20230331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="cxai-20230331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="cxai-20230331.xsd#UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit" xlink:href="cxai-20230331.xsd#UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="cxai-20230331.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperations" xlink:href="cxai-20230331.xsd#DescriptionOfOrganizationAndBusinessOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatements" xlink:href="cxai-20230331.xsd#RestatementOfPreviouslyIssuedFinancialStatements" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PublicOffering" xlink:href="cxai-20230331.xsd#PublicOffering" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PrivatePlacement" xlink:href="cxai-20230331.xsd#PrivatePlacement" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RelatedParties" xlink:href="cxai-20230331.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CommitmentsAndContingencies" xlink:href="cxai-20230331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockholdersDeficit" xlink:href="cxai-20230331.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DerivativeWarrantLiabilities" xlink:href="cxai-20230331.xsd#DerivativeWarrantLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTax" xlink:href="cxai-20230331.xsd#IncomeTax" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurements" xlink:href="cxai-20230331.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SubsequentEvents" xlink:href="cxai-20230331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/OrganizationNatureOfBusinessAndBasisOfPresentation" xlink:href="cxai-20230331.xsd#OrganizationNatureOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombination" xlink:href="cxai-20230331.xsd#BusinessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DisaggregationOfRevenue" xlink:href="cxai-20230331.xsd#DisaggregationOfRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PropertyAndEquipmentNet" xlink:href="cxai-20230331.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNet" xlink:href="cxai-20230331.xsd#SoftwareDevelopmentCostsNet" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssets" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DeferredRevenue" xlink:href="cxai-20230331.xsd#DeferredRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/AccruedLiabilities" xlink:href="cxai-20230331.xsd#AccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/WarrantLiabilities" xlink:href="cxai-20230331.xsd#WarrantLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensation" xlink:href="cxai-20230331.xsd#StockOptionPlanAndStock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueOfFinancialInstruments" xlink:href="cxai-20230331.xsd#FairValueOfFinancialInstruments" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxes" xlink:href="cxai-20230331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CreditRiskAndConcentrations" xlink:href="cxai-20230331.xsd#CreditRiskAndConcentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ForeignOperations" xlink:href="cxai-20230331.xsd#ForeignOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/Leases" xlink:href="cxai-20230331.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CommitmentsAndContingencie" xlink:href="cxai-20230331.xsd#CommitmentsAndContingencie" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:href="cxai-20230331.xsd#RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxTables" xlink:href="cxai-20230331.xsd#IncomeTaxTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurementsTables" xlink:href="cxai-20230331.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombinationTables" xlink:href="cxai-20230331.xsd#BusinessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DisaggregationOfRevenueTables" xlink:href="cxai-20230331.xsd#DisaggregationOfRevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PropertyAndEquipmentNetTables" xlink:href="cxai-20230331.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNetTables" xlink:href="cxai-20230331.xsd#SoftwareDevelopmentCostsNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DeferredRevenueTables" xlink:href="cxai-20230331.xsd#DeferredRevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/AccruedLiabilitiesTables" xlink:href="cxai-20230331.xsd#AccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationTables" xlink:href="cxai-20230331.xsd#StockOptionPlanAndStock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ForeignOperationsTables" xlink:href="cxai-20230331.xsd#ForeignOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:href="cxai-20230331.xsd#DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails" xlink:href="cxai-20230331.xsd#RestatementOfPreviouslyIssuedFinancialStatementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PublicOfferingDetailsNarrative" xlink:href="cxai-20230331.xsd#PublicOfferingDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PrivatePlacementDetailsNarrative" xlink:href="cxai-20230331.xsd#PrivatePlacementDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/RelatedPartiesDetailsNarrative" xlink:href="cxai-20230331.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="cxai-20230331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockholdersDeficitDetailsNarrative" xlink:href="cxai-20230331.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative" xlink:href="cxai-20230331.xsd#DerivativeWarrantLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxDetails" xlink:href="cxai-20230331.xsd#IncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxDetails1" xlink:href="cxai-20230331.xsd#IncomeTaxDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxDetails2" xlink:href="cxai-20230331.xsd#IncomeTaxDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxDetailsNarrative" xlink:href="cxai-20230331.xsd#IncomeTaxDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurementsDetails" xlink:href="cxai-20230331.xsd#FairValueMeasurementsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurementsDetails1" xlink:href="cxai-20230331.xsd#FairValueMeasurementsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative" xlink:href="cxai-20230331.xsd#FairValueMeasurementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails" xlink:href="cxai-20230331.xsd#SummaryOfSignificantAccountingPolicieDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombinationDetails" xlink:href="cxai-20230331.xsd#BusinessCombinationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombinationDetails1" xlink:href="cxai-20230331.xsd#BusinessCombinationDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/BusinessCombinationDetailsNarrative" xlink:href="cxai-20230331.xsd#BusinessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DisaggregationOfRevenueDetails" xlink:href="cxai-20230331.xsd#DisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PropertyAndEquipmentNetDetails" xlink:href="cxai-20230331.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:href="cxai-20230331.xsd#PropertyAndEquipmentNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails" xlink:href="cxai-20230331.xsd#SoftwareDevelopmentCostsNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative" xlink:href="cxai-20230331.xsd#SoftwareDevelopmentCostsNetDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" xlink:href="cxai-20230331.xsd#GoodwillAndIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/DeferredRevenueDetails" xlink:href="cxai-20230331.xsd#DeferredRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/AccruedLiabilitiesDetails" xlink:href="cxai-20230331.xsd#AccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative" xlink:href="cxai-20230331.xsd#AccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative" xlink:href="cxai-20230331.xsd#WarrantLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails" xlink:href="cxai-20230331.xsd#StockAwardPlansAndStock-basedCompensationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative" xlink:href="cxai-20230331.xsd#StockOptionPlanAndStock-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative" xlink:href="cxai-20230331.xsd#FairValueOfFinancialInstrumentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/IncomeTaxesDetailsNarrative" xlink:href="cxai-20230331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/ForeignOperationsDetails" xlink:href="cxai-20230331.xsd#ForeignOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://kins-tech.com/role/LeasesDetailsNarrative" xlink:href="cxai-20230331.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AccruedLiabilitiesExcludingOfferingCostsCurrent" xlink:label="loc_cxaiAccruedLiabilitiesExcludingOfferingCostsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_cxaiAccruedLiabilitiesExcludingOfferingCostsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PromissoryNoteRelatedParty" xlink:label="loc_cxaiPromissoryNoteRelatedParty" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_cxaiPromissoryNoteRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredOfferingCostsNoncurrent" xlink:label="loc_cxaiDeferredOfferingCostsNoncurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_cxaiDeferredOfferingCostsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonClassaSubjectToRedemptionMember" xlink:label="loc_cxaiCommonClassaSubjectToRedemptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_cxaiCommonClassaSubjectToRedemptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingCostsAndExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaapInterestIncomeExpenseNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestIncomeExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainLossOnEliminationOfDeferredUnderwritingFee" xlink:label="loc_cxaiGainLossOnEliminationOfDeferredUnderwritingFee" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_cxaiGainLossOnEliminationOfDeferredUnderwritingFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock" xlink:label="loc_cxaiBasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_cxaiBasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutedNetIncomePerShareClassCommonStock" xlink:label="loc_cxaiBasicAndDilutedNetIncomePerShareClassCommonStock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_cxaiBasicAndDilutedNetIncomePerShareClassCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock" xlink:label="loc_cxaiBasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_cxaiBasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutedNetIncomePerShareClassBCommonStock" xlink:label="loc_cxaiBasicAndDilutedNetIncomePerShareClassBCommonStock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_cxaiBasicAndDilutedNetIncomePerShareClassBCommonStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&apos; DEFICIT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassACommonStockMember" xlink:label="loc_cxaiClassACommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_cxaiClassACommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassBCommonStockMember" xlink:label="loc_cxaiClassBCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_cxaiClassBCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValueAdjustment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValueAdjustment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaapInterestAndOtherIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapInterestAndOtherIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_IncreaseDecreaseInDeferredUnderwritingFee" xlink:label="loc_cxaiIncreaseDecreaseInDeferredUnderwritingFee" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_cxaiIncreaseDecreaseInDeferredUnderwritingFee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" xlink:label="loc_cxaiProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_cxaiProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProceedsFromTrustAccountInConnectionWithRedemption" xlink:label="loc_cxaiProceedsFromTrustAccountInConnectionWithRedemption" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_cxaiProceedsFromTrustAccountInConnectionWithRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ChangeInValueOfClassCommonStockSubjectToPossibleRedemption" xlink:label="loc_cxaiChangeInValueOfClassCommonStockSubjectToPossibleRedemption" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_cxaiChangeInValueOfClassCommonStockSubjectToPossibleRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock" xlink:label="loc_cxaiForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_cxaiForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredUnderwritingFeePayable" xlink:label="loc_cxaiDeferredUnderwritingFeePayable" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_cxaiDeferredUnderwritingFeePayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaapCapitalizedComputerSoftwareNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapCapitalizedComputerSoftwareNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AcquisitionLiability" xlink:label="loc_cxaiAcquisitionLiability" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_cxaiAcquisitionLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtendedProductWarrantyAccrualCurrent" xlink:label="loc_us-gaapExtendedProductWarrantyAccrualCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapExtendedProductWarrantyAccrualCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetParentInvestment" xlink:label="loc_cxaiNetParentInvestment" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_cxaiNetParentInvestment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000008 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="00000009 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ChangeInFairValueOfEarnout" xlink:label="loc_cxaiChangeInFairValueOfEarnout" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_cxaiChangeInFairValueOfEarnout" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaapInterestIncomeExpenseNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestIncomeExpenseNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock" xlink:label="loc_cxaiBasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_cxaiBasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutiveNetIncomePerShareClassCommonStock" xlink:label="loc_cxaiBasicAndDilutiveNetIncomePerShareClassCommonStock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_cxaiBasicAndDilutiveNetIncomePerShareClassCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock" xlink:label="loc_cxaiBasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_cxaiBasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutiveNetIncomePerShareClassCCommonStock" xlink:label="loc_cxaiBasicAndDilutiveNetIncomePerShareClassCCommonStock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_cxaiBasicAndDilutiveNetIncomePerShareClassCCommonStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit" xlink:title="00000010 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY (DEFICIT)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetParentInvestmentMember" xlink:label="loc_cxaiNetParentInvestmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_cxaiNetParentInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TotalMember" xlink:label="loc_cxaiTotalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_cxaiTotalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassACommonStockMember" xlink:label="loc_cxaiClassACommonStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_cxaiClassACommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassCCommonStockMember" xlink:label="loc_cxaiClassCCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_cxaiClassCCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ParentsCommonSharesIssuedForCxappEarnout" xlink:label="loc_cxaiParentsCommonSharesIssuedForCxappEarnout" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiParentsCommonSharesIssuedForCxappEarnout" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits" xlink:label="loc_cxaiTaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiTaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetInvestmentsFromParent" xlink:label="loc_cxaiNetInvestmentsFromParent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiNetInvestmentsFromParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CumulativeTranslationAdjustment" xlink:label="loc_cxaiCumulativeTranslationAdjustment" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiCumulativeTranslationAdjustment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SharesIssuedInConnectionWithBusinessCombination" xlink:label="loc_cxaiSharesIssuedInConnectionWithBusinessCombination" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiSharesIssuedInConnectionWithBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SharesIssuedInConnectionWithBusinessCombinationShares" xlink:label="loc_cxaiSharesIssuedInConnectionWithBusinessCombinationShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiSharesIssuedInConnectionWithBusinessCombinationShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000011 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAssetAmortization" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainOnEarnoutPaymentLiability" xlink:label="loc_cxaiGainOnEarnoutPaymentLiability" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_cxaiGainOnEarnoutPaymentLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainOnChangeInFairValueOfDerivativeLiability" xlink:label="loc_cxaiGainOnChangeInFairValueOfDerivativeLiability" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_cxaiGainOnChangeInFairValueOfDerivativeLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsAndOtherReceivables" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsAndOtherReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxes" xlink:label="loc_us-gaapIncreaseDecreaseInIncomeTaxes" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_InvestmentInCapitalizedSoftware" xlink:label="loc_cxaiInvestmentInCapitalizedSoftware" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_cxaiInvestmentInCapitalizedSoftware" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetEquityInvestmentFromParent" xlink:label="loc_cxaiNetEquityInvestmentFromParent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_cxaiNetEquityInvestmentFromParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TaxesPaidRelatedForStockBasedCompensation" xlink:label="loc_cxaiTaxesPaidRelatedForStockBasedCompensation" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_cxaiTaxesPaidRelatedForStockBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RepaymentOfCxappAcquisitionLiability" xlink:label="loc_cxaiRepaymentOfCxappAcquisitionLiability" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_cxaiRepaymentOfCxappAcquisitionLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract" xlink:label="loc_cxaiSupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiSupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ParentsNetEquityIssuedForCxAppEarnout" xlink:label="loc_cxaiParentsNetEquityIssuedForCxAppEarnout" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiSupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract" xlink:to="loc_cxaiParentsNetEquityIssuedForCxAppEarnout" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NoncashDistribution" xlink:label="loc_cxaiNoncashDistribution" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiSupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract" xlink:to="loc_cxaiNoncashDistribution" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination" xlink:label="loc_cxaiClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiSupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract" xlink:to="loc_cxaiClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FinancingOfDirectorAndOfficerInsurance" xlink:label="loc_cxaiFinancingOfDirectorAndOfficerInsurance" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiSupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract" xlink:to="loc_cxaiFinancingOfDirectorAndOfficerInsurance" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperations" xlink:title="00000012 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatements" xlink:title="00000013 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ErrorCorrectionTextBlock" xlink:label="loc_us-gaapErrorCorrectionTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" xlink:to="loc_us-gaapErrorCorrectionTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PublicOffering" xlink:title="00000015 - Disclosure - PUBLIC OFFERING">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosurePublicOfferingAbstract" xlink:label="loc_cxaiDisclosurePublicOfferingAbstract" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_InitialPublicOfferingDisclosureTextBlock" xlink:label="loc_cxaiInitialPublicOfferingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosurePublicOfferingAbstract" xlink:to="loc_cxaiInitialPublicOfferingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PrivatePlacement" xlink:title="00000016 - Disclosure - PRIVATE PLACEMENT">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosurePrivatePlacementAbstract" xlink:label="loc_cxaiDisclosurePrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementDisclosureTextBlock" xlink:label="loc_cxaiPrivatePlacementDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosurePrivatePlacementAbstract" xlink:to="loc_cxaiPrivatePlacementDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RelatedParties" xlink:title="00000017 - Disclosure - RELATED PARTIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CommitmentsAndContingencies" xlink:title="00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockholdersDeficit" xlink:title="00000019 - Disclosure - STOCKHOLDERS&#8217; DEFICIT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DerivativeWarrantLiabilities" xlink:title="00000020 - Disclosure - DERIVATIVE WARRANT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTax" xlink:title="00000021 - Disclosure - INCOME TAX">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurements" xlink:title="00000022 - Disclosure - FAIR VALUE MEASUREMENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SubsequentEvents" xlink:title="00000023 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/OrganizationNatureOfBusinessAndBasisOfPresentation" xlink:title="00000024 - Disclosure - Organization, Nature of Business and Basis of Presentation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombination" xlink:title="00000025 - Disclosure - Business Combination">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DisaggregationOfRevenue" xlink:title="00000026 - Disclosure - Disaggregation of Revenue">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureDisaggregationOfRevenueAbstract" xlink:label="loc_cxaiDisclosureDisaggregationOfRevenueAbstract" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisaggregationOfRevenueTextBlock" xlink:label="loc_cxaiDisaggregationOfRevenueTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureDisaggregationOfRevenueAbstract" xlink:to="loc_cxaiDisaggregationOfRevenueTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PropertyAndEquipmentNet" xlink:title="00000027 - Disclosure - Property and Equipment, net">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SoftwareDevelopmentCostsNet" xlink:title="00000028 - Disclosure - Software Development Costs, net">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureSoftwareDevelopmentCostsNetAbstract" xlink:label="loc_cxaiDisclosureSoftwareDevelopmentCostsNetAbstract" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SoftwareDevelopmentCostsNetTextBlock" xlink:label="loc_cxaiSoftwareDevelopmentCostsNetTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureSoftwareDevelopmentCostsNetAbstract" xlink:to="loc_cxaiSoftwareDevelopmentCostsNetTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssets" xlink:title="00000029 - Disclosure - Goodwill and Intangible Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DeferredRevenue" xlink:title="00000030 - Disclosure - Deferred Revenue">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureDeferredRevenueAbstract" xlink:label="loc_cxaiDisclosureDeferredRevenueAbstract" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredRevenueTextBlock" xlink:label="loc_cxaiDeferredRevenueTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureDeferredRevenueAbstract" xlink:to="loc_cxaiDeferredRevenueTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/AccruedLiabilities" xlink:title="00000031 - Disclosure - Accrued Liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/WarrantLiabilities" xlink:title="00000032 - Disclosure - Warrant Liabilities">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureWarrantLiabilitiesAbstract" xlink:label="loc_cxaiDisclosureWarrantLiabilitiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantLiabilitiesTextBlock" xlink:label="loc_cxaiWarrantLiabilitiesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureWarrantLiabilitiesAbstract" xlink:to="loc_cxaiWarrantLiabilitiesTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensation" xlink:title="00000033 - Disclosure - Stock Option Plan and Stock-Based Compensation">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract" xlink:label="loc_cxaiDisclosureStockOptionPlanAndStockbasedCompensationAbstract" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_StockAwardPlansAndStockbasedCompensationTextBlock" xlink:label="loc_cxaiStockAwardPlansAndStockbasedCompensationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureStockOptionPlanAndStockbasedCompensationAbstract" xlink:to="loc_cxaiStockAwardPlansAndStockbasedCompensationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueOfFinancialInstruments" xlink:title="00000034 - Disclosure - Fair Value of Financial Instruments">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxes" xlink:title="00000035 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CreditRiskAndConcentrations" xlink:title="00000036 - Disclosure - Credit Risk and Concentrations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ForeignOperations" xlink:title="00000037 - Disclosure - Foreign Operations">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureForeignOperationsAbstract" xlink:label="loc_cxaiDisclosureForeignOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ForeignOperationsTextBlock" xlink:label="loc_cxaiForeignOperationsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureForeignOperationsAbstract" xlink:to="loc_cxaiForeignOperationsTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/Leases" xlink:title="00000038 - Disclosure - Leases">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaapLeasesOfLesseeDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLeasesOfLesseeDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CommitmentsAndContingencie" xlink:title="00000039 - Disclosure - Commitments and Contingencie">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EmergingGrowthCompanyPolicyTextBlock" xlink:label="loc_cxaiEmergingGrowthCompanyPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_cxaiEmergingGrowthCompanyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TemporaryEquityPolicyPolicyTextBlock" xlink:label="loc_cxaiTemporaryEquityPolicyPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_cxaiTemporaryEquityPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="loc_us-gaapDeferredChargesPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDeferredChargesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantLiabilityPolicyTextBlock" xlink:label="loc_cxaiWarrantLiabilityPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_cxaiWarrantLiabilityPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_LiquidityAndGoingConcernPolicyTextBlock" xlink:label="loc_cxaiLiquidityAndGoingConcernPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_cxaiLiquidityAndGoingConcernPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock" xlink:label="loc_cxaiAccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_cxaiAccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="loc_us-gaapGoodwillDisclosureTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_LeasesAndRightofUseAssetsPolicyTextBlock" xlink:label="loc_cxaiLeasesAndRightofUseAssetsPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_cxaiLeasesAndRightofUseAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaapBusinessCombinationsPolicy" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessCombinationsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaapStandardProductWarrantyPolicy" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStandardProductWarrantyPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables" xlink:title="00000041 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" xlink:to="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="loc_us-gaapTemporaryEquityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTemporaryEquityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxTables" xlink:title="00000043 - Disclosure - INCOME TAX (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurementsTables" xlink:title="00000044 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombinationTables" xlink:title="00000045 - Disclosure - Business Combination (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DisaggregationOfRevenueTables" xlink:title="00000046 - Disclosure - Disaggregation of Revenue (Tables)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureDisaggregationOfRevenueAbstract" xlink:label="loc_cxaiDisclosureDisaggregationOfRevenueAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureDisaggregationOfRevenueAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PropertyAndEquipmentNetTables" xlink:title="00000047 - Disclosure - Property and Equipment, net (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SoftwareDevelopmentCostsNetTables" xlink:title="00000048 - Disclosure - Software Development Costs, net (Tables)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureSoftwareDevelopmentCostsNetAbstract" xlink:label="loc_cxaiDisclosureSoftwareDevelopmentCostsNetAbstract" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock" xlink:label="loc_cxaiScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureSoftwareDevelopmentCostsNetAbstract" xlink:to="loc_cxaiScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables" xlink:title="00000049 - Disclosure - Goodwill and Intangible Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaapScheduleOfGoodwillTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfGoodwillTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DeferredRevenueTables" xlink:title="00000050 - Disclosure - Deferred Revenue (Tables)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureDeferredRevenueAbstract" xlink:label="loc_cxaiDisclosureDeferredRevenueAbstract" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ScheduleOfDeferredRevenueTableTextBlock" xlink:label="loc_cxaiScheduleOfDeferredRevenueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureDeferredRevenueAbstract" xlink:to="loc_cxaiScheduleOfDeferredRevenueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/AccruedLiabilitiesTables" xlink:title="00000051 - Disclosure - Accrued Liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationTables" xlink:title="00000052 - Disclosure - Stock Option Plan and Stock-Based Compensation (Tables)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract" xlink:label="loc_cxaiDisclosureStockOptionPlanAndStockbasedCompensationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureStockOptionPlanAndStockbasedCompensationAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ForeignOperationsTables" xlink:title="00000053 - Disclosure - Foreign Operations (Tables)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureForeignOperationsAbstract" xlink:label="loc_cxaiDisclosureForeignOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaapScheduleOfQuarterlyFinancialInformationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureForeignOperationsAbstract" xlink:to="loc_us-gaapScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative" xlink:title="00000054 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SponsorMember" xlink:label="loc_cxaiSponsorMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_cxaiSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="loc_cxaiPrivatePlacementWarrantsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonClassaSubjectToRedemptionMember" xlink:label="loc_cxaiCommonClassaSubjectToRedemptionMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_cxaiCommonClassaSubjectToRedemptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="loc_cxaiUnitsIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiUnitsIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NumberOfWarrantsIssued" xlink:label="loc_cxaiNumberOfWarrantsIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiNumberOfWarrantsIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="loc_cxaiClassOfWarrantOrRightPriceOfWarrantsOrRights" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TransactionCosts" xlink:label="loc_cxaiTransactionCosts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SaleOfStockUnderwritingFees" xlink:label="loc_cxaiSaleOfStockUnderwritingFees" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiSaleOfStockUnderwritingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredOfferingCostsNoncurrent" xlink:label="loc_cxaiDeferredOfferingCostsNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiDeferredOfferingCostsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SaleOfStockOtherOfferingCosts" xlink:label="loc_cxaiSaleOfStockOtherOfferingCosts" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiSaleOfStockOtherOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="loc_cxaiPaymentsForInvestmentOfCashInTrustAccount" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiPaymentsForInvestmentOfCashInTrustAccount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount" xlink:label="loc_cxaiThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination" xlink:label="loc_cxaiThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination" xlink:label="loc_cxaiMinimumNetTangibleAssetsUponConsummationsOfBusinessCombination" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiMinimumNetTangibleAssetsUponConsummationsOfBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent" xlink:label="loc_cxaiThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:label="loc_cxaiPercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiPercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumNetInterestsToPayDissolutionExpenses" xlink:label="loc_cxaiMaximumNetInterestsToPayDissolutionExpenses" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiMaximumNetInterestsToPayDissolutionExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WorkingCapital" xlink:label="loc_cxaiWorkingCapital" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiWorkingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProceedsFromRelatedParty" xlink:label="loc_cxaiProceedsFromRelatedParty" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiProceedsFromRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails" xlink:title="00000055 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="loc_srtRestatementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember" xlink:label="loc_srtRestatementAdjustmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRestatementAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable" xlink:label="loc_cxaiGainOnForgivenessOfDeferredUnderwritingFeePayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_cxaiGainOnForgivenessOfDeferredUnderwritingFeePayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares" xlink:label="loc_cxaiBasicAndDilutedWeightedAverageSharesOutstandingInShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_cxaiBasicAndDilutedWeightedAverageSharesOutstandingInShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare" xlink:label="loc_cxaiBasicAndDilutedEarningsPerShareInDollarsPerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_cxaiBasicAndDilutedEarningsPerShareInDollarsPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValueAdjustment" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValueAdjustment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable" xlink:label="loc_cxaiGainOnForgivenessOfDeferredUnderwritingFeePayable_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_cxaiGainOnForgivenessOfDeferredUnderwritingFeePayable_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" xlink:label="loc_cxaiExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_cxaiExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000056 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TemporaryEquityWaiverOfShareIssuanceCosts" xlink:label="loc_cxaiTemporaryEquityWaiverOfShareIssuanceCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_cxaiTemporaryEquityWaiverOfShareIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaapTemporaryEquityAccretionToRedemptionValue_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTemporaryEquityAccretionToRedemptionValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TemporaryEquityRedemption" xlink:label="loc_cxaiTemporaryEquityRedemption" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_cxaiTemporaryEquityRedemption" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:title="00000057 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasicAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000058 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonStockSubjectToRedemptionMember" xlink:label="loc_cxaiCommonStockSubjectToRedemptionMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_cxaiCommonStockSubjectToRedemptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtStatementScenarioAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TransactionCosts" xlink:label="loc_cxaiTransactionCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SaleOfStockUnderwritingFees" xlink:label="loc_cxaiSaleOfStockUnderwritingFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiSaleOfStockUnderwritingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredOfferingCostsNoncurrent" xlink:label="loc_cxaiDeferredOfferingCostsNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiDeferredOfferingCostsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SaleOfStockOtherOfferingCosts" xlink:label="loc_cxaiSaleOfStockOtherOfferingCosts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiSaleOfStockOtherOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_OfferingCost" xlink:label="loc_cxaiOfferingCost" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiOfferingCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaapUnrecognizedTaxBenefits" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WorkingCapital" xlink:label="loc_cxaiWorkingCapital" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiWorkingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CashAndCashEquivalentsDescription" xlink:label="loc_cxaiCashAndCashEquivalentsDescription" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiCashAndCashEquivalentsDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RevenueRecognized" xlink:label="loc_cxaiRevenueRecognized" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiRevenueRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ChangesInEstimatedFairValueOfWarrants" xlink:label="loc_cxaiChangesInEstimatedFairValueOfWarrants" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_cxaiChangesInEstimatedFairValueOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetImpairmentCharges" xlink:label="loc_us-gaapOtherAssetImpairmentCharges" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapOtherAssetImpairmentCharges" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PublicOfferingDetailsNarrative" xlink:title="00000059 - Disclosure - PUBLIC OFFERING (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosurePublicOfferingAbstract" xlink:label="loc_cxaiDisclosurePublicOfferingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosurePublicOfferingAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaapIPOMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapIPOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="loc_cxaiUnitsIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_cxaiUnitsIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PrivatePlacementDetailsNarrative" xlink:title="00000060 - Disclosure - PRIVATE PLACEMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosurePrivatePlacementAbstract" xlink:label="loc_cxaiDisclosurePrivatePlacementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosurePrivatePlacementAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="loc_cxaiPrivatePlacementWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="loc_cxaiClassOfWarrantOrRightPriceOfWarrantsOrRights" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/RelatedPartiesDetailsNarrative" xlink:title="00000061 - Disclosure - RELATED PARTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FounderSharesMember" xlink:label="loc_cxaiFounderSharesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_cxaiFounderSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AdministrativeServicesAgreementMember" xlink:label="loc_cxaiAdministrativeServicesAgreementMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_cxaiAdministrativeServicesAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PromissoryNoteWithRelatedPartyMember" xlink:label="loc_cxaiPromissoryNoteWithRelatedPartyMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_cxaiPromissoryNoteWithRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WorkingCapitalLoansMember" xlink:label="loc_cxaiWorkingCapitalLoansMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_cxaiWorkingCapitalLoansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SponsorMember" xlink:label="loc_cxaiSponsorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_cxaiSponsorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DirectAnchorMember" xlink:label="loc_cxaiDirectAnchorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_cxaiDirectAnchorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaapOverAllotmentOptionMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapOverAllotmentOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WorkingCapitalLoansWarrantMember" xlink:label="loc_cxaiWorkingCapitalLoansWarrantMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiWorkingCapitalLoansWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NumberOfSharesSubjectToForfeiture" xlink:label="loc_cxaiNumberOfSharesSubjectToForfeiture" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiNumberOfSharesSubjectToForfeiture" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaapStockholdersEquityNoteStockSplitConversionRatio1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapStockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AggregateNumberOfSharesOwned" xlink:label="loc_cxaiAggregateNumberOfSharesOwned" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiAggregateNumberOfSharesOwned" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:label="loc_cxaiPercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiPercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:label="loc_cxaiRestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiRestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:label="loc_cxaiTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:label="loc_cxaiTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:label="loc_cxaiTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiTransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:label="loc_cxaiThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:label="loc_cxaiRelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiRelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ExpensesIncurredAndPaid" xlink:label="loc_cxaiExpensesIncurredAndPaid" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiExpensesIncurredAndPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="loc_us-gaapDebtInstrumentCollateralAmount" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentCollateralAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumLoansConvertibleIntoWarrants" xlink:label="loc_cxaiMaximumLoansConvertibleIntoWarrants" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiMaximumLoansConvertibleIntoWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="loc_cxaiClassOfWarrantOrRightPriceOfWarrantsOrRights" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:label="loc_cxaiMaximumBorrowingCapacityOfRelatedPartyPromissoryNote" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_cxaiMaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000062 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CXAppCommonStockMember" xlink:label="loc_cxaiCXAppCommonStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cxaiCXAppCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtCounterpartyNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_InpixonMember" xlink:label="loc_cxaiInpixonMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cxaiInpixonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SeparationAgreementMember" xlink:label="loc_cxaiSeparationAgreementMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_cxaiSeparationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MergerAgreementMember" xlink:label="loc_cxaiMergerAgreementMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_cxaiMergerAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SponsorSupportAgreementMember" xlink:label="loc_cxaiSponsorSupportAgreementMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_cxaiSponsorSupportAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CxappHoldingCorpMember" xlink:label="loc_cxaiCxappHoldingCorpMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_cxaiCxappHoldingCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MergerAgreementMember" xlink:label="loc_cxaiMergerAgreementMember_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_cxaiMergerAgreementMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands" xlink:label="loc_cxaiMinimumPercentageOfFounderShareHoldersEntitledToMakeDemands" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiMinimumPercentageOfFounderShareHoldersEntitledToMakeDemands" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:label="loc_cxaiMaximumNumberOfDemandsForRegistrationOfSecurities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiMaximumNumberOfDemandsForRegistrationOfSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredFeePerUnit" xlink:label="loc_cxaiDeferredFeePerUnit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiDeferredFeePerUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredOfferingCostsNoncurrent" xlink:label="loc_cxaiDeferredOfferingCostsNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiDeferredOfferingCostsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee" xlink:label="loc_cxaiIncomeRecognizedFromReductionOfDeferredUnderwriterFee" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiIncomeRecognizedFromReductionOfDeferredUnderwriterFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationConsideration" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfCommonStockDistributed" xlink:label="loc_cxaiPercentageOfCommonStockDistributed" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiPercentageOfCommonStockDistributed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger" xlink:label="loc_cxaiMaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiMaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonStockStockPriceTrigger" xlink:label="loc_cxaiCommonStockStockPriceTrigger" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiCommonStockStockPriceTrigger" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdTradingDays" xlink:label="loc_cxaiThresholdTradingDays" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiThresholdTradingDays" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdConsecutiveTradingDays" xlink:label="loc_cxaiThresholdConsecutiveTradingDays" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiThresholdConsecutiveTradingDays" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NumberOfSharesIssuableUponMerger" xlink:label="loc_cxaiNumberOfSharesIssuableUponMerger" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiNumberOfSharesIssuableUponMerger" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfStockAsMergerConsideration" xlink:label="loc_cxaiPercentageOfStockAsMergerConsideration" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiPercentageOfStockAsMergerConsideration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdNetTangibleAssets" xlink:label="loc_cxaiThresholdNetTangibleAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiThresholdNetTangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares" xlink:label="loc_cxaiThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TermOfBreachUnableToBeCuredOrIsNotCured" xlink:label="loc_cxaiTermOfBreachUnableToBeCuredOrIsNotCured" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiTermOfBreachUnableToBeCuredOrIsNotCured" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_TerminationFee" xlink:label="loc_cxaiTerminationFee" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiTerminationFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonStockLockUpPeriod" xlink:label="loc_cxaiCommonStockLockUpPeriod" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiCommonStockLockUpPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp" xlink:label="loc_cxaiPercentageOfSharesNotBeSubjectToForegoingLockUp" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiPercentageOfSharesNotBeSubjectToForegoingLockUp" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NumberOfSharesExchanged" xlink:label="loc_cxaiNumberOfSharesExchanged" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiNumberOfSharesExchanged" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MinimumNumberOfSharesIssuableToSponsor" xlink:label="loc_cxaiMinimumNumberOfSharesIssuableToSponsor" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiMinimumNumberOfSharesIssuableToSponsor" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000063 - Disclosure - STOCKHOLDERS&#8217; DEFICIT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonStockSubjectToRedemptionMember" xlink:label="loc_cxaiCommonStockSubjectToRedemptionMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_cxaiCommonStockSubjectToRedemptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_CommonStockNumberOfVotesPerShare" xlink:label="loc_cxaiCommonStockNumberOfVotesPerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_cxaiCommonStockNumberOfVotesPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ConvertibleStockConversionRatio" xlink:label="loc_cxaiConvertibleStockConversionRatio" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_cxaiConvertibleStockConversionRatio" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative" xlink:title="00000064 - Disclosure - DERIVATIVE WARRANT LIABILITIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="loc_cxaiPrivatePlacementWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PublicWarrantsMember" xlink:label="loc_cxaiPublicWarrantsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_srtStatementScenarioAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:label="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:label="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantExercisePeriodConditionOne" xlink:label="loc_cxaiWarrantExercisePeriodConditionOne" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiWarrantExercisePeriodConditionOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantExercisePeriodConditionTwo" xlink:label="loc_cxaiWarrantExercisePeriodConditionTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiWarrantExercisePeriodConditionTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" xlink:label="loc_cxaiMaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiMaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" xlink:label="loc_cxaiPeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiPeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantRedemptionConditionMinimumSharePrice" xlink:label="loc_cxaiWarrantRedemptionConditionMinimumSharePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiWarrantRedemptionConditionMinimumSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="loc_cxaiClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:label="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:label="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionPeriod" xlink:label="loc_cxaiRedemptionPeriod" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiRedemptionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo" xlink:label="loc_cxaiWarrantRedemptionConditionMinimumSharePriceScenarioTwo" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiWarrantRedemptionConditionMinimumSharePriceScenarioTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant" xlink:label="loc_cxaiSharePricetriggerUsedToMeasureDilutionOfWarrant" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiSharePricetriggerUsedToMeasureDilutionOfWarrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant" xlink:label="loc_cxaiPercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiPercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantExercisePriceAdjustmentMultiple" xlink:label="loc_cxaiWarrantExercisePriceAdjustmentMultiple" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiWarrantExercisePriceAdjustmentMultiple" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantRedemptionPriceAdjustmentMultiple" xlink:label="loc_cxaiWarrantRedemptionPriceAdjustmentMultiple" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiWarrantRedemptionPriceAdjustmentMultiple" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NumberOfWarrantsIssued" xlink:label="loc_cxaiNumberOfWarrantsIssued" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiNumberOfWarrantsIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:label="loc_cxaiRestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_cxaiRestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxDetails" xlink:title="00000065 - Disclosure - INCOME TAX (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:label="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" xlink:label="loc_cxaiDeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="loc_cxaiDeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxDetails1" xlink:title="00000066 - Disclosure - INCOME TAX (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_StateAndLocalAbstract" xlink:label="loc_cxaiStateAndLocalAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_cxaiStateAndLocalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiStateAndLocalAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiStateAndLocalAbstract" xlink:to="loc_us-gaapDeferredFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiStateAndLocalAbstract" xlink:to="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxDetails2" xlink:title="00000067 - Disclosure - INCOME TAX (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent" xlink:label="loc_cxaiEffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_cxaiEffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent" xlink:label="loc_cxaiEffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_cxaiEffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxDetailsNarrative" xlink:title="00000068 - Disclosure - INCOME TAX (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="loc_us-gaapOperatingLossCarryforwardsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwardsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="loc_us-gaapOperatingLossCarryforwardsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapOperatingLossCarryforwardsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingLossCarryforwardsLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurementsDetails" xlink:title="00000069 - Disclosure - FAIR VALUE MEASUREMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaapMoneyMarketFundsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapMoneyMarketFundsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PublicWarrantsMember" xlink:label="loc_cxaiPublicWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="loc_cxaiPrivatePlacementWarrantsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:label="loc_us-gaapSharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapSharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurementsDetails1" xlink:title="00000070 - Disclosure - FAIR VALUE MEASUREMENTS (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="loc_cxaiPrivatePlacementWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PublicWarrantsMember" xlink:label="loc_cxaiPublicWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" xlink:label="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" xlink:label="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative" xlink:title="00000071 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashMember" xlink:label="loc_us-gaapCashMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapCashMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaapMoneyMarketFundsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapMoneyMarketFundsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaapAssetsHeldInTrustNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapAssetsHeldInTrustNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" xlink:label="loc_cxaiProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_cxaiProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProceedsFromTrustAccountInConnectionWithRedemption" xlink:label="loc_cxaiProceedsFromTrustAccountInConnectionWithRedemption" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_cxaiProceedsFromTrustAccountInConnectionWithRedemption" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" xlink:label="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" xlink:label="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_cxaiFairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails" xlink:title="00000072 - Disclosure - Summary of Significant Accounting Policie (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_StockOptionsMember" xlink:label="loc_cxaiStockOptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cxaiStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombinationDetails" xlink:title="00000073 - Disclosure - Business Combination (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaapDevelopedTechnologyRightsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapDevelopedTechnologyRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaapTrademarksAndTradeNamesMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksAndTradeNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PurchasePrice" xlink:label="loc_cxaiPurchasePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_cxaiPurchasePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables" xlink:label="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset" xlink:label="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities" xlink:label="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent" xlink:label="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent" xlink:label="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="loc_cxaiBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombinationDetails1" xlink:title="00000074 - Disclosure - Business Combination (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/BusinessCombinationDetailsNarrative" xlink:title="00000075 - Disclosure - Business Combination (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_MergerAgreementMember" xlink:label="loc_cxaiMergerAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_cxaiMergerAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AggregatePurchasePriceAssetsAndLiabilities" xlink:label="loc_cxaiAggregatePurchasePriceAssetsAndLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_cxaiAggregatePurchasePriceAssetsAndLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ConsiderationTransferredInConnection" xlink:label="loc_cxaiConsiderationTransferredInConnection" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_cxaiConsiderationTransferredInConnection" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="loc_us-gaapBusinessCombinationAcquisitionRelatedCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DisaggregationOfRevenueDetails" xlink:title="00000076 - Disclosure - Disaggregation of Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureDisaggregationOfRevenueAbstract" xlink:label="loc_cxaiDisclosureDisaggregationOfRevenueAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureDisaggregationOfRevenueAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsAxis" xlink:label="loc_us-gaapSubsegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsegmentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsDomain" xlink:label="loc_us-gaapSubsegmentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsegmentsAxis" xlink:to="loc_us-gaapSubsegmentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SubscriptionRevenueMember" xlink:label="loc_cxaiSubscriptionRevenueMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsegmentsDomain" xlink:to="loc_cxaiSubscriptionRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NonSubscriptionRevenueMember" xlink:label="loc_cxaiNonSubscriptionRevenueMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsegmentsDomain" xlink:to="loc_cxaiNonSubscriptionRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SoftwareMember" xlink:label="loc_cxaiSoftwareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_cxaiSoftwareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProfessionalServicesMember" xlink:label="loc_cxaiProfessionalServicesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_cxaiProfessionalServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember" xlink:label="loc_us-gaapTransferredOverTimeMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:to="loc_us-gaapTransferredOverTimeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PropertyAndEquipmentNetDetails" xlink:title="00000077 - Disclosure - Property and Equipment, net (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SoftwareMember" xlink:label="loc_cxaiSoftwareMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_cxaiSoftwareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative" xlink:title="00000078 - Disclosure - Property and Equipment, net (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails" xlink:title="00000079 - Disclosure - Software Development Costs, net (Details)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureSoftwareDevelopmentCostsNetAbstract" xlink:label="loc_cxaiDisclosureSoftwareDevelopmentCostsNetAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureSoftwareDevelopmentCostsNetAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaapCapitalizedComputerSoftwareGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalizedComputerSoftwareGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:label="loc_us-gaapCapitalizedComputerSoftwareAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalizedComputerSoftwareAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaapCapitalizedComputerSoftwareNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalizedComputerSoftwareNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative" xlink:title="00000080 - Disclosure - Software Development Costs, net (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureSoftwareDevelopmentCostsNetAbstract" xlink:label="loc_cxaiDisclosureSoftwareDevelopmentCostsNetAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureSoftwareDevelopmentCostsNetAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentForAmortization" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails" xlink:title="00000081 - Disclosure - Goodwill and Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AcquisitionOfLegacyCxapp" xlink:label="loc_cxaiAcquisitionOfLegacyCxapp" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiAcquisitionOfLegacyCxapp" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1" xlink:title="00000082 - Disclosure - Goodwill and Intangible Assets (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaapTrademarksAndTradeNamesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksAndTradeNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaapDevelopedTechnologyRightsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapDevelopedTechnologyRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PatentsAndIntellectualPropertyMember" xlink:label="loc_cxaiPatentsAndIntellectualPropertyMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_cxaiPatentsAndIntellectualPropertyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_srtStatementScenarioAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapOtherFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapOtherFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2" xlink:title="00000083 - Disclosure - Goodwill and Intangible Assets (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative" xlink:title="00000084 - Disclosure - Goodwill and Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/DeferredRevenueDetails" xlink:title="00000085 - Disclosure - Deferred Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureDeferredRevenueAbstract" xlink:label="loc_cxaiDisclosureDeferredRevenueAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureDeferredRevenueAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember" xlink:label="loc_us-gaapLicensingAgreementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapLicensingAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ProfessionalServiceAgreementsMember" xlink:label="loc_cxaiProfessionalServiceAgreementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_cxaiProfessionalServiceAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredRevenue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/AccruedLiabilitiesDetails" xlink:title="00000086 - Disclosure - Accrued Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_InsurancePremiumsAndAccruedInterest" xlink:label="loc_cxaiInsurancePremiumsAndAccruedInterest" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiInsurancePremiumsAndAccruedInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RelatedPartyPromissoryNote" xlink:label="loc_cxaiRelatedPartyPromissoryNote" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiRelatedPartyPromissoryNote" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxes" xlink:label="loc_us-gaapAccruedIncomeTaxes" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RelatedPartyPayable" xlink:label="loc_cxaiRelatedPartyPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiRelatedPartyPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AccruedCompensationAndBenefits" xlink:label="loc_cxaiAccruedCompensationAndBenefits" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiAccruedCompensationAndBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaapAccruedBonusesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedBonusesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedRentCurrent" xlink:label="loc_us-gaapAccruedRentCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedRentCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AccruedOther" xlink:label="loc_cxaiAccruedOther" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiAccruedOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="loc_us-gaapAccrualForTaxesOtherThanIncomeTaxesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative" xlink:title="00000087 - Disclosure - Accrued Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DirectorAndOfficersMember" xlink:label="loc_cxaiDirectorAndOfficersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_cxaiDirectorAndOfficersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaapOtherBorrowings" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RelatedPartyDescription" xlink:label="loc_cxaiRelatedPartyDescription" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiRelatedPartyDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative" xlink:title="00000088 - Disclosure - Warrant Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureWarrantLiabilitiesAbstract" xlink:label="loc_cxaiDisclosureWarrantLiabilitiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureWarrantLiabilitiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PublicWarrantsMember" xlink:label="loc_cxaiPublicWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="loc_cxaiPrivatePlacementWarrantsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:label="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:label="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_cxaiRedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease" xlink:label="loc_us-gaapWarrantExercisePriceIncrease" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantExercisePriceIncrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantExercisePeriodConditionOne" xlink:label="loc_cxaiWarrantExercisePeriodConditionOne" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiWarrantExercisePeriodConditionOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantExercisePeriodConditionTwo" xlink:label="loc_cxaiWarrantExercisePeriodConditionTwo" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiWarrantExercisePeriodConditionTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantRedemptionConditionMinimumSharePrice" xlink:label="loc_cxaiWarrantRedemptionConditionMinimumSharePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiWarrantRedemptionConditionMinimumSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="loc_cxaiClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RedemptionPeriod" xlink:label="loc_cxaiRedemptionPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiRedemptionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:label="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:label="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders" xlink:label="loc_cxaiThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo" xlink:label="loc_cxaiWarrantRedemptionConditionMinimumSharePriceScenarioTwo" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiWarrantRedemptionConditionMinimumSharePriceScenarioTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:label="loc_cxaiRestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiRestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails" xlink:title="00000089 - Disclosure - Stock Award Plans and Stock-Based Compensation (Details)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract" xlink:label="loc_cxaiDisclosureStockOptionPlanAndStockbasedCompensationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureStockOptionPlanAndStockbasedCompensationAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative" xlink:title="00000090 - Disclosure - Stock Option Plan and Stock-Based Compensation (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract" xlink:label="loc_cxaiDisclosureStockOptionPlanAndStockbasedCompensationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureStockOptionPlanAndStockbasedCompensationAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_N2023EquityIncentivePlanMember" xlink:label="loc_cxaiN2023EquityIncentivePlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_cxaiN2023EquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtStatementScenarioAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EmployeeStockOptionsMember" xlink:label="loc_cxaiEmployeeStockOptionsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_cxaiEmployeeStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtCounterpartyNameAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EmployeesAndDirectorsMember" xlink:label="loc_cxaiEmployeesAndDirectorsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_cxaiEmployeesAndDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueOfOptions" xlink:label="loc_cxaiFairValueOfOptions" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_cxaiFairValueOfOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_AmortizationOfEmployeeStockOptions" xlink:label="loc_cxaiAmortizationOfEmployeeStockOptions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_cxaiAmortizationOfEmployeeStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_FairValueOfNonvestedOptions" xlink:label="loc_cxaiFairValueOfNonvestedOptions" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_cxaiFairValueOfNonvestedOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_WeightedAverageRemainingTermOfNonvestedOptions" xlink:label="loc_cxaiWeightedAverageRemainingTermOfNonvestedOptions" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_cxaiWeightedAverageRemainingTermOfNonvestedOptions" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative" xlink:title="00000091 - Disclosure - Fair Value of Financial Instruments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PublicPlacementWarrantsMember" xlink:label="loc_cxaiPublicPlacementWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPublicPlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PrivatePlacementWarrantsMember" xlink:label="loc_cxaiPrivatePlacementWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_cxaiPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000092 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_IncomeTaxBenefitprovision" xlink:label="loc_cxaiIncomeTaxBenefitprovision" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiIncomeTaxBenefitprovision" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/ForeignOperationsDetails" xlink:title="00000093 - Disclosure - Foreign Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_DisclosureForeignOperationsAbstract" xlink:label="loc_cxaiDisclosureForeignOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cxaiDisclosureForeignOperationsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA" xlink:label="loc_countryCA" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IN" xlink:label="loc_countryIN" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryIN" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_PH" xlink:label="loc_countryPH" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryPH" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_EliminationsMember" xlink:label="loc_cxaiEliminationsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_cxaiEliminationsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_NetAssets" xlink:label="loc_cxaiNetAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiNetAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaapNoncurrentAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNoncurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://kins-tech.com/role/LeasesDetailsNarrative" xlink:title="00000094 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_SuccessorMember" xlink:label="loc_cxaiSuccessorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiSuccessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_PredecessorMember" xlink:label="loc_cxaiPredecessorMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_cxaiPredecessorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cxai-20230331.xsd#cxai_LeasePeriodicPayments" xlink:label="loc_cxaiLeasePeriodicPayments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_cxaiLeasePeriodicPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334061984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">AMENDMENT
NO. 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CXApp Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001820875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-2104918<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Four Palo Alto Square<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">3000 El Camino Real<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palo Alto<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">City Area Code</a></td>
<td class="text">575-4456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Four Palo Alto Square<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">3000
El Camino Real<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palo Alto<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">City Area Code</a></td>
<td class="text">575-4456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Khurram
P. Sheikh<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655336137120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 224,489<span></span>
</td>
<td class="nump">$ 406,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">3,536<span></span>
</td>
<td class="nump">126,667<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">228,025<span></span>
</td>
<td class="nump">532,793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Cash and investments held in trust account</a></td>
<td class="nump">3,923,804<span></span>
</td>
<td class="nump">278,836,080<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">4,151,829<span></span>
</td>
<td class="nump">279,368,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_AccruedLiabilitiesExcludingOfferingCostsCurrent', window );">Accrued expenses</a></td>
<td class="nump">2,833,412<span></span>
</td>
<td class="nump">767,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">49,175<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_PromissoryNoteRelatedParty', window );">Promissory note &#8211; related party</a></td>
<td class="nump">347,961<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,230,548<span></span>
</td>
<td class="nump">767,253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative liabilities</a></td>
<td class="nump">722,400<span></span>
</td>
<td class="nump">11,275,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DeferredOfferingCostsNoncurrent', window );">Deferred underwriting fee payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,660,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">3,952,948<span></span>
</td>
<td class="nump">21,702,622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption, 387,551 and 27,600,000 shares at $10.10 per share redemption value as of December&#160;31, 2022 and 2021, respectively</a></td>
<td class="nump">3,914,265<span></span>
</td>
<td class="nump">278,760,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 2,000,000 shares authorized; none issued or outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,900,000 shares issued and outstanding at December&#160;31, 2022 and 2021</a></td>
<td class="nump">690<span></span>
</td>
<td class="nump">690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(3,716,074)<span></span>
</td>
<td class="num">(21,094,439)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Deficit</a></td>
<td class="num">(3,715,384)<span></span>
</td>
<td class="num">(21,093,749)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS&#8217; DEFICIT</a></td>
<td class="nump">$ 4,151,829<span></span>
</td>
<td class="nump">$ 279,368,873<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_AccruedLiabilitiesExcludingOfferingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_AccruedLiabilitiesExcludingOfferingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DeferredOfferingCostsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DeferredOfferingCostsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_PromissoryNoteRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_PromissoryNoteRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655330978784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cxai_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Class A common stock subject to possible redemption</a></td>
<td class="nump">387,551<span></span>
</td>
<td class="nump">27,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit (in dollars per share)</a></td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="nump">$ 10.10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cxai_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cxai_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334888384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Operating and formation costs</a></td>
<td class="nump">$ 2,950,464<span></span>
</td>
<td class="nump">$ 1,497,914<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(2,950,464)<span></span>
</td>
<td class="num">(1,497,914)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest earned on cash and investments held in Trust Account</a></td>
<td class="nump">421,504<span></span>
</td>
<td class="nump">68,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income - bank</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of derivative liability</a></td>
<td class="nump">10,552,969<span></span>
</td>
<td class="nump">10,637,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_GainLossOnEliminationOfDeferredUnderwritingFee', window );">Gain on forgiveness of deferred underwriting fee</a></td>
<td class="nump">371,910<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">11,346,459<span></span>
</td>
<td class="nump">10,705,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">8,395,995<span></span>
</td>
<td class="nump">9,207,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(49,175)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 8,346,820<span></span>
</td>
<td class="nump">$ 9,207,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock', window );">Basic and diluted weighted average shares outstanding, Class A common stock</a></td>
<td class="nump">12,546,423<span></span>
</td>
<td class="nump">27,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedNetIncomePerShareClassCommonStock', window );">Basic and diluted net income per share, Class A common stock</a></td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock', window );">Basic and diluted weighted average shares outstanding, Class B common stock</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedNetIncomePerShareClassBCommonStock', window );">Basic and diluted net income per share, Class B common stock</a></td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BasicAndDilutedNetIncomePerShareClassBCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BasicAndDilutedNetIncomePerShareClassBCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BasicAndDilutedNetIncomePerShareClassCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BasicAndDilutedNetIncomePerShareClassCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_GainLossOnEliminationOfDeferredUnderwritingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_GainLossOnEliminationOfDeferredUnderwritingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334075888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)<br></strong></div></th>
<th class="th"><div>Class A Common Stock [Member]</div></th>
<th class="th"><div>Class B Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance &#8212; December&#160;31, 2021 at Dec. 31, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 690<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (30,302,323)<span></span>
</td>
<td class="num">$ (30,301,633)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,207,884<span></span>
</td>
<td class="nump">9,207,884<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance &#8212; December&#160;31, 2022 (As&#160;Restated) at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 690<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(21,094,439)<span></span>
</td>
<td class="num">(21,093,749)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance &#8212; December&#160;31, 2021 at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 690<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(21,094,439)<span></span>
</td>
<td class="num">(21,093,749)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,346,820<span></span>
</td>
<td class="nump">8,346,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Change in value of common stock subject to redemption</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,031,545<span></span>
</td>
<td class="nump">9,031,545<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance &#8212; December&#160;31, 2022 (As&#160;Restated) at Dec. 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 690<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (3,716,074)<span></span>
</td>
<td class="num">$ (3,715,384)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655333644736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 8,346,820<span></span>
</td>
<td class="nump">$ 9,207,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest earned on cash and investments held in Trust Account</a></td>
<td class="num">(421,504)<span></span>
</td>
<td class="num">(68,295)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of derivative liability</a></td>
<td class="num">(10,552,969)<span></span>
</td>
<td class="num">(10,637,431)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_IncreaseDecreaseInDeferredUnderwritingFee', window );">Gain on forgiveness of deferred underwriting fee</a></td>
<td class="num">(371,910)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="nump">123,131<span></span>
</td>
<td class="nump">329,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="nump">49,175<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">2,066,159<span></span>
</td>
<td class="nump">572,554<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(761,098)<span></span>
</td>
<td class="num">(595,321)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax', window );">Cash withdrawn from trust account to pay franchise tax</a></td>
<td class="nump">231,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ProceedsFromTrustAccountInConnectionWithRedemption', window );">Cash withdrawn from trust account in connection with redemptions</a></td>
<td class="nump">275,102,280<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">275,333,780<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Redemptions of common stock</a></td>
<td class="num">(275,102,280)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Borrowings under promissory note</a></td>
<td class="nump">347,961<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(17,579)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(274,754,319)<span></span>
</td>
<td class="num">(17,579)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net Change in Cash</a></td>
<td class="num">(181,637)<span></span>
</td>
<td class="num">(612,900)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; Beginning of period</a></td>
<td class="nump">406,126<span></span>
</td>
<td class="nump">1,019,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; End of period</a></td>
<td class="nump">224,489<span></span>
</td>
<td class="nump">406,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ChangeInValueOfClassCommonStockSubjectToPossibleRedemption', window );">Change in value of Class A common stock subject to possible redemption</a></td>
<td class="nump">256,545<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock', window );">Forgiveness of deferred underwriting fee payable allocated to Class A common stock</a></td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DeferredUnderwritingFeePayable', window );">Deferred underwriting fee payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,660,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ChangeInValueOfClassCommonStockSubjectToPossibleRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ChangeInValueOfClassCommonStockSubjectToPossibleRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DeferredUnderwritingFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DeferredUnderwritingFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_IncreaseDecreaseInDeferredUnderwritingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_IncreaseDecreaseInDeferredUnderwritingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ProceedsFromTrustAccountInConnectionWithRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ProceedsFromTrustAccountInConnectionWithRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655330218688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 224,489<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,025<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,151,829<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,230,548<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,952,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,716,074)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,715,384)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS&#8217; DEFICIT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,151,829<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 6,724,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">2,671,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Notes and other receivables</a></td>
<td class="nump">102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,232,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">10,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">153,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">20,753,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset, net</a></td>
<td class="nump">549,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Software development costs, net</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">44,122,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">76,384,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">596,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">3,233,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">2,690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_AcquisitionLiability', window );">Acquisition liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyAccrualCurrent', window );">Warrant liability</a></td>
<td class="nump">963,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease obligation, current</a></td>
<td class="nump">195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">7,677,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease obligation, noncurrent</a></td>
<td class="nump">376,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">2,778,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">10,831,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">71,536,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(5,985,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetParentInvestment', window );">Net parent investment</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Deficit</a></td>
<td class="nump">65,553,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS&#8217; DEFICIT</a></td>
<td class="nump">76,384,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock value</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock value</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,308,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,338,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Notes and other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,569,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,289,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">681,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Software development costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">487,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,280,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,054,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,736,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,162,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_AcquisitionLiability', window );">Acquisition liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtendedProductWarrantyAccrualCurrent', window );">Warrant liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease obligation, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,415,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease obligation, noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">444,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,889,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,155,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetParentInvestment', window );">Net parent investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,236,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,391,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS&#8217; DEFICIT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,280,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_AcquisitionLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_AcquisitionLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_NetParentInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_NetParentInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtendedProductWarrantyAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount at end of the reporting period of the aggregate extended product warranty liability that is expected to be paid within one year of the balance sheet date or normal operating cycle, if longer. Does not include the balance for the standard product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtendedProductWarrantyAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334051088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">8,582,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">5,487,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655330142704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 14, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 342,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of Revenues</a></td>
<td class="nump">87,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">255,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">211,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">174,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">241,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">116,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ChangeInFairValueOfEarnout', window );">Change in fair value of earnout</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="nump">742,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(487,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Income (Expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income (expense), net</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">Change in fair value of derivative liability</a></td>
<td class="nump">1,686,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income</a></td>
<td class="nump">1,685,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net Income (Loss), before tax</a></td>
<td class="nump">1,198,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit/(provision)</a></td>
<td class="nump">1,560,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">2,758,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Unrealized foreign exchange loss from cumulative translation adjustments</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income (Loss)</a></td>
<td class="nump">$ 2,758,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock', window );">Basic and dilutive weighted average shares outstanding, Class A common stock</a></td>
<td class="nump">8,582,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutiveNetIncomePerShareClassCommonStock', window );">Basic and dilutive net income per share, Class A common stock</a></td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock', window );">Basic and dilutive weighted average shares outstanding, Class C common stock</a></td>
<td class="nump">5,487,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutiveNetIncomePerShareClassCCommonStock', window );">Basic and dilutive net income per share, Class C common stock</a></td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,620,000<span></span>
</td>
<td class="nump">$ 2,582,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483,000<span></span>
</td>
<td class="nump">589,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,137,000<span></span>
</td>
<td class="nump">1,993,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,455,000<span></span>
</td>
<td class="nump">1,991,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">964,000<span></span>
</td>
<td class="nump">1,122,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,293,000<span></span>
</td>
<td class="nump">2,304,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">806,000<span></span>
</td>
<td class="nump">975,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ChangeInFairValueOfEarnout', window );">Change in fair value of earnout</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,827,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,518,000<span></span>
</td>
<td class="nump">3,565,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,381,000)<span></span>
</td>
<td class="num">(1,572,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Income (Expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">Change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net Income (Loss), before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,380,000)<span></span>
</td>
<td class="num">(1,571,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit/(provision)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,380,000)<span></span>
</td>
<td class="num">(1,671,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Unrealized foreign exchange loss from cumulative translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,000)<span></span>
</td>
<td class="num">(189,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,408,000)<span></span>
</td>
<td class="num">$ (1,860,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BasicAndDilutiveNetIncomePerShareClassCCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BasicAndDilutiveNetIncomePerShareClassCCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BasicAndDilutiveNetIncomePerShareClassCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BasicAndDilutiveNetIncomePerShareClassCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ChangeInFairValueOfEarnout">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ChangeInFairValueOfEarnout</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.13(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655329264864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Net Parent Investment [Member] </div>
<div>Predecessor [Member]</div>
</th>
<th class="th">
<div>AOCI Attributable to Parent [Member] </div>
<div>Predecessor [Member]</div>
</th>
<th class="th">
<div>AOCI Attributable to Parent [Member] </div>
<div>Successor [Member]</div>
</th>
<th class="th">
<div>Total [Member] </div>
<div>Predecessor [Member]</div>
</th>
<th class="th">
<div>Total [Member] </div>
<div>Successor [Member]</div>
</th>
<th class="th">
<div>Class A Common Stock [Member] </div>
<div>Successor [Member]</div>
</th>
<th class="th">
<div>Class C Common Stock [Member] </div>
<div>Successor [Member]</div>
</th>
<th class="th">
<div>Additional Paid-in Capital [Member] </div>
<div>Successor [Member]</div>
</th>
<th class="th">
<div>Retained Earnings [Member] </div>
<div>Successor [Member]</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance &#8212; December&#160;31, 2022 (As&#160;Restated) at Dec. 31, 2021</a></td>
<td class="nump">$ 20,155<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="num">(1,671)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,671)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">647<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ParentsCommonSharesIssuedForCxappEarnout', window );">Parent&#8217;s common shares issued for CXApp earnout</a></td>
<td class="nump">3,697<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits', window );">Taxes paid related to net share settlement of restricted stock units</a></td>
<td class="num">(104)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetInvestmentsFromParent', window );">Net investments from parent</a></td>
<td class="nump">6,444<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_CumulativeTranslationAdjustment', window );">Cumulative translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(189)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(189)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance &#8212; December&#160;31, 2022 (As&#160;Restated) at Mar. 31, 2022</a></td>
<td class="nump">29,168<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance &#8212; December&#160;31, 2021 at Dec. 31, 2021</a></td>
<td class="nump">20,155<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance &#8212; December&#160;31, 2022 (As&#160;Restated) at Dec. 31, 2022</a></td>
<td class="nump">22,236<span></span>
</td>
<td class="nump">1,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="num">(4,380)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,380)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">158<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetInvestmentsFromParent', window );">Net investments from parent</a></td>
<td class="nump">8,680<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_CumulativeTranslationAdjustment', window );">Cumulative translation adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance &#8212; December&#160;31, 2022 (As&#160;Restated) at Mar. 14, 2023</a></td>
<td class="nump">$ 26,694<span></span>
</td>
<td class="nump">$ 1,127<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 27,821<span></span>
</td>
<td class="num">$ (7,135)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,607<span></span>
</td>
<td class="num">$ (8,743)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Mar. 14, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,034,999<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,758<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,758<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_SharesIssuedInConnectionWithBusinessCombination', window );">Shares issued in connection with Business Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,928<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">69,927<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_SharesIssuedInConnectionWithBusinessCombinationShares', window );">Shares issued in connection with Business Combination, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,547,700<span></span>
</td>
<td class="nump">5,487,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance &#8212; December&#160;31, 2022 (As&#160;Restated) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,553<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 71,536<span></span>
</td>
<td class="num">$ (5,985)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,582,699<span></span>
</td>
<td class="nump">5,487,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_CumulativeTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_CumulativeTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_NetInvestmentsFromParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_NetInvestmentsFromParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ParentsCommonSharesIssuedForCxappEarnout">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ParentsCommonSharesIssuedForCxappEarnout</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_SharesIssuedInConnectionWithBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_SharesIssuedInConnectionWithBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_SharesIssuedInConnectionWithBusinessCombinationShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_SharesIssuedInConnectionWithBusinessCombinationShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655328831264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 14, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,346,820<span></span>
</td>
<td class="nump">$ 9,207,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,066,159<span></span>
</td>
<td class="nump">572,554<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(761,098)<span></span>
</td>
<td class="num">(595,321)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,333,780<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(274,754,319)<span></span>
</td>
<td class="num">(17,579)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net Change in Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(181,637)<span></span>
</td>
<td class="num">(612,900)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; Beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 224,489<span></span>
</td>
<td class="nump">$ 406,126<span></span>
</td>
<td class="nump">406,126<span></span>
</td>
<td class="nump">1,019,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; End of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,489<span></span>
</td>
<td class="nump">406,126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 2,758,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss)&#160;to net cash used in operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">116,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right of use asset</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(1,560,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_GainOnEarnoutPaymentLiability', window );">Gain on earnout payment liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">(Gain) loss on foreign currency transactions</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_GainOnChangeInFairValueOfDerivativeLiability', window );">Gain on change in fair value of derivative liability</a></td>
<td class="num">(1,686,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Accounts receivable and other receivables</a></td>
<td class="num">(335,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(37,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">135,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(3,888,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxes', window );">Income tax liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(7,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">156,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(4,431,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(23,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_InvestmentInCapitalizedSoftware', window );">Investment in capitalized software</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired in connection with Business Combination</a></td>
<td class="nump">10,003,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">9,980,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetEquityInvestmentFromParent', window );">Net equity investment from parent</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_TaxesPaidRelatedForStockBasedCompensation', window );">Taxes paid related to stock based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RepaymentOfCxappAcquisitionLiability', window );">Repayment of CXApp acquisition liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of related party promissory note</a></td>
<td class="num">(328,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(328,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net Change in Cash</a></td>
<td class="nump">5,221,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; Beginning of period</a></td>
<td class="nump">1,503,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; End of period</a></td>
<td class="nump">6,724,000<span></span>
</td>
<td class="nump">1,503,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid for interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract', window );"><strong>Supplemental schedule of noncash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ParentsNetEquityIssuedForCxAppEarnout', window );">Parent&#8217;s net equity issued for CX App earnout</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NoncashDistribution', window );">Noncash distribution</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination', window );">Class A Common Stock and Class C Common Stock issued in connection with Business Combination</a></td>
<td class="nump">69,928,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_FinancingOfDirectorAndOfficerInsurance', window );">Financing of Director and Officer Insurance (see Note 9)</a></td>
<td class="nump">537,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,380,000)<span></span>
</td>
<td class="num">(1,671,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss)&#160;to net cash used in operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,000<span></span>
</td>
<td class="nump">145,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">806,000<span></span>
</td>
<td class="nump">975,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right of use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">56,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,000<span></span>
</td>
<td class="nump">647,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_GainOnEarnoutPaymentLiability', window );">Gain on earnout payment liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,827,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">(Gain) loss on foreign currency transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,000)<span></span>
</td>
<td class="num">(266,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_GainOnChangeInFairValueOfDerivativeLiability', window );">Gain on change in fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Accounts receivable and other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(857,000)<span></span>
</td>
<td class="num">(304,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
<td class="num">(521,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(796,000)<span></span>
</td>
<td class="num">(94,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(787,000)<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxes', window );">Income tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38,000)<span></span>
</td>
<td class="num">(56,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">534,000<span></span>
</td>
<td class="num">(370,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,144,000)<span></span>
</td>
<td class="num">(4,140,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,000)<span></span>
</td>
<td class="num">(12,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_InvestmentInCapitalizedSoftware', window );">Investment in capitalized software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,000)<span></span>
</td>
<td class="num">(39,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired in connection with Business Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,000)<span></span>
</td>
<td class="num">(51,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetEquityInvestmentFromParent', window );">Net equity investment from parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,089,000<span></span>
</td>
<td class="nump">6,444,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_TaxesPaidRelatedForStockBasedCompensation', window );">Taxes paid related to stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(104,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RepaymentOfCxappAcquisitionLiability', window );">Repayment of CXApp acquisition liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(197,000)<span></span>
</td>
<td class="num">(1,787,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of related party promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,892,000<span></span>
</td>
<td class="nump">4,553,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net Change in Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,695,000<span></span>
</td>
<td class="nump">366,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; Beginning of period</a></td>
<td class="nump">$ 10,003,000<span></span>
</td>
<td class="nump">6,308,000<span></span>
</td>
<td class="nump">5,028,000<span></span>
</td>
<td class="nump">5,028,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; End of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,003,000<span></span>
</td>
<td class="nump">5,394,000<span></span>
</td>
<td class="nump">$ 6,308,000<span></span>
</td>
<td class="nump">$ 5,028,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid for interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract', window );"><strong>Supplemental schedule of noncash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ParentsNetEquityIssuedForCxAppEarnout', window );">Parent&#8217;s net equity issued for CX App earnout</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,697,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NoncashDistribution', window );">Noncash distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination', window );">Class A Common Stock and Class C Common Stock issued in connection with Business Combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_FinancingOfDirectorAndOfficerInsurance', window );">Financing of Director and Officer Insurance (see Note 9)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_FinancingOfDirectorAndOfficerInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_FinancingOfDirectorAndOfficerInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_GainOnChangeInFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_GainOnChangeInFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_GainOnEarnoutPaymentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_GainOnEarnoutPaymentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_InvestmentInCapitalizedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_InvestmentInCapitalizedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_NetEquityInvestmentFromParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_NetEquityInvestmentFromParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_NoncashDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_NoncashDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ParentsNetEquityIssuedForCxAppEarnout">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ParentsNetEquityIssuedForCxAppEarnout</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_RepaymentOfCxappAcquisitionLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_RepaymentOfCxappAcquisitionLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_TaxesPaidRelatedForStockBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_TaxesPaidRelatedForStockBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes, and in deferred and other tax liabilities and assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334058896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</a></td>
<td class="text"><p id="xdx_807_eus-gaap--NatureOfOperations_zfzgoDaJmYSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 &#8212; <span id="xdx_829_z5g7nCVFCdmf">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CXApp
Inc. (the &#8220;Company&#8221;) was incorporated in Delaware on July&#160;20, 2020 as KINS Technology Group Inc. (&#8220;KINS&#8221;).
The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses (the &#8220;Business Combination&#8221;). The Company is not limited to a
particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth
company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has one wholly-owned subsidiary, KINS Merger Sub Inc., which was incorporated in the State of Delaware on September&#160;16,
2022 (&#8220;Merger Sub&#8221;). Merger Sub has no activity from date of incorporation, September&#160;16, 2022 through December&#160;31,
2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2022, the Company had not commenced any operations. All activity for the period from July&#160;20, 2020 (inception)
through December&#160;31, 2022 relates to the Company&#8217;s formation, the initial public offering (&#8220;Initial Public Offering&#8221;),
which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The
Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The
Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company&#8217;s Initial Public Offering became effective on December&#160;14, 2020. On December&#160;17,
2020, the Company consummated the Initial Public Offering of <span id="xdx_90D_ecustom--UnitsIssuedDuringPeriodSharesNewIssues_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Number of units issued">27,600,000</span> units (the &#8220;Units&#8221; and, with respect to the Class
A common stock included in the Units sold, the &#8220;Public Shares&#8221;), which includes the full exercise by the underwriter of its
over-allotment option in the amount of <span id="xdx_90C_ecustom--UnitsIssuedDuringPeriodSharesNewIssues_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zjoxgeRjih8l" title="Number of units issued">3,600,000</span> Units, at $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_c20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Purchase price, per unit (in dollars per share)">10.00</span> per Unit, generating gross proceeds of $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvPC2rPMwMn5" title="Proceeds from issuance initial public offering">276,000,000</span> which is described
in Note 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of <span id="xdx_905_ecustom--NumberOfWarrantsIssued_c20201201__20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Number of warrants issued">10,280,000</span> warrants (the &#8220;Private
Placement Warrants&#8221;) at a price of $<span id="xdx_90F_ecustom--ClassOfWarrantOrRightPriceOfWarrantsOrRights_c20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Price of warrant">1.00</span> per Private Placement Warrant in a private placement to KINS Capital LLC (the
&#8220;Sponsor&#8221;) and certain funds and accounts managed by BlackRock, Inc. (the &#8220;Direct Anchor Investors&#8221; and
which the Direct Anchor Investors, together with the Sponsor, are the &#8220;initial stockholders&#8221;), generating gross proceeds
of $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfWarrants_c20201201__20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pp0p0" title="Proceeds from issuance of warrants">10,280,000</span>, which is described in Note 4.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
costs incurred amounted to $<span id="xdx_901_ecustom--TransactionCosts_c20201217_pp0p0" title="Transaction costs">15,688,848</span>, consisting of $<span id="xdx_905_ecustom--SaleOfStockUnderwritingFees_c20201217_pp0p0" title="Underwriting fees">5,520,000</span> in cash underwriting fees, $<span id="xdx_90B_ecustom--DeferredOfferingCostsNoncurrent_c20201217_pp0p0" title="Deferred underwriting fee payable">9,660,000</span> of deferred underwriting fees
and $<span id="xdx_90A_ecustom--SaleOfStockOtherOfferingCosts_c20201217_pp0p0" title="Other offering costs">508,848</span> of other offering costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering on December&#160;17, 2020, an amount of $<span id="xdx_904_ecustom--PaymentsForInvestmentOfCashInTrustAccount_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Investment of cash into trust account">278,760,000</span> ($<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_c20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Purchase price, per unit (in dollars per share)">10.10</span> per Unit) from the net proceeds
of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account
(the &#8220;Trust Account&#8221;), located in the United States and invested only in U.S. government securities, within the meaning set
forth in Section&#160;2(a)(16) of the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity
of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting
certain conditions of Rule&#160;2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion
of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.
The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market
value equal to at least <span id="xdx_90B_ecustom--ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount_dp_c20220101__20221231_zQqs3Kvee19k" title="Threshold minimum aggregate fair market value as a percentage of the assets held in the trust account">80%</span> of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable
on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-transaction company owns
or acquires <span id="xdx_905_ecustom--ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination_dp_c20220101__20221231_zmvaTbYbGSrk" title="Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination">50%</span> or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target
business sufficient for it not to be required to register as an investment company under the Investment Company Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide the holders of the outstanding Public Shares (the &#8220;Public Stockholders&#8221;) with the opportunity to redeem
all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting
called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder
approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to
redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.10 per Public Share, plus any
pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights upon the completion of a Business
Combination with respect to the Company&#8217;s warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will only proceed with a Business Combination if the Company has net tangible assets of at least $<span id="xdx_90C_ecustom--MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_c20221209__us-gaap--StatementClassOfStockAxis__custom--CommonClassaSubjectToRedemptionMember_pp0p0" title="Minimum net tangible assets upon consummation of the business combination">5,000,001</span> following any related
redemptions and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination.).
On December&#160;9, 2022 the Special Meeting the Stockholders voted to allow the Company to redeem shares of Class A Common Stock in
connection with the amendment to the Charter to the extent that such redemption would result in the Company having net tangible assets
of less than $<span id="xdx_90F_ecustom--MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_c20221231_pp0p0" title="Minimum net tangible assets upon consummation of the business combination">5,000,001</span>. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company
does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate
of Incorporation (the &#8220;Certificate of Incorporation&#8221;), conduct the redemptions pursuant to the tender offer rules of the
U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and file tender offer documents with the SEC prior to completing a Business
Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements,
or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction
with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval
in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares
purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder
may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed
transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the
tender offer rules, the Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder
or any other person with whom such stockholder is acting in concert or as a &#8220;group&#8221; (as defined under Section&#160;13 of
the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares with
respect to more than an aggregate of <span id="xdx_90E_ecustom--ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent_c20220101__20221231_pdd" title="Threshold percentage of public shares subject to redemption without the company's prior written consent">20%</span> of the Public Shares, without the prior consent of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares and Public Shares held by it in connection with
the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance
or timing of the Company&#8217;s obligation to allow redemptions in connection with a Business Combination or to redeem <span id="xdx_906_ecustom--PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_c20220101__20221231_pdd" title="Obligation to redeem public shares if entity does not complete a business combination (as a percent)">100%</span> of its Public
Shares if the Company does not complete a Business Combination within the Extended Combination Period (as defined below) or (ii) with
respect to any other provision relating to stockholders&#8217; rights or pre-Business Combination activity, unless the Company provides
the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company previously had until June&#160;17, 2022 to consummate a business combination. On June&#160;10, 2022, the Company held a special
meeting of stockholders pursuant to which its stockholders approved amending the Company&#8217;s amended and restated certificate of
incorporation (the &#8220;Initial Charter Amendment&#8221;) to extend the date by which the Company has to consummate a business combination
from June&#160;17, 2022 to December&#160;16, 2022. The Company&#8217;s stockholders approved the Initial Charter Amendment and as such
the Company had until December&#160;16, 2022 to consummate a business combination. On December&#160;9, 2022, the Company held a special
meeting of the stockholders in which the stockholders approved the proposal to amend the Company&#8217;s amended and restated certificate
of incorporation (the &#8220;Charter Amendment&#8221;) to (A) extend the date by which the Company must (1) consummate a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, (2) cease its operations except for
the purpose of winding up if it fails to complete such initial business combination, and (3) redeem all of the shares of Class A common
stock, par value $<span id="xdx_902_eus-gaap--TemporaryEquityParOrStatedValuePerShare_c20221209__us-gaap--StatementClassOfStockAxis__custom--CommonClassaSubjectToRedemptionMember_pdd" title="Common stock, par value">0.0001</span> per share, of the Company (&#8220;Class A Common Stock&#8221;), included as part of the units sold in the IPO,
from December&#160;16, 2022 to June&#160;15, 2023 (the &#8220;Extended Combination Period&#8221;), and (B) allow the Company to redeem
shares of Class A Common Stock in connection with the amendment to the Charter to the extent that such redemption would result in the
Company having net tangible assets of less than $<span id="xdx_90F_ecustom--MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_iI_pp0p0_c20221209__us-gaap--StatementClassOfStockAxis__custom--CommonClassaSubjectToRedemptionMember_zgc4w14lmzu6" title="Minimum net tangible assets upon consummation of the business combination">5,000,001</span>. On December&#160;14, 2022, the Company filed the Charter Amendment with the
Secretary of State of the State of Delaware.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we have not completed a Business Combination by June&#160;15, 2023 or during any extended time that we have to consummate a Business
Combination beyond June&#160;15, 2023 as a result of a stockholder vote to amend its certificate of incorporation, the Company will (i)
cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days
thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust
Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes (less up to $<span id="xdx_904_ecustom--MaximumNetInterestsToPayDissolutionExpenses_c20220101__20221231_pp0p0" title="Maximum net interest to pay dissolution expenses">100,000</span>
of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish
Public Stockholders&#8217; rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and
the Company&#8217;s board of directors, dissolve and liquidate, subject in each case to the Company&#8217;s obligations under Delaware
law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating
distributions with respect to the Company&#8217;s warrants, which will expire worthless if the Company fails to complete a Business Combination
within the Extended Combination Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination
within the Extended Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such
Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination
within the Extended Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission
(see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Extended Combination
Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund
the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining
available for distribution will be less than $10.10 per Unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims
by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed
entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.10 per Public Share
and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less
than $10.10 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will
not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in
the Trust Account nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the Initial Public Offering
against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Moreover,
in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the
extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify
the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company&#8217;s independent
registered accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements
with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
and Going Concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2022, the Company had $<span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20221231_pp0p0" title="Cash operating bank account">224,489</span> in its operating bank accounts and a working capital deficit of $<span id="xdx_90E_ecustom--WorkingCapital_iI_pp0p0_c20221231_zqsNaqYkHFT" title="Working capital">3,002,523</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the completion of the Initial Public Offering, the Company&#8217;s liquidity needs had been satisfied through a contribution of $<span id="xdx_903_ecustom--ProceedsFromRelatedParty_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--SponsorMember_pp0p0" title="Proceeds from related party">25,000</span>
from Sponsor to cover for certain offering costs in exchange for the issuance of the Founder Shares, unsecured, non-interest bearing
promissory note of up to $<span id="xdx_90B_eus-gaap--ProceedsFromRelatedPartyDebt_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--SponsorMember_pp0p0" title="Proceeds from related Party debt">300,000</span> from the Sponsor, and the proceeds from the consummation of the Private Placement not held in the Trust
Account. The Note was repaid subsequent to the Initial Public Offering. In addition, in order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may,
but are not obligated to, provide the Company Working Capital Loans. As of December&#160;31, 2022 and 2021, there were no amounts outstanding
under any Working Capital Loan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Company&#8217;s assessment of going concern considerations in accordance with Financial Accounting Standard Board&#8217;s
Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue
as a Going Concern,&#8221; the Company has until June&#160;15, 2023 to consummate a Business Combination. It is uncertain that the Company
will be able to consummate a Business Combination by this time. Additionally, the Company may not have sufficient liquidity to fund the
working capital needs of the Company through one year from the issuance of these consolidated financial statements. If a business combination
is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined
that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution,
raises substantial doubt about the Company&#8217;s ability to continue as a going concern. No adjustments have been made to the carrying
amounts of assets or liabilities should the Company be required to liquidate after June&#160;15, 2023. The Company intends to complete
a Business Combination before the mandatory liquidation date. However, there can be no assurance that the Company will be able to consummate
any Business Combination by June&#160;15, 2023. In addition, the Company may need to raise additional capital through loans or additional
investments from our Sponsor, stockholders, officers, directors or third parties. The Company&#8217;s officers, directors and Sponsor
may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their
sole discretion, to meet the Company&#8217;s working capital needs. Accordingly, the Company may not be able to obtain additional financing.
If the Company is unable to raise additional capital, the Company may be required to take additional measures to conserve liquidity,
which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and
reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable
terms, if at all. These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern through the
liquidation date of June&#160;15, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655418244544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionTextBlock', window );">RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--ErrorCorrectionTextBlock_zdLn6BglcwX9" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8212; <span id="xdx_827_z3UI9tzDYQl8">RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had recognized a liability upon closing of their initial public offering in December&#160;2020 for a portion of the underwriter&#8217;s
commissions which was contingently payable upon closing of a future business combination, with the offsetting entry resulting in an initial
discount to the securities sold in the initial public offering. The underwriter waived all claims to this deferred commission in June&#160;2022.
The Company previously recognized the waiver as an extinguishment, with a resulting non-operating gain recognized in its statement of
operations for the three and six months ended June&#160;30, 2022, nine months ended September&#160;30, 2022 and the year ended December&#160;31,
2022. Upon subsequent review and analysis, management concluded that the Company should have recognized the extinguishment of the contingent
liability as a reversal in the same relative allocation applied at the initial public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Therefore,
the Company&#8217;s management and the Audit Committee of the Company&#8217;s Board of Directors (the &#8220;Audit Committee&#8221;)
concluded that the Company&#8217;s previously issued audited financial statements as of December&#160;31, 2022 (the &#8220;Annual Report&#8221;)
should no longer be relied upon and that it is appropriate to restate the Annual Report. As such, the Company will restate its financial
statements in this Form&#160;10-K/A for the Company&#8217;s unaudited financial statements for three and six months ended June&#160;30,
2022, nine months ended September&#160;30, 2022, and the audited financial statements for the year ended December&#160;31, 2022 included
in the Annual Report on the Company&#8217;s Form&#160;10-K, as filed with the Securities and Exchange Commission (&#8220;SEC&#8221;)
on March&#160;21, 2023 (the &#8220;Original Filing&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Impact
of the Restatement</i></b></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
impact of the restatement on the consolidated statements of operations, statements of changes in stockholders&#8217; deficit and statements
of cash flows for the affected period is presented below. The restatement had no impact on net cash flows from operating, investing or
financing activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zPUk2TzfC243" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details)">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8BB_z8jMc3GW9b7j" style="display: none">Summary of impact of the restatement on the financial statements</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9V0T03SUPec" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zkVfltV9ogW" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20220401__20220630_zTYXNm1aHcS8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Operations for the Three Months Ended June&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_i_pp0p0" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,660,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(9,288,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">371,910</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NonoperatingIncomeExpense_i_pp0p0" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,396,046</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,107,956</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_i_pp0p0" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income (loss) before benefit from (provision for) income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,094,313</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">806,223</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProfitLoss_zqq6hziseck" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,071,447</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">783,357</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">14,481,736</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0420">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">14,481,736</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.47</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.43</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.04</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0432">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.47</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.43</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.04</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_za5gosvHb0Gi" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_ztJwaPCyUFB2" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20220630_z7pKEvHi2Dsf" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Operations for the Six Months Ended June&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zjg7tH5s8vYc" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,660,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(9,288,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">371,910</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NonoperatingIncomeExpense_z5MqFlxcGnXi" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,587,467</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,299,377</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zEwvkVARqcBg" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income (loss) before benefit from (provision for) income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,962,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,674,392</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProfitLoss_zYrrHGiVdv5e" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,939,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,651,526</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">21,004,630</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0460">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">21,004,630</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.33</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.31</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0472">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zepXfL3fMr8" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.33</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z0536FcpJPEc" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.31</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zpzBqoK6zM0b" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101_20220930_srt--RestatementAxis_srt--RestatementAdjustmentMember" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_497_20220101_20220930" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Operations for the Nine Months Ended September&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zr0FJn9KywL2" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,660,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(9,288,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">371,910</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NonoperatingIncomeExpense_zc7SaILXmNg6" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,560,364</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,272,274</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z4r4QphEEjTf" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income (loss) before benefit from (provision for) income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,838,653</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,550,563</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProfitLoss_zWwll0rilMue" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,811,924</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,523,834</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding &#8211; Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">16,466,455</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">16,466,455</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share &#8211; Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.81</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.40</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.41</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.81</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.40</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.41</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zK0dZpB3AYih" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zeGWGNAZFCaj" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20221231_zRK7NAYt6hub" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Statement of Operations for the Year Ended December&#160;31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zlDAoOFQjrS6" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,660,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(9,288,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">371,910</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NonoperatingIncomeExpense_zi1ttbcoOQh6" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,634,549</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,346,459</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zc16GdV7HWy6" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income (loss) before benefit from (provision for) income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,684,085</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,395,995</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProfitLoss_zpqpkaFLWYR9" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,634,910</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,346,820</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">12,546,423</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0543">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">12,546,423</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.48</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.43</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0555">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.48</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.43</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unaudited
Statement of Changes in Stockholders&#8217; Deficit for the Three Months Ended June&#160;30, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Deficit</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; font-weight: bold; text-align: left">Balance &#8211; March&#160;31, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zSgv6CfkQ0Wa" style="width: 9%; text-align: right" title="Balance at the beginning">(13,226,270</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zaioDZrrH436" style="width: 9%; text-align: right" title="Balance at the beginning"><span style="-sec-ix-hidden: xdx2ixbrl0567">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_z22D2btkaD8g" style="width: 9%; text-align: right" title="Balance at the beginning">(13,225,580</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKjc4uZxfnui" style="text-align: right" title="Net income">10,071,447</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_z1yjYMFZiw8l" style="text-align: right" title="Net income">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zGeDOwnnS8xc" style="text-align: right" title="Net income">783,357</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Accretion of Class A common stock to redemption value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNN5XGtz0CU1" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption">(242,995</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpCB8A74vcwa" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption">9,288,090</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zZBO4xgWd1zh" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption">9,045,095</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance &#8211; June&#160;30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4iQ3jHwe2Z4" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end">(3,397,818</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zskIucPVM4D4" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"><span style="-sec-ix-hidden: xdx2ixbrl0585">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_znc0i1kAl5Ge" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end">(3,397,128</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statement
of Changes in Stockholders&#8217; Deficit for the Year Ended December&#160;31, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Deficit</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; font-weight: bold; text-align: left">Balance &#8211; December&#160;31, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdx1bW9rYUoj" style="width: 9%; text-align: right" title="Balance at the beginning">(21,094,439</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zEQjAVpq2mJ3" style="width: 9%; text-align: right" title="Balance at the beginning"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zDASNPb4Wihc" style="width: 9%; text-align: right" title="Balance at the beginning">(21,094,439</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zFoD6jeyyzPf" style="text-align: right" title="Net income">17,634,910</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpsRTnIk1QQ1" style="text-align: right" title="Net income">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zpfn9ROF4a66" style="text-align: right" title="Net income">8,346,820</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Accretion of Class A common stock to redemption value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAwMLggIUvEa" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption">(256,545</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zbOhKUqY1YGb" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption">9,288,090</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zHneQqjOnYud" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption">9,031,545</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance &#8211; December&#160;31, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5zJh9p93jl9" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end">(3,716,074</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_z2FZje8sfps5" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"><span style="-sec-ix-hidden: xdx2ixbrl0612">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zCc6Ym4kI9k5" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end">(3,716,074</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZcy8ntEFtWf" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49A_20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z95ehG0xqS5f" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220630_zxITM733eJce" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Cash Flows for the Six Months Ended June&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ProfitLoss_z6RX6DXwrlek" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Net Income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,939,616</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(9,288,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,651,526</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zNRTLVifJE34" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,660,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,288,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(371,910</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zxrggmtn20P6" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Non-Cash Investing and Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_zNkWaAF5G9Wd" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Extinguishment of deferred underwriting fee payable allocated to public shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z88Zh7Mm8ym5" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zXiE7uqfPLE3" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20220930_zSPqzF9nLYGh" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Cash Flows for the Nine Months Ended September&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProfitLoss_z2gj1pbyAOa" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Net Income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">18,811,924</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(9,288,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,523,834</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zrVYm9o87Axb" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,660,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,288,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(371,910</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_z35gCeneCNJb" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Non-Cash Investing and Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_z20ybcrtXbE" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Extinguishment of deferred underwriting fee payable allocated to public shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zMYNTNN8CaOf" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zCcGeEVBlfo1" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_497_20220101__20221231_zT2ZdbJcxSIk" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Statement of Cash Flows for the Year Ended December&#160;31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProfitLoss_zttqKxTZhZHk" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Net Income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,634,910</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(9,288,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,346,820</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zpZ2gyZcPeJj" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,660,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,288,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(371,910</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zlR89okIc0Oe" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Non-Cash Investing and Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_zwg1cb66dG4k" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Extinguishment of deferred underwriting fee payable allocated to public shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0660">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td></tr>
  </table>

<p id="xdx_8AE_zeDfbudSk0il" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>










<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334044768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zPmLo5HYi1l6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            2 &#8211; Summary of Significant Accounting Policies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span>&#160;</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_829_zAfnR3Sa9x59" style="display: none">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></p>

<p id="xdx_846_ecustom--LiquidityAndGoingConcernPolicyTextBlock_zw3E5NpOJlNg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
                                            </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2023 (Successor), the Company has a working capital surplus of approximately $<span id="xdx_900_ecustom--WorkingCapital_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Working capital">3,052</span>&#160;thousand and cash and cash equivalents of approximately
$<span id="xdx_907_eus-gaap--Cash_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Cash">6,724</span>&#160;thousand. For the period ended March 31, 2023 (Successor), the Company incurred net income
of approximately $<span id="xdx_906_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Net income">2,758</span> thousand. During the period ended March 31, 2023 (Successor), the Company used approximately $<span id="xdx_90D_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_di_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFXCqwS29eM8" title="Cash for operating activities">4,431</span> thousand of
cash for operating activities, of which $<span id="xdx_903_eus-gaap--OtherAccruedLiabilitiesCurrent_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Reduction in accrued liabilities">3,888</span> thousand was from a reduction in accrued liabilities, primarily paying merger related
transaction liabilities. In assessing the Company&#8217;s ability to continue as a going concern, the Company monitors and analyzes its
cash and its ability to generate sufficient cash flow in the future to support its operating and capital expenditure commitments.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>The
Company cannot assure that it will ever earn revenues sufficient to support their operations, or that it will ever achieve profitable
operations. The Company&#8217;s recurring losses and utilization of cash in its operations are indicators of substantial doubt that the
entity can continue as a going concern however with the Company&#8217;s current liquidity position the Company has taken steps to reduce
operating expenses and extend it&#8217;s runway. The Company intends to finance its future working capital requirements and capital expenditures
from cash generated from operating activities and may consider raising funds from equity financings. Management believes that the actions
presently being taken to further implement its business plan and generate its revenues provide the opportunity for the Company to continue
as a going concern for at least 12 months from the issuance of these condensed consolidated financial statements. While the Company believes
in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that
effect for at least twelve months from the issuance of these condensed consolidated financial statements. The ability of the Company
to continue as a going concern is dependent upon the Company&#8217;s ability to further implement its business plan. The accompanying
unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization
of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments
relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might
result from the outcome of the uncertainties described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--UseOfEstimates_z2Ou3EfIXRz8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
                                            of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;)
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during each of the reporting
periods. Actual results could differ from those estimates. The Company&#8217;s significant estimates consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            valuation of stock-based compensation;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            valuation of warrant liabilities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            allowance for credit losses;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            valuation allowance for deferred tax assets; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">impairment
                                            of long-lived assets and goodwill.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zWE2s2Vjh8xk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
                                            and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents consist of cash, checking accounts, money market accounts, temporary investments and certificates of deposit with
maturities of three months or less when purchased. <span id="xdx_90B_ecustom--CashAndCashEquivalentsDescription_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFNmvvmyQX9l" title="Cash and cash equivalents, description">As of March 31, 2023 (Successor), the Company had cash equivalents  of approximately $2,000 thousand of certificates of
deposit held by a number of banks limited to $250 thousand per bank with a duration of 90 days or less</span> and at December 31, 2022 (Predecessor)
the Company had no cash equivalents.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_ecustom--AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock_zefF4QCGnSNj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Accounts
                                            Receivable, net and Allowance for Credit Losses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Accounts
receivables are stated at the amount the Company expects to collect. The Company recognizes an allowance for credit losses to ensure
accounts receivables are not overstated due to un-collectability. Bad debt reserves are maintained for various customers based on a variety
of factors, including the length of time the receivables are past due, significant one-time events and historical experience. An additional
reserve for individual accounts is recorded when the Company becomes aware of a customer&#8217;s inability to meet its financial obligation,
such as in the case of bankruptcy filings, or deterioration in such customer&#8217;s operating results or financial position. If circumstances
related to a customer change, estimates of the recoverability of receivables would be further adjusted. The Company&#8217;s allowance
for credit losses is not significant as of March 31, 2023 (Successor) and at December 31, 2022 (Predecessor).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zNREgUj0V3nh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Property
                                            and Equipment, net</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are recorded at cost, less accumulated depreciation and amortization. The Company depreciates its property and equipment
for financial reporting purposes using the straight-line method over the estimated useful lives of the assets, which range from 3 to
10 years. Leasehold improvements are amortized over the lesser of the useful life of the asset or the initial lease term. Expenditures
for maintenance and repairs, which do not extend the economic useful life of the related assets, are charged to operations as incurred,
and expenditures, which extend the economic life, are capitalized. When assets are retired, or otherwise disposed of, the costs and related
accumulated depreciation or amortization are removed from the accounts and any gain or loss on disposal is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z4fAlHyLJg8e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intangible
                                            Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets primarily consist of developed technology, customer lists/relationships, non-compete agreements, intellectual property
agreements, export licenses and trade names/trademarks. They are amortized ratably over a range of <span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zZPQov9BPJu7" title="Intangible assets useful life">1 </span>
to <span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_ziSd4Biku1B2" title="Intangible assets useful life">10</span>
years, which approximates customer attrition rate and technology obsolescence. The Company assesses the carrying value of its
intangible assets for impairment each year. Based on its assessments, the Company did not incur any impairment charges for the
period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022
(Predecessor).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--GoodwillDisclosureTextBlock_zotamlkSrV76" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Goodwill</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company tests goodwill for potential impairment at least annually, or more frequently if an event or other circumstance indicates that
the Company may not be able to recover the carrying amount of the net assets of the reporting unit. The Company has determined that the
reporting unit is the entire company, due to the integration of all of the Company&#8217;s activities. In evaluating goodwill for impairment,
the Company may assess qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50%) that
the fair value of a reporting unit is less than its carrying amount. If the Company bypasses the qualitative assessment, or if the Company
concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs
a quantitative impairment test by comparing the fair value of a reporting unit with its carrying amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company calculates the estimated fair value of a reporting unit using a weighting of the income and market approaches. For the income
approach, the Company uses internally developed discounted cash flow models that include the following assumptions, among others: projections
of revenues, expenses, and related cash flows based on assumed long-term growth rates and demand trends; expected future investments
to grow new units; and estimated discount rates. For the market approach, the Company uses internal analyses based primarily on market
comparables. The Company bases these assumptions on its historical data and experience, third party appraisals, industry projections,
micro and macro general economic condition projections, and its expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_ecustom--LeasesAndRightofUseAssetsPolicyTextBlock_zH39sJYL1091" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Leases
                                            and Right-of-Use Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if an arrangement is a lease at its inception. Operating lease liabilities are recognized at the lease commencement
date based on the present value of lease payments over the lease term. The Company generally uses their incremental borrowing rate based
on the information available at the lease commencement date in determining the present value of future payments, because the implicit
rate of the lease is generally not known. Right-of-use assets related to the Company&#8217;s operating lease liabilities are measured
at lease inception based on the initial measurement of the lease liability, plus any prepaid lease payments and less any lease incentives.
The Company&#8217;s lease terms that are used in determining their operating lease liabilities at lease inception may include options
to extend or terminate the leases when it is reasonably certain that the Company will exercise such options. The Company amortizes their
right-of-use assets as operating lease expense generally on a straight-line basis over the lease term and classify both the lease amortization
and imputed interest as operating expenses. The Company does not recognize lease assets and lease liabilities for any lease with an original
lease term of less than one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zHn9JBCIYIBb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
                                            Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes using the asset and liability method. Accordingly, deferred tax assets and liabilities are recognized
for the future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities
and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in the tax rate is recognized in income or expense in the period that the change is effective. Income tax benefits
are recognized when it is probable that the deduction will be sustained. A valuation allowance is established when it is more likely
than not that all or a portion of a deferred tax asset will either expire before the Company is able to realize the benefit, or that
future deductibility is uncertain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zlwVv8rtPbOj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Comprehensive
                                            Income (Loss) and Foreign Currency Translation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reports comprehensive income (loss) and its components in its unaudited condensed consolidated financial statements. Comprehensive
loss consists of net loss and foreign currency translation adjustments, affecting stockholders&#8217; equity that, under GAAP, are excluded
from net loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities related to the Company&#8217;s foreign operations are calculated using the Philippine peso and Canadian Dollar, and are
translated at end-of-period exchange rates, while the related revenues and expenses are translated at average exchange rates prevailing
during the period. Gains or losses resulting from transactions denominated in foreign currencies are included in general and administrative
expenses in the unaudited condensed consolidated statements of operations. The Company engages in foreign currency denominated transactions
with customers that operate in functional currencies other than the U.S. dollar. Aggregate foreign currency net transaction losses were
not material for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and three months ended March
31, 2022 (Predecessor).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zp5bNAYYFyRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
                                            Recognition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>The
Company recognizes revenue when control is transferred of the promised products or services to its customers, in an amount that reflects
the consideration the Company expects to be entitled to in exchange for those products or services. The Company derives revenue from
its software as a service for cloud based software, as well as design, implementation and other professional services for work performed
in conjunction with its cloud based software. The Company enters into contracts with its customers whereby it grants a non-exclusive
cloud-based license for the use of its proprietary software and for professional services. The contracts may also provide for on-going
services for a specified price, which may include maintenance services, designated support, and enhancements, upgrades and improvements
to the software, depending on the contract. Licenses for cloud software provide the customer with a right to use the software as it exists
when made available to the customer. All software provides customers with the same functionality and differ mainly in the duration over
which the customer benefits from the software.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>License
Subscription Revenue Recognition (Software As A Service)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>With respect
to sales of the Company&#8217;s license agreements, customers generally pay fixed annual fees in advance in exchange for the Company&#8217;s
software service provided by via electronic, which are generally recognized ratably over the license term. Some agreements allow the
customer to terminate their subscription contracts before the end of the applicable term, and in such cases the customer is generally
entitled to a refund pro-rata but only for the elapsed time remaining at the point of termination, which would approximate the deferred
revenue at such time. The Company&#8217;s performance obligation is satisfied over time as the electronic services are provided continuously
throughout the service period. The Company recognizes revenue evenly over the service period using a time-based measure because the Company
is providing continuous access to its service. The Company&#8217;s customers generally pay within 30 to 60 days from the receipt of a
customer approved invoice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The timing
of the Company&#8217;s revenue recognition related to the licensing revenue stream is dependent on whether the software licensing agreement
entered into represents a service. Software that relies on an entity&#8217;s IP and is delivered only through a hosting arrangement,
where the customer cannot take possession of the software, is a service. Customers may purchase perpetual licenses or subscribe to licenses,
which provide customers with the same functionality and differ mainly in the duration over which the customer benefits from the software.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Renewals
or extensions of licenses are evaluated as distinct licenses and revenue attributed to the distinct service is not recognized until (1)
the entity provides the distinct license (or makes the license available) to the customer and (2) the customer is able to use and benefit
from the distinct license. Renewal contracts are not combined with original contracts, and, as a result, the renewal right is evaluated
in the same manner as all other additional rights granted after the initial contract. The revenue is not recognized until the customer
can begin to use and benefit from the license, which is typically at the beginning of the license renewal period. The Company recognizes
revenue resulting from renewal of licensed software over time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
Services Revenue Recognition</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s professional services include milestone, fixed fee and time and materials contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
services under milestone contracts are accounted for using the percentage of completion method. As soon as the outcome of a contract
can be estimated reliably, contract revenue is recognized in the statement of operations in proportion to the stage of completion of
the contract. Contract costs are expensed as incurred. Contract costs include all amounts that relate directly to the specific contract,
are attributable to contract activity, and are specifically chargeable to the customer under the terms of the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Professional
services are also contracted on the fixed fee and in some cases on a time and materials basis. Fixed fees are paid monthly, in phases,
or upon acceptance of deliverables. The Company&#8217;s time and materials contracts are paid weekly or monthly based on hours worked.
Revenue on time and material contracts is recognized based on a fixed hourly rate as direct labor hours are expended. Materials, or other
specified direct costs, are reimbursed as actual costs and may include markup. The Company has elected the practical expedient to recognize
revenue for the right to invoice because the Company&#8217;s right to consideration corresponds directly with the value to the customer
of the performance completed to date. For fixed fee contracts provided by in house personnel, the Company recognizes revenue evenly over
the service period using a time-based measure because the Company is providing continuous service. Because the Company&#8217;s contracts
have an expected duration of one year or less, the Company has elected the practical expedient in ASC 606-10-50-14(a) to not disclose
information about its remaining performance obligations. Anticipated losses are recognized as soon as they become known. For the period
ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor), the
Company did not incur any such losses. These amounts are based on known and estimated factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contract
Balances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
timing of the Company&#8217;s revenue recognition may differ from the timing of invoicing to and payment by its customers. The Company
records an unbilled receivable when revenue is recognized prior to invoicing and the Company has an unconditional right to payment. Alternatively,
when invoicing a customer precedes the company providing of the related services, the Company records deferred revenue until the performance
obligations are satisfied. The Company had deferred revenue of approximately $<span id="xdx_906_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3">2,690
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand and $<span id="xdx_90D_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3">2,162
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand as of March 31, 2023 (Successor) and
December 31, 2022 (Predecessor), respectively, related to customer invoices rendered in advance for software licenses and professional
services provided by the Company&#8217;s technical staff. The Company expects to satisfy its remaining performance obligations for the
deferred revenue associated with professional services, and recognize the deferred revenue related to licenses generally over the remaining
contract term generally twelve months following the commencement of the license. The Company recognized revenue in the reporting period
of $<span id="xdx_901_ecustom--RevenueRecognized_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zCVavrmQRK1" title="Revenue Recognized">170</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;thousand,
$<span id="xdx_90E_ecustom--RevenueRecognized_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zApkMSdjWAUj">865
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand, and $<span id="xdx_902_ecustom--RevenueRecognized_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zdkdnojahzE7">1,328
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand that was included in the contract liability
balance at the beginning of the period, for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and
three months ended March 31, 2022 (Predecessor), respectively.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Costs
to Obtain a Contract</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
recognizes eligible sales commissions as an asset as the commissions are an incremental cost of obtaining a contract with the customer
and the Company expects to recover these costs. The capitalized costs are amortized over the expected contract term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cost
to Fulfill a Contract</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
incurs costs to fulfill their obligations under a contract once it has obtained. These costs are generally not significant and are recorded
to expense as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Multiple
Performance Obligations</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company enters into contracts with customers for its technology that include multiple performance obligations. Each distinct performance
obligation was determined by whether the customer could benefit from the good or service on its own or together with readily available
resources. The Company allocates revenue to each performance obligation based on its relative standalone selling price. The Company&#8217;s
process for determining standalone selling price considers multiple factors including the Company&#8217;s internal pricing model and
market trends that may vary depending upon the facts and circumstances related to each performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
and Use Taxes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company presents transactional taxes such as sales and use tax collected from customers and remitted to government authorities on a net
basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shipping
and Handling Costs</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling costs are expensed as incurred as part of cost of revenues. These costs were deemed to be nominal during each of the reporting
periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_eus-gaap--BusinessCombinationsPolicy_zcQe09j48jy1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
                                            Combinations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for business combinations under Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification
(&#8220;ASC&#8221;) 805 &#8220;Business Combinations&#8221; using the acquisition method of accounting, and accordingly, the assets and
liabilities of the acquired business are recorded at their fair values at the date of acquisition. The excess of the purchase price over
the estimated fair value is recorded as goodwill. All acquisition costs are expensed as incurred. Upon acquisition, the accounts and
results of operations are included as of and subsequent to the acquisition date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zyLHpZiIf0o" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Segments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and its Chief Executive Officer (&#8220;CEO&#8221;), acting as the Chief Operating Decision Maker (&#8220;CODM&#8221;) determines
its reporting units in accordance with FASB ASC 280, &#8220;Segment Reporting&#8221; (&#8220;ASC 280&#8221;). The Company evaluates a
reporting unit by first identifying its operating segments under ASC 280. The Company then evaluates each operating segment to determine
if it includes one or more components that constitute a business. If there are components within an operating segment that meet the definition
of a business, the Company evaluates those components to determine if they must be aggregated into one or more reporting units. If applicable,
when determining if it is appropriate to aggregate different operating segments, the Company determines if the segments are economically
similar and, if so, the operating segments are aggregated. The Company has one operating segment and reporting unit. The Company is organized
and operated as one business. Management reviews its business as a single operating segment, using financial and other information rendered
meaningful only by the fact that such information is presented and reviewed in the aggregate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zqhxlV67YbOj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-Based
                                            Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for options granted to employees by measuring the cost of services received in exchange for the award of equity instruments
based upon the fair value of the award on the date of grant. The fair value of that award is then ratably recognized as an expense over
the period during which the recipient is required to provide services in exchange for that award. Forfeitures of unvested stock options
are recorded when they occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred stock-based compensation charges of approximately $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Stock-based compensation">2</span>&#160;thousand, $<span id="xdx_907_eus-gaap--ShareBasedCompensation_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Stock-based compensation">158</span>&#160;thousand and $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Stock-based compensation">647</span>&#160;thousand for the period ended March 31, 2023 (Successor), the period ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor),
respectively, which are included in general and administrative expenses.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--StandardProductWarrantyPolicy_z8jbBFSUKXZb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Derivative
                                            Warrant Liabilities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s specific
terms and applicable authoritative guidance in FASB ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC 480&#8221;)
and ASC 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#8217;s own common
stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted
at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. The Company currently
has two sets of warrants outstanding, known as the Private Placement Warrants and the Public Warrants, which are both classified as a
liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>For issued or modified warrants that meet all
of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the
time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required
to be recorded at their initial fair value on the date of issuance as a warrant liability, and adjusted to the then fair value in each
balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the condensed
consolidated statements of operations and amounted to approximately $<span id="xdx_90E_ecustom--ChangesInEstimatedFairValueOfWarrants_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zlU3FR3IFPcj" title="Changes in estimated fair value of warrants">1,686&#160;</span>thousand for the period ended March 31, 2023 (Successor).
The Company utilized the Public Warrant quoted market price as the fair value of the Warrants as of each relevant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zExbuawx3YWi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Earnings
                                            Per Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
computes basic and diluted earnings per share by dividing net income by the weighted average number of common shares outstanding during
the period. Diluted earnings per share are similarly calculated with the inclusion of dilutive common stock equivalents. The following
table summarizes the number of common shares and common share equivalents excluded from the calculation of diluted net income per common
share for period ended March 31, 2023 (Successor), which are excluded from the calculation because (i) the warrants were below their
exercise price and (ii) the stock options were not vested :</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_pn3n3_zXBF2PB15Bxd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policie (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; text-align: left"><span id="xdx_8B3_zmSyfTTgVZU" style="display: none">Schedule of antidilutive shares</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to<br/>
    March&#160;31,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"><span>Stock
    options</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zn1dqT8iNFke" style="border-bottom: Black 1pt solid; text-align: right"><span>1,377</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total"><span>24,080</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span>25,457</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zw0p08iuU5m" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
                                            Value Measurements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FASB
ASC 820, &#8220;Fair Value Measurements&#8221; (&#8220;ASC 820&#8221;), provides guidance on the development and disclosure of fair value
measurements. The Company follows this authoritative guidance for fair value measurements, which defines fair value, establishes a framework
for measuring fair value under generally accepted accounting principles in the United States, and expands disclosures about fair value
measurements. The guidance requires fair value measurements be classified and disclosed in one of the following three categories:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.25in"></td><td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date
                                            for identical assets or liabilities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.25in"></td><td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            2: Observable prices that are based on inputs not quoted on active markets but corroborated
                                            by market data.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.25in"></td><td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            3: Unobservable inputs which are supported by little or no market activity and values determined
                                            using pricing models, discounted cash flow methodologies, or similar techniques, as well
                                            as instruments for which the determination of fair value requires significant judgment or
                                            estimation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value measurements discussed herein are based upon certain market assumptions and pertinent information available to management. Fair
value measurements are applied, when applicable, to determine the fair value of the Company&#8217;s warrant liability at each reporting
period. See Note 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>












<p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z1Yer2XJkN4k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
                                            Value of Financial Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments consist of cash and cash equivalents, accounts receivable, notes and other receivable and accounts payable. The Company determines
the estimated fair value of such financial instruments presented in these financial statements using available market information and
appropriate methodologies. These financial instruments are stated at their respective historical carrying amounts, which approximate
fair value due to their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zchAKvjusoEg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Carrying
                                            Value, Recoverability and Impairment of Long-Lived Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
has adopted FASB ASC 360 &#8220;Property, Plant, and Equipment&#8221; (&#8220;ASC 360&#8221;) for its long-lived assets. Pursuant to
ASC 360-10-35-17, an impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable
and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted
cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the
carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount
by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. Pursuant to ASC 360-10-35-20 if an impairment
loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset,
the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized
impairment loss is prohibited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 360-10-35-21, the Company&#8217;s long-lived asset (asset group) is tested for recoverability whenever events or changes in circumstances
indicate that its carrying amount may not be recoverable. The Company considers the following to be some examples of such events or changes
in circumstances that may trigger an impairment review: (a) significant decrease in the market price of a long-lived asset (asset group);
(b) a significant adverse change in the extent or manner in which a long-lived asset (asset group) is being used or in its physical condition;
(c) a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset (asset
group), including an adverse action or assessment by a regulator; (d) an accumulation of costs significantly in excess of the amount
originally expected for the acquisition or construction of a long-lived asset (asset group); (e) a current-period operating or cash flow
loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated
with the use of a long-lived asset (asset group); and (f) a current expectation that, more likely than not, a long-lived asset (asset
group) will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. The Company tests
its long-lived assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on its assessments, the Company recorded <span id="xdx_908_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zAfiZuSmiNrc" title="Impairment charges of long-lived assets"><span id="xdx_903_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zITBxcg1cf54" title="Impairment charges of long-lived assets"><span id="xdx_90F_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zzYDZSs08Vac" title="Impairment charges of long-lived assets">no</span></span></span> impairment charges on long-lived assets for period ended March 31, 2023 (Successor), period
ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor), respectively.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zKtKg42HkPn6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recently
                                            Issued and Adopted Accounting Standards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>In October
2021, the FASB issued ASU 2021-08, &#8220;Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&#8221;
(&#8220;ASU 2021-08&#8221;), which addresses diversity in practice related to the accounting for revenue contracts with customers acquired
in a business combination. Under the new guidance, the acquirer is required to apply Topic 606 to recognize and measure contract assets
and contract liabilities in a business combination. The effective date of the standard is for fiscal years beginning after December 15,
2022, including interim periods within those fiscal years, with early adoption permitted. CXApp adopted ASU 2021-08 on January 1, 2022.
As a result of management&#8217;s evaluation, the adoption of ASU 2021-08 did not have a material impact on the consolidated financial
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
evaluated recently issued FASB accounting pronouncements and noted that no recent announcements were applicable to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_z8xGBXA0mHXk" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8212; <span id="xdx_827_zNyovCW7LCJi">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zuktqF2w8fJ1" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Basis
of Presentation</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles
generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and pursuant to the accounting and disclosure rules and
regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 2&#8212;Restatement of Previously Issued Financial Statements, the Company&#8217;s financial statements for the year
ended December&#160;31, 2022 (collectively, the &#8220;Affected Period&#8221;), are restated in this Annual Report on Form&#160;10-K/A
(Amendment No. 1) (this &#8220;Annual Report&#8221;) to correct the misapplication of accounting guidance related to the liability extinguishment
in the Company&#8217;s previously issued audited financial statements for such period. The restated financial statements are indicated
as &#8220;Restated&#8221; in the audited financial statements and accompanying notes, as applicable. See Note 2&#8212;Restatement of
Previously Issued Financial Statements for further discussion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--ConsolidationPolicyTextBlock_z5OXF1lZ1sd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Principles
of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_ecustom--EmergingGrowthCompanyPolicyTextBlock_zTskIQfKuDvh" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Emerging
Growth Company</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not
being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley
Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s consolidated financial statements with another public
company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition
period difficult or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--UseOfEstimates_zLhWUjXH4x1k" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Use of Estimates</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting
estimates included in these consolidated financial statements is the determination of the fair value of the warrant liabilities. Accordingly,
the actual results could differ significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zKK0E1m2SDX" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Cash
and Cash Equivalents</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of six months or less when purchased to be cash equivalents. The
Company did not have any cash equivalents as of December&#160;31, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zpNq8gvDt5d5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Concentration
of Credit Risk</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit
of $<span id="xdx_907_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zbxBYEbSbSJe" title="Insured amount">250,000</span>. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#8217;s financial
condition, results of operations, and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_ecustom--TemporaryEquityPolicyPolicyTextBlock_zPUqISlM1ggd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Class
A Common Stock Subject to Possible Redemption</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards
Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Shares of Class A common stock subject
to mandatory redemption are classified as liability instruments and are measured at fair value. Conditionally redeemable common stock
(including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon
the occurrence of uncertain events not within the Company&#8217;s control) is classified as temporary equity. At all other times, common
stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock features certain redemption rights that are
considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, as of December&#160;31,
2022 and 2021, <span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_c20221231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_pdd" title="Class A common stock subject to possible redemption, outstanding (in shares)">387,551</span> and <span id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_c20211231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_pdd" title="Class A common stock subject to possible redemption, outstanding (in shares)">27,600,000</span> shares of Class A common stock subject to possible redemption are presented as temporary equity,
outside of the stockholders&#8217; deficit section of the Company&#8217;s consolidated balance sheets, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to
equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock
are affected by charges against additional paid in capital (to the extent available) and accumulated deficit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December&#160;31, 2022 and 2021, the Class A common stock reflected in the consolidated balance sheets are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--TemporaryEquityTableTextBlock_zECvghHTCwL6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8B3_z5tspC3QNLU4" style="display: none">Schedule of reconciliation of Class A common stock reflected in the condensed balance sheet</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 88%; text-align: left">Class A common stock subject to possible redemption, January&#160;1, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_pp0p0_c20210101__20211231_zATWP7fZf60h" style="width: 9%; text-align: right" title="Class A common stock subject to possible redemption, at beginning of year">278,760,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"><span style="-sec-ix-hidden: xdx2ixbrl0696">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Class A common stock subject to possible redemption, December&#160;31, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_pp0p0_c20220101__20221231_zjkwtljQn1Hj" style="font-weight: bold; text-align: right" title="Class A common stock subject to possible redemption, at beginning of year">278,760,000</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: left">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: left">Waiver of Class A common stock issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--TemporaryEquityWaiverOfShareIssuanceCosts_c20220101__20221231_pp0p0" style="text-align: right" title="Waiver of Class A common stock issuance costs">9,288,090</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: left">Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: left">Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--TemporaryEquityAccretionToRedemptionValue_iN_pp0p0_di_c20220101__20221231_zJ3VEP2gCel2" style="text-align: right" title="Accretion of carrying value to redemption value">(9,031,545</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Redemption of Class A Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--TemporaryEquityRedemption_iN_pp0p0_di_c20220101__20221231_zdNc46iem556" style="border-bottom: Black 1pt solid; text-align: right" title="Redemption of Class A Common Stock">(275,102,280</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Class A common stock subject to redemption, December&#160;31, 2022</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_pp0p0_c20220101__20221231_zBkDV3Rqvs4h" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Class A common stock subject to possible redemption, at end of year">3,914,265</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_z11GjiUIYBD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p id="xdx_843_eus-gaap--DeferredChargesPolicyTextBlock_zdDaWmFTZVp2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Offering
Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the
Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based
on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities were expensed as
incurred in the consolidated statements of operations. Offering costs associated with the Class A common stock issued were initially
charged to temporary equity. Offering costs incurred amounted to $<span id="xdx_908_ecustom--TransactionCosts_iI_pp0p0_c20201217_zpUUBSq82EV3" title="Transaction costs">15,688,848</span>, consisting of $<span id="xdx_907_ecustom--SaleOfStockUnderwritingFees_iI_pp0p0_c20201217_z7DhoIX1DKZd" title="Underwriting fees">5,520,000</span> in cash underwriting fees, $<span id="xdx_905_ecustom--DeferredOfferingCostsNoncurrent_iI_pp0p0_c20201217_zACM8B1o1Kjd" title="Deferred underwriting fee payable">9,660,000</span>
of deferred underwriting fees and $<span id="xdx_90E_ecustom--SaleOfStockOtherOfferingCosts_iI_pp0p0_c20201217_zbglZAMf0A8i" title="Other offering costs">508,848</span> of other offering costs, of which $<span id="xdx_90A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_pp0p0_c20201201__20201217_zWImPD8D2FUj" title="Charged to temporary equity">15,239,420</span> was charged to temporary equity and $<span id="xdx_904_ecustom--OfferingCost_pp0p0_c20201201__20201217_zdVtpvILLUm9" title="Offering cost expense">449,428</span>
was allocated to the warrant liability and expensed through the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p id="xdx_845_ecustom--WarrantLiabilityPolicyTextBlock_zy7gcJxh8IRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Derivative
Warrant Liabilities</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s
specific terms and applicable authoritative guidance in Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards
Codification (&#8220;ASC&#8221;) 480, Distinguishing Liabilities from Equity (&#8220;ASC 480&#8221;) and ASC 815, Derivatives and Hedging
(&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet
the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under
ASC 815, including whether the warrants are indexed to the Company&#8217;s own common stock, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification,
the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the consolidated statements of operations.
The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a
binomial lattice model. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market
price was used as the fair value of the Warrants (as defined below) as of each relevant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zAkXDmrMgUre" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Income
Taxes</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes under ASC 740, &#8220;Income Taxes.&#8221; ASC 740, Income Taxes, requires the recognition of deferred
tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation
allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740-270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in
interim periods under ASC 740-270-30-5. As of December&#160;31, 2022 and December&#160;31, 2021, the Company&#8217;s deferred tax asset
had a full valuation allowance recorded against it. The Company&#8217;s effective tax rate was <span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20220101__20221231_zeSoHveIZU2j" title="Effective tax rate (in percent)">0.3%</span> and <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20210101__20211231_zbw1V8igdRf8" title="Effective tax rate (in percent)">0.0%</span>, respectively. The effective
tax rate differs from the statutory tax rate of <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c20220101__20221231_zwkDRRygxUJ8" title="Statutory tax rate"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c20210101__20211231_zX7MjNWI9J04" title="Statutory tax rate">21%</span></span> for the years ended December&#160;31, 2022 and 2021, due to changes in fair value
in warrant liability and the valuation allowance on the deferred tax assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
period, disclosure and transition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were <span id="xdx_903_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20221231_zI6apnoPaO7i" title="Unrecognized tax benefits"><span id="xdx_901_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20211231_zXaHWhMffC9f" title="Unrecognized tax benefits">no</span></span> unrecognized
tax benefits and <span id="xdx_906_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pp0p0_do_c20221231_zUiuIorm9u89" title="Unrecognized tax benefits accrued for interest and penalties"><span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pp0p0_do_c20211231_zFEkKd3bn3eh" title="Unrecognized tax benefits accrued for interest and penalties">no</span></span> amounts accrued for interest and penalties as of December&#160;31, 2022 and December&#160;31, 2021. The Company is
currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has identified the United States as its only &#8220;major&#8221; tax jurisdiction. The Company is subject to income taxation
by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus
of income among various tax jurisdictions and compliance with federal and state tax laws. The Company&#8217;s management does not expect
that the total amount of unrecognized tax benefits will materially change over the next twelve months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zvnZTRGy3S6a" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Net
Income per Common Share</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share&#8221;. Net income per
common share is computed by dividing net income by the weighted average number of shares of common stock outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class
A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of diluted income per share does not consider the effect of the Warrants issued in connection with the (i) Initial Public
Offering, and (ii) the private placement since the exercise of the Warrants is contingent upon the occurrence of future events. The Warrants
are exercisable to purchase <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Number of warrants to purchase shares issued">24,080,000</span> shares of Class A common stock in the aggregate. As of December&#160;31, 2022 and 2021, the Company
did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and
then share in the earnings of the Company. As a result, diluted net income per common share is the same as basic net income per common
share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zYz80eOXU9p1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B0_zsXmGyV3aD93" style="display: none">Schedule of Reconciliation of net income per common share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20220101_20221231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassAMember" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20220101_20221231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z6j1d9NrCpC5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20210101_20211231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="14" style="font-weight: bold; text-align: center">Year Ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December&#160;31,</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class A</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class B</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class A</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class B</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: left">Basic and diluted net income per common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_i01B" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i02_pp0p0" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,385,193</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,961,627</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,366,307</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,841,577</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i02_pdd" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Basic and diluted weighted average shares outstanding</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,546,423</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,900,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">27,600,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,900,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Basic and diluted net income per common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.27</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.27</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8AD_zOrPjkSBYWej" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zezPmwmkfduc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value
Measurement,&#8221; approximate the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their
short-term nature, except the derivative warrant liabilities (see Note 10).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmqYJbCeT0sg" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Recent
Accounting Standards</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August&#160;2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2020-06, Debt &#8212; Debt with Conversion
and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU
2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation
of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance
pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures
for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends
the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU
2020-06 is effective January&#160;1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted
beginning on January&#160;1, 2021. The Company adopted ASU 2020-06 as of January&#160;1, 2021 and the adoption did not have an impact
on its financial position, results of operations or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655418244544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PUBLIC OFFERING<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DisclosurePublicOfferingAbstract', window );"><strong>Public Offering</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_InitialPublicOfferingDisclosureTextBlock', window );">PUBLIC OFFERING</a></td>
<td class="text"><p id="xdx_802_ecustom--InitialPublicOfferingDisclosureTextBlock_zUBYCtXAY5l8" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 &#8212; <span id="xdx_829_zjJpzYbqkTT5">PUBLIC OFFERING</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Initial Public Offering, the Company sold <span id="xdx_90A_ecustom--UnitsIssuedDuringPeriodSharesNewIssues_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zruFXjZeX0A2" title="Number of units sold">27,600,000</span> Units which includes a full exercise by the underwriters of their over-allotment
option in the amount of <span id="xdx_906_ecustom--UnitsIssuedDuringPeriodSharesNewIssues_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zpOJDyEvWTp5" title="Number of units sold">3,600,000</span> Units, at a price of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z4ubdRWRzD97" title="Purchase price, per unit (in dollars per share)">10.00</span> per Unit. Each Unit consists of one share of Class A common stock and one-half
of one redeemable warrant (&#8220;Public Warrant&#8221; and, together with the Private Placement Warrants, the &#8220;Warrants&#8221;).
Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201217__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zLDqxvTR2fU6" title="Exercise price of warrants">11.50</span> per share, subject to
adjustment (see Note 8).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DisclosurePublicOfferingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DisclosurePublicOfferingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_InitialPublicOfferingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_InitialPublicOfferingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655447799696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRIVATE PLACEMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DisclosurePrivatePlacementAbstract', window );"><strong>Private Placement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_PrivatePlacementDisclosureTextBlock', window );">PRIVATE PLACEMENT</a></td>
<td class="text"><p id="xdx_805_ecustom--PrivatePlacementDisclosureTextBlock_zpmKsKsUDvxh" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 &#8212; <span id="xdx_825_z8Qgj4hAL57l">PRIVATE PLACEMENT</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Sponsor and the Direct Anchor Investors purchased an aggregate of <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zgUzerlDWx14" title="Number of warrants to purchase shares issued">10,280,000</span> Private
Placement Warrants at a price of $<span id="xdx_900_ecustom--ClassOfWarrantOrRightPriceOfWarrantsOrRights_iI_c20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zuzrIOCCWYzc" title="Price of warrants">1.00</span> per Private Placement Warrant, or $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfWarrants_pp0p0_c20201201__20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zVmmfwojmtbc" title="Aggregate purchase price">10,280,000</span>. Each Private Placement Warrant is exercisable to
purchase one share of Class A common stock at a price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zV3vu3JualOg" title="Exercise price of warrant">11.50</span> per share, subject to adjustment (see Note 8). The proceeds from the
sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If
the Company does not complete a Business Combination within the Extended Combination Period, the proceeds from the sale of the Private
Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of
applicable law) and the Private Placement Warrants will expire worthless.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DisclosurePrivatePlacementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DisclosurePrivatePlacementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_PrivatePlacementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_PrivatePlacementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338006080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES</a></td>
<td class="text"><p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_ziWg9MRDSGL6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8212; <span id="xdx_823_zc5rFk0SwlC">RELATED PARTIES</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Founder
Shares</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July&#160;27, 2020, the Sponsor paid $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20200701__20200727__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zDl99LScjEI8" title="Aggregate purchase price">25,000</span> to cover certain offering costs of the Company in consideration for <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20200727__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Number of shares issued">5,750,000</span> shares of
Class B common stock (the &#8220;Founder Shares&#8221;). In October&#160;2020, the Sponsor forfeited <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201001__20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DirectAnchorMember_pdd" title="Number of shares issued">625,000</span> Founder Shares and the Direct
Anchor Investors purchased <span id="xdx_906_ecustom--NumberOfSharesSubjectToForfeiture_c20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pdd" title="Shares subject to forfeiture">625,000</span> Founder Shares for an aggregate purchase price of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20201001__20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember_pp0p0" title="Aggregate purchase price">2,717</span>, or approximately $<span id="xdx_90C_eus-gaap--SharePrice_c20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember_pdd" title="Share price">0.004</span> per share. In December&#160;2020,
the Company effected a 1:<span id="xdx_90E_eus-gaap--StockholdersEquityNoteStockSplitConversionRatio1_c20200101__20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zo7m9mlDAXm5" title="Stock split">1.2 </span>stock split of its Class B common stock, resulting in the Sponsor holding an aggregate of <span id="xdx_903_ecustom--AggregateNumberOfSharesOwned_c20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pdd" title="Aggregate number of shares owned">6,150,000</span> Founder
Shares, the Direct Anchor Investors holding an aggregate of <span id="xdx_907_ecustom--AggregateNumberOfSharesOwned_c20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DirectAnchorMember_pdd" title="Aggregate number of shares owned">750,000</span> Founder Shares and there being an aggregate of <span id="xdx_90B_ecustom--AggregateNumberOfSharesOwned_c20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember_pdd" title="Aggregate number of shares owned">6,900,000</span> Founder
Shares outstanding. The Founder Shares included an aggregate of up to <span id="xdx_90E_ecustom--NumberOfSharesSubjectToForfeiture_c20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Shares subject to forfeiture">900,000</span> shares subject to forfeiture by the Sponsor to the extent
that the underwriters&#8217; over-allotment was not exercised in full or in part, so that the number of Founder Shares would equal, on
an as-converted basis, approximately <span id="xdx_90D_ecustom--PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_c20200101__20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember_pdd" title="Percentage of issued and outstanding shares after the initial public offering collectively held by initial stockholders">20%</span> of the Company&#8217;s issued and outstanding common stock after the Initial Public Offering.
As a result of the underwriters&#8217; election to fully exercise their over-allotment option, no Founder Shares are currently subject
to forfeiture.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
initial stockholders have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the
earlier to occur of: (A) one <span id="xdx_90B_ecustom--RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_dtY_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zLaqyPEqxE75" style="display: none" title="Restrictions on transfer period of time after business combination completion">1</span> year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x)
if the last reported sale price of the Class A common stock equals or exceeds $<span id="xdx_90A_ecustom--TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)">12.00</span>
per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any <span id="xdx_90C_ecustom--TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_dtD_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zvqpKZtovvj6" title="Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination">20</span>
trading days within any <span id="xdx_90B_ecustom--TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_dtD_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z5KrA2jtlz43" title="Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination">30</span>-trading
day period commencing at least <span id="xdx_90B_ecustom--ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_dtD_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zMWcahWRI6zi" title="Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences">150</span>
days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or
other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock
for cash, securities or other property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative
Services Agreement</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement, commencing on December&#160;14, 2020 through the earlier of the Company&#8217;s consummation of a
Business Combination and its liquidation, to pay the Sponsor a total of up to $<span id="xdx_90E_ecustom--RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_c20201201__20201214__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pp0p0" title="Expenses per month">20,000</span> per month for office space, utilities and secretarial
and administrative support. For each of the years ended December&#160;31, 2022 and 2021, the Company incurred and paid $<span id="xdx_905_ecustom--ExpensesIncurredAndPaid_pp0p0_c20220101__20221231_zccqLjpQRm4h" title="Expenses incurred and paid"><span id="xdx_900_ecustom--ExpensesIncurredAndPaid_pp0p0_c20210101__20211231_zqbS1Y8w8oM4" title="Expenses incurred and paid">240,000</span></span> in fees
for these services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Promissory
Note &#8212; Related Party</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August&#160;10, 2022, KINS Capital LLC issued an unsecured promissory note to the Company, pursuant to which the Company may borrow up
to an aggregate principal amount of $<span id="xdx_907_eus-gaap--DebtInstrumentCollateralAmount_c20220810__us-gaap--RelatedPartyTransactionAxis__custom--PromissoryNoteWithRelatedPartyMember_pp0p0" title="Aggregate principal amount">400,000</span>. The Promissory Note was non-interest bearing and payable on the earlier of (i) closing
of the Merger as described in the BCA or (ii) June&#160;15, 2023. As December&#160;31, 2022, $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--PromissoryNoteWithRelatedPartyMember_pp0p0" title="Amount outstanding under promissory note">347,961</span> was outstanding under the Promissory
Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Working
Capital Loans</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain
of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#8220;Working
Capital Loans&#8221;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of
a Business Combination, without interest, or, at the lender&#8217;s discretion, up to $<span id="xdx_90C_ecustom--MaximumLoansConvertibleIntoWarrants_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_pp0p0" title="Loan conversion agreement warrant">1,500,000</span> of the notes may be converted upon completion
of a Business Combination into warrants at a price of $<span id="xdx_90C_ecustom--ClassOfWarrantOrRightPriceOfWarrantsOrRights_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_pdd" title="Price of warrant">1.00</span> per warrant. Such warrants would be identical to the Private Placement Warrants.
In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to
repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December&#160;31,
2022 and 2021, there were <span id="xdx_901_ecustom--MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_iI_pp0p0_do_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--WorkingCapitalLoansWarrantMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_z5Mq9VxhXbyd" title="Maximum borrowing capacity of related party promissory note"><span id="xdx_903_ecustom--MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_iI_pp0p0_do_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--WorkingCapitalLoansWarrantMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_zGBj4iPb25Ha" title="Maximum borrowing capacity of related party promissory note">no</span></span> amounts outstanding under the Working Capital Loans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338309824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zJJyEZ35MR49" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            17 &#8211; <span><span id="xdx_828_zxnRMO3h1XN7">Commitments and Contingencie</span>s</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Litigation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
conditions may exist as of the date the financial statements are issued which may result in a loss to the Company, but which will only
be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment
inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the
Company, or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings
or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability
can be estimated, then the estimated liability would be accrued in the Company&#8217;s financial statements. If the assessment indicates
that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then
the nature of the contingent liability and an estimate of the range of possible losses, if determinable and material, would be disclosed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
contingencies considered remote are generally not disclosed, unless they involve guarantees, in which case the guarantees would be disclosed.
There can be no assurance that such matters will not materially and adversely affect the Company&#8217;s business, financial position,
and results of operations or cash flows.</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z7vAgnHWSr26" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8212; <span id="xdx_82D_z3QBY4QkvWs1">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Various
social and political circumstances in the United States and around the world (including wars and other forms of conflict, including rising
trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the United States
and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such
as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility
and economic uncertainties or deterioration in the United States and worldwide. Specifically, the rising conflict between Russia and
Ukraine, and resulting market volatility could adversely affect the Company&#8217;s ability to complete a Business Combination. In response
to the conflict between Russia and Ukraine, the United States and other countries have imposed sanctions or other restrictive actions
against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could
have a material adverse effect on the Company&#8217;s ability to complete a Business Combination and the value of the Company&#8217;s
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
continues to evaluate the impact of these types of risks and has concluded that while it is reasonably possible that these risks and
uncertainties could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target
company, the specific impact is not readily determinable as of the date of these consolidated financial statements. The consolidated
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Inflation
Reduction Act of 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August&#160;16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;) was signed into federal law. The IR Act provides
for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations
and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January&#160;1, 2023. The excise
tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise
tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating
the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair
market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department
of the Treasury (the &#8220;Treasury&#8221;) has been given authority to provide regulations and other guidance to carry out and prevent
the abuse or avoidance of the excise tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
redemption or other repurchase that occurs after December&#160;31, 2022, in connection with a Business Combination, extension vote or
otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection
with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of
the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business
Combination, (iii) the nature and amount of any &#8220;PIPE&#8221; or other equity issuances in connection with a Business Combination
(or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination)
and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the
Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing
could cause a reduction in the cash available on hand to complete a Business Combination and in the Company&#8217;s ability to complete
a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a registration rights agreement entered into on December&#160;14, 2020, the holders of the Founder Shares, Private Placement
Warrants and securities that may be issued upon conversion of Working Capital Loans will be entitled to registration rights pursuant
to a registration rights agreement. The holders of at least <span id="xdx_906_ecustom--MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands_c20201201__20201214_pdd" title="Minimum percentage of founder share holders entitled to make demands">30%</span>
in interest of these securities will be entitled to make up to three <span id="xdx_907_ecustom--MaximumNumberOfDemandsForRegistrationOfSecurities_iI_c20201214_z54hT6zpgLWa" style="display: none" title="Maximum number of demands for registration of securities">3</span> demands, excluding short form registration demands, that we
register such securities for sale under the Securities Act. In addition, these holders will have certain &#8220;piggy-back&#8221;
registration rights to include their securities in other registration statements filed subsequent to the completion of a Business
Combination and rights to require us to register for resale such securities pursuant to Rule&#160;415 under the Securities Act. The
Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriting
Agreement</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters were entitled to a deferred fee of $<span id="xdx_902_ecustom--DeferredFeePerUnit_c20221231_pdd" title="Deferred fee per unit">0.35</span> per Unit, or up to $<span id="xdx_90F_ecustom--DeferredOfferingCostsNoncurrent_iI_pp0p0_c20211231_z3rqmbkjDVGa" title="Deferred underwriting fee payable">9,660,000</span> in the aggregate. The deferred fee was to become
payable to the underwriters from the amounts held in the Trust Account in the event that the Company completed a Business Combination,
subject to the terms of the underwriting agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June&#160;9, 2022, one of the underwriters waived its entitlement to the payment of any deferred fee to be paid under the terms of the
underwriting agreement and is no longer serving in an advisor capacity. As a result, the Company recognized $<span id="xdx_909_ecustom--IncomeRecognizedFromReductionOfDeferredUnderwriterFee_c20220601__20220609_pp0p0" title="Income recognized from reduction of deferred underwriter fee">9,660,000</span> of income in relation
to the reduction of the deferred underwriter fee in the accompanying consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Merger
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;25, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), by and among
the Company, Inpixon, a Nevada corporation (&#8220;Inpixon&#8221;), CXApp Holding Corp., a Delaware corporation and wholly-owned subsidiary
of Inpixon (&#8220;CXApp&#8221; and, together with Inpixon, collectively, the &#8220;Companies&#8221;), and Merger Sub, pursuant to which
the Company will combine with CXApp, Inpixon&#8217;s enterprise apps business (including its workplace experience technologies, indoor
mapping, events platform, augmented reality and related business solutions) (the &#8220;Enterprise Apps Business&#8221;). Also on September&#160;25,
2022, and in connection with the execution of the Merger Agreement, the Company, Inpixon, CXApp and the Sponsor entered into that certain
sponsor support agreement (the &#8220;Sponsor Support Agreement&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
prior to the Merger (as defined below) and pursuant to a Separation and Distribution Agreement, dated as of September&#160;25, 2022,
among the Company, Inpixon, CXApp and Design Reactor, Inc., a California corporation (&#8220;Design Reactor&#8221;) (the &#8220;Separation
Agreement&#8221;), and other ancillary conveyance documents, Inpixon will, among other things and on the terms and subject to the conditions
of the Separation Agreement, transfer the Enterprise Apps Business, including certain related subsidiaries of Inpixon, including Design
Reactor, to CXApp (the &#8220;Reorganization&#8221;) and, in connection therewith, will distribute (the &#8220;Distribution&#8221;) to
Inpixon stockholders and other security holders 100% of the common stock of CXApp, par value $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220925__us-gaap--StatementEquityComponentsAxis__custom--CXAppCommonStockMember_zGG8DefANBxg" title="Common stock, par value (in dollars per share)">0.00001</span> (the &#8220;CXApp Common Stock&#8221;),
as further described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
following the Distribution, in accordance with and subject to the terms and conditions of the Merger Agreement, Merger Sub will merge
with and into CXApp (the &#8220;Merger&#8221;), with CXApp continuing as the surviving company in the Merger and as a wholly-owned subsidiary
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement, along with the Separation Agreement and the other transaction documents to be entered into in connection therewith,
provides for, among other things, the consummation of the following transactions (collectively, the &#8220;Business Combination&#8221;):
(i) Inpixon will transfer the Enterprise Apps Business (the &#8220;Separation&#8221;) to its wholly-owned subsidiary, CXApp, and contribute
$<span id="xdx_90F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_pp0n3_dm_c20220925__srt--CounterpartyNameAxis__custom--InpixonMember__us-gaap--TypeOfArrangementAxis__custom--SeparationAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zgwpD32BjIt2" title="Cash Contribution upon seperation">10</span> million in capital thereto (the &#8220;Cash Contribution&#8221;), (ii) following the Separation, Inpixon will distribute <span id="xdx_90A_ecustom--PercentageOfCommonStockDistributed_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_pdd" title="Percentage of common stock distributed">100%</span> of
the shares of CXApp Common Stock to Inpixon stockholders and other security holders by way of the distribution and (iii) following the
completion of the foregoing transactions and subject to the satisfaction or waiver of certain other conditions set forth in the Merger
Agreement, the parties shall consummate the Merger. The Separation, Distribution and Merger are intended to qualify as &#8220;tax-free&#8221;
transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of the Business Combination, the Company will have two classes of common stock: Class A common stock, par value $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_c20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common stock, par value (in dollars per share)">0.0001</span>
per share (the &#8220;Company&#8217;s Class A Common Stock&#8221;), and Class C common stock, par value $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_c20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Common stock, par value (in dollars per share)">0.0001</span> per share (the &#8220;Company&#8217;s
Class C Common Stock&#8221; and together with the Company&#8217;s Class A Common Stock, the &#8220;Company&#8217;s Common Stock&#8221;).
The Company&#8217;s Class A Common Stock and the Company&#8217;s Class C Common Stock will be identical in all respects, except that
the Company&#8217;s Class C Common Stock will be subject to transfer restrictions and will automatically convert into Company&#8217;s
Class A Common Stock on the earlier to occur of (i) the <span id="xdx_90F_ecustom--MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_z9CooSiozhrc" title="Maximum term for automatic conversion of stock following the closing of the Merger">180</span>th day following the closing of the Merger and (ii) the day that the last
reported sale price of the Company&#8217;s Class A Common Stock equals or exceeds $<span id="xdx_906_ecustom--CommonStockStockPriceTrigger_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zmfc5C4n4Cxf" title="Stock price trigger">12.00</span> per share for any <span id="xdx_90B_ecustom--ThresholdTradingDays_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_z18vCC1eSJx5" title="Threshold trading days">20</span> trading days within any
<span id="xdx_906_ecustom--ThresholdConsecutiveTradingDays_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_ztl2WmhDMSqi" title="Threshold consecutive trading days">30</span>-trading day period following the closing of the Merger. The Company&#8217;s Class A Common Stock will be listed on the Nasdaq Capital
Market (&#8220;Nasdaq&#8221;) and are expected to be trading under a new ticker symbol. The outstanding warrants of the Company will
be listed on Nasdaq and are expected to be trading under a new ticker symbol.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Consideration
Paid</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time the Business Combination is effected (the &#8220;Closing&#8221;), the outstanding shares of CXApp Common Stock after the Distribution
and immediately prior to the effective time of the Merger will be converted into an aggregate of <span id="xdx_903_ecustom--NumberOfSharesIssuableUponMerger_iI_pdn3_dm_c20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zOpnlBGcXtt3" title="Number of shares issuable upon merger">6.9</span> million shares of The Company&#8217;s
Common Stock which shall be issued to Inpixon shareholders, subject to adjustment. Each holder&#8217;s aggregate merger consideration
will consist of <span id="xdx_901_ecustom--PercentageOfStockAsMergerConsideration_c20220901__20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zJP9vPMVMYH9" title="Percentage of stock as merger consideration">10%</span> Company&#8217;s Class A Common Stock and <span id="xdx_903_ecustom--PercentageOfStockAsMergerConsideration_c20220901__20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_pdd" title="Percentage of stock as merger consideration">90%</span> Company&#8217;s Class C Common Stock (such percentages, in each case,
subject to adjustment to comply with the listing requirements set forth under Nasdaq Listing Rule&#160;5505(b)(2) with respect to KINS).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Representations
and Warranties &amp; Covenants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement, the Company, CXApp and Inpixon each made representations and warranties customary for transactions of this type
regarding themselves and their respective businesses. The representations and warranties made pursuant to the Merger Agreement will not
survive the Closing. In addition, the parties to the Merger Agreement agreed to be bound by certain covenants that are customary for
transactions of this type. The covenants made under the Merger Agreement generally will not survive the Closing, with the exception of
certain covenants and agreements that by their terms are to be performed in whole or in part after the Closing, which will survive in
accordance with the terms of the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conditions
to Closing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consummation of the Business Combination is subject to conditions customary for transactions involving special purpose acquisition companies,
including, among others: (i) there is not in force any order, judgment, injunction, decree, writ, stipulation, determination or award,
in each case, entered by or with any governmental authority of competent jurisdiction, statute, rule or regulation enjoining or prohibiting
the consummation of the Merger, (ii) the Company shall have at least $<span id="xdx_908_ecustom--ThresholdNetTangibleAssets_c20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_pp0p0" title="Threshold net tangible assets">5,000,001</span> of net tangible assets as of the Closing, (iii) the Company&#8217;s
Class A Common Stock issuable pursuant to the Business Combination shall have been approved for listing on Nasdaq, (iv) CXApp and the
Company shall each have performed and complied in all material respects with the covenants required by the Merger Agreement to be performed
by it as of or prior to Closing, (v) customary bring down conditions related to the accuracy of the CXApp&#8217;s and the Company&#8217;s
respective representations and warranties in the Merger Agreement, (vi) the consummation of the Distribution, the Reorganization and
other transactions contemplated by the Separation and Distribution Agreement, (vii) the Company&#8217;s registration statement to be
filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) shall have become effective (and no stop order suspending effectiveness
have been issued and no proceedings for that purpose has been initiated or threatened by the SEC), (viii) each of the Company&#8217;s
and CXApp&#8217;s stockholder approvals shall have been obtained and (ix) the sum of (A) the aggregate amount of cash available in KINS&#8217;s
trust account following the Company&#8217;s stockholders&#8217; meeting, after deducting the amount required to satisfy the Acquiror
Share Redemption Amount (as defined in the Merger Agreement) (but prior to payment of any transaction expenses), (B) the aggregate gross
purchase price of any other purchase of shares of the Company&#8217;s Common Stock (or securities convertible or exchangeable for the
Company&#8217;s Common Stock) actually received by the Company prior to or substantially concurrently with the closing of the Merger,
and (C) the aggregate gross purchase price of any other purchase of shares of CXApp Common Stock (or securities convertible or exchangeable
for CXApp Common Stock) actually received by CXApp prior to or substantially concurrently with the closing of the Merger, shall be equal
to or greater than $<span id="xdx_901_ecustom--ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares_pp0n3_dm_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zozBBC4g4UI6" title="Threshold aggregate gross purchase price of any other purchase of shares">9.5</span> million. The Company&#8217;s obligation to consummate the Business Combination is also conditioned on there having
been no event that has had, or would reasonably be expected to have, individually or in the aggregate, a &#8220;Material Adverse Effect&#8221;
on CXApp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Termination</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing, including (i)
by the mutual written consent of the Company and CXApp, (ii) by the Company or CXApp, if the Closing shall not have occurred on or before
March&#160;16, 2023, (iii) by the Company or CXApp, if there has been any order, judgment, injunction, decree, writ, stipulation, determination
or award, in each case, entered by or with any governmental authority that would make the Merger illegal or otherwise prevent or prohibit
the Merger, (iv) by the Company or CXApp, if KINS has not obtained the requisite approval from its stockholders, (v) by KINS or CXApp
if the other party breaches certain representations, warranties, or covenants, as specified in the Merger Agreement, and that breach
is unable to be cured, or is not cured, within <span id="xdx_904_ecustom--TermOfBreachUnableToBeCuredOrIsNotCured_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zgtlwRhE9w7i" title="Term of breach unable to be cured, or is not cured">30</span> days, or by CXApp if there has been an uncured breach by Sponsor of certain of its
obligations under the Sponsor Support Agreement or (vi) by the Company if CXApp has not obtained the requisite approval from its stockholders
within one hour of the effective date of the Company&#8217;s registration statement, provided that CXApp or the Company pay a termination
fee of $<span id="xdx_901_ecustom--TerminationFee_pp0n3_dm_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zcm6CsTaMVPh" title="Termination fee">2.0</span> million to the other party if the Merger Agreement is terminated pursuant to (v) or (vi) above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Separation
and Distribution Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;25, 2022, in connection with the execution of the Merger Agreement, the Company entered into the Separation Agreement
with CXApp, Inpixon and Design Reactor, pursuant to which, among other things, (i) Inpixon will undertake a series of internal reorganization
and restructuring transactions to effect the transfer of its (direct or indirect) ownership of the Enterprise Apps Business to CXApp
in the Separation and (ii) immediately prior to the Merger and after the Separation, Inpixon will distribute 100% of the outstanding
shares of CXApp Common Stock to Inpixon&#8217;s stockholders and certain other security holders in the Distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Separation Agreement also sets forth other agreements among Inpixon and CXApp related to the Separation, including provisions concerning
the termination and settlement of intercompany accounts and the obtaining of third-party consents. The Separation Agreement also sets
forth agreements that will govern certain aspects of the relationship between Inpixon and CXApp after the Distribution, including provisions
with respect to release of claims, indemnification, access to financial and other information and access to and provision of records.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consummation
of the Distribution is subject to a number of conditions, including, among others, (i) the completion of the Reorganization and other
related transactions, (ii) the execution of the ancillary agreements by the parties and (iii) the satisfaction or waiver of all conditions
under the Merger Agreement (other than those conditions that are to be satisfied contemporaneously with the Distribution and/or the Merger,
provided that such conditions are capable of being satisfied at such time).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sponsor
Support Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;25, 2022, in connection with the execution of the Merger Agreement, the Company, Inpixon, CXApp and the Sponsor entered
into the Sponsor Support Agreement, pursuant to which, among other things, the Sponsor agreed to vote any of the Company&#8217;s securities
held by it to approve the Business Combination and the other of the Company&#8217;s stockholder matters required pursuant to the Merger
Agreement, and not to seek redemption of any of the Company&#8217;s securities in connection with the consummation of the Business Combination.
Pursuant to the Sponsor Support Agreement, the Sponsor and the Company also agreed to amend the letter agreement, dated as of December&#160;14,
2020 between the Sponsor and the Company (the &#8220;Insider Letter&#8221;) to amend the Founder Shares Lock-Up Period (as defined in
the Insider Letter) to provide for lock-up of its shares of the Company&#8217;s Class B common stock, par value $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20201214__us-gaap--TransactionTypeAxis__custom--MergerAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zjM90cv4eljd" title="Common stock, par value (in dollars per share)">0.0001</span> per share (&#8220;Company&#8217;s
Class B Common Stock&#8221;) (or Company&#8217;s Class A Common Shares issuable upon conversion thereof) until the earlier of (A) the
<span id="xdx_90A_ecustom--CommonStockLockUpPeriod_dtD_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zjPs1ggtZaWk" title="Lock-up period">180</span>th day after the closing of the Merger and (B) (x) the date on which the Company completes a liquidation, merger, stock exchange,
reorganization or other similar transaction following the closing of the Merger or (y) the day that the last reported sale price of the
Company&#8217;s Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any <span id="xdx_90C_ecustom--ThresholdTradingDays_dtD_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zIzaBI3ZCH02" title="Threshold trading days">20</span> trading days within any <span id="xdx_906_ecustom--ThresholdConsecutiveTradingDays_dtD_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zVfWYSgOx60b" title="Threshold consecutive trading days">30</span>-trading day period following the Closing of the Merger; provided,
that <span id="xdx_908_ecustom--PercentageOfSharesNotBeSubjectToForegoingLockUp_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_pdd" title="Percentage of shares not be subject to foregoing lock-up">22%</span> of such shares (subject to adjustment) shall not be subject to foregoing lock-up. Additionally, Sponsor has agreed to exchange
<span id="xdx_900_ecustom--NumberOfSharesExchanged_c20201201__20201214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--TypeOfArrangementAxis__custom--SponsorSupportAgreementMember_pdd" title="Number of shares exchanged">6,150,000</span> shares of the Company&#8217;s Class B Common Stock, equal to such that the number of shares of the Company&#8217;s Common Stock
issued as aggregate merger consideration exceeds (by one share): (i) the aggregate number of shares of the Company&#8217;s Class A Common
Stock held by Sponsor at Closing (after taking into the exchange), plus (ii) the aggregate number of shares of the Company&#8217;s Class
B Common Stock held by certain funds and accounts managed by BlackRock, Inc. (including all Potential Forfeiture Shares (as defined in
the Sponsor Support Agreement)), plus (iii) the aggregate number of shares of the Company&#8217;s Class A Common Stock that have not
properly elected to redeem their shares of the Company&#8217;s Class A Common Stock pursuant to the Company&#8217;s governing documents,
plus (iii) any shares of the Company&#8217;s Common Stock issued as incentives for non-redemption transactions and financing transactions,
in each case, free and clear of all liens; provided, that, in no instance shall the number of shares issued to Sponsor in the exchange
be less than <span id="xdx_901_ecustom--MinimumNumberOfSharesIssuableToSponsor_c20201201__20201214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SponsorSupportAgreementMember_pdd" title="Minimum number of shares issuable to sponsor">5,150,000</span> shares of the Company&#8217;s Class A Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338013440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; DEFICIT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; DEFICIT</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zI2iVJ20rS6h" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8212; <span id="xdx_824_zDKdRnHUFGxg">STOCKHOLDERS&#8217; DEFICIT</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock &#8212;</i></b> The Company is authorized to issue <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_zcQUOsD0Hrp2" title="Preferred shares, shares authorized"><span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231_ze8W0FVGF7mg" title="Preferred shares, shares authorized">2,000,000</span></span> shares of preferred stock with a par value of $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_zFZX3IpXUdq3" title="Preferred stock, par value, (per share)"><span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211231_zr7lhwkFBXL6" title="Preferred stock, par value, (per share)">0.0001</span></span> per share with
such designations, voting and other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors.
At December&#160;31, 2022 and 2021, there were <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zKMsp8u8YjIg" title="Preferred shares, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_do_c20211231_zDNWwjvaOjpj" title="Preferred shares, shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_z760sd5L7v8j" title="Preferred shares, shares outstanding"><span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20211231_zUsZktTTQVDe" title="Preferred shares, shares outstanding">no</span></span></span></span> shares of preferred stock issued or outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Class
A Common Stock &#8212;</i></b> The Company is authorized to issue <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zbO4RlY8I2l4" title="Common shares, shares authorized (in shares)"><span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zzXogzOYJVll" title="Common shares, shares authorized (in shares)">100,000,000</span></span>
shares of Class A common stock with a par value of $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zDtBAcLoSRY2" title="Common shares, par value (in dollars per share)"><span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zwvkxdQ4OJS9" title="Common shares, par value (in dollars per share)">0.0001</span></span>
per share. Holders of Class A common stock are entitled to one <span id="xdx_90E_ecustom--CommonStockNumberOfVotesPerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zI45fHn3Mbl3" style="display: none" title="Common shares, votes per share">1</span> vote for each share. At December&#160;31, 2022 and 2021, there were
<span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_zBukIontxXpl" title="Common shares, shares issued (in shares)"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_zaFOQeWfH6Wk" title="Common shares, shares outstanding (in shares)">387,551</span></span> and <span id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_z4a5pWJIC34i" title="Common shares, shares issued (in shares)"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_zsrU0JPNRUu" title="Common shares, shares outstanding (in shares)">27,600,000</span></span> shares of Class A common stock issued and outstanding which are subject to possible redemption and presented
as temporary equity, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Class
B Common Stock &#8212;</i></b> The Company is authorized to issue <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhsvbxMYlgPd" title="Common shares, shares authorized (in shares)"><span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zySZYhJYIMzj" title="Common shares, shares authorized (in shares)">20,000,000</span></span>
shares of Class B common stock with a par value of $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zBUJQ00hgFSd" title="Common shares, par value (in dollars per share)"><span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z66M5u3oDxZh" title="Common shares, par value (in dollars per share)">0.0001</span></span>
per share. Holders of Class B common stock are entitled to one <span id="xdx_90D_ecustom--CommonStockNumberOfVotesPerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zlQmTpI51E0l" style="display: none" title="Common shares, votes per share">1</span> vote for each share. At December&#160;31, 2022 and 2021, there were <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zsfPDiDxRCJ2" title="Common shares, shares issued (in shares)"><span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zTeHSgb5LETd" title="Common shares, shares issued (in shares)"><span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zRnlapfUCC5j" title="Common shares, shares outstanding (in shares)"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zBmYF8QAHi9b" title="Common shares, shares outstanding (in shares)">6,900,000</span></span></span></span>
shares of Class B common stock issued and outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
holders of the Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders
of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of
our stockholders except as otherwise required by law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>









<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier
at the option of the holder (except for any Founder Shares held by the Direct Anchor Investors who have agreed not to effect a conversion
with respect to such Founder Shares until the consummation of the initial Business Combination), on a one-for-one basis, subject to adjustment.
In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the
amounts issued in the Initial Public Offering and related to the closing of a Business Combination (including pursuant to a specified
future issuance), the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted
(unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment with respect
to any such issuance or deemed issuance, including pursuant to a specified future issuance) so that the number of shares of Class A common
stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, <span id="xdx_90F_ecustom--ConvertibleStockConversionRatio_c20220101__20221231_pdd" title="Ratio to be applied to the stock in the conversion">20%</span> of the
sum of the total number of all shares of common stock outstanding upon the completion of Initial Public Offering plus all shares of Class
A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or
equity-linked securities issued or issuable to any seller in a Business Combination).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655337987712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE WARRANT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE WARRANT LIABILITIES</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zEDEffAVJVlh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8212; <span id="xdx_827_z11alReubFy2">DERIVATIVE WARRANT LIABILITIES</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2022 and 2021 there were <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_c20221231_pdd" title="Warrants outstanding"><span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_c20211231_pdd" title="Warrants outstanding">13,800,000</span></span> Public Warrants outstanding and <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_pdd" title="Warrants outstanding"><span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_pdd" title="Warrants outstanding">10,280,000</span></span> Private Placement Warrants Outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and
only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) <span id="xdx_90D_ecustom--WarrantExercisePeriodConditionOne_dtD_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zKY7y4YgAJ4" title="Warrant exercise period condition one">30</span>
days after the completion of a Business Combination and (b) <span id="xdx_90B_ecustom--WarrantExercisePeriodConditionTwo_dtM_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zwIuyZeE7t51" title="Warrant exercise period condition two">12</span>
months from the closing of the Initial Public Offering. The Public Warrants will expire five <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zIosOuh7nGEi" style="display: none" title="Public Warrants expiration term">5</span> years after the completion of a
Business Combination or earlier upon redemption or liquidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation
to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class
A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying
its obligations with respect to registration. No warrant will be exercisable, and the Company will not be obligated to issue shares of
Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has agreed that as soon as practicable, but in no event later than <span id="xdx_905_ecustom--MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement_dtD_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zpulS8OQokC1" title="Maximum period after business combination in which to file registration statement">20</span> business days after the closing of a Business Combination,
the Company will use its commercially reasonable efforts to file, and within <span id="xdx_903_ecustom--PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective_dtD_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zV5yGGrWOYg7" title="Period of time within which registration statement is expected to become effective">60</span> business days following a Business Combination to have
declared effective, a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable
upon exercise of the warrants. The Company will use its commercially reasonable efforts to maintain the effectiveness of such registration
statement and a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. Notwithstanding
the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such
that it satisfies the definition of a &#8220;covered security&#8221; under Section&#160;18(b)(1) of the Securities Act, the Company may,
at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance
with Section&#160;3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or
maintain in effect a registration statement, but we will be required to use our commercially reasonable efforts to register or qualify
the shares under applicable blue sky laws to the extent an exemption is not available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemptions
of warrants when the price of Class A common stock equals or exceeds $<span id="xdx_907_ecustom--WarrantRedemptionConditionMinimumSharePrice_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_pdd" title="Warrant redemption condition minimum share price">18.00</span></i> &#8212; Once the warrants become exercisable, the Company
may redeem the Public Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
whole and not in part;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
a price of $<span id="xdx_900_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd" title="Redemption price per public warrant (in dollars per share)">0.01</span> per warrant;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
not less than 30 days&#8217; prior written notice of redemption, or the <span id="xdx_90F_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zoMnAYyBDLe7" title="Threshold consecutive trading days for redemption of public warrants">30</span>-day redemption period, to each warrant holder; and</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
and only if, the reported last sale price of the Company&#8217;s Class A common stock equals or exceeds $<span id="xdx_90C_ecustom--WarrantRedemptionConditionMinimumSharePrice_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd" title="Warrant redemption condition minimum share price">18.00</span> per share (as adjusted
for stock splits, stock dividends, reorganizations, recapitalizations, and the like) for any <span id="xdx_903_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zVsyX4XcoOqj" title="Threshold trading days for redemption of public warrants">20</span> trading days within a <span id="xdx_900_ecustom--RedemptionPeriod_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zNBr8S9w5ysk" title="Redemption period">30</span>-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
of warrants when the price per share of Class A common stock equals or exceeds $<span id="xdx_903_ecustom--WarrantRedemptionConditionMinimumSharePriceScenarioTwo_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_pdd" title="Warrant redemption condition minimum share price scenario two">10.00</span> &#8211;</i> Once the warrants become exercisable,
the Company may redeem the outstanding warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
whole and not in part;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
a price of $<span id="xdx_906_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_pdd" title="Redemption price per public warrant (in dollars per share)">0.10</span> per warrant provided that holders will be able to exercise their warrants prior to redemption and receive that number
of shares of Class A common stock determined based on the redemption date and the &#8220;fair market value&#8221; of the Company&#8217;s
Class A common stock;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
not less than 30 days&#8217; prior written notice of redemption, or the <span id="xdx_903_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zTOqUocrJej" title="Threshold consecutive trading days for redemption of public warrants">30</span>-day redemption period;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
and only if, the last reported sale price of the Company&#8217;s Class A common stock equals or exceeds $<span id="xdx_901_ecustom--WarrantRedemptionConditionMinimumSharePriceScenarioTwo_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" title="Warrant redemption condition minimum share price scenario two">10.00</span> per share (as adjusted
for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the
Company sends the notice of redemption to the warrant holders;</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise
of the warrants and a current prospectus relating thereto is available throughout the <span id="xdx_90A_ecustom--RedemptionPeriod_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zXBtww4vpE11" title="Redemption period">30</span>-day period after the written notice of redemption
is given.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes
in connection with the closing of a Business Combination at an issue price or effective issue price of less than $<span id="xdx_908_ecustom--SharePricetriggerUsedToMeasureDilutionOfWarrant_c20221231_pdd" title="Share PriceTrigger Used To Measure Dilution Of Warrant">9.20</span> per share of Class
A common stock (with such issue price or effective issue price to be determined in good faith by the Company&#8217;s board of directors,
and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor
or its affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from
such issuances represent more than <span id="xdx_901_ecustom--PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant_c20220101__20221231_pdd" title="Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant">60%</span> of the total equity proceeds, and interest thereon, available for the funding of a Business Combination
on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the
Company&#8217;s Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company
completes a Business Combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, the exercise price of the warrants
will be adjusted (to the nearest cent) to be equal to <span id="xdx_901_ecustom--WarrantExercisePriceAdjustmentMultiple_c20220101__20221231_pdd" title="Warrant exercise price adjustment multiple">115%</span> of the higher of the Market Value and the Newly Issued Price, and the $18.00
per share redemption trigger price will be adjusted (to the nearest cent) to be equal to <span id="xdx_903_ecustom--WarrantRedemptionPriceAdjustmentMultiple_c20220101__20221231_pdd" title="Warrant redemption price adjustment multiple">180%</span> of the higher of the Market Value and the
Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted will be adjusted (to the nearest cent) to be equal
to the higher of the Market Value and the Newly Issued Price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2022 and 2021 there were <span id="xdx_90F_ecustom--NumberOfWarrantsIssued_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zrPvNSsJQb04" title="Number of warrants issued"><span id="xdx_900_ecustom--NumberOfWarrantsIssued_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z0otJ00KClji" title="Number of warrants issued">10,280,000</span></span> Private Placement Warrants outstanding. The Private Placement Warrants are identical
to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the shares
of Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable
until <span id="xdx_90F_ecustom--RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_dtD_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zrXuMuSdI9ha" title="Restrictions on transfer period of time after business combination completion">30</span> days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement
Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial
purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or
their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the
same basis as the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655337930752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAX</a></td>
<td class="text"><p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zi27H6MNvap6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            13 &#8211; <span id="xdx_828_z5DrixpnJT98">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company recorded an income tax benefit of
approximately $<span id="xdx_90D_ecustom--IncomeTaxBenefitprovision_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zqiJeTBvEli8" title="Income tax benefit/(provision)">1,560</span> thousand for the period ended March 31, 2023 (Successor). The Company recorded an income tax expense of approximately
$<span id="xdx_90D_ecustom--IncomeTaxBenefitprovision_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zMIdmVgyll" title="Income tax benefit/(provision)">0</span> thousand and $<span id="xdx_90F_ecustom--IncomeTaxBenefitprovision_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zFSCLOziUpod" title="Income tax benefit/(provision)">100</span> thousand for the period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022 (Predecessor),
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The effective tax rate for period ended March 31, 2023 (Successor)
was approximately (<span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zKPxfDx39M04" title="Effective tax rate">164.0%</span>). The income tax benefit, and negative effective tax rate, for the period ended March 31, 2023 (Successor) is
a result of the release of valuation allowance attributable to acquired intangible assets from the Business Combination. The Company acquired
approximately $<span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Deferred tax liability">4,337</span> thousand of deferred tax liability associated with the Business Combination. As a result of the Company released
its valuation allowance as deferred tax assets will become realizable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<span></span>
</td>
<td class="text"><p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_z1s0BM0UfUQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8212; <span id="xdx_829_zR8i78vii3M4">INCOME TAX</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s net deferred tax assets are as follows as of December&#160;31, 2022 and 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z9RDlEVPdePk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details)">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B0_zft8pkkbm5w8" style="display: none">Schedule of Company's net deferred tax assets</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20221231_zszdqVXesDWf" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20211231_zloN0f9oOWt8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNetOfValuationAllowanceAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_i01I_pp0p0_maDTAGzH2n_zJZsPEnXuOj9" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left">Organizational costs/startup expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">924,537</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">322,963</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzH2n_z83CmBuNPOZ2" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Net operating loss carryforward</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1069">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28,689</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_mtDTAGzH2n_maDTANzcuz_zfIn9amPvV82" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">924,537</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">351,652</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di_msDTANzcuz_zXJTTxY4oi33" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(924,537</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(351,652</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_mtDTANzcuz_zU4RTzO2VSyh" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Deferred tax asset, net of allowance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1078">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1079">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zJAMNsc6dsP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax provision consists of the following for the years ended December&#160;31, 2022 and 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYSYFdTFxEch" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B4_zXy6iR0jPuOb" style="display: none">Schedule of income tax provision</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20220101__20221231_zX2KOWuZTfga" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20210101__20211231_z2x1GBkFAzl" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zNtjJVGYBcp2" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">49,175</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1087">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zjsFhKNWOmr9" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(572,885</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(300,205</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--StateAndLocalAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">State and Local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zPC3k8mPn9t4" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1095">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1096">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zLND9QSxl1V2" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1098">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1099">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_i01N_pp0p0_di_msITEBzXu4_z54jCOYWgLf1" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">572,885</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">300,205</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXu4_zFkYyLe9CNyc" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Income tax provision</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">49,175</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zQsJ1tkCFRn7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2022 and 2021, the Company had U.S. federal net operating loss carryover of approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Operating loss carryforwards">0</span> and $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_c20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Operating loss carryforwards">137,000</span> available
to offset future taxable income indefinitely, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all
of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of
future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible.
Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies
in making this assessment. After consideration of all of the information available, management believes that significant uncertainty
exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the
year ended December&#160;31, 2022 and 2021, the change in the valuation allowance was $<span id="xdx_90A_eus-gaap--DeferredTaxAssetsValuationAllowance_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Change in valuation allowance">572,885</span> and $<span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_c20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Change in valuation allowance">300,205</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the federal income tax rate to the Company&#8217;s effective tax rate for the years ended December&#160;31, 2022 and
2021 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zlhQov4oX2Ne" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details 2)">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BB_zwCBpaYt83ld" style="display: none">Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Statutory federal income tax rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20221231_zFtLmiIvZ26f" title="Statutory federal income tax rate">21</span>.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231_zCwUfSn3qwO3" title="Statutory federal income tax rate">21</span>.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">State taxes, net of federal tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20220101__20221231_z79RxeKSIjx" title="State taxes, net of federal tax benefit">0.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20210101__20211231_zh6TFuXVlok" title="State taxes, net of federal tax benefit">0.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Transaction costs allocated to derivative warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_dp_c20220101__20221231_zmbK1VPPXoVk" title="Transaction costs allocated to derivative warrant liabilities">0.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_dp_c20210101__20211231_zX1y4EtnpWIj" title="Transaction costs allocated to derivative warrant liabilities">0.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in fair value of derivative warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_dp_c20220101__20221231_zfZxnyCwqHsa" title="Change in fair value of derivative warrant liabilities">(23.9</span></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_dp_c20210101__20211231_zxi5rbQvqu3c" title="Change in fair value of derivative warrant liabilities">(24.3</span></td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20221231_zNuNGX5EssVe" title="Valuation allowance">3.2</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210101__20211231_z84014VhQuT" title="Valuation allowance">3.3</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Income tax provision</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20221231_znxEB3DdQHq1" title="Income tax provision">0.3</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20211231_zskHnT7LV0C" title="Income tax provision">0.0</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p id="xdx_8A9_zvM7s5Ue5cNg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files income tax returns in the U.S. federal jurisdiction in various state and local jurisdictions and is subject to examination
by the various taxing authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338126032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--FairValueDisclosuresTextBlock_z35Sy0q81rx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>NOTE
                                            12 &#8211; <span id="xdx_82A_zhmle8mvvbWl">Fair Value of Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company&#8217;s estimates of fair value for financial assets and financial
liabilities are based on the framework established in ASC 820. The Company noted that the only financial asset or financial liability
that is subject to the fair value framework established in ASC 820 are the Warrant Liabilities (Note 10). The framework is based on the
inputs used in valuation and gives the highest priority to quoted prices in active markets and requires that observable inputs be used
in the valuations when available. The disclosure of fair value estimates in the ASC 820 hierarchy is based on whether the significant
inputs into the valuation are observable. In determining the level of the hierarchy in which the estimate is disclosed, the highest priority
is given to unadjusted quoted prices in active markets and the lowest priority to unobservable inputs that reflect the Company&#8217;s
significant market assumptions. The Company classified the public placement warrants recorded at fair value of on a recurring basis of
$<span id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicPlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMq2GTSKfxM1" title="Fair value of warrants">552</span> thousand as a level 1 investment, as the fair value was determined using quoted prices of the security in active markets. The Company
classified the private placement warrants liabilities recorded at fair value of $<span id="xdx_902_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNC91dQta9lf">411</span> thousand as a level 2 investment, as the fair
value was determined utilizing the observable market price for the public placement warrants as the private placement warrants are not
actively traded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
<td class="text"><p id="xdx_800_eus-gaap--FairValueDisclosuresTextBlock_zax6DXdQOwm" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 &#8212; <span id="xdx_821_znIKLQ02bgH6">FAIR VALUE MEASUREMENTS</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.6in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                              1:</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted
prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.6in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                              2:</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable
inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
and quoted prices for identical assets or liabilities in markets that are not active.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.6in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                              3:</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable
inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 &#8220;Investments
- Debt and Equity Securities.&#8221; Held-to-maturity securities are those securities which the Company has the ability and intent to
hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying consolidated balance sheets
and adjusted for the amortization or accretion of premiums or discounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December&#160;31 2022, assets held in the Trust Account consisted of $<span id="xdx_90E_eus-gaap--AssetsHeldInTrustNoncurrent_c20221231__us-gaap--FinancialInstrumentAxis__us-gaap--CashMember_pp0p0" title="Assets held in the Trust Account">3,923,804</span> held in an interest-bearing commercial checking account.
Cash held in commercial checking accounts is reported on the balance sheet at its approximate fair value. During the year ended December&#160;31,
2022, the Company withdrew $<span id="xdx_90C_ecustom--ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax_c20220101__20221231_pp0p0" title="Cash withdrawn from trust account to pay franchise tax">231,500</span> of interest income from the Trust Account for taxes and $<span id="xdx_908_ecustom--ProceedsFromTrustAccountInConnectionWithRedemption_c20220101__20221231_pp0p0" title="Cash withdrawn from trust account in connection with redemption">275,102,280</span> was withdrawn from the Trust
Account in connection with the redemption of Class A common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December&#160;31, 2021, assets held in the Trust Account were comprised of $<span id="xdx_90F_eus-gaap--AssetsHeldInTrustNoncurrent_c20211231__us-gaap--FinancialInstrumentAxis__us-gaap--CashMember_pp0p0" title="Assets held in the Trust Account">898</span> in cash and $<span id="xdx_905_eus-gaap--AssetsHeldInTrustNoncurrent_c20211231__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember_pp0p0" title="Assets held in the Trust Account">278,835,182</span> in money market funds, respectively.
Through December&#160;31, 2021, the Company did not withdraw any interest income from the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets and liabilities that are measured at fair value on a recurring
basis at December&#160;31, 2022 and 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine
such fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z4PIr496IIQ1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BB_zpXDUooqaxq9" style="display: none">Schedule of company's assets and liabilities that are measured at fair value on a recurring basis</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="5" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="5" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Description</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Assets:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Money Market Funds</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AssetsHeldInTrustNoncurrent_c20221231__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="width: 9%; text-align: right" title="Assets held in the Trust Account"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsHeldInTrustNoncurrent_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember_pp0p0" style="width: 9%; text-align: right" title="Assets held in the Trust Account">278,835,182</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Liabilities:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Warrant liabilities &#8211; public warrants</td><td>&#160;</td>
    <td style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities">414,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities">6,461,798</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Warrant liabilities &#8211; private placement warrants</td><td>&#160;</td>
    <td style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities">308,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities">4,813,571</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zN5RHb7MXnc1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the accompanying
December&#160;31, 2022 and 2021 consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a
recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statements
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants are measured at fair value on a recurring basis. The Public Warrants were initially valued using a lattice model, specifically
a binomial lattice model incorporating the binomial lattice methodology. As of December&#160;31, 2022, the Public Warrants were valued
using the instrument&#8217;s publicly listed trading price as of the balance sheet date, which is considered to be a Level 1 measurement
due to the use of an observable market quote in an active market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placement Warrants were initially valued using a lattice model, specifically a binomial lattice model incorporating the binomial
lattice methodology, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized in determining
the fair value of the Private Placement Warrants is the expected volatility of our common stock. The expected volatility as of the Initial
Public Offering date was derived from observable public warrant pricing on comparable &#8216;blank-check&#8217; companies without an
identified target. The subsequent measurements of the Private Placement Warrants after the detachment of the Public Warrants from the
Units is classified as Level 2 due to the use of an observable market quote for a similar asset in an active market, as the transfer
of Private Placement Warrants to anyone outside of a small group of individuals who are permitted transferees would result in the Private
Placement Warrants having substantially the same terms as the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the changes in the fair value of Level 3 warrant liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zwu4cfXkCZrf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BA_zraT7XkGrG62" style="display: none">Schedule of change in the fair value of the Level 3 warrant liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Private Placement</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Public</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrant Liabilities</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Fair value as of December&#160;31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zQBCMnSg4Ycb" style="width: 9%; text-align: right" title="Fair value at beginning">9,354,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z4cUM70bNR1l" style="width: 9%; text-align: right" title="Fair value at beginning">12,558,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zj7rzQFsIys" style="width: 9%; text-align: right" title="Fair value at beginning">21,912,800</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value">(2,672,800</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value">(3,588,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value">(6,260,800</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Transfer to Level 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1">(8,970,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1">(8,970,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Transfer to Level 2</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2">(6,682,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2"><span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2">(6,682,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Fair value as of December&#160;31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zsqdPXH9bslk" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"><span style="-sec-ix-hidden: xdx2ixbrl1199">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zCwVI7FgBuw8" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zj0KR7eFqBq7" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"><span style="-sec-ix-hidden: xdx2ixbrl1203">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A3_zVCpjJuSrMIc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfers
to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs.
The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement during the
period ended December&#160;31, 2021 was approximately $<span id="xdx_903_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_pp0n3_dm_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zMkJ0VYPeTu2" title="Transfer to Level 1">9.0</span> million, when the Public Warrants were separately listed and traded and the
estimated fair value of the Private Warrants of approximately $<span id="xdx_902_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_pp0n3_dm_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zy42tSojGoCl" title="Transfer to Level 2">6.7</span> million was transferred from a Level 3 to a Level 2 fair value measurement.
There were no transfers during the year ended December&#160;31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338019600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zSNjuNmfq1l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12 &#8212; <span id="xdx_826_zFPmDdvQPfp9">SUBSEQUENT EVENTS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated
financial statements were issued. Based upon this review, other than as noted below, the Company did not identify any subsequent events
that would have required adjustment or disclosure in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January&#160;9, 2023, the Company received a notice from the Listing Qualifications Department of The Nasdaq Stock Market (&#8220;Nasdaq&#8221;)
stating that the Company failed to hold an annual meeting of stockholders within 12 months after its fiscal year ended December&#160;31,
2021, as required by Nasdaq Listing Rule&#160;5620(a). In accordance with Nasdaq Listing Rule&#160;5810(c)(2)(G), the Company had 45
calendar days (or until February&#160;23, 2023) to submit a plan to regain compliance and, if Nasdaq accepts the plan, Nasdaq may grant
the Company up to 180 calendar days from its fiscal year end, or until June&#160;29, 2023, to regain compliance. The Company submitted
a compliance plan within the specified period. While the plan is pending, the Company&#8217;s securities will continue to trade on Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January&#160;21, 2023, the Company received a written notice (the &#8220;Notice&#8221;) from the Listing Qualifications Department of
The Nasdaq Stock Market (&#8220;Nasdaq&#8221;) indicating that the Company is not in compliance with Listing Rule&#160;5550(a)(4), due
to the Company&#8217;s failure to meet the minimum 500,000 publicly held shares requirement for continued listing on the Nasdaq Capital
Market. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading
of the Company&#8217;s securities on the Nasdaq Capital Market. The Notice stated that the Company had until March&#160;9, 2023 to submit
a plan to regain compliance with Listing Rule&#160;5550(a)(4). The Company believes that the issue identified in the Notice will be resolved
upon completion of the previously announced proposed business combination with CXApp Holding Corp. The Company submitted a compliance
plan within the specified period. If Nasdaq accepts the Company&#8217;s plan, Nasdaq may grant the Company an extension of up to 180
calendar days from the date of the Notice to evidence compliance with Listing Rule&#160;5550(a)(4). If Nasdaq does not accept the Company&#8217;s
plan, the Company will have the opportunity to appeal the decision in front of a Nasdaq Hearings Panel.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338051984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization, Nature of Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Organization, Nature of Business and Basis of Presentation</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zkCn7rVV06pa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            1 &#8211; <span id="xdx_823_zpQ1i1tyFSV9">Organization, Nature of Business and Basis of Presentation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>CXApp
Inc. and its subsidiaries (&#8220;CXApp&#8221; or the &#8220;Company&#8221;) is in the business of delivering intelligent enterprise
workplace experiences. <span style="background-color: white">The CXApp SaaS platform offers a suite of leading-edge technology workplace
experience solutions including an enterprise employee application, indoor mapping, on-device positioning, augmented reality technologies
and an AI-based analytics platform, targeting the emerging hybrid workplace market to provide enhanced experiences across people, places,
and things. CXApp creates a connected workplace by reducing app overload, data fragmentation, and complex workflows and streamlines all
capabilities through The Workplace SuperApp. All features, services and integrations are housed in one easy-to-access platform allowing
businesses to deliver a more holistic employee experiences in a hybrid workplace.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The accompanying
unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting
principles in the United States of America (&#8220;GAAP&#8221;), for interim financial information and the rules and regulations of the
Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly, CXApp does not include all of the information and footnotes required
by GAAP for complete financial statements. In the opinion of CXApp, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Interim results for the three months ended March 31, 2023 are not necessarily indicative
of the results for the full year ending December 31, 2023. These interim unaudited condensed consolidated financial statement should
be read in conjunction with KINS Technology Group Inc.&#8217;s (&#8220;KINS&#8221;) audited consolidated financial statements and notes
for the year ended December 31, 2022 and 2021 included in the annual report on Form 10-K/A for the year ended December 31, 2022, filed
with the SEC on April 19, 2023, and the annual report of Legacy CXApp for the year ended December 31, 2022 and 2021 included as an exhibit
to Form 8-K filed with the SEC on March 20, 2023. All material inter-company balances and transactions have been eliminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>On September
25, 2022, an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), was entered into by and among Inpixon, KINS Technology
Group Inc., a Delaware corporation, CXApp, and KINS Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of KINS (&#8220;Merger
Sub&#8221;), pursuant to which KINS acquired Inpixon&#8217;s enterprise apps business (including its workplace experience technologies,
indoor mapping, events platform, augmented reality and related business solutions) (&#8220;Legacy CXApp&#8221;) in exchange for the issuance
of shares of KINS capital stock (the &#8220;Business Combination&#8221;). As a result of the Business Combination, KINS changed their
name to CXApp Inc. (&#8220;New CXApp&#8221;). The shares are now trading on the Nasdaq using the ticker CXAI. The transaction closed
on March 14, 2023. See Note 3 for more details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>Unless
the context otherwise requires, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;CXApp&#8221; and the &#8220;Company&#8221;
refer to CXApp Inc., a Delaware corporation, and its consolidated subsidiaries following the Business Combination (as defined below).
Unless the context otherwise requires, references to &#8220;KINS&#8221; refer to KINS Technology Group Inc., a Delaware corporation (&#8220;KINS&#8221;),
the Company prior to the Business Combination. All references herein to the &#8220;Board&#8221; refer to the board of directors of the
Company. &#8220;Legacy CXApp&#8221; refers to CXApp Holding Corp., a Delaware corporation and a wholly owned subsidiary of the Company,
which the Company acquired through the Business Combination. Prior to the Separation (as defined below), Legacy CXApp was a wholly owned
subsidiary of Inpixon, a Nevada corporation (&#8220;Inpixon&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Business
Combination was accounted for using the acquisition method (as a forward merger), with goodwill and other identifiable intangible assets
recorded in accordance with GAAP, as applicable. Under this method of accounting, the &#8220;Enterprise Apps Business&#8221; (formerly
known as CXApp) is treated as the &#8220;acquired&#8221; company for financial reporting purposes. KINS (now known as CXApp Inc.) has
been determined to be the accounting acquirer because KINS maintains control of the Board of Directors and management of the combined
company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
unaudited condensed consolidated financial statements of Successor and Predecessor are not comparable due to a new basis of accounting
that was created from the business combination that occurred on the Closing Date (Note 3). Therefore, the reporting period has been separated
by a black line in the condensed consolidated financial statements with the Predecessor representing the pre-Closing Date period (January
1, 2023 through March 14, 2023) and the Successor representing the post-Closing Date period (March 15, 2023 through March 31, 2023).
The Company noted that the &#8220;Predecessor&#8221; includes financial information related to the Enterprise Apps Business (as defined
in Note 3), while the &#8220;Successor&#8221; includes financial information related to the newly formed company after the business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338041392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination</a></td>
<td class="text"><p id="xdx_808_eus-gaap--BusinessCombinationDisclosureTextBlock_z6l5vQG58VVj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            3 &#8211; <span id="xdx_822_zylb3tY9vZZ2">Business Combination</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 14, 2023, the Company completed the Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), by and among KINS,
Inpixon, CXApp, and KINS Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of KINS (&#8220;Merger Sub&#8221;),
pursuant to which KINS combined with CXApp, Inpixon&#8217;s enterprise apps business (including its workplace experience
technologies, indoor mapping, events platform, augmented reality and related business solutions) (the &#8220;Enterprise Apps
Business&#8221;). In exchange for the agreed upon aggregate purchase price of approximately $<span id="xdx_903_ecustom--AggregatePurchasePriceAssetsAndLiabilities_iI_pn3n3_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zgDijKiUOD48" title="Aggregate purchase price assets and liabilities">69,928</span>
thousand, the Company acquired all of the related assets and liabilities of Legacy CXApp. The consideration transferred in
connection with the Business Combination consisted of <span id="xdx_90D_ecustom--ConsiderationTransferredInConnection_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zpGRYGUgslNh" title="Consideration transferred in connection">1,547,700</span>
shares of the Company&#8217;s Class A Common Stock and <span id="xdx_90A_ecustom--ConsiderationTransferredInConnection_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Consideration transferred in connection">5,487,300</span>
shares of the Company&#8217;s Class C Common Stock valued at a price of $<span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20230314_ztb8ypzqLNdg" title="Share price">9.94</span>
per share. The preliminary estimated goodwill of approximately $<span id="xdx_904_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_pn3n3" title="Business combination goodwill">44,122</span>
thousand arising from the Business Combination consists of an acquired workforce, as well as synergies expected from combined
operations of KINS and the CXApp.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
has authorized Class A and Class C common stock. Class A common stock and New CXApp Class C common stock are identical in all respects,
except that New CXApp Class C common stock is not listed and will automatically convert into New CXApp Class A common stock on the earlier
to occur of (i) the 180th day following the closing of the Merger and (ii) the day that the last reported sale price of New CXApp Class
A common stock equals or exceeds $12.00 per share for any 20 trading days within any 30-trading day period following the closing of the
Merger.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Business
Combination is being accounted for as a business combination in accordance with ASC 805 Combinations. The Company has determined preliminary
fair values of the assets acquired and liabilities assumed in the Business Combinations. These values are subject to change as we perform
additional reviews of our assumptions utilized.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has made a provisional allocation of the purchase price of the Business Combination to the assets acquired and the liabilities
assumed as of the closing date. The following table summarizes the preliminary purchase price allocations relating to the Business Combination
(in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_pn3n3_zv4J4BGrrAyi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business Combination (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B8_zaXlKB5klXAa" style="display: none">Schedule of assets acquired</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zhQ5zTcRifU6" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"><span>Description</span></td><td style="text-align: center; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Fair
    Value</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Weighted<br/>
    Average Useful<br/>
    Life<br/>
    (in years)</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--PurchasePrice_iI_z2LNiZ782CYl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Purchase
    Price</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>69,928</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Assets
    acquired:</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Cash
    and cash equivalents</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>10,003</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 10%; text-align: center"><span>&#160;</span></td>
    <td style="width: 1%"><span>&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accounts
    receivable</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>2,226</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables_iI_pn3n3_z8CKXpYtCFU8" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Notes
    and other receivables</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>209</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Prepaid
    assets and other current assets</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>588</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset_iI_pn3n3_za8u4DXnd5Yg" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    lease right of use asset</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>557</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Property
    and equipment, net</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>133</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Other
    assets</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>42</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Developed
    technology</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right" title="Intangible assets"><span>9,268</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zvIHvLVrFPaj">10
    </span><span>years</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Patents</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pn3n3" style="text-align: right" title="Intangible assets"><span>2,703</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zrChEHYpjyw9">10
    </span><span>years</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Customer
    relationships</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right" title="Intangible assets"><span>5,604</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zxUVCZ4SNAm8">5
    </span><span>years</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Tradenames
    and trademarks</span></td><td><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Intangible assets"><span>3,294</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zMy29Hf6sfih">7
    </span><span>years</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span>Total
    assets acquired</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>34,627</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Liabilities
    assumed:</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_i01I_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accounts
    payable</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>461</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_i01I_pn3n3_z1WqlsOPdQ1g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    liabilities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>911</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_i01I_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Deferred
    revenues</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>2,534</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent_i01I_pn3n3_zFEBnlRS0kK6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    lease obligation, current</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>194</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent_i01I_pn3n3_z1lNtq0USiYg" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    lease obligation, noncurrent</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>384</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_i01I_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Deferred
    tax liability</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>4,337</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_i01I_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Total
    liabilities assumed</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>8,821</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span>Goodwill</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>44,122</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td></tr>
  </table>






<p id="xdx_8AF_zlPUGCuVIHii" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The value
of the intangible assets and goodwill were calculated by a third party valuation firm based on projections and financial data provided
by management of the Company. Goodwill represents the excess fair value after allocation to the intangible assets. The calculated goodwill
is not tax deductible for tax purposes.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
acquisition-related costs for the Business Combination were approximately $<span id="xdx_904_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3">3,000
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand, which were incurred by KINS prior to
the close of the Business Combination. These costs are included in the opening retained earnings of the Company on March 15, 2023.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span><b>Measurement
Period</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>The preliminary
purchase price allocations for the acquisitions described above are based on initial estimates and provisional amounts. In accordance
with ASC 805-10-25-13, if the initial accounting for a business combination is incomplete by the end of the reporting period in which
the combination occurs, the acquirer shall report in its financial statements provisional amounts for the items for which the accounting
is incomplete. During the measurement period, acquirer shall adjust the provisional amounts recognized at the acquisition date to reflect
new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the
measurement of the amounts recognized as of that date. The Company continues to refine its inputs and estimates inherent in (i) the valuation
of intangible assets, (ii) deferred income taxes, (iii) realization of tangible assets and (iv) the accuracy and completeness of liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span><b>&#160;</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CXApp
Proforma Financial Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following unaudited proforma financial information presents the condensed consolidated results of operations of the Company for the three
month periods ended March 31, 2023 and March 31, 2022, as if the acquisition had occurred as of the beginning of the first period presented
(January 1, 2022) instead of on March 14, 2023. The proforma information does not necessarily reflect the results of operations that
would have occurred had the entities been a single company during those periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proforma financial information for the Company and the acquired CXApp is as follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_pn3n3_zHZrWn2FodT3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business Combination (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B4_zNFFs4LTose" style="display: none">Schedule of proforma financial information</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>For
    the<br/>
    Three Months Ended March&#160;31,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>For
    the<br/>
    Three Months Ended March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Revenues</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20230101__20230331_pn3n3" style="width: 9%; text-align: right" title="Revenues"><span>1,962</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20220101__20220331_pn3n3" style="width: 9%; text-align: right" title="Revenues"><span>2,582</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    income (loss)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20230101__20230331_pn3n3" style="text-align: right" title="Net income (loss)"><span>(6,365</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20220101__20220331_pn3n3" style="text-align: right" title="Net income (loss)"><span>6,197</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  </table>

<p id="xdx_8A0_zVPkCzQkjR56" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>












<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338025456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DisclosureDisaggregationOfRevenueAbstract', window );"><strong>Disaggregation Of Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DisaggregationOfRevenueTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><p id="xdx_80A_ecustom--DisaggregationOfRevenueTextBlock_zWEQkTvVP2u4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            4 &#8211; <span id="xdx_821_zuDvnBSQj8Ue">Disaggregation of Revenue</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when control is transferred of the promised products or services to its customers, in an amount that reflects
the consideration the Company expects to be entitled to in exchange for those products or services. The Company derives revenue from
software as a service, design and implementation services for its enterprise apps solutions systems, and professional services for work
performed in conjunction with its systems.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues
consisted of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zzydvqXZ8SN7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Disaggregation of Revenue (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;<span id="xdx_8B9_zYzbr6c27m1a" style="display: none">Schedule of disaggregation of Revenue</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to <br/>
    March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    January&#160;1,<br/>
    2023 to<br/>
    March&#160;14,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Three
    months ended March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Subscription
    revenue</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left; padding-bottom: 1pt"><span>Software</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_98B_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"><span>240</span></td><td style="border-right: Black 1.5pt solid; width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_98D_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"><span>1,204</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_98D_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"><span>1,259</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    subscription revenue</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>240</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>1,204</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>1,259</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Non-subscription
    revenue</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Professional
    services</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"><span>102</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_981_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"><span>416</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_98C_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"><span>1,323</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    non-subscription revenue</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>102</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98D_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>416</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>1,323</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    Revenue</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>342</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>1,620</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>2,582</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to <br/>
    March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    January&#160;1,<br/>
    2023 to<br/>
    March&#160;14,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Three
    months ended March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left; padding-bottom: 1pt"><span>Revenue
    recognized over time<sup>(1)(2)</sup></span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_986_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zKxJyCgzCnc9" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"><span>342</span></td><td style="border-right: Black 1.5pt solid; width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zNqBoDOyYQlh" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"><span>1,620</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zd6PyQcWxDfd" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"><span>2,582</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFN8f9NMFGB8" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>342</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zUzL3VcqZNy" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>1,620</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zREhXGB3TMm3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>2,582</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_F00_zuAxaoM7qA89" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F13_z22eIkMiIlRk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                            Professional services are also contracted on the fixed fee and time and materials basis.
                                            Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company has
                                            generally elected the practical expedient to recognize revenue for the right to invoice because
                                            the Company&#8217;s right to consideration corresponds directly with the value to the customer
                                            of the performance completed to date, in which revenue is recognized over time.</span></td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td></td><td style="text-align: left"><span id="xdx_F0F_z8YOj0PS32me" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span id="xdx_F14_zZN9vikJNp6l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software
                                            As A Service Subscription Revenue&#8217;s performance obligation is satisfied evenly over
                                            the service period using a time-based measure because the Company is providing continuous
                                            access to its service and service is recognized overtime.</span></td>
</tr></table>

<p id="xdx_8A7_zAwhJnBd8XMf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DisaggregationOfRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DisaggregationOfRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DisclosureDisaggregationOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DisclosureDisaggregationOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655337960848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, net</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z4aE0IySPPne" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            5 &#8211; <span id="xdx_82E_zvwoDPQWpmUe">Property and Equipment, net</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment consisted of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--PropertyPlantAndEquipmentTextBlock_pn3n3_zIZ1SnmXGa01" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, net (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BA_zyFVPiBxajK6" style="display: none">Schedule of property and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>December&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Computer
    and office equipment</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pn3n3" style="width: 9%; text-align: right" title="Total"><span>139</span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zJRkraja9hdj" style="width: 9%; text-align: right" title="Total"><span>992</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Furniture
    and fixtures</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pn3n3" style="text-align: right" title="Total"><span>11</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z0UDzglPTCQi" style="text-align: right" title="Total"><span>185</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Leasehold
    improvements</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pn3n3" style="text-align: right" title="Total"><span>6</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmvgAo2RnXZ4" style="text-align: right" title="Total"><span>28</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Software</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><span>1</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SoftwareMember_zJfaGhxk2Z" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><span>8</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Total</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Total"><span>157</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zI5WFlAWHCy1" style="text-align: right" title="Total"><span>1,213</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Less:
    accumulated depreciation and amortization</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z21EFw5MvTFe" style="border-bottom: Black 1pt solid; text-align: right" title="Less: accumulated depreciation and amortization"><span>(4</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zwDw0DkaJ0Y7" style="border-bottom: Black 1pt solid; text-align: right" title="Less: accumulated depreciation and amortization"><span>(1,011</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    Property and Equipment, Net</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentNet_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Property and Equipment, Net"><span>153</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Property and Equipment, Net"><span>202</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
and amortization expense were approximately $<span id="xdx_901_eus-gaap--DepreciationAndAmortization_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3">4</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;thousand,
$<span id="xdx_90B_eus-gaap--DepreciationAndAmortization_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3">19</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;thousand
and $<span id="xdx_908_eus-gaap--DepreciationAndAmortization_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3">36
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand for the period ended March 31, 2023
(Successor), the period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022 (Predecessor), respectively.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655337987712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Software Development Costs, net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DisclosureSoftwareDevelopmentCostsNetAbstract', window );"><strong>Software Development Costs Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_SoftwareDevelopmentCostsNetTextBlock', window );">Software Development Costs, net</a></td>
<td class="text"><p id="xdx_802_ecustom--SoftwareDevelopmentCostsNetTextBlock_zC7lWFLpM2Xg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            6 &#8211; <span id="xdx_82D_zbNpWqcN1bb7">Software Development Costs, net</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
software development costs consisted of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock_pn3n3_zUikV4J7Y759" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Software Development Costs, net (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span id="xdx_8B3_zr6VD5hpp3K9" style="display: none">Schedule of capitalized software development</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zG7dxHOXEaB1" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zoUyBm8ovIEl" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>December&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_maCCSNzf4y_zVllVuO8Mafh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Capitalized
    software development costs</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1980">-</span></span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>2,680</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--CapitalizedComputerSoftwareAccumulatedAmortization_iNI_pn3n3_di_msCCSNzf4y_zUOdvQtZJVGh" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Accumulated
    amortization</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1983">-</span></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(2,193</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr id="xdx_409_eus-gaap--CapitalizedComputerSoftwareNet_iTI_pn3n3_mtCCSNzf4y_zwVYEIK8Njjf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Software
    development costs, net</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1986">-</span></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>487</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for capitalized software development costs was approximately $<span id="xdx_90D_eus-gaap--AdjustmentForAmortization_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Amortization expense">209</span>&#160;thousand and $<span id="xdx_90E_eus-gaap--AdjustmentForAmortization_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Amortization expense">113</span>&#160;thousand for the period ended March
14, 2023 (Predecessor) and the three months ended March 31, 2022 (Predecessor). There was <span id="xdx_908_eus-gaap--AdjustmentForAmortization_pn3n3_do_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zeVLxg7jsuba" title="Amortization expense">no</span> amortization expense for capitalized software
development costs for the period ended March 31, 2023 (Successor).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DisclosureSoftwareDevelopmentCostsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DisclosureSoftwareDevelopmentCostsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_SoftwareDevelopmentCostsNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_SoftwareDevelopmentCostsNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338006080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><p id="xdx_803_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zQbGWVp1VLHj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            7 &#8211; <span id="xdx_828_zm6IetZ2kADi">Goodwill and Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews goodwill for impairment on a reporting unit basis on December 31 of each year and whenever events or changes in circumstances
indicate the carrying value of goodwill may not be recoverable. The Company noted that the carrying amount of Goodwill for the period
ended March 31, 2023 (Successor) was $<span id="xdx_907_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Goodwill">44,122</span>&#160;thousand, which was entirely due to the business combination noted in Note 3. The Company
did <span id="xdx_907_eus-gaap--Goodwill_iI_pn3n3_do_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zWZeCA8lcHRc" title="Goodwill"><span id="xdx_90B_eus-gaap--Goodwill_iI_pn3n3_do_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zBHy2OK2asI4" title="Goodwill">no</span></span>t have any goodwill for the period ended March 14, 2023 (Predecessor) and the year ended December 31, 2022 (Predecessor).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
consisted of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfGoodwillTextBlock_pn3n3_zCdhsSSFZI4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"><span id="xdx_8BC_z1G4BW8PF20f" style="display: none">Schedule of goodwill</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: bold; text-align: left"><span>Acquisition</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    as of March 14, 2023</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--Goodwill_iS_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zENOXH1riS2c" style="text-align: right" title="Beginning balance"><span><span style="-sec-ix-hidden: xdx2ixbrl2005">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition
    of Legacy CXApp</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_989_ecustom--AcquisitionOfLegacyCxapp_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z45yDj18TUrc" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Acquisition of Legacy CXApp"><span>44,122</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance
    as of March 31, 2023</b></span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Goodwill_iE_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z4fv8NKdKfr" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ending balance"><span>44,122</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p id="xdx_8A5_zYX3VCiO7N0b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>












<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets consisted of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zWZlcw7OwmSc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BE_zZ6JNFlydzsh" style="display: none">Schedule of intangible assets</span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="12" style="border-bottom: Black 1pt solid; text-align: center"><span><b>March&#160;31,
    2023 (Successor)</b></span></td>
    <td style="border-right: Black 1.5pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="9" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span><b>December&#160;31,
    2022 (Predecessor)</b></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-align: center"><span><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span><b>Weighted Average Remaining<br/>
    Useful Life<br/>
    (Years)</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span><b>Gross
    Amount</b></span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span><b>&#160;</b></span></td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span><b>Accumulated
    Amortization</b></span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span><b>Net
    Carrying Amount</b></span></td>
    <td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span><b>Gross<br/>
    Amount</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span><b>Accumulated
    Amortization</b></span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span><b>&#160;</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span><b>Net Carrying<br/>
    Amount</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 30%; text-align: left"><span>Trade
    Name/Trademarks</span></td>
    <td style="width: 1%"><span>&#160;</span></td>
    <td style="text-align: center; width: 9%"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zNdfQJYF8MMh">7
    </span><span>years</span></td>
    <td style="width: 1%"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"><span>3,294</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td>
    <td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"><span>(20</span></td><td style="width: 1%; text-align: left"><span>)</span></td>
    <td style="width: 1%"><span>$</span></td>
    <td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="text-align: right; width: 7%; vertical-align: bottom" title="Net carrying amount"><span>3,274</span></td>
    <td style="border-right: Black 1.5pt solid; width: 1%"><span>&#160;</span></td>
    <td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%"><span>$</span></td>
    <td id="xdx_983_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="text-align: right; width: 7%; vertical-align: bottom" title="Gross carrying amount"><span>2,183</span></td>
    <td style="width: 1%"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"><span>(725</span></td><td style="width: 1%; text-align: left"><span>)</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%"><span>$</span></td>
    <td id="xdx_980_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="vertical-align: bottom; width: 7%; text-align: right" title="Net carrying amount"><span>1,458</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Customer
    Relationships</span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zB8897e0y01e">5
    </span><span>years</span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_988_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"><span>5,604</span></td><td style="text-align: left"><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"><span>(47</span></td><td style="text-align: left"><span>)</span></td>
    <td></td>
    <td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Net carrying amount"><span>5,557</span></td>
    <td style="border-right: Black 1.5pt solid"><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td></td>
    <td id="xdx_98B_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Gross carrying amount"><span>6,401</span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"><span>(1,765</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td id="xdx_98D_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Net carrying amount"><span>4,636</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Developed
    Technology</span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zx0RCeDD1eC5">10
    </span><span>years</span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_981_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"><span>9,268</span></td><td style="text-align: left"><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"><span>(38</span></td><td style="text-align: left"><span>)</span></td>
    <td></td>
    <td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Net carrying amount"><span>9,230</span></td>
    <td style="border-right: Black 1.5pt solid"><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td></td>
    <td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Gross carrying amount"><span>15,179</span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"><span>(3,398</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Net carrying amount"><span>11,781</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Non-compete
    Agreements</span></td>
    <td><span>&#160;</span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td id="xdx_98E_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"><span>&#160;<span style="-sec-ix-hidden: xdx2ixbrl2045">-</span></span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"><span>&#160;<span style="-sec-ix-hidden: xdx2ixbrl2046">-</span></span></td>
    <td></td>
    <td style="text-align: right; vertical-align: bottom"></td>
    <td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Net carrying amount"><span>&#160;<span style="-sec-ix-hidden: xdx2ixbrl2048">-</span></span></td>
    <td style="border-right: Black 1.5pt solid"><span>&#160;</span></td>
    <td></td>
    <td style="text-align: right; vertical-align: bottom"></td>
    <td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross carrying amount"><span>&#160;3,150</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"><span>(1,736</span></td><td><span>)&#160;</span></td>
    <td><span>&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"></td><td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Net carrying amount"><span>&#160;1,414</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Patents
    and Intellectual Property</span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_zdp9tDsk1yF7">10
    </span><span>years</span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"></td><td id="xdx_980_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right"><span>2,703</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right"><span>(11</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td>
    <td style="border-bottom: Black 1pt solid"></td>
    <td id="xdx_98E_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom" title="Net carrying amount"><span>2,692</span></td>
    <td style="border-right: Black 1.5pt solid; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"></td>
    <td id="xdx_98B_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom" title="Gross carrying amount"><span><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2061">-</span></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span>&#160;</span></td>
    <td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right" title="Net carrying amount"><span><span style="-sec-ix-hidden: xdx2ixbrl2063">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Totals</span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: center"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span>20,869</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span>(116</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>)</span></td>
    <td style="border-bottom: Black 2.5pt double"><span><b>$</b></span></td>
    <td id="xdx_98E_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right; vertical-align: bottom" title="Net carrying amount"><span><b>20,753</b></span></td>
    <td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double"><span><b>$</b></span></td>
    <td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right; vertical-align: bottom" title="Gross carrying amount"><span><b>26,913</b></span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span>(7,624</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>)</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double"><span><b>$</b></span></td>
    <td id="xdx_982_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right" title="Net carrying amount"><span><b>19,289</b></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>



<p id="xdx_8A1_zHbyDIQA6UV4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Aggregate
Amortization Expense</span>:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate
amortization expense for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and three months ended
March 31, 2022 (Predecessor) was $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Aggregate amortization expense">116</span>&#160;thousand, $<span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Aggregate amortization expense">806</span>&#160;thousand and $<span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Aggregate amortization expense">975</span>&#160;thousand, respectively.&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Future amortization
expense on intangible assets is anticipated to be as follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zJqYwSInNWFc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details 2)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_z5HTfbrUy6d3" style="display: none">Schedule of future amortization expense</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20230331_zwQ9856fRWWf" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>For the Years Ending December 31,</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span><b>Amount</b></span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_zxjyh7QA55Y9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left"><span>2023</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>2,091</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_zbdwcY16FOg2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span>2024</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>2,788</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_zKVmOOAolct4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span>2025</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>2,788</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_zLAji46mngA7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span>2026</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>2,788</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_zS9JgRbwsq17" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span>2027</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>2,788</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_zZj7dbgJRHy4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span>2028 and thereafter</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>7,510</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zwOlRtjNtPj2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span>Total</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>20,753</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



<p id="xdx_8A1_zMmLpUyh3tc8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338025456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DisclosureDeferredRevenueAbstract', window );"><strong>Deferred Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DeferredRevenueTextBlock', window );">Deferred Revenue</a></td>
<td class="text"><p id="xdx_80F_ecustom--DeferredRevenueTextBlock_zgU2ny2ItPb3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            8 &#8211; <span id="xdx_825_z1IP8sJhoCDk">Deferred Revenue</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
revenue consisted of the following (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfDeferredRevenueTableTextBlock_pn3n3_zj2KgLFIIkKg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Deferred Revenue (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span id="xdx_8B2_zchqaZqkPx6i" style="display: none">Schedule of deferred revenue</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>December&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>License
    agreements</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_pn3n3" style="width: 9%; text-align: right" title="Total Deferred Revenue"><span>2,388</span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_pn3n3" style="width: 9%; text-align: right" title="Total Deferred Revenue"><span>1,937</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Professional
    Service agreements</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_987_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProfessionalServiceAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Deferred Revenue"><span>302</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_984_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProfessionalServiceAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Deferred Revenue"><span>225</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    Deferred Revenue</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Deferred Revenue"><span>2,690</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Deferred Revenue"><span>2,162</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the deferred revenue approximates the services to be rendered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DeferredRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DeferredRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DisclosureDeferredRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DisclosureDeferredRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655337911360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zG91zv8YL3pd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            9 &#8211; <span id="xdx_823_zOglLK1mChUl">Accrued Liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
liabilities consisted of the following (in thousands):</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_pn3n3_zOeSOxMe5APg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Liabilities (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BC_zKl5L4jOGS6k" style="display: none">Schedule of accrued Liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zmL8jaAuCRW9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zhCV2sZdbhz4" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>March
    31, <br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>December
    31, <br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--InsurancePremiumsAndAccruedInterest_iI_pn3n3_maALCzxmM_zz1sEcoAmQ0j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Insurance
    premiums and accrued interest</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>538</span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2117">-</span></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--RelatedPartyPromissoryNote_iI_pn3n3_maALCzxmM_zvwDIWs3f5Wk" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Related
    party promissory note</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>20</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2120">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedIncomeTaxes_iI_pn3n3_maALCzxmM_zenaZb0oeUsj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Income
    tax payables</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>57</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2123">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--RelatedPartyPayable_iI_pn3n3_maALCzxmM_zjU5qnO5OgEh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Related
    party payable</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>1,155</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2126">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--AccruedCompensationAndBenefits_iI_pn3n3_maALCzxmM_zq3R15YIGTvc" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    compensation and benefits</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>650</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>586</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_pn3n3_maALCzxmM_zBOB8vq7dQv6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    bonus and commissions</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>192</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>422</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedRentCurrent_iI_pn3n3_maALCzxmM_zXTwKPJlqCo9" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    rent</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>3</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>559</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--AccruedOther_iI_pn3n3_maALCzxmM_zu4KRip245Wf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    other</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>561</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>83</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_iI_pn3n3_maALCzxmM_zgDiEBkmJ6H9" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Accrued
    sales and other indirect taxes payable</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>6</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>86</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iTI_pn3n3_mtALCzxmM_z07ywXVdp7mk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255); vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span>Accrued
    liabilities</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>3,182</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>1,736</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>












<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Financed
Director &amp; Officers Insurance</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into a Directors &amp; Officers (&#8220;D&amp;O&#8221;) insurance agreement with Oakwood D&amp;O Insurance,
effective on March 14, 2023. The agreement states that the Company will pay a total of $<span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--TitleOfIndividualAxis__custom--DirectorAndOfficersMember_zo7hS853Zt03" title="Debt payment">671</span>
thousand in premiums at an annual percentage rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_z7GuFfgoV4Tj" title="Interest rate">8%</span>.
The first of nine monthly separate installment payments begin on April 14, 2023. The Company paid a down payment on the policy of
$<span id="xdx_907_eus-gaap--PaymentsOfDebtIssuanceCosts_pn3n3_c20230101__20230314__srt--TitleOfIndividualAxis__custom--DirectorAndOfficersMember__srt--StatementScenarioAxis__custom--PredecessorMember_zKF2pVhORR22" title="Debt issuance cost">134</span>
thousand.  As of March 31, 2023 (Successor) the  Company currently owes $<span id="xdx_901_eus-gaap--OtherBorrowings_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zVv0BhrcV6pd" title="Debt owed balance">538</span>
thousand on the D&amp;O insurance policy.</span></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Related
Party Liabilities</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><span id="xdx_901_ecustom--RelatedPartyDescription_c20230101__20230331_zM0ziQc2RUf7" title="Related party description">As
of March 31, 2023, the Company&#8217;s related party liabilities consisted of a promissory note payable to the KINS sponsor in the amount of $20 thousand for working capital. As of March 31, 2023, accrued
liabilities include an estimate of approximately $1,045 thousand due to Inpixon by CXApp resulting from an agreement to reimburse
Inpixon (subject to review and acceptance by the Company) for certain transaction related costs incurred by Inpixon on behalf of KINS prior to March
14, 2023. This amount is subject to an ongoing review and evaluation by the Company. Additionally, as of March 31, 2023, accrued
liabilities include (i) $30 thousand for estimated costs related to transition services provided by Inpixon to CXApp and (ii) $80
thousand of reimbursable expenses incurred by Inpixon on behalf of CXApp during the period from March 15, 2023 to March 31,
2023.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>In connection
with a distribution of CXApp securities by KINS Capital LLC, Inpixon is entitled to acquire 2,500,000 CXApp Private Placement Warrants,
which reflects Inpixon&#8217;s existing indirect interests in CXApp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655337989712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrant Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DisclosureWarrantLiabilitiesAbstract', window );"><strong>Warrant Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantLiabilitiesTextBlock', window );">Warrant Liabilities</a></td>
<td class="text"><p id="xdx_806_ecustom--WarrantLiabilitiesTextBlock_zBzaT0tsQVla" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            10 - <span id="xdx_82B_zQ857yPpDFV4">Warrant Liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2023 (Successor) there were <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zw3oxaz5fTM1" title="Warrants outstanding">13,800</span> thousand Public Warrants outstanding. Each whole warrant entitles the holder thereof to purchase one share of the Company&#8217;s Class A common stock at a price of $<span id="xdx_906_eus-gaap--WarrantExercisePriceIncrease_pid_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zXYamto7cQk8" title="Warrant Price">11.50</span> per share, subject to adjustments described in the Company&#8217;s registration statement on Form S-1 (Registration No. 333-249177) filed in connection with its initial public offering. </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and
only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) <span id="xdx_902_ecustom--WarrantExercisePeriodConditionOne_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zKCNTaUvQ0z5" title="Warrant exercise period condition one">30</span>
days after the completion of a Business Combination and (b) <span id="xdx_90C_ecustom--WarrantExercisePeriodConditionTwo_dtM_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zioXhGENb6ad" title="Warrant exercise period condition two">12</span>
months from the closing of the Initial Public Offering. The Public Warrants will expire five <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zpCYGmvO5gnc" style="display: none" title="Public Warrants expiration term">5</span> years after the completion of a
Business Combination or earlier upon redemption or liquidation.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation
to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class
A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying
its obligations with respect to registration. No warrant will be exercisable, and the Company will not be obligated to issue shares of
Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
has filed a registration statement on Form S-1 (Registration No. 333-271340) under the Securities Act on April 19, 2023 covering the
issuance of the shares of Class A common stock issuable upon exercise of the warrants, and will use its commercially reasonable efforts
to have it declared effective by the SEC within 60 business days following a Business Combination. The Company will use its commercially
reasonable efforts to maintain the effectiveness of such registration statement and a current prospectus relating to those shares of
Class A common stock until the warrants expire or are redeemed. Notwithstanding the above, if the Class A common stock is at the time
of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a &#8220;covered security&#8221;
under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants
to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so
elects, the Company will not be required to file or maintain in effect a registration statement, but we will be required to use our commercially
reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemptions
of warrants when the price of Class A common stock equals or exceeds $<span id="xdx_904_ecustom--WarrantRedemptionConditionMinimumSharePrice_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_pdd" title="Warrant redemption condition minimum share price">18.00</span> &#8211; </i>Once the warrants become exercisable, the Company
may redeem the Public Warrants:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            whole and not in part;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                            a price of $<span id="xdx_903_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd" title="Redemption price per public warrant (in dollars per share)">0.01</span> per warrant;</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
                                            not less than <span id="xdx_903_ecustom--RedemptionPeriod_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zy6C2BXNoJC5" title="Redemption period">30</span> days&#8217; prior written notice of redemption, or the <span id="xdx_90A_ecustom--RedemptionPeriod_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zezs0zxXwX61" title="Redemption period">30</span>-day redemption
                                            period, to each warrant holder; and</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
                                            and only if, the reported last sale price of the Company&#8217;s Class A common stock equals
                                            or exceeds $<span id="xdx_908_ecustom--WarrantRedemptionConditionMinimumSharePrice_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd" title="Warrant redemption condition minimum share price">18.00</span> per share (as adjusted for stock splits, stock dividends, reorganizations,
                                            recapitalizations, and the like) for any <span id="xdx_90D_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zRMp2O3txJkc" title="Threshold trading days for redemption of public warrants">20</span> trading days within a <span id="xdx_900_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zT4ioKX3vogh" title="Threshold consecutive trading days for redemption of public warrants">30</span>-day trading period ending
                                            on the <span id="xdx_909_ecustom--ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zgEtUvNM2ECl" title="Threshold number of business days before sending notice of redemption to warrant holders">third trading day</span> prior to the date on which the Company sends the notice of redemption
                                            to the warrant holders.</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
of warrants when the price per share of Class A common stock equals or exceeds $<span id="xdx_904_ecustom--WarrantRedemptionConditionMinimumSharePriceScenarioTwo_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_pdd" title="Warrant redemption condition minimum share price scenario two">10.00</span> &#8211; </i>Once the warrants become exercisable,
the Company may redeem the outstanding warrants:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            whole and not in part;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
                                            a price of $<span id="xdx_907_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_pdd" title="Redemption price per public warrant (in dollars per share)">0.10</span> per warrant provided that holders will be able to exercise their warrants
                                            prior to redemption and receive that number of shares of Class A common stock determined
                                            based on the redemption date and the &#8220;fair market value&#8221; of the Company&#8217;s
                                            Class A common stock;</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                                            not less than <span id="xdx_90E_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zVpQtCbeOiAh" title="Threshold consecutive trading days for redemption of public warrants">30</span> days&#8217; prior written notice of redemption, or the <span id="xdx_90D_ecustom--RedemptionPeriod_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zjhoZJNdH5vg" title="Redemption period">30</span>-day redemption
                                            period;</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
                                            and only if, the last reported sale price of the Company&#8217;s Class A common stock equals
                                            or exceeds $<span id="xdx_904_ecustom--WarrantRedemptionConditionMinimumSharePriceScenarioTwo_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" title="Warrant redemption condition minimum share price scenario two">10.00</span> per share (as adjusted for stock splits, stock dividends, reorganizations,
                                            recapitalizations and the like) on the trading day prior to the date on which the Company
                                            sends the notice of redemption to the warrant holders;</span></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
                                            and only if, there is an effective registration statement covering the issuance of the shares
                                            of Class A common stock issuable upon exercise of the warrants and a current prospectus relating
                                            thereto is available throughout the 30-day period after the written notice of redemption
                                            is given.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2023 (Successor), there were <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zfuk3j9tQgi9" title="Warrants outstanding">10,280</span> thousand Private Placement Warrants outstanding. The Private Placement Warrants are identical
to the Public Warrants, except that the Private Placement Warrants and the shares
of Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable
until <span id="xdx_904_ecustom--RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTjl8sAUjwXk" title="Restrictions on transfer period of time after business combination completion">30</span> days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement
Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial
purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or
their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the
same basis as the Public Warrants.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DisclosureWarrantLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DisclosureWarrantLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WarrantLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WarrantLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655337931312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan and Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract', window );"><strong>Stock Option Plan And Stock-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_StockAwardPlansAndStockbasedCompensationTextBlock', window );">Stock Option Plan and Stock-Based Compensation</a></td>
<td class="text"><p id="xdx_809_ecustom--StockAwardPlansAndStockbasedCompensationTextBlock_zOpakbRmBmck" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            11 &#8211; <span id="xdx_82F_zU3OF0LA6Z87">Stock Option Plan and Stock-Based Compensation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
calculate the stock-based compensation resulting from the issuance of options uses the Black-Scholes option pricing model, which is affected
by the Company&#8217;s fair value of its stock price as well as assumptions regarding a number of subjective variables. These variables
include, but are not limited to, the Company&#8217;s expected stock price volatility over the term of the awards, and actual and projected
employee stock option exercise behaviors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><b><i>2023
Equity Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>At the special meeting held on March 10, 2023, the KINS stockholders
considered and approved, among other things, the CXApp Inc. 2023 Equity Incentive Plan (the &#8220;Incentive Plan&#8221;). The Incentive
Plan was previously approved, subject to stockholder approval, by KINS&#8217; board of directors. The Incentive Plan became effective
immediately upon the closing of the Business Combination. Pursuant to the terms of the Incentive Plan, there are <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20230310__us-gaap--PlanNameAxis__custom--N2023EquityIncentivePlanMember_ztqMr22lpbE4" title="Shares available for issuance">2,110,500</span> shares of CXApp
Class A Common Stock available for issuance under the Incentive Plan, which is equal to 15% of the aggregate number of shares of CXApp
common stock issued and outstanding immediately after the closing (giving effect to the redemptions).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employee
Stock Options</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period ended March 31, 2023 (Successor), a total of <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pin3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember_z2mNWCKJr3ib" title="Stock option granted">1,377</span>&#160;thousand of stock options for the purchase of the Company&#8217;s
common stock were granted to employees and directors of the Company. These options vest over a <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember_zWLF8Q8WGDx7" title="Vesting period">2</span> year period, with 50% vested at the
end of year one and 50% vested at the end of year two. The options have a life of <span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember__srt--RangeAxis__srt--MinimumMember_zSQqtXnw9qaa" title="Option life">5</span> to <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember__srt--RangeAxis__srt--MaximumMember_z5QCiCysYhRb" title="Option life">7</span> years and an exercise price of $1.53 per share.
The stock options were valued using the Black-Scholes option valuation model and the fair value of the awards was determined to be approximately
$<span id="xdx_904_ecustom--FairValueOfOptions_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember_zrA3xvph6opa" title="Fair value of options">688</span>&#160;thousand. The fair value of the common stock as of the grant date was determined to be $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember_pdd" title="Fair value of common stock as of grant date">1.53</span> per share.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period ended March 31, 2023 (Successor), the Company recorded a charge of approximately $<span id="xdx_904_ecustom--AmortizationOfEmployeeStockOptions_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember_z6hglpJJRA3" title="Amortization of employee stock options">2</span>&#160;thousand for the amortization of
employee stock options, which is included in the general and administrative section of the condensed
consolidated statement of operations.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2023 (Successor), the fair value of non-vested options totalled approximately $<span id="xdx_90A_ecustom--FairValueOfNonvestedOptions_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zKtxUbYztgm" title="Fair value of non-vested options">686</span>&#160;thousand, which will be amortized
to expense over the weighted average remaining term of <span id="xdx_90B_ecustom--WeightedAverageRemainingTermOfNonvestedOptions_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zbQD81Cr97Ic" title="Weighted average remaining term of non-vested options">2</span>.0 years.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each employee option grant is estimated on the date of the grant using the Black-Scholes option-pricing model. Key weighted-average
assumptions used to apply this pricing model during the period ended March 31, 2023 (Successor) were as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_pn3n3_z2NUvsA0cEHe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Award Plans and Stock-Based Compensation (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BF_znZ31CjRifj1" style="display: none">Schedule of assumptions used</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Risk-free
    interest rate</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zVRZ3IzFBiO5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.62</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>%
    &#8211; <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_zLB2ZDOvl8d2">3.67</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>%</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Expected
    life of option grants</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zsjbfmPoo0R2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#8211; <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_zcGebklMyTh5">7
    </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>years</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 80%; text-align: left"><span>Expected
    volatility of underlying stock</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 18%; text-align: center"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zUPdCMrAqrC9">37.35</span><span>%</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Dividends
    assumption</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z6AuyXgzoIa2">0%</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_StockAwardPlansAndStockbasedCompensationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_StockAwardPlansAndStockbasedCompensationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334059216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--FairValueDisclosuresTextBlock_z35Sy0q81rx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b>NOTE
                                            12 &#8211; <span id="xdx_82A_zhmle8mvvbWl">Fair Value of Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company&#8217;s estimates of fair value for financial assets and financial
liabilities are based on the framework established in ASC 820. The Company noted that the only financial asset or financial liability
that is subject to the fair value framework established in ASC 820 are the Warrant Liabilities (Note 10). The framework is based on the
inputs used in valuation and gives the highest priority to quoted prices in active markets and requires that observable inputs be used
in the valuations when available. The disclosure of fair value estimates in the ASC 820 hierarchy is based on whether the significant
inputs into the valuation are observable. In determining the level of the hierarchy in which the estimate is disclosed, the highest priority
is given to unadjusted quoted prices in active markets and the lowest priority to unobservable inputs that reflect the Company&#8217;s
significant market assumptions. The Company classified the public placement warrants recorded at fair value of on a recurring basis of
$<span id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicPlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMq2GTSKfxM1" title="Fair value of warrants">552</span> thousand as a level 1 investment, as the fair value was determined using quoted prices of the security in active markets. The Company
classified the private placement warrants liabilities recorded at fair value of $<span id="xdx_902_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNC91dQta9lf">411</span> thousand as a level 2 investment, as the fair
value was determined utilizing the observable market price for the public placement warrants as the private placement warrants are not
actively traded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
<td class="text"><p id="xdx_800_eus-gaap--FairValueDisclosuresTextBlock_zax6DXdQOwm" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 &#8212; <span id="xdx_821_znIKLQ02bgH6">FAIR VALUE MEASUREMENTS</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company&#8217;s financial assets and liabilities reflects management&#8217;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.6in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                              1:</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted
prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.6in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                              2:</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable
inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
and quoted prices for identical assets or liabilities in markets that are not active.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0.5in"></td><td style="width: 0.6in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                              3:</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable
inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 &#8220;Investments
- Debt and Equity Securities.&#8221; Held-to-maturity securities are those securities which the Company has the ability and intent to
hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying consolidated balance sheets
and adjusted for the amortization or accretion of premiums or discounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December&#160;31 2022, assets held in the Trust Account consisted of $<span id="xdx_90E_eus-gaap--AssetsHeldInTrustNoncurrent_c20221231__us-gaap--FinancialInstrumentAxis__us-gaap--CashMember_pp0p0" title="Assets held in the Trust Account">3,923,804</span> held in an interest-bearing commercial checking account.
Cash held in commercial checking accounts is reported on the balance sheet at its approximate fair value. During the year ended December&#160;31,
2022, the Company withdrew $<span id="xdx_90C_ecustom--ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax_c20220101__20221231_pp0p0" title="Cash withdrawn from trust account to pay franchise tax">231,500</span> of interest income from the Trust Account for taxes and $<span id="xdx_908_ecustom--ProceedsFromTrustAccountInConnectionWithRedemption_c20220101__20221231_pp0p0" title="Cash withdrawn from trust account in connection with redemption">275,102,280</span> was withdrawn from the Trust
Account in connection with the redemption of Class A common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December&#160;31, 2021, assets held in the Trust Account were comprised of $<span id="xdx_90F_eus-gaap--AssetsHeldInTrustNoncurrent_c20211231__us-gaap--FinancialInstrumentAxis__us-gaap--CashMember_pp0p0" title="Assets held in the Trust Account">898</span> in cash and $<span id="xdx_905_eus-gaap--AssetsHeldInTrustNoncurrent_c20211231__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember_pp0p0" title="Assets held in the Trust Account">278,835,182</span> in money market funds, respectively.
Through December&#160;31, 2021, the Company did not withdraw any interest income from the Trust Account.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company&#8217;s assets and liabilities that are measured at fair value on a recurring
basis at December&#160;31, 2022 and 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine
such fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z4PIr496IIQ1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BB_zpXDUooqaxq9" style="display: none">Schedule of company's assets and liabilities that are measured at fair value on a recurring basis</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="5" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="5" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Description</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Assets:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Money Market Funds</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AssetsHeldInTrustNoncurrent_c20221231__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="width: 9%; text-align: right" title="Assets held in the Trust Account"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsHeldInTrustNoncurrent_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember_pp0p0" style="width: 9%; text-align: right" title="Assets held in the Trust Account">278,835,182</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Liabilities:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Warrant liabilities &#8211; public warrants</td><td>&#160;</td>
    <td style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities">414,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities">6,461,798</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Warrant liabilities &#8211; private placement warrants</td><td>&#160;</td>
    <td style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities">308,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities">4,813,571</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zN5RHb7MXnc1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the accompanying
December&#160;31, 2022 and 2021 consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a
recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statements
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants are measured at fair value on a recurring basis. The Public Warrants were initially valued using a lattice model, specifically
a binomial lattice model incorporating the binomial lattice methodology. As of December&#160;31, 2022, the Public Warrants were valued
using the instrument&#8217;s publicly listed trading price as of the balance sheet date, which is considered to be a Level 1 measurement
due to the use of an observable market quote in an active market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placement Warrants were initially valued using a lattice model, specifically a binomial lattice model incorporating the binomial
lattice methodology, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized in determining
the fair value of the Private Placement Warrants is the expected volatility of our common stock. The expected volatility as of the Initial
Public Offering date was derived from observable public warrant pricing on comparable &#8216;blank-check&#8217; companies without an
identified target. The subsequent measurements of the Private Placement Warrants after the detachment of the Public Warrants from the
Units is classified as Level 2 due to the use of an observable market quote for a similar asset in an active market, as the transfer
of Private Placement Warrants to anyone outside of a small group of individuals who are permitted transferees would result in the Private
Placement Warrants having substantially the same terms as the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the changes in the fair value of Level 3 warrant liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zwu4cfXkCZrf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BA_zraT7XkGrG62" style="display: none">Schedule of change in the fair value of the Level 3 warrant liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Private Placement</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Public</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrant Liabilities</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Fair value as of December&#160;31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zQBCMnSg4Ycb" style="width: 9%; text-align: right" title="Fair value at beginning">9,354,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z4cUM70bNR1l" style="width: 9%; text-align: right" title="Fair value at beginning">12,558,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zj7rzQFsIys" style="width: 9%; text-align: right" title="Fair value at beginning">21,912,800</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value">(2,672,800</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value">(3,588,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value">(6,260,800</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Transfer to Level 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1">(8,970,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1">(8,970,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Transfer to Level 2</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2">(6,682,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2"><span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2">(6,682,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Fair value as of December&#160;31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zsqdPXH9bslk" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"><span style="-sec-ix-hidden: xdx2ixbrl1199">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zCwVI7FgBuw8" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zj0KR7eFqBq7" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"><span style="-sec-ix-hidden: xdx2ixbrl1203">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A3_zVCpjJuSrMIc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfers
to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs.
The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement during the
period ended December&#160;31, 2021 was approximately $<span id="xdx_903_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_pp0n3_dm_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zMkJ0VYPeTu2" title="Transfer to Level 1">9.0</span> million, when the Public Warrants were separately listed and traded and the
estimated fair value of the Private Warrants of approximately $<span id="xdx_902_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_pp0n3_dm_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zy42tSojGoCl" title="Transfer to Level 2">6.7</span> million was transferred from a Level 3 to a Level 2 fair value measurement.
There were no transfers during the year ended December&#160;31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655333653456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zi27H6MNvap6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            13 &#8211; <span id="xdx_828_z5DrixpnJT98">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company recorded an income tax benefit of
approximately $<span id="xdx_90D_ecustom--IncomeTaxBenefitprovision_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zqiJeTBvEli8" title="Income tax benefit/(provision)">1,560</span> thousand for the period ended March 31, 2023 (Successor). The Company recorded an income tax expense of approximately
$<span id="xdx_90D_ecustom--IncomeTaxBenefitprovision_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zMIdmVgyll" title="Income tax benefit/(provision)">0</span> thousand and $<span id="xdx_90F_ecustom--IncomeTaxBenefitprovision_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zFSCLOziUpod" title="Income tax benefit/(provision)">100</span> thousand for the period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022 (Predecessor),
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The effective tax rate for period ended March 31, 2023 (Successor)
was approximately (<span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zKPxfDx39M04" title="Effective tax rate">164.0%</span>). The income tax benefit, and negative effective tax rate, for the period ended March 31, 2023 (Successor) is
a result of the release of valuation allowance attributable to acquired intangible assets from the Business Combination. The Company acquired
approximately $<span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Deferred tax liability">4,337</span> thousand of deferred tax liability associated with the Business Combination. As a result of the Company released
its valuation allowance as deferred tax assets will become realizable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<span></span>
</td>
<td class="text"><p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_z1s0BM0UfUQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8212; <span id="xdx_829_zR8i78vii3M4">INCOME TAX</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s net deferred tax assets are as follows as of December&#160;31, 2022 and 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z9RDlEVPdePk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details)">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B0_zft8pkkbm5w8" style="display: none">Schedule of Company's net deferred tax assets</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20221231_zszdqVXesDWf" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20211231_zloN0f9oOWt8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNetOfValuationAllowanceAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_i01I_pp0p0_maDTAGzH2n_zJZsPEnXuOj9" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left">Organizational costs/startup expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">924,537</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">322,963</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzH2n_z83CmBuNPOZ2" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Net operating loss carryforward</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1069">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28,689</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_mtDTAGzH2n_maDTANzcuz_zfIn9amPvV82" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">924,537</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">351,652</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di_msDTANzcuz_zXJTTxY4oi33" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(924,537</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(351,652</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_mtDTANzcuz_zU4RTzO2VSyh" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Deferred tax asset, net of allowance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1078">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1079">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zJAMNsc6dsP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
income tax provision consists of the following for the years ended December&#160;31, 2022 and 2021:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYSYFdTFxEch" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B4_zXy6iR0jPuOb" style="display: none">Schedule of income tax provision</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20220101__20221231_zX2KOWuZTfga" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20210101__20211231_z2x1GBkFAzl" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zNtjJVGYBcp2" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">49,175</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1087">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zjsFhKNWOmr9" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(572,885</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(300,205</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--StateAndLocalAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">State and Local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zPC3k8mPn9t4" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1095">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1096">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zLND9QSxl1V2" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1098">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1099">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_i01N_pp0p0_di_msITEBzXu4_z54jCOYWgLf1" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">572,885</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">300,205</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXu4_zFkYyLe9CNyc" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Income tax provision</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">49,175</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_zQsJ1tkCFRn7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December&#160;31, 2022 and 2021, the Company had U.S. federal net operating loss carryover of approximately $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Operating loss carryforwards">0</span> and $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_c20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Operating loss carryforwards">137,000</span> available
to offset future taxable income indefinitely, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all
of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of
future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible.
Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies
in making this assessment. After consideration of all of the information available, management believes that significant uncertainty
exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the
year ended December&#160;31, 2022 and 2021, the change in the valuation allowance was $<span id="xdx_90A_eus-gaap--DeferredTaxAssetsValuationAllowance_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Change in valuation allowance">572,885</span> and $<span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_c20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Change in valuation allowance">300,205</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the federal income tax rate to the Company&#8217;s effective tax rate for the years ended December&#160;31, 2022 and
2021 are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zlhQov4oX2Ne" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details 2)">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BB_zwCBpaYt83ld" style="display: none">Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Statutory federal income tax rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20221231_zFtLmiIvZ26f" title="Statutory federal income tax rate">21</span>.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231_zCwUfSn3qwO3" title="Statutory federal income tax rate">21</span>.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">State taxes, net of federal tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20220101__20221231_z79RxeKSIjx" title="State taxes, net of federal tax benefit">0.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20210101__20211231_zh6TFuXVlok" title="State taxes, net of federal tax benefit">0.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Transaction costs allocated to derivative warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_dp_c20220101__20221231_zmbK1VPPXoVk" title="Transaction costs allocated to derivative warrant liabilities">0.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_dp_c20210101__20211231_zX1y4EtnpWIj" title="Transaction costs allocated to derivative warrant liabilities">0.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in fair value of derivative warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_dp_c20220101__20221231_zfZxnyCwqHsa" title="Change in fair value of derivative warrant liabilities">(23.9</span></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_dp_c20210101__20211231_zxi5rbQvqu3c" title="Change in fair value of derivative warrant liabilities">(24.3</span></td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20221231_zNuNGX5EssVe" title="Valuation allowance">3.2</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210101__20211231_z84014VhQuT" title="Valuation allowance">3.3</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Income tax provision</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20221231_znxEB3DdQHq1" title="Income tax provision">0.3</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20211231_zskHnT7LV0C" title="Income tax provision">0.0</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p id="xdx_8A9_zvM7s5Ue5cNg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files income tax returns in the U.S. federal jurisdiction in various state and local jurisdictions and is subject to examination
by the various taxing authorities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338110304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Risk and Concentrations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Credit Risk and Concentrations</a></td>
<td class="text"><p id="xdx_808_eus-gaap--ConcentrationRiskDisclosureTextBlock_zYqz7SmNeksk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            14 &#8211; <span id="xdx_822_z6MSvn9T5Lfc">Credit Risk and Concentrations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that subject the Company to credit risk consist principally of trade accounts receivable and cash and cash equivalents. The
Company performs certain credit evaluation procedures and does not require collateral for financial instruments subject to credit risk.
The Company believes that credit risk is limited because the Company routinely assesses the financial strength of its customers and,
based upon factors surrounding the credit risk of its customers, establishes an allowance for credit losses and, consequently, believes
that its accounts receivable credit risk exposure beyond such allowances is limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains cash deposits with financial institutions, which, from time to time, may exceed federally insured limits. Cash is also
maintained at foreign financial institutions for its Canadian and Philippines subsidiaries and its majority-owned India subsidiary. Cash
in foreign financial institutions as of March 31, 2023 (Successor) and December 31, 2022 (Predecessor) was immaterial. The Company has
not experienced any losses and believes it is not exposed to any significant credit risk from cash.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338228528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Foreign Operations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DisclosureForeignOperationsAbstract', window );"><strong>Foreign Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ForeignOperationsTextBlock', window );">Foreign Operations</a></td>
<td class="text"><p id="xdx_802_ecustom--ForeignOperationsTextBlock_zY2GsZ0N4Jq4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            15 &#8211; <span id="xdx_823_z9bKqAln93S3">Foreign Operations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s operations are located primarily in the United States, Canada, and the Philippines. Revenues by geographic area are attributed
by country of domicile of the Company&#8217;s subsidiaries. The financial data by geographic area are as follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_zZGvyLMcGts1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Foreign Operations (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;<span id="xdx_8BC_zLbtzx9EEIa3" style="display: none">Schedule of financial data by geographic area</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span>&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>United</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>States</b></span></p></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Canada</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>India</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Philippines</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Eliminations</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Total</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">For
    the Period Ended March 31, 2023 (Successor)</span>:</td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left"><span>Revenues
    by geographic area</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"><span>272</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"><span>70</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2267">-</span></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"><span>196</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"><span>(196</span></td><td style="width: 1%; text-align: left"><span>)</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zHHHk5YCIdDb" style="width: 9%; text-align: right" title="Revenues by geographic area"><span>342</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_zWzzmjbBiyM3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(486</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_zQnReV5rrAW2" style="text-align: right" title="Operating income (loss) by geographic area"><span>(158</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_zXKExpq4bLPk" style="text-align: right" title="Operating income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2279">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>157</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2283">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(487</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>2,780</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(158</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2291">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>157</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(21</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>2,758</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">For
    the Period Ended March 14, 2023 (Predecessor)</span>:</td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Revenues
    by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>1,395</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>285</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Revenues by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2303">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>160</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>(220</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zKQARgGUsx78" style="text-align: right" title="Revenues by geographic area"><span>1,620</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(3,479</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(905</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2315">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>3</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2319">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(4,381</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(3,342</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(1,041</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2327">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>3</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2331">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(4,380</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">For
    the Three Months Ended March 31, 2022 (Predecessor)</span>:</td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Revenues
    by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>2,167</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>601</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>270</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Revenues by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2341">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>(456</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zuwXX0ESDeF8" style="text-align: right" title="Revenues by geographic area"><span>2,582</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(650</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98D_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(1,008</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>72</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2353">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>14</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(1,572</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(519</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(1,139</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(27</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2365">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>14</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(1,671</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">As
    of March 31, 2023 (Successor)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Identifiable
    assets by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_znpZI1Rc6fhf" style="text-align: right" title="Identifiable assets by geographic area"><span>75,059</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_zZYPA1LCaawe" style="text-align: right" title="Identifiable assets by geographic area"><span>991</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_znpRbfRKD09l" style="text-align: right" title="Identifiable assets by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2375">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_zJ7a49f51zpi" style="text-align: right" title="Identifiable assets by geographic area"><span>405</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98C_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_zOFdFNj8rmg8" style="text-align: right" title="Identifiable assets by geographic area"><span>(71</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zXRC4kDjFI48" style="text-align: right" title="Identifiable assets by geographic area"><span>76,384</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Long
    lived assets by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>20,817</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>417</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2387">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>222</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2391">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>21,455</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Goodwill
    by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span>44,122</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2397">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2399">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2401">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2403">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span>44,122</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">As
    of December 31, 2022 (Predecessor)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Identifiable
    assets by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_zPVGKa173qfg" style="text-align: right" title="Identifiable assets by geographic area"><span>24,591</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_zf9p6NSjtU52" style="text-align: right" title="Identifiable assets by geographic area"><span>5,484</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_z6K5KYsdGEVe" style="text-align: right" title="Identifiable assets by geographic area"><span>228</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98D_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_zeJEIqXxOymd" style="text-align: right" title="Identifiable assets by geographic area"><span>415</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_zlP5RMOQkOxk" style="text-align: right" title="Identifiable assets by geographic area"><span>(1,438</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zFo4trmxzHp3" style="text-align: right" title="Identifiable assets by geographic area"><span>29,280</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Long
    lived assets by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>15,558</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>4,788</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>98</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>215</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2427">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>20,659</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Goodwill
    by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2431">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2433">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2435">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2437">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2439">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--Goodwill_iI_pn3n3_d0_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zMfxFSYSCSji" style="text-align: right" title="Goodwill by geographic area"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>













<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DisclosureForeignOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DisclosureForeignOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ForeignOperationsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ForeignOperationsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655333925488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOfLesseeDisclosureTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_807_eus-gaap--LeasesOfLesseeDisclosureTextBlock_zt5UZGhTPTgh" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            16 &#8211; <span id="xdx_824_zOLZNaQx4c16">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has operating leases for administrative offices in Canada and the Philippines. The Manila, Philippines office lease expires
in May 2025 and the Canada lease expires in June 2026. The Company entered into a 13-month lease for administrative offices in
California on April 1, 2023 with lease payments of approximately <span id="xdx_907_ecustom--LeasePeriodicPayments_pn3n3_c20230101__20230331_zDFG3rrpw2Aa" title="Lease periodic payments">$19</span>
thousand per month. The Company has no other operating or financing leases with terms greater than 12 months.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
expense for operating leases recorded in the balance sheet is included in operating costs and expenses and is based on the future minimum
lease payments recognized on a straight-line basis over the term of the lease plus any variable lease costs. Operating lease expenses,
inclusive of short-term and variable lease expenses, recognized in the Company&#8217;s condensed consolidated statement of operations
for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022 (Predecessor)
was approximately $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zP7S67bygUP3" title="Operating lease expenses">9</span>&#160;thousand, $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Operating lease expenses">57</span>&#160;thousand and $<span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Operating lease expenses">97</span>&#160;thousand, respectively.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining
the present value of lease payments, the Company used its incremental borrowing rate based on the information available at the date
of adoption of ASC 842 &#8220;Leases&#8221; (&#8220;ASC 842&#8221;). As of March 31, 2023 (Successor), the weighted average
remaining lease term is <span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z8dWSnnnDn2f" title="Weighted average remaining lease term">2.7</span> years and the weighted average discount rate used to determine the operating lease liabilities was <span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zxZ9JyQ3IzT9" title="Weighted average discount rate used to determine operating lease">8.0</span>%.
As of year ended December 31, 2022 (Predecessor), the weighted average remaining lease term is <span id="xdx_900_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zmGyzXZpStpb" title="Weighted average remaining lease term">2.8</span>
years and the weighted average discount rate used to determine the operating lease liabilities was <span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_z5OFOmEqz349" title="Weighted average discount rate used to determine operating lease">8.0</span>%.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -URI https://asc.fasb.org/topic&amp;trid=2208923<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334213040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencie<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencie</a></td>
<td class="text"><p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zJJyEZ35MR49" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
                                            17 &#8211; <span><span id="xdx_828_zxnRMO3h1XN7">Commitments and Contingencie</span>s</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Litigation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
conditions may exist as of the date the financial statements are issued which may result in a loss to the Company, but which will only
be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment
inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the
Company, or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings
or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability
can be estimated, then the estimated liability would be accrued in the Company&#8217;s financial statements. If the assessment indicates
that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then
the nature of the contingent liability and an estimate of the range of possible losses, if determinable and material, would be disclosed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
contingencies considered remote are generally not disclosed, unless they involve guarantees, in which case the guarantees would be disclosed.
There can be no assurance that such matters will not materially and adversely affect the Company&#8217;s business, financial position,
and results of operations or cash flows.</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z7vAgnHWSr26" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 &#8212; <span id="xdx_82D_z3QBY4QkvWs1">COMMITMENTS AND CONTINGENCIES</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Various
social and political circumstances in the United States and around the world (including wars and other forms of conflict, including rising
trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the United States
and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such
as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility
and economic uncertainties or deterioration in the United States and worldwide. Specifically, the rising conflict between Russia and
Ukraine, and resulting market volatility could adversely affect the Company&#8217;s ability to complete a Business Combination. In response
to the conflict between Russia and Ukraine, the United States and other countries have imposed sanctions or other restrictive actions
against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could
have a material adverse effect on the Company&#8217;s ability to complete a Business Combination and the value of the Company&#8217;s
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
continues to evaluate the impact of these types of risks and has concluded that while it is reasonably possible that these risks and
uncertainties could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target
company, the specific impact is not readily determinable as of the date of these consolidated financial statements. The consolidated
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Inflation
Reduction Act of 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August&#160;16, 2022, the Inflation Reduction Act of 2022 (the &#8220;IR Act&#8221;) was signed into federal law. The IR Act provides
for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations
and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January&#160;1, 2023. The excise
tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise
tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating
the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair
market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department
of the Treasury (the &#8220;Treasury&#8221;) has been given authority to provide regulations and other guidance to carry out and prevent
the abuse or avoidance of the excise tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
redemption or other repurchase that occurs after December&#160;31, 2022, in connection with a Business Combination, extension vote or
otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection
with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of
the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business
Combination, (iii) the nature and amount of any &#8220;PIPE&#8221; or other equity issuances in connection with a Business Combination
(or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination)
and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the
Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing
could cause a reduction in the cash available on hand to complete a Business Combination and in the Company&#8217;s ability to complete
a Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a registration rights agreement entered into on December&#160;14, 2020, the holders of the Founder Shares, Private Placement
Warrants and securities that may be issued upon conversion of Working Capital Loans will be entitled to registration rights pursuant
to a registration rights agreement. The holders of at least <span id="xdx_906_ecustom--MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands_c20201201__20201214_pdd" title="Minimum percentage of founder share holders entitled to make demands">30%</span>
in interest of these securities will be entitled to make up to three <span id="xdx_907_ecustom--MaximumNumberOfDemandsForRegistrationOfSecurities_iI_c20201214_z54hT6zpgLWa" style="display: none" title="Maximum number of demands for registration of securities">3</span> demands, excluding short form registration demands, that we
register such securities for sale under the Securities Act. In addition, these holders will have certain &#8220;piggy-back&#8221;
registration rights to include their securities in other registration statements filed subsequent to the completion of a Business
Combination and rights to require us to register for resale such securities pursuant to Rule&#160;415 under the Securities Act. The
Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriting
Agreement</i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters were entitled to a deferred fee of $<span id="xdx_902_ecustom--DeferredFeePerUnit_c20221231_pdd" title="Deferred fee per unit">0.35</span> per Unit, or up to $<span id="xdx_90F_ecustom--DeferredOfferingCostsNoncurrent_iI_pp0p0_c20211231_z3rqmbkjDVGa" title="Deferred underwriting fee payable">9,660,000</span> in the aggregate. The deferred fee was to become
payable to the underwriters from the amounts held in the Trust Account in the event that the Company completed a Business Combination,
subject to the terms of the underwriting agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June&#160;9, 2022, one of the underwriters waived its entitlement to the payment of any deferred fee to be paid under the terms of the
underwriting agreement and is no longer serving in an advisor capacity. As a result, the Company recognized $<span id="xdx_909_ecustom--IncomeRecognizedFromReductionOfDeferredUnderwriterFee_c20220601__20220609_pp0p0" title="Income recognized from reduction of deferred underwriter fee">9,660,000</span> of income in relation
to the reduction of the deferred underwriter fee in the accompanying consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Merger
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;25, 2022, the Company entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), by and among
the Company, Inpixon, a Nevada corporation (&#8220;Inpixon&#8221;), CXApp Holding Corp., a Delaware corporation and wholly-owned subsidiary
of Inpixon (&#8220;CXApp&#8221; and, together with Inpixon, collectively, the &#8220;Companies&#8221;), and Merger Sub, pursuant to which
the Company will combine with CXApp, Inpixon&#8217;s enterprise apps business (including its workplace experience technologies, indoor
mapping, events platform, augmented reality and related business solutions) (the &#8220;Enterprise Apps Business&#8221;). Also on September&#160;25,
2022, and in connection with the execution of the Merger Agreement, the Company, Inpixon, CXApp and the Sponsor entered into that certain
sponsor support agreement (the &#8220;Sponsor Support Agreement&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
prior to the Merger (as defined below) and pursuant to a Separation and Distribution Agreement, dated as of September&#160;25, 2022,
among the Company, Inpixon, CXApp and Design Reactor, Inc., a California corporation (&#8220;Design Reactor&#8221;) (the &#8220;Separation
Agreement&#8221;), and other ancillary conveyance documents, Inpixon will, among other things and on the terms and subject to the conditions
of the Separation Agreement, transfer the Enterprise Apps Business, including certain related subsidiaries of Inpixon, including Design
Reactor, to CXApp (the &#8220;Reorganization&#8221;) and, in connection therewith, will distribute (the &#8220;Distribution&#8221;) to
Inpixon stockholders and other security holders 100% of the common stock of CXApp, par value $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220925__us-gaap--StatementEquityComponentsAxis__custom--CXAppCommonStockMember_zGG8DefANBxg" title="Common stock, par value (in dollars per share)">0.00001</span> (the &#8220;CXApp Common Stock&#8221;),
as further described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
following the Distribution, in accordance with and subject to the terms and conditions of the Merger Agreement, Merger Sub will merge
with and into CXApp (the &#8220;Merger&#8221;), with CXApp continuing as the surviving company in the Merger and as a wholly-owned subsidiary
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement, along with the Separation Agreement and the other transaction documents to be entered into in connection therewith,
provides for, among other things, the consummation of the following transactions (collectively, the &#8220;Business Combination&#8221;):
(i) Inpixon will transfer the Enterprise Apps Business (the &#8220;Separation&#8221;) to its wholly-owned subsidiary, CXApp, and contribute
$<span id="xdx_90F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_pp0n3_dm_c20220925__srt--CounterpartyNameAxis__custom--InpixonMember__us-gaap--TypeOfArrangementAxis__custom--SeparationAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zgwpD32BjIt2" title="Cash Contribution upon seperation">10</span> million in capital thereto (the &#8220;Cash Contribution&#8221;), (ii) following the Separation, Inpixon will distribute <span id="xdx_90A_ecustom--PercentageOfCommonStockDistributed_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_pdd" title="Percentage of common stock distributed">100%</span> of
the shares of CXApp Common Stock to Inpixon stockholders and other security holders by way of the distribution and (iii) following the
completion of the foregoing transactions and subject to the satisfaction or waiver of certain other conditions set forth in the Merger
Agreement, the parties shall consummate the Merger. The Separation, Distribution and Merger are intended to qualify as &#8220;tax-free&#8221;
transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of the Business Combination, the Company will have two classes of common stock: Class A common stock, par value $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_c20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common stock, par value (in dollars per share)">0.0001</span>
per share (the &#8220;Company&#8217;s Class A Common Stock&#8221;), and Class C common stock, par value $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_c20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Common stock, par value (in dollars per share)">0.0001</span> per share (the &#8220;Company&#8217;s
Class C Common Stock&#8221; and together with the Company&#8217;s Class A Common Stock, the &#8220;Company&#8217;s Common Stock&#8221;).
The Company&#8217;s Class A Common Stock and the Company&#8217;s Class C Common Stock will be identical in all respects, except that
the Company&#8217;s Class C Common Stock will be subject to transfer restrictions and will automatically convert into Company&#8217;s
Class A Common Stock on the earlier to occur of (i) the <span id="xdx_90F_ecustom--MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_z9CooSiozhrc" title="Maximum term for automatic conversion of stock following the closing of the Merger">180</span>th day following the closing of the Merger and (ii) the day that the last
reported sale price of the Company&#8217;s Class A Common Stock equals or exceeds $<span id="xdx_906_ecustom--CommonStockStockPriceTrigger_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zmfc5C4n4Cxf" title="Stock price trigger">12.00</span> per share for any <span id="xdx_90B_ecustom--ThresholdTradingDays_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_z18vCC1eSJx5" title="Threshold trading days">20</span> trading days within any
<span id="xdx_906_ecustom--ThresholdConsecutiveTradingDays_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_ztl2WmhDMSqi" title="Threshold consecutive trading days">30</span>-trading day period following the closing of the Merger. The Company&#8217;s Class A Common Stock will be listed on the Nasdaq Capital
Market (&#8220;Nasdaq&#8221;) and are expected to be trading under a new ticker symbol. The outstanding warrants of the Company will
be listed on Nasdaq and are expected to be trading under a new ticker symbol.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Consideration
Paid</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time the Business Combination is effected (the &#8220;Closing&#8221;), the outstanding shares of CXApp Common Stock after the Distribution
and immediately prior to the effective time of the Merger will be converted into an aggregate of <span id="xdx_903_ecustom--NumberOfSharesIssuableUponMerger_iI_pdn3_dm_c20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zOpnlBGcXtt3" title="Number of shares issuable upon merger">6.9</span> million shares of The Company&#8217;s
Common Stock which shall be issued to Inpixon shareholders, subject to adjustment. Each holder&#8217;s aggregate merger consideration
will consist of <span id="xdx_901_ecustom--PercentageOfStockAsMergerConsideration_c20220901__20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zJP9vPMVMYH9" title="Percentage of stock as merger consideration">10%</span> Company&#8217;s Class A Common Stock and <span id="xdx_903_ecustom--PercentageOfStockAsMergerConsideration_c20220901__20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_pdd" title="Percentage of stock as merger consideration">90%</span> Company&#8217;s Class C Common Stock (such percentages, in each case,
subject to adjustment to comply with the listing requirements set forth under Nasdaq Listing Rule&#160;5505(b)(2) with respect to KINS).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Representations
and Warranties &amp; Covenants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement, the Company, CXApp and Inpixon each made representations and warranties customary for transactions of this type
regarding themselves and their respective businesses. The representations and warranties made pursuant to the Merger Agreement will not
survive the Closing. In addition, the parties to the Merger Agreement agreed to be bound by certain covenants that are customary for
transactions of this type. The covenants made under the Merger Agreement generally will not survive the Closing, with the exception of
certain covenants and agreements that by their terms are to be performed in whole or in part after the Closing, which will survive in
accordance with the terms of the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conditions
to Closing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consummation of the Business Combination is subject to conditions customary for transactions involving special purpose acquisition companies,
including, among others: (i) there is not in force any order, judgment, injunction, decree, writ, stipulation, determination or award,
in each case, entered by or with any governmental authority of competent jurisdiction, statute, rule or regulation enjoining or prohibiting
the consummation of the Merger, (ii) the Company shall have at least $<span id="xdx_908_ecustom--ThresholdNetTangibleAssets_c20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_pp0p0" title="Threshold net tangible assets">5,000,001</span> of net tangible assets as of the Closing, (iii) the Company&#8217;s
Class A Common Stock issuable pursuant to the Business Combination shall have been approved for listing on Nasdaq, (iv) CXApp and the
Company shall each have performed and complied in all material respects with the covenants required by the Merger Agreement to be performed
by it as of or prior to Closing, (v) customary bring down conditions related to the accuracy of the CXApp&#8217;s and the Company&#8217;s
respective representations and warranties in the Merger Agreement, (vi) the consummation of the Distribution, the Reorganization and
other transactions contemplated by the Separation and Distribution Agreement, (vii) the Company&#8217;s registration statement to be
filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) shall have become effective (and no stop order suspending effectiveness
have been issued and no proceedings for that purpose has been initiated or threatened by the SEC), (viii) each of the Company&#8217;s
and CXApp&#8217;s stockholder approvals shall have been obtained and (ix) the sum of (A) the aggregate amount of cash available in KINS&#8217;s
trust account following the Company&#8217;s stockholders&#8217; meeting, after deducting the amount required to satisfy the Acquiror
Share Redemption Amount (as defined in the Merger Agreement) (but prior to payment of any transaction expenses), (B) the aggregate gross
purchase price of any other purchase of shares of the Company&#8217;s Common Stock (or securities convertible or exchangeable for the
Company&#8217;s Common Stock) actually received by the Company prior to or substantially concurrently with the closing of the Merger,
and (C) the aggregate gross purchase price of any other purchase of shares of CXApp Common Stock (or securities convertible or exchangeable
for CXApp Common Stock) actually received by CXApp prior to or substantially concurrently with the closing of the Merger, shall be equal
to or greater than $<span id="xdx_901_ecustom--ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares_pp0n3_dm_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zozBBC4g4UI6" title="Threshold aggregate gross purchase price of any other purchase of shares">9.5</span> million. The Company&#8217;s obligation to consummate the Business Combination is also conditioned on there having
been no event that has had, or would reasonably be expected to have, individually or in the aggregate, a &#8220;Material Adverse Effect&#8221;
on CXApp.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Termination</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing, including (i)
by the mutual written consent of the Company and CXApp, (ii) by the Company or CXApp, if the Closing shall not have occurred on or before
March&#160;16, 2023, (iii) by the Company or CXApp, if there has been any order, judgment, injunction, decree, writ, stipulation, determination
or award, in each case, entered by or with any governmental authority that would make the Merger illegal or otherwise prevent or prohibit
the Merger, (iv) by the Company or CXApp, if KINS has not obtained the requisite approval from its stockholders, (v) by KINS or CXApp
if the other party breaches certain representations, warranties, or covenants, as specified in the Merger Agreement, and that breach
is unable to be cured, or is not cured, within <span id="xdx_904_ecustom--TermOfBreachUnableToBeCuredOrIsNotCured_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zgtlwRhE9w7i" title="Term of breach unable to be cured, or is not cured">30</span> days, or by CXApp if there has been an uncured breach by Sponsor of certain of its
obligations under the Sponsor Support Agreement or (vi) by the Company if CXApp has not obtained the requisite approval from its stockholders
within one hour of the effective date of the Company&#8217;s registration statement, provided that CXApp or the Company pay a termination
fee of $<span id="xdx_901_ecustom--TerminationFee_pp0n3_dm_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zcm6CsTaMVPh" title="Termination fee">2.0</span> million to the other party if the Merger Agreement is terminated pursuant to (v) or (vi) above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Separation
and Distribution Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;25, 2022, in connection with the execution of the Merger Agreement, the Company entered into the Separation Agreement
with CXApp, Inpixon and Design Reactor, pursuant to which, among other things, (i) Inpixon will undertake a series of internal reorganization
and restructuring transactions to effect the transfer of its (direct or indirect) ownership of the Enterprise Apps Business to CXApp
in the Separation and (ii) immediately prior to the Merger and after the Separation, Inpixon will distribute 100% of the outstanding
shares of CXApp Common Stock to Inpixon&#8217;s stockholders and certain other security holders in the Distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Separation Agreement also sets forth other agreements among Inpixon and CXApp related to the Separation, including provisions concerning
the termination and settlement of intercompany accounts and the obtaining of third-party consents. The Separation Agreement also sets
forth agreements that will govern certain aspects of the relationship between Inpixon and CXApp after the Distribution, including provisions
with respect to release of claims, indemnification, access to financial and other information and access to and provision of records.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consummation
of the Distribution is subject to a number of conditions, including, among others, (i) the completion of the Reorganization and other
related transactions, (ii) the execution of the ancillary agreements by the parties and (iii) the satisfaction or waiver of all conditions
under the Merger Agreement (other than those conditions that are to be satisfied contemporaneously with the Distribution and/or the Merger,
provided that such conditions are capable of being satisfied at such time).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sponsor
Support Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September&#160;25, 2022, in connection with the execution of the Merger Agreement, the Company, Inpixon, CXApp and the Sponsor entered
into the Sponsor Support Agreement, pursuant to which, among other things, the Sponsor agreed to vote any of the Company&#8217;s securities
held by it to approve the Business Combination and the other of the Company&#8217;s stockholder matters required pursuant to the Merger
Agreement, and not to seek redemption of any of the Company&#8217;s securities in connection with the consummation of the Business Combination.
Pursuant to the Sponsor Support Agreement, the Sponsor and the Company also agreed to amend the letter agreement, dated as of December&#160;14,
2020 between the Sponsor and the Company (the &#8220;Insider Letter&#8221;) to amend the Founder Shares Lock-Up Period (as defined in
the Insider Letter) to provide for lock-up of its shares of the Company&#8217;s Class B common stock, par value $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20201214__us-gaap--TransactionTypeAxis__custom--MergerAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zjM90cv4eljd" title="Common stock, par value (in dollars per share)">0.0001</span> per share (&#8220;Company&#8217;s
Class B Common Stock&#8221;) (or Company&#8217;s Class A Common Shares issuable upon conversion thereof) until the earlier of (A) the
<span id="xdx_90A_ecustom--CommonStockLockUpPeriod_dtD_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zjPs1ggtZaWk" title="Lock-up period">180</span>th day after the closing of the Merger and (B) (x) the date on which the Company completes a liquidation, merger, stock exchange,
reorganization or other similar transaction following the closing of the Merger or (y) the day that the last reported sale price of the
Company&#8217;s Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any <span id="xdx_90C_ecustom--ThresholdTradingDays_dtD_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zIzaBI3ZCH02" title="Threshold trading days">20</span> trading days within any <span id="xdx_906_ecustom--ThresholdConsecutiveTradingDays_dtD_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zVfWYSgOx60b" title="Threshold consecutive trading days">30</span>-trading day period following the Closing of the Merger; provided,
that <span id="xdx_908_ecustom--PercentageOfSharesNotBeSubjectToForegoingLockUp_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_pdd" title="Percentage of shares not be subject to foregoing lock-up">22%</span> of such shares (subject to adjustment) shall not be subject to foregoing lock-up. Additionally, Sponsor has agreed to exchange
<span id="xdx_900_ecustom--NumberOfSharesExchanged_c20201201__20201214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--TypeOfArrangementAxis__custom--SponsorSupportAgreementMember_pdd" title="Number of shares exchanged">6,150,000</span> shares of the Company&#8217;s Class B Common Stock, equal to such that the number of shares of the Company&#8217;s Common Stock
issued as aggregate merger consideration exceeds (by one share): (i) the aggregate number of shares of the Company&#8217;s Class A Common
Stock held by Sponsor at Closing (after taking into the exchange), plus (ii) the aggregate number of shares of the Company&#8217;s Class
B Common Stock held by certain funds and accounts managed by BlackRock, Inc. (including all Potential Forfeiture Shares (as defined in
the Sponsor Support Agreement)), plus (iii) the aggregate number of shares of the Company&#8217;s Class A Common Stock that have not
properly elected to redeem their shares of the Company&#8217;s Class A Common Stock pursuant to the Company&#8217;s governing documents,
plus (iii) any shares of the Company&#8217;s Common Stock issued as incentives for non-redemption transactions and financing transactions,
in each case, free and clear of all liens; provided, that, in no instance shall the number of shares issued to Sponsor in the exchange
be less than <span id="xdx_901_ecustom--MinimumNumberOfSharesIssuableToSponsor_c20201201__20201214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SponsorSupportAgreementMember_pdd" title="Minimum number of shares issuable to sponsor">5,150,000</span> shares of the Company&#8217;s Class A Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655329773616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zuktqF2w8fJ1" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Basis
of Presentation</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles
generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and pursuant to the accounting and disclosure rules and
regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 2&#8212;Restatement of Previously Issued Financial Statements, the Company&#8217;s financial statements for the year
ended December&#160;31, 2022 (collectively, the &#8220;Affected Period&#8221;), are restated in this Annual Report on Form&#160;10-K/A
(Amendment No. 1) (this &#8220;Annual Report&#8221;) to correct the misapplication of accounting guidance related to the liability extinguishment
in the Company&#8217;s previously issued audited financial statements for such period. The restated financial statements are indicated
as &#8220;Restated&#8221; in the audited financial statements and accompanying notes, as applicable. See Note 2&#8212;Restatement of
Previously Issued Financial Statements for further discussion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84B_eus-gaap--ConsolidationPolicyTextBlock_z5OXF1lZ1sd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Principles
of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_EmergingGrowthCompanyPolicyTextBlock', window );">Emerging Growth Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_847_ecustom--EmergingGrowthCompanyPolicyTextBlock_zTskIQfKuDvh" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Emerging
Growth Company</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not
being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley
Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#8217;s consolidated financial statements with another public
company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition
period difficult or impossible because of the potential differences in accounting standards used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_849_eus-gaap--UseOfEstimates_z2Ou3EfIXRz8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use
                                            of Estimates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;)
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during each of the reporting
periods. Actual results could differ from those estimates. The Company&#8217;s significant estimates consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            valuation of stock-based compensation;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            valuation of warrant liabilities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            allowance for credit losses;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            valuation allowance for deferred tax assets; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">impairment
                                            of long-lived assets and goodwill.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--UseOfEstimates_zLhWUjXH4x1k" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Use of Estimates</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting
estimates included in these consolidated financial statements is the determination of the fair value of the warrant liabilities. Accordingly,
the actual results could differ significantly from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zWE2s2Vjh8xk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cash
                                            and Cash Equivalents</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents consist of cash, checking accounts, money market accounts, temporary investments and certificates of deposit with
maturities of three months or less when purchased. <span id="xdx_90B_ecustom--CashAndCashEquivalentsDescription_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFNmvvmyQX9l" title="Cash and cash equivalents, description">As of March 31, 2023 (Successor), the Company had cash equivalents  of approximately $2,000 thousand of certificates of
deposit held by a number of banks limited to $250 thousand per bank with a duration of 90 days or less</span> and at December 31, 2022 (Predecessor)
the Company had no cash equivalents.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zKK0E1m2SDX" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Cash
and Cash Equivalents</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of six months or less when purchased to be cash equivalents. The
Company did not have any cash equivalents as of December&#160;31, 2022 and 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zpNq8gvDt5d5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Concentration
of Credit Risk</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit
of $<span id="xdx_907_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zbxBYEbSbSJe" title="Insured amount">250,000</span>. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#8217;s financial
condition, results of operations, and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_TemporaryEquityPolicyPolicyTextBlock', window );">Class A Common Stock Subject to Possible Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_842_ecustom--TemporaryEquityPolicyPolicyTextBlock_zPUqISlM1ggd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Class
A Common Stock Subject to Possible Redemption</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards
Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Shares of Class A common stock subject
to mandatory redemption are classified as liability instruments and are measured at fair value. Conditionally redeemable common stock
(including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon
the occurrence of uncertain events not within the Company&#8217;s control) is classified as temporary equity. At all other times, common
stock is classified as stockholders&#8217; equity. The Company&#8217;s Class A common stock features certain redemption rights that are
considered to be outside of the Company&#8217;s control and subject to occurrence of uncertain future events. Accordingly, as of December&#160;31,
2022 and 2021, <span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_c20221231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_pdd" title="Class A common stock subject to possible redemption, outstanding (in shares)">387,551</span> and <span id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_c20211231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_pdd" title="Class A common stock subject to possible redemption, outstanding (in shares)">27,600,000</span> shares of Class A common stock subject to possible redemption are presented as temporary equity,
outside of the stockholders&#8217; deficit section of the Company&#8217;s consolidated balance sheets, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to
equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock
are affected by charges against additional paid in capital (to the extent available) and accumulated deficit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December&#160;31, 2022 and 2021, the Class A common stock reflected in the consolidated balance sheets are reconciled in the following
table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--TemporaryEquityTableTextBlock_zECvghHTCwL6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8B3_z5tspC3QNLU4" style="display: none">Schedule of reconciliation of Class A common stock reflected in the condensed balance sheet</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 88%; text-align: left">Class A common stock subject to possible redemption, January&#160;1, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_pp0p0_c20210101__20211231_zATWP7fZf60h" style="width: 9%; text-align: right" title="Class A common stock subject to possible redemption, at beginning of year">278,760,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"><span style="-sec-ix-hidden: xdx2ixbrl0696">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Class A common stock subject to possible redemption, December&#160;31, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_pp0p0_c20220101__20221231_zjkwtljQn1Hj" style="font-weight: bold; text-align: right" title="Class A common stock subject to possible redemption, at beginning of year">278,760,000</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: left">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: left">Waiver of Class A common stock issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--TemporaryEquityWaiverOfShareIssuanceCosts_c20220101__20221231_pp0p0" style="text-align: right" title="Waiver of Class A common stock issuance costs">9,288,090</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: left">Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: left">Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--TemporaryEquityAccretionToRedemptionValue_iN_pp0p0_di_c20220101__20221231_zJ3VEP2gCel2" style="text-align: right" title="Accretion of carrying value to redemption value">(9,031,545</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Redemption of Class A Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--TemporaryEquityRedemption_iN_pp0p0_di_c20220101__20221231_zdNc46iem556" style="border-bottom: Black 1pt solid; text-align: right" title="Redemption of Class A Common Stock">(275,102,280</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Class A common stock subject to redemption, December&#160;31, 2022</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_pp0p0_c20220101__20221231_zBkDV3Rqvs4h" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Class A common stock subject to possible redemption, at end of year">3,914,265</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_z11GjiUIYBD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Offering Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_843_eus-gaap--DeferredChargesPolicyTextBlock_zdDaWmFTZVp2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Offering
Costs</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the
Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based
on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities were expensed as
incurred in the consolidated statements of operations. Offering costs associated with the Class A common stock issued were initially
charged to temporary equity. Offering costs incurred amounted to $<span id="xdx_908_ecustom--TransactionCosts_iI_pp0p0_c20201217_zpUUBSq82EV3" title="Transaction costs">15,688,848</span>, consisting of $<span id="xdx_907_ecustom--SaleOfStockUnderwritingFees_iI_pp0p0_c20201217_z7DhoIX1DKZd" title="Underwriting fees">5,520,000</span> in cash underwriting fees, $<span id="xdx_905_ecustom--DeferredOfferingCostsNoncurrent_iI_pp0p0_c20201217_zACM8B1o1Kjd" title="Deferred underwriting fee payable">9,660,000</span>
of deferred underwriting fees and $<span id="xdx_90E_ecustom--SaleOfStockOtherOfferingCosts_iI_pp0p0_c20201217_zbglZAMf0A8i" title="Other offering costs">508,848</span> of other offering costs, of which $<span id="xdx_90A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_pp0p0_c20201201__20201217_zWImPD8D2FUj" title="Charged to temporary equity">15,239,420</span> was charged to temporary equity and $<span id="xdx_904_ecustom--OfferingCost_pp0p0_c20201201__20201217_zdVtpvILLUm9" title="Offering cost expense">449,428</span>
was allocated to the warrant liability and expensed through the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantLiabilityPolicyTextBlock', window );">Derivative Warrant Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_845_ecustom--WarrantLiabilityPolicyTextBlock_zy7gcJxh8IRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Derivative
Warrant Liabilities</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s
specific terms and applicable authoritative guidance in Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards
Codification (&#8220;ASC&#8221;) 480, Distinguishing Liabilities from Equity (&#8220;ASC 480&#8221;) and ASC 815, Derivatives and Hedging
(&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet
the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under
ASC 815, including whether the warrants are indexed to the Company&#8217;s own common stock, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification,
the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the consolidated statements of operations.
The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a
binomial lattice model. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market
price was used as the fair value of the Warrants (as defined below) as of each relevant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zHn9JBCIYIBb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
                                            Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes using the asset and liability method. Accordingly, deferred tax assets and liabilities are recognized
for the future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities
and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in the tax rate is recognized in income or expense in the period that the change is effective. Income tax benefits
are recognized when it is probable that the deduction will be sustained. A valuation allowance is established when it is more likely
than not that all or a portion of a deferred tax asset will either expire before the Company is able to realize the benefit, or that
future deductibility is uncertain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zAkXDmrMgUre" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Income
Taxes</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes under ASC 740, &#8220;Income Taxes.&#8221; ASC 740, Income Taxes, requires the recognition of deferred
tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation
allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740-270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in
interim periods under ASC 740-270-30-5. As of December&#160;31, 2022 and December&#160;31, 2021, the Company&#8217;s deferred tax asset
had a full valuation allowance recorded against it. The Company&#8217;s effective tax rate was <span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20220101__20221231_zeSoHveIZU2j" title="Effective tax rate (in percent)">0.3%</span> and <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20210101__20211231_zbw1V8igdRf8" title="Effective tax rate (in percent)">0.0%</span>, respectively. The effective
tax rate differs from the statutory tax rate of <span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c20220101__20221231_zwkDRRygxUJ8" title="Statutory tax rate"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c20210101__20211231_zX7MjNWI9J04" title="Statutory tax rate">21%</span></span> for the years ended December&#160;31, 2022 and 2021, due to changes in fair value
in warrant liability and the valuation allowance on the deferred tax assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#8217;s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
period, disclosure and transition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were <span id="xdx_903_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20221231_zI6apnoPaO7i" title="Unrecognized tax benefits"><span id="xdx_901_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20211231_zXaHWhMffC9f" title="Unrecognized tax benefits">no</span></span> unrecognized
tax benefits and <span id="xdx_906_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pp0p0_do_c20221231_zUiuIorm9u89" title="Unrecognized tax benefits accrued for interest and penalties"><span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pp0p0_do_c20211231_zFEkKd3bn3eh" title="Unrecognized tax benefits accrued for interest and penalties">no</span></span> amounts accrued for interest and penalties as of December&#160;31, 2022 and December&#160;31, 2021. The Company is
currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has identified the United States as its only &#8220;major&#8221; tax jurisdiction. The Company is subject to income taxation
by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus
of income among various tax jurisdictions and compliance with federal and state tax laws. The Company&#8217;s management does not expect
that the total amount of unrecognized tax benefits will materially change over the next twelve months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zExbuawx3YWi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Earnings
                                            Per Share</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
computes basic and diluted earnings per share by dividing net income by the weighted average number of common shares outstanding during
the period. Diluted earnings per share are similarly calculated with the inclusion of dilutive common stock equivalents. The following
table summarizes the number of common shares and common share equivalents excluded from the calculation of diluted net income per common
share for period ended March 31, 2023 (Successor), which are excluded from the calculation because (i) the warrants were below their
exercise price and (ii) the stock options were not vested :</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_pn3n3_zXBF2PB15Bxd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policie (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; text-align: left"><span id="xdx_8B3_zmSyfTTgVZU" style="display: none">Schedule of antidilutive shares</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to<br/>
    March&#160;31,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"><span>Stock
    options</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zn1dqT8iNFke" style="border-bottom: Black 1pt solid; text-align: right"><span>1,377</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total"><span>24,080</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span>25,457</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zvnZTRGy3S6a" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Net
Income per Common Share</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share&#8221;. Net income per
common share is computed by dividing net income by the weighted average number of shares of common stock outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class
A common stock is excluded from earnings per share as the redemption value approximates fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
calculation of diluted income per share does not consider the effect of the Warrants issued in connection with the (i) Initial Public
Offering, and (ii) the private placement since the exercise of the Warrants is contingent upon the occurrence of future events. The Warrants
are exercisable to purchase <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Number of warrants to purchase shares issued">24,080,000</span> shares of Class A common stock in the aggregate. As of December&#160;31, 2022 and 2021, the Company
did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and
then share in the earnings of the Company. As a result, diluted net income per common share is the same as basic net income per common
share for the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zYz80eOXU9p1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B0_zsXmGyV3aD93" style="display: none">Schedule of Reconciliation of net income per common share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20220101_20221231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassAMember" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20220101_20221231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z6j1d9NrCpC5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20210101_20211231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="14" style="font-weight: bold; text-align: center">Year Ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December&#160;31,</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class A</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class B</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class A</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class B</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: left">Basic and diluted net income per common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_i01B" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i02_pp0p0" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,385,193</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,961,627</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,366,307</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,841,577</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i02_pdd" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Basic and diluted weighted average shares outstanding</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,546,423</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,900,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">27,600,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,900,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Basic and diluted net income per common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.27</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.27</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8AD_zOrPjkSBYWej" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z1Yer2XJkN4k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
                                            Value of Financial Instruments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments consist of cash and cash equivalents, accounts receivable, notes and other receivable and accounts payable. The Company determines
the estimated fair value of such financial instruments presented in these financial statements using available market information and
appropriate methodologies. These financial instruments are stated at their respective historical carrying amounts, which approximate
fair value due to their short-term nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zezPmwmkfduc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
fair value of the Company&#8217;s assets and liabilities which qualify as financial instruments under ASC Topic 820, &#8220;Fair Value
Measurement,&#8221; approximate the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their
short-term nature, except the derivative warrant liabilities (see Note 10).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued and Adopted Accounting Standards</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zKtKg42HkPn6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recently
                                            Issued and Adopted Accounting Standards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>In October
2021, the FASB issued ASU 2021-08, &#8220;Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&#8221;
(&#8220;ASU 2021-08&#8221;), which addresses diversity in practice related to the accounting for revenue contracts with customers acquired
in a business combination. Under the new guidance, the acquirer is required to apply Topic 606 to recognize and measure contract assets
and contract liabilities in a business combination. The effective date of the standard is for fiscal years beginning after December 15,
2022, including interim periods within those fiscal years, with early adoption permitted. CXApp adopted ASU 2021-08 on January 1, 2022.
As a result of management&#8217;s evaluation, the adoption of ASU 2021-08 did not have a material impact on the consolidated financial
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
evaluated recently issued FASB accounting pronouncements and noted that no recent announcements were applicable to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmqYJbCeT0sg" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Recent
Accounting Standards</span></i></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August&#160;2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2020-06, Debt &#8212; Debt with Conversion
and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8212; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40) (&#8220;ASU
2020-06&#8221;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation
of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance
pertaining to equity classification of contracts in an entity&#8217;s own equity. The new standard also introduces additional disclosures
for convertible debt and freestanding instruments that are indexed to and settled in an entity&#8217;s own equity. ASU 2020-06 amends
the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU
2020-06 is effective January&#160;1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted
beginning on January&#160;1, 2021. The Company adopted ASU 2020-06 as of January&#160;1, 2021 and the adoption did not have an impact
on its financial position, results of operations or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_LiquidityAndGoingConcernPolicyTextBlock', window );">Liquidity</a></td>
<td class="text"><p id="xdx_846_ecustom--LiquidityAndGoingConcernPolicyTextBlock_zw3E5NpOJlNg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
                                            </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2023 (Successor), the Company has a working capital surplus of approximately $<span id="xdx_900_ecustom--WorkingCapital_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Working capital">3,052</span>&#160;thousand and cash and cash equivalents of approximately
$<span id="xdx_907_eus-gaap--Cash_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Cash">6,724</span>&#160;thousand. For the period ended March 31, 2023 (Successor), the Company incurred net income
of approximately $<span id="xdx_906_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Net income">2,758</span> thousand. During the period ended March 31, 2023 (Successor), the Company used approximately $<span id="xdx_90D_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_di_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFXCqwS29eM8" title="Cash for operating activities">4,431</span> thousand of
cash for operating activities, of which $<span id="xdx_903_eus-gaap--OtherAccruedLiabilitiesCurrent_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Reduction in accrued liabilities">3,888</span> thousand was from a reduction in accrued liabilities, primarily paying merger related
transaction liabilities. In assessing the Company&#8217;s ability to continue as a going concern, the Company monitors and analyzes its
cash and its ability to generate sufficient cash flow in the future to support its operating and capital expenditure commitments.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>The
Company cannot assure that it will ever earn revenues sufficient to support their operations, or that it will ever achieve profitable
operations. The Company&#8217;s recurring losses and utilization of cash in its operations are indicators of substantial doubt that the
entity can continue as a going concern however with the Company&#8217;s current liquidity position the Company has taken steps to reduce
operating expenses and extend it&#8217;s runway. The Company intends to finance its future working capital requirements and capital expenditures
from cash generated from operating activities and may consider raising funds from equity financings. Management believes that the actions
presently being taken to further implement its business plan and generate its revenues provide the opportunity for the Company to continue
as a going concern for at least 12 months from the issuance of these condensed consolidated financial statements. While the Company believes
in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that
effect for at least twelve months from the issuance of these condensed consolidated financial statements. The ability of the Company
to continue as a going concern is dependent upon the Company&#8217;s ability to further implement its business plan. The accompanying
unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization
of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments
relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might
result from the outcome of the uncertainties described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock', window );">Accounts Receivable, net and Allowance for Credit Losses</a></td>
<td class="text"><p id="xdx_84A_ecustom--AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock_zefF4QCGnSNj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Accounts
                                            Receivable, net and Allowance for Credit Losses</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Accounts
receivables are stated at the amount the Company expects to collect. The Company recognizes an allowance for credit losses to ensure
accounts receivables are not overstated due to un-collectability. Bad debt reserves are maintained for various customers based on a variety
of factors, including the length of time the receivables are past due, significant one-time events and historical experience. An additional
reserve for individual accounts is recorded when the Company becomes aware of a customer&#8217;s inability to meet its financial obligation,
such as in the case of bankruptcy filings, or deterioration in such customer&#8217;s operating results or financial position. If circumstances
related to a customer change, estimates of the recoverability of receivables would be further adjusted. The Company&#8217;s allowance
for credit losses is not significant as of March 31, 2023 (Successor) and at December 31, 2022 (Predecessor).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment, net</a></td>
<td class="text"><p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zNREgUj0V3nh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Property
                                            and Equipment, net</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are recorded at cost, less accumulated depreciation and amortization. The Company depreciates its property and equipment
for financial reporting purposes using the straight-line method over the estimated useful lives of the assets, which range from 3 to
10 years. Leasehold improvements are amortized over the lesser of the useful life of the asset or the initial lease term. Expenditures
for maintenance and repairs, which do not extend the economic useful life of the related assets, are charged to operations as incurred,
and expenditures, which extend the economic life, are capitalized. When assets are retired, or otherwise disposed of, the costs and related
accumulated depreciation or amortization are removed from the accounts and any gain or loss on disposal is recognized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z4fAlHyLJg8e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intangible
                                            Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets primarily consist of developed technology, customer lists/relationships, non-compete agreements, intellectual property
agreements, export licenses and trade names/trademarks. They are amortized ratably over a range of <span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zZPQov9BPJu7" title="Intangible assets useful life">1 </span>
to <span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_ziSd4Biku1B2" title="Intangible assets useful life">10</span>
years, which approximates customer attrition rate and technology obsolescence. The Company assesses the carrying value of its
intangible assets for impairment each year. Based on its assessments, the Company did not incur any impairment charges for the
period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022
(Predecessor).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text"><p id="xdx_843_eus-gaap--GoodwillDisclosureTextBlock_zotamlkSrV76" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Goodwill</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company tests goodwill for potential impairment at least annually, or more frequently if an event or other circumstance indicates that
the Company may not be able to recover the carrying amount of the net assets of the reporting unit. The Company has determined that the
reporting unit is the entire company, due to the integration of all of the Company&#8217;s activities. In evaluating goodwill for impairment,
the Company may assess qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50%) that
the fair value of a reporting unit is less than its carrying amount. If the Company bypasses the qualitative assessment, or if the Company
concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs
a quantitative impairment test by comparing the fair value of a reporting unit with its carrying amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company calculates the estimated fair value of a reporting unit using a weighting of the income and market approaches. For the income
approach, the Company uses internally developed discounted cash flow models that include the following assumptions, among others: projections
of revenues, expenses, and related cash flows based on assumed long-term growth rates and demand trends; expected future investments
to grow new units; and estimated discount rates. For the market approach, the Company uses internal analyses based primarily on market
comparables. The Company bases these assumptions on its historical data and experience, third party appraisals, industry projections,
micro and macro general economic condition projections, and its expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_LeasesAndRightofUseAssetsPolicyTextBlock', window );">Leases and Right-of-Use Assets</a></td>
<td class="text"><p id="xdx_844_ecustom--LeasesAndRightofUseAssetsPolicyTextBlock_zH39sJYL1091" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Leases
                                            and Right-of-Use Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if an arrangement is a lease at its inception. Operating lease liabilities are recognized at the lease commencement
date based on the present value of lease payments over the lease term. The Company generally uses their incremental borrowing rate based
on the information available at the lease commencement date in determining the present value of future payments, because the implicit
rate of the lease is generally not known. Right-of-use assets related to the Company&#8217;s operating lease liabilities are measured
at lease inception based on the initial measurement of the lease liability, plus any prepaid lease payments and less any lease incentives.
The Company&#8217;s lease terms that are used in determining their operating lease liabilities at lease inception may include options
to extend or terminate the leases when it is reasonably certain that the Company will exercise such options. The Company amortizes their
right-of-use assets as operating lease expense generally on a straight-line basis over the lease term and classify both the lease amortization
and imputed interest as operating expenses. The Company does not recognize lease assets and lease liabilities for any lease with an original
lease term of less than one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Comprehensive Income (Loss) and Foreign Currency Translation</a></td>
<td class="text"><p id="xdx_844_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zlwVv8rtPbOj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Comprehensive
                                            Income (Loss) and Foreign Currency Translation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reports comprehensive income (loss) and its components in its unaudited condensed consolidated financial statements. Comprehensive
loss consists of net loss and foreign currency translation adjustments, affecting stockholders&#8217; equity that, under GAAP, are excluded
from net loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
and liabilities related to the Company&#8217;s foreign operations are calculated using the Philippine peso and Canadian Dollar, and are
translated at end-of-period exchange rates, while the related revenues and expenses are translated at average exchange rates prevailing
during the period. Gains or losses resulting from transactions denominated in foreign currencies are included in general and administrative
expenses in the unaudited condensed consolidated statements of operations. The Company engages in foreign currency denominated transactions
with customers that operate in functional currencies other than the U.S. dollar. Aggregate foreign currency net transaction losses were
not material for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and three months ended March
31, 2022 (Predecessor).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zp5bNAYYFyRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue
                                            Recognition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span>The
Company recognizes revenue when control is transferred of the promised products or services to its customers, in an amount that reflects
the consideration the Company expects to be entitled to in exchange for those products or services. The Company derives revenue from
its software as a service for cloud based software, as well as design, implementation and other professional services for work performed
in conjunction with its cloud based software. The Company enters into contracts with its customers whereby it grants a non-exclusive
cloud-based license for the use of its proprietary software and for professional services. The contracts may also provide for on-going
services for a specified price, which may include maintenance services, designated support, and enhancements, upgrades and improvements
to the software, depending on the contract. Licenses for cloud software provide the customer with a right to use the software as it exists
when made available to the customer. All software provides customers with the same functionality and differ mainly in the duration over
which the customer benefits from the software.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>License
Subscription Revenue Recognition (Software As A Service)</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>With respect
to sales of the Company&#8217;s license agreements, customers generally pay fixed annual fees in advance in exchange for the Company&#8217;s
software service provided by via electronic, which are generally recognized ratably over the license term. Some agreements allow the
customer to terminate their subscription contracts before the end of the applicable term, and in such cases the customer is generally
entitled to a refund pro-rata but only for the elapsed time remaining at the point of termination, which would approximate the deferred
revenue at such time. The Company&#8217;s performance obligation is satisfied over time as the electronic services are provided continuously
throughout the service period. The Company recognizes revenue evenly over the service period using a time-based measure because the Company
is providing continuous access to its service. The Company&#8217;s customers generally pay within 30 to 60 days from the receipt of a
customer approved invoice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The timing
of the Company&#8217;s revenue recognition related to the licensing revenue stream is dependent on whether the software licensing agreement
entered into represents a service. Software that relies on an entity&#8217;s IP and is delivered only through a hosting arrangement,
where the customer cannot take possession of the software, is a service. Customers may purchase perpetual licenses or subscribe to licenses,
which provide customers with the same functionality and differ mainly in the duration over which the customer benefits from the software.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Renewals
or extensions of licenses are evaluated as distinct licenses and revenue attributed to the distinct service is not recognized until (1)
the entity provides the distinct license (or makes the license available) to the customer and (2) the customer is able to use and benefit
from the distinct license. Renewal contracts are not combined with original contracts, and, as a result, the renewal right is evaluated
in the same manner as all other additional rights granted after the initial contract. The revenue is not recognized until the customer
can begin to use and benefit from the license, which is typically at the beginning of the license renewal period. The Company recognizes
revenue resulting from renewal of licensed software over time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
Services Revenue Recognition</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s professional services include milestone, fixed fee and time and materials contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
services under milestone contracts are accounted for using the percentage of completion method. As soon as the outcome of a contract
can be estimated reliably, contract revenue is recognized in the statement of operations in proportion to the stage of completion of
the contract. Contract costs are expensed as incurred. Contract costs include all amounts that relate directly to the specific contract,
are attributable to contract activity, and are specifically chargeable to the customer under the terms of the contract.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Professional
services are also contracted on the fixed fee and in some cases on a time and materials basis. Fixed fees are paid monthly, in phases,
or upon acceptance of deliverables. The Company&#8217;s time and materials contracts are paid weekly or monthly based on hours worked.
Revenue on time and material contracts is recognized based on a fixed hourly rate as direct labor hours are expended. Materials, or other
specified direct costs, are reimbursed as actual costs and may include markup. The Company has elected the practical expedient to recognize
revenue for the right to invoice because the Company&#8217;s right to consideration corresponds directly with the value to the customer
of the performance completed to date. For fixed fee contracts provided by in house personnel, the Company recognizes revenue evenly over
the service period using a time-based measure because the Company is providing continuous service. Because the Company&#8217;s contracts
have an expected duration of one year or less, the Company has elected the practical expedient in ASC 606-10-50-14(a) to not disclose
information about its remaining performance obligations. Anticipated losses are recognized as soon as they become known. For the period
ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor), the
Company did not incur any such losses. These amounts are based on known and estimated factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contract
Balances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
timing of the Company&#8217;s revenue recognition may differ from the timing of invoicing to and payment by its customers. The Company
records an unbilled receivable when revenue is recognized prior to invoicing and the Company has an unconditional right to payment. Alternatively,
when invoicing a customer precedes the company providing of the related services, the Company records deferred revenue until the performance
obligations are satisfied. The Company had deferred revenue of approximately $<span id="xdx_906_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3">2,690
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand and $<span id="xdx_90D_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3">2,162
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand as of March 31, 2023 (Successor) and
December 31, 2022 (Predecessor), respectively, related to customer invoices rendered in advance for software licenses and professional
services provided by the Company&#8217;s technical staff. The Company expects to satisfy its remaining performance obligations for the
deferred revenue associated with professional services, and recognize the deferred revenue related to licenses generally over the remaining
contract term generally twelve months following the commencement of the license. The Company recognized revenue in the reporting period
of $<span id="xdx_901_ecustom--RevenueRecognized_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zCVavrmQRK1" title="Revenue Recognized">170</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;thousand,
$<span id="xdx_90E_ecustom--RevenueRecognized_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zApkMSdjWAUj">865
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand, and $<span id="xdx_902_ecustom--RevenueRecognized_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zdkdnojahzE7">1,328
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand that was included in the contract liability
balance at the beginning of the period, for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and
three months ended March 31, 2022 (Predecessor), respectively.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Costs
to Obtain a Contract</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
recognizes eligible sales commissions as an asset as the commissions are an incremental cost of obtaining a contract with the customer
and the Company expects to recover these costs. The capitalized costs are amortized over the expected contract term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cost
to Fulfill a Contract</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
incurs costs to fulfill their obligations under a contract once it has obtained. These costs are generally not significant and are recorded
to expense as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Multiple
Performance Obligations</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company enters into contracts with customers for its technology that include multiple performance obligations. Each distinct performance
obligation was determined by whether the customer could benefit from the good or service on its own or together with readily available
resources. The Company allocates revenue to each performance obligation based on its relative standalone selling price. The Company&#8217;s
process for determining standalone selling price considers multiple factors including the Company&#8217;s internal pricing model and
market trends that may vary depending upon the facts and circumstances related to each performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
and Use Taxes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company presents transactional taxes such as sales and use tax collected from customers and remitted to government authorities on a net
basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shipping
and Handling Costs</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling costs are expensed as incurred as part of cost of revenues. These costs were deemed to be nominal during each of the reporting
periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><p id="xdx_841_eus-gaap--BusinessCombinationsPolicy_zcQe09j48jy1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
                                            Combinations</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for business combinations under Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification
(&#8220;ASC&#8221;) 805 &#8220;Business Combinations&#8221; using the acquisition method of accounting, and accordingly, the assets and
liabilities of the acquired business are recorded at their fair values at the date of acquisition. The excess of the purchase price over
the estimated fair value is recorded as goodwill. All acquisition costs are expensed as incurred. Upon acquisition, the accounts and
results of operations are included as of and subsequent to the acquisition date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text"><p id="xdx_849_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zyLHpZiIf0o" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Segments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and its Chief Executive Officer (&#8220;CEO&#8221;), acting as the Chief Operating Decision Maker (&#8220;CODM&#8221;) determines
its reporting units in accordance with FASB ASC 280, &#8220;Segment Reporting&#8221; (&#8220;ASC 280&#8221;). The Company evaluates a
reporting unit by first identifying its operating segments under ASC 280. The Company then evaluates each operating segment to determine
if it includes one or more components that constitute a business. If there are components within an operating segment that meet the definition
of a business, the Company evaluates those components to determine if they must be aggregated into one or more reporting units. If applicable,
when determining if it is appropriate to aggregate different operating segments, the Company determines if the segments are economically
similar and, if so, the operating segments are aggregated. The Company has one operating segment and reporting unit. The Company is organized
and operated as one business. Management reviews its business as a single operating segment, using financial and other information rendered
meaningful only by the fact that such information is presented and reviewed in the aggregate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>












<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zqhxlV67YbOj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock-Based
                                            Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for options granted to employees by measuring the cost of services received in exchange for the award of equity instruments
based upon the fair value of the award on the date of grant. The fair value of that award is then ratably recognized as an expense over
the period during which the recipient is required to provide services in exchange for that award. Forfeitures of unvested stock options
are recorded when they occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred stock-based compensation charges of approximately $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Stock-based compensation">2</span>&#160;thousand, $<span id="xdx_907_eus-gaap--ShareBasedCompensation_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Stock-based compensation">158</span>&#160;thousand and $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Stock-based compensation">647</span>&#160;thousand for the period ended March 31, 2023 (Successor), the period ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor),
respectively, which are included in general and administrative expenses.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Derivative Warrant Liabilities</a></td>
<td class="text"><p id="xdx_842_eus-gaap--StandardProductWarrantyPolicy_z8jbBFSUKXZb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Derivative
                                            Warrant Liabilities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s specific
terms and applicable authoritative guidance in FASB ASC 480, &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC 480&#8221;)
and ASC 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#8217;s own common
stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted
at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. The Company currently
has two sets of warrants outstanding, known as the Private Placement Warrants and the Public Warrants, which are both classified as a
liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>For issued or modified warrants that meet all
of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the
time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required
to be recorded at their initial fair value on the date of issuance as a warrant liability, and adjusted to the then fair value in each
balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the condensed
consolidated statements of operations and amounted to approximately $<span id="xdx_90E_ecustom--ChangesInEstimatedFairValueOfWarrants_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zlU3FR3IFPcj" title="Changes in estimated fair value of warrants">1,686&#160;</span>thousand for the period ended March 31, 2023 (Successor).
The Company utilized the Public Warrant quoted market price as the fair value of the Warrants as of each relevant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p id="xdx_841_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zw0p08iuU5m" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fair
                                            Value Measurements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FASB
ASC 820, &#8220;Fair Value Measurements&#8221; (&#8220;ASC 820&#8221;), provides guidance on the development and disclosure of fair value
measurements. The Company follows this authoritative guidance for fair value measurements, which defines fair value, establishes a framework
for measuring fair value under generally accepted accounting principles in the United States, and expands disclosures about fair value
measurements. The guidance requires fair value measurements be classified and disclosed in one of the following three categories:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.25in"></td><td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date
                                            for identical assets or liabilities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.25in"></td><td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            2: Observable prices that are based on inputs not quoted on active markets but corroborated
                                            by market data.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: justify; width: 0.25in"></td><td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
                                            3: Unobservable inputs which are supported by little or no market activity and values determined
                                            using pricing models, discounted cash flow methodologies, or similar techniques, as well
                                            as instruments for which the determination of fair value requires significant judgment or
                                            estimation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value measurements discussed herein are based upon certain market assumptions and pertinent information available to management. Fair
value measurements are applied, when applicable, to determine the fair value of the Company&#8217;s warrant liability at each reporting
period. See Note 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>












<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Carrying Value, Recoverability and Impairment of Long-Lived Assets</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zchAKvjusoEg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Carrying
                                            Value, Recoverability and Impairment of Long-Lived Assets</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company
has adopted FASB ASC 360 &#8220;Property, Plant, and Equipment&#8221; (&#8220;ASC 360&#8221;) for its long-lived assets. Pursuant to
ASC 360-10-35-17, an impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable
and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted
cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the
carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount
by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. Pursuant to ASC 360-10-35-20 if an impairment
loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset,
the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized
impairment loss is prohibited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 360-10-35-21, the Company&#8217;s long-lived asset (asset group) is tested for recoverability whenever events or changes in circumstances
indicate that its carrying amount may not be recoverable. The Company considers the following to be some examples of such events or changes
in circumstances that may trigger an impairment review: (a) significant decrease in the market price of a long-lived asset (asset group);
(b) a significant adverse change in the extent or manner in which a long-lived asset (asset group) is being used or in its physical condition;
(c) a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset (asset
group), including an adverse action or assessment by a regulator; (d) an accumulation of costs significantly in excess of the amount
originally expected for the acquisition or construction of a long-lived asset (asset group); (e) a current-period operating or cash flow
loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated
with the use of a long-lived asset (asset group); and (f) a current expectation that, more likely than not, a long-lived asset (asset
group) will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. The Company tests
its long-lived assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on its assessments, the Company recorded <span id="xdx_908_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zAfiZuSmiNrc" title="Impairment charges of long-lived assets"><span id="xdx_903_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zITBxcg1cf54" title="Impairment charges of long-lived assets"><span id="xdx_90F_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zzYDZSs08Vac" title="Impairment charges of long-lived assets">no</span></span></span> impairment charges on long-lived assets for period ended March 31, 2023 (Successor), period
ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor), respectively.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_EmergingGrowthCompanyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_EmergingGrowthCompanyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_LeasesAndRightofUseAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_LeasesAndRightofUseAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_LiquidityAndGoingConcernPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_LiquidityAndGoingConcernPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_TemporaryEquityPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_TemporaryEquityPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WarrantLiabilityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WarrantLiabilityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334107568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock', window );">Summary of impact of the restatement on the financial statements</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zPUk2TzfC243" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details)">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8BB_z8jMc3GW9b7j" style="display: none">Summary of impact of the restatement on the financial statements</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9V0T03SUPec" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zkVfltV9ogW" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20220401__20220630_zTYXNm1aHcS8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Operations for the Three Months Ended June&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_i_pp0p0" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,660,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(9,288,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">371,910</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NonoperatingIncomeExpense_i_pp0p0" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,396,046</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,107,956</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_i_pp0p0" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income (loss) before benefit from (provision for) income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,094,313</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">806,223</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProfitLoss_zqq6hziseck" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,071,447</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">783,357</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">14,481,736</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0420">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">14,481,736</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.47</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.43</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.04</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0432">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.47</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.43</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.04</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_za5gosvHb0Gi" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_ztJwaPCyUFB2" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20220630_z7pKEvHi2Dsf" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Operations for the Six Months Ended June&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zjg7tH5s8vYc" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,660,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(9,288,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">371,910</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NonoperatingIncomeExpense_z5MqFlxcGnXi" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,587,467</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,299,377</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zEwvkVARqcBg" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income (loss) before benefit from (provision for) income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,962,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,674,392</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProfitLoss_zYrrHGiVdv5e" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,939,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,651,526</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">21,004,630</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0460">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">21,004,630</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.33</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.31</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0472">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zepXfL3fMr8" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.33</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z0536FcpJPEc" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.31</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>










<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zpzBqoK6zM0b" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20220101_20220930_srt--RestatementAxis_srt--RestatementAdjustmentMember" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_497_20220101_20220930" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Operations for the Nine Months Ended September&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zr0FJn9KywL2" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,660,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(9,288,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">371,910</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NonoperatingIncomeExpense_zc7SaILXmNg6" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,560,364</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,272,274</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z4r4QphEEjTf" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income (loss) before benefit from (provision for) income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,838,653</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,550,563</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProfitLoss_zWwll0rilMue" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,811,924</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,523,834</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding &#8211; Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">16,466,455</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">16,466,455</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share &#8211; Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.81</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.40</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.41</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.81</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.40</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.41</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zK0dZpB3AYih" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zeGWGNAZFCaj" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20221231_zRK7NAYt6hub" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Statement of Operations for the Year Ended December&#160;31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zlDAoOFQjrS6" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,660,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(9,288,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">371,910</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NonoperatingIncomeExpense_zi1ttbcoOQh6" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total other income (expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,634,549</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,346,459</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zc16GdV7HWy6" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Income (loss) before benefit from (provision for) income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,684,085</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,395,995</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProfitLoss_zpqpkaFLWYR9" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,634,910</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,346,820</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">12,546,423</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0543">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">12,546,423</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class A common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.48</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.43</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted weighted average shares outstanding - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl0555">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)">6,900,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Basic and diluted earnings per share - Class B common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">(0.48</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)">0.43</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unaudited
Statement of Changes in Stockholders&#8217; Deficit for the Three Months Ended June&#160;30, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Deficit</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; font-weight: bold; text-align: left">Balance &#8211; March&#160;31, 2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zSgv6CfkQ0Wa" style="width: 9%; text-align: right" title="Balance at the beginning">(13,226,270</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zaioDZrrH436" style="width: 9%; text-align: right" title="Balance at the beginning"><span style="-sec-ix-hidden: xdx2ixbrl0567">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_z22D2btkaD8g" style="width: 9%; text-align: right" title="Balance at the beginning">(13,225,580</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKjc4uZxfnui" style="text-align: right" title="Net income">10,071,447</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_z1yjYMFZiw8l" style="text-align: right" title="Net income">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zGeDOwnnS8xc" style="text-align: right" title="Net income">783,357</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Accretion of Class A common stock to redemption value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNN5XGtz0CU1" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption">(242,995</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpCB8A74vcwa" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption">9,288,090</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zZBO4xgWd1zh" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption">9,045,095</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance &#8211; June&#160;30, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4iQ3jHwe2Z4" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end">(3,397,818</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zskIucPVM4D4" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"><span style="-sec-ix-hidden: xdx2ixbrl0585">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_znc0i1kAl5Ge" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end">(3,397,128</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>










<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statement
of Changes in Stockholders&#8217; Deficit for the Year Ended December&#160;31, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated Deficit</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; font-weight: bold; text-align: left">Balance &#8211; December&#160;31, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdx1bW9rYUoj" style="width: 9%; text-align: right" title="Balance at the beginning">(21,094,439</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zEQjAVpq2mJ3" style="width: 9%; text-align: right" title="Balance at the beginning"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zDASNPb4Wihc" style="width: 9%; text-align: right" title="Balance at the beginning">(21,094,439</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zFoD6jeyyzPf" style="text-align: right" title="Net income">17,634,910</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpsRTnIk1QQ1" style="text-align: right" title="Net income">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zpfn9ROF4a66" style="text-align: right" title="Net income">8,346,820</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Accretion of Class A common stock to redemption value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAwMLggIUvEa" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption">(256,545</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zbOhKUqY1YGb" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption">9,288,090</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zHneQqjOnYud" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption">9,031,545</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance &#8211; December&#160;31, 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5zJh9p93jl9" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end">(3,716,074</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_z2FZje8sfps5" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"><span style="-sec-ix-hidden: xdx2ixbrl0612">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zCc6Ym4kI9k5" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end">(3,716,074</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_490_20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZcy8ntEFtWf" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49A_20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z95ehG0xqS5f" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220630_zxITM733eJce" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Cash Flows for the Six Months Ended June&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ProfitLoss_z6RX6DXwrlek" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Net Income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,939,616</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(9,288,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,651,526</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zNRTLVifJE34" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,660,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,288,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(371,910</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zxrggmtn20P6" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Non-Cash Investing and Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_zNkWaAF5G9Wd" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Extinguishment of deferred underwriting fee payable allocated to public shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_498_20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z88Zh7Mm8ym5" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_497_20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zXiE7uqfPLE3" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20220930_zSPqzF9nLYGh" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Unaudited Statement of Cash Flows for the Nine Months Ended September&#160;30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ProfitLoss_z2gj1pbyAOa" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Net Income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">18,811,924</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(9,288,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,523,834</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zrVYm9o87Axb" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,660,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,288,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(371,910</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_z35gCeneCNJb" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Non-Cash Investing and Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_z20ybcrtXbE" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Extinguishment of deferred underwriting fee payable allocated to public shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zMYNTNN8CaOf" style="font-weight: bold; text-align: center">As Previously</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zCcGeEVBlfo1" style="font-weight: bold; text-align: center">Restatement</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_497_20220101__20221231_zT2ZdbJcxSIk" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjustment</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Statement of Cash Flows for the Year Ended December&#160;31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ProfitLoss_zttqKxTZhZHk" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left">Net Income</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17,634,910</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(9,288,090</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,346,820</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zpZ2gyZcPeJj" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Gain on forgiveness of deferred underwriting fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,660,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,288,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(371,910</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zlR89okIc0Oe" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left">Non-Cash Investing and Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_zwg1cb66dG4k" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Extinguishment of deferred underwriting fee payable allocated to public shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0660">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,288,090</td><td style="text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655333643520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Schedule of reconciliation of Class A common stock reflected in the condensed balance sheet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--TemporaryEquityTableTextBlock_zECvghHTCwL6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)">
  <tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8B3_z5tspC3QNLU4" style="display: none">Schedule of reconciliation of Class A common stock reflected in the condensed balance sheet</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 88%; text-align: left">Class A common stock subject to possible redemption, January&#160;1, 2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_pp0p0_c20210101__20211231_zATWP7fZf60h" style="width: 9%; text-align: right" title="Class A common stock subject to possible redemption, at beginning of year">278,760,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"><span style="-sec-ix-hidden: xdx2ixbrl0696">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Class A common stock subject to possible redemption, December&#160;31, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_pp0p0_c20220101__20221231_zjkwtljQn1Hj" style="font-weight: bold; text-align: right" title="Class A common stock subject to possible redemption, at beginning of year">278,760,000</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: left">Plus:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: left">Waiver of Class A common stock issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--TemporaryEquityWaiverOfShareIssuanceCosts_c20220101__20221231_pp0p0" style="text-align: right" title="Waiver of Class A common stock issuance costs">9,288,090</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: left">Less:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-align: left">Accretion of carrying value to redemption value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--TemporaryEquityAccretionToRedemptionValue_iN_pp0p0_di_c20220101__20221231_zJ3VEP2gCel2" style="text-align: right" title="Accretion of carrying value to redemption value">(9,031,545</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Redemption of Class A Common Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--TemporaryEquityRedemption_iN_pp0p0_di_c20220101__20221231_zdNc46iem556" style="border-bottom: Black 1pt solid; text-align: right" title="Redemption of Class A Common Stock">(275,102,280</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Class A common stock subject to redemption, December&#160;31, 2022</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_pp0p0_c20220101__20221231_zBkDV3Rqvs4h" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Class A common stock subject to possible redemption, at end of year">3,914,265</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Reconciliation of net income per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zYz80eOXU9p1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B0_zsXmGyV3aD93" style="display: none">Schedule of Reconciliation of net income per common share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20220101_20221231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassAMember" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20220101_20221231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z6j1d9NrCpC5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20210101_20211231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="14" style="font-weight: bold; text-align: center">Year Ended</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December&#160;31,</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class A</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class B</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class A</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class B</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: left">Basic and diluted net income per common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_i01B" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i02_pp0p0" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,385,193</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,961,627</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">7,366,307</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,841,577</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i02_pdd" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Basic and diluted weighted average shares outstanding</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,546,423</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,900,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">27,600,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,900,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Basic and diluted net income per common stock</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.27</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.27</td><td style="text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of antidilutive shares</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_pn3n3_zXBF2PB15Bxd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policie (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; text-align: left"><span id="xdx_8B3_zmSyfTTgVZU" style="display: none">Schedule of antidilutive shares</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to<br/>
    March&#160;31,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"><span>Stock
    options</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zn1dqT8iNFke" style="border-bottom: Black 1pt solid; text-align: right"><span>1,377</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total"><span>24,080</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span>25,457</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338127504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Company's net deferred tax assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z9RDlEVPdePk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details)">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B0_zft8pkkbm5w8" style="display: none">Schedule of Company's net deferred tax assets</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20221231_zszdqVXesDWf" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20211231_zloN0f9oOWt8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNetOfValuationAllowanceAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_i01I_pp0p0_maDTAGzH2n_zJZsPEnXuOj9" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left">Organizational costs/startup expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">924,537</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">322,963</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzH2n_z83CmBuNPOZ2" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Net operating loss carryforward</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1069">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28,689</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_mtDTAGzH2n_maDTANzcuz_zfIn9amPvV82" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">924,537</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">351,652</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di_msDTANzcuz_zXJTTxY4oi33" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(924,537</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(351,652</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_mtDTANzcuz_zU4RTzO2VSyh" style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Deferred tax asset, net of allowance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1078">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1079">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of income tax provision</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYSYFdTFxEch" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B4_zXy6iR0jPuOb" style="display: none">Schedule of income tax provision</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20220101__20221231_zX2KOWuZTfga" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20210101__20211231_z2x1GBkFAzl" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zNtjJVGYBcp2" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">49,175</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1087">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zjsFhKNWOmr9" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(572,885</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(300,205</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--StateAndLocalAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">State and Local</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zPC3k8mPn9t4" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1095">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1096">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zLND9QSxl1V2" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1098">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1099">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_i01N_pp0p0_di_msITEBzXu4_z54jCOYWgLf1" style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">572,885</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">300,205</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXu4_zFkYyLe9CNyc" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Income tax provision</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">49,175</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1105">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zlhQov4oX2Ne" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details 2)">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BB_zwCBpaYt83ld" style="display: none">Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Statutory federal income tax rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20221231_zFtLmiIvZ26f" title="Statutory federal income tax rate">21</span>.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231_zCwUfSn3qwO3" title="Statutory federal income tax rate">21</span>.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">State taxes, net of federal tax benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20220101__20221231_z79RxeKSIjx" title="State taxes, net of federal tax benefit">0.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20210101__20211231_zh6TFuXVlok" title="State taxes, net of federal tax benefit">0.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Transaction costs allocated to derivative warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_ecustom--EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_dp_c20220101__20221231_zmbK1VPPXoVk" title="Transaction costs allocated to derivative warrant liabilities">0.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_ecustom--EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_dp_c20210101__20211231_zX1y4EtnpWIj" title="Transaction costs allocated to derivative warrant liabilities">0.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in fair value of derivative warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_909_ecustom--EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_dp_c20220101__20221231_zfZxnyCwqHsa" title="Change in fair value of derivative warrant liabilities">(23.9</span></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_ecustom--EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_dp_c20210101__20211231_zxi5rbQvqu3c" title="Change in fair value of derivative warrant liabilities">(24.3</span></td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20221231_zNuNGX5EssVe" title="Valuation allowance">3.2</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210101__20211231_z84014VhQuT" title="Valuation allowance">3.3</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Income tax provision</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20221231_znxEB3DdQHq1" title="Income tax provision">0.3</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20211231_zskHnT7LV0C" title="Income tax provision">0.0</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655333668480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of company's assets and liabilities that are measured at fair value on a recurring basis</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z4PIr496IIQ1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BB_zpXDUooqaxq9" style="display: none">Schedule of company's assets and liabilities that are measured at fair value on a recurring basis</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="5" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="5" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Description</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Assets:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Money Market Funds</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--AssetsHeldInTrustNoncurrent_c20221231__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="width: 9%; text-align: right" title="Assets held in the Trust Account"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: center">1</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--AssetsHeldInTrustNoncurrent_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember_pp0p0" style="width: 9%; text-align: right" title="Assets held in the Trust Account">278,835,182</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Liabilities:</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Warrant liabilities &#8211; public warrants</td><td>&#160;</td>
    <td style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities">414,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities">6,461,798</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Warrant liabilities &#8211; private placement warrants</td><td>&#160;</td>
    <td style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities">308,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities">4,813,571</td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of change in the fair value of the Level 3 warrant liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zwu4cfXkCZrf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details 1)">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BA_zraT7XkGrG62" style="display: none">Schedule of change in the fair value of the Level 3 warrant liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Private Placement</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Public</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrant Liabilities</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Fair value as of December&#160;31, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zQBCMnSg4Ycb" style="width: 9%; text-align: right" title="Fair value at beginning">9,354,800</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z4cUM70bNR1l" style="width: 9%; text-align: right" title="Fair value at beginning">12,558,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zj7rzQFsIys" style="width: 9%; text-align: right" title="Fair value at beginning">21,912,800</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value">(2,672,800</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value">(3,588,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value">(6,260,800</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Transfer to Level 1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1">(8,970,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1">(8,970,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Transfer to Level 2</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2">(6,682,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2"><span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2">(6,682,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Fair value as of December&#160;31, 2021</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zsqdPXH9bslk" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"><span style="-sec-ix-hidden: xdx2ixbrl1199">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zCwVI7FgBuw8" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zj0KR7eFqBq7" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"><span style="-sec-ix-hidden: xdx2ixbrl1203">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655328637232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of assets acquired</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_pn3n3_zv4J4BGrrAyi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business Combination (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B8_zaXlKB5klXAa" style="display: none">Schedule of assets acquired</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zhQ5zTcRifU6" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"><span>Description</span></td><td style="text-align: center; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Fair
    Value</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Weighted<br/>
    Average Useful<br/>
    Life<br/>
    (in years)</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--PurchasePrice_iI_z2LNiZ782CYl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Purchase
    Price</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>69,928</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Assets
    acquired:</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Cash
    and cash equivalents</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>10,003</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 10%; text-align: center"><span>&#160;</span></td>
    <td style="width: 1%"><span>&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accounts
    receivable</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>2,226</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables_iI_pn3n3_z8CKXpYtCFU8" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Notes
    and other receivables</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>209</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Prepaid
    assets and other current assets</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>588</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset_iI_pn3n3_za8u4DXnd5Yg" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    lease right of use asset</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>557</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Property
    and equipment, net</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>133</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Other
    assets</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>42</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Developed
    technology</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right" title="Intangible assets"><span>9,268</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zvIHvLVrFPaj">10
    </span><span>years</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Patents</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pn3n3" style="text-align: right" title="Intangible assets"><span>2,703</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zrChEHYpjyw9">10
    </span><span>years</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Customer
    relationships</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right" title="Intangible assets"><span>5,604</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zxUVCZ4SNAm8">5
    </span><span>years</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Tradenames
    and trademarks</span></td><td><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Intangible assets"><span>3,294</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zMy29Hf6sfih">7
    </span><span>years</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span>Total
    assets acquired</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>34,627</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Liabilities
    assumed:</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_i01I_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accounts
    payable</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td style="text-align: right"><span>461</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_i01I_pn3n3_z1WqlsOPdQ1g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    liabilities</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>911</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_i01I_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Deferred
    revenues</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>2,534</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent_i01I_pn3n3_zFEBnlRS0kK6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    lease obligation, current</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>194</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent_i01I_pn3n3_z1lNtq0USiYg" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    lease obligation, noncurrent</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>384</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_i01I_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Deferred
    tax liability</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>4,337</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_i01I_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Total
    liabilities assumed</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>8,821</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1pt"><span>&#160;</span></td>
    <td><span>&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span>Goodwill</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>44,122</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="text-align: center; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td></tr>
  </table>






<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of proforma financial information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_pn3n3_zHZrWn2FodT3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business Combination (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B4_zNFFs4LTose" style="display: none">Schedule of proforma financial information</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>For
    the<br/>
    Three Months Ended March&#160;31,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>For
    the<br/>
    Three Months Ended March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Revenues</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20230101__20230331_pn3n3" style="width: 9%; text-align: right" title="Revenues"><span>1,962</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20220101__20220331_pn3n3" style="width: 9%; text-align: right" title="Revenues"><span>2,582</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    income (loss)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20230101__20230331_pn3n3" style="text-align: right" title="Net income (loss)"><span>(6,365</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20220101__20220331_pn3n3" style="text-align: right" title="Net income (loss)"><span>6,197</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338160736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DisclosureDisaggregationOfRevenueAbstract', window );"><strong>Disaggregation Of Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of disaggregation of Revenue</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zzydvqXZ8SN7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Disaggregation of Revenue (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;<span id="xdx_8B9_zYzbr6c27m1a" style="display: none">Schedule of disaggregation of Revenue</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to <br/>
    March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    January&#160;1,<br/>
    2023 to<br/>
    March&#160;14,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Three
    months ended March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Subscription
    revenue</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left; padding-bottom: 1pt"><span>Software</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_98B_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"><span>240</span></td><td style="border-right: Black 1.5pt solid; width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_98D_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"><span>1,204</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_98D_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"><span>1,259</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    subscription revenue</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>240</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>1,204</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>1,259</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span>Non-subscription
    revenue</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Professional
    services</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"><span>102</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_981_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"><span>416</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_98C_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"><span>1,323</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    non-subscription revenue</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>102</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98D_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>416</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>1,323</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    Revenue</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>342</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>1,620</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>2,582</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    March&#160;15,<br/>
    2023 to <br/>
    March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Period
    from<br/>
    January&#160;1,<br/>
    2023 to<br/>
    March&#160;14,<br/>
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Three
    months ended March&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left; padding-bottom: 1pt"><span>Revenue
    recognized over time<sup>(1)(2)</sup></span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_986_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zKxJyCgzCnc9" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"><span>342</span></td><td style="border-right: Black 1.5pt solid; width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zNqBoDOyYQlh" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"><span>1,620</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zd6PyQcWxDfd" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"><span>2,582</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFN8f9NMFGB8" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>342</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zUzL3VcqZNy" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>1,620</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zREhXGB3TMm3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"><span>2,582</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify; border-collapse: collapse">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_F00_zuAxaoM7qA89" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span id="xdx_F13_z22eIkMiIlRk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                            Professional services are also contracted on the fixed fee and time and materials basis.
                                            Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company has
                                            generally elected the practical expedient to recognize revenue for the right to invoice because
                                            the Company&#8217;s right to consideration corresponds directly with the value to the customer
                                            of the performance completed to date, in which revenue is recognized over time.</span></td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td></td><td style="text-align: left"><span id="xdx_F0F_z8YOj0PS32me" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span id="xdx_F14_zZN9vikJNp6l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software
                                            As A Service Subscription Revenue&#8217;s performance obligation is satisfied evenly over
                                            the service period using a time-based measure because the Company is providing continuous
                                            access to its service and service is recognized overtime.</span></td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DisclosureDisaggregationOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DisclosureDisaggregationOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338122048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--PropertyPlantAndEquipmentTextBlock_pn3n3_zIZ1SnmXGa01" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, net (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BA_zyFVPiBxajK6" style="display: none">Schedule of property and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>December&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Computer
    and office equipment</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pn3n3" style="width: 9%; text-align: right" title="Total"><span>139</span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zJRkraja9hdj" style="width: 9%; text-align: right" title="Total"><span>992</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Furniture
    and fixtures</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pn3n3" style="text-align: right" title="Total"><span>11</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z0UDzglPTCQi" style="text-align: right" title="Total"><span>185</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Leasehold
    improvements</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pn3n3" style="text-align: right" title="Total"><span>6</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmvgAo2RnXZ4" style="text-align: right" title="Total"><span>28</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Software</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><span>1</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SoftwareMember_zJfaGhxk2Z" style="border-bottom: Black 1pt solid; text-align: right" title="Total"><span>8</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Total</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Total"><span>157</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zI5WFlAWHCy1" style="text-align: right" title="Total"><span>1,213</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Less:
    accumulated depreciation and amortization</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z21EFw5MvTFe" style="border-bottom: Black 1pt solid; text-align: right" title="Less: accumulated depreciation and amortization"><span>(4</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>)</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zwDw0DkaJ0Y7" style="border-bottom: Black 1pt solid; text-align: right" title="Less: accumulated depreciation and amortization"><span>(1,011</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    Property and Equipment, Net</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentNet_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Property and Equipment, Net"><span>153</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Property and Equipment, Net"><span>202</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338148112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Software Development Costs, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DisclosureSoftwareDevelopmentCostsNetAbstract', window );"><strong>Software Development Costs Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock', window );">Schedule of capitalized software development</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock_pn3n3_zUikV4J7Y759" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Software Development Costs, net (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span id="xdx_8B3_zr6VD5hpp3K9" style="display: none">Schedule of capitalized software development</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zG7dxHOXEaB1" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zoUyBm8ovIEl" style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>December&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_maCCSNzf4y_zVllVuO8Mafh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Capitalized
    software development costs</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1980">-</span></span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>2,680</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--CapitalizedComputerSoftwareAccumulatedAmortization_iNI_pn3n3_di_msCCSNzf4y_zUOdvQtZJVGh" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Accumulated
    amortization</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1983">-</span></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>(2,193</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td></tr>
  <tr id="xdx_409_eus-gaap--CapitalizedComputerSoftwareNet_iTI_pn3n3_mtCCSNzf4y_zwVYEIK8Njjf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Software
    development costs, net</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl1986">-</span></span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>487</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DisclosureSoftwareDevelopmentCostsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DisclosureSoftwareDevelopmentCostsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338005648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of goodwill</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfGoodwillTextBlock_pn3n3_zCdhsSSFZI4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"><span id="xdx_8BC_z1G4BW8PF20f" style="display: none">Schedule of goodwill</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: bold; text-align: left"><span>Acquisition</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Amount</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    as of March 14, 2023</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--Goodwill_iS_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zENOXH1riS2c" style="text-align: right" title="Beginning balance"><span><span style="-sec-ix-hidden: xdx2ixbrl2005">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition
    of Legacy CXApp</span></td><td style="width: 1%; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td id="xdx_989_ecustom--AcquisitionOfLegacyCxapp_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z45yDj18TUrc" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Acquisition of Legacy CXApp"><span>44,122</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance
    as of March 31, 2023</b></span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Goodwill_iE_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z4fv8NKdKfr" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ending balance"><span>44,122</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zWZlcw7OwmSc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BE_zZ6JNFlydzsh" style="display: none">Schedule of intangible assets</span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="12" style="border-bottom: Black 1pt solid; text-align: center"><span><b>March&#160;31,
    2023 (Successor)</b></span></td>
    <td style="border-right: Black 1.5pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="9" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span><b>December&#160;31,
    2022 (Predecessor)</b></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-align: center"><span><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span><b>Weighted Average Remaining<br/>
    Useful Life<br/>
    (Years)</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span><b>Gross
    Amount</b></span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span><b>&#160;</b></span></td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span><b>Accumulated
    Amortization</b></span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"><span><b>Net
    Carrying Amount</b></span></td>
    <td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span><b>Gross<br/>
    Amount</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span><b>&#160;</b></span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span><b>Accumulated
    Amortization</b></span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"><span><b>&#160;</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span><b>Net Carrying<br/>
    Amount</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span><b>&#160;</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 30%; text-align: left"><span>Trade
    Name/Trademarks</span></td>
    <td style="width: 1%"><span>&#160;</span></td>
    <td style="text-align: center; width: 9%"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zNdfQJYF8MMh">7
    </span><span>years</span></td>
    <td style="width: 1%"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"><span>3,294</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td>
    <td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"><span>(20</span></td><td style="width: 1%; text-align: left"><span>)</span></td>
    <td style="width: 1%"><span>$</span></td>
    <td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="text-align: right; width: 7%; vertical-align: bottom" title="Net carrying amount"><span>3,274</span></td>
    <td style="border-right: Black 1.5pt solid; width: 1%"><span>&#160;</span></td>
    <td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%"><span>$</span></td>
    <td id="xdx_983_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="text-align: right; width: 7%; vertical-align: bottom" title="Gross carrying amount"><span>2,183</span></td>
    <td style="width: 1%"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"><span>(725</span></td><td style="width: 1%; text-align: left"><span>)</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%"><span>$</span></td>
    <td id="xdx_980_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="vertical-align: bottom; width: 7%; text-align: right" title="Net carrying amount"><span>1,458</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Customer
    Relationships</span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zB8897e0y01e">5
    </span><span>years</span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_988_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"><span>5,604</span></td><td style="text-align: left"><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"><span>(47</span></td><td style="text-align: left"><span>)</span></td>
    <td></td>
    <td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Net carrying amount"><span>5,557</span></td>
    <td style="border-right: Black 1.5pt solid"><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td></td>
    <td id="xdx_98B_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Gross carrying amount"><span>6,401</span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"><span>(1,765</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td id="xdx_98D_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Net carrying amount"><span>4,636</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Developed
    Technology</span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zx0RCeDD1eC5">10
    </span><span>years</span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_981_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"><span>9,268</span></td><td style="text-align: left"><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: left"></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"><span>(38</span></td><td style="text-align: left"><span>)</span></td>
    <td></td>
    <td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Net carrying amount"><span>9,230</span></td>
    <td style="border-right: Black 1.5pt solid"><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td></td>
    <td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Gross carrying amount"><span>15,179</span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"><span>(3,398</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td><span>&#160;</span></td>
    <td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Net carrying amount"><span>11,781</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Non-compete
    Agreements</span></td>
    <td><span>&#160;</span></td>
    <td><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td id="xdx_98E_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"><span>&#160;<span style="-sec-ix-hidden: xdx2ixbrl2045">-</span></span></td>
    <td><span>&#160;</span></td>
    <td style="text-align: left"></td><td style="text-align: right"></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"><span>&#160;<span style="-sec-ix-hidden: xdx2ixbrl2046">-</span></span></td>
    <td></td>
    <td style="text-align: right; vertical-align: bottom"></td>
    <td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Net carrying amount"><span>&#160;<span style="-sec-ix-hidden: xdx2ixbrl2048">-</span></span></td>
    <td style="border-right: Black 1.5pt solid"><span>&#160;</span></td>
    <td></td>
    <td style="text-align: right; vertical-align: bottom"></td>
    <td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross carrying amount"><span>&#160;3,150</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"><span>(1,736</span></td><td><span>)&#160;</span></td>
    <td><span>&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"></td><td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Net carrying amount"><span>&#160;1,414</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Patents
    and Intellectual Property</span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_zdp9tDsk1yF7">10
    </span><span>years</span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"></td><td id="xdx_980_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right"><span>2,703</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right"><span>(11</span></td><td style="padding-bottom: 1pt; text-align: left"><span>)</span></td>
    <td style="border-bottom: Black 1pt solid"></td>
    <td id="xdx_98E_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom" title="Net carrying amount"><span>2,692</span></td>
    <td style="border-right: Black 1.5pt solid; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"></td>
    <td id="xdx_98B_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom" title="Gross carrying amount"><span><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></span></td>
    <td style="padding-bottom: 1pt"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span>&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2061">-</span></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid"><span>&#160;</span></td>
    <td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right" title="Net carrying amount"><span><span style="-sec-ix-hidden: xdx2ixbrl2063">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Totals</span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt; text-align: center"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span>20,869</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>&#160;</span></td>
    <td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span>(116</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>)</span></td>
    <td style="border-bottom: Black 2.5pt double"><span><b>$</b></span></td>
    <td id="xdx_98E_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right; vertical-align: bottom" title="Net carrying amount"><span><b>20,753</b></span></td>
    <td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double"><span><b>$</b></span></td>
    <td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right; vertical-align: bottom" title="Gross carrying amount"><span><b>26,913</b></span></td>
    <td style="padding-bottom: 2.5pt"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span>(7,624</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span>)</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double"><span><b>$</b></span></td>
    <td id="xdx_982_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right" title="Net carrying amount"><span><b>19,289</b></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>



<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of future amortization expense</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zJqYwSInNWFc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details 2)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_z5HTfbrUy6d3" style="display: none">Schedule of future amortization expense</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20230331_zwQ9856fRWWf" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>For the Years Ending December 31,</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span><b>Amount</b></span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_zxjyh7QA55Y9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left"><span>2023</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>2,091</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_zbdwcY16FOg2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span>2024</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>2,788</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_zKVmOOAolct4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span>2025</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>2,788</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_zLAji46mngA7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span>2026</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>2,788</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_zS9JgRbwsq17" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span>2027</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>2,788</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_zZj7dbgJRHy4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span>2028 and thereafter</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>7,510</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zwOlRtjNtPj2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span>Total</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>20,753</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338345616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DisclosureDeferredRevenueAbstract', window );"><strong>Deferred Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ScheduleOfDeferredRevenueTableTextBlock', window );">Schedule of deferred revenue</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfDeferredRevenueTableTextBlock_pn3n3_zj2KgLFIIkKg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Deferred Revenue (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span id="xdx_8B2_zchqaZqkPx6i" style="display: none">Schedule of deferred revenue</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>March&#160;31,<br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>December&#160;31,<br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>License
    agreements</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_pn3n3" style="width: 9%; text-align: right" title="Total Deferred Revenue"><span>2,388</span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_pn3n3" style="width: 9%; text-align: right" title="Total Deferred Revenue"><span>1,937</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Professional
    Service agreements</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_987_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProfessionalServiceAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Deferred Revenue"><span>302</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td id="xdx_984_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProfessionalServiceAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Deferred Revenue"><span>225</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span>Total
    Deferred Revenue</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Deferred Revenue"><span>2,690</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Deferred Revenue"><span>2,162</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DisclosureDeferredRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DisclosureDeferredRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ScheduleOfDeferredRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ScheduleOfDeferredRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655457629504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of accrued Liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_pn3n3_zOeSOxMe5APg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Liabilities (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BC_zKl5L4jOGS6k" style="display: none">Schedule of accrued Liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zmL8jaAuCRW9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zhCV2sZdbhz4" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Successor</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>Predecessor</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>March
    31, <br/>
    2023</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span>December
    31, <br/>
    2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span>&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--InsurancePremiumsAndAccruedInterest_iI_pn3n3_maALCzxmM_zz1sEcoAmQ0j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span>Insurance
    premiums and accrued interest</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span>538</span></td><td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td style="width: 9%; text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2117">-</span></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--RelatedPartyPromissoryNote_iI_pn3n3_maALCzxmM_zvwDIWs3f5Wk" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Related
    party promissory note</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>20</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2120">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedIncomeTaxes_iI_pn3n3_maALCzxmM_zenaZb0oeUsj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Income
    tax payables</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>57</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2123">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--RelatedPartyPayable_iI_pn3n3_maALCzxmM_zjU5qnO5OgEh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Related
    party payable</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>1,155</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span><span style="-sec-ix-hidden: xdx2ixbrl2126">-</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--AccruedCompensationAndBenefits_iI_pn3n3_maALCzxmM_zq3R15YIGTvc" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    compensation and benefits</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>650</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>586</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_pn3n3_maALCzxmM_zBOB8vq7dQv6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    bonus and commissions</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>192</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>422</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedRentCurrent_iI_pn3n3_maALCzxmM_zXTwKPJlqCo9" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    rent</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>3</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>559</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--AccruedOther_iI_pn3n3_maALCzxmM_zu4KRip245Wf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Accrued
    other</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>561</span></td><td style="border-right: Black 1.5pt solid; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>83</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_iI_pn3n3_maALCzxmM_zgDiEBkmJ6H9" style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span>Accrued
    sales and other indirect taxes payable</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>6</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 1pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span>&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span>86</span></td><td style="padding-bottom: 1pt; text-align: left"><span>&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iTI_pn3n3_mtALCzxmM_z07ywXVdp7mk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="color: rgb(204,238,255); vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span>Accrued
    liabilities</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>3,182</span></td><td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td><td style="padding-bottom: 2.5pt"><span>&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span>$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span>1,736</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span>&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338202096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan and Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract', window );"><strong>Stock Option Plan And Stock-based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_pn3n3_z2NUvsA0cEHe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Award Plans and Stock-Based Compensation (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BF_znZ31CjRifj1" style="display: none">Schedule of assumptions used</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Risk-free
    interest rate</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zVRZ3IzFBiO5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.62</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>%
    &#8211; <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_zLB2ZDOvl8d2">3.67</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>%</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Expected
    life of option grants</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zsjbfmPoo0R2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#8211; <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_zcGebklMyTh5">7
    </span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>years</span></span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 80%; text-align: left"><span>Expected
    volatility of underlying stock</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 18%; text-align: center"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zUPdCMrAqrC9">37.35</span><span>%</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Dividends
    assumption</span></td><td><span>&#160;</span></td>
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z6AuyXgzoIa2">0%</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655338160736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Foreign Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DisclosureForeignOperationsAbstract', window );"><strong>Foreign Operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Schedule of financial data by geographic area</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_zZGvyLMcGts1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Foreign Operations (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">&#160;<span id="xdx_8BC_zLbtzx9EEIa3" style="display: none">Schedule of financial data by geographic area</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span>&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>United</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>States</b></span></p></td><td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Canada</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>India</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Philippines</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Eliminations</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"><span>&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"><span>Total</span></td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">For
    the Period Ended March 31, 2023 (Successor)</span>:</td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left"><span>Revenues
    by geographic area</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"><span>272</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"><span>70</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2267">-</span></span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"><span>196</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"><span>(196</span></td><td style="width: 1%; text-align: left"><span>)</span></td><td style="width: 1%"><span>&#160;</span></td>
    <td style="width: 1%; text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zHHHk5YCIdDb" style="width: 9%; text-align: right" title="Revenues by geographic area"><span>342</span></td><td style="width: 1%; text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_zWzzmjbBiyM3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(486</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_zQnReV5rrAW2" style="text-align: right" title="Operating income (loss) by geographic area"><span>(158</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_zXKExpq4bLPk" style="text-align: right" title="Operating income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2279">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>157</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2283">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(487</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>2,780</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(158</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2291">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>157</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(21</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>2,758</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">For
    the Period Ended March 14, 2023 (Predecessor)</span>:</td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Revenues
    by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>1,395</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>285</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Revenues by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2303">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>160</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>(220</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zKQARgGUsx78" style="text-align: right" title="Revenues by geographic area"><span>1,620</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(3,479</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(905</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2315">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>3</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2319">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(4,381</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(3,342</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(1,041</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2327">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>3</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2331">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98D_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(4,380</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">For
    the Three Months Ended March 31, 2022 (Predecessor)</span>:</td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Revenues
    by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>2,167</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>601</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>270</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Revenues by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2341">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Revenues by geographic area"><span>(456</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zuwXX0ESDeF8" style="text-align: right" title="Revenues by geographic area"><span>2,582</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Operating
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(650</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98D_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(1,008</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>72</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2353">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>14</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"><span>(1,572</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Net
    income (loss) by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(519</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(1,139</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_980_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(27</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2365">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>14</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"><span>(1,671</span></td><td style="text-align: left"><span>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">As
    of March 31, 2023 (Successor)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Identifiable
    assets by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_znpZI1Rc6fhf" style="text-align: right" title="Identifiable assets by geographic area"><span>75,059</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_zZYPA1LCaawe" style="text-align: right" title="Identifiable assets by geographic area"><span>991</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_znpRbfRKD09l" style="text-align: right" title="Identifiable assets by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2375">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_zJ7a49f51zpi" style="text-align: right" title="Identifiable assets by geographic area"><span>405</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98C_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_zOFdFNj8rmg8" style="text-align: right" title="Identifiable assets by geographic area"><span>(71</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zXRC4kDjFI48" style="text-align: right" title="Identifiable assets by geographic area"><span>76,384</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Long
    lived assets by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>20,817</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>417</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2387">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>222</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2391">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>21,455</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Goodwill
    by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span>44,122</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2397">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98F_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2399">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98E_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2401">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2403">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span>44,122</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="text-decoration: underline">As
    of December 31, 2022 (Predecessor)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>&#160;</span></td><td style="text-align: right"><span>&#160;</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Identifiable
    assets by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_zPVGKa173qfg" style="text-align: right" title="Identifiable assets by geographic area"><span>24,591</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_zf9p6NSjtU52" style="text-align: right" title="Identifiable assets by geographic area"><span>5,484</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98A_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_z6K5KYsdGEVe" style="text-align: right" title="Identifiable assets by geographic area"><span>228</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98D_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_zeJEIqXxOymd" style="text-align: right" title="Identifiable assets by geographic area"><span>415</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_zlP5RMOQkOxk" style="text-align: right" title="Identifiable assets by geographic area"><span>(1,438</span></td><td style="text-align: left"><span>)</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zFo4trmxzHp3" style="text-align: right" title="Identifiable assets by geographic area"><span>29,280</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Long
    lived assets by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>15,558</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_983_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>4,788</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>98</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_984_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>215</span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_98B_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2427">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_982_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"><span>20,659</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span>Goodwill
    by geographic area</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2431">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2433">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_987_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2435">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_986_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2437">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_988_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Goodwill by geographic area"><span><span style="-sec-ix-hidden: xdx2ixbrl2439">-</span></span></td><td style="text-align: left"><span>&#160;</span></td><td><span>&#160;</span></td>
    <td style="text-align: left"><span>$</span></td><td id="xdx_985_eus-gaap--Goodwill_iI_pn3n3_d0_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zMfxFSYSCSji" style="text-align: right" title="Goodwill by geographic area"><span>-</span></td><td style="text-align: left"><span>&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DisclosureForeignOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DisclosureForeignOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655331012528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 17, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_TransactionCosts', window );">Transaction costs</a></td>
<td class="nump">$ 15,688,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_SaleOfStockUnderwritingFees', window );">Underwriting fees</a></td>
<td class="nump">5,520,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DeferredOfferingCostsNoncurrent', window );">Deferred underwriting fee payable</a></td>
<td class="nump">9,660,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_SaleOfStockOtherOfferingCosts', window );">Other offering costs</a></td>
<td class="nump">$ 508,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount', window );">Threshold minimum aggregate fair market value as a percentage of the assets held in the trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination', window );">Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination', window );">Minimum net tangible assets upon consummation of the business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent', window );">Threshold percentage of public shares subject to redemption without the company's prior written consent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination', window );">Obligation to redeem public shares if entity does not complete a business combination (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_MaximumNetInterestsToPayDissolutionExpenses', window );">Maximum net interest to pay dissolution expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash operating bank account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WorkingCapital', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,002,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related Party debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 347,961<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cxai_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination', window );">Minimum net tangible assets upon consummation of the business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units issued</a></td>
<td class="nump">27,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit (in dollars per share)</a></td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance initial public offering</a></td>
<td class="nump">$ 276,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_PaymentsForInvestmentOfCashInTrustAccount', window );">Investment of cash into trust account</a></td>
<td class="nump">$ 278,760,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units issued</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit (in dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NumberOfWarrantsIssued', window );">Number of warrants issued</a></td>
<td class="nump">10,280,000<span></span>
</td>
<td class="nump">10,280,000<span></span>
</td>
<td class="nump">10,280,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="nump">$ 10,280,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cxai_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ProceedsFromRelatedParty', window );">Proceeds from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related Party debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DeferredOfferingCostsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DeferredOfferingCostsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_MaximumNetInterestsToPayDissolutionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum net interest to pay dissolution expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_MaximumNetInterestsToPayDissolutionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum net tangible assets upon consummation of the Business Combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_NumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_NumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_PaymentsForInvestmentOfCashInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for investment of cash in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_PaymentsForInvestmentOfCashInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the threshold percentage of Obligation to redeem Public Shares if entity does not complete a Business Combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ProceedsFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Definition: The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ProceedsFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_SaleOfStockOtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of other offering costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_SaleOfStockOtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_SaleOfStockUnderwritingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of offering fees incurred and paid for underwriters.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_SaleOfStockUnderwritingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents threshold percentage of Public Shares subject to redemption without the Company's prior written consent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of transaction costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount represents the information about the working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cxai_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cxai_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cxai_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cxai_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655328858704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable', window );">Gain on forgiveness of deferred underwriting fee payable</a></td>
<td class="nump">$ 371,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 371,910<span></span>
</td>
<td class="nump">$ 371,910<span></span>
</td>
<td class="nump">$ 371,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expenses)</a></td>
<td class="nump">1,107,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,299,377<span></span>
</td>
<td class="nump">11,272,274<span></span>
</td>
<td class="nump">11,346,459<span></span>
</td>
<td class="nump">$ 10,705,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before benefit from (provision for) income taxes</a></td>
<td class="nump">806,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,674,392<span></span>
</td>
<td class="nump">9,550,563<span></span>
</td>
<td class="nump">8,395,995<span></span>
</td>
<td class="nump">9,207,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">783,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,651,526<span></span>
</td>
<td class="nump">9,523,834<span></span>
</td>
<td class="nump">8,346,820<span></span>
</td>
<td class="nump">9,207,884<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion of Class A common stock to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,031,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable', window );">Gain on forgiveness of deferred underwriting fee payable</a></td>
<td class="num">(371,910)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(371,910)<span></span>
</td>
<td class="num">(371,910)<span></span>
</td>
<td class="num">(371,910)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-Cash Investing and Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares', window );">Extinguishment of deferred underwriting fee payable allocated to public shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">783,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,346,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at the beginning</a></td>
<td class="num">(13,225,580)<span></span>
</td>
<td class="num">$ (21,094,439)<span></span>
</td>
<td class="num">(21,094,439)<span></span>
</td>
<td class="num">$ (21,094,439)<span></span>
</td>
<td class="num">(21,094,439)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion of Class A common stock to redemption</a></td>
<td class="nump">9,045,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,031,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at the end</a></td>
<td class="num">$ (3,397,128)<span></span>
</td>
<td class="num">(13,225,580)<span></span>
</td>
<td class="num">$ (3,397,128)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,716,074)<span></span>
</td>
<td class="num">(21,094,439)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares', window );">Basic and diluted weighted average shares outstanding (in shares)</a></td>
<td class="nump">14,481,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,004,630<span></span>
</td>
<td class="nump">16,466,455<span></span>
</td>
<td class="nump">12,546,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare', window );">Basic and diluted earnings per share (in dollars per share)</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares', window );">Basic and diluted weighted average shares outstanding (in shares)</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare', window );">Basic and diluted earnings per share (in dollars per share)</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable', window );">Gain on forgiveness of deferred underwriting fee payable</a></td>
<td class="nump">$ 9,660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,660,000<span></span>
</td>
<td class="nump">$ 9,660,000<span></span>
</td>
<td class="nump">$ 9,660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expenses)</a></td>
<td class="nump">10,396,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,587,467<span></span>
</td>
<td class="nump">20,560,364<span></span>
</td>
<td class="nump">20,634,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before benefit from (provision for) income taxes</a></td>
<td class="nump">10,094,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,962,482<span></span>
</td>
<td class="nump">18,838,653<span></span>
</td>
<td class="nump">17,684,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">10,071,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,939,616<span></span>
</td>
<td class="nump">18,811,924<span></span>
</td>
<td class="nump">17,634,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable', window );">Gain on forgiveness of deferred underwriting fee payable</a></td>
<td class="num">(9,660,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,660,000)<span></span>
</td>
<td class="num">(9,660,000)<span></span>
</td>
<td class="num">(9,660,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-Cash Investing and Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares', window );">Extinguishment of deferred underwriting fee payable allocated to public shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Retained Earnings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">10,071,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,634,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at the beginning</a></td>
<td class="num">(13,226,270)<span></span>
</td>
<td class="num">(21,094,439)<span></span>
</td>
<td class="num">(21,094,439)<span></span>
</td>
<td class="num">$ (21,094,439)<span></span>
</td>
<td class="num">(21,094,439)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion of Class A common stock to redemption</a></td>
<td class="num">(242,995)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(256,545)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at the end</a></td>
<td class="num">$ (3,397,818)<span></span>
</td>
<td class="num">(13,226,270)<span></span>
</td>
<td class="num">$ (3,397,818)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,716,074)<span></span>
</td>
<td class="num">(21,094,439)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares', window );">Basic and diluted weighted average shares outstanding (in shares)</a></td>
<td class="nump">14,481,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,004,630<span></span>
</td>
<td class="nump">16,466,455<span></span>
</td>
<td class="nump">12,546,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare', window );">Basic and diluted earnings per share (in dollars per share)</a></td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.64<span></span>
</td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="nump">$ 0.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares', window );">Basic and diluted weighted average shares outstanding (in shares)</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare', window );">Basic and diluted earnings per share (in dollars per share)</a></td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.64<span></span>
</td>
<td class="nump">$ 0.81<span></span>
</td>
<td class="nump">$ 0.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of Prior Period, Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable', window );">Gain on forgiveness of deferred underwriting fee payable</a></td>
<td class="num">$ (9,288,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,288,090)<span></span>
</td>
<td class="num">$ (9,288,090)<span></span>
</td>
<td class="num">$ (9,288,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expenses)</a></td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before benefit from (provision for) income taxes</a></td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable', window );">Gain on forgiveness of deferred underwriting fee payable</a></td>
<td class="nump">9,288,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,288,090<span></span>
</td>
<td class="nump">9,288,090<span></span>
</td>
<td class="nump">9,288,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-Cash Investing and Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares', window );">Extinguishment of deferred underwriting fee payable allocated to public shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of Prior Period, Adjustment [Member] | Retained Earnings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,288,090)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at the beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion of Class A common stock to redemption</a></td>
<td class="nump">9,288,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,288,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at the end</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of Prior Period, Adjustment [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares', window );">Basic and diluted weighted average shares outstanding (in shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare', window );">Basic and diluted earnings per share (in dollars per share)</a></td>
<td class="num">$ (0.43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.40)<span></span>
</td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of Prior Period, Adjustment [Member] | Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares', window );">Basic and diluted weighted average shares outstanding (in shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare', window );">Basic and diluted earnings per share (in dollars per share)</a></td>
<td class="num">$ (0.43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.40)<span></span>
</td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of extinguishment of deferred underwriting fee payable allocated to public shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of gain on forgiveness of deferred underwriting fee payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655330159488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption, at beginning of year</a></td>
<td class="nump">$ 278,760,000<span></span>
</td>
<td class="nump">$ 278,760,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Accretion of carrying value to redemption value</a></td>
<td class="nump">9,031,545<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_TemporaryEquityWaiverOfShareIssuanceCosts', window );">Waiver of Class A common stock issuance costs</a></td>
<td class="nump">9,288,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Accretion of carrying value to redemption value</a></td>
<td class="num">(9,031,545)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_TemporaryEquityRedemption', window );">Redemption of Class A Common Stock</a></td>
<td class="num">(275,102,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A common stock subject to possible redemption, at end of year</a></td>
<td class="nump">$ 3,914,265<span></span>
</td>
<td class="nump">$ 278,760,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_TemporaryEquityRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of temporary equity redeemed during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_TemporaryEquityRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_TemporaryEquityWaiverOfShareIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of waiver of share issuance costs pertaining to temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_TemporaryEquityWaiverOfShareIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655333522592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Allocation of net income, as adjusted</a></td>
<td class="nump">$ 5,385,193<span></span>
</td>
<td class="nump">$ 7,366,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic and diluted weighted average shares outstanding</a></td>
<td class="nump">12,546,423<span></span>
</td>
<td class="nump">27,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and diluted net income per common stock</a></td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Allocation of net income, as adjusted</a></td>
<td class="nump">$ 2,961,627<span></span>
</td>
<td class="nump">$ 1,841,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic and diluted weighted average shares outstanding</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and diluted net income per common stock</a></td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="nump">$ 0.27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655326732608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 17, 2020</div></th>
<th class="th"><div>Mar. 14, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Insured amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_TransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,688,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_SaleOfStockUnderwritingFees', window );">Underwriting fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,520,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DeferredOfferingCostsNoncurrent', window );">Deferred underwriting fee payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,660,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_SaleOfStockOtherOfferingCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">508,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Charged to temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,239,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_OfferingCost', window );">Offering cost expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 449,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits accrued for interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WorkingCapital', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,002,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,489<span></span>
</td>
<td class="nump">406,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,346,820<span></span>
</td>
<td class="nump">9,207,884<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash for operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">761,098<span></span>
</td>
<td class="nump">$ 595,321<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate (in percent)</a></td>
<td class="nump">164.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WorkingCapital', window );">Working capital</a></td>
<td class="nump">$ 3,052,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,052,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">6,724,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,724,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">2,758,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash for operating activities</a></td>
<td class="nump">4,431,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Reduction in accrued liabilities</a></td>
<td class="nump">$ 3,888,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,888,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_CashAndCashEquivalentsDescription', window );">Cash and cash equivalents, description</a></td>
<td class="text">As of March 31, 2023 (Successor), the Company had cash equivalents  of approximately $2,000 thousand of certificates of
deposit held by a number of banks limited to $250 thousand per bank with a duration of 90 days or less<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="nump">$ 2,690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RevenueRecognized', window );">Revenue Recognized</a></td>
<td class="nump">170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ChangesInEstimatedFairValueOfWarrants', window );">Changes in estimated fair value of warrants</a></td>
<td class="nump">1,686,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Impairment charges of long-lived assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,380,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,671,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash for operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,144,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,162,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RevenueRecognized', window );">Revenue Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">865,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,328,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">647,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Impairment charges of long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cxai_CommonStockSubjectToRedemptionMember', window );">Common stock subject to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Class A common stock subject to possible redemption, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387,551<span></span>
</td>
<td class="nump">27,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,080,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_CashAndCashEquivalentsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_CashAndCashEquivalentsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ChangesInEstimatedFairValueOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ChangesInEstimatedFairValueOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DeferredOfferingCostsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DeferredOfferingCostsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_OfferingCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of offering cost expense through statement of operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_OfferingCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_RevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_RevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_SaleOfStockOtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of other offering costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_SaleOfStockOtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_SaleOfStockUnderwritingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of offering fees incurred and paid for underwriters.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_SaleOfStockUnderwritingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of transaction costs incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount represents the information about the working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cxai_CommonStockSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cxai_CommonStockSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655339729968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PUBLIC OFFERING (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 17, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units sold | shares</a></td>
<td class="nump">27,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit (in dollars per share)</a></td>
<td class="nump">$ 10.10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units sold | shares</a></td>
<td class="nump">3,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit (in dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655330288064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PRIVATE PLACEMENT (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 17, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,080,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member] | Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued</a></td>
<td class="nump">10,280,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrants</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Aggregate purchase price</a></td>
<td class="nump">$ 10,280,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member] | Private Placement [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334738624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 14, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 27, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 14, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 10, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ExpensesIncurredAndPaid', window );">Expenses incurred and paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cxai_FounderSharesMember', window );">Founder Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_AggregateNumberOfSharesOwned', window );">Aggregate number of shares owned | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders', window );">Percentage of issued and outstanding shares after the initial public offering collectively held by initial stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cxai_FounderSharesMember', window );">Founder Shares [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NumberOfSharesSubjectToForfeiture', window );">Shares subject to forfeiture | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_AggregateNumberOfSharesOwned', window );">Aggregate number of shares owned | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion', window );">Restrictions on transfer period of time after business combination completion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays', window );">Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences', window );">Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">150 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cxai_FounderSharesMember', window );">Founder Shares [Member] | Sponsor [Member] | Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NumberOfSharesSubjectToForfeiture', window );">Shares subject to forfeiture | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cxai_FounderSharesMember', window );">Founder Shares [Member] | Sponsor [Member] | Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cxai_FounderSharesMember', window );">Founder Shares [Member] | Sponsor [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger', window );">Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cxai_FounderSharesMember', window );">Founder Shares [Member] | Direct Anchor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_AggregateNumberOfSharesOwned', window );">Aggregate number of shares owned | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cxai_AdministrativeServicesAgreementMember', window );">Administrative Services Agreement [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth', window );">Expenses per month</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cxai_PromissoryNoteWithRelatedPartyMember', window );">Promissory Note With Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCollateralAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount outstanding under promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 347,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cxai_WorkingCapitalLoansMember', window );">Working Capital Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_MaximumLoansConvertibleIntoWarrants', window );">Loan conversion agreement warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cxai_WorkingCapitalLoansMember', window );">Working Capital Loans | Working capital loans warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote', window );">Maximum borrowing capacity of related party promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_AggregateNumberOfSharesOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders after the impact of the stock dividend.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_AggregateNumberOfSharesOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ExpensesIncurredAndPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ExpensesIncurredAndPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of maximum borrowing capacity of related party promissory note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_MaximumLoansConvertibleIntoWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum amount which a potential loan could have repaid through issuance of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_MaximumLoansConvertibleIntoWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_NumberOfSharesSubjectToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_NumberOfSharesSubjectToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected ownership percentage by the founders after completion of the proposed public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The contractual monthly amount to be paid for support services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after completion of a business combination during which the shares or warrant may not be transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after a business combination which must elapse before consideration of the share price condition for transfer of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCollateralAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets pledged to secure a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCollateralAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cxai_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cxai_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cxai_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cxai_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cxai_DirectAnchorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cxai_DirectAnchorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cxai_AdministrativeServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cxai_AdministrativeServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cxai_PromissoryNoteWithRelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cxai_PromissoryNoteWithRelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cxai_WorkingCapitalLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cxai_WorkingCapitalLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_WorkingCapitalLoansWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cxai_WorkingCapitalLoansWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655331038464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 09, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 14, 2020 </div>
<div>Integer </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 25, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 17, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands', window );">Minimum percentage of founder share holders entitled to make demands</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_MaximumNumberOfDemandsForRegistrationOfSecurities', window );">Maximum number of demands for registration of securities | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DeferredFeePerUnit', window );">Deferred fee per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DeferredOfferingCostsNoncurrent', window );">Deferred underwriting fee payable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,660,000<span></span>
</td>
<td class="nump">$ 9,660,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee', window );">Income recognized from reduction of deferred underwriter fee | $</a></td>
<td class="nump">$ 9,660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member] | Merger Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cxai_MergerAgreementMember', window );">Merger Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_PercentageOfCommonStockDistributed', window );">Percentage of common stock distributed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger', window );">Maximum term for automatic conversion of stock following the closing of the Merger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_CommonStockStockPriceTrigger', window );">Stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ThresholdTradingDays', window );">Threshold trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ThresholdNetTangibleAssets', window );">Threshold net tangible assets | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares', window );">Threshold aggregate gross purchase price of any other purchase of shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_CommonStockLockUpPeriod', window );">Lock-up period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cxai_MergerAgreementMember', window );">Merger Agreement | CXApp</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NumberOfSharesIssuableUponMerger', window );">Number of shares issuable upon merger | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_TermOfBreachUnableToBeCuredOrIsNotCured', window );">Term of breach unable to be cured, or is not cured</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_TerminationFee', window );">Termination fee | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp', window );">Percentage of shares not be subject to foregoing lock-up</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cxai_MergerAgreementMember', window );">Merger Agreement | CXApp | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_PercentageOfStockAsMergerConsideration', window );">Percentage of stock as merger consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cxai_MergerAgreementMember', window );">Merger Agreement | CXApp | Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_PercentageOfStockAsMergerConsideration', window );">Percentage of stock as merger consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cxai_SponsorSupportAgreementMember', window );">Sponsor Support Agreement | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_MinimumNumberOfSharesIssuableToSponsor', window );">Minimum number of shares issuable to sponsor | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=cxai_SponsorSupportAgreementMember', window );">Sponsor Support Agreement | Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NumberOfSharesExchanged', window );">Number of shares exchanged | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cxai_InpixonMember', window );">Inpixon | Separation Agreement | CXApp</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Cash Contribution upon seperation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=cxai_CXAppCommonStockMember', window );">C X App Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_CommonStockLockUpPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the lock-up period of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_CommonStockLockUpPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_CommonStockStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the stock price trigger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_CommonStockStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DeferredFeePerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred fee per unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DeferredFeePerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DeferredOfferingCostsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DeferredOfferingCostsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income recognized from reduction of deferred underwriter fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_MaximumNumberOfDemandsForRegistrationOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum number of demands for registration of securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_MaximumNumberOfDemandsForRegistrationOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum term for automatic conversion of stock following the closing of the Merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_MinimumNumberOfSharesIssuableToSponsor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum number of shares issuable to sponsor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_MinimumNumberOfSharesIssuableToSponsor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum Percentage of Founder Share Holders Entitled To Make Demands.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_NumberOfSharesExchanged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares exchanged.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_NumberOfSharesExchanged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_NumberOfSharesIssuableUponMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares issuable upon merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_NumberOfSharesIssuableUponMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_PercentageOfCommonStockDistributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of common stock distributed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_PercentageOfCommonStockDistributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of shares not be subject to foregoing lock-up.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_PercentageOfStockAsMergerConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of stock as merger consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_PercentageOfStockAsMergerConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_TermOfBreachUnableToBeCuredOrIsNotCured">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the term of breach unable to be cured, or is not cured.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_TermOfBreachUnableToBeCuredOrIsNotCured</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_TerminationFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of termination fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_TerminationFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the threshold aggregate gross purchase price of any other purchase of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ThresholdNetTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the threshold net tangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ThresholdNetTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=cxai_MergerAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=cxai_MergerAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=cxai_MergerAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=cxai_MergerAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cxai_CxappHoldingCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cxai_CxappHoldingCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=cxai_SponsorSupportAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=cxai_SponsorSupportAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cxai_InpixonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cxai_InpixonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=cxai_SeparationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=cxai_SeparationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=cxai_CXAppCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=cxai_CXAppCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655330240496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; DEFICIT (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Integer </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 25, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, shares authorized</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value, (per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ConvertibleStockConversionRatio', window );">Ratio to be applied to the stock in the conversion</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_CommonStockNumberOfVotesPerShare', window );">Common shares, votes per share | Integer</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cxai_CommonStockSubjectToRedemptionMember', window );">Common stock subject to redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">387,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding (in shares)</a></td>
<td class="nump">387,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_CommonStockNumberOfVotesPerShare', window );">Common shares, votes per share | Integer</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares, shares outstanding (in shares)</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_CommonStockNumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of votes that each common share is entitled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_CommonStockNumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ConvertibleStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ratio to be applied to the stock in a conversion of convertible stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ConvertibleStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cxai_CommonStockSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cxai_CommonStockSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655336177232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE WARRANT LIABILITIES (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 17, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,800,000<span></span>
</td>
<td class="nump">13,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant', window );">Share PriceTrigger Used To Measure Dilution Of Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant', window );">Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantExercisePriceAdjustmentMultiple', window );">Warrant exercise price adjustment multiple</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantRedemptionPriceAdjustmentMultiple', window );">Warrant redemption price adjustment multiple</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member', window );">Redemption Of Warrants When The Price per Class A Ordinary Share Equals Or Exceeds $18.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantRedemptionConditionMinimumSharePrice', window );">Warrant redemption condition minimum share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member', window );">Redemption Of Warrants When The Price Per Class A Ordinary Share Equals Or Exceeds $10.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights', window );">Redemption price per public warrant (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo', window );">Warrant redemption condition minimum share price scenario two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,280,000<span></span>
</td>
<td class="nump">10,280,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member] | Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NumberOfWarrantsIssued', window );">Number of warrants issued | shares</a></td>
<td class="nump">10,280,000<span></span>
</td>
<td class="nump">10,280,000<span></span>
</td>
<td class="nump">10,280,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PublicWarrantsMember', window );">Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantExercisePeriodConditionOne', window );">Warrant exercise period condition one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantExercisePeriodConditionTwo', window );">Warrant exercise period condition two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Public Warrants expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion', window );">Restrictions on transfer period of time after business combination completion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PublicWarrantsMember', window );">Public Warrants [Member] | Redemption Of Warrants When The Price per Class A Ordinary Share Equals Or Exceeds $18.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantRedemptionConditionMinimumSharePrice', window );">Warrant redemption condition minimum share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights', window );">Redemption price per public warrant (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for redemption of public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays', window );">Threshold trading days for redemption of public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RedemptionPeriod', window );">Redemption period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement', window );">Maximum period after business combination in which to file registration statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective', window );">Period of time within which registration statement is expected to become effective</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Redemption Of Warrants When The Price Per Class A Ordinary Share Equals Or Exceeds $10.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for redemption of public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RedemptionPeriod', window );">Redemption period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo', window );">Warrant redemption condition minimum share price scenario two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days for stock price trigger considered for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after completion of a business combination in which the reporting entity is required to file a registration statement with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_NumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_NumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ratio of gross proceeds from a future offering to total equity proceeds which is used to measure whether dilution of the warrant has occurred. If aggregate gross proceeds from a new offering exceeds a specified percentage of total equity proceeds, the warrant exercise price will be adjusted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after filing within which the registration statement filed with the SEC is expected to become effective.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_RedemptionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_RedemptionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after completion of a business combination during which the shares or warrant may not be transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cut off price used to measure whether dilution of the warrant has occurred. Shares issued below this price will cause the exercise price of the warrant to be adjusted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WarrantExercisePeriodConditionOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after completion of a business combination before a warrant may be exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WarrantExercisePeriodConditionOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WarrantExercisePeriodConditionTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The alternate period of time after completion of an initial public offering before a warrant may be exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WarrantExercisePeriodConditionTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WarrantExercisePriceAdjustmentMultiple">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In the event of dilution of the warrant, the multiple to be applied to the higher of the market price or the price of newly issued shares in order to obtain the adjusted exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WarrantExercisePriceAdjustmentMultiple</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WarrantRedemptionConditionMinimumSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum trading price for the reporting entity's stock which must be achieved as a condition for redemption of the warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WarrantRedemptionConditionMinimumSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum trading price for the reporting entity's stock which must be achieved as a condition for redemption of the warrant under another scenario.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WarrantRedemptionPriceAdjustmentMultiple">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In the event of dilution of the warrant, the multiple to be applied to the higher of the market price or the price of newly issued shares in order to obtain the adjusted redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WarrantRedemptionPriceAdjustmentMultiple</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cxai_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334059872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAX (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract', window );"><strong>Deferred tax asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts', window );">Organizational costs/startup expenses</a></td>
<td class="nump">$ 924,537<span></span>
</td>
<td class="nump">$ 322,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">28,689<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax asset</a></td>
<td class="nump">924,537<span></span>
</td>
<td class="nump">351,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(924,537)<span></span>
</td>
<td class="num">(351,652)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax asset, net of allowance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from capitalized start up and organization costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655328699984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (Details 1) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Federal</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">$ 49,175<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(572,885)<span></span>
</td>
<td class="num">(300,205)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_StateAndLocalAbstract', window );"><strong>State and Local</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit', window );">Deferred</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Change in valuation allowance</a></td>
<td class="nump">572,885<span></span>
</td>
<td class="nump">300,205<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">$ 49,175<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_StateAndLocalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_StateAndLocalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655339692800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAX (Details 2)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal tax benefit</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent', window );">Transaction costs allocated to derivative warrant liabilities</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent', window );">Change in fair value of derivative warrant liabilities</a></td>
<td class="num">(23.90%)<span></span>
</td>
<td class="num">(24.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax provision</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Change in fair value of derivative warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Transaction costs allocated to derivative warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655328695872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAX (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">$ 924,537<span></span>
</td>
<td class="nump">$ 351,652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">137,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">$ 572,885<span></span>
</td>
<td class="nump">$ 300,205<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655329874624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Assets held in the Trust Account</a></td>
<td class="nump">$ 3,923,804<span></span>
</td>
<td class="nump">$ 278,836,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Warrant liabilities</a></td>
<td class="nump">414,000<span></span>
</td>
<td class="nump">6,461,798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Warrant liabilities</a></td>
<td class="nump">308,400<span></span>
</td>
<td class="nump">4,813,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Assets held in the Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">278,835,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Assets held in the Trust Account</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 278,835,182<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cxai_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334658288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details 1) - Fair Value, Inputs, Level 3 [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1', window );">Transfer to Level 1</a></td>
<td class="nump">$ 9,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2', window );">Transfer to Level 2</a></td>
<td class="nump">6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 21,912,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,260,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1', window );">Transfer to Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,970,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2', window );">Transfer to Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,682,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">9,354,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,672,800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1', window );">Transfer to Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2', window );">Transfer to Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,682,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PublicWarrantsMember', window );">Public Warrants [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">12,558,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,588,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1', window );">Transfer to Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,970,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2', window );">Transfer to Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value at ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into level 1 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into level 2 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cxai_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334646576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Assets held in the Trust Account</a></td>
<td class="nump">$ 3,923,804<span></span>
</td>
<td class="nump">$ 278,836,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax', window );">Cash withdrawn from trust account to pay franchise tax</a></td>
<td class="nump">231,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ProceedsFromTrustAccountInConnectionWithRedemption', window );">Cash withdrawn from trust account in connection with redemption</a></td>
<td class="nump">275,102,280<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1', window );">Transfer to Level 1</a></td>
<td class="nump">9,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2', window );">Transfer to Level 2</a></td>
<td class="nump">6,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashMember', window );">Cash [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Assets held in the Trust Account</a></td>
<td class="nump">$ 3,923,804<span></span>
</td>
<td class="nump">898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Assets held in the Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 278,835,182<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into level 1 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into level 2 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ProceedsFromTrustAccountInConnectionWithRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ProceedsFromTrustAccountInConnectionWithRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655339958720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policie (Details) - Successor [Member]<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">25,457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">1,377,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td>
<td class="nump">24,080<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=cxai_StockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=cxai_StockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655330998048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Details) - Predecessor [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 14, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_PurchasePrice', window );">Purchase Price</a></td>
<td class="nump">$ 69,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">10,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">2,226<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables', window );">Notes and other receivables</a></td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid assets and other current assets</a></td>
<td class="nump">588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset', window );">Operating lease right of use asset</a></td>
<td class="nump">557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other assets</a></td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">34,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenues</a></td>
<td class="nump">2,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent', window );">Operating lease obligation, current</a></td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent', window );">Operating lease obligation, noncurrent</a></td>
<td class="nump">384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Deferred tax liability</a></td>
<td class="nump">4,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">8,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Goodwill</a></td>
<td class="nump">44,122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Developed Technology Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">$ 9,268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">$ 2,703<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">$ 5,604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Trademarks and Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">$ 3,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_PurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_PurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334213040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenues</a></td>
<td class="nump">$ 1,962<span></span>
</td>
<td class="nump">$ 2,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (6,365)<span></span>
</td>
<td class="nump">$ 6,197<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655329907504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Details Narrative)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 14, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="nump">$ 9.94<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business combination goodwill</a></td>
<td class="nump">$ 44,122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business Combination, Acquisition Related Costs</a></td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Merger Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_AggregatePurchasePriceAssetsAndLiabilities', window );">Aggregate purchase price assets and liabilities</a></td>
<td class="nump">69,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business combination goodwill</a></td>
<td class="nump">$ 44,122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Merger Agreement | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ConsiderationTransferredInConnection', window );">Consideration transferred in connection | shares</a></td>
<td class="nump">1,547,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Merger Agreement | Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ConsiderationTransferredInConnection', window );">Consideration transferred in connection | shares</a></td>
<td class="nump">5,487,300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_AggregatePurchasePriceAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_AggregatePurchasePriceAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ConsiderationTransferredInConnection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ConsiderationTransferredInConnection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=cxai_MergerAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=cxai_MergerAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655330958848">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 14, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Transferred over Time [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Subscription Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Subscription Revenue [Member] | Software [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Non Subscription Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Non Subscription Revenue [Member] | Professional Services [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,620<span></span>
</td>
<td class="nump">$ 2,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Transferred over Time [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,620<span></span>
</td>
<td class="nump">2,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Subscription Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,204<span></span>
</td>
<td class="nump">1,259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Subscription Revenue [Member] | Software [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,204<span></span>
</td>
<td class="nump">1,259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Non Subscription Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="nump">1,323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Non Subscription Revenue [Member] | Professional Services [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 416<span></span>
</td>
<td class="nump">$ 1,323<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Professional services are also contracted on the fixed fee and time and materials basis.
                                            Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company has
                                            generally elected the practical expedient to recognize revenue for the right to invoice because
                                            the Company&#8217;s right to consideration corresponds directly with the value to the customer
                                            of the performance completed to date, in which revenue is recognized over time.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Software
                                            As A Service Subscription Revenue&#8217;s performance obligation is satisfied evenly over
                                            the service period using a time-based measure because the Company is providing continuous
                                            access to its service and service is recognized overtime.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cxai_SubscriptionRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cxai_SubscriptionRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cxai_SoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cxai_SoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=cxai_NonSubscriptionRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=cxai_NonSubscriptionRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cxai_ProfessionalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cxai_ProfessionalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655330222560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total Property and Equipment, Net</a></td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,011)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total Property and Equipment, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Office Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">992<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cxai_SoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cxai_SoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655333630992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, net (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 14, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation, Depletion and Amortization, Nonproduction</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation, Depletion and Amortization, Nonproduction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655330627024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Software Development Costs, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Capitalized software development costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Software development costs, net</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Capitalized software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,193)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Software development costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 487<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655333509904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Software Development Costs, net (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 14, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 209<span></span>
</td>
<td class="nump">$ 113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655418035184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Details) - Successor [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_AcquisitionOfLegacyCxapp', window );">Acquisition of Legacy CXApp</a></td>
<td class="nump">44,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 44,122<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_AcquisitionOfLegacyCxapp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_AcquisitionOfLegacyCxapp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655328581344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">$ 20,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net carrying amount</a></td>
<td class="nump">$ 20,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,624)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,289<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and Trade Names [Member] | Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">$ 3,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net carrying amount</a></td>
<td class="nump">$ 3,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and Trade Names [Member] | Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(725)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,458<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member] | Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">$ 5,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(47)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net carrying amount</a></td>
<td class="nump">$ 5,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member] | Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,765)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,636<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Rights [Member] | Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">$ 9,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net carrying amount</a></td>
<td class="nump">9,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Rights [Member] | Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,398)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,781<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member] | Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net carrying amount</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member] | Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,736)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cxai_PatentsAndIntellectualPropertyMember', window );">Patents And Intellectual Property [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cxai_PatentsAndIntellectualPropertyMember', window );">Patents And Intellectual Property [Member] | Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">$ 2,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net carrying amount</a></td>
<td class="nump">$ 2,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cxai_PatentsAndIntellectualPropertyMember', window );">Patents And Intellectual Property [Member] | Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of finite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherFiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cxai_PatentsAndIntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cxai_PatentsAndIntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655334062352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Details 2)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 2,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">2,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">2,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">2,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">2,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">2028 and thereafter</a></td>
<td class="nump">7,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 20,753<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655329242608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 14, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 44,122<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Aggregate amortization expense</a></td>
<td class="nump">$ 116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ (0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Aggregate amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 806<span></span>
</td>
<td class="nump">$ 975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655328643920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Total Deferred Revenue</a></td>
<td class="nump">$ 2,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Licensing Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Total Deferred Revenue</a></td>
<td class="nump">2,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Professional Service Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Total Deferred Revenue</a></td>
<td class="nump">$ 302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Total Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,162<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Licensing Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Total Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,937<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Professional Service Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Total Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cxai_ProfessionalServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=cxai_ProfessionalServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655330998384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_InsurancePremiumsAndAccruedInterest', window );">Insurance premiums and accrued interest</a></td>
<td class="nump">$ 538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RelatedPartyPromissoryNote', window );">Related party promissory note</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxes', window );">Income tax payables</a></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RelatedPartyPayable', window );">Related party payable</a></td>
<td class="nump">1,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_AccruedCompensationAndBenefits', window );">Accrued compensation and benefits</a></td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Accrued bonus and commissions</a></td>
<td class="nump">192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRentCurrent', window );">Accrued rent</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_AccruedOther', window );">Accrued other</a></td>
<td class="nump">561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Accrued sales and other indirect taxes payable</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued liabilities</a></td>
<td class="nump">$ 3,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_InsurancePremiumsAndAccruedInterest', window );">Insurance premiums and accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RelatedPartyPromissoryNote', window );">Related party promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxes', window );">Income tax payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RelatedPartyPayable', window );">Related party payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_AccruedCompensationAndBenefits', window );">Accrued compensation and benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Accrued bonus and commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedRentCurrent', window );">Accrued rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">559<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_AccruedOther', window );">Accrued other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Accrued sales and other indirect taxes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,736<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_AccruedCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_AccruedCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_AccruedOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_AccruedOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_InsurancePremiumsAndAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_InsurancePremiumsAndAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_RelatedPartyPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_RelatedPartyPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_RelatedPartyPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_RelatedPartyPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6419918&amp;loc=d3e35281-107843<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due. This amount is the total of current and noncurrent accrued income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655330198480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 14, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RelatedPartyDescription', window );">Related party description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As
of March 31, 2023, the Company&#8217;s related party liabilities consisted of a promissory note payable to the KINS sponsor in the amount of $20 thousand for working capital. As of March 31, 2023, accrued
liabilities include an estimate of approximately $1,045 thousand due to Inpixon by CXApp resulting from an agreement to reimburse
Inpixon (subject to review and acceptance by the Company) for certain transaction related costs incurred by Inpixon on behalf of KINS prior to March
14, 2023. This amount is subject to an ongoing review and evaluation by the Company. Additionally, as of March 31, 2023, accrued
liabilities include (i) $30 thousand for estimated costs related to transition services provided by Inpixon to CXApp and (ii) $80
thousand of reimbursable expenses incurred by Inpixon on behalf of CXApp during the period from March 15, 2023 to March 31,
2023.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Director And Officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt payment</a></td>
<td class="nump">$ 671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance cost</a></td>
<td class="nump">$ 134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Debt owed balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 538<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_RelatedPartyDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_RelatedPartyDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cxai_DirectorAndOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cxai_DirectorAndOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655330341824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrant Liabilities (Details Narrative) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,800,000<span></span>
</td>
<td class="nump">13,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PublicWarrantsMember', window );">Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantExercisePeriodConditionOne', window );">Warrant exercise period condition one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantExercisePeriodConditionTwo', window );">Warrant exercise period condition two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Public Warrants expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion', window );">Restrictions on transfer period of time after business combination completion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,280,000<span></span>
</td>
<td class="nump">10,280,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">13,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceIncrease', window );">Warrant Price</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Redemption Of Warrants When The Price per Class A Ordinary Share Equals Or Exceeds $18.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantRedemptionConditionMinimumSharePrice', window );">Warrant redemption condition minimum share price</a></td>
<td class="nump">18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Redemption Of Warrants When The Price Per Class A Ordinary Share Equals Or Exceeds $10.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights', window );">Redemption price per public warrant (in dollars per share)</a></td>
<td class="nump">0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo', window );">Warrant redemption condition minimum share price scenario two</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantExercisePeriodConditionOne', window );">Warrant exercise period condition one</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantExercisePeriodConditionTwo', window );">Warrant exercise period condition two</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Public Warrants expiration term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion', window );">Restrictions on transfer period of time after business combination completion</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Public Warrants [Member] | Redemption Of Warrants When The Price per Class A Ordinary Share Equals Or Exceeds $18.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantRedemptionConditionMinimumSharePrice', window );">Warrant redemption condition minimum share price</a></td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights', window );">Redemption price per public warrant (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RedemptionPeriod', window );">Redemption period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays', window );">Threshold trading days for redemption of public warrants</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders', window );">Threshold number of business days before sending notice of redemption to warrant holders</a></td>
<td class="text">third trading day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Warrant [Member] | Redemption Of Warrants When The Price Per Class A Ordinary Share Equals Or Exceeds $10.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_RedemptionPeriod', window );">Redemption period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo', window );">Warrant redemption condition minimum share price scenario two</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">10,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days for stock price trigger considered for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_RedemptionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_RedemptionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after completion of a business combination during which the shares or warrant may not be transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WarrantExercisePeriodConditionOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The period of time after completion of a business combination before a warrant may be exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WarrantExercisePeriodConditionOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WarrantExercisePeriodConditionTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The alternate period of time after completion of an initial public offering before a warrant may be exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WarrantExercisePeriodConditionTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WarrantRedemptionConditionMinimumSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum trading price for the reporting entity's stock which must be achieved as a condition for redemption of the warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WarrantRedemptionConditionMinimumSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum trading price for the reporting entity's stock which must be achieved as a condition for redemption of the warrant under another scenario.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cxai_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655329232384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Award Plans and Stock-Based Compensation (Details) - Successor [Member]<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</a></td>
<td class="nump">37.35%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">3.62%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</a></td>
<td class="nump">3.67%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655328625728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan and Stock-Based Compensation (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 10, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_FairValueOfNonvestedOptions', window );">Fair value of non-vested options</a></td>
<td class="nump">$ 686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_WeightedAverageRemainingTermOfNonvestedOptions', window );">Weighted average remaining term of non-vested options</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Employee Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_AmortizationOfEmployeeStockOptions', window );">Amortization of employee stock options</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Employee Stock Options [Member] | Employees And Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock option granted</a></td>
<td class="nump">1,377,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_FairValueOfOptions', window );">Fair value of options</a></td>
<td class="nump">$ 688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value of common stock as of grant date</a></td>
<td class="nump">$ 1.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Employee Stock Options [Member] | Employees And Directors [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Option life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Employee Stock Options [Member] | Employees And Directors [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Option life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cxai_N2023EquityIncentivePlanMember', window );">N 2023 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,110,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_AmortizationOfEmployeeStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_AmortizationOfEmployeeStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_FairValueOfNonvestedOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_FairValueOfNonvestedOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_FairValueOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_FairValueOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_WeightedAverageRemainingTermOfNonvestedOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_WeightedAverageRemainingTermOfNonvestedOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cxai_EmployeeStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cxai_EmployeeStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cxai_EmployeesAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cxai_EmployeesAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cxai_N2023EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cxai_N2023EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655339985648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,552,969)<span></span>
</td>
<td class="num">$ (10,637,431)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Public Placement Warrants [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="nump">$ 552,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Private Placement Warrants [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants</a></td>
<td class="nump">$ 411,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PublicPlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cxai_PublicPlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cxai_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655333493008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 14, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_IncomeTaxBenefitprovision', window );">Income tax benefit/(provision)</a></td>
<td class="nump">$ 1,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">164.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_IncomeTaxBenefitprovision', window );">Income tax benefit/(provision)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_IncomeTaxBenefitprovision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_IncomeTaxBenefitprovision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655328241264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Foreign Operations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 14, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss) by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,950,464)<span></span>
</td>
<td class="num">$ (1,497,914)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,346,820<span></span>
</td>
<td class="nump">$ 9,207,884<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues by geographic area</a></td>
<td class="nump">$ 342,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss) by geographic area</a></td>
<td class="num">(487,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) by geographic area</a></td>
<td class="nump">2,758,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetAssets', window );">Identifiable assets by geographic area</a></td>
<td class="nump">76,384,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long lived assets by geographic area</a></td>
<td class="nump">21,455,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill by geographic area</a></td>
<td class="nump">44,122,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues by geographic area</a></td>
<td class="nump">272,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss) by geographic area</a></td>
<td class="num">(486,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) by geographic area</a></td>
<td class="nump">2,780,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetAssets', window );">Identifiable assets by geographic area</a></td>
<td class="nump">75,059,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long lived assets by geographic area</a></td>
<td class="nump">20,817,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill by geographic area</a></td>
<td class="nump">44,122,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues by geographic area</a></td>
<td class="nump">70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss) by geographic area</a></td>
<td class="num">(158,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) by geographic area</a></td>
<td class="num">(158,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetAssets', window );">Identifiable assets by geographic area</a></td>
<td class="nump">991,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long lived assets by geographic area</a></td>
<td class="nump">417,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill by geographic area</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | INDIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues by geographic area</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss) by geographic area</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) by geographic area</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetAssets', window );">Identifiable assets by geographic area</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long lived assets by geographic area</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill by geographic area</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | PHILIPPINES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues by geographic area</a></td>
<td class="nump">196,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss) by geographic area</a></td>
<td class="nump">157,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) by geographic area</a></td>
<td class="nump">157,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetAssets', window );">Identifiable assets by geographic area</a></td>
<td class="nump">405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long lived assets by geographic area</a></td>
<td class="nump">222,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill by geographic area</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member] | Eliminations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues by geographic area</a></td>
<td class="num">(196,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss) by geographic area</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) by geographic area</a></td>
<td class="num">(21,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetAssets', window );">Identifiable assets by geographic area</a></td>
<td class="num">(71,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long lived assets by geographic area</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill by geographic area</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,620,000<span></span>
</td>
<td class="nump">$ 2,582,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss) by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,381,000)<span></span>
</td>
<td class="num">(1,572,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,380,000)<span></span>
</td>
<td class="num">(1,671,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetAssets', window );">Identifiable assets by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,280,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long lived assets by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,659,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,395,000<span></span>
</td>
<td class="nump">2,167,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss) by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,479,000)<span></span>
</td>
<td class="num">(650,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,342,000)<span></span>
</td>
<td class="num">(519,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetAssets', window );">Identifiable assets by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,591,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long lived assets by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,558,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285,000<span></span>
</td>
<td class="nump">601,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss) by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(905,000)<span></span>
</td>
<td class="num">(1,008,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,041,000)<span></span>
</td>
<td class="num">(1,139,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetAssets', window );">Identifiable assets by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,484,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long lived assets by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,788,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | INDIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss) by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(27,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetAssets', window );">Identifiable assets by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long lived assets by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | PHILIPPINES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss) by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetAssets', window );">Identifiable assets by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">415,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long lived assets by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member] | Eliminations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(220,000)<span></span>
</td>
<td class="num">(456,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss) by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_NetAssets', window );">Identifiable assets by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,438,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long lived assets by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill by geographic area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_NetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_NetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cxai_EliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cxai_EliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139655331034240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 14, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cxai_LeasePeriodicPayments', window );">Lease periodic payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_SuccessorMember', window );">Successor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expenses</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate used to determine operating lease</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=cxai_PredecessorMember', window );">Predecessor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate used to determine operating lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cxai_LeasePeriodicPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cxai_LeasePeriodicPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cxai_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_SuccessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_SuccessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=cxai_PredecessorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=cxai_PredecessorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>cxapp_s1a3_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:cxai="http://kins-tech.com/20230331"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cxai-20230331.xsd" xlink:type="simple"/>
    <context id="From2023-01-01to2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CommonClassaSubjectToRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cxai:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CommonClassaSubjectToRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cxai:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_ClassACommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_ClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ClassACommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ClassACommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ClassACommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ClassACommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassBCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2020-12-012020-12-17_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-17</endDate>
        </period>
    </context>
    <context id="From2020-12-012020-12-17_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-17</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-17_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-17</instant>
        </period>
    </context>
    <context id="From2020-12-012020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-17</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-17</instant>
        </period>
    </context>
    <context id="AsOf2020-12-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <instant>2020-12-17</instant>
        </period>
    </context>
    <context id="AsOf2020-12-17_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-17</instant>
        </period>
    </context>
    <context id="AsOf2022-12-09_custom_CommonClassaSubjectToRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cxai:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-09</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cxai:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-09-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CommonStockSubjectToRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cxai:CommonStockSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CommonStockSubjectToRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cxai:CommonStockSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2020-12-012020-12-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-17</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_SuccessorMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_SuccessorMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-17_us-gaap_CommonClassAMember_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-17</instant>
        </period>
    </context>
    <context id="AsOf2020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_CommonClassAMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-17</instant>
        </period>
    </context>
    <context id="From2020-07-012020-07-27_custom_FounderSharesMember_custom_SponsorMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-27</endDate>
        </period>
    </context>
    <context id="From2020-10-012020-10-31_custom_FounderSharesMember_custom_DirectAnchorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:DirectAnchorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-10-31_custom_FounderSharesMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="From2020-10-012020-10-31_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-10-31_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_FounderSharesMember_custom_SponsorMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_FounderSharesMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_FounderSharesMember_custom_DirectAnchorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:DirectAnchorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-10-31_custom_FounderSharesMember_custom_SponsorMember_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_FounderSharesMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_FounderSharesMember_custom_SponsorMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2020-12-012020-12-14_custom_AdministrativeServicesAgreementMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:AdministrativeServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cxai:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2022-08-10_custom_PromissoryNoteWithRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:PromissoryNoteWithRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-10</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PromissoryNoteWithRelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:PromissoryNoteWithRelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_WorkingCapitalLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:WorkingCapitalLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_WorkingCapitalLoansWarrantMember_custom_WorkingCapitalLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:WorkingCapitalLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_WorkingCapitalLoansWarrantMember_custom_WorkingCapitalLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cxai:WorkingCapitalLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2020-12-012020-12-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <instant>2020-12-14</instant>
        </period>
    </context>
    <context id="From2022-06-012022-06-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-09</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-25_custom_CXAppCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:CXAppCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="AsOf2022-09-25_custom_InpixonMember_custom_SeparationAgreementMember_custom_CxappHoldingCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cxai:InpixonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:SeparationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cxai:CxappHoldingCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="From2022-09-012022-09-25_custom_MergerAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-25</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-25_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="AsOf2022-09-25_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="AsOf2022-09-25_custom_MergerAgreementMember_custom_CxappHoldingCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cxai:CxappHoldingCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="From2022-09-012022-09-25_us-gaap_CommonClassAMember_custom_MergerAgreementMember_custom_CxappHoldingCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cxai:CxappHoldingCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-25</endDate>
        </period>
    </context>
    <context id="From2022-09-012022-09-25_us-gaap_CommonClassCMember_custom_MergerAgreementMember_custom_CxappHoldingCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cxai:CxappHoldingCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-25</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-25_custom_MergerAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-25</instant>
        </period>
    </context>
    <context id="From2022-09-012022-09-25_custom_MergerAgreementMember_custom_CxappHoldingCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cxai:CxappHoldingCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-25</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-14_custom_MergerAgreementMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-14</instant>
        </period>
    </context>
    <context id="From2020-12-012020-12-14_custom_MergerAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-14</endDate>
        </period>
    </context>
    <context id="From2020-12-012020-12-14_custom_MergerAgreementMember_custom_CxappHoldingCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cxai:CxappHoldingCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-14</endDate>
        </period>
    </context>
    <context id="From2020-12-012020-12-14_us-gaap_CommonClassBMember_custom_SponsorSupportAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:SponsorSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-14</endDate>
        </period>
    </context>
    <context id="From2020-12-012020-12-14_us-gaap_CommonClassAMember_custom_SponsorSupportAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:SponsorSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CashMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CashMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_MoneyMarketFundsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MoneyMarketFundsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_NetParentInvestmentMember_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:NetParentInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PredecessorMember_custom_TotalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_NetParentInvestmentMember_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:NetParentInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_custom_TotalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-14_custom_ClassACommonStockMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="AsOf2023-03-14_custom_ClassCCommonStockMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="AsOf2023-03-14_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="AsOf2023-03-14_us-gaap_RetainedEarningsMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="AsOf2023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="AsOf2023-03-14_custom_TotalMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:NetParentInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PredecessorMember_custom_TotalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_NetParentInvestmentMember_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:NetParentInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_TotalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_us-gaap_RetainedEarningsMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_TotalMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:NetParentInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_PredecessorMember_custom_TotalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-14_custom_NetParentInvestmentMember_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:NetParentInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="AsOf2023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="AsOf2023-03-14_custom_PredecessorMember_custom_TotalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:ClassCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_TotalMember_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:TotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-14_custom_SuccessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-14_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_custom_PredecessorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_StockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-14_custom_PredecessorMember_custom_MergerAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_MergerAgreementMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_MergerAgreementMember_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">cxai:MergerAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="AsOf2023-03-14_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-14_custom_PredecessorMember_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_PatentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-14_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-14_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-14</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_SubscriptionRevenueMember_custom_SoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cxai:SoftwareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_SubscriptionRevenueMember_custom_SoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cxai:SoftwareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PredecessorMember_custom_SubscriptionRevenueMember_custom_SoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cxai:SoftwareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PredecessorMember_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_NonSubscriptionRevenueMember_custom_ProfessionalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cxai:ProfessionalServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:NonSubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_NonSubscriptionRevenueMember_custom_ProfessionalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cxai:ProfessionalServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:NonSubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PredecessorMember_custom_NonSubscriptionRevenueMember_custom_ProfessionalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cxai:ProfessionalServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:NonSubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_NonSubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:NonSubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_NonSubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:NonSubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PredecessorMember_custom_NonSubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">cxai:NonSubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_us-gaap_TransferredOverTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_TransferredOverTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PredecessorMember_us-gaap_TransferredOverTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_custom_SoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cxai:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_custom_SoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cxai:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_PatentsAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cxai:PatentsAndIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_custom_PatentsAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cxai:PatentsAndIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_custom_PatentsAndIntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cxai:PatentsAndIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_us-gaap_LicensingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_us-gaap_LicensingAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_custom_ProfessionalServiceAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cxai:ProfessionalServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_custom_ProfessionalServiceAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">cxai:ProfessionalServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_DirectorAndOfficersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cxai:DirectorAndOfficersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cxai:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-10_custom_N2023EquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cxai:N2023EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-10</instant>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cxai:EmployeesAndDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cxai:EmployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cxai:EmployeesAndDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cxai:EmployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cxai:EmployeesAndDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cxai:EmployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cxai:EmployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_PublicPlacementWarrantsMember_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PublicPlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cxai:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_country_IN">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_country_PH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-03-152023-03-31_custom_SuccessorMember_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cxai:EliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-15</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_country_IN">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_country_PH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-14_custom_PredecessorMember_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cxai:EliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-14</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PredecessorMember_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PredecessorMember_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PredecessorMember_country_IN">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PredecessorMember_country_PH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PredecessorMember_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cxai:EliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_country_IN">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_country_PH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SuccessorMember_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cxai:EliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:SuccessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_country_IN">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_country_PH">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PredecessorMember_custom_EliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001820875</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cxai:EliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">cxai:PredecessorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Integer">
        <measure>cxai:Integer</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-01-01to2023-03-31">0001820875</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-01-01to2023-03-31">true</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2023-01-01to2023-03-31">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2023-01-01to2023-03-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType contextRef="From2023-01-01to2023-03-31" id="xdx2ixbrl0014">S-1/A</dei:DocumentType>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0074"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:PromissoryNoteRelatedParty
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0077"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:DeferredOfferingCostsNoncurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0085"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0108"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0109"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl0146"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0147"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:GainLossOnEliminationOfDeferredUnderwritingFee
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0177"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0186"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_custom_ClassACommonStockMember"
      id="xdx2ixbrl0203"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0205"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_custom_ClassACommonStockMember"
      id="xdx2ixbrl0209"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_custom_ClassACommonStockMember"
      id="xdx2ixbrl0213"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_custom_ClassBCommonStockMember"
      id="xdx2ixbrl0214"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0215"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_ClassACommonStockMember"
      id="xdx2ixbrl0219"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0221"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_ClassACommonStockMember"
      id="xdx2ixbrl0225"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2022-01-012022-12-31_custom_ClassACommonStockMember"
      id="xdx2ixbrl0229"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2022-01-012022-12-31_custom_ClassBCommonStockMember"
      id="xdx2ixbrl0230"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0231"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_ClassACommonStockMember"
      id="xdx2ixbrl0235"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_ClassBCommonStockMember"
      id="xdx2ixbrl0236"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0237"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ClassACommonStockMember"
      id="xdx2ixbrl0241"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0243"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_ClassACommonStockMember"
      id="xdx2ixbrl0247"
      unitRef="Shares"
      xsi:nil="true"/>
    <cxai:IncreaseDecreaseInDeferredUnderwritingFee
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0267"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0276"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0288"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:ProceedsFromTrustAccountInConnectionWithRedemption
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0291"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0294"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0300"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0303"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0305"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:ChangeInValueOfClassCommonStockSubjectToPossibleRedemption
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0324"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0327"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:DeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0420"
      unitRef="Shares"
      xsi:nil="true"/>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0432"
      unitRef="Shares"
      xsi:nil="true"/>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0460"
      unitRef="Shares"
      xsi:nil="true"/>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0472"
      unitRef="Shares"
      xsi:nil="true"/>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0503"
      unitRef="Shares"
      xsi:nil="true"/>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0515"
      unitRef="Shares"
      xsi:nil="true"/>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl0543"
      unitRef="Shares"
      xsi:nil="true"/>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0555"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember"
      id="xdx2ixbrl0567"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember"
      id="xdx2ixbrl0585"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember"
      id="xdx2ixbrl0594"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember"
      id="xdx2ixbrl0612"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares
      contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl0628"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares
      contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl0644"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl0660"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl0696"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1069"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1078"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl1079"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl1087"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1095"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl1096"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1098"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl1099"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      id="xdx2ixbrl1105"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2022-12-31_us-gaap_MoneyMarketFundsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl1158"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1
      contextRef="From2021-01-012021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl1187"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2
      contextRef="From2021-01-012021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl1195"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl1199"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl1201"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl1203"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1241"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:AcquisitionLiability
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1268"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ExtendedProductWarrantyAccrualCurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      id="xdx2ixbrl1272"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1283"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      id="xdx2ixbrl1287"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassAMember"
      id="xdx2ixbrl1303"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassCMember"
      id="xdx2ixbrl1310"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      id="xdx2ixbrl1313"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      id="xdx2ixbrl1316"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1318"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:NetParentInvestment
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1321"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:ChangeInFairValueOfEarnout
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1362"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:ChangeInFairValueOfEarnout
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1363"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1383"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      id="xdx2ixbrl1384"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1402"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember"
      id="xdx2ixbrl1431"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember"
      id="xdx2ixbrl1435"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:ParentsCommonSharesIssuedForCxappEarnout
      contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember"
      id="xdx2ixbrl1439"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits
      contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember"
      id="xdx2ixbrl1443"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:NetInvestmentsFromParent
      contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember"
      id="xdx2ixbrl1447"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:CumulativeTranslationAdjustment
      contextRef="From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember"
      id="xdx2ixbrl1450"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember"
      id="xdx2ixbrl1463"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember"
      id="xdx2ixbrl1467"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:NetInvestmentsFromParent
      contextRef="From2023-01-012023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember"
      id="xdx2ixbrl1471"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:CumulativeTranslationAdjustment
      contextRef="From2023-01-012023-03-14_custom_NetParentInvestmentMember_custom_PredecessorMember"
      id="xdx2ixbrl1474"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-14_custom_ClassCCommonStockMember_custom_SuccessorMember"
      id="xdx2ixbrl1483"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember"
      id="xdx2ixbrl1486"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-14_custom_ClassCCommonStockMember_custom_SuccessorMember"
      id="xdx2ixbrl1489"
      unitRef="Shares"
      xsi:nil="true"/>
    <cxai:SharesIssuedInConnectionWithBusinessCombination
      contextRef="From2023-03-152023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember"
      id="xdx2ixbrl1491"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:SharesIssuedInConnectionWithBusinessCombination
      contextRef="From2023-03-152023-03-31_us-gaap_RetainedEarningsMember_custom_SuccessorMember"
      id="xdx2ixbrl1494"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:SharesIssuedInConnectionWithBusinessCombination
      contextRef="From2023-03-152023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember"
      id="xdx2ixbrl1495"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember"
      id="xdx2ixbrl1501"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember"
      id="xdx2ixbrl1502"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember"
      id="xdx2ixbrl1503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember"
      id="xdx2ixbrl1505"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-152023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember"
      id="xdx2ixbrl1508"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-152023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember"
      id="xdx2ixbrl1509"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-152023-03-31_us-gaap_RetainedEarningsMember_custom_SuccessorMember"
      id="xdx2ixbrl1511"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-152023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember"
      id="xdx2ixbrl1512"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_SuccessorMember"
      id="xdx2ixbrl1519"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1550"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:GainOnEarnoutPaymentLiability
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1557"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:GainOnEarnoutPaymentLiability
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1558"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:GainOnChangeInFairValueOfDerivativeLiability
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1566"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:GainOnChangeInFairValueOfDerivativeLiability
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      id="xdx2ixbrl1567"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1582"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInIncomeTaxes
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1593"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInIncomeTaxes
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1594"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:InvestmentInCapitalizedSoftware
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1617"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1622"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      id="xdx2ixbrl1623"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:NetEquityInvestmentFromParent
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1633"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:TaxesPaidRelatedForStockBasedCompensation
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1637"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:TaxesPaidRelatedForStockBasedCompensation
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1638"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:RepaymentOfCxappAcquisitionLiability
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1641"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1646"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      id="xdx2ixbrl1647"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1653"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1673"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1674"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      id="xdx2ixbrl1675"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaid
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1677"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaid
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1678"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaid
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      id="xdx2ixbrl1679"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:ParentsNetEquityIssuedForCxAppEarnout
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1685"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:ParentsNetEquityIssuedForCxAppEarnout
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1686"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:NoncashDistribution
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1689"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:NoncashDistribution
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      id="xdx2ixbrl1691"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1694"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      id="xdx2ixbrl1695"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:FinancingOfDirectorAndOfficerInsurance
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      id="xdx2ixbrl1698"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:FinancingOfDirectorAndOfficerInsurance
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      id="xdx2ixbrl1699"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1980"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1983"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      id="xdx2ixbrl1986"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Goodwill
      contextRef="AsOf2023-03-14_custom_SuccessorMember"
      id="xdx2ixbrl2005"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_NoncompeteAgreementsMember"
      id="xdx2ixbrl2045"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_NoncompeteAgreementsMember"
      id="xdx2ixbrl2046"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_NoncompeteAgreementsMember"
      id="xdx2ixbrl2048"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_PatentsAndIntellectualPropertyMember"
      id="xdx2ixbrl2060"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_PatentsAndIntellectualPropertyMember"
      id="xdx2ixbrl2061"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_PatentsAndIntellectualPropertyMember"
      id="xdx2ixbrl2063"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:InsurancePremiumsAndAccruedInterest
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      id="xdx2ixbrl2117"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:RelatedPartyPromissoryNote
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      id="xdx2ixbrl2120"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccruedIncomeTaxes
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      id="xdx2ixbrl2123"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:RelatedPartyPayable
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      id="xdx2ixbrl2126"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_IN"
      id="xdx2ixbrl2267"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_IN"
      id="xdx2ixbrl2279"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EliminationsMember"
      id="xdx2ixbrl2283"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_IN"
      id="xdx2ixbrl2291"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_IN"
      id="xdx2ixbrl2303"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_IN"
      id="xdx2ixbrl2315"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_EliminationsMember"
      id="xdx2ixbrl2319"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_IN"
      id="xdx2ixbrl2327"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_EliminationsMember"
      id="xdx2ixbrl2331"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_PH"
      id="xdx2ixbrl2341"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_PH"
      id="xdx2ixbrl2353"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_PH"
      id="xdx2ixbrl2365"
      unitRef="USD"
      xsi:nil="true"/>
    <cxai:NetAssets
      contextRef="AsOf2023-03-31_custom_SuccessorMember_country_IN"
      id="xdx2ixbrl2375"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2023-03-31_custom_SuccessorMember_country_IN"
      id="xdx2ixbrl2387"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_EliminationsMember"
      id="xdx2ixbrl2391"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Goodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember_country_CA"
      id="xdx2ixbrl2397"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Goodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember_country_IN"
      id="xdx2ixbrl2399"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Goodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember_country_PH"
      id="xdx2ixbrl2401"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Goodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_EliminationsMember"
      id="xdx2ixbrl2403"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_EliminationsMember"
      id="xdx2ixbrl2427"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Goodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember_country_US"
      id="xdx2ixbrl2431"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Goodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember_country_CA"
      id="xdx2ixbrl2433"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Goodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember_country_IN"
      id="xdx2ixbrl2435"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Goodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember_country_PH"
      id="xdx2ixbrl2437"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Goodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_EliminationsMember"
      id="xdx2ixbrl2439"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:AmendmentDescription contextRef="From2023-01-01to2023-03-31">AMENDMENT
NO. 3</dei:AmendmentDescription>
    <dei:EntityRegistrantName contextRef="From2023-01-01to2023-03-31">CXApp Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-01-01to2023-03-31">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-01-01to2023-03-31">85-2104918</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-01-01to2023-03-31">Four Palo Alto Square</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-01-01to2023-03-31">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="From2023-01-01to2023-03-31">3000 El Camino Real</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="From2023-01-01to2023-03-31">Palo Alto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-01-01to2023-03-31">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-01-01to2023-03-31">94306</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-01-01to2023-03-31">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-01-01to2023-03-31">575-4456</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName contextRef="From2023-01-012023-03-31_dei_BusinessContactMember">Khurram P. Sheikh</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="From2023-01-012023-03-31_dei_BusinessContactMember">Four Palo Alto Square</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-01-012023-03-31_dei_BusinessContactMember">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="From2023-01-012023-03-31_dei_BusinessContactMember">3000 El Camino Real</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="From2023-01-012023-03-31_dei_BusinessContactMember">Palo Alto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-01-012023-03-31_dei_BusinessContactMember">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-01-012023-03-31_dei_BusinessContactMember">94306</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-01-012023-03-31_dei_BusinessContactMember">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-01-012023-03-31_dei_BusinessContactMember">575-4456</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2023-01-01to2023-03-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2023-01-01to2023-03-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-01-01to2023-03-31">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2023-01-01to2023-03-31">false</dei:EntityExTransitionPeriod>
    <us-gaap:Cash contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">224489</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">406126</us-gaap:Cash>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">3536</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">126667</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">228025</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">532793</us-gaap:AssetsCurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">3923804</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">278836080</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">4151829</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">279368873</us-gaap:Assets>
    <cxai:AccruedLiabilitiesExcludingOfferingCostsCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">2833412</cxai:AccruedLiabilitiesExcludingOfferingCostsCurrent>
    <cxai:AccruedLiabilitiesExcludingOfferingCostsCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">767253</cxai:AccruedLiabilitiesExcludingOfferingCostsCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">49175</us-gaap:AccruedIncomeTaxesCurrent>
    <cxai:PromissoryNoteRelatedParty contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">347961</cxai:PromissoryNoteRelatedParty>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">3230548</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">767253</us-gaap:LiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">722400</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">11275369</us-gaap:DerivativeLiabilitiesNoncurrent>
    <cxai:DeferredOfferingCostsNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">9660000</cxai:DeferredOfferingCostsNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">3952948</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">21702622</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_custom_CommonClassaSubjectToRedemptionMember"
      decimals="INF"
      unitRef="Shares">387551</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2021-12-31_custom_CommonClassaSubjectToRedemptionMember"
      decimals="INF"
      unitRef="Shares">27600000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2022-12-31_custom_CommonClassaSubjectToRedemptionMember"
      decimals="INF"
      unitRef="USDPShares">10.10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2021-12-31_custom_CommonClassaSubjectToRedemptionMember"
      decimals="INF"
      unitRef="USDPShares">10.10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">3914265</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">278760000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">690</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">690</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">-3716074</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-21094439</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">-3715384</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-21093749</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">4151829</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">279368873</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">2950464</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">1497914</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">-2950464</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-1497914</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">421504</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">68295</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">76</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">72</us-gaap:InvestmentIncomeInterest>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">-10552969</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-10637431</us-gaap:FairValueAdjustmentOfWarrants>
    <cxai:GainLossOnEliminationOfDeferredUnderwritingFee
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">371910</cxai:GainLossOnEliminationOfDeferredUnderwritingFee>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">11346459</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">10705798</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">8395995</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">9207884</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">49175</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">8346820</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">9207884</us-gaap:NetIncomeLoss>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Shares">12546423</cxai:BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">27600000</cxai:BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock>
    <cxai:BasicAndDilutedNetIncomePerShareClassCommonStock
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.43</cxai:BasicAndDilutedNetIncomePerShareClassCommonStock>
    <cxai:BasicAndDilutedNetIncomePerShareClassCommonStock
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.27</cxai:BasicAndDilutedNetIncomePerShareClassCommonStock>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Shares">6900000</cxai:BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Shares">6900000</cxai:BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock>
    <cxai:BasicAndDilutedNetIncomePerShareClassBCommonStock
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.43</cxai:BasicAndDilutedNetIncomePerShareClassBCommonStock>
    <cxai:BasicAndDilutedNetIncomePerShareClassBCommonStock
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.27</cxai:BasicAndDilutedNetIncomePerShareClassBCommonStock>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-12-31_custom_ClassBCommonStockMember"
      decimals="INF"
      unitRef="Shares">6900000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_custom_ClassBCommonStockMember"
      decimals="0"
      unitRef="USD">690</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-30302323</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">-30301633</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">9207884</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">9207884</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_ClassBCommonStockMember"
      decimals="INF"
      unitRef="Shares">6900000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_ClassBCommonStockMember"
      decimals="0"
      unitRef="USD">690</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-21094439</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">-21093749</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">9031545</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">9031545</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">8346820</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">8346820</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_ClassBCommonStockMember"
      decimals="INF"
      unitRef="Shares">6900000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ClassBCommonStockMember"
      decimals="0"
      unitRef="USD">690</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-3716074</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">-3715384</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">8346820</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">9207884</us-gaap:ProfitLoss>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">421504</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">68295</us-gaap:InterestAndOtherIncome>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">-10552969</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-10637431</us-gaap:FairValueAdjustmentOfWarrants>
    <cxai:IncreaseDecreaseInDeferredUnderwritingFee
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">-371910</cxai:IncreaseDecreaseInDeferredUnderwritingFee>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">-123131</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-329967</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">49175</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">2066159</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">572554</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">-761098</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-595321</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <cxai:ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">231500</cxai:ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax>
    <cxai:ProceedsFromTrustAccountInConnectionWithRedemption
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">275102280</cxai:ProceedsFromTrustAccountInConnectionWithRedemption>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">275333780</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">275102280</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">347961</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">17579</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">-274754319</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-17579</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">-181637</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-612900</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">406126</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">1019026</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">224489</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">406126</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <cxai:ChangeInValueOfClassCommonStockSubjectToPossibleRedemption
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">256545</cxai:ChangeInValueOfClassCommonStockSubjectToPossibleRedemption>
    <cxai:ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">-9288090</cxai:ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock>
    <cxai:DeferredUnderwritingFeePayable
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">9660000</cxai:DeferredUnderwritingFeePayable>
    <us-gaap:NatureOfOperations contextRef="From2022-01-012022-12-31">&lt;p id="xdx_807_eus-gaap--NatureOfOperations_zfzgoDaJmYSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 &#x2014; &lt;span id="xdx_829_z5g7nCVFCdmf"&gt;DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CXApp
Inc. (the &#x201c;Company&#x201d;) was incorporated in Delaware on July&#160;20, 2020 as KINS Technology Group Inc. (&#x201c;KINS&#x201d;).
The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses (the &#x201c;Business Combination&#x201d;). The Company is not limited to a
particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth
company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has one wholly-owned subsidiary, KINS Merger Sub Inc., which was incorporated in the State of Delaware on September&#160;16,
2022 (&#x201c;Merger Sub&#x201d;). Merger Sub has no activity from date of incorporation, September&#160;16, 2022 through December&#160;31,
2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December&#160;31, 2022, the Company had not commenced any operations. All activity for the period from July&#160;20, 2020 (inception)
through December&#160;31, 2022 relates to the Company&#x2019;s formation, the initial public offering (&#x201c;Initial Public Offering&#x201d;),
which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The
Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The
Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
registration statement for the Company&#x2019;s Initial Public Offering became effective on December&#160;14, 2020. On December&#160;17,
2020, the Company consummated the Initial Public Offering of &lt;span id="xdx_90D_ecustom--UnitsIssuedDuringPeriodSharesNewIssues_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Number of units issued"&gt;27,600,000&lt;/span&gt; units (the &#x201c;Units&#x201d; and, with respect to the Class
A common stock included in the Units sold, the &#x201c;Public Shares&#x201d;), which includes the full exercise by the underwriter of its
over-allotment option in the amount of &lt;span id="xdx_90C_ecustom--UnitsIssuedDuringPeriodSharesNewIssues_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zjoxgeRjih8l" title="Number of units issued"&gt;3,600,000&lt;/span&gt; Units, at $&lt;span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_c20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Purchase price, per unit (in dollars per share)"&gt;10.00&lt;/span&gt; per Unit, generating gross proceeds of $&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zvPC2rPMwMn5" title="Proceeds from issuance initial public offering"&gt;276,000,000&lt;/span&gt; which is described
in Note 3.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of &lt;span id="xdx_905_ecustom--NumberOfWarrantsIssued_c20201201__20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Number of warrants issued"&gt;10,280,000&lt;/span&gt; warrants (the &#x201c;Private
Placement Warrants&#x201d;) at a price of $&lt;span id="xdx_90F_ecustom--ClassOfWarrantOrRightPriceOfWarrantsOrRights_c20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pdd" title="Price of warrant"&gt;1.00&lt;/span&gt; per Private Placement Warrant in a private placement to KINS Capital LLC (the
&#x201c;Sponsor&#x201d;) and certain funds and accounts managed by BlackRock, Inc. (the &#x201c;Direct Anchor Investors&#x201d; and
which the Direct Anchor Investors, together with the Sponsor, are the &#x201c;initial stockholders&#x201d;), generating gross proceeds
of $&lt;span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfWarrants_c20201201__20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_pp0p0" title="Proceeds from issuance of warrants"&gt;10,280,000&lt;/span&gt;, which is described in Note 4.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transaction
costs incurred amounted to $&lt;span id="xdx_901_ecustom--TransactionCosts_c20201217_pp0p0" title="Transaction costs"&gt;15,688,848&lt;/span&gt;, consisting of $&lt;span id="xdx_905_ecustom--SaleOfStockUnderwritingFees_c20201217_pp0p0" title="Underwriting fees"&gt;5,520,000&lt;/span&gt; in cash underwriting fees, $&lt;span id="xdx_90B_ecustom--DeferredOfferingCostsNoncurrent_c20201217_pp0p0" title="Deferred underwriting fee payable"&gt;9,660,000&lt;/span&gt; of deferred underwriting fees
and $&lt;span id="xdx_90A_ecustom--SaleOfStockOtherOfferingCosts_c20201217_pp0p0" title="Other offering costs"&gt;508,848&lt;/span&gt; of other offering costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the closing of the Initial Public Offering on December&#160;17, 2020, an amount of $&lt;span id="xdx_904_ecustom--PaymentsForInvestmentOfCashInTrustAccount_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Investment of cash into trust account"&gt;278,760,000&lt;/span&gt; ($&lt;span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_c20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Purchase price, per unit (in dollars per share)"&gt;10.10&lt;/span&gt; per Unit) from the net proceeds
of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account
(the &#x201c;Trust Account&#x201d;), located in the United States and invested only in U.S. government securities, within the meaning set
forth in Section&#160;2(a)(16) of the Investment Company Act of 1940, as amended (the &#x201c;Investment Company Act&#x201d;), with a maturity
of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting
certain conditions of Rule&#160;2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion
of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.
The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market
value equal to at least &lt;span id="xdx_90B_ecustom--ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount_dp_c20220101__20221231_zQqs3Kvee19k" title="Threshold minimum aggregate fair market value as a percentage of the assets held in the trust account"&gt;80%&lt;/span&gt; of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable
on the interest earned on the Trust Account). The Company will only complete a Business Combination if the post-transaction company owns
or acquires &lt;span id="xdx_905_ecustom--ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination_dp_c20220101__20221231_zmvaTbYbGSrk" title="Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination"&gt;50%&lt;/span&gt; or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target
business sufficient for it not to be required to register as an investment company under the Investment Company Act.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will provide the holders of the outstanding Public Shares (the &#x201c;Public Stockholders&#x201d;) with the opportunity to redeem
all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting
called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder
approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to
redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.10 per Public Share, plus any
pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights upon the completion of a Business
Combination with respect to the Company&#x2019;s warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will only proceed with a Business Combination if the Company has net tangible assets of at least $&lt;span id="xdx_90C_ecustom--MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_c20221209__us-gaap--StatementClassOfStockAxis__custom--CommonClassaSubjectToRedemptionMember_pp0p0" title="Minimum net tangible assets upon consummation of the business combination"&gt;5,000,001&lt;/span&gt; following any related
redemptions and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination.).
On December&#160;9, 2022 the Special Meeting the Stockholders voted to allow the Company to redeem shares of Class A Common Stock in
connection with the amendment to the Charter to the extent that such redemption would result in the Company having net tangible assets
of less than $&lt;span id="xdx_90F_ecustom--MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_c20221231_pp0p0" title="Minimum net tangible assets upon consummation of the business combination"&gt;5,000,001&lt;/span&gt;. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company
does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate
of Incorporation (the &#x201c;Certificate of Incorporation&#x201d;), conduct the redemptions pursuant to the tender offer rules of the
U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and file tender offer documents with the SEC prior to completing a Business
Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements,
or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction
with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval
in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares
purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder
may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed
transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Notwithstanding
the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the
tender offer rules, the Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder
or any other person with whom such stockholder is acting in concert or as a &#x201c;group&#x201d; (as defined under Section&#160;13 of
the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;)), will be restricted from redeeming its shares with
respect to more than an aggregate of &lt;span id="xdx_90E_ecustom--ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent_c20220101__20221231_pdd" title="Threshold percentage of public shares subject to redemption without the company's prior written consent"&gt;20%&lt;/span&gt; of the Public Shares, without the prior consent of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares and Public Shares held by it in connection with
the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance
or timing of the Company&#x2019;s obligation to allow redemptions in connection with a Business Combination or to redeem &lt;span id="xdx_906_ecustom--PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_c20220101__20221231_pdd" title="Obligation to redeem public shares if entity does not complete a business combination (as a percent)"&gt;100%&lt;/span&gt; of its Public
Shares if the Company does not complete a Business Combination within the Extended Combination Period (as defined below) or (ii) with
respect to any other provision relating to stockholders&#x2019; rights or pre-Business Combination activity, unless the Company provides
the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company previously had until June&#160;17, 2022 to consummate a business combination. On June&#160;10, 2022, the Company held a special
meeting of stockholders pursuant to which its stockholders approved amending the Company&#x2019;s amended and restated certificate of
incorporation (the &#x201c;Initial Charter Amendment&#x201d;) to extend the date by which the Company has to consummate a business combination
from June&#160;17, 2022 to December&#160;16, 2022. The Company&#x2019;s stockholders approved the Initial Charter Amendment and as such
the Company had until December&#160;16, 2022 to consummate a business combination. On December&#160;9, 2022, the Company held a special
meeting of the stockholders in which the stockholders approved the proposal to amend the Company&#x2019;s amended and restated certificate
of incorporation (the &#x201c;Charter Amendment&#x201d;) to (A) extend the date by which the Company must (1) consummate a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, (2) cease its operations except for
the purpose of winding up if it fails to complete such initial business combination, and (3) redeem all of the shares of Class A common
stock, par value $&lt;span id="xdx_902_eus-gaap--TemporaryEquityParOrStatedValuePerShare_c20221209__us-gaap--StatementClassOfStockAxis__custom--CommonClassaSubjectToRedemptionMember_pdd" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share, of the Company (&#x201c;Class A Common Stock&#x201d;), included as part of the units sold in the IPO,
from December&#160;16, 2022 to June&#160;15, 2023 (the &#x201c;Extended Combination Period&#x201d;), and (B) allow the Company to redeem
shares of Class A Common Stock in connection with the amendment to the Charter to the extent that such redemption would result in the
Company having net tangible assets of less than $&lt;span id="xdx_90F_ecustom--MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination_iI_pp0p0_c20221209__us-gaap--StatementClassOfStockAxis__custom--CommonClassaSubjectToRedemptionMember_zgc4w14lmzu6" title="Minimum net tangible assets upon consummation of the business combination"&gt;5,000,001&lt;/span&gt;. On December&#160;14, 2022, the Company filed the Charter Amendment with the
Secretary of State of the State of Delaware.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
we have not completed a Business Combination by June&#160;15, 2023 or during any extended time that we have to consummate a Business
Combination beyond June&#160;15, 2023 as a result of a stockholder vote to amend its certificate of incorporation, the Company will (i)
cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days
thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust
Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes (less up to $&lt;span id="xdx_904_ecustom--MaximumNetInterestsToPayDissolutionExpenses_c20220101__20221231_pp0p0" title="Maximum net interest to pay dissolution expenses"&gt;100,000&lt;/span&gt;
of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish
Public Stockholders&#x2019; rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of the Company&#x2019;s remaining stockholders and
the Company&#x2019;s board of directors, dissolve and liquidate, subject in each case to the Company&#x2019;s obligations under Delaware
law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating
distributions with respect to the Company&#x2019;s warrants, which will expire worthless if the Company fails to complete a Business Combination
within the Extended Combination Period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination
within the Extended Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such
Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination
within the Extended Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission
(see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Extended Combination
Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund
the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining
available for distribution will be less than $10.10 per Unit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims
by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed
entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.10 per Public Share
and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less
than $10.10 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will
not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in
the Trust Account nor will it apply to any claims under the Company&#x2019;s indemnity of the underwriters of the Initial Public Offering
against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). Moreover,
in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the
extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify
the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company&#x2019;s independent
registered accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements
with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Liquidity
and Going Concern&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December&#160;31, 2022, the Company had $&lt;span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20221231_pp0p0" title="Cash operating bank account"&gt;224,489&lt;/span&gt; in its operating bank accounts and a working capital deficit of $&lt;span id="xdx_90E_ecustom--WorkingCapital_iI_pp0p0_c20221231_zqsNaqYkHFT" title="Working capital"&gt;3,002,523&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to the completion of the Initial Public Offering, the Company&#x2019;s liquidity needs had been satisfied through a contribution of $&lt;span id="xdx_903_ecustom--ProceedsFromRelatedParty_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--SponsorMember_pp0p0" title="Proceeds from related party"&gt;25,000&lt;/span&gt;
from Sponsor to cover for certain offering costs in exchange for the issuance of the Founder Shares, unsecured, non-interest bearing
promissory note of up to $&lt;span id="xdx_90B_eus-gaap--ProceedsFromRelatedPartyDebt_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__custom--SponsorMember_pp0p0" title="Proceeds from related Party debt"&gt;300,000&lt;/span&gt; from the Sponsor, and the proceeds from the consummation of the Private Placement not held in the Trust
Account. The Note was repaid subsequent to the Initial Public Offering. In addition, in order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may,
but are not obligated to, provide the Company Working Capital Loans. As of December&#160;31, 2022 and 2021, there were no amounts outstanding
under any Working Capital Loan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Company&#x2019;s assessment of going concern considerations in accordance with Financial Accounting Standard Board&#x2019;s
Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-15, &#x201c;Disclosures of Uncertainties about an Entity&#x2019;s Ability to Continue
as a Going Concern,&#x201d; the Company has until June&#160;15, 2023 to consummate a Business Combination. It is uncertain that the Company
will be able to consummate a Business Combination by this time. Additionally, the Company may not have sufficient liquidity to fund the
working capital needs of the Company through one year from the issuance of these consolidated financial statements. If a business combination
is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined
that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution,
raises substantial doubt about the Company&#x2019;s ability to continue as a going concern. No adjustments have been made to the carrying
amounts of assets or liabilities should the Company be required to liquidate after June&#160;15, 2023. The Company intends to complete
a Business Combination before the mandatory liquidation date. However, there can be no assurance that the Company will be able to consummate
any Business Combination by June&#160;15, 2023. In addition, the Company may need to raise additional capital through loans or additional
investments from our Sponsor, stockholders, officers, directors or third parties. The Company&#x2019;s officers, directors and Sponsor
may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their
sole discretion, to meet the Company&#x2019;s working capital needs. Accordingly, the Company may not be able to obtain additional financing.
If the Company is unable to raise additional capital, the Company may be required to take additional measures to conserve liquidity,
which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and
reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable
terms, if at all. These conditions raise substantial doubt about the Company&#x2019;s ability to continue as a going concern through the
liquidation date of June&#160;15, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NatureOfOperations>
    <cxai:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-012020-12-17_us-gaap_IPOMember"
      decimals="INF"
      unitRef="Shares">27600000</cxai:UnitsIssuedDuringPeriodSharesNewIssues>
    <cxai:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-012020-12-17_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="Shares">3600000</cxai:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-17_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2020-12-012020-12-17_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">276000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <cxai:NumberOfWarrantsIssued
      contextRef="From2020-12-012020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="Shares">10280000</cxai:NumberOfWarrantsIssued>
    <cxai:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="AsOf2020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="USDPShares">1.00</cxai:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2020-12-012020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember"
      decimals="0"
      unitRef="USD">10280000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <cxai:TransactionCosts contextRef="AsOf2020-12-17" decimals="0" unitRef="USD">15688848</cxai:TransactionCosts>
    <cxai:SaleOfStockUnderwritingFees contextRef="AsOf2020-12-17" decimals="0" unitRef="USD">5520000</cxai:SaleOfStockUnderwritingFees>
    <cxai:DeferredOfferingCostsNoncurrent contextRef="AsOf2020-12-17" decimals="0" unitRef="USD">9660000</cxai:DeferredOfferingCostsNoncurrent>
    <cxai:SaleOfStockOtherOfferingCosts contextRef="AsOf2020-12-17" decimals="0" unitRef="USD">508848</cxai:SaleOfStockOtherOfferingCosts>
    <cxai:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="From2020-12-012020-12-17_us-gaap_IPOMember"
      decimals="0"
      unitRef="USD">278760000</cxai:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-17_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">10.10</us-gaap:SharesIssuedPricePerShare>
    <cxai:ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">0.80</cxai:ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount>
    <cxai:ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">0.50</cxai:ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination>
    <cxai:MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination
      contextRef="AsOf2022-12-09_custom_CommonClassaSubjectToRedemptionMember"
      decimals="0"
      unitRef="USD">5000001</cxai:MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination>
    <cxai:MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">5000001</cxai:MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination>
    <cxai:ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">0.20</cxai:ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent>
    <cxai:PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">1</cxai:PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2022-12-09_custom_CommonClassaSubjectToRedemptionMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <cxai:MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination
      contextRef="AsOf2022-12-09_custom_CommonClassaSubjectToRedemptionMember"
      decimals="0"
      unitRef="USD">5000001</cxai:MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination>
    <cxai:MaximumNetInterestsToPayDissolutionExpenses
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">100000</cxai:MaximumNetInterestsToPayDissolutionExpenses>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">224489</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <cxai:WorkingCapital contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">3002523</cxai:WorkingCapital>
    <cxai:ProceedsFromRelatedParty
      contextRef="From2022-01-012022-12-31_custom_SponsorMember"
      decimals="0"
      unitRef="USD">25000</cxai:ProceedsFromRelatedParty>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-01-012022-12-31_custom_SponsorMember"
      decimals="0"
      unitRef="USD">300000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ErrorCorrectionTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_80D_eus-gaap--ErrorCorrectionTextBlock_zdLn6BglcwX9" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2014; &lt;span id="xdx_827_z3UI9tzDYQl8"&gt;RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company had recognized a liability upon closing of their initial public offering in December&#160;2020 for a portion of the underwriter&#x2019;s
commissions which was contingently payable upon closing of a future business combination, with the offsetting entry resulting in an initial
discount to the securities sold in the initial public offering. The underwriter waived all claims to this deferred commission in June&#160;2022.
The Company previously recognized the waiver as an extinguishment, with a resulting non-operating gain recognized in its statement of
operations for the three and six months ended June&#160;30, 2022, nine months ended September&#160;30, 2022 and the year ended December&#160;31,
2022. Upon subsequent review and analysis, management concluded that the Company should have recognized the extinguishment of the contingent
liability as a reversal in the same relative allocation applied at the initial public offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Therefore,
the Company&#x2019;s management and the Audit Committee of the Company&#x2019;s Board of Directors (the &#x201c;Audit Committee&#x201d;)
concluded that the Company&#x2019;s previously issued audited financial statements as of December&#160;31, 2022 (the &#x201c;Annual Report&#x201d;)
should no longer be relied upon and that it is appropriate to restate the Annual Report. As such, the Company will restate its financial
statements in this Form&#160;10-K/A for the Company&#x2019;s unaudited financial statements for three and six months ended June&#160;30,
2022, nine months ended September&#160;30, 2022, and the audited financial statements for the year ended December&#160;31, 2022 included
in the Annual Report on the Company&#x2019;s Form&#160;10-K, as filed with the Securities and Exchange Commission (&#x201c;SEC&#x201d;)
on March&#160;21, 2023 (the &#x201c;Original Filing&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Impact
of the Restatement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
impact of the restatement on the consolidated statements of operations, statements of changes in stockholders&#x2019; deficit and statements
of cash flows for the affected period is presented below. The restatement had no impact on net cash flows from operating, investing or
financing activities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zPUk2TzfC243" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;&lt;span id="xdx_8BB_z8jMc3GW9b7j" style="display: none"&gt;Summary of impact of the restatement on the financial statements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9V0T03SUPec" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zkVfltV9ogW" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20220401__20220630_zTYXNm1aHcS8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Restatement&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Unaudited Statement of Operations for the Three Months Ended June&#160;30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_i_pp0p0" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left"&gt;Gain on forgiveness of deferred underwriting fee payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,660,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;371,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NonoperatingIncomeExpense_i_pp0p0" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total other income (expenses)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,396,046&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,107,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_i_pp0p0" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Income (loss) before benefit from (provision for) income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,094,313&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;806,223&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ProfitLoss_zqq6hziseck" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,071,447&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;783,357&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding - Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;14,481,736&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0420"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;14,481,736&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share - Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.47&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.04&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0432"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.47&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.04&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_za5gosvHb0Gi" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_ztJwaPCyUFB2" style="font-weight: bold; text-align: center"&gt;Restatement&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20220630_z7pKEvHi2Dsf" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Unaudited Statement of Operations for the Six Months Ended June&#160;30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zjg7tH5s8vYc" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left"&gt;Gain on forgiveness of deferred underwriting fee payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,660,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;371,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NonoperatingIncomeExpense_z5MqFlxcGnXi" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total other income (expenses)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,587,467&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,299,377&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zEwvkVARqcBg" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Income (loss) before benefit from (provision for) income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,962,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,674,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ProfitLoss_zYrrHGiVdv5e" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,939,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,651,526&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding - Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;21,004,630&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0460"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;21,004,630&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share - Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.33&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0472"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zepXfL3fMr8" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.33&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z0536FcpJPEc" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zpzBqoK6zM0b" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220101_20220930_srt--RestatementAxis_srt--RestatementAdjustmentMember" style="font-weight: bold; text-align: center"&gt;Restatement&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220101_20220930" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Unaudited Statement of Operations for the Nine Months Ended September&#160;30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zr0FJn9KywL2" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left"&gt;Gain on forgiveness of deferred underwriting fee payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,660,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;371,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--NonoperatingIncomeExpense_zc7SaILXmNg6" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total other income (expenses)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,560,364&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,272,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z4r4QphEEjTf" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Income (loss) before benefit from (provision for) income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,838,653&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,550,563&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ProfitLoss_zWwll0rilMue" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,811,924&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,523,834&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding &#x2013; Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;16,466,455&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0503"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;16,466,455&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share &#x2013; Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.81&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.40&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.41&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0515"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.81&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.40&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.41&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zK0dZpB3AYih" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zeGWGNAZFCaj" style="font-weight: bold; text-align: center"&gt;Restatement&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20221231_zRK7NAYt6hub" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Statement of Operations for the Year Ended December&#160;31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zlDAoOFQjrS6" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left"&gt;Gain on forgiveness of deferred underwriting fee payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,660,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;371,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NonoperatingIncomeExpense_zi1ttbcoOQh6" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total other income (expenses)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,634,549&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,346,459&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zc16GdV7HWy6" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Income (loss) before benefit from (provision for) income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,684,085&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,395,995&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ProfitLoss_zpqpkaFLWYR9" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,634,910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,346,820&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding - Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;12,546,423&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0543"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;12,546,423&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share - Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.91&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.48&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0555"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.91&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.48&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unaudited
Statement of Changes in Stockholders&#x2019; Deficit for the Three Months Ended June&#160;30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; font-weight: bold; text-align: left"&gt;Balance &#x2013; March&#160;31, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zSgv6CfkQ0Wa" style="width: 9%; text-align: right" title="Balance at the beginning"&gt;(13,226,270&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zaioDZrrH436" style="width: 9%; text-align: right" title="Balance at the beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0567"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_z22D2btkaD8g" style="width: 9%; text-align: right" title="Balance at the beginning"&gt;(13,225,580&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Net income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKjc4uZxfnui" style="text-align: right" title="Net income"&gt;10,071,447&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_z1yjYMFZiw8l" style="text-align: right" title="Net income"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zGeDOwnnS8xc" style="text-align: right" title="Net income"&gt;783,357&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Accretion of Class A common stock to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNN5XGtz0CU1" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption"&gt;(242,995&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpCB8A74vcwa" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption"&gt;9,288,090&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zZBO4xgWd1zh" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption"&gt;9,045,095&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Balance &#x2013; June&#160;30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4iQ3jHwe2Z4" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"&gt;(3,397,818&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zskIucPVM4D4" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0585"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_znc0i1kAl5Ge" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"&gt;(3,397,128&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statement
of Changes in Stockholders&#x2019; Deficit for the Year Ended December&#160;31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; font-weight: bold; text-align: left"&gt;Balance &#x2013; December&#160;31, 2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdx1bW9rYUoj" style="width: 9%; text-align: right" title="Balance at the beginning"&gt;(21,094,439&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zEQjAVpq2mJ3" style="width: 9%; text-align: right" title="Balance at the beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0594"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zDASNPb4Wihc" style="width: 9%; text-align: right" title="Balance at the beginning"&gt;(21,094,439&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Net income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zFoD6jeyyzPf" style="text-align: right" title="Net income"&gt;17,634,910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpsRTnIk1QQ1" style="text-align: right" title="Net income"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zpfn9ROF4a66" style="text-align: right" title="Net income"&gt;8,346,820&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Accretion of Class A common stock to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAwMLggIUvEa" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption"&gt;(256,545&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zbOhKUqY1YGb" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption"&gt;9,288,090&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zHneQqjOnYud" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption"&gt;9,031,545&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Balance &#x2013; December&#160;31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5zJh9p93jl9" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"&gt;(3,716,074&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_z2FZje8sfps5" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0612"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zCc6Ym4kI9k5" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"&gt;(3,716,074&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZcy8ntEFtWf" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z95ehG0xqS5f" style="font-weight: bold; text-align: center"&gt;Restatement&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20220630_zxITM733eJce" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Unaudited Statement of Cash Flows for the Six Months Ended June&#160;30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ProfitLoss_z6RX6DXwrlek" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,939,616&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,651,526&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zNRTLVifJE34" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Gain on forgiveness of deferred underwriting fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,660,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(371,910&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zxrggmtn20P6" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Non-Cash Investing and Financing Activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_zNkWaAF5G9Wd" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Extinguishment of deferred underwriting fee payable allocated to public shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0628"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z88Zh7Mm8ym5" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zXiE7uqfPLE3" style="font-weight: bold; text-align: center"&gt;Restatement&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20220930_zSPqzF9nLYGh" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Unaudited Statement of Cash Flows for the Nine Months Ended September&#160;30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ProfitLoss_z2gj1pbyAOa" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;18,811,924&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,523,834&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zrVYm9o87Axb" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Gain on forgiveness of deferred underwriting fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,660,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(371,910&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_z35gCeneCNJb" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Non-Cash Investing and Financing Activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_z20ybcrtXbE" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Extinguishment of deferred underwriting fee payable allocated to public shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0644"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zMYNTNN8CaOf" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zCcGeEVBlfo1" style="font-weight: bold; text-align: center"&gt;Restatement&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220101__20221231_zT2ZdbJcxSIk" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Statement of Cash Flows for the Year Ended December&#160;31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ProfitLoss_zttqKxTZhZHk" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,634,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,346,820&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zpZ2gyZcPeJj" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Gain on forgiveness of deferred underwriting fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,660,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(371,910&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zlR89okIc0Oe" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Non-Cash Investing and Financing Activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_zwg1cb66dG4k" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Extinguishment of deferred underwriting fee payable allocated to public shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0660"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zeDfbudSk0il" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;










</us-gaap:ErrorCorrectionTextBlock>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock contextRef="From2022-01-012022-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zPUk2TzfC243" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;&lt;span id="xdx_8BB_z8jMc3GW9b7j" style="display: none"&gt;Summary of impact of the restatement on the financial statements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9V0T03SUPec" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_zkVfltV9ogW" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20220401__20220630_zTYXNm1aHcS8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Restatement&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Unaudited Statement of Operations for the Three Months Ended June&#160;30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_i_pp0p0" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left"&gt;Gain on forgiveness of deferred underwriting fee payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,660,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;371,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NonoperatingIncomeExpense_i_pp0p0" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total other income (expenses)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,396,046&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,107,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_i_pp0p0" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Income (loss) before benefit from (provision for) income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,094,313&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;806,223&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ProfitLoss_zqq6hziseck" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,071,447&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;783,357&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding - Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;14,481,736&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0420"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;14,481,736&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share - Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.47&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.04&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0432"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.47&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220401__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.04&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_za5gosvHb0Gi" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_ztJwaPCyUFB2" style="font-weight: bold; text-align: center"&gt;Restatement&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20220630_z7pKEvHi2Dsf" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Unaudited Statement of Operations for the Six Months Ended June&#160;30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zjg7tH5s8vYc" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left"&gt;Gain on forgiveness of deferred underwriting fee payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,660,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;371,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NonoperatingIncomeExpense_z5MqFlxcGnXi" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total other income (expenses)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,587,467&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,299,377&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zEwvkVARqcBg" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Income (loss) before benefit from (provision for) income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,962,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,674,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ProfitLoss_zYrrHGiVdv5e" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,939,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,651,526&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding - Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;21,004,630&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0460"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;21,004,630&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share - Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.33&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0472"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zepXfL3fMr8" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.33&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z0536FcpJPEc" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zpzBqoK6zM0b" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20220101_20220930_srt--RestatementAxis_srt--RestatementAdjustmentMember" style="font-weight: bold; text-align: center"&gt;Restatement&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220101_20220930" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Unaudited Statement of Operations for the Nine Months Ended September&#160;30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zr0FJn9KywL2" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left"&gt;Gain on forgiveness of deferred underwriting fee payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,660,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;371,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--NonoperatingIncomeExpense_zc7SaILXmNg6" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total other income (expenses)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,560,364&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,272,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_z4r4QphEEjTf" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Income (loss) before benefit from (provision for) income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,838,653&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,550,563&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ProfitLoss_zWwll0rilMue" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,811,924&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,523,834&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding &#x2013; Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;16,466,455&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0503"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;16,466,455&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share &#x2013; Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.81&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.40&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.41&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0515"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.81&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.40&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.41&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zK0dZpB3AYih" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zeGWGNAZFCaj" style="font-weight: bold; text-align: center"&gt;Restatement&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20221231_zRK7NAYt6hub" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Statement of Operations for the Year Ended December&#160;31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_zlDAoOFQjrS6" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left"&gt;Gain on forgiveness of deferred underwriting fee payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,660,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;371,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NonoperatingIncomeExpense_zi1ttbcoOQh6" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Total other income (expenses)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,634,549&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,346,459&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zc16GdV7HWy6" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Income (loss) before benefit from (provision for) income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,684,085&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,395,995&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ProfitLoss_zpqpkaFLWYR9" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,634,910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,346,820&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding - Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;12,546,423&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0543"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;12,546,423&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share - Class A common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.91&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.48&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted weighted average shares outstanding - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0555"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--BasicAndDilutedWeightedAverageSharesOutstandingInShares_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted weighted average shares outstanding (in shares)"&gt;6,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted earnings per share - Class B common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.91&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;(0.48&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--BasicAndDilutedEarningsPerShareInDollarsPerShare_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" style="text-align: right" title="Basic and diluted earnings per share (in dollars per share)"&gt;0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unaudited
Statement of Changes in Stockholders&#x2019; Deficit for the Three Months Ended June&#160;30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; font-weight: bold; text-align: left"&gt;Balance &#x2013; March&#160;31, 2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zSgv6CfkQ0Wa" style="width: 9%; text-align: right" title="Balance at the beginning"&gt;(13,226,270&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zaioDZrrH436" style="width: 9%; text-align: right" title="Balance at the beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0567"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_z22D2btkaD8g" style="width: 9%; text-align: right" title="Balance at the beginning"&gt;(13,225,580&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Net income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKjc4uZxfnui" style="text-align: right" title="Net income"&gt;10,071,447&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_z1yjYMFZiw8l" style="text-align: right" title="Net income"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ProfitLoss_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zGeDOwnnS8xc" style="text-align: right" title="Net income"&gt;783,357&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Accretion of Class A common stock to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNN5XGtz0CU1" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption"&gt;(242,995&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpCB8A74vcwa" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption"&gt;9,288,090&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zZBO4xgWd1zh" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption"&gt;9,045,095&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Balance &#x2013; June&#160;30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4iQ3jHwe2Z4" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"&gt;(3,397,818&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zskIucPVM4D4" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0585"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220401__20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_znc0i1kAl5Ge" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"&gt;(3,397,128&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Statement
of Changes in Stockholders&#x2019; Deficit for the Year Ended December&#160;31, 2022&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; font-weight: bold; text-align: left"&gt;Balance &#x2013; December&#160;31, 2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdx1bW9rYUoj" style="width: 9%; text-align: right" title="Balance at the beginning"&gt;(21,094,439&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zEQjAVpq2mJ3" style="width: 9%; text-align: right" title="Balance at the beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0594"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zDASNPb4Wihc" style="width: 9%; text-align: right" title="Balance at the beginning"&gt;(21,094,439&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Net income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zFoD6jeyyzPf" style="text-align: right" title="Net income"&gt;17,634,910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zpsRTnIk1QQ1" style="text-align: right" title="Net income"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ProfitLoss_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zpfn9ROF4a66" style="text-align: right" title="Net income"&gt;8,346,820&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Accretion of Class A common stock to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAwMLggIUvEa" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption"&gt;(256,545&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_zbOhKUqY1YGb" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption"&gt;9,288,090&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zHneQqjOnYud" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of Class A common stock to redemption"&gt;9,031,545&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Balance &#x2013; December&#160;31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5zJh9p93jl9" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"&gt;(3,716,074&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember__srt--RestatementAxis__srt--RestatementAdjustmentMember_z2FZje8sfps5" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0612"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pp0p0_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zCc6Ym4kI9k5" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at the end"&gt;(3,716,074&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220101__20220630__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZcy8ntEFtWf" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220101__20220630__srt--RestatementAxis__srt--RestatementAdjustmentMember_z95ehG0xqS5f" style="font-weight: bold; text-align: center"&gt;Restatement&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20220630_zxITM733eJce" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Unaudited Statement of Cash Flows for the Six Months Ended June&#160;30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ProfitLoss_z6RX6DXwrlek" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,939,616&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,651,526&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zNRTLVifJE34" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Gain on forgiveness of deferred underwriting fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,660,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(371,910&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zxrggmtn20P6" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Non-Cash Investing and Financing Activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_zNkWaAF5G9Wd" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Extinguishment of deferred underwriting fee payable allocated to public shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0628"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20220930__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z88Zh7Mm8ym5" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220101__20220930__srt--RestatementAxis__srt--RestatementAdjustmentMember_zXiE7uqfPLE3" style="font-weight: bold; text-align: center"&gt;Restatement&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20220930_zSPqzF9nLYGh" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Unaudited Statement of Cash Flows for the Nine Months Ended September&#160;30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ProfitLoss_z2gj1pbyAOa" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;18,811,924&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,523,834&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zrVYm9o87Axb" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Gain on forgiveness of deferred underwriting fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,660,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(371,910&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_z35gCeneCNJb" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Non-Cash Investing and Financing Activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_z20ybcrtXbE" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Extinguishment of deferred underwriting fee payable allocated to public shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0644"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zMYNTNN8CaOf" style="font-weight: bold; text-align: center"&gt;As Previously&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zCcGeEVBlfo1" style="font-weight: bold; text-align: center"&gt;Restatement&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20220101__20221231_zT2ZdbJcxSIk" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Statement of Cash Flows for the Year Ended December&#160;31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ProfitLoss_zttqKxTZhZHk" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 64%; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17,634,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,346,820&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--GainOnForgivenessOfDeferredUnderwritingFeePayable_iN_pp0p0_di_zpZ2gyZcPeJj" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Gain on forgiveness of deferred underwriting fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,660,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(371,910&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zlR89okIc0Oe" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; font-weight: bold; text-align: left"&gt;Non-Cash Investing and Financing Activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares_i01_pp0p0_zwg1cb66dG4k" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Extinguishment of deferred underwriting fee payable allocated to public shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0660"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">9660000</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">371910</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">10396046</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">1107956</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">10094313</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">806223</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">10071447</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-06-30"
      decimals="0"
      unitRef="USD">783357</us-gaap:ProfitLoss>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">14481736</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-04-012022-06-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">14481736</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.47</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">-0.43</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-04-012022-06-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.04</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-04-012022-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-04-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.47</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-04-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">-0.43</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-04-012022-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.04</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">9660000</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-06-30"
      decimals="0"
      unitRef="USD">371910</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">18587467</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-06-30"
      decimals="0"
      unitRef="USD">9299377</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">17962482</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-06-30"
      decimals="0"
      unitRef="USD">8674392</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">17939616</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-06-30"
      decimals="0"
      unitRef="USD">8651526</us-gaap:ProfitLoss>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">21004630</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-06-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">21004630</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.64</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">-0.33</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-06-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.31</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.64</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">-0.33</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.31</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">9660000</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">371910</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">20560364</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">11272274</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">18838653</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">9550563</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">18811924</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">9523834</us-gaap:ProfitLoss>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">16466455</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">16466455</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.81</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">-0.40</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-09-30_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.41</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-09-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.81</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">-0.40</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-09-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.41</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">9660000</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">371910</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">20634549</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">11346459</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">17684085</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">8395995</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">17634910</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">8346820</us-gaap:ProfitLoss>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">12546423</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">12546423</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.91</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">-0.48</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.43</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</cxai:BasicAndDilutedWeightedAverageSharesOutstandingInShares>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.91</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">-0.48</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.43</cxai:BasicAndDilutedEarningsPerShareInDollarsPerShare>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-13226270</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-13225580</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">10071447</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">783357</us-gaap:ProfitLoss>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-242995</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">9288090</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2022-04-012022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">9045095</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-3397818</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-3397128</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-21094439</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-21094439</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">17634910</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">8346820</us-gaap:ProfitLoss>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-256545</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">9288090</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">9031545</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">-3716074</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-3716074</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">17939616</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-06-30"
      decimals="0"
      unitRef="USD">8651526</us-gaap:ProfitLoss>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-06-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">9660000</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-06-30"
      decimals="0"
      unitRef="USD">371910</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares
      contextRef="From2022-01-012022-06-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares>
    <cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares
      contextRef="From2022-01-012022-06-30"
      decimals="0"
      unitRef="USD">-9288090</cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">18811924</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">9523834</us-gaap:ProfitLoss>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-09-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">9660000</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">371910</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares
      contextRef="From2022-01-012022-09-30_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares>
    <cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares
      contextRef="From2022-01-012022-09-30"
      decimals="0"
      unitRef="USD">-9288090</cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">17634910</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">8346820</us-gaap:ProfitLoss>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      unitRef="USD">9660000</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">371910</cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable>
    <cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares
      contextRef="From2022-01-012022-12-31_srt_RestatementAdjustmentMember"
      decimals="0"
      unitRef="USD">-9288090</cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares>
    <cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">-9288090</cxai:ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_z8xGBXA0mHXk" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3 &#x2014; &lt;span id="xdx_827_zNyovCW7LCJi"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zuktqF2w8fJ1" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Basis
of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles
generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and pursuant to the accounting and disclosure rules and
regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
described in Note 2&#x2014;Restatement of Previously Issued Financial Statements, the Company&#x2019;s financial statements for the year
ended December&#160;31, 2022 (collectively, the &#x201c;Affected Period&#x201d;), are restated in this Annual Report on Form&#160;10-K/A
(Amendment No. 1) (this &#x201c;Annual Report&#x201d;) to correct the misapplication of accounting guidance related to the liability extinguishment
in the Company&#x2019;s previously issued audited financial statements for such period. The restated financial statements are indicated
as &#x201c;Restated&#x201d; in the audited financial statements and accompanying notes, as applicable. See Note 2&#x2014;Restatement of
Previously Issued Financial Statements for further discussion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--ConsolidationPolicyTextBlock_z5OXF1lZ1sd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Principles
of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_ecustom--EmergingGrowthCompanyPolicyTextBlock_zTskIQfKuDvh" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Emerging
Growth Company&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not
being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley
Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#x2019;s consolidated financial statements with another public
company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition
period difficult or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zLhWUjXH4x1k" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Use of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting
estimates included in these consolidated financial statements is the determination of the fair value of the warrant liabilities. Accordingly,
the actual results could differ significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zKK0E1m2SDX" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of six months or less when purchased to be cash equivalents. The
Company did not have any cash equivalents as of December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zpNq8gvDt5d5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit
of $&lt;span id="xdx_907_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zbxBYEbSbSJe" title="Insured amount"&gt;250,000&lt;/span&gt;. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial
condition, results of operations, and cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_ecustom--TemporaryEquityPolicyPolicyTextBlock_zPUqISlM1ggd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Class
A Common Stock Subject to Possible Redemption&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards
Codification (&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Shares of Class A common stock subject
to mandatory redemption are classified as liability instruments and are measured at fair value. Conditionally redeemable common stock
(including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon
the occurrence of uncertain events not within the Company&#x2019;s control) is classified as temporary equity. At all other times, common
stock is classified as stockholders&#x2019; equity. The Company&#x2019;s Class A common stock features certain redemption rights that are
considered to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events. Accordingly, as of December&#160;31,
2022 and 2021, &lt;span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_c20221231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_pdd" title="Class A common stock subject to possible redemption, outstanding (in shares)"&gt;387,551&lt;/span&gt; and &lt;span id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_c20211231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_pdd" title="Class A common stock subject to possible redemption, outstanding (in shares)"&gt;27,600,000&lt;/span&gt; shares of Class A common stock subject to possible redemption are presented as temporary equity,
outside of the stockholders&#x2019; deficit section of the Company&#x2019;s consolidated balance sheets, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to
equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock
are affected by charges against additional paid in capital (to the extent available) and accumulated deficit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December&#160;31, 2022 and 2021, the Class A common stock reflected in the consolidated balance sheets are reconciled in the following
table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--TemporaryEquityTableTextBlock_zECvghHTCwL6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B3_z5tspC3QNLU4" style="display: none"&gt;Schedule of reconciliation of Class A common stock reflected in the condensed balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Class A common stock subject to possible redemption, January&#160;1, 2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_pp0p0_c20210101__20211231_zATWP7fZf60h" style="width: 9%; text-align: right" title="Class A common stock subject to possible redemption, at beginning of year"&gt;278,760,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0696"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Class A common stock subject to possible redemption, December&#160;31, 2021&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_pp0p0_c20220101__20221231_zjkwtljQn1Hj" style="font-weight: bold; text-align: right" title="Class A common stock subject to possible redemption, at beginning of year"&gt;278,760,000&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: left"&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Waiver of Class A common stock issuance costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--TemporaryEquityWaiverOfShareIssuanceCosts_c20220101__20221231_pp0p0" style="text-align: right" title="Waiver of Class A common stock issuance costs"&gt;9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: left"&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--TemporaryEquityAccretionToRedemptionValue_iN_pp0p0_di_c20220101__20221231_zJ3VEP2gCel2" style="text-align: right" title="Accretion of carrying value to redemption value"&gt;(9,031,545&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Redemption of Class A Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--TemporaryEquityRedemption_iN_pp0p0_di_c20220101__20221231_zdNc46iem556" style="border-bottom: Black 1pt solid; text-align: right" title="Redemption of Class A Common Stock"&gt;(275,102,280&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Class A common stock subject to redemption, December&#160;31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_pp0p0_c20220101__20221231_zBkDV3Rqvs4h" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Class A common stock subject to possible redemption, at end of year"&gt;3,914,265&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_z11GjiUIYBD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--DeferredChargesPolicyTextBlock_zdDaWmFTZVp2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Offering
Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering
costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the
Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based
on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities were expensed as
incurred in the consolidated statements of operations. Offering costs associated with the Class A common stock issued were initially
charged to temporary equity. Offering costs incurred amounted to $&lt;span id="xdx_908_ecustom--TransactionCosts_iI_pp0p0_c20201217_zpUUBSq82EV3" title="Transaction costs"&gt;15,688,848&lt;/span&gt;, consisting of $&lt;span id="xdx_907_ecustom--SaleOfStockUnderwritingFees_iI_pp0p0_c20201217_z7DhoIX1DKZd" title="Underwriting fees"&gt;5,520,000&lt;/span&gt; in cash underwriting fees, $&lt;span id="xdx_905_ecustom--DeferredOfferingCostsNoncurrent_iI_pp0p0_c20201217_zACM8B1o1Kjd" title="Deferred underwriting fee payable"&gt;9,660,000&lt;/span&gt;
of deferred underwriting fees and $&lt;span id="xdx_90E_ecustom--SaleOfStockOtherOfferingCosts_iI_pp0p0_c20201217_zbglZAMf0A8i" title="Other offering costs"&gt;508,848&lt;/span&gt; of other offering costs, of which $&lt;span id="xdx_90A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_pp0p0_c20201201__20201217_zWImPD8D2FUj" title="Charged to temporary equity"&gt;15,239,420&lt;/span&gt; was charged to temporary equity and $&lt;span id="xdx_904_ecustom--OfferingCost_pp0p0_c20201201__20201217_zdVtpvILLUm9" title="Offering cost expense"&gt;449,428&lt;/span&gt;
was allocated to the warrant liability and expensed through the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;p id="xdx_845_ecustom--WarrantLiabilityPolicyTextBlock_zy7gcJxh8IRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Derivative
Warrant Liabilities&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#x2019;s
specific terms and applicable authoritative guidance in Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards
Codification (&#x201c;ASC&#x201d;) 480, Distinguishing Liabilities from Equity (&#x201c;ASC 480&#x201d;) and ASC 815, Derivatives and Hedging
(&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet
the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under
ASC 815, including whether the warrants are indexed to the Company&#x2019;s own common stock, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification,
the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the consolidated statements of operations.
The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a
binomial lattice model. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market
price was used as the fair value of the Warrants (as defined below) as of each relevant date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zAkXDmrMgUre" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes under ASC 740, &#x201c;Income Taxes.&#x201d; ASC 740, Income Taxes, requires the recognition of deferred
tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation
allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740-270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in
interim periods under ASC 740-270-30-5. As of December&#160;31, 2022 and December&#160;31, 2021, the Company&#x2019;s deferred tax asset
had a full valuation allowance recorded against it. The Company&#x2019;s effective tax rate was &lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20220101__20221231_zeSoHveIZU2j" title="Effective tax rate (in percent)"&gt;0.3%&lt;/span&gt; and &lt;span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20210101__20211231_zbw1V8igdRf8" title="Effective tax rate (in percent)"&gt;0.0%&lt;/span&gt;, respectively. The effective
tax rate differs from the statutory tax rate of &lt;span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c20220101__20221231_zwkDRRygxUJ8" title="Statutory tax rate"&gt;&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c20210101__20211231_zX7MjNWI9J04" title="Statutory tax rate"&gt;21%&lt;/span&gt;&lt;/span&gt; for the years ended December&#160;31, 2022 and 2021, due to changes in fair value
in warrant liability and the valuation allowance on the deferred tax assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
period, disclosure and transition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were &lt;span id="xdx_903_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20221231_zI6apnoPaO7i" title="Unrecognized tax benefits"&gt;&lt;span id="xdx_901_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20211231_zXaHWhMffC9f" title="Unrecognized tax benefits"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized
tax benefits and &lt;span id="xdx_906_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pp0p0_do_c20221231_zUiuIorm9u89" title="Unrecognized tax benefits accrued for interest and penalties"&gt;&lt;span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pp0p0_do_c20211231_zFEkKd3bn3eh" title="Unrecognized tax benefits accrued for interest and penalties"&gt;no&lt;/span&gt;&lt;/span&gt; amounts accrued for interest and penalties as of December&#160;31, 2022 and December&#160;31, 2021. The Company is
currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has identified the United States as its only &#x201c;major&#x201d; tax jurisdiction. The Company is subject to income taxation
by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus
of income among various tax jurisdictions and compliance with federal and state tax laws. The Company&#x2019;s management does not expect
that the total amount of unrecognized tax benefits will materially change over the next twelve months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zvnZTRGy3S6a" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Net
Income per Common Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share&#x201d;. Net income per
common share is computed by dividing net income by the weighted average number of shares of common stock outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class
A common stock is excluded from earnings per share as the redemption value approximates fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of diluted income per share does not consider the effect of the Warrants issued in connection with the (i) Initial Public
Offering, and (ii) the private placement since the exercise of the Warrants is contingent upon the occurrence of future events. The Warrants
are exercisable to purchase &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Number of warrants to purchase shares issued"&gt;24,080,000&lt;/span&gt; shares of Class A common stock in the aggregate. As of December&#160;31, 2022 and 2021, the Company
did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and
then share in the earnings of the Company. As a result, diluted net income per common share is the same as basic net income per common
share for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zYz80eOXU9p1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B0_zsXmGyV3aD93" style="display: none"&gt;Schedule of Reconciliation of net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20220101_20221231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassAMember" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20220101_20221231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z6j1d9NrCpC5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20210101_20211231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class A&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class B&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class A&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class B&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: left"&gt;Basic and diluted net income per common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_i01B" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i02_pp0p0" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left"&gt;Allocation of net income, as adjusted&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,385,193&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,961,627&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,366,307&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,841,577&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i02_pdd" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,546,423&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,900,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;27,600,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,900,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Basic and diluted net income per common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AD_zOrPjkSBYWej" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zezPmwmkfduc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;The
fair value of the Company&#x2019;s assets and liabilities which qualify as financial instruments under ASC Topic 820, &#x201c;Fair Value
Measurement,&#x201d; approximate the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their
short-term nature, except the derivative warrant liabilities (see Note 10).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmqYJbCeT0sg" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August&#160;2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2020-06, Debt &#x2014; Debt with Conversion
and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40) (&#x201c;ASU
2020-06&#x201d;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation
of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance
pertaining to equity classification of contracts in an entity&#x2019;s own equity. The new standard also introduces additional disclosures
for convertible debt and freestanding instruments that are indexed to and settled in an entity&#x2019;s own equity. ASU 2020-06 amends
the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU
2020-06 is effective January&#160;1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted
beginning on January&#160;1, 2021. The Company adopted ASU 2020-06 as of January&#160;1, 2021 and the adoption did not have an impact
on its financial position, results of operations or cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zuktqF2w8fJ1" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Basis
of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles
generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and pursuant to the accounting and disclosure rules and
regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
described in Note 2&#x2014;Restatement of Previously Issued Financial Statements, the Company&#x2019;s financial statements for the year
ended December&#160;31, 2022 (collectively, the &#x201c;Affected Period&#x201d;), are restated in this Annual Report on Form&#160;10-K/A
(Amendment No. 1) (this &#x201c;Annual Report&#x201d;) to correct the misapplication of accounting guidance related to the liability extinguishment
in the Company&#x2019;s previously issued audited financial statements for such period. The restated financial statements are indicated
as &#x201c;Restated&#x201d; in the audited financial statements and accompanying notes, as applicable. See Note 2&#x2014;Restatement of
Previously Issued Financial Statements for further discussion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_84B_eus-gaap--ConsolidationPolicyTextBlock_z5OXF1lZ1sd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Principles
of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <cxai:EmergingGrowthCompanyPolicyTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_847_ecustom--EmergingGrowthCompanyPolicyTextBlock_zTskIQfKuDvh" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Emerging
Growth Company&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not
being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley
Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments
not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#x2019;s consolidated financial statements with another public
company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition
period difficult or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</cxai:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2022-01-012022-12-31">&lt;p id="xdx_84C_eus-gaap--UseOfEstimates_zLhWUjXH4x1k" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Use of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting
estimates included in these consolidated financial statements is the determination of the fair value of the warrant liabilities. Accordingly,
the actual results could differ significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zKK0E1m2SDX" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of six months or less when purchased to be cash equivalents. The
Company did not have any cash equivalents as of December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2022-01-012022-12-31">&lt;p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zpNq8gvDt5d5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Concentration
of Credit Risk&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit
of $&lt;span id="xdx_907_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zbxBYEbSbSJe" title="Insured amount"&gt;250,000&lt;/span&gt;. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial
condition, results of operations, and cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <cxai:TemporaryEquityPolicyPolicyTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_842_ecustom--TemporaryEquityPolicyPolicyTextBlock_zPUqISlM1ggd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Class
A Common Stock Subject to Possible Redemption&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards
Codification (&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Shares of Class A common stock subject
to mandatory redemption are classified as liability instruments and are measured at fair value. Conditionally redeemable common stock
(including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon
the occurrence of uncertain events not within the Company&#x2019;s control) is classified as temporary equity. At all other times, common
stock is classified as stockholders&#x2019; equity. The Company&#x2019;s Class A common stock features certain redemption rights that are
considered to be outside of the Company&#x2019;s control and subject to occurrence of uncertain future events. Accordingly, as of December&#160;31,
2022 and 2021, &lt;span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_c20221231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_pdd" title="Class A common stock subject to possible redemption, outstanding (in shares)"&gt;387,551&lt;/span&gt; and &lt;span id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_c20211231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_pdd" title="Class A common stock subject to possible redemption, outstanding (in shares)"&gt;27,600,000&lt;/span&gt; shares of Class A common stock subject to possible redemption are presented as temporary equity,
outside of the stockholders&#x2019; deficit section of the Company&#x2019;s consolidated balance sheets, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to
equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock
are affected by charges against additional paid in capital (to the extent available) and accumulated deficit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December&#160;31, 2022 and 2021, the Class A common stock reflected in the consolidated balance sheets are reconciled in the following
table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--TemporaryEquityTableTextBlock_zECvghHTCwL6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B3_z5tspC3QNLU4" style="display: none"&gt;Schedule of reconciliation of Class A common stock reflected in the condensed balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Class A common stock subject to possible redemption, January&#160;1, 2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_pp0p0_c20210101__20211231_zATWP7fZf60h" style="width: 9%; text-align: right" title="Class A common stock subject to possible redemption, at beginning of year"&gt;278,760,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0696"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Class A common stock subject to possible redemption, December&#160;31, 2021&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_pp0p0_c20220101__20221231_zjkwtljQn1Hj" style="font-weight: bold; text-align: right" title="Class A common stock subject to possible redemption, at beginning of year"&gt;278,760,000&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: left"&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Waiver of Class A common stock issuance costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--TemporaryEquityWaiverOfShareIssuanceCosts_c20220101__20221231_pp0p0" style="text-align: right" title="Waiver of Class A common stock issuance costs"&gt;9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: left"&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--TemporaryEquityAccretionToRedemptionValue_iN_pp0p0_di_c20220101__20221231_zJ3VEP2gCel2" style="text-align: right" title="Accretion of carrying value to redemption value"&gt;(9,031,545&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Redemption of Class A Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--TemporaryEquityRedemption_iN_pp0p0_di_c20220101__20221231_zdNc46iem556" style="border-bottom: Black 1pt solid; text-align: right" title="Redemption of Class A Common Stock"&gt;(275,102,280&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Class A common stock subject to redemption, December&#160;31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_pp0p0_c20220101__20221231_zBkDV3Rqvs4h" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Class A common stock subject to possible redemption, at end of year"&gt;3,914,265&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_z11GjiUIYBD8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

</cxai:TemporaryEquityPolicyPolicyTextBlock>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_custom_CommonStockSubjectToRedemptionMember"
      decimals="INF"
      unitRef="Shares">387551</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2021-12-31_custom_CommonStockSubjectToRedemptionMember"
      decimals="INF"
      unitRef="Shares">27600000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="From2022-01-012022-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--TemporaryEquityTableTextBlock_zECvghHTCwL6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B3_z5tspC3QNLU4" style="display: none"&gt;Schedule of reconciliation of Class A common stock reflected in the condensed balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Class A common stock subject to possible redemption, January&#160;1, 2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_pp0p0_c20210101__20211231_zATWP7fZf60h" style="width: 9%; text-align: right" title="Class A common stock subject to possible redemption, at beginning of year"&gt;278,760,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--TemporaryEquityAccretionToRedemptionValue_c20210101__20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Accretion of carrying value to redemption value"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0696"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Class A common stock subject to possible redemption, December&#160;31, 2021&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_pp0p0_c20220101__20221231_zjkwtljQn1Hj" style="font-weight: bold; text-align: right" title="Class A common stock subject to possible redemption, at beginning of year"&gt;278,760,000&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: left"&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Waiver of Class A common stock issuance costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--TemporaryEquityWaiverOfShareIssuanceCosts_c20220101__20221231_pp0p0" style="text-align: right" title="Waiver of Class A common stock issuance costs"&gt;9,288,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: left"&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--TemporaryEquityAccretionToRedemptionValue_iN_pp0p0_di_c20220101__20221231_zJ3VEP2gCel2" style="text-align: right" title="Accretion of carrying value to redemption value"&gt;(9,031,545&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Redemption of Class A Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--TemporaryEquityRedemption_iN_pp0p0_di_c20220101__20221231_zdNc46iem556" style="border-bottom: Black 1pt solid; text-align: right" title="Redemption of Class A Common Stock"&gt;(275,102,280&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Class A common stock subject to redemption, December&#160;31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_pp0p0_c20220101__20221231_zBkDV3Rqvs4h" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Class A common stock subject to possible redemption, at end of year"&gt;3,914,265&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2020-12-31" decimals="0" unitRef="USD">278760000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">278760000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <cxai:TemporaryEquityWaiverOfShareIssuanceCosts
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">9288090</cxai:TemporaryEquityWaiverOfShareIssuanceCosts>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">9031545</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <cxai:TemporaryEquityRedemption
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">275102280</cxai:TemporaryEquityRedemption>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">3914265</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_843_eus-gaap--DeferredChargesPolicyTextBlock_zdDaWmFTZVp2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Offering
Costs&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offering
costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the
Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based
on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities were expensed as
incurred in the consolidated statements of operations. Offering costs associated with the Class A common stock issued were initially
charged to temporary equity. Offering costs incurred amounted to $&lt;span id="xdx_908_ecustom--TransactionCosts_iI_pp0p0_c20201217_zpUUBSq82EV3" title="Transaction costs"&gt;15,688,848&lt;/span&gt;, consisting of $&lt;span id="xdx_907_ecustom--SaleOfStockUnderwritingFees_iI_pp0p0_c20201217_z7DhoIX1DKZd" title="Underwriting fees"&gt;5,520,000&lt;/span&gt; in cash underwriting fees, $&lt;span id="xdx_905_ecustom--DeferredOfferingCostsNoncurrent_iI_pp0p0_c20201217_zACM8B1o1Kjd" title="Deferred underwriting fee payable"&gt;9,660,000&lt;/span&gt;
of deferred underwriting fees and $&lt;span id="xdx_90E_ecustom--SaleOfStockOtherOfferingCosts_iI_pp0p0_c20201217_zbglZAMf0A8i" title="Other offering costs"&gt;508,848&lt;/span&gt; of other offering costs, of which $&lt;span id="xdx_90A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_pp0p0_c20201201__20201217_zWImPD8D2FUj" title="Charged to temporary equity"&gt;15,239,420&lt;/span&gt; was charged to temporary equity and $&lt;span id="xdx_904_ecustom--OfferingCost_pp0p0_c20201201__20201217_zdVtpvILLUm9" title="Offering cost expense"&gt;449,428&lt;/span&gt;
was allocated to the warrant liability and expensed through the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










</us-gaap:DeferredChargesPolicyTextBlock>
    <cxai:TransactionCosts contextRef="AsOf2020-12-17" decimals="0" unitRef="USD">15688848</cxai:TransactionCosts>
    <cxai:SaleOfStockUnderwritingFees contextRef="AsOf2020-12-17" decimals="0" unitRef="USD">5520000</cxai:SaleOfStockUnderwritingFees>
    <cxai:DeferredOfferingCostsNoncurrent contextRef="AsOf2020-12-17" decimals="0" unitRef="USD">9660000</cxai:DeferredOfferingCostsNoncurrent>
    <cxai:SaleOfStockOtherOfferingCosts contextRef="AsOf2020-12-17" decimals="0" unitRef="USD">508848</cxai:SaleOfStockOtherOfferingCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2020-12-012020-12-17"
      decimals="0"
      unitRef="USD">15239420</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <cxai:OfferingCost
      contextRef="From2020-12-012020-12-17"
      decimals="0"
      unitRef="USD">449428</cxai:OfferingCost>
    <cxai:WarrantLiabilityPolicyTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_845_ecustom--WarrantLiabilityPolicyTextBlock_zy7gcJxh8IRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Derivative
Warrant Liabilities&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#x2019;s
specific terms and applicable authoritative guidance in Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards
Codification (&#x201c;ASC&#x201d;) 480, Distinguishing Liabilities from Equity (&#x201c;ASC 480&#x201d;) and ASC 815, Derivatives and Hedging
(&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet
the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under
ASC 815, including whether the warrants are indexed to the Company&#x2019;s own common stock, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification,
the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the consolidated statements of operations.
The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a
binomial lattice model. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market
price was used as the fair value of the Warrants (as defined below) as of each relevant date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</cxai:WarrantLiabilityPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zAkXDmrMgUre" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes under ASC 740, &#x201c;Income Taxes.&#x201d; ASC 740, Income Taxes, requires the recognition of deferred
tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation
allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740-270-25-2 requires that an annual effective tax rate be determined and such annual effective rate applied to year to date income in
interim periods under ASC 740-270-30-5. As of December&#160;31, 2022 and December&#160;31, 2021, the Company&#x2019;s deferred tax asset
had a full valuation allowance recorded against it. The Company&#x2019;s effective tax rate was &lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20220101__20221231_zeSoHveIZU2j" title="Effective tax rate (in percent)"&gt;0.3%&lt;/span&gt; and &lt;span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_c20210101__20211231_zbw1V8igdRf8" title="Effective tax rate (in percent)"&gt;0.0%&lt;/span&gt;, respectively. The effective
tax rate differs from the statutory tax rate of &lt;span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c20220101__20221231_zwkDRRygxUJ8" title="Statutory tax rate"&gt;&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_c20210101__20211231_zX7MjNWI9J04" title="Statutory tax rate"&gt;21%&lt;/span&gt;&lt;/span&gt; for the years ended December&#160;31, 2022 and 2021, due to changes in fair value
in warrant liability and the valuation allowance on the deferred tax assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
period, disclosure and transition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were &lt;span id="xdx_903_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20221231_zI6apnoPaO7i" title="Unrecognized tax benefits"&gt;&lt;span id="xdx_901_eus-gaap--UnrecognizedTaxBenefits_iI_pp0p0_do_c20211231_zXaHWhMffC9f" title="Unrecognized tax benefits"&gt;no&lt;/span&gt;&lt;/span&gt; unrecognized
tax benefits and &lt;span id="xdx_906_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pp0p0_do_c20221231_zUiuIorm9u89" title="Unrecognized tax benefits accrued for interest and penalties"&gt;&lt;span id="xdx_90C_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pp0p0_do_c20211231_zFEkKd3bn3eh" title="Unrecognized tax benefits accrued for interest and penalties"&gt;no&lt;/span&gt;&lt;/span&gt; amounts accrued for interest and penalties as of December&#160;31, 2022 and December&#160;31, 2021. The Company is
currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has identified the United States as its only &#x201c;major&#x201d; tax jurisdiction. The Company is subject to income taxation
by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus
of income among various tax jurisdictions and compliance with federal and state tax laws. The Company&#x2019;s management does not expect
that the total amount of unrecognized tax benefits will materially change over the next twelve months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">0.003</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zvnZTRGy3S6a" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Net
Income per Common Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share&#x201d;. Net income per
common share is computed by dividing net income by the weighted average number of shares of common stock outstanding for the period.
The Company applies the two-class method in calculating earnings per share. Accretion associated with the redeemable shares of Class
A common stock is excluded from earnings per share as the redemption value approximates fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of diluted income per share does not consider the effect of the Warrants issued in connection with the (i) Initial Public
Offering, and (ii) the private placement since the exercise of the Warrants is contingent upon the occurrence of future events. The Warrants
are exercisable to purchase &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Number of warrants to purchase shares issued"&gt;24,080,000&lt;/span&gt; shares of Class A common stock in the aggregate. As of December&#160;31, 2022 and 2021, the Company
did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and
then share in the earnings of the Company. As a result, diluted net income per common share is the same as basic net income per common
share for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zYz80eOXU9p1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B0_zsXmGyV3aD93" style="display: none"&gt;Schedule of Reconciliation of net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20220101_20221231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassAMember" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20220101_20221231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z6j1d9NrCpC5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20210101_20211231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class A&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class B&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class A&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class B&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: left"&gt;Basic and diluted net income per common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_i01B" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i02_pp0p0" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left"&gt;Allocation of net income, as adjusted&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,385,193&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,961,627&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,366,307&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,841,577&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i02_pdd" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,546,423&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,900,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;27,600,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,900,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Basic and diluted net income per common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AD_zOrPjkSBYWej" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">24080000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2022-01-012022-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zYz80eOXU9p1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B0_zsXmGyV3aD93" style="display: none"&gt;Schedule of Reconciliation of net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20220101_20221231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassAMember" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20220101_20221231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20210101__20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z6j1d9NrCpC5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20210101_20211231_us-gaap--StatementClassOfStockAxis_us-gaap--CommonClassBMember" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class A&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class B&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class A&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Class B&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: left"&gt;Basic and diluted net income per common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_i01B" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i02_pp0p0" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left"&gt;Allocation of net income, as adjusted&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,385,193&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,961,627&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,366,307&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,841,577&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i02_pdd" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"&gt;Basic and diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,546,423&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,900,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;27,600,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,900,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Basic and diluted net income per common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.27&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">5385193</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">2961627</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-012021-12-31_us-gaap_CommonClassAMember"
      decimals="0"
      unitRef="USD">7366307</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-01-012021-12-31_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">1841577</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">12546423</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-012021-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">27600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-01-012021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-012021-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-01-012021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2022-01-012022-12-31">&lt;p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zezPmwmkfduc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;The
fair value of the Company&#x2019;s assets and liabilities which qualify as financial instruments under ASC Topic 820, &#x201c;Fair Value
Measurement,&#x201d; approximate the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their
short-term nature, except the derivative warrant liabilities (see Note 10).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zmqYJbCeT0sg" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August&#160;2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2020-06, Debt &#x2014; Debt with Conversion
and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2014; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40) (&#x201c;ASU
2020-06&#x201d;) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation
of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance
pertaining to equity classification of contracts in an entity&#x2019;s own equity. The new standard also introduces additional disclosures
for convertible debt and freestanding instruments that are indexed to and settled in an entity&#x2019;s own equity. ASU 2020-06 amends
the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU
2020-06 is effective January&#160;1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted
beginning on January&#160;1, 2021. The Company adopted ASU 2020-06 as of January&#160;1, 2021 and the adoption did not have an impact
on its financial position, results of operations or cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material
effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <cxai:InitialPublicOfferingDisclosureTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_802_ecustom--InitialPublicOfferingDisclosureTextBlock_zUBYCtXAY5l8" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4 &#x2014; &lt;span id="xdx_829_zjJpzYbqkTT5"&gt;PUBLIC OFFERING&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Initial Public Offering, the Company sold &lt;span id="xdx_90A_ecustom--UnitsIssuedDuringPeriodSharesNewIssues_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zruFXjZeX0A2" title="Number of units sold"&gt;27,600,000&lt;/span&gt; Units which includes a full exercise by the underwriters of their over-allotment
option in the amount of &lt;span id="xdx_906_ecustom--UnitsIssuedDuringPeriodSharesNewIssues_c20201201__20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zpOJDyEvWTp5" title="Number of units sold"&gt;3,600,000&lt;/span&gt; Units, at a price of $&lt;span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20201217__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z4ubdRWRzD97" title="Purchase price, per unit (in dollars per share)"&gt;10.00&lt;/span&gt; per Unit. Each Unit consists of one share of Class A common stock and one-half
of one redeemable warrant (&#x201c;Public Warrant&#x201d; and, together with the Private Placement Warrants, the &#x201c;Warrants&#x201d;).
Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201217__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zLDqxvTR2fU6" title="Exercise price of warrants"&gt;11.50&lt;/span&gt; per share, subject to
adjustment (see Note 8).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</cxai:InitialPublicOfferingDisclosureTextBlock>
    <cxai:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-012020-12-17_us-gaap_IPOMember"
      decimals="INF"
      unitRef="Shares">27600000</cxai:UnitsIssuedDuringPeriodSharesNewIssues>
    <cxai:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-12-012020-12-17_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="Shares">3600000</cxai:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-12-17_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-12-17_us-gaap_CommonClassAMember_us-gaap_IPOMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cxai:PrivatePlacementDisclosureTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_805_ecustom--PrivatePlacementDisclosureTextBlock_zpmKsKsUDvxh" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5 &#x2014; &lt;span id="xdx_825_z8Qgj4hAL57l"&gt;PRIVATE PLACEMENT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the Initial Public Offering, the Sponsor and the Direct Anchor Investors purchased an aggregate of &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zgUzerlDWx14" title="Number of warrants to purchase shares issued"&gt;10,280,000&lt;/span&gt; Private
Placement Warrants at a price of $&lt;span id="xdx_900_ecustom--ClassOfWarrantOrRightPriceOfWarrantsOrRights_iI_c20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zuzrIOCCWYzc" title="Price of warrants"&gt;1.00&lt;/span&gt; per Private Placement Warrant, or $&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfWarrants_pp0p0_c20201201__20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zVmmfwojmtbc" title="Aggregate purchase price"&gt;10,280,000&lt;/span&gt;. Each Private Placement Warrant is exercisable to
purchase one share of Class A common stock at a price of $&lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201217__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zV3vu3JualOg" title="Exercise price of warrant"&gt;11.50&lt;/span&gt; per share, subject to adjustment (see Note 8). The proceeds from the
sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If
the Company does not complete a Business Combination within the Extended Combination Period, the proceeds from the sale of the Private
Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of
applicable law) and the Private Placement Warrants will expire worthless.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</cxai:PrivatePlacementDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="Shares">10280000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <cxai:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="AsOf2020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="USDPShares">1.00</cxai:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2020-12-012020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember"
      decimals="0"
      unitRef="USD">10280000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_CommonClassAMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_ziWg9MRDSGL6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6 &#x2014; &lt;span id="xdx_823_zc5rFk0SwlC"&gt;RELATED PARTIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Founder
Shares&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July&#160;27, 2020, the Sponsor paid $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20200701__20200727__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zDl99LScjEI8" title="Aggregate purchase price"&gt;25,000&lt;/span&gt; to cover certain offering costs of the Company in consideration for &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200701__20200727__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_pdd" title="Number of shares issued"&gt;5,750,000&lt;/span&gt; shares of
Class B common stock (the &#x201c;Founder Shares&#x201d;). In October&#160;2020, the Sponsor forfeited &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201001__20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DirectAnchorMember_pdd" title="Number of shares issued"&gt;625,000&lt;/span&gt; Founder Shares and the Direct
Anchor Investors purchased &lt;span id="xdx_906_ecustom--NumberOfSharesSubjectToForfeiture_c20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pdd" title="Shares subject to forfeiture"&gt;625,000&lt;/span&gt; Founder Shares for an aggregate purchase price of $&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20201001__20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember_pp0p0" title="Aggregate purchase price"&gt;2,717&lt;/span&gt;, or approximately $&lt;span id="xdx_90C_eus-gaap--SharePrice_c20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember_pdd" title="Share price"&gt;0.004&lt;/span&gt; per share. In December&#160;2020,
the Company effected a 1:&lt;span id="xdx_90E_eus-gaap--StockholdersEquityNoteStockSplitConversionRatio1_c20200101__20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zo7m9mlDAXm5" title="Stock split"&gt;1.2 &lt;/span&gt;stock split of its Class B common stock, resulting in the Sponsor holding an aggregate of &lt;span id="xdx_903_ecustom--AggregateNumberOfSharesOwned_c20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pdd" title="Aggregate number of shares owned"&gt;6,150,000&lt;/span&gt; Founder
Shares, the Direct Anchor Investors holding an aggregate of &lt;span id="xdx_907_ecustom--AggregateNumberOfSharesOwned_c20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--DirectAnchorMember_pdd" title="Aggregate number of shares owned"&gt;750,000&lt;/span&gt; Founder Shares and there being an aggregate of &lt;span id="xdx_90B_ecustom--AggregateNumberOfSharesOwned_c20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember_pdd" title="Aggregate number of shares owned"&gt;6,900,000&lt;/span&gt; Founder
Shares outstanding. The Founder Shares included an aggregate of up to &lt;span id="xdx_90E_ecustom--NumberOfSharesSubjectToForfeiture_c20201031__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Shares subject to forfeiture"&gt;900,000&lt;/span&gt; shares subject to forfeiture by the Sponsor to the extent
that the underwriters&#x2019; over-allotment was not exercised in full or in part, so that the number of Founder Shares would equal, on
an as-converted basis, approximately &lt;span id="xdx_90D_ecustom--PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_c20200101__20201231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember_pdd" title="Percentage of issued and outstanding shares after the initial public offering collectively held by initial stockholders"&gt;20%&lt;/span&gt; of the Company&#x2019;s issued and outstanding common stock after the Initial Public Offering.
As a result of the underwriters&#x2019; election to fully exercise their over-allotment option, no Founder Shares are currently subject
to forfeiture.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
initial stockholders have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the
earlier to occur of: (A) one &lt;span id="xdx_90B_ecustom--RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_dtY_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zLaqyPEqxE75" style="display: none" title="Restrictions on transfer period of time after business combination completion"&gt;1&lt;/span&gt; year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x)
if the last reported sale price of the Class A common stock equals or exceeds $&lt;span id="xdx_90A_ecustom--TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)"&gt;12.00&lt;/span&gt;
per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any &lt;span id="xdx_90C_ecustom--TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_dtD_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zvqpKZtovvj6" title="Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination"&gt;20&lt;/span&gt;
trading days within any &lt;span id="xdx_90B_ecustom--TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_dtD_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z5KrA2jtlz43" title="Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination"&gt;30&lt;/span&gt;-trading
day period commencing at least &lt;span id="xdx_90B_ecustom--ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences_dtD_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--FounderSharesMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zMWcahWRI6zi" title="Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences"&gt;150&lt;/span&gt;
days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or
other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock
for cash, securities or other property.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Administrative
Services Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into an agreement, commencing on December&#160;14, 2020 through the earlier of the Company&#x2019;s consummation of a
Business Combination and its liquidation, to pay the Sponsor a total of up to $&lt;span id="xdx_90E_ecustom--RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_c20201201__20201214__us-gaap--RelatedPartyTransactionAxis__custom--AdministrativeServicesAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pp0p0" title="Expenses per month"&gt;20,000&lt;/span&gt; per month for office space, utilities and secretarial
and administrative support. For each of the years ended December&#160;31, 2022 and 2021, the Company incurred and paid $&lt;span id="xdx_905_ecustom--ExpensesIncurredAndPaid_pp0p0_c20220101__20221231_zccqLjpQRm4h" title="Expenses incurred and paid"&gt;&lt;span id="xdx_900_ecustom--ExpensesIncurredAndPaid_pp0p0_c20210101__20211231_zqbS1Y8w8oM4" title="Expenses incurred and paid"&gt;240,000&lt;/span&gt;&lt;/span&gt; in fees
for these services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Promissory
Note &#x2014; Related Party&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August&#160;10, 2022, KINS Capital LLC issued an unsecured promissory note to the Company, pursuant to which the Company may borrow up
to an aggregate principal amount of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentCollateralAmount_c20220810__us-gaap--RelatedPartyTransactionAxis__custom--PromissoryNoteWithRelatedPartyMember_pp0p0" title="Aggregate principal amount"&gt;400,000&lt;/span&gt;. The Promissory Note was non-interest bearing and payable on the earlier of (i) closing
of the Merger as described in the BCA or (ii) June&#160;15, 2023. As December&#160;31, 2022, $&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--PromissoryNoteWithRelatedPartyMember_pp0p0" title="Amount outstanding under promissory note"&gt;347,961&lt;/span&gt; was outstanding under the Promissory
Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Working
Capital Loans&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain
of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working
Capital Loans&#x201d;). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of
a Business Combination, without interest, or, at the lender&#x2019;s discretion, up to $&lt;span id="xdx_90C_ecustom--MaximumLoansConvertibleIntoWarrants_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_pp0p0" title="Loan conversion agreement warrant"&gt;1,500,000&lt;/span&gt; of the notes may be converted upon completion
of a Business Combination into warrants at a price of $&lt;span id="xdx_90C_ecustom--ClassOfWarrantOrRightPriceOfWarrantsOrRights_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_pdd" title="Price of warrant"&gt;1.00&lt;/span&gt; per warrant. Such warrants would be identical to the Private Placement Warrants.
In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to
repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December&#160;31,
2022 and 2021, there were &lt;span id="xdx_901_ecustom--MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_iI_pp0p0_do_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--WorkingCapitalLoansWarrantMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_z5Mq9VxhXbyd" title="Maximum borrowing capacity of related party promissory note"&gt;&lt;span id="xdx_903_ecustom--MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_iI_pp0p0_do_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--WorkingCapitalLoansWarrantMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoansMember_zGBj4iPb25Ha" title="Maximum borrowing capacity of related party promissory note"&gt;no&lt;/span&gt;&lt;/span&gt; amounts outstanding under the Working Capital Loans.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-07-012020-07-27_custom_FounderSharesMember_custom_SponsorMember_us-gaap_CommonClassBMember"
      decimals="0"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-07-012020-07-27_custom_FounderSharesMember_custom_SponsorMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-10-012020-10-31_custom_FounderSharesMember_custom_DirectAnchorMember"
      decimals="INF"
      unitRef="Shares">625000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <cxai:NumberOfSharesSubjectToForfeiture
      contextRef="AsOf2020-10-31_custom_FounderSharesMember_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">625000</cxai:NumberOfSharesSubjectToForfeiture>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2020-10-012020-10-31_custom_FounderSharesMember"
      decimals="0"
      unitRef="USD">2717</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharePrice
      contextRef="AsOf2020-10-31_custom_FounderSharesMember"
      decimals="INF"
      unitRef="USDPShares">0.004</us-gaap:SharePrice>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="From2020-01-012020-12-31_custom_FounderSharesMember_custom_SponsorMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Pure">1.2</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <cxai:AggregateNumberOfSharesOwned
      contextRef="AsOf2020-12-31_custom_FounderSharesMember_custom_SponsorMember"
      decimals="INF"
      unitRef="Shares">6150000</cxai:AggregateNumberOfSharesOwned>
    <cxai:AggregateNumberOfSharesOwned
      contextRef="AsOf2020-12-31_custom_FounderSharesMember_custom_DirectAnchorMember"
      decimals="INF"
      unitRef="Shares">750000</cxai:AggregateNumberOfSharesOwned>
    <cxai:AggregateNumberOfSharesOwned
      contextRef="AsOf2020-12-31_custom_FounderSharesMember"
      decimals="INF"
      unitRef="Shares">6900000</cxai:AggregateNumberOfSharesOwned>
    <cxai:NumberOfSharesSubjectToForfeiture
      contextRef="AsOf2020-10-31_custom_FounderSharesMember_custom_SponsorMember_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      unitRef="Shares">900000</cxai:NumberOfSharesSubjectToForfeiture>
    <cxai:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders
      contextRef="From2020-01-012020-12-31_custom_FounderSharesMember"
      decimals="INF"
      unitRef="Pure">0.20</cxai:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders>
    <cxai:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion contextRef="From2022-01-012022-12-31_custom_FounderSharesMember_custom_SponsorMember">P1Y</cxai:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion>
    <cxai:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger
      contextRef="From2022-01-012022-12-31_custom_FounderSharesMember_custom_SponsorMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">12.00</cxai:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger>
    <cxai:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays contextRef="From2022-01-012022-12-31_custom_FounderSharesMember_custom_SponsorMember">P20D</cxai:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays>
    <cxai:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays contextRef="From2022-01-012022-12-31_custom_FounderSharesMember_custom_SponsorMember">P30D</cxai:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays>
    <cxai:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences contextRef="From2022-01-012022-12-31_custom_FounderSharesMember_custom_SponsorMember">P150D</cxai:ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences>
    <cxai:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth
      contextRef="From2020-12-012020-12-14_custom_AdministrativeServicesAgreementMember_custom_SponsorMember"
      decimals="0"
      unitRef="USD">20000</cxai:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth>
    <cxai:ExpensesIncurredAndPaid
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">240000</cxai:ExpensesIncurredAndPaid>
    <cxai:ExpensesIncurredAndPaid
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">240000</cxai:ExpensesIncurredAndPaid>
    <us-gaap:DebtInstrumentCollateralAmount
      contextRef="AsOf2022-08-10_custom_PromissoryNoteWithRelatedPartyMember"
      decimals="0"
      unitRef="USD">400000</us-gaap:DebtInstrumentCollateralAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-12-31_custom_PromissoryNoteWithRelatedPartyMember"
      decimals="0"
      unitRef="USD">347961</us-gaap:DebtInstrumentFaceAmount>
    <cxai:MaximumLoansConvertibleIntoWarrants
      contextRef="AsOf2022-12-31_custom_WorkingCapitalLoansMember"
      decimals="0"
      unitRef="USD">1500000</cxai:MaximumLoansConvertibleIntoWarrants>
    <cxai:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="AsOf2022-12-31_custom_WorkingCapitalLoansMember"
      decimals="INF"
      unitRef="USDPShares">1.00</cxai:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <cxai:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="AsOf2022-12-31_custom_WorkingCapitalLoansWarrantMember_custom_WorkingCapitalLoansMember"
      decimals="0"
      unitRef="USD">0</cxai:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <cxai:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="AsOf2021-12-31_custom_WorkingCapitalLoansWarrantMember_custom_WorkingCapitalLoansMember"
      decimals="0"
      unitRef="USD">0</cxai:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z7vAgnHWSr26" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 &#x2014; &lt;span id="xdx_82D_z3QBY4QkvWs1"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Risks
and Uncertainties&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Various
social and political circumstances in the United States and around the world (including wars and other forms of conflict, including rising
trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the United States
and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such
as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility
and economic uncertainties or deterioration in the United States and worldwide. Specifically, the rising conflict between Russia and
Ukraine, and resulting market volatility could adversely affect the Company&#x2019;s ability to complete a Business Combination. In response
to the conflict between Russia and Ukraine, the United States and other countries have imposed sanctions or other restrictive actions
against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could
have a material adverse effect on the Company&#x2019;s ability to complete a Business Combination and the value of the Company&#x2019;s
securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
continues to evaluate the impact of these types of risks and has concluded that while it is reasonably possible that these risks and
uncertainties could have a negative effect on the Company&#x2019;s financial position, results of its operations and/or search for a target
company, the specific impact is not readily determinable as of the date of these consolidated financial statements. The consolidated
financial statements do not include any adjustments that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Inflation
Reduction Act of 2022&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August&#160;16, 2022, the Inflation Reduction Act of 2022 (the &#x201c;IR Act&#x201d;) was signed into federal law. The IR Act provides
for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations
and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January&#160;1, 2023. The excise
tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise
tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating
the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair
market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department
of the Treasury (the &#x201c;Treasury&#x201d;) has been given authority to provide regulations and other guidance to carry out and prevent
the abuse or avoidance of the excise tax.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
redemption or other repurchase that occurs after December&#160;31, 2022, in connection with a Business Combination, extension vote or
otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection
with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of
the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business
Combination, (iii) the nature and amount of any &#x201c;PIPE&#x201d; or other equity issuances in connection with a Business Combination
(or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination)
and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the
Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing
could cause a reduction in the cash available on hand to complete a Business Combination and in the Company&#x2019;s ability to complete
a Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Registration
Rights&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to a registration rights agreement entered into on December&#160;14, 2020, the holders of the Founder Shares, Private Placement
Warrants and securities that may be issued upon conversion of Working Capital Loans will be entitled to registration rights pursuant
to a registration rights agreement. The holders of at least &lt;span id="xdx_906_ecustom--MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands_c20201201__20201214_pdd" title="Minimum percentage of founder share holders entitled to make demands"&gt;30%&lt;/span&gt;
in interest of these securities will be entitled to make up to three &lt;span id="xdx_907_ecustom--MaximumNumberOfDemandsForRegistrationOfSecurities_iI_c20201214_z54hT6zpgLWa" style="display: none" title="Maximum number of demands for registration of securities"&gt;3&lt;/span&gt; demands, excluding short form registration demands, that we
register such securities for sale under the Securities Act. In addition, these holders will have certain &#x201c;piggy-back&#x201d;
registration rights to include their securities in other registration statements filed subsequent to the completion of a Business
Combination and rights to require us to register for resale such securities pursuant to Rule&#160;415 under the Securities Act. The
Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Underwriting
Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
underwriters were entitled to a deferred fee of $&lt;span id="xdx_902_ecustom--DeferredFeePerUnit_c20221231_pdd" title="Deferred fee per unit"&gt;0.35&lt;/span&gt; per Unit, or up to $&lt;span id="xdx_90F_ecustom--DeferredOfferingCostsNoncurrent_iI_pp0p0_c20211231_z3rqmbkjDVGa" title="Deferred underwriting fee payable"&gt;9,660,000&lt;/span&gt; in the aggregate. The deferred fee was to become
payable to the underwriters from the amounts held in the Trust Account in the event that the Company completed a Business Combination,
subject to the terms of the underwriting agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June&#160;9, 2022, one of the underwriters waived its entitlement to the payment of any deferred fee to be paid under the terms of the
underwriting agreement and is no longer serving in an advisor capacity. As a result, the Company recognized $&lt;span id="xdx_909_ecustom--IncomeRecognizedFromReductionOfDeferredUnderwriterFee_c20220601__20220609_pp0p0" title="Income recognized from reduction of deferred underwriter fee"&gt;9,660,000&lt;/span&gt; of income in relation
to the reduction of the deferred underwriter fee in the accompanying consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Merger
Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September&#160;25, 2022, the Company entered into an Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;), by and among
the Company, Inpixon, a Nevada corporation (&#x201c;Inpixon&#x201d;), CXApp Holding Corp., a Delaware corporation and wholly-owned subsidiary
of Inpixon (&#x201c;CXApp&#x201d; and, together with Inpixon, collectively, the &#x201c;Companies&#x201d;), and Merger Sub, pursuant to which
the Company will combine with CXApp, Inpixon&#x2019;s enterprise apps business (including its workplace experience technologies, indoor
mapping, events platform, augmented reality and related business solutions) (the &#x201c;Enterprise Apps Business&#x201d;). Also on September&#160;25,
2022, and in connection with the execution of the Merger Agreement, the Company, Inpixon, CXApp and the Sponsor entered into that certain
sponsor support agreement (the &#x201c;Sponsor Support Agreement&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Immediately
prior to the Merger (as defined below) and pursuant to a Separation and Distribution Agreement, dated as of September&#160;25, 2022,
among the Company, Inpixon, CXApp and Design Reactor, Inc., a California corporation (&#x201c;Design Reactor&#x201d;) (the &#x201c;Separation
Agreement&#x201d;), and other ancillary conveyance documents, Inpixon will, among other things and on the terms and subject to the conditions
of the Separation Agreement, transfer the Enterprise Apps Business, including certain related subsidiaries of Inpixon, including Design
Reactor, to CXApp (the &#x201c;Reorganization&#x201d;) and, in connection therewith, will distribute (the &#x201c;Distribution&#x201d;) to
Inpixon stockholders and other security holders 100% of the common stock of CXApp, par value $&lt;span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220925__us-gaap--StatementEquityComponentsAxis__custom--CXAppCommonStockMember_zGG8DefANBxg" title="Common stock, par value (in dollars per share)"&gt;0.00001&lt;/span&gt; (the &#x201c;CXApp Common Stock&#x201d;),
as further described below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Immediately
following the Distribution, in accordance with and subject to the terms and conditions of the Merger Agreement, Merger Sub will merge
with and into CXApp (the &#x201c;Merger&#x201d;), with CXApp continuing as the surviving company in the Merger and as a wholly-owned subsidiary
of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Merger Agreement, along with the Separation Agreement and the other transaction documents to be entered into in connection therewith,
provides for, among other things, the consummation of the following transactions (collectively, the &#x201c;Business Combination&#x201d;):
(i) Inpixon will transfer the Enterprise Apps Business (the &#x201c;Separation&#x201d;) to its wholly-owned subsidiary, CXApp, and contribute
$&lt;span id="xdx_90F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_pp0n3_dm_c20220925__srt--CounterpartyNameAxis__custom--InpixonMember__us-gaap--TypeOfArrangementAxis__custom--SeparationAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zgwpD32BjIt2" title="Cash Contribution upon seperation"&gt;10&lt;/span&gt; million in capital thereto (the &#x201c;Cash Contribution&#x201d;), (ii) following the Separation, Inpixon will distribute &lt;span id="xdx_90A_ecustom--PercentageOfCommonStockDistributed_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_pdd" title="Percentage of common stock distributed"&gt;100%&lt;/span&gt; of
the shares of CXApp Common Stock to Inpixon stockholders and other security holders by way of the distribution and (iii) following the
completion of the foregoing transactions and subject to the satisfaction or waiver of certain other conditions set forth in the Merger
Agreement, the parties shall consummate the Merger. The Separation, Distribution and Merger are intended to qualify as &#x201c;tax-free&#x201d;
transactions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
consummation of the Business Combination, the Company will have two classes of common stock: Class A common stock, par value $&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_c20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Common stock, par value (in dollars per share)"&gt;0.0001&lt;/span&gt;
per share (the &#x201c;Company&#x2019;s Class A Common Stock&#x201d;), and Class C common stock, par value $&lt;span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_c20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Common stock, par value (in dollars per share)"&gt;0.0001&lt;/span&gt; per share (the &#x201c;Company&#x2019;s
Class C Common Stock&#x201d; and together with the Company&#x2019;s Class A Common Stock, the &#x201c;Company&#x2019;s Common Stock&#x201d;).
The Company&#x2019;s Class A Common Stock and the Company&#x2019;s Class C Common Stock will be identical in all respects, except that
the Company&#x2019;s Class C Common Stock will be subject to transfer restrictions and will automatically convert into Company&#x2019;s
Class A Common Stock on the earlier to occur of (i) the &lt;span id="xdx_90F_ecustom--MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_z9CooSiozhrc" title="Maximum term for automatic conversion of stock following the closing of the Merger"&gt;180&lt;/span&gt;th day following the closing of the Merger and (ii) the day that the last
reported sale price of the Company&#x2019;s Class A Common Stock equals or exceeds $&lt;span id="xdx_906_ecustom--CommonStockStockPriceTrigger_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zmfc5C4n4Cxf" title="Stock price trigger"&gt;12.00&lt;/span&gt; per share for any &lt;span id="xdx_90B_ecustom--ThresholdTradingDays_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_z18vCC1eSJx5" title="Threshold trading days"&gt;20&lt;/span&gt; trading days within any
&lt;span id="xdx_906_ecustom--ThresholdConsecutiveTradingDays_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_ztl2WmhDMSqi" title="Threshold consecutive trading days"&gt;30&lt;/span&gt;-trading day period following the closing of the Merger. The Company&#x2019;s Class A Common Stock will be listed on the Nasdaq Capital
Market (&#x201c;Nasdaq&#x201d;) and are expected to be trading under a new ticker symbol. The outstanding warrants of the Company will
be listed on Nasdaq and are expected to be trading under a new ticker symbol.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Consideration
Paid&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
the time the Business Combination is effected (the &#x201c;Closing&#x201d;), the outstanding shares of CXApp Common Stock after the Distribution
and immediately prior to the effective time of the Merger will be converted into an aggregate of &lt;span id="xdx_903_ecustom--NumberOfSharesIssuableUponMerger_iI_pdn3_dm_c20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zOpnlBGcXtt3" title="Number of shares issuable upon merger"&gt;6.9&lt;/span&gt; million shares of The Company&#x2019;s
Common Stock which shall be issued to Inpixon shareholders, subject to adjustment. Each holder&#x2019;s aggregate merger consideration
will consist of &lt;span id="xdx_901_ecustom--PercentageOfStockAsMergerConsideration_c20220901__20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zJP9vPMVMYH9" title="Percentage of stock as merger consideration"&gt;10%&lt;/span&gt; Company&#x2019;s Class A Common Stock and &lt;span id="xdx_903_ecustom--PercentageOfStockAsMergerConsideration_c20220901__20220925__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_pdd" title="Percentage of stock as merger consideration"&gt;90%&lt;/span&gt; Company&#x2019;s Class C Common Stock (such percentages, in each case,
subject to adjustment to comply with the listing requirements set forth under Nasdaq Listing Rule&#160;5505(b)(2) with respect to KINS).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Representations
and Warranties &amp;amp; Covenants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Merger Agreement, the Company, CXApp and Inpixon each made representations and warranties customary for transactions of this type
regarding themselves and their respective businesses. The representations and warranties made pursuant to the Merger Agreement will not
survive the Closing. In addition, the parties to the Merger Agreement agreed to be bound by certain covenants that are customary for
transactions of this type. The covenants made under the Merger Agreement generally will not survive the Closing, with the exception of
certain covenants and agreements that by their terms are to be performed in whole or in part after the Closing, which will survive in
accordance with the terms of the Merger Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conditions
to Closing&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consummation of the Business Combination is subject to conditions customary for transactions involving special purpose acquisition companies,
including, among others: (i) there is not in force any order, judgment, injunction, decree, writ, stipulation, determination or award,
in each case, entered by or with any governmental authority of competent jurisdiction, statute, rule or regulation enjoining or prohibiting
the consummation of the Merger, (ii) the Company shall have at least $&lt;span id="xdx_908_ecustom--ThresholdNetTangibleAssets_c20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_pp0p0" title="Threshold net tangible assets"&gt;5,000,001&lt;/span&gt; of net tangible assets as of the Closing, (iii) the Company&#x2019;s
Class A Common Stock issuable pursuant to the Business Combination shall have been approved for listing on Nasdaq, (iv) CXApp and the
Company shall each have performed and complied in all material respects with the covenants required by the Merger Agreement to be performed
by it as of or prior to Closing, (v) customary bring down conditions related to the accuracy of the CXApp&#x2019;s and the Company&#x2019;s
respective representations and warranties in the Merger Agreement, (vi) the consummation of the Distribution, the Reorganization and
other transactions contemplated by the Separation and Distribution Agreement, (vii) the Company&#x2019;s registration statement to be
filed with the Securities and Exchange Commission (&#x201c;SEC&#x201d;) shall have become effective (and no stop order suspending effectiveness
have been issued and no proceedings for that purpose has been initiated or threatened by the SEC), (viii) each of the Company&#x2019;s
and CXApp&#x2019;s stockholder approvals shall have been obtained and (ix) the sum of (A) the aggregate amount of cash available in KINS&#x2019;s
trust account following the Company&#x2019;s stockholders&#x2019; meeting, after deducting the amount required to satisfy the Acquiror
Share Redemption Amount (as defined in the Merger Agreement) (but prior to payment of any transaction expenses), (B) the aggregate gross
purchase price of any other purchase of shares of the Company&#x2019;s Common Stock (or securities convertible or exchangeable for the
Company&#x2019;s Common Stock) actually received by the Company prior to or substantially concurrently with the closing of the Merger,
and (C) the aggregate gross purchase price of any other purchase of shares of CXApp Common Stock (or securities convertible or exchangeable
for CXApp Common Stock) actually received by CXApp prior to or substantially concurrently with the closing of the Merger, shall be equal
to or greater than $&lt;span id="xdx_901_ecustom--ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares_pp0n3_dm_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zozBBC4g4UI6" title="Threshold aggregate gross purchase price of any other purchase of shares"&gt;9.5&lt;/span&gt; million. The Company&#x2019;s obligation to consummate the Business Combination is also conditioned on there having
been no event that has had, or would reasonably be expected to have, individually or in the aggregate, a &#x201c;Material Adverse Effect&#x201d;
on CXApp.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Termination&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Merger Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing, including (i)
by the mutual written consent of the Company and CXApp, (ii) by the Company or CXApp, if the Closing shall not have occurred on or before
March&#160;16, 2023, (iii) by the Company or CXApp, if there has been any order, judgment, injunction, decree, writ, stipulation, determination
or award, in each case, entered by or with any governmental authority that would make the Merger illegal or otherwise prevent or prohibit
the Merger, (iv) by the Company or CXApp, if KINS has not obtained the requisite approval from its stockholders, (v) by KINS or CXApp
if the other party breaches certain representations, warranties, or covenants, as specified in the Merger Agreement, and that breach
is unable to be cured, or is not cured, within &lt;span id="xdx_904_ecustom--TermOfBreachUnableToBeCuredOrIsNotCured_dtD_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zgtlwRhE9w7i" title="Term of breach unable to be cured, or is not cured"&gt;30&lt;/span&gt; days, or by CXApp if there has been an uncured breach by Sponsor of certain of its
obligations under the Sponsor Support Agreement or (vi) by the Company if CXApp has not obtained the requisite approval from its stockholders
within one hour of the effective date of the Company&#x2019;s registration statement, provided that CXApp or the Company pay a termination
fee of $&lt;span id="xdx_901_ecustom--TerminationFee_pp0n3_dm_c20220901__20220925__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_zcm6CsTaMVPh" title="Termination fee"&gt;2.0&lt;/span&gt; million to the other party if the Merger Agreement is terminated pursuant to (v) or (vi) above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Separation
and Distribution Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September&#160;25, 2022, in connection with the execution of the Merger Agreement, the Company entered into the Separation Agreement
with CXApp, Inpixon and Design Reactor, pursuant to which, among other things, (i) Inpixon will undertake a series of internal reorganization
and restructuring transactions to effect the transfer of its (direct or indirect) ownership of the Enterprise Apps Business to CXApp
in the Separation and (ii) immediately prior to the Merger and after the Separation, Inpixon will distribute 100% of the outstanding
shares of CXApp Common Stock to Inpixon&#x2019;s stockholders and certain other security holders in the Distribution.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Separation Agreement also sets forth other agreements among Inpixon and CXApp related to the Separation, including provisions concerning
the termination and settlement of intercompany accounts and the obtaining of third-party consents. The Separation Agreement also sets
forth agreements that will govern certain aspects of the relationship between Inpixon and CXApp after the Distribution, including provisions
with respect to release of claims, indemnification, access to financial and other information and access to and provision of records.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Consummation
of the Distribution is subject to a number of conditions, including, among others, (i) the completion of the Reorganization and other
related transactions, (ii) the execution of the ancillary agreements by the parties and (iii) the satisfaction or waiver of all conditions
under the Merger Agreement (other than those conditions that are to be satisfied contemporaneously with the Distribution and/or the Merger,
provided that such conditions are capable of being satisfied at such time).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Sponsor
Support Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September&#160;25, 2022, in connection with the execution of the Merger Agreement, the Company, Inpixon, CXApp and the Sponsor entered
into the Sponsor Support Agreement, pursuant to which, among other things, the Sponsor agreed to vote any of the Company&#x2019;s securities
held by it to approve the Business Combination and the other of the Company&#x2019;s stockholder matters required pursuant to the Merger
Agreement, and not to seek redemption of any of the Company&#x2019;s securities in connection with the consummation of the Business Combination.
Pursuant to the Sponsor Support Agreement, the Sponsor and the Company also agreed to amend the letter agreement, dated as of December&#160;14,
2020 between the Sponsor and the Company (the &#x201c;Insider Letter&#x201d;) to amend the Founder Shares Lock-Up Period (as defined in
the Insider Letter) to provide for lock-up of its shares of the Company&#x2019;s Class B common stock, par value $&lt;span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20201214__us-gaap--TransactionTypeAxis__custom--MergerAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zjM90cv4eljd" title="Common stock, par value (in dollars per share)"&gt;0.0001&lt;/span&gt; per share (&#x201c;Company&#x2019;s
Class B Common Stock&#x201d;) (or Company&#x2019;s Class A Common Shares issuable upon conversion thereof) until the earlier of (A) the
&lt;span id="xdx_90A_ecustom--CommonStockLockUpPeriod_dtD_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zjPs1ggtZaWk" title="Lock-up period"&gt;180&lt;/span&gt;th day after the closing of the Merger and (B) (x) the date on which the Company completes a liquidation, merger, stock exchange,
reorganization or other similar transaction following the closing of the Merger or (y) the day that the last reported sale price of the
Company&#x2019;s Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like) for any &lt;span id="xdx_90C_ecustom--ThresholdTradingDays_dtD_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zIzaBI3ZCH02" title="Threshold trading days"&gt;20&lt;/span&gt; trading days within any &lt;span id="xdx_906_ecustom--ThresholdConsecutiveTradingDays_dtD_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zVfWYSgOx60b" title="Threshold consecutive trading days"&gt;30&lt;/span&gt;-trading day period following the Closing of the Merger; provided,
that &lt;span id="xdx_908_ecustom--PercentageOfSharesNotBeSubjectToForegoingLockUp_c20201201__20201214__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__dei--LegalEntityAxis__custom--CxappHoldingCorpMember_pdd" title="Percentage of shares not be subject to foregoing lock-up"&gt;22%&lt;/span&gt; of such shares (subject to adjustment) shall not be subject to foregoing lock-up. Additionally, Sponsor has agreed to exchange
&lt;span id="xdx_900_ecustom--NumberOfSharesExchanged_c20201201__20201214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__us-gaap--TypeOfArrangementAxis__custom--SponsorSupportAgreementMember_pdd" title="Number of shares exchanged"&gt;6,150,000&lt;/span&gt; shares of the Company&#x2019;s Class B Common Stock, equal to such that the number of shares of the Company&#x2019;s Common Stock
issued as aggregate merger consideration exceeds (by one share): (i) the aggregate number of shares of the Company&#x2019;s Class A Common
Stock held by Sponsor at Closing (after taking into the exchange), plus (ii) the aggregate number of shares of the Company&#x2019;s Class
B Common Stock held by certain funds and accounts managed by BlackRock, Inc. (including all Potential Forfeiture Shares (as defined in
the Sponsor Support Agreement)), plus (iii) the aggregate number of shares of the Company&#x2019;s Class A Common Stock that have not
properly elected to redeem their shares of the Company&#x2019;s Class A Common Stock pursuant to the Company&#x2019;s governing documents,
plus (iii) any shares of the Company&#x2019;s Common Stock issued as incentives for non-redemption transactions and financing transactions,
in each case, free and clear of all liens; provided, that, in no instance shall the number of shares issued to Sponsor in the exchange
be less than &lt;span id="xdx_901_ecustom--MinimumNumberOfSharesIssuableToSponsor_c20201201__20201214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SponsorSupportAgreementMember_pdd" title="Minimum number of shares issuable to sponsor"&gt;5,150,000&lt;/span&gt; shares of the Company&#x2019;s Class A Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <cxai:MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands
      contextRef="From2020-12-012020-12-14"
      decimals="INF"
      unitRef="Pure">0.30</cxai:MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands>
    <cxai:MaximumNumberOfDemandsForRegistrationOfSecurities
      contextRef="AsOf2020-12-14"
      decimals="INF"
      unitRef="Integer">3</cxai:MaximumNumberOfDemandsForRegistrationOfSecurities>
    <cxai:DeferredFeePerUnit
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.35</cxai:DeferredFeePerUnit>
    <cxai:DeferredOfferingCostsNoncurrent contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">9660000</cxai:DeferredOfferingCostsNoncurrent>
    <cxai:IncomeRecognizedFromReductionOfDeferredUnderwriterFee
      contextRef="From2022-06-012022-06-09"
      decimals="0"
      unitRef="USD">9660000</cxai:IncomeRecognizedFromReductionOfDeferredUnderwriterFee>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-25_custom_CXAppCommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="AsOf2022-09-25_custom_InpixonMember_custom_SeparationAgreementMember_custom_CxappHoldingCorpMember"
      decimals="0"
      unitRef="USD">10000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <cxai:PercentageOfCommonStockDistributed
      contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember"
      decimals="INF"
      unitRef="Pure">1</cxai:PercentageOfCommonStockDistributed>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-25_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-25_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <cxai:MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember">P180D</cxai:MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger>
    <cxai:CommonStockStockPriceTrigger
      contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember"
      decimals="INF"
      unitRef="USDPShares">12.00</cxai:CommonStockStockPriceTrigger>
    <cxai:ThresholdTradingDays contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember">P20D</cxai:ThresholdTradingDays>
    <cxai:ThresholdConsecutiveTradingDays contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember">P30D</cxai:ThresholdConsecutiveTradingDays>
    <cxai:NumberOfSharesIssuableUponMerger
      contextRef="AsOf2022-09-25_custom_MergerAgreementMember_custom_CxappHoldingCorpMember"
      decimals="INF"
      unitRef="Shares">6900000</cxai:NumberOfSharesIssuableUponMerger>
    <cxai:PercentageOfStockAsMergerConsideration
      contextRef="From2022-09-012022-09-25_us-gaap_CommonClassAMember_custom_MergerAgreementMember_custom_CxappHoldingCorpMember"
      decimals="INF"
      unitRef="Pure">0.10</cxai:PercentageOfStockAsMergerConsideration>
    <cxai:PercentageOfStockAsMergerConsideration
      contextRef="From2022-09-012022-09-25_us-gaap_CommonClassCMember_custom_MergerAgreementMember_custom_CxappHoldingCorpMember"
      decimals="INF"
      unitRef="Pure">0.90</cxai:PercentageOfStockAsMergerConsideration>
    <cxai:ThresholdNetTangibleAssets
      contextRef="AsOf2022-09-25_custom_MergerAgreementMember"
      decimals="0"
      unitRef="USD">5000001</cxai:ThresholdNetTangibleAssets>
    <cxai:ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares
      contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember"
      decimals="0"
      unitRef="USD">9500000</cxai:ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares>
    <cxai:TermOfBreachUnableToBeCuredOrIsNotCured contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember_custom_CxappHoldingCorpMember">P30D</cxai:TermOfBreachUnableToBeCuredOrIsNotCured>
    <cxai:TerminationFee
      contextRef="From2022-09-012022-09-25_custom_MergerAgreementMember_custom_CxappHoldingCorpMember"
      decimals="0"
      unitRef="USD">2000000.0</cxai:TerminationFee>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-12-14_custom_MergerAgreementMember_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <cxai:CommonStockLockUpPeriod contextRef="From2020-12-012020-12-14_custom_MergerAgreementMember">P180D</cxai:CommonStockLockUpPeriod>
    <cxai:ThresholdTradingDays contextRef="From2020-12-012020-12-14_custom_MergerAgreementMember">P20D</cxai:ThresholdTradingDays>
    <cxai:ThresholdConsecutiveTradingDays contextRef="From2020-12-012020-12-14_custom_MergerAgreementMember">P30D</cxai:ThresholdConsecutiveTradingDays>
    <cxai:PercentageOfSharesNotBeSubjectToForegoingLockUp
      contextRef="From2020-12-012020-12-14_custom_MergerAgreementMember_custom_CxappHoldingCorpMember"
      decimals="INF"
      unitRef="Pure">0.22</cxai:PercentageOfSharesNotBeSubjectToForegoingLockUp>
    <cxai:NumberOfSharesExchanged
      contextRef="From2020-12-012020-12-14_us-gaap_CommonClassBMember_custom_SponsorSupportAgreementMember"
      decimals="INF"
      unitRef="Shares">6150000</cxai:NumberOfSharesExchanged>
    <cxai:MinimumNumberOfSharesIssuableToSponsor
      contextRef="From2020-12-012020-12-14_us-gaap_CommonClassAMember_custom_SponsorSupportAgreementMember"
      decimals="INF"
      unitRef="Shares">5150000</cxai:MinimumNumberOfSharesIssuableToSponsor>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zI2iVJ20rS6h" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 &#x2014; &lt;span id="xdx_824_zDKdRnHUFGxg"&gt;STOCKHOLDERS&#x2019; DEFICIT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Preferred
Stock &#x2014;&lt;/i&gt;&lt;/b&gt; The Company is authorized to issue &lt;span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_zcQUOsD0Hrp2" title="Preferred shares, shares authorized"&gt;&lt;span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231_ze8W0FVGF7mg" title="Preferred shares, shares authorized"&gt;2,000,000&lt;/span&gt;&lt;/span&gt; shares of preferred stock with a par value of $&lt;span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_zFZX3IpXUdq3" title="Preferred stock, par value, (per share)"&gt;&lt;span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211231_zr7lhwkFBXL6" title="Preferred stock, par value, (per share)"&gt;0.0001&lt;/span&gt;&lt;/span&gt; per share with
such designations, voting and other rights and preferences as may be determined from time to time by the Company&#x2019;s board of directors.
At December&#160;31, 2022 and 2021, there were &lt;span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zKMsp8u8YjIg" title="Preferred shares, shares issued"&gt;&lt;span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_do_c20211231_zDNWwjvaOjpj" title="Preferred shares, shares issued"&gt;&lt;span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_z760sd5L7v8j" title="Preferred shares, shares outstanding"&gt;&lt;span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20211231_zUsZktTTQVDe" title="Preferred shares, shares outstanding"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of preferred stock issued or outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Class
A Common Stock &#x2014;&lt;/i&gt;&lt;/b&gt; The Company is authorized to issue &lt;span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zbO4RlY8I2l4" title="Common shares, shares authorized (in shares)"&gt;&lt;span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zzXogzOYJVll" title="Common shares, shares authorized (in shares)"&gt;100,000,000&lt;/span&gt;&lt;/span&gt;
shares of Class A common stock with a par value of $&lt;span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zDtBAcLoSRY2" title="Common shares, par value (in dollars per share)"&gt;&lt;span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zwvkxdQ4OJS9" title="Common shares, par value (in dollars per share)"&gt;0.0001&lt;/span&gt;&lt;/span&gt;
per share. Holders of Class A common stock are entitled to one &lt;span id="xdx_90E_ecustom--CommonStockNumberOfVotesPerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zI45fHn3Mbl3" style="display: none" title="Common shares, votes per share"&gt;1&lt;/span&gt; vote for each share. At December&#160;31, 2022 and 2021, there were
&lt;span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_zBukIontxXpl" title="Common shares, shares issued (in shares)"&gt;&lt;span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_zaFOQeWfH6Wk" title="Common shares, shares outstanding (in shares)"&gt;387,551&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_z4a5pWJIC34i" title="Common shares, shares issued (in shares)"&gt;&lt;span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--CommonStockSubjectToRedemptionMember_zsrU0JPNRUu" title="Common shares, shares outstanding (in shares)"&gt;27,600,000&lt;/span&gt;&lt;/span&gt; shares of Class A common stock issued and outstanding which are subject to possible redemption and presented
as temporary equity, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Class
B Common Stock &#x2014;&lt;/i&gt;&lt;/b&gt; The Company is authorized to issue &lt;span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhsvbxMYlgPd" title="Common shares, shares authorized (in shares)"&gt;&lt;span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zySZYhJYIMzj" title="Common shares, shares authorized (in shares)"&gt;20,000,000&lt;/span&gt;&lt;/span&gt;
shares of Class B common stock with a par value of $&lt;span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zBUJQ00hgFSd" title="Common shares, par value (in dollars per share)"&gt;&lt;span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z66M5u3oDxZh" title="Common shares, par value (in dollars per share)"&gt;0.0001&lt;/span&gt;&lt;/span&gt;
per share. Holders of Class B common stock are entitled to one &lt;span id="xdx_90D_ecustom--CommonStockNumberOfVotesPerShare_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zlQmTpI51E0l" style="display: none" title="Common shares, votes per share"&gt;1&lt;/span&gt; vote for each share. At December&#160;31, 2022 and 2021, there were &lt;span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zsfPDiDxRCJ2" title="Common shares, shares issued (in shares)"&gt;&lt;span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zTeHSgb5LETd" title="Common shares, shares issued (in shares)"&gt;&lt;span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zRnlapfUCC5j" title="Common shares, shares outstanding (in shares)"&gt;&lt;span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zBmYF8QAHi9b" title="Common shares, shares outstanding (in shares)"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
shares of Class B common stock issued and outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Only
holders of the Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders
of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of
our stockholders except as otherwise required by law.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier
at the option of the holder (except for any Founder Shares held by the Direct Anchor Investors who have agreed not to effect a conversion
with respect to such Founder Shares until the consummation of the initial Business Combination), on a one-for-one basis, subject to adjustment.
In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the
amounts issued in the Initial Public Offering and related to the closing of a Business Combination (including pursuant to a specified
future issuance), the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted
(unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment with respect
to any such issuance or deemed issuance, including pursuant to a specified future issuance) so that the number of shares of Class A common
stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, &lt;span id="xdx_90F_ecustom--ConvertibleStockConversionRatio_c20220101__20221231_pdd" title="Ratio to be applied to the stock in the conversion"&gt;20%&lt;/span&gt; of the
sum of the total number of all shares of common stock outstanding upon the completion of Initial Public Offering plus all shares of Class
A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or
equity-linked securities issued or issuable to any seller in a Business Combination).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">2000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <cxai:CommonStockNumberOfVotesPerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Integer">1</cxai:CommonStockNumberOfVotesPerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_custom_CommonStockSubjectToRedemptionMember"
      decimals="INF"
      unitRef="Shares">387551</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_custom_CommonStockSubjectToRedemptionMember"
      decimals="INF"
      unitRef="Shares">387551</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-12-31_custom_CommonStockSubjectToRedemptionMember"
      decimals="INF"
      unitRef="Shares">27600000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-12-31_custom_CommonStockSubjectToRedemptionMember"
      decimals="INF"
      unitRef="Shares">27600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <cxai:CommonStockNumberOfVotesPerShare
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Integer">1</cxai:CommonStockNumberOfVotesPerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="Shares">6900000</us-gaap:CommonStockSharesOutstanding>
    <cxai:ConvertibleStockConversionRatio
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">0.20</cxai:ConvertibleStockConversionRatio>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_80E_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zEDEffAVJVlh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9 &#x2014; &lt;span id="xdx_827_z11alReubFy2"&gt;DERIVATIVE WARRANT LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December&#160;31, 2022 and 2021 there were &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_c20221231_pdd" title="Warrants outstanding"&gt;&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_c20211231_pdd" title="Warrants outstanding"&gt;13,800,000&lt;/span&gt;&lt;/span&gt; Public Warrants outstanding and &lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_pdd" title="Warrants outstanding"&gt;&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_pdd" title="Warrants outstanding"&gt;10,280,000&lt;/span&gt;&lt;/span&gt; Private Placement Warrants Outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Public
Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and
only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) &lt;span id="xdx_90D_ecustom--WarrantExercisePeriodConditionOne_dtD_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zKY7y4YgAJ4" title="Warrant exercise period condition one"&gt;30&lt;/span&gt;
days after the completion of a Business Combination and (b) &lt;span id="xdx_90B_ecustom--WarrantExercisePeriodConditionTwo_dtM_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zwIuyZeE7t51" title="Warrant exercise period condition two"&gt;12&lt;/span&gt;
months from the closing of the Initial Public Offering. The Public Warrants will expire five &lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zIosOuh7nGEi" style="display: none" title="Public Warrants expiration term"&gt;5&lt;/span&gt; years after the completion of a
Business Combination or earlier upon redemption or liquidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation
to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class
A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying
its obligations with respect to registration. No warrant will be exercisable, and the Company will not be obligated to issue shares of
Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has agreed that as soon as practicable, but in no event later than &lt;span id="xdx_905_ecustom--MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement_dtD_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zpulS8OQokC1" title="Maximum period after business combination in which to file registration statement"&gt;20&lt;/span&gt; business days after the closing of a Business Combination,
the Company will use its commercially reasonable efforts to file, and within &lt;span id="xdx_903_ecustom--PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective_dtD_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zV5yGGrWOYg7" title="Period of time within which registration statement is expected to become effective"&gt;60&lt;/span&gt; business days following a Business Combination to have
declared effective, a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable
upon exercise of the warrants. The Company will use its commercially reasonable efforts to maintain the effectiveness of such registration
statement and a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. Notwithstanding
the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such
that it satisfies the definition of a &#x201c;covered security&#x201d; under Section&#160;18(b)(1) of the Securities Act, the Company may,
at its option, require holders of Public Warrants who exercise their warrants to do so on a &#x201c;cashless basis&#x201d; in accordance
with Section&#160;3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or
maintain in effect a registration statement, but we will be required to use our commercially reasonable efforts to register or qualify
the shares under applicable blue sky laws to the extent an exemption is not available.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Redemptions
of warrants when the price of Class A common stock equals or exceeds $&lt;span id="xdx_907_ecustom--WarrantRedemptionConditionMinimumSharePrice_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_pdd" title="Warrant redemption condition minimum share price"&gt;18.00&lt;/span&gt;&lt;/i&gt; &#x2014; Once the warrants become exercisable, the Company
may redeem the Public Warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
whole and not in part;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at
a price of $&lt;span id="xdx_900_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd" title="Redemption price per public warrant (in dollars per share)"&gt;0.01&lt;/span&gt; per warrant;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon
not less than 30 days&#x2019; prior written notice of redemption, or the &lt;span id="xdx_90F_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zoMnAYyBDLe7" title="Threshold consecutive trading days for redemption of public warrants"&gt;30&lt;/span&gt;-day redemption period, to each warrant holder; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
and only if, the reported last sale price of the Company&#x2019;s Class A common stock equals or exceeds $&lt;span id="xdx_90C_ecustom--WarrantRedemptionConditionMinimumSharePrice_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd" title="Warrant redemption condition minimum share price"&gt;18.00&lt;/span&gt; per share (as adjusted
for stock splits, stock dividends, reorganizations, recapitalizations, and the like) for any &lt;span id="xdx_903_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zVsyX4XcoOqj" title="Threshold trading days for redemption of public warrants"&gt;20&lt;/span&gt; trading days within a &lt;span id="xdx_900_ecustom--RedemptionPeriod_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zNBr8S9w5ysk" title="Redemption period"&gt;30&lt;/span&gt;-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Redemption
of warrants when the price per share of Class A common stock equals or exceeds $&lt;span id="xdx_903_ecustom--WarrantRedemptionConditionMinimumSharePriceScenarioTwo_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_pdd" title="Warrant redemption condition minimum share price scenario two"&gt;10.00&lt;/span&gt; &#x2013;&lt;/i&gt; Once the warrants become exercisable,
the Company may redeem the outstanding warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
whole and not in part;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at
a price of $&lt;span id="xdx_906_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_pdd" title="Redemption price per public warrant (in dollars per share)"&gt;0.10&lt;/span&gt; per warrant provided that holders will be able to exercise their warrants prior to redemption and receive that number
of shares of Class A common stock determined based on the redemption date and the &#x201c;fair market value&#x201d; of the Company&#x2019;s
Class A common stock;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon
not less than 30 days&#x2019; prior written notice of redemption, or the &lt;span id="xdx_903_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zTOqUocrJej" title="Threshold consecutive trading days for redemption of public warrants"&gt;30&lt;/span&gt;-day redemption period;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
and only if, the last reported sale price of the Company&#x2019;s Class A common stock equals or exceeds $&lt;span id="xdx_901_ecustom--WarrantRedemptionConditionMinimumSharePriceScenarioTwo_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" title="Warrant redemption condition minimum share price scenario two"&gt;10.00&lt;/span&gt; per share (as adjusted
for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the
Company sends the notice of redemption to the warrant holders;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise
of the warrants and a current prospectus relating thereto is available throughout the &lt;span id="xdx_90A_ecustom--RedemptionPeriod_dtD_c20220101__20221231__srt--StatementScenarioAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zXBtww4vpE11" title="Redemption period"&gt;30&lt;/span&gt;-day period after the written notice of redemption
is given.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes
in connection with the closing of a Business Combination at an issue price or effective issue price of less than $&lt;span id="xdx_908_ecustom--SharePricetriggerUsedToMeasureDilutionOfWarrant_c20221231_pdd" title="Share PriceTrigger Used To Measure Dilution Of Warrant"&gt;9.20&lt;/span&gt; per share of Class
A common stock (with such issue price or effective issue price to be determined in good faith by the Company&#x2019;s board of directors,
and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor
or its affiliates, as applicable, prior to such issuance) (the &#x201c;Newly Issued Price&#x201d;), (y) the aggregate gross proceeds from
such issuances represent more than &lt;span id="xdx_901_ecustom--PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant_c20220101__20221231_pdd" title="Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant"&gt;60%&lt;/span&gt; of the total equity proceeds, and interest thereon, available for the funding of a Business Combination
on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the
Company&#x2019;s Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company
completes a Business Combination (such price, the &#x201c;Market Value&#x201d;) is below $9.20 per share, the exercise price of the warrants
will be adjusted (to the nearest cent) to be equal to &lt;span id="xdx_901_ecustom--WarrantExercisePriceAdjustmentMultiple_c20220101__20221231_pdd" title="Warrant exercise price adjustment multiple"&gt;115%&lt;/span&gt; of the higher of the Market Value and the Newly Issued Price, and the $18.00
per share redemption trigger price will be adjusted (to the nearest cent) to be equal to &lt;span id="xdx_903_ecustom--WarrantRedemptionPriceAdjustmentMultiple_c20220101__20221231_pdd" title="Warrant redemption price adjustment multiple"&gt;180%&lt;/span&gt; of the higher of the Market Value and the
Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted will be adjusted (to the nearest cent) to be equal
to the higher of the Market Value and the Newly Issued Price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December&#160;31, 2022 and 2021 there were &lt;span id="xdx_90F_ecustom--NumberOfWarrantsIssued_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zrPvNSsJQb04" title="Number of warrants issued"&gt;&lt;span id="xdx_900_ecustom--NumberOfWarrantsIssued_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z0otJ00KClji" title="Number of warrants issued"&gt;10,280,000&lt;/span&gt;&lt;/span&gt; Private Placement Warrants outstanding. The Private Placement Warrants are identical
to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the shares
of Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable
until &lt;span id="xdx_90F_ecustom--RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_dtD_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zrXuMuSdI9ha" title="Restrictions on transfer period of time after business combination completion"&gt;30&lt;/span&gt; days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement
Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial
purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or
their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the
same basis as the Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">13800000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">13800000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember"
      decimals="INF"
      unitRef="Shares">10280000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember"
      decimals="INF"
      unitRef="Shares">10280000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <cxai:WarrantExercisePeriodConditionOne contextRef="From2022-01-012022-12-31_custom_PublicWarrantsMember">P30D</cxai:WarrantExercisePeriodConditionOne>
    <cxai:WarrantExercisePeriodConditionTwo contextRef="From2022-01-012022-12-31_custom_PublicWarrantsMember">P12M</cxai:WarrantExercisePeriodConditionTwo>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2022-12-31_custom_PublicWarrantsMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <cxai:MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement contextRef="From2022-01-012022-12-31_us-gaap_WarrantMember">P20D</cxai:MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement>
    <cxai:PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective contextRef="From2022-01-012022-12-31_us-gaap_WarrantMember">P60D</cxai:PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective>
    <cxai:WarrantRedemptionConditionMinimumSharePrice
      contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member"
      decimals="INF"
      unitRef="USDPShares">18.00</cxai:WarrantRedemptionConditionMinimumSharePrice>
    <cxai:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">0.01</cxai:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember">P30D</cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <cxai:WarrantRedemptionConditionMinimumSharePrice
      contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">18.00</cxai:WarrantRedemptionConditionMinimumSharePrice>
    <cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember">P20D</cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <cxai:RedemptionPeriod contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember">P30D</cxai:RedemptionPeriod>
    <cxai:WarrantRedemptionConditionMinimumSharePriceScenarioTwo
      contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member"
      decimals="INF"
      unitRef="USDPShares">10.00</cxai:WarrantRedemptionConditionMinimumSharePriceScenarioTwo>
    <cxai:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member"
      decimals="INF"
      unitRef="USDPShares">0.10</cxai:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember">P30D</cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <cxai:WarrantRedemptionConditionMinimumSharePriceScenarioTwo
      contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="USDPShares">10.00</cxai:WarrantRedemptionConditionMinimumSharePriceScenarioTwo>
    <cxai:RedemptionPeriod contextRef="From2022-01-012022-12-31_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember">P30D</cxai:RedemptionPeriod>
    <cxai:SharePricetriggerUsedToMeasureDilutionOfWarrant
      contextRef="AsOf2022-12-31"
      decimals="INF"
      unitRef="USDPShares">9.20</cxai:SharePricetriggerUsedToMeasureDilutionOfWarrant>
    <cxai:PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">0.60</cxai:PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant>
    <cxai:WarrantExercisePriceAdjustmentMultiple
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">1.15</cxai:WarrantExercisePriceAdjustmentMultiple>
    <cxai:WarrantRedemptionPriceAdjustmentMultiple
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">1.80</cxai:WarrantRedemptionPriceAdjustmentMultiple>
    <cxai:NumberOfWarrantsIssued
      contextRef="From2022-01-012022-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="Shares">10280000</cxai:NumberOfWarrantsIssued>
    <cxai:NumberOfWarrantsIssued
      contextRef="From2021-01-012021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember"
      decimals="INF"
      unitRef="Shares">10280000</cxai:NumberOfWarrantsIssued>
    <cxai:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion contextRef="From2022-01-012022-12-31_custom_PublicWarrantsMember">P30D</cxai:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_z1s0BM0UfUQ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
10 &#x2014; &lt;span id="xdx_829_zR8i78vii3M4"&gt;INCOME TAX&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s net deferred tax assets are as follows as of December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z9RDlEVPdePk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;&lt;span id="xdx_8B0_zft8pkkbm5w8" style="display: none"&gt;Schedule of Company's net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20221231_zszdqVXesDWf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20211231_zloN0f9oOWt8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsNetOfValuationAllowanceAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Deferred tax asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_i01I_pp0p0_maDTAGzH2n_zJZsPEnXuOj9" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"&gt;Organizational costs/startup expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;924,537&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;322,963&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzH2n_z83CmBuNPOZ2" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"&gt;Net operating loss carryforward&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1069"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28,689&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_mtDTAGzH2n_maDTANzcuz_zfIn9amPvV82" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Total deferred tax asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;924,537&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;351,652&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di_msDTANzcuz_zXJTTxY4oi33" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(924,537&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(351,652&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_mtDTANzcuz_zU4RTzO2VSyh" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Deferred tax asset, net of allowance&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1078"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1079"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zJAMNsc6dsP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
income tax provision consists of the following for the years ended December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYSYFdTFxEch" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B4_zXy6iR0jPuOb" style="display: none"&gt;Schedule of income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20220101__20221231_zX2KOWuZTfga" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20210101__20211231_z2x1GBkFAzl" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zNtjJVGYBcp2" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"&gt;Current&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;49,175&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1087"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zjsFhKNWOmr9" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(572,885&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(300,205&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--StateAndLocalAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;State and Local&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zPC3k8mPn9t4" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1095"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1096"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zLND9QSxl1V2" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1098"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1099"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_i01N_pp0p0_di_msITEBzXu4_z54jCOYWgLf1" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;572,885&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;300,205&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXu4_zFkYyLe9CNyc" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;49,175&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1105"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zQsJ1tkCFRn7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December&#160;31, 2022 and 2021, the Company had U.S. federal net operating loss carryover of approximately $&lt;span id="xdx_907_eus-gaap--OperatingLossCarryforwards_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Operating loss carryforwards"&gt;0&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--OperatingLossCarryforwards_c20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Operating loss carryforwards"&gt;137,000&lt;/span&gt; available
to offset future taxable income indefinitely, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all
of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of
future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible.
Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies
in making this assessment. After consideration of all of the information available, management believes that significant uncertainty
exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the
year ended December&#160;31, 2022 and 2021, the change in the valuation allowance was $&lt;span id="xdx_90A_eus-gaap--DeferredTaxAssetsValuationAllowance_c20221231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Change in valuation allowance"&gt;572,885&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_c20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_pp0p0" title="Change in valuation allowance"&gt;300,205&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
reconciliation of the federal income tax rate to the Company&#x2019;s effective tax rate for the years ended December&#160;31, 2022 and
2021 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zlhQov4oX2Ne" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BB_zwCBpaYt83ld" style="display: none"&gt;Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;Statutory federal income tax rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20221231_zFtLmiIvZ26f" title="Statutory federal income tax rate"&gt;21&lt;/span&gt;.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231_zCwUfSn3qwO3" title="Statutory federal income tax rate"&gt;21&lt;/span&gt;.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;State taxes, net of federal tax benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20220101__20221231_z79RxeKSIjx" title="State taxes, net of federal tax benefit"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20210101__20211231_zh6TFuXVlok" title="State taxes, net of federal tax benefit"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Transaction costs allocated to derivative warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_dp_c20220101__20221231_zmbK1VPPXoVk" title="Transaction costs allocated to derivative warrant liabilities"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_dp_c20210101__20211231_zX1y4EtnpWIj" title="Transaction costs allocated to derivative warrant liabilities"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Change in fair value of derivative warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_dp_c20220101__20221231_zfZxnyCwqHsa" title="Change in fair value of derivative warrant liabilities"&gt;(23.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_dp_c20210101__20211231_zxi5rbQvqu3c" title="Change in fair value of derivative warrant liabilities"&gt;(24.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20221231_zNuNGX5EssVe" title="Valuation allowance"&gt;3.2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210101__20211231_z84014VhQuT" title="Valuation allowance"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20221231_znxEB3DdQHq1" title="Income tax provision"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20211231_zskHnT7LV0C" title="Income tax provision"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zvM7s5Ue5cNg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company files income tax returns in the U.S. federal jurisdiction in various state and local jurisdictions and is subject to examination
by the various taxing authorities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2022-01-012022-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z9RDlEVPdePk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;&lt;span id="xdx_8B0_zft8pkkbm5w8" style="display: none"&gt;Schedule of Company's net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20221231_zszdqVXesDWf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20211231_zloN0f9oOWt8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsNetOfValuationAllowanceAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Deferred tax asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts_i01I_pp0p0_maDTAGzH2n_zJZsPEnXuOj9" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"&gt;Organizational costs/startup expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;924,537&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;322,963&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_maDTAGzH2n_z83CmBuNPOZ2" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"&gt;Net operating loss carryforward&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1069"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28,689&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_mtDTAGzH2n_maDTANzcuz_zfIn9amPvV82" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Total deferred tax asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;924,537&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;351,652&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di_msDTANzcuz_zXJTTxY4oi33" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(924,537&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(351,652&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_mtDTANzcuz_zU4RTzO2VSyh" style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Deferred tax asset, net of allowance&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1078"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1079"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <cxai:DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">924537</cxai:DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts>
    <cxai:DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">322963</cxai:DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">28689</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">924537</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">351652</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2022-12-31" decimals="0" unitRef="USD">924537</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2021-12-31" decimals="0" unitRef="USD">351652</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2022-01-012022-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYSYFdTFxEch" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B4_zXy6iR0jPuOb" style="display: none"&gt;Schedule of income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20220101__20221231_zX2KOWuZTfga" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20210101__20211231_z2x1GBkFAzl" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zNtjJVGYBcp2" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"&gt;Current&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;49,175&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1087"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zjsFhKNWOmr9" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(572,885&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(300,205&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--StateAndLocalAbstract_iB" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;State and Local&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zPC3k8mPn9t4" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1095"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1096"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_i01_pp0p0_maITEBzXu4_zLND9QSxl1V2" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1098"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1099"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_i01N_pp0p0_di_msITEBzXu4_z54jCOYWgLf1" style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;572,885&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;300,205&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzXu4_zFkYyLe9CNyc" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;49,175&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1105"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">49175</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">-572885</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-300205</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">-572885</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      unitRef="USD">-300205</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">49175</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2022-12-31_us-gaap_DomesticCountryMember"
      decimals="0"
      unitRef="USD">0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2021-12-31_us-gaap_DomesticCountryMember"
      decimals="0"
      unitRef="USD">137000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2022-12-31_us-gaap_DomesticCountryMember"
      decimals="0"
      unitRef="USD">572885</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2021-12-31_us-gaap_DomesticCountryMember"
      decimals="0"
      unitRef="USD">300205</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2022-01-012022-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zlhQov4oX2Ne" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BB_zwCBpaYt83ld" style="display: none"&gt;Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;Statutory federal income tax rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20221231_zFtLmiIvZ26f" title="Statutory federal income tax rate"&gt;21&lt;/span&gt;.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231_zCwUfSn3qwO3" title="Statutory federal income tax rate"&gt;21&lt;/span&gt;.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;State taxes, net of federal tax benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20220101__20221231_z79RxeKSIjx" title="State taxes, net of federal tax benefit"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_c20210101__20211231_zh6TFuXVlok" title="State taxes, net of federal tax benefit"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Transaction costs allocated to derivative warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_ecustom--EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_dp_c20220101__20221231_zmbK1VPPXoVk" title="Transaction costs allocated to derivative warrant liabilities"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_ecustom--EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent_dp_c20210101__20211231_zX1y4EtnpWIj" title="Transaction costs allocated to derivative warrant liabilities"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Change in fair value of derivative warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_dp_c20220101__20221231_zfZxnyCwqHsa" title="Change in fair value of derivative warrant liabilities"&gt;(23.9&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_ecustom--EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent_dp_c20210101__20211231_zxi5rbQvqu3c" title="Change in fair value of derivative warrant liabilities"&gt;(24.3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20221231_zNuNGX5EssVe" title="Valuation allowance"&gt;3.2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210101__20211231_z84014VhQuT" title="Valuation allowance"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Income tax provision&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20221231_znxEB3DdQHq1" title="Income tax provision"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20211231_zskHnT7LV0C" title="Income tax provision"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <cxai:EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">0.000</cxai:EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent>
    <cxai:EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.000</cxai:EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent>
    <cxai:EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">-0.239</cxai:EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent>
    <cxai:EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">-0.243</cxai:EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">0.032</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.033</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      unitRef="Pure">0.003</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_800_eus-gaap--FairValueDisclosuresTextBlock_zax6DXdQOwm" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
11 &#x2014; &lt;span id="xdx_821_znIKLQ02bgH6"&gt;FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s financial assets and liabilities reflects management&#x2019;s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.6in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                              1:&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Quoted
prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.6in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                              2:&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Observable
inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
and quoted prices for identical assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.6in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                              3:&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Unobservable
inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 &#x201c;Investments
- Debt and Equity Securities.&#x201d; Held-to-maturity securities are those securities which the Company has the ability and intent to
hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying consolidated balance sheets
and adjusted for the amortization or accretion of premiums or discounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December&#160;31 2022, assets held in the Trust Account consisted of $&lt;span id="xdx_90E_eus-gaap--AssetsHeldInTrustNoncurrent_c20221231__us-gaap--FinancialInstrumentAxis__us-gaap--CashMember_pp0p0" title="Assets held in the Trust Account"&gt;3,923,804&lt;/span&gt; held in an interest-bearing commercial checking account.
Cash held in commercial checking accounts is reported on the balance sheet at its approximate fair value. During the year ended December&#160;31,
2022, the Company withdrew $&lt;span id="xdx_90C_ecustom--ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax_c20220101__20221231_pp0p0" title="Cash withdrawn from trust account to pay franchise tax"&gt;231,500&lt;/span&gt; of interest income from the Trust Account for taxes and $&lt;span id="xdx_908_ecustom--ProceedsFromTrustAccountInConnectionWithRedemption_c20220101__20221231_pp0p0" title="Cash withdrawn from trust account in connection with redemption"&gt;275,102,280&lt;/span&gt; was withdrawn from the Trust
Account in connection with the redemption of Class A common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December&#160;31, 2021, assets held in the Trust Account were comprised of $&lt;span id="xdx_90F_eus-gaap--AssetsHeldInTrustNoncurrent_c20211231__us-gaap--FinancialInstrumentAxis__us-gaap--CashMember_pp0p0" title="Assets held in the Trust Account"&gt;898&lt;/span&gt; in cash and $&lt;span id="xdx_905_eus-gaap--AssetsHeldInTrustNoncurrent_c20211231__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember_pp0p0" title="Assets held in the Trust Account"&gt;278,835,182&lt;/span&gt; in money market funds, respectively.
Through December&#160;31, 2021, the Company did not withdraw any interest income from the Trust Account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents information about the Company&#x2019;s assets and liabilities that are measured at fair value on a recurring
basis at December&#160;31, 2022 and 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine
such fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z4PIr496IIQ1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BB_zpXDUooqaxq9" style="display: none"&gt;Schedule of company's assets and liabilities that are measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="5" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="5" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Description&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"&gt;Money Market Funds&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: center"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsHeldInTrustNoncurrent_c20221231__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="width: 9%; text-align: right" title="Assets held in the Trust Account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1158"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: center"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsHeldInTrustNoncurrent_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember_pp0p0" style="width: 9%; text-align: right" title="Assets held in the Trust Account"&gt;278,835,182&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Warrant liabilities &#x2013; public warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities"&gt;414,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities"&gt;6,461,798&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Warrant liabilities &#x2013; private placement warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities"&gt;308,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities"&gt;4,813,571&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zN5RHb7MXnc1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the accompanying
December&#160;31, 2022 and 2021 consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a
recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statements
of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrants are measured at fair value on a recurring basis. The Public Warrants were initially valued using a lattice model, specifically
a binomial lattice model incorporating the binomial lattice methodology. As of December&#160;31, 2022, the Public Warrants were valued
using the instrument&#x2019;s publicly listed trading price as of the balance sheet date, which is considered to be a Level 1 measurement
due to the use of an observable market quote in an active market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Private Placement Warrants were initially valued using a lattice model, specifically a binomial lattice model incorporating the binomial
lattice methodology, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized in determining
the fair value of the Private Placement Warrants is the expected volatility of our common stock. The expected volatility as of the Initial
Public Offering date was derived from observable public warrant pricing on comparable &#x2018;blank-check&#x2019; companies without an
identified target. The subsequent measurements of the Private Placement Warrants after the detachment of the Public Warrants from the
Units is classified as Level 2 due to the use of an observable market quote for a similar asset in an active market, as the transfer
of Private Placement Warrants to anyone outside of a small group of individuals who are permitted transferees would result in the Private
Placement Warrants having substantially the same terms as the Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the changes in the fair value of Level 3 warrant liabilities:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zwu4cfXkCZrf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BA_zraT7XkGrG62" style="display: none"&gt;Schedule of change in the fair value of the Level 3 warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Private Placement&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Public&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrant Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"&gt;Fair value as of December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zQBCMnSg4Ycb" style="width: 9%; text-align: right" title="Fair value at beginning"&gt;9,354,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z4cUM70bNR1l" style="width: 9%; text-align: right" title="Fair value at beginning"&gt;12,558,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zj7rzQFsIys" style="width: 9%; text-align: right" title="Fair value at beginning"&gt;21,912,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value"&gt;(2,672,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value"&gt;(3,588,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value"&gt;(6,260,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Transfer to Level 1&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1187"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1"&gt;(8,970,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1"&gt;(8,970,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Transfer to Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2"&gt;(6,682,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1195"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2"&gt;(6,682,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Fair value as of December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zsqdPXH9bslk" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1199"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zCwVI7FgBuw8" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zj0KR7eFqBq7" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1203"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zVCpjJuSrMIc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transfers
to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs.
The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement during the
period ended December&#160;31, 2021 was approximately $&lt;span id="xdx_903_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_pp0n3_dm_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zMkJ0VYPeTu2" title="Transfer to Level 1"&gt;9.0&lt;/span&gt; million, when the Public Warrants were separately listed and traded and the
estimated fair value of the Private Warrants of approximately $&lt;span id="xdx_902_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_pp0n3_dm_c20220101__20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zy42tSojGoCl" title="Transfer to Level 2"&gt;6.7&lt;/span&gt; million was transferred from a Level 3 to a Level 2 fair value measurement.
There were no transfers during the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2022-12-31_us-gaap_CashMember"
      decimals="0"
      unitRef="USD">3923804</us-gaap:AssetsHeldInTrustNoncurrent>
    <cxai:ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">231500</cxai:ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax>
    <cxai:ProceedsFromTrustAccountInConnectionWithRedemption
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      unitRef="USD">275102280</cxai:ProceedsFromTrustAccountInConnectionWithRedemption>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2021-12-31_us-gaap_CashMember"
      decimals="0"
      unitRef="USD">898</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2021-12-31_us-gaap_MoneyMarketFundsMember"
      decimals="0"
      unitRef="USD">278835182</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="From2022-01-012022-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_z4PIr496IIQ1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BB_zpXDUooqaxq9" style="display: none"&gt;Schedule of company's assets and liabilities that are measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="5" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="5" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Description&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"&gt;Money Market Funds&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: center"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsHeldInTrustNoncurrent_c20221231__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="width: 9%; text-align: right" title="Assets held in the Trust Account"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1158"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: center"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsHeldInTrustNoncurrent_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--MoneyMarketFundsMember_pp0p0" style="width: 9%; text-align: right" title="Assets held in the Trust Account"&gt;278,835,182&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Warrant liabilities &#x2013; public warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities"&gt;414,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities"&gt;6,461,798&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Warrant liabilities &#x2013; private placement warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities"&gt;308,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_c20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Warrant liabilities"&gt;4,813,571&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2021-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MoneyMarketFundsMember"
      decimals="0"
      unitRef="USD">278835182</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="AsOf2022-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      unitRef="USD">414000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="AsOf2021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      unitRef="USD">6461798</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="AsOf2022-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      unitRef="USD">308400</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="AsOf2021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      unitRef="USD">4813571</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="From2022-01-012022-12-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zwu4cfXkCZrf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BA_zraT7XkGrG62" style="display: none"&gt;Schedule of change in the fair value of the Level 3 warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Private Placement&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Public&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrant Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left"&gt;Fair value as of December&#160;31, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zQBCMnSg4Ycb" style="width: 9%; text-align: right" title="Fair value at beginning"&gt;9,354,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z4cUM70bNR1l" style="width: 9%; text-align: right" title="Fair value at beginning"&gt;12,558,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zj7rzQFsIys" style="width: 9%; text-align: right" title="Fair value at beginning"&gt;21,912,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value"&gt;(2,672,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value"&gt;(3,588,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Change in fair value"&gt;(6,260,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Transfer to Level 1&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1187"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1"&gt;(8,970,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="text-align: right" title="Transfer to Level 1"&gt;(8,970,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;Transfer to Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2"&gt;(6,682,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1195"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Transfer to Level 2"&gt;(6,682,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;Fair value as of December&#160;31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zsqdPXH9bslk" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1199"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zCwVI7FgBuw8" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zj0KR7eFqBq7" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1203"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      unitRef="USD">9354800</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      unitRef="USD">12558000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      unitRef="USD">21912800</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2021-01-012021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      unitRef="USD">-2672800</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2021-01-012021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      unitRef="USD">-3588000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      unitRef="USD">-6260800</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1
      contextRef="From2021-01-012021-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      unitRef="USD">-8970000</cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1>
    <cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1
      contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      unitRef="USD">-8970000</cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1>
    <cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2
      contextRef="From2021-01-012021-12-31_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      unitRef="USD">-6682000</cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2>
    <cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2
      contextRef="From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="0"
      unitRef="USD">-6682000</cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2>
    <cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1
      contextRef="From2022-01-012022-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">9000000.0</cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1>
    <cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2
      contextRef="From2022-01-012022-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      unitRef="USD">6700000</cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2022-01-012022-12-31">&lt;p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zSNjuNmfq1l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
12 &#x2014; &lt;span id="xdx_826_zFPmDdvQPfp9"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated
financial statements were issued. Based upon this review, other than as noted below, the Company did not identify any subsequent events
that would have required adjustment or disclosure in the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January&#160;9, 2023, the Company received a notice from the Listing Qualifications Department of The Nasdaq Stock Market (&#x201c;Nasdaq&#x201d;)
stating that the Company failed to hold an annual meeting of stockholders within 12 months after its fiscal year ended December&#160;31,
2021, as required by Nasdaq Listing Rule&#160;5620(a). In accordance with Nasdaq Listing Rule&#160;5810(c)(2)(G), the Company had 45
calendar days (or until February&#160;23, 2023) to submit a plan to regain compliance and, if Nasdaq accepts the plan, Nasdaq may grant
the Company up to 180 calendar days from its fiscal year end, or until June&#160;29, 2023, to regain compliance. The Company submitted
a compliance plan within the specified period. While the plan is pending, the Company&#x2019;s securities will continue to trade on Nasdaq.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January&#160;21, 2023, the Company received a written notice (the &#x201c;Notice&#x201d;) from the Listing Qualifications Department of
The Nasdaq Stock Market (&#x201c;Nasdaq&#x201d;) indicating that the Company is not in compliance with Listing Rule&#160;5550(a)(4), due
to the Company&#x2019;s failure to meet the minimum 500,000 publicly held shares requirement for continued listing on the Nasdaq Capital
Market. The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading
of the Company&#x2019;s securities on the Nasdaq Capital Market. The Notice stated that the Company had until March&#160;9, 2023 to submit
a plan to regain compliance with Listing Rule&#160;5550(a)(4). The Company believes that the issue identified in the Notice will be resolved
upon completion of the previously announced proposed business combination with CXApp Holding Corp. The Company submitted a compliance
plan within the specified period. If Nasdaq accepts the Company&#x2019;s plan, Nasdaq may grant the Company an extension of up to 180
calendar days from the date of the Notice to evidence compliance with Listing Rule&#160;5550(a)(4). If Nasdaq does not accept the Company&#x2019;s
plan, the Company will have the opportunity to appeal the decision in front of a Nasdaq Hearings Panel.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">6724000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">6308000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2671000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1338000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">102000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">273000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssets
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">1232000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:PrepaidExpenseAndOtherAssets
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">650000</us-gaap:PrepaidExpenseAndOtherAssets>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">10729000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">8569000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">153000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">202000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">20753000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">19289000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">549000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">681000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">487000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:Goodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">44122000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">78000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">52000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">76384000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">29280000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">596000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1054000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">3233000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1736000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2690000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2162000</us-gaap:DeferredRevenueCurrent>
    <cxai:AcquisitionLiability
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">197000</cxai:AcquisitionLiability>
    <us-gaap:ExtendedProductWarrantyAccrualCurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">963000</us-gaap:ExtendedProductWarrantyAccrualCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">195000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">266000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">7677000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">5415000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">376000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">444000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">30000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2778000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">10831000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">5889000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">8582699</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CommonClassAMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">5487300</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">71536000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-5985000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1155000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <cxai:NetParentInvestment
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">22236000</cxai:NetParentInvestment>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">65553000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">23391000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">76384000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">29280000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">342000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1620000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2582000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">87000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">483000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">589000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">255000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1137000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1993000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">211000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1455000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1991000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">174000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">964000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1122000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">241000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2293000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2304000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">116000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">806000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">975000</us-gaap:AmortizationOfIntangibleAssets>
    <cxai:ChangeInFairValueOfEarnout
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2827000</cxai:ChangeInFairValueOfEarnout>
    <us-gaap:OperatingExpenses
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">742000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">5518000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">3565000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-487000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-4381000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-1572000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-1000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">1686000</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">1685000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">1198000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-4380000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-1571000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-1560000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2758000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-4380000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-1671000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">28000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">189000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2758000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-4408000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-1860000</us-gaap:ComprehensiveIncomeNetOfTax>
    <cxai:BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="INF"
      unitRef="Shares">8582699</cxai:BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock>
    <cxai:BasicAndDilutiveNetIncomePerShareClassCommonStock
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="INF"
      unitRef="USDPShares">0.20</cxai:BasicAndDilutiveNetIncomePerShareClassCommonStock>
    <cxai:BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="INF"
      unitRef="Shares">5487300</cxai:BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock>
    <cxai:BasicAndDilutiveNetIncomePerShareClassCCommonStock
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="INF"
      unitRef="USDPShares">0.20</cxai:BasicAndDilutiveNetIncomePerShareClassCCommonStock>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_NetParentInvestmentMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">20155000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">56000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_PredecessorMember_custom_TotalMember"
      decimals="-3"
      unitRef="USD">20211000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-1671000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_TotalMember"
      decimals="-3"
      unitRef="USD">-1671000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">647000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_TotalMember"
      decimals="-3"
      unitRef="USD">647000</us-gaap:ShareBasedCompensation>
    <cxai:ParentsCommonSharesIssuedForCxappEarnout
      contextRef="From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">3697000</cxai:ParentsCommonSharesIssuedForCxappEarnout>
    <cxai:ParentsCommonSharesIssuedForCxappEarnout
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_TotalMember"
      decimals="-3"
      unitRef="USD">3697000</cxai:ParentsCommonSharesIssuedForCxappEarnout>
    <cxai:TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits
      contextRef="From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-104000</cxai:TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits>
    <cxai:TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_TotalMember"
      decimals="-3"
      unitRef="USD">-104000</cxai:TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits>
    <cxai:NetInvestmentsFromParent
      contextRef="From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">6444000</cxai:NetInvestmentsFromParent>
    <cxai:NetInvestmentsFromParent
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_TotalMember"
      decimals="-3"
      unitRef="USD">6444000</cxai:NetInvestmentsFromParent>
    <cxai:CumulativeTranslationAdjustment
      contextRef="From2022-01-012022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-189000</cxai:CumulativeTranslationAdjustment>
    <cxai:CumulativeTranslationAdjustment
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_TotalMember"
      decimals="-3"
      unitRef="USD">-189000</cxai:CumulativeTranslationAdjustment>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">29168000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-133000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-03-31_custom_PredecessorMember_custom_TotalMember"
      decimals="-3"
      unitRef="USD">29035000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_NetParentInvestmentMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">22236000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1155000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_TotalMember"
      decimals="-3"
      unitRef="USD">23391000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_NetParentInvestmentMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-4380000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_TotalMember"
      decimals="-3"
      unitRef="USD">-4380000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-03-14_custom_NetParentInvestmentMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">158000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_TotalMember"
      decimals="-3"
      unitRef="USD">158000</us-gaap:ShareBasedCompensation>
    <cxai:NetInvestmentsFromParent
      contextRef="From2023-01-012023-03-14_custom_NetParentInvestmentMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">8680000</cxai:NetInvestmentsFromParent>
    <cxai:NetInvestmentsFromParent
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_TotalMember"
      decimals="-3"
      unitRef="USD">8680000</cxai:NetInvestmentsFromParent>
    <cxai:CumulativeTranslationAdjustment
      contextRef="From2023-01-012023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-28000</cxai:CumulativeTranslationAdjustment>
    <cxai:CumulativeTranslationAdjustment
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_TotalMember"
      decimals="-3"
      unitRef="USD">-28000</cxai:CumulativeTranslationAdjustment>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-14_custom_NetParentInvestmentMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">26694000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-14_us-gaap_AccumulatedOtherComprehensiveIncomeMember_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1127000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-14_custom_PredecessorMember_custom_TotalMember"
      decimals="-3"
      unitRef="USD">27821000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-14_custom_ClassACommonStockMember_custom_SuccessorMember"
      decimals="INF"
      unitRef="Shares">7034999</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-14_custom_ClassACommonStockMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-14_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">1607000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-14_us-gaap_RetainedEarningsMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-8743000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-14_custom_TotalMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-7135000</us-gaap:StockholdersEquity>
    <cxai:SharesIssuedInConnectionWithBusinessCombinationShares
      contextRef="From2023-03-152023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember"
      decimals="INF"
      unitRef="Shares">1547700</cxai:SharesIssuedInConnectionWithBusinessCombinationShares>
    <cxai:SharesIssuedInConnectionWithBusinessCombinationShares
      contextRef="From2023-03-152023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember"
      decimals="INF"
      unitRef="Shares">5487300</cxai:SharesIssuedInConnectionWithBusinessCombinationShares>
    <cxai:SharesIssuedInConnectionWithBusinessCombination
      contextRef="From2023-03-152023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">1000</cxai:SharesIssuedInConnectionWithBusinessCombination>
    <cxai:SharesIssuedInConnectionWithBusinessCombination
      contextRef="From2023-03-152023-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">69927000</cxai:SharesIssuedInConnectionWithBusinessCombination>
    <cxai:SharesIssuedInConnectionWithBusinessCombination
      contextRef="From2023-03-152023-03-31_custom_TotalMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">69928000</cxai:SharesIssuedInConnectionWithBusinessCombination>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_us-gaap_RetainedEarningsMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2758000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_TotalMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2758000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-152023-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-152023-03-31_custom_TotalMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2000</us-gaap:ShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember"
      decimals="INF"
      unitRef="Shares">8582699</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_custom_ClassACommonStockMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember"
      decimals="INF"
      unitRef="Shares">5487300</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_custom_ClassCCommonStockMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">71536000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-5985000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_custom_TotalMember_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">65553000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2758000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-4380000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-1671000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">4000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">228000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">145000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">116000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">806000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">975000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">8000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">40000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">56000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-1560000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-2000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">158000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">647000</us-gaap:ShareBasedCompensation>
    <cxai:GainOnEarnoutPaymentLiability
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2827000</cxai:GainOnEarnoutPaymentLiability>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-3000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">32000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">266000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <cxai:GainOnChangeInFairValueOfDerivativeLiability
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">1686000</cxai:GainOnChangeInFairValueOfDerivativeLiability>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">335000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">857000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">304000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">100000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">20000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">521000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">37000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-42000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">135000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-796000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-94000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-3888000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-787000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">100000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInIncomeTaxes
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">6000</us-gaap:IncreaseDecreaseInIncomeTaxes>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-7000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-38000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-56000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">156000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">534000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-370000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-4431000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-5144000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-4140000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">23000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">9000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">12000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <cxai:InvestmentInCapitalizedSoftware
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">45000</cxai:InvestmentInCapitalizedSoftware>
    <cxai:InvestmentInCapitalizedSoftware
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">39000</cxai:InvestmentInCapitalizedSoftware>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">10003000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">9980000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-54000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-51000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <cxai:NetEquityInvestmentFromParent
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">9089000</cxai:NetEquityInvestmentFromParent>
    <cxai:NetEquityInvestmentFromParent
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">6444000</cxai:NetEquityInvestmentFromParent>
    <cxai:TaxesPaidRelatedForStockBasedCompensation
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">104000</cxai:TaxesPaidRelatedForStockBasedCompensation>
    <cxai:RepaymentOfCxappAcquisitionLiability
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">197000</cxai:RepaymentOfCxappAcquisitionLiability>
    <cxai:RepaymentOfCxappAcquisitionLiability
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1787000</cxai:RepaymentOfCxappAcquisitionLiability>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">328000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-328000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">8892000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">4553000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">4000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">5221000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">3695000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">366000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-03-14_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">1503000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">6308000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2021-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">5028000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">6724000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">10003000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">5394000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <cxai:ParentsNetEquityIssuedForCxAppEarnout
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">3697000</cxai:ParentsNetEquityIssuedForCxAppEarnout>
    <cxai:NoncashDistribution
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">409000</cxai:NoncashDistribution>
    <cxai:ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">69928000</cxai:ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination>
    <cxai:FinancingOfDirectorAndOfficerInsurance
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">537000</cxai:FinancingOfDirectorAndOfficerInsurance>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_80C_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zkCn7rVV06pa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            1 &#x2013; &lt;span id="xdx_823_zpQ1i1tyFSV9"&gt;Organization, Nature of Business and Basis of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;CXApp
Inc. and its subsidiaries (&#x201c;CXApp&#x201d; or the &#x201c;Company&#x201d;) is in the business of delivering intelligent enterprise
workplace experiences. &lt;span style="background-color: white"&gt;The CXApp SaaS platform offers a suite of leading-edge technology workplace
experience solutions including an enterprise employee application, indoor mapping, on-device positioning, augmented reality technologies
and an AI-based analytics platform, targeting the emerging hybrid workplace market to provide enhanced experiences across people, places,
and things. CXApp creates a connected workplace by reducing app overload, data fragmentation, and complex workflows and streamlines all
capabilities through The Workplace SuperApp. All features, services and integrations are housed in one easy-to-access platform allowing
businesses to deliver a more holistic employee experiences in a hybrid workplace.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The accompanying
unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting
principles in the United States of America (&#x201c;GAAP&#x201d;), for interim financial information and the rules and regulations of the
Securities and Exchange Commission (&#x201c;SEC&#x201d;). Accordingly, CXApp does not include all of the information and footnotes required
by GAAP for complete financial statements. In the opinion of CXApp, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Interim results for the three months ended March 31, 2023 are not necessarily indicative
of the results for the full year ending December 31, 2023. These interim unaudited condensed consolidated financial statement should
be read in conjunction with KINS Technology Group Inc.&#x2019;s (&#x201c;KINS&#x201d;) audited consolidated financial statements and notes
for the year ended December 31, 2022 and 2021 included in the annual report on Form 10-K/A for the year ended December 31, 2022, filed
with the SEC on April 19, 2023, and the annual report of Legacy CXApp for the year ended December 31, 2022 and 2021 included as an exhibit
to Form 8-K filed with the SEC on March 20, 2023. All material inter-company balances and transactions have been eliminated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;On September
25, 2022, an Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;), was entered into by and among Inpixon, KINS Technology
Group Inc., a Delaware corporation, CXApp, and KINS Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of KINS (&#x201c;Merger
Sub&#x201d;), pursuant to which KINS acquired Inpixon&#x2019;s enterprise apps business (including its workplace experience technologies,
indoor mapping, events platform, augmented reality and related business solutions) (&#x201c;Legacy CXApp&#x201d;) in exchange for the issuance
of shares of KINS capital stock (the &#x201c;Business Combination&#x201d;). As a result of the Business Combination, KINS changed their
name to CXApp Inc. (&#x201c;New CXApp&#x201d;). The shares are now trading on the Nasdaq using the ticker CXAI. The transaction closed
on March 14, 2023. See Note 3 for more details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;Unless
the context otherwise requires, &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; &#x201c;CXApp&#x201d; and the &#x201c;Company&#x201d;
refer to CXApp Inc., a Delaware corporation, and its consolidated subsidiaries following the Business Combination (as defined below).
Unless the context otherwise requires, references to &#x201c;KINS&#x201d; refer to KINS Technology Group Inc., a Delaware corporation (&#x201c;KINS&#x201d;),
the Company prior to the Business Combination. All references herein to the &#x201c;Board&#x201d; refer to the board of directors of the
Company. &#x201c;Legacy CXApp&#x201d; refers to CXApp Holding Corp., a Delaware corporation and a wholly owned subsidiary of the Company,
which the Company acquired through the Business Combination. Prior to the Separation (as defined below), Legacy CXApp was a wholly owned
subsidiary of Inpixon, a Nevada corporation (&#x201c;Inpixon&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Business
Combination was accounted for using the acquisition method (as a forward merger), with goodwill and other identifiable intangible assets
recorded in accordance with GAAP, as applicable. Under this method of accounting, the &#x201c;Enterprise Apps Business&#x201d; (formerly
known as CXApp) is treated as the &#x201c;acquired&#x201d; company for financial reporting purposes. KINS (now known as CXApp Inc.) has
been determined to be the accounting acquirer because KINS maintains control of the Board of Directors and management of the combined
company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
unaudited condensed consolidated financial statements of Successor and Predecessor are not comparable due to a new basis of accounting
that was created from the business combination that occurred on the Closing Date (Note 3). Therefore, the reporting period has been separated
by a black line in the condensed consolidated financial statements with the Predecessor representing the pre-Closing Date period (January
1, 2023 through March 14, 2023) and the Successor representing the post-Closing Date period (March 15, 2023 through March 31, 2023).
The Company noted that the &#x201c;Predecessor&#x201d; includes financial information related to the Enterprise Apps Business (as defined
in Note 3), while the &#x201c;Successor&#x201d; includes financial information related to the newly formed company after the business combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zPmLo5HYi1l6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            2 &#x2013; Summary of Significant Accounting Policies&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_829_zAfnR3Sa9x59" style="display: none"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--LiquidityAndGoingConcernPolicyTextBlock_zw3E5NpOJlNg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Liquidity
                                            &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2023 (Successor), the Company has a working capital surplus of approximately $&lt;span id="xdx_900_ecustom--WorkingCapital_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Working capital"&gt;3,052&lt;/span&gt;&#160;thousand and cash and cash equivalents of approximately
$&lt;span id="xdx_907_eus-gaap--Cash_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Cash"&gt;6,724&lt;/span&gt;&#160;thousand. For the period ended March 31, 2023 (Successor), the Company incurred net income
of approximately $&lt;span id="xdx_906_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Net income"&gt;2,758&lt;/span&gt; thousand. During the period ended March 31, 2023 (Successor), the Company used approximately $&lt;span id="xdx_90D_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_di_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFXCqwS29eM8" title="Cash for operating activities"&gt;4,431&lt;/span&gt; thousand of
cash for operating activities, of which $&lt;span id="xdx_903_eus-gaap--OtherAccruedLiabilitiesCurrent_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Reduction in accrued liabilities"&gt;3,888&lt;/span&gt; thousand was from a reduction in accrued liabilities, primarily paying merger related
transaction liabilities. In assessing the Company&#x2019;s ability to continue as a going concern, the Company monitors and analyzes its
cash and its ability to generate sufficient cash flow in the future to support its operating and capital expenditure commitments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;The
Company cannot assure that it will ever earn revenues sufficient to support their operations, or that it will ever achieve profitable
operations. The Company&#x2019;s recurring losses and utilization of cash in its operations are indicators of substantial doubt that the
entity can continue as a going concern however with the Company&#x2019;s current liquidity position the Company has taken steps to reduce
operating expenses and extend it&#x2019;s runway. The Company intends to finance its future working capital requirements and capital expenditures
from cash generated from operating activities and may consider raising funds from equity financings. Management believes that the actions
presently being taken to further implement its business plan and generate its revenues provide the opportunity for the Company to continue
as a going concern for at least 12 months from the issuance of these condensed consolidated financial statements. While the Company believes
in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that
effect for at least twelve months from the issuance of these condensed consolidated financial statements. The ability of the Company
to continue as a going concern is dependent upon the Company&#x2019;s ability to further implement its business plan. The accompanying
unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization
of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments
relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might
result from the outcome of the uncertainties described above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--UseOfEstimates_z2Ou3EfIXRz8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Use
                                            of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;)
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during each of the reporting
periods. Actual results could differ from those estimates. The Company&#x2019;s significant estimates consist of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            valuation of stock-based compensation;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            valuation of warrant liabilities;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            allowance for credit losses;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            valuation allowance for deferred tax assets; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;impairment
                                            of long-lived assets and goodwill.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zWE2s2Vjh8xk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Cash
                                            and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents consist of cash, checking accounts, money market accounts, temporary investments and certificates of deposit with
maturities of three months or less when purchased. &lt;span id="xdx_90B_ecustom--CashAndCashEquivalentsDescription_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFNmvvmyQX9l" title="Cash and cash equivalents, description"&gt;As of March 31, 2023 (Successor), the Company had cash equivalents  of approximately $2,000 thousand of certificates of
deposit held by a number of banks limited to $250 thousand per bank with a duration of 90 days or less&lt;/span&gt; and at December 31, 2022 (Predecessor)
the Company had no cash equivalents.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock_zefF4QCGnSNj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Accounts
                                            Receivable, net and Allowance for Credit Losses&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;Accounts
receivables are stated at the amount the Company expects to collect. The Company recognizes an allowance for credit losses to ensure
accounts receivables are not overstated due to un-collectability. Bad debt reserves are maintained for various customers based on a variety
of factors, including the length of time the receivables are past due, significant one-time events and historical experience. An additional
reserve for individual accounts is recorded when the Company becomes aware of a customer&#x2019;s inability to meet its financial obligation,
such as in the case of bankruptcy filings, or deterioration in such customer&#x2019;s operating results or financial position. If circumstances
related to a customer change, estimates of the recoverability of receivables would be further adjusted. The Company&#x2019;s allowance
for credit losses is not significant as of March 31, 2023 (Successor) and at December 31, 2022 (Predecessor).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












&lt;p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zNREgUj0V3nh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Property
                                            and Equipment, net&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are recorded at cost, less accumulated depreciation and amortization. The Company depreciates its property and equipment
for financial reporting purposes using the straight-line method over the estimated useful lives of the assets, which range from 3 to
10 years. Leasehold improvements are amortized over the lesser of the useful life of the asset or the initial lease term. Expenditures
for maintenance and repairs, which do not extend the economic useful life of the related assets, are charged to operations as incurred,
and expenditures, which extend the economic life, are capitalized. When assets are retired, or otherwise disposed of, the costs and related
accumulated depreciation or amortization are removed from the accounts and any gain or loss on disposal is recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z4fAlHyLJg8e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Intangible
                                            Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets primarily consist of developed technology, customer lists/relationships, non-compete agreements, intellectual property
agreements, export licenses and trade names/trademarks. They are amortized ratably over a range of &lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zZPQov9BPJu7" title="Intangible assets useful life"&gt;1 &lt;/span&gt;
to &lt;span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_ziSd4Biku1B2" title="Intangible assets useful life"&gt;10&lt;/span&gt;
years, which approximates customer attrition rate and technology obsolescence. The Company assesses the carrying value of its
intangible assets for impairment each year. Based on its assessments, the Company did not incur any impairment charges for the
period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022
(Predecessor).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--GoodwillDisclosureTextBlock_zotamlkSrV76" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Goodwill&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company tests goodwill for potential impairment at least annually, or more frequently if an event or other circumstance indicates that
the Company may not be able to recover the carrying amount of the net assets of the reporting unit. The Company has determined that the
reporting unit is the entire company, due to the integration of all of the Company&#x2019;s activities. In evaluating goodwill for impairment,
the Company may assess qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50%) that
the fair value of a reporting unit is less than its carrying amount. If the Company bypasses the qualitative assessment, or if the Company
concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs
a quantitative impairment test by comparing the fair value of a reporting unit with its carrying amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company calculates the estimated fair value of a reporting unit using a weighting of the income and market approaches. For the income
approach, the Company uses internally developed discounted cash flow models that include the following assumptions, among others: projections
of revenues, expenses, and related cash flows based on assumed long-term growth rates and demand trends; expected future investments
to grow new units; and estimated discount rates. For the market approach, the Company uses internal analyses based primarily on market
comparables. The Company bases these assumptions on its historical data and experience, third party appraisals, industry projections,
micro and macro general economic condition projections, and its expectations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--LeasesAndRightofUseAssetsPolicyTextBlock_zH39sJYL1091" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Leases
                                            and Right-of-Use Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines if an arrangement is a lease at its inception. Operating lease liabilities are recognized at the lease commencement
date based on the present value of lease payments over the lease term. The Company generally uses their incremental borrowing rate based
on the information available at the lease commencement date in determining the present value of future payments, because the implicit
rate of the lease is generally not known. Right-of-use assets related to the Company&#x2019;s operating lease liabilities are measured
at lease inception based on the initial measurement of the lease liability, plus any prepaid lease payments and less any lease incentives.
The Company&#x2019;s lease terms that are used in determining their operating lease liabilities at lease inception may include options
to extend or terminate the leases when it is reasonably certain that the Company will exercise such options. The Company amortizes their
right-of-use assets as operating lease expense generally on a straight-line basis over the lease term and classify both the lease amortization
and imputed interest as operating expenses. The Company does not recognize lease assets and lease liabilities for any lease with an original
lease term of less than one year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












&lt;p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zHn9JBCIYIBb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Income
                                            Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes using the asset and liability method. Accordingly, deferred tax assets and liabilities are recognized
for the future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities
and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in the tax rate is recognized in income or expense in the period that the change is effective. Income tax benefits
are recognized when it is probable that the deduction will be sustained. A valuation allowance is established when it is more likely
than not that all or a portion of a deferred tax asset will either expire before the Company is able to realize the benefit, or that
future deductibility is uncertain.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zlwVv8rtPbOj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Comprehensive
                                            Income (Loss) and Foreign Currency Translation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reports comprehensive income (loss) and its components in its unaudited condensed consolidated financial statements. Comprehensive
loss consists of net loss and foreign currency translation adjustments, affecting stockholders&#x2019; equity that, under GAAP, are excluded
from net loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
and liabilities related to the Company&#x2019;s foreign operations are calculated using the Philippine peso and Canadian Dollar, and are
translated at end-of-period exchange rates, while the related revenues and expenses are translated at average exchange rates prevailing
during the period. Gains or losses resulting from transactions denominated in foreign currencies are included in general and administrative
expenses in the unaudited condensed consolidated statements of operations. The Company engages in foreign currency denominated transactions
with customers that operate in functional currencies other than the U.S. dollar. Aggregate foreign currency net transaction losses were
not material for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and three months ended March
31, 2022 (Predecessor).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zp5bNAYYFyRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Revenue
                                            Recognition&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;The
Company recognizes revenue when control is transferred of the promised products or services to its customers, in an amount that reflects
the consideration the Company expects to be entitled to in exchange for those products or services. The Company derives revenue from
its software as a service for cloud based software, as well as design, implementation and other professional services for work performed
in conjunction with its cloud based software. The Company enters into contracts with its customers whereby it grants a non-exclusive
cloud-based license for the use of its proprietary software and for professional services. The contracts may also provide for on-going
services for a specified price, which may include maintenance services, designated support, and enhancements, upgrades and improvements
to the software, depending on the contract. Licenses for cloud software provide the customer with a right to use the software as it exists
when made available to the customer. All software provides customers with the same functionality and differ mainly in the duration over
which the customer benefits from the software.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;License
Subscription Revenue Recognition (Software As A Service)&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;With respect
to sales of the Company&#x2019;s license agreements, customers generally pay fixed annual fees in advance in exchange for the Company&#x2019;s
software service provided by via electronic, which are generally recognized ratably over the license term. Some agreements allow the
customer to terminate their subscription contracts before the end of the applicable term, and in such cases the customer is generally
entitled to a refund pro-rata but only for the elapsed time remaining at the point of termination, which would approximate the deferred
revenue at such time. The Company&#x2019;s performance obligation is satisfied over time as the electronic services are provided continuously
throughout the service period. The Company recognizes revenue evenly over the service period using a time-based measure because the Company
is providing continuous access to its service. The Company&#x2019;s customers generally pay within 30 to 60 days from the receipt of a
customer approved invoice.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The timing
of the Company&#x2019;s revenue recognition related to the licensing revenue stream is dependent on whether the software licensing agreement
entered into represents a service. Software that relies on an entity&#x2019;s IP and is delivered only through a hosting arrangement,
where the customer cannot take possession of the software, is a service. Customers may purchase perpetual licenses or subscribe to licenses,
which provide customers with the same functionality and differ mainly in the duration over which the customer benefits from the software.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;Renewals
or extensions of licenses are evaluated as distinct licenses and revenue attributed to the distinct service is not recognized until (1)
the entity provides the distinct license (or makes the license available) to the customer and (2) the customer is able to use and benefit
from the distinct license. Renewal contracts are not combined with original contracts, and, as a result, the renewal right is evaluated
in the same manner as all other additional rights granted after the initial contract. The revenue is not recognized until the customer
can begin to use and benefit from the license, which is typically at the beginning of the license renewal period. The Company recognizes
revenue resulting from renewal of licensed software over time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Professional
Services Revenue Recognition&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s professional services include milestone, fixed fee and time and materials contracts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Professional
services under milestone contracts are accounted for using the percentage of completion method. As soon as the outcome of a contract
can be estimated reliably, contract revenue is recognized in the statement of operations in proportion to the stage of completion of
the contract. Contract costs are expensed as incurred. Contract costs include all amounts that relate directly to the specific contract,
are attributable to contract activity, and are specifically chargeable to the customer under the terms of the contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;Professional
services are also contracted on the fixed fee and in some cases on a time and materials basis. Fixed fees are paid monthly, in phases,
or upon acceptance of deliverables. The Company&#x2019;s time and materials contracts are paid weekly or monthly based on hours worked.
Revenue on time and material contracts is recognized based on a fixed hourly rate as direct labor hours are expended. Materials, or other
specified direct costs, are reimbursed as actual costs and may include markup. The Company has elected the practical expedient to recognize
revenue for the right to invoice because the Company&#x2019;s right to consideration corresponds directly with the value to the customer
of the performance completed to date. For fixed fee contracts provided by in house personnel, the Company recognizes revenue evenly over
the service period using a time-based measure because the Company is providing continuous service. Because the Company&#x2019;s contracts
have an expected duration of one year or less, the Company has elected the practical expedient in ASC 606-10-50-14(a) to not disclose
information about its remaining performance obligations. Anticipated losses are recognized as soon as they become known. For the period
ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor), the
Company did not incur any such losses. These amounts are based on known and estimated factors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Contract
Balances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
timing of the Company&#x2019;s revenue recognition may differ from the timing of invoicing to and payment by its customers. The Company
records an unbilled receivable when revenue is recognized prior to invoicing and the Company has an unconditional right to payment. Alternatively,
when invoicing a customer precedes the company providing of the related services, the Company records deferred revenue until the performance
obligations are satisfied. The Company had deferred revenue of approximately $&lt;span id="xdx_906_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3"&gt;2,690
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;thousand and $&lt;span id="xdx_90D_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3"&gt;2,162
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;thousand as of March 31, 2023 (Successor) and
December 31, 2022 (Predecessor), respectively, related to customer invoices rendered in advance for software licenses and professional
services provided by the Company&#x2019;s technical staff. The Company expects to satisfy its remaining performance obligations for the
deferred revenue associated with professional services, and recognize the deferred revenue related to licenses generally over the remaining
contract term generally twelve months following the commencement of the license. The Company recognized revenue in the reporting period
of $&lt;span id="xdx_901_ecustom--RevenueRecognized_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zCVavrmQRK1" title="Revenue Recognized"&gt;170&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;thousand,
$&lt;span id="xdx_90E_ecustom--RevenueRecognized_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zApkMSdjWAUj"&gt;865
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;thousand, and $&lt;span id="xdx_902_ecustom--RevenueRecognized_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zdkdnojahzE7"&gt;1,328
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;thousand that was included in the contract liability
balance at the beginning of the period, for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and
three months ended March 31, 2022 (Predecessor), respectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Costs
to Obtain a Contract&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company
recognizes eligible sales commissions as an asset as the commissions are an incremental cost of obtaining a contract with the customer
and the Company expects to recover these costs. The capitalized costs are amortized over the expected contract term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Cost
to Fulfill a Contract&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company
incurs costs to fulfill their obligations under a contract once it has obtained. These costs are generally not significant and are recorded
to expense as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Multiple
Performance Obligations&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company enters into contracts with customers for its technology that include multiple performance obligations. Each distinct performance
obligation was determined by whether the customer could benefit from the good or service on its own or together with readily available
resources. The Company allocates revenue to each performance obligation based on its relative standalone selling price. The Company&#x2019;s
process for determining standalone selling price considers multiple factors including the Company&#x2019;s internal pricing model and
market trends that may vary depending upon the facts and circumstances related to each performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Sales
and Use Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company presents transactional taxes such as sales and use tax collected from customers and remitted to government authorities on a net
basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Shipping
and Handling Costs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shipping
and handling costs are expensed as incurred as part of cost of revenues. These costs were deemed to be nominal during each of the reporting
periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--BusinessCombinationsPolicy_zcQe09j48jy1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Business
                                            Combinations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for business combinations under Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification
(&#x201c;ASC&#x201d;) 805 &#x201c;Business Combinations&#x201d; using the acquisition method of accounting, and accordingly, the assets and
liabilities of the acquired business are recorded at their fair values at the date of acquisition. The excess of the purchase price over
the estimated fair value is recorded as goodwill. All acquisition costs are expensed as incurred. Upon acquisition, the accounts and
results of operations are included as of and subsequent to the acquisition date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zyLHpZiIf0o" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Segments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company and its Chief Executive Officer (&#x201c;CEO&#x201d;), acting as the Chief Operating Decision Maker (&#x201c;CODM&#x201d;) determines
its reporting units in accordance with FASB ASC 280, &#x201c;Segment Reporting&#x201d; (&#x201c;ASC 280&#x201d;). The Company evaluates a
reporting unit by first identifying its operating segments under ASC 280. The Company then evaluates each operating segment to determine
if it includes one or more components that constitute a business. If there are components within an operating segment that meet the definition
of a business, the Company evaluates those components to determine if they must be aggregated into one or more reporting units. If applicable,
when determining if it is appropriate to aggregate different operating segments, the Company determines if the segments are economically
similar and, if so, the operating segments are aggregated. The Company has one operating segment and reporting unit. The Company is organized
and operated as one business. Management reviews its business as a single operating segment, using financial and other information rendered
meaningful only by the fact that such information is presented and reviewed in the aggregate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












&lt;p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zqhxlV67YbOj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Stock-Based
                                            Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for options granted to employees by measuring the cost of services received in exchange for the award of equity instruments
based upon the fair value of the award on the date of grant. The fair value of that award is then ratably recognized as an expense over
the period during which the recipient is required to provide services in exchange for that award. Forfeitures of unvested stock options
are recorded when they occur.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company incurred stock-based compensation charges of approximately $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Stock-based compensation"&gt;2&lt;/span&gt;&#160;thousand, $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensation_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Stock-based compensation"&gt;158&lt;/span&gt;&#160;thousand and $&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Stock-based compensation"&gt;647&lt;/span&gt;&#160;thousand for the period ended March 31, 2023 (Successor), the period ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor),
respectively, which are included in general and administrative expenses.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--StandardProductWarrantyPolicy_z8jbBFSUKXZb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Derivative
                                            Warrant Liabilities&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company
accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#x2019;s specific
terms and applicable authoritative guidance in FASB ASC 480, &#x201c;Distinguishing Liabilities from Equity&#x201d; (&#x201c;ASC 480&#x201d;)
and ASC 815, &#x201c;Derivatives and Hedging&#x201d; (&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#x2019;s own common
stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted
at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. The Company currently
has two sets of warrants outstanding, known as the Private Placement Warrants and the Public Warrants, which are both classified as a
liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;For issued or modified warrants that meet all
of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the
time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required
to be recorded at their initial fair value on the date of issuance as a warrant liability, and adjusted to the then fair value in each
balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the condensed
consolidated statements of operations and amounted to approximately $&lt;span id="xdx_90E_ecustom--ChangesInEstimatedFairValueOfWarrants_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zlU3FR3IFPcj" title="Changes in estimated fair value of warrants"&gt;1,686&#160;&lt;/span&gt;thousand for the period ended March 31, 2023 (Successor).
The Company utilized the Public Warrant quoted market price as the fair value of the Warrants as of each relevant date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zExbuawx3YWi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Earnings
                                            Per Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company
computes basic and diluted earnings per share by dividing net income by the weighted average number of common shares outstanding during
the period. Diluted earnings per share are similarly calculated with the inclusion of dilutive common stock equivalents. The following
table summarizes the number of common shares and common share equivalents excluded from the calculation of diluted net income per common
share for period ended March 31, 2023 (Successor), which are excluded from the calculation because (i) the warrants were below their
exercise price and (ii) the stock options were not vested :&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_pn3n3_zXBF2PB15Bxd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policie (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span id="xdx_8B3_zmSyfTTgVZU" style="display: none"&gt;Schedule of antidilutive shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Period
    from&lt;br/&gt;
    March&#160;15,&lt;br/&gt;
    2023 to&lt;br/&gt;
    March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;Stock
    options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zn1dqT8iNFke" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;1,377&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total"&gt;&lt;span&gt;24,080&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span&gt;25,457&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zw0p08iuU5m" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
                                            Value Measurements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FASB
ASC 820, &#x201c;Fair Value Measurements&#x201d; (&#x201c;ASC 820&#x201d;), provides guidance on the development and disclosure of fair value
measurements. The Company follows this authoritative guidance for fair value measurements, which defines fair value, establishes a framework
for measuring fair value under generally accepted accounting principles in the United States, and expands disclosures about fair value
measurements. The guidance requires fair value measurements be classified and disclosed in one of the following three categories:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date
                                            for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            2: Observable prices that are based on inputs not quoted on active markets but corroborated
                                            by market data.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            3: Unobservable inputs which are supported by little or no market activity and values determined
                                            using pricing models, discounted cash flow methodologies, or similar techniques, as well
                                            as instruments for which the determination of fair value requires significant judgment or
                                            estimation.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value measurements discussed herein are based upon certain market assumptions and pertinent information available to management. Fair
value measurements are applied, when applicable, to determine the fair value of the Company&#x2019;s warrant liability at each reporting
period. See Note 10.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;












&lt;p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z1Yer2XJkN4k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
                                            Value of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments consist of cash and cash equivalents, accounts receivable, notes and other receivable and accounts payable. The Company determines
the estimated fair value of such financial instruments presented in these financial statements using available market information and
appropriate methodologies. These financial instruments are stated at their respective historical carrying amounts, which approximate
fair value due to their short-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zchAKvjusoEg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Carrying
                                            Value, Recoverability and Impairment of Long-Lived Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company
has adopted FASB ASC 360 &#x201c;Property, Plant, and Equipment&#x201d; (&#x201c;ASC 360&#x201d;) for its long-lived assets. Pursuant to
ASC 360-10-35-17, an impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable
and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted
cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the
carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount
by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. Pursuant to ASC 360-10-35-20 if an impairment
loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset,
the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized
impairment loss is prohibited.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to ASC 360-10-35-21, the Company&#x2019;s long-lived asset (asset group) is tested for recoverability whenever events or changes in circumstances
indicate that its carrying amount may not be recoverable. The Company considers the following to be some examples of such events or changes
in circumstances that may trigger an impairment review: (a) significant decrease in the market price of a long-lived asset (asset group);
(b) a significant adverse change in the extent or manner in which a long-lived asset (asset group) is being used or in its physical condition;
(c) a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset (asset
group), including an adverse action or assessment by a regulator; (d) an accumulation of costs significantly in excess of the amount
originally expected for the acquisition or construction of a long-lived asset (asset group); (e) a current-period operating or cash flow
loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated
with the use of a long-lived asset (asset group); and (f) a current expectation that, more likely than not, a long-lived asset (asset
group) will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. The Company tests
its long-lived assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based
on its assessments, the Company recorded &lt;span id="xdx_908_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zAfiZuSmiNrc" title="Impairment charges of long-lived assets"&gt;&lt;span id="xdx_903_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zITBxcg1cf54" title="Impairment charges of long-lived assets"&gt;&lt;span id="xdx_90F_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zzYDZSs08Vac" title="Impairment charges of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; impairment charges on long-lived assets for period ended March 31, 2023 (Successor), period
ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor), respectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zKtKg42HkPn6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Recently
                                            Issued and Adopted Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;In October
2021, the FASB issued ASU 2021-08, &#x201c;Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&#x201d;
(&#x201c;ASU 2021-08&#x201d;), which addresses diversity in practice related to the accounting for revenue contracts with customers acquired
in a business combination. Under the new guidance, the acquirer is required to apply Topic 606 to recognize and measure contract assets
and contract liabilities in a business combination. The effective date of the standard is for fiscal years beginning after December 15,
2022, including interim periods within those fiscal years, with early adoption permitted. CXApp adopted ASU 2021-08 on January 1, 2022.
As a result of management&#x2019;s evaluation, the adoption of ASU 2021-08 did not have a material impact on the consolidated financial
statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company
evaluated recently issued FASB accounting pronouncements and noted that no recent announcements were applicable to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <cxai:LiquidityAndGoingConcernPolicyTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_846_ecustom--LiquidityAndGoingConcernPolicyTextBlock_zw3E5NpOJlNg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Liquidity
                                            &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2023 (Successor), the Company has a working capital surplus of approximately $&lt;span id="xdx_900_ecustom--WorkingCapital_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Working capital"&gt;3,052&lt;/span&gt;&#160;thousand and cash and cash equivalents of approximately
$&lt;span id="xdx_907_eus-gaap--Cash_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Cash"&gt;6,724&lt;/span&gt;&#160;thousand. For the period ended March 31, 2023 (Successor), the Company incurred net income
of approximately $&lt;span id="xdx_906_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Net income"&gt;2,758&lt;/span&gt; thousand. During the period ended March 31, 2023 (Successor), the Company used approximately $&lt;span id="xdx_90D_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn3n3_di_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFXCqwS29eM8" title="Cash for operating activities"&gt;4,431&lt;/span&gt; thousand of
cash for operating activities, of which $&lt;span id="xdx_903_eus-gaap--OtherAccruedLiabilitiesCurrent_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Reduction in accrued liabilities"&gt;3,888&lt;/span&gt; thousand was from a reduction in accrued liabilities, primarily paying merger related
transaction liabilities. In assessing the Company&#x2019;s ability to continue as a going concern, the Company monitors and analyzes its
cash and its ability to generate sufficient cash flow in the future to support its operating and capital expenditure commitments.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;The
Company cannot assure that it will ever earn revenues sufficient to support their operations, or that it will ever achieve profitable
operations. The Company&#x2019;s recurring losses and utilization of cash in its operations are indicators of substantial doubt that the
entity can continue as a going concern however with the Company&#x2019;s current liquidity position the Company has taken steps to reduce
operating expenses and extend it&#x2019;s runway. The Company intends to finance its future working capital requirements and capital expenditures
from cash generated from operating activities and may consider raising funds from equity financings. Management believes that the actions
presently being taken to further implement its business plan and generate its revenues provide the opportunity for the Company to continue
as a going concern for at least 12 months from the issuance of these condensed consolidated financial statements. While the Company believes
in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that
effect for at least twelve months from the issuance of these condensed consolidated financial statements. The ability of the Company
to continue as a going concern is dependent upon the Company&#x2019;s ability to further implement its business plan. The accompanying
unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization
of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments
relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might
result from the outcome of the uncertainties described above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</cxai:LiquidityAndGoingConcernPolicyTextBlock>
    <cxai:WorkingCapital
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">3052000</cxai:WorkingCapital>
    <us-gaap:Cash
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">6724000</us-gaap:Cash>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2758000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-4431000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">3888000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:UseOfEstimates contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_849_eus-gaap--UseOfEstimates_z2Ou3EfIXRz8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Use
                                            of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;)
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during each of the reporting
periods. Actual results could differ from those estimates. The Company&#x2019;s significant estimates consist of:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            valuation of stock-based compensation;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            valuation of warrant liabilities;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            allowance for credit losses;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the
                                            valuation allowance for deferred tax assets; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;impairment
                                            of long-lived assets and goodwill.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_84B_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zWE2s2Vjh8xk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Cash
                                            and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents consist of cash, checking accounts, money market accounts, temporary investments and certificates of deposit with
maturities of three months or less when purchased. &lt;span id="xdx_90B_ecustom--CashAndCashEquivalentsDescription_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFNmvvmyQX9l" title="Cash and cash equivalents, description"&gt;As of March 31, 2023 (Successor), the Company had cash equivalents  of approximately $2,000 thousand of certificates of
deposit held by a number of banks limited to $250 thousand per bank with a duration of 90 days or less&lt;/span&gt; and at December 31, 2022 (Predecessor)
the Company had no cash equivalents.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <cxai:CashAndCashEquivalentsDescription contextRef="From2023-03-152023-03-31_custom_SuccessorMember">As of March 31, 2023 (Successor), the Company had cash equivalents  of approximately $2,000 thousand of certificates of
deposit held by a number of banks limited to $250 thousand per bank with a duration of 90 days or less</cxai:CashAndCashEquivalentsDescription>
    <cxai:AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_84A_ecustom--AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock_zefF4QCGnSNj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Accounts
                                            Receivable, net and Allowance for Credit Losses&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;Accounts
receivables are stated at the amount the Company expects to collect. The Company recognizes an allowance for credit losses to ensure
accounts receivables are not overstated due to un-collectability. Bad debt reserves are maintained for various customers based on a variety
of factors, including the length of time the receivables are past due, significant one-time events and historical experience. An additional
reserve for individual accounts is recorded when the Company becomes aware of a customer&#x2019;s inability to meet its financial obligation,
such as in the case of bankruptcy filings, or deterioration in such customer&#x2019;s operating results or financial position. If circumstances
related to a customer change, estimates of the recoverability of receivables would be further adjusted. The Company&#x2019;s allowance
for credit losses is not significant as of March 31, 2023 (Successor) and at December 31, 2022 (Predecessor).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












</cxai:AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zNREgUj0V3nh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Property
                                            and Equipment, net&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are recorded at cost, less accumulated depreciation and amortization. The Company depreciates its property and equipment
for financial reporting purposes using the straight-line method over the estimated useful lives of the assets, which range from 3 to
10 years. Leasehold improvements are amortized over the lesser of the useful life of the asset or the initial lease term. Expenditures
for maintenance and repairs, which do not extend the economic useful life of the related assets, are charged to operations as incurred,
and expenditures, which extend the economic life, are capitalized. When assets are retired, or otherwise disposed of, the costs and related
accumulated depreciation or amortization are removed from the accounts and any gain or loss on disposal is recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_84F_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z4fAlHyLJg8e" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Intangible
                                            Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets primarily consist of developed technology, customer lists/relationships, non-compete agreements, intellectual property
agreements, export licenses and trade names/trademarks. They are amortized ratably over a range of &lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zZPQov9BPJu7" title="Intangible assets useful life"&gt;1 &lt;/span&gt;
to &lt;span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_ziSd4Biku1B2" title="Intangible assets useful life"&gt;10&lt;/span&gt;
years, which approximates customer attrition rate and technology obsolescence. The Company assesses the carrying value of its
intangible assets for impairment each year. Based on its assessments, the Company did not incur any impairment charges for the
period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022
(Predecessor).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2023-01-012023-03-31_custom_SuccessorMember_srt_MinimumMember">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2023-01-012023-03-31_custom_SuccessorMember_srt_MaximumMember">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_843_eus-gaap--GoodwillDisclosureTextBlock_zotamlkSrV76" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Goodwill&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company tests goodwill for potential impairment at least annually, or more frequently if an event or other circumstance indicates that
the Company may not be able to recover the carrying amount of the net assets of the reporting unit. The Company has determined that the
reporting unit is the entire company, due to the integration of all of the Company&#x2019;s activities. In evaluating goodwill for impairment,
the Company may assess qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50%) that
the fair value of a reporting unit is less than its carrying amount. If the Company bypasses the qualitative assessment, or if the Company
concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs
a quantitative impairment test by comparing the fair value of a reporting unit with its carrying amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company calculates the estimated fair value of a reporting unit using a weighting of the income and market approaches. For the income
approach, the Company uses internally developed discounted cash flow models that include the following assumptions, among others: projections
of revenues, expenses, and related cash flows based on assumed long-term growth rates and demand trends; expected future investments
to grow new units; and estimated discount rates. For the market approach, the Company uses internal analyses based primarily on market
comparables. The Company bases these assumptions on its historical data and experience, third party appraisals, industry projections,
micro and macro general economic condition projections, and its expectations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillDisclosureTextBlock>
    <cxai:LeasesAndRightofUseAssetsPolicyTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_844_ecustom--LeasesAndRightofUseAssetsPolicyTextBlock_zH39sJYL1091" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Leases
                                            and Right-of-Use Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines if an arrangement is a lease at its inception. Operating lease liabilities are recognized at the lease commencement
date based on the present value of lease payments over the lease term. The Company generally uses their incremental borrowing rate based
on the information available at the lease commencement date in determining the present value of future payments, because the implicit
rate of the lease is generally not known. Right-of-use assets related to the Company&#x2019;s operating lease liabilities are measured
at lease inception based on the initial measurement of the lease liability, plus any prepaid lease payments and less any lease incentives.
The Company&#x2019;s lease terms that are used in determining their operating lease liabilities at lease inception may include options
to extend or terminate the leases when it is reasonably certain that the Company will exercise such options. The Company amortizes their
right-of-use assets as operating lease expense generally on a straight-line basis over the lease term and classify both the lease amortization
and imputed interest as operating expenses. The Company does not recognize lease assets and lease liabilities for any lease with an original
lease term of less than one year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












</cxai:LeasesAndRightofUseAssetsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_zHn9JBCIYIBb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Income
                                            Taxes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes using the asset and liability method. Accordingly, deferred tax assets and liabilities are recognized
for the future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities
and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in the tax rate is recognized in income or expense in the period that the change is effective. Income tax benefits
are recognized when it is probable that the deduction will be sustained. A valuation allowance is established when it is more likely
than not that all or a portion of a deferred tax asset will either expire before the Company is able to realize the benefit, or that
future deductibility is uncertain.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_844_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zlwVv8rtPbOj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Comprehensive
                                            Income (Loss) and Foreign Currency Translation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reports comprehensive income (loss) and its components in its unaudited condensed consolidated financial statements. Comprehensive
loss consists of net loss and foreign currency translation adjustments, affecting stockholders&#x2019; equity that, under GAAP, are excluded
from net loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Assets
and liabilities related to the Company&#x2019;s foreign operations are calculated using the Philippine peso and Canadian Dollar, and are
translated at end-of-period exchange rates, while the related revenues and expenses are translated at average exchange rates prevailing
during the period. Gains or losses resulting from transactions denominated in foreign currencies are included in general and administrative
expenses in the unaudited condensed consolidated statements of operations. The Company engages in foreign currency denominated transactions
with customers that operate in functional currencies other than the U.S. dollar. Aggregate foreign currency net transaction losses were
not material for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and three months ended March
31, 2022 (Predecessor).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zp5bNAYYFyRi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Revenue
                                            Recognition&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;The
Company recognizes revenue when control is transferred of the promised products or services to its customers, in an amount that reflects
the consideration the Company expects to be entitled to in exchange for those products or services. The Company derives revenue from
its software as a service for cloud based software, as well as design, implementation and other professional services for work performed
in conjunction with its cloud based software. The Company enters into contracts with its customers whereby it grants a non-exclusive
cloud-based license for the use of its proprietary software and for professional services. The contracts may also provide for on-going
services for a specified price, which may include maintenance services, designated support, and enhancements, upgrades and improvements
to the software, depending on the contract. Licenses for cloud software provide the customer with a right to use the software as it exists
when made available to the customer. All software provides customers with the same functionality and differ mainly in the duration over
which the customer benefits from the software.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;License
Subscription Revenue Recognition (Software As A Service)&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;With respect
to sales of the Company&#x2019;s license agreements, customers generally pay fixed annual fees in advance in exchange for the Company&#x2019;s
software service provided by via electronic, which are generally recognized ratably over the license term. Some agreements allow the
customer to terminate their subscription contracts before the end of the applicable term, and in such cases the customer is generally
entitled to a refund pro-rata but only for the elapsed time remaining at the point of termination, which would approximate the deferred
revenue at such time. The Company&#x2019;s performance obligation is satisfied over time as the electronic services are provided continuously
throughout the service period. The Company recognizes revenue evenly over the service period using a time-based measure because the Company
is providing continuous access to its service. The Company&#x2019;s customers generally pay within 30 to 60 days from the receipt of a
customer approved invoice.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The timing
of the Company&#x2019;s revenue recognition related to the licensing revenue stream is dependent on whether the software licensing agreement
entered into represents a service. Software that relies on an entity&#x2019;s IP and is delivered only through a hosting arrangement,
where the customer cannot take possession of the software, is a service. Customers may purchase perpetual licenses or subscribe to licenses,
which provide customers with the same functionality and differ mainly in the duration over which the customer benefits from the software.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;Renewals
or extensions of licenses are evaluated as distinct licenses and revenue attributed to the distinct service is not recognized until (1)
the entity provides the distinct license (or makes the license available) to the customer and (2) the customer is able to use and benefit
from the distinct license. Renewal contracts are not combined with original contracts, and, as a result, the renewal right is evaluated
in the same manner as all other additional rights granted after the initial contract. The revenue is not recognized until the customer
can begin to use and benefit from the license, which is typically at the beginning of the license renewal period. The Company recognizes
revenue resulting from renewal of licensed software over time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Professional
Services Revenue Recognition&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s professional services include milestone, fixed fee and time and materials contracts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Professional
services under milestone contracts are accounted for using the percentage of completion method. As soon as the outcome of a contract
can be estimated reliably, contract revenue is recognized in the statement of operations in proportion to the stage of completion of
the contract. Contract costs are expensed as incurred. Contract costs include all amounts that relate directly to the specific contract,
are attributable to contract activity, and are specifically chargeable to the customer under the terms of the contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;Professional
services are also contracted on the fixed fee and in some cases on a time and materials basis. Fixed fees are paid monthly, in phases,
or upon acceptance of deliverables. The Company&#x2019;s time and materials contracts are paid weekly or monthly based on hours worked.
Revenue on time and material contracts is recognized based on a fixed hourly rate as direct labor hours are expended. Materials, or other
specified direct costs, are reimbursed as actual costs and may include markup. The Company has elected the practical expedient to recognize
revenue for the right to invoice because the Company&#x2019;s right to consideration corresponds directly with the value to the customer
of the performance completed to date. For fixed fee contracts provided by in house personnel, the Company recognizes revenue evenly over
the service period using a time-based measure because the Company is providing continuous service. Because the Company&#x2019;s contracts
have an expected duration of one year or less, the Company has elected the practical expedient in ASC 606-10-50-14(a) to not disclose
information about its remaining performance obligations. Anticipated losses are recognized as soon as they become known. For the period
ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor), the
Company did not incur any such losses. These amounts are based on known and estimated factors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Contract
Balances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
timing of the Company&#x2019;s revenue recognition may differ from the timing of invoicing to and payment by its customers. The Company
records an unbilled receivable when revenue is recognized prior to invoicing and the Company has an unconditional right to payment. Alternatively,
when invoicing a customer precedes the company providing of the related services, the Company records deferred revenue until the performance
obligations are satisfied. The Company had deferred revenue of approximately $&lt;span id="xdx_906_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3"&gt;2,690
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;thousand and $&lt;span id="xdx_90D_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3"&gt;2,162
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;thousand as of March 31, 2023 (Successor) and
December 31, 2022 (Predecessor), respectively, related to customer invoices rendered in advance for software licenses and professional
services provided by the Company&#x2019;s technical staff. The Company expects to satisfy its remaining performance obligations for the
deferred revenue associated with professional services, and recognize the deferred revenue related to licenses generally over the remaining
contract term generally twelve months following the commencement of the license. The Company recognized revenue in the reporting period
of $&lt;span id="xdx_901_ecustom--RevenueRecognized_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zCVavrmQRK1" title="Revenue Recognized"&gt;170&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;thousand,
$&lt;span id="xdx_90E_ecustom--RevenueRecognized_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zApkMSdjWAUj"&gt;865
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;thousand, and $&lt;span id="xdx_902_ecustom--RevenueRecognized_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zdkdnojahzE7"&gt;1,328
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;thousand that was included in the contract liability
balance at the beginning of the period, for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and
three months ended March 31, 2022 (Predecessor), respectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Costs
to Obtain a Contract&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company
recognizes eligible sales commissions as an asset as the commissions are an incremental cost of obtaining a contract with the customer
and the Company expects to recover these costs. The capitalized costs are amortized over the expected contract term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Cost
to Fulfill a Contract&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company
incurs costs to fulfill their obligations under a contract once it has obtained. These costs are generally not significant and are recorded
to expense as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Multiple
Performance Obligations&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company enters into contracts with customers for its technology that include multiple performance obligations. Each distinct performance
obligation was determined by whether the customer could benefit from the good or service on its own or together with readily available
resources. The Company allocates revenue to each performance obligation based on its relative standalone selling price. The Company&#x2019;s
process for determining standalone selling price considers multiple factors including the Company&#x2019;s internal pricing model and
market trends that may vary depending upon the facts and circumstances related to each performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Sales
and Use Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company presents transactional taxes such as sales and use tax collected from customers and remitted to government authorities on a net
basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="text-decoration: underline; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Shipping
and Handling Costs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shipping
and handling costs are expensed as incurred as part of cost of revenues. These costs were deemed to be nominal during each of the reporting
periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DeferredRevenue
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2690000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2162000</us-gaap:DeferredRevenue>
    <cxai:RevenueRecognized
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">170000</cxai:RevenueRecognized>
    <cxai:RevenueRecognized
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">865000</cxai:RevenueRecognized>
    <cxai:RevenueRecognized
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1328000</cxai:RevenueRecognized>
    <us-gaap:BusinessCombinationsPolicy contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_841_eus-gaap--BusinessCombinationsPolicy_zcQe09j48jy1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Business
                                            Combinations&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for business combinations under Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification
(&#x201c;ASC&#x201d;) 805 &#x201c;Business Combinations&#x201d; using the acquisition method of accounting, and accordingly, the assets and
liabilities of the acquired business are recorded at their fair values at the date of acquisition. The excess of the purchase price over
the estimated fair value is recorded as goodwill. All acquisition costs are expensed as incurred. Upon acquisition, the accounts and
results of operations are included as of and subsequent to the acquisition date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_849_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zyLHpZiIf0o" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Segments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company and its Chief Executive Officer (&#x201c;CEO&#x201d;), acting as the Chief Operating Decision Maker (&#x201c;CODM&#x201d;) determines
its reporting units in accordance with FASB ASC 280, &#x201c;Segment Reporting&#x201d; (&#x201c;ASC 280&#x201d;). The Company evaluates a
reporting unit by first identifying its operating segments under ASC 280. The Company then evaluates each operating segment to determine
if it includes one or more components that constitute a business. If there are components within an operating segment that meet the definition
of a business, the Company evaluates those components to determine if they must be aggregated into one or more reporting units. If applicable,
when determining if it is appropriate to aggregate different operating segments, the Company determines if the segments are economically
similar and, if so, the operating segments are aggregated. The Company has one operating segment and reporting unit. The Company is organized
and operated as one business. Management reviews its business as a single operating segment, using financial and other information rendered
meaningful only by the fact that such information is presented and reviewed in the aggregate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zqhxlV67YbOj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Stock-Based
                                            Compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for options granted to employees by measuring the cost of services received in exchange for the award of equity instruments
based upon the fair value of the award on the date of grant. The fair value of that award is then ratably recognized as an expense over
the period during which the recipient is required to provide services in exchange for that award. Forfeitures of unvested stock options
are recorded when they occur.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company incurred stock-based compensation charges of approximately $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Stock-based compensation"&gt;2&lt;/span&gt;&#160;thousand, $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensation_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Stock-based compensation"&gt;158&lt;/span&gt;&#160;thousand and $&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Stock-based compensation"&gt;647&lt;/span&gt;&#160;thousand for the period ended March 31, 2023 (Successor), the period ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor),
respectively, which are included in general and administrative expenses.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">158000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">647000</us-gaap:ShareBasedCompensation>
    <us-gaap:StandardProductWarrantyPolicy contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_842_eus-gaap--StandardProductWarrantyPolicy_z8jbBFSUKXZb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Derivative
                                            Warrant Liabilities&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company
accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#x2019;s specific
terms and applicable authoritative guidance in FASB ASC 480, &#x201c;Distinguishing Liabilities from Equity&#x201d; (&#x201c;ASC 480&#x201d;)
and ASC 815, &#x201c;Derivatives and Hedging&#x201d; (&#x201c;ASC 815&#x201d;). The assessment considers whether the warrants are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all
of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company&#x2019;s own common
stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted
at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. The Company currently
has two sets of warrants outstanding, known as the Private Placement Warrants and the Public Warrants, which are both classified as a
liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;For issued or modified warrants that meet all
of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the
time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required
to be recorded at their initial fair value on the date of issuance as a warrant liability, and adjusted to the then fair value in each
balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the condensed
consolidated statements of operations and amounted to approximately $&lt;span id="xdx_90E_ecustom--ChangesInEstimatedFairValueOfWarrants_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zlU3FR3IFPcj" title="Changes in estimated fair value of warrants"&gt;1,686&#160;&lt;/span&gt;thousand for the period ended March 31, 2023 (Successor).
The Company utilized the Public Warrant quoted market price as the fair value of the Warrants as of each relevant date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StandardProductWarrantyPolicy>
    <cxai:ChangesInEstimatedFairValueOfWarrants
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">1686000</cxai:ChangesInEstimatedFairValueOfWarrants>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zExbuawx3YWi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Earnings
                                            Per Share&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company
computes basic and diluted earnings per share by dividing net income by the weighted average number of common shares outstanding during
the period. Diluted earnings per share are similarly calculated with the inclusion of dilutive common stock equivalents. The following
table summarizes the number of common shares and common share equivalents excluded from the calculation of diluted net income per common
share for period ended March 31, 2023 (Successor), which are excluded from the calculation because (i) the warrants were below their
exercise price and (ii) the stock options were not vested :&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_pn3n3_zXBF2PB15Bxd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policie (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span id="xdx_8B3_zmSyfTTgVZU" style="display: none"&gt;Schedule of antidilutive shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Period
    from&lt;br/&gt;
    March&#160;15,&lt;br/&gt;
    2023 to&lt;br/&gt;
    March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;Stock
    options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zn1dqT8iNFke" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;1,377&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total"&gt;&lt;span&gt;24,080&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span&gt;25,457&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2023-01-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_pn3n3_zXBF2PB15Bxd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policie (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span id="xdx_8B3_zmSyfTTgVZU" style="display: none"&gt;Schedule of antidilutive shares&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Period
    from&lt;br/&gt;
    March&#160;15,&lt;br/&gt;
    2023 to&lt;br/&gt;
    March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;Stock
    options&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--StockOptionsMember_zn1dqT8iNFke" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;1,377&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total"&gt;&lt;span&gt;24,080&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span&gt;25,457&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_StockOptionsMember"
      decimals="-3"
      unitRef="Shares">1377000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="Shares">24080</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="INF"
      unitRef="Shares">25457</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_841_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zw0p08iuU5m" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
                                            Value Measurements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FASB
ASC 820, &#x201c;Fair Value Measurements&#x201d; (&#x201c;ASC 820&#x201d;), provides guidance on the development and disclosure of fair value
measurements. The Company follows this authoritative guidance for fair value measurements, which defines fair value, establishes a framework
for measuring fair value under generally accepted accounting principles in the United States, and expands disclosures about fair value
measurements. The guidance requires fair value measurements be classified and disclosed in one of the following three categories:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date
                                            for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            2: Observable prices that are based on inputs not quoted on active markets but corroborated
                                            by market data.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                            3: Unobservable inputs which are supported by little or no market activity and values determined
                                            using pricing models, discounted cash flow methodologies, or similar techniques, as well
                                            as instruments for which the determination of fair value requires significant judgment or
                                            estimation.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value measurements discussed herein are based upon certain market assumptions and pertinent information available to management. Fair
value measurements are applied, when applicable, to determine the fair value of the Company&#x2019;s warrant liability at each reporting
period. See Note 10.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;












</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_846_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z1Yer2XJkN4k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
                                            Value of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments consist of cash and cash equivalents, accounts receivable, notes and other receivable and accounts payable. The Company determines
the estimated fair value of such financial instruments presented in these financial statements using available market information and
appropriate methodologies. These financial instruments are stated at their respective historical carrying amounts, which approximate
fair value due to their short-term nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_84F_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zchAKvjusoEg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Carrying
                                            Value, Recoverability and Impairment of Long-Lived Assets&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company
has adopted FASB ASC 360 &#x201c;Property, Plant, and Equipment&#x201d; (&#x201c;ASC 360&#x201d;) for its long-lived assets. Pursuant to
ASC 360-10-35-17, an impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable
and exceeds its fair value. The carrying amount of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted
cash flows expected to result from the use and eventual disposition of the asset (asset group). That assessment shall be based on the
carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be measured as the amount
by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. Pursuant to ASC 360-10-35-20 if an impairment
loss is recognized, the adjusted carrying amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset,
the new cost basis shall be depreciated (amortized) over the remaining useful life of that asset. Restoration of a previously recognized
impairment loss is prohibited.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to ASC 360-10-35-21, the Company&#x2019;s long-lived asset (asset group) is tested for recoverability whenever events or changes in circumstances
indicate that its carrying amount may not be recoverable. The Company considers the following to be some examples of such events or changes
in circumstances that may trigger an impairment review: (a) significant decrease in the market price of a long-lived asset (asset group);
(b) a significant adverse change in the extent or manner in which a long-lived asset (asset group) is being used or in its physical condition;
(c) a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset (asset
group), including an adverse action or assessment by a regulator; (d) an accumulation of costs significantly in excess of the amount
originally expected for the acquisition or construction of a long-lived asset (asset group); (e) a current-period operating or cash flow
loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated
with the use of a long-lived asset (asset group); and (f) a current expectation that, more likely than not, a long-lived asset (asset
group) will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. The Company tests
its long-lived assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based
on its assessments, the Company recorded &lt;span id="xdx_908_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zAfiZuSmiNrc" title="Impairment charges of long-lived assets"&gt;&lt;span id="xdx_903_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zITBxcg1cf54" title="Impairment charges of long-lived assets"&gt;&lt;span id="xdx_90F_eus-gaap--OtherAssetImpairmentCharges_pn3n3_do_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zzYDZSs08Vac" title="Impairment charges of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; impairment charges on long-lived assets for period ended March 31, 2023 (Successor), period
ended March 14, 2023 (Predecessor) and three months ended March 31, 2022 (Predecessor), respectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_84E_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zKtKg42HkPn6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Recently
                                            Issued and Adopted Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;In October
2021, the FASB issued ASU 2021-08, &#x201c;Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&#x201d;
(&#x201c;ASU 2021-08&#x201d;), which addresses diversity in practice related to the accounting for revenue contracts with customers acquired
in a business combination. Under the new guidance, the acquirer is required to apply Topic 606 to recognize and measure contract assets
and contract liabilities in a business combination. The effective date of the standard is for fiscal years beginning after December 15,
2022, including interim periods within those fiscal years, with early adoption permitted. CXApp adopted ASU 2021-08 on January 1, 2022.
As a result of management&#x2019;s evaluation, the adoption of ASU 2021-08 did not have a material impact on the consolidated financial
statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company
evaluated recently issued FASB accounting pronouncements and noted that no recent announcements were applicable to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_808_eus-gaap--BusinessCombinationDisclosureTextBlock_z6l5vQG58VVj" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            3 &#x2013; &lt;span id="xdx_822_zylb3tY9vZZ2"&gt;Business Combination&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 14, 2023, the Company completed the Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;), by and among KINS,
Inpixon, CXApp, and KINS Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of KINS (&#x201c;Merger Sub&#x201d;),
pursuant to which KINS combined with CXApp, Inpixon&#x2019;s enterprise apps business (including its workplace experience
technologies, indoor mapping, events platform, augmented reality and related business solutions) (the &#x201c;Enterprise Apps
Business&#x201d;). In exchange for the agreed upon aggregate purchase price of approximately $&lt;span id="xdx_903_ecustom--AggregatePurchasePriceAssetsAndLiabilities_iI_pn3n3_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zgDijKiUOD48" title="Aggregate purchase price assets and liabilities"&gt;69,928&lt;/span&gt;
thousand, the Company acquired all of the related assets and liabilities of Legacy CXApp. The consideration transferred in
connection with the Business Combination consisted of &lt;span id="xdx_90D_ecustom--ConsiderationTransferredInConnection_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zpGRYGUgslNh" title="Consideration transferred in connection"&gt;1,547,700&lt;/span&gt;
shares of the Company&#x2019;s Class A Common Stock and &lt;span id="xdx_90A_ecustom--ConsiderationTransferredInConnection_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pdd" title="Consideration transferred in connection"&gt;5,487,300&lt;/span&gt;
shares of the Company&#x2019;s Class C Common Stock valued at a price of $&lt;span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20230314_ztb8ypzqLNdg" title="Share price"&gt;9.94&lt;/span&gt;
per share. The preliminary estimated goodwill of approximately $&lt;span id="xdx_904_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_pn3n3" title="Business combination goodwill"&gt;44,122&lt;/span&gt;
thousand arising from the Business Combination consists of an acquired workforce, as well as synergies expected from combined
operations of KINS and the CXApp.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company
has authorized Class A and Class C common stock. Class A common stock and New CXApp Class C common stock are identical in all respects,
except that New CXApp Class C common stock is not listed and will automatically convert into New CXApp Class A common stock on the earlier
to occur of (i) the 180th day following the closing of the Merger and (ii) the day that the last reported sale price of New CXApp Class
A common stock equals or exceeds $12.00 per share for any 20 trading days within any 30-trading day period following the closing of the
Merger.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Business
Combination is being accounted for as a business combination in accordance with ASC 805 Combinations. The Company has determined preliminary
fair values of the assets acquired and liabilities assumed in the Business Combinations. These values are subject to change as we perform
additional reviews of our assumptions utilized.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has made a provisional allocation of the purchase price of the Business Combination to the assets acquired and the liabilities
assumed as of the closing date. The following table summarizes the preliminary purchase price allocations relating to the Business Combination
(in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_pn3n3_zv4J4BGrrAyi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business Combination (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B8_zaXlKB5klXAa" style="display: none"&gt;Schedule of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zhQ5zTcRifU6" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"&gt;&lt;span&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span&gt;Fair
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span&gt;Weighted&lt;br/&gt;
    Average Useful&lt;br/&gt;
    Life&lt;br/&gt;
    (in years)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--PurchasePrice_iI_z2LNiZ782CYl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Purchase
    Price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;69,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Assets
    acquired:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span&gt;Cash
    and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span&gt;10,003&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;2,226&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables_iI_pn3n3_z8CKXpYtCFU8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Notes
    and other receivables&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Prepaid
    assets and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;588&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset_iI_pn3n3_za8u4DXnd5Yg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Operating
    lease right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;557&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Property
    and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;133&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Other
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;42&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Developed
    technology&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right" title="Intangible assets"&gt;&lt;span&gt;9,268&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zvIHvLVrFPaj"&gt;10
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pn3n3" style="text-align: right" title="Intangible assets"&gt;&lt;span&gt;2,703&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zrChEHYpjyw9"&gt;10
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right" title="Intangible assets"&gt;&lt;span&gt;5,604&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zxUVCZ4SNAm8"&gt;5
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Tradenames
    and trademarks&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Intangible assets"&gt;&lt;span&gt;3,294&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zMy29Hf6sfih"&gt;7
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total
    assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span&gt;34,627&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Liabilities
    assumed:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_i01I_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Accounts
    payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;461&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_i01I_pn3n3_z1WqlsOPdQ1g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Accrued
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;911&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_i01I_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Deferred
    revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;2,534&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent_i01I_pn3n3_zFEBnlRS0kK6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Operating
    lease obligation, current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;194&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent_i01I_pn3n3_z1lNtq0USiYg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Operating
    lease obligation, noncurrent&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;384&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_i01I_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Deferred
    tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;4,337&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_i01I_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Total
    liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;8,821&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span&gt;44,122&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;






&lt;p id="xdx_8AF_zlPUGCuVIHii" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The value
of the intangible assets and goodwill were calculated by a third party valuation firm based on projections and financial data provided
by management of the Company. Goodwill represents the excess fair value after allocation to the intangible assets. The calculated goodwill
is not tax deductible for tax purposes.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
acquisition-related costs for the Business Combination were approximately $&lt;span id="xdx_904_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3"&gt;3,000
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;thousand, which were incurred by KINS prior to
the close of the Business Combination. These costs are included in the opening retained earnings of the Company on March 15, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span&gt;&lt;b&gt;Measurement
Period&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span&gt;The preliminary
purchase price allocations for the acquisitions described above are based on initial estimates and provisional amounts. In accordance
with ASC 805-10-25-13, if the initial accounting for a business combination is incomplete by the end of the reporting period in which
the combination occurs, the acquirer shall report in its financial statements provisional amounts for the items for which the accounting
is incomplete. During the measurement period, acquirer shall adjust the provisional amounts recognized at the acquisition date to reflect
new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the
measurement of the amounts recognized as of that date. The Company continues to refine its inputs and estimates inherent in (i) the valuation
of intangible assets, (ii) deferred income taxes, (iii) realization of tangible assets and (iv) the accuracy and completeness of liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;CXApp
Proforma Financial Information&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following unaudited proforma financial information presents the condensed consolidated results of operations of the Company for the three
month periods ended March 31, 2023 and March 31, 2022, as if the acquisition had occurred as of the beginning of the first period presented
(January 1, 2022) instead of on March 14, 2023. The proforma information does not necessarily reflect the results of operations that
would have occurred had the entities been a single company during those periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
proforma financial information for the Company and the acquired CXApp is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_pn3n3_zHZrWn2FodT3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business Combination (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B4_zNFFs4LTose" style="display: none"&gt;Schedule of proforma financial information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;For
    the&lt;br/&gt;
    Three Months Ended March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;For
    the&lt;br/&gt;
    Three Months Ended March&#160;31,&lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20230101__20230331_pn3n3" style="width: 9%; text-align: right" title="Revenues"&gt;&lt;span&gt;1,962&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20220101__20220331_pn3n3" style="width: 9%; text-align: right" title="Revenues"&gt;&lt;span&gt;2,582&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Net
    income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20230101__20230331_pn3n3" style="text-align: right" title="Net income (loss)"&gt;&lt;span&gt;(6,365&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20220101__20220331_pn3n3" style="text-align: right" title="Net income (loss)"&gt;&lt;span&gt;6,197&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zVPkCzQkjR56" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;












</us-gaap:BusinessCombinationDisclosureTextBlock>
    <cxai:AggregatePurchasePriceAssetsAndLiabilities
      contextRef="AsOf2023-03-14_custom_PredecessorMember_custom_MergerAgreementMember"
      decimals="-3"
      unitRef="USD">69928000</cxai:AggregatePurchasePriceAssetsAndLiabilities>
    <cxai:ConsiderationTransferredInConnection
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_MergerAgreementMember_us-gaap_CommonClassAMember"
      decimals="INF"
      unitRef="Shares">1547700</cxai:ConsiderationTransferredInConnection>
    <cxai:ConsiderationTransferredInConnection
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_MergerAgreementMember_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">5487300</cxai:ConsiderationTransferredInConnection>
    <us-gaap:SharePrice
      contextRef="AsOf2023-03-14"
      decimals="INF"
      unitRef="USDPShares">9.94</us-gaap:SharePrice>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="AsOf2023-03-14_custom_PredecessorMember_custom_MergerAgreementMember"
      decimals="-3"
      unitRef="USD">44122000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2023-01-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_pn3n3_zv4J4BGrrAyi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business Combination (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B8_zaXlKB5klXAa" style="display: none"&gt;Schedule of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zhQ5zTcRifU6" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left"&gt;&lt;span&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span&gt;Fair
    Value&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span&gt;Weighted&lt;br/&gt;
    Average Useful&lt;br/&gt;
    Life&lt;br/&gt;
    (in years)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--PurchasePrice_iI_z2LNiZ782CYl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Purchase
    Price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;69,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Assets
    acquired:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span&gt;Cash
    and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span&gt;10,003&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;2,226&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables_iI_pn3n3_z8CKXpYtCFU8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Notes
    and other receivables&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;209&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Prepaid
    assets and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;588&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset_iI_pn3n3_za8u4DXnd5Yg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Operating
    lease right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;557&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Property
    and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;133&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Other
    assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;42&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Developed
    technology&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right" title="Intangible assets"&gt;&lt;span&gt;9,268&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_901_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zvIHvLVrFPaj"&gt;10
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pn3n3" style="text-align: right" title="Intangible assets"&gt;&lt;span&gt;2,703&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zrChEHYpjyw9"&gt;10
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right" title="Intangible assets"&gt;&lt;span&gt;5,604&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zxUVCZ4SNAm8"&gt;5
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Tradenames
    and trademarks&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Intangible assets"&gt;&lt;span&gt;3,294&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zMy29Hf6sfih"&gt;7
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total
    assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span&gt;34,627&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Liabilities
    assumed:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_i01I_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Accounts
    payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;461&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_i01I_pn3n3_z1WqlsOPdQ1g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Accrued
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;911&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_i01I_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Deferred
    revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;2,534&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent_i01I_pn3n3_zFEBnlRS0kK6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Operating
    lease obligation, current&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;194&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent_i01I_pn3n3_z1lNtq0USiYg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Operating
    lease obligation, noncurrent&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;384&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_i01I_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Deferred
    tax liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;4,337&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_i01I_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Total
    liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;8,821&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pn3n3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span&gt;44,122&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;






</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <cxai:PurchasePrice
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">69928000</cxai:PurchasePrice>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">10003000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2226000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">209000</cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">588000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">557000</cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">133000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">42000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="AsOf2023-03-14_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-3"
      unitRef="USD">9268000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="AsOf2023-03-14_custom_PredecessorMember_us-gaap_PatentsMember"
      decimals="-3"
      unitRef="USD">2703000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_PatentsMember">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="AsOf2023-03-14_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">5604000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="AsOf2023-03-14_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-3"
      unitRef="USD">3294000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember">P7Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">34627000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">461000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">911000</cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2534000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">194000</cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent>
    <cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">384000</cxai:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">4337000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">8821000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">44122000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">3000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="From2023-01-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_pn3n3_zHZrWn2FodT3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Business Combination (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8B4_zNFFs4LTose" style="display: none"&gt;Schedule of proforma financial information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;For
    the&lt;br/&gt;
    Three Months Ended March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;For
    the&lt;br/&gt;
    Three Months Ended March&#160;31,&lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20230101__20230331_pn3n3" style="width: 9%; text-align: right" title="Revenues"&gt;&lt;span&gt;1,962&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20220101__20220331_pn3n3" style="width: 9%; text-align: right" title="Revenues"&gt;&lt;span&gt;2,582&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Net
    income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20230101__20230331_pn3n3" style="text-align: right" title="Net income (loss)"&gt;&lt;span&gt;(6,365&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20220101__20220331_pn3n3" style="text-align: right" title="Net income (loss)"&gt;&lt;span&gt;6,197&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2023-01-01to2023-03-31"
      decimals="-3"
      unitRef="USD">1962000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">2582000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2023-01-01to2023-03-31"
      decimals="-3"
      unitRef="USD">-6365000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">6197000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <cxai:DisaggregationOfRevenueTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_80A_ecustom--DisaggregationOfRevenueTextBlock_zWEQkTvVP2u4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            4 &#x2013; &lt;span id="xdx_821_zuDvnBSQj8Ue"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue when control is transferred of the promised products or services to its customers, in an amount that reflects
the consideration the Company expects to be entitled to in exchange for those products or services. The Company derives revenue from
software as a service, design and implementation services for its enterprise apps solutions systems, and professional services for work
performed in conjunction with its systems.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenues
consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zzydvqXZ8SN7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Disaggregation of Revenue (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;span id="xdx_8B9_zYzbr6c27m1a" style="display: none"&gt;Schedule of disaggregation of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Predecessor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Period
    from&lt;br/&gt;
    March&#160;15,&lt;br/&gt;
    2023 to &lt;br/&gt;
    March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Period
    from&lt;br/&gt;
    January&#160;1,&lt;br/&gt;
    2023 to&lt;br/&gt;
    March&#160;14,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Three
    months ended March&#160;31,&lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span&gt;Subscription
    revenue&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"&gt;&lt;span&gt;240&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,204&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,259&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total
    subscription revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;240&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,204&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,259&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span&gt;Non-subscription
    revenue&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Professional
    services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"&gt;&lt;span&gt;102&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"&gt;&lt;span&gt;416&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,323&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total
    non-subscription revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;102&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;416&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,323&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total
    Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,620&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;2,582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Predecessor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Period
    from&lt;br/&gt;
    March&#160;15,&lt;br/&gt;
    2023 to &lt;br/&gt;
    March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Period
    from&lt;br/&gt;
    January&#160;1,&lt;br/&gt;
    2023 to&lt;br/&gt;
    March&#160;14,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Three
    months ended March&#160;31,&lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Revenue
    recognized over time&lt;sup&gt;(1)(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zKxJyCgzCnc9" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zNqBoDOyYQlh" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,620&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zd6PyQcWxDfd" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"&gt;&lt;span&gt;2,582&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFN8f9NMFGB8" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zUzL3VcqZNy" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,620&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zREhXGB3TMm3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;2,582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;



&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F00_zuAxaoM7qA89" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F13_z22eIkMiIlRk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;
                                            Professional services are also contracted on the fixed fee and time and materials basis.
                                            Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company has
                                            generally elected the practical expedient to recognize revenue for the right to invoice because
                                            the Company&#x2019;s right to consideration corresponds directly with the value to the customer
                                            of the performance completed to date, in which revenue is recognized over time.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span id="xdx_F0F_z8YOj0PS32me" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_zZN9vikJNp6l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software
                                            As A Service Subscription Revenue&#x2019;s performance obligation is satisfied evenly over
                                            the service period using a time-based measure because the Company is providing continuous
                                            access to its service and service is recognized overtime.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A7_zAwhJnBd8XMf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












</cxai:DisaggregationOfRevenueTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2023-01-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zzydvqXZ8SN7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Disaggregation of Revenue (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;span id="xdx_8B9_zYzbr6c27m1a" style="display: none"&gt;Schedule of disaggregation of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Predecessor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Period
    from&lt;br/&gt;
    March&#160;15,&lt;br/&gt;
    2023 to &lt;br/&gt;
    March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Period
    from&lt;br/&gt;
    January&#160;1,&lt;br/&gt;
    2023 to&lt;br/&gt;
    March&#160;14,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Three
    months ended March&#160;31,&lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span&gt;Subscription
    revenue&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"&gt;&lt;span&gt;240&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,204&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,259&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total
    subscription revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;240&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,204&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--SubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,259&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span&gt;Non-subscription
    revenue&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Professional
    services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"&gt;&lt;span&gt;102&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"&gt;&lt;span&gt;416&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember__srt--ProductOrServiceAxis__custom--ProfessionalServicesMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,323&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total
    non-subscription revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;102&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;416&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--SubsegmentsAxis__custom--NonSubscriptionRevenueMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,323&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total
    Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,620&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;2,582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Predecessor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Period
    from&lt;br/&gt;
    March&#160;15,&lt;br/&gt;
    2023 to &lt;br/&gt;
    March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Period
    from&lt;br/&gt;
    January&#160;1,&lt;br/&gt;
    2023 to&lt;br/&gt;
    March&#160;14,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Three
    months ended March&#160;31,&lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Revenue
    recognized over time&lt;sup&gt;(1)(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zKxJyCgzCnc9" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zNqBoDOyYQlh" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,620&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_fKDEpICgyKQ_____zd6PyQcWxDfd" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Total Revenue"&gt;&lt;span&gt;2,582&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zFN8f9NMFGB8" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zUzL3VcqZNy" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;1,620&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zREhXGB3TMm3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Revenue"&gt;&lt;span&gt;2,582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;div style="width: 25%"&gt;&lt;div style="border-top: Black 1pt solid; font-size: 1pt"&gt;&#160;&lt;/div&gt;&lt;/div&gt;



&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify; border-collapse: collapse"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F00_zuAxaoM7qA89" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F13_z22eIkMiIlRk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;
                                            Professional services are also contracted on the fixed fee and time and materials basis.
                                            Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company has
                                            generally elected the practical expedient to recognize revenue for the right to invoice because
                                            the Company&#x2019;s right to consideration corresponds directly with the value to the customer
                                            of the performance completed to date, in which revenue is recognized over time.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span id="xdx_F0F_z8YOj0PS32me" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_zZN9vikJNp6l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software
                                            As A Service Subscription Revenue&#x2019;s performance obligation is satisfied evenly over
                                            the service period using a time-based measure because the Company is providing continuous
                                            access to its service and service is recognized overtime.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_SubscriptionRevenueMember_custom_SoftwareMember"
      decimals="-3"
      unitRef="USD">240000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_SubscriptionRevenueMember_custom_SoftwareMember"
      decimals="-3"
      unitRef="USD">1204000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_SubscriptionRevenueMember_custom_SoftwareMember"
      decimals="-3"
      unitRef="USD">1259000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_SubscriptionRevenueMember"
      decimals="-3"
      unitRef="USD">240000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_SubscriptionRevenueMember"
      decimals="-3"
      unitRef="USD">1204000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_SubscriptionRevenueMember"
      decimals="-3"
      unitRef="USD">1259000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_NonSubscriptionRevenueMember_custom_ProfessionalServicesMember"
      decimals="-3"
      unitRef="USD">102000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_NonSubscriptionRevenueMember_custom_ProfessionalServicesMember"
      decimals="-3"
      unitRef="USD">416000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_NonSubscriptionRevenueMember_custom_ProfessionalServicesMember"
      decimals="-3"
      unitRef="USD">1323000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_NonSubscriptionRevenueMember"
      decimals="-3"
      unitRef="USD">102000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_NonSubscriptionRevenueMember"
      decimals="-3"
      unitRef="USD">416000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_NonSubscriptionRevenueMember"
      decimals="-3"
      unitRef="USD">1323000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">342000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1620000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2582000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_us-gaap_TransferredOverTimeMember"
      decimals="-3"
      id="Fact001924"
      unitRef="USD">342000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_us-gaap_TransferredOverTimeMember"
      decimals="-3"
      id="Fact001926"
      unitRef="USD">1620000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_us-gaap_TransferredOverTimeMember"
      decimals="-3"
      id="Fact001928"
      unitRef="USD">2582000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">342000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1620000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2582000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z4aE0IySPPne" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            5 &#x2013; &lt;span id="xdx_82E_zvwoDPQWpmUe"&gt;Property and Equipment, net&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--PropertyPlantAndEquipmentTextBlock_pn3n3_zIZ1SnmXGa01" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, net (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BA_zyFVPiBxajK6" style="display: none"&gt;Schedule of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Predecessor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;December&#160;31,&lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span&gt;Computer
    and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pn3n3" style="width: 9%; text-align: right" title="Total"&gt;&lt;span&gt;139&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zJRkraja9hdj" style="width: 9%; text-align: right" title="Total"&gt;&lt;span&gt;992&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Furniture
    and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pn3n3" style="text-align: right" title="Total"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z0UDzglPTCQi" style="text-align: right" title="Total"&gt;&lt;span&gt;185&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pn3n3" style="text-align: right" title="Total"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmvgAo2RnXZ4" style="text-align: right" title="Total"&gt;&lt;span&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SoftwareMember_zJfaGhxk2Z" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Total"&gt;&lt;span&gt;157&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zI5WFlAWHCy1" style="text-align: right" title="Total"&gt;&lt;span&gt;1,213&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Less:
    accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z21EFw5MvTFe" style="border-bottom: Black 1pt solid; text-align: right" title="Less: accumulated depreciation and amortization"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zwDw0DkaJ0Y7" style="border-bottom: Black 1pt solid; text-align: right" title="Less: accumulated depreciation and amortization"&gt;&lt;span&gt;(1,011&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total
    Property and Equipment, Net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentNet_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Property and Equipment, Net"&gt;&lt;span&gt;153&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Property and Equipment, Net"&gt;&lt;span&gt;202&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
and amortization expense were approximately $&lt;span id="xdx_901_eus-gaap--DepreciationAndAmortization_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;thousand,
$&lt;span id="xdx_90B_eus-gaap--DepreciationAndAmortization_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3"&gt;19&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;thousand
and $&lt;span id="xdx_908_eus-gaap--DepreciationAndAmortization_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3"&gt;36
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;thousand for the period ended March 31, 2023
(Successor), the period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022 (Predecessor), respectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2023-01-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--PropertyPlantAndEquipmentTextBlock_pn3n3_zIZ1SnmXGa01" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, net (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BA_zyFVPiBxajK6" style="display: none"&gt;Schedule of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Predecessor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;December&#160;31,&lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span&gt;Computer
    and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pn3n3" style="width: 9%; text-align: right" title="Total"&gt;&lt;span&gt;139&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zJRkraja9hdj" style="width: 9%; text-align: right" title="Total"&gt;&lt;span&gt;992&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Furniture
    and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pn3n3" style="text-align: right" title="Total"&gt;&lt;span&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z0UDzglPTCQi" style="text-align: right" title="Total"&gt;&lt;span&gt;185&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pn3n3" style="text-align: right" title="Total"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zmvgAo2RnXZ4" style="text-align: right" title="Total"&gt;&lt;span&gt;28&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SoftwareMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;&lt;span&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--SoftwareMember_zJfaGhxk2Z" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;&lt;span&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Total"&gt;&lt;span&gt;157&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zI5WFlAWHCy1" style="text-align: right" title="Total"&gt;&lt;span&gt;1,213&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Less:
    accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z21EFw5MvTFe" style="border-bottom: Black 1pt solid; text-align: right" title="Less: accumulated depreciation and amortization"&gt;&lt;span&gt;(4&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zwDw0DkaJ0Y7" style="border-bottom: Black 1pt solid; text-align: right" title="Less: accumulated depreciation and amortization"&gt;&lt;span&gt;(1,011&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total
    Property and Equipment, Net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentNet_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Property and Equipment, Net"&gt;&lt;span&gt;153&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Property and Equipment, Net"&gt;&lt;span&gt;202&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_OfficeEquipmentMember"
      decimals="-3"
      unitRef="USD">139000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_OfficeEquipmentMember"
      decimals="-3"
      unitRef="USD">992000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_FurnitureAndFixturesMember"
      decimals="-3"
      unitRef="USD">11000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_FurnitureAndFixturesMember"
      decimals="-3"
      unitRef="USD">185000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="USD">6000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="USD">28000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_SoftwareMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_SoftwareMember"
      decimals="-3"
      unitRef="USD">8000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">157000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1213000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">4000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1011000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">153000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">202000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">4000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">19000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">36000</us-gaap:DepreciationAndAmortization>
    <cxai:SoftwareDevelopmentCostsNetTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_802_ecustom--SoftwareDevelopmentCostsNetTextBlock_zC7lWFLpM2Xg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            6 &#x2013; &lt;span id="xdx_82D_zbNpWqcN1bb7"&gt;Software Development Costs, net&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Capitalized
software development costs consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock_pn3n3_zUikV4J7Y759" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Software Development Costs, net (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_8B3_zr6VD5hpp3K9" style="display: none"&gt;Schedule of capitalized software development&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zG7dxHOXEaB1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zoUyBm8ovIEl" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Predecessor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;December&#160;31,&lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_maCCSNzf4y_zVllVuO8Mafh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1980"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span&gt;2,680&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--CapitalizedComputerSoftwareAccumulatedAmortization_iNI_pn3n3_di_msCCSNzf4y_zUOdvQtZJVGh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Accumulated
    amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1983"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;(2,193&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--CapitalizedComputerSoftwareNet_iTI_pn3n3_mtCCSNzf4y_zwVYEIK8Njjf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Software
    development costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1986"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span&gt;487&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
expense for capitalized software development costs was approximately $&lt;span id="xdx_90D_eus-gaap--AdjustmentForAmortization_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Amortization expense"&gt;209&lt;/span&gt;&#160;thousand and $&lt;span id="xdx_90E_eus-gaap--AdjustmentForAmortization_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Amortization expense"&gt;113&lt;/span&gt;&#160;thousand for the period ended March
14, 2023 (Predecessor) and the three months ended March 31, 2022 (Predecessor). There was &lt;span id="xdx_908_eus-gaap--AdjustmentForAmortization_pn3n3_do_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zeVLxg7jsuba" title="Amortization expense"&gt;no&lt;/span&gt; amortization expense for capitalized software
development costs for the period ended March 31, 2023 (Successor).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</cxai:SoftwareDevelopmentCostsNetTextBlock>
    <cxai:ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock contextRef="From2023-01-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock_pn3n3_zUikV4J7Y759" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Software Development Costs, net (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_8B3_zr6VD5hpp3K9" style="display: none"&gt;Schedule of capitalized software development&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zG7dxHOXEaB1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zoUyBm8ovIEl" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Predecessor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;December&#160;31,&lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_maCCSNzf4y_zVllVuO8Mafh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1980"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span&gt;2,680&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--CapitalizedComputerSoftwareAccumulatedAmortization_iNI_pn3n3_di_msCCSNzf4y_zUOdvQtZJVGh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Accumulated
    amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1983"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;(2,193&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--CapitalizedComputerSoftwareNet_iTI_pn3n3_mtCCSNzf4y_zwVYEIK8Njjf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Software
    development costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1986"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span&gt;487&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cxai:ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2680000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2193000</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareNet
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">487000</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">209000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">113000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AdjustmentForAmortization>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_803_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zQbGWVp1VLHj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            7 &#x2013; &lt;span id="xdx_828_zm6IetZ2kADi"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reviews goodwill for impairment on a reporting unit basis on December 31 of each year and whenever events or changes in circumstances
indicate the carrying value of goodwill may not be recoverable. The Company noted that the carrying amount of Goodwill for the period
ended March 31, 2023 (Successor) was $&lt;span id="xdx_907_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Goodwill"&gt;44,122&lt;/span&gt;&#160;thousand, which was entirely due to the business combination noted in Note 3. The Company
did &lt;span id="xdx_907_eus-gaap--Goodwill_iI_pn3n3_do_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zWZeCA8lcHRc" title="Goodwill"&gt;&lt;span id="xdx_90B_eus-gaap--Goodwill_iI_pn3n3_do_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zBHy2OK2asI4" title="Goodwill"&gt;no&lt;/span&gt;&lt;/span&gt;t have any goodwill for the period ended March 14, 2023 (Predecessor) and the year ended December 31, 2022 (Predecessor).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill
consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfGoodwillTextBlock_pn3n3_zCdhsSSFZI4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"&gt;&lt;span id="xdx_8BC_z1G4BW8PF20f" style="display: none"&gt;Schedule of goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: bold; text-align: left"&gt;&lt;span&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance
    as of March 14, 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Goodwill_iS_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zENOXH1riS2c" style="text-align: right" title="Beginning balance"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2005"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Acquisition
    of Legacy CXApp&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AcquisitionOfLegacyCxapp_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z45yDj18TUrc" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Acquisition of Legacy CXApp"&gt;&lt;span&gt;44,122&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Balance
    as of March 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Goodwill_iE_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z4fv8NKdKfr" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span&gt;44,122&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zYX3VCiO7N0b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;












&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zWZlcw7OwmSc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BE_zZ6JNFlydzsh" style="display: none"&gt;Schedule of intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="12" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span&gt;&lt;b&gt;March&#160;31,
    2023 (Successor)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;span&gt;&lt;b&gt;December&#160;31,
    2022 (Predecessor)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; text-align: center"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span&gt;&lt;b&gt;Weighted Average Remaining&lt;br/&gt;
    Useful Life&lt;br/&gt;
    (Years)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;&lt;b&gt;Gross
    Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;&lt;b&gt;Accumulated
    Amortization&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;span&gt;&lt;b&gt;Net
    Carrying Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: center"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span&gt;&lt;b&gt;Gross&lt;br/&gt;
    Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;&lt;b&gt;Accumulated
    Amortization&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span&gt;&lt;b&gt;Net Carrying&lt;br/&gt;
    Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 30%; text-align: left"&gt;&lt;span&gt;Trade
    Name/Trademarks&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; width: 9%"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zNdfQJYF8MMh"&gt;7
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"&gt;&lt;span&gt;3,294&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"&gt;&lt;span&gt;(20&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="text-align: right; width: 7%; vertical-align: bottom" title="Net carrying amount"&gt;&lt;span&gt;3,274&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid; width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="text-align: right; width: 7%; vertical-align: bottom" title="Gross carrying amount"&gt;&lt;span&gt;2,183&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"&gt;&lt;span&gt;(725&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="vertical-align: bottom; width: 7%; text-align: right" title="Net carrying amount"&gt;&lt;span&gt;1,458&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Customer
    Relationships&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zB8897e0y01e"&gt;5
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;5,604&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;(47&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Net carrying amount"&gt;&lt;span&gt;5,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Gross carrying amount"&gt;&lt;span&gt;6,401&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;(1,765&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Net carrying amount"&gt;&lt;span&gt;4,636&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Developed
    Technology&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zx0RCeDD1eC5"&gt;10
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;9,268&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;(38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Net carrying amount"&gt;&lt;span&gt;9,230&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Gross carrying amount"&gt;&lt;span&gt;15,179&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;(3,398&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Net carrying amount"&gt;&lt;span&gt;11,781&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Non-compete
    Agreements&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2045"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2046"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: right; vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Net carrying amount"&gt;&lt;span&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2048"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: right; vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross carrying amount"&gt;&lt;span&gt;&#160;3,150&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;(1,736&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;)&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Net carrying amount"&gt;&lt;span&gt;&#160;1,414&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Patents
    and Intellectual Property&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_zdp9tDsk1yF7"&gt;10
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;2,703&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;(11&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom" title="Net carrying amount"&gt;&lt;span&gt;2,692&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom" title="Gross carrying amount"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2060"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2061"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right" title="Net carrying amount"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2063"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Totals&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span&gt;20,869&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span&gt;(116&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;span&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right; vertical-align: bottom" title="Net carrying amount"&gt;&lt;span&gt;&lt;b&gt;20,753&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;span&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right; vertical-align: bottom" title="Gross carrying amount"&gt;&lt;span&gt;&lt;b&gt;26,913&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span&gt;(7,624&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;span&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right" title="Net carrying amount"&gt;&lt;span&gt;&lt;b&gt;19,289&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;



&lt;p id="xdx_8A1_zHbyDIQA6UV4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Aggregate
Amortization Expense&lt;/span&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Aggregate
amortization expense for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor) and three months ended
March 31, 2022 (Predecessor) was $&lt;span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" title="Aggregate amortization expense"&gt;116&lt;/span&gt;&#160;thousand, $&lt;span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Aggregate amortization expense"&gt;806&lt;/span&gt;&#160;thousand and $&lt;span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Aggregate amortization expense"&gt;975&lt;/span&gt;&#160;thousand, respectively.&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;Future amortization
expense on intangible assets is anticipated to be as follows (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zJqYwSInNWFc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_z5HTfbrUy6d3" style="display: none"&gt;Schedule of future amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20230331_zwQ9856fRWWf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;For the Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_zxjyh7QA55Y9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span&gt;2,091&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_zbdwcY16FOg2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;2,788&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_zKVmOOAolct4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;2,788&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_zLAji46mngA7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;2,788&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_zS9JgRbwsq17" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;2,788&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_zZj7dbgJRHy4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;7,510&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zwOlRtjNtPj2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span&gt;20,753&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p id="xdx_8A1_zMmLpUyh3tc8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">44122000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Goodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="From2023-01-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfGoodwillTextBlock_pn3n3_zCdhsSSFZI4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"&gt;&lt;span id="xdx_8BC_z1G4BW8PF20f" style="display: none"&gt;Schedule of goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; font-weight: bold; text-align: left"&gt;&lt;span&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance
    as of March 14, 2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Goodwill_iS_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zENOXH1riS2c" style="text-align: right" title="Beginning balance"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2005"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Acquisition
    of Legacy CXApp&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AcquisitionOfLegacyCxapp_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z45yDj18TUrc" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Acquisition of Legacy CXApp"&gt;&lt;span&gt;44,122&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Balance
    as of March 31, 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Goodwill_iE_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z4fv8NKdKfr" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span&gt;44,122&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfGoodwillTextBlock>
    <cxai:AcquisitionOfLegacyCxapp
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">44122000</cxai:AcquisitionOfLegacyCxapp>
    <us-gaap:Goodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">44122000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2023-01-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zWZlcw7OwmSc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BE_zZ6JNFlydzsh" style="display: none"&gt;Schedule of intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="12" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span&gt;&lt;b&gt;March&#160;31,
    2023 (Successor)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="9" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;span&gt;&lt;b&gt;December&#160;31,
    2022 (Predecessor)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; text-align: center"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span&gt;&lt;b&gt;Weighted Average Remaining&lt;br/&gt;
    Useful Life&lt;br/&gt;
    (Years)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;&lt;b&gt;Gross
    Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;&lt;b&gt;Accumulated
    Amortization&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&lt;span&gt;&lt;b&gt;Net
    Carrying Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: center"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span&gt;&lt;b&gt;Gross&lt;br/&gt;
    Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;&lt;b&gt;Accumulated
    Amortization&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span&gt;&lt;b&gt;Net Carrying&lt;br/&gt;
    Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 30%; text-align: left"&gt;&lt;span&gt;Trade
    Name/Trademarks&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; width: 9%"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_zNdfQJYF8MMh"&gt;7
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"&gt;&lt;span&gt;3,294&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"&gt;&lt;span&gt;(20&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="text-align: right; width: 7%; vertical-align: bottom" title="Net carrying amount"&gt;&lt;span&gt;3,274&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid; width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="text-align: right; width: 7%; vertical-align: bottom" title="Gross carrying amount"&gt;&lt;span&gt;2,183&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="width: 7%; text-align: right"&gt;&lt;span&gt;(725&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksAndTradeNamesMember_pn3n3" style="vertical-align: bottom; width: 7%; text-align: right" title="Net carrying amount"&gt;&lt;span&gt;1,458&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Customer
    Relationships&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zB8897e0y01e"&gt;5
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;5,604&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;(47&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Net carrying amount"&gt;&lt;span&gt;5,557&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Gross carrying amount"&gt;&lt;span&gt;6,401&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;(1,765&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Net carrying amount"&gt;&lt;span&gt;4,636&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Developed
    Technology&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_zx0RCeDD1eC5"&gt;10
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;9,268&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;(38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Net carrying amount"&gt;&lt;span&gt;9,230&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right; vertical-align: bottom" title="Gross carrying amount"&gt;&lt;span&gt;15,179&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;(3,398&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--DevelopedTechnologyRightsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Net carrying amount"&gt;&lt;span&gt;11,781&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Non-compete
    Agreements&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2045"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2046"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: right; vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Net carrying amount"&gt;&lt;span&gt;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2048"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: right; vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross carrying amount"&gt;&lt;span&gt;&#160;3,150&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right"&gt;&lt;span&gt;(1,736&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;)&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Net carrying amount"&gt;&lt;span&gt;&#160;1,414&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Patents
    and Intellectual Property&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_zdp9tDsk1yF7"&gt;10
    &lt;/span&gt;&lt;span&gt;years&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;2,703&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;(11&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom" title="Net carrying amount"&gt;&lt;span&gt;2,692&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom" title="Gross carrying amount"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2060"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2061"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndIntellectualPropertyMember_pn3n3" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right" title="Net carrying amount"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2063"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Totals&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span&gt;20,869&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span&gt;(116&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;span&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right; vertical-align: bottom" title="Net carrying amount"&gt;&lt;span&gt;&lt;b&gt;20,753&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;span&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--OtherFiniteLivedIntangibleAssetsGross_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right; vertical-align: bottom" title="Gross carrying amount"&gt;&lt;span&gt;&lt;b&gt;26,913&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span&gt;(7,624&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&lt;span&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; vertical-align: bottom; text-align: right" title="Net carrying amount"&gt;&lt;span&gt;&lt;b&gt;19,289&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;



</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2023-01-012023-03-31_us-gaap_TrademarksAndTradeNamesMember">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-3"
      unitRef="USD">3294000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-3"
      unitRef="USD">-20000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-3"
      unitRef="USD">3274000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-3"
      unitRef="USD">2183000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-3"
      unitRef="USD">-725000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_TrademarksAndTradeNamesMember"
      decimals="-3"
      unitRef="USD">1458000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2023-01-012023-03-31_us-gaap_CustomerRelationshipsMember">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">5604000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">-47000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">5557000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">6401000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">-1765000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">4636000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2023-01-012023-03-31_us-gaap_DevelopedTechnologyRightsMember">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-3"
      unitRef="USD">9268000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-3"
      unitRef="USD">-38000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-3"
      unitRef="USD">9230000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-3"
      unitRef="USD">15179000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-3"
      unitRef="USD">-3398000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_DevelopedTechnologyRightsMember"
      decimals="-3"
      unitRef="USD">11781000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">3150000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">-1736000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">1414000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2023-01-012023-03-31_custom_PatentsAndIntellectualPropertyMember">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_PatentsAndIntellectualPropertyMember"
      decimals="-3"
      unitRef="USD">2703000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_PatentsAndIntellectualPropertyMember"
      decimals="-3"
      unitRef="USD">-11000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_PatentsAndIntellectualPropertyMember"
      decimals="-3"
      unitRef="USD">2692000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">20869000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-116000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">20753000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">26913000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-7624000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">19289000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">116000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">806000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">975000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2023-01-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zJqYwSInNWFc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Goodwill and Intangible Assets (Details 2)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_z5HTfbrUy6d3" style="display: none"&gt;Schedule of future amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20230331_zwQ9856fRWWf" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;For the Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_zxjyh7QA55Y9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;&lt;span&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span&gt;2,091&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_zbdwcY16FOg2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;2,788&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_zKVmOOAolct4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;2,788&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_zLAji46mngA7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;2,788&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_zS9JgRbwsq17" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;2,788&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_zZj7dbgJRHy4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;7,510&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zwOlRtjNtPj2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span&gt;20,753&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">2091000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">2788000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">2788000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">2788000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">2788000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">7510000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">20753000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <cxai:DeferredRevenueTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_80F_ecustom--DeferredRevenueTextBlock_zgU2ny2ItPb3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            8 &#x2013; &lt;span id="xdx_825_z1IP8sJhoCDk"&gt;Deferred Revenue&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
revenue consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfDeferredRevenueTableTextBlock_pn3n3_zj2KgLFIIkKg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Deferred Revenue (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_8B2_zchqaZqkPx6i" style="display: none"&gt;Schedule of deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Predecessor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;December&#160;31,&lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span&gt;License
    agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_pn3n3" style="width: 9%; text-align: right" title="Total Deferred Revenue"&gt;&lt;span&gt;2,388&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_pn3n3" style="width: 9%; text-align: right" title="Total Deferred Revenue"&gt;&lt;span&gt;1,937&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Professional
    Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProfessionalServiceAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Deferred Revenue"&gt;&lt;span&gt;302&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProfessionalServiceAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Deferred Revenue"&gt;&lt;span&gt;225&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total
    Deferred Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Deferred Revenue"&gt;&lt;span&gt;2,690&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Deferred Revenue"&gt;&lt;span&gt;2,162&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the deferred revenue approximates the services to be rendered.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</cxai:DeferredRevenueTextBlock>
    <cxai:ScheduleOfDeferredRevenueTableTextBlock contextRef="From2023-01-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfDeferredRevenueTableTextBlock_pn3n3_zj2KgLFIIkKg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Deferred Revenue (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_8B2_zchqaZqkPx6i" style="display: none"&gt;Schedule of deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Predecessor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;March&#160;31,&lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;December&#160;31,&lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span&gt;License
    agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_pn3n3" style="width: 9%; text-align: right" title="Total Deferred Revenue"&gt;&lt;span&gt;2,388&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicensingAgreementsMember_pn3n3" style="width: 9%; text-align: right" title="Total Deferred Revenue"&gt;&lt;span&gt;1,937&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Professional
    Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProfessionalServiceAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Deferred Revenue"&gt;&lt;span&gt;302&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProfessionalServiceAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; text-align: right" title="Total Deferred Revenue"&gt;&lt;span&gt;225&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Total
    Deferred Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DeferredRevenue_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Deferred Revenue"&gt;&lt;span&gt;2,690&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DeferredRevenue_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Deferred Revenue"&gt;&lt;span&gt;2,162&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cxai:ScheduleOfDeferredRevenueTableTextBlock>
    <us-gaap:DeferredRevenue
      contextRef="AsOf2023-03-31_custom_SuccessorMember_us-gaap_LicensingAgreementsMember"
      decimals="-3"
      unitRef="USD">2388000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="AsOf2022-12-31_custom_PredecessorMember_us-gaap_LicensingAgreementsMember"
      decimals="-3"
      unitRef="USD">1937000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_ProfessionalServiceAgreementsMember"
      decimals="-3"
      unitRef="USD">302000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_ProfessionalServiceAgreementsMember"
      decimals="-3"
      unitRef="USD">225000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2690000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2162000</us-gaap:DeferredRevenue>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_80B_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zG91zv8YL3pd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            9 &#x2013; &lt;span id="xdx_823_zOglLK1mChUl"&gt;Accrued Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_pn3n3_zOeSOxMe5APg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BC_zKl5L4jOGS6k" style="display: none"&gt;Schedule of accrued Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zmL8jaAuCRW9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zhCV2sZdbhz4" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Predecessor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;March
    31, &lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;December
    31, &lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--InsurancePremiumsAndAccruedInterest_iI_pn3n3_maALCzxmM_zz1sEcoAmQ0j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span&gt;Insurance
    premiums and accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span&gt;538&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2117"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--RelatedPartyPromissoryNote_iI_pn3n3_maALCzxmM_zvwDIWs3f5Wk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Related
    party promissory note&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2120"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccruedIncomeTaxes_iI_pn3n3_maALCzxmM_zenaZb0oeUsj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Income
    tax payables&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;57&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2123"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--RelatedPartyPayable_iI_pn3n3_maALCzxmM_zjU5qnO5OgEh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Related
    party payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;1,155&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2126"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--AccruedCompensationAndBenefits_iI_pn3n3_maALCzxmM_zq3R15YIGTvc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Accrued
    compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;650&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;586&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_pn3n3_maALCzxmM_zBOB8vq7dQv6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Accrued
    bonus and commissions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;192&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;422&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedRentCurrent_iI_pn3n3_maALCzxmM_zXTwKPJlqCo9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Accrued
    rent&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;559&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AccruedOther_iI_pn3n3_maALCzxmM_zu4KRip245Wf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Accrued
    other&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;561&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;83&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_iI_pn3n3_maALCzxmM_zgDiEBkmJ6H9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Accrued
    sales and other indirect taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;86&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iTI_pn3n3_mtALCzxmM_z07ywXVdp7mk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255); vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Accrued
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span&gt;3,182&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span&gt;1,736&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;












&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Financed
Director &amp;amp; Officers Insurance&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into a Directors &amp;amp; Officers (&#x201c;D&amp;amp;O&#x201d;) insurance agreement with Oakwood D&amp;amp;O Insurance,
effective on March 14, 2023. The agreement states that the Company will pay a total of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--TitleOfIndividualAxis__custom--DirectorAndOfficersMember_zo7hS853Zt03" title="Debt payment"&gt;671&lt;/span&gt;
thousand in premiums at an annual percentage rate of &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_z7GuFfgoV4Tj" title="Interest rate"&gt;8%&lt;/span&gt;.
The first of nine monthly separate installment payments begin on April 14, 2023. The Company paid a down payment on the policy of
$&lt;span id="xdx_907_eus-gaap--PaymentsOfDebtIssuanceCosts_pn3n3_c20230101__20230314__srt--TitleOfIndividualAxis__custom--DirectorAndOfficersMember__srt--StatementScenarioAxis__custom--PredecessorMember_zKF2pVhORR22" title="Debt issuance cost"&gt;134&lt;/span&gt;
thousand.  As of March 31, 2023 (Successor) the  Company currently owes $&lt;span id="xdx_901_eus-gaap--OtherBorrowings_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zVv0BhrcV6pd" title="Debt owed balance"&gt;538&lt;/span&gt;
thousand on the D&amp;amp;O insurance policy.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Related
Party Liabilities&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;&lt;span id="xdx_901_ecustom--RelatedPartyDescription_c20230101__20230331_zM0ziQc2RUf7" title="Related party description"&gt;As
of March 31, 2023, the Company&#x2019;s related party liabilities consisted of a promissory note payable to the KINS sponsor in the amount of $20 thousand for working capital. As of March 31, 2023, accrued
liabilities include an estimate of approximately $1,045 thousand due to Inpixon by CXApp resulting from an agreement to reimburse
Inpixon (subject to review and acceptance by the Company) for certain transaction related costs incurred by Inpixon on behalf of KINS prior to March
14, 2023. This amount is subject to an ongoing review and evaluation by the Company. Additionally, as of March 31, 2023, accrued
liabilities include (i) $30 thousand for estimated costs related to transition services provided by Inpixon to CXApp and (ii) $80
thousand of reimbursable expenses incurred by Inpixon on behalf of CXApp during the period from March 15, 2023 to March 31,
2023.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;In connection
with a distribution of CXApp securities by KINS Capital LLC, Inpixon is entitled to acquire 2,500,000 CXApp Private Placement Warrants,
which reflects Inpixon&#x2019;s existing indirect interests in CXApp.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="From2023-01-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_pn3n3_zOeSOxMe5APg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued Liabilities (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BC_zKl5L4jOGS6k" style="display: none"&gt;Schedule of accrued Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zmL8jaAuCRW9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zhCV2sZdbhz4" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Successor&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;Predecessor&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;March
    31, &lt;br/&gt;
    2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span&gt;December
    31, &lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--InsurancePremiumsAndAccruedInterest_iI_pn3n3_maALCzxmM_zz1sEcoAmQ0j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"&gt;&lt;span&gt;Insurance
    premiums and accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span&gt;538&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2117"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--RelatedPartyPromissoryNote_iI_pn3n3_maALCzxmM_zvwDIWs3f5Wk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Related
    party promissory note&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2120"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccruedIncomeTaxes_iI_pn3n3_maALCzxmM_zenaZb0oeUsj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Income
    tax payables&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;57&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2123"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--RelatedPartyPayable_iI_pn3n3_maALCzxmM_zjU5qnO5OgEh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Related
    party payable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;1,155&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2126"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--AccruedCompensationAndBenefits_iI_pn3n3_maALCzxmM_zq3R15YIGTvc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Accrued
    compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;650&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;586&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccruedBonusesCurrent_iI_pn3n3_maALCzxmM_zBOB8vq7dQv6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Accrued
    bonus and commissions&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;192&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;422&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedRentCurrent_iI_pn3n3_maALCzxmM_zXTwKPJlqCo9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Accrued
    rent&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;559&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AccruedOther_iI_pn3n3_maALCzxmM_zu4KRip245Wf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Accrued
    other&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;561&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;83&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_iI_pn3n3_maALCzxmM_zgDiEBkmJ6H9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"&gt;&lt;span&gt;Accrued
    sales and other indirect taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span&gt;86&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iTI_pn3n3_mtALCzxmM_z07ywXVdp7mk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="color: rgb(204,238,255); vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span&gt;Accrued
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span&gt;3,182&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right: Black 1.5pt solid; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span&gt;1,736&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <cxai:InsurancePremiumsAndAccruedInterest
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">538000</cxai:InsurancePremiumsAndAccruedInterest>
    <cxai:RelatedPartyPromissoryNote
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">20000</cxai:RelatedPartyPromissoryNote>
    <us-gaap:AccruedIncomeTaxes
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">57000</us-gaap:AccruedIncomeTaxes>
    <cxai:RelatedPartyPayable
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">1155000</cxai:RelatedPartyPayable>
    <cxai:AccruedCompensationAndBenefits
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">650000</cxai:AccruedCompensationAndBenefits>
    <cxai:AccruedCompensationAndBenefits
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">586000</cxai:AccruedCompensationAndBenefits>
    <us-gaap:AccruedBonusesCurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">192000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">422000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedRentCurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">3000</us-gaap:AccruedRentCurrent>
    <us-gaap:AccruedRentCurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">559000</us-gaap:AccruedRentCurrent>
    <cxai:AccruedOther
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">561000</cxai:AccruedOther>
    <cxai:AccruedOther
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">83000</cxai:AccruedOther>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">6000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">86000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">3182000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1736000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_DirectorAndOfficersMember"
      decimals="-3"
      unitRef="USD">671000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_DirectorAndOfficersMember"
      decimals="-3"
      unitRef="USD">134000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:OtherBorrowings
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">538000</us-gaap:OtherBorrowings>
    <cxai:RelatedPartyDescription contextRef="From2023-01-01to2023-03-31">As
of March 31, 2023, the Company&#x2019;s related party liabilities consisted of a promissory note payable to the KINS sponsor in the amount of $20 thousand for working capital. As of March 31, 2023, accrued
liabilities include an estimate of approximately $1,045 thousand due to Inpixon by CXApp resulting from an agreement to reimburse
Inpixon (subject to review and acceptance by the Company) for certain transaction related costs incurred by Inpixon on behalf of KINS prior to March
14, 2023. This amount is subject to an ongoing review and evaluation by the Company. Additionally, as of March 31, 2023, accrued
liabilities include (i) $30 thousand for estimated costs related to transition services provided by Inpixon to CXApp and (ii) $80
thousand of reimbursable expenses incurred by Inpixon on behalf of CXApp during the period from March 15, 2023 to March 31,
2023.</cxai:RelatedPartyDescription>
    <cxai:WarrantLiabilitiesTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_806_ecustom--WarrantLiabilitiesTextBlock_zBzaT0tsQVla" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            10 - &lt;span id="xdx_82B_zQ857yPpDFV4"&gt;Warrant Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2023 (Successor) there were &lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zw3oxaz5fTM1" title="Warrants outstanding"&gt;13,800&lt;/span&gt; thousand Public Warrants outstanding. Each whole warrant entitles the holder thereof to purchase one share of the Company&#x2019;s Class A common stock at a price of $&lt;span id="xdx_906_eus-gaap--WarrantExercisePriceIncrease_pid_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zXYamto7cQk8" title="Warrant Price"&gt;11.50&lt;/span&gt; per share, subject to adjustments described in the Company&#x2019;s registration statement on Form S-1 (Registration No. 333-249177) filed in connection with its initial public offering. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Public
Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and
only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) &lt;span id="xdx_902_ecustom--WarrantExercisePeriodConditionOne_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zKCNTaUvQ0z5" title="Warrant exercise period condition one"&gt;30&lt;/span&gt;
days after the completion of a Business Combination and (b) &lt;span id="xdx_90C_ecustom--WarrantExercisePeriodConditionTwo_dtM_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zioXhGENb6ad" title="Warrant exercise period condition two"&gt;12&lt;/span&gt;
months from the closing of the Initial Public Offering. The Public Warrants will expire five &lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zpCYGmvO5gnc" style="display: none" title="Public Warrants expiration term"&gt;5&lt;/span&gt; years after the completion of a
Business Combination or earlier upon redemption or liquidation.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation
to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class
A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying
its obligations with respect to registration. No warrant will be exercisable, and the Company will not be obligated to issue shares of
Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company
has filed a registration statement on Form S-1 (Registration No. 333-271340) under the Securities Act on April 19, 2023 covering the
issuance of the shares of Class A common stock issuable upon exercise of the warrants, and will use its commercially reasonable efforts
to have it declared effective by the SEC within 60 business days following a Business Combination. The Company will use its commercially
reasonable efforts to maintain the effectiveness of such registration statement and a current prospectus relating to those shares of
Class A common stock until the warrants expire or are redeemed. Notwithstanding the above, if the Class A common stock is at the time
of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a &#x201c;covered security&#x201d;
under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants
to do so on a &#x201c;cashless basis&#x201d; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so
elects, the Company will not be required to file or maintain in effect a registration statement, but we will be required to use our commercially
reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Redemptions
of warrants when the price of Class A common stock equals or exceeds $&lt;span id="xdx_904_ecustom--WarrantRedemptionConditionMinimumSharePrice_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_pdd" title="Warrant redemption condition minimum share price"&gt;18.00&lt;/span&gt; &#x2013; &lt;/i&gt;Once the warrants become exercisable, the Company
may redeem the Public Warrants:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            whole and not in part;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
                                            a price of $&lt;span id="xdx_903_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd" title="Redemption price per public warrant (in dollars per share)"&gt;0.01&lt;/span&gt; per warrant;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
                                            not less than &lt;span id="xdx_903_ecustom--RedemptionPeriod_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zy6C2BXNoJC5" title="Redemption period"&gt;30&lt;/span&gt; days&#x2019; prior written notice of redemption, or the &lt;span id="xdx_90A_ecustom--RedemptionPeriod_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zezs0zxXwX61" title="Redemption period"&gt;30&lt;/span&gt;-day redemption
                                            period, to each warrant holder; and&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If,
                                            and only if, the reported last sale price of the Company&#x2019;s Class A common stock equals
                                            or exceeds $&lt;span id="xdx_908_ecustom--WarrantRedemptionConditionMinimumSharePrice_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_pdd" title="Warrant redemption condition minimum share price"&gt;18.00&lt;/span&gt; per share (as adjusted for stock splits, stock dividends, reorganizations,
                                            recapitalizations, and the like) for any &lt;span id="xdx_90D_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zRMp2O3txJkc" title="Threshold trading days for redemption of public warrants"&gt;20&lt;/span&gt; trading days within a &lt;span id="xdx_900_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zT4ioKX3vogh" title="Threshold consecutive trading days for redemption of public warrants"&gt;30&lt;/span&gt;-day trading period ending
                                            on the &lt;span id="xdx_909_ecustom--ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zgEtUvNM2ECl" title="Threshold number of business days before sending notice of redemption to warrant holders"&gt;third trading day&lt;/span&gt; prior to the date on which the Company sends the notice of redemption
                                            to the warrant holders.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Redemption
of warrants when the price per share of Class A common stock equals or exceeds $&lt;span id="xdx_904_ecustom--WarrantRedemptionConditionMinimumSharePriceScenarioTwo_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_pdd" title="Warrant redemption condition minimum share price scenario two"&gt;10.00&lt;/span&gt; &#x2013; &lt;/i&gt;Once the warrants become exercisable,
the Company may redeem the outstanding warrants:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
                                            whole and not in part;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
                                            a price of $&lt;span id="xdx_907_ecustom--ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_pdd" title="Redemption price per public warrant (in dollars per share)"&gt;0.10&lt;/span&gt; per warrant provided that holders will be able to exercise their warrants
                                            prior to redemption and receive that number of shares of Class A common stock determined
                                            based on the redemption date and the &#x201c;fair market value&#x201d; of the Company&#x2019;s
                                            Class A common stock;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon
                                            not less than &lt;span id="xdx_90E_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zVpQtCbeOiAh" title="Threshold consecutive trading days for redemption of public warrants"&gt;30&lt;/span&gt; days&#x2019; prior written notice of redemption, or the &lt;span id="xdx_90D_ecustom--RedemptionPeriod_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zjhoZJNdH5vg" title="Redemption period"&gt;30&lt;/span&gt;-day redemption
                                            period;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
                                            and only if, the last reported sale price of the Company&#x2019;s Class A common stock equals
                                            or exceeds $&lt;span id="xdx_904_ecustom--WarrantRedemptionConditionMinimumSharePriceScenarioTwo_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--StatementEquityComponentsAxis__custom--RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" title="Warrant redemption condition minimum share price scenario two"&gt;10.00&lt;/span&gt; per share (as adjusted for stock splits, stock dividends, reorganizations,
                                            recapitalizations and the like) on the trading day prior to the date on which the Company
                                            sends the notice of redemption to the warrant holders;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-collapse: collapse"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
                                            and only if, there is an effective registration statement covering the issuance of the shares
                                            of Class A common stock issuable upon exercise of the warrants and a current prospectus relating
                                            thereto is available throughout the 30-day period after the written notice of redemption
                                            is given.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2023 (Successor), there were &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember_zfuk3j9tQgi9" title="Warrants outstanding"&gt;10,280&lt;/span&gt; thousand Private Placement Warrants outstanding. The Private Placement Warrants are identical
to the Public Warrants, except that the Private Placement Warrants and the shares
of Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable
until &lt;span id="xdx_904_ecustom--RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion_dtD_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zTjl8sAUjwXk" title="Restrictions on transfer period of time after business combination completion"&gt;30&lt;/span&gt; days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement
Warrants will be exercisable on a cashless basis and be non-redeemable, except as described above, so long as they are held by the initial
purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or
their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the
same basis as the Public Warrants.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












</cxai:WarrantLiabilitiesTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="Shares">13800000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:WarrantExercisePriceIncrease
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="INF"
      unitRef="USDPShares">11.50</us-gaap:WarrantExercisePriceIncrease>
    <cxai:WarrantExercisePeriodConditionOne contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_PublicWarrantsMember">P30D</cxai:WarrantExercisePeriodConditionOne>
    <cxai:WarrantExercisePeriodConditionTwo contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_PublicWarrantsMember">P12M</cxai:WarrantExercisePeriodConditionTwo>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_PublicWarrantsMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <cxai:WarrantRedemptionConditionMinimumSharePrice
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member"
      decimals="INF"
      unitRef="USDPShares">18.00</cxai:WarrantRedemptionConditionMinimumSharePrice>
    <cxai:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">0.01</cxai:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <cxai:RedemptionPeriod contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember">P30D</cxai:RedemptionPeriod>
    <cxai:RedemptionPeriod contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember">P30D</cxai:RedemptionPeriod>
    <cxai:WarrantRedemptionConditionMinimumSharePrice
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">18.00</cxai:WarrantRedemptionConditionMinimumSharePrice>
    <cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember">P20D</cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember">P30D</cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <cxai:ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_custom_PublicWarrantsMember">third trading day</cxai:ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders>
    <cxai:WarrantRedemptionConditionMinimumSharePriceScenarioTwo
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member"
      decimals="INF"
      unitRef="USDPShares">10.00</cxai:WarrantRedemptionConditionMinimumSharePriceScenarioTwo>
    <cxai:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member"
      decimals="INF"
      unitRef="USDPShares">0.10</cxai:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember">P30D</cxai:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <cxai:RedemptionPeriod contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember">P30D</cxai:RedemptionPeriod>
    <cxai:WarrantRedemptionConditionMinimumSharePriceScenarioTwo
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_us-gaap_WarrantMember"
      decimals="INF"
      unitRef="USDPShares">10.00</cxai:WarrantRedemptionConditionMinimumSharePriceScenarioTwo>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_PrivatePlacementWarrantsMember"
      decimals="INF"
      unitRef="Shares">10280</us-gaap:ClassOfWarrantOrRightOutstanding>
    <cxai:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_PublicWarrantsMember">P30D</cxai:RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion>
    <cxai:StockAwardPlansAndStockbasedCompensationTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_809_ecustom--StockAwardPlansAndStockbasedCompensationTextBlock_zOpakbRmBmck" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            11 &#x2013; &lt;span id="xdx_82F_zU3OF0LA6Z87"&gt;Stock Option Plan and Stock-Based Compensation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To
calculate the stock-based compensation resulting from the issuance of options uses the Black-Scholes option pricing model, which is affected
by the Company&#x2019;s fair value of its stock price as well as assumptions regarding a number of subjective variables. These variables
include, but are not limited to, the Company&#x2019;s expected stock price volatility over the term of the awards, and actual and projected
employee stock option exercise behaviors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;b&gt;&lt;i&gt;2023
Equity Incentive Plan&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;At the special meeting held on March 10, 2023, the KINS stockholders
considered and approved, among other things, the CXApp Inc. 2023 Equity Incentive Plan (the &#x201c;Incentive Plan&#x201d;). The Incentive
Plan was previously approved, subject to stockholder approval, by KINS&#x2019; board of directors. The Incentive Plan became effective
immediately upon the closing of the Business Combination. Pursuant to the terms of the Incentive Plan, there are &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_pid_c20230310__us-gaap--PlanNameAxis__custom--N2023EquityIncentivePlanMember_ztqMr22lpbE4" title="Shares available for issuance"&gt;2,110,500&lt;/span&gt; shares of CXApp
Class A Common Stock available for issuance under the Incentive Plan, which is equal to 15% of the aggregate number of shares of CXApp
common stock issued and outstanding immediately after the closing (giving effect to the redemptions).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Employee
Stock Options&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the period ended March 31, 2023 (Successor), a total of &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_pin3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember_z2mNWCKJr3ib" title="Stock option granted"&gt;1,377&lt;/span&gt;&#160;thousand of stock options for the purchase of the Company&#x2019;s
common stock were granted to employees and directors of the Company. These options vest over a &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember_zWLF8Q8WGDx7" title="Vesting period"&gt;2&lt;/span&gt; year period, with 50% vested at the
end of year one and 50% vested at the end of year two. The options have a life of &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember__srt--RangeAxis__srt--MinimumMember_zSQqtXnw9qaa" title="Option life"&gt;5&lt;/span&gt; to &lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember__srt--RangeAxis__srt--MaximumMember_z5QCiCysYhRb" title="Option life"&gt;7&lt;/span&gt; years and an exercise price of $1.53 per share.
The stock options were valued using the Black-Scholes option valuation model and the fair value of the awards was determined to be approximately
$&lt;span id="xdx_904_ecustom--FairValueOfOptions_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember_zrA3xvph6opa" title="Fair value of options"&gt;688&lt;/span&gt;&#160;thousand. The fair value of the common stock as of the grant date was determined to be $&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember__srt--CounterpartyNameAxis__custom--EmployeesAndDirectorsMember_pdd" title="Fair value of common stock as of grant date"&gt;1.53&lt;/span&gt; per share.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the period ended March 31, 2023 (Successor), the Company recorded a charge of approximately $&lt;span id="xdx_904_ecustom--AmortizationOfEmployeeStockOptions_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--AwardTypeAxis__custom--EmployeeStockOptionsMember_z6hglpJJRA3" title="Amortization of employee stock options"&gt;2&lt;/span&gt;&#160;thousand for the amortization of
employee stock options, which is included in the general and administrative section of the condensed
consolidated statement of operations.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2023 (Successor), the fair value of non-vested options totalled approximately $&lt;span id="xdx_90A_ecustom--FairValueOfNonvestedOptions_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zKtxUbYztgm" title="Fair value of non-vested options"&gt;686&lt;/span&gt;&#160;thousand, which will be amortized
to expense over the weighted average remaining term of &lt;span id="xdx_90B_ecustom--WeightedAverageRemainingTermOfNonvestedOptions_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zbQD81Cr97Ic" title="Weighted average remaining term of non-vested options"&gt;2&lt;/span&gt;.0 years.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of each employee option grant is estimated on the date of the grant using the Black-Scholes option-pricing model. Key weighted-average
assumptions used to apply this pricing model during the period ended March 31, 2023 (Successor) were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_pn3n3_z2NUvsA0cEHe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Award Plans and Stock-Based Compensation (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BF_znZ31CjRifj1" style="display: none"&gt;Schedule of assumptions used&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Risk-free
    interest rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zVRZ3IzFBiO5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.62&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;%
    &#x2013; &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_zLB2ZDOvl8d2"&gt;3.67&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Expected
    life of option grants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zsjbfmPoo0R2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5
    &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&#x2013; &lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_zcGebklMyTh5"&gt;7
    &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 80%; text-align: left"&gt;&lt;span&gt;Expected
    volatility of underlying stock&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 18%; text-align: center"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zUPdCMrAqrC9"&gt;37.35&lt;/span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Dividends
    assumption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z6AuyXgzoIa2"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

</cxai:StockAwardPlansAndStockbasedCompensationTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2023-03-10_custom_N2023EquityIncentivePlanMember"
      decimals="INF"
      unitRef="Shares">2110500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember"
      decimals="INF"
      unitRef="Shares">1377000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember_srt_MinimumMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember_srt_MaximumMember">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <cxai:FairValueOfOptions
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember"
      decimals="-3"
      unitRef="USD">688000</cxai:FairValueOfOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember_custom_EmployeesAndDirectorsMember"
      decimals="INF"
      unitRef="USDPShares">1.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <cxai:AmortizationOfEmployeeStockOptions
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EmployeeStockOptionsMember"
      decimals="-3"
      unitRef="USD">2000</cxai:AmortizationOfEmployeeStockOptions>
    <cxai:FairValueOfNonvestedOptions
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">686000</cxai:FairValueOfNonvestedOptions>
    <cxai:WeightedAverageRemainingTermOfNonvestedOptions contextRef="From2023-03-152023-03-31_custom_SuccessorMember">P2Y</cxai:WeightedAverageRemainingTermOfNonvestedOptions>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2023-01-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_pn3n3_z2NUvsA0cEHe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Award Plans and Stock-Based Compensation (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span id="xdx_8BF_znZ31CjRifj1" style="display: none"&gt;Schedule of assumptions used&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Risk-free
    interest rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zVRZ3IzFBiO5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.62&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;%
    &#x2013; &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_zLB2ZDOvl8d2"&gt;3.67&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Expected
    life of option grants&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MinimumMember_zsjbfmPoo0R2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5
    &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&#x2013; &lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--RangeAxis__srt--MaximumMember_zcGebklMyTh5"&gt;7
    &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 80%; text-align: left"&gt;&lt;span&gt;Expected
    volatility of underlying stock&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 18%; text-align: center"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zUPdCMrAqrC9"&gt;37.35&lt;/span&gt;&lt;span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Dividends
    assumption&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z6AuyXgzoIa2"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_srt_MinimumMember"
      decimals="INF"
      unitRef="Pure">0.0362</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_srt_MaximumMember"
      decimals="INF"
      unitRef="Pure">0.0367</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2023-03-152023-03-31_custom_SuccessorMember_srt_MinimumMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2023-03-152023-03-31_custom_SuccessorMember_srt_MaximumMember">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="INF"
      unitRef="Pure">0.3735</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_80D_eus-gaap--FairValueDisclosuresTextBlock_z35Sy0q81rx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;&lt;b&gt;NOTE
                                            12 &#x2013; &lt;span id="xdx_82A_zhmle8mvvbWl"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company&#x2019;s estimates of fair value for financial assets and financial
liabilities are based on the framework established in ASC 820. The Company noted that the only financial asset or financial liability
that is subject to the fair value framework established in ASC 820 are the Warrant Liabilities (Note 10). The framework is based on the
inputs used in valuation and gives the highest priority to quoted prices in active markets and requires that observable inputs be used
in the valuations when available. The disclosure of fair value estimates in the ASC 820 hierarchy is based on whether the significant
inputs into the valuation are observable. In determining the level of the hierarchy in which the estimate is disclosed, the highest priority
is given to unadjusted quoted prices in active markets and the lowest priority to unobservable inputs that reflect the Company&#x2019;s
significant market assumptions. The Company classified the public placement warrants recorded at fair value of on a recurring basis of
$&lt;span id="xdx_90B_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicPlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zMq2GTSKfxM1" title="Fair value of warrants"&gt;552&lt;/span&gt; thousand as a level 1 investment, as the fair value was determined using quoted prices of the security in active markets. The Company
classified the private placement warrants liabilities recorded at fair value of $&lt;span id="xdx_902_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNC91dQta9lf"&gt;411&lt;/span&gt; thousand as a level 2 investment, as the fair
value was determined utilizing the observable market price for the public placement warrants as the private placement warrants are not
actively traded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_PublicPlacementWarrantsMember_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      unitRef="USD">552000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_PrivatePlacementWarrantsMember_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      unitRef="USD">411000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zi27H6MNvap6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            13 &#x2013; &lt;span id="xdx_828_z5DrixpnJT98"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The Company recorded an income tax benefit of
approximately $&lt;span id="xdx_90D_ecustom--IncomeTaxBenefitprovision_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zqiJeTBvEli8" title="Income tax benefit/(provision)"&gt;1,560&lt;/span&gt; thousand for the period ended March 31, 2023 (Successor). The Company recorded an income tax expense of approximately
$&lt;span id="xdx_90D_ecustom--IncomeTaxBenefitprovision_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zMIdmVgyll" title="Income tax benefit/(provision)"&gt;0&lt;/span&gt; thousand and $&lt;span id="xdx_90F_ecustom--IncomeTaxBenefitprovision_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zFSCLOziUpod" title="Income tax benefit/(provision)"&gt;100&lt;/span&gt; thousand for the period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022 (Predecessor),
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The effective tax rate for period ended March 31, 2023 (Successor)
was approximately (&lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zKPxfDx39M04" title="Effective tax rate"&gt;164.0%&lt;/span&gt;). The income tax benefit, and negative effective tax rate, for the period ended March 31, 2023 (Successor) is
a result of the release of valuation allowance attributable to acquired intangible assets from the Business Combination. The Company acquired
approximately $&lt;span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_c20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Deferred tax liability"&gt;4,337&lt;/span&gt; thousand of deferred tax liability associated with the Business Combination. As a result of the Company released
its valuation allowance as deferred tax assets will become realizable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;












</us-gaap:IncomeTaxDisclosureTextBlock>
    <cxai:IncomeTaxBenefitprovision
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">1560000</cxai:IncomeTaxBenefitprovision>
    <cxai:IncomeTaxBenefitprovision
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">0</cxai:IncomeTaxBenefitprovision>
    <cxai:IncomeTaxBenefitprovision
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">100000</cxai:IncomeTaxBenefitprovision>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="INF"
      unitRef="Pure">1.640</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="AsOf2023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">4337000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_808_eus-gaap--ConcentrationRiskDisclosureTextBlock_zYqz7SmNeksk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            14 &#x2013; &lt;span id="xdx_822_z6MSvn9T5Lfc"&gt;Credit Risk and Concentrations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that subject the Company to credit risk consist principally of trade accounts receivable and cash and cash equivalents. The
Company performs certain credit evaluation procedures and does not require collateral for financial instruments subject to credit risk.
The Company believes that credit risk is limited because the Company routinely assesses the financial strength of its customers and,
based upon factors surrounding the credit risk of its customers, establishes an allowance for credit losses and, consequently, believes
that its accounts receivable credit risk exposure beyond such allowances is limited.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company maintains cash deposits with financial institutions, which, from time to time, may exceed federally insured limits. Cash is also
maintained at foreign financial institutions for its Canadian and Philippines subsidiaries and its majority-owned India subsidiary. Cash
in foreign financial institutions as of March 31, 2023 (Successor) and December 31, 2022 (Predecessor) was immaterial. The Company has
not experienced any losses and believes it is not exposed to any significant credit risk from cash.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;



</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <cxai:ForeignOperationsTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_802_ecustom--ForeignOperationsTextBlock_zY2GsZ0N4Jq4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            15 &#x2013; &lt;span id="xdx_823_z9bKqAln93S3"&gt;Foreign Operations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s operations are located primarily in the United States, Canada, and the Philippines. Revenues by geographic area are attributed
by country of domicile of the Company&#x2019;s subsidiaries. The financial data by geographic area are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_zZGvyLMcGts1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Foreign Operations (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;span id="xdx_8BC_zLbtzx9EEIa3" style="display: none"&gt;Schedule of financial data by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;United&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;States&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span&gt;India&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span&gt;Philippines&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="text-decoration: underline"&gt;For
    the Period Ended March 31, 2023 (Successor)&lt;/span&gt;:&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left"&gt;&lt;span&gt;Revenues
    by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;272&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2267"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;196&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;(196&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zHHHk5YCIdDb" style="width: 9%; text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Operating
    income (loss) by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_zWzzmjbBiyM3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(486&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_zQnReV5rrAW2" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(158&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_zXKExpq4bLPk" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2279"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;157&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2283"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(487&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Net
    income (loss) by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;2,780&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(158&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2291"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;157&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(21&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;2,758&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="text-decoration: underline"&gt;For
    the Period Ended March 14, 2023 (Predecessor)&lt;/span&gt;:&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Revenues
    by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;1,395&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;285&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2303"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;160&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;(220&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zKQARgGUsx78" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;1,620&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Operating
    income (loss) by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(3,479&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(905&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2315"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2319"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(4,381&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Net
    income (loss) by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(3,342&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(1,041&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2327"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2331"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(4,380&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="text-decoration: underline"&gt;For
    the Three Months Ended March 31, 2022 (Predecessor)&lt;/span&gt;:&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Revenues
    by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;2,167&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;601&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;270&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2341"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;(456&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zuwXX0ESDeF8" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;2,582&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Operating
    income (loss) by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(650&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(1,008&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;72&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2353"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(1,572&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Net
    income (loss) by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(519&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(1,139&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(27&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2365"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(1,671&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="text-decoration: underline"&gt;As
    of March 31, 2023 (Successor)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Identifiable
    assets by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_znpZI1Rc6fhf" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;75,059&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_zZYPA1LCaawe" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;991&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_znpRbfRKD09l" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2375"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_zJ7a49f51zpi" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;405&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_zOFdFNj8rmg8" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;(71&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zXRC4kDjFI48" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;76,384&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Long
    lived assets by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;20,817&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;417&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2387"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;222&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2391"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;21,455&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Goodwill
    by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;44,122&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2397"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2399"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2401"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2403"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;44,122&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="text-decoration: underline"&gt;As
    of December 31, 2022 (Predecessor)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Identifiable
    assets by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_zPVGKa173qfg" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;24,591&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_zf9p6NSjtU52" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;5,484&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_z6K5KYsdGEVe" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;228&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_zeJEIqXxOymd" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;415&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_zlP5RMOQkOxk" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;(1,438&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zFo4trmxzHp3" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;29,280&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Long
    lived assets by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;15,558&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;4,788&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;98&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;215&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2427"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;20,659&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Goodwill
    by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2431"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2433"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2435"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2437"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2439"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Goodwill_iI_pn3n3_d0_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zMfxFSYSCSji" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;













</cxai:ForeignOperationsTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="From2023-01-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_zZGvyLMcGts1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Foreign Operations (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;span id="xdx_8BC_zLbtzx9EEIa3" style="display: none"&gt;Schedule of financial data by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;United&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;States&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span&gt;India&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span&gt;Philippines&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;&lt;span&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-weight: bold; vertical-align: bottom"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="text-decoration: underline"&gt;For
    the Period Ended March 31, 2023 (Successor)&lt;/span&gt;:&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left"&gt;&lt;span&gt;Revenues
    by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;272&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2267"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;196&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="width: 9%; text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;(196&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zHHHk5YCIdDb" style="width: 9%; text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;342&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Operating
    income (loss) by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_zWzzmjbBiyM3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(486&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_zQnReV5rrAW2" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(158&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_zXKExpq4bLPk" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2279"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;157&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2283"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(487&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Net
    income (loss) by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;2,780&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(158&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2291"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;157&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(21&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;2,758&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="text-decoration: underline"&gt;For
    the Period Ended March 14, 2023 (Predecessor)&lt;/span&gt;:&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Revenues
    by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;1,395&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;285&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2303"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;160&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;(220&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_zKQARgGUsx78" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;1,620&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Operating
    income (loss) by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(3,479&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(905&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2315"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2319"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(4,381&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Net
    income (loss) by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(3,342&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(1,041&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2327"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2331"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLoss_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(4,380&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="text-decoration: underline"&gt;For
    the Three Months Ended March 31, 2022 (Predecessor)&lt;/span&gt;:&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Revenues
    by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;2,167&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;601&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;270&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2341"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;(456&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_zuwXX0ESDeF8" style="text-align: right" title="Revenues by geographic area"&gt;&lt;span&gt;2,582&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Operating
    income (loss) by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(650&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(1,008&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;72&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2353"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OperatingIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Operating income (loss) by geographic area"&gt;&lt;span&gt;(1,572&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Net
    income (loss) by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(519&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(1,139&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(27&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2365"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--NetIncomeLoss_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Net income (loss) by geographic area"&gt;&lt;span&gt;(1,671&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="text-decoration: underline"&gt;As
    of March 31, 2023 (Successor)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Identifiable
    assets by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_znpZI1Rc6fhf" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;75,059&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_zZYPA1LCaawe" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;991&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_znpRbfRKD09l" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2375"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_zJ7a49f51zpi" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;405&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_zOFdFNj8rmg8" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;(71&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zXRC4kDjFI48" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;76,384&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Long
    lived assets by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;20,817&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;417&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2387"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;222&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2391"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NoncurrentAssets_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;21,455&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Goodwill
    by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;44,122&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2397"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2399"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2401"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2403"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Goodwill_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;44,122&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;&lt;span style="text-decoration: underline"&gt;As
    of December 31, 2022 (Predecessor)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Identifiable
    assets by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_zPVGKa173qfg" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;24,591&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_zf9p6NSjtU52" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;5,484&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_z6K5KYsdGEVe" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;228&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_zeJEIqXxOymd" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;415&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_zlP5RMOQkOxk" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;(1,438&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NetAssets_iI_pn3n3_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zFo4trmxzHp3" style="text-align: right" title="Identifiable assets by geographic area"&gt;&lt;span&gt;29,280&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Long
    lived assets by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;15,558&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;4,788&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;98&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;215&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2427"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--NoncurrentAssets_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" style="text-align: right" title="Long lived assets by geographic area"&gt;&lt;span&gt;20,659&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span&gt;Goodwill
    by geographic area&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--US_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2431"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--CA_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2433"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--IN_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2435"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__country--PH_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2437"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Goodwill_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember__srt--StatementGeographicalAxis__custom--EliminationsMember_pn3n3" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2439"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Goodwill_iI_pn3n3_d0_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zMfxFSYSCSji" style="text-align: right" title="Goodwill by geographic area"&gt;&lt;span&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_US"
      decimals="-3"
      unitRef="USD">272000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_CA"
      decimals="-3"
      unitRef="USD">70000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_PH"
      decimals="-3"
      unitRef="USD">196000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-196000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">342000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_US"
      decimals="-3"
      unitRef="USD">-486000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_CA"
      decimals="-3"
      unitRef="USD">-158000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_PH"
      decimals="-3"
      unitRef="USD">157000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">-487000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_US"
      decimals="-3"
      unitRef="USD">2780000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_CA"
      decimals="-3"
      unitRef="USD">-158000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_country_PH"
      decimals="-3"
      unitRef="USD">157000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-21000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">2758000</us-gaap:NetIncomeLoss>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_US"
      decimals="-3"
      unitRef="USD">1395000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_CA"
      decimals="-3"
      unitRef="USD">285000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_PH"
      decimals="-3"
      unitRef="USD">160000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-220000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">1620000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_US"
      decimals="-3"
      unitRef="USD">-3479000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_CA"
      decimals="-3"
      unitRef="USD">-905000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_PH"
      decimals="-3"
      unitRef="USD">3000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-4381000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_US"
      decimals="-3"
      unitRef="USD">-3342000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_CA"
      decimals="-3"
      unitRef="USD">-1041000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember_country_PH"
      decimals="-3"
      unitRef="USD">3000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-4380000</us-gaap:NetIncomeLoss>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_US"
      decimals="-3"
      unitRef="USD">2167000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_CA"
      decimals="-3"
      unitRef="USD">601000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_IN"
      decimals="-3"
      unitRef="USD">270000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-456000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">2582000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_US"
      decimals="-3"
      unitRef="USD">-650000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_CA"
      decimals="-3"
      unitRef="USD">-1008000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_IN"
      decimals="-3"
      unitRef="USD">72000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">14000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-1572000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_US"
      decimals="-3"
      unitRef="USD">-519000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_CA"
      decimals="-3"
      unitRef="USD">-1139000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_country_IN"
      decimals="-3"
      unitRef="USD">-27000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">14000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-1671000</us-gaap:NetIncomeLoss>
    <cxai:NetAssets
      contextRef="AsOf2023-03-31_custom_SuccessorMember_country_US"
      decimals="-3"
      unitRef="USD">75059000</cxai:NetAssets>
    <cxai:NetAssets
      contextRef="AsOf2023-03-31_custom_SuccessorMember_country_CA"
      decimals="-3"
      unitRef="USD">991000</cxai:NetAssets>
    <cxai:NetAssets
      contextRef="AsOf2023-03-31_custom_SuccessorMember_country_PH"
      decimals="-3"
      unitRef="USD">405000</cxai:NetAssets>
    <cxai:NetAssets
      contextRef="AsOf2023-03-31_custom_SuccessorMember_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-71000</cxai:NetAssets>
    <cxai:NetAssets
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">76384000</cxai:NetAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2023-03-31_custom_SuccessorMember_country_US"
      decimals="-3"
      unitRef="USD">20817000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2023-03-31_custom_SuccessorMember_country_CA"
      decimals="-3"
      unitRef="USD">417000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2023-03-31_custom_SuccessorMember_country_PH"
      decimals="-3"
      unitRef="USD">222000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">21455000</us-gaap:NoncurrentAssets>
    <us-gaap:Goodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember_country_US"
      decimals="-3"
      unitRef="USD">44122000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">44122000</us-gaap:Goodwill>
    <cxai:NetAssets
      contextRef="AsOf2022-12-31_custom_PredecessorMember_country_US"
      decimals="-3"
      unitRef="USD">24591000</cxai:NetAssets>
    <cxai:NetAssets
      contextRef="AsOf2022-12-31_custom_PredecessorMember_country_CA"
      decimals="-3"
      unitRef="USD">5484000</cxai:NetAssets>
    <cxai:NetAssets
      contextRef="AsOf2022-12-31_custom_PredecessorMember_country_IN"
      decimals="-3"
      unitRef="USD">228000</cxai:NetAssets>
    <cxai:NetAssets
      contextRef="AsOf2022-12-31_custom_PredecessorMember_country_PH"
      decimals="-3"
      unitRef="USD">415000</cxai:NetAssets>
    <cxai:NetAssets
      contextRef="AsOf2022-12-31_custom_PredecessorMember_custom_EliminationsMember"
      decimals="-3"
      unitRef="USD">-1438000</cxai:NetAssets>
    <cxai:NetAssets
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">29280000</cxai:NetAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2022-12-31_custom_PredecessorMember_country_US"
      decimals="-3"
      unitRef="USD">15558000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2022-12-31_custom_PredecessorMember_country_CA"
      decimals="-3"
      unitRef="USD">4788000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2022-12-31_custom_PredecessorMember_country_IN"
      decimals="-3"
      unitRef="USD">98000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2022-12-31_custom_PredecessorMember_country_PH"
      decimals="-3"
      unitRef="USD">215000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">20659000</us-gaap:NoncurrentAssets>
    <us-gaap:Goodwill
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:Goodwill>
    <us-gaap:LeasesOfLesseeDisclosureTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_807_eus-gaap--LeasesOfLesseeDisclosureTextBlock_zt5UZGhTPTgh" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            16 &#x2013; &lt;span id="xdx_824_zOLZNaQx4c16"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has operating leases for administrative offices in Canada and the Philippines. The Manila, Philippines office lease expires
in May 2025 and the Canada lease expires in June 2026. The Company entered into a 13-month lease for administrative offices in
California on April 1, 2023 with lease payments of approximately &lt;span id="xdx_907_ecustom--LeasePeriodicPayments_pn3n3_c20230101__20230331_zDFG3rrpw2Aa" title="Lease periodic payments"&gt;$19&lt;/span&gt;
thousand per month. The Company has no other operating or financing leases with terms greater than 12 months.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
expense for operating leases recorded in the balance sheet is included in operating costs and expenses and is based on the future minimum
lease payments recognized on a straight-line basis over the term of the lease plus any variable lease costs. Operating lease expenses,
inclusive of short-term and variable lease expenses, recognized in the Company&#x2019;s condensed consolidated statement of operations
for the period ended March 31, 2023 (Successor), period ended March 14, 2023 (Predecessor), and three months ended March 31, 2022 (Predecessor)
was approximately $&lt;span id="xdx_904_eus-gaap--OperatingLeaseExpense_pn3n3_c20230315__20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zP7S67bygUP3" title="Operating lease expenses"&gt;9&lt;/span&gt;&#160;thousand, $&lt;span id="xdx_904_eus-gaap--OperatingLeaseExpense_c20230101__20230314__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Operating lease expenses"&gt;57&lt;/span&gt;&#160;thousand and $&lt;span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20220101__20220331__srt--StatementScenarioAxis__custom--PredecessorMember_pn3n3" title="Operating lease expenses"&gt;97&lt;/span&gt;&#160;thousand, respectively.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining
the present value of lease payments, the Company used its incremental borrowing rate based on the information available at the date
of adoption of ASC 842 &#x201c;Leases&#x201d; (&#x201c;ASC 842&#x201d;). As of March 31, 2023 (Successor), the weighted average
remaining lease term is &lt;span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_z8dWSnnnDn2f" title="Weighted average remaining lease term"&gt;2.7&lt;/span&gt; years and the weighted average discount rate used to determine the operating lease liabilities was &lt;span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20230331__srt--StatementScenarioAxis__custom--SuccessorMember_zxZ9JyQ3IzT9" title="Weighted average discount rate used to determine operating lease"&gt;8.0&lt;/span&gt;%.
As of year ended December 31, 2022 (Predecessor), the weighted average remaining lease term is &lt;span id="xdx_900_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_zmGyzXZpStpb" title="Weighted average remaining lease term"&gt;2.8&lt;/span&gt;
years and the weighted average discount rate used to determine the operating lease liabilities was &lt;span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20221231__srt--StatementScenarioAxis__custom--PredecessorMember_z5OFOmEqz349" title="Weighted average discount rate used to determine operating lease"&gt;8.0&lt;/span&gt;%.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



</us-gaap:LeasesOfLesseeDisclosureTextBlock>
    <cxai:LeasePeriodicPayments
      contextRef="From2023-01-01to2023-03-31"
      decimals="-3"
      unitRef="USD">19000</cxai:LeasePeriodicPayments>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2023-03-152023-03-31_custom_SuccessorMember"
      decimals="-3"
      unitRef="USD">9000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2023-01-012023-03-14_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">57000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2022-01-012022-03-31_custom_PredecessorMember"
      decimals="-3"
      unitRef="USD">97000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2023-03-31_custom_SuccessorMember">P2Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2023-03-31_custom_SuccessorMember"
      decimals="INF"
      unitRef="Pure">0.080</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2022-12-31_custom_PredecessorMember">P2Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2022-12-31_custom_PredecessorMember"
      decimals="INF"
      unitRef="Pure">0.080</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-01-01to2023-03-31">&lt;p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zJJyEZ35MR49" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
                                            17 &#x2013; &lt;span&gt;&lt;span id="xdx_828_zxnRMO3h1XN7"&gt;Commitments and Contingencie&lt;/span&gt;s&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Litigation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
conditions may exist as of the date the financial statements are issued which may result in a loss to the Company, but which will only
be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment
inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the
Company, or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings
or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability
can be estimated, then the estimated liability would be accrued in the Company&#x2019;s financial statements. If the assessment indicates
that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then
the nature of the contingent liability and an estimate of the range of possible losses, if determinable and material, would be disclosed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
contingencies considered remote are generally not disclosed, unless they involve guarantees, in which case the guarantees would be disclosed.
There can be no assurance that such matters will not materially and adversely affect the Company&#x2019;s business, financial position,
and results of operations or cash flows.&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact001924"
          xlink:label="Fact001924"
          xlink:type="locator"/>
        <link:footnote id="Footnote001935" xlink:label="Footnote001935" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">
                                            Professional services are also contracted on the fixed fee and time and materials basis.
                                            Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company has
                                            generally elected the practical expedient to recognize revenue for the right to invoice because
                                            the Company&#x2019;s right to consideration corresponds directly with the value to the customer
                                            of the performance completed to date, in which revenue is recognized over time.</link:footnote>
        <link:footnote id="Footnote001936" xlink:label="Footnote001936" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Software
                                            As A Service Subscription Revenue&#x2019;s performance obligation is satisfied evenly over
                                            the service period using a time-based measure because the Company is providing continuous
                                            access to its service and service is recognized overtime.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001924"
          xlink:to="Footnote001935"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001924"
          xlink:to="Footnote001936"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001926"
          xlink:label="Fact001926"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001926"
          xlink:to="Footnote001935"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001926"
          xlink:to="Footnote001936"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001928"
          xlink:label="Fact001928"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001928"
          xlink:to="Footnote001935"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001928"
          xlink:to="Footnote001936"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>105
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M970R+GAM;*U8;7/:.!#^*QK:Z=S-T&#)[PUAA@"=<D=")M"[SP)$\-6V?)*
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MMO;D9-5B'*9SGC"DZ#.3**,O=!8S(QE9U=T38O^T,>O?9JXWJBDU/F!9?&$
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MR^]_C'V<X8;Q>^$#2/00T%",#%_*Z-@TA>M#@$6+11"J)TO& RS5D*],$7'
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M:GLI+Z3YC[:5;!0Z*%U+Q<N=,B H<U8]R?-N(PX4\#D%?Z?@GRITSB@$.X7
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M)ZL-+JL-R(X-,$%?>:&F$ET78S;>5M 'M#5DLH9\2:P:KUCR$;GX+T0<0@R
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MQ6&BF B:YAOXD@IY',B'H3R  5,+Y/,5I6(W46>"ZDCG_@502P,$%     @
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MSMJJ>?W@WB4IYDG.44IG,K1SW)/=%_6S</4'P9;5TV$/3 B656\7E,B+<ME
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M0 +Z_B2*9F:J94;*RXSI->1XD'6L*&F! @GH^Y,HFA%K=_QXR;7_>?*.&E=
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M($H7CM99G'.<#[[.92Z^0J?*PQQND7X45HY8PTSM$<X*@S5ZDA-0KSGP>6*
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M[Y136465\SYB[>'!S)G=>U[SC%<L3Z.[(8ER/@@/[O/VKL2M$*KEM\%S.:S
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M\8OK4_P]_> _2W_7FK]GN)-97;_'?[Q9?/UD@@#YM9]W.$,!?WSPUWZ]QHD
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MH_ZT04<CV2"!O=>S=;DBZLM=V\,5*H*D@VOBE9J;?MO-T4I8HXE %N7"=\C
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M>U38&ET[QCIOL4B(['TX9*?W%3<^G-E,G-*F295F3.&<:$,@'9!@0U+(0'X
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M\GO$NWW<+,7X*4P3-GF89_=EOY%\O5&OL!MQ'S_V73B"PSX.QWXQ8_@,&,_
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MPHH'0"P=RJ!*V:G:N3=)Z^&DU&&E\+.FOH/_DKSYMNB*;[["?'=_[=?T@BW
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MIQ'H=O1:QZHZM/M263<\P2S=:X7:)[AXH93=.OZ [OU+_P!02P,$%     @
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M![M6.#+NQ.#$A$*OY9IZ771FE!H_1U$/W[/6CVC[FEM)@Q>G<@8ZUW[4'6=
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MVBC#8TG79K1L0/,S0]MT]\(!EA?Q\;]02P,$%     @ $HC>5LP6:DKW!0
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MM)NXW9PEH)7MJC44KXO8);2W,WUSL\F 0Z%&7;,$"&HJBB4--55E#QR@.U.
MIU 4:FON8#JGD+*CJW!VHSHWH8FJ&].AVC@&)3T5'W8*R,3YA$V\2DQC\,?B
M\JLLZR(PG_ L%=W@RHH&%OS9C""7'0JYD'8XQ EYMBGE&Q)#FEH5C%\T-<&1
MHOK6X=FI^#S0,UTQHN=8OG,,&VL@ZQJ)A3_>0]28,*7-PW!RN9>2G<GE&'$^
MCZ_PW#(NA303CT&9,RC0=(K\T8F5*O)];_:1Z(8'+8>;QAL&@@K%0VSDVM28
MA3-P$L+]=/+B;05RY9GB)OOBM5IX5G0)19!RU2D9\WIPY9^W-?4-82X(-M&_
MN>8=K9LK&>A<6^"DD*"J(@*:K P%#QDN1*MCO*O5MV'94M^?Z9ABR,H?N,@,
M2$A$& H+VT%9P1!PIM T%'+DON!H\?$X5%]'>+K^##)C/UF29E6X6"+7JM1-
MR15)Q(J'Z%A\J!*<#E6Y0#/-IGQ '+6U2XEKZ>*UA2YQGO$^-DVS;DC^7LQ&
MS]/9:#XY%"E.F4>3B4A/CD;323I*YQ-Q[OLJ^! Z_08=]PHAHW!8[5I%\^=S
MB)Z/YC.(GZ>!>G1@[QF"F<!4W.MK= F#98B7/ +\77?&^;Q#Q#986!)8&)9L
M>YJR9'(YEE(.=/#QS# XG6(WKYEUQT/75=J@ KEX *HMRU:):U#,:YFGR56&
M U$3J$XLK'_]0QX'A-Y,;/\B8=_);ZQQF=4,3!&.>V?:[1O).5MWFKPWE7H0
M[P.$O6FJW 'A]_'O^WX%)._Z,[0]Y_7=:L_1D6IW!)L$'4X/1Q-4*_T^'AT>
M3T<GS^=/2[' ./#0 <:>4B-,YJ-#*G\2/II/9Z.CDRE7Z6_M,BYK&6H\]BX@
M9YM.#L#C?'JT?SCAM%&68IE#!*V@P3U@]@"L[/1BKT*?0)Q K(9T/%$R=("'
MB+H[+M.?9*N&1L'%#)/\)GC?D[#C95BVM0KE/619A)4-KYS'GS!2B/;6Z+KU
M,6V=I;_8!R$Z'T.);:8:?-CCU(.# 6^GV4O;I"BD]\1D2Y.K8B1<K3(^16)I
M(L5"5Z;D%R+]911.8VM#1L>YO;L0)W>3F\+<8#:=,PG:27DX&0S:&ZQ,@I6T
M2G<OFCK,#+T$EXHP!, 6<UK>4O,6PS9*B$\WHSAR 98\0T"/ XHML*\C<KTS
M49(WJGWU$X\31!/7C#N2'*9B\22VP>5"8C_&OOW8]>W_GR7Q-[*4#&3I6V(R
MZU=@+SRA\!!W^FXQ<!193PJ]\3XFV3U'<D4\'B8=)I#ZB@A0SL'JI8^'@"4S
M4F!,B>9PWF2WP:ZAQ>OJ>!MBGL0R_+#$\9KB176"?G:PU_(AG@^=/<\VH;QC
ML:8*0\[R(B[6XQ<+5.#M/N9@=AO+-TY"IG_ %.(%LDH"<0\O9J2]B75#+Q\=
MGV5\/^KN&^(EESZ^/T/89;;J,_7MQF,'Z5WCYTJ'4/?>$R$0[2'F+_4"3Y;-
M0\Q0?Q 3VWC#0;CXA%_0CT&"X8R<>RI6-D.X$BTA;JQI:GXI 9Z#HUXC"R+9
M)DPL*CX?\8)5*=4>2 #S3>%;Q([JDP'U*WE'N::\>-P(/1M>Z= 9$RI<Z]!6
ME,=/LT6>%.L9M-L?;2,.3)HMIM6-J.$F>T+0 $YM>M%_A9V\Z4W:09R?@(8\
M'\V.0$4F]'N:CHZ.YDQYP**FH^>X@2?)Q=!0?9:.CD_XN?A1/ .3F8>=N#@>
MI<>3\"2Y;E^,H3!:_-X7S^:CYR>3=GWO8F!]2@*/YVE<O;]Q^>=.$GG;[_ZU
MXEWBS0'W%2L!W\-BYB"S[BQV4S$RQA=QJLK;#%E5TTF*)AH@R.3K]R*RE]TU
M0_<J6U7Z"Z78]I$]O!YQX^2Z]V8['\+=+4!H&\2VZ+>> _WWA=2+7="'!P0P
MHWUOF$1GZ,U=/A!&@EQ9U]9\93O15ZB>\40<CT_$T&>S@]ZGVE(!,^D+-LTP
M,-OPU;:[VWTD/^=OPP?KY>$+.VC^#7B&*-026R?CDZ,]8<-7ZW#A3<T??A?&
M>U/RSY62&!"T ,^7!I 7+TA!][\.G/T/4$L#!!0    ( !*(WE:?'';WZ 4
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M!P<HJ?(NF&:A4;=0RI58@$L^6D?5L&1V,!6;P$();(GD2/2(W]6:1'Q74EO
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M9'D#UC.#RU<[8 /]@_+D/U!+ P04    "  2B-Y6&J4>6R,*  !W&@  &0
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M!Y1;@@TJ!JL,V5! )7QF.D1"7"T+?\@@0/V2(:@[@!##&IN"NI+:B6K(W#T
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M,+?29_*+(/5Q=,3 <@]@0=!-W#\H*I$6%AR<="5Z^J(MT3E:QBT(3YQQY'@
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M(B[O2FF5U)EDE<PVVA1FK:1+N-*Y,19,4);8E7!Y"^&.8U=%3 T ZC7!"8W
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MA#Z\>:E,Z3\(+TV%UM@_;A TTM("S*\,;@3QA0YH_T-P\5]02P,$%     @
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MK!)N7A(3U" :R(7*VUH3M1PU$TTA<FX03(F0<Z4VUM@CKUJTP .YFF^@D<0
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M&D 2G4 <QLD!O:0O,7%ZR7^4V"H,7U:PC3'1-4MQYM.?KU%MT)\?'T6C\.*
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MKWZ6+9X9ZTMT8?TOK9J]<3R@I+9.EZTP/"A5U?P5-VT<-@2.PGL$HE8@>JA
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MS*5 2'@#OF=:N^Z!#:S_]^+L;U!+ P04    "  2B-Y6"-?C<Q\$  !M"0
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MTY3Z2'7]7_=A9.MZKJ4TT,&Y80DM,U=V ZROI#3#AW4P-N&+?P%02P,$%
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M970S.2YX;6RU6VUS&S>2_CZ_ J5-4E85HU?;2?Q6I<C>7>_9CLJR-U=U=1_
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MDZ!HRP S(I30Z!@%N#%\3(_#!RB92#C&?[-X0.Z/^I* -^ZB#6)DT<R2:)'
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M=#0P+GAM;+U]:7/;1M;N]_X5*,]2<A4DD]1BV5FJ9,7)>&X2^UK)Y+YUZWX
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MQ"&-RP>VJP0IPG']_7[!S%_D]$[054>/-S[D*7F+EF=S[UAZ\$SW%)I>5V'
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M!68(('J[BI8-/%8_8U4:7EKGNSKE&E6$3,:BC-O**P@K4CUI*"TC9@B3,D\
M1:+;9I,OHH>!RDJ3(@.Q_8S^QG0&UOOO>X<6*)VP:.GP9L("8!+39-J'TI-[
MY/XD2+ON=D?0F-EAT)@?!(EY<)<? ?"B[77\:'B12!U GSG7-2"_1[SH:!MS
M=0U6;P9,VXJK<-'!NB)__$>JN*BTZ-XH(>'B)S9RG-6^T $C]4&QMFT16.T
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M5.QD5R!O--4HI$K/F[ST+'0AFVTBHLB24;E*8S&]H9XNH"A1:P#W[!8#$M1
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M5N'>6X\?9_;P869_"UB,DZL?$!2^X?B>8;O7$A'&06 0SWLV* !:+H:<P]=
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MM(<*%F6_7$X4WYJ6<\D5-K!FN,&_&%3H#?A^Q;G:3[2#^D_+^!]02P,$%
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M%5#R5N*=WGR!K9]SQY=K:?T_VW2YH_.0Y:U%K;9@4J!$W3WYX_8][ '&\0N
M9 M(O.[N(J_RAB//)D9OF''9Q.86WJI'DSA1NZ(LT="I(!QF2UWBAAM@-_!
M%6KH?2.;:XMVP&KZ)MY_YRL)]F02(=WF,%&^99YUS,D+S"F[U356EGVJ"RC^
MQ4>DLI>:[*3.DJ.$M]R<L70X8$F<I$?XTMYZZOG25UMGWP /&>[X1H?Y7/M<
MV8;G, VI/RR8!PBS=V^&%_''(VI'O=K1,?9L2>U8M!*8+EG.&X%<BB<HF-VY
M*)Y='-)^E/VP]M=<&2S;/ =KM6$+ P5TZX!JEE>^:#>TI59@7!#,G]F"0VPL
M]V5XRT[IEPPNQG%PG>>M:B5'@G"E#8HG[OOZE+U/!L,/*3L)=A4-_J/J/N93
M-AI?LD/%B/8Z2(%9^SEA"=O6V#53O]N/HNNN Y_3NSE&EM>BMDQ"2=#X[)(Z
MWW2SH0M0-[X?5QJIN_VRHG$*QB70>:DU[@)W03^@L[]02P,$%     @ $HC>
M5N#\V#DA!   V0D  !D   !X;"]W;W)K<VAE971S+W-H965T-#DN>&ULG59M
M;^,V#/[N7R%XPY ";FW)K^F2 &E[NQVP*X*VVVT8]D&QF<2H;?DDN6GWZT?)
MSLNP7.XP%&A(B7SX9I*:;(5\5AL 35[KJE%3=Z-U>^W[*M] S=65:*'!FY60
M-=?(RK6O6@F\L$IUY;,@2/R:EXT[F]BSA9Q-1*>KLH&%)*JK:R[?;J 2VZE+
MW=W!0[G>:'/@SR8M7\,CZ%_;A43.WZ,490V-*D5#)*RF[IQ>WR1&W@K\5L)6
M'='$1+(4XMDP'XJI&QB'H()<&P2./R]P"U5E@-"-SP.FNS=I%(_I'?I/-G:,
M9<D5W(KJ4UGHS=3-7%+ BG>5?A#;GV&()S9XN:B4_4^VO6P<NB3OE!;UH(P>
MU&73__+7(0]'"EGP!04V*##K=V_(>GG'-9]-I-@2::01S1 V5*N-SI6-*<JC
MEGA;HIZ>O1>BV)9517A3D ^-YLVZ7%9 YDJ!5F3TQ)%3%Q-?HS&CXN<#\$T/
MS+X ')*/HM$;1=XU!13_UO?1R;VG;.?I#3L+^)'+*Q)2C[" A6?PPGWDH<4+
M_U_D=Z7**Z$Z">3/^5)IB=_/7Z?2T%N)3ELQ/76M6I[#U,6F42!?P)W]\!U-
M@A_/Q!#M8XC.H<\>L4>+#IT6*[(>XCGEXUF4TSZ>@G;F^>>N5*7MIWDMND8[
M-[SB30X.5T82BY1O"(WZ*I'OR>6QCH,2O\":YV_D]O=YVY(H\BAC)S%VE4:,
M7HJ<R5>\SU?\S?DJ#R7GMN2G$G<6[NN)^X^-0W".#6[TV.4Y*"7D!;F#'.HE
MR-TM(Z.%A *&>^>3G3!0D/D+2!R8Y ',U"V;-7DOA5).7Q$RS_.N[BJ.HN9(
MZO)O;BMV#]JYY5*^&95!V&J>52$[%>=)\@*<>UZ#;TF<XL^*I,X;<*FP3J''
MQA'^CEA +GH^-3SS:&;J.$I9;"^H%\69<VNG&TCG 2IK36W*5I%XP(N])(C(
M*$I1)?;B."6)%P64C*B7)@8G\I(P<>[@!3=+BXX_0;YI1"76;X0& \C88TE&
M1F&&\DB' :&Q1],Q'GGAV)Q2A,NH<R^:RUS4+6APYFL)@(L'RW5I_T*/QH$U
M'"9&Q8MHY"PP6RCB#.,#]PHNFHY79"'1':F/O&!>&F"M*45EYB5CUN,Z3T+S
MRF2.!5Z6C$V**$ULBO DC4W26.*-:9\]+V%1GS\,)1N?:XADWQ#)-S?$JM-F
MVO'C^L,K;G\%IUKC+/#76^.,-0?W+=$;('_8[.$",1_L<7OLAL\P()@7C*EA
M(I/J+#-D?""3 YD>R,P.?C2#;YF51MS4B[%BMB:' IS*L7^T;O'[7=M'A2*Y
M<:G?O/O3_;MEWJ_K@WC_Z,%QL"X;12I8H6IPE>+ D?U#HF>T:.WR7@J-S6+)
M#;Z]0!H!O%\)H7>,,;!_S<W^ 5!+ P04    "  2B-Y6"9FT.UP"  !D!0
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M(%S,'F[FO][<WZ'[G]']PR]7=S?_N2J_7]T%Z/K;XN8N7"S0_3Q\* \OT*>
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M\[*RV8\\OZF+U>F C_:VJ.MBL7XY9?F$E8T!__ZN*.KG-XV#IZ+\MA[.V?\
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M4B&K#MWT9&&(3$V0[^>4BDU'.<A*S?Y?4$L#!!0    ( !*(WE;8YI3YG L
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M\+J2I5'@@L1^$"_KZAXTUJWE;5NWCDZI^[JL^UI;][/<U"@2%,T D20) ZF
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M0)I:EI\!Y@U!D^Q4;$:%H%%VN0+B TM?D,\75,[+HI$2E">QX_\!4$L#!!0
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M3L89Q,?(=S\CS_&\%D'3Y\/=#CE^LV6^X?/W\)U# AR3MIVI@+UVH+Z1)Z+
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M,L>K@J7J2%:8G'_+I*H@3#-511YP':#F%XS)34<OT)2-T7]02P,$%     @
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MH1G,R9*I*UY^AT:/;_@2SF3UB\HZ=H ME"REXED#UAED-*^?Y+'QH0-P!Z\
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ME54%;??#ZCZXR4"B)C%G&VC__=E.&@)-O0N'5#Y G'B>F>?QC!FGLR7TF44
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M#]'?VLZ;SJRH@DO!/[-49V>#V0"EL*8EUQ_$_F]H.C2NXB6"*_L7[>MOI]$
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MC#%35=V<U!,C#U5#L)4&VXMJF&%#!\INP/]W4IJGB570MHC+?P%02P,$%
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MH5&\]G .#.5O&N#]J1!Z>V(2E+O41O\!4$L#!!0    ( !*(WE8&?%)7UP0
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MM#V *CJVAVD/;G)M+!([V$X+^_4[.VG6BI(5J=I+X[/O^\[W^7IVN!3R064
MFCP5.5<C)].Z/'-=E6104'4B2N"X,A.RH!I-.7=5*8&F%E3DKM_K#=V",NY$
MH9T;RR@4E<X9A[$DJBH**I\O(!?+D>,YJXD[-L^TF7"CL*1SF("^+\<2+;=E
M25D!7#'!B839R#GWSN*A\;<.WQDLU=J8F$RF0CP8XVLZ<GIF0Y!#H@T#Q<\"
M+B'/#1%NX['A=-J0!K@^7K%?V]PQERE5<"GR'RS5V<CYZ) 49K3*]9U8?H$F
MGX'A2T2N["]9UKZG@4.22FE1-&#<0<%X_:5/C0YK .39#O ;@+\K(&@ P:Z
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M9;76'UHH*H1D:2U6)TA)5EWQ4QV''4&OOT?@U@+WK0*O%G@&M#J9P9IAB<.
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M+H=*SJO^J)I(EIL68\FD:EC,,%$M)7"]0#U?,2:W$]VU-$UJ^ =02P,$%
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MV9-PEG<U^4#0)&L,YE3(-B-[7<M.$)A:(+\O*14O ]5KE+VE]Q=02P,$%
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MS/.M,/OXL6'/"*LSX?6_4$L#!!0    ( !*(WE8/CYGUE 0  (,.   9
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M\US:>[7^$;:"^L07*6G<+UL7:P=]CT6YL2K9@M&#1*3%/W_<!J(&"%\"=+:
MSC/ ,'@!T-T"NDYHX9F3=<TMGXRT6C--JY&-'EQL'!K5B)32^& UOA6(LY-I
M%.D<8O:SX#,AA15@V/$U6"ZD89^YUIS"?,*^8U\>KMGQT0D[8B)EORY5;G@:
MFY%OT0OB\J.MQ<O"8N<%BQUVJU*[-.S[-(9X#_ZJ&=]MP/NHO@I!IPS!9:>1
M\);K-@M[IZP3=+K[_'D%O!ON@^^XTZTRTG5\O1?X[D%RBQG)N+8;K$@3:9%1
MR>\+=2,5M8 +D_$(QA[N<0-Z!=[DXX=P$'S:I[/9KZEIJ3E#M=&RDGO*[!+8
ME4HRGFX^?AAVPK-/!G=W78&L55:D</\;>H=4G&5:)<(8I3<L5180L.$S"<PJ
MQ_O3S><'9C+$*$U%1W,\47EJ"7[4"7"F*$.&_<SU"Y$N6,0S8;ELLZEA>SSF
M1<6WZGZ)-))YC.PI V,%=@=P'F;HX:,;R@T["D^#7O_)9IP[3V_23#QB0YIM
MV-4?TRQ#^09["'DR1WW$R1<: 'N?I?4:1#++M8%6B3PV^>QO;&O%VQ7U/N)'
M1R&S/(V N&N!/G%R(]"X2S$JFJ>&%TVQC'RDC'6J<JUQB/#2%CD*2R[GI,\%
M.-,"V="T"U2KW AMW./"E/'&IYJ3G'@6BB36_(45ESEW?NSZBYF(8T$ON)0;
MS,#!>3D6V'>ZS_)=9JJ46XJGZJ&8.(N,JEY$R(6I7(EX-QJXM,@9<1X+LC(,
M6I45]++,EJM+>,2OIX%71+9@C7--,:)09(!ACHN**)2'_4)Y%7J*1<N%OJ&+
M]*HNTFO<K7?H':!LVCI_WD(R _W7O@;2R')H WDGLAW!_4IPOU'P36H!62W#
M+Q;L4UK SQV<#C>K2= .AB-_55?0:..-"@:5@L'!*6/_LFNA<=OAW!0K\I?Y
M'(M9F\:<-IHY-*?O1+83D;,J(F>-$;F&F:6/ K7.?4(+=+^6TL%9^"RCC1;>
MZ/^P\G_X;?_Q Y>[)DY=:I^*X?]4A-W>,Q6-=MZHXKQ2<=ZHXB&/7M%(&CD.
M+;IW(MN1&P9/1^+@VVE3:VKO7%+J]AYR&SD.%;QEJQ=!O_O4G HA?NV8GX!>
MN-L/':KP"UV<^*O9ZH8U=?<*_VEY<3W##\Y"I(9)F",T:)^A95W<>(J!59F[
M-,R4Q2N(>USB+1$T+<#W<X4'MNV #%3WSLE_4$L#!!0    ( !*(WE:L:UMI
MA08  ,(P   9    >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;,5;46_;-A#^
M*X17#"VP11)ENVZ7&&BL#ANPK$'2K0_#'FB)CHE*HDO2<0+LQX^4%-%TY;.5
MTF@>8LG2?>1]/![O8YCS#1>?Y9)2A1Z*O)07@Z52J[=!(-,E+8@\XRM:ZB<+
M+@JB]*VX"^1*4))51D4>X# <!P5AY6!Z7GUW+:;G?*UR5M)K@>2Z*(AXO*0Y
MWUP,HL'3%S?L;JG,%\'T?$7NZ"U5?ZVNA;X+6I2,%;24C)=(T,7%X%WT-HG'
MQJ!ZXV]&-W+K&AE7YIQ_-C>_9Q>#T/2(YC15!H+HCWLZHWEND'0_OC2@@[9-
M8[A]_83^:^6\=F9.))WQ_!/+U/)B,!F@C"[(.E<W?/,;;1P:&;R4Y[+ZC3;-
MN^$ I6NI>-$8ZQX4K*P_R4-#Q)9!--EC@!L#O&LPWF,0-P;QKL%PC\&P,1A6
MS-2N5#PD1)'IN> ;),S;&LU<5&16UMI]5IIQOU5"/V7:3DT_$2%(J= ?C,Q9
MSA2C$KU,J"(LE^A/\]",RROT,WJ! B271%!Y'BC=LK$/TJ:5R[H5O*>5"%WQ
M4BTE>E]F-.NPGQVPQP! H%UN_<9/?E]B$/&*B#,41S\A'.*XJT.P>4+3UAQW
MF"?'FT> -W$[BG&%-X1'42(]LZ4B9<;*NZY1 E%,BGDK5R2E%P.=0R05]W0P
M_?&':!S^TL50#3:NP$QZN9]&\20T/^?!_3871[SH>#ULO1Z"7E^OYSE+4>O\
M/U>TF%/Q;Y?G(%)?SWV")9[ ' 9'+8.C8^(&T0<J4B8I6E'!>(92KD.HRLN\
MI%UT@K!]Z83[&(<H(X]=22?QU N'NG%+W?@;J5,;WD4="-N7.KB/.FT65=KL
M(L]3/QSR7K?DO>XU<^G#BIF5QK!&1=%%&PC8ES:X=R/T2(GH),U3+QS2)BUI
M$[!;-U0JP:IR22=ZS93F3BZH>(H\OD!*EV2(+#2':+Z6VEY*'9#%G)4UN?IZ
ME5-SV44QV'Q?BF%?@$GMJ1<.Q6]:BM_ <2G8/5$47>>Z!5W=JN,6%Q"T+W$^
MP1)/8 Z946AKR]!+60+#]"6P07/JC1!/.@J38]YT7=\JJR/0]=MUFNK9QP48
M.#!(;\=]HB6^T%P"L240^XD=?&09.H,;[$V/)S27'EOP1T=5_$AGK+2S0FOL
M)]N\1&>C74Y\*H+$%YK+B94#$:P'OIYSZ#]T0S-:K*K5[\/"IO-/2UJBCTM:
M$VB64#3+B5XNWZ$/0L<:$8_HUJA=]/[+FF@M_$&@]P\II9E$+Z+)61C"$]NK
MWO"*EOA"<T?)2H[H.,TA[,#8FKE@)2O61;W1@%9[@WOT]:2?[(:V3XV2^$)S
M2;-B(X(K^6\([>M^H1T>#&VO L8K6N(+S1TEJVHB6#AL#<BJ32NK6NMLFK!_
MR4J4\3S7 J-Z7$7ZJTZBZ\:BX5:4AV?1;IC[%$:)+S270*MP(E@6],T-2*94
MQS/C^\1VT][(J?!V&?2I>Q)?:"Z#5L!$L(+I3!1]-LI@_-[3VZN:\87F[AA;
M.8./DC/]=\L.X.X7PS/8LB]_OM!<_JPFPK F>O:6V0%<:)MK!MOV9O 4H@A;
M481A4?2,?;,#B/OWNF:P96_F3J&7L-5+&-9+)]\\.] ^-,>]:C!?:"[/5H/A
M9VBP?>O/=Y-GL!-]%SFO:(DO-'< K3S#IY=G31-.U;4KS^!N]";M%/(,6WF&
M87GFM_!O&MO>NM&J;+?PA[O4F\!3*"=LE1,^7CE5";F3%Q@#2K%>19(O-)<K
M*Y(P+)(^+C7JDN>96<3,MFCE-EKHG+LU:?6"Y@9@Y[&- TUA@%*OJLD7FDNI
M54T85DV64IWK)$W7YM"+#WKA9J&(]2J<?*&YAU.L<(IA@6/I+==F33;LM256
MQ>Z<:GZUG*?5/C\JN3)95+^V1;GB;2XU6+2S:KT\T!6U9,*9.)TG6[RJ+E]H
M+OE6=<5]_Q*ERZZG5?Z[[R;"G>]]),FKV/.%Y@Z<%7LQ+,V.6A,/8  9!K;L
MS=4IY%V\=?X-EE>G2N 'FH7H]:KJ?*&Y]%I5%\.JSON^;-,>N"\+]ZDW@Z>0
M5;&553$LJ[IU\?..F\!-]<Z97H68+S279BO$XJ-.Y1T^"#ON/OFQ&X)>-98O
MM)J;8.O0=T'%775XWNQ8K4M5G_]NOVT/Z+^KCJ4']O7Z=/\5$7>LE"BG"VT:
MGKW6@RCJ _/UC>*KZ@CYG"O%B^IR28DNP<P+^OF"<_5T8QIH_VUA^C]02P,$
M%     @ $HC>5@%A',;? @  $ H  !D   !X;"]W;W)K<VAE971S+W-H965T
M.#DN>&ULU59=;]HP%/TK5B9-F]22$ J4#B)!NVI]0$*P=0_3'DQR(19VG-D.
M'_]^UPZD3 JIM)=N+\1V?(_/N3GXWN%.JHU. 0S9"Y[ID9<:D]_YOHY3$%2W
M9 X9OEE)):C!J5K[.E= $Q<DN!\&0<\7E&5>-'1K,Q4-96$XRV"FB"Z$H.HP
M 2YW(Z_MG1;F;)T:N^!'PYRN80'F6SY3./,KE(0)R#23&5&P&GGC]MVD'=@
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M[[+V#.(GICT1D9N;)6DXJJ"42&]T(RO/VE.&=B#H6N^*%U3(/;:^7 $N@*D
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MWO?TKDULU1.,,I]P/?P G*.$VAXH3:)H9I1:^/B\\7&M36S3LZLV@;H>*$U
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    "  2B-Y64,>#M-L&  "0/0  #P
M 'AL+W=O<FMB;V]K+GAM;,6;6W/:.!2 _XJ&I^Y,=XF-;W2:SCA@$L\2P]I
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ML E)R,=>.086 UMA$Y*0CSV[ V*:B7@ 22A EA!8LVPO0(<D%"!+",8T.SV
M)!0@2PC&;'4Z9*$ V4(PIEE]"2 +!<@6>EFH[M!Y  DH0!909Z6Z"Q+23X"L
M'PA2)QDF)J2? %D_':M_7L,$WX7!UD]3^ ]U:-\U=7_YZDJ@ -)/@*T?<'["
M#)AC2#]C[!P(6K#4TL\8TL\863_F@J6.!-W$A/0S[F&VIR,:C2'WC)'=<UHG
M]!]5CC&DG7&CG6%SLOSP?L?V.E?9)?KJ4N_?TGR[%*3^J*]DV8Y;OTNP/^;Y
M1.];E/.*[IY>*'YZ&?K#OU!+ P04    "  2B-Y6MO4_!K8"  !1-P  &@
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M_@102P$"% ,4    "  2B-Y6!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( !*(WE8EL@1+[@   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( !*(WE:97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ $HC>5J5$\ZP7!0  @Q<  !@
M         ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( !*(WE;Q4:UNM 4  '05   8              " @5H-  !X;"]W;W)K
M<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  2B-Y6'"8YG60#  "0#
M&               @(%$$P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L!
M A0#%     @ $HC>5E3JGRR;!   A1   !@              ("!WA8  'AL
M+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( !*(WE8'FR662@0
M -,6   8              " @:\;  !X;"]W;W)K<VAE971S+W-H965T-2YX
M;6Q02P$"% ,4    "  2B-Y6]JV?JU(&   P&P  &               @($O
M(   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ $HC>5MJO
M0Z:!"@  HU,  !@              ("!MR8  'AL+W=O<FMS:&5E=',O<VAE
M970W+GAM;%!+ 0(4 Q0    ( !*(WE:/=@3;X0(  -X)   8
M  " @6XQ  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  2
MB-Y6%$98GR4(  "=.   &               @(&%-   >&PO=V]R:W-H965T
M<R]S:&5E=#DN>&UL4$L! A0#%     @ $HC>5J.2&=P4"   4$0  !D
M         ("!X#P  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
M    "  2B-Y63ZC]5V(1  !,NP  &0              @($K10  >&PO=V]R
M:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( !*(WE;J7J;,S1$  /(T
M   9              " @<16  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL
M4$L! A0#%     @ $HC>5AT]DZDB"0  8"(  !D              ("!R&@
M 'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    "  2B-Y6?;@[
M5IHW  !MMP  &0              @($A<@  >&PO=V]R:W-H965T<R]S:&5E
M=#$T+GAM;%!+ 0(4 Q0    ( !*(WE:Y;D^T/@(   L%   9
M  " @?*I  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @
M$HC>5I>[0KMT @  7P4  !D              ("!9ZP  'AL+W=O<FMS:&5E
M=',O<VAE970Q-BYX;6Q02P$"% ,4    "  2B-Y6;#^VN[($   %"@  &0
M            @($2KP  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4
M Q0    ( !*(WE:EYZ[MMQ0   $^   9              " @?NS  !X;"]W
M;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ $HC>5JI-$Y;.!
ME L  !D              ("!Z<@  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX
M;6Q02P$"% ,4    "  2B-Y6S!9J2O<%  #.#P  &0              @('N
MS0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( !*(WE80
MUO#Z7P8  ,40   9              " @1S4  !X;"]W;W)K<VAE971S+W-H
M965T,C$N>&UL4$L! A0#%     @ $HC>5@+W4?,;"P  1B   !D
M     ("!LMH  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !*(WE;Y;/H<30,  '4'   9              "
M@=T% 0!X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ $HC>
M5OVIHTZ[ @  =@8  !D              ("!80D! 'AL+W=O<FMS:&5E=',O
M<VAE970R."YX;6Q02P$"% ,4    "  2B-Y6]0XN&QH%  "J"P  &0
M        @(%3# $ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0
M   ( !*(WE:4:3AKJ (  /P%   9              " @:01 0!X;"]W;W)K
M<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ $HC>5M50_:U;!0  * P
M !D              ("!@Q0! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q0
M2P$"% ,4    "  2B-Y6ZYSG&/P&  !+$P  &0              @($5&@$
M>&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( !*(WE88O&"Y
M$ 4  .8+   9              " @4@A 0!X;"]W;W)K<VAE971S+W-H965T
M,S,N>&UL4$L! A0#%     @ $HC>5B['RJ 9"P  7B   !D
M ("!CR8! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    "  2
MB-Y6TZP%FEH&  #)$   &0              @('?,0$ >&PO=V]R:W-H965T
M<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( !*(WE8(U^-S'P0  &T)   9
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M970T,"YX;6Q02P$"% ,4    "  2B-Y6FW*6-"4&  #=&0  &0
M    @($^E@$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    (
M !*(WE;_$+'1200  , ,   9              " @9J< 0!X;"]W;W)K<VAE
M971S+W-H965T-#(N>&UL4$L! A0#%     @ $HC>5EB4LZ+/ P  -PH  !D
M             ("!&J$! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"
M% ,4    "  2B-Y6I'W5AHP#  #G"   &0              @($@I0$ >&PO
M=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( !*(WE8+C ]?[ ,
M .<(   9              " @>.H 0!X;"]W;W)K<VAE971S+W-H965T-#4N
M>&UL4$L! A0#%     @ $HC>5L((91$"!   ;PD  !D              ("!
M!JT! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    "  2B-Y6
M:9^\-\,"   .!@  &0              @($_L0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0W+GAM;%!+ 0(4 Q0    ( !*(WE;_7F&0< (  *P%   9
M      " @3FT 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%
M  @ $HC>5N#\V#DA!   V0D  !D              ("!X+8! 'AL+W=O<FMS
M:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    "  2B-Y6"9FT.UP"  !D!0
M&0              @($XNP$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+
M 0(4 Q0    ( !*(WE8C*: \Y (  &<&   9              " @<N] 0!X
M;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ $HC>5L(3L7^%
M @  J 4  !D              ("!YL ! 'AL+W=O<FMS:&5E=',O<VAE970U
M,BYX;6Q02P$"% ,4    "  2B-Y6@)L%N. #  !]"@  &0
M@(&BPP$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( !*(
MWE8QS#S"DP@  %(_   9              " @;G' 0!X;"]W;W)K<VAE971S
M+W-H965T-30N>&UL4$L! A0#%     @ $HC>5@MD 9C #0  /)   !D
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M=#4Y+GAM;%!+ 0(4 Q0    ( !*(WE:,3;O46@,  '8.   9
M  " @8SU 0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @
M$HC>5MCFE/F<"P  N(@  !D              ("!'?D! 'AL+W=O<FMS:&5E
M=',O<VAE970V,2YX;6Q02P$"% ,4    "  2B-Y6LK@6NIH)  !W60  &0
M            @('P! ( >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4
M Q0    ( !*(WE;]5/C2[ 0  )4=   9              " @<$. @!X;"]W
M;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ $HC>5N10Z$2T!P
M/CH  !D              ("!Y!," 'AL+W=O<FMS:&5E=',O<VAE970V-"YX
M;6Q02P$"% ,4    "  2B-Y6%HXG#:8"   &"   &0              @('/
M&P( >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( !*(WE9]
MD"#UX (  $(*   9              " @:P> @!X;"]W;W)K<VAE971S+W-H
M965T-C8N>&UL4$L! A0#%     @ $HC>5FG;FC(6 P  -@D  !D
M     ("!PR$" 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4
M"  2B-Y6[<=BY*L"  !A"   &0              @($0)0( >&PO=V]R:W-H
M965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( !*(WE:A&2^'JP,  /D1   9
M              " @?(G @!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L!
M A0#%     @ $HC>5OW?G-J1!   J!H  !D              ("!U"L" 'AL
M+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    "  2B-Y6.]TGF_(#
M  !+$0  &0              @(&<, ( >&PO=V]R:W-H965T<R]S:&5E=#<Q
M+GAM;%!+ 0(4 Q0    ( !*(WE9%X#IB8@(  "H&   9              "
M@<4T @!X;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ $HC>
M5D\</'ID!0  A1@  !D              ("!7C<" 'AL+W=O<FMS:&5E=',O
M<VAE970W,RYX;6Q02P$"% ,4    "  2B-Y6#JWA:W\"  !0!@  &0
M        @('Y/ ( >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0
M   ( !*(WE8RP'FAH ,  "X.   9              " @:\_ @!X;"]W;W)K
M<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @ $HC>5J#0R0 \!@  L28
M !D              ("!AD," 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q0
M2P$"% ,4    "  2B-Y6!GQ25]<$   &(P  &0              @('Y20(
M>&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( !*(WE9A#'^;
MO@(  *X)   9              " @0=/ @!X;"]W;W)K<VAE971S+W-H965T
M-S@N>&UL4$L! A0#%     @ $HC>5HY QA.Z @  L H  !D
M ("!_%$" 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"% ,4    "  2
MB-Y6Q1CS8:X"  !N"0  &0              @('M5 ( >&PO=V]R:W-H965T
M<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( !*(WE:I\'3P4 (  #0%   9
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M970X-2YX;6Q02P$"% ,4    "  2B-Y66=?S8A<$   ?%@  &0
M    @('':P( >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    (
M !*(WE8/CYGUE 0  (,.   9              " @15P @!X;"]W;W)K<VAE
M971S+W-H965T.#<N>&UL4$L! A0#%     @ $HC>5JQK6VF%!@  PC   !D
M             ("!X'0" 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"
M% ,4    "  2B-Y6 6$<QM\"   0"@  &0              @(&<>P( >&PO
M=V]R:W-H965T<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0    ( !*(WE:H@N7]O@0
M )\:   9              " @;)^ @!X;"]W;W)K<VAE971S+W-H965T.3 N
M>&UL4$L! A0#%     @ $HC>5LFM^"UR P  F@\  !D              ("!
MIX," 'AL+W=O<FMS:&5E=',O<VAE970Y,2YX;6Q02P$"% ,4    "  2B-Y6
M8,HX17$#  #V$0  &0              @(%0AP( >&PO=V]R:W-H965T<R]S
M:&5E=#DR+GAM;%!+ 0(4 Q0    ( !*(WE:H(Z7$I@P  +F@   9
M      " @?B* @!X;"]W;W)K<VAE971S+W-H965T.3,N>&UL4$L! A0#%
M  @ $HC>5KGD+Y_) P  U!4  !D              ("!U9<" 'AL+W=O<FMS
M:&5E=',O<VAE970Y-"YX;6Q02P$"% ,4    "  2B-Y6OHXN]E<#  #6%0
M#0              @ '5FP( >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( !*(
MWE:7BKL<P    !,"   +              "  5>? @!?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( !*(WE90QX.TVP8  ) ]   /              "  4"@ @!X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  2B-Y6MO4_!K8"  !1-P  &@
M            @ %(IP( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    "  2B-Y6N.0S3$8"  ",-0  $P              @ $VJ@( 6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     9@!F  $<  "MK (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>318</ContextCount>
  <ElementCount>429</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>81</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperations</Role>
      <ShortName>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatements</Role>
      <ShortName>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - PUBLIC OFFERING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/PublicOffering</Role>
      <ShortName>PUBLIC OFFERING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - PRIVATE PLACEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/PrivatePlacement</Role>
      <ShortName>PRIVATE PLACEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - RELATED PARTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/RelatedParties</Role>
      <ShortName>RELATED PARTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - STOCKHOLDERS??? DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/StockholdersDeficit</Role>
      <ShortName>STOCKHOLDERS??? DEFICIT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - DERIVATIVE WARRANT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/DerivativeWarrantLiabilities</Role>
      <ShortName>DERIVATIVE WARRANT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - INCOME TAX</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/IncomeTax</Role>
      <ShortName>INCOME TAX</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/FairValueMeasurements</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Organization, Nature of Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/OrganizationNatureOfBusinessAndBasisOfPresentation</Role>
      <ShortName>Organization, Nature of Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Business Combination</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/BusinessCombination</Role>
      <ShortName>Business Combination</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Disaggregation of Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/DisaggregationOfRevenue</Role>
      <ShortName>Disaggregation of Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Property and Equipment, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>Property and Equipment, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Software Development Costs, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/SoftwareDevelopmentCostsNet</Role>
      <ShortName>Software Development Costs, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/GoodwillAndIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Deferred Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/DeferredRevenue</Role>
      <ShortName>Deferred Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/AccruedLiabilities</Role>
      <ShortName>Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Warrant Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/WarrantLiabilities</Role>
      <ShortName>Warrant Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Stock Option Plan and Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensation</Role>
      <ShortName>Stock Option Plan and Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/FairValueOfFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Credit Risk and Concentrations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/CreditRiskAndConcentrations</Role>
      <ShortName>Credit Risk and Concentrations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Foreign Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/ForeignOperations</Role>
      <ShortName>Foreign Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Commitments and Contingencie</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/CommitmentsAndContingencie</Role>
      <ShortName>Commitments and Contingencie</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables</Role>
      <ShortName>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatements</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kins-tech.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - INCOME TAX (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/IncomeTaxTables</Role>
      <ShortName>INCOME TAX (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kins-tech.com/role/IncomeTax</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/FairValueMeasurementsTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kins-tech.com/role/FairValueMeasurements</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Business Combination (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/BusinessCombinationTables</Role>
      <ShortName>Business Combination (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kins-tech.com/role/BusinessCombination</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Disaggregation of Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/DisaggregationOfRevenueTables</Role>
      <ShortName>Disaggregation of Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kins-tech.com/role/DisaggregationOfRevenue</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Property and Equipment, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kins-tech.com/role/PropertyAndEquipmentNet</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Software Development Costs, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/SoftwareDevelopmentCostsNetTables</Role>
      <ShortName>Software Development Costs, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kins-tech.com/role/SoftwareDevelopmentCostsNet</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kins-tech.com/role/GoodwillAndIntangibleAssets</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Deferred Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/DeferredRevenueTables</Role>
      <ShortName>Deferred Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kins-tech.com/role/DeferredRevenue</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/AccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kins-tech.com/role/AccruedLiabilities</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Stock Option Plan and Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationTables</Role>
      <ShortName>Stock Option Plan and Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensation</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Foreign Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/ForeignOperationsTables</Role>
      <ShortName>Foreign Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://kins-tech.com/role/ForeignOperations</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperations</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails</Role>
      <ShortName>RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - PUBLIC OFFERING (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/PublicOfferingDetailsNarrative</Role>
      <ShortName>PUBLIC OFFERING (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/PublicOffering</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - PRIVATE PLACEMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/PrivatePlacementDetailsNarrative</Role>
      <ShortName>PRIVATE PLACEMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/PrivatePlacement</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - RELATED PARTIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/RelatedPartiesDetailsNarrative</Role>
      <ShortName>RELATED PARTIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/RelatedParties</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - STOCKHOLDERS??? DEFICIT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/StockholdersDeficitDetailsNarrative</Role>
      <ShortName>STOCKHOLDERS??? DEFICIT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/StockholdersDeficit</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - DERIVATIVE WARRANT LIABILITIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative</Role>
      <ShortName>DERIVATIVE WARRANT LIABILITIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/DerivativeWarrantLiabilities</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - INCOME TAX (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/IncomeTaxDetails</Role>
      <ShortName>INCOME TAX (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/IncomeTaxTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - INCOME TAX (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/IncomeTaxDetails1</Role>
      <ShortName>INCOME TAX (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/IncomeTaxTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - INCOME TAX (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/IncomeTaxDetails2</Role>
      <ShortName>INCOME TAX (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/IncomeTaxTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - INCOME TAX (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/IncomeTaxDetailsNarrative</Role>
      <ShortName>INCOME TAX (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/IncomeTaxTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - FAIR VALUE MEASUREMENTS (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/FairValueMeasurementsDetails1</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - Summary of Significant Accounting Policie (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails</Role>
      <ShortName>Summary of Significant Accounting Policie (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - Business Combination (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/BusinessCombinationDetails</Role>
      <ShortName>Business Combination (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/BusinessCombinationTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - Business Combination (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/BusinessCombinationDetails1</Role>
      <ShortName>Business Combination (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/BusinessCombinationTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - Business Combination (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/BusinessCombinationDetailsNarrative</Role>
      <ShortName>Business Combination (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/BusinessCombinationTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/DisaggregationOfRevenueDetails</Role>
      <ShortName>Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/DisaggregationOfRevenueTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - Property and Equipment, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/PropertyAndEquipmentNetDetails</Role>
      <ShortName>Property and Equipment, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000078 - Disclosure - Property and Equipment, net (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative</Role>
      <ShortName>Property and Equipment, net (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/PropertyAndEquipmentNetTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - Software Development Costs, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails</Role>
      <ShortName>Software Development Costs, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/SoftwareDevelopmentCostsNetTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - Software Development Costs, net (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative</Role>
      <ShortName>Software Development Costs, net (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/SoftwareDevelopmentCostsNetTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000081 - Disclosure - Goodwill and Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - Goodwill and Intangible Assets (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1</Role>
      <ShortName>Goodwill and Intangible Assets (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>00000083 - Disclosure - Goodwill and Intangible Assets (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2</Role>
      <ShortName>Goodwill and Intangible Assets (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>00000084 - Disclosure - Goodwill and Intangible Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative</Role>
      <ShortName>Goodwill and Intangible Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>00000085 - Disclosure - Deferred Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/DeferredRevenueDetails</Role>
      <ShortName>Deferred Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/DeferredRevenueTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>00000086 - Disclosure - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/AccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/AccruedLiabilitiesTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>00000087 - Disclosure - Accrued Liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative</Role>
      <ShortName>Accrued Liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/AccruedLiabilitiesTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>00000088 - Disclosure - Warrant Liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative</Role>
      <ShortName>Warrant Liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/WarrantLiabilities</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>00000089 - Disclosure - Stock Award Plans and Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails</Role>
      <ShortName>Stock Award Plans and Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>00000090 - Disclosure - Stock Option Plan and Stock-Based Compensation (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative</Role>
      <ShortName>Stock Option Plan and Stock-Based Compensation (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>00000091 - Disclosure - Fair Value of Financial Instruments (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative</Role>
      <ShortName>Fair Value of Financial Instruments (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/FairValueOfFinancialInstruments</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>00000092 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/IncomeTaxes</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>00000093 - Disclosure - Foreign Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/ForeignOperationsDetails</Role>
      <ShortName>Foreign Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/ForeignOperationsTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="cxapp_s1a3.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>00000094 - Disclosure - Leases (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kins-tech.com/role/LeasesDetailsNarrative</Role>
      <ShortName>Leases (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://kins-tech.com/role/Leases</ParentRole>
      <Position>94</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-1/A" original="cxapp_s1a3.htm">cxapp_s1a3.htm</File>
    <File>cxai-20230331.xsd</File>
    <File>cxai-20230331_cal.xml</File>
    <File>cxai-20230331_def.xml</File>
    <File>cxai-20230331_lab.xml</File>
    <File>cxai-20230331_pre.xml</File>
    <File>cxapp_107.htm</File>
    <File>cxapp_ex23-1.htm</File>
    <File>cxapp_ex23-2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="924">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>110
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cxapp_s1a3.htm": {
   "axisCustom": 0,
   "axisStandard": 28,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 924,
    "http://xbrl.sec.gov/dei/2022": 30
   },
   "contextCount": 318,
   "dts": {
    "calculationLink": {
     "local": [
      "cxai-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cxai-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cxapp_s1a3.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cxai-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cxai-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cxai-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 680,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 125,
    "http://kins-tech.com/20230331": 56,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 186
   },
   "keyCustom": 153,
   "keyStandard": 276,
   "memberCustom": 39,
   "memberStandard": 36,
   "nsprefix": "cxai",
   "nsuri": "http://kins-tech.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AmendmentDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://kins-tech.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AmendmentDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2021-12-31_custom_NetParentInvestmentMember_custom_PredecessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000010 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)",
     "menuCat": "Statements",
     "order": "10",
     "role": "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-03-31_custom_NetParentInvestmentMember_custom_PredecessorMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000011 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "11",
     "role": "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperations",
     "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatements",
     "shortName": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ErrorCorrectionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://kins-tech.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:InitialPublicOfferingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - PUBLIC OFFERING",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://kins-tech.com/role/PublicOffering",
     "shortName": "PUBLIC OFFERING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:InitialPublicOfferingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:PrivatePlacementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - PRIVATE PLACEMENT",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://kins-tech.com/role/PrivatePlacement",
     "shortName": "PRIVATE PLACEMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:PrivatePlacementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - RELATED PARTIES",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://kins-tech.com/role/RelatedParties",
     "shortName": "RELATED PARTIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://kins-tech.com/role/CommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - STOCKHOLDERS\u2019 DEFICIT",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://kins-tech.com/role/StockholdersDeficit",
     "shortName": "STOCKHOLDERS\u2019 DEFICIT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://kins-tech.com/role/ConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - DERIVATIVE WARRANT LIABILITIES",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://kins-tech.com/role/DerivativeWarrantLiabilities",
     "shortName": "DERIVATIVE WARRANT LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - INCOME TAX",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://kins-tech.com/role/IncomeTax",
     "shortName": "INCOME TAX",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - FAIR VALUE MEASUREMENTS",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://kins-tech.com/role/FairValueMeasurements",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - SUBSEQUENT EVENTS",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://kins-tech.com/role/SubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - Organization, Nature of Business and Basis of Presentation",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://kins-tech.com/role/OrganizationNatureOfBusinessAndBasisOfPresentation",
     "shortName": "Organization, Nature of Business and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - Business Combination",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://kins-tech.com/role/BusinessCombination",
     "shortName": "Business Combination",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:DisaggregationOfRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - Disaggregation of Revenue",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://kins-tech.com/role/DisaggregationOfRevenue",
     "shortName": "Disaggregation of Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:DisaggregationOfRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - Property and Equipment, net",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://kins-tech.com/role/PropertyAndEquipmentNet",
     "shortName": "Property and Equipment, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:SoftwareDevelopmentCostsNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - Software Development Costs, net",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://kins-tech.com/role/SoftwareDevelopmentCostsNet",
     "shortName": "Software Development Costs, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:SoftwareDevelopmentCostsNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - Goodwill and Intangible Assets",
     "menuCat": "Notes",
     "order": "29",
     "role": "http://kins-tech.com/role/GoodwillAndIntangibleAssets",
     "shortName": "Goodwill and Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31_custom_CommonClassaSubjectToRedemptionMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:DeferredRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - Deferred Revenue",
     "menuCat": "Notes",
     "order": "30",
     "role": "http://kins-tech.com/role/DeferredRevenue",
     "shortName": "Deferred Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:DeferredRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - Accrued Liabilities",
     "menuCat": "Notes",
     "order": "31",
     "role": "http://kins-tech.com/role/AccruedLiabilities",
     "shortName": "Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:WarrantLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - Warrant Liabilities",
     "menuCat": "Notes",
     "order": "32",
     "role": "http://kins-tech.com/role/WarrantLiabilities",
     "shortName": "Warrant Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:WarrantLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:StockAwardPlansAndStockbasedCompensationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - Stock Option Plan and Stock-Based Compensation",
     "menuCat": "Notes",
     "order": "33",
     "role": "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensation",
     "shortName": "Stock Option Plan and Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:StockAwardPlansAndStockbasedCompensationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - Fair Value of Financial Instruments",
     "menuCat": "Notes",
     "order": "34",
     "role": "http://kins-tech.com/role/FairValueOfFinancialInstruments",
     "shortName": "Fair Value of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "35",
     "role": "http://kins-tech.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - Credit Risk and Concentrations",
     "menuCat": "Notes",
     "order": "36",
     "role": "http://kins-tech.com/role/CreditRiskAndConcentrations",
     "shortName": "Credit Risk and Concentrations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:ForeignOperationsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - Foreign Operations",
     "menuCat": "Notes",
     "order": "37",
     "role": "http://kins-tech.com/role/ForeignOperations",
     "shortName": "Foreign Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:ForeignOperationsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "38",
     "role": "http://kins-tech.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - Commitments and Contingencie",
     "menuCat": "Notes",
     "order": "39",
     "role": "http://kins-tech.com/role/CommitmentsAndContingencie",
     "shortName": "Commitments and Contingencie",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://kins-tech.com/role/ConsolidatedStatementsOfOperations",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "40",
     "role": "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ErrorCorrectionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables",
     "shortName": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ErrorCorrectionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "cxai:TemporaryEquityPolicyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "cxai:TemporaryEquityPolicyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - INCOME TAX (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://kins-tech.com/role/IncomeTaxTables",
     "shortName": "INCOME TAX (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://kins-tech.com/role/FairValueMeasurementsTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - Business Combination (Tables)",
     "menuCat": "Tables",
     "order": "45",
     "role": "http://kins-tech.com/role/BusinessCombinationTables",
     "shortName": "Business Combination (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "cxai:DisaggregationOfRevenueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - Disaggregation of Revenue (Tables)",
     "menuCat": "Tables",
     "order": "46",
     "role": "http://kins-tech.com/role/DisaggregationOfRevenueTables",
     "shortName": "Disaggregation of Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "cxai:DisaggregationOfRevenueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - Property and Equipment, net (Tables)",
     "menuCat": "Tables",
     "order": "47",
     "role": "http://kins-tech.com/role/PropertyAndEquipmentNetTables",
     "shortName": "Property and Equipment, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "cxai:SoftwareDevelopmentCostsNetTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - Software Development Costs, net (Tables)",
     "menuCat": "Tables",
     "order": "48",
     "role": "http://kins-tech.com/role/SoftwareDevelopmentCostsNetTables",
     "shortName": "Software Development Costs, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "cxai:SoftwareDevelopmentCostsNetTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "49",
     "role": "http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2020-12-31_custom_ClassBCommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2020-12-31_custom_ClassBCommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "cxai:DeferredRevenueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:ScheduleOfDeferredRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - Deferred Revenue (Tables)",
     "menuCat": "Tables",
     "order": "50",
     "role": "http://kins-tech.com/role/DeferredRevenueTables",
     "shortName": "Deferred Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "cxai:DeferredRevenueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:ScheduleOfDeferredRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure - Accrued Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "51",
     "role": "http://kins-tech.com/role/AccruedLiabilitiesTables",
     "shortName": "Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "cxai:StockAwardPlansAndStockbasedCompensationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000052 - Disclosure - Stock Option Plan and Stock-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "52",
     "role": "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationTables",
     "shortName": "Stock Option Plan and Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "cxai:StockAwardPlansAndStockbasedCompensationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "cxai:ForeignOperationsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000053 - Disclosure - Foreign Operations (Tables)",
     "menuCat": "Tables",
     "order": "53",
     "role": "http://kins-tech.com/role/ForeignOperationsTables",
     "shortName": "Foreign Operations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "cxai:ForeignOperationsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2020-12-17",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cxai:TransactionCosts",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000054 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
     "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "cxai:ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "us-gaap:ErrorCorrectionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cxai:GainOnForgivenessOfDeferredUnderwritingFeePayable",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000055 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails",
     "shortName": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "us-gaap:ErrorCorrectionTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-04-012022-06-30",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:NonoperatingIncomeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000056 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:TemporaryEquityTableTextBlock",
       "cxai:TemporaryEquityPolicyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31_us-gaap_CommonClassAMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000057 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31_us-gaap_CommonClassAMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashFDICInsuredAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000058 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashFDICInsuredAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2020-12-012020-12-17_us-gaap_IPOMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cxai:UnitsIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000059 - Disclosure - PUBLIC OFFERING (Details Narrative)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://kins-tech.com/role/PublicOfferingDetailsNarrative",
     "shortName": "PUBLIC OFFERING (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "cxai:InitialPublicOfferingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2020-12-17_us-gaap_CommonClassAMember_us-gaap_IPOMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:InterestAndOtherIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31_us-gaap_CommonClassAMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000060 - Disclosure - PRIVATE PLACEMENT (Details Narrative)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://kins-tech.com/role/PrivatePlacementDetailsNarrative",
     "shortName": "PRIVATE PLACEMENT (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "cxai:PrivatePlacementDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2020-12-17_custom_PrivatePlacementWarrantsMember_us-gaap_PrivatePlacementMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-14",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000061 - Disclosure - RELATED PARTIES (Details Narrative)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://kins-tech.com/role/RelatedPartiesDetailsNarrative",
     "shortName": "RELATED PARTIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "0",
      "lang": null,
      "name": "cxai:ExpensesIncurredAndPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2020-12-012020-12-14",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cxai:MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000062 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2020-12-012020-12-14",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "cxai:MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000063 - Disclosure - STOCKHOLDERS\u2019 DEFICIT (Details Narrative)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative",
     "shortName": "STOCKHOLDERS\u2019 DEFICIT (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "cxai:ConvertibleStockConversionRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000064 - Disclosure - DERIVATIVE WARRANT LIABILITIES (Details Narrative)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
     "shortName": "DERIVATIVE WARRANT LIABILITIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "cxai:SharePricetriggerUsedToMeasureDilutionOfWarrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cxai:DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000065 - Disclosure - INCOME TAX (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://kins-tech.com/role/IncomeTaxDetails",
     "shortName": "INCOME TAX (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cxai:DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000066 - Disclosure - INCOME TAX (Details 1)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://kins-tech.com/role/IncomeTaxDetails1",
     "shortName": "INCOME TAX (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000067 - Disclosure - INCOME TAX (Details 2)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://kins-tech.com/role/IncomeTaxDetails2",
     "shortName": "INCOME TAX (Details 2)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000068 - Disclosure - INCOME TAX (Details Narrative)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://kins-tech.com/role/IncomeTaxDetailsNarrative",
     "shortName": "INCOME TAX (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31_us-gaap_DomesticCountryMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000069 - Disclosure - FAIR VALUE MEASUREMENTS (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://kins-tech.com/role/FairValueMeasurementsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31_custom_PublicWarrantsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000007 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31_us-gaap_FairValueInputsLevel3Member",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "cxai:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000070 - Disclosure - FAIR VALUE MEASUREMENTS (Details 1)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://kins-tech.com/role/FairValueMeasurementsDetails1",
     "shortName": "FAIR VALUE MEASUREMENTS (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2020-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000071 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative",
     "shortName": "FAIR VALUE MEASUREMENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31_us-gaap_CashMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AssetsHeldInTrustNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000072 - Disclosure - Summary of Significant Accounting Policie (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails",
     "shortName": "Summary of Significant Accounting Policie (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-14_custom_PredecessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cxai:PurchasePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000073 - Disclosure - Business Combination (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://kins-tech.com/role/BusinessCombinationDetails",
     "shortName": "Business Combination (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-14_custom_PredecessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cxai:PurchasePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000074 - Disclosure - Business Combination (Details 1)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://kins-tech.com/role/BusinessCombinationDetails1",
     "shortName": "Business Combination (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-14",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000075 - Disclosure - Business Combination (Details Narrative)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://kins-tech.com/role/BusinessCombinationDetailsNarrative",
     "shortName": "Business Combination (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-012023-03-14_custom_PredecessorMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000076 - Disclosure - Disaggregation of Revenue (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://kins-tech.com/role/DisaggregationOfRevenueDetails",
     "shortName": "Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "cxai:DisaggregationOfRevenueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember_us-gaap_TransferredOverTimeMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000077 - Disclosure - Property and Equipment, net (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://kins-tech.com/role/PropertyAndEquipmentNetDetails",
     "shortName": "Property and Equipment, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000078 - Disclosure - Property and Equipment, net (Details Narrative)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative",
     "shortName": "Property and Equipment, net (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cxai:ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock",
       "cxai:SoftwareDevelopmentCostsNetTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31_custom_PredecessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CapitalizedComputerSoftwareGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000079 - Disclosure - Software Development Costs, net (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails",
     "shortName": "Software Development Costs, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cxai:ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock",
       "cxai:SoftwareDevelopmentCostsNetTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31_custom_PredecessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CapitalizedComputerSoftwareGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31_us-gaap_CommonClassAMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000008 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31_custom_PredecessorMember_us-gaap_CommonClassAMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "cxai:SoftwareDevelopmentCostsNetTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-012023-03-14_custom_PredecessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000080 - Disclosure - Software Development Costs, net (Details Narrative)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative",
     "shortName": "Software Development Costs, net (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "cxai:SoftwareDevelopmentCostsNetTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-012023-03-14_custom_PredecessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cxai:AcquisitionOfLegacyCxapp",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000081 - Disclosure - Goodwill and Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cxai:AcquisitionOfLegacyCxapp",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherFiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000082 - Disclosure - Goodwill and Intangible Assets (Details 1)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1",
     "shortName": "Goodwill and Intangible Assets (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherFiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000083 - Disclosure - Goodwill and Intangible Assets (Details 2)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2",
     "shortName": "Goodwill and Intangible Assets (Details 2)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000084 - Disclosure - Goodwill and Intangible Assets (Details Narrative)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative",
     "shortName": "Goodwill and Intangible Assets (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredRevenue",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000085 - Disclosure - Deferred Revenue (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://kins-tech.com/role/DeferredRevenueDetails",
     "shortName": "Deferred Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "cxai:ScheduleOfDeferredRevenueTableTextBlock",
       "cxai:DeferredRevenueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-31_custom_SuccessorMember_us-gaap_LicensingAgreementsMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DeferredRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cxai:InsurancePremiumsAndAccruedInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000086 - Disclosure - Accrued Liabilities (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://kins-tech.com/role/AccruedLiabilitiesDetails",
     "shortName": "Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cxai:InsurancePremiumsAndAccruedInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:RelatedPartyDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000087 - Disclosure - Accrued Liabilities (Details Narrative)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative",
     "shortName": "Accrued Liabilities (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cxai:RelatedPartyDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000088 - Disclosure - Warrant Liabilities (Details Narrative)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative",
     "shortName": "Warrant Liabilities (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "cxai:WarrantLiabilitiesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "cxai:StockAwardPlansAndStockbasedCompensationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000089 - Disclosure - Stock Award Plans and Stock-Based Compensation (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails",
     "shortName": "Stock Award Plans and Stock-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "cxai:StockAwardPlansAndStockbasedCompensationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000009 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "cxai:StockAwardPlansAndStockbasedCompensationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cxai:FairValueOfNonvestedOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000090 - Disclosure - Stock Option Plan and Stock-Based Compensation (Details Narrative)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative",
     "shortName": "Stock Option Plan and Stock-Based Compensation (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "cxai:StockAwardPlansAndStockbasedCompensationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cxai:FairValueOfNonvestedOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000091 - Disclosure - Fair Value of Financial Instruments (Details Narrative)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative",
     "shortName": "Fair Value of Financial Instruments (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember_custom_PublicPlacementWarrantsMember_us-gaap_FairValueInputsLevel1Member",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000092 - Disclosure - Income Taxes (Details Narrative)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://kins-tech.com/role/IncomeTaxesDetailsNarrative",
     "shortName": "Income Taxes (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-03-152023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "lang": null,
      "name": "cxai:IncomeTaxBenefitprovision",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2022-01-012022-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000093 - Disclosure - Foreign Operations (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://kins-tech.com/role/ForeignOperationsDetails",
     "shortName": "Foreign Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "cxai:ForeignOperationsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "AsOf2023-03-31_custom_SuccessorMember",
      "decimals": "-3",
      "lang": null,
      "name": "cxai:NetAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cxai:LeasePeriodicPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000094 - Disclosure - Leases (Details Narrative)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://kins-tech.com/role/LeasesDetailsNarrative",
     "shortName": "Leases (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:LeasesOfLesseeDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "cxapp_s1a3.htm",
      "contextRef": "From2023-01-01to2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "cxai:LeasePeriodicPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 81,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://kins-tech.com/role/ForeignOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "INDIA"
       }
      }
     },
     "localname": "IN",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://kins-tech.com/role/ForeignOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_PH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PHILIPPINES"
       }
      }
     },
     "localname": "PH",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://kins-tech.com/role/ForeignOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://kins-tech.com/role/ForeignOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, net and Allowance for Credit Losses"
       }
      }
     },
     "localname": "AccountsReceivablenetAndAllowanceForCreditLossesPolicyTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_AccruedCompensationAndBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/AccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "AccruedCompensationAndBenefits",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_AccruedLiabilitiesExcludingOfferingCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesExcludingOfferingCostsCurrent",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_AccruedOther": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/AccruedLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued other"
       }
      }
     },
     "localname": "AccruedOther",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_AcquisitionLiability": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition liability"
       }
      }
     },
     "localname": "AcquisitionLiability",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_AcquisitionOfLegacyCxapp": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition of Legacy CXApp"
       }
      }
     },
     "localname": "AcquisitionOfLegacyCxapp",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_AdministrativeServicesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Administrative Services Agreement.",
        "label": "Administrative Services Agreement [Member]"
       }
      }
     },
     "localname": "AdministrativeServicesAgreementMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_AggregateNumberOfSharesOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares owned by the founders after the impact of the stock dividend.",
        "label": "Aggregate number of shares owned"
       }
      }
     },
     "localname": "AggregateNumberOfSharesOwned",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "cxai_AggregatePurchasePriceAssetsAndLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate purchase price assets and liabilities"
       }
      }
     },
     "localname": "AggregatePurchasePriceAssetsAndLiabilities",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_AmortizationOfEmployeeStockOptions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of employee stock options"
       }
      }
     },
     "localname": "AmortizationOfEmployeeStockOptions",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_BasicAndDilutedEarningsPerShareInDollarsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted earnings per share (in dollars per share)"
       }
      }
     },
     "localname": "BasicAndDilutedEarningsPerShareInDollarsPerShare",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cxai_BasicAndDilutedNetIncomePerShareClassBCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted net income per share, Class B common stock"
       }
      }
     },
     "localname": "BasicAndDilutedNetIncomePerShareClassBCommonStock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "cxai_BasicAndDilutedNetIncomePerShareClassCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted net income per share, Class A common stock"
       }
      }
     },
     "localname": "BasicAndDilutedNetIncomePerShareClassCommonStock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted weighted average shares outstanding, Class B common stock"
       }
      }
     },
     "localname": "BasicAndDilutedWeightedAverageSharesOutstandingClassBCommonStock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "cxai_BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted weighted average shares outstanding, Class A common stock"
       }
      }
     },
     "localname": "BasicAndDilutedWeightedAverageSharesOutstandingClassCommonStock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "cxai_BasicAndDilutedWeightedAverageSharesOutstandingInShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "BasicAndDilutedWeightedAverageSharesOutstandingInShares",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cxai_BasicAndDilutiveNetIncomePerShareClassCCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and dilutive net income per share, Class C common stock"
       }
      }
     },
     "localname": "BasicAndDilutiveNetIncomePerShareClassCCommonStock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "cxai_BasicAndDilutiveNetIncomePerShareClassCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and dilutive net income per share, Class A common stock"
       }
      }
     },
     "localname": "BasicAndDilutiveNetIncomePerShareClassCommonStock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and dilutive weighted average shares outstanding, Class C common stock"
       }
      }
     },
     "localname": "BasicAndDilutiveWeightedAverageSharesOutstandingClassCCommonStock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    },
    "cxai_BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and dilutive weighted average shares outstanding, Class A common stock"
       }
      }
     },
     "localname": "BasicAndDilutiveWeightedAverageSharesOutstandingClassCommonStock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    },
    "cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities",
        "verboseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent",
        "verboseLabel": "Operating lease obligation, current"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationCurrent",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent",
        "verboseLabel": "Operating lease obligation, noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseObligationNonCurrent",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables",
        "verboseLabel": "Notes and other receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedNotesAndOtherReceivables",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease right of use asset"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAssumedOperatingLeaseRightOfUseAsset",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_CXAppCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "C X App Common Stock [Member]"
       }
      }
     },
     "localname": "CXAppCommonStockMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_CashAndCashEquivalentsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents, description"
       }
      }
     },
     "localname": "CashAndCashEquivalentsDescription",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "cxai_ChangeInFairValueOfEarnout": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "ChangeInFairValueOfEarnout",
        "negatedLabel": "Change in fair value of earnout"
       }
      }
     },
     "localname": "ChangeInFairValueOfEarnout",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ChangeInValueOfClassCommonStockSubjectToPossibleRedemption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in value of Class A common stock subject to possible redemption"
       }
      }
     },
     "localname": "ChangeInValueOfClassCommonStockSubjectToPossibleRedemption",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ChangesInEstimatedFairValueOfWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in estimated fair value of warrants"
       }
      }
     },
     "localname": "ChangesInEstimatedFairValueOfWarrants",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ClassACommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Common Stock [Member]"
       }
      }
     },
     "localname": "ClassACommonStockMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_ClassBCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Common Stock [Member]"
       }
      }
     },
     "localname": "ClassBCommonStockMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_ClassCCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class C Common Stock [Member]"
       }
      }
     },
     "localname": "ClassCCommonStockMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Common Stock and Class C Common Stock issued in connection with Business Combination"
       }
      }
     },
     "localname": "ClassCommonStockAndClassCCommonStockIssuedInConnectionWithBusinessCombination",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ClassOfWarrantOrRightPriceOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price per share or per unit of warrants or rights outstanding.",
        "label": "Price of warrant",
        "verboseLabel": "Price of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightPriceOfWarrantsOrRights",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative",
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.",
        "label": "Threshold consecutive trading days for redemption of public warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days for stock price trigger considered for redemption of warrants.",
        "label": "Threshold trading days for redemption of public warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redemption price per share or per unit of warrants or rights outstanding.",
        "label": "Redemption price per public warrant (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "cxai_CommonClassaSubjectToRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation that is subject to redemption.",
        "label": "Class A Common Stock Subject to Redemption"
       }
      }
     },
     "localname": "CommonClassaSubjectToRedemptionMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_CommonStockLockUpPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the lock-up period of shares.",
        "label": "Lock-up period"
       }
      }
     },
     "localname": "CommonStockLockUpPeriod",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_CommonStockNumberOfVotesPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of votes that each common share is entitled.",
        "label": "Common shares, votes per share"
       }
      }
     },
     "localname": "CommonStockNumberOfVotesPerShare",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "cxai_CommonStockStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the stock price trigger.",
        "label": "Stock price trigger"
       }
      }
     },
     "localname": "CommonStockStockPriceTrigger",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "cxai_CommonStockSubjectToRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing shares subject to possible redemption.",
        "label": "Common stock subject to redemption"
       }
      }
     },
     "localname": "CommonStockSubjectToRedemptionMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_ConsiderationTransferredInConnection": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consideration transferred in connection"
       }
      }
     },
     "localname": "ConsiderationTransferredInConnection",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "cxai_ConvertibleStockConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ratio to be applied to the stock in a conversion of convertible stock.",
        "label": "Ratio to be applied to the stock in the conversion"
       }
      }
     },
     "localname": "ConvertibleStockConversionRatio",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "cxai_CumulativeTranslationAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative translation adjustment"
       }
      }
     },
     "localname": "CumulativeTranslationAdjustment",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_CxappHoldingCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to CXApp Holding Corp.",
        "label": "CXApp"
       }
      }
     },
     "localname": "CxappHoldingCorpMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_DeferredFeePerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the deferred fee per unit.",
        "label": "Deferred fee per unit"
       }
      }
     },
     "localname": "DeferredFeePerUnit",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "cxai_DeferredOfferingCostsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred underwriting fee payable"
       }
      }
     },
     "localname": "DeferredOfferingCostsNoncurrent",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets",
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_DeferredRevenueTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DeferredRevenueTextBlock",
        "verboseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenueTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DeferredRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/IncomeTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from capitalized start up and organization costs.",
        "label": "Organizational costs/startup expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_DeferredUnderwritingFeePayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of underwriting fee payable deferred during the period, classified as non-cash investing and financing activity.",
        "label": "Deferred Underwriting Fees Payable",
        "verboseLabel": "Deferred underwriting fee payable"
       }
      }
     },
     "localname": "DeferredUnderwritingFeePayable",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_DirectAnchorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Direct Anchor.",
        "label": "Direct Anchor [Member]"
       }
      }
     },
     "localname": "DirectAnchorMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_DirectorAndOfficersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director And Officers [Member]"
       }
      }
     },
     "localname": "DirectorAndOfficersMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_DisaggregationOfRevenueTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DisaggregationOfRevenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_DisclosureDeferredRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenue"
       }
      }
     },
     "localname": "DisclosureDeferredRevenueAbstract",
     "nsuri": "http://kins-tech.com/20230331",
     "xbrltype": "stringItemType"
    },
    "cxai_DisclosureDisaggregationOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation Of Revenue"
       }
      }
     },
     "localname": "DisclosureDisaggregationOfRevenueAbstract",
     "nsuri": "http://kins-tech.com/20230331",
     "xbrltype": "stringItemType"
    },
    "cxai_DisclosureForeignOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Operations"
       }
      }
     },
     "localname": "DisclosureForeignOperationsAbstract",
     "nsuri": "http://kins-tech.com/20230331",
     "xbrltype": "stringItemType"
    },
    "cxai_DisclosurePrivatePlacementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement"
       }
      }
     },
     "localname": "DisclosurePrivatePlacementAbstract",
     "nsuri": "http://kins-tech.com/20230331",
     "xbrltype": "stringItemType"
    },
    "cxai_DisclosurePublicOfferingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Offering"
       }
      }
     },
     "localname": "DisclosurePublicOfferingAbstract",
     "nsuri": "http://kins-tech.com/20230331",
     "xbrltype": "stringItemType"
    },
    "cxai_DisclosureSoftwareDevelopmentCostsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software Development Costs Net"
       }
      }
     },
     "localname": "DisclosureSoftwareDevelopmentCostsNetAbstract",
     "nsuri": "http://kins-tech.com/20230331",
     "xbrltype": "stringItemType"
    },
    "cxai_DisclosureStockOptionPlanAndStockbasedCompensationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Option Plan And Stock-based Compensation"
       }
      }
     },
     "localname": "DisclosureStockOptionPlanAndStockbasedCompensationAbstract",
     "nsuri": "http://kins-tech.com/20230331",
     "xbrltype": "stringItemType"
    },
    "cxai_DisclosureWarrantLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Liabilities"
       }
      }
     },
     "localname": "DisclosureWarrantLiabilitiesAbstract",
     "nsuri": "http://kins-tech.com/20230331",
     "xbrltype": "stringItemType"
    },
    "cxai_EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Change in fair value of derivative warrant liabilities.",
        "label": "Change in fair value of derivative warrant liabilities"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionFairValueAdjustmentOfWarrantsPercent",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails2"
     ],
     "xbrltype": "percentItemType"
    },
    "cxai_EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Transaction costs allocated to derivative warrant liabilities.",
        "label": "Transaction costs allocated to derivative warrant liabilities"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionTransactionCostsOfDerivativeWarrantLiabilitiesPercent",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails2"
     ],
     "xbrltype": "percentItemType"
    },
    "cxai_EliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Eliminations [Member]"
       }
      }
     },
     "localname": "EliminationsMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ForeignOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_EmergingGrowthCompanyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Emerging Growth Company"
       }
      }
     },
     "localname": "EmergingGrowthCompanyPolicyTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_EmployeeStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Options [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionsMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_EmployeesAndDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employees And Directors [Member]"
       }
      }
     },
     "localname": "EmployeesAndDirectorsMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_ExpensesIncurredAndPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses incurred and paid"
       }
      }
     },
     "localname": "ExpensesIncurredAndPaid",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of extinguishment of deferred underwriting fee payable allocated to public shares.",
        "label": "Extinguishment of deferred underwriting fee payable allocated to public shares"
       }
      }
     },
     "localname": "ExtinguishmentOfDeferredUnderwritingFeePayableAllocatedToPublicShares",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as a liability into level 1 of the fair value hierarchy.",
        "label": "Transfer to Level 1"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel1",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails1",
      "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as a liability into level 2 of the fair value hierarchy.",
        "label": "Transfer to Level 2"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel2",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails1",
      "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_FairValueOfNonvestedOptions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of non-vested options"
       }
      }
     },
     "localname": "FairValueOfNonvestedOptions",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_FairValueOfOptions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of options"
       }
      }
     },
     "localname": "FairValueOfOptions",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_FinancingOfDirectorAndOfficerInsurance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing of Director and Officer Insurance (see Note 9)"
       }
      }
     },
     "localname": "FinancingOfDirectorAndOfficerInsurance",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ForeignOperationsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ForeignOperationsTextBlock",
        "verboseLabel": "Foreign Operations"
       }
      }
     },
     "localname": "ForeignOperationsTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ForeignOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgiveness of deferred underwriting fee payable allocated to Class A common stock"
       }
      }
     },
     "localname": "ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassCommonStock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_FounderSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "n/a",
        "label": "Founder Shares [Member]"
       }
      }
     },
     "localname": "FounderSharesMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_GainLossOnEliminationOfDeferredUnderwritingFee": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on forgiveness of deferred underwriting fee"
       }
      }
     },
     "localname": "GainLossOnEliminationOfDeferredUnderwritingFee",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_GainOnChangeInFairValueOfDerivativeLiability": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "GainOnChangeInFairValueOfDerivativeLiability",
        "negatedLabel": "Gain on change in fair value of derivative liability"
       }
      }
     },
     "localname": "GainOnChangeInFairValueOfDerivativeLiability",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_GainOnEarnoutPaymentLiability": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "GainOnEarnoutPaymentLiability",
        "negatedLabel": "Gain on earnout payment liability"
       }
      }
     },
     "localname": "GainOnEarnoutPaymentLiability",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_GainOnForgivenessOfDeferredUnderwritingFeePayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of gain on forgiveness of deferred underwriting fee payable.",
        "label": "Gain on forgiveness of deferred underwriting fee payable",
        "negatedLabel": "Gain on forgiveness of deferred underwriting fee payable"
       }
      }
     },
     "localname": "GainOnForgivenessOfDeferredUnderwritingFeePayable",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_IncomeRecognizedFromReductionOfDeferredUnderwriterFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income recognized from reduction of deferred underwriter fee.",
        "label": "Income recognized from reduction of deferred underwriter fee"
       }
      }
     },
     "localname": "IncomeRecognizedFromReductionOfDeferredUnderwriterFee",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_IncomeTaxBenefitprovision": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax benefit/(provision)"
       }
      }
     },
     "localname": "IncomeTaxBenefitprovision",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_IncreaseDecreaseInDeferredUnderwritingFee": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInDeferredUnderwritingFee",
        "verboseLabel": "Gain on forgiveness of deferred underwriting fee"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredUnderwritingFee",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_InitialPublicOfferingDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PUBLIC OFFERING"
       }
      }
     },
     "localname": "InitialPublicOfferingDisclosureTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/PublicOffering"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_InpixonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Inpixon.",
        "label": "Inpixon"
       }
      }
     },
     "localname": "InpixonMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_InsurancePremiumsAndAccruedInterest": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/AccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance premiums and accrued interest"
       }
      }
     },
     "localname": "InsurancePremiumsAndAccruedInterest",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_InvestmentInCapitalizedSoftware": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "InvestmentInCapitalizedSoftware",
        "negatedLabel": "Investment in capitalized software"
       }
      }
     },
     "localname": "InvestmentInCapitalizedSoftware",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_LeasePeriodicPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease periodic payments"
       }
      }
     },
     "localname": "LeasePeriodicPayments",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_LeasesAndRightofUseAssetsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases and Right-of-Use Assets"
       }
      }
     },
     "localname": "LeasesAndRightofUseAssetsPolicyTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_LiquidityAndGoingConcernPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidity"
       }
      }
     },
     "localname": "LiquidityAndGoingConcernPolicyTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of maximum borrowing capacity of related party promissory note.",
        "label": "Maximum borrowing capacity of related party promissory note"
       }
      }
     },
     "localname": "MaximumBorrowingCapacityOfRelatedPartyPromissoryNote",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_MaximumLoansConvertibleIntoWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum amount which a potential loan could have repaid through issuance of warrants.",
        "label": "Loan conversion agreement warrant"
       }
      }
     },
     "localname": "MaximumLoansConvertibleIntoWarrants",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_MaximumNetInterestsToPayDissolutionExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum net interest to pay dissolution expenses.",
        "label": "Maximum net interest to pay dissolution expenses"
       }
      }
     },
     "localname": "MaximumNetInterestsToPayDissolutionExpenses",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_MaximumNumberOfDemandsForRegistrationOfSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum number of demands for registration of securities.",
        "label": "Maximum number of demands for registration of securities"
       }
      }
     },
     "localname": "MaximumNumberOfDemandsForRegistrationOfSecurities",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "cxai_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time after completion of a business combination in which the reporting entity is required to file a registration statement with the SEC.",
        "label": "Maximum period after business combination in which to file registration statement"
       }
      }
     },
     "localname": "MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum term for automatic conversion of stock following the closing of the Merger.",
        "label": "Maximum term for automatic conversion of stock following the closing of the Merger"
       }
      }
     },
     "localname": "MaximumTermForAutomaticConversionOfStockFollowingClosingOfMerger",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_MergerAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to merger agreement.",
        "label": "Merger Agreement"
       }
      }
     },
     "localname": "MergerAgreementMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative",
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the minimum net tangible assets upon consummation of the Business Combination.",
        "label": "Minimum net tangible assets upon consummation of the business combination"
       }
      }
     },
     "localname": "MinimumNetTangibleAssetsUponConsummationsOfBusinessCombination",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_MinimumNumberOfSharesIssuableToSponsor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the minimum number of shares issuable to sponsor.",
        "label": "Minimum number of shares issuable to sponsor"
       }
      }
     },
     "localname": "MinimumNumberOfSharesIssuableToSponsor",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "cxai_MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum Percentage of Founder Share Holders Entitled To Make Demands.",
        "label": "Minimum percentage of founder share holders entitled to make demands"
       }
      }
     },
     "localname": "MinimumPercentageOfFounderShareHoldersEntitledToMakeDemands",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "cxai_N2023EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "N 2023 Equity Incentive Plan [Member]"
       }
      }
     },
     "localname": "N2023EquityIncentivePlanMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_NetAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Identifiable assets by geographic area"
       }
      }
     },
     "localname": "NetAssets",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ForeignOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_NetEquityInvestmentFromParent": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net equity investment from parent"
       }
      }
     },
     "localname": "NetEquityInvestmentFromParent",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_NetInvestmentsFromParent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net investments from parent"
       }
      }
     },
     "localname": "NetInvestmentsFromParent",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_NetParentInvestment": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net parent investment"
       }
      }
     },
     "localname": "NetParentInvestment",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_NetParentInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Parent Investment [Member]"
       }
      }
     },
     "localname": "NetParentInvestmentMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_NonSubscriptionRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Subscription Revenue [Member]"
       }
      }
     },
     "localname": "NonSubscriptionRevenueMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_NoncashDistribution": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash distribution"
       }
      }
     },
     "localname": "NoncashDistribution",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_NumberOfSharesExchanged": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of shares exchanged.",
        "label": "Number of shares exchanged"
       }
      }
     },
     "localname": "NumberOfSharesExchanged",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "cxai_NumberOfSharesIssuableUponMerger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of shares issuable upon merger.",
        "label": "Number of shares issuable upon merger"
       }
      }
     },
     "localname": "NumberOfSharesIssuableUponMerger",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "cxai_NumberOfSharesSubjectToForfeiture": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.",
        "label": "Shares subject to forfeiture"
       }
      }
     },
     "localname": "NumberOfSharesSubjectToForfeiture",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "cxai_NumberOfWarrantsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of warrants issued during the period.",
        "label": "Number of warrants issued"
       }
      }
     },
     "localname": "NumberOfWarrantsIssued",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "cxai_OfferingCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of offering cost expense through statement of operations.",
        "label": "Offering cost expense"
       }
      }
     },
     "localname": "OfferingCost",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ParentsCommonSharesIssuedForCxappEarnout": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent\u2019s common shares issued for CXApp earnout"
       }
      }
     },
     "localname": "ParentsCommonSharesIssuedForCxappEarnout",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ParentsNetEquityIssuedForCxAppEarnout": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent\u2019s net equity issued for CX App earnout"
       }
      }
     },
     "localname": "ParentsNetEquityIssuedForCxAppEarnout",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_PatentsAndIntellectualPropertyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents And Intellectual Property [Member]"
       }
      }
     },
     "localname": "PatentsAndIntellectualPropertyMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_PaymentsForInvestmentOfCashInTrustAccount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash outflow for investment of cash in trust account.",
        "label": "Investment of cash into trust account"
       }
      }
     },
     "localname": "PaymentsForInvestmentOfCashInTrustAccount",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the threshold percentage of Obligation to redeem Public Shares if entity does not complete a Business Combination.",
        "label": "Obligation to redeem public shares if entity does not complete a business combination (as a percent)"
       }
      }
     },
     "localname": "PercentageObligationsToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "cxai_PercentageOfCommonStockDistributed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of common stock distributed.",
        "label": "Percentage of common stock distributed"
       }
      }
     },
     "localname": "PercentageOfCommonStockDistributed",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "cxai_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ratio of gross proceeds from a future offering to total equity proceeds which is used to measure whether dilution of the warrant has occurred. If aggregate gross proceeds from a new offering exceeds a specified percentage of total equity proceeds, the warrant exercise price will be adjusted.",
        "label": "Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant"
       }
      }
     },
     "localname": "PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "pureItemType"
    },
    "cxai_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expected ownership percentage by the founders after completion of the proposed public offering.",
        "label": "Percentage of issued and outstanding shares after the initial public offering collectively held by initial stockholders"
       }
      }
     },
     "localname": "PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "cxai_PercentageOfSharesNotBeSubjectToForegoingLockUp": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of shares not be subject to foregoing lock-up.",
        "label": "Percentage of shares not be subject to foregoing lock-up"
       }
      }
     },
     "localname": "PercentageOfSharesNotBeSubjectToForegoingLockUp",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "cxai_PercentageOfStockAsMergerConsideration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of stock as merger consideration.",
        "label": "Percentage of stock as merger consideration"
       }
      }
     },
     "localname": "PercentageOfStockAsMergerConsideration",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "cxai_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time after filing within which the registration statement filed with the SEC is expected to become effective.",
        "label": "Period of time within which registration statement is expected to become effective"
       }
      }
     },
     "localname": "PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_PredecessorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Predecessor [Member]"
       }
      }
     },
     "localname": "PredecessorMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails",
      "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/BusinessCombinationDetails",
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/DeferredRevenueDetails",
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails",
      "http://kins-tech.com/role/ForeignOperationsDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative",
      "http://kins-tech.com/role/IncomeTaxesDetailsNarrative",
      "http://kins-tech.com/role/LeasesDetailsNarrative",
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails",
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative",
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails",
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_PrivatePlacementDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PRIVATE PLACEMENT"
       }
      }
     },
     "localname": "PrivatePlacementDisclosureTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/PrivatePlacement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_PrivatePlacementWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.",
        "label": "Private Placement Warrants [Member]"
       }
      }
     },
     "localname": "PrivatePlacementWarrantsMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetails1",
      "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative",
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_ProceedsFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Definition: The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds from related party"
       }
      }
     },
     "localname": "ProceedsFromRelatedParty",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ProceedsFromTrustAccountInConnectionWithRedemption": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash withdrawn from trust account in connection with redemptions",
        "verboseLabel": "Cash withdrawn from trust account in connection with redemption"
       }
      }
     },
     "localname": "ProceedsFromTrustAccountInConnectionWithRedemption",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash withdrawn from trust account to pay franchise tax"
       }
      }
     },
     "localname": "ProceedsFromTrustAccountsTowardsPaymentOfFranchiseTax",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ProfessionalServiceAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional Service Agreements [Member]"
       }
      }
     },
     "localname": "ProfessionalServiceAgreementsMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DeferredRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_ProfessionalServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional Services [Member]"
       }
      }
     },
     "localname": "ProfessionalServicesMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_PromissoryNoteRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory note \u2013 related party"
       }
      }
     },
     "localname": "PromissoryNoteRelatedParty",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_PromissoryNoteWithRelatedPartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for promissory note with related party.",
        "label": "Promissory Note With Related Party [Member]"
       }
      }
     },
     "localname": "PromissoryNoteWithRelatedPartyMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_PublicPlacementWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Placement Warrants [Member]"
       }
      }
     },
     "localname": "PublicPlacementWarrantsMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_PublicWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.",
        "label": "Public Warrants [Member]"
       }
      }
     },
     "localname": "PublicWarrantsMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetails1",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_PurchasePrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Price"
       }
      }
     },
     "localname": "PurchasePrice",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $10.00.",
        "label": "Redemption Of Warrants When The Price Per Class A Ordinary Share Equals Or Exceeds $10.00 [Member]"
       }
      }
     },
     "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $18.00.",
        "label": "Redemption Of Warrants When The Price per Class A Ordinary Share Equals Or Exceeds $18.00 [Member]"
       }
      }
     },
     "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_RedemptionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redemption period.",
        "label": "Redemption period"
       }
      }
     },
     "localname": "RedemptionPeriod",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_RelatedPartyDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party description"
       }
      }
     },
     "localname": "RelatedPartyDescription",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "cxai_RelatedPartyPayable": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/AccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party payable"
       }
      }
     },
     "localname": "RelatedPartyPayable",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_RelatedPartyPromissoryNote": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/AccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party promissory note"
       }
      }
     },
     "localname": "RelatedPartyPromissoryNote",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The contractual monthly amount to be paid for support services.",
        "label": "Expenses per month"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_RepaymentOfCxappAcquisitionLiability": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "RepaymentOfCxappAcquisitionLiability",
        "negatedLabel": "Repayment of CXApp acquisition liability"
       }
      }
     },
     "localname": "RepaymentOfCxappAcquisitionLiability",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time after completion of a business combination during which the shares or warrant may not be transferred.",
        "label": "Restrictions on transfer period of time after business combination completion"
       }
      }
     },
     "localname": "RestrictionsOnTransferPeriodOfTimeAfterBusinessCombinationCompletion",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_RevenueRecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognized"
       }
      }
     },
     "localname": "RevenueRecognized",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_SaleOfStockOtherOfferingCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of other offering costs incurred.",
        "label": "Other offering costs"
       }
      }
     },
     "localname": "SaleOfStockOtherOfferingCosts",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_SaleOfStockUnderwritingFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of offering fees incurred and paid for underwriters.",
        "label": "Underwriting fees"
       }
      }
     },
     "localname": "SaleOfStockUnderwritingFees",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of capitalized software development"
       }
      }
     },
     "localname": "ScheduleOfCapitalizedSoftwareDevelopmentTableTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_ScheduleOfDeferredRevenueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of deferred revenue"
       }
      }
     },
     "localname": "ScheduleOfDeferredRevenueTableTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DeferredRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_SeparationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to separation agreement.",
        "label": "Separation Agreement"
       }
      }
     },
     "localname": "SeparationAgreementMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_SharePricetriggerUsedToMeasureDilutionOfWarrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cut off price used to measure whether dilution of the warrant has occurred. Shares issued below this price will cause the exercise price of the warrant to be adjusted.",
        "label": "Share PriceTrigger Used To Measure Dilution Of Warrant"
       }
      }
     },
     "localname": "SharePricetriggerUsedToMeasureDilutionOfWarrant",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "cxai_SharesIssuedInConnectionWithBusinessCombination": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued in connection with Business Combination"
       }
      }
     },
     "localname": "SharesIssuedInConnectionWithBusinessCombination",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_SharesIssuedInConnectionWithBusinessCombinationShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued in connection with Business Combination, shares"
       }
      }
     },
     "localname": "SharesIssuedInConnectionWithBusinessCombinationShares",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "cxai_SoftwareDevelopmentCostsNetTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software Development Costs, net"
       }
      }
     },
     "localname": "SoftwareDevelopmentCostsNetTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_SoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software [Member]"
       }
      }
     },
     "localname": "SoftwareMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails",
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_SponsorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for sponsor.",
        "label": "Sponsor [Member]"
       }
      }
     },
     "localname": "SponsorMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_SponsorSupportAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Sponsor Support Agreement.",
        "label": "Sponsor Support Agreement"
       }
      }
     },
     "localname": "SponsorSupportAgreementMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_StateAndLocalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local"
       }
      }
     },
     "localname": "StateAndLocalAbstract",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "cxai_StockAwardPlansAndStockbasedCompensationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Option Plan and Stock-Based Compensation"
       }
      }
     },
     "localname": "StockAwardPlansAndStockbasedCompensationTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_StockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options [Member]"
       }
      }
     },
     "localname": "StockOptionsMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_SubscriptionRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription Revenue [Member]"
       }
      }
     },
     "localname": "SubscriptionRevenueMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_SuccessorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Successor [Member]"
       }
      }
     },
     "localname": "SuccessorMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails",
      "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/DeferredRevenueDetails",
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails",
      "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative",
      "http://kins-tech.com/role/ForeignOperationsDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative",
      "http://kins-tech.com/role/IncomeTaxesDetailsNarrative",
      "http://kins-tech.com/role/LeasesDetailsNarrative",
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails",
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative",
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails",
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative",
      "http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails",
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental schedule of noncash investing and financing activities"
       }
      }
     },
     "localname": "SupplementalScheduleOfNoncashInvestingAndFinancingActivitiesAbstract",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "cxai_TaxesPaidRelatedForStockBasedCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "TaxesPaidRelatedForStockBasedCompensation",
        "negatedLabel": "Taxes paid related to stock based compensation"
       }
      }
     },
     "localname": "TaxesPaidRelatedForStockBasedCompensation",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes paid related to net share settlement of restricted stock units"
       }
      }
     },
     "localname": "TaxesPaidRelatedToNetShareSettlementOfRestrictedStockUnits",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_TemporaryEquityPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Common Stock Subject to Possible Redemption"
       }
      }
     },
     "localname": "TemporaryEquityPolicyPolicyTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_TemporaryEquityRedemption": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of temporary equity redeemed during the period.",
        "label": "Temporary Equity, Redemption",
        "negatedLabel": "Redemption of Class A Common Stock"
       }
      }
     },
     "localname": "TemporaryEquityRedemption",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_TemporaryEquityWaiverOfShareIssuanceCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of waiver of share issuance costs pertaining to temporary equity.",
        "label": "Waiver of Class A common stock issuance costs"
       }
      }
     },
     "localname": "TemporaryEquityWaiverOfShareIssuanceCosts",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_TermOfBreachUnableToBeCuredOrIsNotCured": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the term of breach unable to be cured, or is not cured.",
        "label": "Term of breach unable to be cured, or is not cured"
       }
      }
     },
     "localname": "TermOfBreachUnableToBeCuredOrIsNotCured",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_TerminationFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of termination fee.",
        "label": "Termination fee"
       }
      }
     },
     "localname": "TerminationFee",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the threshold aggregate gross purchase price of any other purchase of shares.",
        "label": "Threshold aggregate gross purchase price of any other purchase of shares"
       }
      }
     },
     "localname": "ThresholdAggregateGrossPurchasePriceOfAnyOtherPurchaseOfShares",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Threshold consecutive trading days"
       }
      }
     },
     "localname": "ThresholdConsecutiveTradingDays",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account.",
        "label": "Threshold minimum aggregate fair market value as a percentage of the assets held in the trust account"
       }
      }
     },
     "localname": "ThresholdMinimumAggregateFairMarketValuePercentageOfAssetsHeldInTrustAccount",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "cxai_ThresholdNetTangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the threshold net tangible assets.",
        "label": "Threshold net tangible assets"
       }
      }
     },
     "localname": "ThresholdNetTangibleAssets",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Threshold number of business days before sending notice of redemption to warrant holders"
       }
      }
     },
     "localname": "ThresholdNumberOfBusinessDaysBeforeSendingNoticeOfRedemptionToWarrantHolders",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "cxai_ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination.",
        "label": "Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination"
       }
      }
     },
     "localname": "ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionsCompanyToCompleteBusinessCombination",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "cxai_ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents threshold percentage of Public Shares subject to redemption without the Company's prior written consent",
        "label": "Threshold percentage of public shares subject to redemption without the company's prior written consent"
       }
      }
     },
     "localname": "ThresholdPercentageOfPublicSharesSubjectToRedemptionWithoutCompanyPriorWrittenConsent",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "cxai_ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time after a business combination which must elapse before consideration of the share price condition for transfer of shares.",
        "label": "Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences"
       }
      }
     },
     "localname": "ThresholdPeriodAfterBusinessCombinationInWhichSpecifiedTradingDaysWithinAnySpecifiedTradingDayPeriodCommences",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_ThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Threshold trading days"
       }
      }
     },
     "localname": "ThresholdTradingDays",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_TotalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total [Member]"
       }
      }
     },
     "localname": "TotalMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_TransactionCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of transaction costs incurred.",
        "label": "Transaction costs"
       }
      }
     },
     "localname": "TransactionCosts",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.",
        "label": "Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)"
       }
      }
     },
     "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.",
        "label": "Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination"
       }
      }
     },
     "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.",
        "label": "Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination"
       }
      }
     },
     "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_UnitsIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new units issued during the period.",
        "label": "Number of units issued",
        "verboseLabel": "Number of units sold"
       }
      }
     },
     "localname": "UnitsIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/PublicOfferingDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "cxai_WarrantExercisePeriodConditionOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time after completion of a business combination before a warrant may be exercised.",
        "label": "Warrant exercise period condition one"
       }
      }
     },
     "localname": "WarrantExercisePeriodConditionOne",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_WarrantExercisePeriodConditionTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The alternate period of time after completion of an initial public offering before a warrant may be exercised.",
        "label": "Warrant exercise period condition two"
       }
      }
     },
     "localname": "WarrantExercisePeriodConditionTwo",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_WarrantExercisePriceAdjustmentMultiple": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In the event of dilution of the warrant, the multiple to be applied to the higher of the market price or the price of newly issued shares in order to obtain the adjusted exercise price.",
        "label": "Warrant exercise price adjustment multiple"
       }
      }
     },
     "localname": "WarrantExercisePriceAdjustmentMultiple",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "pureItemType"
    },
    "cxai_WarrantLiabilitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WarrantLiabilitiesTextBlock",
        "verboseLabel": "Warrant Liabilities"
       }
      }
     },
     "localname": "WarrantLiabilitiesTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/WarrantLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_WarrantLiabilityPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Warrant Liabilities"
       }
      }
     },
     "localname": "WarrantLiabilityPolicyTextBlock",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cxai_WarrantRedemptionConditionMinimumSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum trading price for the reporting entity's stock which must be achieved as a condition for redemption of the warrant.",
        "label": "Warrant redemption condition minimum share price"
       }
      }
     },
     "localname": "WarrantRedemptionConditionMinimumSharePrice",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "cxai_WarrantRedemptionConditionMinimumSharePriceScenarioTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum trading price for the reporting entity's stock which must be achieved as a condition for redemption of the warrant under another scenario.",
        "label": "Warrant redemption condition minimum share price scenario two"
       }
      }
     },
     "localname": "WarrantRedemptionConditionMinimumSharePriceScenarioTwo",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "cxai_WarrantRedemptionPriceAdjustmentMultiple": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In the event of dilution of the warrant, the multiple to be applied to the higher of the market price or the price of newly issued shares in order to obtain the adjusted redemption price.",
        "label": "Warrant redemption price adjustment multiple"
       }
      }
     },
     "localname": "WarrantRedemptionPriceAdjustmentMultiple",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "pureItemType"
    },
    "cxai_WeightedAverageRemainingTermOfNonvestedOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining term of non-vested options"
       }
      }
     },
     "localname": "WeightedAverageRemainingTermOfNonvestedOptions",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "cxai_WorkingCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount represents the information about the working capital.",
        "label": "Working capital"
       }
      }
     },
     "localname": "WorkingCapital",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cxai_WorkingCapitalLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for working capital loans.",
        "label": "Working Capital Loans"
       }
      }
     },
     "localname": "WorkingCapitalLoansMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "cxai_WorkingCapitalLoansWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Working capital loans warrant.",
        "label": "Working capital loans warrant [Member]"
       }
      }
     },
     "localname": "WorkingCapitalLoansWarrantMember",
     "nsuri": "http://kins-tech.com/20230331",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r665",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r663",
      "r665",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Addresses [Line Items]"
       }
      }
     },
     "localname": "EntityAddressesLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesTable": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container of address information for the entity",
        "label": "Entity Addresses [Table]"
       }
      }
     },
     "localname": "EntityAddressesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "verboseLabel": "City Area Code"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://kins-tech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r218",
      "r219",
      "r334",
      "r340",
      "r622",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r323",
      "r373",
      "r555",
      "r586",
      "r615",
      "r616",
      "r636",
      "r643",
      "r651",
      "r729",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails",
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r323",
      "r373",
      "r555",
      "r586",
      "r615",
      "r616",
      "r636",
      "r643",
      "r651",
      "r729",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails",
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r281",
      "r559",
      "r637",
      "r649",
      "r724",
      "r725",
      "r730",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r281",
      "r559",
      "r637",
      "r649",
      "r724",
      "r725",
      "r730",
      "r788"
     ],
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r323",
      "r365",
      "r373",
      "r399",
      "r400",
      "r401",
      "r531",
      "r555",
      "r586",
      "r615",
      "r616",
      "r636",
      "r643",
      "r651",
      "r723",
      "r729",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails",
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r323",
      "r365",
      "r373",
      "r399",
      "r400",
      "r401",
      "r531",
      "r555",
      "r586",
      "r615",
      "r616",
      "r636",
      "r643",
      "r651",
      "r723",
      "r729",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786"
     ],
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails",
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r218",
      "r219",
      "r334",
      "r340",
      "r623",
      "r624"
     ],
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r220",
      "r221",
      "r222",
      "r233",
      "r234",
      "r249",
      "r463",
      "r464",
      "r691",
      "r692",
      "r693",
      "r694",
      "r696",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Adjustment [Member]"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r181",
      "r220",
      "r221",
      "r222",
      "r224",
      "r225",
      "r228",
      "r229",
      "r230",
      "r231",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r249",
      "r296",
      "r297",
      "r428",
      "r459",
      "r463",
      "r464",
      "r465",
      "r504",
      "r515",
      "r516",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r181",
      "r220",
      "r221",
      "r222",
      "r224",
      "r225",
      "r228",
      "r229",
      "r230",
      "r231",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r249",
      "r296",
      "r297",
      "r428",
      "r459",
      "r463",
      "r464",
      "r465",
      "r504",
      "r515",
      "r516",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598"
     ],
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r181",
      "r220",
      "r222",
      "r224",
      "r225",
      "r228",
      "r229",
      "r237",
      "r249",
      "r428",
      "r459",
      "r463",
      "r464",
      "r504",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r695",
      "r696",
      "r698",
      "r699",
      "r700",
      "r709",
      "r710",
      "r770",
      "r775",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r238",
      "r374",
      "r673",
      "r697"
     ],
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails",
      "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/BusinessCombinationDetails",
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/DeferredRevenueDetails",
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails",
      "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative",
      "http://kins-tech.com/role/ForeignOperationsDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative",
      "http://kins-tech.com/role/IncomeTaxesDetailsNarrative",
      "http://kins-tech.com/role/LeasesDetailsNarrative",
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails",
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative",
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails",
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative",
      "http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails",
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r282",
      "r283",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r638",
      "r650",
      "r730"
     ],
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/ForeignOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r282",
      "r283",
      "r601",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r638",
      "r650",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/ForeignOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r238",
      "r374",
      "r673",
      "r674",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails",
      "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/BusinessCombinationDetails",
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/DeferredRevenueDetails",
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails",
      "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative",
      "http://kins-tech.com/role/ForeignOperationsDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative",
      "http://kins-tech.com/role/IncomeTaxesDetailsNarrative",
      "http://kins-tech.com/role/LeasesDetailsNarrative",
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails",
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative",
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails",
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative",
      "http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails",
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r704",
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r12",
      "r648"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r285",
      "r286"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": {
     "auth_ref": [
      "r15",
      "r109",
      "r621"
     ],
     "calculation": {
      "http://kins-tech.com/role/AccruedLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued sales and other indirect taxes payable"
       }
      }
     },
     "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedBonusesCurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://kins-tech.com/role/AccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued bonus and commissions"
       }
      }
     },
     "localname": "AccruedBonusesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxes": {
     "auth_ref": [
      "r2",
      "r3",
      "r113",
      "r154",
      "r166"
     ],
     "calculation": {
      "http://kins-tech.com/role/AccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due. This amount is the total of current and noncurrent accrued income taxes.",
        "label": "Income tax payables"
       }
      }
     },
     "localname": "AccruedIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r2",
      "r154",
      "r167"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r157",
      "r172"
     ],
     "calculation": {
      "http://kins-tech.com/role/AccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.",
        "label": "Accrued Liabilities [Default Label]",
        "totalLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRentCurrent": {
     "auth_ref": [
      "r15",
      "r621"
     ],
     "calculation": {
      "http://kins-tech.com/role/AccruedLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued rent"
       }
      }
     },
     "localname": "AccruedRentCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r81",
      "r188"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r24",
      "r26",
      "r27",
      "r196",
      "r582",
      "r594",
      "r598"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r23",
      "r27",
      "r136",
      "r516",
      "r589",
      "r590",
      "r678",
      "r679",
      "r680",
      "r688",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r7",
      "r648"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r403",
      "r404",
      "r405",
      "r688",
      "r689",
      "r690",
      "r769"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r48",
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization expense"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r93",
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Charged to temporary equity"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash used in operating activities:",
        "verboseLabel": "Adjustments to reconcile net income (loss)\u00a0to net cash used in operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r48",
      "r67",
      "r74"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of intangible assets",
        "verboseLabel": "Aggregate amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Total"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative",
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r153",
      "r165",
      "r192",
      "r215",
      "r266",
      "r275",
      "r279",
      "r291",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r447",
      "r451",
      "r475",
      "r648",
      "r727",
      "r728",
      "r779"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r184",
      "r198",
      "r215",
      "r291",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r447",
      "r451",
      "r475",
      "r648",
      "r727",
      "r728",
      "r779"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets",
        "verboseLabel": "Current Assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldInTrustNoncurrent": {
     "auth_ref": [
      "r684"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.",
        "label": "Cash and investments held in trust account",
        "verboseLabel": "Assets held in the Trust Account"
       }
      }
     },
     "localname": "AssetsHeldInTrustNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheets",
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Schedule of proforma financial information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r439",
      "r440"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Net income (loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r439",
      "r440"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r132",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombination"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets acquired:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Prepaid assets and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Deferred revenues"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "verboseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails",
      "http://kins-tech.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r124",
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities assumed:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r124",
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business combination goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails",
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r0",
      "r54",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Organization, Nature of Business and Basis of Presentation"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/OrganizationNatureOfBusinessAndBasisOfPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CapitalizedComputerSoftwareNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.",
        "label": "Capitalized Computer Software, Accumulated Amortization",
        "negatedLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CapitalizedComputerSoftwareNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.",
        "label": "Capitalized software development costs"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareNet": {
     "auth_ref": [
      "r617"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.",
        "label": "Software development costs, net",
        "totalLabel": "Software development costs, net"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r599",
      "r600",
      "r648",
      "r675"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheets",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash acquired in connection with Business Combination"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r50",
      "r186",
      "r619"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents",
        "verboseLabel": "Cash operating bank account"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r44",
      "r50",
      "r53"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash \u2013 End of period",
        "periodStartLabel": "Cash \u2013 Beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r44",
      "r147"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net Change in Cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFDICInsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.",
        "label": "Insured amount"
       }
      }
     },
     "localname": "CashFDICInsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash investing and financing activities:",
        "verboseLabel": "Non-Cash Investing and Financing Activities"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r215",
      "r241",
      "r242",
      "r245",
      "r247",
      "r252",
      "r253",
      "r291",
      "r324",
      "r326",
      "r327",
      "r328",
      "r331",
      "r332",
      "r338",
      "r339",
      "r342",
      "r346",
      "r353",
      "r475",
      "r618",
      "r672",
      "r685",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative",
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative",
      "http://kins-tech.com/role/PublicOfferingDetailsNarrative",
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative",
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails",
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r102",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetails1",
      "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative",
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative",
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetails1",
      "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative",
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative",
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Exercise price of warrants",
        "verboseLabel": "Exercise price of warrant"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative",
      "http://kins-tech.com/role/PublicOfferingDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Number of warrants to purchase shares issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Warrants outstanding"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r102",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r20",
      "r158",
      "r171"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r85",
      "r318",
      "r319",
      "r602",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "COMMITMENTS AND CONTINGENCIES",
        "verboseLabel": "Commitments and Contingencie"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingencie",
      "http://kins-tech.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative",
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative",
      "http://kins-tech.com/role/PublicOfferingDetailsNarrative",
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative",
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails",
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative",
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails",
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation.",
        "label": "Common Class C [Member]"
       }
      }
     },
     "localname": "CommonClassCMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative",
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock, par value (in dollars per share)",
        "terseLabel": "Common shares, par value (in dollars per share)",
        "verboseLabel": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common shares, shares authorized",
        "terseLabel": "Common shares, shares authorized (in shares)",
        "verboseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common shares, shares issued",
        "verboseLabel": "Common shares, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r6",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common shares, shares outstanding",
        "terseLabel": "Common shares, shares outstanding (in shares)",
        "verboseLabel": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r6",
      "r648"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,900,000 shares issued and outstanding at December\u00a031, 2022 and 2021",
        "verboseLabel": "Common Stock value"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Stock-Based Compensation"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r28",
      "r201",
      "r203",
      "r209",
      "r578",
      "r583"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r164",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Credit Risk and Concentrations"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CreditRiskAndConcentrations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r135",
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r32",
      "r215",
      "r291",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r475",
      "r727"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenues"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r687",
      "r762",
      "r764"
     ],
     "calculation": {
      "http://kins-tech.com/role/IncomeTaxDetails1": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r687",
      "r762",
      "r764"
     ],
     "calculation": {
      "http://kins-tech.com/role/IncomeTaxDetails1": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentCollateralAmount": {
     "auth_ref": [
      "r163"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets pledged to secure a debt instrument.",
        "label": "Aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentCollateralAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r148",
      "r149",
      "r333",
      "r500",
      "r634",
      "r635"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Amount outstanding under promissory note"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r17",
      "r148",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r18"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Offering Costs"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r687",
      "r763",
      "r764"
     ],
     "calculation": {
      "http://kins-tech.com/role/IncomeTaxDetails1": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r758"
     ],
     "calculation": {
      "http://kins-tech.com/role/IncomeTaxDetails1": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal, State and Local, Tax Expense (Benefit)",
        "verboseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r48",
      "r119",
      "r423",
      "r431",
      "r432",
      "r687"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r409",
      "r410"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r677"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Total Deferred Revenue",
        "verboseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DeferredRevenueDetails",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r676"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r418"
     ],
     "calculation": {
      "http://kins-tech.com/role/IncomeTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r760"
     ],
     "calculation": {
      "http://kins-tech.com/role/IncomeTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax asset, net of allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetOfValuationAllowanceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r117",
      "r761"
     ],
     "calculation": {
      "http://kins-tech.com/role/IncomeTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Net operating loss carryforward"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://kins-tech.com/role/IncomeTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Change in valuation allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails",
      "http://kins-tech.com/role/IncomeTaxDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r48",
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r48",
      "r264"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r138",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "DERIVATIVE WARRANT LIABILITIES"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r199"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Schedule of disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DisaggregationOfRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Cash Contribution upon seperation"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and diluted net income per common stock"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r210",
      "r228",
      "r229",
      "r231",
      "r232",
      "r233",
      "r239",
      "r241",
      "r245",
      "r246",
      "r247",
      "r249",
      "r464",
      "r465",
      "r579",
      "r584",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic and diluted net income per common stock"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r59",
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r489"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective tax rate (in percent)",
        "terseLabel": "Effective tax rate",
        "verboseLabel": "Income tax provision"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails2",
      "http://kins-tech.com/role/IncomeTaxesDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r216",
      "r412",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Statutory tax rate",
        "verboseLabel": "Statutory federal income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails2",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r759",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails2"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r759",
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "State taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails2"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r93",
      "r180",
      "r205",
      "r206",
      "r207",
      "r220",
      "r221",
      "r222",
      "r225",
      "r234",
      "r237",
      "r251",
      "r295",
      "r355",
      "r403",
      "r404",
      "r405",
      "r427",
      "r428",
      "r463",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r496",
      "r516",
      "r589",
      "r590",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ErrorCorrectionTextBlock": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting error correction.",
        "label": "RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS"
       }
      }
     },
     "localname": "ErrorCorrectionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ExtendedProductWarrantyAccrualCurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount at end of the reporting period of the aggregate extended product warranty liability that is expected to be paid within one year of the balance sheet date or normal operating cycle, if longer. Does not include the balance for the standard product warranty liability.",
        "label": "Warrant liability"
       }
      }
     },
     "localname": "ExtendedProductWarrantyAccrualCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r48",
      "r87"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Change in fair value of derivative liability",
        "negatedLabel": "Change in fair value of derivative liability",
        "verboseLabel": "Fair value of warrants"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations",
      "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetails1",
      "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r467",
      "r468",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetails1",
      "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r139",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of company's assets and liabilities that are measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r335",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r468",
      "r528",
      "r529",
      "r530",
      "r634",
      "r635",
      "r640",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetails1",
      "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative",
      "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r467",
      "r468",
      "r469",
      "r470",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "FAIR VALUE MEASUREMENTS",
        "verboseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurements",
      "http://kins-tech.com/role/FairValueOfFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r335",
      "r366",
      "r371",
      "r468",
      "r528",
      "r640",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r335",
      "r366",
      "r371",
      "r468",
      "r529",
      "r634",
      "r635",
      "r640",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r335",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r468",
      "r530",
      "r634",
      "r635",
      "r640",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails1",
      "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r141",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Schedule of change in the fair value of the Level 3 warrant liabilities"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency."
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Change in fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value at ending",
        "periodStartLabel": "Fair value at beginning"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r335",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r528",
      "r529",
      "r530",
      "r634",
      "r635",
      "r640",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetails1",
      "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative",
      "http://kins-tech.com/role/FairValueOfFinancialInstrumentsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r472",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r143",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]"
       }
      }
     },
     "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r507",
      "r508",
      "r647"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Amortization of right of use asset"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r289",
      "r290",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r337",
      "r351",
      "r453",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r632",
      "r705",
      "r706",
      "r707",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Intangible assets useful life",
        "verboseLabel": "Finite-Lived Intangible Asset, Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r190",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.",
        "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2028 and thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r312",
      "r314",
      "r315",
      "r317",
      "r560",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r68",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r73",
      "r560"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r484",
      "r485",
      "r486",
      "r488"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedLabel": "(Gain) loss on foreign currency transactions"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Comprehensive Income (Loss) and Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfDerivatives": {
     "auth_ref": [
      "r48",
      "r162"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.",
        "label": "Gain (Loss) on Sale of Derivatives",
        "verboseLabel": "Change in fair value of derivative liability"
       }
      }
     },
     "localname": "GainLossOnSaleOfDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r189",
      "r308",
      "r577",
      "r633",
      "r648",
      "r711",
      "r718"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "verboseLabel": "Goodwill by geographic area"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ForeignOperationsDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r31",
      "r215",
      "r266",
      "r274",
      "r278",
      "r280",
      "r291",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r475",
      "r631",
      "r727"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross Profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/PublicOfferingDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r78",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Carrying Value, Recoverability and Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r29",
      "r152",
      "r159",
      "r174",
      "r266",
      "r274",
      "r278",
      "r280",
      "r580",
      "r631"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income before provision for income taxes",
        "totalLabel": "Net Income (Loss), before tax",
        "verboseLabel": "Income (loss) before benefit from (provision for) income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations",
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r216",
      "r413",
      "r416",
      "r422",
      "r429",
      "r434",
      "r436",
      "r437",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "INCOME TAX",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTax",
      "http://kins-tech.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r217",
      "r236",
      "r237",
      "r265",
      "r411",
      "r430",
      "r435",
      "r585"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://kins-tech.com/role/IncomeTaxDetails1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes",
        "negatedTerseLabel": "Income tax benefit/(provision)",
        "totalLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations",
      "http://kins-tech.com/role/IncomeTaxDetails1",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r204",
      "r407",
      "r408",
      "r416",
      "r417",
      "r421",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r45",
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Cash paid for taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.",
        "label": "Increase (Decrease) in Accounts and Other Receivables",
        "negatedLabel": "Accounts receivable and other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsAndOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Income tax payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Accounts payable and accrued expenses",
        "verboseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r625"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxes": {
     "auth_ref": [
      "r681"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes, and in deferred and other tax liabilities and assets.",
        "label": "Income tax liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:",
        "verboseLabel": "Change in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r681",
      "r774"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r313",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DeferredRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r70",
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DeferredRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r72",
      "r556",
      "r557",
      "r558",
      "r560",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r66",
      "r71"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible assets, net",
        "verboseLabel": "Net carrying amount"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest and Other Income",
        "negatedLabel": "Interest earned on cash and investments held in Trust Account"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r161"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest earned on cash and investments held in Trust Account",
        "verboseLabel": "Interest income (expense), net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r683"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r34",
      "r263"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Interest income - bank"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOfLesseeDisclosureTextBlock": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.",
        "label": "Leases"
       }
      }
     },
     "localname": "LeasesOfLesseeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r14",
      "r215",
      "r291",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r448",
      "r451",
      "r452",
      "r475",
      "r630",
      "r727",
      "r779",
      "r780"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r11",
      "r155",
      "r169",
      "r648",
      "r686",
      "r708",
      "r772"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS\u2019 DEFICIT",
        "verboseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r16",
      "r185",
      "r215",
      "r291",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r448",
      "r451",
      "r452",
      "r475",
      "r648",
      "r727",
      "r779",
      "r780"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "verboseLabel": "Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DeferredRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r254",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities:",
        "verboseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing Activities:",
        "verboseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r44",
      "r46",
      "r49"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "negatedLabel": "Cash for operating activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities:",
        "verboseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r30",
      "r49",
      "r160",
      "r173",
      "r183",
      "r200",
      "r202",
      "r207",
      "r215",
      "r224",
      "r228",
      "r229",
      "r231",
      "r232",
      "r236",
      "r237",
      "r243",
      "r266",
      "r274",
      "r278",
      "r280",
      "r291",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r465",
      "r475",
      "r631",
      "r727"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net income",
        "terseLabel": "Net income (loss) by geographic area",
        "totalLabel": "Net income",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations",
      "http://kins-tech.com/role/ForeignOperationsDetails",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r228",
      "r229",
      "r231",
      "r232",
      "r239",
      "r240",
      "r244",
      "r247",
      "r266",
      "r274",
      "r278",
      "r280",
      "r631"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Allocation of net income, as adjusted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r55",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r231",
      "r238",
      "r249",
      "r287",
      "r288",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r403",
      "r404",
      "r405",
      "r425",
      "r426",
      "r427",
      "r428",
      "r443",
      "r444",
      "r445",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r504",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r561",
      "r562",
      "r563",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recently Issued and Adopted Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long lived assets by geographic area"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ForeignOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Total other income (expenses)",
        "totalLabel": "Other income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations",
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income:",
        "verboseLabel": "Other Income (Expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating and formation costs"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses [Default Label]",
        "totalLabel": "Total Operating Expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r266",
      "r274",
      "r278",
      "r280",
      "r631"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating income (loss) by geographic area",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfOperations",
      "http://kins-tech.com/role/ForeignOperationsDetails",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r773"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating lease expenses"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating lease obligation, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating lease obligation, noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r505"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating lease right-of-use asset, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r510",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Weighted average discount rate used to determine operating lease"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r509",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/LeasesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r15"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Reduction in accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "auth_ref": [
      "r682",
      "r722"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.",
        "label": "Impairment charges of long-lived assets"
       }
      }
     },
     "localname": "OtherAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r191"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherBorrowings": {
     "auth_ref": [
      "r156"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.",
        "label": "Debt owed balance"
       }
      }
     },
     "localname": "OtherBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r22",
      "r25",
      "r487",
      "r495"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "negatedLabel": "Unrealized foreign exchange loss from cumulative translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherFiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r73"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of finite-lived intangible assets classified as other.",
        "label": "Gross carrying amount"
       }
      }
     },
     "localname": "OtherFiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Notes and other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/PublicOfferingDetailsNarrative",
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Redemptions of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Debt issuance cost"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Payment of offering costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock, par value (in dollars per share)",
        "verboseLabel": "Preferred stock, par value, (per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred stock, shares authorized",
        "verboseLabel": "Preferred shares, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r5",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred stock, shares issued",
        "verboseLabel": "Preferred shares, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred stock, shares outstanding",
        "verboseLabel": "Preferred shares, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r5",
      "r648"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, $0.0001 par value; 2,000,000 shares authorized; none issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.",
        "label": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r197",
      "r306",
      "r307",
      "r620"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from issuance initial public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from issuance of warrants",
        "verboseLabel": "Aggregate purchase price"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Borrowings under promissory note",
        "verboseLabel": "Proceeds from related Party debt"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r183",
      "r200",
      "r202",
      "r211",
      "r215",
      "r224",
      "r236",
      "r237",
      "r266",
      "r274",
      "r278",
      "r280",
      "r291",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r446",
      "r449",
      "r450",
      "r465",
      "r475",
      "r580",
      "r631",
      "r645",
      "r646",
      "r680",
      "r727"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r84",
      "r603",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/PropertyAndEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r80",
      "r187"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r82",
      "r170",
      "r581",
      "r648"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net",
        "verboseLabel": "Total Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r82",
      "r603",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "verboseLabel": "Property and Equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/PropertyAndEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r372",
      "r519",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r176",
      "r519",
      "r520",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party."
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r372",
      "r519",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r517",
      "r518",
      "r520",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "RELATED PARTIES"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RelatedParties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Repayment of related party promissory note"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r110",
      "r175",
      "r787"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r8",
      "r100",
      "r168",
      "r593",
      "r598",
      "r648"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r180",
      "r220",
      "r221",
      "r222",
      "r225",
      "r234",
      "r237",
      "r295",
      "r403",
      "r404",
      "r405",
      "r427",
      "r428",
      "r463",
      "r589",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r208",
      "r215",
      "r261",
      "r262",
      "r273",
      "r276",
      "r277",
      "r281",
      "r282",
      "r284",
      "r291",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r475",
      "r580",
      "r727"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues by geographic area",
        "verboseLabel": "Total Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails",
      "http://kins-tech.com/role/ForeignOperationsDetails",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative",
      "http://kins-tech.com/role/PublicOfferingDetailsNarrative",
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of antidilutive shares"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r122",
      "r123",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of income tax provision"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Company's net deferred tax assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Reconciliation of net income per common share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": {
     "auth_ref": [
      "r56",
      "r57",
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.",
        "label": "Summary of impact of the restatement on the financial statements"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": {
     "auth_ref": [
      "r145",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing the information required and determined to be disclosed regarding the fair value of financial assets and financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.",
        "label": "Schedule of Fair Value, off-Balance-Sheet Risks [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r68",
      "r72",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r68",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r633",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetails",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Schedule of financial data by geographic area"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ForeignOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of assets acquired"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r150",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of assumptions used"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r89",
      "r91",
      "r92",
      "r94",
      "r95",
      "r96",
      "r97",
      "r98",
      "r99",
      "r100",
      "r193",
      "r194",
      "r195",
      "r252",
      "r338",
      "r339",
      "r340",
      "r342",
      "r346",
      "r351",
      "r353",
      "r636",
      "r672",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of future amortization expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Stock-based compensation",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Shares available for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Stock option granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Fair value of common stock as of grant date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative",
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Option life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockOptionPlanAndStock-basedCompensationDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Purchase price, per unit (in dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/PublicOfferingDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.",
        "label": "Warrant liabilities"
       }
      }
     },
     "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r54",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "verboseLabel": "Derivative Warrant Liabilities"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r215",
      "r241",
      "r242",
      "r245",
      "r247",
      "r252",
      "r253",
      "r291",
      "r324",
      "r326",
      "r327",
      "r328",
      "r331",
      "r332",
      "r338",
      "r339",
      "r342",
      "r346",
      "r353",
      "r475",
      "r618",
      "r672",
      "r685",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative",
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative",
      "http://kins-tech.com/role/PublicOfferingDetailsNarrative",
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative",
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails",
      "http://kins-tech.com/role/StockholdersDeficitDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r21",
      "r93",
      "r180",
      "r205",
      "r206",
      "r207",
      "r220",
      "r221",
      "r222",
      "r225",
      "r234",
      "r237",
      "r251",
      "r295",
      "r355",
      "r403",
      "r404",
      "r405",
      "r427",
      "r428",
      "r463",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r496",
      "r516",
      "r589",
      "r590",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails",
      "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://kins-tech.com/role/DeferredRevenueDetails",
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails",
      "http://kins-tech.com/role/ForeignOperationsDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative",
      "http://kins-tech.com/role/IncomeTaxesDetailsNarrative",
      "http://kins-tech.com/role/LeasesDetailsNarrative",
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative",
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails",
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative",
      "http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r220",
      "r221",
      "r222",
      "r251",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/AccruedLiabilitiesDetails",
      "http://kins-tech.com/role/AccruedLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://kins-tech.com/role/DeferredRevenueDetails",
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails",
      "http://kins-tech.com/role/ForeignOperationsDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetailsNarrative",
      "http://kins-tech.com/role/IncomeTaxesDetailsNarrative",
      "http://kins-tech.com/role/LeasesDetailsNarrative",
      "http://kins-tech.com/role/PropertyAndEquipmentNetDetailsNarrative",
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetails",
      "http://kins-tech.com/role/SoftwareDevelopmentCostsNetDetailsNarrative",
      "http://kins-tech.com/role/StockAwardPlansAndStock-basedCompensationDetails",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r5",
      "r6",
      "r93",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Number of shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r5",
      "r6",
      "r93",
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Aggregate purchase price"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r6",
      "r9",
      "r10",
      "r65",
      "r648",
      "r686",
      "r708",
      "r772"
     ],
     "calculation": {
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance \u2014 December\u00a031, 2022 (As\u00a0Restated)",
        "periodStartLabel": "Balance \u2014 December\u00a031, 2021",
        "totalLabel": "Total Stockholders\u2019 Deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Deficit",
        "verboseLabel": "Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CondensedConsolidatedBalanceSheets",
      "http://kins-tech.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r133",
      "r134",
      "r137",
      "r180",
      "r181",
      "r206",
      "r220",
      "r221",
      "r222",
      "r225",
      "r234",
      "r295",
      "r355",
      "r403",
      "r404",
      "r405",
      "r427",
      "r428",
      "r463",
      "r490",
      "r491",
      "r496",
      "r516",
      "r590",
      "r591",
      "r686",
      "r708",
      "r772"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance at the end",
        "periodStartLabel": "Balance at the beginning"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r103",
      "r214",
      "r339",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r352",
      "r355",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "STOCKHOLDERS\u2019 DEFICIT"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/StockholdersDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stock split"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/PublicOfferingDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/PrivatePlacementDetailsNarrative",
      "http://kins-tech.com/role/PublicOfferingDetailsNarrative",
      "http://kins-tech.com/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative",
      "http://kins-tech.com/role/PublicOfferingDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosures of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity to its redemption value during the period.",
        "label": "Accretion of carrying value to redemption value",
        "negatedLabel": "Accretion of carrying value to redemption value"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.",
        "label": "Change in value of common stock subject to redemption",
        "verboseLabel": "Accretion of Class A common stock to redemption"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit",
      "http://kins-tech.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r324",
      "r326",
      "r327",
      "r328",
      "r331",
      "r332"
     ],
     "calculation": {
      "http://kins-tech.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Class A common stock subject to possible redemption, 387,551 and 27,600,000 shares at $10.10 per share redemption value as of December\u00a031, 2022 and 2021, respectively",
        "periodEndLabel": "Class A common stock subject to possible redemption, at end of year",
        "periodStartLabel": "Class A common stock subject to possible redemption, at beginning of year"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheets",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r1",
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Common stock, par value"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Class A common stock subject to possible redemption",
        "verboseLabel": "Class A common stock subject to possible redemption, outstanding (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r1",
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Schedule of reconciliation of Class A common stock reflected in the condensed balance sheet"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r639",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r639",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time."
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetails",
      "http://kins-tech.com/role/GoodwillAndIntangibleAssetsDetails1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r289",
      "r290",
      "r337",
      "r351",
      "r453",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r705",
      "r706",
      "r707",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/FairValueMeasurementsDetails",
      "http://kins-tech.com/role/FairValueMeasurementsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/BusinessCombinationDetailsNarrative",
      "http://kins-tech.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r406",
      "r415"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized tax benefits accrued for interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r61",
      "r62",
      "r63",
      "r255",
      "r256",
      "r258",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://kins-tech.com/role/IncomeTaxDetails1": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "negatedLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/IncomeTaxDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantExercisePriceIncrease": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.",
        "label": "Warrant Price"
       }
      }
     },
     "localname": "WarrantExercisePriceIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPolicieDetails",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Public Warrants expiration term"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/DerivativeWarrantLiabilitiesDetailsNarrative",
      "http://kins-tech.com/role/WarrantLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r239",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Basic and diluted weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://kins-tech.com/role/SummaryOfSignificantAccountingPoliciesDetails1"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.13(h))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "840",
   "URI": "https://asc.fasb.org/topic&trid=2208923",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=d3e1280-108306",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r652": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r653": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r654": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r655": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r656": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r657": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r658": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r659": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r661": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r662": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r663": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r664": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r665": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r666": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r667": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r668": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r669": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r671": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(b))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>111
<FILENAME>0001829126-23-004526-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001829126-23-004526-xbrl.zip
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MT\N)4D6@@P!CYH#! D#X.].Q((L\LKN'G"9=2Z6#*,/-UG9W&)=O=)44.HG
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M0:PHQ'?4_K),#6S'/YU1:PT#'7[^/U!+ P04    "  2B-Y6==PS[(\;  !
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MP3U1T#3T?*8E)3&"\:W-T9"N;&*:4H#RZD>W9H]7JR!E,Y=9##8AR$D70!<
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M0V3I26U'S:I%]P(VI[P*T4Z;4RT.0Z&>;)7ALSB9H;MUXM\2^S%9EIYG2$)
M %A+]RB)%K=#0V !6>4IE]=@^8'O*;J65E:105FZ*VGH$B 4F[:@8NY-EFRB
MT>8R-+>5Y=^IEV4]E*4A)/T%*1.*54N1LDO_I0G4]UY(::?=@Y+ )_./_F(0
M+:H_*(V<HB2(%[R#GY>W&#WZ[$9I1N;R:+DDME4\+_JFP_36;T;NVYD!^F<[
M*W,J;!:FS"W=09C=[8$V"U.V$5OVYF-!XY0+S<*([_G+YM/1>#XZE;_\6$<>
M$2_YQ-]>RR5"#!Y]&%>=MX.T>$2E>M4. S=M7J %%\&2L,GS+&(Q,^0C0O9U
M2%/O(16I)%"F31A$81"^;=(3NP9_)A9#M"2#,6T9(3I2\VR3AJJW:D7F@JJ\
MIAS*])VR?J73>KYMTM-KP=.>PE*L?PXM49]N-=&1AJ4D4';8%7'(2<FP30K:
M[C]"R-S4TBS:E$@SSP#0=A@9<8X96  V*6X346"5\V>4FLF2'.D8%Q)G0 YF
MAZ41.0(0EFW245Y-*?@SZ\BQ3E%2-+>2[G\J.-/)2%(MP9BV24WJ?4YW+^LN
M/T@J>JOWJV=W$%)15##<=.J.?'^2L6B3+HP4.F\M1I%GKX&C$]OC37OT.L6R
M)0S;-*'X]#-H-7/(]+*]FOE+*>Y<:>*G5)!HO&EO'JP=.</=9Y0-?'+VPT%V
M^Y'1+"HQ7S_4M#,.;<8@9M.F^3_*+YS("7VQ]M/\$<H36\->J%P.0'#3KCEX
M=6B)PR8]5D^!FRFG#H,KX$Q[]F#-P01@D\I>.SI8MEA )S UJ$6.FMY:L?MX
MQLZ1FATX9# 6>6RRDW-??3=:\Z0W+ZK*E,OB>DI BSP^A5.MX-TF=;W,/AW=
M=X6PH$/':U<(*YMUO':%T.P*84$GCY?9%:)$)?,!Z(U1@FY1A(-[]%PBBEB6
MR;+^/>5S*$X/D6E3"U^,S434?7R+?#&KC_Y<$E80WJH=:3I2HE: D'3[UM%K
M=Q79 5U/8R^D*\G+Z=6@R-L'-&WXL&L2?Y^M'*Z*K]:R7M_<@?65*>WKE=)D
M%5%\W!+%U7AP=>I>9J*H$XJH"80S&-.1%]/9Z"L!<[^-G//)W%"=O2\)83BK
MRB;)PB@/,N5NLKLD21CS>83I?;-&IIS/6.7&)HM&WW=.ECF%LL-O99CIO5PM
M\UJ^K'J_NHF9:O0Y$?<WZ6M=8D3$1Q_?G!+1AC'+N576_5* F5[!0DUPZQC
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M$Y40:*Y=XQ[1LC(MIM@\7VAW)Y-[WFKS*G1W,LT)8'9W,IN^DZGR%F"_Q"W
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MP36(8L:MT&A5\FL4V,1=)U6+QF1I^6F9&LK!=BJFZ:38!PJ27_9>]>A6QZI
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M93-7#PE\GR-P.OJ=3H?>Y+8_B"=%K5,_#KQ3;3$$L?^0G]BW\;,!D_YT7B_
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M?+M5TZ)!B4#SJ^KS\.!#NT%(CY+8C33V8SE04A,%;+R84\LYYN8J"JA<@F"
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M]FF=[*LZ=RCD)G]\.$[^V [2LWRGMQOF/WH^"G6G?X!/!^5@R\\QF;ZZ:WV
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M" KX@L#[I+A8V,0*V9<3-P7R/&2'D>5MZY?PLR4DNFHK77,B2.7X P\]Q;<
MSCB05MGP+!]D4UL1K@NR=4&V+LA6?Y#-].MA1?3"YX(I^8VFI^,54PSN*@9Z
M#N\#M(B\6W?!"1+(]'ZX^&"<)B4*!LCSI3I.>GIY\/ )$0[K@JN44MW;"&D)
MQHQS!7'(+GW1LOQ8;42[*I?-J-XEH#^F_@Z%PQ?;BQS77XIS3V1ZMQ%>>;Y
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M-K2R](RP$T:<X<B$@H24[7GY-_@J]8N3L\L)"<P^*09"'K%"C$Q"BTH84&F
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MG1[+Y6(>21HG!=VR\(_;QP"_P$U9Y*0'Q<#DJ^!*)<O;"P8.##89%!H>4<\
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M_9@E$43YQ=]*4OM2/6$Q5[=)EK%.=>EDJNM-'!H)>,C&J_7J='VUOEM?W)Z
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MVFC[0DX./?< "H\W4PEO>DDA+/F1Y;]2,?<GDQM$5[B+)_779%L<(D$GQ."
M"LG12/E'D"$T!4F(**V*E[MGRF!%6U=[R%S-X:Z$LOZ0J8XW##,$.L,6@W,R
M,M_HA2_1%L4AW$)$_R9K?')YJT%,![L7RV3"WA!.AY!;L<4/?PQR" Y$^(3N
M/Y5I7(#OXQ1$69($*&\WI?[DG&7]M>AM@#:(!N>(KAAJ*&>J[&Y_0.>0?,M
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M8C=4KV-M"<D4?K-XI%-P3JLQ*/DSH$08U-*+G?>,"SPS[B-K$<N"U4A=BR=
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M.^+@5O<NVD;_A-2F77QX5U]U>H[C=)+1!Y]E.:VM:S;$,S+@8)@WPC'!4,]
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M54_S2TXO:H%!7B)X'B=E+TJ+WM%H$]8(/-&YAKDC]?V@[#30W/$[2L-N259
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MV>XA+=KNYV#KR>1HF.1*?,Q-_9":0?JZZ4;YY>46()C 2!"2,!CGCE\E\)"
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M""8W#J,&UC$:5M#.Y6YODDV"F0<QY:L2BBB)DD64T;" C1'[<"0/^5C+E)*
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MC5E&6FVU)FROFH5#S^/F'B>8.SZ]L8O@!8G!5P0 CI2VAJ$*W-'/S05)'7K
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M+@PI&':A;C7=J[<)@ KHO%J2(,A;O7YTXM]("3^)JBN!P:[5K<LE-?[H+/I
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M__MALOKGX ^WX[O):++"K[/5KN0T"+Q/)#NKTE:+DHA]6IE1GEB25M:& ;D
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M)86PX[)2T[U\7P%(<.U7%@]VGG'7'+.XT-W.?_/UH[!#S<D.JL=V,.A!/N&
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MLR%YM&HI-V(2YK\2O A:SX9M*S#R,#B3MI?A^/[EN0]0G82W]%QQXD02T=N
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M'2O-2ED$G@/*/_NL*_J4NNHJ8MQH6+R)[GWGD:H\_&H4FK0+0!4<5  LLNP
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M:8S94RPH3R.P*CR$+-B.)QG<9DR1G.>M)'F^XI1\YG\262&AP-C%UT'*8MD
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M SLK/],-1F(J%4+??JNYL$LRP=AT%J'0]8U2N-3<B6<QQSDO>S@O+D&5%J@
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M UYV3JSD<G?@!A6W_.4W0/ZI\ =02P,$%     @ $HC>5G_=&#-4 P  (@T
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M+1J/J\/C/?4)<ZAU1;C#G*ZWZT#,G@^-P!5*Q$4]Y=T#9;'\Y!W#Z:0SO'M
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M*'[[P'R;-CL 6#9D%CB'B;=.G>+-"]ZMLD#2HL5O[X(V3-HWPCG9:A&[2G-
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MCQ%!*GR7/4)F%&T.,/#@ /DNNOQ#Y@GSQ2&.R8B-GA(6UT)*/557 _=17>Q
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MJ6Z-)JKG5OWF:K+QR48M>34G9VG+^/H0-/%-73#T90.7_9/(]##>7#1OKV\
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M_-0'@-()*AZ9/4'P(]X>DB6VLQ@ DG!LJ0=.DB<VLF *07K@B#NC&0 K&^W
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M3 XXX)1PD;WEJV->5J9?)#69&+*E^FC(F<#YP7FY</M]\(I:OFO^/, 8<($
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MFJ*NR4/*7VJAB)8,9<#=>JD_B._.N7:BGGIY)]S<PD0><IU3)Z.<\(8XF<$
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M2%0J#+DL\3"++[E8@<4*W-OLWDS.CH='*))9,WOAC[T1M 34=>. Z2J[ZI;
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M]=K^D\XN%U;]]GM*1=JJ%N43^=,_1V8<YN$3.2DY_O&Z%)>"UY_9%H+ST,E
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M"YM)^C6=\AVXF]/AVH=1O%Z;DS">D?I2I;%(VJ_6?^#M/?1205Q#UJ$N9-[
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MK3Q)TXW3G*C)+<[]X@K</\%_W60<<.61BSCZ43S^'=_$#"79FR(V2_L RI
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M!7Q%5ZBU@0A>MN__!&I6&W&_BC9P4PX\Q9GW"TN5=$O:Z]@SIHE>+L4)7$?
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M"]<AN.-_],A H!7QHNPLL$E"A8EB#E%&HHTUSE:T[JMVLZGZWG)*X$Q_1>)
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M$'PL+JJSV&%%KL(UEU77-A[2/G2T5I(*YGX2M#"WZJR,M8-^2R?+)QCL(-I
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M$!Q!RI50QC6@CTOY$3S"(D$';0%[A%J2 Q0VU1FMZ<SY^:STUE7(S5U,;O/
MX]H7RH#CZ+I5'K@I.QTP<V1,9=<S/K?R+9\MAP?@DEME6P?YSLKV3-8*.#J.
MR(5DP)&FSNJ>T3Y MX5Y@:$,A:6E!,6Y\2"IU@ XWNQCF+6G_HXTK_H!_&[W
M*' LP"2-;NQ9OFW*SV&"FTDS4M61',<CGWJI\,LD&YA2 RNJ&$F7O,I84;'"
MJ43FXG0A*QZ*$K%5]77B2KBR8WEC*BPMC]K=IRQ\&<,AD7@?9N@Q'OEW20I"
M=SJ;:N^9<+RJU&3'Z6P^HVU5TK4%D0/4';W(YJ\]Z!E@@#I.;8,K5&62X PD
M-HMP+9)WW#,=KBL]9SLB*FHA2"%1],I26.45R61]A-LA"#A!-9=W"GY:YU*@
M4K M#9,X,&=%.!82A\9ZD;N P4B-@E].Q2_5"^L;L(HTPK:"<OXL]W+>95^V
M8ZRT!J=261N'/J6Z*[_SK!]?>V5D<FZ$VC\*_T)E![^Y0^M*)F,2RHS1PD1R
ME&&#@2LD,G33C^E^+&*"YS.#PRT;31FT[?2HE?-Y]",XF;$W0X2L_N&GB4N@
M$>3IF@"9H"#':&6863!F;/11L!!%X!TZGV>2-&31",4K0/Q&H4E+G:GE,O)8
M8E:(TJ\=LL;9GMD42Z$A*^E3BP%'MQA0^*J4V8DR ?LOH=PI0KYAZVQ?>3/&
MY#U\QM*Z5KH%:EOU1F5P2M;)9SI)6$(U)M)K1)_%R9CR=.-(,@ABE,"(#!L"
MCP7\7>(.FHK&F$&<-5G^90QAY3Y%Y'EEDSM\R5%UG):,Y8C;0JEH76=N,<6Z
MG&5OQS=U(Z"%Z0/.HO2!!5D#&@YL*96@"^(LWYY,<E$3IOC>C,-\J82$LC>3
M-=:BO(0P-UDDYG(U<Q<&\10&GL.&&QN*LNKIH2_/I8,HA<+-,/16),;=5+X+
M4^*.]0'*O!,W8<;;[LA",IU&SCUYV=VJT]Y*>X%$2EJ.?0YD9\B<-$K)H))(
M790G\^-U%L^"[#E5&2(U@$G"B.RST@LA6A"3*)FJ2H^Y(V.</;D+=E8')]-M
M3/U6O8W\$@I1.8Q$-41?AV@YY/Y7>4T2N@[W7'4M<;\(U76L3P ;;J_3ZU%)
M(H<>\"_WW) .F-8TP9/2=9S@4A*LZXS1%>:/,+102IWM>CCF;GNKJA/M7\9.
MO[B!C\DS.J!#ZGD@BCG!+7<_XO\1\RO ;RP16(9ZMOZ^\V7'W=\]/'BO\7-M
M4'=T$Z#+77;X<WRW^[U-K0AK(--^ @G'@(AKDT0!N$BY.RG2X:U4_V&JZ=!]
MD Y+Z>=G_-%K_ZO&"G<P4=O\7J'M2' Z*F+W0P5?8.QFQK16,PIX,AZSCEH,
M+)&3=V0Y=?DKG',GVS-BCCZ:S1Q*GN.\DPCNMFY_A@,)-UFV4'IP#VR_B3UZ
M!=MC,<)'5<)[8K"./+@H1ESV!3.7(Q Z'_<VBK#\,LL*PFFR0!IE-5S%9]RJ
MSY"%HG;&H30K?6<!DBI8?^4SF_F(]-+[)*5AYH^Q[#X2Z'QUIP(!8 =%7GW8
M3GDM.##H>TX>PP.611"51&+O 7:$VE3HH5Z;[61E.QVWV4[UI^AF&2IL&5+J
M"4(@:RQDO'#<H:#+LXH[L8ZH2J^.'__%4I*C!#(]L[7B:D.G?R#Z(;K',R'^
MHCMD&,-]3^87T<G*8#C5*&YC&&0JN\%I(WX1@5 %_2W5.Q(Q1*S*,;!H=>N(
M? 1'U+YNIT0L[D62H_JEN"8CY9!GQWY(>G<,#@,BM""0/A,C5V_K(D30Y[_Y
M8&-)<Z:C[)FK$ @._OA/K R:.A^!=-TM:>1=_?.CLN[<>S]3%332*1G&A3(@
M[<:?LGI%%6J>"L*9 =,7=I3<-"?&(*51P63#EB48GL]4$7Q*S9;A^[S!LJTV
MCGOAR\@LS126>P6W:Q_MNM1G3!SN*HT7=?PP'1<-1$8=_FO)I>RX?6JQ8VU;
M3V\;[#N>C2RW0\_,8U1!QW6+M3Z<JL.QZ#(1E,[74VEJ0>)8_7)5J90%WBS!
M#7!MN ,S30A4<4C\R/PDH7K&GE[0QC=9U%U,-<U$U0J,13LLV_:Z?T_N$:G<
MH^)XN01)J<0:U7O )J>!T*?352=KI8+J-I7"#MXC1W#& H5)" LZL8O,'M^4
M^\7P^IL6PJ^I4@*-_07Q[)TO%N+%Y3T&K6_#B6++*WV!>%0'UW2=#3ZA-[%X
MI"F'M8;R-LD PSI4IV^4NMLM2UR4TS*&R;6S)26!<4Y/M_3E#F01 MEC@*^D
M%<KI5A3<<TH1PRE#ENM.(@00/8Q J"QG+#[7=CV$//JBX@O/!ONMR'B+.9P3
M]LY<L2L(U/6]  W+86YL,P.&!)I9MWYFG5N8/7)L^M1VP.J)55^K*.&8[T@B
MR(>4.:#!URR4:G@^I<@THCFXO6-E"Q YD2.)%X'32GWJ1TRU"]]U=WI=PC?H
M=7<Z'79A\0LJ%L/I.<XL41JU%NAFQU;GY5#U=.,<->E)T9HP SV'1;[6&V,&
M^[;Z5L.N67\G#$1'[2M82:II#T,R$F &P:-2.)N]Y:8WEVT+8'S/U!GKR.:.
M^^^D<"O _]%B@#,FGB",D,SQ"9_+SRG\34D2M+T!GZ=M2\O&VS,(*J-$UK'_
MN':JF;  W2'LV 3MG?CF;^\Z[^AG>&JH?EYYM?=AD-_BHYWOE_7;Y.GJGP%C
MBF"LU$[")WZ2=?S;B+[A3S)8O?K7NP^PWF#UKU2>E5RA/*4?/KS4R,]Z_L<'
MA\>& /+@V6;]G-.4EP5R:BW[GS*Z/ 4G")958TJ4RNG+?F""+,URA=6#6A1$
M0'F;?LA3_!]DEB?R?^51+\<9K0!H!4 K +Y) "0&+1<M")&'+8^W/-[R^)OQ
MN$176XG'*7YOJ7%?IV=)0-M*9Z(=:3</8$K#6)5$K#@+?<].!4;_,6;-$QI,
M6[NBE3FMS*FIS*%;_TJ\CIQ[ET3%6&C?G,K2L6#_:5R^5: O)G-O&"8TFK;,
MWC)[R^QOPNS8/"D7-^%P-88?:DUN59FU-X:6H5N&;N:- 5L;"0;@#C'G1I6P
M<ID-*.I1:+IQJ%H]A;! =9(MS[<\W_+\F_"\'\=)H=HHK\3YBQ2XJB%3S.V5
M6^3.EF#9A5>J?C;S5C0I-#@,?.U/S%##\F)J].3)["UMK,RTFJ%:W@EF-MC0
MOZU :@52*Y#>2"!-5V+^DOP@ X8PTJCY*C;@'LN.7(' ' ?5^^TO,94US;&(
M6FYON;WE]B9=.:3[SQ6J05FBZ]"L-DF$#R?B(%,206.0Z<=;3=_R?LO[C>)]
MN\F[A9)J^-X.1Q*8Q3SZ)4%NB/N9;M KYT/,=JTJHY64($?L*H16YK0RIY4Y
M;R)S.(UAM0N&W0/$SG8W,*4F):%E[9:U6]9^$]96^3\K,;?I-<37!02W,ME'
M"?6/*V)"ERSC;,Y+ _8KWK&V1['PU)PG/P*C)*:Q6GG2RI-6GKR-/$%0H)5$
M"0&ZZK:/J<@FV!6'.^K@?47"UEOPYA))MA2#,7&54LOEU2(BY@+$7<^Q@69F
M0(BNSDY:P=(*EE:PO(E@,1TD5K40&/.>6AK8[DQ") 9BN^7NT61)Z(8)@ZG=
MGYT@[@@(5I=RK.;T2#>]U.,1U*_=%O7+H'[M=EK4KP:0=*LD6R59-R5Y4X0!
MU1:MIB-'"";J<77BO="M+"7\ =O;'@&.RN@#%QJ$F:L^J#*:K"9;V#!XI6F4
M!MP0O=@*D5:(U$V(K'J%MW#:N"T(3,DW'=22$8&<,,") L.1:0>JP8+M$FPY
MO^7\EO/?)HMPN/K==C"U\0RYER4Q>YCE7'>(D(9B8VZZ+5^W?%TWOGYBSI _
M'"*,/K67,>U'37-2M-4%HOE1\E I)T@VSHF'V&NY9?V6]5O6?R./ .?\KL3Z
M.C]8M0XCLK!SA%531@2SSC*5/@@20(#2QY(A^'E4B$A"$'AD]Z]VJ[CW4Q0V
M, 4!4\G<+?7-D\M_GI]N=X_?>RXVZQ#Q<%H&02"(TR$73\(H7#Z5IDD:9F-J
M5=M*HU8:M=*H":X%;MG.Q9%^7F#Q0A!F?@;\C$)%<G6.$*H^ IPH;/X,+!$_
MP!]_P.O( "22:F@7QB/J_E.L9@[!9RD-P7-GY9"=."T;"F43V;' -.K5D4->
M0EI,)-;\*I.(_ '#U.K7=9_+@!M&2J!@ L3/&&]YS$T6(]5@ &RT9&=#1& S
M\7"O;T4FG$&:^(&-GZSK<$K:#I&&Y]#[9T& JF&GN7DRM>J2?_=QW,@ 'CL6
M7MF.>Q[KW@.>'-=&7N:F,3?4RB+%H(()'L"4$Y]7H3R $KZH*D,8<:Z3^TWI
M.M"0E9S'CH+B]@SP-*:"ADE !*1:FFF2\$K^'P;\5KXB$=B0=$-J6L?N)]=D
M>E#'WWOLBY$*F<DA @?[CII7S=-6]U_9(<1"JR?QR/U-L?L*]68%PM,=4[%I
M7$["FENSBJ_P"7)96P6Q!-I9:E]=9B$""R_RH>PHSCTYS&K6@0S6I/_5'\+Y
M#T@Z&!M5.0PM&P+!.>-D;E07<]DE6C8)(OVN,-:$'\LVSY0<:"BR/\RE&B;B
MS;%Y+TAH[.)S0W1AFCZJQH,.418H=@3KQ_BI[/_+N8VZ;R(J].H9DC]&DS_U
M"Y[I <$=&0W4/ REL1\5MKY#+V('Y03F$(2C$:+;Y]QH #Z3\J@V"KZ*$9>!
M\4N)F@8:O^T05B-.!A:@'M\O0/N9;%;-+<GQD?^Y_'AE& /#?CXJ>1C#S[C)
M4:F/!78.K9X-M1Y#4V,9MF*!K?K0IX):.U!C4XN[5+=S9Z;TL)*$36]T:EBU
MB!?-E8#;A>+#U)2)NNEYLC6$-95 \5@T=73"L0\CY+A5H)@RV<^I-'5L_,6M
M3)DL]SI[^DS\=."#BMJ^_!J)*6\]-T@-;#F3P/)4SB/K,IR45GX.92K&&7];
M)7U,TH1N.$6F^GI(,X!P8G"3,P54]76*KF.^?<G+R>SQ<'O<\JK09,")^+!3
M<&$(J46< Z<=9EBU>@?7*NQL991T:9X4A#:6!]:4ILF='W$H&KNG1-B_&.29
M/[P%4P3^->5/X[G U?$.Z06M:7I1!-@H#>;"^-^>H]NA*,M&=?M@LV.(/C$Z
M3TF0<.5$V2@[K @VE;$W++4/3M%"V7'_P#ZSL9P [&2N&]T;,7T?1A%B!<_U
M4ID5[@-!W7C(=L)W4KP;\-<S89T &5@9FBOF(VK\AY2';[9#]96!3X0L_N<_
MX]$AEQKAZ"N']15Y@P#+DCI!^W*WB!/OL8,O]RK#]D1TCU4O^#0_Y^$4@Q(
M<K#2A$@;ZM8ZZR#[UT>+?>).>YY3$H3=3F]K\'ZK^UZ)0Z5_)%%F#XAN$DJ+
MA#-[>+ (GNK601YA#R3=XK(J8N;B+\@3?H<]A<R'MDB7A)EJ?4D_D@AA61(
M89=5*XKHD#"Y0FKMK=Q:V%3+QWFROPP%-_J)$DLHR2O6;(=J'$[@FT4<B%1U
MRV9 (/C@>U)UB[8!GUZT%5;PT-%;P8VA]%G(/$.E5)6*1SGHBDBZT)()-B/4
MO;R!F@1,E?P(,:.72>7#[0UGIF<K%H<_@_W3<6#4+(NI +6VK_HJJOF0 #=3
MPO[O*:P\&7)3\S^$;&H5<7=)W/WR"G T9_$25$,UM*_DKH 2P*ZJ:@OIF]0?
MW-YUNFSDU)8+C78XT#A72 HT?$"(\B@*I4&3I,X<0:)IY<GKT$+K"\_&#W!)
M%:>O9^GSGW/@W0K"+[WO5+POVW:A^*4;"5\^0/?'2D@;.C/F!9^Z'U=8;E.Y
ML3!H+$+Z^_PB'?5LG%3]>68HW&Q8!AX$GRVZ!&X>HU%SI\*:$]#^61:BP:D4
M=C)B+XOV&ZOS5/UU*P5,MK[MXANZDO,1W6K0,[_<E8;,M#BA.Q%0I]4W;OF+
MCK[@D*$-_S/(8'D.\X/U<,+6FAA9G@5MBE^=G9@)^5%&DW]( SSEEN(LO*60
M%*5OPQ4*/=*FV2WVV(@SYH,A0M"Q0*:)D)BFF;$1JNXEEO..=UCP(@*!=PC'
M&IUD%=U/1B G27"'V%A:I[7:ZZ;/V8M<5_9[I&YKKZW;LNJVNFW=5OTINEGN
M1NVMEL8\)MG$),$FZ$,(T7Y&J#[9YKL<WP/9C?9**O(BC:7W8##3P]=R2[FE
MWKVSP[7.VSH1-E"$O"G*)*@<,>+C3%$&7Z.RVX=)A.]C?'N4(31_C/8EN^_8
M*Z:\9K*756E V<>V*HBKJ$U>!4#@"W(\ C6&QH[_F)"YC\XO7@9ZW8 TA^&$
M&O#*BC3IQ"*K1\Y#^&E,^ PC1J!QK#(4SZ1;2)?C! UQ\UF-AD<!068MZ[.\
M(^3A3G$;R!4YOZ-D,\U,QY'3P6F)3 @VKNB9'?=2K=AXL*FT7%KU&J"3YJR2
M\&R(OO+51__%Y10/ZDY8[CC(SDICYM$*R)J15$/)<GKE 3^ 5E+F:8AOV]#Q
M--QXX4>>&XD;_+_<_^K)26AH0<P%3,.AG ;:4O(VJDE1>>9 'H5!"!LN,@D$
M8M.>V6]9A%]RO7+!$5AC;.6J/LFRD[;9;'2W.H@E<D?>UE(J VV1K%::DZS4
M=)M%Y&"J  3$ '[6!*3\EN:Q87(G8E\:OQ;SV*_B!8%LW+)W&1M$:X<RYE>2
MOU6+<9=.VP8^"N?YVBUB\MCB4-1T>NX!BL"PX]-1&1O2XTI.![SAXML3/^1P
M39BOJXG;+!7&!@%<+ZL:^DE)1JZ/C!+10"PA;Z0F+C,@=X4M Q.5K#/5;X*(
M&<+P* OAKT4\\N^2E 2('I,&<N:-CERW?N<,H25S?CAPC8(7)M7:&G7B&; 1
MG"7J-DVD";,2"8')D\$@BVI(1S ILOO; I>VG,>*HA5!,K69SAF*>&<D.86R
M*H9!>4KVDI+1Z$M(<XHI*5BZ<1((5KU&?>ZX,KZ (2 /V22)R;=.(2'IQ-!?
MN;]-D 51^*>(1A4D]_$-)K[C8V'J"C2NE0JL2L@CU]^B?+T9%G'.:3)N>3*9
M-9TAXV;E9D;DV.%A(HPXW(59*/5>N7-@U?DJYS0^B8J(QG&DVU*I937]=);G
MR>>BF+OY/+$F>J0?3QUIFDC 5CAW=#B396W0BL84;L+S14[B,[>3ZX*0>]7@
M,<^99TQP_-(""G>8PDM$TFJ VE [:@"D#PIAT96O.F\WME-^691X"B#48(:R
MX">CG8F."21!B\/3"9SI6!*+P,N+T3V.)I_%,Z%[;29IVLR @BW2S+_E>ZEZ
MB.A:SH"<WN/PYC9W%^3#@7A$783$CM8U7H_R4HMEN1.2M2BXJ?W+]!,O@C5@
M3I>3C+--X ]@=6V*C&S(2CX7:5: J'.DD^P\A@LK:-1?18X7IRV,NPHP.T2@
M3OX*42R![JX* L-U^W#)H@OT>\\-BE1%"C\E''>_8E+^%6AW^_>)^YF#A17C
MRB\[_&48[!_G%U?JTAS )7VH\SE-<E2"="M4_A#<$+"(9?"G#+!SQ%+C^<*?
M59U(B!85$+C'@4Q0"Q@>QM9!GCN)1' C/$? #78\P+_<3B=X!Q_*2T,&EE;D
MIQ'>I;.)!+^CB/I"MB5.I4<8*%PE#RE/@I!I72YB"S-?,V2P9$#_GL*A8"E2
M;)2\-O2A<#P6 ?(5S,:DKN/"3\ .PG^'L2[;4:40\X,].LR.\ZGT:[ R0^F&
M@KG>^YAYKJQ&/.M"';6L*I);HUQG JB<HL,CNL"AH"J=')M6'@:Y8AZ8A#0V
MCF=O"%F[TN!D0OM21$*FR.SM[;A7"J7=5N;L OQV$>]8(IZ65)+P3ZI9D>X6
M%LHE>>RR/$Y]M.E'!;F+;M.DN+FU;\K&MBE)Z%;<UFHEYYP$43(DI:#Z8B=
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M .&D6B9OF;QE\D8X>HT25T4G46CXW=,XN!@V';//4C[,F!CE>B)51=0*@%8
MM +@300 9UJLKN:EFX\C/6&&=6FIR CAO,AOX=;_OQRZP*H-K'_-.14I%1/A
M,WC,@#*:VNYY+?NW[-\8_9^*L6I[8%1Y$E/U:BH!&4BSXZ^*B<1JP8(3ZE;
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M4\&1LFM/DO% PA[-]@'A<1P>AZ,JW!6'>(=:3^M& JH+%C7JL+N6RPP%W:5
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M+)7'!U,14T\5QHR%'YOFE*4OPC;/DM)LP]W9U7F<,HNO^O2R&X5_B2B\39)
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M?XI>%ZW5-5KK_)_GIV<7I\[GRU_/3_[=:JFWU5)<0"WNR"<SC'R\YJ!2\L.
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M_QIH _[/2G:E!]5R1A81Z%I$C!/3(.B-G>EWY!A !956GYB3D1FG1*3SIX@
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MX.KW>O9;/ZC7\$^XF3__ !M3L46I\/_:9JR7'T&\X@X_:5M6/'[[G.VIV4O
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M_*, !,&03TG]HK8$**,L[F*KU*G_G4MQL5"7<Q>(A^=/G@:S7]SR ;QR2@_
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MUBESB3FK2)YKK$=5"(9Y))=DP'PKV9=+\  *90^*\R*G-9S73LO/(W7X:3X
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MN'7 Q@<1P8_-G8*XQ^Z,JEDB-L^B=E,S&;\N(*/-T&<89:1&@?!'EQ/I!02
M]F?G2\?%03LNTP3ZLH:@U42$R>Z@0PF#KR[S<@/:2F$@RP#T2"-BKR3,"*S
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MUCU3GUE:Y6M/M\7*,)%-)K'5#=IS"C\\:(2NU@)]CA;H?F<2MQGY6Y'\@X9
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M7=V$H5..UZ<Z<82@J/W4P'4 P3,H7VB!I@Z+S?3*>?KUQ$^E%+JI@)K,L4Y
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M5 #-4+EXKUM5O+=;57PQK \XZB?-;RF@KYRZ=&Z?\SY(<'5\[K_R&-/D9"J
MU'+2)5F#]IDC_AB?EFQJLTONN@9U/U$X^[0-9YMP]L5)&\Y^ME)&_C&@"!=\
M<;=H;J 6O W>_2_8@,XOA8*L@F>^)Y.7#/P+_L)=\8LN(GCO4*5XNA-ZLHO>
M.7+?UT)2'V,VJO &Z"6,M%YG3(RLNKVT5+A7HA.4M'C]4IA3ZIH-5N\C!8TI
MV,Q]\I:W.[-R!$'C$:E;;03EJD90"58V93)@I >1^6LRXY@0O()(]?0  QET
MC/["280,[S+(-,C:M=?#D_]!BLQCR.0')Y%'!/=<"K!9P/U\@<+#0O4L8W4R
MRW\A18S!H2R<T_%)IXLG]9,K=W <BA&=G_QS+0*H??[X?7,Z5<C+8\[>Q?6$
M0S.-$DC=6?'7>K6P9SSJ_WS1/7NQ4K7I&M6F_@CD91;74=527KQ3*:W_2X^Y
MGH67MUBG[=3LL78-RVZL_C#7GFF-8:NGW'NQFH[J3^SA5]H> &)H/H^7?O%8
M#QWE<;,>\GKGMR5I/^:YM@RR99#/FT&"W:A6U]<@X#5_W=4)U\ZWZJ"7G<[&
M \'"X^2O[E]ZI]U1[V2C%[R;XUAC 4M.[!78<4^RS9W=34L^+?DT@WQ>/CKE
M/,DV7SW -K<77=MJ<AO2/(NT(_+GQ'GJ$ZP7ILC,,AM$_77Y7-:89G/[H'=O
M/7;+%W]#63U;*S'WX #KJT_;G?B]=<%'O@G9*"]M[^+I[Z)]%4VYB?95-.<N
MW/>42=%>Q=-?!=_$_WGJJUA7R?O)[<-Y(,!K-#R6<R?C_E'OY,SKG5YYO?/S
MUP_BPY!!I=[5J^J>J\K@,F:C0E.50>K)XZY?U4W]<LF<UW?\FCH6O7AWY9U=
MGJR][/6=WWJ(=7>ZX<#7KVJWTSU9M9GJ'*_V[\8NO-.+J_;&=KGN53=2L^2>
MUSVIQ$JV/YC'/O'3TVT._#X<^]LDR,2#L.F[B?T]82X:8*G55OG*F]CV9:WQ
MJ'O>R<79)K^KFV_5VM==:]W:*@M;XU4VXUB[WL7915./M;*P%<?Z0&LXZU8D
MR5.=QOG:I]%XW?%N OLM0:@*1GAHYLNY\,Y.FOIR+C=Y.<TZUC/OLIIFT91C
MW83//] :@&%?K;&,1SF/T_7);%^5HT^5+BW-?#:GY]Y9-<^P(>]F+2':5'YT
M[?6JHK<A!WMY6;%4'I\C'75/O<OK-7C2ZX=>2&\-,GM].#K2WU%%XE9VNK:@
MF8_HJ'?MG6SSBAZ<9$[/UGA!KQO*FX[.SKSSD\H&&G"L%]?7FQSK0^E*(!0O
MFV*_'9VN8<#M@CL]J;HD^X<0OM615)GNR/-X,I6IH4*]XNW=&UVIJ?KG)B?Z
M4-Z;AG"A7C68<,ANI(\&:6^6Q-RMJYEOYZA[WD1!O@;=-E4[ZGGGO<N&<J2S
M!K"DHYYW<;7&.AZ:QKI5-^K!N9%^%QGA]3[H2ZD$:=>TS+J7S;3,UG$I/"SO
MV>I$S[K>=2-/].*\$499S[M:1PEY)*-L'0988CYOJ(*?,'<.JB.%!2CS1QZ*
M8P4J8X/@J*RO\U<OWM7@!]'R*QEZ]NSVY(AE(_^O#693F)P.^8$@$RQ<A'4O
MP B>]:>IE1E+X1I 0EG4>$^JDCL\>?'FW>X'W3E:QO_1]%A\DO=:[RX7R,GK
M*3&@=?^7I[*;KFYG-\2;3B2 N*J&T0BNB!6I&[=%.<)(:*!;74Y3!)G;:#UJ
M'81$HR!70#.:JD:MV&,$L650=S( 19'P"9M\ G\EW"*Y%$_U)-EH$6",#?,!
MH]^F_E3U(;, 4Q7#-=SVD%CM'N(VO>U;2;PM#E6#0(;4M3@VKM1J6"EJ*O#R
MJG/NPI0A >':B&0O+SIGZA.-5F7Z+:IN I6.+OA=QZ?6"MA-AI&OL8_(#]F&
MR'W9ZW3-G C#7?CX]/251+K20P2IU?VQV+)0]NL,\U3B.LO6)-E<A+?"D;T+
M3&HCXE(*:FA-4;,4!L5Q1@0>.8/+][GQHH3>2@MG$D<P_Y5K!IW&_2"D'Z:%
M7W9="Q1L(@IXV?"S#P*AH]T_!'5?4;\Y6+2KTDZP **!@)K W"CCS/D'37LG
M@VOH-@Z'IV%2LF,E);N;\C:+SQ196[=SL2%K<W#."EM2S>JM-5:YW8GAHS7<
M#JPHC]H0&0;G9UD2]',V>&"Y$[!31>).8"KL^S(2$F1> N^7L/-9G0J)[V+N
MI$A3Z@?GIB*Y#;#A&C6C,1Q4;6?HOO^?&^" K)=E;HB]O)FIZ;9N?/;/A5'M
MR4ZH,9*5*RO7M,ES 9*XO'A5>"279Z_6'D%"4SJ&E.02"H)[R"V.J97&'7(7
MS.4T3VEH99),L)LZOP3L&N*#C.=-\U0[Z[/0=*)LJ-@!Z:GS))U?=)YD*T.?
MEJ#,G:C<U8VEZ.FY90B@W'EY=MWIK2$_EXSM,,/X-&*WP\ON:>=*CS84S$&H
M*0?,/B=AI?Z*XJI@ER"+,>U:X%/5',<K_N:Z:LLX!K@>>W'&>:;2>TN_[1D+
MB9J^9/'@N_3.X)[A%[[4ZT?8GK4/ OP.Z^=:CX>->+#-45GD&T8:5Y*/JQQ5
MM=')_.\B(C\3_"N?XH3<8A'E^G&Q_Y"9 ;LC^@2RC\:C0,-$_)"'0\U"\1"Z
M)1J +5K;0B6G9UV*T8^8K5/+!(+IMS?2<;\IA:74=<^AWD'8[C. )0^Q<8'J
MI><5FD:B4.!=IYF8R1Y]Y%6JGEO'_2W&?\NNIU+;P4\'H$:!L28*#:'>2,1B
M[+1G>A6QTN59AR9[<'IRA ))E#2MB?"'W.$KX6:WTOWV7V<&Z/F_NM20S\/?
M@@D;4H\('-DI*'-:"03)ER?4K4'O\Q#XUEX+0DS*=7Y%]\(G*RFW%85/2U)T
M*Z54Z0UUY)>]Z\Z)X8-%Y]#+LS-+4JPR*YVBQTSAN@O#-@W?/;?&#%99B>KG
MM2*#AK+EK)\ZIIM='Q1J=Q;FJ?*FR8'JC(JJ/.MV+M6P3\AZ%)VNT0?EK.V#
M8O5!Z;9]4!K&J/9:]E'VM\,YEV^.?M'9WZWT>V)#D.Z%L_+?2+FP31,2-@IE
M=G^=L_/DM&@LPE^L:(]L#!_<"HQ9XQ>H0VHP4OU"4,P&4]67M-5EG_H]?U8I
MTQ19E+G47[%?>ONFGYJPOJ*+Q"$7B=W*WFB/)S5^FKLU76G?6P/V1210!ZQS
M9FCU=.W0<Y?[\6)3YIHYUAZ%FPQR\R!T@H &#$P$NU<7AE/=5+'9GW+(4&M
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MO*OH/H1O<CTJ_M.JIZ(WILIQF;BJPX_R1/7CY&D<C3CULMNYT+/-A7I40WY
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MHI$8>&,.U[;S;ZR("-!/C%:-IW]"EILU.EY+$E"(6[K4)*U)OQ9:*E(BPR'
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MU81NI\,[1QL D9O2]9MHM"9 E%OJQ4=F^7=1QQC<T.[Y=9A(6_O"D!\N9@<
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M-+'71F#@1&C7[7.U _#,E"Y:V(Y02E9-VQ4*>+G,C:[*E%X>234LE_+7 :+
MCT><0A8188-T<G:U,3<( BY0O7[5NW!WK"ZYA]@&Q"5N0)ZM,CGB][^-?+&N
MV)R3NB3Q-Y7(Q8R&4\P2?]V5#?BOX!UC+>%$A>5&Z I9&HO7>I)'G-%6,_^.
MJCNZFB)J31*]*\H-K869+HLR+Q<L[-+9)<\G(2-[D=4:"E*R1X[=!96]LH8@
M3$#;-+JAEUE5%A)64>LP!)3T;;X*HV1G/YQ!Z3U[L?\_YYA8*U&W5HHB$8+$
MW#1F'VF1XR473?:,=6Y\4K0GXE<AY, [?N4)V>$.OU*B11U.>FNGR"SLB?[@
M8>X<83W9@:#50$RO573(H!@V7/)M$FUZZNPM7X??V8]?9BT>#>K(Q:Z6J7'-
M/%L705R10YL<(0//1[_II#7]%>/#:5?,RC8675=9)]]ZBX7H\,*#X['P("@\
M^&8L//A=3O0=:'9L.?3$*"59L= 89."(X>T=AT]%F%1Z=WB@F/S($VMV>/:3
M^&\9$@UTCE9BQ#._YF'LPYZV_E7S7'40E&!#)*#L!$C0(W9\-,+J1<0MO-HK
M>KQ4%[RQL=:IE->3GR8Y':<<X5;L+$%/FYS*"'ASAM!<,*#4O6G&:FH:%-YZ
MYR8H7KZK,OJ6S@14$_L1%'=/P!+I$V$-D^#"V2Y:SO+AZ'$98F #>7.QWS@/
M+(NNT1?!I XR7SRD_,XJ]5LZ$R #BC3?_BL4I_.LJIL@&OY;P#.KKDNB_*3P
MG*95Z3P;']](=ET-)SX"1T,#/0P5+Q816K!8=,'4,>5UL-H6N2"<IRM8CI*H
MQT$L^,!Y3JF.I$W]B[C7"[Z?2[ ?\1$F4M/8L;HM7'+$5'(<S C)$[K#(+U"
M#TK)B0+KJ,22&(G0I%D>KNQN3B+UY :6 Z$R%GF <1W0A,BY(1V#;C!X%PMW
MR6.3-N3[)BN0+4OQ@7E1>%*/CO[,KAP<@>TZU<1&N)U!.%&@#.("\Q+N+7'T
M^RVQ?(?]1@XX^47[+6 YWENO,-<2?<+[':/+CG!B9Y!4_52BAUU7]R//%&18
M2J,&(@8#<>XZ5V9P*DRXE]F92:=+X$U^U'"8_93^B2-W;:U$O 7+X1D29.5:
M61LU1NN<)]J1F<D5;9*Y#3-10*$6DAI*0)C-(]S6&<Y"P.KU;1#<K8,<?)T$
ML5RYIN*#!EZ<YPI6%E_V'7%+HD55;FCM*\>F*.$1#8Q^YYU%]0U]%T'.P^'K
M=*TVTI7INPZKB%\6>;Q?VYUE9P\X7-N895WM8"CD9])7,@01"OME']R6&#,3
M9>Z'T[L(%K*64AEC &5IEEDU.P!V81MA2&E6ISFS,VE8)UCX)";I";YC/CSX
M:2'$I_&^:.U^S[YUVE@TU5.?;@3=#$_%$<E%2JP?A)GGP8E/.OR.6=&9,S2Z
M]!WQN [+76?#26"_L_&), /,"Y_I7IGW*7#8290"#JPBEND0ZBN!(F7!,MYT
M-S]NFTR:308]#\)/=6^.@+CN[=S!^]%.6R\RH4MZ_3E]/2=]S![GCA00F(OF
M9A@F>LD\M3WF??>;B7!KB_3 N/$]A- F<DH"[OZ3H&?F/;L6]Z7)Y4G06NR>
M7;/[S#_H0F.CK76C9D*VEL/+[FHVG(X]MD;/;NY<WN!KH6&/!GF/PF9S."+'
MQX>/W6_\PZ-/2,CX\&7G/'VD<T6 /NRFF]@,Y"+N;AN-XZ]]9]POY;#>4.#2
M]Y,G3XWPOT3G(A[?H)WB",2Z[C-U7D2[S.C@/OOZX5&LE.?A?BGUN:-#UX]:
M1O0DY'.M2M*>!52-C0J(@]!U)T2%H:4S&QBP=C/1TWAID[[WY0.>=-PCP_3C
M,V/9*ND+#H-4A 2]CBN7<=S%-O8IZ126K63G_?@CB?V)C_JI?F&-06MI,B?$
MZ-&),QKV!AEWHAC:UYH5^*\D4.M9-A5L>\0VS&'\C[Q1Z9;L+ASSQ^VO@OAT
MBFV+V[5:4F+^V>^ID4S?TBP9K[V3Z4S%*02_D<L5-F9%\X13&IIT$R-?-6"2
ML@%'I"@Q(ND3HOM(_T8W$G&=#FA/A&9*2\VMW<6;J&H-@Y&OBY6=1,%AL[4'
M- 3R16*!I5V*NU28A:@-PXTZIB;(C 96MB=M[N UULBEH6J&]!J<<QB"H%&&
M=2P+%[F_!/@-3!# #O;GR1ZG75LPF?Z'$!WNB'N@_LX6(Y@;M)G:7\%(.1'A
M6*8U'1[&8Y,,F%?IRAS&;V"#9JR@.[?5+J"! 7L_[K3Q6J:S<*%\%QD![V2T
MOZ+U&8_"B/3((^W=86._MF[!=LTEGX+4#& R53F7NQ]S$DH@)GPKNG5$Z@#L
M'W<23!D&'ZQ]Y-=>_#SZ1":P=7)6?VO3Z388@C7=)<A>S#HPDX\T9!:GCZ^8
M;8MF]SKR@2NQNO86LUF2N%PLKW@XF49S.G([5:L.".:B9L%^:L(S:\*<9R3\
MW70F,G):4N8U[Y.#H@?4./-TE?O2!<LCQ!?Q+X9'P?.SG95?+^D:K]<XXE<U
M6=]-:/.%+8.>R$Q^4035#1V=L EB7+'M^2 L[%^*R7=+9H+DP:+-Q,[@>C';
M%T#+E7(Z4XQ*M(?;NLVNB113UQH2_]S5KRP"*V&'&)KA_U]_5UOBU:SV>+7H
MZN<Y$GP1(:7-W7&H%J&;LK#P<V^?:!SK,/ZY]$,MJ^#)#/YP3I;HU>@3P6OV
M9MS5T_P1N,+)"%<(X J/1[C"S3_1M\2%)9?\![4^T3_ \86/+OEUGRED38..
M@7W B#I@$ BQ(!J"9H2(Y:_29F !="^HU.&_A;UR=Z @D7M[&NHPR<]E8?%+
M;>NP&-O1Q:B(;O;P%?8;VFJZ3+G+ PI9'8"E+U,6*2N.O+MVD4FRBXOM;B:X
M[P'NK?"?'.Y0'[C3 [=6ET;-7KB%871B)7!"S;W:S(.4+',<H-02)C(HU&_P
MM:_[2Y/$'&>P/<T[]:H]RP03?0J?#J9\=QGJ=E*S1FC"=CV(=/0^0Z;J6@&Y
ME O*ML,.9'N]C&3 @,S.<"/(T(Y.$2G9@235#K59U+)KEL%,04@'EO0?$*>T
MFBXUD<?92?5)[6/"@]<%%"'SNP-)BG8A2;8TPW 3JFZ5@6!$4W:OI&[:,\@E
M>)V$.X1-V]T;KG1VB&$^N]PWQ*8=!?4:"3+X0GLGY$&#EIE08BMV>J_^KO_.
M<XFDZUCHEC;8>#VSX5XPMQ"W945S@\"\[GN'I21TB37/@N=*&1O/>!<6$G6[
MVP6)O;MJN=[2F?R#G)BH(X#DQ'2().2B=WD7N3F\E0H^0O+QT^?@V#OMU]7L
MH'__Z&3,A>_YYJ3FWFF^"]MPJPW'O[WZX2(ZG38A2^:S7$ #H_UXW4?K1XO4
MX1A#H&>2W5B=T^2%3?;0W</X%[$B;*8^GH*\3^H18FIMX2C0,6@X>PO4WNY+
M(OL20ZN0*3M(PRUM44[D>%MMR/2]L8 0%@"VI9&'.70J/L5^X4:W,%PX2;-N
M)SDC6C#T3'F#(EMRU3]##LW[M #; )D/A;(8HC]Q@+-!2CU5NMY@+#2+"[D#
M<I8>'CVT5MQ%6DU24K8'K][G9LM7QV>SPNF4,2/Q4AHJ>>.9MIJ<768UBJ@N
MT3RSY$6:MEKQN8(5X)4W[+T%/<(4 *RDTV6+IDU";"1@;IO0R!41<HDTR\[!
M %43/LN +B8]DG(BFP?KW4*N'>*4EP]-^^UDJ.#.:]!R/MI_$&?1KGY2(A\0
M3%=9"7*(#N5LY_$N"!@V9!?$(!AV4L8=B&LB&B_2&M=4/R2=..F3O N*X-H/
M>?>_ARTI,+/SO\3RUN>S"W%9 LPP0I9OV$R0#U=.L:1[G8^/OK;7V0J]D%0)
M<JBX0KIL>>?W#[H4=302 &9!G05U>9'CRR.YV!W*@WOI?2=;2!94XKP_LST4
M3Z7AZ_'C!P\3]I)6\HY[^(**^O##/H$_MXUG&<\*X1<!*,G5XE+_&/@$W P7
M6<<$]"R%1"1H(;KW(U$_[8JU23CI.S-YNM6T7+EV7 "J%?P[(_=.==<D/^U_
M*[60K DVVL!1E -=P4M8HT[@]TH]Y;3MEW"2.=4-B_8VS!$J:M$A_.C>=L9!
MVC]@.V#SN:P=C;E77KHCHHL8&M_=DZAO3PZ''E_)J:JDUU &;06XXCY^6'%P
MHN[!B3_AX,"1SBKZA$0U[JHP_$B6X\&8Y?!9CJ^/QBS';3C1_\9D/GAJ^HZ;
MG4PV^Y\_I?_OZ/C1GYR/^;LF1/YQ<?[SLXN+C_JPMW??;NE,OL^>_*. 56Y;
M3.-]@9:WT<F$G8;*A$4&K+5K+<XEG:;VS\8DUJW5W[2U^PVI+?TE:47[2WXL
MGL#EN@"R'J+UZUU8WS_LI/S.D:A7ER!"-9L_Z,;>RB7_CQ\>O@[6"X[6Y-=R
MM1UR)-P3G7XS-2%5EOL(O(V@V;IKN"U=LCW[C&85R-QI)3:T-/FZ]YMP)#)P
MM@A@IS)+D/9>!@6BO]*-+LQ6JLZY93L/_:OO$&\Z((=D P->IX,/Y)(S,F3;
MEEN#A4 I$/J;)L%[,3Z0K@A3&R^)T$[742'PTU4**!SG8]-\VV13<.84!S/#
M3+X6;03S&&R\KYZ^EF*<(&U3=Y=$G,YLQ<"W2JB*RC5[$@N.T]Q5<_J6SH1;
MS+L#8_N7!*?8GV\^G(A]&BFRWZ3;,$#IT\V>02KIO6N).[?THH6B0Y.(G+YW
M2JMJ)*I:EBO.Q%:7J4;9_./" SN=MK0>T[#(4]J ">J4+Q\W!JN #Q=_>]46
M[@0+P+-Q2+\ZB82C+GQ>SE4^4B?GK@VMP=Q&1/&0]%(YWL=C?J-F@F,>'&K:
MOCC4"5*F3'^N/>>C$VO;A/]FZR))5K9T77QX.U B#,TN9ZD'>RZW) 5G_MQ&
M-L;N3[+&,03N/9Z;:[3<SJR B"X$H;\=;;AKAF>7*,V@.U>4FT387$B4LS4D
MM>HAV]LB8W8(9Q1)Z-.D*[G@%KV/Q@TLUUV94!,WV[4 LM3NDM?&8#I$LJ_6
M^QQ9 $#&O/PU-_E08\GF%!E45:X8O0+S)VV6L5;":+^.O&PZ\=3QSM^HF;PU
MD3U6JY+.#*N+VI+W:5F^4PX:#*=W3W.35ODV,"XT4QM8Z9(-#BUF"="OE]N:
M:V_0< QI@&=.645EM:!C\J\.Y$5J;C@%& PQ6PDTYM*WJ:M;[LD,OL.@$@>%
M>5GM.GI %]$7IG8T',] (@8OD*L0Y?2'>IJNZ=Z]LKC( @&/.5['50/,[&&7
M#C&/0.-V)V'OBF46\9,(;J=<LSX#,@*R+N.)CI?G9LTDN#SB;V9(BF6_M8 :
M6G]2P%H:-;,4=0)GI).Y:S)9^A?;/X/=RA[/TA6L!1Y^%))AXW3ALL)1KX-T
MUJ3-&-_ .7!-&N+"\,6L2JX;O12++3B$K'_0)^V=V>[<Z![W)CRR'3>F:TMR
MKQ_M1<F10L!E PJ_W0B")?2P.#?_8+M:=>GE#QN? 7P.4@M,\/$\K>FF)K:)
M,DA1TB8]F%7TCL(EX!P#SSR7]$>G69J@-('=\(M&ZG:\GS=J)F_DCD3P\FT9
MZM1FO_FBL137"(Y>3[&Z0D='D5;^N#E(DMQZYUP5$.>H38XWRS+>EBT4&#B"
MR>Z*W#^Y,PH=+?J%6EH M)- 6(S'YR84X[S$P1A]H6OVA>1J^3MG0W,2U;Y(
MTPLK>7>#V!WK*_&V7Y_UQ8:;<Z&T=)\-W^ AA]&YHV*30E0)M@4V9KTEG;+B
MN/'9RXO[4$0^T C-([4:^.H\6[16)ZGAVK'\:M,T3&8 ;5F4*T8*<O<0-$AV
MO4%'67&C9H*8&S"&RC9!Q[*UODO=*/$>JF_X[[9?[-Q(7?[&,-,)6N$%'<Y=
MCT$T**>S2@>C76N-#DXL0*HT/EM+Q R/Z6K==MJ[S+)%)D4RJW3M>L.&9U"K
MQA9Y.4ES+3]8R "8(&(\:->HE-XXUSL:,ZTWX!Q]*-/:=59Z\ZY6B27LEC'0
MW>=-*Z;(<4Y4#)Y(X70E_:#7TP4OP/))#A-K0.:T5<5V(.R^*UH"E,DUI9BS
M,VZ 0BK2%;R%Y#>@95(Z3!90O6,/?#KOA3)S(PAJZAKOKHR)5!5V-. ,($A>
MM$88;1AG7S>6,05\PVMN"!HTD-J)>7()JM1%T5O!]SCE)^ G%  N32J5C2:M
MM]'*MP&_JP+L(YC&AR.F,< T'H^8QIM_HF_I3."N[')C!3%SKR64S;F_ =6W
M=V$I^C:UD<ZO9..N4=E1+/[G3T=_XG\C_F__/7BVFVS6+/'1HS]_JN!HJN&O
M(<W2(%EA5Y)>\5VLLG-:YCE9U31[^].?GM!\9\/?TKM7.D/=I;\^^4\]^7?=
M_\=???W8'X!F]KN-^O?VUN(!_X6&'@+HC9!$<A2"XXC:<V8^/R"SZ* FZV[N
MPA,,G!-7SG*E<2Z+#"K2E8/&(1:5#4MT5OFO387_A[OVF>*C]Z1\VL4:Y<<H
M/[XD^?&2W)!LG9M!E[?E7@MSDR(T1#\%)@(GWQ33*DS:>1ZOVSP7]KV2G2PK
MA!(0N:8:SH3E7 V4(LMV,LJ.47:,LN-:9,<OW)-UF/W1KL&[PG#U1<FPKV*)
MT(94LTI7$1?O8 'B6Q$@!%34K0H5&Y-Q,)]!XQ#;1]KNV#8GW2S^*%A&P3(*
MEFL1+*?YYS@3@2C@D*RV@P3'R31O.90]S<L6OY7F@,+?IBUIX-DP^\'6-I&R
MO-&C(!@%P2@(KD40/$NGR\^3!"#@2!E#JQB[K(K1AOYJQ$- U,2U<BU:_C5:
M6I1\AG'![@X3;ZJ[,PJ249",@N1:! D2&T-N</;J(L17H75J*KW%0L^!>Q"E
MW/"33@V3W5QLLGD3<X<4Y)['*S]>^?'*WXHK?UK,JC*;_>_GW7OW[?'JCU=_
MO/K7>_65QW [Z/XS'!7MD9G=;\I=CYN2=M[Q5;-[$(B 9_^(GVOSXZ?XXFOZ
M@E9%26C4U@<-RVEPX^(B/K]X%9]\?71TS-2%CN1@%"NC6!G%RO6$)97-=6"2
MTL45N=(X52XQ 5!=7+SXZYL7%_'QX0E'(Y^7Y8*./0I&GJ%:TB3QZ;.+DT=?
MQ9.LB4_!(#HU,_K;M-HRM>E@$:=O..-(Z-_--KYHRI"_XFY+E1L/,/]^\N2U
MH&VD[/-"X38C5OX:L8  67T0!2^P>5L-<Y#6!^F!K7E!)17@5?>[7&7,@>M*
MO798R@*HI?(@,7H^FEL^?I B&=]'4$M\N=0Y*SIM6)K2/D(:W'#K7*C6'?X;
M7U>=5F7KV6[RN]O]<C0Q1A/CAID8)/Z_SYZ\=3P(0[3[,W>AA4IT\L2Q"4"X
M?%B *0RC#D@0/&_'D%%,MLH%SB0D._0A3(6P+/.,%FZ:N(*_@W3#]>0V>W,P
M(3,)W.!N,.EZ/6@4PMBS$B')Q? FH*9 IP80N=K)"[-$=[!*:([6QI4T3V?.
MV"&#$.:)XC*KRF*E78VZ);H.0R=4[&G]+:T.N.^44H^I]"9E^8Y9ZY3%SK/5
M#1L-NZUM1;)G>X#_C6=99;2(BD' 7&&9@G%FG5A*_8,-%J$PFQK%FZ#G9RUR
M@.B8?F30*.2=Z$#"5$HYF<0+[OA7A-0A:#+ ?0B2L*@4"\$BN^0*JU8^LD/F
M5A\.&@]NQC3/6(=:HWQ.PE][& H-%1T4IJABEA_M*"_:=;I,:0KHD!>R@WBN
MCD%CD9<QK0EWJ._3U7670%1Z9+_1K\Y+ND'<+A"5N_2K/./&Y8,&P:E26"+T
MC'3ZCO.GM/(,C?+\(++JVH!].F(D1I-A-!FNTV3XB=F7!MWTE\+7VFLL^+90
M]%BTZ5KL:LLK:"H$T3W,9%AFBR4==^[XQ3]S2TYE6%.Z/IJP!W<H[W*M *X#
MRS98F56I30*7P]=#^6N5,5KIK-RLF8!9.1%$LM(NK8">/Q *+#>Z4%@KM]6@
M<0 A'UH-VJI%JHHQXY5B]MV()7;-;F(VST@!N*ZLM(@+4\Q27JIA42LT^.7>
M63))U%T+[I^9%VSY#HM#[X:R<F+6(;<<[@"1^EA4Z8B"&57%J"INF:IX!EKM
MNE=3J)P4XFTG+5T[*#J)RS"C+MSV9+R3G\'?&0;O2]>^OWA =-:80OMREVT-
MQDNAJ7': "VB69%PZ\6.:(:#U^;Y,"]&_=.$Y/2,;M\!_E>70'73X?[BN) >
M6)0 4/:"G#\P7$9?2=0IW725A\(66O @ E8.UKBLNZ2]=\,-N;!G3!,P#/(X
M:RO?()Y;8'. \U+Z8LM*[SJ[72VBB@I:G,1.0R=9VB8.S>.JFRH@[Z9+$"\%
M)E]0OF-40J,2NI%*Z*6T8AATLR]L3XM>1=3M\?")[@I)A-DP51CV%! 5M"()
M_MZ^GD-$M7(:F07"0#08QT_$ !,VZ!>FI,\V69J#$V\Z;:NA;I.?L.A"=KQ0
MN&+09S(&PQ;K0?U<X%*@@VYWM;+:CC>G9PUS%$3/X"F[\5SM>\5T3871UH]P
M6&P;+.3&SLLW]VEP$%1T6$EV-):[>L@H0F6&=L!&2 H"'D3KD+@>#VLR$.@\
M<//.2Y,C:.=;J>P>HX&#4?JIG2U">5(B<V7>!*O^X5?9Z+CZ7;4L%[ZIT6J-
MO@T[(K*MTF>S9.X&(_1\-M;;;#)NFY'N<)G;("A0CN+QT?5GZF\S&VRGZ+.Z
MC5XL+,*'_9E/MJS>=7UHA("9 *Q*I^]LQY8O2(=_A!SKT4B.%9!CG8SD6+?@
M2(]FZ6B6WDRS]-2V)QNDWYZF]7)2IM6LUS"MR@D3)@-Q=S#A4F/7!8T,0OUJ
MC3XXYDH[=:!E6&>+9:.-");EAGWJV'#?\'VZ%NG'8$DU [9.G]),P())OQGF
MBKM&!=[^]3T)RK@MR&!\%]<IDJMPV;4/00\$ :8!>KFOD =09-7 3.];YK5J
MJV#Q/0_-ACDE:*'80.=V0<XZJTU1E]J6D?]<TU-@7-XCV[*:'8#N9MBZZ!,3
M+2[9,S;]N^ZS+6G0#K+E)(@V(Q*4.7D9OT_2^0LQI4:],^J=FZEW7A4'3]EE
M'71W7_<T>NU50?V]8<-6B>A^Q2VRWA7E9B"JO+:._H3\D'A6-J[WM;CU)&C+
MC:G0F\=%"$0/LN,K!,Y93BJP72/3ZMWO87E3FZ$ED;FC2VN'\2'IC>PM=-$F
MY:9R%NCE855P.#.E")$ PK#UH(M:T$+<"[2GID>@BN<Y1V.:Z>%]21*X2-4L
MJ^GC6PR2%J83J)BBH]B003@N?8:1M1;BQ?&5];)$80'_O$F;Z9*U*[-@GY=O
M2!>F%<M)/3+6^Q<%,VP86+ZR;7RGSL(T7XJRN?$ ?5]K$/U2IC.Z<[S7SP)&
MKK'LX)K+#H+NE^DL73.&U'<M0[@NE:(@(5#3>&<I\7"A-<M(^E496P[X-OZ6
ME\7B@&[CRC8:Y(V7=E*'\2DDD##4)_AXY-%  6W*2KO -%G12F<7QKMZDC;I
M.M8@#YMFW(A:>=RD09LANUG"DK^UV?0=HN \0?P5[3HJ1#X*6JRP25L43+"'
ME=;K@%2SC)TNYQ-#:HX$VF6:Y1 X"(.'O>RTLA,]2<M4.FIQ-:8@8- LT45A
M*[TP,PD=KS3!"Y3S,ILN'9944YAX>V50,RXT=N_IC##($X*18\[S.&T7>(R9
ML;>&38=./_U%>K<_>!J[]M58%9=>@,&_L;Z-H]X,NX %7<$M>:^> WI@(BTC
M_>\8?*R88Z^;I,,0U!?WG'-!6+^KUK6+R./CG,?63JX*NLPQ*OQ*BZ3K )7:
MF,%W:Z"QT5&>&'3<H\&,E2FCGS+Z*7^DGQ)X'(/LP/.B*"_%('T-7P W>!N_
M3*<DS$W\@B1KT0=%?2L4H%Y<0G2HN%S)EX=9Q?HB%B^%:9'N)(L4BHOEG^N$
M&<@DR<U.MTG("2AF->0FQV/*H2SLX?.9\Y0E.S)]AF:GP[ J/<_Q&X3FKI:<
MWI<;RN0\"YT@+N[@G*7UY79[TKE6.(?QCZX:L>%AAU2NP]!#00/B0+/7<)C:
M',(^9H$()<2N&8H<?971&F42W.PU$9UDT^D#6=LR5Q"3>D]5%5QJM2"G+<4I
M<@%)49L(6LJ627_D95K--D-Y:;55JW;H PT5WJ3L,H'[1C<5OIJ+)"K7G<^
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M>6EMV]'NN%[@@W(F=,.M78_()E_D;Y590Y44C21Y$^9O2K4E!LDX5N1B3L2
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MO1%/E$LO[GQJD2;1IJSR&9JFB_PQ[^F< TU#)[:JS"4Y)Q.@U:MRF^:@%:S
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M/Q<T&7CN[P^3J47\M[1HT\IZWNQX'XWB;11OHWB[=>*-&=,8"H0&BYR,U6S
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MF_W/G]+_=W3\U9^<A?Y[N@,O3W\^??[LY;.?WXP^P+6=M>_^](346>1QY)Q
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M\,(:H63]S\!+3E[].B?;(;Y'Y_-IMF"B6%!0MH5MJ*(WXR5-I%Z&CX58 'L
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M0T(&.T]"ONC2T,E6EX<2#> B(E)]DRGW7*:2T3,/,\SA+VS5'N$B(^"_^<W
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M,$A0]9P44$FF-9.2'8G(+]4"E:ET0"V26 :<C$98J!*K=.:.%/CT;QC?G_I
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M$ 6/%?-A5RJ4MB8L.95.V%P[+9KRA99X>:B!$^JM2,OR9A<>QN&GR\HU-%0
MWHOE'(-^U76G; &/4#@?)R<%T\("F(;0CE5DS+"33W:';;-\@J>B'<4?C,_P
M(L!NLYU\LF.8=YZ2+HA]UY PS*6D&+:9#":E)(%^S]96*=R3W,28@(0>"-W>
M#6\TLI<%4D2B+/,(!0C5U05&5SX(B](UHTQ!TRW^9(@AL<W2:S<>\DI@Y5&6
M /_.5Y-DHW\!Y21M.%^^>L +7!1+<'-*+0;6#DR6&:1JJE@[WTB.O;FTQ#4?
M1*>)#^P$9C>BVUO0!0$ 5:6Z(-B8H04.3<!",@[_#MP^',-Q(;Z.P?@V\$ "
M.T=*B9&%EQRV:'KTH>2!GGKBTWDKH.(FW)QU2E15*:+O^*=<1[]"D0/8=IBA
M$[\8TF@Z(>6!C2HT@'1R*_3 AHPW3=52%&B</254,"0U? "K@">0$@_,CU5K
MF8QCG[Y;IUM7C:FV6ET&PE:2A#"Z-(L1S]>"NB:\;M"%UUGA=6==>%T77F<D
MIK>H50?(>,5YT1@P//_#=3Y^?-M)3CM' HT&)CS#N143<\O)@T7K#UM1Z+R;
M3/KY PV6?8T8R*[>R0"#\:0(_+F/7"?P@>R0WK\'S^WG39@IGOZ3!Z*,<Q[X
M+(:-LSC&^1L\P,3;M.QCY2JX-7F9,!FI>T(IPV@9\),H7N;A]:CX?0>]&51#
M96F*0GF0 JA-U@)93%YQ&@''_&M83*54TA>2P*L(OULA!HBMQ( ZF-_"K/"J
M41@0ST@8>(JDJ3GT\8+;CG8$>*?03IO6)_):!M&"-(TUC6.UAG/#?0!))<3[
M2-EM]O.HQZ Q4[K<]9WU#=B>:BB*.RV\(8@JC[0I/"(E$Y:1&'_G&*0W;6RU
M-4_*HZ*%!>@F '6-XK,I$PFSJSSLT3J/8#!4O7 TH#K<01%$,7\"!(][W1*5
MIUPLH:*Q U"\#\B2GV1CH+ZM[:O^%"\BD)MWBJT6J$U'978*VW20#>85"C9R
MX!TL"7@7>$U1P'E$0;T]%^T><IFMX_/)WR!O@B7Y:H"B _5$)U]T@^0]R4:)
M/_%5FK"5F8M$'&EVWI";!J#OWZ. OXC]1)4T,CY1JP_N#(,BX;'0"T0LH_C*
M"_W_59[:<V[G[6HO*?(+91!;X65UR=!EA/,2QU,828;#*^!TNI&NVI*.^Q'F
M2=<* F>Q>H1O8 PX"N)*-Z'W!J_A4FC8:.1'W->MLYU+T$4"+PZ6G)R\ 8S%
MEGLO7D$3QK0).$@\WP@FAX!3<KNMM^'"M.?J,_W6*&:?5T>F=VTG: KSDEE)
M'/*[4]JIG?P#W4>B1#'9@:_=]@TT&$-4*)!3.7=4@04N84&!,>9%]$'!MGQT
M7E', )>B>3EDN]!"<IBE4 S8[OL>8X&&F&IE*/\.T^JJ)\_9,XY%?N0W?$0;
MVESG9?^X,!NQ>S6/E@B\;.*GPNB+SA@++>*KO;6OUFN<9H23Y@'4SFAN2U<5
M+X_6OM.DYJ)0^W) OL55KX<1A>XH&8A?[K3*G=K))^LFBCGE6UNN90O1<U$H
MEOY\E,4)AR\Y\CNB"%EKR3H\J:N]@O*JQHX. W9J)\!'.9BBXZ0[O1,=!6)5
MN-J>GRK.6?]\ QO-(U?QM3P/316D8F\*/+_0%92R!7X<E&L[:7)BAWT40FR(
M2ZG0FEH:U%&.G=H):TM_1<^:^#V*L<1'IRKMXDX^9[%@@9;B:WV,)U=UVO35
MKG. <"!8VD!>E'.U6AP@Q8 K/81'U612$!%3YUL8W83"!/M/),QH!.]_99,K
M[=&EH@.Y+(+>"5X^AN+3&^@K'DN5L96!^$$$ ]>JO,BM]5ZLB9P:=I%3>>34
M6:^+G-I]C'Z*+BM@?1\Q?H;=N4"0/IHH&J1)'V#6>0ABTMAX<=\9.P(^H.)E
MNMI(NX6=V.RCFNGLQ2FGOU2RJLC=3X%4Q+/R4*IB*DK%W9 0:YUX<[C.B9W"
M*Y,4%.H4MB<6F/B4JMJG.FK+@?\=4O01T;(4/2:K)R)6BQP8D]L XZ*0<M1P
MJ8$);=(I,XK?VZ'ZPEXI.6= G,\"XM,H/F!QWQA+V :JXC=^H^IY8+E4A)Q*
M].'7]=+0?07[37YI ^+478&N <EVXD!#KY GT87D/__C[.3TK*G9Y0^M^BZ7
MF6[9S @+56=SI>$CK<OI"ID#QV3;A=M^%443) (IEHNG/#_.(.7T65\56U Y
MK]>^O-FNPT64.\2!0AH#I0Z7Q.7-@+B,I R!/(TR))M4RON9M(WH2$U':G:,
MU/C;=?=AD\&U5'0&;[>F-4:HJ9<U,.0[]5.J*N\YJ+QQ74,60+9:! HK4W^2
MC2G89))1DZ&"T,)E_M&9H2;RP^LHN.9H?8P>1_'*F?L)UI'),!AS&GO9ENV6
M,- =;25(6Z_]*# Z! I_SX2B/4TQ<)7^$$OJ4E"HJ(<X["M=D35'71[!>-72
MR*U7$)R"@N M%@'04&0#@"6NL&.]8,%Y:66<XPHKNK+Y3B\$L^Q9O<F1/=%I
MK924J4;0W\&C64Q+59[Z:H9'6@.-24$-SI>%-8]P1+S$5[B.U-*F*/=CS%69
M4N^;#%5U!]_H%NJBUH]^*+"80="D*^D# OI#B1D)];")91I''J?G<@J*4=2H
MZ2QI-_!**M7"J! )QFTG.H"OH ["F"+WM)BH!D7K4L K4\\03OD*S9QCSK;A
MPA"X)D4 (Z OB7*ZX%<J"98""N$K:]K88)>R1+35*OI$=_(A%"BO<8ABI7@&
MF4<Y#2R1"P_S@LKGF:>$)94*'&ON'-W_Q*JFEKBB+OM>T:UFLE4@-<5KC1=7
M]^W3%,U55=LHH0WX21S*I:$JF+3E"NT+@&>QF L/FL@TU6X+JI9C11P@ ;3R
MSN*\IVJH+PZQ4+JQ8REY<K@P%#>:::>#'1B$->C#<DV1&I#FD]'?9$4A^(US
MFXK, WYMXJCL,;H:C-571E&%TJP"CP(80'>)=VHG?THL?>W+:[HCB;0-A*H*
M41/+(>^8Q&0;%#CS'!X[<R=/4F1T6<7HV@#.[7U>1YW/R_)Y]3N?U^YC].UW
MLA)EZG!-[\2?_.6%]S^]_JL7QN-TE^ZPM^^_?#W_\$E\>?_Q_.N'SY\N__;A
MXM(Y__3.H6_>OW,NSK]\_6_GZY?S3Y?G;^F1!_)^[>Q9[HKLJ16;0A"(9[5P
M8=FRR'1J^O;D>4!<-4@%3.=E B@93HMI=KBA"J.FX!#UUA]>Z%W9Q0Q,<FPL
MK_Q$5R-4RE@^M0P2>4-%D(CYLF$)2U:EF:HEE:=947:7710 :_YZXYF T6%E
M+#4FV,O(^2\OS(!)J_)65-VJQU9M+M+(A1&")<ZVB#!,Q1X#ED)B7^?LZBS0
MG07Z82S0-]OYNJ@\ 'F0(A;,J6HET =LJ>./?5A6^OJ96%^[V]S=YAV[S=NZ
MKE5%9>.?D=_1[D,V&C:NT6?G99_CU#MO<7>[N]O]:+<;O2/;W&X5%6YYN&K4
M$;CJW.R#JM7JTK/PZCPB>S:L_?@G/=386_BI%VRU"I7"HLR^IE2IPU!0(>PP
M 3VBC+V8#Z,=1+,H2R2NB_0KEXW'4[8B;N<]MZK[[&GS/6POE:$7LJM*Q^\G
M^RZ(.A-#!TGLT<9SY3'BOW5D_Y8KX1B=SD^]RQH<U381&#)%SEM?N5C(.3+)
MT$EM%[":^Z$_A[?AX92[!%#+ 'B10['TF1N/RC2.YH3,$^EA@:K$\5.JZ$_(
M1K8$<K/"10WPPB2D]V,*F2X%B%E@BY@ND[4H74#%:I2C/*.QQ)2Q>.T**;@$
M5R*_^_"1%DJ^5[2 P/\/Q246MYYR)X=BV4):<C&)&CW#:,AWZS*L*22-[17)
M NM=*Z\LI=9A#!S\+Z#"OZII9VXO:*TE?_<-?%C8SW0U$';#G$(WW,YP^4"'
ML4L=3)_D>=Q_=F'7K[3K5]KU*]V5Z_B$"?TN="=]DD?Q1&E\UXNTZT7:]2+=
M"0IR]\1\)SJ//LFS>+!BZ!M1[*[/:-=GM.LS*G>SSVB!)HR\\;>K& YX@HZP
M*/X%9TTE2F_WWHU45+N1YOUIBNU(G0=H1RK6MB-U'J =J2VMKFY'^O1YRO9A
MV\==V+85MCWHPK;O!*/OO\E;RUNZ=2)SW4ZZ!FY= [>N@=M3-DF\Y3Q4\45R
M085DYB_8SO9%N>$OR W_U7+#.ZJ)!XNV'0%^H,/RW^2N=I;D%1EZH*K43_($
M'BAHB,L;<E'F:"$I*5UGIP>ZOC2I18ML!-J_SH,^A+<J9>&1$E_RRV0AX-9+
M2I'$\)D"*[WV8NS0;F6L8RULW?N[,)0.9V*^A$58YO(FBK\1%Z+AC?<@MNB!
M8R.;U6_<7F.>O5[\17!R4\)M]7 --F,)G?=:+_S#0R-H4N0[7[WOU1^8N3!%
MXD2M2\U9+7-Z.8W?\&,=+N4%0:3*!8QD>H,I#@5 %XYT6BDN[B6)1!>%B2!T
MC<BA \<B..DKAJ*S9P!$'!D#N62LZF(:W5@[/MBIXGT_T*%0/!E];4VR3XG1
M"%==M9 -83B\C[N,7,R9)W#1H=G[,^GS28X>%/AESEF;!;G)DZE8$!<XA09=
M%69U>-*Q^IW:"1;FR=/^R%H<(_*J?+]*:$8"V)<0/HXB= K&LN@#XV(12MK$
M@38*:LB+] B[;H?IHS;U [8IR>^J$@V-!)+E.9MTOTB0+KOZ#S^TDSOOGK$1
M"WBD?AHM.;/[B&> 8TLI0%_%-+ 9>N#6M:\A"S_KRKF+Z0\97]E1H6ZN+-OL
MIV(>0"3Y^X=/EUJX$23<U,@O]9BDZ 6Q2>#P:G7 !T/,40SR0EEDY3;ELE:+
M7H?BZ\;SLPMGRB6W:!EJ*A13@ 3&:)*W)0252)D V:6^RQ,V47CCU/J-HLU)
MGE/TV.;.17$EH8!I?0RZ3:93;)-I982G2A7GHBJJ"AL@4MZ0),SWF49BA%T-
M)D3&[8G9%K$9C,@B8!T1AW981)\"T4ORAD=9ZL24[!ZD&TBJQ<:A]7[7M>+W
MBOT(!IT2T0#1 HILL4I'%8_(A[/&)U5] 8R%,6U@"@_:O6"<O+'-H=G91*\'
MD .7B/*D ^OUN*XLRK8:$:(L35)8*''XS::S.\PD<+UC/UWJ/"&V\UE13R?L
MM$$7\40&/AP= 3S2*0DYW*C 'A:CC*)O!_ G@BI+9U&L<3.66%D7KY$ZLDW6
M.Y)D ;, 8@3\\5B[=1MVP[A;L\B9#'1!RWRQ:C4UP]?+U5:Y<&>/X6:2H8*E
MDH_KO/0VMNT[V Y$ X2):R?I[-1.@&L2KJ/.7W.";MVM=>[EU@HKFZ^NKQ1S
M&457F?A:;U"->[X@JG!D[4WG2U.@B#<HG)/!@:SKPFQX-PB""D8H+/G!B82H
M(Q+./1()6G898*(&8#=2=2.RI16R*&@S@I+TE,L"!N/&A<6MYE.1&%>88E$,
M.A4='=LU)0;['>J&EQ6+6Z>F[13*7>"U%.I:%ED-7KT&C8N(O]+.+K-1T8B,
M(ZTRQ1KMRE*N..*[&I)M2INJ\8P5<Z[&;="[K$S/0C74W$X+@RL3J;,(,*3/
MF$6%K5EIFV23KN3"5-)+M:,5"UF%'*1$'3\=="1/3)7* MO0T>Y-@91"[W6,
M5=LIRYP!A-FOK.,H^DWU<V1K4UK71#F==%%.5I33L(MRVGV,?HH\#[CZ5^][
MQ]!W'-O6,O1&QV2%B==[3"V[6L*F1"JN8-G0R,B&@5Q<.=(MEF>H\V@2WU8O
MDEP/,Y<]H'DF%_ZJO94("K;.%JUL6/<"\Q>F I^.99K!<EV=S(#16U38 NM)
M)'9J&#R<%S!/:I1<+7CD8?CP3GMY[Q/=R8=0@%XM8R]@M*^Q<<=2M^BCN+D@
M</YQ>'GH3.6$7TM2$+Y<!P7&@%$*F"-Z&>B\0<%&5S@51F$I35= <5&!]@+"
M6[B)7++$F^#.26C;YQN$\^_Y^]@JF&J9UET!A;;\@LY^!/X[:[S$;JYA4P<3
M4JYIP8+:B95\_(5AE.[]/B^E#]\F1CRE$DM[_FV6;$\C8'JR$)@5HWA/V3%>
M O F$P#>0A5^L$<U9V+E<4$_0S3=!V( &!:22&]" VQBUUW'G=K)IRA%9-%F
M2)':(:=--Q03AT:%2ZHI,=] [I)IJB&I.D!IG(T!!8DPVW&&5"^9?74FI"F#
MBRLZU-GIG6!<25&,2:,K2:R8Z$\AE*A8$QI&I9!AH(03KK/%$29+W66UX,WD
M@MJ7JMD0 W!XS.EBPY-7>][^7G]_[]V^SDM_&TWDH?.A:D%U)I%,B,0E9D97
M6:RG.H!%VQ7H)G@^RA7Q-YDZUZC)YHGP0 C9GJ\F+5!2926U70&CI1'GRLXW
MVSJL<R1A?+I<&%;-);JT>[ -J-.>2_#^6H;"G^;BJVU#FA1OAR)Q?$=<EEIO
MD)L7D-\NG9[[\?UPRPO@5K'?1T\$XI=&KARKG#W-_*WO;,3<+UCWU5+,2O;D
MOF/-C0"A!D(QEYLTS5O&W$[)<XY[/^&O5VBAXSY/7*-N;RX][H0&]^4Z2FD,
MNGG[VE+'O@;+DQ/%);L?YW $2V%5= R65G FC!-'V=6,%Y3D1DTLADGC[[MV
MJ(7'ALB(6B2IT+DZJE:0K9*JZ"-^1Y$IBU%(4X3#QW1/%$VMJ!K\C@ SJ5G$
MZBE<!\_1&LOX%[T 3V3B3P2>,J?R5C!$Q\U4T*- @IN.'=[E<2UW8Z,'3T0W
MH5V,M)=7([6>ZJC=3NWD0L:BDO9_B1:$"-T-"U0';(>"_3.&M%/0#/%[XV?,
M%OBQ[\"" E_5B+4<C&\#+P%-I^AHQ&1TTI_"3%69K7_MO.073_ QYJ^%SE.2
MNB\ZIOMJX["%X3C0A^K07%VAT0&HU9QO';IR?=16[0XCF]P*4ZH;[P-V=DN=
M "AB2N24%J.*V]:L4M2N$JZ9:A*'<0?E:(#*\]7201L>KQ4E)9370]77I3,'
MK3T;_4NKHS-4'N:J.$+1X831:J0KPS=3"0KZ8. .!D<K3Z+&I;ZPC6UUGG6F
MC_L=@=FIG:!.46_<-,&+]2HIG#35\%CFGD835Z),F137J(0(7=\Y0;14G61A
MB"^7?SC_N'0^?KP0->Y+KQ@?@BI M/!#TR!>,TN0-Z2/=?<M2Z0*UF1U!UXL
M^"9K'9!*?1)U@D:'M3NUDV:LU:5,6%K+W<5D#O''9".I#1G2@=*F#7%>0!GU
M"-T+W'S..WVB\$W,,6_\6>D:G@6(G!X(Y2#HD2T'.Y2.U2WP)M>P"PY,,OEE
M]=A+H;7<)"8+O-C5]RN]B:B"3E(*SRW*JK1, PJL0V( Q#E);"@F<BZO$9[U
MEY^L3&BR)4<)-;?BJD[+0C,K#F^@W6.L@Z2PN1%5LJ'[K1P-MD"_5\QX4TS#
M518NJJ/B'!T7=!DEUZ!; EAOC '+FC/KPXSJD[1,9,*=:QXNF8?%V&K0K-L[
M<Z]V.Z*C(=05- LV-^--@.$ W-=1D %YC;'@/Y#&) JH_!"L-O!A*Q./\)O.
MS&Q9Y);Q/?]ZGS01,C6JEM[T=Z3BQ:V8PL0+4*=5D6OT"%9(BA*/_44<)%*6
MK1 L!BF-F.8*E A2/\U09#,ZR)!U$"TQ8 P" ?HJCI*D88:RD3P+ PP8*9KO
M1[J[.$@EUR@F!E0+3L194#"2?OAR2>F269@G7&D.0\C (2AT(X#)1%<A%<\B
MKQO7'V \L*\_7:1<Y?,,,;!2"/!>B\*])OA:.0()!^[S46B#+;OQ[-D.G9(]
MF7GA(C7/\9;=?%NQ'AXA2<H%W_3*1FC]2?,&G-(&ZDD%T[Z159C><C.Q]5I5
M\A<DC.+9M)7;KHG>.>VB=ZSHG:,N>N=.,/K^:Q3=?["-R4D7U9ST+NAFI\C>
MAU!L57AA==C-JF($-56"K-!446SZ4A/U@+4/B\\0Z]8%#4Q=(9,F2-(J2!1S
M%L",6!AA?2$L@E0(S@$) 7O9Z-ZQKOCP%=@KF71<9TH5!MF[I9(9*"=%S>F:
MI,72*/3"W#2KM5[( W?L-T#@5'.:1X5I2T-,F91\3IRADHNAE!.N#^HG>8"R
M H672P$I4&^6&1J/TY1ZI(H)9*Y2>CHR>5<4H9JG1%B9HER12:I\"#M[/LU1
MH["\W+:EA-#5!2TH%74UFA%6Y!4[51U8T-_\O':HMM'JOP,T(:IUY7!@H[Z?
M,C1 ;0PC:QQ!J4Y^4BB127IF=:]D"@Q53$OEU_*2TQL97*/@'8*@:(6)V+E5
M*VFL:YVEMMGR82+6<D<AMO22!9)^QH W1Y7ZQ0B<1(&*#[%I8[1G,E&+Q/^N
MESQ:J@7@=-4BJ_EOO!34$E5%5IWX!<OQ,354 X6<?=0^#56]!C#Z4U<8S%2Z
M,X@A2<K8J'?EUL(#S>]9(CE*7<983I2(AC("2 R\ #QE^I)@')*?@.P-BXRN
ML/ ,E@C547]"Y9&!@LM70AM\Z:#)YH$UU+.$PNNOHFB"0CM:T #(239*2'I*
M]?)ISFD6T]6C;4R:[A39&W1JK2M0YZ_;;+%.KE>/D[ >AF;Q!-UB] (:Y!<J
M9H%BK*3/)$)/)(K5<U=?7ETQ]UI9_DC9&Y/#4YLD'10:,=ULR:B2S^9RR>F1
M%WZ+LT4*1(X<G*AV@RRZU-[?PAL<&:; I(]I _"HD+/J;JS-T&KF68K5.?*"
MSX44N#SB A@C-1).%9E&_ DE&J,0 4"YCL8^\2_#HS<@@Z/<DDLF" [B(.61
M=<D9,!ZX;&-JBI;HW/.\W;%*.ZG$9Q3V8''6E.H-): <Y"C9!C&I+9'P/UCJ
M#FT&#U3IKJ4"_)V?)_9 @U,1OT<J!H'\@ ]8$[:E!W4?FM:GZ-JN*M,;](H^
M8M"0QB"'P!WL'W/54S+2%8^VXOI_RZ[>2^WZ)\W >-R!A;-<]9(;=AV*SZ'S
M#N2!?"%]KOW>4S9!D\/N.4>GAV?]DY/3 QCVH*^\R<DB\+F>6E09Z:AI)'Z5
M.M&B^!)-1?]PT!3,4-D1,7QV[Z]\UBX84-!1],2N%7L+LL:)>\;M=L0F*^&<
M>EV_!'>13W?HG >JD@G7%\38(OY$;142BZG&,HTC]B^0B$GQ^L@^L5U.H!U*
M96 7(=AQU9W:B0X*$>N"0DH%H &YKDK^$F.7M\9Q;><3?E]'%TB=YB 20>T(
ME-\0_>'.A;X-&$'V(?2I#^X%5^&D_COD=:"D7K13?T%<^Q!>2Q0/36#BQ#E5
M=&F3ZX)6'8Y>.E:] I-\H7B+=!"=#3#>D=ZME5*]5^VKL2;R1E70OM!M?S&Z
M$"-FT#?"(#-M)]J @JT2:<X+1C%1.>%.OMDY_'MK>B^)=7)!'N:X\):%JZRD
M%VWC+8=0@BH>I>S0?CE@2H2,ELQ.)"A$5*H>N*8WEJ[(4F60<;&<#;!=CPP(
MVL1*UMR2]=784?ZQX+)!V/:(++G&OZ^B(CP=/6)'+AB_OLY:Y2KXW%L&-JNB
M"Q)EW0/VSY7LZ5$_I K\+%M0$ZB7)[Q)_,)4PM>E9M(90)%^"F%=VO;&OMY2
M 4/55&;@BCS'-5AV9&]WZ "3O7>9%!3MH!"^(W,[AV_G*1G.QMS?HR"/-8A5
M-6K2J2:'GLX0-051.(4[R8->,+"G,,T%!\F("Q#46*;\TXMCB@JKMA,=N/W!
M$?Q[3.7))MRIBH;A7 8JWX5Z#/K0C&\!8.F<JZ)=2&ZP/#KN9.PM?*2_.D?C
M4-!0QE%$D/&2&6[Y=SF*,R]>JBV_HBWWVTISUL2*O.IB1:Q8D>,N5J2+%3%,
M3_&Z3LA_ I2/"K&(<EY+P1M4B0I9H:9/=!(?<)Z&FMMM91A/="<;&[I*V4]:
MXW.5S4O%DL^P5HWJS[%TYE*F9:'JTDJR=76G77B6!A!C/QYG<S3"CBFDG -@
M\&5,CG5U["R^IZ)M%AA]X 6-<U 6,":_IBZ%S,,+THMQA6R$QK "L\XX3U+6
MW5^#0%>19<N8;1%CD8O$*I6[R@DXG-?EL:QEY[^.O0#S!K@_G//O+(JSN0H-
MI_!RT)"QRHC*5L71!7XYV2=(<55Z5A%5$5H817OS-6@PIX"M?ZO6_HNSUZ<4
MXZEWS=W?"!R6EQ#DTHC"S5\[>X-]X5UA3#>?ZT+]HJJ4<]!Z@T*]IS'#L^*!
M2C,D^S#'$,[&FD-E%N9=]#"YFKX3Y2'+Q?F-M=6D+^3A[3XW)S;K<XT\CG$:
MJ4>61=,&IUB8 3\KB5E_(S@-0"4=6-8"7.Z-SYZ+;$&IOC'ZW/$@8+-'Q<WF
M.12X[)&I<V.%FBDC 1WD;Y$73VS(UF5OK0(VH=QQ<0WZ4%TKD<8KUMJZH6#R
MO7,JO",QYWZ*JD5,Y8E4R@HFH8=9P/G]X3+O%[UA^FSE,-7&^7NXP[_M%[)1
M5/2(HB+*'"(HU&1I\FO<4G*<"]H3J5A+'0K%L,PK@15WK^WBA;50O5&V;]<M
MW!5[;PM+#9=6MH4V@Q?BY<XQKPBP\</_:>H[H2H:4Q9%%DQ]ZOR(,2_O]BTD
MHOOC 3K0RH3QTBVP13=MN8C&,%NYUQ60'4IGH+IIC@8GN05,2JI2'KO$]1T3
M3UD,;S8K='+XSF'>I3\',N&%,LJ28)EW--_"+.6:1'$T<2OCC4[ TDRNWW,'
MKZQ0!(4D3HWMR4N%9T4;] ^5<7[U>V7_GRDM7/5"NBK?D0@-YYP9:QG-:-;*
M8<)K%XQN2.I7@^%O:AW\$D/*/$E$.]#&>W[F'R%U"@"A4;/A&F"+'-@<)YG'
MXZY=G0)$H5Q#09HT+E2*,^0@9PQ<338V%YK<-ZOF/8[HJJ8[-#H&W'H!3T1M
MZH<]T-N6=F"RY2:A-+PZP<ZU?=/:OZO;%.=!I(?.N6D,0RTC&6R>%69M:B!L
M $4=!:D@PQL"AB?02DF9B*KI!&4" "S" ]!=@7?2DTGD!*BL>)0QNB2,(8.I
MBCWUU6'KN!VL&4$0\6.=KJGS4#'P\G%B(1_;]'G6F3XMT^=)9_K\<72^&[OG
MRN.MPPM]C_S)7UYX_]/KG[TP(M%=RF(77SY\>OOAXORCN/SZ^>W?__;YX[OW
M7QXJ[+9-XM;70F-/+AU;:HW'V5^8[)%7(]!UMHK!3"1C_%<62F=PQBV @ O\
M0KMZ6!GR*8NM=1C!YS*60;# Q)7PZB\O>B_H,T9QZ,];[_;&GZ0S?+3WTZ;T
M/(VWG^9:QB0_:DC"%*\=Q=+&@'O>(H'=Z[]> +*DD^UGJ3TKM4-U2C^_N:^1
M[^S\7R,"G)V<GN48D$[N;-EWNDZT$1&OV_0?+N'HW,PB-"!_"[%ZGZH66$-F
MD)98M?U,68UJP[.M%F%U+*9*C29(4^L/*.;RWV\+Y*UX(#^G,?X'[^4M24TM
M5FUV"3M:T]&:.SK_)T!J;D%I=!50#!5$ Z\W)P6:&A!?2Q4!&2>JP"[6=HWB
MA$SXW27O+GEWR1_CDGM!L-T=MR[XNJO-5;&OXBA;'#Z3&_Y$M_)XFO!O1OX4
MN9KK8T(-I[E++FNB:G&R)3S. IG7,'[_5E<7L8L.<ND5[@JC16 LI-"D5GM"
MMY7%<AHSZ8*,2A9F[&488>D\#'Q((F5V1OEUHEV+%/J!K@ N)A/=H!A]+75)
M-S6N[9>,V*1,UT7Y;U4Y%33DJOL%^R@8A^/"1W2L8)Y@R>0-0TPX4Y_KI.]Y
M^Q4#//EO%P7O,7;5(0^IZ^R-]K5K%XM)&M-YOH^]L2I*0#NEA*[KZ!N7(\BP
M(CJ6D(C)ZD[]UG6/78";#_B),2LXZ94T]>KV)C2B\#+ ;@^X3*&\!DU_BZ%5
M]_CY(C,-BBOUH7-\ '!3Q67LE&Y01OLZX"-:VM"B6$ ; C@_ZUI:3<5(8Y50
MUF=O G^49QK3R(P/77@CP*!]RZ9OYG%6XXG+\1KD7* &%"N0AH-[$'-<&A#=
M"]BQWM+U3%43O4FX:FBLLAH,>ZH],;_ME-\N1 V9PV@":![!P!-2E1+!@M-(
M!M$-%RE1Z:C)2E/9BO-8[:%:L)=-WTR\'-K]N#">'/WKH?/>,_!10J^NI4I3
M(-DAPJ'(!97L*=.+<M\G%?%$8?:L;B<SU-R].I1%#"D<4NZ;REM58 C/6'75
MLE:'16:C*(4#I-L $#Y\!#;P\/'":N)_4-5/40,F0'5".5]>:T:"1;U40XR:
M<V;TI&3JK8\[#U015HOW^I.&9^=P+3AA%NTY@9Q<P;T/HU487S\67K>*&(?X
MKH4X*SE\0?-0=*#F!8<.P\]",T2D";M 0<>))8?9<%V<LJT)^/SXYTA%YWX(
MQX<N9@['SH471,YYD$;B\M\9[ B..?/A\@UZ/=<9HLO_?>"\!5D'MOQ%8J"7
M><-UWIX[9T?#WLFS0N-SJNQ4< *X3-ZY?7S_R.V=G+EG9V>V[:U,$:O% [1H
M1>P&B#>VL,,:"<XK]_C5P#TICH?V.W%>R;5VCMVC5Z?NL)"=76?L>XPC>])>
MBS8$##VV+^Z^3N.>C#V-!I>"'>@%^L,M*T_9=L-ZY OE-<_M$K4A#_T\Y*%^
MG#)D46%5FSX(Y%1_99\)?OTC40#K5./1&PQPV-9\F6NCSN?_ET1)=FXO:@TX
M!S<217>$0C#)=ZP7TK>Q&]XVL(830T3YRXO!BTWA7C-=710 4V"<Y[R\X)K5
MU0Q;6/#.;_>GY[#)_$S?/H?M/HLSK?*<@H\7J-=7K"9!*U%ETY)L\6:OOP\\
M)EL48Y[;#ZZ?>/<#L_L?WS*:H&_'(N^-!1H)AA>_"3>DHN;'/VW%YNR4,HZ?
MWX"[T40:?OZ;M0>_X<%NB(2W>[!;7[>^Y[B^34D;Z!) CM$]%TY0GXCB7YSX
M:K0WZ!VY@^$K=W!\O+^>_)$7^%:TSR@L@U<__3 =I$JCVY#!MRKGZ^/'M\Q=
MAH:[5.FAUJQ^JC_@\E-U=+[^*-4K9Z57R"7PXDW_V#T]/G&'O:/&!6T]U4/O
MX0?/]=798>]LY9'4+;0B1#[2Y@^>[KEMM_1= 7@;;LS)Z>'9V6V@_R.$_\^9
MG\K[I/:UE(!M=9M3 Y-[YVY%Z]&UP$3^J(;(KSK<34]T,\*W[78'+E;&Z_=K
M">"ZI>WPMGJ'IX/-MO33@^RI0NL>";8;K.-A -+A;M.V^L/#P<DM</>QA?*#
MWF$?_1T56JV_9BL4#O>+0P45QG4T_)V.[:,5H&_OO?$>?U9!@/=\B.L??$",
MZA;3+>8A%O,HHMU:FE'5Z&N-Q6NLW7^?97'LS6E]%X?.Y4SZWV9EG7Q36_=*
M47V=.7K30]UFG+6*2:WU>M.5/"$(W)<A8$/X;>)7VE705>3"YX(SM]WX3T]^
MYQV]J#6#;'?9=U[HWI"!8JAC$$2T@#^P$V 8/>&#W1@S6XG6W>Z[W7>[[W9_
MZ]T_:57PG7]P'H8T_WL_";&/2'>BW>Z[W7>[[W;_O';?%N7L<H:EUMEZ&?M+
MKSO;;O?=[KO==[M_;KM_TIK97[%!B%0FQG3F^=V)=KOO=M_MOMO]<]M]6S2S
MCS)B4^.%M_@63:?=V7:[[W;?[;[;_7/;_6YJ9IN%7)^K"JU66=6POJRRJ;;J
M[)U0';-K?Y)AFT0-P57'_ ,!K<VQ2H\487M?H88KH@KO:2==9LJNXUIMF-K:
MB+0?*GY\AZ6NUA7BLOHI?<D">:![*MD]H'06]S%F<5?;9U&AIOK*'VIV>W)L
MY:3^:_=R*DQN0ZU0#:I:"VK=GIM*=MDENLHEO+8^KT)]]E4%TU=R*-ABE0NM
M+5]>K"OC<PD9OQ!0O^HRK*@X7AX9&QMR)<?:GH"ZDBX]PN6,:BH EEH?8@?8
M(-"%,I-JKT)[PIJ1K+*[NM<=#I;&/C4&SK.8J&"NJ3Y,-3*Y_G'*W>)7;$S7
MC_7BP.=RR-%XG%&-8>S2C;_U7_4HGR&=<3H#5M]U3/\G6D1-BTS5,=<TU<;O
M\$6S>5A-BNV HQBKNE)C3-/EL@R<TJ+EOU$PX)K2U*>2%O&R/]"],:E0(]7O
MQ1*A@Q["CTKZ4N%@54<8?QKV#JR?\%T_FCA6<ZNFC1V6\;"&.-Y3#;T"T4!)
MK$PV\+M"-;W5][*6!A<;(.B+6FY?4+C M5G3ZZ_TH'*E?_PV8]EENT@SEFI5
M+=^Y<BQ)EQI[=^R?4J7O#0KJPBEB,9#\I6J_(RI:6KA1U+.HA@#M(DCHVJL2
M] FK#71]+>#@9>=JKT1<_(1.NERS%RM'<=EM$H"H5O7XWQDH)[5UN'<1%L4J
MZ!4Z)'XM]J?@?QY ./AQ":"N*.EZ^C%<*Q*4WZNG=^NG^J+*MO]"?0E.W)/C
M@7MZ>M)XPPH\BVKAPR.@!H,,A1>7.Q#GA7R<O1>J6_.+?9<9YVC?.7/[O:%[
M/'A5TW:L,$&IF;(N^6[*P%<78/6'/G3^@']5+F.>QXB$$Y^"D_>N<.2YU"3&
M>ID7BX6UL8I[_4!81KZ^I'C>$Z&VKKAUQ5?N@(:= P\?Z4X . +7,^=^%TV%
M]K>9Y=!IV!_N(O#\>7./CJTVPTT$J(N=@@.@+$)+$3Z 4!;ZV$3"QUI; $N'
MCFG).TYU+V<VNR"[B,FFPI]@%Q=9G&0U?<(OLP5*9,[Y52Q5AXLRD&/);'2!
MN3RX$YC1+0BK1(#G@-=TJJ8M1+XL^#B5U*%Z,' '@Z/J%;(Q>X^;A/IS.%0?
MIJ86*7X4Z[E UDVR^=RTV\BEM'ULP(!MJ.?4:*/8? $;4L]U.XNI,QCVW"%<
M,[J6JH>"6I:9[2V+@M36(>_&;56*UW"".8NUX)T?JP5?)VO6J>'K%<J'TA5O
MQ0XJE'I[#?'HP=@!XD LKU#20/*BBE("%AB5"% -?@K'J-\0)C47I#\Z=D^.
M3C=C)7@)^V[_],0].ATTO<)*ZA8,@INH3.$IMM&J[C0)O\<L@'N' *W*2QE1
M>:+*9\4WLB#UX5YR8 [0"WP;X81KP/U3OY0I\XWJS(?.YQ#(Z<P+IBN>4MT:
M%@NXL(352+] @_,CM>88MY88'E8R1^N!46E'<N8R!5W5_D)U1]*]30JMZVO@
MEQ]Y6L 86DB.-?48 PR&6J-4]@0,88%4)U@:WM/<'BH(RFO-@6FL"#G8OQ;;
M7S0 GCXD#:L#!#@^=MZCCG\\@.<N4^ GP$R0=/QW% .>?/IOI!/'Q^LUZ1J#
MN#:Y:</;@B1=V^AV0=W<=2-XHDFOG7]Z089_DQV.R$+5XE=T\0QRH]^M.L.'
M43R'X]BVE1J7T-RT7+RU;;WAU\[7Y0*V>AY[(_3,8#UY!LJG"'=_=EJP4.K7
MR#I:ZDIO@RB6WK>#D03^#:,M",2W LN6AN+<PEI<FKV%.OOJ75JE[37\R!PK
M#[,."S0O\B=_>>']3V_0RPV_=]?\8?3F\OW'CQ\^_55<OG_[CR\?OO[WWSY_
M?/?^RV6A6/?]M;?H>G+4[02%5[&((]*(LD2)W@F*HMHZ"T0:3:= IK,%?G_B
MGIV>EM32,8L!"8D!P#6N_2A#QJ&ZY@ [&(-TYOE&>KX$01#9WZ7JE*2XE"N,
M*;<\;;_G#E[U7)1HC<8)7R^R> RJGRPN01F%&X8:'+D]-53]%@1\)^-K.2&C
M#S5#0])5VPQM[6*8VS5LF#2J:1S-'9!C).D;^/]H"EQ:$/N3:'D/2;^J-#VK
M@-YNF&BI1=QZ:U'0R'S4.LRY$]L-N6,@24VXUOQWD8#6%JBN@7_.9(C-OTB4
MT"K2?_['J\&@][IAF_1K_S4W!"O,3&W$YM(+=1]!:A^FK&O5_F&N,"T'J=T6
MXO8D"NG_VH5!'T!$A8M$?X($,09!(T(Q;2+5U]S)"?7%A'J_(]K'#G4$1*T>
MENTHV7$%NN*V^J>OA5&1U8(+9X)F0],IS]*Z50=*SZB"@*.';: I[:&.C[<'
M[.IH.8GH L!]3OA"D[JA4)/:F=+?I7M%5GYO;K6";:"YQO?H75V!\H#C&4._
MV(30&(_;*B)')&T5#6(Z6=[T))*)P/:9RJJRLJ,E6>SK%USL:%E+P#/NU<>]
M.W,[&NI55I-0$<7:]^G7] PMMYE[5FWV[N[F_2G%V OQW+W)-1[4,LH0Z0%M
M;F924=%FA"-_-9S*U!NG=2R4SKB)2E-?7#1240M@L0ZQ<?B<^9B^M=3M$11G
M;.X*4\(M2VD1Q-_Q^E2XOEOE'84&R,A<<!:/G?.(E',X(1['*/XQ6REC24XG
MY-@6 3!(?0YPT3V1&VG(H?-[J4$M/L#=9HEODR$#.&U&QO!U5( .1??_G!2D
MF7QA8[1]:+]C448QXA>** $9](4:@(@+VDW;P'4>C'_>W:+K D-O.# 4%#_E
M]B4C8:?M/<RB6]!L\1XR89H"%^^DK]?)7??URMLM_CJ*?^89/QMYYS<RDN6_
M(!W\K.C@1C'A#]OU[,ZAPXW?>.M1#H81,"!D+W[X?$&S&G'.D>_?'W!NWSKN
MMMU5UT"%+[[I=XI.5"6A_(TDDWLYTSMO\O>)5#*U@_ST5/O#W4/JKO-E=\K=
M*3>X6S8/I[ 08M-_ '%0ZMOFE4W^V6+1&EWOIA?IKI_FG:#LSB>5Y\T(;Q&&
M;=H/5MH*]E>W,.CZI-UZ#[?ND_;H*V\#]'\PQU(=WA/MZ]A[NN>VW=(?L[/@
M+8P?:ZATJ7U@WA9P4$^D=S,]>1<[JZFV:(^=+FV!I@/+BCO_2.#88!U/M7/'
M>MKS]<-?F>S4=)Q^"*K3[U%$T*Z@PF&OMP,WHP-*J\C%/9=5*$4>[&AQA&=0
MR("UZOO-3ZDF%^H00,Y04B%_^S2YRM90J6@<$&#B,-9DKFR9!HDA$S4IC6Q]
M:'YM3>[*W:4O<@G9.TYAM%(O-D]?5*ZSC5(8[1E,RM]F&9ZK$Q>U2X;10]=J
M4*=VSSF*=HX=)ZG<?YY=31;*CZ6PK2<&@_LG!HV9:G@(-.-C9JK9=0>Z3#6/
M<=V0K$?+5%-XT8 U#Y:I1LMH!/L#9:K1(G2VVJJ:+^5B"_=7^*4I?^A'"[^L
M%HWNIR;,+:/:7B@E] <*Q]QZYEPAWO0?%,(V$+2:<\MI2CW,": L_ >$#86O
M6ZVEG(5Y4L3KFAHBNQ]25Q,'N"XCM-]EA%H9H:^ZC-#'R0A]L*#3T9L_E0C5
MDCC?5@3.;A4G5V]^:AJRCH \<$SD+7?;%"M9'V"[*DAR&]C\6/Q+>T_!2DW1
MP;SE0-[N"![J(C@$\'+$L/KV,8_AX4.+:Y2+$842UX41CRI*PH-CR^;!;3^(
M+9],*4A&BYSO/YN;^6"PKH3U=$#M$/@IP;I#X Z!GS2L'QR![S? 9[M8GEK#
M[K;AX+=5RLMNYEV.&C=NYZ<;_CH\/=QN];L2<MS!_O$6WH5[_W"X]QU0Y/ND
MPB6?]F-$A1LO_XY$WQT=;M[6J -*%Y_9Q6?>)CZS"V^X3[)>BA-]J.@&E0^Z
M0?#H9O$,/Q*:*>ZSL\0689EBZZX2]Q>2N0/AF#HL13Q(*&8U'*4C00]%@@:/
M1(*PPN86P8?W&1&Z*WT+=J)GP>/W*\"%BL?K5=!,EIYD",VZ$+E!%R)GA<B=
M=2%R.X6]C]B%H7\_71C>O;]\^^7#Q=</GS^)S[^#/'3QX>OY1^?RZ^>W?V])
MT-[.+QJ.X:_ F6(OZ"#^J,TO["+K$PG*G+_@CG+8[2V&1T$QC.:F8S#<TGG"
M[4]CZFCA@W"A:B?[(6AWP/NY_#)* Z-EX-TDIKKZN[^^_:BZQ=E3^4D^VT1@
M,6=.%\0.Q# \=T'P0<! 60R43=+QC%3DH$ZSQ6I<1WH@HV#9<Q+ 4+<=21FJ
M)@0@.TW] -9!ZBQIDN_?DI!X0T6TM38>R&LLXKZ(HVL_T?WMS";;@!OMP?)'
MWL.;SUDL5 UQTGPBP.0KZIG,';(!+:<9X-8XI0+MX]2_]M.EU6[7PF2NN!Y&
M-_@HVA.XAOD(<#Z^\D*\0DHCRV\<S(^MRV<1W["QLCIQ@76J28[M'4']H!Z-
M_0$6/+!ZP[C.2ZP[T.MCTIYSC:)JW@'<-3?I%WBU5WJ51R?##G8=H9Z6<(7L
M<MBOZ6Z6YVQX\8*N/6JKE]Q8AK,<\0X#KN3=&V!-_2.W=W+FGIV=V4F1=N8D
MM^8A\Y?=S-G+6QCT3TP+@\?"H">7_D 9IZ(F2;78 MOI:J$_6BWTAZ> *&>
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MLDH$CH$\\9#9PI3\<\OQ1D;A8ELY*02J"F8 FDO T4*,BKG@4J!0QAB?/R=
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M_H.IC-T!/'*,V.\Z#IW(\6\Z#18(XL@/E8M?IC<8JDTED9 C?I17WGAI&;Z
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M. ?&70 +\1:SQ*K-J):O1<A?_3?D%AZ\/@?Z=S#Q51>N<U/SEJI5*\%2L/A
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M.E6[GL$X\ B>!5P#^*L"PH1^I(/TXL#GAP7,!G^5@>+B#?06"Z!Z#):1A_N
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M<\E ^13A[C%1RGKM9_T>_H;@_/5G@$P-C&+I?3L82;B^,-R"8'PKN&R)9K8
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MTREP) Q>W7>-I3<$R7?L<Q#)34@^Z^\H3R'0C@[/?D*6<7;XZB=G3YL3F0&
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MUE2'&M6IBB8>M,;S745M5)2T4<#R8FY2R37%T0AT0.4B3NK@RFLRAY;'LE.
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MN(<I^>5E)"J"UVJ3A>/CSQ$+T:T8TBU+.266<AH;59QL\?B&2F0ZBV0/^UY
M!O6A?)4.GP$TH3%!S\AS;+8 -H2='IQ@4N1DQJ6<YF(NNXC28O*3O1>])JI5
MT6]"<V7JOTCL49F#WL1HJT'&EMDW>TP9Z@,=G .A@H,^6,^F+&"(_&E/[9FW
MYDBE5P#.T#1)J,Q0^G4L"RBY4MVWG71LC@#N02Q?S-;0LABE+N4G38!]3WC[
M1]B\9\S(AZOZ)J= T(2O6OH8M8\"6H%CI' $!)%\8 *D^3I>:KL.M*":I@5Y
M--X>4[O&U8/PEC1 6.?7P72D.SS/XBL#"2X=$R$]CK+.]N*K!BDG8CO,%YF
MY>] OZJ&%ICK'02=,GY")3!VXMIV1)R%(^/^(6'\)[H3*DYA>)Z Z]/O6F#N
M!/\YR9/5?)Q>?HE(%@WH?7Y1^@M@<581  W9]<ABE.- >S\@$"^]41 !6$8(
MUI%U^8W(G?<T/0%^N.DJS"=AV3TL"M='(]OC%Z<C1V)%@,NT;NW1+0E,,DJ(
MV#VJT3W2%6%,;ZZL)T:)P4R@.^(P1<9E<$PM%(O',"/9._9+L8P[>SJ"J_*6
M\"E'B3L+ L3=&:7%+]0: E+&WX#D<=%OTOU2_\7IF2X/,YM.Y 4\2AJ$/.BR
MH;:&_3*\5HS-BL,% ]8_WLQ'"2OJF@;#9+8=[GS!'N W&:!FY_>IL'W"(%R7
M64*6/O+P-:PUR2'=F<AOAC0Z$.&.Q1^%U93.%=R0<J!;D<JO 41C:U;2UHQ\
MX6?^T9<6!P<FEQK-E@@:,P4> I;&B!13_=Q8=,/XG0I?(P27I:-20T<E@TPO
M/#$L11N16S+BXS?8W%&6$\&X5R#9'(%:F3\E7'EDK8*>>/M2X]2:,CAJ,2 Y
MOY/V:B?HA:"5=RT;&-?  ]11$=X$3I7!@=?H8!BRFY!Z#Z'PS9C_"Y84=R7$
MY20Y!8H4_6&7PM2)$R39%??"4^^8C82W([P/#<1E7!#T Q5TD>S TT&YF^BS
M<1 =6)2Q[)+0)#JJV$G$J&3TB&AFF-S#_+-4!'!6X!HZ@4AX(Q+=\(,;:?2/
M L^+XI$Y,B=15'?8C93HWS\'>5FAJ*22%Y7(127EO*@D+RIAPO2=*)$[)631
M^-XPSC@356H)^!74T3='..V4I0SE6:B /$&(Q6PVJ=A/?I0B06$X&5,7J%=#
MH];LJ0<^ >A&S+M%MC?!BH81M=\AV, L_,C]IN#*A'4:FE$:BJ_VQ:P;$>,(
MC&$IUL$L/[]&T=/O>=C%OP#(0 _6$TJ.1F.#+.8Q@>I:[!*>.+9*::>K76KH
MNUKX#MK<$I7P$MDUA9Z/'3+DG^OU\D1WDL1$8H3)',S,O*7'\A#N$L$1%E0(
M51NSN*"2(2Z'[&T"/1;8M"PX";-V%J=&1%Q2C!U6&/M2SA^:$^HY$^\.---\
M9'XNV;[(X#3 4A<#G.7,4F*T/=9-S5CP!6:ZR![S+;)T$D(("!M]P>* /T)Y
M(C5;GNBKA:4>@8L:CL+&GV]JG:&"A^\71[!2-=5"?UJNCO!"TRNS$2M73'NU
MDUJ";Z6*$;S!4%X,BHYX$@"=.)A?:!W\,J'2,C1R+252!(X:).RBR'A*!!DO
M4FJW&E(70]_JSD0N$O:IA[L:V,-Y4@<VK?#^IP7(?=S4\2#42WT^NAS!^G"+
M9WL$BXQZ/'XGY*U/[:/1#(IZ#<S<9 @91FD5.@V_ "J!A+E$[M5.J!O  JA!
MQ$08RF!"XL4@6<P]O*-CA62)- J[BD0RA4U$'AE*2KGK<^6:1?&+:AZ_D.,7
MAWG\8O]Y^A'G&A]N9Z[Q1>-][4+Y7.MT&M?M?'+Q(Y<:WM)W&CAZED?'_5NG
MSFZ<MG_C?(\F[KGQ(RI()KH+*4.LF(7LZ13SJ>U?ND$WH%%%-(&UC+!,Y#/1
M!Q .^E]]/'FKG(^H1W)Q<:51_32RU=K(LS6U3E=&'V.9^G.]KQY1MH^V(]N-
M'U>-ZTXNU8_':&^96 ?=4+ZO@$+]J7G9AB9R^L\SZK. E\-V7BYJ:JE0*J&D
MTW\4625:GW>5S8CN0"$F%+<O^"+4@]%/^[4Y8=<NB&'K4ZIW6/G/=],;3L?M
M,?W/_W?JV'=TDU=UC?FH!ID0I)6<%.6U=GQJ$(9H36>,$ "A" K6E"@.@:X
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M='FDVV61;G#P4-K4C-*FOH3G\UZP.GL)[_]ZI61L[&:]=0P2(;2X,"B%[0=
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M ^J24F>H2[E>W,VB 7DHV=Y=((=4*4YT!,AUW>F8S9OCBD+H3<0Q3$'7HAK
M57W-K,S!:RU<#HZQD]]H C:\@&YP=)P^R&<HT2_VJ71C32,UF*A&AU&+(_/W
ME,$U6@CEKKO*'2+7NSCW<T35(%UU=TJ5*J@+AM.$%AW@3'R<6F(6"$_C2+."
MPU0@NLO0XR63D-R#R>;KI<G4F0 @!=5);%DZH@0I@ $1K),2A6T(U1S0!A]
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M?3T???NU+\HY2?;87E0/-D._-(-"^,<->"?1>"N.X8E6K.YO9D#N>3AP2>_
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M.?^27IUDH\CI^1EN?D;J8QQ2[EL^0=,\7TR^F">]F-B"@%-,B)7\A%@I6T%
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MSG8Q=S^)E3P;<* L![A=&2MIA4I%*QXM]LQS.*>U3FQCP;FC:DD[.MKV/-)
MX9ROE%F';$OG9NPQO0/ZYY]O[9L'NV]VCC[,K+O:HMSI-F[@U2%6?)S/A<F7
MZ#&L4S"5D8G7Z/I=\]'90FC9N69'MGZU B-TCE<3H:WUU.9LD,H&FW=7CDZ.
MM')IL<NW-AOLJB3P"454]FHQ"_-5":S;Q#QK<D79W:=QNW_Y;^OT2_>)593Y
M.\LKRM9DHU*08J'LTR/$<$&A83I>.#\=^TYW#'"J67J):B*K-S1=\+7]VK-_
M1X<W#X.CCOG/K_'EER];BQHFCR@"'KDSO:'AZ'<6XQ,/JPITM@\H4*%N'/T+
M7SZ$-!XEE(%)EY7(O65O"X9[9,!6VO.0QO'Q1D,:1XM%I&G5;<LB2*WOE 6#
M02UA^2C?%D_[C8^CS_:B@IP=5G<EF'J+Y8FZ&#U_V_A1:?C7\XN*I$IM,@=L
M662K1UJQ4-)*QSGB];)ZXF0)",15PQ/5E<RT(#P!:L,/3WSOG!3_(8-NQ1YL
MZWK=5 QBPC>I=F>\WB^/0ZSD?\9PQ_8U2KE<UJJK:I0UZ/P<E<SAMI3,OM@/
M>^SR[-5BDDK<%MT/YPR'*]&-O_I5G38']I?!=67+3M=*OKJ__-Q77Y-7SN3N
M+^8=NN>V<TTF4Z<WU%W2ZDL0JV!#^#4]/[Z-;Q[NK.,O[6;G:]/:**[\NMHC
M,)7=Z%SA+9_,@HCP8AKOCVV_MZ60Y<+*,WL7%AC(SM@U&4'#\Y7N>+,STO5\
MQQM9OU_].BF6?M[W[Q?-VMX\?Y_:CF/? >XJJ_D%VWALNJ[MS!"4\5&K:=)(
MN%WN+A]6M9/*_E:T967O%!CD-0O)A/YI]5'9-%UW"B#P==O%+I2(=O_YN5M^
M_ZUV]F"1_='N"5X<WQFH>[O?)PY8!SW8UO-W",J%?%!CUHLWCO&W6[U2K&I'
MU8T5&V7M-\MN^ >!(9!Y/S#T;[TR*3D?&Z>513-J'STP)(I3^KY;\&<'A5:K
M2HAAC1T5IY2JAUKUZ% K%U<4D[Q Y7%880M]?VLHRVW4I^0QK[U;S$(7#C@:
M_@]&&-SJ([CU ;O*,7O4$X$_U"PC_ OIDU?4<K2-^9K7WF@*A]BX[V&3V37U
M:AK4S(1X&;L\\=(\/ODR,^X?+H^KBUJW=Q(W@QLRZ-N&G2[4@:GJ;K/#5I97
M5[L]V5VU81T7H==YH<[;T"67'W#Z 6_^3JL42S!B;*,''*L$BYM2@C<FU657
M)Q\;,_?#/R=GP[UW_C%!@%- BV_54S(P+1A*!+& "3+%$_9KMR@PL=-]UO1V
M#PL5K5BJY(4CCW1\A36#%5JA>*(5MG. 2:5PFU):#:JT:LUZO3DK?/NXM7*6
M#<PM#JFKAF4D*ZH_9##9KJ5DW2Q:Z5 [/%[>3<UG%NXI/SS2I;<J/^31B^<5
MO3B,W(%0ZG)I6Q#<#FKU+",F+'=FNKV1[4X=$JK?.1I5W7NC71E:6\.H6BH.
M85L'&*F7RC8M(S9>GY?QK,A _BAP='*;%B*XM?HX)EDJ+VE/N_]2U[=C7]FN
M:U*5'.DK>&@6[8>3JU^WWXU'Q 3/;DGYT2T?D!!WK-9"13^JR[:-_3I\XU)C
M028]O>Z5NIG[<[G6@M698<ME2$<5[>AP,=!)PH6YJI^XY^>8,=M?6J+\-Q/!
MDI+)0J6<!W"#K7X"C!^'QZF-1G8/*GXZ=I39F'JY[3T8YM%D,OR^XZ*I1!5R
MGA%,,<!K$7L$;1*G;9XV&Z:A.FZ&$W846#_12L?'6N%D^9Z#1*F9"Z\_K:/-
MK&%2H"8WIV$DHR6=E5!S3":%2>$)6"1GB_3''\)")QMFH2=+L&1MFL[U&\].
M47$AL=,N*I6"5LB0H%I+]-_@#-^=3<)>- ;[J0Q[-M]UAD2!]N@Q?>8,= D4
M>+NJ[@!R'/5\/#)P]!'5+@X6OWI#XA)@'<Q)H)G"_6SZ(5=,/79?T]-.'P^]
MO7/9ZJQHNA%I OL5CH,7D^3IUTJ';U7TANB_<3([J@IYG'RLE <YGI5&RUL@
MHZ-,))WGITR,2.W8 WGC8LMOU<YL0C=;<_2NV7NK7E+UP\AR:</^*Z%Y]>);
M\)?H7'N91@[1?QUT"54]]&$3I/%*=%F2QV21EI<F;P&VA@?[.(KF$?0,6%3=
MFT*A\L(7Z.Z[^H_:%9M\K[X\?_/I34W]U+QL*YU&_<-EZZ+U_J?Z_KKUE7WB
MU=]=Y\T[Y;+5:;353BL\#_V\>5F[K#=K%])D=/;YLT:]\?FT<:V6BYJ*\SSQ
MU[6V>MW SYZQ48%<N0C#KW!X?-/SIX3[8\)O'HX^D?MOOW]7/WX.&FIV>D6P
MZ^]R.J9/[&7T40B]5B=@33I3>F-'JBMU;^J05I_C?5&5C!(@"'$<[N2?^_#-
M0_]A8)_I'\<_V_]NA2(;'A()#*0466*S]%8-N!-W6SJA1SRH6O5OYW5CW*>6
M<J-=OVY>=9JM2[5UKK:NW]<NF__4\.?:Y9EZ^K7=O&RTVVKKJG&-OV[[FKZ[
MB[MKRS?5;O03HN5O<B=4LTPF2M/J4<U"C0T\[E+A;9T9*/A3\>TK]4YW<8J7
M,[$=M$),2STC(_T.#!=J!W^<CF:,**4"JH^"2K\!2DKMD-[0HM[;8*:^I[[<
M1&4OXR^"CXBWO%:H=:3R5^,KP1H&D\=VP!)2)U/Z?A?CP@1KOC#;H%()'Q!'
M4WMLN@$/$A->(::QH0&JWOL]-5T3A%'C'Q$MFYKJ$-L9Z);Y@,*JT/>Y)B6H
M[JC=J6MB-(G:;%UJ>@50-K9%5^*H8WIM^I^BM)?)>"J^7 ^^[.]6E7=KNF )
MJB/Z5AZ+TA4P LW>%%9!&8 RA#.#%U(WS:/_ :)P@O"V6,N=CL<<SU.->_7<
M*RD3$=T9S<"4'##L8@+4A$=0Q_O.&RK<5(6_ 255=]H;:G@:TG.D@+P^&G'#
ME?I,[B\7J&]3<Q5VA61;\$*5O= D8-0^??EZ/IH"/!=QY%1HD/WOAO9H-#NP
M[V""&V4"US1,W9EI3/(_HURJ[6D795ZC'S=[PUA= NS2!G<&>$=6+&TR\:1!
M\L6*IL"%[>N/X!V!7$GOA85:MLA(SAC@@,'?$RP"=<+\J] .HFNC:FLP5.=&
MVN-*<B[=JYW47 4Y*')4>))AM374#52Y$.L'+\E0X;>V;["]5FM4E06<(^X@
MK.QBC!1SZ[VD3$4PY_9*260<QE<.=E/CN$QI76AO5=^Z/!*$G E_-BUZ=4%D
M8-H=47O6[XH5@M#D?[]B?V_QOPNIT!0F?%19&]3*=<PN0"^1D7VGH18&X45W
MT1/K27B@1FU ^BEZENR>\>B9$T\5UP20*>7R\37(G4F)"^0?$ LH3F3JTP<[
MY)984P(=\9Y)CZ%/721<%KQH1/ 6!A'V7)\R<2^EF_/P:W#KT#O%"Z]"O!R4
MA'40O)T/+.6*"4Z"Z0L^LI+_F2'> 4_P'GDV/H\8P5\2B)@KC;W:";"$0P8F
MU-P@9_F1-5_LH]*9<+!4I'K4:Q3FZ2W>86'Y+QXR5?%:;<W]J8IW2B&LJ'S#
M#NS"9)X"#@T[:2< "".2,E_IMUQHE";&V10^SQHLVD-ZT;J45/@G%WUY\(F9
M+T__5:S>W/AN;=N_XMOZB/#NZ]J]Z4J?:5ZU/N.>;B:&\4+U3 _.A_KA]%>P
M1HA74Z'%E:0&U+.M.#:PCG73Z-KCO^@>^/)N_-5E#+4W+\^E$#M[-_2X:I5"
M4I@=Y8%O4W8&<#]<'S-SFB-BNA-N.^.I0WI5B12\F-CV$IA*^"B(81J,5?@;
M.$>P5?J:GYM=_!DN4VE3JG[)/7%Z '/;G>$O_1P7.RCZ"L6^)<X!I,@]!L>
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M27D<+^"=&)"5_]:-O>3WD)FNQ,8Y^=++J)<@0*IY\&C\%+(@%AD0_+WJ'/.
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M'%/W^Q;&<XA H?--*+9F. P(2#2Q4EO6H.%RQ@\]V3[K-SGKLQSGP"'_",8
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MZ<VO[_WTCM>E7&)A.D9#R\Q4/%2BQ#/$Z^T3V;^LYHX@'D#:=O4'K9L8[Y#
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M"D*1SKTOO)=:^C7TKO7R09:TMM[5L9L>L<#>RLMU)RG43! J^HWV.MV&DC.
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MZOCE27E#6H\N!LRT;8:_H+ 7@K>@X_=>/-P3L5H)WA->HS65M0;CW:5$V\+
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M[P=LVEDR:3I9YG0^;)!YI@%FS)1 W,*-Y"+6J$YNUZ6LSB@LK<LH7"E;;L+
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MU^$XELPA-XULD19(-/,)!'<R$PDA9*0+EOS!-[;Q\(";&?^#\^8<YX#Y0/O
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M'K8''>G!\Q^HPQ*7BX(6!G.SP;I:0'<F:'N&2;%OS:N<;_G1$H=D$B47DF/
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MT%]HT#,BF_WCG%[R YQR$JMD5WK7J]X2;.Q%,X.6]PSV9 )P? \"B,>!--V
M!\%?PO1>>;,7$17A+'H13IFC0B>]FJ3<5$CP\W]^]%.1:MB%_R1@:Z.P6]1#
MTQBJ+YH'J-22?8BL;F>"JY3)GO!><4OP)@A1LQS@1J?-=XEZSL,U8<O5[@(R
MRE/"')VR5N%.#"A RIBK'24GNM& 0!3+X/>5+KW"<F7D0U$97Z]0KFR=<J"I
MB25,_?< /9Q#5+CX072UUZ,V3$"DK,H+/^A:L5K)+5Q'2I@"$]VM(1 7HYQE
M]\52FPBDK$^T^/Y;)81EM13X[53/9FY!S^94MR;'=Z81F( =&YL>*(6(UWBY
M,?DX]Y.37HT/,]*%J7AK#-ZU8T5T8I=#W9L,J)&>*,_/!X7-\T%Y%_F@O!$^
M4.?B T7L<@@?\)IJ.7H?5HX9QDDA 7WIA1"6^ZC<S#FT9S.&/QQ<B5?>XW=5
M0 \*_ YQ(74"^&2X,!2H5A8>5]8(A(7GX3X*M8$>U@:@<&DN0] 473^X<R5T
M3\:6/=8X#<OPL!)?=%##OTU)1^9U/C>ZW3NU[)*82]FKI.-'[50H1V76D>VR
MS92(^Y9;68=^/"J6+:MN6*..W9RH?T(W%H/>$_,=*_UCRG/03."MY(+NKG?S
M@8,OJR03^GMK8+>TX;N0ZJJEJ0Y:="$Y 7/.SC><1OC</(L7NN\'#CTX]%.>
M@=%<[-]A40,:*OCQ&LG,>]:QIA\D%2K >)2PPT=8ISW/&O<%*I.J^+T;VWA
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M3!XJA&*DPA,$8!]V"%F&%:*@3..@;QCE_O^T7O\?8+1GW433]6"XQ(H-99C
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M/BAAYH.8=?)!9,H25L=X:);-HT56 RI[G,-1C5'F]C10PIGO>?.G!_CZF!Q
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MFE'B!">_#XB6 F!]J@*>"R>^H9\.%2IR3W<" [F0-ZYI%.-8%3@ZS9,6B;I
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MEJ.HR%:*GM_0X=*T3^ MX&?[RM%7$"FQ;P+]VM;U:J(KZ.^" .W ZHN@HQ=
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MZ)F!+.% 33M4CV!/=P)'S8C8&#-D"^'<,"N<FX3+N0DBH!F[3K#)*E$%Z!!
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MM<-6#&]"Y)X75T96%+;G]V6+@4MM8V9O@-E;]1YSJX\2V&9!;>Q%QE[DI]B
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M^G!0DO\R; J);5L<(E>T(;PSM\J0DY/D%TFF):AB_QLSY-0G43Y!BACI6%B
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M7C7U1\%7BD:=Z>:@P+9D-+:'%;8S'CGRV3Z(41EV(6+4/I0^;Q&=+BQ%N6/
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M9;2=Q]%7)^;.^B[W4W:Y3U>_#WP/Y8N;"0N#U) ),UM_G6WK@$N0_S!ONFT
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MM:F/N=C]@C/[PM]X;2@\U'3:\$JXO32/"<>?67)T$'G7<(0EX[4\;27TM6\
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M:0+XQ/<HI"&Z6L8&D:11WI;YF05UC%Y3TJUX5Y\_541)!!D;0<JI6X,G*Q1
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M$D=5&/X#YU7;JODSH-8GM7GU[<=X= L&KP5-*O)M4&8YA1@V:GNP?#V/2!(
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M>Q+T9>E?[O3,NH@GP??/56V["416EF8](&UM669*Z#;WGUN4SX4F%WES@;C
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M#9Y]28@6=0[W/#3J S!W/-CV^T]%[-U_N?X\74=J1N1E"ZNBX!ZJ9B2&:$3
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M_&_;SC13VBF2PK?-KTW-W/8,P_.NZ2WCJV!]ON'?6@CHQ7U/R@>Z8K(<W0&
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MZLZE]SQ,6YT+F>P(WY:L03?,.M_BMV0QP6@>L-?0R_O(;(--J3M@R<,%1+L
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M #AC$(HBBBG"^]0;,W3_-0A#,C?(VSF3@A45Z6JBT=P$2DQ4? &. 9+I3"W
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M_+3_T(=_?ODUDD-X3.=N_19]<+-QVQY3=,"&O+2:M.56>4P1^0=!Z@%7![_
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MP]H<"Z;2SRB&1H<9;"=1YU.-RT5G<S:R(Q0H]R.6*#($%(;/D*?6Y9JAP^T
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M!S?_!U!+ 0(4 Q0    ( !*(WE;Q?H=K;QT  -1J 0 1              "
M 0    !C>&%I+3(P,C,P,S,Q+GAS9%!+ 0(4 Q0    ( !*(WE9UW#/LCQL
M $"" 0 5              "  9X=  !C>&%I+3(P,C,P,S,Q7V-A;"YX;6Q0
M2P$"% ,4    "  2B-Y6&3Z[14QB  #-[@8 %0              @ %@.0
M8WAA:2TR,#(S,#,S,5]D968N>&UL4$L! A0#%     @ $HC>5H)+IW?SFP
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M+3$N:'1M4$L! A0#%     @ $HC>5G_=&#-4 P  (@T  !
M ( !LKH! &-X87!P7V5X,C,M,BYH=&U02P$"% ,4    "  2B-Y6HL'L.%/F
M! ""EC  #@              @ $TO@$ 8WAA<'!?<S%A,RYH=&U02P4&
/  D "0 ^ @  LZ0&

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
